Citrus Sinensis ID: 002349
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 933 | 2.2.26 [Sep-21-2011] | |||||||
| Q42371 | 976 | LRR receptor-like serine/ | yes | no | 0.984 | 0.941 | 0.779 | 0.0 | |
| C0LGW6 | 966 | LRR receptor-like serine/ | no | no | 0.975 | 0.942 | 0.607 | 0.0 | |
| Q6XAT2 | 967 | LRR receptor-like serine/ | no | no | 0.973 | 0.938 | 0.605 | 0.0 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.834 | 0.623 | 0.377 | 1e-136 | |
| O49318 | 1124 | Probable leucine-rich rep | no | no | 0.840 | 0.697 | 0.375 | 1e-136 | |
| O49545 | 1003 | Leucine-rich repeat recep | no | no | 0.894 | 0.832 | 0.351 | 1e-134 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.842 | 0.627 | 0.371 | 1e-133 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.822 | 0.696 | 0.384 | 1e-131 | |
| Q9LYN8 | 1192 | Leucine-rich repeat recep | no | no | 0.837 | 0.655 | 0.376 | 1e-129 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.841 | 0.712 | 0.358 | 1e-126 |
| >sp|Q42371|ERECT_ARATH LRR receptor-like serine/threonine-protein kinase ERECTA OS=Arabidopsis thaliana GN=ERECTA PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 1531 bits (3963), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 762/977 (77%), Positives = 844/977 (86%), Gaps = 58/977 (5%)
Query: 8 ILLLVFLFCLSF-GSVDSEDGATLLKIKKSFRDVDNVLYDWTDSPSSDYCVWRGITCDNV 66
I+LL FLFCLS +V SE+GATLL+IKKSF+DV+NVLYDWT SPSSDYCVWRG++C+NV
Sbjct: 7 IVLLGFLFCLSLVATVTSEEGATLLEIKKSFKDVNNVLYDWTTSPSSDYCVWRGVSCENV 66
Query: 67 TFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFN 126
TF V+ALNLS LNLDGEISPA+GDLK L SIDLRGNRLSGQIPDEIGDCSSL++LDLSFN
Sbjct: 67 TFNVVALNLSDLNLDGEISPAIGDLKSLLSIDLRGNRLSGQIPDEIGDCSSLQNLDLSFN 126
Query: 127 ELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKV------------------ 168
EL GDIPFSISKLKQLE LILKNNQLIGPIPSTLSQ+PNLK+
Sbjct: 127 ELSGDIPFSISKLKQLEQLILKNNQLIGPIPSTLSQIPNLKILDLAQNKLSGEIPRLIYW 186
Query: 169 ------FGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYN 222
GLRGNNLVG +SPD+CQL+GLWYFDVRNNSLTGSIP+ IGNCT+FQVLDLSYN
Sbjct: 187 NEVLQYLGLRGNNLVGNISPDLCQLTGLWYFDVRNNSLTGSIPETIGNCTAFQVLDLSYN 246
Query: 223 QLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNL 282
QL+GEIPF+IGFLQ+ATLSLQGNQL+GKIPSVIGLMQALAVLDLS N+LSG IPPILGNL
Sbjct: 247 QLTGEIPFDIGFLQVATLSLQGNQLSGKIPSVIGLMQALAVLDLSGNLLSGSIPPILGNL 306
Query: 283 SYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNH 342
++TEKLYLHSNKLTG IPPELGNM+KLHYLELNDN LTGHIPP LGKLTDLFDLNVANN
Sbjct: 307 TFTEKLYLHSNKLTGSIPPELGNMSKLHYLELNDNHLTGHIPPELGKLTDLFDLNVANND 366
Query: 343 LEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRI 402
LEGPIPD+LSSCTNLNSLNVHGNK +GTIP AFQ+LESMTYLNLS NNI+GPIPVELSRI
Sbjct: 367 LEGPIPDHLSSCTNLNSLNVHGNKFSGTIPRAFQKLESMTYLNLSSNNIKGPIPVELSRI 426
Query: 403 GNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNH 462
GNLDTLD+SNNKI+G IPS LGDLEHLLK+NLSRN +TG +PG+FGNLRS+MEIDLS+N
Sbjct: 427 GNLDTLDLSNNKINGIIPSSLGDLEHLLKMNLSRNHITGVVPGDFGNLRSIMEIDLSNND 486
Query: 463 LTGVIPEELSQLQNMFSLRLDYNNLSGDVMSLINCLSLSVL------------------- 503
++G IPEEL+QLQN+ LRL+ NNL+G+V SL NCLSL+VL
Sbjct: 487 ISGPIPEELNQLQNIILLRLENNNLTGNVGSLANCLSLTVLNVSHNNLVGDIPKNNNFSR 546
Query: 504 -----FIGNPGLCGYWLHSACRDSHPTERVTISKAAILGIALGALVILLMILVAACRPHN 558
FIGNPGLCG WL+S C DS T RV+IS+AAILGIA+G LVILLM+L+AACRPHN
Sbjct: 547 FSPDSFIGNPGLCGSWLNSPCHDSRRTVRVSISRAAILGIAIGGLVILLMVLIAACRPHN 606
Query: 559 PTHFPDGSLDKPVNYSTPKLVILHMNMALHVYEDIMRMTENLSEKYIIGYGASSTVYKCV 618
P F DGSLDKPV YSTPKLVILHMNMALHVYEDIMRMTENLSEKYIIG+GASSTVYKCV
Sbjct: 607 PPPFLDGSLDKPVTYSTPKLVILHMNMALHVYEDIMRMTENLSEKYIIGHGASSTVYKCV 666
Query: 619 LKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMEN 678
LKNCKPVAIKRLYSH PQ +K+FETELE + SIKHRNLVSLQ YSLS G+LLFYD++EN
Sbjct: 667 LKNCKPVAIKRLYSHNPQSMKQFETELEMLSSIKHRNLVSLQAYSLSHLGSLLFYDYLEN 726
Query: 679 GSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFE 738
GSLWD+LHGPTKKK LDWDTRLKIA GAAQGLAYLHHDCSPRIIHRDVKSSNILLDKD E
Sbjct: 727 GSLWDLLHGPTKKKTLDWDTRLKIAYGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDLE 786
Query: 739 AHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGR 798
A LTDFGIAKSLCVSKS+TSTY+MGTIGYIDPEYARTSRLTEKSDVYS+GIVLLELLT R
Sbjct: 787 ARLTDFGIAKSLCVSKSHTSTYVMGTIGYIDPEYARTSRLTEKSDVYSYGIVLLELLTRR 846
Query: 799 KAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPT 858
KAVD+E NLHHLI+SKT NN VME DP+I++TCKDLG VKKVFQLALLC+KRQP DRPT
Sbjct: 847 KAVDDESNLHHLIMSKTGNNEVMEMADPDITSTCKDLGVVKKVFQLALLCTKRQPNDRPT 906
Query: 859 MHEVSRVLGSLVPAPEPQKQPTSIPSALLSSAKVP--CYKDEYANLKTPHMLNCPSMSTS 916
MH+V+RVLGS + + +P P+A +SA + CY DEYANLKTPH +NC SMS S
Sbjct: 907 MHQVTRVLGSFMLSEQP-------PAATDTSATLAGSCYVDEYANLKTPHSVNCSSMSAS 959
Query: 917 DAQLFLKFGEVISQNSE 933
DAQLFL+FG+VISQNSE
Sbjct: 960 DAQLFLRFGQVISQNSE 976
|
Receptor kinase that, together with ERL1 and ERL2, regulates aerial architecture, including inflorescence (e.g. shoot apical meristem-originating organ shape, elongation of the internode and pedicels, and adaxial-abaxial polarity), and stomatal patterning (e.g. density and clustering), probably by tuning cell division and expansion. Modulates plant transpiration efficiency by controlling stomatal density, leaf photosynthetic capacity, epidermal cell expansion, mesophyll cell proliferation and cell-cell contact. Probable major trait regulating canalization (maintenance of phenotype despite varying environment) in many aspect of the plant physiology (e.g. plant morphology, light-dependent leaves number, branch number, flowering time, phytate and mineral concentrations) by transducing microenvironmental variation into phenotypic differentiation (ecological amplifier). May maintain development integrity in heat stress conditions. Regulates cell wall composition and structure. Confers resistance to the pathogenic bacteria Ralstonia solanacearum and to the necrotrophic fungi Plectosphaerella cucumerina and Pythium irregulare, and required for callose deposition upon infection. Resistance to P.cucumerina seems cell wall-mediated. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGW6|ERL1_ARATH LRR receptor-like serine/threonine-protein kinase ERL1 OS=Arabidopsis thaliana GN=ERL1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 1155 bits (2989), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 594/978 (60%), Positives = 720/978 (73%), Gaps = 68/978 (6%)
Query: 4 RLEFILLLVFLFCLSFGSVDSEDGATLLKIKKSFRDVDNVLYDWTDSPSSDYCVWRGITC 63
R+ L +V S + +G L+ IK SF ++ N+L DW D +SD C WRG+ C
Sbjct: 7 RMVLSLAMVGFMVFGVASAMNNEGKALMAIKGSFSNLVNMLLDWDDVHNSDLCSWRGVFC 66
Query: 64 DNVTFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDL 123
DNV+++V++LNLS LNL GEISPA+GDL++LQSIDL+GN+L+GQIPDEIG+C+SL LDL
Sbjct: 67 DNVSYSVVSLNLSSLNLGGEISPAIGDLRNLQSIDLQGNKLAGQIPDEIGNCASLVYLDL 126
Query: 124 SFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLK---------------- 167
S N LYGDIPFSISKLKQLE L LKNNQL GP+P+TL+Q+PNLK
Sbjct: 127 SENLLYGDIPFSISKLKQLETLNLKNNQLTGPVPATLTQIPNLKRLDLAGNHLTGEISRL 186
Query: 168 --------VFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDL 219
GLRGN L GTLS DMCQL+GLWYFDVR N+LTG+IP++IGNCTSFQ+LD+
Sbjct: 187 LYWNEVLQYLGLRGNMLTGTLSSDMCQLTGLWYFDVRGNNLTGTIPESIGNCTSFQILDI 246
Query: 220 SYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPIL 279
SYNQ++GEIP+NIGFLQ+ATLSLQGN+LTG+IP VIGLMQALAVLDLS N L GPIPPIL
Sbjct: 247 SYNQITGEIPYNIGFLQVATLSLQGNRLTGRIPEVIGLMQALAVLDLSDNELVGPIPPIL 306
Query: 280 GNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVA 339
GNLS+T KLYLH N LTG IP ELGNM++L YL+LNDN+L G IPP LGKL LF+LN+A
Sbjct: 307 GNLSFTGKLYLHGNMLTGPIPSELGNMSRLSYLQLNDNKLVGTIPPELGKLEQLFELNLA 366
Query: 340 NNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVEL 399
NN L GPIP N+SSC LN NVHGN L+G+IP AF+ L S+TYLNLS NN +G IPVEL
Sbjct: 367 NNRLVGPIPSNISSCAALNQFNVHGNLLSGSIPLAFRNLGSLTYLNLSSNNFKGKIPVEL 426
Query: 400 SRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLS 459
I NLD LD+S N SGSIP LGDLEHLL LNLSRN L+G +P EFGNLRS+ ID+S
Sbjct: 427 GHIINLDKLDLSGNNFSGSIPLTLGDLEHLLILNLSRNHLSGQLPAEFGNLRSIQMIDVS 486
Query: 460 HNHLTGVIPEELS---------------------QLQNMFS---LRLDYNNLSGDVMSLI 495
N L+GVIP EL QL N F+ L + +NNLSG V +
Sbjct: 487 FNLLSGVIPTELGQLQNLNSLILNNNKLHGKIPDQLTNCFTLVNLNVSFNNLSGIVPPMK 546
Query: 496 NCLSLS-VLFIGNPGLCGYWLHSACRDSHPTERVTISKAAILGIALGALVILLMILVAAC 554
N + F+GNP LCG W+ S C P RV S+ A++ I LG + +L MI +A
Sbjct: 547 NFSRFAPASFVGNPYLCGNWVGSIC-GPLPKSRV-FSRGALICIVLGVITLLCMIFLAVY 604
Query: 555 RPHNPTHFPDGSLDKPVNYSTPKLVILHMNMALHVYEDIMRMTENLSEKYIIGYGASSTV 614
+ GS + + KLVILHM+MA+H ++DIMR+TENL+EK+IIGYGASSTV
Sbjct: 605 KSMQQKKILQGSSKQAEGLT--KLVILHMDMAIHTFDDIMRVTENLNEKFIIGYGASSTV 662
Query: 615 YKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYD 674
YKC LK+ +P+AIKRLY+ YP L+EFETELET+GSI+HRN+VSL GY+LS +GNLLFYD
Sbjct: 663 YKCALKSSRPIAIKRLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSPTGNLLFYD 722
Query: 675 FMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLD 734
+MENGSLWD+LHG KK KLDW+TRLKIA+GAAQGLAYLHHDC+PRIIHRD+KSSNILLD
Sbjct: 723 YMENGSLWDLLHGSLKKVKLDWETRLKIAVGAAQGLAYLHHDCTPRIIHRDIKSSNILLD 782
Query: 735 KDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLEL 794
++FEAHL+DFGIAKS+ SK++ STY++GTIGYIDPEYARTSR+ EKSD+YSFGIVLLEL
Sbjct: 783 ENFEAHLSDFGIAKSIPASKTHASTYVLGTIGYIDPEYARTSRINEKSDIYSFGIVLLEL 842
Query: 795 LTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPT 854
LTG+KAVDNE NLH LILSK +N VME VDPE++ TC DLG ++K FQLALLC+KR P
Sbjct: 843 LTGKKAVDNEANLHQLILSKADDNTVMEAVDPEVTVTCMDLGHIRKTFQLALLCTKRNPL 902
Query: 855 DRPTMHEVSRVLGSLVPAPEPQKQPTSIPSALLSSAKVPCYKDEYANLKTPHMLNCPSMS 914
+RPTM EVSRVL SLVP+ + K K+P L+ + + P
Sbjct: 903 ERPTMLEVSRVLLSLVPSLQVAK-------------KLPSLDHSTKKLQQENEVRNPDAE 949
Query: 915 TSDAQLFLKFGEVISQNS 932
S Q F++F EVIS++S
Sbjct: 950 AS--QWFVQFREVISKSS 965
|
Receptor kinase that regulates inflorescence architecture and organ shape as well as stomatal patterning, including density and clustering, together with ER and ERL2. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6XAT2|ERL2_ARATH LRR receptor-like serine/threonine-protein kinase ERL2 OS=Arabidopsis thaliana GN=ERL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 1135 bits (2936), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 592/977 (60%), Positives = 708/977 (72%), Gaps = 69/977 (7%)
Query: 5 LEFILLLVFLFCLSFGSVDSEDGATLLKIKKSFRDVDNVLYDWTDSPSSDYCVWRGITCD 64
L F L +V L S + +G L+ IK SF +V N+L DW D + D+C WRG+ CD
Sbjct: 10 LFFCLGMVVFMLLGSVSPMNNEGKALMAIKASFSNVANMLLDWDDVHNHDFCSWRGVFCD 69
Query: 65 NVTFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLS 124
NV+ V++LNLS LNL GEIS A+GDL +LQSIDL+GN+L GQIPDEIG+C SL +D S
Sbjct: 70 NVSLNVVSLNLSNLNLGGEISSALGDLMNLQSIDLQGNKLGGQIPDEIGNCVSLAYVDFS 129
Query: 125 FNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVF--------------- 169
N L+GDIPFSISKLKQLEFL LKNNQL GPIP+TL+Q+PNLK
Sbjct: 130 TNLLFGDIPFSISKLKQLEFLNLKNNQLTGPIPATLTQIPNLKTLDLARNQLTGEIPRLL 189
Query: 170 ---------GLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLS 220
GLRGN L GTLSPDMCQL+GLWYFDVR N+LTG+IP++IGNCTSF++LD+S
Sbjct: 190 YWNEVLQYLGLRGNMLTGTLSPDMCQLTGLWYFDVRGNNLTGTIPESIGNCTSFEILDVS 249
Query: 221 YNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILG 280
YNQ++G IP+NIGFLQ+ATLSLQGN+LTG+IP VIGLMQALAVLDLS N L+GPIPPILG
Sbjct: 250 YNQITGVIPYNIGFLQVATLSLQGNKLTGRIPEVIGLMQALAVLDLSDNELTGPIPPILG 309
Query: 281 NLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVAN 340
NLS+T KLYLH NKLTG IPPELGNM++L YL+LNDN+L G IPP LGKL LF+LN+AN
Sbjct: 310 NLSFTGKLYLHGNKLTGQIPPELGNMSRLSYLQLNDNELVGKIPPELGKLEQLFELNLAN 369
Query: 341 NHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELS 400
N+L G IP N+SSC LN NVHGN L+G +P F+ L S+TYLNLS N+ +G IP EL
Sbjct: 370 NNLVGLIPSNISSCAALNQFNVHGNFLSGAVPLEFRNLGSLTYLNLSSNSFKGKIPAELG 429
Query: 401 RIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSH 460
I NLDTLD+S N SGSIP LGDLEHLL LNLSRN L G +P EFGNLRS+ ID+S
Sbjct: 430 HIINLDTLDLSGNNFSGSIPLTLGDLEHLLILNLSRNHLNGTLPAEFGNLRSIQIIDVSF 489
Query: 461 NHLTGVIPEELSQLQ---------------------NMFS---LRLDYNNLSGDVMSLIN 496
N L GVIP EL QLQ N FS L + +NNLSG + + N
Sbjct: 490 NFLAGVIPTELGQLQNINSLILNNNKIHGKIPDQLTNCFSLANLNISFNNLSGIIPPMKN 549
Query: 497 CLSLS-VLFIGNPGLCGYWLHSACRDSHPTERVTISKAAILGIALGALVILLMILVAACR 555
S F GNP LCG W+ S C S P +V ++ A++ + LG + ++ MI +A +
Sbjct: 550 FTRFSPASFFGNPFLCGNWVGSICGPSLPKSQV-FTRVAVICMVLGFITLICMIFIAVYK 608
Query: 556 PHNPTHFPDGSLDKPVNYSTPKLVILHMNMALHVYEDIMRMTENLSEKYIIGYGASSTVY 615
GS +P + KLVILHM+MA+H ++DIMR+TENL EKYIIGYGASSTVY
Sbjct: 609 SKQQKPVLKGSSKQP--EGSTKLVILHMDMAIHTFDDIMRVTENLDEKYIIGYGASSTVY 666
Query: 616 KCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDF 675
KC K +P+AIKR+Y+ YP +EFETELET+GSI+HRN+VSL GY+LS GNLLFYD+
Sbjct: 667 KCTSKTSRPIAIKRIYNQYPSNFREFETELETIGSIRHRNIVSLHGYALSPFGNLLFYDY 726
Query: 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDK 735
MENGSLWD+LHGP KK KLDW+TRLKIA+GAAQGLAYLHHDC+PRIIHRD+KSSNILLD
Sbjct: 727 MENGSLWDLLHGPGKKVKLDWETRLKIAVGAAQGLAYLHHDCTPRIIHRDIKSSNILLDG 786
Query: 736 DFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELL 795
+FEA L+DFGIAKS+ +K+Y STY++GTIGYIDPEYARTSRL EKSD+YSFGIVLLELL
Sbjct: 787 NFEARLSDFGIAKSIPATKTYASTYVLGTIGYIDPEYARTSRLNEKSDIYSFGIVLLELL 846
Query: 796 TGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTD 855
TG+KAVDNE NLH +ILSK +N VME VD E+S TC D G +KK FQLALLC+KR P +
Sbjct: 847 TGKKAVDNEANLHQMILSKADDNTVMEAVDAEVSVTCMDSGHIKKTFQLALLCTKRNPLE 906
Query: 856 RPTMHEVSRVLGSLVPAPEPQKQPTSIPSALLSSAKVPCYKDEYANLKTPHMLNCPSMST 915
RPTM EVSRVL SLVP+ P L S AKV E + H S T
Sbjct: 907 RPTMQEVSRVLLSLVPS--------PPPKKLPSPAKV----QEGEERRESH-----SSDT 949
Query: 916 SDAQLFLKFGEVISQNS 932
+ Q F++F E IS++S
Sbjct: 950 TTPQWFVQFREDISKSS 966
|
Receptor kinase that regulates inflorescence architecture and organ shape as well as stomatal patterning, including density and clustering, together with ERL1 and ER. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 486 bits (1251), Expect = e-136, Method: Compositional matrix adjust.
Identities = 309/818 (37%), Positives = 460/818 (56%), Gaps = 39/818 (4%)
Query: 79 NLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISK 138
NL+G++ + L+ L+ + L NR SG+IP EIG+C+SLK +D+ N G+IP SI +
Sbjct: 419 NLEGKLPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGR 478
Query: 139 LKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNN 198
LK+L L L+ N+L+G +P++L L + L N L G++ L GL + NN
Sbjct: 479 LKELNLLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNN 538
Query: 199 SLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLM 258
SL G++P ++ + + ++LS+N+L+G I G + + N +IP +G
Sbjct: 539 SLQGNLPDSLISLRNLTRINLSHNRLNGTIHPLCGSSSYLSFDVTNNGFEDEIPLELGNS 598
Query: 259 QALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQ 318
Q L L L N L+G IP LG + L + SN LTG IP +L KL +++LN+N
Sbjct: 599 QNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNF 658
Query: 319 LTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRL 378
L+G IPP LGKL+ L +L +++N +P L +CT L L++ GN LNG+IP L
Sbjct: 659 LSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNL 718
Query: 379 ESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLK-LNLSRN 437
++ LNL N G +P + ++ L L +S N ++G IP +G L+ L L+LS N
Sbjct: 719 GALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYN 778
Query: 438 QLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDVMSLINC 497
TG IP G L + +DLSHN LTG +P + ++++ L + +NNL G + +
Sbjct: 779 NFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKKQFSR 838
Query: 498 LSLSVLFIGNPGLCGYWLHSACRDSHPTERVTISKAAILGI-ALGAL-VILLMILVAACR 555
F+GN GLCG L R ++ +S +++ I A+ AL I LMILV A
Sbjct: 839 WPADS-FLGNTGLCGSPLSRCNRVRSNNKQQGLSARSVVIISAISALTAIGLMILVIALF 897
Query: 556 PHNPTHFPDGSLDKPVNYSTPKLVILHMNMALHV-------------YEDIMRMTENLSE 602
F K + ST + A H +EDIM T NLSE
Sbjct: 898 FKQRHDF----FKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSE 953
Query: 603 KYIIGYGASSTVYKCVLKNCKPVAIKR-LYSHYPQCLKEFETELETVGSIKHRNLVSLQG 661
+++IG G S VYK L+N + VA+K+ L+ K F E++T+G I+HR+LV L G
Sbjct: 954 EFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKSFSREVKTLGRIRHRHLVKLMG 1013
Query: 662 YSLSSSG--NLLFYDFMENGSLWDILHG-----PTKKKKLDWDTRLKIALGAAQGLAYLH 714
Y S S NLL Y++M+NGS+WD LH KKK LDW+ RL+IA+G AQG+ YLH
Sbjct: 1014 YCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLH 1073
Query: 715 HDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSL---CVSKSYTSTYIMGTIGYIDPE 771
HDC P I+HRD+KSSN+LLD + EAHL DFG+AK L C + + ++T+ + GYI PE
Sbjct: 1074 HDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFACSYGYIAPE 1133
Query: 772 YARTSRLTEKSDVYSFGIVLLELLTGRKAVDN----ECNLHHLILS--KTANNAVMETVD 825
YA + + TEKSDVYS GIVL+E++TG+ D+ E ++ + + + A +A + +D
Sbjct: 1134 YAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVRWVETHLEVAGSARDKLID 1193
Query: 826 PEISATCK-DLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
P++ + A +V ++AL C+K P +RP+ +
Sbjct: 1194 PKLKPLLPFEEDAACQVLEIALQCTKTSPQERPSSRQA 1231
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 485 bits (1248), Expect = e-136, Method: Compositional matrix adjust.
Identities = 312/830 (37%), Positives = 458/830 (55%), Gaps = 46/830 (5%)
Query: 72 ALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGD 131
L L G +L G I +G++K L+ + L N+L+G IP E+G S + +D S N L G+
Sbjct: 281 TLALYGNSLVGPIPSEIGNMKSLKKLYLYQNQLNGTIPKELGKLSKVMEIDFSENLLSGE 340
Query: 132 IPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLW 191
IP +SK+ +L L L N+L G IP+ LS+L NL L N+L G + P L+ +
Sbjct: 341 IPVELSKISELRLLYLFQNKLTGIIPNELSKLRNLAKLDLSINSLTGPIPPGFQNLTSMR 400
Query: 192 YFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIP-FNIGFLQIATLSLQGNQLTGK 250
+ +NSL+G IPQ +G + V+D S NQLSG+IP F + L+L N++ G
Sbjct: 401 QLQLFHNSLSGVIPQGLGLYSPLWVVDFSENQLSGKIPPFICQQSNLILLNLGSNRIFGN 460
Query: 251 IPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLH 310
IP + ++L L + N L+G P L L + L N+ +G +PPE+G KL
Sbjct: 461 IPPGVLRCKSLLQLRVVGNRLTGQFPTELCKLVNLSAIELDQNRFSGPLPPEIGTCQKLQ 520
Query: 311 YLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGT 370
L L NQ + ++P + KL++L NV++N L GPIP +++C L L++ N G+
Sbjct: 521 RLHLAANQFSSNLPNEISKLSNLVTFNVSSNSLTGPIPSEIANCKMLQRLDLSRNSFIGS 580
Query: 371 IPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHL- 429
+PP L + L LS N G IP + + +L L M N SGSIP LG L L
Sbjct: 581 LPPELGSLHQLEILRLSENRFSGNIPFTIGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQ 640
Query: 430 LKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSG 489
+ +NLS N +G IP E GNL +M + L++NHL+G IP L ++ YNNL+G
Sbjct: 641 IAMNLSYNDFSGEIPPEIGNLHLLMYLSLNNNHLSGEIPTTFENLSSLLGCNFSYNNLTG 700
Query: 490 DV--MSLINCLSLSVLFIGNPGLCGYWLHSACRDSHPT-----------ERVTISKAAIL 536
+ + ++L+ F+GN GLCG L S C SH + R +
Sbjct: 701 QLPHTQIFQNMTLTS-FLGNKGLCGGHLRS-CDPSHSSWPHISSLKAGSARRGRIIIIVS 758
Query: 537 GIALGALVILLMILVAACR-PHNPT----HFPDGSLDKPVNYSTPKLVILHMNMALHVYE 591
+ G ++L+ I+V R P PT H + + Y PK +
Sbjct: 759 SVIGGISLLLIAIVVHFLRNPVEPTAPYVHDKEPFFQESDIYFVPK--------ERFTVK 810
Query: 592 DIMRMTENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRL-------YSHYPQCLKEFETE 644
DI+ T+ + YI+G GA TVYK V+ + K +A+K+L ++ F E
Sbjct: 811 DILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKKLESNREGNNNNSNNTDNSFRAE 870
Query: 645 LETVGSIKHRNLVSLQG--YSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKI 702
+ T+G I+HRN+V L Y S+ NLL Y++M GSL ++LHG K +DW TR I
Sbjct: 871 ILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRGSLGELLHG-GKSHSMDWPTRFAI 929
Query: 703 ALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIM 762
ALGAA+GLAYLHHDC PRIIHRD+KS+NIL+D++FEAH+ DFG+AK + + S + + +
Sbjct: 930 ALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVIDMPLSKSVSAVA 989
Query: 763 GTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAV---DNECNLHHLILSKTANNA 819
G+ GYI PEYA T ++TEK D+YSFG+VLLELLTG+ V + +L + +++
Sbjct: 990 GSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAPVQPLEQGGDLATWTRNHIRDHS 1049
Query: 820 VM-ETVDPEISATCKD--LGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866
+ E +DP ++ D L + V ++A+LC+K P+DRPTM EV +L
Sbjct: 1050 LTSEILDPYLTKVEDDVILNHMITVTKIAVLCTKSSPSDRPTMREVVLML 1099
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49545|BAME1_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1 OS=Arabidopsis thaliana GN=BAM1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 478 bits (1231), Expect = e-134, Method: Compositional matrix adjust.
Identities = 347/987 (35%), Positives = 486/987 (49%), Gaps = 152/987 (15%)
Query: 29 TLLKIKKSFR----DVDNVLYDWTDSPSSDYCVWRGITCDNVTFTVIALNLSGLNLDGEI 84
LL +K S D ++ L W S S +C W G+TCD V +L+LSGLNL G +
Sbjct: 28 ALLSLKTSLTGAGDDKNSPLSSWKVSTS--FCTWIGVTCDVSRRHVTSLDLSGLNLSGTL 85
Query: 85 SPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFN------------------ 126
SP V L+ LQ++ L N +SG IP EI S L+ L+LS N
Sbjct: 86 SPDVSHLRLLQNLSLAENLISGPIPPEISSLSGLRHLNLSNNVFNGSFPDEISSGLVNLR 145
Query: 127 -------ELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGT 179
L GD+P S++ L QL L L N G IP + P ++ + GN LVG
Sbjct: 146 VLDVYNNNLTGDLPVSVTNLTQLRHLHLGGNYFAGKIPPSYGSWPVIEYLAVSGNELVGK 205
Query: 180 -------------------------LSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSF 214
L P++ LS L FD N LTG IP IG
Sbjct: 206 IPPEIGNLTTLRELYIGYYNAFEDGLPPEIGNLSELVRFDGANCGLTGEIPPEIGKLQKL 265
Query: 215 QVLDLSYNQLSGEIPFNIGFLQ-IATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSG 273
L L N SG + + +G L + ++ L N TG+IP+ ++ L +L+L N L G
Sbjct: 266 DTLFLQVNVFSGPLTWELGTLSSLKSMDLSNNMFTGEIPASFAELKNLTLLNLFRNKLHG 325
Query: 274 PIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDL 333
IP +G+L E L L N TG IP +LG KL+ ++L+ N+LTG +PP + L
Sbjct: 326 EIPEFIGDLPELEVLQLWENNFTGSIPQKLGENGKLNLVDLSSNKLTGTLPPNMCSGNKL 385
Query: 334 FDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRG 393
L N L G IPD+L C +L + + N LNG+IP L +T + L N + G
Sbjct: 386 ETLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKGLFGLPKLTQVELQDNYLSG 445
Query: 394 PIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSV 453
+PV NL + +SNN++SG +P +G+ + KL L N+ G IP E G L+ +
Sbjct: 446 ELPVAGGVSVNLGQISLSNNQLSGPLPPAIGNFTGVQKLLLDGNKFQGPIPSEVGKLQQL 505
Query: 454 MEIDLSH------------------------------------------------NHLTG 465
+ID SH NHL G
Sbjct: 506 SKIDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGEIPNEITAMKILNYLNLSRNHLVG 565
Query: 466 VIPEELSQLQNMFSLRLDYNNLSGDV-----MSLINCLSLSVLFIGNPGLCGYWLHSACR 520
IP +S +Q++ SL YNNLSG V S N S F+GNP LCG +L C+
Sbjct: 566 SIPGSISSMQSLTSLDFSYNNLSGLVPGTGQFSYFNYTS----FLGNPDLCGPYL-GPCK 620
Query: 521 D--------SHPTERVTIS-KAAILGIALGALVILLMILVAACRPHNPTHFPDGSLDKPV 571
D SH ++ S K ++ L + ++ + R SL K
Sbjct: 621 DGVAKGGHQSHSKGPLSASMKLLLVLGLLVCSIAFAVVAIIKAR----------SLKKAS 670
Query: 572 NYSTPKLVILHMNMALHVYEDIMRMTENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLY 631
+L +D++ ++L E IIG G + VYK V+ N VA+KRL
Sbjct: 671 ESRAWRLTAFQ--RLDFTCDDVL---DSLKEDNIIGKGGAGIVYKGVMPNGDLVAVKRLA 725
Query: 632 SHYPQCLKE--FETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPT 689
+ + F E++T+G I+HR++V L G+ + NLL Y++M NGSL ++LHG
Sbjct: 726 AMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHG-K 784
Query: 690 KKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKS 749
K L WDTR KIAL AA+GL YLHHDCSP I+HRDVKS+NILLD +FEAH+ DFG+AK
Sbjct: 785 KGGHLHWDTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKF 844
Query: 750 LCVS-KSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLH 808
L S S + I G+ GYI PEYA T ++ EKSDVYSFG+VLLEL+TGRK V +
Sbjct: 845 LQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELVTGRKPVGEFGDGV 904
Query: 809 HLI-----LSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVS 863
++ ++ + ++V++ +DP +S+ + V VF +A+LC + Q +RPTM EV
Sbjct: 905 DIVQWVRKMTDSNKDSVLKVLDPRLSSI--PIHEVTHVFYVAMLCVEEQAVERPTMREVV 962
Query: 864 RVLGSLVPAPEPQKQP--TSIPSALLS 888
++L + P + QP S P + LS
Sbjct: 963 QILTEIPKLPPSKDQPMTESAPESELS 989
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 477 bits (1227), Expect = e-133, Method: Compositional matrix adjust.
Identities = 303/815 (37%), Positives = 454/815 (55%), Gaps = 29/815 (3%)
Query: 79 NLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISK 138
NL+G++ +G L L+ + L NR SG++P EIG+C+ L+ +D N L G+IP SI +
Sbjct: 420 NLEGKVPKEIGFLGKLEIMYLYENRFSGEMPVEIGNCTRLQEIDWYGNRLSGEIPSSIGR 479
Query: 139 LKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNN 198
LK L L L+ N+L+G IP++L + V L N L G++ L+ L F + NN
Sbjct: 480 LKDLTRLHLRENELVGNIPASLGNCHQMTVIDLADNQLSGSIPSSFGFLTALELFMIYNN 539
Query: 199 SLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLM 258
SL G++P ++ N + ++ S N+ +G I G + + N G IP +G
Sbjct: 540 SLQGNLPDSLINLKNLTRINFSSNKFNGSISPLCGSSSYLSFDVTENGFEGDIPLELGKS 599
Query: 259 QALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQ 318
L L L N +G IP G +S L + N L+G IP ELG KL +++LN+N
Sbjct: 600 TNLDRLRLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNY 659
Query: 319 LTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRL 378
L+G IP LGKL L +L +++N G +P + S TN+ +L + GN LNG+IP L
Sbjct: 660 LSGVIPTWLGKLPLLGELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNL 719
Query: 379 ESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLK-LNLSRN 437
+++ LNL N + GP+P + ++ L L +S N ++G IP +G L+ L L+LS N
Sbjct: 720 QALNALNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYN 779
Query: 438 QLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDVMSLINC 497
TG IP L + +DLSHN L G +P ++ ++++ L L YNNL G + +
Sbjct: 780 NFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKKQFSR 839
Query: 498 LSLSVLFIGNPGLCGYWLHSACRDSHPTERVTISKAAILGIALGALV-ILLMILVAAC-- 554
F+GN GLCG L R +R K ++ A+ +L I LM+LV
Sbjct: 840 WQADA-FVGNAGLCGSPLSHCNRAGSKNQRSLSPKTVVIISAISSLAAIALMVLVIILFF 898
Query: 555 -RPHNPTHFPDGSLDKPVNYSTPKLVILHMNMALHV---YEDIMRMTENLSEKYIIGYGA 610
+ H+ G + S+ L N ++DIM T L+E+++IG G
Sbjct: 899 KQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGG 958
Query: 611 SSTVYKCVLKNCKPVAIKR-LYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSG- 668
S VYK LKN + +A+K+ L+ K F E++T+G+I+HR+LV L GY S +
Sbjct: 959 SGKVYKAELKNGETIAVKKILWKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKADG 1018
Query: 669 -NLLFYDFMENGSLWDILHGP--TKKKK-LDWDTRLKIALGAAQGLAYLHHDCSPRIIHR 724
NLL Y++M NGS+WD LH TKKK+ L W+TRLKIALG AQG+ YLH+DC P I+HR
Sbjct: 1019 LNLLIYEYMANGSVWDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHR 1078
Query: 725 DVKSSNILLDKDFEAHLTDFGIAKSLCV---SKSYTSTYIMGTIGYIDPEYARTSRLTEK 781
D+KSSN+LLD + EAHL DFG+AK L + + ++T G+ GYI PEYA + + TEK
Sbjct: 1079 DIKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKATEK 1138
Query: 782 SDVYSFGIVLLELLTGR----KAVDNECNL----HHLILSKTANNAVMETVDPEISAT-- 831
SDVYS GIVL+E++TG+ D E ++ ++ + + A + +D E+ +
Sbjct: 1139 SDVYSMGIVLMEIVTGKMPTEAMFDEETDMVRWVETVLDTPPGSEAREKLIDSELKSLLP 1198
Query: 832 CKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866
C++ A +V ++AL C+K P +RP+ + S L
Sbjct: 1199 CEE-EAAYQVLEIALQCTKSYPQERPSSRQASEYL 1232
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 471 bits (1211), Expect = e-131, Method: Compositional matrix adjust.
Identities = 316/822 (38%), Positives = 450/822 (54%), Gaps = 55/822 (6%)
Query: 80 LDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKL 139
L G I +GDL+ L+ + L N L+G IP EIG+ S +D S N L G+IP + +
Sbjct: 277 LVGPIPKELGDLQSLEFLYLYRNGLNGTIPREIGNLSYAIEIDFSENALTGEIPLELGNI 336
Query: 140 KQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNS 199
+ LE L L NQL G IP LS L NL L N L G + L GL+ + NS
Sbjct: 337 EGLELLYLFENQLTGTIPVELSTLKNLSKLDLSINALTGPIPLGFQYLRGLFMLQLFQNS 396
Query: 200 LTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGF-LQIATLSLQGNQLTGKIPSVIGLM 258
L+G+IP +G + VLD+S N LSG IP + + L+L N L+G IP+ I
Sbjct: 397 LSGTIPPKLGWYSDLWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTNNLSGNIPTGITTC 456
Query: 259 QALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQ 318
+ L L L+ N L G P L + L N+ G IP E+GN + L L+L DN
Sbjct: 457 KTLVQLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGNCSALQRLQLADNG 516
Query: 319 LTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRL 378
TG +P +G L+ L LN+++N L G +P + +C L L++ N +GT+P L
Sbjct: 517 FTGELPREIGMLSQLGTLNISSNKLTGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGSL 576
Query: 379 ESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHL-LKLNLSRN 437
+ L LS NN+ G IPV L + L L M N +GSIP LG L L + LNLS N
Sbjct: 577 YQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYN 636
Query: 438 QLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDVMSLINC 497
+LTG IP E NL + + L++N+L+G IP + L ++ YN+L+G + L+
Sbjct: 637 KLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPI-PLLRN 695
Query: 498 LSLSVLFIGNPGLCGYWLHSACRDSHP---------------TERVTISKAAILGIALG- 541
+S+S FIGN GLCG L+ C + P ++ + I+ A I G++L
Sbjct: 696 ISMSS-FIGNEGLCGPPLNQ-CIQTQPFAPSQSTGKPGGMRSSKIIAITAAVIGGVSLML 753
Query: 542 -ALVILLM-----ILVAACRPHNPTHFPDGSLDKPVNYSTPKLVILHMNMALHVYEDIMR 595
AL++ LM + ++ + P+ SLD Y PK ++D++
Sbjct: 754 IALIVYLMRRPVRTVASSAQDGQPSEM---SLDI---YFPPK--------EGFTFQDLVA 799
Query: 596 MTENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYP-----QCLKEFETELETVGS 650
T+N E +++G GA TVYK VL +A+K+L S++ F E+ T+G+
Sbjct: 800 ATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRAEILTLGN 859
Query: 651 IKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGL 710
I+HRN+V L G+ NLL Y++M GSL +ILH P+ LDW R KIALGAAQGL
Sbjct: 860 IRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILHDPSCN--LDWSKRFKIALGAAQGL 917
Query: 711 AYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDP 770
AYLHHDC PRI HRD+KS+NILLD FEAH+ DFG+AK + + S + + I G+ GYI P
Sbjct: 918 AYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPHSKSMSAIAGSYGYIAP 977
Query: 771 EYARTSRLTEKSDVYSFGIVLLELLTGR---KAVDNECNLHHLILSKTANNAVMETVDPE 827
EYA T ++TEKSD+YS+G+VLLELLTG+ + +D ++ + + S +A+ V +
Sbjct: 978 EYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPIDQGGDVVNWVRSYIRRDALSSGV-LD 1036
Query: 828 ISATCKDLGAVK---KVFQLALLCSKRQPTDRPTMHEVSRVL 866
T +D V V ++ALLC+ P RP+M +V +L
Sbjct: 1037 ARLTLEDERIVSHMLTVLKIALLCTSVSPVARPSMRQVVLML 1078
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1 | Back alignment and function description |
|---|
Score = 463 bits (1191), Expect = e-129, Method: Compositional matrix adjust.
Identities = 313/831 (37%), Positives = 444/831 (53%), Gaps = 50/831 (6%)
Query: 80 LDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKL 139
L G I + L++IDL GN LSG I + CSSL L L+ N++ G IP + KL
Sbjct: 365 LSGSIPRELCGSGSLEAIDLSGNLLSGTIEEVFDGCSSLGELLLTNNQINGSIPEDLWKL 424
Query: 140 KQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNS 199
L L L +N G IP +L + NL F N L G L ++ + L + +N
Sbjct: 425 P-LMALDLDSNNFTGEIPKSLWKSTNLMEFTASYNRLEGYLPAEIGNAASLKRLVLSDNQ 483
Query: 200 LTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIG-FLQIATLSLQGNQLTGKIPSVIGLM 258
LTG IP+ IG TS VL+L+ N G+IP +G + TL L N L G+IP I +
Sbjct: 484 LTGEIPREIGKLTSLSVLNLNANMFQGKIPVELGDCTSLTTLDLGSNNLQGQIPDKITAL 543
Query: 259 QALAVLDLSCNMLSGPIP------------PILGNLSYTEKLYLHSNKLTGHIPPELGNM 306
L L LS N LSG IP P L L + L N+L+G IP ELG
Sbjct: 544 AQLQCLVLSYNNLSGSIPSKPSAYFHQIEMPDLSFLQHHGIFDLSYNRLSGPIPEELGEC 603
Query: 307 TKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNK 366
L + L++N L+G IP +L +LT+L L+++ N L G IP + + L LN+ N+
Sbjct: 604 LVLVEISLSNNHLSGEIPASLSRLTNLTILDLSGNALTGSIPKEMGNSLKLQGLNLANNQ 663
Query: 367 LNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDL 426
LNG IP +F L S+ LNL+ N + GP+P L + L +D+S N +SG + S L +
Sbjct: 664 LNGHIPESFGLLGSLVKLNLTKNKLDGPVPASLGNLKELTHMDLSFNNLSGELSSELSTM 723
Query: 427 EHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNN 486
E L+ L + +N+ TG IP E GNL + +D+S N L+G IP ++ L N+ L L NN
Sbjct: 724 EKLVGLYIEQNKFTGEIPSELGNLTQLEYLDVSENLLSGEIPTKICGLPNLEFLNLAKNN 783
Query: 487 LSGDVMSLINCLSLS-VLFIGNPGLCGYWLHSACRDSHPTERVTISKAAILGIALGALVI 545
L G+V S C S L GN LCG + S C+ R S I G+ LG +I
Sbjct: 784 LRGEVPSDGVCQDPSKALLSGNKELCGRVVGSDCKIEGTKLR---SAWGIAGLMLGFTII 840
Query: 546 LLMILVAACR---------PHNPTHFPD----GSLDKPVNYSTPKLVILHMNMALHVYE- 591
+ + + + R +P + G +D+ + + + +++ + ++E
Sbjct: 841 VFVFVFSLRRWAMTKRVKQRDDPERMEESRLKGFVDQNLYFLSGSRSREPLSINIAMFEQ 900
Query: 592 --------DIMRMTENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFET 643
DI+ T++ S+K IIG G TVYK L K VA+K+L Q +EF
Sbjct: 901 PLLKVRLGDIVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKLSEAKTQGNREFMA 960
Query: 644 ELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKK-KKLDWDTRLKI 702
E+ET+G +KH NLVSL GY S LL Y++M NGSL L T + LDW RLKI
Sbjct: 961 EMETLGKVKHPNLVSLLGYCSFSEEKLLVYEYMVNGSLDHWLRNQTGMLEVLDWSKRLKI 1020
Query: 703 ALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIM 762
A+GAA+GLA+LHH P IIHRD+K+SNILLD DFE + DFG+A+ + +S+ ST I
Sbjct: 1021 AVGAARGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGLARLISACESHVSTVIA 1080
Query: 763 GTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNEC------NLHHLILSKTA 816
GT GYI PEY +++R T K DVYSFG++LLEL+TG++ + NL + K
Sbjct: 1081 GTFGYIPPEYGQSARATTKGDVYSFGVILLELVTGKEPTGPDFKESEGGNLVGWAIQKIN 1140
Query: 817 NNAVMETVDP-EISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866
++ +DP +S K+ + ++ Q+A+LC P RP M +V + L
Sbjct: 1141 QGKAVDVIDPLLVSVALKN--SQLRLLQIAMLCLAETPAKRPNMLDVLKAL 1189
|
Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 453 bits (1166), Expect = e-126, Method: Compositional matrix adjust.
Identities = 313/874 (35%), Positives = 440/874 (50%), Gaps = 89/874 (10%)
Query: 63 CDNVTFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLD 122
C+++ +A NL L+G + + L++L + L NRLSG+IP +G+ S L+ L
Sbjct: 210 CESLKVLGLAENL----LEGSLPKQLEKLQNLTDLILWQNRLSGEIPPSVGNISRLEVLA 265
Query: 123 LSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSP 182
L N G IP I KL +++ L L NQL G IP + L + N L G +
Sbjct: 266 LHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPREIGNLIDAAEIDFSENQLTGFIPK 325
Query: 183 DMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFL-QIATLS 241
+ + L + N L G IP+ +G T + LDLS N+L+G IP + FL + L
Sbjct: 326 EFGHILNLKLLHLFENILLGPIPRELGELTLLEKLDLSINRLNGTIPQELQFLPYLVDLQ 385
Query: 242 LQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPP 301
L NQL GKIP +IG +VLD+S N LSGPIP L L SNKL+G+IP
Sbjct: 386 LFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCRFQTLILLSLGSNKLSGNIPR 445
Query: 302 ELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLN 361
+L L L L DNQLTG +P L L +L L + N L G I +L NL L
Sbjct: 446 DLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTALELHQNWLSGNISADLGKLKNLERLR 505
Query: 362 VHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPS 421
+ N G IPP L + N+S N + G IP EL + LD+S NK SG I
Sbjct: 506 LANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSCVTIQRLDLSGNKFSGYIAQ 565
Query: 422 PLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDL----------------------- 458
LG L +L L LS N+LTG IP FG+L +ME+ L
Sbjct: 566 ELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLSENIPVELGKLTSLQISL 625
Query: 459 --SHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDV-MSLINCLSLSVL------------ 503
SHN+L+G IP+ L LQ + L L+ N LSG++ S+ N +SL +
Sbjct: 626 NISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMSLLICNISNNNLVGTVP 685
Query: 504 ------------FIGNPGLCGYWLHSACRDSHP------------TERVTISKAAILGIA 539
F GN GLC S C+ P ++R I I I
Sbjct: 686 DTAVFQRMDSSNFAGNHGLCNSQ-RSHCQPLVPHSDSKLNWLINGSQRQKI--LTITCIV 742
Query: 540 LGALVILLMI-LVAACRPHNPTHFPDGSLDKP---VNYSTPKLVILHMNMALHVYEDIMR 595
+G++ ++ + L + P KP +Y PK Y+ ++
Sbjct: 743 IGSVFLITFLGLCWTIKRREPAFVALEDQTKPDVMDSYYFPK--------KGFTYQGLVD 794
Query: 596 MTENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKE--FETELETVGSIKH 653
T N SE ++G GA TVYK + + +A+K+L S + F E+ T+G I+H
Sbjct: 795 ATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNSRGEGASSDNSFRAEISTLGKIRH 854
Query: 654 RNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYL 713
RN+V L G+ + NLL Y++M GSL + L K LDW+ R +IALGAA+GL YL
Sbjct: 855 RNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIALGAAEGLCYL 914
Query: 714 HHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYA 773
HHDC P+I+HRD+KS+NILLD+ F+AH+ DFG+AK + +S S + + + G+ GYI PEYA
Sbjct: 915 HHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMSAVAGSYGYIAPEYA 974
Query: 774 RTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLI--LSKTANNAV--METVDPEIS 829
T ++TEK D+YSFG+VLLEL+TG+ V L+ + ++ N + +E D +
Sbjct: 975 YTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGGDLVNWVRRSIRNMIPTIEMFDARLD 1034
Query: 830 ATCK-DLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
K + + V ++AL C+ P RPTM EV
Sbjct: 1035 TNDKRTVHEMSLVLKIALFCTSNSPASRPTMREV 1068
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 933 | ||||||
| 343887334 | 933 | LRR receptor-like serine/threonine-prote | 1.0 | 1.0 | 0.997 | 0.0 | |
| 255550187 | 980 | erecta, putative [Ricinus communis] gi|2 | 0.998 | 0.951 | 0.861 | 0.0 | |
| 225429690 | 986 | PREDICTED: LRR receptor-like serine/thre | 0.978 | 0.925 | 0.843 | 0.0 | |
| 356552384 | 980 | PREDICTED: LRR receptor-like serine/thre | 0.998 | 0.951 | 0.805 | 0.0 | |
| 449447167 | 991 | PREDICTED: LRR receptor-like serine/thre | 0.997 | 0.939 | 0.795 | 0.0 | |
| 356507090 | 985 | PREDICTED: LRR receptor-like serine/thre | 0.998 | 0.946 | 0.787 | 0.0 | |
| 356514745 | 984 | PREDICTED: LRR receptor-like serine/thre | 1.0 | 0.948 | 0.784 | 0.0 | |
| 15225286 | 976 | LRR receptor-like serine/threonine-prote | 0.984 | 0.941 | 0.779 | 0.0 | |
| 297825789 | 976 | hypothetical protein ARALYDRAFT_481491 [ | 0.984 | 0.941 | 0.777 | 0.0 | |
| 357437333 | 978 | LRR receptor-like serine/threonine-prote | 0.992 | 0.946 | 0.768 | 0.0 |
| >gi|343887334|dbj|BAK61880.1| LRR receptor-like serine/threonine-protein kinase [Citrus unshiu] | Back alignment and taxonomy information |
|---|
Score = 1896 bits (4912), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 931/933 (99%), Positives = 932/933 (99%)
Query: 1 MAFRLEFILLLVFLFCLSFGSVDSEDGATLLKIKKSFRDVDNVLYDWTDSPSSDYCVWRG 60
MAFRLEFILLLVFLFCLSFGSVDSEDGATLLKIKKSFRDVDNVLYDWTDSPSSDYCVWRG
Sbjct: 1 MAFRLEFILLLVFLFCLSFGSVDSEDGATLLKIKKSFRDVDNVLYDWTDSPSSDYCVWRG 60
Query: 61 ITCDNVTFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKS 120
ITCDNVTFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKS
Sbjct: 61 ITCDNVTFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKS 120
Query: 121 LDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTL 180
LDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTL
Sbjct: 121 LDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTL 180
Query: 181 SPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATL 240
SPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQL+GEIPFNIGFLQIATL
Sbjct: 181 SPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLNGEIPFNIGFLQIATL 240
Query: 241 SLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIP 300
SLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIP
Sbjct: 241 SLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIP 300
Query: 301 PELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSL 360
PELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSL
Sbjct: 301 PELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSL 360
Query: 361 NVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIP 420
NVHGNKLNGTIPPAFQRLESMTYLNLS NNIRGPIPVELSRIGNLDTLDMSNNKISGSIP
Sbjct: 361 NVHGNKLNGTIPPAFQRLESMTYLNLSSNNIRGPIPVELSRIGNLDTLDMSNNKISGSIP 420
Query: 421 SPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSL 480
SPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSL
Sbjct: 421 SPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSL 480
Query: 481 RLDYNNLSGDVMSLINCLSLSVLFIGNPGLCGYWLHSACRDSHPTERVTISKAAILGIAL 540
RLDYNNLSGDVMSLINCLSLSVLFIGNPGLCGYWLHSACRDSHPTERVTISKAAILGIAL
Sbjct: 481 RLDYNNLSGDVMSLINCLSLSVLFIGNPGLCGYWLHSACRDSHPTERVTISKAAILGIAL 540
Query: 541 GALVILLMILVAACRPHNPTHFPDGSLDKPVNYSTPKLVILHMNMALHVYEDIMRMTENL 600
GALVILLMILVAACRPHNPTHFPDGSLDKPVNYSTPKLVILHMNMALHVYEDIMRMTENL
Sbjct: 541 GALVILLMILVAACRPHNPTHFPDGSLDKPVNYSTPKLVILHMNMALHVYEDIMRMTENL 600
Query: 601 SEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQ 660
SEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQ
Sbjct: 601 SEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQ 660
Query: 661 GYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPR 720
GYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPR
Sbjct: 661 GYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPR 720
Query: 721 IIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTE 780
IIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTE
Sbjct: 721 IIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTE 780
Query: 781 KSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKK 840
KSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKK
Sbjct: 781 KSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKK 840
Query: 841 VFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAPEPQKQPTSIPSALLSSAKVPCYKDEYA 900
VFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAPEPQKQPTSIPSALLSSAKVPCYKDEYA
Sbjct: 841 VFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAPEPQKQPTSIPSALLSSAKVPCYKDEYA 900
Query: 901 NLKTPHMLNCPSMSTSDAQLFLKFGEVISQNSE 933
NLKTPHMLNCPSMSTSDAQLFLKFGEVISQNSE
Sbjct: 901 NLKTPHMLNCPSMSTSDAQLFLKFGEVISQNSE 933
|
Source: Citrus unshiu Species: Citrus unshiu Genus: Citrus Family: Rutaceae Order: Sapindales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255550187|ref|XP_002516144.1| erecta, putative [Ricinus communis] gi|223544630|gb|EEF46146.1| erecta, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1691 bits (4380), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 845/981 (86%), Positives = 887/981 (90%), Gaps = 49/981 (4%)
Query: 1 MAFRLEFILLLVFLFCLSFGSVDSEDGATLLKIKKSFRDVDNVLYDWTDSPSSDYCVWRG 60
MAFR+E ++ L L CL FG VDS+DGATLL++KKSFRDVDNVLYDWTDSPSSDYCVWRG
Sbjct: 1 MAFRVE-VVFLALLLCLGFGFVDSDDGATLLEVKKSFRDVDNVLYDWTDSPSSDYCVWRG 59
Query: 61 ITCDNVTFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKS 120
+TCDN TF VIALNLSGLNLDGEISPA+G+LKD+ SIDLRGN LSGQIPDEIGDCSSLKS
Sbjct: 60 VTCDNATFNVIALNLSGLNLDGEISPAIGNLKDIVSIDLRGNLLSGQIPDEIGDCSSLKS 119
Query: 121 LDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVF----------- 169
LDLSFNE+YGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQ+PNLKV
Sbjct: 120 LDLSFNEIYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQIPNLKVLDLAQNRLSGEI 179
Query: 170 -------------GLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQV 216
GLRGNNLVGTLSPDMCQL+GLWYFDVRNNSLTGSIP+NIGNCTSFQV
Sbjct: 180 PRLIYWNEVLQYLGLRGNNLVGTLSPDMCQLTGLWYFDVRNNSLTGSIPENIGNCTSFQV 239
Query: 217 LDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIP 276
LDLSYNQL+GEIPFNIGFLQ+ATLSLQGNQL GKIPSVIGLMQALAVLDLSCN+LSGPIP
Sbjct: 240 LDLSYNQLTGEIPFNIGFLQVATLSLQGNQLGGKIPSVIGLMQALAVLDLSCNILSGPIP 299
Query: 277 PILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDL 336
PI+GNL+YTEKLYLH N LTG IPPELGNMT+LHYLELNDNQLTG IPP LGKLTDLFDL
Sbjct: 300 PIVGNLTYTEKLYLHGNMLTGSIPPELGNMTRLHYLELNDNQLTGRIPPELGKLTDLFDL 359
Query: 337 NVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIP 396
NVANN+LEGPIPDNLSSCTNLNSLNVHGNKLNGTIP AFQRLESMTYLNLS NNI+GPIP
Sbjct: 360 NVANNNLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPHAFQRLESMTYLNLSSNNIKGPIP 419
Query: 397 VELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEI 456
+ELSRIGNLDTLD+SNNKISGSIPS LGDLEHLLKLNLSRNQL G IP EFGNLRSVMEI
Sbjct: 420 IELSRIGNLDTLDISNNKISGSIPSSLGDLEHLLKLNLSRNQLLGVIPAEFGNLRSVMEI 479
Query: 457 DLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDVMSLINCLSLSVL------------- 503
DLS+NHL+GVIP+ELSQLQNMFSLRL+ NNLSGDV+SLINCLSL+VL
Sbjct: 480 DLSNNHLSGVIPQELSQLQNMFSLRLENNNLSGDVLSLINCLSLTVLNVSYNNLAGVIPM 539
Query: 504 -----------FIGNPGLCGYWLHSACRDSHPTERVTISKAAILGIALGALVILLMILVA 552
FIGNP LCGYWL+S C +SHPTERVTISKAAILGIALGALVILLMILVA
Sbjct: 540 SNNFSRFSPNSFIGNPDLCGYWLNSPCNESHPTERVTISKAAILGIALGALVILLMILVA 599
Query: 553 ACRPHNPTHFPDGSLDKPVNYSTPKLVILHMNMALHVYEDIMRMTENLSEKYIIGYGASS 612
ACRPHNPT F DGSLDKPV YSTPKLVILHMNMALHVYEDIMRMTENLSEKYIIGYGASS
Sbjct: 600 ACRPHNPTPFLDGSLDKPVTYSTPKLVILHMNMALHVYEDIMRMTENLSEKYIIGYGASS 659
Query: 613 TVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLF 672
TVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLS GNLLF
Sbjct: 660 TVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSPLGNLLF 719
Query: 673 YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNIL 732
YD+MENGSLWD+LHGP KKKKLDWDTRL+IALGAAQGLAYLHHDCSPRIIHRDVKSSNIL
Sbjct: 720 YDYMENGSLWDLLHGPMKKKKLDWDTRLQIALGAAQGLAYLHHDCSPRIIHRDVKSSNIL 779
Query: 733 LDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLL 792
LDKDFEAHLTDFGIAKSLCVSKS+TSTYIMGTIGYIDPEYARTSRLTEKSDVYS+GIVLL
Sbjct: 780 LDKDFEAHLTDFGIAKSLCVSKSHTSTYIMGTIGYIDPEYARTSRLTEKSDVYSYGIVLL 839
Query: 793 ELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQ 852
ELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLC+KRQ
Sbjct: 840 ELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCTKRQ 899
Query: 853 PTDRPTMHEVSRVLGSLVPAPEPQKQPTSIPSALLSSAKVPCYKDEYANLKTPHMLNCPS 912
PTDRPTMHEV+RVLGSLVP+ P KQ P A + SAKV CY DEYANLKTPHM+NCPS
Sbjct: 900 PTDRPTMHEVTRVLGSLVPSTTPPKQCMPAPPAPIPSAKVSCYMDEYANLKTPHMVNCPS 959
Query: 913 MSTSDAQLFLKFGEVISQNSE 933
MSTSDAQLFLKFGEVISQNSE
Sbjct: 960 MSTSDAQLFLKFGEVISQNSE 980
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225429690|ref|XP_002280069.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase ERECTA [Vitis vinifera] gi|296081722|emb|CBI20727.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1636 bits (4237), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 811/962 (84%), Positives = 861/962 (89%), Gaps = 49/962 (5%)
Query: 18 SFGSVDSEDGATLLKIKKSFRDVDNVLYDWTDSPSSDYCVWRGITCDNVTFTVIALNLSG 77
+FGSV S+DGATLL+IKKSFRDVDNVLYDWTDSPSSDYCVWRG++CDNVTF VIALNLSG
Sbjct: 17 AFGSVVSDDGATLLEIKKSFRDVDNVLYDWTDSPSSDYCVWRGVSCDNVTFNVIALNLSG 76
Query: 78 LNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSIS 137
LNLDGEISPA+GDLK L S+DLRGNRLSGQIPDEIGDCSS+ SLDLSFNELYGDIPFSIS
Sbjct: 77 LNLDGEISPAIGDLKGLLSVDLRGNRLSGQIPDEIGDCSSMSSLDLSFNELYGDIPFSIS 136
Query: 138 KLKQLEFLILKNNQLIGPIPSTLSQLPNLKVF------------------------GLRG 173
KLKQLE L+LKNNQLIGPIPSTLSQ+PNLK+ GLRG
Sbjct: 137 KLKQLEQLVLKNNQLIGPIPSTLSQIPNLKILDLAQNRLSGEIPRLIYWNEVLQYLGLRG 196
Query: 174 NNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIG 233
NNLVGTLSPDMCQL+GLWYFDVRNNSLTG+IPQNIGNCT+FQVLDLSYN+L+GEIPFNIG
Sbjct: 197 NNLVGTLSPDMCQLTGLWYFDVRNNSLTGTIPQNIGNCTAFQVLDLSYNRLTGEIPFNIG 256
Query: 234 FLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSN 293
FLQ+ATLSLQGNQL+G+IPSVIGLMQALAVLDLSCNMLSGPIPPILGNL+YTEKLYLH N
Sbjct: 257 FLQVATLSLQGNQLSGQIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLTYTEKLYLHGN 316
Query: 294 KLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSS 353
KL G IPPELGNMTKLHYLELNDN LTG IP LGKLTDLFDLNVANNHLEGPIPDNLSS
Sbjct: 317 KLAGSIPPELGNMTKLHYLELNDNHLTGSIPSELGKLTDLFDLNVANNHLEGPIPDNLSS 376
Query: 354 CTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNN 413
CTNLNSLNVHGNKLNGTIPPAF++LESMTYLNLS NN+RG IP+ELSRIGNLDTLD+SNN
Sbjct: 377 CTNLNSLNVHGNKLNGTIPPAFEKLESMTYLNLSSNNLRGSIPIELSRIGNLDTLDISNN 436
Query: 414 KISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQ 473
+I+GSIPS LGDLEHLLKLNLSRN LTG IP EFGNLRSVMEIDLS+NHL+GVIP+EL Q
Sbjct: 437 RITGSIPSSLGDLEHLLKLNLSRNHLTGCIPAEFGNLRSVMEIDLSNNHLSGVIPQELGQ 496
Query: 474 LQNMFSLRLDYNNLSGDVMSLINCLSLSVL------------------------FIGNPG 509
LQNMF LR++ NNLSGDV SLINCLSL+VL FIGNPG
Sbjct: 497 LQNMFFLRVENNNLSGDVTSLINCLSLTVLNVSYNNLGGDIPTSNNFSRFSPDSFIGNPG 556
Query: 510 LCGYWLHSACRDSHPTERVTISKAAILGIALGALVILLMILVAACRPHNPTHFPDGSLDK 569
LCGYWL S C +HPTERV ISKAAILGIALGALVILLMILVAACRPHNP FPDGSLDK
Sbjct: 557 LCGYWLSSPCHQAHPTERVAISKAAILGIALGALVILLMILVAACRPHNPIPFPDGSLDK 616
Query: 570 PVNYSTPKLVILHMNMALHVYEDIMRMTENLSEKYIIGYGASSTVYKCVLKNCKPVAIKR 629
PV YSTPKLVILHMNMALHVYEDIMRMTENLSEKYIIGYGASSTVYKCVLKNCKPVAIKR
Sbjct: 617 PVTYSTPKLVILHMNMALHVYEDIMRMTENLSEKYIIGYGASSTVYKCVLKNCKPVAIKR 676
Query: 630 LYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPT 689
LYSH Q LKEFETELETVGSIKHRNLV LQGYSLS SGNLLFYD+MENGSLWD+LHGPT
Sbjct: 677 LYSHNTQYLKEFETELETVGSIKHRNLVCLQGYSLSPSGNLLFYDYMENGSLWDLLHGPT 736
Query: 690 KKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKS 749
KKKKLDW+TRL+IALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAK
Sbjct: 737 KKKKLDWETRLQIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKV 796
Query: 750 LCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHH 809
LC SKS+TSTYIMGTIGYIDPEYARTSRLTEKSDVYS+GIVLLELLTGRKAVDNE NLHH
Sbjct: 797 LCSSKSHTSTYIMGTIGYIDPEYARTSRLTEKSDVYSYGIVLLELLTGRKAVDNESNLHH 856
Query: 810 LILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869
LILSKT NNAVMETVDP+I+ATCKDLGAVKKVFQLALLC+K+QP+DRPTMHEV+RVLGSL
Sbjct: 857 LILSKTTNNAVMETVDPDITATCKDLGAVKKVFQLALLCTKKQPSDRPTMHEVTRVLGSL 916
Query: 870 VPAPEPQKQP-TSIPSALLSSAKVPCYKDEYANLKTPHMLNCPSMSTSDAQLFLKFGEVI 928
VPA P++ T+ P A L S KVPCY DEYANLKTPHM+NC SMSTSDAQLFLKFGEVI
Sbjct: 917 VPATAPKQIALTTTPPAPLPSTKVPCYMDEYANLKTPHMVNCSSMSTSDAQLFLKFGEVI 976
Query: 929 SQ 930
SQ
Sbjct: 977 SQ 978
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356552384|ref|XP_003544548.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase ERECTA-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1575 bits (4078), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 790/981 (80%), Positives = 856/981 (87%), Gaps = 49/981 (4%)
Query: 1 MAFRLEFILLLVFLFCLSFGSVDSEDGATLLKIKKSFRDVDNVLYDWTDSPSSDYCVWRG 60
MAFR +L+L L CLS SV+S+DGATLL+IKKSFRDVDNVLYDWTDSPSSDYC WRG
Sbjct: 1 MAFRFG-VLILALLICLSVNSVESDDGATLLEIKKSFRDVDNVLYDWTDSPSSDYCAWRG 59
Query: 61 ITCDNVTFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKS 120
I CDNVTF V+ALNLSGLNLDGEISPA+G L L SIDLR NRLSGQIPDEIGDCSSLK+
Sbjct: 60 IACDNVTFNVVALNLSGLNLDGEISPAIGKLHSLVSIDLRENRLSGQIPDEIGDCSSLKN 119
Query: 121 LDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVF----------- 169
LDLSFNE+ GDIPFSISKLKQ+E LILKNNQLIGPIPSTLSQ+P+LK+
Sbjct: 120 LDLSFNEIRGDIPFSISKLKQMENLILKNNQLIGPIPSTLSQIPDLKILDLAQNNLSGEI 179
Query: 170 -------------GLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQV 216
GLRGNNLVG+LSPD+CQL+GLWYFDVRNNSLTGSIP+NIGNCT+FQV
Sbjct: 180 PRLIYWNEVLQYLGLRGNNLVGSLSPDLCQLTGLWYFDVRNNSLTGSIPENIGNCTAFQV 239
Query: 217 LDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIP 276
LDLSYNQL+GEIPFNIGFLQ+ATLSLQGN+L+G IPSVIGLMQALAVLDLSCNMLSGPIP
Sbjct: 240 LDLSYNQLTGEIPFNIGFLQVATLSLQGNKLSGHIPSVIGLMQALAVLDLSCNMLSGPIP 299
Query: 277 PILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDL 336
PILGNL+YTEKLYLH NKLTG IPPELGNM+KLHYLELNDN L+GHIPP LGKLTDLFDL
Sbjct: 300 PILGNLTYTEKLYLHGNKLTGFIPPELGNMSKLHYLELNDNHLSGHIPPELGKLTDLFDL 359
Query: 337 NVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIP 396
NVANN+L+GPIP NLSSC NLNSLNVHGNKLNG+IPP+ Q LESMT LNLS NN++G IP
Sbjct: 360 NVANNNLKGPIPSNLSSCKNLNSLNVHGNKLNGSIPPSLQSLESMTSLNLSSNNLQGAIP 419
Query: 397 VELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEI 456
+ELSRIGNLDTLD+SNNK+ GSIPS LGDLEHLLKLNLSRN LTG IP EFGNLRSVMEI
Sbjct: 420 IELSRIGNLDTLDISNNKLVGSIPSSLGDLEHLLKLNLSRNNLTGVIPAEFGNLRSVMEI 479
Query: 457 DLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDVMSLINCLSLSVL------------- 503
DLS N L+G IPEELSQLQNM SLRL+ N L+GDV SL +CLSLS+L
Sbjct: 480 DLSDNQLSGFIPEELSQLQNMISLRLENNKLTGDVASLSSCLSLSLLNVSYNKLFGVIPT 539
Query: 504 -----------FIGNPGLCGYWLHSACRDSHPTERVTISKAAILGIALGALVILLMILVA 552
FIGNPGLCG WL+ C + P+ERVT+SKAAILGI LGALVILLM+LVA
Sbjct: 540 SNNFTRFPPDSFIGNPGLCGNWLNLPCHGARPSERVTLSKAAILGITLGALVILLMVLVA 599
Query: 553 ACRPHNPTHFPDGSLDKPVNYSTPKLVILHMNMALHVYEDIMRMTENLSEKYIIGYGASS 612
ACRPH+P+ FPDGS DKP+N+S PKLVILHMNMALHVYEDIMRMTENLSEKYIIGYGASS
Sbjct: 600 ACRPHSPSPFPDGSFDKPINFSPPKLVILHMNMALHVYEDIMRMTENLSEKYIIGYGASS 659
Query: 613 TVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLF 672
TVYKCVLKNCKPVAIKR+YSHYPQC+KEFETELETVGSIKHRNLVSLQGYSLS G+LLF
Sbjct: 660 TVYKCVLKNCKPVAIKRIYSHYPQCIKEFETELETVGSIKHRNLVSLQGYSLSPYGHLLF 719
Query: 673 YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNIL 732
YD+MENGSLWD+LHGPTKKKKLDW+ RLKIALGAAQGLAYLHHDC PRIIHRDVKSSNI+
Sbjct: 720 YDYMENGSLWDLLHGPTKKKKLDWELRLKIALGAAQGLAYLHHDCCPRIIHRDVKSSNII 779
Query: 733 LDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLL 792
LD DFE HLTDFGIAKSLC SKS+TSTYIMGTIGYIDPEYARTS LTEKSDVYS+GIVLL
Sbjct: 780 LDADFEPHLTDFGIAKSLCPSKSHTSTYIMGTIGYIDPEYARTSHLTEKSDVYSYGIVLL 839
Query: 793 ELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQ 852
ELLTGRKAVDNE NLHHLILSK A NAVMETVDP+I+ATCKDLGAVKKV+QLALLC+KRQ
Sbjct: 840 ELLTGRKAVDNESNLHHLILSKAATNAVMETVDPDITATCKDLGAVKKVYQLALLCTKRQ 899
Query: 853 PTDRPTMHEVSRVLGSLVPAPEPQKQPTSIPSALLSSAKVPCYKDEYANLKTPHMLNCPS 912
P DRPTMHEV+RVLGSLVP+ P KQ +P A SAKVPCY DEYANLKTPH++NCPS
Sbjct: 900 PADRPTMHEVTRVLGSLVPSSIPPKQLADLPPASNPSAKVPCYVDEYANLKTPHLVNCPS 959
Query: 913 MSTSDAQLFLKFGEVISQNSE 933
MSTSDAQLFLKFGEVISQNSE
Sbjct: 960 MSTSDAQLFLKFGEVISQNSE 980
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449447167|ref|XP_004141340.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase ERECTA-like [Cucumis sativus] gi|449486710|ref|XP_004157376.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase ERECTA-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1552 bits (4018), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 784/985 (79%), Positives = 851/985 (86%), Gaps = 54/985 (5%)
Query: 1 MAFRLEFILLLVFLFCLSFGSVDSEDGATLLKIKKSFRDVDNVLYDWTDSPSSDYCVWRG 60
MA +E ++L FLFC + G VDS+DGATLL+IKKS+RDVDNVLYDWT SPSSD+CVWRG
Sbjct: 9 MALLVELVIL-AFLFCATVGVVDSDDGATLLEIKKSYRDVDNVLYDWTSSPSSDFCVWRG 67
Query: 61 ITCDNVTFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKS 120
+TCDN T VI+LNLSGLNLDGEISP++G+LK LQ++DLRGN LSGQIPDEIGDCSSL +
Sbjct: 68 VTCDNATLNVISLNLSGLNLDGEISPSIGNLKSLQTLDLRGNGLSGQIPDEIGDCSSLIN 127
Query: 121 LDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVF----------- 169
+DLSFNE+YGDIPFSISKLKQLE L+LKNN+LIGPIPSTLSQ+PNLKV
Sbjct: 128 MDLSFNEIYGDIPFSISKLKQLEMLVLKNNRLIGPIPSTLSQIPNLKVLDLAQNNLSGEI 187
Query: 170 -------------GLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQV 216
GLRGNNLVGTLSPDMCQL+GLWYFDVRNNSLTGSIPQ IGNCT+FQV
Sbjct: 188 PRLIYWNEVLQYLGLRGNNLVGTLSPDMCQLTGLWYFDVRNNSLTGSIPQTIGNCTAFQV 247
Query: 217 LDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIP 276
LDLSYN LSGEIPFNIGFLQ+ATLSLQGNQL+G IP VIGLMQALAVLDLSCNML+GPIP
Sbjct: 248 LDLSYNHLSGEIPFNIGFLQVATLSLQGNQLSGPIPPVIGLMQALAVLDLSCNMLTGPIP 307
Query: 277 PILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDL 336
ILGNL+YTEKLYLHSNKLTG IP ELGNMTKLHYLELNDN L G+IP LGKLTDLFDL
Sbjct: 308 SILGNLTYTEKLYLHSNKLTGPIPAELGNMTKLHYLELNDNHLAGNIPAELGKLTDLFDL 367
Query: 337 NVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIP 396
NVANN+L GPIPDNLSSC NLNSLNVHGNKLNGTIPP+FQRLESMTYLNLS N++RGPIP
Sbjct: 368 NVANNNLGGPIPDNLSSCINLNSLNVHGNKLNGTIPPSFQRLESMTYLNLSSNDLRGPIP 427
Query: 397 VELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEI 456
VELSRIGNLDTLD+SNNKISG+I S GDLEHLLKLNLSRN LTGFIP EFGNLRSVMEI
Sbjct: 428 VELSRIGNLDTLDISNNKISGTISSSFGDLEHLLKLNLSRNHLTGFIPAEFGNLRSVMEI 487
Query: 457 DLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDVMSLINCLSLSVLFI----------- 505
D+SHN L+G IP+ELSQLQN+ SLRL+ NNLSGD+ SLI+CLSL+ L +
Sbjct: 488 DISHNQLSGFIPQELSQLQNLLSLRLENNNLSGDLTSLISCLSLTELNVSYNNLAGDIPT 547
Query: 506 -------------GNPGLCGYWLHS--ACRDSHPTERVTISKAAILGIALGALVILLMIL 550
GN LCGYW + C ++H TERVTISKAAILGIALGALVILLMIL
Sbjct: 548 SNNFSRFSSDSFFGNIALCGYWNSNNYPCHEAHTTERVTISKAAILGIALGALVILLMIL 607
Query: 551 VAACRPHNPTHFPDGSLDKPVNYSTPKLVILHMNMALHVYEDIMRMTENLSEKYIIGYGA 610
+ CRP+N FPDGSLDKPV YSTPKLVILHMNMALHVYEDIMRMTENL+EKYIIGYGA
Sbjct: 608 LTVCRPNNTIPFPDGSLDKPVTYSTPKLVILHMNMALHVYEDIMRMTENLNEKYIIGYGA 667
Query: 611 SSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNL 670
SSTVYKCVLKNCKPVA+K+LYSH P +K FETELETVGSIKHRNLVSLQGYSLS SGNL
Sbjct: 668 SSTVYKCVLKNCKPVAVKKLYSHQPHSMKVFETELETVGSIKHRNLVSLQGYSLSPSGNL 727
Query: 671 LFYDFMENGSLWDILH--GPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKS 728
LFYD+MENGSLWD LH G TKKKKLDWDTRL IA GAAQGL+YLHHDCSPRIIHRDVKS
Sbjct: 728 LFYDYMENGSLWDHLHGSGSTKKKKLDWDTRLNIAHGAAQGLSYLHHDCSPRIIHRDVKS 787
Query: 729 SNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFG 788
SNILLDKDFEAHLTDFGIAKSLC SK+YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFG
Sbjct: 788 SNILLDKDFEAHLTDFGIAKSLCTSKTYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFG 847
Query: 789 IVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLC 848
IVLLELLTGRKAVDNE NLH LILSKTANNAVMETVDPEI+ATCKDLGAVKK FQLALLC
Sbjct: 848 IVLLELLTGRKAVDNESNLHQLILSKTANNAVMETVDPEITATCKDLGAVKKAFQLALLC 907
Query: 849 SKRQPTDRPTMHEVSRVLGSLVPAPEPQKQPTSIPSALLSSAKVPCYKDEYANLKTPHML 908
+KRQP+DRPTMHEV+RV+GSL+P+ KQ +I + + SAK CYKDEYANLKTPH+L
Sbjct: 908 TKRQPSDRPTMHEVTRVIGSLLPSAATPKQIPTI-TTIPPSAKSSCYKDEYANLKTPHVL 966
Query: 909 NCPSMSTSDAQLFLKFGEVISQNSE 933
NCP+MSTSDAQLF KFGEVISQNSE
Sbjct: 967 NCPTMSTSDAQLFAKFGEVISQNSE 991
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356507090|ref|XP_003522304.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase ERECTA-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1550 bits (4012), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 776/986 (78%), Positives = 846/986 (85%), Gaps = 54/986 (5%)
Query: 1 MAFRLEFILLLVFLFCLSFGSVDSEDGATLLKIKKSFRDVDNVLYDWTDSPSSDYCVWRG 60
MAFR +LL L S GSV+S DG TLL+IKKSF DVDNVLYDWTDSPSSDYCVWRG
Sbjct: 1 MAFRFGLLLLFSLLCLDSIGSVNSHDGETLLEIKKSFSDVDNVLYDWTDSPSSDYCVWRG 60
Query: 61 ITCDNVTFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKS 120
+TCDNVTF V+ALNLSGLNL+GEISP +G L L SID + NRLSGQIPDE+GDCSSLKS
Sbjct: 61 VTCDNVTFNVVALNLSGLNLEGEISPVIGRLNSLVSIDFKENRLSGQIPDELGDCSSLKS 120
Query: 121 LDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVF----------- 169
+DLSFNE+ GDIPFS+SK+KQLE LILKNNQLIGPIPSTLSQ+PNLK+
Sbjct: 121 IDLSFNEIRGDIPFSVSKMKQLENLILKNNQLIGPIPSTLSQVPNLKILDLAQNNLSGEI 180
Query: 170 -------------GLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQV 216
GLRGNNLVG+LSPDMCQL+GLWYFDVRNNSLTG+IP+NIGNCT+ V
Sbjct: 181 PRLIYWNEVLQYLGLRGNNLVGSLSPDMCQLTGLWYFDVRNNSLTGTIPENIGNCTTLGV 240
Query: 217 LDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIP 276
LDLSYN+L+GEIPFNIG+LQ+ATLSLQGN+ G IPSVIGLMQAL VLDLSCNMLSGPIP
Sbjct: 241 LDLSYNKLTGEIPFNIGYLQVATLSLQGNKFLGHIPSVIGLMQALTVLDLSCNMLSGPIP 300
Query: 277 PILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDL 336
PILGNL+YTEKLYLH NKLTG IPPELGNMT LHYLELNDN L+GHIPP LGKLTDLFDL
Sbjct: 301 PILGNLTYTEKLYLHGNKLTGLIPPELGNMTNLHYLELNDNHLSGHIPPELGKLTDLFDL 360
Query: 337 NVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIP 396
NVANN+LEGP+PDNLSSC NLNSLNVHGNKL+GT+P AF LESMTYLNLS NN++G IP
Sbjct: 361 NVANNNLEGPVPDNLSSCKNLNSLNVHGNKLSGTVPSAFHSLESMTYLNLSSNNLQGSIP 420
Query: 397 VELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEI 456
+ELSRIGNLDTLD+SNN I GSIPS +GDLEHLLKLNLSRN LTGFIP EFGNLRSVM+I
Sbjct: 421 IELSRIGNLDTLDISNNNIIGSIPSSIGDLEHLLKLNLSRNHLTGFIPAEFGNLRSVMDI 480
Query: 457 DLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDVMSLINCLSLSVL------------- 503
DLS+N L+G+IPEELSQLQN+ SLRL+ N LSGDV SL+NC SLS+L
Sbjct: 481 DLSNNQLSGLIPEELSQLQNIISLRLEKNKLSGDVSSLLNCFSLSLLNVSYNNLVGVIPS 540
Query: 504 -----------FIGNPGLCGYWLHSACRDSHPTERVTISKAAILGIALGALVILLMILVA 552
FIGNPGLC WL S+C SH TERVT+SKAAILGIA+GAL IL MIL+A
Sbjct: 541 SKNFSRFSPDSFIGNPGLCVDWLDSSCLGSHSTERVTLSKAAILGIAIGALAILFMILLA 600
Query: 553 ACRPHNPTHFP-DGSLDKPVNYSTPKLVILHMNMALHVYEDIMRMTENLSEKYIIGYGAS 611
ACRPHNP F DGS DKPVNYS PKLVILHMNMALHVY+DIMRMTENLSEKYIIGYGAS
Sbjct: 601 ACRPHNPASFSDDGSFDKPVNYSPPKLVILHMNMALHVYDDIMRMTENLSEKYIIGYGAS 660
Query: 612 STVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLL 671
STVYKCVLKNCKPVAIK+LYSHYPQ LKEFETELETVGSIKHRNLVSLQGYSLS GNLL
Sbjct: 661 STVYKCVLKNCKPVAIKKLYSHYPQYLKEFETELETVGSIKHRNLVSLQGYSLSPYGNLL 720
Query: 672 FYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNI 731
FYD+MENGS+WD+LHGPTKKKKLDWD RLKIALG+AQGL+YLHHDCSPRIIHRDVKSSNI
Sbjct: 721 FYDYMENGSIWDLLHGPTKKKKLDWDLRLKIALGSAQGLSYLHHDCSPRIIHRDVKSSNI 780
Query: 732 LLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVL 791
LLDKDFE HLTDFGIAKSLC SK++TSTYIMGTIGYIDPEYARTSRLTEKSDVYS+GIVL
Sbjct: 781 LLDKDFEPHLTDFGIAKSLCPSKTHTSTYIMGTIGYIDPEYARTSRLTEKSDVYSYGIVL 840
Query: 792 LELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKR 851
LELLTGRKAVDNE NLHHLILSKTAN+ VMETVDP+I+ATCKD+GAVKKVFQLALLC+K+
Sbjct: 841 LELLTGRKAVDNESNLHHLILSKTANDGVMETVDPDITATCKDMGAVKKVFQLALLCTKK 900
Query: 852 QPTDRPTMHEVSRVLGSLVPAPEPQKQPTSIPSALLS----SAKVPCYKDEYANLKTPHM 907
QP DRPTMHEV+RVL SLVP+ P KQ T +LS SAK+ CYKDEYANL TPH+
Sbjct: 901 QPVDRPTMHEVTRVLASLVPSITPPKQ-TDQTQVVLSDSQPSAKMQCYKDEYANLTTPHL 959
Query: 908 LNCPSMSTSDAQLFLKFGEVISQNSE 933
+NCPSMSTSDAQLFLKFGEVISQNS
Sbjct: 960 VNCPSMSTSDAQLFLKFGEVISQNSH 985
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356514745|ref|XP_003526064.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase ERECTA-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1541 bits (3990), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 772/984 (78%), Positives = 843/984 (85%), Gaps = 51/984 (5%)
Query: 1 MAFRLEFILLLVFLFCLSFGSVDSEDGATLLKIKKSFRDVDNVLYDWTDSPSSDYCVWRG 60
MAFR +LL+ L S SV+S G TLL+IKK FRDVDNVLYDWTDS SSDYCVWRG
Sbjct: 1 MAFRFGLLLLVSLLCLDSISSVNSHVGETLLEIKKWFRDVDNVLYDWTDSTSSDYCVWRG 60
Query: 61 ITCDNVTFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKS 120
+TCDNVTF V+ALNLSGLNL+GEISPA+G L L SID + NRLSGQIPDE+GDCSSLKS
Sbjct: 61 VTCDNVTFNVVALNLSGLNLEGEISPAIGRLNSLISIDFKENRLSGQIPDELGDCSSLKS 120
Query: 121 LDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVF----------- 169
+DLSFNE+ GDIPFS+SK+KQLE LILKNNQLIGPIPSTLSQ+PNLK+
Sbjct: 121 IDLSFNEIRGDIPFSVSKMKQLENLILKNNQLIGPIPSTLSQVPNLKILDLAQNNLSGEI 180
Query: 170 -------------GLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQV 216
GLRGNNLVG+LSPDMCQL+GLWYFDVRNNSLTGSIP+NIGNCT+ V
Sbjct: 181 PRLIYWNEVLQYLGLRGNNLVGSLSPDMCQLTGLWYFDVRNNSLTGSIPENIGNCTTLGV 240
Query: 217 LDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIP 276
LDLSYN+L+GEIPFNIG+LQ+ATLSLQGN+L+G IPSVIGLMQAL VLDLSCNMLSGPIP
Sbjct: 241 LDLSYNKLTGEIPFNIGYLQVATLSLQGNKLSGHIPSVIGLMQALTVLDLSCNMLSGPIP 300
Query: 277 PILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDL 336
PILGNL+YTEKLYLH NKLTG IPPELGNMT LHYLELNDN L+GHIPP LGKLTDLFDL
Sbjct: 301 PILGNLTYTEKLYLHGNKLTGLIPPELGNMTNLHYLELNDNHLSGHIPPELGKLTDLFDL 360
Query: 337 NVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIP 396
NVANN+LEGP+PDNLS C NLNSLNVHGNKL+GT+P AF LESMTYLNLS N ++G IP
Sbjct: 361 NVANNNLEGPVPDNLSLCKNLNSLNVHGNKLSGTVPSAFHSLESMTYLNLSSNKLQGSIP 420
Query: 397 VELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEI 456
VELSRIGNLDTLD+SNN I GSIPS +GDLEHLLKLNLSRN LTGFIP EFGNLRSVM+I
Sbjct: 421 VELSRIGNLDTLDISNNNIIGSIPSSIGDLEHLLKLNLSRNHLTGFIPAEFGNLRSVMDI 480
Query: 457 DLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDVMSLINCLSLSVL------------- 503
DLS+N L+G+IPEELSQLQN+ SLRL+ N LSGDV SL NC SLS+L
Sbjct: 481 DLSNNQLSGLIPEELSQLQNIISLRLEKNKLSGDVSSLANCFSLSLLNVSYNNLVGVIPT 540
Query: 504 -----------FIGNPGLCGYWLHSACRDSHPTERVTISKAAILGIALGALVILLMILVA 552
FIGNPGLCG WL +C S+ TERVT+SKAAILGIA+GALVIL MIL+A
Sbjct: 541 SKNFSRFSPDSFIGNPGLCGDWLDLSCHGSNSTERVTLSKAAILGIAIGALVILFMILLA 600
Query: 553 ACRPHNPTHFPDGSLDKPVNYSTPKLVILHMNMALHVYEDIMRMTENLSEKYIIGYGASS 612
ACRPHNPT F DGS DKPVNYS PKLVILH+NM LHVY+DIMRMTENLSEKYIIGYGASS
Sbjct: 601 ACRPHNPTSFADGSFDKPVNYSPPKLVILHINMTLHVYDDIMRMTENLSEKYIIGYGASS 660
Query: 613 TVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLF 672
TVYKCVLKNCKPVAIK+LYSHYPQ LKEFETELETVGS+KHRNLVSLQGYSLS+ GNLLF
Sbjct: 661 TVYKCVLKNCKPVAIKKLYSHYPQYLKEFETELETVGSVKHRNLVSLQGYSLSTYGNLLF 720
Query: 673 YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNIL 732
YD+MENGSLWD+LHGPTKKKKLDWD RLKIALG+AQGLAYLHHDCSP IIHRDVKSSNIL
Sbjct: 721 YDYMENGSLWDLLHGPTKKKKLDWDLRLKIALGSAQGLAYLHHDCSPLIIHRDVKSSNIL 780
Query: 733 LDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLL 792
LDKDFE HL DFGIAKSLC SK++TSTYIMGTIGYIDPEYARTSRLTEKSDVYS+GIVLL
Sbjct: 781 LDKDFEPHLADFGIAKSLCPSKTHTSTYIMGTIGYIDPEYARTSRLTEKSDVYSYGIVLL 840
Query: 793 ELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQ 852
ELLTGRKAVDNE NLHHLILSKTAN+ VMETVDP+I+ TC+D+GAVKKVFQLALLC+K+Q
Sbjct: 841 ELLTGRKAVDNESNLHHLILSKTANDGVMETVDPDITTTCRDMGAVKKVFQLALLCTKKQ 900
Query: 853 PTDRPTMHEVSRVLGSLVPAPEPQKQPTSIPSAL---LSSAKVPCYKDEYANLKTPHMLN 909
P DRPTMHEV+RVLGSLVP+ KQ S L SSAK+ CYKDEYANLKTPH++N
Sbjct: 901 PVDRPTMHEVTRVLGSLVPSITLPKQTDSTQVLLPDSQSSAKMQCYKDEYANLKTPHLVN 960
Query: 910 CPSMSTSDAQLFLKFGEVISQNSE 933
CPSMSTSDAQLFLKFGEVISQNS
Sbjct: 961 CPSMSTSDAQLFLKFGEVISQNSH 984
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15225286|ref|NP_180201.1| LRR receptor-like serine/threonine-protein kinase ERECTA [Arabidopsis thaliana] gi|75319658|sp|Q42371.1|ERECT_ARATH RecName: Full=LRR receptor-like serine/threonine-protein kinase ERECTA; AltName: Full=Protein QUANTITATIVE RESISTANCE TO PLECTOSPHAERELLA 1; AltName: Full=Protein QUANTITATIVE RESISTANCE TO RALSTONIA SOLANACEARUM 1; AltName: Full=Protein TRANSPIRATION EFFICIENCY 1; Flags: Precursor gi|1345132|gb|AAC49302.1| ERECTA [Arabidopsis thaliana] gi|1389566|dbj|BAA11869.1| receptor protein kinase [Arabidopsis thaliana] gi|3075386|gb|AAC14518.1| putative receptor-like protein kinase, ERECTA [Arabidopsis thaliana] gi|14334874|gb|AAK59615.1| putative receptor protein kinase, ERECTA [Arabidopsis thaliana] gi|224589525|gb|ACN59296.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|330252731|gb|AEC07825.1| LRR receptor-like serine/threonine-protein kinase ERECTA [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1531 bits (3963), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 762/977 (77%), Positives = 844/977 (86%), Gaps = 58/977 (5%)
Query: 8 ILLLVFLFCLSF-GSVDSEDGATLLKIKKSFRDVDNVLYDWTDSPSSDYCVWRGITCDNV 66
I+LL FLFCLS +V SE+GATLL+IKKSF+DV+NVLYDWT SPSSDYCVWRG++C+NV
Sbjct: 7 IVLLGFLFCLSLVATVTSEEGATLLEIKKSFKDVNNVLYDWTTSPSSDYCVWRGVSCENV 66
Query: 67 TFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFN 126
TF V+ALNLS LNLDGEISPA+GDLK L SIDLRGNRLSGQIPDEIGDCSSL++LDLSFN
Sbjct: 67 TFNVVALNLSDLNLDGEISPAIGDLKSLLSIDLRGNRLSGQIPDEIGDCSSLQNLDLSFN 126
Query: 127 ELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKV------------------ 168
EL GDIPFSISKLKQLE LILKNNQLIGPIPSTLSQ+PNLK+
Sbjct: 127 ELSGDIPFSISKLKQLEQLILKNNQLIGPIPSTLSQIPNLKILDLAQNKLSGEIPRLIYW 186
Query: 169 ------FGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYN 222
GLRGNNLVG +SPD+CQL+GLWYFDVRNNSLTGSIP+ IGNCT+FQVLDLSYN
Sbjct: 187 NEVLQYLGLRGNNLVGNISPDLCQLTGLWYFDVRNNSLTGSIPETIGNCTAFQVLDLSYN 246
Query: 223 QLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNL 282
QL+GEIPF+IGFLQ+ATLSLQGNQL+GKIPSVIGLMQALAVLDLS N+LSG IPPILGNL
Sbjct: 247 QLTGEIPFDIGFLQVATLSLQGNQLSGKIPSVIGLMQALAVLDLSGNLLSGSIPPILGNL 306
Query: 283 SYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNH 342
++TEKLYLHSNKLTG IPPELGNM+KLHYLELNDN LTGHIPP LGKLTDLFDLNVANN
Sbjct: 307 TFTEKLYLHSNKLTGSIPPELGNMSKLHYLELNDNHLTGHIPPELGKLTDLFDLNVANND 366
Query: 343 LEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRI 402
LEGPIPD+LSSCTNLNSLNVHGNK +GTIP AFQ+LESMTYLNLS NNI+GPIPVELSRI
Sbjct: 367 LEGPIPDHLSSCTNLNSLNVHGNKFSGTIPRAFQKLESMTYLNLSSNNIKGPIPVELSRI 426
Query: 403 GNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNH 462
GNLDTLD+SNNKI+G IPS LGDLEHLLK+NLSRN +TG +PG+FGNLRS+MEIDLS+N
Sbjct: 427 GNLDTLDLSNNKINGIIPSSLGDLEHLLKMNLSRNHITGVVPGDFGNLRSIMEIDLSNND 486
Query: 463 LTGVIPEELSQLQNMFSLRLDYNNLSGDVMSLINCLSLSVL------------------- 503
++G IPEEL+QLQN+ LRL+ NNL+G+V SL NCLSL+VL
Sbjct: 487 ISGPIPEELNQLQNIILLRLENNNLTGNVGSLANCLSLTVLNVSHNNLVGDIPKNNNFSR 546
Query: 504 -----FIGNPGLCGYWLHSACRDSHPTERVTISKAAILGIALGALVILLMILVAACRPHN 558
FIGNPGLCG WL+S C DS T RV+IS+AAILGIA+G LVILLM+L+AACRPHN
Sbjct: 547 FSPDSFIGNPGLCGSWLNSPCHDSRRTVRVSISRAAILGIAIGGLVILLMVLIAACRPHN 606
Query: 559 PTHFPDGSLDKPVNYSTPKLVILHMNMALHVYEDIMRMTENLSEKYIIGYGASSTVYKCV 618
P F DGSLDKPV YSTPKLVILHMNMALHVYEDIMRMTENLSEKYIIG+GASSTVYKCV
Sbjct: 607 PPPFLDGSLDKPVTYSTPKLVILHMNMALHVYEDIMRMTENLSEKYIIGHGASSTVYKCV 666
Query: 619 LKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMEN 678
LKNCKPVAIKRLYSH PQ +K+FETELE + SIKHRNLVSLQ YSLS G+LLFYD++EN
Sbjct: 667 LKNCKPVAIKRLYSHNPQSMKQFETELEMLSSIKHRNLVSLQAYSLSHLGSLLFYDYLEN 726
Query: 679 GSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFE 738
GSLWD+LHGPTKKK LDWDTRLKIA GAAQGLAYLHHDCSPRIIHRDVKSSNILLDKD E
Sbjct: 727 GSLWDLLHGPTKKKTLDWDTRLKIAYGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDLE 786
Query: 739 AHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGR 798
A LTDFGIAKSLCVSKS+TSTY+MGTIGYIDPEYARTSRLTEKSDVYS+GIVLLELLT R
Sbjct: 787 ARLTDFGIAKSLCVSKSHTSTYVMGTIGYIDPEYARTSRLTEKSDVYSYGIVLLELLTRR 846
Query: 799 KAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPT 858
KAVD+E NLHHLI+SKT NN VME DP+I++TCKDLG VKKVFQLALLC+KRQP DRPT
Sbjct: 847 KAVDDESNLHHLIMSKTGNNEVMEMADPDITSTCKDLGVVKKVFQLALLCTKRQPNDRPT 906
Query: 859 MHEVSRVLGSLVPAPEPQKQPTSIPSALLSSAKVP--CYKDEYANLKTPHMLNCPSMSTS 916
MH+V+RVLGS + + +P P+A +SA + CY DEYANLKTPH +NC SMS S
Sbjct: 907 MHQVTRVLGSFMLSEQP-------PAATDTSATLAGSCYVDEYANLKTPHSVNCSSMSAS 959
Query: 917 DAQLFLKFGEVISQNSE 933
DAQLFL+FG+VISQNSE
Sbjct: 960 DAQLFLRFGQVISQNSE 976
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297825789|ref|XP_002880777.1| hypothetical protein ARALYDRAFT_481491 [Arabidopsis lyrata subsp. lyrata] gi|297326616|gb|EFH57036.1| hypothetical protein ARALYDRAFT_481491 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1529 bits (3959), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 760/977 (77%), Positives = 845/977 (86%), Gaps = 58/977 (5%)
Query: 8 ILLLVFLFCLSF-GSVDSEDGATLLKIKKSFRDVDNVLYDWTDSPSSDYCVWRGITCDNV 66
++LL FL CLS +V+S++GATLL+IKKSF+DV+NVLYDWT SPSSDYCVWRG+TC+NV
Sbjct: 7 VVLLGFLICLSLVATVNSDEGATLLEIKKSFKDVNNVLYDWTASPSSDYCVWRGVTCENV 66
Query: 67 TFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFN 126
TF V+ALNLS LNLDGEISPA+GDLK L SIDLRGNRLSGQIPDEIGDCSSL++LDLSFN
Sbjct: 67 TFNVVALNLSDLNLDGEISPAIGDLKSLLSIDLRGNRLSGQIPDEIGDCSSLQNLDLSFN 126
Query: 127 ELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKV------------------ 168
EL GDIPFSISKLKQLE LILKNNQLIGPIPSTLSQ+PNLK+
Sbjct: 127 ELSGDIPFSISKLKQLEQLILKNNQLIGPIPSTLSQIPNLKILDLAQNKLSGEIPRLIYW 186
Query: 169 ------FGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYN 222
GLRGNNLVG +SPD+CQL+GLWYFDVRNNSLTGSIP+ IGNCT+FQVLDLSYN
Sbjct: 187 NEVLQYLGLRGNNLVGNISPDLCQLTGLWYFDVRNNSLTGSIPETIGNCTAFQVLDLSYN 246
Query: 223 QLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNL 282
QL+GEIPF+IGFLQ+ATLSLQGNQL+GKIPSVIGLMQALAVLDLS N+LSGPIPPILGNL
Sbjct: 247 QLTGEIPFDIGFLQVATLSLQGNQLSGKIPSVIGLMQALAVLDLSGNLLSGPIPPILGNL 306
Query: 283 SYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNH 342
++TEKLYLHSNKLTG IPPELGNM+KLHYLELNDN LTGHIPP LGKLTDLFDLNVANN
Sbjct: 307 TFTEKLYLHSNKLTGSIPPELGNMSKLHYLELNDNHLTGHIPPELGKLTDLFDLNVANND 366
Query: 343 LEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRI 402
LEGPIPD+LSSCTNLNSLNVHGNK +GTIP AFQ+LESMTYLNLS NNI+GPIPVELSRI
Sbjct: 367 LEGPIPDHLSSCTNLNSLNVHGNKFSGTIPRAFQKLESMTYLNLSNNNIKGPIPVELSRI 426
Query: 403 GNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNH 462
GNLDTLD+SNNKI+G IPS LGDLEHLLK+NLSRN +TG +PG+FGNLRS+MEIDLS+N
Sbjct: 427 GNLDTLDLSNNKINGIIPSSLGDLEHLLKMNLSRNHITGVVPGDFGNLRSIMEIDLSNND 486
Query: 463 LTGVIPEELSQLQNMFSLRLDYNNLSGDVMSLINCLSLSVL------------------- 503
++G IPEEL+QLQN+ LRL+ NNL+G+V SL NCLSL+VL
Sbjct: 487 ISGPIPEELNQLQNIVLLRLENNNLTGNVGSLANCLSLTVLNVSHNNLVGDIPKNNNFSR 546
Query: 504 -----FIGNPGLCGYWLHSACRDSHPTERVTISKAAILGIALGALVILLMILVAACRPHN 558
FIGNPGLCG WL+S C DS PT RV+IS+AAILGIA+G LVILLM+L+AAC+PHN
Sbjct: 547 FSPDSFIGNPGLCGSWLNSPCHDSRPTVRVSISRAAILGIAIGGLVILLMVLIAACQPHN 606
Query: 559 PTHFPDGSLDKPVNYSTPKLVILHMNMALHVYEDIMRMTENLSEKYIIGYGASSTVYKCV 618
P DGSLDKPV YSTPKLVILHMNMALHVYEDIMRMTENLSEKYIIG+GASSTVYKCV
Sbjct: 607 PPPVLDGSLDKPVTYSTPKLVILHMNMALHVYEDIMRMTENLSEKYIIGHGASSTVYKCV 666
Query: 619 LKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMEN 678
LKNCKPVAIKRLYSH PQ +K+FETELE + SIKHRNLVSLQ YSLS G+LLFYD++EN
Sbjct: 667 LKNCKPVAIKRLYSHNPQSMKQFETELEMLSSIKHRNLVSLQAYSLSPLGSLLFYDYLEN 726
Query: 679 GSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFE 738
GSLWD+LHGPTKKK LDWDTRLKIA GAAQGLAYLHHDCSPRIIHRDVKSSNILLDKD E
Sbjct: 727 GSLWDLLHGPTKKKTLDWDTRLKIAYGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDLE 786
Query: 739 AHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGR 798
A LTDFGIAKSLCVSKS+TSTY+MGTIGYIDPEYARTSRLTEKSDVYS+GIVLLELLT R
Sbjct: 787 ARLTDFGIAKSLCVSKSHTSTYVMGTIGYIDPEYARTSRLTEKSDVYSYGIVLLELLTRR 846
Query: 799 KAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPT 858
KAVD+E NLHHLI+SKT NN VME DP+I++TCKDLG VKKVFQLALLC+KRQP DRPT
Sbjct: 847 KAVDDESNLHHLIMSKTGNNEVMEMADPDITSTCKDLGVVKKVFQLALLCTKRQPNDRPT 906
Query: 859 MHEVSRVLGSLVPAPEPQKQPTSIPSALLSSAKVP--CYKDEYANLKTPHMLNCPSMSTS 916
MH+V+RVLGS + + +P P+A +SA + CY DEYANLKTPH +NC SMS S
Sbjct: 907 MHQVTRVLGSFMLSEQP-------PAATDTSATLAGSCYVDEYANLKTPHSVNCSSMSAS 959
Query: 917 DAQLFLKFGEVISQNSE 933
DAQLFL+FG+VISQNSE
Sbjct: 960 DAQLFLRFGQVISQNSE 976
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357437333|ref|XP_003588942.1| LRR receptor-like serine/threonine-protein kinase ERECTA [Medicago truncatula] gi|355477990|gb|AES59193.1| LRR receptor-like serine/threonine-protein kinase ERECTA [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1514 bits (3920), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 757/985 (76%), Positives = 838/985 (85%), Gaps = 59/985 (5%)
Query: 1 MAFRLEFILLLVFLFCLSFGSVDSEDGATLLKIKKSFRDVDNVLYDWTDSPSSDYCVWRG 60
MAF + +LV L C + SV+S+DG+T+L+IKKSFRDVDNVLYDWTDSP+SDYC WRG
Sbjct: 1 MAFEFGVVFVLVLLSCFNVNSVESDDGSTMLEIKKSFRDVDNVLYDWTDSPTSDYCAWRG 60
Query: 61 ITCDNVTFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKS 120
ITCDNVTF V+ALNLSGLNLDGEISP +G L+ L SIDL+ NRLSGQIPDEIGDCS L++
Sbjct: 61 ITCDNVTFNVVALNLSGLNLDGEISPTIGKLQSLVSIDLKQNRLSGQIPDEIGDCSLLQT 120
Query: 121 LDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVF----------- 169
LD SFNE+ GDIPFSISKLKQLEFL+L+NNQLIGPIPSTLSQ+PNLK
Sbjct: 121 LDFSFNEIRGDIPFSISKLKQLEFLVLRNNQLIGPIPSTLSQIPNLKYLDLAHNNLSGEI 180
Query: 170 -------------GLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQV 216
GLRGNNLVG+LSPDMCQL+GLWYFDV+NNSLTG+IP+NIGNCTSFQV
Sbjct: 181 PRLLYWNEVLQYLGLRGNNLVGSLSPDMCQLTGLWYFDVKNNSLTGNIPENIGNCTSFQV 240
Query: 217 LDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIP 276
LDLS N+L+GEIPFNIGFLQIATLSLQGN L+G IP V+GLMQAL VLDLS NML+G IP
Sbjct: 241 LDLSSNELTGEIPFNIGFLQIATLSLQGNNLSGHIPPVLGLMQALTVLDLSYNMLTGSIP 300
Query: 277 PILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDL 336
PILGNL+YT KLYLH NKLTG IPPELGNMT+L+YLELNDN L+GHIPP LGK
Sbjct: 301 PILGNLTYTAKLYLHGNKLTGFIPPELGNMTQLNYLELNDNLLSGHIPPELGK------- 353
Query: 337 NVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIP 396
NVANN+LEGPIP +LS CT+L LNVHGNKLNGTIP F LESMT LNLS NN++GPIP
Sbjct: 354 NVANNNLEGPIPSDLSLCTSLTGLNVHGNKLNGTIPATFHSLESMTSLNLSSNNLQGPIP 413
Query: 397 VELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEI 456
+ELSRIGNLDTLD+SNNKISG IPS LGDLEHLLKLNLSRN LTG IP EFGNL+S+MEI
Sbjct: 414 IELSRIGNLDTLDISNNKISGPIPSSLGDLEHLLKLNLSRNNLTGPIPAEFGNLKSIMEI 473
Query: 457 DLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDVMSLINCLSLSVL------------- 503
DLSHN L+ +IP EL QLQ++ SLRL+ N+L+GDV SL+NCLSLS+L
Sbjct: 474 DLSHNQLSEMIPVELGQLQSIASLRLENNDLTGDVTSLVNCLSLSLLNVSYNQLVGLIPT 533
Query: 504 -----------FIGNPGLCGYWLHSACRDSHPTERVTISKAAILGIALGALVILLMILVA 552
F+GNPGLCG WL+S C+ SHPTERVT+SKAAILGI LGALVILLMIL+A
Sbjct: 534 SNNFTRFSPDSFMGNPGLCGNWLNSPCQGSHPTERVTLSKAAILGITLGALVILLMILLA 593
Query: 553 ACRPHNPTHFPDGSLDKP----VNYSTPKLVILHMNMALHVYEDIMRMTENLSEKYIIGY 608
A RPH+P+ FPDGSL+KP + +S PKLVILHMNMALHVY+DIMRMTENLSEKYI+G
Sbjct: 594 AFRPHHPSPFPDGSLEKPGDKSIIFSPPKLVILHMNMALHVYDDIMRMTENLSEKYIVGS 653
Query: 609 GASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSG 668
GASSTVYKCVLKNCKPVAIKRLYSHYPQ LKEFETEL TVGSIKHRNLV LQGYSLS G
Sbjct: 654 GASSTVYKCVLKNCKPVAIKRLYSHYPQYLKEFETELATVGSIKHRNLVCLQGYSLSPYG 713
Query: 669 NLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKS 728
+LLFYD+MENGSLWD+LHGP+KKKKLDW RLKIALGAAQGL+YLHHDCSPRIIHRDVKS
Sbjct: 714 HLLFYDYMENGSLWDLLHGPSKKKKLDWHLRLKIALGAAQGLSYLHHDCSPRIIHRDVKS 773
Query: 729 SNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFG 788
SNILLD DFE HLTDFGIAKSLC +KS+TSTYIMGTIGYIDPEYARTSRLTEKSDVYS+G
Sbjct: 774 SNILLDSDFEPHLTDFGIAKSLCPTKSHTSTYIMGTIGYIDPEYARTSRLTEKSDVYSYG 833
Query: 789 IVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLC 848
IVLLELLTGRKAVDNE NLHHLILSKTA+NAVMETVDP+++ATCKDLGAVKKVFQLALLC
Sbjct: 834 IVLLELLTGRKAVDNESNLHHLILSKTASNAVMETVDPDVTATCKDLGAVKKVFQLALLC 893
Query: 849 SKRQPTDRPTMHEVSRVLGSLVPAPEPQKQPTSIPSALLSSAKVPCYKDEYANLKTPHML 908
+KRQP DRPTMHEVSRVLGSL+P+ P KQ T + A SAKVPCY DEYANLKTPH++
Sbjct: 894 TKRQPADRPTMHEVSRVLGSLMPSVAPAKQLTPLQPASHPSAKVPCYMDEYANLKTPHLV 953
Query: 909 NCPSMSTSDAQLFLKFGEVISQNSE 933
NCPSMSTSDAQLFLKFGEVISQNSE
Sbjct: 954 NCPSMSTSDAQLFLKFGEVISQNSE 978
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 933 | ||||||
| TAIR|locus:2005507 | 976 | ER "ERECTA" [Arabidopsis thali | 0.915 | 0.875 | 0.567 | 2e-246 | |
| TAIR|locus:2167948 | 966 | ERL1 "ERECTA-like 1" [Arabidop | 0.904 | 0.873 | 0.480 | 3.6e-199 | |
| TAIR|locus:2182855 | 967 | ERL2 "ERECTA-like 2" [Arabidop | 0.868 | 0.837 | 0.486 | 6.8e-198 | |
| TAIR|locus:2160791 | 1102 | AT5G63930 [Arabidopsis thalian | 0.546 | 0.462 | 0.370 | 4e-138 | |
| TAIR|locus:2046525 | 1124 | AT2G33170 [Arabidopsis thalian | 0.531 | 0.441 | 0.364 | 2.5e-137 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.540 | 0.403 | 0.366 | 7.5e-137 | |
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.545 | 0.462 | 0.362 | 1.7e-133 | |
| TAIR|locus:2156349 | 1252 | GSO2 "GASSHO 2" [Arabidopsis t | 0.538 | 0.400 | 0.355 | 6.1e-131 | |
| UNIPROTKB|P93194 | 1109 | INRPK1 "Receptor-like protein | 0.518 | 0.436 | 0.331 | 2e-127 | |
| TAIR|locus:2085949 | 1141 | AT3G24240 [Arabidopsis thalian | 0.543 | 0.444 | 0.344 | 9.2e-126 |
| TAIR|locus:2005507 ER "ERECTA" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2374 (840.7 bits), Expect = 2.0e-246, P = 2.0e-246
Identities = 490/863 (56%), Positives = 596/863 (69%)
Query: 73 LNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDI 132
L+LS L G+I ++ LK L+ + L+ N+L G IP + +LK LDL+ N+L G+I
Sbjct: 121 LDLSFNELSGDIPFSISKLKQLEQLILKNNQLIGPIPSTLSQIPNLKILDLAQNKLSGEI 180
Query: 133 PFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWY 192
P I + L++L L+ N L+G I L QL L F +R N+L G++ + +
Sbjct: 181 PRLIYWNEVLQYLGLRGNNLVGNISPDLCQLTGLWYFDVRNNSLTGSIPETIGNCTAFQV 240
Query: 193 FDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQ-IATLSLQGNQLTGKI 251
D+ N LTG IP +IG L L NQLSG+IP IG +Q +A L L GN L+G I
Sbjct: 241 LDLSYNQLTGEIPFDIG-FLQVATLSLQGNQLSGKIPSVIGLMQALAVLDLSGNLLSGSI 299
Query: 252 PSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHY 311
P ++G + L L N L+G IPP LGN+S L L+ N LTGHIPPELG +T L
Sbjct: 300 PPILGNLTFTEKLYLHSNKLTGSIPPELGNMSKLHYLELNDNHLTGHIPPELGKLTDLFD 359
Query: 312 LELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDXXXXXXXXXXXXVHGNKLNGTI 371
L + +N L G IP L T+L LNV N G IP + N + G I
Sbjct: 360 LNVANNDLEGPIPDHLSSCTNLNSLNVHGNKFSGTIPRAFQKLESMTYLNLSSNNIKGPI 419
Query: 372 PPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLK 431
P R+ ++ L+LS N I G IP L + +L +++S N I+G +P G+L +++
Sbjct: 420 PVELSRIGNLDTLDLSNNKINGIIPSSLGDLEHLLKMNLSRNHITGVVPGDFGNLRSIME 479
Query: 432 LNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDV 491
++LS N ++G IP E L++++ + L +N+LTG + L+ ++ L + +NNL GD+
Sbjct: 480 IDLSNNDISGPIPEELNQLQNIILLRLENNNLTGNVGS-LANCLSLTVLNVSHNNLVGDI 538
Query: 492 MSLINCLSLSV-LFIGNPGLCGYWLHSACRDSHPTERVTISKXXXXXXXXXXXXXXXXXX 550
N S FIGNPGLCG WL+S C DS T RV+IS+
Sbjct: 539 PKNNNFSRFSPDSFIGNPGLCGSWLNSPCHDSRRTVRVSISRAAILGIAIGGLVILLMVL 598
Query: 551 XXXCRPHNPTHFPDGSLDKPVNYSTPKLVILHMNMALHVYEDIMRMTENLSEKYIIGYGA 610
CRPHNP F DGSLDKPV YSTPKLVILHMNMALHVYEDIMRMTENLSEKYIIG+GA
Sbjct: 599 IAACRPHNPPPFLDGSLDKPVTYSTPKLVILHMNMALHVYEDIMRMTENLSEKYIIGHGA 658
Query: 611 SSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNL 670
SSTVYKCVLKNCKPVAIKRLYSH PQ +K+FETELE + SIKHRNLVSLQ YSLS G+L
Sbjct: 659 SSTVYKCVLKNCKPVAIKRLYSHNPQSMKQFETELEMLSSIKHRNLVSLQAYSLSHLGSL 718
Query: 671 LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSN 730
LFYD++ENGSLWD+LHGPTKKK LDWDTRLKIA GAAQGLAYLHHDCSPRIIHRDVKSSN
Sbjct: 719 LFYDYLENGSLWDLLHGPTKKKTLDWDTRLKIAYGAAQGLAYLHHDCSPRIIHRDVKSSN 778
Query: 731 ILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIV 790
ILLDKD EA LTDFGIAKSLCVSKS+TSTY+MGTIGYIDPEYARTSRLTEKSDVYS+GIV
Sbjct: 779 ILLDKDLEARLTDFGIAKSLCVSKSHTSTYVMGTIGYIDPEYARTSRLTEKSDVYSYGIV 838
Query: 791 LLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSK 850
LLELLT RKAVD+E NLHHLI+SKT NN VME DP+I++TCKDLG VKKVFQLALLC+K
Sbjct: 839 LLELLTRRKAVDDESNLHHLIMSKTGNNEVMEMADPDITSTCKDLGVVKKVFQLALLCTK 898
Query: 851 RQPTDRPTMHEVSRVLGSLVPAPEPQKQPTSIPSALLSSAKVPCYKDEYANLKTPHMLNC 910
RQP DRPTMH+V+RVLGS + + +P + SA L+ + CY DEYANLKTPH +NC
Sbjct: 899 RQPNDRPTMHQVTRVLGSFMLSEQPPAATDT--SATLAGS---CYVDEYANLKTPHSVNC 953
Query: 911 PSMSTSDAQLFLKFGEVISQNSE 933
SMS SDAQLFL+FG+VISQNSE
Sbjct: 954 SSMSASDAQLFLRFGQVISQNSE 976
|
|
| TAIR|locus:2167948 ERL1 "ERECTA-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1928 (683.7 bits), Expect = 3.6e-199, P = 3.6e-199
Identities = 416/866 (48%), Positives = 555/866 (64%)
Query: 69 TVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNEL 128
+++ L+LS L G+I ++ LK L++++L+ N+L+G +P + +LK LDL+ N L
Sbjct: 120 SLVYLDLSENLLYGDIPFSISKLKQLETLNLKNNQLTGPVPATLTQIPNLKRLDLAGNHL 179
Query: 129 YGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLS 188
G+I + + L++L L+ N L G + S + QL L F +RGNNL GT+ + +
Sbjct: 180 TGEISRLLYWNEVLQYLGLRGNMLTGTLSSDMCQLTGLWYFDVRGNNLTGTIPESIGNCT 239
Query: 189 GLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQ-IATLSLQGNQL 247
D+ N +TG IP NIG L L N+L+G IP IG +Q +A L L N+L
Sbjct: 240 SFQILDISYNQITGEIPYNIG-FLQVATLSLQGNRLTGRIPEVIGLMQALAVLDLSDNEL 298
Query: 248 TGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMT 307
G IP ++G + L L NML+GPIP LGN+S L L+ NKL G IPPELG +
Sbjct: 299 VGPIPPILGNLSFTGKLYLHGNMLTGPIPSELGNMSRLSYLQLNDNKLVGTIPPELGKLE 358
Query: 308 KLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDXXXXXXXXXXXXVHGNKL 367
+L L L +N+L G IP + L NV N L G IP + N
Sbjct: 359 QLFELNLANNRLVGPIPSNISSCAALNQFNVHGNLLSGSIPLAFRNLGSLTYLNLSSNNF 418
Query: 368 NGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLE 427
G IP + ++ L+LS NN G IP+ L + +L L++S N +SG +P+ G+L
Sbjct: 419 KGKIPVELGHIINLDKLDLSGNNFSGSIPLTLGDLEHLLILNLSRNHLSGQLPAEFGNLR 478
Query: 428 HLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNL 487
+ +++S N L+G IP E G L+++ + L++N L G IP++L+ + +L + +NNL
Sbjct: 479 SIQMIDVSFNLLSGVIPTELGQLQNLNSLILNNNKLHGKIPDQLTNCFTLVNLNVSFNNL 538
Query: 488 SGDVMSLINCLSLS-VLFIGNPGLCGYWLHSACRDSHPTERVTISKXXXXXXXXXXXXXX 546
SG V + N + F+GNP LCG W+ S C P RV S+
Sbjct: 539 SGIVPPMKNFSRFAPASFVGNPYLCGNWVGSICGPL-PKSRV-FSRGALICIVLGVITLL 596
Query: 547 XXXXXXXCRPHNPTHFPDGSLDKPVNYSTPKLVILHMNMALHVYEDIMRMTENLSEKYII 606
+ GS K T KLVILHM+MA+H ++DIMR+TENL+EK+II
Sbjct: 597 CMIFLAVYKSMQQKKILQGS-SKQAEGLT-KLVILHMDMAIHTFDDIMRVTENLNEKFII 654
Query: 607 GYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSS 666
GYGASSTVYKC LK+ +P+AIKRLY+ YP L+EFETELET+GSI+HRN+VSL GY+LS
Sbjct: 655 GYGASSTVYKCALKSSRPIAIKRLYNQYPHNLREFETELETIGSIRHRNIVSLHGYALSP 714
Query: 667 SGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDV 726
+GNLLFYD+MENGSLWD+LHG KK KLDW+TRLKIA+GAAQGLAYLHHDC+PRIIHRD+
Sbjct: 715 TGNLLFYDYMENGSLWDLLHGSLKKVKLDWETRLKIAVGAAQGLAYLHHDCTPRIIHRDI 774
Query: 727 KSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYS 786
KSSNILLD++FEAHL+DFGIAKS+ SK++ STY++GTIGYIDPEYARTSR+ EKSD+YS
Sbjct: 775 KSSNILLDENFEAHLSDFGIAKSIPASKTHASTYVLGTIGYIDPEYARTSRINEKSDIYS 834
Query: 787 FGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLAL 846
FGIVLLELLTG+KAVDNE NLH LILSK +N VME VDPE++ TC DLG ++K FQLAL
Sbjct: 835 FGIVLLELLTGKKAVDNEANLHQLILSKADDNTVMEAVDPEVTVTCMDLGHIRKTFQLAL 894
Query: 847 LCSKRQPTDRPTMHEVSRVLGSLVPAPEPQKQPTSIPSALLSSAKVPCYKDEYANLKTPH 906
LC+KR P +RPTM EVSRVL SLVP+ + K+ +PS S+ K+ ++E N
Sbjct: 895 LCTKRNPLERPTMLEVSRVLLSLVPSLQVAKK---LPSLDHSTKKLQ-QENEVRN----- 945
Query: 907 MLNCPSMSTSDAQLFLKFGEVISQNS 932
P S Q F++F EVIS++S
Sbjct: 946 ----PDAEAS--QWFVQFREVISKSS 965
|
|
| TAIR|locus:2182855 ERL2 "ERECTA-like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1916 (679.5 bits), Expect = 6.8e-198, P = 6.8e-198
Identities = 399/820 (48%), Positives = 528/820 (64%)
Query: 63 CDNVTFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLD 122
C ++ + + NL L G+I ++ LK L+ ++L+ N+L+G IP + +LK+LD
Sbjct: 120 CVSLAYVDFSTNL----LFGDIPFSISKLKQLEFLNLKNNQLTGPIPATLTQIPNLKTLD 175
Query: 123 LSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSP 182
L+ N+L G+IP + + L++L L+ N L G + + QL L F +RGNNL GT+
Sbjct: 176 LARNQLTGEIPRLLYWNEVLQYLGLRGNMLTGTLSPDMCQLTGLWYFDVRGNNLTGTIPE 235
Query: 183 DMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQ-IATLS 241
+ + DV N +TG IP NIG L L N+L+G IP IG +Q +A L
Sbjct: 236 SIGNCTSFEILDVSYNQITGVIPYNIG-FLQVATLSLQGNKLTGRIPEVIGLMQALAVLD 294
Query: 242 LQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPP 301
L N+LTG IP ++G + L L N L+G IPP LGN+S L L+ N+L G IPP
Sbjct: 295 LSDNELTGPIPPILGNLSFTGKLYLHGNKLTGQIPPELGNMSRLSYLQLNDNELVGKIPP 354
Query: 302 ELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDXXXXXXXXXXXX 361
ELG + +L L L +N L G IP + L NV N L G +P
Sbjct: 355 ELGKLEQLFELNLANNNLVGLIPSNISSCAALNQFNVHGNFLSGAVPLEFRNLGSLTYLN 414
Query: 362 VHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPS 421
+ N G IP + ++ L+LS NN G IP+ L + +L L++S N ++G++P+
Sbjct: 415 LSSNSFKGKIPAELGHIINLDTLDLSGNNFSGSIPLTLGDLEHLLILNLSRNHLNGTLPA 474
Query: 422 PLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLR 481
G+L + +++S N L G IP E G L+++ + L++N + G IP++L+ ++ +L
Sbjct: 475 EFGNLRSIQIIDVSFNFLAGVIPTELGQLQNINSLILNNNKIHGKIPDQLTNCFSLANLN 534
Query: 482 LDYNNLSGDVMSLINCLSLS-VLFIGNPGLCGYWLHSACRDSHPTERVTISKXXXXXXXX 540
+ +NNLSG + + N S F GNP LCG W+ S C S P +V ++
Sbjct: 535 ISFNNLSGIIPPMKNFTRFSPASFFGNPFLCGNWVGSICGPSLPKSQV-FTRVAVICMVL 593
Query: 541 XXXXXXXXXXXXXCRPHNPTHFPDGSLDKPVNYSTPKLVILHMNMALHVYEDIMRMTENL 600
+ GS +P ST KLVILHM+MA+H ++DIMR+TENL
Sbjct: 594 GFITLICMIFIAVYKSKQQKPVLKGSSKQPEG-ST-KLVILHMDMAIHTFDDIMRVTENL 651
Query: 601 SEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQ 660
EKYIIGYGASSTVYKC K +P+AIKR+Y+ YP +EFETELET+GSI+HRN+VSL
Sbjct: 652 DEKYIIGYGASSTVYKCTSKTSRPIAIKRIYNQYPSNFREFETELETIGSIRHRNIVSLH 711
Query: 661 GYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPR 720
GY+LS GNLLFYD+MENGSLWD+LHGP KK KLDW+TRLKIA+GAAQGLAYLHHDC+PR
Sbjct: 712 GYALSPFGNLLFYDYMENGSLWDLLHGPGKKVKLDWETRLKIAVGAAQGLAYLHHDCTPR 771
Query: 721 IIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTE 780
IIHRD+KSSNILLD +FEA L+DFGIAKS+ +K+Y STY++GTIGYIDPEYARTSRL E
Sbjct: 772 IIHRDIKSSNILLDGNFEARLSDFGIAKSIPATKTYASTYVLGTIGYIDPEYARTSRLNE 831
Query: 781 KSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKK 840
KSD+YSFGIVLLELLTG+KAVDNE NLH +ILSK +N VME VD E+S TC D G +KK
Sbjct: 832 KSDIYSFGIVLLELLTGKKAVDNEANLHQMILSKADDNTVMEAVDAEVSVTCMDSGHIKK 891
Query: 841 VFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAPEPQKQPT 880
FQLALLC+KR P +RPTM EVSRVL SLVP+P P+K P+
Sbjct: 892 TFQLALLCTKRNPLERPTMQEVSRVLLSLVPSPPPKKLPS 931
|
|
| TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 777 (278.6 bits), Expect = 4.0e-138, Sum P(2) = 4.0e-138
Identities = 191/516 (37%), Positives = 276/516 (53%)
Query: 1 MAFRLEFILLLVFLFCLSFGSVDSEDGATLLKIKKSFRDVDNVLYDWTDSPSSDYCVWRG 60
M + FI LL+ L ++ E G LL+IK F D L +W + S C W G
Sbjct: 6 MKLAVFFISLLLILLISETTGLNLE-GQYLLEIKSKFVDAKQNLRNWNSNDSVP-CGWTG 63
Query: 61 ITCDNVTFT--VIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSL 118
+ C N + V++LNLS + L G++SP++G L L+ +DL N LSG+IP EIG+CSSL
Sbjct: 64 VMCSNYSSDPEVLSLNLSSMVLSGKLSPSIGGLVHLKQLDLSYNGLSGKIPKEIGNCSSL 123
Query: 119 KSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVG 178
+ L L+ N+ G+IP I KL LE LI+ NN++ G +P + L +L NN+ G
Sbjct: 124 EILKLNNNQFDGEIPVEIGKLVSLENLIIYNNRISGSLPVEIGNLLSLSQLVTYSNNISG 183
Query: 179 TLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQ-I 237
L + L L F N ++GS+P IG C S +L L+ NQLSGE+P IG L+ +
Sbjct: 184 QLPRSIGNLKRLTSFRAGQNMISGSLPSEIGGCESLVMLGLAQNQLSGELPKEIGMLKKL 243
Query: 238 ATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTG 297
+ + L N+ +G IP I +L L L N L GPIP LG+L E LYL+ N L G
Sbjct: 244 SQVILWENEFSGFIPREISNCTSLETLALYKNQLVGPIPKELGDLQSLEFLYLYRNGLNG 303
Query: 298 HIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDXXXXXXXX 357
IP E+GN++ ++ ++N LTG IP LG + L L + N L G IP
Sbjct: 304 TIPREIGNLSYAIEIDFSENALTGEIPLELGNIEGLELLYLFENQLTGTIPVELSTLKNL 363
Query: 358 XXXXVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISG 417
+ N L G IP FQ L + L L N++ G IP +L +L LDMS+N +SG
Sbjct: 364 SKLDLSINALTGPIPLGFQYLRGLFMLQLFQNSLSGTIPPKLGWYSDLWVLDMSDNHLSG 423
Query: 418 SIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNM 477
IPS L +++ LNL N L+G IP ++++++ L+ N+L G P L + N+
Sbjct: 424 RIPSYLCLHSNMIILNLGTNNLSGNIPTGITTCKTLVQLRLARNNLVGRFPSNLCKQVNV 483
Query: 478 FSLRLDYNNLSGDVMSLI-NCLSLSVLFIGNPGLCG 512
++ L N G + + NC +L L + + G G
Sbjct: 484 TAIELGQNRFRGSIPREVGNCSALQRLQLADNGFTG 519
|
|
| TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 767 (275.1 bits), Expect = 2.5e-137, Sum P(2) = 2.5e-137
Identities = 185/508 (36%), Positives = 279/508 (54%)
Query: 8 ILLLVFLFCLSFGSVDSEDGATLLKIK-KSFRDVDNVLYDWTDSPSSDYCVWRGITCDNV 66
+L L+ L + S++S DG LL++K + F+D N L++W + C W G+ C +
Sbjct: 19 VLFLLTLLVWTSESLNS-DGQFLLELKNRGFQDSLNRLHNWNGIDETP-CNWIGVNCSSQ 76
Query: 67 -------TFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLK 119
+ V +L+LS +NL G +SP++G L +L ++L N L+G IP EIG+CS L+
Sbjct: 77 GSSSSSNSLVVTSLDLSSMNLSGIVSPSIGGLVNLVYLNLAYNALTGDIPREIGNCSKLE 136
Query: 120 SLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGT 179
+ L+ N+ G IP I+KL QL + NN+L GP+P + L NL+ NNL G
Sbjct: 137 VMFLNNNQFGGSIPVEINKLSQLRSFNICNNKLSGPLPEEIGDLYNLEELVAYTNNLTGP 196
Query: 180 LSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFL-QIA 238
L + L+ L F N +G+IP IG C + ++L L+ N +SGE+P IG L ++
Sbjct: 197 LPRSLGNLNKLTTFRAGQNDFSGNIPTEIGKCLNLKLLGLAQNFISGELPKEIGMLVKLQ 256
Query: 239 TLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGH 298
+ L N+ +G IP IG + +L L L N L GPIP +GN+ +KLYL+ N+L G
Sbjct: 257 EVILWQNKFSGFIPKDIGNLTSLETLALYGNSLVGPIPSEIGNMKSLKKLYLYQNQLNGT 316
Query: 299 IPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDXXXXXXXXX 358
IP ELG ++K+ ++ ++N L+G IP L K+++L L + N L G IP+
Sbjct: 317 IPKELGKLSKVMEIDFSENLLSGEIPVELSKISELRLLYLFQNKLTGIIPNELSKLRNLA 376
Query: 359 XXXVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGS 418
+ N L G IPP FQ L SM L L N++ G IP L L +D S N++SG
Sbjct: 377 KLDLSINSLTGPIPPGFQNLTSMRQLQLFHNSLSGVIPQGLGLYSPLWVVDFSENQLSGK 436
Query: 419 IPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMF 478
IP + +L+ LNL N++ G IP +S++++ + N LTG P EL +L N+
Sbjct: 437 IPPFICQQSNLILLNLGSNRIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPTELCKLVNLS 496
Query: 479 SLRLDYNNLSGDVMSLIN-CLSLSVLFI 505
++ LD N SG + I C L L +
Sbjct: 497 AIELDQNRFSGPLPPEIGTCQKLQRLHL 524
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 766 (274.7 bits), Expect = 7.5e-137, Sum P(2) = 7.5e-137
Identities = 189/515 (36%), Positives = 273/515 (53%)
Query: 8 ILLLVFLFCLS-FGS--VDSEDGATLLKIKKSF---RDVDNVLYDWTDSPSSDYCVWRGI 61
+LLL+F+ C S G + + D TLL++KKS D+ L W +S + +YC W G+
Sbjct: 5 VLLLLFILCFSGLGQPGIINNDLQTLLEVKKSLVTNPQEDDPLRQW-NSDNINYCSWTGV 63
Query: 62 TCDNV-TFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKS 120
TCDN F VIALNL+GL L G ISP G +L +DL N L G IP + + +SL+S
Sbjct: 64 TCDNTGLFRVIALNLTGLGLTGSISPWFGRFDNLIHLDLSSNNLVGPIPTALSNLTSLES 123
Query: 121 LDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTL 180
L L N+L G+IP + L + L + +N+L+G IP TL L NL++ L L G +
Sbjct: 124 LFLFSNQLTGEIPSQLGSLVNIRSLRIGDNELVGDIPETLGNLVNLQMLALASCRLTGPI 183
Query: 181 SPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQ-IAT 239
+ +L + +++N L G IP +GNC+ V + N L+G IP +G L+ +
Sbjct: 184 PSQLGRLVRVQSLILQDNYLEGPIPAELGNCSDLTVFTAAENMLNGTIPAELGRLENLEI 243
Query: 240 LSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHI 299
L+L N LTG+IPS +G M L L L N L G IP L +L + L L +N LTG I
Sbjct: 244 LNLANNSLTGEIPSQLGEMSQLQYLSLMANQLQGLIPKSLADLGNLQTLDLSANNLTGEI 303
Query: 300 PPELGNMTKLHYLELNDNQLTGHIPPAL-GKLTDLFDLNVANNHLEGPIPDXXXXXXXXX 358
P E NM++L L L +N L+G +P ++ T+L L ++ L G IP
Sbjct: 304 PEEFWNMSQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQLSGEIPVELSKCQSLK 363
Query: 359 XXXVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGS 418
+ N L G+IP A L +T L L N + G + +S + NL L + +N + G
Sbjct: 364 QLDLSNNSLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGK 423
Query: 419 IPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMF 478
+P + L L L L N+ +G IP E GN S+ ID+ NH G IP + +L+ +
Sbjct: 424 LPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKELN 483
Query: 479 SLRLDYNNLSGDV-MSLINCLSLSVLFIGNPGLCG 512
L L N L G + SL NC L++L + + L G
Sbjct: 484 LLHLRQNELVGGLPASLGNCHQLNILDLADNQLSG 518
|
|
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 756 (271.2 bits), Expect = 1.7e-133, Sum P(2) = 1.7e-133
Identities = 187/516 (36%), Positives = 275/516 (53%)
Query: 1 MAFRLEFILLLVFLFCLSFGSVDS--EDGATLLKIKKSFRDVDNVLYDWTDSPSSDYCVW 58
M R+ F L +V L SF V S E+G LL+ K D + L W S+ C W
Sbjct: 1 MRGRICF-LAIVILCSFSFILVRSLNEEGRVLLEFKAFLNDSNGYLASWNQLDSNP-CNW 58
Query: 59 RGITCDNVTFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSL 118
GI C ++ TV +++L+G+NL G +SP + L L+ +++ N +SG IP ++ C SL
Sbjct: 59 TGIACTHLR-TVTSVDLNGMNLSGTLSPLICKLHGLRKLNVSTNFISGPIPQDLSLCRSL 117
Query: 119 KSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVG 178
+ LDL N +G IP ++ + L+ L L N L G IP + L +L+ + NNL G
Sbjct: 118 EVLDLCTNRFHGVIPIQLTMIITLKKLYLCENYLFGSIPRQIGNLSSLQELVIYSNNLTG 177
Query: 179 TLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIA 238
+ P M +L L N +G IP I C S +VL L+ N L G +P + LQ
Sbjct: 178 VIPPSMAKLRQLRIIRAGRNGFSGVIPSEISGCESLKVLGLAENLLEGSLPKQLEKLQNL 237
Query: 239 T-LSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTG 297
T L L N+L+G+IP +G + L VL L N +G IP +G L+ ++LYL++N+LTG
Sbjct: 238 TDLILWQNRLSGEIPPSVGNISRLEVLALHENYFTGSIPREIGKLTKMKRLYLYTNQLTG 297
Query: 298 HIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDXXXXXXXX 357
IP E+GN+ ++ ++NQLTG IP G + +L L++ N L GPIP
Sbjct: 298 EIPREIGNLIDAAEIDFSENQLTGFIPKEFGHILNLKLLHLFENILLGPIPRELGELTLL 357
Query: 358 XXXXVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISG 417
+ N+LNGTIP Q L + L L N + G IP + N LDMS N +SG
Sbjct: 358 EKLDLSINRLNGTIPQELQFLPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSG 417
Query: 418 SIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNM 477
IP+ + L+ L+L N+L+G IP + +S+ ++ L N LTG +P EL LQN+
Sbjct: 418 PIPAHFCRFQTLILLSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNL 477
Query: 478 FSLRLDYNNLSGDVMSLINCL-SLSVLFIGNPGLCG 512
+L L N LSG++ + + L +L L + N G
Sbjct: 478 TALELHQNWLSGNISADLGKLKNLERLRLANNNFTG 513
|
|
| TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 727 (261.0 bits), Expect = 6.1e-131, Sum P(2) = 6.1e-131
Identities = 184/517 (35%), Positives = 271/517 (52%)
Query: 8 ILLLVFLFCLSFGSVDSEDGA-----TLLKIKKSF---RDVDNVLYDWTDSPSSDYCVWR 59
+LL +F C S G + G TLL++K SF ++VL DW +S S YC W
Sbjct: 6 VLLALFFLCFSSGLGSGQPGQRDDLQTLLELKNSFITNPKEEDVLRDW-NSGSPSYCNWT 64
Query: 60 GITCDNVTFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSS-L 118
G+TC +I LNLSGL L G ISP++G +L IDL NRL G IP + + SS L
Sbjct: 65 GVTCGGRE--IIGLNLSGLGLTGSISPSIGRFNNLIHIDLSSNRLVGPIPTTLSNLSSSL 122
Query: 119 KSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVG 178
+SL L N L GDIP + L L+ L L +N+L G IP T L NL++ L L G
Sbjct: 123 ESLHLFSNLLSGDIPSQLGSLVNLKSLKLGDNELNGTIPETFGNLVNLQMLALASCRLTG 182
Query: 179 TLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQ-I 237
+ +L L +++N L G IP IGNCTS + ++N+L+G +P + L+ +
Sbjct: 183 LIPSRFGRLVQLQTLILQDNELEGPIPAEIGNCTSLALFAAAFNRLNGSLPAELNRLKNL 242
Query: 238 ATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTG 297
TL+L N +G+IPS +G + ++ L+L N L G IP L L+ + L L SN LTG
Sbjct: 243 QTLNLGDNSFSGEIPSQLGDLVSIQYLNLIGNQLQGLIPKRLTELANLQTLDLSSNNLTG 302
Query: 298 HIPPELGNMTKLHYLELNDNQLTGHIPPAL-GKLTDLFDLNVANNHLEGPIPDXXXXXXX 356
I E M +L +L L N+L+G +P + T L L ++ L G IP
Sbjct: 303 VIHEEFWRMNQLEFLVLAKNRLSGSLPKTICSNNTSLKQLFLSETQLSGEIPAEISNCQS 362
Query: 357 XXXXXVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKIS 416
+ N L G IP + +L +T L L+ N++ G + +S + NL + +N +
Sbjct: 363 LKLLDLSNNTLTGQIPDSLFQLVELTNLYLNNNSLEGTLSSSISNLTNLQEFTLYHNNLE 422
Query: 417 GSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQN 476
G +P +G L L + L N+ +G +P E GN + EID N L+G IP + +L++
Sbjct: 423 GKVPKEIGFLGKLEIMYLYENRFSGEMPVEIGNCTRLQEIDWYGNRLSGEIPSSIGRLKD 482
Query: 477 MFSLRLDYNNLSGDV-MSLINCLSLSVLFIGNPGLCG 512
+ L L N L G++ SL NC ++V+ + + L G
Sbjct: 483 LTRLHLRENELVGNIPASLGNCHQMTVIDLADNQLSG 519
|
|
| UNIPROTKB|P93194 INRPK1 "Receptor-like protein kinase" [Ipomoea nil (taxid:35883)] | Back alignment and assigned GO terms |
|---|
Score = 708 (254.3 bits), Expect = 2.0e-127, Sum P(2) = 2.0e-127
Identities = 164/494 (33%), Positives = 253/494 (51%)
Query: 7 FILLLVFLFCLSFGSVDSEDGATLLKIKKSFRDV-DNVLYDWTDSPSSDYCVWRGITCDN 65
F+L L + + DGA LL + + + + ++ W S S+ C W G+ CD
Sbjct: 8 FLLFLCSTSSIYAAFALNSDGAALLSLTRHWTSIPSDITQSWNASDSTP-CSWLGVECDR 66
Query: 66 VTFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSF 125
F V LNLS + GE P + LK L+ + L GN G IP ++G+CS L+ +DLS
Sbjct: 67 RQF-VDTLNLSSYGISGEFGPEISHLKHLKKVVLSGNGFFGSIPSQLGNCSLLEHIDLSS 125
Query: 126 NELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPD-- 183
N G+IP ++ L+ L L L N LIGP P +L +P+L+ GN L G++ +
Sbjct: 126 NSFTGNIPDTLGALQNLRNLSLFFNSLIGPFPESLLSIPHLETVYFTGNGLNGSIPSNIG 185
Query: 184 -MCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQ-IATLS 241
M +L+ LW D N +G +P ++GN T+ Q L L+ N L G +P + L+ + L
Sbjct: 186 NMSELTTLWLDD---NQFSGPVPSSLGNITTLQELYLNDNNLVGTLPVTLNNLENLVYLD 242
Query: 242 LQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPP 301
++ N L G IP + + + LS N +G +PP LGN + + S L+G IP
Sbjct: 243 VRNNSLVGAIPLDFVSCKQIDTISLSNNQFTGGLPPGLGNCTSLREFGAFSCALSGPIPS 302
Query: 302 ELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDXXXXXXXXXXXX 361
G +TKL L L N +G IPP LGK + DL + N LEG IP
Sbjct: 303 CFGQLTKLDTLYLAGNHFSGRIPPELGKCKSMIDLQLQQNQLEGEIPGELGMLSQLQYLH 362
Query: 362 VHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPS 421
++ N L+G +P + +++S+ L L NN+ G +PV+++ + L +L + N +G IP
Sbjct: 363 LYTNNLSGEVPLSIWKIQSLQSLQLYQNNLSGELPVDMTELKQLVSLALYENHFTGVIPQ 422
Query: 422 PLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLR 481
LG L L+L+RN TG IP + + + + L +N+L G +P +L + L
Sbjct: 423 DLGANSSLEVLDLTRNMFTGHIPPNLCSQKKLKRLLLGYNYLEGSVPSDLGGCSTLERLI 482
Query: 482 LDYNNLSGDVMSLI 495
L+ NNL G + +
Sbjct: 483 LEENNLRGGLPDFV 496
|
|
| TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 747 (268.0 bits), Expect = 9.2e-126, Sum P(2) = 9.2e-126
Identities = 177/514 (34%), Positives = 276/514 (53%)
Query: 5 LEFILLLVFLFCLSFGSVDSEDGATLLK--IKKSFRDVDNV-LYDWTDSPSSDYCVWRGI 61
L F +F+FC S + A++L + S ++ L++W ++ W I
Sbjct: 16 LLFSFFFIFIFCFSLSDAEQNPEASILYSWLHSSSPTPSSLSLFNWNSIDNTPCNNWTFI 75
Query: 62 TCDNVTFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSL 121
TC + F + +++ + L + + + LQ + + G L+G +P+ +GDC LK L
Sbjct: 76 TCSSQGF-ITDIDIESVPLQLSLPKNLPAFRSLQKLTISGANLTGTLPESLGDCLGLKVL 134
Query: 122 DLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLS 181
DLS N L GDIP+S+SKL+ LE LIL +NQL G IP +S+ LK L N L G++
Sbjct: 135 DLSSNGLVGDIPWSLSKLRNLETLILNSNQLTGKIPPDISKCSKLKSLILFDNLLTGSIP 194
Query: 182 PDMCQLSGLWYFDVRNNS-LTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQ-IAT 239
++ +LSGL + N ++G IP IG+C++ VL L+ +SG +P ++G L+ + T
Sbjct: 195 TELGKLSGLEVIRIGGNKEISGQIPSEIGDCSNLTVLGLAETSVSGNLPSSLGKLKKLET 254
Query: 240 LSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHI 299
LS+ ++G+IPS +G L L L N LSG IP +G L+ E+L+L N L G I
Sbjct: 255 LSIYTTMISGEIPSDLGNCSELVDLFLYENSLSGSIPREIGQLTKLEQLFLWQNSLVGGI 314
Query: 300 PPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDXXXXXXXXXX 359
P E+GN + L ++L+ N L+G IP ++G+L+ L + +++N G IP
Sbjct: 315 PEEIGNCSNLKMIDLSLNLLSGSIPSSIGRLSFLEEFMISDNKFSGSIPTTISNCSSLVQ 374
Query: 360 XXVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSI 419
+ N+++G IP L +T N + G IP L+ +L LD+S N ++G+I
Sbjct: 375 LQLDKNQISGLIPSELGTLTKLTLFFAWSNQLEGSIPPGLADCTDLQALDLSRNSLTGTI 434
Query: 420 PSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFS 479
PS L L +L KL L N L+GFIP E GN S++ + L N +TG IP + L+ +
Sbjct: 435 PSGLFMLRNLTKLLLISNSLSGFIPQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINF 494
Query: 480 LRLDYNNLSGDVMSLI-NCLSLSVLFIGNPGLCG 512
L N L G V I +C L ++ + N L G
Sbjct: 495 LDFSSNRLHGKVPDEIGSCSELQMIDLSNNSLEG 528
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q42371 | ERECT_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7799 | 0.9849 | 0.9415 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| GSVIVG00032282001 | SubName- Full=Chromosome chr4 scaffold_6, whole genome shotgun sequence; (986 aa) | ||||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 933 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-106 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-85 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-60 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 7e-45 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-42 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-40 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-40 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-39 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-39 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-39 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-34 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-31 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-29 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-28 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-27 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-26 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-26 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-25 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-25 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-24 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-24 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-24 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-24 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-23 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-23 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-23 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-23 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-22 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 9e-22 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-21 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-21 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-21 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-20 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-20 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-20 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-20 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-19 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-19 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-19 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 9e-19 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-18 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-18 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-18 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-18 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-18 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-17 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-17 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-17 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-17 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-17 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-16 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-16 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-16 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-16 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-16 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-16 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-16 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-16 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 7e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-15 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-15 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-15 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-15 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-15 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 8e-15 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 8e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 9e-15 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-14 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-14 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-14 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-14 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-14 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-14 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-14 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-14 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-14 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 8e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-13 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-13 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-13 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-13 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-13 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-13 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-13 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-13 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-13 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 5e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-13 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-13 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-13 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 7e-13 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 8e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-12 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-12 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-12 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-12 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 7e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 9e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 9e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-11 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-11 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-11 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-11 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 5e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 6e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 6e-11 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-11 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 8e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-10 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-10 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-10 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-10 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-10 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-10 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-10 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-10 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 8e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 8e-10 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 8e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-09 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-09 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-09 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-09 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-09 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-09 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-09 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-09 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-09 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 7e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 7e-09 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 8e-09 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 8e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 9e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-08 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-08 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-08 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-08 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-08 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-08 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-08 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 5e-08 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-08 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-08 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-08 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 6e-08 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 8e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 8e-08 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 9e-08 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 9e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-07 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-07 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-07 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-07 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-07 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-07 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-07 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-07 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-07 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 3e-07 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-07 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 6e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 8e-07 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 8e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 8e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 9e-07 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-06 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-06 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-06 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-06 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-06 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-06 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 2e-06 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-06 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-06 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 5e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-06 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 9e-06 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-05 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 6e-05 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 7e-05 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 8e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 9e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 9e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 5e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 7e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 8e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 8e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 0.001 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 0.002 | |
| PLN03210 | 1153 | PLN03210, PLN03210, Resistant to P | 0.003 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 351 bits (901), Expect = e-106
Identities = 256/806 (31%), Positives = 401/806 (49%), Gaps = 34/806 (4%)
Query: 73 LNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDI 132
L+L G L G+I ++ +L L+ + L N+L GQIP E+G SLK + L +N L G+I
Sbjct: 169 LDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEI 228
Query: 133 PFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWY 192
P+ I L L L L N L GPIPS+L L NL+ L N L G + P + L L
Sbjct: 229 PYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLIS 288
Query: 193 FDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFL-QIATLSLQGNQLTGKI 251
D+ +NSL+G IP+ + + ++L L N +G+IP + L ++ L L N+ +G+I
Sbjct: 289 LDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEI 348
Query: 252 PSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHY 311
P +G L VLDLS N L+G IP L + KL L SN L G IP LG L
Sbjct: 349 PKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRR 408
Query: 312 LELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTI 371
+ L DN +G +P KL ++ L+++NN+L+G I +L L++ NK G +
Sbjct: 409 VRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGL 468
Query: 372 PPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLK 431
P +F + + L+LS N G +P +L + L L +S NK+SG IP L + L+
Sbjct: 469 PDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVS 527
Query: 432 LNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDV 491
L+LS NQL+G IP F + + ++DLS N L+G IP+ L ++++ + + +N+L G +
Sbjct: 528 LDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSL 587
Query: 492 MSLINCLSLSVLFI-GNPGLCGYWLHSACRDSHPTERVTISKAAILGIALGALVILLMIL 550
S L+++ + GN LCG S P +RV + + I L++ L
Sbjct: 588 PSTGAFLAINASAVAGNIDLCGGDTTSGLP---PCKRVRKTPSWWFYITCTLGAFLVLAL 644
Query: 551 VAACRPHNPTHFPDGSLDKPVNYSTPKLVILHMNMALHVYEDIMRMTENLSEKYIIGYGA 610
VA + K V + + + I + +L E+ +I G
Sbjct: 645 VAFGFVFIRGR--NNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGK 702
Query: 611 SSTVYKC-VLKNCKPVAIKRL--YSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSS 667
YK +KN +K + + P +E+ +G ++H N+V L G S
Sbjct: 703 KGASYKGKSIKNGMQFVVKEINDVNSIP------SSEIADMGKLQHPNIVKLIGLCRSEK 756
Query: 668 GNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVK 727
G L ++++E +L ++L L W+ R KIA+G A+ L +LH CSP ++ ++
Sbjct: 757 GAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLS 810
Query: 728 SSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSF 787
I++D E HL + LC T T + Y+ PE T +TEKSD+Y F
Sbjct: 811 PEKIIIDGKDEPHLR-LSLPGLLC-----TDTKCFISSAYVAPETRETKDITEKSDIYGF 864
Query: 788 GIVLLELLTGRKAVDNECNLHHLILS---KTANNAVMET-VDPEISA-TCKDLGAVKKVF 842
G++L+ELLTG+ D E +H I+ ++ ++ +DP I + + +V
Sbjct: 865 GLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVM 924
Query: 843 QLALLCSKRQPTDRPTMHEVSRVLGS 868
LAL C+ PT RP ++V + L S
Sbjct: 925 NLALHCTATDPTARPCANDVLKTLES 950
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 292 bits (750), Expect = 7e-85
Identities = 184/486 (37%), Positives = 267/486 (54%), Gaps = 30/486 (6%)
Query: 7 FILLLVFLFCLSFGSVDSEDGATLLKIKKSFRDVDNVLYDWTDSPSSDYCVWRGITCDNV 66
I +L FLF L+F + +E+ LL K S D L +W + S+D C+W+GITC+N
Sbjct: 12 LIFMLFFLF-LNFSMLHAEELELLLSFKSSINDPLKYLSNW--NSSADVCLWQGITCNNS 68
Query: 67 TFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEI-GDCSSLKSLDLSF 125
+ V++++LSG N+ G+IS A+ L +Q+I+L N+LSG IPD+I SSL+ L+LS
Sbjct: 69 S-RVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSN 127
Query: 126 NELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMC 185
N G IP + LE L L NN L G IP+ + +LKV L GN LVG + +
Sbjct: 128 NNFTGSIPRG--SIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLT 185
Query: 186 QLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGN 245
L+ L + + +N L G IP+ +G S + + L YN LSGEIP+ IG
Sbjct: 186 NLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIG------------ 233
Query: 246 QLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGN 305
LT +L LDL N L+GPIP LGNL + L+L+ NKL+G IPP + +
Sbjct: 234 GLT-----------SLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFS 282
Query: 306 MTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGN 365
+ KL L+L+DN L+G IP + +L +L L++ +N+ G IP L+S L L + N
Sbjct: 283 LQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSN 342
Query: 366 KLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGD 425
K +G IP + ++T L+LS NN+ G IP L GNL L + +N + G IP LG
Sbjct: 343 KFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGA 402
Query: 426 LEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYN 485
L ++ L N +G +P EF L V +D+S+N+L G I + ++ L L N
Sbjct: 403 CRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARN 462
Query: 486 NLSGDV 491
G +
Sbjct: 463 KFFGGL 468
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 223 bits (569), Expect = 1e-60
Identities = 136/350 (38%), Positives = 197/350 (56%), Gaps = 5/350 (1%)
Query: 166 LKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNI-GNCTSFQVLDLSYNQL 224
+ L G N+ G +S + +L + ++ NN L+G IP +I +S + L+LS N
Sbjct: 71 VVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNF 130
Query: 225 SGEIPFNIGFLQ-IATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLS 283
+G IP G + + TL L N L+G+IP+ IG +L VLDL N+L G IP L NL+
Sbjct: 131 TGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLT 188
Query: 284 YTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHL 343
E L L SN+L G IP ELG M L ++ L N L+G IP +G LT L L++ N+L
Sbjct: 189 SLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNL 248
Query: 344 EGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIG 403
GPIP +L + NL L ++ NKL+G IPP+ L+ + L+LS N++ G IP + ++
Sbjct: 249 TGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQ 308
Query: 404 NLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHL 463
NL+ L + +N +G IP L L L L L N+ +G IP G ++ +DLS N+L
Sbjct: 309 NLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNL 368
Query: 464 TGVIPEELSQLQNMFSLRLDYNNLSGDV-MSLINCLSLSVLFIGNPGLCG 512
TG IPE L N+F L L N+L G++ SL C SL + + + G
Sbjct: 369 TGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSG 418
|
Length = 968 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 7e-45
Identities = 85/265 (32%), Positives = 119/265 (44%), Gaps = 23/265 (8%)
Query: 605 IIGYGASSTVYKCVLKN-CKPVAIKRLYSH--YPQCLKEFETELETVGSIKHRNLVSLQG 661
+G G+ TVYK K K VA+K L + + E+ + + H N+V L
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 662 YSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRI 721
L ++ E G L+D L ++ L D KIAL +GL YLH S I
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLH---SNGI 119
Query: 722 IHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRL-TE 780
IHRD+K NILLD++ + DFG+AK L S S +T++ GT Y+ PE
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYGP 178
Query: 781 KSDVYSFGIVLLELLTGR---KAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGA 837
K DV+S G++L ELLTG+ + L + E S KDL
Sbjct: 179 KVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDL-- 236
Query: 838 VKKVFQLALLCSKRQPTDRPTMHEV 862
+KK C + P+ RPT E+
Sbjct: 237 IKK-------CLNKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 1e-42
Identities = 75/193 (38%), Positives = 99/193 (51%), Gaps = 10/193 (5%)
Query: 606 IGYGASSTVYKCVLKN-CKPVAIKRLYSHYPQCLKE-FETELETVGSIKHRNLVSLQGYS 663
+G G TVY K K VAIK + L E E+E + + H N+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 664 LSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIH 723
+ L ++ E GSL D+L + KL D L+I L +GL YLH S IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK--ENEGKLSEDEILRILLQILEGLEYLH---SNGIIH 115
Query: 724 RDVKSSNILLDKD-FEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPE-YARTSRLTEK 781
RD+K NILLD D + L DFG++K L KS T I+GT Y+ PE +EK
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT-IVGTPAYMAPEVLLGKGYYSEK 174
Query: 782 SDVYSFGIVLLEL 794
SD++S G++L EL
Sbjct: 175 SDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 149 bits (380), Expect = 1e-40
Identities = 74/276 (26%), Positives = 117/276 (42%), Gaps = 39/276 (14%)
Query: 606 IGYGASSTVYKCVLK-----NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSL 659
+G GA VYK LK VA+K L + +EF E + + H N+V L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 660 QGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSP 719
G + ++M G L D L +KL L++AL A+G+ YL S
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLR--KHGEKLTLKDLLQMALQIAKGMEYLE---SK 121
Query: 720 RIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYID-----PEYAR 774
+HRD+ + N L+ ++ ++DFG+++ + Y G + PE +
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFGLSRDI----YEDDYYRKRGGGKLPIKWMAPESLK 177
Query: 775 TSRLTEKSDVYSFGIVLLELLT-GR---KAVDNECNLHHLILSKTANNAVMETVDPEISA 830
+ T KSDV+SFG++L E+ T G + NE +L + + PE
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNE-----EVLELLEDGYRLPR--PE--- 227
Query: 831 TCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866
++++L L C P DRPT E+ L
Sbjct: 228 -----NCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 74/260 (28%), Positives = 112/260 (43%), Gaps = 19/260 (7%)
Query: 605 IIGYGASSTVYKCVLKNC-KPVAIKRL-YSHYPQCLKEFETELETVGSIKHRNLVSLQGY 662
+G G+ VY K K VAIK + + + E++ + +KH N+V L
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 663 SLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRII 722
L ++ E G L+D+L K+ +L D L YLH S I+
Sbjct: 66 FEDEDKLYLVMEYCEGGDLFDLLK---KRGRLSEDEARFYLRQILSALEYLH---SKGIV 119
Query: 723 HRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKS 782
HRD+K NILLD+D L DFG+A+ L +T++ GT Y+ PE +
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLD-PGEKLTTFV-GTPEYMAPEVLLGKGYGKAV 177
Query: 783 DVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVF 842
D++S G++L ELLTG+ + L L + +IS KDL ++K+
Sbjct: 178 DIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDL--IRKLL 235
Query: 843 QLALLCSKRQPTDRPTMHEV 862
+ P R T E
Sbjct: 236 V-------KDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 1e-39
Identities = 77/272 (28%), Positives = 117/272 (43%), Gaps = 30/272 (11%)
Query: 605 IIGYGASSTVYKCVLKNCK-----PVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVS 658
+G GA VYK LK VA+K L Q ++EF E + + H N+V
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 659 LQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCS 718
L G + ++ME G L L + KL L AL A+G+ YL S
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYLR--KNRPKLSLSDLLSFALQIARGMEYLE---S 120
Query: 719 PRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRL 778
IHRD+ + N L+ ++ ++DFG+++ L Y I ++ PE + +
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKF 180
Query: 779 TEKSDVYSFGIVLLELLT-GRK---AVDNECNLHHLILSKTANNAVMETVDPEISATCKD 834
T KSDV+SFG++L E+ T G + + NE +L N + C
Sbjct: 181 TSKSDVWSFGVLLWEIFTLGEQPYPGMSNE-----EVLEYLKNGYRL-----PQPPNC-- 228
Query: 835 LGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866
+++ L L C P DRPT E+ +L
Sbjct: 229 ---PPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 146 bits (372), Expect = 1e-39
Identities = 75/272 (27%), Positives = 118/272 (43%), Gaps = 29/272 (10%)
Query: 605 IIGYGASSTVYKCVLKNCK-----PVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVS 658
+G GA VYK LK VA+K L Q ++EF E + + H N+V
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 659 LQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCS 718
L G ++ ++M G L D L + K+L L AL A+G+ YL S
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE---S 121
Query: 719 PRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRL 778
IHRD+ + N L+ ++ ++DFG+++ L Y I ++ PE + +
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKF 181
Query: 779 TEKSDVYSFGIVLLELLT-GRK---AVDNECNLHHLILSKTANNAVMETVDPEISATCKD 834
T KSDV+SFG++L E+ T G + + N +L + C
Sbjct: 182 TSKSDVWSFGVLLWEIFTLGEEPYPGMSNA-----EVLEYLKKGYRL-----PKPPNC-- 229
Query: 835 LGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866
++++L L C P DRPT E+ +L
Sbjct: 230 ---PPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 5e-39
Identities = 78/282 (27%), Positives = 118/282 (41%), Gaps = 42/282 (14%)
Query: 605 IIGYGASSTVYKCVLK----NCKPVAIKRL-YSHYPQCLKEFETELETVGSIKHRNLVSL 659
+G GA VYK LK VA+K L + K+F E + + H N+V L
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 660 QGYSLSSSGNLLFYDFMENGSLWDIL------HGPTKKKKLDWDTRLKIALGAAQGLAYL 713
G L ++ME G L D L +K L L A+ A+G+ YL
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 714 HHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYI----- 768
S + +HRD+ + N L+ +D ++DFG+++ + Y T G +
Sbjct: 122 A---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDV----YDDDYYRKKTGGKLPIRWM 174
Query: 769 DPEYARTSRLTEKSDVYSFGIVLLELLT-GRK---AVDNECNLHHLILSKTANNAVMETV 824
PE + T KSDV+SFG++L E+ T G + N +L +
Sbjct: 175 APESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-----EEVLEYLRKGYRLP-- 227
Query: 825 DPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866
PE C D ++++L L C + P DRPT E+ L
Sbjct: 228 KPEY---CPD-----ELYELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 3e-34
Identities = 74/263 (28%), Positives = 116/263 (44%), Gaps = 28/263 (10%)
Query: 605 IIGYGASSTVYKCVLKNCKP-VAIK--RLYSHYPQCLKEFETELETVGSIKHRNLVSLQG 661
++G G+ +VY + K+ +A+K L + L+ E E+ + S++H N+V G
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 662 YSLSSSGN--LLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQ---GLAYLHHD 716
N +F +++ GSL +L K KL I Q GLAYLH
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSSLLK---KFGKLPEPV---IRKYTRQILEGLAYLH-- 118
Query: 717 CSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSL-CVSKSYTSTYIMGTIGYIDPEYART 775
S I+HRD+K +NIL+D D L DFG AK L + + + GT ++ PE R
Sbjct: 119 -SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177
Query: 776 SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDL 835
+D++S G ++E+ TG+ N + K ++ + +S KD
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALY-KIGSSGEPPEIPEHLSEEAKD- 235
Query: 836 GAVKKVFQLALLCSKRQPTDRPT 858
F C +R P RPT
Sbjct: 236 ------F--LRKCLRRDPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 63/197 (31%), Positives = 103/197 (52%), Gaps = 12/197 (6%)
Query: 606 IGYGASSTVYKCVLK-NCKPVAIKRLY-SHYPQCLKEFETELETVGSIKHRNLVSLQGYS 663
+G G+S VYK K K A+K+++ + K+ EL+T+ S + +V G +
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG-A 67
Query: 664 LSSSGNL-LFYDFMENGSLWDILHGPTKKKKLDWDTRLK-IALGAAQGLAYLHHDCSPRI 721
G + + ++M+ GSL D+L KK + L IA +GL YLH I
Sbjct: 68 FYKEGEISIVLEYMDGGSLADLL----KKVGKIPEPVLAYIARQILKGLDYLHTK--RHI 121
Query: 722 IHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEK 781
IHRD+K SN+L++ E + DFGI+K L + +T++ GT+ Y+ PE + +
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGESYSYA 180
Query: 782 SDVYSFGIVLLELLTGR 798
+D++S G+ LLE G+
Sbjct: 181 ADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 6e-29
Identities = 61/195 (31%), Positives = 93/195 (47%), Gaps = 10/195 (5%)
Query: 606 IGYGASSTVYKC-VLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSL 664
IG G VYK + K VAIK + + ++ E++ + KH N+V G S
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYG-SY 66
Query: 665 SSSGNL-LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIH 723
L + +F GSL D+L + + L + +GL YLH S IIH
Sbjct: 67 LKKDELWIVMEFCSGGSLKDLLK--STNQTLTESQIAYVCKELLKGLEYLH---SNGIIH 121
Query: 724 RDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSD 783
RD+K++NILL D E L DFG++ +S + ++GT ++ PE K+D
Sbjct: 122 RDIKAANILLTSDGEVKLIDFGLSA--QLSDTKARNTMVGTPYWMAPEVINGKPYDYKAD 179
Query: 784 VYSFGIVLLELLTGR 798
++S GI +EL G+
Sbjct: 180 IWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 79/269 (29%), Positives = 117/269 (43%), Gaps = 30/269 (11%)
Query: 606 IGYGASSTVYK--CVLKNCKPVAIKRL-YSHYPQCLKEFETELETVGSIKHRNLVSLQGY 662
IG GA++ VY C+ N K VAIKR+ + E E++ + H N+V
Sbjct: 9 IGVGATAVVYAAICLPNNEK-VAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67
Query: 663 SLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRII 722
+ L ++ GSL DI+ + LD + +GL YLH S I
Sbjct: 68 FVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQI 124
Query: 723 HRDVKSSNILLDKDFEAHLTDFGIAKSL----CVSKSYTSTYIMGTIGYIDPEYARTSR- 777
HRD+K+ NILL +D + DFG++ SL ++ T++ GT ++ PE
Sbjct: 125 HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFV-GTPCWMAPEVMEQVHG 183
Query: 778 LTEKSDVYSFGIVLLELLTGRKAVDNECNLHHL----ILSKTANNAVMETVDPEISATCK 833
K+D++SFGI +EL TG +L T N DP T
Sbjct: 184 YDFKADIWSFGITAIELATGAAP------YSKYPPMKVLMLTLQN------DPPSLETGA 231
Query: 834 DLGAVKKVF-QLALLCSKRQPTDRPTMHE 861
D K F ++ LC ++ P+ RPT E
Sbjct: 232 DYKKYSKSFRKMISLCLQKDPSKRPTAEE 260
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 78/284 (27%), Positives = 126/284 (44%), Gaps = 22/284 (7%)
Query: 603 KYI--IGYGASSTVYKCVLKNCKP-----VAIKRL-YSHYPQCLKEFETELETVGSIKHR 654
K+I +G G V C VA+K L +S Q +FE E+E + ++ H
Sbjct: 7 KFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHE 66
Query: 655 NLVSLQGYSLSSSGN--LLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAY 712
N+V +G G L +++ +GSL D L + +++ L + +G+ Y
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDY 124
Query: 713 LHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGT--IGYIDP 770
L S R IHRD+ + NIL++ + ++DFG+AK L K Y G I + P
Sbjct: 125 LG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAP 181
Query: 771 EYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAV---METVDP 826
E RTS+ + SDV+SFG+ L EL T G + +I V +E +
Sbjct: 182 ECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE 241
Query: 827 EISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLV 870
+V+ L LC + +P DRP+ ++ ++ L
Sbjct: 242 GERLPRPP-SCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 3e-26
Identities = 76/270 (28%), Positives = 115/270 (42%), Gaps = 20/270 (7%)
Query: 606 IGYGASSTVYKCVLKNCKPVAIKRL---YSHYPQCLKEFETELETVGSIKH-RNLVSLQG 661
+G G+ VY + K VA+K L + ++ F E++ + S+ H N+V L
Sbjct: 8 LGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 662 YSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRI 721
+ L ++++ GSL D+L +K L L I L YLH S I
Sbjct: 66 FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGI 122
Query: 722 IHRDVKSSNILLDKD-FEAHLTDFGIAKSLCVSKS-----YTSTYIMGTIGYIDPEYAR- 774
IHRD+K NILLD+D L DFG+AK L S + +GT GY+ PE
Sbjct: 123 IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLG 182
Query: 775 --TSRLTEKSDVYSFGIVLLELLTGRKAVDNE-CNLHHLILSKTANNAVMETVDPEISAT 831
+ + SD++S GI L ELLTG + E + K ++ +S +
Sbjct: 183 LSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPS 242
Query: 832 CKDLGAVKKVFQLALLCSKRQPTDRPTMHE 861
+L K L + P +R +
Sbjct: 243 NPEL-ISKAASDLLKKLLAKDPKNRLSSSS 271
|
Length = 384 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 81/267 (30%), Positives = 119/267 (44%), Gaps = 42/267 (15%)
Query: 605 IIGYGASSTVYKCV-LKNCKPVAIKRLYSH--YPQCLKEFETELETVGSIKHRNLVSLQG 661
+IG GA VYK + L+ VAIK++ + LK E++ + ++KH N+V G
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 662 YSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQ---GLAYLHHDCS 718
+S + ++ ENGSL I+ KK +A+ Q GLAYLH
Sbjct: 67 SIETSDSLYIILEYAENGSLRQII------KKFGPFPESLVAVYVYQVLQGLAYLH---E 117
Query: 719 PRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRL 778
+IHRD+K++NIL KD L DFG+A L S ++GT ++ PE S
Sbjct: 118 QGVIHRDIKAANILTTKDGVVKLADFGVATKL-NDVSKDDASVVGTPYWMAPEVIEMSGA 176
Query: 779 TEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETV-DPE------ISAT 831
+ SD++S G ++ELLTG + L A+ V D IS
Sbjct: 177 STASDIWSLGCTVIELLTGNPP------YYDL----NPMAALFRIVQDDHPPLPEGISPE 226
Query: 832 CKDLGAVKKVFQLALLCSKRQPTDRPT 858
KD + C ++ P RPT
Sbjct: 227 LKD---------FLMQCFQKDPNLRPT 244
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 74/294 (25%), Positives = 126/294 (42%), Gaps = 45/294 (15%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLKNCKP------VAIKRLYSHYPQCLKE-FETELETVGS 650
+ + K +G GA V+ + +P VA+K L ++ FE E E + +
Sbjct: 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTN 64
Query: 651 IKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDIL--HGP---------TKKKKLDWDTR 699
+H N+V G ++ +++ME+G L L HGP + +L
Sbjct: 65 FQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQL 124
Query: 700 LKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTST 759
L+IA+ A G+ YL S +HRD+ + N L+ D + DFG+++ + YT+
Sbjct: 125 LQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDV-----YTTD 176
Query: 760 YI------MGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLIL 812
Y M I ++ PE + T +SDV+SFG+VL E+ T G++
Sbjct: 177 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP-----------W 225
Query: 813 SKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866
+N V+E + +V+ + L C KR P R + ++ L
Sbjct: 226 YGLSNEEVIECITQGRLLQRPR-TCPSEVYDIMLGCWKRDPQQRINIKDIHERL 278
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 72/270 (26%), Positives = 113/270 (41%), Gaps = 39/270 (14%)
Query: 606 IGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLS 665
IG G V + K VA+K L + F E + +++H NLV L G L
Sbjct: 14 IGKGEFGDVMLGDYRGQK-VAVKCLKDD-STAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 666 SSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRD 725
+ + ++M GSL D L + + +L AL +G+ YL +HRD
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRS-RGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRD 127
Query: 726 VKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVY 785
+ + N+L+ +D A ++DFG+AK + + T PE R + + KSDV+
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWTA----PEALREKKFSTKSDVW 183
Query: 786 SFGIVLLELLT-GR--------KAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLG 836
SFGI+L E+ + GR K V + ME PE C
Sbjct: 184 SFGILLWEIYSFGRVPYPRIPLKDV----------VPHVEKGYRMEA--PE---GCPP-- 226
Query: 837 AVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866
+V+++ C + P RPT ++ L
Sbjct: 227 ---EVYKVMKDCWELDPAKRPTFKQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 88/278 (31%), Positives = 126/278 (45%), Gaps = 30/278 (10%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLKNCKPVAIKR--LYSHYPQCLKEFETELETVGSIKHRN 655
E + E +G GA +V KC LKN + + P K+ ELE S K
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 656 LVSLQG-YSLSSSGNL-LFYDFMENGSLWDILHGPTKKKKLDWDTR--LKIALGAAQGLA 711
+V G + SS ++ + ++ E GSL D ++ KK+ + KIA +GL+
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 712 YLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPE 771
YLH S +IIHRD+K SNILL + + L DFG++ L S + T T GT Y+ PE
Sbjct: 120 YLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT---GTSFYMAPE 173
Query: 772 YARTSRLTEKSDVYSFGIVLLELLTGRKAV--DNECNLHHL-ILSKTANNAVMETVD-PE 827
+ + SDV+S G+ LLE+ R + E L + +LS N E D P
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG 233
Query: 828 I----SATCKDLGAVKKVFQLALLCSKRQPTDRPTMHE 861
S KD C ++ PT RPT +
Sbjct: 234 NGIKWSEEFKDFIKQ---------CLEKDPTRRPTPWD 262
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 74/266 (27%), Positives = 129/266 (48%), Gaps = 29/266 (10%)
Query: 606 IGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLS 665
IG G V+ + VAIK + ++F E + + + H LV L G
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 666 SSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRD 725
S L ++FME+G L D L ++ K +T L + L +G+AYL +IHRD
Sbjct: 71 RSPICLVFEFMEHGCLSDYLR--AQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRD 125
Query: 726 VKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGT---IGYIDPEYARTSRLTEKS 782
+ + N L+ ++ ++DFG+ + + YTS+ GT + + PE S+ + KS
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTR-FVLDDQYTSST--GTKFPVKWSSPEVFSFSKYSSKS 182
Query: 783 DVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKV 841
DV+SFG+++ E+ + G+ +N +N+ V+ET++ L A + V
Sbjct: 183 DVWSFGVLMWEVFSEGKTPYENR-----------SNSEVVETINAGFRLYKPRL-ASQSV 230
Query: 842 FQLALLCSKRQPTDRPT----MHEVS 863
++L C K +P DRP+ +H+++
Sbjct: 231 YELMQHCWKERPEDRPSFSLLLHQLA 256
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 72/219 (32%), Positives = 105/219 (47%), Gaps = 15/219 (6%)
Query: 593 IMRMTENLSEKYIIGYGASSTVYKCVL-----KNCKPVAIKRLY-SHYPQCLKEFETELE 646
I++ TE L + ++G GA TVYK V K PVAIK L P+ KE E
Sbjct: 3 ILKETE-LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAY 61
Query: 647 TVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGA 706
+ S+ H ++V L G LSS L M G L D + K + L +
Sbjct: 62 VMASVDHPHVVRLLGICLSSQ-VQLITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQI 118
Query: 707 AQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV-SKSYTSTYIMGTI 765
A+G++YL R++HRD+ + N+L+ +TDFG+AK L V K Y + I
Sbjct: 119 AKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPI 175
Query: 766 GYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDN 803
++ E T KSDV+S+G+ + EL+T G K +
Sbjct: 176 KWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG 214
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 83/300 (27%), Positives = 115/300 (38%), Gaps = 71/300 (23%)
Query: 605 IIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIK----------- 652
IIG G+ STV K K AIK K + + V +K
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIK-------ILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 653 HRNLVSLQGYSLSSSGNLLF-YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQ--- 708
H ++ L Y+ NL F ++ NG L + K LD AA+
Sbjct: 61 HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIR---KYGSLDEKC---TRFYAAEILL 113
Query: 709 GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTST--------- 759
L YLH S IIHRD+K NILLDKD +TDFG AK L + S S
Sbjct: 114 ALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170
Query: 760 ----------YIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGR---KAVDNECN 806
+GT Y+ PE + SD+++ G ++ ++LTG+ + NE
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRG-SNE-- 227
Query: 807 LHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866
+L K + P KDL ++K LL P DR ++E L
Sbjct: 228 --YLTFQKILKLEY--SFPPNFPPDAKDL--IEK-----LL--VLDPQDRLGVNEGYDEL 274
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 67/207 (32%), Positives = 97/207 (46%), Gaps = 18/207 (8%)
Query: 597 TENLSEKYIIGYGASSTVYKC--VLKNCKPVAIK--RLYSHYPQCLKEFETELETVGSIK 652
E IG GAS VYK + VAIK RL + + E+ + K
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKE-VAIKKMRLRKQNKELII---NEILIMKDCK 73
Query: 653 HRNLVSLQGYSLSSSGNLLF--YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGL 710
H N+V Y G+ L+ ++M+ GSL DI+ +++ + QGL
Sbjct: 74 HPNIVDY--YDSYLVGDELWVVMEYMDGGSLTDIITQ--NFVRMNEPQIAYVCREVLQGL 129
Query: 711 AYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDP 770
YLH S +IHRD+KS NILL KD L DFG A L KS ++ ++GT ++ P
Sbjct: 130 EYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS-VVGTPYWMAP 185
Query: 771 EYARTSRLTEKSDVYSFGIVLLELLTG 797
E + K D++S GI+ +E+ G
Sbjct: 186 EVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 3e-23
Identities = 72/263 (27%), Positives = 122/263 (46%), Gaps = 16/263 (6%)
Query: 606 IGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLS 665
+G G V++ + KN VAIK L S ++F+ E++ + ++H++L+SL
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 666 SSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRD 725
+ + ME GSL L P + + L + + +A A+G+AYL IHRD
Sbjct: 74 GEPVYIITELMEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRD 129
Query: 726 VKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVY 785
+ + NIL+ +D + DFG+A+ L Y S+ + PE A + KSDV+
Sbjct: 130 LAARNILVGEDLVCKVADFGLAR-LIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVW 188
Query: 786 SFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLA 845
SFGI+L E+ T V +H + + M A C ++++++
Sbjct: 189 SFGILLYEMFT-YGQVPYPGMNNHEVYDQITAGYRMPC-----PAKCP-----QEIYKIM 237
Query: 846 LLCSKRQPTDRPTMHEVSRVLGS 868
L C +P DRP+ + L +
Sbjct: 238 LECWAAEPEDRPSFKALREELDN 260
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.5 bits (249), Expect = 3e-23
Identities = 54/170 (31%), Positives = 79/170 (46%), Gaps = 15/170 (8%)
Query: 650 SIKHRNLVSLQGYSLSSSGNLLF-YDFMENGSLWDILHGPTKKKKLD-WDTRLKIA-LGA 706
I H +V L Y+ + L ++ G L+ L K+ + R A +
Sbjct: 49 RINHPFIVKLH-YAFQTEEKLYLVLEYAPGGELFSHLS---KEGRFSEERARFYAAEI-- 102
Query: 707 AQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIG 766
L YLH S II+RD+K NILLD D LTDFG+AK L S T+T+ GT
Sbjct: 103 VLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPE 158
Query: 767 YIDPEYARTSRLTEKSDVYSFGIVLLELLTGRK--AVDNECNLHHLILSK 814
Y+ PE + D +S G++L E+LTG+ ++ ++ IL
Sbjct: 159 YLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD 208
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 5e-23
Identities = 78/272 (28%), Positives = 121/272 (44%), Gaps = 38/272 (13%)
Query: 606 IGYGASSTVYKCV-LKNCKPVAIK--RLYSHYPQCLKEFETELETVGSIKHRNLVSLQGY 662
IG G VY V L + +A+K R+ + P+ +KE E++ + +KH NLV G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 663 SLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRII 722
+ +F ++ G+L ++L + LD L +GLAYLH S I+
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLH---SHGIV 121
Query: 723 HRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTY------IMGTIGYIDPEYARTS 776
HRD+K +NI LD + L DFG A L K+ T+T + GT Y+ PE
Sbjct: 122 HRDIKPANIFLDHNGVIKLGDFGCAVKL---KNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 777 RLTEK---SDVYSFGIVLLELLTGRK---AVDNECNLHHLILSKTANNAVMETVDP-EIS 829
+ +D++S G V+LE+ TG++ +DNE I+ D ++S
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE----FQIMFHVGAGHKPPIPDSLQLS 234
Query: 830 ATCKDLGAVKKVFQLALLCSKRQPTDRPTMHE 861
KD + + + P RPT E
Sbjct: 235 PEGKDF--LDRCLE-------SDPKKRPTASE 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 7e-23
Identities = 65/204 (31%), Positives = 103/204 (50%), Gaps = 14/204 (6%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRN 655
E L E +G G S V K + + K +A+K + K+ EL+ +
Sbjct: 4 EYLGE---LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY 60
Query: 656 LVSLQGYSLSSSGNL-LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLH 714
+V G + ++G++ + ++M+ GSL IL + ++ KIA+ +GL YLH
Sbjct: 61 IVGFYG-AFYNNGDISICMEYMDGGSLDKIL--KEVQGRIPERILGKIAVAVLKGLTYLH 117
Query: 715 HDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYAR 774
IIHRDVK SNIL++ + L DFG++ L S + T GT Y+ PE +
Sbjct: 118 EKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV---GTSSYMAPERIQ 172
Query: 775 TSRLTEKSDVYSFGIVLLELLTGR 798
+ + KSD++S G+ L+EL TGR
Sbjct: 173 GNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 97.2 bits (243), Expect = 3e-22
Identities = 69/268 (25%), Positives = 111/268 (41%), Gaps = 34/268 (12%)
Query: 606 IGYGASSTVYKCV-LKNCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGY 662
IG G+ VY + K +K + + ++ E++ + + H N++
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE- 66
Query: 663 SLSSSGNLLF-YDFMENGSLWDILHGPTKKKK-------LDWDTRLKIALGAAQGLAYLH 714
S G L ++ + G L + K+ K LDW +L +AL YLH
Sbjct: 67 SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL------KYLH 120
Query: 715 HDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYAR 774
S +I+HRD+K NI L + L DFGI+K L + T + GT Y+ PE +
Sbjct: 121 ---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPELCQ 176
Query: 775 TSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKD 834
KSD++S G VL EL T + + E NL L + P S +
Sbjct: 177 NKPYNYKSDIWSLGCVLYELCTLKHPFEGE-NLLELA-----LKILKGQYPPIPSQYSSE 230
Query: 835 LGAVKKVFQLALLCSKRQPTDRPTMHEV 862
L L ++ P +RP++ ++
Sbjct: 231 L------RNLVSSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 9e-22
Identities = 74/283 (26%), Positives = 126/283 (44%), Gaps = 44/283 (15%)
Query: 605 IIGYGASSTVYKCVL----KNCKPVAIKRLYSHYPQCLK-EFETELETVGSIKHRNLVSL 659
+IG G V + L K VAIK L + + +F TE +G H N++ L
Sbjct: 11 VIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRL 70
Query: 660 QGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSP 719
+G S ++ ++MENGSL L K + + G A G+ YL
Sbjct: 71 EGVVTKSRPVMIITEYMENGSLDKFLR--ENDGKFTVGQLVGMLRGIASGMKYLSEMNY- 127
Query: 720 RIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS-YTSTYIMG---TIGYIDPEYART 775
+HRD+ + NIL++ + ++DFG+++ L S++ YT+ G I + PE
Sbjct: 128 --VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTT---KGGKIPIRWTAPEAIAY 182
Query: 776 SRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVD-------PE 827
+ T SDV+SFGIV+ E+++ G + + +N V++ V+ P
Sbjct: 183 RKFTSASDVWSFGIVMWEVMSYGERPYWD-----------MSNQDVIKAVEDGYRLPPPM 231
Query: 828 ISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLV 870
C ++QL L C ++ +RPT ++ L ++
Sbjct: 232 ---DCPSA-----LYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 74/259 (28%), Positives = 122/259 (47%), Gaps = 28/259 (10%)
Query: 606 IGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLS 665
+G G V++ + N PVA+K L K+F E + + ++H L+ L Y++
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQL--YAVC 70
Query: 666 SSGN--LLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIH 723
+ + + M+ GSL + L G + L + +A A G+AYL + IH
Sbjct: 71 TLEEPIYIVTELMKYGSLLEYLQG-GAGRALKLPQLIDMAAQVASGMAYLE---AQNYIH 126
Query: 724 RDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGT---IGYIDPEYARTSRLTE 780
RD+ + N+L+ ++ + DFG+A+ + Y + G I + PE A +R +
Sbjct: 127 RDLAARNVLVGENNICKVADFGLAR-VIKEDIYEAR--EGAKFPIKWTAPEAALYNRFSI 183
Query: 781 KSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVK 839
KSDV+SFGI+L E++T GR + N V++ VD C G K
Sbjct: 184 KSDVWSFGILLTEIVTYGR-----------MPYPGMTNAEVLQQVDQGYRMPCPP-GCPK 231
Query: 840 KVFQLALLCSKRQPTDRPT 858
+++ + L C K P DRPT
Sbjct: 232 ELYDIMLDCWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 4e-21
Identities = 65/248 (26%), Positives = 102/248 (41%), Gaps = 38/248 (15%)
Query: 624 PVAIKRLYSHYPQ-CLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLW 682
PVA+K L S + +F E + S+ H NL+ L G L+ ++ + GSL
Sbjct: 25 PVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVT-ELAPLGSLL 83
Query: 683 DILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLT 742
D L T A+ A G+ YL S R IHRD+ + NILL D + +
Sbjct: 84 DRLRKD-ALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIG 139
Query: 743 DFGIAKSLCVSKSYTSTYIMGT-----IGYIDPEYARTSRLTEKSDVYSFGIVLLELLT- 796
DFG+ ++L ++ + Y+M + PE RT + SDV+ FG+ L E+ T
Sbjct: 140 DFGLMRALPQNEDH---YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTY 196
Query: 797 ------GRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSK 850
G +++ +D E + + ++ + L C
Sbjct: 197 GEEPWAGLSGSQ-----------------ILKKIDKEGERLERPEACPQDIYNVMLQCWA 239
Query: 851 RQPTDRPT 858
P DRPT
Sbjct: 240 HNPADRPT 247
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 5e-21
Identities = 75/265 (28%), Positives = 119/265 (44%), Gaps = 34/265 (12%)
Query: 603 KYIIGYGASSTVYKCVLKNCKPV-AIKRL------YSHYPQCLKEFE--TELETVGSIKH 653
IG G+ V+K V K K V A+K++ + + E +L++ I++
Sbjct: 5 LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRY 64
Query: 654 RNLVSLQGYSLSSSGNL-LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAY 712
S G L + ++ ENG L +L + + L D + + GLA+
Sbjct: 65 YE-------SFLDKGKLNIVMEYAENGDLHKLLKM-QRGRPLPEDQVWRFFIQILLGLAH 116
Query: 713 LHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEY 772
LH S +I+HRD+KS N+ LD + D G+AK L + ++ +T I+GT Y+ PE
Sbjct: 117 LH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT-IVGTPYYLSPEL 172
Query: 773 ARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATC 832
EKSDV++ G+VL E TG+ D N LIL ++ V P +S
Sbjct: 173 CEDKPYNEKSDVWALGVVLYECCTGKHPFDAN-NQGALILK------IIRGVFPPVSQ-- 223
Query: 833 KDLGAVKKVFQLALLCSKRQPTDRP 857
+++ QL C + RP
Sbjct: 224 ---MYSQQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 6e-21
Identities = 56/154 (36%), Positives = 79/154 (51%), Gaps = 11/154 (7%)
Query: 405 LDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLT 464
+D L + N + G IP+ + L HL +NLS N + G IP G++ S+ +DLS+N
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 465 GVIPEELSQLQNMFSLRLDYNNLSGDVMSLINCLSL---SVLFIGNPGLCGYWLHSACRD 521
G IPE L QL ++ L L+ N+LSG V + + L S F N GLCG AC
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACGP 539
Query: 522 SHPTERVTISKAAILGIALGALV-ILLMILVAAC 554
+S A +GIA G V L +++ A C
Sbjct: 540 -------HLSVGAKIGIAFGVSVAFLFLVICAMC 566
|
Length = 623 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 1e-20
Identities = 70/251 (27%), Positives = 117/251 (46%), Gaps = 19/251 (7%)
Query: 625 VAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQG--YSLSSSGNLLFYDFMENGSLW 682
VA+K+L + L++FE E+E + S++H N+V +G YS L +++ GSL
Sbjct: 36 VAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLR 95
Query: 683 DILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLT 742
D L +++LD L A +G+ YL S R +HRD+ + NIL++ + +
Sbjct: 96 DYLQ--KHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIG 150
Query: 743 DFGIAKSLCVSKSYTSTYIMGT--IGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKA 800
DFG+ K L K Y G I + PE S+ + SDV+SFG+VL EL T
Sbjct: 151 DFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT---Y 207
Query: 801 VDNECNLHHLILSKTANNAVMETVDPEISATCKD-------LGAVKKVFQLALLCSKRQP 853
D C+ + N+ + + + K+ G +++ + C P
Sbjct: 208 SDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDP 267
Query: 854 TDRPTMHEVSR 864
+ RP+ E++
Sbjct: 268 SQRPSFSELAL 278
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 57/198 (28%), Positives = 99/198 (50%), Gaps = 11/198 (5%)
Query: 603 KYIIGYGASSTVYKCV-LKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQG 661
+G G+ +VYK + + + VAIK + + L+E E+ + +V G
Sbjct: 8 LEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE--EDLQEIIKEISILKQCDSPYIVKYYG 65
Query: 662 YSLSSSGNL-LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPR 720
S + +L + ++ GS+ DI+ K L + I +GL YLH S +
Sbjct: 66 -SYFKNTDLWIVMEYCGAGSVSDIMK--ITNKTLTEEEIAAILYQTLKGLEYLH---SNK 119
Query: 721 IIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTE 780
IHRD+K+ NILL+++ +A L DFG++ L + + +T I GT ++ PE +
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYNN 178
Query: 781 KSDVYSFGIVLLELLTGR 798
K+D++S GI +E+ G+
Sbjct: 179 KADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 4e-20
Identities = 67/236 (28%), Positives = 97/236 (41%), Gaps = 25/236 (10%)
Query: 604 YIIGYGASSTVYKCVLKNCKPV-AIKRLYSHYPQCLKEFET-----ELETVGSIKHRNLV 657
+IG GA V ++ K + A+K Y + +C+++ E + + H LV
Sbjct: 6 RVIGKGAFGKVCIVQKRDTKKMFAMK--YMNKQKCVEKGSVRNVLNERRILQELNHPFLV 63
Query: 658 SLQGYSLSSSGNL-LFYDFMENGSL-WDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHH 715
+L YS N+ L D + G L + + K K + L YLH
Sbjct: 64 NLW-YSFQDEENMYLVVDLLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLH- 117
Query: 716 DCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYART 775
S IIHRD+K NILLD+ H+TDF IA V+ +T GT GY+ PE
Sbjct: 118 --SKGIIHRDIKPDNILLDEQGHVHITDFNIATK--VTPDTLTTSTSGTPGYMAPEVLCR 173
Query: 776 SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISAT 831
+ D +S G+ E L G++ H + A ET D AT
Sbjct: 174 QGYSVAVDWWSLGVTAYECLRGKRPYRG-----HSRTIRDQIRAKQETADVLYPAT 224
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 6e-20
Identities = 73/264 (27%), Positives = 113/264 (42%), Gaps = 20/264 (7%)
Query: 606 IGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKE-FETELETVGSIKHRNLVSLQGYSL 664
IG G VYK VLK VA+K S P LK F E E + H N+V L G +
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 665 SSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHR 724
+ + + GSL L KK +L L+++L AA G+ YL IHR
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLRK--KKNRLTVKKLLQMSLDAAAGMEYLESKNC---IHR 117
Query: 725 DVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTI--GYIDPEYARTSRLTEKS 782
D+ + N L+ ++ ++DFG+++ YT + + I + PE R T +S
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSREE-EGGIYTVSDGLKQIPIKWTAPEALNYGRYTSES 176
Query: 783 DVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVF 842
DV+S+GI+L E + +N E ++ L +++
Sbjct: 177 DVWSYGILLWETFSLGDTP----------YPGMSNQQTRERIESGYRMPAPQLCPE-EIY 225
Query: 843 QLALLCSKRQPTDRPTMHEVSRVL 866
+L L C P +RP+ E+ L
Sbjct: 226 RLMLQCWAYDPENRPSFSEIYNEL 249
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 6e-20
Identities = 81/275 (29%), Positives = 125/275 (45%), Gaps = 34/275 (12%)
Query: 592 DIMRMTENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLY--SHYPQCLKEFETELETVG 649
+I R + L K +G G V+ VA+K L + P+ F E + +
Sbjct: 2 EIPRESLKLERK--LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE---AFLQEAQIMK 56
Query: 650 SIKHRNLVSLQGYSLSSSGNLLFY--DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAA 707
++H LV L Y++ S ++ ++M GSL D L KK L + +A A
Sbjct: 57 KLRHDKLVQL--YAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKK-LRLPQLVDMAAQIA 113
Query: 708 QGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGT--- 764
+G+AYL S IHRD+ + NIL+ ++ + DFG+A+ L YT+ G
Sbjct: 114 EGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLAR-LIEDDEYTAR--EGAKFP 167
Query: 765 IGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMET 823
I + PE A R T KSDV+SFGI+L E++T GR + N V+E
Sbjct: 168 IKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGR-----------VPYPGMTNREVLEQ 216
Query: 824 VDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPT 858
V+ ++++ L L C + P +RPT
Sbjct: 217 VERGYRMPRPP-NCPEELYDLMLQCWDKDPEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 1e-19
Identities = 73/273 (26%), Positives = 123/273 (45%), Gaps = 31/273 (11%)
Query: 605 IIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCL---KEFETELETVG---SIKHRNLVS 658
++G GA TVY + + +A+K++ L KE+E E V S+KH N+V
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 659 LQGYSLSSSGNLLFYDFMENGSLWDILH--GPTKKKKLDWDTRLKIALGAAQGLAYLHHD 716
G L + +F +F+ GS+ IL+ GP + T+ + G+AYLH++
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQIL-----DGVAYLHNN 121
Query: 717 CSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLC-----VSKSYTSTYIMGTIGYIDPE 771
C ++HRD+K +N++L + L DFG A+ L + S + GT ++ PE
Sbjct: 122 C---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178
Query: 772 YARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISAT 831
S KSD++S G + E+ TG+ + + L + A+ +M + SA
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL-AAMFYIGAHRGLMPRLPDSFSAA 237
Query: 832 CKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSR 864
D C R +RP+ ++ R
Sbjct: 238 AID---------FVTSCLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 2e-19
Identities = 74/293 (25%), Positives = 127/293 (43%), Gaps = 51/293 (17%)
Query: 606 IGYGASSTVYKCVL------KNCKPVAIKRLY-SHYPQCLKEFETELETVGSIKHRNLVS 658
+G GA VYK L + VAIK L + P+ +EF E E + ++H N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 659 LQGYSLSSSGNLLFYDFMENGSLWDIL--HGP-----------TKKKKLDWDTRLKIALG 705
L G + ++++ +G L + L + P T K LD L IA+
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 706 AAQGLAYL--HHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTY--I 761
A G+ YL HH +HRD+ + N L+ + ++DFG+++ + Y++ Y +
Sbjct: 133 IAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDI-----YSADYYRV 182
Query: 762 MGT----IGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTA 816
+ ++ PE + T +SD++SFG+VL E+ + G + + S
Sbjct: 183 QSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP--------YYGFS--- 231
Query: 817 NNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869
N V+E + C + +V+ L + C P RP ++ L S
Sbjct: 232 NQEVIEMIRSRQLLPCPE-DCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 3e-19
Identities = 80/281 (28%), Positives = 130/281 (46%), Gaps = 31/281 (11%)
Query: 592 DIMRMTENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLY--SHYPQCLKEFETELETVG 649
++ R T L +K +G G V+ VAIK L S P+ F E +
Sbjct: 2 EVPRETLKLVKK--LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA---FLAEANLMK 56
Query: 650 SIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQG 709
++H LV L ++ + ++MENGSL D L P + KL + + +A A+G
Sbjct: 57 QLQHPRLVRLYAV-VTQEPIYIITEYMENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEG 114
Query: 710 LAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGT---IG 766
+A++ IHRD++++NIL+ + + DFG+A+ L YT+ G I
Sbjct: 115 MAFIERKNY---IHRDLRAANILVSETLCCKIADFGLAR-LIEDNEYTAR--EGAKFPIK 168
Query: 767 YIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVD 825
+ PE T KSDV+SFGI+L E++T GR + N V++ ++
Sbjct: 169 WTAPEAINYGTFTIKSDVWSFGILLTEIVTYGR-----------IPYPGMTNPEVIQNLE 217
Query: 826 PEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866
D +++++L LC K +P +RPT + VL
Sbjct: 218 RGYRMPRPD-NCPEELYELMRLCWKEKPEERPTFEYLRSVL 257
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 4e-19
Identities = 70/272 (25%), Positives = 125/272 (45%), Gaps = 31/272 (11%)
Query: 605 IIGYGASSTVYKC------VLKNCKPVAIKR-LYSHYPQCLKEFETELETVGSIKHRNLV 657
+G GA S+ Y+ L K V R S + ++ E+ + + H +++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 658 SLQGYSLSSSGNLLFYDFMENGSLWDILH--GPTKKKKLDWDTRLKIALGAAQGLAYLHH 715
+ G + S LF ++M GS+ +L G K+ + + +GL+YLH
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-----INYTEQLLRGLSYLHE 121
Query: 716 DCSPRIIHRDVKSSNILLDKDFE-AHLTDFGIAKSLCVSKSYTSTY---IMGTIGYIDPE 771
+ +IIHRDVK +N+L+D + + DFG A L + + ++GTI ++ PE
Sbjct: 122 N---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178
Query: 772 YARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHL-ILSKTANNAVMETVDPEISA 830
R + DV+S G V++E+ T + + E + +HL ++ K A+ ++ +S
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSP 238
Query: 831 TCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
+D + L C + QP DRP E+
Sbjct: 239 GLRD---------VTLRCLELQPEDRPPSREL 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 9e-19
Identities = 61/231 (26%), Positives = 107/231 (46%), Gaps = 22/231 (9%)
Query: 640 EFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTR 699
+F E + + + H NLV L G + ++M NG L + L +K KL +
Sbjct: 45 DFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLR--ERKGKLGTEWL 102
Query: 700 LKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTST 759
L + + + YL + IHRD+ + N L+ +D ++DFG+A+ + + YTS+
Sbjct: 103 LDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYV-LDDQYTSS 158
Query: 760 YIMGT---IGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTA 816
GT + + PE SR + KSDV+SFG+++ E+ + K + + +
Sbjct: 159 Q--GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGK----------MPYERFS 206
Query: 817 NNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLG 867
N+ V+E+V L A +V+ + C +P DRP ++ L
Sbjct: 207 NSEVVESVSAGYRLYRPKL-APTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 1e-18
Identities = 84/275 (30%), Positives = 125/275 (45%), Gaps = 29/275 (10%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLY--SHYPQCLKEFETELETVGSIKHRN 655
E+L +G G V+ VAIK L + P+ F E + + ++H
Sbjct: 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA---FLQEAQIMKKLRHDK 62
Query: 656 LVSLQGYSLSSSGNL-LFYDFMENGSLWDIL-HGPTKKKKLDWDTRLKIALGAAQGLAYL 713
LV L Y++ S + + +FM GSL D L G K KL + +A A G+AY+
Sbjct: 63 LVPL--YAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLP--QLVDMAAQIADGMAYI 118
Query: 714 HHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTY-IMGTIGYIDPEY 772
IHRD++++NIL+ + + DFG+A+ L YT+ I + PE
Sbjct: 119 ER---MNYIHRDLRAANILVGDNLVCKIADFGLAR-LIEDNEYTARQGAKFPIKWTAPEA 174
Query: 773 ARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISAT 831
A R T KSDV+SFGI+L EL+T GR + N V+E V+
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGR-----------VPYPGMVNREVLEQVERGYRMP 223
Query: 832 CKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866
C G + + +L LC K+ P +RPT + L
Sbjct: 224 CPQ-GCPESLHELMKLCWKKDPDERPTFEYIQSFL 257
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-18
Identities = 72/285 (25%), Positives = 128/285 (44%), Gaps = 36/285 (12%)
Query: 606 IGYGASSTVYKCVLKNCKP------VAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSL 659
+G GA V+ N P VA+K L K+F+ E E + +++H ++V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 660 QGYSLSSSGNLLFYDFMENGSLWDIL--HGP-----------TKKKKLDWDTRLKIALGA 706
G ++ +++M++G L L HGP K +L L IA
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 707 AQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY-TSTYIMGTI 765
A G+ YL S +HRD+ + N L+ + + DFG+++ + + Y + M I
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 766 GYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETV 824
++ PE + T +SDV+SFG++L E+ T G++ N ++ V+E
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN--TEVIECITQGRVLER- 246
Query: 825 DPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869
P + K+V+ + L C +R+P R + E+ ++L +L
Sbjct: 247 -PRVCP--------KEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-18
Identities = 70/232 (30%), Positives = 111/232 (47%), Gaps = 29/232 (12%)
Query: 639 KEFETELETVGSIKHRNLVSLQGYSLSSSGNL-LFYDFMENGSLWDILHGP-----TKKK 692
+E E+ + ++KH N+V Q S +GNL + D+ E G L+ ++ + +
Sbjct: 44 EESRKEVAVLSNMKHPNIVQYQ-ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQ 102
Query: 693 KLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV 752
LDW ++ +AL HD +I+HRD+KS NI L KD L DFGIA+ L
Sbjct: 103 ILDWFVQICLALKHV-------HD--RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS 153
Query: 753 SKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLIL 812
+ T I GT Y+ PE KSD+++ G VL E+ T + A + N+ +L+L
Sbjct: 154 TVELARTCI-GTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFE-AGNMKNLVL 211
Query: 813 SKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSR 864
+ V S ++L V ++F KR P DRP+++ +
Sbjct: 212 KIIRGS--YPPVSSHYSYDLRNL--VSQLF-------KRNPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 68/266 (25%), Positives = 114/266 (42%), Gaps = 32/266 (12%)
Query: 606 IGYGASSTVYKCV-LKNCKPVAIKRLY-----SHYPQCLKEFETELETVGSIKHRNLVSL 659
+G G+ +VY+ + L + A+K + + +K+ E E+ + ++H N+V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 660 QGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQ---GLAYLHHD 716
G +F + + GSL +L KK I L Q GL YLH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLL------KKYGSFPEPVIRLYTRQILLGLEYLH-- 119
Query: 717 CSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEY-ART 775
+HRD+K +NIL+D + L DFG+AK V + + G+ ++ PE A+
Sbjct: 120 -DRNTVHRDIKGANILVDTNGVVKLADFGMAKQ--VVEFSFAKSFKGSPYWMAPEVIAQQ 176
Query: 776 SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDL 835
+D++S G +LE+ TG K ++ + K + + + +S KD
Sbjct: 177 GGYGLAADIWSLGCTVLEMATG-KPPWSQLEGVAAVF-KIGRSKELPPIPDHLSDEAKD- 233
Query: 836 GAVKKVFQLALLCSKRQPTDRPTMHE 861
L C +R P+ RPT E
Sbjct: 234 --------FILKCLQRDPSLRPTAAE 251
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 3e-18
Identities = 77/296 (26%), Positives = 134/296 (45%), Gaps = 41/296 (13%)
Query: 599 NLSEKYIIGYGASSTVYKCVLKNCKP------VAIKRLYSHYPQCLKEFETELETVGSIK 652
N+ K +G GA V+ N P VA+K L K+F E E + +++
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65
Query: 653 HRNLVSLQGYSLSSSGNLLFYDFMENGSLWDIL--HGP--------TKKKKLDWDTRLKI 702
H ++V G + ++ +++M++G L L HGP + +L L I
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 703 ALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY-TSTYI 761
A A G+ YL S +HRD+ + N L+ ++ + DFG+++ + + Y +
Sbjct: 126 AQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHT 182
Query: 762 MGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAV 820
M I ++ PE + T +SDV+S G+VL E+ T G++ + +NN V
Sbjct: 183 MLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP-----------WYQLSNNEV 231
Query: 821 METVDP----EISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPA 872
+E + + TC K+V+ L L C +R+P R + E+ +L +L A
Sbjct: 232 IECITQGRVLQRPRTCP-----KEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 4e-18
Identities = 69/281 (24%), Positives = 132/281 (46%), Gaps = 29/281 (10%)
Query: 600 LSEKYIIGYGASSTVYKCVLK----NCKPVAIKRLYSHYPQCLK-EFETELETVGSIKHR 654
++++ +IG G V++ +LK VAIK L Y + + +F +E +G H
Sbjct: 7 ITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHH 66
Query: 655 NLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIAL--GAAQGLAY 712
N++ L+G ++ ++MENG+L L + ++ + + + G A G+ Y
Sbjct: 67 NIIRLEGVVTKFKPAMIITEYMENGALDKYL----RDHDGEFSSYQLVGMLRGIAAGMKY 122
Query: 713 LHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSL--CVSKSYTSTYIMGTIGYIDP 770
L +HRD+ + NIL++ + E ++DFG+++ L +YT++ I + P
Sbjct: 123 L---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAP 179
Query: 771 EYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEIS 829
E + T SDV+SFGIV+ E+++ G + +N+ VM+ ++
Sbjct: 180 EAIAYRKFTSASDVWSFGIVMWEVMSFGERP-----------YWDMSNHEVMKAINDGFR 228
Query: 830 ATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLV 870
+ V+QL L C ++ RP ++ +L L+
Sbjct: 229 LPAP-MDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 72/275 (26%), Positives = 126/275 (45%), Gaps = 23/275 (8%)
Query: 599 NLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLV 657
+++ K+ +G G VY+ V K VA+K L + ++EF E + IKH NLV
Sbjct: 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLV 65
Query: 658 SLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDC 717
L G + +FM G+L D L +++++ L +A + + YL
Sbjct: 66 QLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISSAMEYLE--- 121
Query: 718 SPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGT---IGYIDPEYAR 774
IHRD+ + N L+ ++ + DFG+++ L +YT+ G I + PE
Sbjct: 122 KKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAH--AGAKFPIKWTAPESLA 178
Query: 775 TSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKD 834
++ + KSDV++FG++L E+ T + +L + ME PE
Sbjct: 179 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLEKGYRMER--PE------- 228
Query: 835 LGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869
G KV++L C + P+DRP+ E+ + ++
Sbjct: 229 -GCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 2e-17
Identities = 49/146 (33%), Positives = 68/146 (46%), Gaps = 15/146 (10%)
Query: 54 DYCV-----WRGITC--DNVT--FTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRL 104
D CV W G C D+ + + L L L G I + L+ LQSI+L GN +
Sbjct: 395 DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSI 454
Query: 105 SGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLP 164
G IP +G +SL+ LDLS+N G IP S+ +L L L L N L G +P+ L
Sbjct: 455 RGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRL 514
Query: 165 NLKVFGLRGNNLVGTLSPDMCQLSGL 190
L + T + +C + GL
Sbjct: 515 ------LHRASFNFTDNAGLCGIPGL 534
|
Length = 623 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 2e-17
Identities = 75/266 (28%), Positives = 120/266 (45%), Gaps = 30/266 (11%)
Query: 605 IIGYGASSTVYKCVLKNC-KPVAIKRLYSHYPQCLKEFE----TELETVGSIKHRNLVSL 659
++G GA V+ C K K V IK++ Q K+ E + + + H N++
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVE--QMTKDERLAAQNECQVLKLLSHPNIIEY 64
Query: 660 QGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSP 719
L ++ ++ G+L + + LD DT L + Q L LHH +
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYIQ-KRCNSLLDEDTILHFFV---QILLALHHVHTK 120
Query: 720 RIIHRDVKSSNILLDK-DFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRL 778
I+HRD+K+ NILLDK + DFGI+K L SKS T ++GT YI PE
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKIL-SSKSKAYT-VVGTPCYISPELCEGKPY 178
Query: 779 TEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTAN--NAVMETVDPEISATCKDLG 836
+KSD+++ G VL EL + ++A + NL L+L + + + P++
Sbjct: 179 NQKSDIWALGCVLYELASLKRAFEAA-NLPALVLKIMSGTFAPISDRYSPDLR------- 230
Query: 837 AVKKVFQLALLCSKRQPTDRPTMHEV 862
QL L P+ RP + ++
Sbjct: 231 ------QLILSMLNLDPSKRPQLSQI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 77/268 (28%), Positives = 122/268 (45%), Gaps = 31/268 (11%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLY--SHYPQCLKEFETELETVGSIKHRN 655
E+L + +G G V+ VAIK L + P+ F E + + ++H
Sbjct: 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEK 62
Query: 656 LVSLQGYSLSSSGNL-LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLH 714
LV L Y++ S + + ++M GSL D L G K L + +A A G+AY+
Sbjct: 63 LVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE 119
Query: 715 HDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGT---IGYIDPE 771
+HRD++++NIL+ ++ + DFG+A+ L YT+ G I + PE
Sbjct: 120 R---MNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTAR--QGAKFPIKWTAPE 173
Query: 772 YARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISA 830
A R T KSDV+SFGI+L EL T GR + N V++ V+
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELTTKGR-----------VPYPGMVNREVLDQVERGYRM 222
Query: 831 TCKDLGAVKKVFQLALLCSKRQPTDRPT 858
C + + L C +++P +RPT
Sbjct: 223 PCPP-ECPESLHDLMCQCWRKEPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (204), Expect = 5e-17
Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 33/209 (15%)
Query: 605 IIGYGASSTVYKCVLKNC-KPVAIKRLYSHYPQ------------CLKEFETELETVGSI 651
+G G VYK K + VA+K++ + LKE +
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKE----------L 55
Query: 652 KHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLA 711
KH N+V L + L +++ + L L + L + I +GLA
Sbjct: 56 KHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLD--KRPGPLSPNLIKSIMYQLLRGLA 112
Query: 712 YLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV-SKSYTSTYIMGTIGYIDP 770
Y H S RI+HRD+K NIL+++D L DFG+A++ + ++YT + T+ Y P
Sbjct: 113 YCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV--TLWYRAP 167
Query: 771 EYARTSRLTEKS-DVYSFGIVLLELLTGR 798
E S+ + D++S G + E++TG+
Sbjct: 168 EILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 6e-17
Identities = 71/267 (26%), Positives = 116/267 (43%), Gaps = 21/267 (7%)
Query: 605 IIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLK-EFETELETVGSIKHRNLVSLQGYS 663
++G G V+K LK+ PVA+K PQ LK +F +E + H N+V L G
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 664 LSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTR--LKIALGAAQGLAYLHHDCSPRI 721
+ + + G L +KKK + T+ +K AL AA G+AYL S
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFL----RKKKDELKTKQLVKFALDAAAGMAYLE---SKNC 114
Query: 722 IHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEK 781
IHRD+ + N L+ ++ ++DFG+++ +S I + PE R + +
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSE 174
Query: 782 SDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKV 841
SDV+S+GI+L E + L N E V+ +C V
Sbjct: 175 SDVWSYGILLWETFS----------LGVCPYPGMTNQQAREQVEKGYRMSCPQ-KCPDDV 223
Query: 842 FQLALLCSKRQPTDRPTMHEVSRVLGS 868
+++ C +P +RP E+ + L +
Sbjct: 224 YKVMQRCWDYKPENRPKFSELQKELAA 250
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 7e-17
Identities = 49/172 (28%), Positives = 94/172 (54%), Gaps = 13/172 (7%)
Query: 638 LKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDIL--HGPTKKKKLD 695
+K +E+ET+ + H N+V G+ + +F +++ GS+ L +G +++ +
Sbjct: 52 VKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVR 111
Query: 696 WDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAK-SLCVSK 754
+ T + +GLAYLH S I+HRD+K+ N+L+D D ++DFGI+K S +
Sbjct: 112 FFTEQVL-----EGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYD 163
Query: 755 SYTSTYIMGTIGYIDPEYARTSR--LTEKSDVYSFGIVLLELLTGRKAVDNE 804
+ + + G++ ++ PE + + K D++S G V+LE+ GR+ +E
Sbjct: 164 NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 8e-17
Identities = 82/274 (29%), Positives = 124/274 (45%), Gaps = 33/274 (12%)
Query: 592 DIMRMTENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCL--KEFETELETVG 649
+I R + L +K +G G V+ VA+K L P + + F E + +
Sbjct: 2 EIPRESLQLIKK--LGNGQFGEVWMGTWNGNTKVAVKTLK---PGTMSPESFLEEAQIMK 56
Query: 650 SIKHRNLVSLQGYSLSSSGNL-LFYDFMENGSLWDILH-GPTKKKKLDWDTRLKIALGAA 707
++H LV L Y++ S + + ++M GSL D L G + KL + +A A
Sbjct: 57 KLRHDKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLP--NLVDMAAQVA 112
Query: 708 QGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGT--- 764
G+AY+ IHRD++S+NIL+ + DFG+A+ L YT+ G
Sbjct: 113 AGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLAR-LIEDNEYTAR--QGAKFP 166
Query: 765 IGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETV 824
I + PE A R T KSDV+SFGI+L EL+T + N N V+E V
Sbjct: 167 IKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN----------NREVLEQV 216
Query: 825 DPEISATCKDLGAVKKVFQLALLCSKRQPTDRPT 858
+ C + +L L C K+ P +RPT
Sbjct: 217 ERGYRMPCPQ-DCPISLHELMLQCWKKDPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 58/196 (29%), Positives = 92/196 (46%), Gaps = 16/196 (8%)
Query: 606 IGYGASSTVYKCV-LKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSL 664
IG G VYK + + VAIK + + + E+ + +H N+V+ G L
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 665 SSSGNLLFYDFMENGSLWDILH---GPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRI 721
+ ++ GSL DI GP + ++ + R +GLAYLH
Sbjct: 71 RRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCR-----ETLKGLAYLHET---GK 122
Query: 722 IHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYA---RTSRL 778
IHRD+K +NILL +D + L DFG++ L + + ++I GT ++ PE A R
Sbjct: 123 IHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVAAVERKGGY 181
Query: 779 TEKSDVYSFGIVLLEL 794
K D+++ GI +EL
Sbjct: 182 DGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 1e-16
Identities = 82/280 (29%), Positives = 129/280 (46%), Gaps = 17/280 (6%)
Query: 606 IGYGASSTVYKCV-LKNCKPVAIKRL-YSHYPQCLKEFE-TELETVGSIKHRNLVSLQGY 662
IG GAS TVY + + + VAIK++ P+ KE E+ + KH N+V+
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPK--KELIINEILVMRENKHPNIVNYLDS 84
Query: 663 SLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRII 722
L + +++ GSL D++ + +D + Q L +LH S ++I
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLH---SNQVI 137
Query: 723 HRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKS 782
HRD+KS NILL D LTDFG + +S ST ++GT ++ PE K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPKV 196
Query: 783 DVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPE-ISATCKDLGAVKKV 841
D++S GI+ +E++ G NE L L L A N E +PE +SA +D
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENPLRALYL--IATNGTPELQNPEKLSAIFRDFLNRCLE 254
Query: 842 FQLALLCSKRQPTDRPTMHEVSRVLGSLVPAPEPQKQPTS 881
+ S ++ P + ++++ L SL P K+ T
Sbjct: 255 MDVEKRGSAKELLQHPFL-KIAKPLSSLTPLIAAAKEATK 293
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 52/145 (35%), Positives = 80/145 (55%), Gaps = 12/145 (8%)
Query: 656 LVSLQGYSLSSSGNLLFYDFMENGSLWDILH--GPTKKKKLDWDTRLKIALGAAQGLAYL 713
+VS G L+ + + +FM+ GSL I GP + + KIA+ +GL YL
Sbjct: 65 IVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGP-----IPVEILGKIAVAVVEGLTYL 119
Query: 714 HHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYA 773
++ RI+HRD+K SNIL++ + L DFG++ L S + T +GT Y+ PE
Sbjct: 120 YN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT---FVGTSTYMSPERI 174
Query: 774 RTSRLTEKSDVYSFGIVLLELLTGR 798
+ + T KSDV+S GI ++EL G+
Sbjct: 175 QGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 60/210 (28%), Positives = 93/210 (44%), Gaps = 32/210 (15%)
Query: 605 IIGYGASSTVYKCV-LKNCKPVAIKRLYSHYPQCLKEFETELE-----TVGSIK------ 652
IG G VYK K + VA+K++ E E E + IK
Sbjct: 6 QIGEGTYGQVYKARNKKTGELVALKKI---------RMENEKEGFPITAIREIKLLQKLR 56
Query: 653 HRNLVSLQGYSLSSSGNLLF--YDFMENGSLWDILHGPTKKKKLDWDTRLK-IALGAAQG 709
H N+V L+ S ++ +++M++ L +L P K ++K +G
Sbjct: 57 HPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTES---QIKCYMKQLLEG 112
Query: 710 LAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYID 769
L YLH + I+HRD+K SNIL++ D L DFG+A+ S T + T+ Y
Sbjct: 113 LQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRP 169
Query: 770 PE-YARTSRLTEKSDVYSFGIVLLELLTGR 798
PE +R + D++S G +L EL G+
Sbjct: 170 PELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 69/274 (25%), Positives = 113/274 (41%), Gaps = 37/274 (13%)
Query: 606 IGYGASSTVYKCV--LKNCK--PVAIKRLY-SHYPQCLKEFETELETVGSIKHRNLVSLQ 660
+G+G +V K V +K+ K VA+K L H KEF E + + H +V L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 661 GYSLSSSGNLLFYDFMENGSLWDIL--HGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCS 718
G +L + G L L L ++A A G+AYL S
Sbjct: 63 GVCKGE-PLMLVMELAPLGPLLKYLKKRREIPVSDL-----KELAHQVAMGMAYLE---S 113
Query: 719 PRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIG-----YIDPEYA 773
+HRD+ + N+LL +A ++DFG++++L Y Y T G + PE
Sbjct: 114 KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY---YRATTAGRWPLKWYAPECI 170
Query: 774 RTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISATC 832
+ + KSDV+S+G+ L E + G K + V+ ++
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFSYGAKP-----------YGEMKGAEVIAMLESGERLPR 219
Query: 833 KDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866
+ ++++ + L C K +P DRPT E+
Sbjct: 220 PE-ECPQEIYSIMLSCWKYRPEDRPTFSELESTF 252
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 53/171 (30%), Positives = 84/171 (49%), Gaps = 16/171 (9%)
Query: 636 QCLKE------FETELETVGSIKHRNLVSLQGYSLSSSGNL-LFYDFMENGSLWDILHGP 688
+C+K F E + ++H NLV L G + G L + ++M GSL D L
Sbjct: 35 KCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS- 93
Query: 689 TKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAK 748
+ L D LK +L + + YL + +HRD+ + N+L+ +D A ++DFG+ K
Sbjct: 94 RGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTK 150
Query: 749 SLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GR 798
S T + + PE R + + KSDV+SFGI+L E+ + GR
Sbjct: 151 EA----SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 55/219 (25%), Positives = 98/219 (44%), Gaps = 17/219 (7%)
Query: 644 ELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIA 703
E+ + ++H N+++ + + + L+ ++ G+L+D + K + + + L
Sbjct: 49 EIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKI-VRQKGQLFEEEMVLWYL 107
Query: 704 LGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMG 763
++Y+H I+HRD+K+ NI L K L DFGI+K L S T ++G
Sbjct: 108 FQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVG 163
Query: 764 TIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMET 823
T Y+ PE + + KSD+++ G VL ELLT ++ D N +L++ N
Sbjct: 164 TPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT-NPLNLVVKIVQGNYTPV- 221
Query: 824 VDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
++ L ++ P RPT EV
Sbjct: 222 ----------VSVYSSELISLVHSLLQQDPEKRPTADEV 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 3e-16
Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 605 IIGYGASSTVYKCV-LKNCKPVAIKR-----LYSHYPQCLKEFETELETVGSIKHRNLVS 658
++G GA VY C + + +A+K+ + + E E++ + +++H +V
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 659 LQGYSLSSSGNL-LFYDFMENGSLWDIL--HGPTKKKKLDWDTRLKIALGAAQGLAYLHH 715
G L L +F ++M GS+ D L +G L K +G+ YLH
Sbjct: 69 YYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGA-----LTETVTRKYTRQILEGVEYLH- 121
Query: 716 DCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSL---CVSKSYTSTYIMGTIGYIDPEY 772
S I+HRD+K +NIL D L DFG +K L C S + + GT ++ PE
Sbjct: 122 --SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT-GTPYWMSPEV 178
Query: 773 ARTSRLTEKSDVYSFGIVLLELLT 796
K+DV+S G ++E+LT
Sbjct: 179 ISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 4e-16
Identities = 61/244 (25%), Positives = 108/244 (44%), Gaps = 19/244 (7%)
Query: 625 VAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDI 684
VAIK + + ++F E + + + H LV L G + +FMENG L +
Sbjct: 31 VAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNY 89
Query: 685 LHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDF 744
L ++ KL D L + +G+ YL + IHRD+ + N L+ ++DF
Sbjct: 90 LR--QRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDF 144
Query: 745 GIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDN 803
G+ + + + +S+ + + PE S+ + KSDV+SFG+++ E+ T G+ +
Sbjct: 145 GMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK 204
Query: 804 ECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVS 863
+ N V+E + L A V+++ C +P RPT E+
Sbjct: 205 KSNYE-----------VVEMISRGFRLYRPKL-ASMTVYEVMYSCWHEKPEGRPTFAELL 252
Query: 864 RVLG 867
R +
Sbjct: 253 RAIT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 5e-16
Identities = 62/213 (29%), Positives = 93/213 (43%), Gaps = 31/213 (14%)
Query: 605 IIGYGASSTVYKCV-LKNCKPVAIKRLYSHYPQCLK-EFETELETVGSI-KHRNLVSLQG 661
+IG G VYK K + VAIK + + + E + E + H N+ + G
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIM--DIIEDEEEEIKEEYNILRKYSNHPNIATFYG 70
Query: 662 -YSLSSSGNL-----LFYDFMENGSLWDILHGPTKKKKLDWDTRLK------IALGAAQG 709
+ + L + GS+ D++ K RLK I +G
Sbjct: 71 AFIKKNPPGNDDQLWLVMELCGGGSVTDLV-----KGLRKKGKRLKEEWIAYILRETLRG 125
Query: 710 LAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYID 769
LAYLH ++IHRD+K NILL K+ E L DFG++ L + +T+I GT ++
Sbjct: 126 LAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-GTPYWMA 181
Query: 770 PE-----YARTSRLTEKSDVYSFGIVLLELLTG 797
PE + +SDV+S GI +EL G
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 5e-16
Identities = 71/280 (25%), Positives = 122/280 (43%), Gaps = 35/280 (12%)
Query: 603 KYIIGYGASSTVYKCVLKNCKP------VAIKRLYSHYPQCLKEFETELETVGSIKHRNL 656
K+ +G GA V+ N P VA+K L ++F+ E E + ++H+++
Sbjct: 10 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHI 69
Query: 657 VSLQGYSLSSSGNLLFYDFMENGSLWDIL--HGPTKK----------KKLDWDTRLKIAL 704
V G L+ +++M +G L L HGP K +L L IA
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 705 GAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY-TSTYIMG 763
A G+ YL S +HRD+ + N L+ + + DFG+++ + + Y M
Sbjct: 130 QIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186
Query: 764 TIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKT-ANNAVME 822
I ++ PE + T +SD++SFG+VL E+ T K + LS T A + +
Sbjct: 187 PIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQ-------LSNTEAIECITQ 239
Query: 823 TVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
+ E TC +V+ + C +R+P R + ++
Sbjct: 240 GRELERPRTCPP-----EVYAIMQGCWQREPQQRMVIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 79.4 bits (195), Expect = 5e-16
Identities = 70/232 (30%), Positives = 109/232 (46%), Gaps = 12/232 (5%)
Query: 606 IGYGASSTVYKCV-LKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSL 664
IG GAS TVY + + + VAIK++ + E+ + K+ N+V+ L
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 665 SSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHR 724
+ +++ GSL D++ + +D + Q L +LH S ++IHR
Sbjct: 87 VGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALDFLH---SNQVIHR 139
Query: 725 DVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDV 784
D+KS NILL D LTDFG + +S ST ++GT ++ PE K D+
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPKVDI 198
Query: 785 YSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPE-ISATCKDL 835
+S GI+ +E++ G NE L L L A N E +PE +SA +D
Sbjct: 199 WSLGIMAIEMVEGEPPYLNENPLRALYL--IATNGTPELQNPERLSAVFRDF 248
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 7e-16
Identities = 59/206 (28%), Positives = 87/206 (42%), Gaps = 30/206 (14%)
Query: 606 IGYGASSTVYKCVLKNCKPV-AIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSL-Q 660
+G G V +K+ A+K + + + +E E + H +V L +
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 661 GYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLD-WDTRLKIALGAAQGLAYLHHDCSP 719
+ +L ++ G LW IL + D + R IA YLH+
Sbjct: 61 TFKDKKYIYMLM-EYCLGGELWTILR---DRGLFDEYTARFYIA-CVVLAFEYLHNR--- 112
Query: 720 RIIHRDVKSSNILLDKDFEAHLTDFGIAKSL-CVSKSYTSTYIMGTIGYIDPE------Y 772
II+RD+K N+LLD + L DFG AK L K++T GT Y+ PE Y
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTPEYVAPEIILNKGY 169
Query: 773 ARTSRLTEKSDVYSFGIVLLELLTGR 798
+ D +S GI+L ELLTGR
Sbjct: 170 DFS------VDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 1e-15
Identities = 72/271 (26%), Positives = 122/271 (45%), Gaps = 27/271 (9%)
Query: 598 ENLSEKYIIGYGASSTVYKC-VLKNCKPVAIKRL-YSHYPQCLKEFETELETVGSIKHRN 655
+++ + I+G+G TVYK L + +A+K + + K+ +ELE +
Sbjct: 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPY 60
Query: 656 LVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHH 715
++ G + + +FM+ GSL D+ +K+ +IA+ +GL YL
Sbjct: 61 IIGFYGAFFVENRISICTEFMDGGSL-DVY------RKIPEHVLGRIAVAVVKGLTYL-- 111
Query: 716 DCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYART 775
S +I+HRDVK SN+L++ + L DFG++ L S TY+ GT Y+ PE
Sbjct: 112 -WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV--NSIAKTYV-GTNAYMAPERISG 167
Query: 776 SRLTEKSDVYSFGIVLLELLTGR----KAVDNECNLHHLILSKTANNAVMETVDPEISAT 831
+ SDV+S GI +EL GR + N+ +L L L ++ + E
Sbjct: 168 EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQL--------LQCIVDEDPPV 219
Query: 832 CKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
+K C ++QP +RP +
Sbjct: 220 LPVGQFSEKFVHFITQCMRKQPKERPAPENL 250
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 77.5 bits (190), Expect = 2e-15
Identities = 78/280 (27%), Positives = 127/280 (45%), Gaps = 19/280 (6%)
Query: 606 IGYGASSTVYKCV-LKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSL 664
IG GAS TVY + + + VAI+++ + E+ + K+ N+V+ L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 665 SSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHR 724
+ +++ GSL D++ + +D + Q L +LH S ++IHR
Sbjct: 88 VGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLH---SNQVIHR 140
Query: 725 DVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDV 784
D+KS NILL D LTDFG + +S ST ++GT ++ PE K D+
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPKVDI 199
Query: 785 YSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPE-ISATCKDLGAVKKVFQ 843
+S GI+ +E++ G NE L L L A N E +PE +SA +D + +
Sbjct: 200 WSLGIMAIEMIEGEPPYLNENPLRALYL--IATNGTPELQNPEKLSAIFRDF--LNRCLD 255
Query: 844 LALLCSKRQPTDRPTMHE---VSRVLGSLVPAPEPQKQPT 880
+ + KR H+ +++ L SL P K+ T
Sbjct: 256 MDV--EKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEAT 293
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 3e-15
Identities = 61/210 (29%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 602 EKYIIGYGASSTVYKCVLKNC-KPVAIKRL-YSHYPQCLKEFE-----TELETVGSIKHR 654
IG G+ TV K K+ K + K + Y + + E E +E+ + +KH
Sbjct: 4 VLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGN----MTEKEKQQLVSEVNILRELKHP 59
Query: 655 NLVSLQGYSLSSSGNLLFYDFME---NGSLWDILHGPTK-KKKLDWDTRLKIALGAAQGL 710
N+V + S L Y ME G L ++ K +K ++ + +I L
Sbjct: 60 NIVRYYDRIIDRSNQTL-YIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLAL 118
Query: 711 AYLHH--DCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYI 768
H+ D ++HRD+K +NI LD + L DFG+AK L S+ TY+ GT Y+
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYM 177
Query: 769 DPEYARTSRLTEKSDVYSFGIVLLELLTGR 798
PE EKSD++S G ++ EL
Sbjct: 178 SPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 4e-15
Identities = 82/282 (29%), Positives = 123/282 (43%), Gaps = 38/282 (13%)
Query: 597 TENLSEKYIIGYGASSTVYKCV-LKNCKPVAIKRL---YSHYPQCLKEFETELETVGSIK 652
+ E+ ++G G VY L +AIK + S Y Q L E E+ +K
Sbjct: 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHE---EIALHSYLK 63
Query: 653 HRNLVSLQGYSLSSSGNLLFYDFMEN---GSLWDILH---GPTKKKKLDWDTRLKIALGA 706
HRN+V G S S N F FME GSL +L GP K + T +
Sbjct: 64 HRNIVQYLG---SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNE---QTIIFYTKQI 117
Query: 707 AQGLAYLHHDCSPRIIHRDVKSSNILLDK-DFEAHLTDFGIAKSLCVSKSYTSTYIMGTI 765
+GL YLH + +I+HRD+K N+L++ ++DFG +K L T T+ GT+
Sbjct: 118 LEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF-TGTL 173
Query: 766 GYIDPEYARTSR--LTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAV-ME 822
Y+ PE +D++S G ++E+ TG+ L + A V M
Sbjct: 174 QYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP------FIELGEPQAAMFKVGMF 227
Query: 823 TVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSR 864
+ PEI + L A K F L C + P R + H++ +
Sbjct: 228 KIHPEIP---ESLSAEAKNFILR--CFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 5e-15
Identities = 71/275 (25%), Positives = 111/275 (40%), Gaps = 50/275 (18%)
Query: 606 IGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFE-------------TELETVGSIK 652
+G G+ +VYK +KRL + LKE + E+ + S+
Sbjct: 8 LGKGSYGSVYK----------VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVN 57
Query: 653 HRNLVSLQGYSLSSSGNLLFYDFMENGSLWD----ILHGPTKKKKLDWDTRLKIALGAAQ 708
H N++S + L GN L ME D I K+K + +I + +
Sbjct: 58 HPNIISYKEAFLD--GNKL-CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLR 114
Query: 709 GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYI 768
GL LH +I+HRD+KS+NILL + + D GI+K L K+ T I GT Y+
Sbjct: 115 GLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVL--KKNMAKTQI-GTPHYM 168
Query: 769 DPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEI 828
PE + + KSD++S G +L E+ T + ++ L V P I
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEAR-SMQDL------RYKVQRGKYPPI 221
Query: 829 SAT-CKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
+DL + +P RP ++
Sbjct: 222 PPIYSQDLQ------NFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 6e-15
Identities = 70/230 (30%), Positives = 99/230 (43%), Gaps = 24/230 (10%)
Query: 598 ENLSEKYIIGYGASSTVYKC-VLKNCKPVAIKRLY-SHYPQCLKEFETELETVGSIKHR- 654
ENL E IG G VYK K +A+K++ + + K +L+ V H
Sbjct: 18 ENLGE---IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVV-LKSHDC 73
Query: 655 -NLVSLQGYSLSSSGNLLFYDFMEN--GSLWDILHGPTKKKKLDWDTRLKIALGAAQGLA 711
+V GY ++ S + + M L + GP + L K+ + + L
Sbjct: 74 PYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILG-----KMTVAIVKALH 128
Query: 712 YLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPE 771
YL +IHRDVK SNILLD L DFGI+ L SK+ T + G Y+ PE
Sbjct: 129 YLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS--AGCAAYMAPE 184
Query: 772 YARTSRLTEK----SDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTAN 817
K +DV+S GI L+EL TG+ N C +L+K
Sbjct: 185 RIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN-CKTEFEVLTKILQ 233
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 6e-15
Identities = 69/214 (32%), Positives = 101/214 (47%), Gaps = 27/214 (12%)
Query: 591 EDIMRMTENLSEKYIIGYGASSTVY--KCVLKNCKPVAIKRLYSHYPQCLKEFE---TEL 645
+D ++ +L E IG+G+ VY + V N + VAIK++ Q ++++ E+
Sbjct: 11 DDPEKLFTDLRE---IGHGSFGAVYFARDVRTN-EVVAIKKMSYSGKQSNEKWQDIIKEV 66
Query: 646 ETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMEN--GSLWDILHGPTKKKKLDWDTRLKIA 703
+ ++H N + +G L L ME GS DIL KK L I
Sbjct: 67 RFLQQLRHPNTIEYKGCYLREHTAWLV---MEYCLGSASDILE--VHKKPLQEVEIAAIC 121
Query: 704 LGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMG 763
GA QGLAYLH S IHRD+K+ NILL + L DFG A + + S+ +G
Sbjct: 122 HGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSF-----VG 173
Query: 764 TIGYIDPEY---ARTSRLTEKSDVYSFGIVLLEL 794
T ++ PE + K DV+S GI +EL
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 7e-15
Identities = 77/289 (26%), Positives = 123/289 (42%), Gaps = 50/289 (17%)
Query: 605 IIGYGASSTVYKCVLKNC-------KPVAIKRLY-SHYPQCLKEFETELETVGSIKHRNL 656
+G GA VY+ + VA+K L Q KEF E + + H N+
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 657 VSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKK----LDWDTRLKIALGAAQGLAY 712
V L G L + + + ME G L L ++ L L I L A+G Y
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 713 LHHDCSPRIIHRDVKSSNILL-DKDFEAHLT----DFGIAKSLCVSKSYTSTYI------ 761
L IHRD+ + N L+ +K ++A DFG+A+ + Y S Y
Sbjct: 122 LE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI-----YKSDYYRKEGEG 173
Query: 762 MGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRK---AVDNECNLHHLILSKTAN 817
+ + ++ PE + T +SDV+SFG+++ E+LT G++ A++N+ L H
Sbjct: 174 LLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQH-------- 225
Query: 818 NAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866
V + C D K++QL C + P++RPT + +L
Sbjct: 226 --VTAGGRLQKPENCPD-----KIYQLMTNCWAQDPSERPTFDRIQEIL 267
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 7e-15
Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 18/203 (8%)
Query: 605 IIGYGASSTVYKCVLKNC----KPVAIKRLYSHYP-QCLKEFETELETVGSIKHRNLVSL 659
+IG G V + LK VAIK L S Y + ++F +E +G H N++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 660 QGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSP 719
+G S ++ +FMENG+L L + + + G A G+ YL
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLR--QNDGQFTVIQLVGMLRGIAAGMKYL---SEM 125
Query: 720 RIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS---YTSTYIMG---TIGYIDPEYA 773
+HRD+ + NIL++ + ++DFG+++ L S YTS+ +G I + PE
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSS--LGGKIPIRWTAPEAI 183
Query: 774 RTSRLTEKSDVYSFGIVLLELLT 796
+ T SDV+S+GIV+ E+++
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 8e-15
Identities = 61/228 (26%), Positives = 109/228 (47%), Gaps = 24/228 (10%)
Query: 641 FETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKL-DWDTR 699
F E + + H+NLV L G L + G + + M G+L + L T+ + L
Sbjct: 46 FLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLR--TRGRALVSVIQL 102
Query: 700 LKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTST 759
L+ +L A+G+ YL S +++HRD+ + NIL+ +D A ++DFG+A+ S ++
Sbjct: 103 LQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARV--GSMGVDNS 157
Query: 760 YIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANN 818
+ + + PE + + + KSDV+S+G++L E+ + GR K +
Sbjct: 158 KL--PVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAP-----------YPKMSLK 204
Query: 819 AVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866
V E V+ + G V+ L C + +P RP+ H++ L
Sbjct: 205 EVKECVEKGYRMEPPE-GCPADVYVLMTSCWETEPKKRPSFHKLREKL 251
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 8e-15
Identities = 62/206 (30%), Positives = 102/206 (49%), Gaps = 24/206 (11%)
Query: 605 IIGYGASSTVYKCVLKNCKP----VAIKRLYSHYP-QCLKEFETELETVGSIKHRNLVSL 659
+IG G VY L + A+K L + +++F E + H N++SL
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 660 QGYSLSSSGN-LLFYDFMENGSLWDIL----HGPTKKKKLDWDTRLKIALGAAQGLAYLH 714
G L S G+ L+ +M++G L + + H PT K + + L A+G+ YL
Sbjct: 62 LGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGF------GLQVAKGMEYL- 114
Query: 715 HDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTS----TYIMGTIGYIDP 770
S + +HRD+ + N +LD+ F + DFG+A+ + K Y S T + ++
Sbjct: 115 --ASKKFVHRDLAARNCMLDESFTVKVADFGLARDI-YDKEYYSVHNHTGAKLPVKWMAL 171
Query: 771 EYARTSRLTEKSDVYSFGIVLLELLT 796
E +T + T KSDV+SFG++L EL+T
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 9e-15
Identities = 61/290 (21%), Positives = 111/290 (38%), Gaps = 40/290 (13%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLKNC------KPVAIKRLYSHYP--QCLKEFETELETVG 649
NL E +G G V+ K V +K L EF EL+
Sbjct: 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKAL-QKTKDENLQSEFRRELDMFR 63
Query: 650 SIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDIL------HGPTKKKKLDWDTRLKIA 703
+ H+N+V L G + + + ++ + G L L K L ++ +
Sbjct: 64 KLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALC 123
Query: 704 LGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMG 763
A G+ +L + R +HRD+ + N L+ E ++ ++K + S+ Y +
Sbjct: 124 TQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI 180
Query: 764 TIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMET 823
+ ++ PE + + KSDV+SFG+++ E+ T + L ++ V+
Sbjct: 181 PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGE----------LPFYGLSDEEVLN- 229
Query: 824 VDPEISATCKDL------GAVKKVFQLALLCSKRQPTDRPTMHEVSRVLG 867
L G ++++L C P DRP+ E+ LG
Sbjct: 230 -----RLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-14
Identities = 61/230 (26%), Positives = 110/230 (47%), Gaps = 20/230 (8%)
Query: 644 ELETVGSIKHRNLVSLQGYSLSSSGN--LLFYDFMENGSLWDILHGPTKKKKLDWDTRLK 701
E+E + ++ H N+V +G GN L +F+ +GSL + L P K K++ +LK
Sbjct: 56 EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLK 113
Query: 702 IALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTY- 760
A+ +G+ YL S + +HRD+ + N+L++ + + + DFG+ K++ K Y +
Sbjct: 114 YAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKD 170
Query: 761 -IMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILS------ 813
+ + + PE S+ SDV+SFG+ L ELLT D+E + L L
Sbjct: 171 DLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT---YCDSESSPMTLFLKMIGPTH 227
Query: 814 -KTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
+ ++ ++ ++V+QL C + QP+ R T +
Sbjct: 228 GQMTVTRLVRVLEEGKRLPRPP-NCPEEVYQLMRKCWEFQPSKRTTFQNL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 1e-14
Identities = 56/177 (31%), Positives = 86/177 (48%), Gaps = 12/177 (6%)
Query: 625 VAIKRLYSHYPQCLKE-FETELETVGSIKHRNLVSLQGYSLSSSGN--LLFYDFMENGSL 681
VA+K L Q ++ E+ + ++ H N+V +G G L +++ GSL
Sbjct: 36 VAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSL 95
Query: 682 WDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHL 741
D L K KL+ L A +G+AYLH S IHRD+ + N+LLD D +
Sbjct: 96 RDYL----PKHKLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKI 148
Query: 742 TDFGIAKSLCVSKSYTSTYIMGT--IGYIDPEYARTSRLTEKSDVYSFGIVLLELLT 796
DFG+AK++ Y G + + E + ++ + SDV+SFG+ L ELLT
Sbjct: 149 GDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 43/125 (34%), Positives = 69/125 (55%), Gaps = 8/125 (6%)
Query: 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILL 733
+ M+ GSL +L K ++ + KI++ +GL YL I+HRDVK SNIL+
Sbjct: 79 EHMDGGSLDQVLK---KAGRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILV 133
Query: 734 DKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLE 793
+ E L DFG++ L S + + +GT Y+ PE + + T +SD++S G+ L+E
Sbjct: 134 NSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVE 190
Query: 794 LLTGR 798
+ GR
Sbjct: 191 MAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 66/276 (23%), Positives = 119/276 (43%), Gaps = 21/276 (7%)
Query: 592 DIMRMTENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSI 651
+I R + L +K +G G V+ VA+K + ++ F E + ++
Sbjct: 2 EIPRESLKLEKK--LGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTL 58
Query: 652 KHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLA 711
+H LV L ++ + +FM GSL D L + K + + A+G+A
Sbjct: 59 QHDKLVKLHAV-VTKEPIYIITEFMAKGSLLDFLKS-DEGSKQPLPKLIDFSAQIAEGMA 116
Query: 712 YLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPE 771
++ IHRD++++NIL+ + DFG+A+ + ++ I + PE
Sbjct: 117 FIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 173
Query: 772 YARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISA 830
T KSDV+SFGI+L+E++T GR N ++ M +
Sbjct: 174 AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--VIRALERGYRMPRPE----- 226
Query: 831 TCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866
C ++++ + + C K +P +RPT + VL
Sbjct: 227 NCP-----EELYNIMMRCWKNRPEERPTFEYIQSVL 257
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 68/256 (26%), Positives = 120/256 (46%), Gaps = 31/256 (12%)
Query: 624 PVAIKRLYSHYPQ-CLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLW 682
PVAIK L + Y + ++F +E +G H N++ L+G S ++ ++MENGSL
Sbjct: 34 PVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLD 93
Query: 683 DILHGPTKKKKLDWDTRLKIAL-----GAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDF 737
L +K D + I L G A G+ YL D +HRD+ + NIL++ +
Sbjct: 94 AFL------RKHDGQFTV-IQLVGMLRGIASGMKYL-SDMG--YVHRDLAARNILVNSNL 143
Query: 738 EAHLTDFGIAKSL--CVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELL 795
++DFG+++ L +YT+ I + PE + T SDV+S+GIV+ E++
Sbjct: 144 VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM 203
Query: 796 T-GRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPT 854
+ G + +N V++ ++ E + + QL L C ++
Sbjct: 204 SYGERPYWE-----------MSNQDVIKAIE-EGYRLPAPMDCPAALHQLMLDCWQKDRN 251
Query: 855 DRPTMHEVSRVLGSLV 870
+RP ++ +L L+
Sbjct: 252 ERPKFEQIVSILDKLI 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 70/218 (32%), Positives = 108/218 (49%), Gaps = 15/218 (6%)
Query: 593 IMRMTENLSEKYIIGYGASSTVYKCVL----KNCK-PVAIKRL-YSHYPQCLKEFETELE 646
I++ TE L ++G GA TVYK + + K PVAIK L + P+ EF E
Sbjct: 3 ILKETE-LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEAL 61
Query: 647 TVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGA 706
+ S+ H +LV L G LS + L+ M +G L D +H K + L +
Sbjct: 62 IMASMDHPHLVRLLGVCLSPTIQLV-TQLMPHGCLLDYVH--EHKDNIGSQLLLNWCVQI 118
Query: 707 AQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSL-CVSKSYTSTYIMGTI 765
A+G+ YL R++HRD+ + N+L+ +TDFG+A+ L K Y + I
Sbjct: 119 AKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPI 175
Query: 766 GYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVD 802
++ E + T +SDV+S+G+ + EL+T G K D
Sbjct: 176 KWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 74.4 bits (182), Expect = 2e-14
Identities = 64/223 (28%), Positives = 105/223 (47%), Gaps = 11/223 (4%)
Query: 606 IGYGASSTVYKCV-LKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSL 664
IG GAS TV+ + + + VAIK++ + E+ + +K+ N+V+ L
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 665 SSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHR 724
+ +++ GSL D++ + +D + Q L +LH + ++IHR
Sbjct: 87 VGDELFVVMEYLAGGSLTDVV----TETCMDEAQIAAVCRECLQALEFLHAN---QVIHR 139
Query: 725 DVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDV 784
D+KS N+LL D LTDFG + +S ST ++GT ++ PE K D+
Sbjct: 140 DIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPKVDI 198
Query: 785 YSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPE 827
+S GI+ +E++ G NE L L L A N E +PE
Sbjct: 199 WSLGIMAIEMVEGEPPYLNENPLRALYL--IATNGTPELQNPE 239
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 3e-14
Identities = 64/207 (30%), Positives = 98/207 (47%), Gaps = 36/207 (17%)
Query: 606 IGYGASSTVYKCVLKNC-KPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVS------ 658
IG G+ VYK + K + VAIK + L+E E E+E + + +S
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIKVID------LEEAEDEIEDI--QQEIQFLSQCRSPY 60
Query: 659 --------LQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGL 710
L+G L + ++ GS D+L K KLD I GL
Sbjct: 61 ITKYYGSFLKGSKL-----WIIMEYCGGGSCLDLL----KPGKLDETYIAFILREVLLGL 111
Query: 711 AYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDP 770
YLH + IHRD+K++NILL ++ + L DFG++ L + S +T++ GT ++ P
Sbjct: 112 EYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAP 167
Query: 771 EYARTSRLTEKSDVYSFGIVLLELLTG 797
E + S EK+D++S GI +EL G
Sbjct: 168 EVIKQSGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 18/205 (8%)
Query: 606 IGYGASSTVYKCVLKNC--KPVAIKRLYSHYPQCLKEFETELETVGSI-----------K 652
+G GA VYK KN +A+K + H P K+ +++G I +
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 653 HRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRL-KIALGAAQGLA 711
H N+V L + + D +E L + + +KK+ + R+ I + L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 712 YLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPE 771
YLH + RI+HRD+ +NI+L +D + +TDFG+AK TS ++GTI Y PE
Sbjct: 128 YLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTS--VVGTILYSCPE 183
Query: 772 YARTSRLTEKSDVYSFGIVLLELLT 796
+ EK+DV++FG +L ++ T
Sbjct: 184 IVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 4e-14
Identities = 53/153 (34%), Positives = 80/153 (52%), Gaps = 15/153 (9%)
Query: 708 QGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAK--SLCVSKSYTSTYIMGTI 765
Q L +HH S +IHRD+KS+NILL + L DFG +K + VS T+ GT
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC-GTP 209
Query: 766 GYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVD 825
Y+ PE R ++K+D++S G++L ELLT ++ D E N+ ++ KT + +
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE-NMEE-VMHKTLAGR-YDPLP 266
Query: 826 PEISATCKDLGAVKKVFQLALLCSKRQPTDRPT 858
P IS +++ ALL S P RP+
Sbjct: 267 PSISPEMQEIVT-------ALLSS--DPKRRPS 290
|
Length = 496 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 64/209 (30%), Positives = 94/209 (44%), Gaps = 13/209 (6%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLKNCKPV-AIKRLYSHYPQC-LKEFETELETV-GSIKHR 654
E+L + IG GA TV K + K + A+KR+ S + K +L+ V S
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCP 63
Query: 655 NLVSLQGYSLSSSGNLLFYDFMENG--SLWDILHGPTKKKKLDWDTRLKIALGAAQGLAY 712
+V G + + M+ + ++ K + + KIA+ + L Y
Sbjct: 64 YIVKFYGALFREGDCWICMELMDISLDKFYKYVYE-VLKSVIPEEILGKIAVATVKALNY 122
Query: 713 LHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEY 772
L + +IIHRDVK SNILLD++ L DFGI+ L S T G Y+ PE
Sbjct: 123 LKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQL--VDSIAKTRDAGCRPYMAPER 178
Query: 773 ARTSRLTE---KSDVYSFGIVLLELLTGR 798
S +SDV+S GI L E+ TG+
Sbjct: 179 IDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 5e-14
Identities = 54/201 (26%), Positives = 95/201 (47%), Gaps = 18/201 (8%)
Query: 605 IIGYGASSTVYK--CVLKNCKPVAIKRLYSHYPQC-LKEFETELETVGSIKH---RNLVS 658
+IG GA VY+ V + VA+K + P + + + E+ + ++ N+
Sbjct: 8 LIGRGAYGAVYRGKHVPTG-RVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITK 66
Query: 659 LQGYSLSSSGNLLFYDFMENGSLWDILH-GPTKKKKLDWDTRLKIALGAAQGLAYLHHDC 717
G L + ++ E GS+ ++ GP +K + R + L Y+H
Sbjct: 67 YYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVL-----VALKYIHKV- 120
Query: 718 SPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSR 777
+IHRD+K++NIL+ L DFG+A L + S ST++ GT ++ PE +
Sbjct: 121 --GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGK 177
Query: 778 LTE-KSDVYSFGIVLLELLTG 797
+ K+D++S GI + E+ TG
Sbjct: 178 YYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 5e-14
Identities = 64/266 (24%), Positives = 113/266 (42%), Gaps = 26/266 (9%)
Query: 606 IGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLS 665
+G G V+ N VA+K L ++ F E + +++H LV L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 666 SSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRD 725
+ ++M GSL D L + K+ + + A+G+AY+ IHRD
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKS-DEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRD 128
Query: 726 VKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVY 785
++++N+L+ + + DFG+A+ + ++ I + PE T KSDV+
Sbjct: 129 LRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 188
Query: 786 SFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVD-----PEISATCKDLGAVKK 840
SFGI+L E++T K + +N+ VM + P + C D +
Sbjct: 189 SFGILLYEIVTYGK----------IPYPGMSNSDVMSALQRGYRMPRME-NCPD-----E 232
Query: 841 VFQLALLCSKRQPTDRPTMHEVSRVL 866
++ + C K + +RPT + VL
Sbjct: 233 LYDIMKTCWKEKAEERPTFDYLQSVL 258
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 5e-14
Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 12/199 (6%)
Query: 606 IGYGASSTVYKCVLKNCKPV-AIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSL 664
+G GA VYK K A K + + L++F E++ + KH N+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 665 SSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHR 724
+ + +F + G+L I+ ++ L + + L +LH S ++IHR
Sbjct: 73 YENKLWILIEFCDGGALDSIML--ELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHR 127
Query: 725 DVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTE---- 780
D+K+ NILL D + L DFG++ + T+I GT ++ PE +
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVACETFKDNPYD 186
Query: 781 -KSDVYSFGIVLLELLTGR 798
K+D++S GI L+EL
Sbjct: 187 YKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 6e-14
Identities = 35/88 (39%), Positives = 56/88 (63%), Gaps = 1/88 (1%)
Query: 170 GLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIP 229
GL L G + D+ +L L ++ NS+ G+IP ++G+ TS +VLDLSYN +G IP
Sbjct: 424 GLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIP 483
Query: 230 FNIGFL-QIATLSLQGNQLTGKIPSVIG 256
++G L + L+L GN L+G++P+ +G
Sbjct: 484 ESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 7e-14
Identities = 76/314 (24%), Positives = 120/314 (38%), Gaps = 82/314 (26%)
Query: 591 EDIMRMTENLSEKYIIGYGASSTVYKCVLKNCKP------VAIK----------RLYSHY 634
E I + E +G G+ VY+ + K VAIK R+
Sbjct: 6 EKITLIRE-------LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI---- 54
Query: 635 PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHG------- 687
EF E + ++V L G + L+ + M G L L
Sbjct: 55 -----EFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAEN 109
Query: 688 ------PTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHL 741
PT +K + A A G+AYL + + +HRD+ + N ++ +D +
Sbjct: 110 NPGLGPPTLQKFIQM------AAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKI 160
Query: 742 TDFGIAKSLCVSKSYTSTYIMGTIG-----YIDPEYARTSRLTEKSDVYSFGIVLLELLT 796
DFG+ + + T Y G G ++ PE + T KSDV+SFG+VL E+ T
Sbjct: 161 GDFGMTRDI----YETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
Query: 797 ----GRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQ 852
+ + NE L +I + ++ PE C D K+ +L +C +
Sbjct: 217 LAEQPYQGLSNEEVLKFVI-----DGGHLDL--PE---NCPD-----KLLELMRMCWQYN 261
Query: 853 PTDRPTMHEVSRVL 866
P RPT E+ L
Sbjct: 262 PKMRPTFLEIVSSL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 8e-14
Identities = 39/92 (42%), Positives = 51/92 (55%)
Query: 237 IATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLT 296
I L L L G IP+ I ++ L ++LS N + G IPP LG+++ E L L N
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 297 GHIPPELGNMTKLHYLELNDNQLTGHIPPALG 328
G IP LG +T L L LN N L+G +P ALG
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 8e-14
Identities = 58/195 (29%), Positives = 98/195 (50%), Gaps = 12/195 (6%)
Query: 606 IGYGASSTVYKCVLKNCKPV-AIKRL-YSHYPQCLKEFETELETVGSIKHRNLVSLQGYS 663
IG G+ VYK + K V AIK + +++ + E+ + + G
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 664 LSSSGNLLFYDFMENGSLWDILH-GPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRII 722
L + + +++ GS D+L GP ++ + T L+ L +GL YLH S R I
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLLKPGPLEETYIA--TILREIL---KGLDYLH---SERKI 123
Query: 723 HRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKS 782
HRD+K++N+LL + + L DFG+A L ++ +T++ GT ++ PE + S K+
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDFKA 182
Query: 783 DVYSFGIVLLELLTG 797
D++S GI +EL G
Sbjct: 183 DIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 75/270 (27%), Positives = 125/270 (46%), Gaps = 33/270 (12%)
Query: 605 IIGYGASSTVYKCVLK-NCKPVAIKRL-YSHYPQCLKEF-ETELETVGSIKHRNLVSLQG 661
IG G+ +Y K + + IK + + P KE + E+ + +KH N+V+
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 662 YSLSSSGNL-LFYDFMENGSLWDIL---HGP--TKKKKLDWDTRLKIALGAAQGLAYLHH 715
S +G L + ++ + G L + G ++ + L W ++I+LG L H
Sbjct: 67 -SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW--FVQISLG-------LKH 116
Query: 716 DCSPRIIHRDVKSSNILLDKD-FEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYAR 774
+I+HRD+KS NI L K+ A L DFGIA+ L S T + GT Y+ PE +
Sbjct: 117 IHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV-GTPYYLSPEICQ 175
Query: 775 TSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKD 834
K+D++S G VL EL T + + NLH L+L + P S +
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHPFEGN-NLHQLVLKIC--QGYFAPISPNFSRDLRS 232
Query: 835 LGAVKKVFQLALLCSKRQPTDRPTMHEVSR 864
L + ++F+++ P DRP++ + +
Sbjct: 233 L--ISQLFKVS-------PRDRPSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-13
Identities = 73/297 (24%), Positives = 128/297 (43%), Gaps = 40/297 (13%)
Query: 203 SIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALA 262
+N+ N LDL+ N+L I + + +L L N +T
Sbjct: 84 DGSENLLNLLPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNNIT-------------- 129
Query: 263 VLDLSCNMLSGPIPPILGNLSYTEK-LYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTG 321
IPP++G L K L L NK+ +P L N+ L L+L+ N L+
Sbjct: 130 -----------DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS- 176
Query: 322 HIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESM 381
+P L L++L +L+++ N + +P + + L L++ N + + + L+++
Sbjct: 177 DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNL 234
Query: 382 TYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTG 441
+ L LS N + +P + + NL+TLD+SNN+I S S LG L +L +L+LS N L+
Sbjct: 235 SGLELSNNKLE-DLPESIGNLSNLETLDLSNNQI--SSISSLGSLTNLRELDLSGNSLSN 291
Query: 442 FIP--GEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDVMSLIN 496
+P L ++ L EL + + + N + +L
Sbjct: 292 ALPLIALLLLLLELLLNLLLTLKAL-----ELKLNSILLNNNILSNGETSSPEALSI 343
|
Length = 394 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 54/201 (26%), Positives = 88/201 (43%), Gaps = 19/201 (9%)
Query: 606 IGYGASSTVYKCVLKNCKP-VAIKRL----YSHYPQC--LKEFETELETVGSIKHRNLVS 658
IG G VYK K VAIK++ S L+E + E + H N++
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKE----LNHPNIIK 62
Query: 659 LQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCS 718
L L ++FM+ L+ ++ +++ L QGLA+ H S
Sbjct: 63 LLDVFRHKGDLYLVFEFMDT-DLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCH---S 116
Query: 719 PRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRL 778
I+HRD+K N+L++ + L DFG+A+S + Y++ T Y PE +
Sbjct: 117 HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV-TRWYRAPELLLGDKG 175
Query: 779 -TEKSDVYSFGIVLLELLTGR 798
+ D++S G + ELL+ R
Sbjct: 176 YSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 66/218 (30%), Positives = 107/218 (49%), Gaps = 15/218 (6%)
Query: 593 IMRMTENLSEKYIIGYGASSTVYKCVL----KNCK-PVAIKRLYSHY-PQCLKEFETELE 646
I++ TE L + ++G GA TVYK + +N K PVAIK L + P+ KE E
Sbjct: 3 ILKETE-LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAY 61
Query: 647 TVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGA 706
+ + + L G L+S+ L+ M G L D + K ++ L +
Sbjct: 62 VMAGVGSPYVCRLLGICLTSTVQLV-TQLMPYGCLLD--YVRENKDRIGSQDLLNWCVQI 118
Query: 707 AQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV-SKSYTSTYIMGTI 765
A+G++YL R++HRD+ + N+L+ +TDFG+A+ L + Y + I
Sbjct: 119 AKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPI 175
Query: 766 GYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVD 802
++ E R T +SDV+S+G+ + EL+T G K D
Sbjct: 176 KWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-13
Identities = 74/235 (31%), Positives = 119/235 (50%), Gaps = 10/235 (4%)
Query: 275 IPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTD-L 333
L NL L L+ N+L +I L T L L+L++N +T IPP +G L L
Sbjct: 85 GSENLLNLLPLPSLDLNLNRLRSNISELLEL-TNLTSLDLDNNNIT-DIPPLIGLLKSNL 142
Query: 334 FDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRG 393
+L++++N +E +P L + NL +L++ N L+ +P L ++ L+LS N I
Sbjct: 143 KELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS- 199
Query: 394 PIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSV 453
+P E+ + L+ LD+SNN I + S L +L++L L LS N+L GNL ++
Sbjct: 200 DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDLPESI-GNLSNL 257
Query: 454 MEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDVMSLINCLSLSVLFIGNP 508
+DLS+N ++ L L N+ L L N+LS + + L L L +
Sbjct: 258 ETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLL 310
|
Length = 394 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 49/168 (29%), Positives = 90/168 (53%), Gaps = 15/168 (8%)
Query: 638 LKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDIL--HGPTKKKKLD 695
L E+ + ++H N+V G SL + +F +++ GS+ +L +G ++ +
Sbjct: 50 LDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR 109
Query: 696 WDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS 755
R + +GL YLH + IIHRD+K +NIL+D ++DFGI+K L +
Sbjct: 110 NFVRQIL-----KGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSL 161
Query: 756 YTST-----YIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGR 798
T T + G++ ++ PE + + T K+D++S G +++E+LTG+
Sbjct: 162 STKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 56/226 (24%), Positives = 105/226 (46%), Gaps = 22/226 (9%)
Query: 640 EFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTR 699
EF E + + + H LV L G + ++M NG L + L K+
Sbjct: 45 EFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLR--EHGKRFQPSQL 102
Query: 700 LKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTST 759
L++ +G+AYL S + IHRD+ + N L+D ++DFG+++ + + YTS+
Sbjct: 103 LEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYV-LDDEYTSS 158
Query: 760 YIMGT---IGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTA 816
+G+ + + PE S+ + KSDV++FG+++ E+ + L + +
Sbjct: 159 --VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYS----------LGKMPYERFN 206
Query: 817 NNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
N+ +E V + L A +KV+ + C + +RPT ++
Sbjct: 207 NSETVEKVSQGLRLYRPHL-ASEKVYAIMYSCWHEKAEERPTFQQL 251
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 3e-13
Identities = 58/210 (27%), Positives = 94/210 (44%), Gaps = 36/210 (17%)
Query: 605 IIGYGASSTVYKCVLK-NCKPVAIKRLY-SHYPQCLKEFETELETVGSIKHRNLVSLQGY 662
IG GA TVYK + + + A+K +Y +H ++ E+E + + H N+V
Sbjct: 81 RIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDM 140
Query: 663 SLSSSGNL-LFYDFMENGSLWDILHGPTKKKKLDWDTRL--KIALGAAQGLAYLHHDCSP 719
+G + + +FM+ GSL + D + +A G+AYLH
Sbjct: 141 -FDHNGEIQVLLEFMDGGSL---------EGTHIADEQFLADVARQILSGIAYLH---RR 187
Query: 720 RIIHRDVKSSNILLDKDFEAHLTDFGIAKSL------CVSKSYTSTYIMGTIGYIDPEYA 773
I+HRD+K SN+L++ + DFG+++ L C S +GTI Y+ PE
Sbjct: 188 HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS-------VGTIAYMSPERI 240
Query: 774 RTSRLTEK-----SDVYSFGIVLLELLTGR 798
T D++S G+ +LE GR
Sbjct: 241 NTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 73/287 (25%), Positives = 113/287 (39%), Gaps = 51/287 (17%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLKNCK------PVAIKRL-YSHYPQCLKEFETELETVGS 650
++++ +G+GA VY+ + + VA+K L S Q +F E +
Sbjct: 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSK 65
Query: 651 IKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILH----GPTKKKKLDWDTRLKIALGA 706
H+N+V L G S + + M G L L P + L L A
Sbjct: 66 FNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDV 125
Query: 707 AQGLAYLHHDCSPRIIHRDVKSSNILLD---KDFEAHLTDFGIAKSLCVSKSYTSTY--- 760
A+G YL IHRD+ + N LL A + DFG+A+ + Y ++Y
Sbjct: 126 AKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDI-----YRASYYRK 177
Query: 761 ---IMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTAN 817
M I ++ PE T K+DV+SFG++L E+ + L ++ N
Sbjct: 178 GGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS----------LGYMPYPGRTN 227
Query: 818 NAVMETV------DPEISATCKDLGAVKKVFQLALLCSKRQPTDRPT 858
VME V DP C V+++ C + P DRP
Sbjct: 228 QEVMEFVTGGGRLDP--PKGCPG-----PVYRIMTDCWQHTPEDRPN 267
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 14/211 (6%)
Query: 593 IMRMTENLSEKYIIGYGASSTVYKCVL----KNCK-PVAIKRLYSHYP-QCLKEFETELE 646
I++ TE L + ++G G TV+K + + K PVAIK + Q +E +
Sbjct: 3 ILKETE-LRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHML 61
Query: 647 TVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGA 706
+GS+ H +V L G +S L+ GSL D H + LD L +
Sbjct: 62 AMGSLDHAYIVRLLGICPGASLQLV-TQLSPLGSLLD--HVRQHRDSLDPQRLLNWCVQI 118
Query: 707 AQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV-SKSYTSTYIMGTI 765
A+G+ YL ++HR++ + NILL D + DFG+A L K Y + I
Sbjct: 119 AKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPI 175
Query: 766 GYIDPEYARTSRLTEKSDVYSFGIVLLELLT 796
++ E R T +SDV+S+G+ + E+++
Sbjct: 176 KWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 66/259 (25%), Positives = 117/259 (45%), Gaps = 21/259 (8%)
Query: 606 IGYGASSTVYKCVLKNC-KPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSL 664
IG G++ V K+ K VA+K++ Q + E+ + H N+V + L
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 665 SSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHR 724
+ +F+E G+L DI+ +++ + + L + L+YLH + +IHR
Sbjct: 90 VGDELWVVMEFLEGGALTDIV----THTRMNEEQIATVCLSVLRALSYLH---NQGVIHR 142
Query: 725 DVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTS-TYIMGTIGYIDPEYARTSRLTEKSD 783
D+KS +ILL D L+DFG VSK ++GT ++ PE + D
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGFCAQ--VSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVD 200
Query: 784 VYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQ 843
++S GI+++E++ G NE L A + + + P + + K ++
Sbjct: 201 IWSLGIMVIEMIDGEPPYFNEPPLQ-------AMRRIRDNLPPRVKDSHKVSSVLRGFLD 253
Query: 844 LALLCSKRQPTDRPTMHEV 862
L L+ R+P+ R T E+
Sbjct: 254 LMLV---REPSQRATAQEL 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 43/108 (39%), Positives = 58/108 (53%), Gaps = 10/108 (9%)
Query: 701 KIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTY 760
KIA+ + L YLH S +IHRDVK SN+L++++ + L DFGI+ L S T
Sbjct: 107 KIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLV--DSVAKTI 162
Query: 761 IMGTIGY-----IDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDN 803
G Y I+PE KSDV+S GI ++EL TGR D+
Sbjct: 163 DAGCKPYMAPERINPE-LNQKGYDVKSDVWSLGITMIELATGRFPYDS 209
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 69/294 (23%), Positives = 124/294 (42%), Gaps = 53/294 (18%)
Query: 606 IGYGASSTVYKCVLKNCKP------VAIKRLYSHYP-QCLKEFETELETVGSIKHRNLVS 658
IG GA V++ P VA+K L +F+ E + H N+V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 659 LQGYSLSSSGNLLFYDFMENGSLWDIL------------HGPTKKKKLDWD-------TR 699
L G L +++M G L + L H + +K + +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 700 LKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTST 759
L IA A G+AYL + +HRD+ + N L+ ++ + DFG+++++ Y++
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNI-----YSAD 184
Query: 760 YIMGT------IGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLIL 812
Y + I ++ PE +R T +SDV+++G+VL E+ + G +
Sbjct: 185 YYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP-----------Y 233
Query: 813 SKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866
A+ V+ V +C D +++ L LC + P+DRP+ ++R+L
Sbjct: 234 YGMAHEEVIYYVRDGNVLSCPD-NCPLELYNLMRLCWSKLPSDRPSFASINRIL 286
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 5e-13
Identities = 65/259 (25%), Positives = 105/259 (40%), Gaps = 57/259 (22%)
Query: 638 LKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILH--------GPT 689
++F E++ + + N+ L G + ++MENG L L
Sbjct: 63 REDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLAC 122
Query: 690 KKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKS 749
K L + T L +A A G+ YL S +HRD+ + N L+ K++ + DFG++++
Sbjct: 123 NSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRN 179
Query: 750 LCVSKSYTSTY--IMGT----IGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVD 802
L Y+S Y + G I ++ E + T KSDV++FG+ L E+LT R+
Sbjct: 180 L-----YSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPY 234
Query: 803 NEC-------NLHHL--------ILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALL 847
N H L + N C K +++L L
Sbjct: 235 EHLTDQQVIENAGHFFRDDGRQIYLPRPPN--------------CP-----KDIYELMLE 275
Query: 848 CSKRQPTDRPTMHEVSRVL 866
C +R DRPT E+ L
Sbjct: 276 CWRRDEEDRPTFREIHLFL 294
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 5e-13
Identities = 68/260 (26%), Positives = 118/260 (45%), Gaps = 24/260 (9%)
Query: 606 IGYGASSTVYKCV-LKNCKPVAIKRL-YSHYPQCLKEFETELETVGSIKHRNLVSLQGYS 663
IG G+ V+K + + K VAIK + +++ + E+ + + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 664 LSSSGNLLFYDFMENGSLWDILH-GPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRII 722
L + + +++ GS D+L GP + ++ T L+ L +GL YLH S + I
Sbjct: 72 LKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA--TILREIL---KGLDYLH---SEKKI 123
Query: 723 HRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKS 782
HRD+K++N+LL + E L DFG+A L ++ +T++ GT ++ PE + S K+
Sbjct: 124 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDSKA 182
Query: 783 DVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVF 842
D++S GI +EL G + L L N +E K +
Sbjct: 183 DIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEG------------NYSKPLK 230
Query: 843 QLALLCSKRQPTDRPTMHEV 862
+ C ++P+ RPT E+
Sbjct: 231 EFVEACLNKEPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 6e-13
Identities = 61/214 (28%), Positives = 92/214 (42%), Gaps = 32/214 (14%)
Query: 602 EKY----IIGYGASSTVYKCVLKNC-KPVAIKRLYSHYPQCLKEFET----------ELE 646
KY ++G GA V KC K + VAIK+ KE E E++
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKF--------KESEDDEDVKKTALREVK 52
Query: 647 TVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGA 706
+ ++H N+V+L+ L ++++E +L ++L L D
Sbjct: 53 VLRQLRHENIVNLKEAFRRKGRLYLVFEYVER-TLLELLE--ASPGGLPPDAVRSYIWQL 109
Query: 707 AQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSL-CVSKSYTSTYIMGTI 765
Q +AY H S IIHRD+K NIL+ + L DFG A++L S + Y+ T
Sbjct: 110 LQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATR 165
Query: 766 GYIDPEYARTSRLTEKS-DVYSFGIVLLELLTGR 798
Y PE K DV++ G ++ ELL G
Sbjct: 166 WYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 6e-13
Identities = 83/291 (28%), Positives = 128/291 (43%), Gaps = 32/291 (10%)
Query: 591 EDIMRMTENLSEKYIIGYGASSTVYKCV-LKNCKPVAIKRLYSHYPQCLKEFE---TELE 646
ED ++ +L E IG+G+ VY ++ + VAIK++ Q ++++ E++
Sbjct: 21 EDPEKLFTDLRE---IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVK 77
Query: 647 TVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGA 706
+ IKH N + +G L L ++ GS D+L KK L I GA
Sbjct: 78 FLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLE--VHKKPLQEVEIAAITHGA 134
Query: 707 AQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIG 766
QGLAYLH S +IHRD+K+ NILL + + L DFG A + S+ +GT
Sbjct: 135 LQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSF-----VGTPY 186
Query: 767 YIDPEY---ARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMET 823
++ PE + K DV+S GI +EL + + N A +A+
Sbjct: 187 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN----------MNAMSALYHI 236
Query: 824 VDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAPE 874
E S T + C ++ P DRPT E+ + + L PE
Sbjct: 237 AQNE-SPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPE 286
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 6e-13
Identities = 68/260 (26%), Positives = 121/260 (46%), Gaps = 24/260 (9%)
Query: 606 IGYGASSTVYKCVLKNCKPV-AIKRL-YSHYPQCLKEFETELETVGSIKHRNLVSLQGYS 663
IG G+ V+K + + V AIK + +++ + E+ + + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 664 LSSSGNLLFYDFMENGSLWDILH-GPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRII 722
L + + +++ GS D+L GP + ++ T LK L +GL YLH S + I
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIA--TMLKEIL---KGLDYLH---SEKKI 123
Query: 723 HRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKS 782
HRD+K++N+LL + + L DFG+A L ++ +T++ GT ++ PE + S K+
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAYDSKA 182
Query: 783 DVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVF 842
D++S GI +EL G +++ + ++ NN T+ E S K+
Sbjct: 183 DIWSLGITAIELAKGEPP-NSDMHPMRVLFLIPKNNP--PTLTGEFSKPFKEFIDA---- 235
Query: 843 QLALLCSKRQPTDRPTMHEV 862
C + P+ RPT E+
Sbjct: 236 -----CLNKDPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 7e-13
Identities = 65/253 (25%), Positives = 107/253 (42%), Gaps = 54/253 (21%)
Query: 592 DIMRMTENLSEKYIIGYGASSTVYKCVLKNC-KPVAIKRL---YSHYPQCLKEFETELET 647
DI+R+ IG G VY C + VA+K++ S P K F E +
Sbjct: 5 DIIRL---------IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKI 55
Query: 648 VGSIKHRNLVSLQGYSLSSSGNLLFYD--FMENGSLWDILHGPTKKKKLDWDTRLKIALG 705
+ H +V + YS+ S G+ ++Y ++E +L +L +K+ L + K ++G
Sbjct: 56 AADLIHPGIVPV--YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVG 113
Query: 706 A--------AQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKS-------- 749
A + Y+H S ++HRD+K NILL E + D+G A
Sbjct: 114 AFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDL 170
Query: 750 ---------LCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT---- 796
+C S I+GT Y+ PE +E +D+Y+ G++L ++LT
Sbjct: 171 LDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
Query: 797 -----GRKAVDNE 804
GRK +
Sbjct: 231 YRRKKGRKISYRD 243
|
Length = 932 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 8e-13
Identities = 47/144 (32%), Positives = 62/144 (43%), Gaps = 14/144 (9%)
Query: 662 YSLSSSGNL-LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPR 720
YS NL L +++ G L +L LD D L YLH S
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLE---NVGSLDEDVARIYIAEIVLALEYLH---SNG 113
Query: 721 IIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTY-------IMGTIGYIDPEYA 773
IIHRD+K NIL+D + LTDFG++K V + I+GT YI PE
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173
Query: 774 RTSRLTEKSDVYSFGIVLLELLTG 797
++ D +S G +L E L G
Sbjct: 174 LGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 8e-13
Identities = 63/213 (29%), Positives = 98/213 (46%), Gaps = 25/213 (11%)
Query: 588 HVYEDIMRMTENLSEKYIIGYGASSTVYKCV-LKNCKPVAIKRLYSHYPQCLKEFETELE 646
H YE I R +G G VYK L + A+K + + E+
Sbjct: 9 HDYELIQR----------VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIF 58
Query: 647 TVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILH--GPTKKKKLDWDTRLKIAL 704
V KH N+V+ G LS + ++ GSL DI H GP + ++ + R +
Sbjct: 59 MVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-- 116
Query: 705 GAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGT 764
QGLAYLH S +HRD+K +NILL + + L DFG+A + + + ++I GT
Sbjct: 117 ---QGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GT 169
Query: 765 IGYIDPEYARTSR---LTEKSDVYSFGIVLLEL 794
++ PE A + + D+++ GI +EL
Sbjct: 170 PYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 9e-13
Identities = 34/89 (38%), Positives = 55/89 (61%)
Query: 145 LILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSI 204
L L N L G IP+ +S+L +L+ L GN++ G + P + ++ L D+ NS GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 205 PQNIGNCTSFQVLDLSYNQLSGEIPFNIG 233
P+++G TS ++L+L+ N LSG +P +G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 1e-12
Identities = 67/218 (30%), Positives = 105/218 (48%), Gaps = 15/218 (6%)
Query: 593 IMRMTENLSEKYIIGYGASSTVYKCVL----KNCK-PVAIKRLY-SHYPQCLKEFETELE 646
I++ TE K ++G GA TVYK + + K PVAIK L + P+ KE E
Sbjct: 3 ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 61
Query: 647 TVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGA 706
+ S+ + ++ L G L+S+ L+ M G L D + K + L +
Sbjct: 62 VMASVDNPHVCRLLGICLTSTVQLI-TQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQI 118
Query: 707 AQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV-SKSYTSTYIMGTI 765
A+G+ YL R++HRD+ + N+L+ +TDFG+AK L K Y + I
Sbjct: 119 AKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPI 175
Query: 766 GYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVD 802
++ E T +SDV+S+G+ + EL+T G K D
Sbjct: 176 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 50/194 (25%), Positives = 89/194 (45%), Gaps = 19/194 (9%)
Query: 619 LKNCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFME 677
+ + + VAIK L PQ EF+ E + + H N+V L G + ++++
Sbjct: 31 MDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLN 90
Query: 678 NGSLWD--ILHGP------------TKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIH 723
G L + I+ P T K LD L IA+ A G+ YL S +H
Sbjct: 91 QGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYL---SSHFFVH 147
Query: 724 RDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY-TSTYIMGTIGYIDPEYARTSRLTEKS 782
+D+ + NIL+ + ++D G+++ + + Y + I ++ PE + + S
Sbjct: 148 KDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDS 207
Query: 783 DVYSFGIVLLELLT 796
D++SFG+VL E+ +
Sbjct: 208 DIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-12
Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 17/210 (8%)
Query: 591 EDIMRMTENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRL--YSHYPQCLKEFETELETV 648
+D R++E +G G V K K + ++L P + EL+ +
Sbjct: 5 DDFERISE-------LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVL 57
Query: 649 GSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQ 708
+V G S + + M+ GSL +L + K++ + K+++ +
Sbjct: 58 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KEAKRIPEEILGKVSIAVLR 114
Query: 709 GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYI 768
GLAYL +I+HRDVK SNIL++ E L DFG++ L S + + +GT Y+
Sbjct: 115 GLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYM 169
Query: 769 DPEYARTSRLTEKSDVYSFGIVLLELLTGR 798
PE + + + +SD++S G+ L+EL GR
Sbjct: 170 SPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 67/265 (25%), Positives = 111/265 (41%), Gaps = 21/265 (7%)
Query: 606 IGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLK-EFETELETVGSIKHRNLVSLQGYS 663
IG G V+ L+ + PVA+K P LK +F E + H N+V L G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 664 LSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIH 723
+ + ++ G L T+ +L +++ AA G+ YL IH
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLR--TEGPRLKVKELIQMVENAAAGMEYLESKHC---IH 117
Query: 724 RDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTI--GYIDPEYARTSRLTEK 781
RD+ + N L+ + ++DFG+++ Y ST M I + PE R + +
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSREE-EDGVYASTGGMKQIPVKWTAPEALNYGRYSSE 176
Query: 782 SDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKV 841
SDV+SFGI+L E + L + + +N E ++ + C +L V
Sbjct: 177 SDVWSFGILLWEAFS----------LGAVPYANLSNQQTREAIEQGVRLPCPEL-CPDAV 225
Query: 842 FQLALLCSKRQPTDRPTMHEVSRVL 866
++L C + P RP+ V + L
Sbjct: 226 YRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 51/156 (32%), Positives = 82/156 (52%), Gaps = 11/156 (7%)
Query: 644 ELETVGSIKHRNLVSLQGYSLSSSGNL-LFYDFMENGSLWDILHGPTKKKKLDWDTRLKI 702
E + + + H +V L Y+ + G L L DF+ G L+ L K+ + + +K
Sbjct: 48 ERDILAEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRL----SKEVMFTEEDVKF 102
Query: 703 ALGA-AQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYI 761
L A L +LH S II+RD+K NILLD++ LTDFG++K + ++
Sbjct: 103 YLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC 159
Query: 762 MGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTG 797
GT+ Y+ PE T+ +D +SFG+++ E+LTG
Sbjct: 160 -GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 2e-12
Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 20/206 (9%)
Query: 605 IIGYGASSTVYKCV-LKNCKPVAIKRLY--SHYPQCLKE---FETELETVGSIKHRNLVS 658
++G GA VY C + + +A K++ P+ KE E E++ + +++H +V
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 659 LQGYSLSSSGN---LLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHH 715
G L +F ++M GS+ D L L K +G++YLH
Sbjct: 69 YYG-CLRDRAEKTLTIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLH- 123
Query: 716 DCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSL---CVSKSYTSTYIMGTIGYIDPEY 772
S I+HRD+K +NIL D L DFG +K L C+S + + + GT ++ PE
Sbjct: 124 --SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS-VTGTPYWMSPEV 180
Query: 773 ARTSRLTEKSDVYSFGIVLLELLTGR 798
K+DV+S G ++E+LT +
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 57/215 (26%), Positives = 103/215 (47%), Gaps = 23/215 (10%)
Query: 598 ENLSEKYIIGYGASSTVYKCV---LKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHR 654
L IG G++ V C+ + VA+K++ Q + E+ + +H
Sbjct: 19 SYLDNFVKIGEGSTGIV--CIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHP 76
Query: 655 NLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLH 714
N+V + L + +F+E G+L DI+ +++ + + L + L++LH
Sbjct: 77 NIVEMYSSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIATVCLAVLKALSFLH 132
Query: 715 HDCSPRIIHRDVKSSNILLDKDFEAHLTDFG----IAKSLCVSKSYTSTYIMGTIGYIDP 770
+ +IHRD+KS +ILL D L+DFG ++K + KS ++GT ++ P
Sbjct: 133 ---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS-----LVGTPYWMAP 184
Query: 771 EY-ARTSRLTEKSDVYSFGIVLLELLTGRKAVDNE 804
E +R TE D++S GI+++E++ G NE
Sbjct: 185 EVISRLPYGTE-VDIWSLGIMVIEMVDGEPPYFNE 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 53/199 (26%), Positives = 95/199 (47%), Gaps = 28/199 (14%)
Query: 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILL 733
++M+ GSL + G + + D +I +GL +L + + IIHRDVK +N+L+
Sbjct: 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLV 136
Query: 734 DKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYAR----TSRLTE--KSDVYSF 787
+ + + L DFG++ +L S + T+ +G Y+ PE + T +SDV+S
Sbjct: 137 NGNGQVKLCDFGVSGNLVASLAKTN---IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSL 193
Query: 788 GIVLLELLTGRKAVDNECNLHHLILSKTANNAVME----TVDPEISATCKDLGAVKKVFQ 843
G+ +LE+ GR E + I ++ + A+++ T+ S +D V K
Sbjct: 194 GLSILEMALGRYPYPPE--TYANIFAQLS--AIVDGDPPTLPSGYSDDAQDF--VAK--- 244
Query: 844 LALLCSKRQPTDRPTMHEV 862
C + P RPT ++
Sbjct: 245 ----CLNKIPNRRPTYAQL 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 3e-12
Identities = 57/195 (29%), Positives = 92/195 (47%), Gaps = 15/195 (7%)
Query: 606 IGYGASSTVYKCVLKNCKPVAIKRLYSHYP-QCLKEFETELETVGSIKHRNLVSLQGYSL 664
IG G VYK N +A ++ P + + E+ + KH N+V+ G L
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 665 SSSGNLLFYDFMENGSLWDILH--GPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRII 722
+ +F GSL DI H GP + ++ + +R + QGL YLH S +
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLH---SKGKM 128
Query: 723 HRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSR---LT 779
HRD+K +NILL + L DFG++ + + + ++I GT ++ PE A R
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVERKGGYN 187
Query: 780 EKSDVYSFGIVLLEL 794
+ D+++ GI +EL
Sbjct: 188 QLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 41/119 (34%), Positives = 58/119 (48%), Gaps = 6/119 (5%)
Query: 721 IIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYART-SRLT 779
II+RD+K NILLD + LTDFG++K + + GTI Y+ PE R S
Sbjct: 126 IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGH 185
Query: 780 EKS-DVYSFGIVLLELLTGRK--AVDNECNLHHLILSKTANNAVMETVDPEISATCKDL 835
+K+ D +S G++ ELLTG VD E N I + + +SA +D
Sbjct: 186 DKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPP--FPKTMSAEARDF 242
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 3e-12
Identities = 74/256 (28%), Positives = 111/256 (43%), Gaps = 34/256 (13%)
Query: 606 IGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFE---TELETVGSIKHRNLVSLQG 661
+G G+ V K + K A+K L LK+ E E + SI+H LV+L G
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 662 YSLSSSGNL-LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQ---GLAYLHHDC 717
S NL L +++ G L+ L K + AAQ L YLH
Sbjct: 69 -SFQDDSNLYLVMEYVPGGELFSHLR---KSGRFPEPV---ARFYAAQVVLALEYLHS-L 120
Query: 718 SPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSR 777
I++RD+K N+LLD D +TDFG AK + ++YT + GT Y+ PE +
Sbjct: 121 D--IVYRDLKPENLLLDSDGYIKITDFGFAKRV-KGRTYT---LCGTPEYLAPEIILSKG 174
Query: 778 LTEKSDVYSFGIVLLELLTGRK--AVDNECNLHHLILSKTANNAVMETVDPEISATCKDL 835
+ D ++ GI++ E+L G DN ++ IL S KDL
Sbjct: 175 YGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKV------RFPSFFSPDAKDL 228
Query: 836 GAVKKVFQLALLCSKR 851
++ + Q+ L +KR
Sbjct: 229 --IRNLLQVDL--TKR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 63/205 (30%), Positives = 96/205 (46%), Gaps = 18/205 (8%)
Query: 606 IGYGASSTVYKCVLKNCKP-VAIKRLYSHYPQCLKEFE---TELETVGSIKHRNLVSLQG 661
IG+G+ VY + VA+K++ Q ++++ E++ + +KH N + +G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 662 YSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRI 721
L L ++ GS D+L KK L I GA QGLAYLH +
Sbjct: 89 CYLKEHTAWLVMEYCL-GSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHN---M 142
Query: 722 IHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEY---ARTSRL 778
IHRD+K+ NILL + + L DFG A SKS + +GT ++ PE +
Sbjct: 143 IHRDIKAGNILLTEPGQVKLADFGSA-----SKSSPANSFVGTPYWMAPEVILAMDEGQY 197
Query: 779 TEKSDVYSFGIVLLELLTGRKAVDN 803
K DV+S GI +EL + + N
Sbjct: 198 DGKVDVWSLGITCIELAERKPPLFN 222
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 31/215 (14%)
Query: 651 IKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHG--PTKKKKLDWDTRLKIALGAAQ 708
+KH N+V+ + S + G+L Y ME D++ + K DT L+ +
Sbjct: 55 MKHPNIVAFK-ESFEADGHL--YIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL 111
Query: 709 GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYI 768
G+ ++H R++HRD+KS NI L ++ + L DFG A+ L +Y TY+ GT Y+
Sbjct: 112 GVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYV 167
Query: 769 DPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVME----TV 824
PE KSD++S G +L EL C L H + + N +++ +
Sbjct: 168 PPEIWENMPYNNKSDIWSLGCILYEL----------CTLKHPFQANSWKNLILKVCQGSY 217
Query: 825 DPEISATCKDLGA-VKKVFQLALLCSKRQPTDRPT 858
P S +L + +K++F KR P RP+
Sbjct: 218 KPLPSHYSYELRSLIKQMF-------KRNPRSRPS 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 40/109 (36%), Positives = 58/109 (53%), Gaps = 6/109 (5%)
Query: 709 GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYI 768
GL +LH II+RD+K N+LLDKD + DFG+ K + ST+ GT YI
Sbjct: 108 GLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDYI 163
Query: 769 DPEYARTSRLTEKSDVYSFGIVLLELLTGRKAV--DNECNLHHLILSKT 815
PE + + E D +SFG++L E+L G+ ++E L IL+
Sbjct: 164 APEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDR 212
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 5e-12
Identities = 53/149 (35%), Positives = 73/149 (48%), Gaps = 9/149 (6%)
Query: 650 SIKHRNLVSLQGYSLSSSGNLLF-YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQ 708
++KH LV L YS ++ L F DF+ G L+ H ++ + R A A
Sbjct: 52 NVKHPFLVGLH-YSFQTTEKLYFVLDFVNGGELF--FHLQRERSFPEPRARFYAA-EIAS 107
Query: 709 GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYI 768
L YLH S I++RD+K NILLD LTDFG+ K +++S T+T GT Y+
Sbjct: 108 ALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKE-GIAQSDTTTTFCGTPEYL 163
Query: 769 DPEYARTSRLTEKSDVYSFGIVLLELLTG 797
PE R D + G VL E+L G
Sbjct: 164 APEVIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 5e-12
Identities = 61/196 (31%), Positives = 94/196 (47%), Gaps = 18/196 (9%)
Query: 606 IGYGASSTVYKCV-LKNCKPVAIKRLYSHYPQCLKEFE---TELETVGSIKHRNLVSLQG 661
IG+G+ VY ++N + VAIK++ Q ++++ E+ + ++H N + +G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 662 YSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRI 721
L L ++ GS D+L KK L + GA QGLAYLH S +
Sbjct: 83 CYLREHTAWLVMEYCL-GSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLH---SHNM 136
Query: 722 IHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEY---ARTSRL 778
IHRDVK+ NILL + L DFG A + + + +GT ++ PE +
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF-----VGTPYWMAPEVILAMDEGQY 191
Query: 779 TEKSDVYSFGIVLLEL 794
K DV+S GI +EL
Sbjct: 192 DGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 5e-12
Identities = 53/151 (35%), Positives = 71/151 (47%), Gaps = 9/151 (5%)
Query: 648 VGSIKHRNLVSLQGYSLSSSGNLLF-YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGA 706
+ ++KH LV L YS ++ L F D++ G L+ H ++ + R A
Sbjct: 50 LKNVKHPFLVGLH-YSFQTADKLYFVLDYVNGGELF--FHLQRERSFPEPRARF-YAAEI 105
Query: 707 AQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIG 766
A L YLH S II+RD+K NILLD LTDFG+ K TST+ GT
Sbjct: 106 ASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC-GTPE 161
Query: 767 YIDPEYARTSRLTEKSDVYSFGIVLLELLTG 797
Y+ PE R D + G VL E+L G
Sbjct: 162 YLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 7e-12
Identities = 58/206 (28%), Positives = 103/206 (50%), Gaps = 22/206 (10%)
Query: 600 LSEKYI-IGYGASSTVYKCVLK---NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRN 655
L E YI IG G++ V C+ + + + VA+K + Q + E+ + +H+N
Sbjct: 22 LLENYIKIGEGSTGIV--CIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQN 79
Query: 656 LVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHH 715
+V + L + +F++ G+L DI+ + +L+ + + Q L YLH
Sbjct: 80 VVEMYKSYLVGEELWVLMEFLQGGALTDIV----SQTRLNEEQIATVCESVLQALCYLH- 134
Query: 716 DCSPRIIHRDVKSSNILLDKDFEAHLTDFG----IAKSLCVSKSYTSTYIMGTIGYIDPE 771
S +IHRD+KS +ILL D L+DFG I+K + KS ++GT ++ PE
Sbjct: 135 --SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS-----LVGTPYWMAPE 187
Query: 772 YARTSRLTEKSDVYSFGIVLLELLTG 797
+ + D++S GI+++E++ G
Sbjct: 188 VISRTPYGTEVDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 7e-12
Identities = 61/227 (26%), Positives = 97/227 (42%), Gaps = 18/227 (7%)
Query: 639 KEFETELETVGSIKHRNLVSLQGYSLSSSGNL-LFYDFMENGSLWDILHGPTKKKKLDWD 697
K E E + + +KH N+V+ + G L + F E G L+ L K K L +
Sbjct: 44 KAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLK-EQKGKLLPEN 102
Query: 698 TRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYT 757
++ + A L YLH I+HRD+K+ N+ L + + D GIA+ L
Sbjct: 103 QVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA 159
Query: 758 STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTAN 817
ST I GT Y+ PE KSDV++ G + E+ T L H +K N
Sbjct: 160 STLI-GTPYYMSPELFSNKPYNYKSDVWALGCCVYEMAT----------LKHAFNAKDMN 208
Query: 818 NAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSR 864
+ V ++ ++ KD +L ++P RP++ + R
Sbjct: 209 SLVYRIIEGKLPPMPKDYSPELGELIATMLS--KRPEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 8e-12
Identities = 73/273 (26%), Positives = 122/273 (44%), Gaps = 34/273 (12%)
Query: 605 IIGYGASSTVYKCV-LKNCKPVAIKRLY--SHYPQCLKE---FETELETVGSIKHRNLVS 658
++G GA VY C + +A+K++ P+ KE E E++ + ++ H +V
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 659 LQGYSLSSSGNLL--FYDFMENGSLWDIL--HGPTKKKKLDWDTRLKIALGAAQGLAYLH 714
G L F + M GS+ D L +G + TR + +G++YLH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQIL-----EGVSYLH 123
Query: 715 HDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSL---CVSKSYTSTYIMGTIGYIDPE 771
S I+HRD+K +NIL D L DFG +K L C+S + + + GT ++ PE
Sbjct: 124 ---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-VTGTPYWMSPE 179
Query: 772 YARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISAT 831
K+D++S G ++E+LT + + + K A + P +S
Sbjct: 180 VISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIF--KIATQPTNPVLPPHVSDH 237
Query: 832 CKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSR 864
C+D +K++F A L RP+ E+ R
Sbjct: 238 CRDF--LKRIFVEAKL--------RPSADELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 9e-12
Identities = 72/271 (26%), Positives = 120/271 (44%), Gaps = 32/271 (11%)
Query: 598 ENLSEKYIIGYGASSTVYKCV-LKNCKPVAIKRLYSHYPQC------LKEFETELETVGS 650
N ++G GA VY C + +A+K++ P + E E++ + +
Sbjct: 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQV-PFDPDSQETSKEVNALECEIQLLKN 60
Query: 651 IKHRNLVSLQGYSLSSSGNLL--FYDFMENGSLWDIL--HGPTKKKKLDWDTRLKIALGA 706
++H +V G L F ++M GS+ D L +G + TR +
Sbjct: 61 LRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQIL---- 116
Query: 707 AQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAK---SLCVSKSYTSTYIMG 763
QG++YLH S I+HRD+K +NIL D L DFG +K ++C+S + + + G
Sbjct: 117 -QGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-VTG 171
Query: 764 TIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMET 823
T ++ PE K+DV+S ++E+LT K E I K A
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSVACTVVEMLT-EKPPWAEYEAMAAIF-KIATQPTKPM 229
Query: 824 VDPEISATCKDLGAVKKVFQLALLCSKRQPT 854
+ +S C+D +K++F + KR+PT
Sbjct: 230 LPDGVSDACRDF--LKQIF----VEEKRRPT 254
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 9e-12
Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 13/203 (6%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRL--YSHYPQCLKEFETELETVGSIKHRN 655
E +SE +G G V+K K + ++L P + EL+ +
Sbjct: 8 EKISE---LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 656 LVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHH 715
+V G S + + M+ GSL +L K ++ K+++ +GL YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLRE 121
Query: 716 DCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYART 775
+I+HRDVK SNIL++ E L DFG++ L S + + +GT Y+ PE +
Sbjct: 122 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYMSPERLQG 176
Query: 776 SRLTEKSDVYSFGIVLLELLTGR 798
+ + +SD++S G+ L+E+ GR
Sbjct: 177 THYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 65/259 (25%), Positives = 116/259 (44%), Gaps = 21/259 (8%)
Query: 606 IGYGASSTVYKCVLKNC-KPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSL 664
IG G++ V +K+ K VA+K++ Q + E+ + +H N+V + L
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 665 SSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHR 724
+ +F+E G+L DI+ +++ + + L + L+ LH + +IHR
Sbjct: 88 VGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVLKALSVLH---AQGVIHR 140
Query: 725 DVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYT-STYIMGTIGYIDPEYARTSRLTEKSD 783
D+KS +ILL D L+DFG VSK ++GT ++ PE + D
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKSLVGTPYWMAPELISRLPYGPEVD 198
Query: 784 VYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQ 843
++S GI+++E++ G NE L A + + + P++ K ++K
Sbjct: 199 IWSLGIMVIEMVDGEPPYFNEPPL-------KAMKMIRDNLPPKLKNLHKVSPSLKGFLD 251
Query: 844 LALLCSKRQPTDRPTMHEV 862
L+ R P R T E+
Sbjct: 252 RLLV---RDPAQRATAAEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 1e-11
Identities = 53/149 (35%), Positives = 72/149 (48%), Gaps = 9/149 (6%)
Query: 650 SIKHRNLVSLQGYSLSSSGNLLF-YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQ 708
++KH LV L YS ++ L F D++ G L+ H ++ L+ R A A
Sbjct: 52 NLKHPFLVGLH-YSFQTAEKLYFVLDYVNGGELF--FHLQRERCFLEPRARF-YAAEVAS 107
Query: 709 GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYI 768
+ YLH S II+RD+K NILLD LTDFG+ K + TST+ GT Y+
Sbjct: 108 AIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC-GTPEYL 163
Query: 769 DPEYARTSRLTEKSDVYSFGIVLLELLTG 797
PE R D + G VL E+L G
Sbjct: 164 APEVLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 2e-11
Identities = 80/251 (31%), Positives = 114/251 (45%), Gaps = 12/251 (4%)
Query: 73 LNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGD-CSSLKSLDLSFNELYGD 131
L+L+ L IS + +L +L S+DL N ++ IP IG S+LK LDLS N++
Sbjct: 98 LDLNLNRLRSNISELL-ELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKI-ES 154
Query: 132 IPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLW 191
+P + L L+ L L N L +P LS L NL L GN + L P++ LS L
Sbjct: 155 LPSPLRNLPNLKNLDLSFNDLSD-LPKLLSNLSNLNNLDLSGNKI-SDLPPEIELLSALE 212
Query: 192 YFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKI 251
D+ NNS+ + ++ N + L+LS N+L + TL L NQ++
Sbjct: 213 ELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQIS--S 269
Query: 252 PSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHY 311
S +G + L LDLS N LS +P I L E L L EL + L
Sbjct: 270 ISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTL---KALELKLNSILLN 326
Query: 312 LELNDNQLTGH 322
+ N T
Sbjct: 327 NNILSNGETSS 337
|
Length = 394 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 73/285 (25%), Positives = 120/285 (42%), Gaps = 38/285 (13%)
Query: 605 IIGYGASSTVYKCVLK----NCKPVAIK--RLYSHYPQCLKEFETELETVGSIKHRNLVS 658
I+G G +V + L + VA+K +L H ++EF +E + H N++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 659 LQGYSLSSSGN------LLFYDFMENGSLWDIL---HGPTKKKKLDWDTRLKIALGAAQG 709
L G +S ++ FM++G L L +KL T LK + A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 710 LAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGT-IGYI 768
+ YL + IHRD+ + N +L +D + DFG++K + Y I + +I
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182
Query: 769 DPEYARTSRLTEKSDVYSFGIVLLELLT-GRK---AVDNECNLHHLILSKTANNAVMETV 824
E T KSDV++FG+ + E+ T G+ V+N +L
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQ------ 236
Query: 825 DPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869
PE C D +++ L C + P DRPT ++ VL ++
Sbjct: 237 -PE---DCLD-----ELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 49/211 (23%), Positives = 89/211 (42%), Gaps = 38/211 (18%)
Query: 606 IGYGASSTVYKC-VLKNCKPVAIKRLYSHYPQCLKEFET--------ELETVGSIKHRNL 656
IG GA V+K + + VA+K++ L+ E E++ + + +H +
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKV------ALRRLEGGIPNQALREIKALQACQHPYV 61
Query: 657 VSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQ-------- 708
V L SG +L ++M L ++L D + +
Sbjct: 62 VKLLDVFPHGSGFVLVMEYMP-SDLSEVLR----------DEERPLPEAQVKSYMRMLLK 110
Query: 709 GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYI 768
G+AY+H + I+HRD+K +N+L+ D + DFG+A+ + ++ + T Y
Sbjct: 111 GVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYR 167
Query: 769 DPEYARTSR-LTEKSDVYSFGIVLLELLTGR 798
PE +R D+++ G + ELL G
Sbjct: 168 APELLYGARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 37/108 (34%), Positives = 53/108 (49%), Gaps = 6/108 (5%)
Query: 709 GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYI 768
GL +LH II+RD+K N+LLD + + DFG+ K + TST+ GT YI
Sbjct: 108 GLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC-GTPDYI 163
Query: 769 DPEYARTSRLTEKSDVYSFGIVLLELLTGRKA--VDNECNLHHLILSK 814
PE D ++ G++L E+L G+ D+E L IL
Sbjct: 164 APEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED 211
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 3e-11
Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 23/210 (10%)
Query: 605 IIGYGASSTVYKCV-LKNCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQG 661
IG GA V + ++ K VAIK++ + P K EL+ + KH N+++++
Sbjct: 12 NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRD 71
Query: 662 YSLSSSGNL-----LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHD 716
L G + D ME+ L I+H + L + +GL Y+H
Sbjct: 72 I-LRPPGADFKDVYVVMDLMES-DLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIH-- 124
Query: 717 CSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS----KSYTSTYIMGTIGYIDPEY 772
S +IHRD+K SN+L+++D E + DFG+A+ L S K + + Y+ T Y PE
Sbjct: 125 -SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV-ATRWYRAPEL 182
Query: 773 ARTS-RLTEKSDVYSFGIVLLELLTGRKAV 801
+ T D++S G + E+L GR+ +
Sbjct: 183 LLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 62/206 (30%), Positives = 95/206 (46%), Gaps = 19/206 (9%)
Query: 602 EKY----IIGYGASSTVYKCVLKNC-KPVAIKRLYSHY--PQCLKEFETELETVGSIKHR 654
EKY IG G+ V+KC + + VAIK+ P K E+ + +KH
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHP 60
Query: 655 NLVSL-QGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYL 713
NLV+L + + +L+F ++ ++ L ++ P + + KI Q + +
Sbjct: 61 NLVNLIEVFRRKRKLHLVF-EYCDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFC 116
Query: 714 H-HDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEY 772
H H+C IHRDVK NIL+ K + L DFG A+ L + Y+ T Y PE
Sbjct: 117 HKHNC----IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-ATRWYRAPEL 171
Query: 773 -ARTSRLTEKSDVYSFGIVLLELLTG 797
++ DV++ G V ELLTG
Sbjct: 172 LVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 72/303 (23%), Positives = 127/303 (41%), Gaps = 54/303 (17%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLK---NCKPVAIKRLYSHYPQC-LKEFETELETVGSI-K 652
E++ + +IG G V + ++K AIK L + ++F ELE + +
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61
Query: 653 HRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTR------------- 699
H N+++L G + + ++ G+L D L K + L+ D
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLR---KSRVLETDPAFAKEHGTASTLTS 118
Query: 700 ---LKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY 756
L+ A A G+ YL + IHRD+ + N+L+ ++ + + DFG+++
Sbjct: 119 QQLLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRG------- 168
Query: 757 TSTYIMGTIG-----YIDPEYARTSRLTEKSDVYSFGIVLLEL--LTGRKAVDNECNLHH 809
Y+ T+G ++ E S T KSDV+SFG++L E+ L G C
Sbjct: 169 EEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA--- 225
Query: 810 LILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869
+ K ME C D +V++L C + +P +RP ++S L +
Sbjct: 226 ELYEKLPQGYRMEK-----PRNCDD-----EVYELMRQCWRDRPYERPPFAQISVQLSRM 275
Query: 870 VPA 872
+ A
Sbjct: 276 LEA 278
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 50/227 (22%), Positives = 103/227 (45%), Gaps = 24/227 (10%)
Query: 590 YEDIMRMTENLSEKY---IIGYGASSTVYKCVLKNCKPVAIKRL---YSHYPQCLKEFET 643
DI + + +KY +I +++YK + N K V I+ + + + E
Sbjct: 9 INDIKCIESDDIDKYTSVLIKENDQNSIYKGIFNN-KEVIIRTFKKFHKGHKVLIDITEN 67
Query: 644 ELETVGSIKHRNLVSLQGYSLSSSGNL----LFYDFMENGSLWDILHGPTKKKKLDWDTR 699
E++ + I N++ + G+ + +L L ++ G L ++L K+K L + T+
Sbjct: 68 EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLD---KEKDLSFKTK 124
Query: 700 LKIALGAAQGLAYLH-HDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTS 758
L +A+ +GL L+ + P ++++ S + L+ ++++ + G+ K L
Sbjct: 125 LDMAIDCCKGLYNLYKYTNKP---YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKN- 180
Query: 759 TYIMGTIGYIDPEYART--SRLTEKSDVYSFGIVLLELLTGRKAVDN 803
+ + Y + S T K D+YS G+VL E+ TG+ +N
Sbjct: 181 ---VNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFEN 224
|
Length = 283 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 5e-11
Identities = 60/211 (28%), Positives = 89/211 (42%), Gaps = 38/211 (18%)
Query: 606 IGYGASSTVYKCVLKNCK-PVAIKRLYSHYPQCLKEFET---------ELETVGSIKHRN 655
+G GA V VAIK+L + F++ EL + + H N
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLS-------RPFQSAIHAKRTYRELRLLKHMDHEN 75
Query: 656 LVSLQGYSLSSSGNLLFYDFMENGSLWDI-LHGPTKKKKLDWDTRLKIALGAAQGLAYLH 714
++ L +S F D L L+ K +KL D + +GL Y+H
Sbjct: 76 VIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIH 135
Query: 715 HDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPE--- 771
S IIHRD+K SNI +++D E + DFG+A+ T Y+ T Y PE
Sbjct: 136 ---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHT--DDEMT-GYV-ATRWYRAPEIML 188
Query: 772 ----YARTSRLTEKSDVYSFGIVLLELLTGR 798
Y +T D++S G ++ ELLTG+
Sbjct: 189 NWMHYNQT------VDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 6e-11
Identities = 63/260 (24%), Positives = 110/260 (42%), Gaps = 31/260 (11%)
Query: 625 VAIKRLYSHYPQCLK-EFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWD 683
VA+K L + + + +F E++ + +K+ N++ L G +S + ++MENG L
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106
Query: 684 ILHGPTKKKKL---------DWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLD 734
L + L +A+ A G+ YL S +HRD+ + N L+
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVG 163
Query: 735 KDFEAHLTDFGIAKSLCVSKSYTSTY--IMG----TIGYIDPEYARTSRLTEKSDVYSFG 788
+ + DFG++++L Y+ Y I G I ++ E + T SDV++FG
Sbjct: 164 NHYTIKIADFGMSRNL-----YSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFG 218
Query: 789 IVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISAT--CKDLGAVKKVFQLAL 846
+ L E+ T K ++ T + +S T C VF+L +
Sbjct: 219 VTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPS-----PVFKLMM 273
Query: 847 LCSKRQPTDRPTMHEVSRVL 866
C R DRPT +++ L
Sbjct: 274 RCWSRDIKDRPTFNKIHHFL 293
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 6e-11
Identities = 65/230 (28%), Positives = 102/230 (44%), Gaps = 16/230 (6%)
Query: 580 ILHMNMALHVYEDIMRMTENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLK 639
+ N ++ E + T+ IG G VYK K +A ++ +
Sbjct: 4 LFPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDE 63
Query: 640 EFETELETVGSI-KHRNLVSLQGYSLSSS----GNL-LFYDFMENGSLWDILHGPTKK-K 692
E E E + S+ H N+V G + G L L + GS+ +++ G +
Sbjct: 64 EIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQ 123
Query: 693 KLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV 752
+LD I GA GL +LH++ RIIHRDVK +NILL + L DFG++ L
Sbjct: 124 RLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 180
Query: 753 SKSYTSTYIMGTIGYIDPEYARTSRLTEKS-----DVYSFGIVLLELLTG 797
++ +T + GT ++ PE + + S DV+S GI +EL G
Sbjct: 181 TRLRRNTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 6e-11
Identities = 53/217 (24%), Positives = 103/217 (47%), Gaps = 21/217 (9%)
Query: 589 VYEDIMRMTENLSEKYIIGYGASSTVYKCVLKNC---KPVAIKRLYSHY--PQCLKEFET 643
++ + +T + +G GA V C ++ + VAIK++ + P K
Sbjct: 1 IFGTVFEITNRYVDLQPVGMGAFGLV--CSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR 58
Query: 644 ELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILH-GPTKKKKLDWDTRLKI 702
EL+ + ++H N++SL +S ++ F + L +L P +K+ + +
Sbjct: 59 ELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQY-----F 113
Query: 703 ALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIM 762
+GL Y+H S ++HRD+K SNIL++++ + + DFG+A+ + + Y+
Sbjct: 114 LYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLAR---IQDPQMTGYV- 166
Query: 763 GTIGYIDPEYART-SRLTEKSDVYSFGIVLLELLTGR 798
T Y PE T + + D++S G + E+L G+
Sbjct: 167 STRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 6e-11
Identities = 60/232 (25%), Positives = 98/232 (42%), Gaps = 47/232 (20%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLKNCKP------VAIKRLYSH-YPQCLKEFETELETVGS 650
+ L+ +G GA V K VA+K L + L + +E+E +
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71
Query: 651 I-KHRNLVSLQGYS-----------LSSSGNLLFYDF--------MENGSLWDILHGPTK 690
I KH+N+++L G ++ GNL DF T
Sbjct: 72 IGKHKNIINLLGVCTQEGPLYVVVEYAAHGNL--RDFLRARRPPGEYASPDDPRPPEETL 129
Query: 691 KKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSL 750
+K + A A+G+ +L S + IHRD+ + N+L+ +D + DFG+A+ +
Sbjct: 130 TQK----DLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDI 182
Query: 751 CVSKSYTSTYIMGTIG-----YIDPEYARTSRL-TEKSDVYSFGIVLLELLT 796
Y T T G ++ PE A R+ T +SDV+SFG++L E+ T
Sbjct: 183 HHIDYYRKT----TNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 7e-11
Identities = 38/107 (35%), Positives = 53/107 (49%), Gaps = 6/107 (5%)
Query: 264 LDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHI 323
L L L G IP + L + + + L N + G+IPP LG++T L L+L+ N G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 324 PPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGT 370
P +LG+LT L LN+ N L G +P L +H N T
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVP------AALGGRLLHRASFNFT 523
|
Length = 623 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 8e-11
Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 32/205 (15%)
Query: 606 IGYGASSTVYKCVLKNCKPVAI-KRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSL 664
+G GA VYK K +A K + + + L+++ E+E + + H +V L G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLG--- 76
Query: 665 SSSGNLLFYDFMENGSLWDILH----GPTKKKKLDWDTRLK------IALGAAQGLAYLH 714
F +G LW ++ G L+ D L I + L YLH
Sbjct: 77 ---------AFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH 127
Query: 715 HDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYAR 774
S +IIHRD+K+ N+LL D + L DFG++ + ++I GT ++ PE
Sbjct: 128 ---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-GTPYWMAPEVVM 183
Query: 775 TSRLTE-----KSDVYSFGIVLLEL 794
+ + K+D++S GI L+E+
Sbjct: 184 CETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-10
Identities = 36/90 (40%), Positives = 52/90 (57%)
Query: 70 VIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELY 129
++ L LS L GEI + K L S+DL N+LSGQIP + L LDLS N+L
Sbjct: 501 LMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLS 560
Query: 130 GDIPFSISKLKQLEFLILKNNQLIGPIPST 159
G+IP ++ ++ L + + +N L G +PST
Sbjct: 561 GEIPKNLGNVESLVQVNISHNHLHGSLPST 590
|
Length = 968 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 1e-10
Identities = 35/90 (38%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 709 GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYI 768
GL +LH S I++RD+K NILLD D + DFG+ K + + T T+ GT YI
Sbjct: 108 GLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC-GTPDYI 163
Query: 769 DPEYARTSRLTEKSDVYSFGIVLLELLTGR 798
PE + D +SFG++L E+L G+
Sbjct: 164 APEILLGQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 1e-10
Identities = 46/148 (31%), Positives = 71/148 (47%), Gaps = 14/148 (9%)
Query: 652 KHRNLVSLQGYSLSS-SGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGL 710
+ N + L YS+++ G++L D++++G L+D+L K+ KL KI + L
Sbjct: 67 DNPNFIKLY-YSVTTLKGHVLIMDYIKDGDLFDLLK---KEGKLSEAEVKKIIRQLVEAL 122
Query: 711 AYLHHDCSPRIIHRDVKSSNILLD-KDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYID 769
LH IIH D+K N+L D +L D+G LC S Y GT+ Y
Sbjct: 123 NDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYG----LCKIIGTPSCY-DGTLDYFS 174
Query: 770 PEYARTSRLTEKSDVYSFGIVLLELLTG 797
PE + D ++ G++ ELLTG
Sbjct: 175 PEKIKGHNYDVSFDWWAVGVLTYELLTG 202
|
Length = 267 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 35/90 (38%), Positives = 52/90 (57%), Gaps = 4/90 (4%)
Query: 709 GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYI 768
GL +LH S II+RD+K N++LD+D + DFG+ K + ST+ GT YI
Sbjct: 108 GLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYI 163
Query: 769 DPEYARTSRLTEKSDVYSFGIVLLELLTGR 798
PE + + T D +SFG++L E+L G+
Sbjct: 164 APEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 77/289 (26%), Positives = 122/289 (42%), Gaps = 45/289 (15%)
Query: 602 EKY----IIGYGASSTVYKCVLKNC-KPVAIKRLY-SHYPQCLKEFET-ELETVGSIKHR 654
EKY ++G G+ V KC K + VAIK+ S + +K+ E+ + ++H
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60
Query: 655 NLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLH 714
NLV+L L ++F+++ L D+ P LD K +G+ + H
Sbjct: 61 NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG---LDESRVRKYLFQILRGIEFCH 117
Query: 715 HDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEY-A 773
S IIHRD+K NIL+ + L DFG A++L + Y+ T Y PE
Sbjct: 118 ---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV-ATRWYRAPELLV 173
Query: 774 RTSRLTEKSDVYSFGIVLLELLTGR----------------KAVDNECNLHHLILSKTAN 817
++ D+++ G ++ E+LTG K + N H I K
Sbjct: 174 GDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL 233
Query: 818 NAVMETVDPEISATCKDLGAVKKVF--------QLALLCSKRQPTDRPT 858
A M PE+ K++ ++K F LA C + P DRP+
Sbjct: 234 FAGMRL--PEV----KEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPS 276
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-10
Identities = 33/87 (37%), Positives = 53/87 (60%)
Query: 288 LYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPI 347
L L + L G IP ++ + L + L+ N + G+IPP+LG +T L L+++ N G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 348 PDNLSSCTNLNSLNVHGNKLNGTIPPA 374
P++L T+L LN++GN L+G +P A
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAA 509
|
Length = 623 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-10
Identities = 55/196 (28%), Positives = 90/196 (45%), Gaps = 25/196 (12%)
Query: 625 VAIKRLYSHYPQCLKE---FETELETVGSIKHRNLVSLQGYSLSSSGNLLF--YDFMENG 679
VAIK L + P+ + F E + H N+V+L + G LLF ++++
Sbjct: 6 VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPG-LLFAVFEYVPGR 64
Query: 680 SLWDIL--HGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILL---D 734
+L ++L G L ++ L LA H+ I+HRD+K NI++
Sbjct: 65 TLREVLAADGA-----LPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTG 116
Query: 735 KDFEAHLTDFGI------AKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFG 788
A + DFGI + V+ +T ++GT Y PE R +T SD+Y++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176
Query: 789 IVLLELLTGRKAVDNE 804
++ LE LTG++ V
Sbjct: 177 LIFLECLTGQRVVQGA 192
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 20/203 (9%)
Query: 605 IIGYGASSTVYKCVLKN------CKPVAIKRLYSHYPQCLKEFETE-LETVGSIKHRNLV 657
++G G V C ++ CK + KR+ + + E + LE V S R +V
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNS---RFVV 63
Query: 658 SLQGYSLSSSGNL-LFYDFMENGSL-WDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHH 715
SL Y+ + L L M G L + I H + + + A GL LH
Sbjct: 64 SL-AYAYETKDALCLVLTLMNGGDLKFHIYH--MGEAGFEEGRAVFYAAEICCGLEDLHQ 120
Query: 716 DCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYART 775
+ RI++RD+K NILLD ++D G+A + V + T +GT+GY+ PE +
Sbjct: 121 E---RIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMAPEVVKN 175
Query: 776 SRLTEKSDVYSFGIVLLELLTGR 798
R T D ++ G +L E++ G+
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 53/201 (26%), Positives = 94/201 (46%), Gaps = 19/201 (9%)
Query: 643 TELETVGSIKHRNLVSLQGYSLSSSGNL-LFYDFMENGSLWDILHGPTKKKKLDWDTRLK 701
TE + + I+ + Y+ + L L D++ G L+ L +++++ +
Sbjct: 53 TERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHL---SQRERF---KEQE 106
Query: 702 IALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYI 761
+ + + + + L H II+RD+K NILLD + LTDFG++K + +
Sbjct: 107 VQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSF 166
Query: 762 MGTIGYIDPEYAR--TSRLTEKSDVYSFGIVLLELLTGRK--AVDNECNLHHLILSKTAN 817
GTI Y+ P+ R + D +S G+++ ELLTG VD E N I +
Sbjct: 167 CGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRR--- 223
Query: 818 NAVMETVDP---EISATCKDL 835
++++ P E+SA KD+
Sbjct: 224 --ILKSEPPYPQEMSALAKDI 242
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 31/89 (34%), Positives = 46/89 (51%), Gaps = 8/89 (8%)
Query: 709 GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYI 768
G+ LH IIHRD+K N+L+D+ LTDFG++++ +K +GT Y+
Sbjct: 109 GVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK-----FVGTPDYL 160
Query: 769 DPEYARTSRLTEKSDVYSFGIVLLELLTG 797
PE + SD +S G V+ E L G
Sbjct: 161 APETILGVGDDKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 47/218 (21%)
Query: 606 IGYGASSTVYKCVLKNC-KPVAIKRLYSHYPQCLKEFETELETVGS-----------IKH 653
IG G VYK K + VA+K++ +TE E V S + H
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKI---------RLDTETEGVPSTAIREISLLKELNH 58
Query: 654 RNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAA------ 707
N+V L + + L ++F+ + L KK +D I L
Sbjct: 59 PNIVKLLDVIHTENKLYLVFEFL-HQDL---------KKFMDASPLSGIPLPLIKSYLFQ 108
Query: 708 --QGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS-KSYTSTYIMGT 764
QGLA+ H S R++HRD+K N+L++ + L DFG+A++ V ++YT + T
Sbjct: 109 LLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--T 163
Query: 765 IGYIDPEYARTSRL-TEKSDVYSFGIVLLELLTGRKAV 801
+ Y PE + + D++S G + E++T R+A+
Sbjct: 164 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 50/167 (29%), Positives = 83/167 (49%), Gaps = 19/167 (11%)
Query: 653 HRNLVSLQGYSLSSS--GN----LLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGA 706
HRN+ + G + S G+ L +F GS+ D++ TK L D I
Sbjct: 72 HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKN-TKGNALKEDWIAYICREI 130
Query: 707 AQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIG 766
+GLA+LH + ++IHRD+K N+LL ++ E L DFG++ L + +T+I GT
Sbjct: 131 LRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPY 186
Query: 767 YIDPEYART-----SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLH 808
++ PE + +SD++S GI +E+ G + C++H
Sbjct: 187 WMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL---CDMH 230
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 4e-10
Identities = 33/88 (37%), Positives = 52/88 (59%)
Query: 312 LELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTI 371
L L++ L G IP + KL L +N++ N + G IP +L S T+L L++ N NG+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 372 PPAFQRLESMTYLNLSLNNIRGPIPVEL 399
P + +L S+ LNL+ N++ G +P L
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 4e-10
Identities = 55/199 (27%), Positives = 87/199 (43%), Gaps = 19/199 (9%)
Query: 606 IGYGASSTVYKC-VLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIK----HRNLVSLQ 660
IG G S V K K K AIK + H+ E L + +++ H N++ L
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS--LEQVNNLREIQALRRLSPHPNILRLI 64
Query: 661 GYSL-SSSGNL-LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCS 718
+G L L ++ M+ +L++++ G +K+ L + L ++H +
Sbjct: 65 EVLFDRKTGRLALVFELMD-MNLYELIKG--RKRPLPEKRVKSYMYQLLKSLDHMHRN-- 119
Query: 719 PRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTS-R 777
I HRD+K NIL+ D L DFG + + YT YI T Y PE T
Sbjct: 120 -GIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTE-YI-STRWYRAPECLLTDGY 175
Query: 778 LTEKSDVYSFGIVLLELLT 796
K D+++ G V E+L+
Sbjct: 176 YGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-10
Identities = 46/163 (28%), Positives = 78/163 (47%), Gaps = 9/163 (5%)
Query: 643 TELETVGSIKHRNLVSLQGYSLSSSGNLLF-YDFMENGSLWDILHGPTKKKKLDWDTRLK 701
TE + + +H L SL+ YS + L F +++ G L+ L ++++ D
Sbjct: 44 TESRVLKNTRHPFLTSLK-YSFQTKDRLCFVMEYVNGGELFFHL---SRERVFSEDRTRF 99
Query: 702 IALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYI 761
L YLH S +I++RD+K N++LDKD +TDFG+ K ++ + T
Sbjct: 100 YGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKE-GITDAATMKTF 155
Query: 762 MGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNE 804
GT Y+ PE + D + G+V+ E++ GR N+
Sbjct: 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 43/156 (27%), Positives = 82/156 (52%), Gaps = 6/156 (3%)
Query: 644 ELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIA 703
E+ + +KH N+V L + + +L +++M+ L + + LD +T
Sbjct: 48 EISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFT 106
Query: 704 LGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMG 763
+G+A+ H + R++HRD+K N+L++K E L DFG+A++ + + S ++
Sbjct: 107 YQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV- 162
Query: 764 TIGYIDPEYARTSRLTEKS-DVYSFGIVLLELLTGR 798
T+ Y P+ SR S D++S G ++ E++TGR
Sbjct: 163 TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 4e-10
Identities = 35/88 (39%), Positives = 52/88 (59%), Gaps = 7/88 (7%)
Query: 710 LAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYID 769
L YLH S I++RD+K NILLDK+ LTDFG AK L +++T + GT Y+
Sbjct: 114 LEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL-RDRTWT---LCGTPEYLA 166
Query: 770 PEYARTSRLTEKSDVYSFGIVLLELLTG 797
PE ++ + D ++ GI++ E+L G
Sbjct: 167 PEVIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 4e-10
Identities = 58/217 (26%), Positives = 96/217 (44%), Gaps = 39/217 (17%)
Query: 606 IGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELET-VG-------------SI 651
IG G VYK KN K + Y+ +K+F+ + E G +
Sbjct: 8 IGRGTYGRVYKAKRKNGKD---GKEYA-----IKKFKGDKEQYTGISQSACREIALLREL 59
Query: 652 KHRNLVSLQGYSLSSSGNLLF--YDFMENGSLWDILHGPTKKKKLDWDTR-LKIAL-GAA 707
KH N+VSL L + ++ +D+ E+ LW I+ + K++ +K L
Sbjct: 60 KHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQIL 118
Query: 708 QGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAH----LTDFGIAKSLCVSKS---YTSTY 760
G+ YLH S ++HRD+K +NIL+ + + D G+A+ L +
Sbjct: 119 NGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR-LFNAPLKPLADLDP 174
Query: 761 IMGTIGYIDPEYARTSR-LTEKSDVYSFGIVLLELLT 796
++ TI Y PE +R T+ D+++ G + ELLT
Sbjct: 175 VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 60/256 (23%), Positives = 107/256 (41%), Gaps = 50/256 (19%)
Query: 639 KEFETELETVGSIKHR-NLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWD 697
++F ELE + + H N+++L G L ++ +G+L D L K + L+ D
Sbjct: 40 RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR---KSRVLETD 96
Query: 698 TR----------------LKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHL 741
L A A+G+ YL + IHRD+ + NIL+ +++ A +
Sbjct: 97 PAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKI 153
Query: 742 TDFGIAKSLCVSKSYTSTYIMGTIG-----YIDPEYARTSRLTEKSDVYSFGIVLLEL-- 794
DFG+++ Y+ T+G ++ E S T SDV+S+G++L E+
Sbjct: 154 ADFGLSRG-------QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
Query: 795 LTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPT 854
L G C + K +E C D +V+ L C + +P
Sbjct: 207 LGGTPYCGMTCA---ELYEKLPQGYRLEK-----PLNCDD-----EVYDLMRQCWREKPY 253
Query: 855 DRPTMHEVSRVLGSLV 870
+RP+ ++ L ++
Sbjct: 254 ERPSFAQILVSLNRML 269
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 5e-10
Identities = 61/224 (27%), Positives = 91/224 (40%), Gaps = 28/224 (12%)
Query: 606 IGYGASSTVYKCVLKN------CKPVAIKRLYSHYPQCLKEFETE-LETVGSIKHRNLVS 658
+G G V C +K CK + KRL + + E + LE V S R +VS
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSS---RFIVS 57
Query: 659 LQGYSLSSSGNL-LFYDFMENGSL-WDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHD 716
L Y+ + +L L M G L + I + + + A GL +LH
Sbjct: 58 L-AYAFETKDDLCLVMTLMNGGDLKYHIYN--VGEPGFPEARAIFYAAQIICGLEHLHQR 114
Query: 717 CSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTS 776
RI++RD+K N+LLD ++D G+A L K GT GY+ PE +
Sbjct: 115 ---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR--AGTPGYMAPEVLQGE 169
Query: 777 RLTEKSDVYSFGIVLLELLTGR-------KAVDNECNLHHLILS 813
D ++ G L E++ GR + V+ E L L
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE-ELKRRTLE 212
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 64/270 (23%), Positives = 114/270 (42%), Gaps = 51/270 (18%)
Query: 626 AIKRLYSHYPQC-LKEFETELETVGSI-KHRNLVSLQGYSLSSSGNLLFYDFMENGSLWD 683
AIKR+ + + ++F ELE + + H N+++L G L ++ +G+L D
Sbjct: 38 AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD 97
Query: 684 ILHGPTKKKKLDWDTRLKIA----------------LGAAQGLAYLHHDCSPRIIHRDVK 727
L K + L+ D IA A+G+ YL + IHRD+
Sbjct: 98 FLR---KSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLA 151
Query: 728 SSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIG-----YIDPEYARTSRLTEKS 782
+ NIL+ +++ A + DFG+++ Y+ T+G ++ E S T S
Sbjct: 152 ARNILVGENYVAKIADFGLSRG-------QEVYVKKTMGRLPVRWMAIESLNYSVYTTNS 204
Query: 783 DVYSFGIVLLEL--LTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKK 840
DV+S+G++L E+ L G C A + P+ K L +
Sbjct: 205 DVWSYGVLLWEIVSLGGTPYCGMTC-------------AELYEKLPQGYRLEKPLNCDDE 251
Query: 841 VFQLALLCSKRQPTDRPTMHEVSRVLGSLV 870
V+ L C + +P +RP+ ++ L ++
Sbjct: 252 VYDLMRQCWREKPYERPSFAQILVSLNRML 281
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 6e-10
Identities = 42/135 (31%), Positives = 64/135 (47%), Gaps = 18/135 (13%)
Query: 708 QGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGY 767
GL +LH RII+RD+K N+LLD D ++D G+A L +S T Y GT G+
Sbjct: 108 SGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY-AGTPGF 163
Query: 768 IDPEYARTSRLTEKSDVYSFGIVLLELLTGR-------KAVDNECNLHHLILSKTANNAV 820
+ PE + D ++ G+ L E++ R + V+N+ L IL N++V
Sbjct: 164 MAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK-ELKQRIL----NDSV 218
Query: 821 METVDPEISATCKDL 835
T + S K
Sbjct: 219 --TYPDKFSPASKSF 231
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 8e-10
Identities = 36/104 (34%), Positives = 55/104 (52%), Gaps = 5/104 (4%)
Query: 692 KKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLC 751
+ L D L I +GL YLH + RIIHRDVK+ NI ++ + + D G A+
Sbjct: 152 RPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208
Query: 752 VSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELL 795
V+ ++ + GT+ PE + K+D++S GIVL E+L
Sbjct: 209 VAPAFLG--LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 8e-10
Identities = 36/94 (38%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 710 LAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIM----GTI 765
L Y+H S +IHRD+K SNILL+ D L DFG+A+SL + ++ T
Sbjct: 120 LKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATR 176
Query: 766 GYIDPEYARTS-RLTEKSDVYSFGIVLLELLTGR 798
Y PE S R T+ D++S G +L E+L G+
Sbjct: 177 WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 61/245 (24%), Positives = 100/245 (40%), Gaps = 50/245 (20%)
Query: 640 EFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHG------------ 687
EF E + ++V L G L+ + M G L L
Sbjct: 55 EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQA 114
Query: 688 -PTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGI 746
P+ KK + ++A A G+AYL+ + + +HRD+ + N ++ +DF + DFG+
Sbjct: 115 PPSLKKMI------QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGM 165
Query: 747 AKSLCVSKSYTSTYIMGTIG-----YIDPEYARTSRLTEKSDVYSFGIVLLELLT----G 797
+ + T Y G G ++ PE + T SDV+SFG+VL E+ T
Sbjct: 166 TRDI----YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 221
Query: 798 RKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRP 857
+ + NE L VME + C D+ +F+L +C + P RP
Sbjct: 222 YQGMSNEQVLRF----------VMEGGLLDKPDNCPDM-----LFELMRMCWQYNPKMRP 266
Query: 858 TMHEV 862
+ E+
Sbjct: 267 SFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 51/149 (34%), Positives = 70/149 (46%), Gaps = 9/149 (6%)
Query: 650 SIKHRNLVSLQGYSLSSSGNLLF-YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQ 708
++KH LV L +S ++ L F D++ G L+ H ++ L+ R A A
Sbjct: 52 NVKHPFLVGLH-FSFQTADKLYFVLDYINGGELF--YHLQRERCFLEPRARF-YAAEIAS 107
Query: 709 GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYI 768
L YLH S I++RD+K NILLD LTDFG+ K TST+ GT Y+
Sbjct: 108 ALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC-GTPEYL 163
Query: 769 DPEYARTSRLTEKSDVYSFGIVLLELLTG 797
PE D + G VL E+L G
Sbjct: 164 APEVLHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 35/98 (35%), Positives = 51/98 (52%), Gaps = 4/98 (4%)
Query: 707 AQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIG 766
A GL +LH S II+RD+K N++LD + + DFG+ K T T+ GT
Sbjct: 111 AIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC-GTPD 166
Query: 767 YIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNE 804
YI PE + D ++FG++L E+L G+ D E
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE 204
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 1e-09
Identities = 51/205 (24%), Positives = 80/205 (39%), Gaps = 27/205 (13%)
Query: 609 GASSTVYKCVLKNCKPVAIKR--LYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSS 666
+ K VA+K+ L S + LK + E+ T ++H N++ +
Sbjct: 13 LMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD 71
Query: 667 SGNLLFYDFMENGSLWDIL--HGPTKKKKLDWDTRLKIAL---GAAQGLAYLHHDCSPRI 721
S + M GS D+L H P +L IA L Y+H
Sbjct: 72 SELYVVSPLMAYGSCEDLLKTHFPEGLPEL------AIAFILKDVLNALDYIHSK---GF 122
Query: 722 IHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMG-------TIGYIDPEYAR 774
IHR VK+S+ILL D + L+ + S+ + + + ++ PE +
Sbjct: 123 IHRSVKASHILLSGDGKVVLSGLRYSVSM-IKHGKRQRVVHDFPKSSVKNLPWLSPEVLQ 181
Query: 775 TSRL--TEKSDVYSFGIVLLELLTG 797
+ EKSD+YS GI EL G
Sbjct: 182 QNLQGYNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 1e-09
Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 23/203 (11%)
Query: 606 IGYGASSTVYKCVLKNCKP-VAIKRL---YSHYPQCLKEFETELETVGSIK----HRNLV 657
+G G +VY K VAIK++ + + +C+ L V S++ H N+V
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN-----LREVKSLRKLNEHPNIV 61
Query: 658 SLQGYSLSSSGNLLF-YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHD 716
L+ + L F +++ME G+L+ ++ K K I QGLA++H
Sbjct: 62 KLKE-VFRENDELYFVFEYME-GNLYQLMKD-RKGKPFSESVIRSIIYQILQGLAHIHKH 118
Query: 717 CSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPE-YART 775
HRD+K N+L+ + DFG+A+ + YT Y+ T Y PE R+
Sbjct: 119 ---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYT-DYV-STRWYRAPEILLRS 173
Query: 776 SRLTEKSDVYSFGIVLLELLTGR 798
+ + D+++ G ++ EL T R
Sbjct: 174 TSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 58/259 (22%), Positives = 95/259 (36%), Gaps = 33/259 (12%)
Query: 625 VAIKRLY-SHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWD 683
V +K L S P F E++ + H N++ G + S LL +F G L +
Sbjct: 25 VVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKN 84
Query: 684 ILHGPTKKKKLDWDTRL--KIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHL 741
L + ++A A GL +LH IH D+ N L D +
Sbjct: 85 YLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKI 141
Query: 742 TDFGIAKSLCVSKSYTSTYIMGT------IGYIDPEYA-------RTSRLTEKSDVYSFG 788
D+G+A Y Y + + ++ PE T+KS+++S G
Sbjct: 142 GDYGLALE-----QYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLG 196
Query: 789 IVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALL 847
+ + EL T + + + L V E D ++ DL + +++
Sbjct: 197 VTMWELFTAADQPYPDLSDEQVL------KQVVREQ-DIKLPKPQLDLKYSDRWYEVMQF 249
Query: 848 CSKRQPTDRPTMHEVSRVL 866
C P RPT EV +L
Sbjct: 250 CW-LDPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 32/78 (41%), Positives = 45/78 (57%), Gaps = 1/78 (1%)
Query: 721 IIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTE 780
I++RD+K NILLD + LTDFG++K + + GTI Y+ PE R
Sbjct: 126 IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHG 185
Query: 781 KS-DVYSFGIVLLELLTG 797
K+ D +S GI++ ELLTG
Sbjct: 186 KAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 67/264 (25%), Positives = 116/264 (43%), Gaps = 40/264 (15%)
Query: 625 VAIKRLYSHYPQCLK-EFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWD 683
VA+K L + + +F E++ + +K N++ L ++S + ++MENG L
Sbjct: 49 VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108
Query: 684 IL--HGP------TKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDK 735
L H P + + T + +A A G+ YL S +HRD+ + N L+ K
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGK 165
Query: 736 DFEAHLTDFGIAKSLCVSKSYTSTY--IMG----TIGYIDPEYARTSRLTEKSDVYSFGI 789
++ + DFG++++L Y+ Y I G I ++ E + T SDV++FG+
Sbjct: 166 NYTIKIADFGMSRNL-----YSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGV 220
Query: 790 VLLELLTGRKAVDNECNLHHLILSKTANNA-------VMETVDPEISATCKDLGAVKKVF 842
L E+LT K E L + N + P+ A C D ++
Sbjct: 221 TLWEILTLCK----EQPYSQLSDEQVIENTGEFFRDQGRQVYLPK-PALCPDS-----LY 270
Query: 843 QLALLCSKRQPTDRPTMHEVSRVL 866
+L L C +R +RP+ E+ L
Sbjct: 271 KLMLSCWRRNAKERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 54/180 (30%), Positives = 84/180 (46%), Gaps = 13/180 (7%)
Query: 621 NCKPVAIKRLYSHYPQCLKEFE---TELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFME 677
+ PVAIKR K+ + +E + + I H V+L G S L +F+
Sbjct: 55 DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVI 114
Query: 678 NGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDF 737
G + L + K+ D AAQ + + S I++RD+K N+LLDKD
Sbjct: 115 GGEFFTFLR---RNKRFPNDVG---CFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDG 168
Query: 738 EAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTG 797
+TDFG AK + +++YT + GT YI PE + +D ++ GI + E+L G
Sbjct: 169 FIKMTDFGFAK-VVDTRTYT---LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 44/147 (29%), Positives = 69/147 (46%), Gaps = 7/147 (4%)
Query: 656 LVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHH 715
LV L ++S L +++ G D++ +++KL + A L +LH
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGG---DLMFHMQRQRKLPEEHARFYAAEICIALNFLHE 114
Query: 716 DCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYART 775
II+RD+K N+LLD D LTD+G+ K TST+ GT YI PE R
Sbjct: 115 R---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC-GTPNYIAPEILRG 170
Query: 776 SRLTEKSDVYSFGIVLLELLTGRKAVD 802
D ++ G+++ E++ GR D
Sbjct: 171 EEYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 59.1 bits (144), Expect = 3e-09
Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 36/211 (17%)
Query: 606 IGYGASSTVYK-CVLKNCKPVAIKRLYSHYPQCLKE---FET--ELETVGSIKHRNLVSL 659
+G G + VYK + + VAIK++ + K+ F E++ + +KH N++ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 660 QG-YSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAA----------Q 708
+ S+ NL+F +FME D+ +K+ D I L A +
Sbjct: 68 LDVFGHKSNINLVF-EFME----TDL-------EKVIKDK--SIVLTPADIKSYMLMTLR 113
Query: 709 GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYI 768
GL YLH S I+HRD+K +N+L+ D L DFG+A+S S + T+ + T Y
Sbjct: 114 GLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARS-FGSPNRKMTHQVVTRWYR 169
Query: 769 DPEYARTSRL-TEKSDVYSFGIVLLELLTGR 798
PE +R D++S G + ELL
Sbjct: 170 APELLFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (142), Expect = 3e-09
Identities = 47/167 (28%), Positives = 80/167 (47%), Gaps = 19/167 (11%)
Query: 653 HRNLVSLQGYSLSSSGN------LLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGA 706
HRN+ + G + + L +F GS+ D++ TK L + I
Sbjct: 62 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN-TKGNTLKEEWIAYICREI 120
Query: 707 AQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIG 766
+GL++LH ++IHRD+K N+LL ++ E L DFG++ L + +T+I GT
Sbjct: 121 LRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPY 176
Query: 767 YIDPEYARTSRLTE-----KSDVYSFGIVLLELLTGRKAVDNECNLH 808
++ PE + KSD++S GI +E+ G + C++H
Sbjct: 177 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL---CDMH 220
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 3e-09
Identities = 58/222 (26%), Positives = 103/222 (46%), Gaps = 27/222 (12%)
Query: 591 EDIMRMTENLSEKYI----IGYGASSTVYKCV-LKNCKPVAIKRLYSHYPQCL--KEFET 643
E++ + L E+Y +G GA +V + + + VAIK+L + + K
Sbjct: 4 EEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR 63
Query: 644 ELETVGSIKHRNLVSLQGYSLSSSGNLLFYDF------MENGSLWDILHGPTKKKKLDWD 697
EL + ++H N++ L S+ F DF M+ L I+ P + K+ +
Sbjct: 64 ELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHPLSEDKVQY- 121
Query: 698 TRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYT 757
+ GL Y+H S IIHRD+K N+ +++D E + DFG+A+ + +
Sbjct: 122 ----LVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARH---ADAEM 171
Query: 758 STYIMGTIGYIDPEYART-SRLTEKSDVYSFGIVLLELLTGR 798
+ Y++ T Y PE + D++S G ++ E+LTG+
Sbjct: 172 TGYVV-TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 52/200 (26%), Positives = 97/200 (48%), Gaps = 21/200 (10%)
Query: 606 IGYGASSTVYK--CVLKNCKPVAIKRLY-------SHYPQCLKEFETELETVGSIKHRNL 656
IG G S VY+ C+L KPVA+K++ C+KE ++ + + H N+
Sbjct: 10 IGRGQFSEVYRATCLLDR-KPVALKKVQIFEMMDAKARQDCVKE----IDLLKQLNHPNV 64
Query: 657 VS-LQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWD-TRLKIALGAAQGLAYLH 714
+ L + + N++ + + G L ++ K+K+L + T K + + ++H
Sbjct: 65 IKYLDSFIEDNELNIVL-ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 715 HDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYAR 774
S R++HRD+K +N+ + L D G+ + SK+ + ++GT Y+ PE
Sbjct: 124 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERIH 179
Query: 775 TSRLTEKSDVYSFGIVLLEL 794
+ KSD++S G +L E+
Sbjct: 180 ENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 43/131 (32%), Positives = 65/131 (49%), Gaps = 8/131 (6%)
Query: 707 AQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIG 766
A GL +LH S II+RD+K N++LD + + DFG+ K T T+ GT
Sbjct: 111 AIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFC-GTPD 166
Query: 767 YIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVD--NECNLHHLILSKTANNAVMETV 824
YI PE + D ++FG++L E+L G+ + +E L I+ N A +++
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH--NVAYPKSM 224
Query: 825 DPEISATCKDL 835
E A CK L
Sbjct: 225 SKEAVAICKGL 235
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 4e-09
Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 20/202 (9%)
Query: 606 IGYGASSTV-YKCVLKNCKPVAIKRLYSHYPQCL--KEFETELETVGSIKHRNLVSLQGY 662
+G GA TV + VAIK+LY + L K EL + +KH N++ L
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 663 SLSSSGNLLFYDF-----MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDC 717
F+DF L ++ K +KL D + +GL Y+H
Sbjct: 83 FTPDLSLDRFHDFYLVMPFMGTDLGKLM----KHEKLSEDRIQFLVYQMLKGLKYIH--- 135
Query: 718 SPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYART-S 776
+ IIHRD+K N+ +++D E + DFG+A+ + S + Y++ T Y PE
Sbjct: 136 AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ---TDSEMTGYVV-TRWYRAPEVILNWM 191
Query: 777 RLTEKSDVYSFGIVLLELLTGR 798
T+ D++S G ++ E+LTG+
Sbjct: 192 HYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 39/147 (26%), Positives = 71/147 (48%), Gaps = 9/147 (6%)
Query: 653 HRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAY 712
H N+V+L G L+ ++ G L + L ++ L + L + A+G+A+
Sbjct: 98 HENIVNLLGACTIGGPILVITEYCCYGDLLNFLR-RKRESFLTLEDLLSFSYQVAKGMAF 156
Query: 713 LHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYT---STYIMGTIGYID 769
L S IHRD+ + N+LL + DFG+A+ + +Y + + + ++
Sbjct: 157 L---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL--PVKWMA 211
Query: 770 PEYARTSRLTEKSDVYSFGIVLLELLT 796
PE T +SDV+S+GI+L E+ +
Sbjct: 212 PESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 5e-09
Identities = 53/211 (25%), Positives = 91/211 (43%), Gaps = 43/211 (20%)
Query: 606 IGYGASSTVYKCV-LKNCKPVAIKRLY-------SHYPQCLKEFETELETVGSIKHRNLV 657
IG G S VYK + L + + VA+K++ CLKE ++ + + H N++
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKE----IDLLKQLDHPNVI 65
Query: 658 SLQGYSLSSSGNLLFYD-FMENGSLWDIL-------------HGPTKKKKLDWDTRLKIA 703
+ F+EN L +L H +K+ + T K
Sbjct: 66 K-------------YLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYF 112
Query: 704 LGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMG 763
+ L ++H S RI+HRD+K +N+ + L D G+ + SK+ + ++G
Sbjct: 113 VQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVG 168
Query: 764 TIGYIDPEYARTSRLTEKSDVYSFGIVLLEL 794
T Y+ PE + KSD++S G +L E+
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 6e-09
Identities = 52/203 (25%), Positives = 90/203 (44%), Gaps = 11/203 (5%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLKNCK----PVAIKRLYSHYPQCLKE-FETELETVGSIK 652
E+++ IG G VY+ V + + VA+K + ++E F E +
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD 65
Query: 653 HRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAY 712
H ++V L G ++ + + + G L L K LD + + + + LAY
Sbjct: 66 HPHIVKLIGV-ITENPVWIVMELAPLGELRSYLQ--VNKYSLDLASLILYSYQLSTALAY 122
Query: 713 LHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEY 772
L S R +HRD+ + N+L+ L DFG+++ L Y ++ I ++ PE
Sbjct: 123 LE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPES 179
Query: 773 ARTSRLTEKSDVYSFGIVLLELL 795
R T SDV+ FG+ + E+L
Sbjct: 180 INFRRFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 7e-09
Identities = 52/189 (27%), Positives = 94/189 (49%), Gaps = 21/189 (11%)
Query: 625 VAIKRLYSHYPQC-LKEFETELETVGSI-KHRNLVSLQGYSLSSSGNLLFYDFMENGSLW 682
VA+K L S + L + +E+E + I KH+N+++L G + ++ G+L
Sbjct: 53 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 112
Query: 683 DIL-----------HGPTK--KKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSS 729
+ L + PT+ +++L + + A A+G+ YL S + IHRD+ +
Sbjct: 113 EYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAAR 169
Query: 730 NILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMG--TIGYIDPEYARTSRLTEKSDVYSF 787
N+L+ +D + DFG+A+ + Y T G + ++ PE T +SDV+SF
Sbjct: 170 NVLVTEDNVMKIADFGLARDIHHIDYYKKT-TNGRLPVKWMAPEALFDRIYTHQSDVWSF 228
Query: 788 GIVLLELLT 796
G++L E+ T
Sbjct: 229 GVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 7e-09
Identities = 33/93 (35%), Positives = 48/93 (51%), Gaps = 4/93 (4%)
Query: 710 LAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYID 769
L +LH II+RD+K N+LLD + LTD+G+ K TST+ GT YI
Sbjct: 109 LNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC-GTPNYIA 164
Query: 770 PEYARTSRLTEKSDVYSFGIVLLELLTGRKAVD 802
PE R D ++ G+++ E++ GR D
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 52.2 bits (126), Expect = 8e-09
Identities = 24/60 (40%), Positives = 34/60 (56%)
Query: 404 NLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHL 463
NL +LD+SNN+++ L +L L+LS N LT P F L S+ +DLS N+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 8e-09
Identities = 63/285 (22%), Positives = 119/285 (41%), Gaps = 49/285 (17%)
Query: 609 GASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSG 668
G ++ K + +N ++ L S + LK+ + H +++ L G
Sbjct: 29 GYTTVAVKMLKENASSSELRDLLSEF-NLLKQ----------VNHPHVIKLYGACSQDGP 77
Query: 669 NLLFYDFMENGSLWDILH-------------GPTKKKKLDWDTRLKIALG--------AA 707
LL ++ + GSL L G LD + +G +
Sbjct: 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQIS 137
Query: 708 QGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTS-TYIMGTIG 766
+G+ YL +++HRD+ + N+L+ + + ++DFG+++ + SY + +
Sbjct: 138 RGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVK 194
Query: 767 YIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVD 825
++ E T +SDV+SFG++L E++T G L KT ME
Sbjct: 195 WMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYR--MER-- 250
Query: 826 PEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLV 870
PE C + +++ L L C K++P RPT ++S+ L ++
Sbjct: 251 PE---NCSE-----EMYNLMLTCWKQEPDKRPTFADISKELEKMM 287
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 9e-09
Identities = 50/168 (29%), Positives = 80/168 (47%), Gaps = 15/168 (8%)
Query: 650 SIKHRNLVSLQGYSLSSSGNLLFYDFME--NGSLWDILHGPTKKKKLDWDTRLKIALGAA 707
+ KH L +L + + + LF+ ME NG D++ + +K D A
Sbjct: 52 AAKHPFLTAL--HCCFQTKDRLFF-VMEYVNGG--DLMFQIQRSRKFDEPRSRFYAAEVT 106
Query: 708 QGLAYLH-HDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIG 766
L +LH H +I+RD+K NILLD + L DFG+ K ++ T+T+ GT
Sbjct: 107 LALMFLHRHG----VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC-GTPD 161
Query: 767 YIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKA--VDNECNLHHLIL 812
YI PE + D ++ G+++ E++ G+ DNE +L IL
Sbjct: 162 YIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESIL 209
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 34/88 (38%), Positives = 47/88 (53%), Gaps = 4/88 (4%)
Query: 710 LAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYID 769
L +LH II+RD+K NILLD LTDFG+ K + T T+ GTI Y+
Sbjct: 113 LEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC-GTIEYMA 168
Query: 770 PEYARTSRLTEKSDVYSFGIVLLELLTG 797
PE S + D +S G ++ ++LTG
Sbjct: 169 PEILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-08
Identities = 55/229 (24%), Positives = 102/229 (44%), Gaps = 27/229 (11%)
Query: 604 YIIGYGASSTVYKCVLKNC-KPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGY 662
+G G++ V+ V +C K VA+K++ PQ +K E++ + + H N+V +
Sbjct: 11 RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVY-E 69
Query: 663 SLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAA-------------QG 709
L SG+ L D L + ++ ++ D + G +G
Sbjct: 70 VLGPSGSDLTEDVGSLTELNSVYIV---QEYMETDLANVLEQGPLSEEHARLFMYQLLRG 126
Query: 710 LAYLHHDCSPRIIHRDVKSSNILLD-KDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIG-- 766
L Y+H S ++HRD+K +N+ ++ +D + DFG+A+ + S+ G +
Sbjct: 127 LKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW 183
Query: 767 YIDPEYARTSR-LTEKSDVYSFGIVLLELLTGRK--AVDNECNLHHLIL 812
Y P + T+ D+++ G + E+LTG+ A +E LIL
Sbjct: 184 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL 232
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 41/156 (26%), Positives = 72/156 (46%), Gaps = 7/156 (4%)
Query: 643 TELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKI 702
TE + + +H L +L+ Y+ + L F ME + ++ ++++ +
Sbjct: 44 TESRVLQNTRHPFLTALK-YAFQTHDRLCF--VMEYANGGELFFHLSRERVFTEERARFY 100
Query: 703 ALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIM 762
L YLH S +++RD+K N++LDKD +TDFG+ K +S T
Sbjct: 101 GAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDGATMKTFC 156
Query: 763 GTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGR 798
GT Y+ PE + D + G+V+ E++ GR
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-08
Identities = 57/240 (23%), Positives = 96/240 (40%), Gaps = 68/240 (28%)
Query: 663 SLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKI------ALGAAQGLAYLHHD 716
S+SSS + F+E+ SL D ++ + L + + A+G+ +L
Sbjct: 135 SVSSSQSSASSGFIEDKSLSD--VEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL--- 189
Query: 717 CSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYART- 775
S + IHRD+ + NILL ++ + DFG+A+ + Y DP+Y R
Sbjct: 190 ASRKCIHRDLAARNILLSENNVVKICDFGLARDI----------------YKDPDYVRKG 233
Query: 776 -SRL---------------TEKSDVYSFGIVLLELLT-------GRKAVDNECNLHHLIL 812
+RL T +SDV+SFG++L E+ + G + + C
Sbjct: 234 DARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCR------ 287
Query: 813 SKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPA 872
+ M A +++ + L C P DRPT E+ +LG L+
Sbjct: 288 -RLKEGTRM----------RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQE 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 58/220 (26%), Positives = 91/220 (41%), Gaps = 34/220 (15%)
Query: 700 LKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTST 759
L I + + YLH + RIIHRD+K+ NI ++ + L DFG A C +
Sbjct: 185 LAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA---CFPVDINAN 238
Query: 760 YI---MGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTG------RKAVDNECNLHH- 809
GTI PE D++S GIVL E+ T + +D +C+
Sbjct: 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQ 298
Query: 810 --LILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPT---MHEVSR 864
LI+ ++ + +D + + +G KK S R+P RP ++E+
Sbjct: 299 IKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKK--------SSRKPGSRPLWTNLYELPI 350
Query: 865 VLGSLVP---APEPQKQPTSIPSALLSSAKVPCYKDEYAN 901
L L+ A + +P++ ALL A D Y N
Sbjct: 351 DLEYLICKMLAFDAHHRPSA--EALLDFAAFQDIPDPYPN 388
|
Length = 391 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 30/89 (33%), Positives = 47/89 (52%), Gaps = 4/89 (4%)
Query: 710 LAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYID 769
L YLH S +++RD+K N++LDKD +TDFG+ K + T+ GT Y+
Sbjct: 108 LGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLA 163
Query: 770 PEYARTSRLTEKSDVYSFGIVLLELLTGR 798
PE + D + G+V+ E++ GR
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 50/199 (25%), Positives = 93/199 (46%), Gaps = 19/199 (9%)
Query: 606 IGYGASSTVYK--CVLKNCKPVAIKRLY-------SHYPQCLKEFETELETVGSIKHRNL 656
IG G S VY+ C+L PVA+K++ C+KE ++ + + H N+
Sbjct: 10 IGRGQFSEVYRATCLLDGV-PVALKKVQIFDLMDAKARADCIKE----IDLLKQLNHPNV 64
Query: 657 VSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWD-TRLKIALGAAQGLAYLHH 715
+ + + + + + G L ++ K+K+L + T K + L ++H
Sbjct: 65 IKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH- 123
Query: 716 DCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYART 775
S R++HRD+K +N+ + L D G+ + SK+ + ++GT Y+ PE
Sbjct: 124 --SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERIHE 180
Query: 776 SRLTEKSDVYSFGIVLLEL 794
+ KSD++S G +L E+
Sbjct: 181 NGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 2e-08
Identities = 45/147 (30%), Positives = 69/147 (46%), Gaps = 11/147 (7%)
Query: 671 LFY--DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKS 728
LF+ +F+ G D++ K ++ D A L +LH II+RD+K
Sbjct: 71 LFFVMEFVNGG---DLMFHIQKSRRFDEARARFYAAEITSALMFLH---DKGIIYRDLKL 124
Query: 729 SNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFG 788
N+LLD + L DFG+ K + TST+ GT YI PE + D ++ G
Sbjct: 125 DNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC-GTPDYIAPEILQEMLYGPSVDWWAMG 183
Query: 789 IVLLELLTGRKA--VDNECNLHHLILS 813
++L E+L G +NE +L IL+
Sbjct: 184 VLLYEMLCGHAPFEAENEDDLFEAILN 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 2e-08
Identities = 49/178 (27%), Positives = 86/178 (48%), Gaps = 22/178 (12%)
Query: 694 LDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753
LD D L+ + AQG+ +L S IHRDV + N+LL A + DFG+A+ +
Sbjct: 209 LDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMND 265
Query: 754 KSYTSTYIMGT----IGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLH 808
+Y + G + ++ PE T +SDV+S+GI+L E+ + G+
Sbjct: 266 SNYV---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPG----- 317
Query: 809 HLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866
IL N+ + V + D A +++ + +C +PT+RPT ++S+++
Sbjct: 318 --IL---VNSKFYKMVKRGYQMSRPDF-APPEIYSIMKMCWNLEPTERPTFSQISQLI 369
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 56/254 (22%), Positives = 106/254 (41%), Gaps = 29/254 (11%)
Query: 624 PVAIKRLY-SHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLW 682
PVAI L + + F E T+G H N+V L+G + ++ ++M NG+L
Sbjct: 35 PVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALD 94
Query: 683 DILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLT 742
L + +L + + G A G+ YL +H+ + + +L++ D ++
Sbjct: 95 SFLR--KHEGQLVAGQLMGMLPGLASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKIS 149
Query: 743 DFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT--GRKA 800
F + YT+ + + PE + + SDV+SFGIV+ E+++ R
Sbjct: 150 GFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPY 209
Query: 801 VDNECNLHHLILSKTANNAVMETVDPEIS----ATCKDLGAVKKVFQLALLCSKRQPTDR 856
D + V++ V+ C +L + QL L C +++ +R
Sbjct: 210 WD------------MSGQDVIKAVEDGFRLPAPRNCPNL-----LHQLMLDCWQKERGER 252
Query: 857 PTMHEVSRVLGSLV 870
P ++ +L +V
Sbjct: 253 PRFSQIHSILSKMV 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 52/198 (26%), Positives = 94/198 (47%), Gaps = 18/198 (9%)
Query: 606 IGYGASSTVYKCVLKNCKPVAIKRLY-SHYPQCLKEFETELETVGSIKHRNLVSLQGYSL 664
+G GA VYK K +A ++ + + L+++ E++ + S H N+V L
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 665 SSSGNLLFYDFMENGSLWDI---LHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRI 721
+ + +F G++ + L P + ++ + + + L YLH + +I
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTL-----EALNYLHEN---KI 124
Query: 722 IHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPE--YARTSR-- 777
IHRD+K+ NIL D + L DFG++ + ++I GT ++ PE TS+
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDR 183
Query: 778 -LTEKSDVYSFGIVLLEL 794
K+DV+S GI L+E+
Sbjct: 184 PYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-08
Identities = 61/239 (25%), Positives = 101/239 (42%), Gaps = 65/239 (27%)
Query: 663 SLSSSGNLLFYDFMENGSLWDILHGPTK-----KKKLDWDTRLKIALGAAQGLAYLHHDC 717
S++SS + F+E SL D+ + KK L + + + A+G+ +L
Sbjct: 140 SITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFL---A 196
Query: 718 SPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYART-- 775
S + IHRD+ + NILL ++ + DFG+A+ + Y DP+Y R
Sbjct: 197 SRKCIHRDLAARNILLSENNVVKICDFGLARDI----------------YKDPDYVRKGD 240
Query: 776 SRL---------------TEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAV 820
+RL T +SDV+SFG++L E I S A+
Sbjct: 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE-----------------IFSLGASPYP 283
Query: 821 METVDPEISATCKDLGAVK-------KVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPA 872
+D E K+ ++ +++Q L C +P+ RPT E+ LG+L+ A
Sbjct: 284 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 62/221 (28%), Positives = 96/221 (43%), Gaps = 52/221 (23%)
Query: 602 EKYIIGYGASSTVYK-CVLKNCKPVAIKRLYSHYPQCLKEFETELETVGS---------- 650
EK IG G VYK + VA+K++ ETE E V S
Sbjct: 5 EK--IGEGTYGVVYKARDKLTGEIVALKKI---------RLETEDEGVPSTAIREISLLK 53
Query: 651 -IKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAA-- 707
+ H N+V L S + L ++F++ D+ KK +D + L
Sbjct: 54 ELNHPNIVRLLDVVHSENKLYLVFEFLDL----DL------KKYMD--SSPLTGLDPPLI 101
Query: 708 --------QGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS-KSYTS 758
QG+AY H S R++HRD+K N+L+D++ L DFG+A++ V ++YT
Sbjct: 102 KSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH 158
Query: 759 TYIMGTIGYIDPEYARTSRLTEKS-DVYSFGIVLLELLTGR 798
+ T+ Y PE SR D++S G + E++ R
Sbjct: 159 EVV--TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 2e-08
Identities = 42/166 (25%), Positives = 74/166 (44%), Gaps = 20/166 (12%)
Query: 640 EFETELETVGSIKHRNLVSLQ--------GYSLSSSGNLLFYDFMENGSL-WDILHGPTK 690
+ E E+ +G + H N++ ++ Y ++ + Y FM + + W K
Sbjct: 209 QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDW-------K 261
Query: 691 KKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSL 750
+ L TR I + Y+H ++IHRD+K NI L+ D + L DFG A
Sbjct: 262 DRPLLKQTR-AIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPF 317
Query: 751 CVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT 796
+ +GT+ PE E +D++S G++LL++L+
Sbjct: 318 EKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 46/162 (28%), Positives = 70/162 (43%), Gaps = 10/162 (6%)
Query: 639 KEFETELETVGSIKHRNLVSL-QGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWD 697
K E++ + +I HR +++L Y S+ ++ + D+ + L +
Sbjct: 131 KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-----CDLFTYVDRSGPLPLE 185
Query: 698 TRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYT 757
+ I + LAYLH IIHRDVK+ NI LD+ A L DFG A L
Sbjct: 186 QAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP 242
Query: 758 STY-IMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGR 798
Y GT+ PE K+D++S G+VL E+
Sbjct: 243 QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKN 284
|
Length = 392 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 41/150 (27%), Positives = 69/150 (46%), Gaps = 7/150 (4%)
Query: 653 HRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAY 712
H LV L + S +++ G D++ +++KL + + + L Y
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGG---DLMFHMQRQRKLPEEHARFYSAEISLALNY 111
Query: 713 LHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEY 772
LH II+RD+K N+LLD + LTD+G+ K + T++ GT YI PE
Sbjct: 112 LHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTFCGTPNYIAPEI 167
Query: 773 ARTSRLTEKSDVYSFGIVLLELLTGRKAVD 802
R D ++ G+++ E++ GR D
Sbjct: 168 LRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 4e-08
Identities = 55/218 (25%), Positives = 95/218 (43%), Gaps = 28/218 (12%)
Query: 598 ENLSEKY----IIGYGASSTVYKCVLK-NCKPVAIKRL--YSHYPQCLKEFETELETVGS 650
++ +Y IG GA V K VAIK++ + H C + E++ +
Sbjct: 1 FDVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR-EIKILRR 59
Query: 651 IKHRNLVSLQGYSLSSSGNL-------LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIA 703
KH N++ + + + + + ME L+ K + L D
Sbjct: 60 FKHENIIGI--LDIIRPPSFESFNDVYIVQELMETD-----LYKLIKTQHLSNDHIQYFL 112
Query: 704 LGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTS--TYI 761
+GL Y+H S ++HRD+K SN+LL+ + + + DFG+A+ +T T
Sbjct: 113 YQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEY 169
Query: 762 MGTIGYIDPEYARTSRLTEKS-DVYSFGIVLLELLTGR 798
+ T Y PE S+ K+ D++S G +L E+L+ R
Sbjct: 170 VATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 50.2 bits (121), Expect = 5e-08
Identities = 26/60 (43%), Positives = 36/60 (60%)
Query: 428 HLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNL 487
+L L+LS N+LT G F L ++ +DLS N+LT + PE S L ++ SL L NNL
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 47/175 (26%), Positives = 85/175 (48%), Gaps = 20/175 (11%)
Query: 638 LKEFETELETVGSI-KHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHG---PT---- 689
L + +E+E + I KH+N+++L G + ++ G+L + L P
Sbjct: 61 LADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYT 120
Query: 690 ------KKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTD 743
+++L + + A A+G+ YL S R IHRD+ + N+L+ +D + D
Sbjct: 121 FDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIAD 177
Query: 744 FGIAKSLCVSKSY--TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT 796
FG+A+ + Y TS + + ++ PE T +SDV+SFGI++ E+ T
Sbjct: 178 FGLARGVHDIDYYKKTSNGRL-PVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 5e-08
Identities = 30/86 (34%), Positives = 48/86 (55%), Gaps = 7/86 (8%)
Query: 712 YLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPE 771
YLH S II+RD+K N+LLD +TDFG AK + +++T + GT Y+ PE
Sbjct: 133 YLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV-PDRTFT---LCGTPEYLAPE 185
Query: 772 YARTSRLTEKSDVYSFGIVLLELLTG 797
++ + D ++ G++L E + G
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 5e-08
Identities = 49/155 (31%), Positives = 72/155 (46%), Gaps = 31/155 (20%)
Query: 718 SPRIIHRDVKSSNILLDKDFEAHLTDFGIAK--SLCVSKSYTSTYIMGTIGYIDPEYART 775
S +++HRD+KS+NI L L DFG +K S VS S++ GT Y+ PE
Sbjct: 187 SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFC-GTPYYLAPELWER 245
Query: 776 SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETV-----DP---E 827
R ++K+D++S G++L ELLT H + +M+ V DP
Sbjct: 246 KRYSKKADMWSLGVILYELLT-----------LHRPFKGPSQREIMQQVLYGKYDPFPCP 294
Query: 828 ISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
+S+ K L L L SK P RPT ++
Sbjct: 295 VSSGMKAL--------LDPLLSK-NPALRPTTQQL 320
|
Length = 478 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 5e-08
Identities = 39/136 (28%), Positives = 62/136 (45%), Gaps = 6/136 (4%)
Query: 662 YSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRI 721
+S S L NG ++ H ++ + D +R + A+ L L + +
Sbjct: 60 FSFQSPEKLYLVLAFINGG--ELFHHLQREGRFD-LSRARFY--TAELLCALENLHKFNV 114
Query: 722 IHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEK 781
I+RD+K NILLD L DFG+ K L + + GT Y+ PE T+
Sbjct: 115 IYRDLKPENILLDYQGHIALCDFGLCK-LNMKDDDKTNTFCGTPEYLAPELLLGHGYTKA 173
Query: 782 SDVYSFGIVLLELLTG 797
D ++ G++L E+LTG
Sbjct: 174 VDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 45/170 (26%), Positives = 74/170 (43%), Gaps = 23/170 (13%)
Query: 637 CLKEFETELETVGSIKHRNLVSLQGYSLSSSGN------LLFYDFMENGSLWDIL---HG 687
C+KEF+ H N++ L G L + + ++ FM++G L L
Sbjct: 53 CMKEFD----------HPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRL 102
Query: 688 PTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIA 747
+ L +K A G+ YL S IHRD+ + N +L+++ + DFG++
Sbjct: 103 GDCPQYLPTQMLVKFMTDIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLS 159
Query: 748 KSLCVSKSYTSTYIMGT-IGYIDPEYARTSRLTEKSDVYSFGIVLLELLT 796
K + Y I + +I E T KSDV+SFG+ + E+ T
Sbjct: 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 6e-08
Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 29/207 (14%)
Query: 606 IGYGASSTVYKCVLKNC-KPVAIKRLYSHYPQCLKEFETELETVGS-----------IKH 653
IG G VYK K + VA+K++ E+E E V S ++H
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKI---------RLESEEEGVPSTAIREISLLKELQH 58
Query: 654 RNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYL 713
N+V LQ + S L ++F+ L L K + +D + QG+ +
Sbjct: 59 PNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFC 117
Query: 714 HHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS-KSYTSTYIMGTIGYIDPEY 772
H S R++HRD+K N+L+D L DFG+A++ + + YT + T+ Y PE
Sbjct: 118 H---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV--TLWYRAPEV 172
Query: 773 ARTS-RLTEKSDVYSFGIVLLELLTGR 798
S R + D++S G + E+ T +
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 6e-08
Identities = 52/205 (25%), Positives = 93/205 (45%), Gaps = 35/205 (17%)
Query: 606 IGYGASSTVYKCVLKNCKP-VAIKRLYSHYPQCLKEFETELETVGS-----------IKH 653
IG G TV+K + VA+KR+ + + E V S +KH
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRV---------RLDDDDEGVPSSALREICLLKELKH 58
Query: 654 RNLVSLQGYSLSSSGNLLFYDFMENG--SLWDILHGPTKKKKLDWDTRLKIALGAAQGLA 711
+N+V L S L +++ + +D +G +D + +GLA
Sbjct: 59 KNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNG-----DIDPEIVKSFMFQLLKGLA 113
Query: 712 YLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS-KSYTSTYIMGTIGYIDP 770
+ H S ++HRD+K N+L++K+ E L DFG+A++ + + Y++ + T+ Y P
Sbjct: 114 FCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV--TLWYRPP 168
Query: 771 EYARTSRLTEKS-DVYSFGIVLLEL 794
+ ++L S D++S G + EL
Sbjct: 169 DVLFGAKLYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 6e-08
Identities = 45/175 (25%), Positives = 83/175 (47%), Gaps = 20/175 (11%)
Query: 638 LKEFETELETVGSI-KHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHG--------- 687
L + +E+E + I KH+N+++L G + ++ G+L + L
Sbjct: 61 LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYS 120
Query: 688 ----PTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTD 743
+++L + + A A+G+ YL S + IHRD+ + N+L+ +D + D
Sbjct: 121 FDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIAD 177
Query: 744 FGIAKSLCVSKSYTSTYIMG--TIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT 796
FG+A+ + Y T G + ++ PE T +SDV+SFG++L E+ T
Sbjct: 178 FGLARDVHNIDYYKKT-TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-08
Identities = 33/98 (33%), Positives = 51/98 (52%), Gaps = 4/98 (4%)
Query: 707 AQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIG 766
+ GL +LH II+RD+K N++LD + + DFG+ K V T T+ GT
Sbjct: 111 SVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFC-GTPD 166
Query: 767 YIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNE 804
YI PE + D +++G++L E+L G+ D E
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (133), Expect = 7e-08
Identities = 54/226 (23%), Positives = 90/226 (39%), Gaps = 60/226 (26%)
Query: 605 IIGYGASSTVYKCV-LKNCKPVAIKRLYSHYPQCLKEFET---------ELETVGSIKHR 654
IG GA V V + + VAIK++ F+ E++ + ++H
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIKKIS-------NVFDDLIDAKRILREIKLLRHLRHE 59
Query: 655 NLVSLQGYSLSSSGN-----LLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQ- 708
N++ L S + + ME L ++ + L T I Q
Sbjct: 60 NIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIK---SPQPL---TDDHIQYFLYQI 112
Query: 709 --GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS-------YTST 759
GL YLH S +IHRD+K SNIL++ + + + DFG+A+ + + Y T
Sbjct: 113 LRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVT 169
Query: 760 --Y-----IMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGR 798
Y ++ + Y T+ D++S G + ELLT +
Sbjct: 170 RWYRAPELLLSSSRY-----------TKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 8e-08
Identities = 42/162 (25%), Positives = 73/162 (45%), Gaps = 6/162 (3%)
Query: 643 TELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKI 702
TE + + +H L +L+ YS + L F ME + ++ ++++ D
Sbjct: 44 TENRVLQNSRHPFLTALK-YSFQTHDRLCF--VMEYANGGELFFHLSRERVFSEDRARFY 100
Query: 703 ALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIM 762
L YLH + +++RD+K N++LDKD +TDFG+ K + T
Sbjct: 101 GAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKE-GIKDGATMKTFC 157
Query: 763 GTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNE 804
GT Y+ PE + D + G+V+ E++ GR N+
Sbjct: 158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 8e-08
Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 33/215 (15%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLKNCKP---VAIKRLYSHYPQCLKEFET--ELETVGSIK 652
+NLS +G GA +V C + K VA+K+L + + T EL + +K
Sbjct: 20 QNLSP---VGSGAYGSV--CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 74
Query: 653 HRNLVSL-----QGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAA 707
H N++ L SL ++ + L +I+ K +KL D +
Sbjct: 75 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQFLIYQIL 130
Query: 708 QGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIG- 766
+GL Y+H S IIHRD+K SN+ +++D E + DFG+A+ +T + G +
Sbjct: 131 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVAT 180
Query: 767 --YIDPEYART-SRLTEKSDVYSFGIVLLELLTGR 798
Y PE + D++S G ++ ELLTGR
Sbjct: 181 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 9e-08
Identities = 52/180 (28%), Positives = 84/180 (46%), Gaps = 14/180 (7%)
Query: 622 CKPVAIKRLYSHYPQCLKEFETE-LETVGSIKHRNLVSLQGYSLSSSGNL-LFYDFMENG 679
CK + KRL + + E E LE V S +V+L Y+ S +L L M G
Sbjct: 23 CKKLDKKRLKKKSGEKMALLEKEILEKVNSP---FIVNL-AYAFESKTHLCLVMSLMNGG 78
Query: 680 SL-WDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFE 738
L + I + ++ L+ + + + G+ +LH S I++RD+K N+LLD
Sbjct: 79 DLKYHIYN--VGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGN 133
Query: 739 AHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGR 798
L+D G+A L K+ T GT GY+ PE + + D ++ G + E++ GR
Sbjct: 134 CRLSDLGLAVELKDGKTITQR--AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 9e-08
Identities = 44/176 (25%), Positives = 78/176 (44%), Gaps = 26/176 (14%)
Query: 640 EFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKK------ 693
+F E++ + +K N++ L G + + ++MENG L L K
Sbjct: 65 DFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGND 124
Query: 694 ----------LDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTD 743
+ + + L +AL A G+ YL S +HRD+ + N L+ ++ + D
Sbjct: 125 AVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIAD 181
Query: 744 FGIAKSLCVSKSYTSTYIMG----TIGYIDPEYARTSRLTEKSDVYSFGIVLLELL 795
FG++++L Y I G I ++ E + T SDV++FG+ L E+L
Sbjct: 182 FGMSRNLYAGDYYR---IQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 45/181 (24%), Positives = 81/181 (44%), Gaps = 46/181 (25%)
Query: 707 AQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIG 766
A+G+ +L S + IHRD+ + NILL ++ + DFG+A+ +
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDI---------------- 224
Query: 767 YIDPEYAR--TSRL---------------TEKSDVYSFGIVLLELLTGRKAVDNECNLHH 809
Y DP+Y R ++RL T +SDV+SFG++L E+ + + ++
Sbjct: 225 YKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE 284
Query: 810 LILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869
+ + M PE A +++++ L C + P +RPT + +LG L
Sbjct: 285 EFCQRLKDGTRMRA--PEN--------ATPEIYRIMLACWQGDPKERPTFSALVEILGDL 334
Query: 870 V 870
+
Sbjct: 335 L 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 1e-07
Identities = 51/195 (26%), Positives = 93/195 (47%), Gaps = 13/195 (6%)
Query: 608 YGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFET--ELETVGSIKHRNLVSLQG-YSL 664
YG+ + Y L+ + VA+K+L + + T EL + +KH N++ L ++
Sbjct: 28 YGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTP 85
Query: 665 SSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHR 724
++S ++ + L+ K +KL + + +GL Y+H S IIHR
Sbjct: 86 ATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIH---SAGIIHR 142
Query: 725 DVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYART-SRLTEKSD 783
D+K SN+ +++D E + DFG+A+ + + Y+ T Y PE + D
Sbjct: 143 DLKPSNVAVNEDCELRILDFGLARQ---ADDEMTGYV-ATRWYRAPEIMLNWMHYNQTVD 198
Query: 784 VYSFGIVLLELLTGR 798
++S G ++ ELL G+
Sbjct: 199 IWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 34/92 (36%), Positives = 52/92 (56%), Gaps = 6/92 (6%)
Query: 709 GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYI 768
GL Y+H S ++HRD+K SN+LL+ + + + DFG+A++ + + Y++ T Y
Sbjct: 120 GLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYR 175
Query: 769 DPE-YARTSRLTEKSDVYSFGIVLLELLTGRK 799
PE S T DV+S G + ELL GRK
Sbjct: 176 APELLLNCSEYTTAIDVWSVGCIFAELL-GRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 64/252 (25%), Positives = 113/252 (44%), Gaps = 40/252 (15%)
Query: 605 IIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETEL---ETVGSIKHRNLVSL-- 659
IIG G VY C+ ++Y+ +CL + ++ ET+ ++ R ++SL
Sbjct: 1 IIGRGGFGEVY-----GCRKADTGKMYAM--KCLDKKRIKMKQGETL-ALNERIMLSLVS 52
Query: 660 ---------QGYSLSSSGNLLF-YDFMENGSLWDIL--HGPTKKKKLDWDTRLKIALGAA 707
Y+ + L F D M G L L HG +K++ + A
Sbjct: 53 TGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-----YATEII 107
Query: 708 QGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGY 767
GL ++H+ +++RD+K +NILLD+ ++D G+A K + S +GT GY
Sbjct: 108 LGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGY 161
Query: 768 IDPEYARTSRLTEKS-DVYSFGIVLLELLTGRKAV-DNECNLHHLI--LSKTANNAVMET 823
+ PE + + S D +S G +L +LL G ++ H I ++ T N + ++
Sbjct: 162 MAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDS 221
Query: 824 VDPEISATCKDL 835
PE+ + + L
Sbjct: 222 FSPELKSLLEGL 233
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 28/90 (31%), Positives = 46/90 (51%), Gaps = 5/90 (5%)
Query: 709 GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYI 768
GL LH + ++RD+K NILLD ++D G+A + +S +GT+GY+
Sbjct: 114 GLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR--VGTVGYM 168
Query: 769 DPEYARTSRLTEKSDVYSFGIVLLELLTGR 798
PE R T D + G ++ E++ G+
Sbjct: 169 APEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 45/160 (28%), Positives = 84/160 (52%), Gaps = 16/160 (10%)
Query: 644 ELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIA 703
E+ + ++KH N+V+L + L ++++++ D+ L +KI
Sbjct: 53 EVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS----DLKQYLDNCGNLMSMHNVKIF 108
Query: 704 L-GAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV-SKSYTSTYI 761
+ +GL+Y H +I+HRD+K N+L+++ E L DFG+A++ V +K+Y++ +
Sbjct: 109 MFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV 165
Query: 762 MGTIGYIDPEYARTSRLTEKS---DVYSFGIVLLELLTGR 798
T+ Y P+ S TE S D++ G +L E+ TGR
Sbjct: 166 --TLWYRPPDVLLGS--TEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 32/96 (33%), Positives = 51/96 (53%), Gaps = 8/96 (8%)
Query: 706 AAQ---GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIM 762
AA+ GL LH RI++RD+K NILLD ++D G+A + + T +
Sbjct: 108 AAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVE--IPEGETIRGRV 162
Query: 763 GTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGR 798
GT+GY+ PE + R T D + G ++ E++ G+
Sbjct: 163 GTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 50/163 (30%), Positives = 66/163 (40%), Gaps = 34/163 (20%)
Query: 655 NLVSLQGYSLSSSGNLLFYDFMENGSLWD----ILHGPTKKKKLDWDTRLKIALGAAQGL 710
N+V L Y +S L E G LW L+ P + K W + +AL A
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVK-RWAAEMVVALDA---- 100
Query: 711 AYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFG----IAKSLC---VSKSYTSTYIMG 763
LH + I+ RD+ +NILLD LT F + S V Y +
Sbjct: 101 --LHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCA----- 150
Query: 764 TIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECN 806
PE S TE D +S G +L ELLTG+ V EC+
Sbjct: 151 ------PEVGGISEETEACDWWSLGAILFELLTGKTLV--ECH 185
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 39/154 (25%), Positives = 68/154 (44%), Gaps = 18/154 (11%)
Query: 709 GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYI 768
GL ++H+ +++RD+K +NILLD+ ++D G+A K + S +GT GY+
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYM 162
Query: 769 DPE-YARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPE 827
PE + +D +S G +L +LL G H K + + T+ E
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR-----QHKTKDKHEIDRMTLTMAVE 217
Query: 828 I----SATCKDL--GAVKKVFQLALLCSKRQPTD 855
+ S + L G +++ L C R +
Sbjct: 218 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQE 251
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-07
Identities = 48/181 (26%), Positives = 83/181 (45%), Gaps = 17/181 (9%)
Query: 624 PVAIKRLYSHYPQCL--KEFETELETVGSIKHRNLVSLQGY-----SLSSSGNLLFYDFM 676
VA+K+L + K EL + + H+N++SL SL ++ +
Sbjct: 48 NVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMEL 107
Query: 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKD 736
+ +L ++H +LD + + G+ +LH S IIHRD+K SNI++ D
Sbjct: 108 MDANLCQVIH-----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSD 159
Query: 737 FEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT 796
+ DFG+A++ C ++ T + T Y PE E D++S G ++ EL+
Sbjct: 160 CTLKILDFGLARTACT--NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVK 217
Query: 797 G 797
G
Sbjct: 218 G 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 54/208 (25%), Positives = 89/208 (42%), Gaps = 26/208 (12%)
Query: 605 IIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFET-----ELETVGSIKHRNLVSL 659
+IG GA V LKN V ++ + + + LK ET E + + + ++ + +L
Sbjct: 8 VIGRGAFGEVAVVKLKNADKVFAMKILNKW-EMLKRAETACFREERDVLVNGDNQWITTL 66
Query: 660 QGYSLSSSGNL-LFYDFMENGSLWDILHGPTKKKKLD----WDTRLKIALGAAQGLAYLH 714
Y+ NL L D+ G L +L + D + + IA+ + L Y
Sbjct: 67 H-YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY-- 123
Query: 715 HDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYAR 774
+HRD+K NIL+D + L DFG L + S+ +GT YI PE +
Sbjct: 124 -------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 176
Query: 775 T-----SRLTEKSDVYSFGIVLLELLTG 797
+ + D +S G+ + E+L G
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 2e-07
Identities = 60/230 (26%), Positives = 90/230 (39%), Gaps = 76/230 (33%)
Query: 605 IIGYGASSTVYKCV-LKNCKPVAIKRLYSHYPQC--------LKEFETELETVGSIKHRN 655
IG GA TVYK L + VA+K++ P L+E L+ + S +H N
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALKKV--RVPLSEEGIPLSTLREIAL-LKQLESFEHPN 62
Query: 656 LVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKL---------DWDTRLKIA--- 703
+V L D+ HGP ++L D D ++
Sbjct: 63 IVRL----------------------LDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCP 100
Query: 704 ---LGAAQ----------GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSL 750
L G+ +LH S RI+HRD+K NIL+ D + + DFG+A+
Sbjct: 101 KPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIY 157
Query: 751 CVSKSYTSTYIMGTIGYIDPE------YARTSRLTEKSDVYSFGIVLLEL 794
+ TS ++ T+ Y PE YA D++S G + EL
Sbjct: 158 SFEMALTS--VVVTLWYRAPEVLLQSSYATP------VDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-07
Identities = 62/245 (25%), Positives = 93/245 (37%), Gaps = 57/245 (23%)
Query: 596 MTENLSEKYI-----IGYGASSTVYKCV-LKNCKPVAIKRL-YSHYP-----------QC 637
M+ ++SE+YI +G G V K K VAIK++ C
Sbjct: 2 MSFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMC 61
Query: 638 LKEFET--ELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLD 695
F T EL+ + IKH N++ L + L D M L KK +D
Sbjct: 62 GIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDL---------KKVVD 111
Query: 696 WDTRLK------IALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKS 749
RL I L GL LH +HRD+ +NI ++ + DFG+A+
Sbjct: 112 RKIRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARR 168
Query: 750 ---------------LCVSKSYTSTYIMGTIGYIDPEYARTS-RLTEKSDVYSFGIVLLE 793
+ + TS + T+ Y PE + + D++S G + E
Sbjct: 169 YGYPPYSDTLSKDETMQRREEMTSKVV--TLWYRAPELLMGAEKYHFAVDMWSVGCIFAE 226
Query: 794 LLTGR 798
LLTG+
Sbjct: 227 LLTGK 231
|
Length = 335 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 2e-07
Identities = 48/164 (29%), Positives = 78/164 (47%), Gaps = 22/164 (13%)
Query: 644 ELETVGSIKHRNLVSL----QGYSLSSSGNLLFYDFMEN--GSLWDILHGPTKKKKLDWD 697
E+ + +++H N+V L G L S L ++ E SL D + P +
Sbjct: 56 EITLLLNLRHPNIVELKEVVVGKHLDSI--FLVMEYCEQDLASLLDNMPTPFS------E 107
Query: 698 TRLK-IALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSL-CVSKS 755
+++K + L +GL YLH + IIHRD+K SN+LL + DFG+A++ +K
Sbjct: 108 SQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP 164
Query: 756 YTSTYIMGTIGYIDPEYARTSRL-TEKSDVYSFGIVLLELLTGR 798
T + T+ Y PE T D+++ G +L ELL +
Sbjct: 165 MTPKVV--TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 2e-07
Identities = 30/89 (33%), Positives = 48/89 (53%), Gaps = 4/89 (4%)
Query: 709 GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYI 768
GL YLH + +I++RD+K N+LLD + + DFG+ K TST+ GT ++
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFC-GTPEFL 168
Query: 769 DPEYARTSRLTEKSDVYSFGIVLLELLTG 797
PE + T D + G+++ E+L G
Sbjct: 169 APEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 2e-07
Identities = 34/97 (35%), Positives = 53/97 (54%), Gaps = 8/97 (8%)
Query: 709 GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMG---TI 765
GL Y+H S ++HRD+K N+L++ D E + DFG+A+ + + ++ T
Sbjct: 117 GLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173
Query: 766 GYIDPEYARTSRLTEKS-DVYSFGIVLLELLTGRKAV 801
Y PE + + K+ DV+S G +L ELL GRK V
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 2e-07
Identities = 27/77 (35%), Positives = 41/77 (53%), Gaps = 4/77 (5%)
Query: 721 IIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTE 780
IHRD+K N L+D LTDFG++K + V+ + + ++G+ Y+ PE R
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSKGI-VTYANS---VVGSPDYMAPEVLRGKGYDF 177
Query: 781 KSDVYSFGIVLLELLTG 797
D +S G +L E L G
Sbjct: 178 TVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 58/211 (27%), Positives = 92/211 (43%), Gaps = 37/211 (17%)
Query: 606 IGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRN---------- 655
IG G VY+ V K +R+Y+ KE + E +I RN
Sbjct: 1 IGKGTFGQVYQ-VRKK----DTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDES 55
Query: 656 --LVSLQGYSLSSSGNLLFY-DFMENGSL-WDILHG---PTKKKKLDWDTRLKIALGAAQ 708
+V L+ +S + +L D+M G L W + + K + L +AL
Sbjct: 56 PFIVGLK-FSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKF-YIAELVLAL---- 109
Query: 709 GLAYLH-HDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGY 767
+LH +D I++RD+K NILLD L DFG++K+ T+T+ GT Y
Sbjct: 110 --EHLHKYD----IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC-GTTEY 162
Query: 768 IDPEYARTSR-LTEKSDVYSFGIVLLELLTG 797
+ PE + T+ D +S G+++ E+ G
Sbjct: 163 LAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 57/210 (27%), Positives = 93/210 (44%), Gaps = 11/210 (5%)
Query: 605 IIGYGASSTVYKCVLKNCKP-VAIKRLY-SHYPQCLKEFE-TELETVGSIKHRNLVSLQG 661
++G GA V KC K K VAIK+ S + +KE EL+ + ++K N+V L+
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELK- 66
Query: 662 YSLSSSGNL-LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPR 720
+ G L L ++++E L + P K+ Q + +H
Sbjct: 67 EAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPE------KVRSYIYQLIKAIHWCHKND 120
Query: 721 IIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTE 780
I+HRD+K N+L+ + L DFG A++L + T + T Y PE + +
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGK 180
Query: 781 KSDVYSFGIVLLELLTGRKAVDNECNLHHL 810
D++S G +L EL G+ E + L
Sbjct: 181 AVDMWSVGCILGELSDGQPLFPGESEIDQL 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-07
Identities = 51/218 (23%), Positives = 94/218 (43%), Gaps = 33/218 (15%)
Query: 658 SLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDC 717
S +G + S NLL D E + D+L A+G+ +L
Sbjct: 213 SYKGSNDSEVKNLLSDDGSEGLTTLDLL---------------SFTYQVARGMEFL---A 254
Query: 718 SPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYT---STYIMGTIGYIDPEYAR 774
S +HRD+ + N+LL + + DFG+A+ + +Y ST++ + ++ PE
Sbjct: 255 SKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL--PVKWMAPESIF 312
Query: 775 TSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKD 834
+ T SDV+S+GI+L E+ + + +K + M D
Sbjct: 313 DNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPD--------- 363
Query: 835 LGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPA 872
A ++V+ + + C +P RP+ +S ++ SL+P+
Sbjct: 364 -HATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLPS 400
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 53/201 (26%), Positives = 93/201 (46%), Gaps = 13/201 (6%)
Query: 606 IGYGASSTVYKCVLKNCKP---VAIKRLYSHYPQCLK-EFETELETVGSIKHRNLVSLQG 661
+G G V K V K K VAIK L + + ++ E E E + + + +V + G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 662 YSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRI 721
+ + +L + G L L G KK ++ +++ + G+ YL
Sbjct: 63 VCEAEA-LMLVMEMASGGPLNKFLSG--KKDEITVSNVVELMHQVSMGMKYLE---GKNF 116
Query: 722 IHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGT--IGYIDPEYARTSRLT 779
+HRD+ + N+LL A ++DFG++K+L SY G + + PE + +
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176
Query: 780 EKSDVYSFGIVLLELLT-GRK 799
+SDV+S+GI + E + G+K
Sbjct: 177 SRSDVWSYGITMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 3e-07
Identities = 38/120 (31%), Positives = 53/120 (44%), Gaps = 8/120 (6%)
Query: 722 IHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLT-- 779
IHRDVK N+LLDK L DFG + + +GT YI PE ++
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGY 223
Query: 780 --EKSDVYSFGIVLLELLTGRKA--VDNECNLHHLILSKTANNAVMETVDPEISATCKDL 835
+ D +S G+ L E+L G D+ + I+ N++ D EIS KDL
Sbjct: 224 YGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDH--KNSLTFPDDIEISKQAKDL 281
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 3e-07
Identities = 66/280 (23%), Positives = 103/280 (36%), Gaps = 37/280 (13%)
Query: 239 TLSLQGNQL-TGKIPSVIGLMQALAVLDLSCNMLSGP----IPPILGNLSYTEKLYLHSN 293
LSL+G L T + ++ + L VL L N L + L ++L L N
Sbjct: 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLN 61
Query: 294 KLTG-----HIPPE-LGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVA--NNHLEG 345
+ + L L L+L+DN L L L L NN+ G
Sbjct: 62 ETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLG 121
Query: 346 PIPDNLSSCT------NLNSLNVHGNKLNGT----IPPAFQRLESMTYLNLSLNNIRGP- 394
L + L L + N+L G + A + + LNL+ N I
Sbjct: 122 DRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAG 181
Query: 395 ---IPVELSRIGNLDTLDMSNNKI----SGSIPSPLGDLEHLLKLNLSRNQLTG-----F 442
+ L NL+ LD++NN + + ++ L L+ L LNL N LT
Sbjct: 182 IRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAAL 241
Query: 443 IPGEFGNLRSVMEIDLSHNHLTGVIPEELSQ-LQNMFSLR 481
S++ + LS N +T ++L++ L SL
Sbjct: 242 ASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLL 281
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 45/178 (25%), Positives = 79/178 (44%), Gaps = 39/178 (21%)
Query: 637 CLKEFETELETVGSIKHRNLVSLQGYSLSSSGN------LLFYDFMENGSLWDILHGPTK 690
C+KEF+ H N++ L G SL S ++ FM++G L L
Sbjct: 54 CMKEFD----------HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRI 103
Query: 691 KKK---LDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIA 747
++ L T ++ + A G+ YL S IHRD+ + N +L+++ + DFG++
Sbjct: 104 GEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLS 160
Query: 748 KSL---------CVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT 796
K + C SK + ++ E + T SDV++FG+ + E++T
Sbjct: 161 KKIYSGDYYRQGCASKL--------PVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 16/204 (7%)
Query: 606 IGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIK-HRNLVSLQGYSL 664
IG G V+K + K A ++ +E E E + ++ H N+V G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYY 85
Query: 665 SS---SGNLLFY--DFMENGSLWDILHGPTKK-KKLDWDTRLKIALGAAQGLAYLHHDCS 718
+G+ L+ + GS+ D++ G K+ ++++ I A GL +LH +
Sbjct: 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN-- 143
Query: 719 PRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYART--- 775
+ IHRDVK +NILL + L DFG++ L ++ +T + GT ++ PE
Sbjct: 144 -KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIACEQQ 201
Query: 776 --SRLTEKSDVYSFGIVLLELLTG 797
S + DV+S GI +EL G
Sbjct: 202 LDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 5e-07
Identities = 35/94 (37%), Positives = 54/94 (57%), Gaps = 11/94 (11%)
Query: 709 GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV-SKSYTSTYIMGTIGY 767
GLAY H R++HRD+K N+L+ + E L DFG+A++ V SK+Y++ + T+ Y
Sbjct: 115 GLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV--TLWY 169
Query: 768 IDPEYARTSRLTEKS---DVYSFGIVLLELLTGR 798
P+ S TE S D++ G + E+ TGR
Sbjct: 170 RPPDVLLGS--TEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 5e-07
Identities = 30/86 (34%), Positives = 48/86 (55%), Gaps = 5/86 (5%)
Query: 709 GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYI 768
G+ Y+H RI+HRD+K+ NI L + + DFG+++ L S +T+ GT Y+
Sbjct: 118 GVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTF-TGTPYYM 172
Query: 769 DPEYARTSRLTEKSDVYSFGIVLLEL 794
PE + KSD++S G +L E+
Sbjct: 173 SPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 56/246 (22%), Positives = 97/246 (39%), Gaps = 44/246 (17%)
Query: 640 EFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDIL-------HGPTKKK 692
EF E + ++V L G L+ + M +G L L +
Sbjct: 55 EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 114
Query: 693 KLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV 752
+++A A G+AYL+ + + +HRD+ + N ++ DF + DFG+ + +
Sbjct: 115 PPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI-- 169
Query: 753 SKSYTSTYIMGTIG-----YIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNL 807
T Y G G ++ PE + T SD++SFG+VL E+ + L
Sbjct: 170 --YETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS----------L 217
Query: 808 HHLILSKTANNAVMETV-------DPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMH 860
+N V++ V P+ C + +V L +C + P RPT
Sbjct: 218 AEQPYQGLSNEQVLKFVMDGGYLDQPD---NCPE-----RVTDLMRMCWQFNPKMRPTFL 269
Query: 861 EVSRVL 866
E+ +L
Sbjct: 270 EIVNLL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 6e-07
Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 606 IGYGASSTVYKCV-LKNCKPVAIKRL---YSHYPQCLKEFETELETVGSIKHRNLVSLQG 661
IGYGA V+ ++ K VA+K++ + + C + F EL+ + KH N++S
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFR-ELKMLCFFKHDNVLSA-- 64
Query: 662 YSLSSSGNLLFYDFMENGSLWDILHGPTKK-----KKLDWDTRLKIAL-GAAQGLAYLHH 715
+ ++ F E + +++ K + L D +K+ L +GL YLH
Sbjct: 65 LDILQPPHIDP--FEEIYVVTELMQSDLHKIIVSPQPLSSD-HVKVFLYQILRGLKYLH- 120
Query: 716 DCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYART 775
S I+HRD+K N+L++ + + DFG+A+ +S T + T Y PE
Sbjct: 121 --SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMG 178
Query: 776 SR-LTEKSDVYSFGIVLLELLTGR 798
SR T D++S G + ELL R
Sbjct: 179 SRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 8e-07
Identities = 46/174 (26%), Positives = 77/174 (44%), Gaps = 32/174 (18%)
Query: 708 QGLAYLHHDCSPRIIHRDVKSSNILLDKDFEA-HLTDFGIAKSLCVS-KSYTSTYIMGTI 765
+G+AY H S R++HRD+K N+L+D+ A L DFG+A++ + +++T + T+
Sbjct: 113 RGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV--TL 167
Query: 766 GYIDPEYARTSR-LTEKSDVYSFGIVLLELLTGRKAV--DNECNLHHLILSKTANNAVME 822
Y PE SR + D++S G + E++ + D+E + I ++
Sbjct: 168 WYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFR------ILG 221
Query: 823 TVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAPEPQ 876
T + E L K F K P D L ++VP EP
Sbjct: 222 TPNEETWPGVTSLPDYKSAF------PKWPPKD----------LATVVPTLEPA 259
|
Length = 294 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 8e-07
Identities = 32/97 (32%), Positives = 56/97 (57%), Gaps = 11/97 (11%)
Query: 708 QGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV-SKSYTSTYIMGTIG 766
+GLAY+H I+HRD+K N+L+ E L DFG+A++ + S++Y+S + T+
Sbjct: 114 RGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLW 168
Query: 767 YIDPEYARTSRLTEKS---DVYSFGIVLLELLTGRKA 800
Y P+ + T+ S D++ G + +E+L G+ A
Sbjct: 169 YRPPDVLLGA--TDYSSALDIWGAGCIFIEMLQGQPA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 8e-07
Identities = 51/195 (26%), Positives = 89/195 (45%), Gaps = 14/195 (7%)
Query: 606 IGYGASSTVYKCVL---KNCKPVAIKRLY--SHYPQCLKEFETELETVGSIKHRNLVSLQ 660
+G G TV K + K+ K VA+K L ++ P E E + + + +V +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 661 GYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPR 720
G + S +L + E G L L K K + ++ + G+ YL
Sbjct: 63 GICEAESW-MLVMELAELGPLNKFLQ---KNKHVTEKNITELVHQVSMGMKYLEET---N 115
Query: 721 IIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGT--IGYIDPEYARTSRL 778
+HRD+ + N+LL A ++DFG++K+L ++Y G + + PE +
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKF 175
Query: 779 TEKSDVYSFGIVLLE 793
+ KSDV+SFG+++ E
Sbjct: 176 SSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 9e-07
Identities = 61/221 (27%), Positives = 93/221 (42%), Gaps = 21/221 (9%)
Query: 593 IMRMTENLSEKYIIGYGASSTV---YKCVLKNCKPVAIKRLYSHYPQCL--KEFETELET 647
+++ +NL IG GA V Y VL + VAIK+L + K EL
Sbjct: 15 VLKRYQNLKP---IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYRELVL 69
Query: 648 VGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAA 707
+ + H+N++SL F D L D + +LD + +
Sbjct: 70 MKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQML 129
Query: 708 QGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGY 767
G+ +LH S IIHRD+K SNI++ D + DFG+A++ S+ T + T Y
Sbjct: 130 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYY 184
Query: 768 IDPEYARTSRLTEKSDVYSFGIVLLE------LLTGRKAVD 802
PE E D++S G ++ E L GR +D
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 39/182 (21%), Positives = 76/182 (41%), Gaps = 23/182 (12%)
Query: 708 QGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGY 767
+GL +LH S R++HRD+K NIL+ + L DFG+A+ + TS + T+ Y
Sbjct: 121 RGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWY 175
Query: 768 IDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVD-P 826
PE S D++S G + E+ + ++ L +++ + P
Sbjct: 176 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL-------GKILDVIGLP 228
Query: 827 EISATCKDLGAVKKVFQLALLCSKR--QPTDR--PTMHEVSRVLGSLVPAPEPQKQPTSI 882
+D+ ++ F + QP ++ + E+ + L P K+ ++
Sbjct: 229 GEEDWPRDVALPRQAF------HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAY 282
Query: 883 PS 884
+
Sbjct: 283 SA 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 28/83 (33%), Positives = 40/83 (48%), Gaps = 5/83 (6%)
Query: 720 RIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYAR----- 774
+HRD+K N+LLDK+ L DFG L + S +GT YI PE +
Sbjct: 122 GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDG 181
Query: 775 TSRLTEKSDVYSFGIVLLELLTG 797
R + D +S G+ + E+L G
Sbjct: 182 KGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 62/263 (23%), Positives = 108/263 (41%), Gaps = 45/263 (17%)
Query: 623 KPVAIKRLYSHYPQCLKE-FETELETVGSIKHRNLVSLQG-----------YSLSSSGNL 670
+ VAIK L L+E F+ E ++H N+V L G +S S +L
Sbjct: 36 QAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDL 95
Query: 671 LFYDFMEN-----GSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYL--HHDCSPRIIH 723
+ M + GS D T K L+ + I A G+ +L HH ++H
Sbjct: 96 HEFLVMRSPHSDVGSTDD---DKTVKSTLEPADFVHIVTQIAAGMEFLSSHH-----VVH 147
Query: 724 RDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGT----IGYIDPEYARTSRLT 779
+D+ + N+L+ ++D G+ + + + Y +MG I ++ PE + +
Sbjct: 148 KDLATRNVLVFDKLNVKISDLGLFREVYAADYYK---LMGNSLLPIRWMSPEAIMYGKFS 204
Query: 780 EKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVK 839
SD++S+G+VL E+ + + C +N V+E + C D
Sbjct: 205 IDSDIWSYGVVLWEVFS--YGLQPYCGY--------SNQDVIEMIRNRQVLPCPD-DCPA 253
Query: 840 KVFQLALLCSKRQPTDRPTMHEV 862
V+ L L C P+ RP ++
Sbjct: 254 WVYTLMLECWNEFPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 48/196 (24%), Positives = 90/196 (45%), Gaps = 25/196 (12%)
Query: 620 KNCKPVAIKRLYSHYPQC-LKEFETELETVGSI-KHRNLVSLQGYSLSSSGNLLFYDFME 677
K VA+K L + L + +E+E + I KH+N+++L G + ++
Sbjct: 45 KEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS 104
Query: 678 NGSL---------------WDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRII 722
G+L +DI P +++ + + A+G+ YL S + I
Sbjct: 105 KGNLREYLRARRPPGMEYSYDIARVP--DEQMTFKDLVSCTYQVARGMEYL---ASQKCI 159
Query: 723 HRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMG--TIGYIDPEYARTSRLTE 780
HRD+ + N+L+ ++ + DFG+A+ + Y T G + ++ PE T
Sbjct: 160 HRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT-TNGRLPVKWMAPEALFDRVYTH 218
Query: 781 KSDVYSFGIVLLELLT 796
+SDV+SFG+++ E+ T
Sbjct: 219 QSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 29/83 (34%), Positives = 41/83 (49%), Gaps = 6/83 (7%)
Query: 722 IHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEK 781
+HRD+K N+L+D+ L DFG A L +K S +GT YI PE T K
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGK 183
Query: 782 S------DVYSFGIVLLELLTGR 798
D +S G++ E++ GR
Sbjct: 184 GTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 56/191 (29%), Positives = 91/191 (47%), Gaps = 40/191 (20%)
Query: 605 IIGYGASSTVYKCVLKNCKP-VAIKRLYSHYPQCLKEFET---------ELETVGSIKHR 654
IG G V+K K K VA+K++ L E E E++ + +KH
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKV-------LMENEKEGFPITALREIKILQLLKHE 71
Query: 655 NLVSLQG--YSLSSSGN------LLFYDFMENGSLWDILHGPTKKKKL-DWDTRLKIALG 705
N+V+L + ++ N L ++F E+ L +L K L + +K+ L
Sbjct: 72 NVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLL- 129
Query: 706 AAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS-----YTSTY 760
GL Y+H +I+HRD+K++NIL+ KD L DFG+A++ +SK+ YT+
Sbjct: 130 --NGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRV 184
Query: 761 IMGTIGYIDPE 771
+ T+ Y PE
Sbjct: 185 V--TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 40/189 (21%), Positives = 84/189 (44%), Gaps = 21/189 (11%)
Query: 621 NCKPVAIKRLYSHYPQC-LKEFETELETVGSIKHRNLVSLQGYSLSSSGN-LLFYDFMEN 678
+ V +K + H + + E + + H+N++ + + + Y +M
Sbjct: 34 KEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNW 93
Query: 679 GSLWDIL----HGP-TKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILL 733
G+L L G + L + +A+ A G++YLH +IH+D+ + N ++
Sbjct: 94 GNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVI 150
Query: 734 DKDFEAHLTDFGIAKSLCVSKSYTSTY-IMGT-----IGYIDPEYARTSRLTEKSDVYSF 787
D++ + +TD +++ L + Y +G + ++ E + SDV+SF
Sbjct: 151 DEELQVKITDNALSRDL-----FPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSF 205
Query: 788 GIVLLELLT 796
G++L EL+T
Sbjct: 206 GVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 2e-06
Identities = 31/106 (29%), Positives = 44/106 (41%), Gaps = 32/106 (30%)
Query: 722 IHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTY--------------------- 760
IHRD+K NIL+D D L DFG+ K + +K+ Y
Sbjct: 123 IHRDIKPDNILIDADGHIKLADFGLCKKM--NKAKDREYYLNDSHNLLFRDNVLVRRRDH 180
Query: 761 ---------IMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTG 797
+GT YI PE R + + D +S G++L E+L G
Sbjct: 181 KQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 28/90 (31%), Positives = 47/90 (52%), Gaps = 5/90 (5%)
Query: 709 GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYI 768
GL L + RI++RD+K NILLD ++D G+A + + T +GT+GY+
Sbjct: 114 GLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQ--IPEGETVRGRVGTVGYM 168
Query: 769 DPEYARTSRLTEKSDVYSFGIVLLELLTGR 798
PE + T D + G ++ E++ G+
Sbjct: 169 APEVINNEKYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 52/229 (22%), Positives = 89/229 (38%), Gaps = 36/229 (15%)
Query: 605 IIGYGASSTVYKCVLKNC-KPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYS 663
IG G VYK KN K VA+K+ E + E + R + LQ S
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRL---------EMDEEGIPPTALREISLLQMLS 58
Query: 664 LS--------------SSGNLLFY---DFMENG-SLWDILHGPTKKKKLDWDTRLKIALG 705
S +G Y +++++ + +G + L T
Sbjct: 59 ESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 706 AAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEA-HLTDFGIAKSLCVS-KSYTSTYIMG 763
+G+A+ H ++HRD+K N+L+DK + D G+ ++ + KSYT +
Sbjct: 119 LLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-- 173
Query: 764 TIGYIDPEYARTSR-LTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLI 811
T+ Y PE S + D++S G + E+ + + L L+
Sbjct: 174 TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLL 222
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 56/211 (26%), Positives = 91/211 (43%), Gaps = 15/211 (7%)
Query: 593 IMRMTENLSEKYIIGYGASSTV---YKCVLKNCKPVAIKRLYSHYPQCL--KEFETELET 647
+++ +NL IG GA V Y +L+ + VAIK+L + K EL
Sbjct: 22 VLKRYQNLKP---IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 648 VGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAA 707
+ + H+N++ L F D L D + +LD + +
Sbjct: 77 MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQML 136
Query: 708 QGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGY 767
G+ +LH S IIHRD+K SNI++ D + DFG+A++ S+ T + T Y
Sbjct: 137 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYY 191
Query: 768 IDPEYARTSRLTEKSDVYSFGIVLLELLTGR 798
PE E D++S G ++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 2e-06
Identities = 18/43 (41%), Positives = 21/43 (48%), Gaps = 2/43 (4%)
Query: 23 DSEDGATLLKIKKSF-RDVDNVLYDWTDSPSSDYCVWRGITCD 64
++D LL K S D L W S SSD C W G+TCD
Sbjct: 1 LNDDRDALLAFKSSLNGDPSGALSSWNPS-SSDPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 35/94 (37%), Positives = 48/94 (51%), Gaps = 8/94 (8%)
Query: 708 QGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV--SKSYTSTYIMGTI 765
+GL Y H +HRD+K SNILL+ + L DFG+A+ S+ YT+ I T+
Sbjct: 127 EGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI--TL 181
Query: 766 GYIDPEYAR-TSRLTEKSDVYSFGIVLLELLTGR 798
Y PE R DV+S G +L EL T +
Sbjct: 182 WYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 29/93 (31%), Positives = 56/93 (60%), Gaps = 7/93 (7%)
Query: 708 QGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV-SKSYTSTYIMGTIG 766
+GLAY H +++HRD+K N+L+++ E L DFG+A++ V +K+Y++ + T+
Sbjct: 115 RGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLW 169
Query: 767 YIDPEYAR-TSRLTEKSDVYSFGIVLLELLTGR 798
Y P+ +S + + D++ G + E+ +GR
Sbjct: 170 YRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-06
Identities = 52/163 (31%), Positives = 85/163 (52%), Gaps = 8/163 (4%)
Query: 347 IPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLD 406
+P +LS +L+ L+ + L + L+L+LN +R I EL + NL
Sbjct: 62 LPSSLSRLLSLDLLS-PSGISSLDGSENLLNLLPLPSLDLNLNRLRSNIS-ELLELTNLT 119
Query: 407 TLDMSNNKISGSIPSPLGDL-EHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTG 465
+LD+ NN I+ IP +G L +L +L+LS N++ +P NL ++ +DLS N L+
Sbjct: 120 SLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS- 176
Query: 466 VIPEELSQLQNMFSLRLDYNNLSGDVMSLIN-CLSLSVLFIGN 507
+P+ LS L N+ +L L N +S D+ I +L L + N
Sbjct: 177 DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSN 218
|
Length = 394 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 33/109 (30%), Positives = 48/109 (44%), Gaps = 11/109 (10%)
Query: 709 GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYI 768
GL +LH +C I+HRD+K NIL+ + L DFG+A+ + T + T+ Y
Sbjct: 120 GLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV--TLWYR 174
Query: 769 DPEYARTSRLTEKSDVYSFGIVLLE------LLTGRKAVDNECNLHHLI 811
PE S D++S G + E L G D + LI
Sbjct: 175 APEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLI 223
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 4e-06
Identities = 23/59 (38%), Positives = 28/59 (47%)
Query: 94 LQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQL 152
L+S+DL NRL+ +LK LDLS N L P + S L L L L N L
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 5e-06
Identities = 21/60 (35%), Positives = 34/60 (56%)
Query: 356 NLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKI 415
NL SL++ N+L AF+ L ++ L+LS NN+ P S + +L +LD+S N +
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 5e-06
Identities = 32/107 (29%), Positives = 55/107 (51%), Gaps = 10/107 (9%)
Query: 694 LDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753
LD + L + A+G+++L S IHRD+ + NILL + DFG+A+ +
Sbjct: 211 LDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267
Query: 754 KSYTSTYIMGT----IGYIDPEYARTSRLTEKSDVYSFGIVLLELLT 796
+Y + G + ++ PE T +SDV+S+GI+L E+ +
Sbjct: 268 SNYV---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 5e-06
Identities = 67/269 (24%), Positives = 106/269 (39%), Gaps = 32/269 (11%)
Query: 587 LHVYEDIMRMTENL---SEKY----IIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLK 639
L+ YE I+R L +E Y +IG GA V K+ + V +L S + +
Sbjct: 25 LNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKR 84
Query: 640 E----FETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHG---PTKKK 692
F E + + +V L + ++M G L +++ P K
Sbjct: 85 SDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWA 144
Query: 693 KLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV 752
K + + +AL A + +IHRDVK N+LLDK L DFG +
Sbjct: 145 KF-YTAEVVLALDAIHSMG---------LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194
Query: 753 SKSYTSTYIMGTIGYIDPEYARTS----RLTEKSDVYSFGIVLLELLTGRKA--VDNECN 806
+ +GT YI PE ++ + D +S G+ L E+L G D+
Sbjct: 195 TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG 254
Query: 807 LHHLILSKTANNAVMETVDPEISATCKDL 835
+ I+ N++ D EIS K+L
Sbjct: 255 TYSKIMDH--KNSLNFPEDVEISKHAKNL 281
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 9e-06
Identities = 27/93 (29%), Positives = 55/93 (59%), Gaps = 7/93 (7%)
Query: 708 QGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV-SKSYTSTYIMGTIG 766
+GL Y H +++HRD+K N+L+++ E L DFG+A++ + +K+Y++ + T+
Sbjct: 115 RGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLW 169
Query: 767 YIDPE-YARTSRLTEKSDVYSFGIVLLELLTGR 798
Y P+ ++ + + D++ G + E+ TGR
Sbjct: 170 YRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 1e-05
Identities = 49/188 (26%), Positives = 91/188 (48%), Gaps = 30/188 (15%)
Query: 625 VAIKRLYSH-----YP-QCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLF--YDFM 676
VA+K+L +P L+E L ++H N+V+++ + S+ + ++ +++
Sbjct: 33 VALKKLKMEKEKEGFPITSLREINILL----KLQHPNIVTVKEVVVGSNLDKIYMVMEYV 88
Query: 677 ENG--SLWDILHGP--TKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNIL 732
E+ SL + + P + K + L G+A+LH + I+HRD+K+SN+L
Sbjct: 89 EHDLKSLMETMKQPFLQSEVK----CLMLQLL---SGVAHLHDN---WILHRDLKTSNLL 138
Query: 733 LDKDFEAHLTDFGIAKSL-CVSKSYTSTYIMGTIGYIDPE-YARTSRLTEKSDVYSFGIV 790
L+ + DFG+A+ K YT ++ T+ Y PE + D++S G +
Sbjct: 139 LNNRGILKICDFGLAREYGSPLKPYTQ--LVVTLWYRAPELLLGAKEYSTAIDMWSVGCI 196
Query: 791 LLELLTGR 798
ELLT +
Sbjct: 197 FAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 1e-05
Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 13/98 (13%)
Query: 708 QGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYI-----M 762
+ L Y+H + + HRD+K NIL + D + + DFG+A+ V+ + T T I +
Sbjct: 114 RALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLAR---VAFNDTPTAIFWTDYV 167
Query: 763 GTIGYIDPEYART--SRLTEKSDVYSFGIVLLELLTGR 798
T Y PE + S+ T D++S G + E+LTG+
Sbjct: 168 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 25/83 (30%), Positives = 40/83 (48%), Gaps = 5/83 (6%)
Query: 720 RIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYART---- 775
+HRD+K N+LLD + L DFG + + S+ +GT YI PE +
Sbjct: 122 HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDG 181
Query: 776 -SRLTEKSDVYSFGIVLLELLTG 797
+ + D +S G+ + E+L G
Sbjct: 182 MGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 57/220 (25%), Positives = 94/220 (42%), Gaps = 40/220 (18%)
Query: 588 HVYEDIMRMTENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELET 647
+Y I+ ++ + GY + K +LK P SH L FET
Sbjct: 10 QIYAGILNYKDDDEDD---GYSYEKEI-KVILKVLDP-------SHRDISLAFFETA-SM 57
Query: 648 VGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAA 707
+ + H+++V L G + N++ +F+E G L +H + W + K+A A
Sbjct: 58 MRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLA 115
Query: 708 QGLAYLHHDCSPRIIHRDVKSSNILLDK---DFEA----HLTDFGI-----AKSLCVSKS 755
L+YL ++H +V + NILL + D E L+D GI ++ CV +
Sbjct: 116 SALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVER- 171
Query: 756 YTSTYIMGTIGYIDPEYARTSR-LTEKSDVYSFGIVLLEL 794
I +I PE S+ L+ +D +SFG L E+
Sbjct: 172 ---------IPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-05
Identities = 30/106 (28%), Positives = 55/106 (51%), Gaps = 8/106 (7%)
Query: 694 LDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753
L + + + A G+ +L S +HRD+ + N+L+ + + DFG+A+ +
Sbjct: 236 LSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRD 292
Query: 754 KSYTS---TYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT 796
+Y S T++ + ++ PE + T SDV+SFGI+L E+ T
Sbjct: 293 SNYISKGSTFL--PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 3e-05
Identities = 31/90 (34%), Positives = 48/90 (53%), Gaps = 5/90 (5%)
Query: 709 GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYI 768
G+ +LH S IIHRD+K SNI++ D + DFG+A++ S T Y++ T Y
Sbjct: 130 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP-YVV-TRYYR 184
Query: 769 DPEYARTSRLTEKSDVYSFGIVLLELLTGR 798
PE E D++S G ++ E++ G
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 3e-05
Identities = 34/123 (27%), Positives = 47/123 (38%), Gaps = 50/123 (40%)
Query: 722 IHRDVKSSNILLDKDFEAHLTDFGIAKSLCV-------SKSY------------------ 756
IHRD+K NIL+D+D LTDFG LC SK Y
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFG----LCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWS 178
Query: 757 ---------------------TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELL 795
+ ++GT YI PE + T+ D +S G++L E+L
Sbjct: 179 EIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238
Query: 796 TGR 798
G+
Sbjct: 239 VGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 3e-05
Identities = 31/104 (29%), Positives = 46/104 (44%), Gaps = 18/104 (17%)
Query: 708 QGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSK------------S 755
+G+ YLH I+HRD+K++NIL+D + DFG+A+
Sbjct: 126 EGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRK 182
Query: 756 YTSTYIMGTIGYIDPEY-ARTSRLTEKSDVYSFGIVLLELLTGR 798
YT+ + T Y PE R T D++ G V E+ T R
Sbjct: 183 YTNLVV--TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 4e-05
Identities = 36/120 (30%), Positives = 53/120 (44%), Gaps = 8/120 (6%)
Query: 722 IHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTS----R 777
IHRDVK N+LLDK L DFG + +GT YI PE ++
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGY 223
Query: 778 LTEKSDVYSFGIVLLELLTGRKA--VDNECNLHHLILSKTANNAVMETVDPEISATCKDL 835
+ D +S G+ L E+L G D+ + I++ N++ D +IS K+L
Sbjct: 224 YGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH--KNSLTFPDDNDISKEAKNL 281
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 4e-05
Identities = 51/205 (24%), Positives = 84/205 (40%), Gaps = 33/205 (16%)
Query: 638 LKEFET-----ELETVGSIKHRNLVSLQGYSLSSSGNLLF--YDFMENGSLWDILHGPTK 690
LKE E E+ + +KH+N+V L+ + L+ +F + G L + K
Sbjct: 51 LKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYK 110
Query: 691 K-KKLDWDTRLKIALGAAQGLAYLHH----DCSPRIIHRDVKSSNILLDKDFE------- 738
K++ + I LAY H+ R++HRD+K NI L
Sbjct: 111 MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170
Query: 739 ----------AHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYA--RTSRLTEKSDVYS 786
A + DFG++K++ + S +GT Y PE T +KSD+++
Sbjct: 171 QANNLNGRPIAKIGDFGLSKNIGIESMAHSC--VGTPYYWSPELLLHETKSYDDKSDMWA 228
Query: 787 FGIVLLELLTGRKAVDNECNLHHLI 811
G ++ EL +G+ N LI
Sbjct: 229 LGCIIYELCSGKTPFHKANNFSQLI 253
|
Length = 1021 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 6e-05
Identities = 64/268 (23%), Positives = 99/268 (36%), Gaps = 50/268 (18%)
Query: 606 IGYGASSTVYKCVLKNCKP-----VAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQ 660
+G G V+ LK V K+ + +K TE E + ++ H L +L
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNK-VKRVLTEQEILATLDHPFLPTLY 67
Query: 661 GYSLSSSGNLLF-YDFMENGSLWDILHGPTKKKKLDWDTRLKIA-LGAAQGLAYLHHDCS 718
S + L D+ G L+ +L K + R A + A L YLH
Sbjct: 68 A-SFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLA--LEYLH---L 121
Query: 719 PRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSK------------------------ 754
I++RD+K NILL + L+DF ++K V
Sbjct: 122 LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETF 181
Query: 755 ----SYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGR---KAVDNECNL 807
S+ S +GT YI PE D ++ GI+L E+L G K + +
Sbjct: 182 SEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETF 241
Query: 808 HHLILSKTANNAVMETVDPEISATCKDL 835
+ IL K P +S++ +DL
Sbjct: 242 SN-ILKKEVTFPGS----PPVSSSARDL 264
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 7e-05
Identities = 49/180 (27%), Positives = 80/180 (44%), Gaps = 21/180 (11%)
Query: 624 PVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWD 683
V +K L S + L FET + + H++LV L G + N++ ++++ G L
Sbjct: 32 SVVLKVLGSDHRDSLAFFET-ASLMSQLSHKHLVKLYGVCVRD-ENIMVEEYVKFGPLDV 89
Query: 684 ILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKD------- 736
LH L W +L +A A L YL +++H +V NIL+ +
Sbjct: 90 FLHREKNNVSLHW--KLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYV 144
Query: 737 FEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYAR--TSRLTEKSDVYSFGIVLLEL 794
L+D GI ++ + + I +I PE R + LT +D +SFG LLE+
Sbjct: 145 PFIKLSDPGIPITV-----LSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 8e-05
Identities = 55/202 (27%), Positives = 91/202 (45%), Gaps = 18/202 (8%)
Query: 606 IGYGASSTVYKCVLK-NCKPVAIK--RLYSHYPQCLKEFETELETVGSIKHRNLVSLQGY 662
+G G+ +TVYK K N K VA+K RL E + +KH N+V L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIVLLHDI 71
Query: 663 SLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRII 722
+ L ++++ + P L + +GL+Y+H I+
Sbjct: 72 IHTKETLTLVFEYVHTDLCQYMDKHP---GGLHPENVKLFLFQLLRGLSYIHQR---YIL 125
Query: 723 HRDVKSSNILLDKDFEAHLTDFGIAKSLCV-SKSYTSTYIMGTIGYIDPEYARTSRLTEK 781
HRD+K N+L+ E L DFG+A++ V S +Y++ + T+ Y P+ S TE
Sbjct: 126 HRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--TLWYRPPDVLLGS--TEY 181
Query: 782 S---DVYSFGIVLLELLTGRKA 800
S D++ G + +E++ G A
Sbjct: 182 STCLDMWGVGCIFVEMIQGVAA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 9e-05
Identities = 25/60 (41%), Positives = 30/60 (50%)
Query: 117 SLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNL 176
+LKSLDLS N L + L L+ L L N L P S LP+L+ L GNNL
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 9e-05
Identities = 32/102 (31%), Positives = 47/102 (46%), Gaps = 17/102 (16%)
Query: 710 LAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAK----SLCV----------SKS 755
L YLH + I+HRD+K N+L+ LTDFG++K SL ++
Sbjct: 114 LEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 756 YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTG 797
+ + GT YI PE + D ++ GI+L E L G
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 45/210 (21%), Positives = 90/210 (42%), Gaps = 29/210 (13%)
Query: 606 IGYGASSTVYKCVLKNCK--------PVAIKRLYSHYPQCLKEFETELETVGSIKHRNLV 657
+G G + ++K + + V +K L + + F + + H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 658 SLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAY-LHHD 716
G + +++ ++++ GSL L KK K + K L A+ LA+ LH
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYL----KKNKNLINISWK--LEVAKQLAWALHFL 116
Query: 717 CSPRIIHRDVKSSNILLDKDFEAH--------LTDFGIAKSLCVSKSYTSTYIMGTIGYI 768
+ H +V + N+LL ++ + L+D GI+ ++ ++ I ++
Sbjct: 117 EDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV-----LPKEILLERIPWV 171
Query: 769 DPEYARTSR-LTEKSDVYSFGIVLLELLTG 797
PE + L+ +D +SFG L E+ +G
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 40/151 (26%), Positives = 60/151 (39%), Gaps = 28/151 (18%)
Query: 682 WDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILL-------D 734
W + HGP + L +I L Y H + ++H D+K NIL+ D
Sbjct: 221 WIMKHGPFSHRHL-----AQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVD 273
Query: 735 KDFEAHL---------TDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVY 785
L D G C + ++ T I+ T Y PE +D++
Sbjct: 274 PVTNRALPPDPCRVRICDLG----GCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMW 329
Query: 786 SFGIVLLELLTGRKAVDNECNLHHL-ILSKT 815
S G ++ EL TG+ D NL HL ++ KT
Sbjct: 330 SMGCIIYELYTGKLLYDTHDNLEHLHLMEKT 360
|
Length = 467 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 2e-04
Identities = 30/88 (34%), Positives = 45/88 (51%), Gaps = 7/88 (7%)
Query: 662 YSLSSSGNL-LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPR 720
YSL S+ N+ L +++ G + +LH D + +K A L YLH
Sbjct: 71 YSLQSANNVYLVMEYLIGGDVKSLLH---IYGYFDEEMAVKYISEVALALDYLHRH---G 124
Query: 721 IIHRDVKSSNILLDKDFEAHLTDFGIAK 748
IIHRD+K N+L+ + LTDFG++K
Sbjct: 125 IIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 2e-04
Identities = 26/77 (33%), Positives = 43/77 (55%), Gaps = 7/77 (9%)
Query: 721 IIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSK-SYTSTYIMGTIGYID---PEYARTS 776
IIHRD+K+ N+L++ + L DFG A C ++ S+++ + G G +D PE
Sbjct: 281 IIHRDIKTENVLVNGPEDICLGDFGAA---CFARGSWSTPFHYGIAGTVDTNAPEVLAGD 337
Query: 777 RLTEKSDVYSFGIVLLE 793
T D++S G+V+ E
Sbjct: 338 PYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.4 bits (93), Expect = 3e-04
Identities = 20/56 (35%), Positives = 28/56 (50%)
Query: 336 LNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNI 391
L+++NN L NL L++ GN L P AF L S+ L+LS NN+
Sbjct: 5 LDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 44/169 (26%), Positives = 79/169 (46%), Gaps = 21/169 (12%)
Query: 644 ELETVGSIKHRNLVSLQGYSLSSSGN--LLFYDFMENGSLWDIL--HGPTKKKKLDWDTR 699
E+ + +KH N++SLQ LS + L +D+ E+ LW I+ H +K K
Sbjct: 48 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANK----KP 102
Query: 700 LKIALGAAQGLAY-----LHHDCSPRIIHRDVKSSNILL----DKDFEAHLTDFGIAKSL 750
+++ G + L Y +H+ + ++HRD+K +NIL+ + + D G A+
Sbjct: 103 VQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
Query: 751 CVSKSYTSTY--IMGTIGYIDPEYARTSR-LTEKSDVYSFGIVLLELLT 796
+ ++ T Y PE +R T+ D+++ G + ELLT
Sbjct: 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 4e-04
Identities = 61/256 (23%), Positives = 101/256 (39%), Gaps = 27/256 (10%)
Query: 625 VAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWD 683
V +K L Q +F E + S++H NL+ G + LL +F G L
Sbjct: 25 VVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKG 84
Query: 684 ILHGPTKKKKLDWDTRL--KIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHL 741
L K + + D ++A A GL +LH + IH D+ N LL D +
Sbjct: 85 YLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKI 141
Query: 742 TDFGIAKSLCVSKSY-TSTYIMGTIGYIDPEYAR-------TSRLTEKSDVYSFGIVLLE 793
D+G++ + Y T + + +I PE T++S+V+S G+ + E
Sbjct: 142 GDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWE 201
Query: 794 LLTGRKAVDNECNLHH---LILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSK 850
L + ++ H +L+ T ++ P + D +V Q L
Sbjct: 202 LF----ELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWY--EVMQFCWL--- 252
Query: 851 RQPTDRPTMHEVSRVL 866
QP RP+ EV +L
Sbjct: 253 -QPEQRPSAEEVHLLL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 36/215 (16%)
Query: 606 IGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFE---------TELETVGSIKHRNL 656
+G G VYK K+ K ++ Y+ LK+ E E+ + +KH N+
Sbjct: 9 VGRGTYGHVYKAKRKDGKD---EKEYA-----LKQIEGTGISMSACREIALLRELKHPNV 60
Query: 657 VSLQGYSLSSSGN--LLFYDFMENGSLWDIL--HGPTK--KKKLDWDTRLKIAL--GAAQ 708
++LQ LS S L +D+ E+ LW I+ H +K KK + + +L
Sbjct: 61 IALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILD 119
Query: 709 GLAYLHHDCSPRIIHRDVKSSNILL----DKDFEAHLTDFGIAKSLCVSKSYTSTY--IM 762
G+ YLH + ++HRD+K +NIL+ + + D G A+ + ++
Sbjct: 120 GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 763 GTIGYIDPEYARTSR-LTEKSDVYSFGIVLLELLT 796
T Y PE +R T+ D+++ G + ELLT
Sbjct: 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 5e-04
Identities = 47/184 (25%), Positives = 65/184 (35%), Gaps = 30/184 (16%)
Query: 679 GSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFE 738
SL DIL + + L+ + + L L LH R KS NILL D
Sbjct: 1 VSLADILE--VRGRPLNEEEIWAVCLQCLGALRELH---------RQAKSGNILLTWD-- 47
Query: 739 AHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGR 798
L G +S Y M PE + TEK+D+YS GI L E L
Sbjct: 48 GLLKLDGSVAFKTPEQSRPDPYFMA------PEVIQGQSYTEKADIYSLGITLYEALDYE 101
Query: 799 KAVDNECN----LHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPT 854
+ E L L+ A++ + +SA ++ LC+ R P
Sbjct: 102 LPYNEERELSAILEILLNGMPADDPRDRSNLEGVSAARSFEDFMR-------LCASRLPQ 154
Query: 855 DRPT 858
R
Sbjct: 155 RREA 158
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 7e-04
Identities = 23/70 (32%), Positives = 34/70 (48%), Gaps = 8/70 (11%)
Query: 709 GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYI 768
GL LH I+HRD+K N+L+ D + + DFG A +C ++ Y G +
Sbjct: 321 GLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLY-----GML 372
Query: 769 DPEYARTSRL 778
DP Y+ L
Sbjct: 373 DPRYSPPEEL 382
|
Length = 507 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 8e-04
Identities = 35/127 (27%), Positives = 47/127 (37%), Gaps = 54/127 (42%)
Query: 722 IHRDVKSSNILLDKDFEAHLTDFGIAKSLCV-------SKSYTST--------------- 759
IHRD+K NIL+D+D LTDFG LC SK Y S
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFG----LCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178
Query: 760 ----------------------------YIMGTIGYIDPEYARTSRLTEKSDVYSFGIVL 791
++GT YI PE + T+ D +S G++L
Sbjct: 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238
Query: 792 LELLTGR 798
E+L G+
Sbjct: 239 YEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 8e-04
Identities = 28/115 (24%), Positives = 44/115 (38%), Gaps = 41/115 (35%)
Query: 722 IHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTY--------------------- 760
IHRD+K N+LLD L+DFG+ L KS+ + +
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGL--KKSHRTEFYRILSHALPSNFLDFISKPMS 180
Query: 761 ------------------IMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTG 797
+GT YI PE + ++ D +S G+++ E+L G
Sbjct: 181 SKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 62/243 (25%), Positives = 100/243 (41%), Gaps = 32/243 (13%)
Query: 632 SHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKK 691
SH L FET + + H +L + G + S N++ +F+E+G L L +
Sbjct: 55 SHRDIALAFFETA-SLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGR 113
Query: 692 KKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAH-------LTDF 744
+ W ++ +A A L+YL ++H +V + NILL + A L+D
Sbjct: 114 VPVAW--KITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDP 168
Query: 745 GIAKSLCVSKSYTSTYIMGTIGYIDPEYART-SRLTEKSDVYSFGIVLLELLTGRKAVDN 803
G++ + + I +I PE + L+ +D +SFG LLE+ D
Sbjct: 169 GVSFTALSREERVE-----RIPWIAPECVPGGNSLSTAADKWSFGTTLLEI-----CFDG 218
Query: 804 ECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVS 863
E L S+ + PE S CK+L L C +PT RP+ +
Sbjct: 219 EVPLKERTPSEKERFYEKKHRLPEPS--CKELAT------LISQCLTYEPTQRPSFRTIL 270
Query: 864 RVL 866
R L
Sbjct: 271 RDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 33/107 (30%), Positives = 52/107 (48%), Gaps = 15/107 (14%)
Query: 702 IALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYI 761
I GA +GL YLH + IHR++K+S+IL+ D L+ G++ + ++ +
Sbjct: 106 ILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKV 160
Query: 762 M--------GTIGYIDPEYART--SRLTEKSDVYSFGIVLLELLTGR 798
+ + ++ PE R KSD+YS GI EL TGR
Sbjct: 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.1 bits (87), Expect = 0.002
Identities = 21/60 (35%), Positives = 31/60 (51%), Gaps = 4/60 (6%)
Query: 286 EKLYLHSNKLTGHIPPE-LGNMTKLHYLELNDNQLTGHIPP-ALGKLTDLFDLNVANNHL 343
+ L L +N+LT IP + L L+L+ N LT I P A L L L+++ N+L
Sbjct: 3 KSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLT-SISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.002
Identities = 59/225 (26%), Positives = 95/225 (42%), Gaps = 34/225 (15%)
Query: 605 IIGYGASSTVYKCV-LKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYS 663
IIG G+ VY+ + + + VAIK++ PQ EL + ++ H N++ L+ Y
Sbjct: 73 IIGNGSFGVVYEAICIDTSEKVAIKKVLQD-PQYKNR---ELLIMKNLNHINIIFLKDYY 128
Query: 664 LSSS-----GNLLFYDFMENGSLWDILHGPTKKKKLDWDTR-------LKIALGAAQ--- 708
+ N+ ME T K + R + L + Q
Sbjct: 129 YTECFKKNEKNIFLNVVME-------FIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCR 181
Query: 709 GLAYLHHDCSPRIIHRDVKSSNILLDKDFEA-HLTDFGIAKSLCVSKSYTSTYIMGTIGY 767
LAY+H S I HRD+K N+L+D + L DFG AK+L + S YI Y
Sbjct: 182 ALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVS-YICSRF-Y 236
Query: 768 IDPEYAR-TSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLI 811
PE + T D++S G ++ E++ G + ++ L+
Sbjct: 237 RAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLV 281
|
Length = 440 |
| >gnl|CDD|215633 PLN03210, PLN03210, Resistant to P | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.003
Identities = 72/333 (21%), Positives = 143/333 (42%), Gaps = 68/333 (20%)
Query: 88 VGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLIL 147
V L L++IDLRG++ +IPD + ++L++L LS ++P SI L +LE L +
Sbjct: 630 VHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDM 688
Query: 148 KNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQN 207
+ + +P+ + NLK L N
Sbjct: 689 SRCENLEILPTGI----NLKSLY----------------------------RL------N 710
Query: 208 IGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLS 267
+ C+ + +I NI +L + +++ + PS + L + L L L
Sbjct: 711 LSGCSRLKSFP--------DISTNISWLDLDETAIE------EFPSNLRL-ENLDELIL- 754
Query: 268 CNMLSG-------PIPPILGNLSYT-EKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQL 319
C M S P+ P++ LS + +L+L +P + N+ KL +LE+ +
Sbjct: 755 CEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCIN 814
Query: 320 TGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLE 379
+P + L L L+++ PD TN++ LN+ + +P ++
Sbjct: 815 LETLPTGI-NLESLESLDLSGCSRLRTFPD---ISTNISDLNLSRTGIE-EVPWWIEKFS 869
Query: 380 SMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSN 412
++++L+++ N + + +S++ +L+T+D S+
Sbjct: 870 NLSFLDMNGCNNLQRVSLNISKLKHLETVDFSD 902
|
syringae 6; Provisional. Length = 1153 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 933 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.98 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.98 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.98 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.98 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.98 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.92 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.91 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.89 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.8 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.77 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.77 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.76 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.76 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.75 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.74 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.73 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.73 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.72 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.7 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.7 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.68 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.67 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.66 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.66 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.65 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.57 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.56 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.56 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.53 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.5 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.49 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.47 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.42 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.38 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.38 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.31 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.3 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.27 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.22 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.21 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.2 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.17 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.15 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.12 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.12 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.12 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.1 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.08 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.07 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 99.03 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.03 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.01 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.0 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.99 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.97 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.97 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.93 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.9 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.87 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.83 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.81 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.8 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.8 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.77 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.75 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.75 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.74 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.68 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.62 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.55 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.47 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.47 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.42 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-104 Score=1000.56 Aligned_cols=832 Identities=34% Similarity=0.562 Sum_probs=548.0
Q ss_pred HHHHhhcCCCChHHHHHHHHHHHhCCCCCCCcCCCCCCCCCCCCCccceEecCCCCcEEEEEcCCCCcCcccCCCCCCCC
Q 002349 13 FLFCLSFGSVDSEDGATLLKIKKSFRDVDNVLYDWTDSPSSDYCVWRGITCDNVTFTVIALNLSGLNLDGEISPAVGDLK 92 (933)
Q Consensus 13 ~~~~~~~~~~~~~d~~all~~k~~~~~~~~~l~~w~~~~~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~ 92 (933)
+++++.++-.+++|+.||++||+++.+|.+.+.+|+. ..+||.|.||+|++ .++|+.|+|++++++|.+++.+..++
T Consensus 17 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~w~~--~~~~c~w~gv~c~~-~~~v~~L~L~~~~i~~~~~~~~~~l~ 93 (968)
T PLN00113 17 FFLFLNFSMLHAEELELLLSFKSSINDPLKYLSNWNS--SADVCLWQGITCNN-SSRVVSIDLSGKNISGKISSAIFRLP 93 (968)
T ss_pred HHHHHHccCCCHHHHHHHHHHHHhCCCCcccCCCCCC--CCCCCcCcceecCC-CCcEEEEEecCCCccccCChHHhCCC
Confidence 3344445555789999999999999988888999964 46899999999986 46999999999999999988888899
Q ss_pred CccEEEccCCcccccCCCCcc-CCCCCceecccccccCC----------------------CCCcccccccchhhhhhcc
Q 002349 93 DLQSIDLRGNRLSGQIPDEIG-DCSSLKSLDLSFNELYG----------------------DIPFSISKLKQLEFLILKN 149 (933)
Q Consensus 93 ~L~~L~Ls~n~l~~~~p~~l~-~l~~L~~L~Ls~n~l~~----------------------~~p~~~~~l~~L~~L~L~~ 149 (933)
+|++|+|++|+++|.+|..+. ++++|++|+|++|.++| .+|..++++++|++|+|++
T Consensus 94 ~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~ 173 (968)
T PLN00113 94 YIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGG 173 (968)
T ss_pred CCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECcc
Confidence 999999999988888887654 66666666666665544 4455555566666666666
Q ss_pred cCccCCCCcccccCCCCceeeeecCCCCCCcccccccCCCCcEEeccCccccCccCcCCcCCCCCcEEccccccccCcCC
Q 002349 150 NQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIP 229 (933)
Q Consensus 150 n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p 229 (933)
|.+.+.+|..++++++|++|+|++|++.+.+|..++++++|++|+|++|.+++.+|..++++++|++|++++|++++.+|
T Consensus 174 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p 253 (968)
T PLN00113 174 NVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIP 253 (968)
T ss_pred CcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccC
Confidence 66655566666666666666666666665555556666666666666666655556556666666666666666555555
Q ss_pred CCcccc-ccceEeccccccccccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCc
Q 002349 230 FNIGFL-QIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTK 308 (933)
Q Consensus 230 ~~~~~~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 308 (933)
..+... +|++|+|++|++++.+|..+..+++|++|+|++|.+.+.+|..+.++++|+.|++++|.+.+.+|..+..+++
T Consensus 254 ~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~ 333 (968)
T PLN00113 254 SSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPR 333 (968)
T ss_pred hhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCC
Confidence 444332 4555555555555555555555555555555555555555555555555555555555555555555555555
Q ss_pred ceEeeeccccccccCCccccccccccccccccccC------------------------CCCCCCCcccCCCCCceeccC
Q 002349 309 LHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHL------------------------EGPIPDNLSSCTNLNSLNVHG 364 (933)
Q Consensus 309 L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l------------------------~~~~p~~l~~l~~L~~L~l~~ 364 (933)
|+.|++++|.+++.+|..++.+++|+.|++++|++ .+.+|..+..+++|+.|++++
T Consensus 334 L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~ 413 (968)
T PLN00113 334 LQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQD 413 (968)
T ss_pred CCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcC
Confidence 55555555555544454444444444444444444 444444455556666666666
Q ss_pred cccCCCCCcccccccccceecCCcc-----------------------------------------------cccCCCcc
Q 002349 365 NKLNGTIPPAFQRLESMTYLNLSLN-----------------------------------------------NIRGPIPV 397 (933)
Q Consensus 365 N~l~~~~~~~~~~l~~L~~L~L~~N-----------------------------------------------~l~~~~~~ 397 (933)
|++++.+|..|..+++|++|++++| ++++.+|.
T Consensus 414 n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~ 493 (968)
T PLN00113 414 NSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPR 493 (968)
T ss_pred CEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCccCh
Confidence 6666555555544444443333333 33344444
Q ss_pred ccccccccceeeccCCccCCCCCCCCCCccccccccccCcccccccccccccccccceEEccCCccccccchhhcccccc
Q 002349 398 ELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNM 477 (933)
Q Consensus 398 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 477 (933)
.+..+++|+.|+|++|++.+.+|..+..+++|+.|+|++|.+++.+|..|.++++|+.|||++|+++|.+|..+..+++|
T Consensus 494 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L 573 (968)
T PLN00113 494 KLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESL 573 (968)
T ss_pred hhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCccc
Confidence 45555566666666666666666667777777777777777777777777777777777777777777777777777777
Q ss_pred ceeeecCCCCcCcccchhhccccc-eeecCCCCCCCccc---CCcccCCCCCcccchhhhhhhhhhhHHHHHHHHHHhh-
Q 002349 478 FSLRLDYNNLSGDVMSLINCLSLS-VLFIGNPGLCGYWL---HSACRDSHPTERVTISKAAILGIALGALVILLMILVA- 552 (933)
Q Consensus 478 ~~L~l~~N~l~~~~~~~~~~~~~~-~~~~~N~~~C~~~l---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~- 552 (933)
+.|++++|+++|.+|....+.++. ..+.|||.+|+... .+.|........+.+ +++++++++++++++++++
T Consensus 574 ~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 650 (968)
T PLN00113 574 VQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWF---YITCTLGAFLVLALVAFGFV 650 (968)
T ss_pred CEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccccceeee---ehhHHHHHHHHHHHHHHHHH
Confidence 777777777777777666655555 66889999998653 234533221111111 1112222222222222222
Q ss_pred hcccCCCCCCCCCCCCCCccCCCCcceeec-ccccccCHHHHHHHhhccCcceeeecccceeEEEEEEc-CCceEEEEEe
Q 002349 553 ACRPHNPTHFPDGSLDKPVNYSTPKLVILH-MNMALHVYEDIMRMTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRL 630 (933)
Q Consensus 553 ~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~ 630 (933)
++|++++...+....... ........ .......+++ ....+...++||+|+||.||+|+.. +++.||||++
T Consensus 651 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~ 723 (968)
T PLN00113 651 FIRGRNNLELKRVENEDG----TWELQFFDSKVSKSITIND---ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEI 723 (968)
T ss_pred HHHhhhcccccccccccc----cccccccccccchhhhHHH---HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEc
Confidence 223222111111100000 00000000 0011223333 3456788889999999999999974 6889999998
Q ss_pred cccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHH
Q 002349 631 YSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGL 710 (933)
Q Consensus 631 ~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l 710 (933)
..... ...+|++.+++++|||||+++|++.+++..++||||+++|+|.++++ .++|.++.+++.|+|+|+
T Consensus 724 ~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L 793 (968)
T PLN00113 724 NDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR------NLSWERRRKIAIGIAKAL 793 (968)
T ss_pred cCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh------cCCHHHHHHHHHHHHHHH
Confidence 65432 12356889999999999999999999999999999999999999994 379999999999999999
Q ss_pred HHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHH
Q 002349 711 AYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIV 790 (933)
Q Consensus 711 ~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~ 790 (933)
+|||.+++++|+||||||+||+++.++.+++. ||.+...... ....||+.|||||++.+..++.++|||||||+
T Consensus 794 ~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvv 867 (968)
T PLN00113 794 RFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLI 867 (968)
T ss_pred HHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CCccccccccCcccccCCCCCcccchhhHHHH
Confidence 99997767799999999999999999988875 6665433211 12368899999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCc----chhHHHHhhhcccccccccCcccccc-ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 791 LLELLTGRKAVDNEC----NLHHLILSKTANNAVMETVDPEISAT-CKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 791 l~elltg~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
+|||+||+.||+... ....+.............+++.+... ..+..+..++.+++.+||+.||++||||+||++.
T Consensus 868 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 868 LIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred HHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 999999999986322 22333322222222222233333221 1234556788899999999999999999999999
Q ss_pred HccCCCCC
Q 002349 866 LGSLVPAP 873 (933)
Q Consensus 866 L~~~~~~~ 873 (933)
|+.+....
T Consensus 948 L~~~~~~~ 955 (968)
T PLN00113 948 LESASRSS 955 (968)
T ss_pred HHHhhccc
Confidence 99876533
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-50 Score=438.84 Aligned_cols=285 Identities=50% Similarity=0.773 Sum_probs=247.0
Q ss_pred cccccCHHHHHHHhhccCcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEE
Q 002349 584 NMALHVYEDIMRMTENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYS 663 (933)
Q Consensus 584 ~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 663 (933)
....|+++++..+|++|+..+.||+|+||.||+|...+++.||||++.....+..++|..|++++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45678999999999999999999999999999999999999999988765533156699999999999999999999999
Q ss_pred ecCC-ccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEe
Q 002349 664 LSSS-GNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLT 742 (933)
Q Consensus 664 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~ 742 (933)
.+.+ +.++|||||++|+|.+++++.... +++|..|.+|+.++|+||+|||+.+.+.|+||||||+|||+|+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9998 599999999999999999864333 89999999999999999999999888889999999999999999999999
Q ss_pred ecccccccccCCCceeeee-cccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCC-----CcchhHHHHhhhc
Q 002349 743 DFGIAKSLCVSKSYTSTYI-MGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDN-----ECNLHHLILSKTA 816 (933)
Q Consensus 743 DfGla~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~-----~~~~~~~~~~~~~ 816 (933)
|||+|+..... ....... .||.+|+|||++..+..+.|+|||||||+++|++||+.|.+. ......|......
T Consensus 220 DFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 220 DFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred CccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence 99999765331 1111222 799999999999999999999999999999999999998873 2346677766777
Q ss_pred ccccccccCcccc-ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCC
Q 002349 817 NNAVMETVDPEIS-ATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLV 870 (933)
Q Consensus 817 ~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 870 (933)
.....+.+|+.+. ....+..+..++.+++.+|++.+|.+||+|.||++.|+.+.
T Consensus 299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 7788888999887 33333367888999999999999999999999999996544
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-51 Score=514.21 Aligned_cols=419 Identities=35% Similarity=0.580 Sum_probs=330.9
Q ss_pred cEEEEEcCCCCcCcccCCCCCCCCCccEEEccCCcccccCCCCccCCCCCceecccccccCCCCCcccccccchhhhhhc
Q 002349 69 TVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILK 148 (933)
Q Consensus 69 ~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~ 148 (933)
++..|+|++|.+.+.+|..++++++|++|+|++|++.+.+|..++++++|++|+|++|.+++.+|..|+++++|++|+|+
T Consensus 165 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~ 244 (968)
T PLN00113 165 SLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLV 244 (968)
T ss_pred CCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECc
Confidence 56788899988888888888888999999999888888888888888888888888888888888888888888888888
Q ss_pred ccCccCCCCcccccCCCCceeeeecCCCCCCcccccccCCCCcEEeccCccccCccCcCCcCCCCCcEEccccccccCcC
Q 002349 149 NNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEI 228 (933)
Q Consensus 149 ~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 228 (933)
+|.+++.+|..++++++|+.|+|++|++.+.+|..+.++++|++|++++|.+++.+|..+.++++|+.|++++|.+++.+
T Consensus 245 ~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~ 324 (968)
T PLN00113 245 YNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKI 324 (968)
T ss_pred CceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcC
Confidence 88888888888888888888888888888888888888888888888888888888887888888888888888877777
Q ss_pred CCCccc-cccceEeccccccccccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCc-------------
Q 002349 229 PFNIGF-LQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNK------------- 294 (933)
Q Consensus 229 p~~~~~-~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~------------- 294 (933)
|..+.. .+|+.|+|++|.+++.+|..++.+++|+.|+|++|++++.+|..+..+++|+.|++++|+
T Consensus 325 ~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~ 404 (968)
T PLN00113 325 PVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACR 404 (968)
T ss_pred ChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCC
Confidence 765543 357777777777777677666666777777777666666555555555455555555544
Q ss_pred -----------cCCCCCCccccCCcceEeeeccccccccCCccccccccccccccccccCCCCCCCCcccCCCCCceecc
Q 002349 295 -----------LTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVH 363 (933)
Q Consensus 295 -----------l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~ 363 (933)
+++.+|..+.++++|+.|++++|.+++.+|..+..+++|+.|++++|++.+.+|..+ ..++|+.|+++
T Consensus 405 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls 483 (968)
T PLN00113 405 SLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLS 483 (968)
T ss_pred CCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECc
Confidence 444444445555555555555555555555555555555555555555555555443 34678888888
Q ss_pred CcccCCCCCcccccccccceecCCcccccCCCccccccccccceeeccCCccCCCCCCCCCCccccccccccCccccccc
Q 002349 364 GNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFI 443 (933)
Q Consensus 364 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 443 (933)
+|++++.+|..|..+++|+.|+|++|++.+.+|..+..+++|+.|+|++|.+++.+|..|..+++|+.|+|++|++++.+
T Consensus 484 ~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 563 (968)
T PLN00113 484 RNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEI 563 (968)
T ss_pred CCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccC
Confidence 88888889999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccceEEccCCccccccchhhccccccceeeecCCCCcC
Q 002349 444 PGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSG 489 (933)
Q Consensus 444 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 489 (933)
|..+.++++|+.|++++|+++|.+|.. ..+..+....+.+|+.-|
T Consensus 564 p~~l~~l~~L~~l~ls~N~l~~~~p~~-~~~~~~~~~~~~~n~~lc 608 (968)
T PLN00113 564 PKNLGNVESLVQVNISHNHLHGSLPST-GAFLAINASAVAGNIDLC 608 (968)
T ss_pred ChhHhcCcccCEEeccCCcceeeCCCc-chhcccChhhhcCCcccc
Confidence 999999999999999999999999964 344455566677887443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=386.57 Aligned_cols=252 Identities=29% Similarity=0.439 Sum_probs=208.7
Q ss_pred ccCcceeeecccceeEEEEEEcC-CceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCC-ccEEEEEe
Q 002349 599 NLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSS-GNLLFYDF 675 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~ 675 (933)
+++..+.||+|..|+|||++|+. ++.+|+|++.... +...+++.+|++++++.+||+||+++|.|.... ...++|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 34556779999999999999885 6789999995543 456788999999999999999999999999988 49999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS 755 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 755 (933)
|++|||++++. ..+++++....+++.+|++||.|||+. .+||||||||+|||++..|.|||||||.++.+...
T Consensus 160 MDgGSLd~~~k---~~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 160 MDGGSLDDILK---RVGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred cCCCCHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 99999999994 457899999999999999999999962 49999999999999999999999999999987543
Q ss_pred ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcc-hhHHHHhhhcccccccccCccccccccC
Q 002349 756 YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECN-LHHLILSKTANNAVMETVDPEISATCKD 834 (933)
Q Consensus 756 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (933)
.....+||..|||||.+.+..|+.++||||||++++|+++|+.||..... ...+. .....+....+|.++..
T Consensus 233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~---~Ll~~Iv~~ppP~lP~~--- 305 (364)
T KOG0581|consen 233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIF---ELLCAIVDEPPPRLPEG--- 305 (364)
T ss_pred -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHH---HHHHHHhcCCCCCCCcc---
Confidence 45667899999999999999999999999999999999999999975411 00110 00011112222333322
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 835 LGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 835 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
....++..++..|+++||.+||+++|++++
T Consensus 306 -~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 306 -EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred -cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 245789999999999999999999999875
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=399.61 Aligned_cols=257 Identities=34% Similarity=0.520 Sum_probs=214.3
Q ss_pred ccCcceeeecccceeEEEEEEcCCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCC-ccEEEEEe
Q 002349 599 NLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSS-GNLLFYDF 675 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~ 675 (933)
.+...+.||+|+||+||+|.+++...||||++.... ....++|.+|+.++.+++|||||+++|++.+.. ..++||||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 334445699999999999999887669999997653 223668999999999999999999999999887 78999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC-eeeccCCCCceEeCCCC-CeEEeecccccccccC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPR-IIHRDVKSSNILLDKDF-EAHLTDFGIAKSLCVS 753 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-ivH~Dikp~NIll~~~~-~~kl~DfGla~~~~~~ 753 (933)
+++|+|.++++.. ....+++..+++++.+||+||+|||++ + ||||||||+|||++.++ ++||+|||+++.....
T Consensus 122 ~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 122 MPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred CCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 9999999999743 467899999999999999999999976 6 99999999999999997 9999999999875432
Q ss_pred CCceeeeecccccccCccccc--cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccc
Q 002349 754 KSYTSTYIMGTIGYIDPEYAR--TSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISAT 831 (933)
Q Consensus 754 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (933)
. ...+...||+.|||||++. ...|+.|+||||||+++|||+||+.||.+... .+....... ...++.++..
T Consensus 198 ~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~v~~-----~~~Rp~~p~~ 270 (362)
T KOG0192|consen 198 K-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASAVVV-----GGLRPPIPKE 270 (362)
T ss_pred c-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHh-----cCCCCCCCcc
Confidence 2 3334468999999999999 56999999999999999999999999997765 333322221 2222333322
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCC
Q 002349 832 CKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVP 871 (933)
Q Consensus 832 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 871 (933)
++..+..++.+||+.||++||++.+++..|+.+..
T Consensus 271 -----~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 271 -----CPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred -----CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 45688999999999999999999999999987654
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-45 Score=394.86 Aligned_cols=248 Identities=25% Similarity=0.371 Sum_probs=218.2
Q ss_pred hccCcceeeecccceeEEEEEE-cCCceEEEEEeccc---CchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVL-KNCKPVAIKRLYSH---YPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
.+|...+.||+|||+.||+++. ..|+.||+|++.+. .+...+...+|+++.++++|||||+++++|++.+.+|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999997 77999999999763 3556788999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
|+|+.++|..++ +.++++++.++..+++||+.||.|||++ +|+|||||..|+|++++.+|||+|||+|+.+..+
T Consensus 98 ELC~~~sL~el~---Krrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELL---KRRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHH---HhcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCc
Confidence 999999999999 4678999999999999999999999965 9999999999999999999999999999988543
Q ss_pred CCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccccc
Q 002349 754 KSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCK 833 (933)
Q Consensus 754 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (933)
.......+|||-|+|||++.....+..+||||+||++|.|++|++||+...-.+....++.....++.. +
T Consensus 172 -~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~----l----- 241 (592)
T KOG0575|consen 172 -GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSH----L----- 241 (592)
T ss_pred -ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccc----c-----
Confidence 334566899999999999999999999999999999999999999999776666665555544443332 1
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 834 DLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 834 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.....++|..+++.||.+|||+++|+++
T Consensus 242 ----s~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 242 ----SAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ----CHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 2345678999999999999999999964
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=378.64 Aligned_cols=250 Identities=27% Similarity=0.392 Sum_probs=204.9
Q ss_pred HhhccCcceeeecccceeEEEEEEcC-CceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEE
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSH--YPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLF 672 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 672 (933)
...+|...+.||+|+||+||+|+++. +..||||.+... .....+.+..|+++|+.++|||||.+++++..++..|+|
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 34578888889999999999999774 789999999776 455667789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCC------CCeEEeeccc
Q 002349 673 YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKD------FEAHLTDFGI 746 (933)
Q Consensus 673 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~------~~~kl~DfGl 746 (933)
||||+||+|.++++ ..+.+++..+..++.|+|.||++||++ +||||||||+|||++.. ..+||+|||+
T Consensus 88 MEyC~gGDLs~yi~---~~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIR---RRGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EEeCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 99999999999995 566899999999999999999999965 99999999999999865 4589999999
Q ss_pred ccccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCc
Q 002349 747 AKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDP 826 (933)
Q Consensus 747 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 826 (933)
|+.+. ........+|++.|||||++...+|+.|+|+||+|+++|+|++|+.||+.....+-..+.+.....+ .....
T Consensus 162 AR~L~--~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~-~~~~~ 238 (429)
T KOG0595|consen 162 ARFLQ--PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIV-PVLPA 238 (429)
T ss_pred hhhCC--chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccccc-Cchhh
Confidence 99874 3334456799999999999999999999999999999999999999999777666655443332222 11111
Q ss_pred cccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 002349 827 EISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVS 863 (933)
Q Consensus 827 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 863 (933)
..+ ..+.+++...++.+|.+|-++.+-.
T Consensus 239 ~~s---------~~~~~Ll~~ll~~~~~~~~~~~~~~ 266 (429)
T KOG0595|consen 239 ELS---------NPLRELLISLLQRNPKDRISFEDFF 266 (429)
T ss_pred hcc---------CchhhhhhHHHhcCccccCchHHhh
Confidence 111 2233556666677777776665544
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-45 Score=374.87 Aligned_cols=254 Identities=25% Similarity=0.314 Sum_probs=205.9
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccCch-------hHHHHHHHHHHHhcCCCCceeeeeeEEecCCc
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQ-------CLKEFETELETVGSIKHRNLVSLQGYSLSSSG 668 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 668 (933)
.+.|...+.||+|+||.|-+|..+ +|+.||||++...... ......+|+++|++++|||||+++++|..++.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 356778889999999999999955 6899999999654211 12335799999999999999999999999999
Q ss_pred cEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCC---CCeEEeecc
Q 002349 669 NLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKD---FEAHLTDFG 745 (933)
Q Consensus 669 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~---~~~kl~DfG 745 (933)
.|+||||++||+|.+.+ ...+.+.+..-..+++|++.|+.|||++ ||+||||||+|||+..+ ..+||+|||
T Consensus 251 ~YmVlE~v~GGeLfd~v---v~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKV---VANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred eEEEEEEecCccHHHHH---HhccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccc
Confidence 99999999999999998 4566788888899999999999999965 99999999999999766 678999999
Q ss_pred cccccccCCCceeeeecccccccCccccccCCC---CcchhhHHHHHHHHHHHhCCCCCCCCcchhHH-HHhhhcccccc
Q 002349 746 IAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRL---TEKSDVYSFGIVLLELLTGRKAVDNECNLHHL-ILSKTANNAVM 821 (933)
Q Consensus 746 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~-~~~~~~~~~~~ 821 (933)
+|+..+ ....+...+|||.|.|||++.+..+ ..++|+||+||++|-+++|..||.+......+ ..+......+.
T Consensus 325 lAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~ 402 (475)
T KOG0615|consen 325 LAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFG 402 (475)
T ss_pred hhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCccccc
Confidence 999865 3445667899999999999987643 45889999999999999999999865443312 11222222222
Q ss_pred cccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 002349 822 ETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLG 867 (933)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 867 (933)
... .....++..++|.+|+..||++|||++|++++-+
T Consensus 403 p~~---------w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW 439 (475)
T KOG0615|consen 403 PLQ---------WDRISEEALDLINWMLVVDPENRPSADEALNHPW 439 (475)
T ss_pred Chh---------hhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChh
Confidence 121 2234567888999999999999999999997643
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-45 Score=355.61 Aligned_cols=258 Identities=22% Similarity=0.293 Sum_probs=208.3
Q ss_pred hccCcceeeecccceeEEEEE-EcCCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCceeeeee-EEecCCc-cEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCV-LKNCKPVAIKRLYSH--YPQCLKEFETELETVGSIKHRNLVSLQG-YSLSSSG-NLLF 672 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~-~~~~~~~-~~lv 672 (933)
.+|++.++||.|.||+||++. ..+|..||.|.+.-. .....++...|+.+|++++|||||++++ -+.++.. .++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 457778899999999999999 457899999998743 2445677899999999999999999998 4444444 7899
Q ss_pred EEecCCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--eeeccCCCCceEeCCCCCeEEeecccccc
Q 002349 673 YDFMENGSLWDILHGP-TKKKKLDWDTRLKIALGAAQGLAYLHHDCSPR--IIHRDVKSSNILLDKDFEAHLTDFGIAKS 749 (933)
Q Consensus 673 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dikp~NIll~~~~~~kl~DfGla~~ 749 (933)
||||..|+|..+++.. +.++.+++..+++++.|++.||.++|... ++ |+||||||.||+++.+|.||++|||+++.
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 9999999999998543 34567899999999999999999999631 34 88999999999999999999999999998
Q ss_pred cccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccc
Q 002349 750 LCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEIS 829 (933)
Q Consensus 750 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (933)
+... .......+|||.||+||.+++.+|+.|+||||+||++|||+.-+.||.+..-..-... +..+... .
T Consensus 178 l~s~-~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~K--I~qgd~~-----~-- 247 (375)
T KOG0591|consen 178 LSSK-TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKK--IEQGDYP-----P-- 247 (375)
T ss_pred hcch-hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHH--HHcCCCC-----C--
Confidence 8543 3344567899999999999999999999999999999999999999998733332222 2222111 1
Q ss_pred ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcc
Q 002349 830 ATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGS 868 (933)
Q Consensus 830 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 868 (933)
.++...+.++.++|..|+.+||+.||+...+++.+..
T Consensus 248 --~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 248 --LPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred --CcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 1233456789999999999999999986555554443
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=377.10 Aligned_cols=257 Identities=28% Similarity=0.405 Sum_probs=214.5
Q ss_pred cCcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecCCC
Q 002349 600 LSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENG 679 (933)
Q Consensus 600 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 679 (933)
+...+.||+|.||.||.|.+++...||+|.++... ...+.|.+|+++|++++|+|||+++|+|..++..+||||||+.|
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 44456799999999999999998899999998753 34578899999999999999999999999988999999999999
Q ss_pred CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCceee
Q 002349 680 SLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTST 759 (933)
Q Consensus 680 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 759 (933)
+|.++|+. ..+..+...+.+.++.|||+|++||+++ ++|||||.++||||+++..|||+|||+|+...++......
T Consensus 287 sLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~ 362 (468)
T KOG0197|consen 287 SLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASE 362 (468)
T ss_pred cHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceeecC
Confidence 99999974 3567899999999999999999999955 9999999999999999999999999999965544444444
Q ss_pred eecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHHH
Q 002349 760 YIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAV 838 (933)
Q Consensus 760 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (933)
...-+..|.|||.+....++.|+|||||||+||||+| |+.|+.+-...+.... ........ . +..|+
T Consensus 363 ~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~-le~GyRlp----------~-P~~CP 430 (468)
T KOG0197|consen 363 GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLEL-LERGYRLP----------R-PEGCP 430 (468)
T ss_pred CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHH-HhccCcCC----------C-CCCCC
Confidence 4455678999999999999999999999999999999 6677765443333222 22222111 1 22467
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHHHccCCCCC
Q 002349 839 KKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAP 873 (933)
Q Consensus 839 ~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 873 (933)
..++++|..||..+|++|||++.+...++++....
T Consensus 431 ~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 431 DEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred HHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 88999999999999999999999999988776543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=347.29 Aligned_cols=259 Identities=24% Similarity=0.342 Sum_probs=210.9
Q ss_pred hccCcceeeecccceeEEEEEEcC-CceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYD 674 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 674 (933)
+.|+...++|+|+||+|||+++++ |+.||||++.... +...+-..||+++|++++|||+|.++++|......++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 467778899999999999999875 8899999997643 3445567899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCC
Q 002349 675 FMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSK 754 (933)
Q Consensus 675 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 754 (933)
||+..-|.+.= .....++.+.+.++++|++.|+.|+|.+ +++||||||+|||++..|.+||||||.|+.+.. .
T Consensus 82 ~~dhTvL~eLe---~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-p 154 (396)
T KOG0593|consen 82 YCDHTVLHELE---RYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA-P 154 (396)
T ss_pred ecchHHHHHHH---hccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-C
Confidence 99875444443 3456789999999999999999999966 999999999999999999999999999998853 3
Q ss_pred CceeeeecccccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccccccc-----------
Q 002349 755 SYTSTYIMGTIGYIDPEYART-SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVME----------- 822 (933)
Q Consensus 755 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------- 822 (933)
....+..+.|.+|+|||.+.| .+|...+||||+||++.||++|.+-|.+..+.+++..+...-+....
T Consensus 155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~ 234 (396)
T KOG0593|consen 155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF 234 (396)
T ss_pred cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence 333455688999999999988 68999999999999999999999999999998887655443333211
Q ss_pred --ccC-ccccccccCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002349 823 --TVD-PEISATCKDL-----GAVKKVFQLALLCSKRQPTDRPTMHEVSR 864 (933)
Q Consensus 823 --~~~-~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~evl~ 864 (933)
.+. |+.. ..+.. ....-+++++..|++.||++|++-+|++.
T Consensus 235 F~Gv~lP~~~-~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 235 FHGVRLPEPE-HPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeeeecCCCC-CccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 111 1110 01111 12346789999999999999999999873
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=391.90 Aligned_cols=262 Identities=24% Similarity=0.429 Sum_probs=219.0
Q ss_pred hccCcceeeecccceeEEEEEEcC------CceEEEEEecccCch-hHHHHHHHHHHHhcCCCCceeeeeeEEecCCccE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKN------CKPVAIKRLYSHYPQ-CLKEFETELETVGSIKHRNLVSLQGYSLSSSGNL 670 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 670 (933)
.+....+.||+|+||+||+|+..+ ...||||.++..... ..++|++|+++++.++|||||+++|+|.+++.++
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 445556779999999999999543 356999999887655 7899999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCCC-------C----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCe
Q 002349 671 LFYDFMENGSLWDILHGPT-------K----KKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEA 739 (933)
Q Consensus 671 lv~e~~~~gsL~~~l~~~~-------~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~ 739 (933)
+|+|||..|||.++|.... . ..+++..+.+.|+.|||.|++||-++ .+|||||..+|+||.++..|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEE
Confidence 9999999999999995321 1 23488999999999999999999965 99999999999999999999
Q ss_pred EEeecccccccccCCCceee-eecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcc
Q 002349 740 HLTDFGIAKSLCVSKSYTST-YIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTAN 817 (933)
Q Consensus 740 kl~DfGla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 817 (933)
||+|||+++.+...+.+... ...-+.+|||||.+..++++.++|||||||++||+++ |+.|+.+-.+.+-+.... .
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~--~ 720 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIR--A 720 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHH--c
Confidence 99999999976554444433 3345779999999999999999999999999999998 888998766655444332 2
Q ss_pred cccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCCCCC
Q 002349 818 NAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAPE 874 (933)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 874 (933)
+...+. +..++.++++++..||+..|++||+++||-..|+....+.+
T Consensus 721 g~lL~~----------Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~ 767 (774)
T KOG1026|consen 721 GQLLSC----------PENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP 767 (774)
T ss_pred CCcccC----------CCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence 222221 33567899999999999999999999999999988765443
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=333.03 Aligned_cols=261 Identities=23% Similarity=0.262 Sum_probs=221.1
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccCc--hhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYP--QCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYD 674 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 674 (933)
++|...+++|+|.||.||+|++. .|+.||||+++.... .......||++.|+.++|+||+.++++|...+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 46777889999999999999954 689999999976532 223557899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCC
Q 002349 675 FMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSK 754 (933)
Q Consensus 675 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 754 (933)
||+. +|...++ .+...++..++..++.++++|++|||.+ .|+||||||.|+|++.+|.+||+|||+|+.+....
T Consensus 82 fm~t-dLe~vIk--d~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMPT-DLEVVIK--DKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred eccc-cHHHHhc--ccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 9975 8999997 3567899999999999999999999965 89999999999999999999999999999886443
Q ss_pred CceeeeecccccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccccc
Q 002349 755 SYTSTYIMGTIGYIDPEYARTS-RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCK 833 (933)
Q Consensus 755 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (933)
... ...+-|.+|+|||.+.|. .|+..+||||.||++.||+-|.+-|.+..+.+++..+...-+...+..+|++.....
T Consensus 156 ~~~-~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpd 234 (318)
T KOG0659|consen 156 RIQ-THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPD 234 (318)
T ss_pred ccc-ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccccc
Confidence 333 333678999999988875 699999999999999999999999999999999988877776666655555433221
Q ss_pred C---------------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 834 D---------------LGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 834 ~---------------~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
. ..+.....+++..++..||.+|.|++|++++
T Consensus 235 Y~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 235 YVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 0 0223667999999999999999999999875
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=363.92 Aligned_cols=262 Identities=23% Similarity=0.278 Sum_probs=219.5
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecC--CccEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSS--SGNLLF 672 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv 672 (933)
+.|+..++||+|.||.||+|++. +|+.||+|+++.+. +....-..+|+.+|++++||||+++.+...+. ..+|+|
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 45666678999999999999954 68899999997654 44556678999999999999999999998876 689999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccccc
Q 002349 673 YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV 752 (933)
Q Consensus 673 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 752 (933)
+|||+. +|.-++. ...-.|++.++..+++|++.||+|||.+ +|+|||||.+|||||.+|.+||+|||+|+.+..
T Consensus 197 FeYMdh-DL~GLl~--~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLS--SPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred Eecccc-hhhhhhc--CCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 999987 8888885 3345799999999999999999999954 999999999999999999999999999998876
Q ss_pred CCCceeeeecccccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCc--ccc
Q 002349 753 SKSYTSTYIMGTIGYIDPEYARTS-RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDP--EIS 829 (933)
Q Consensus 753 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 829 (933)
......+..+-|.+|+|||.+.|. .|+.++|+||.|||+.||++|++.|.+..+.+++..+....+...+..++ .++
T Consensus 271 ~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP 350 (560)
T KOG0600|consen 271 SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP 350 (560)
T ss_pred CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC
Confidence 666556777889999999999886 79999999999999999999999999999999988777666665555444 111
Q ss_pred c--cc---c----CH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 830 A--TC---K----DL-----GAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 830 ~--~~---~----~~-----~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
. .. . .. ..+....+++..+|..||.+|.||.++++.
T Consensus 351 ~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 351 HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 0 00 0 00 113567789999999999999999999863
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=351.14 Aligned_cols=249 Identities=25% Similarity=0.296 Sum_probs=207.6
Q ss_pred hhccCcceeeecccceeEEEEEEcC-CceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLF 672 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 672 (933)
.++|+..++||+|+||+||.++.++ ++.+|+|++++.. ....+....|..+|.+++||+||+++-.|++.+..|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 4678999999999999999999765 7889999997653 23456678999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccccc
Q 002349 673 YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV 752 (933)
Q Consensus 673 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 752 (933)
+||+.||.|.-+| ++.+.+++..+.-++..|+.||.|||+. +|||||+||+|||+|.+|.++|+|||+++....
T Consensus 104 ld~~~GGeLf~hL---~~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHL---QREGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHH---HhcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 9999999999999 4678899999999999999999999955 999999999999999999999999999986533
Q ss_pred CCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccc
Q 002349 753 SKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATC 832 (933)
Q Consensus 753 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (933)
. .......+||+.|||||++.+..|+.++|.||+|+++|||++|.+||.+.........+...... ..+.
T Consensus 178 ~-~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~-------~~p~-- 247 (357)
T KOG0598|consen 178 D-GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLP-------LPPG-- 247 (357)
T ss_pred C-CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCC-------CCCc--
Confidence 2 23344579999999999999999999999999999999999999999877655444333322201 1111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCC----CHHHHHH
Q 002349 833 KDLGAVKKVFQLALLCSKRQPTDRP----TMHEVSR 864 (933)
Q Consensus 833 ~~~~~~~~l~~li~~cl~~dP~~RP----t~~evl~ 864 (933)
....+..+++...+..||++|. .+.+|-+
T Consensus 248 ---~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~ 280 (357)
T KOG0598|consen 248 ---YLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKR 280 (357)
T ss_pred ---cCCHHHHHHHHHHhccCHHHhcCCCCChHHhhc
Confidence 1124677889999999999995 4555543
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=361.36 Aligned_cols=261 Identities=20% Similarity=0.270 Sum_probs=215.6
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHH-HHHHHHHHHhcCC-CCceeeeeeEEecCC-ccEEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLK-EFETELETVGSIK-HRNLVSLQGYSLSSS-GNLLF 672 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~-~~~~E~~~l~~l~-h~niv~~~~~~~~~~-~~~lv 672 (933)
-++|...++||.|.||.||+|+.+ .++.||||+++.....+.+ .-.||++.|++++ |||||++.+++.+.+ ..++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 468888999999999999999954 5888999999876543222 2368999999998 999999999999888 89999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccccc
Q 002349 673 YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV 752 (933)
Q Consensus 673 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 752 (933)
||||+ .+|++++++ ++..+++..+..|+.||++||+|+|++ |+.|||+||+|||+.....+||+|||+||.+..
T Consensus 89 fE~Md-~NLYqLmK~--R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 89 FEFMD-CNLYQLMKD--RNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred HHhhh-hhHHHHHhh--cCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccccc
Confidence 99996 599999975 478899999999999999999999977 999999999999999999999999999998754
Q ss_pred CCCceeeeecccccccCccccc-cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcc----
Q 002349 753 SKSYTSTYIMGTIGYIDPEYAR-TSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPE---- 827 (933)
Q Consensus 753 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 827 (933)
.. ..+..+.|.+|+|||++. .+.|+.+.||||+||+++|+.+-++-|.+..+.+++..+...-+...+..+++
T Consensus 163 kp--PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L 240 (538)
T KOG0661|consen 163 KP--PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL 240 (538)
T ss_pred CC--CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence 33 345668999999999774 56789999999999999999999999999888888765543333322221111
Q ss_pred ---------------ccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 002349 828 ---------------ISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLG 867 (933)
Q Consensus 828 ---------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 867 (933)
+....+ ....+..+++.+|++.||++||||+|.+++--
T Consensus 241 a~~mnf~~P~~~~~~l~~L~p--~~s~~~~~li~~ll~WDP~kRpTA~~al~~pf 293 (538)
T KOG0661|consen 241 ASAMNFRFPQVKPSPLKDLLP--NASSEAASLIERLLAWDPDKRPTASQALQHPF 293 (538)
T ss_pred HHHhccCCCcCCCCChHHhCc--ccCHHHHHHHHHHhcCCCccCccHHHHhcCcc
Confidence 111111 24578899999999999999999999998653
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=378.42 Aligned_cols=275 Identities=25% Similarity=0.401 Sum_probs=227.8
Q ss_pred cccCHHHHHHHhhcc---------CcceeeecccceeEEEEEEcC----CceEEEEEecccC-chhHHHHHHHHHHHhcC
Q 002349 586 ALHVYEDIMRMTENL---------SEKYIIGYGASSTVYKCVLKN----CKPVAIKRLYSHY-PQCLKEFETELETVGSI 651 (933)
Q Consensus 586 ~~~~~~~~~~~~~~~---------~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l 651 (933)
..++|||.-++...| .+.++||.|.||.||+|+++- ...||||.++... ...+.+|..|+.||.++
T Consensus 608 DP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF 687 (996)
T KOG0196|consen 608 DPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF 687 (996)
T ss_pred CCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC
Confidence 346666666665544 456799999999999999763 3569999998765 45678899999999999
Q ss_pred CCCceeeeeeEEecCCccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCce
Q 002349 652 KHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNI 731 (933)
Q Consensus 652 ~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NI 731 (933)
+||||+++.|+.......+||.|||++|+|+.+|+ .+.+.+++.+...+.++||.|++||-+. ++|||||.++||
T Consensus 688 dHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR--~~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNI 762 (996)
T KOG0196|consen 688 DHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLR--QNDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNI 762 (996)
T ss_pred CCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHh--hcCCceEeehHHHHHHHHHHHhHHHhhc---Cchhhhhhhhhe
Confidence 99999999999999999999999999999999997 4567899999999999999999999955 999999999999
Q ss_pred EeCCCCCeEEeecccccccccCCCce--eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchh
Q 002349 732 LLDKDFEAHLTDFGIAKSLCVSKSYT--STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLH 808 (933)
Q Consensus 732 ll~~~~~~kl~DfGla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~ 808 (933)
|++.+-.+|++|||+++.+.++.... .....-+.+|.|||.+..++++.++||||||+++||.++ |.+|+.+-.+.+
T Consensus 763 LVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd 842 (996)
T KOG0196|consen 763 LVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD 842 (996)
T ss_pred eeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH
Confidence 99999999999999999875544222 222234679999999999999999999999999999776 889998655444
Q ss_pred HHHHhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCCCCCCCC
Q 002349 809 HLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAPEPQK 877 (933)
Q Consensus 809 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~ 877 (933)
-+.. .......+ ++++++..+.+++..||++|-.+||+++||+.+|+++...+..-+
T Consensus 843 VIka-Ie~gyRLP-----------pPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk 899 (996)
T KOG0196|consen 843 VIKA-IEQGYRLP-----------PPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLK 899 (996)
T ss_pred HHHH-HHhccCCC-----------CCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhc
Confidence 3322 21222211 245678899999999999999999999999999999887765433
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=366.26 Aligned_cols=250 Identities=27% Similarity=0.372 Sum_probs=215.8
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEec
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFM 676 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 676 (933)
..|....+||+|+.|.||.|... .++.||||++........+-+..|+.+|+..+|+|||.+++.|..++..|+|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 46677788999999999999944 57889999997766666677899999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCc
Q 002349 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY 756 (933)
Q Consensus 677 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 756 (933)
+||+|.|.+. ...+++.++..|+++++.||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+.....
T Consensus 353 ~ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~- 424 (550)
T KOG0578|consen 353 EGGSLTDVVT----KTRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS- 424 (550)
T ss_pred CCCchhhhhh----cccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence 9999999984 34599999999999999999999965 999999999999999999999999999998754443
Q ss_pred eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHH
Q 002349 757 TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLG 836 (933)
Q Consensus 757 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (933)
.....+||+.|||||+.....|++|+||||||++++||+-|.+||-.+..+..+..+..... |++.. ...
T Consensus 425 KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~-------P~lk~---~~k 494 (550)
T KOG0578|consen 425 KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT-------PKLKN---PEK 494 (550)
T ss_pred ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCC-------CCcCC---ccc
Confidence 45567899999999999999999999999999999999999999998877776655443322 22221 112
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 837 AVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 837 ~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
....+.+++.+||..||++||++.|++++
T Consensus 495 lS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 495 LSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred cCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 34678899999999999999999999985
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=355.85 Aligned_cols=254 Identities=28% Similarity=0.350 Sum_probs=218.3
Q ss_pred HHHhhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcC-CCCceeeeeeEEecCCc
Q 002349 594 MRMTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSI-KHRNLVSLQGYSLSSSG 668 (933)
Q Consensus 594 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 668 (933)
++-..+|..++.||+|+|++||+|+.+ .++.+|||++.+.. ....+.+.+|-.+|.+| .||.|++++-.|.+...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 445578999999999999999999965 57899999986542 23345577899999999 89999999999999999
Q ss_pred cEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccc
Q 002349 669 NLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAK 748 (933)
Q Consensus 669 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 748 (933)
.|+|+||+++|+|.++++ +-+.+++.....++.+|+.||+|||.+ |||||||||+|||+|++|++||+|||.|+
T Consensus 149 LYFvLe~A~nGdll~~i~---K~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK 222 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIK---KYGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAK 222 (604)
T ss_pred eEEEEEecCCCcHHHHHH---HhCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccc
Confidence 999999999999999994 568899999999999999999999954 99999999999999999999999999999
Q ss_pred ccccCCCc----------e--eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhc
Q 002349 749 SLCVSKSY----------T--STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTA 816 (933)
Q Consensus 749 ~~~~~~~~----------~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~ 816 (933)
.+...... . ....+||..|.+||++.....++++|+|+|||++|+|+.|++||.+..+...+..+...
T Consensus 223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l 302 (604)
T KOG0592|consen 223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL 302 (604)
T ss_pred cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh
Confidence 87432111 1 14579999999999999999999999999999999999999999988887777666655
Q ss_pred ccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 817 NNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
...+.+.++ +...+++.+.+..||.+|+|++||.++.
T Consensus 303 ~y~fp~~fp-------------~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 303 DYEFPEGFP-------------EDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred cccCCCCCC-------------HHHHHHHHHHHccCccccccHHHHhhCc
Confidence 555554433 4567789999999999999999998754
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=354.23 Aligned_cols=255 Identities=29% Similarity=0.421 Sum_probs=203.8
Q ss_pred hccCcceeeecccceeEEEEEEcC-CceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCC--ccEEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSS--GNLLFYD 674 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e 674 (933)
.++...+.||+|+||+||++...+ |+..|||.+........+.+.+|+.+|++++|||||+++|...... .++++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 356778899999999999999765 8899999987664333677899999999999999999999855554 5889999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCC-CCCeEEeeccccccccc-
Q 002349 675 FMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDK-DFEAHLTDFGIAKSLCV- 752 (933)
Q Consensus 675 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~-~~~~kl~DfGla~~~~~- 752 (933)
|+++|+|.+++.. .++++++..+..+.+|+++||+|||++ |||||||||+|||++. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~--~g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKR--YGGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999999963 222799999999999999999999955 9999999999999999 79999999999987652
Q ss_pred -CCCceeeeecccccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCC-cchhHHHHhhhcccccccccCcccc
Q 002349 753 -SKSYTSTYIMGTIGYIDPEYARTS-RLTEKSDVYSFGIVLLELLTGRKAVDNE-CNLHHLILSKTANNAVMETVDPEIS 829 (933)
Q Consensus 753 -~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (933)
..........||+.|||||++..+ ...+++||||+||++.||+||+.||... ............. . -|.++
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~-~-----~P~ip 245 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED-S-----LPEIP 245 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC-C-----CCCCC
Confidence 222234457899999999999953 3446999999999999999999999863 2222222221111 1 11222
Q ss_pred ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcc
Q 002349 830 ATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGS 868 (933)
Q Consensus 830 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 868 (933)
.. .+....+++.+|+..||++||||++++++...
T Consensus 246 ~~-----ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 246 DS-----LSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred cc-----cCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 22 23567789999999999999999999987644
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=364.03 Aligned_cols=266 Identities=30% Similarity=0.451 Sum_probs=215.0
Q ss_pred HHHHHHhhccCcceeeecccceeEEEEEEcCCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCc
Q 002349 591 EDIMRMTENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSG 668 (933)
Q Consensus 591 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 668 (933)
++++...+++...+.||+|.||+||+|+|.+ .||||++.... ++..+.|+.|+.++++-+|.||+-+.|||..+..
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 4555556677788899999999999999876 69999997654 5577889999999999999999999999998887
Q ss_pred cEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccc
Q 002349 669 NLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAK 748 (933)
Q Consensus 669 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 748 (933)
.||..+|+|-+|+.++|. .+.+|+..+.+.|++|||.|+.|||. ++|||||+|..||++.+++.|||+|||++.
T Consensus 463 -AIiTqwCeGsSLY~hlHv--~etkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHV--QETKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred -eeeehhccCchhhhhccc--hhhhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEeccccee
Confidence 999999999999999984 55789999999999999999999995 499999999999999999999999999997
Q ss_pred ccccCC-CceeeeecccccccCccccccC---CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccccccccc
Q 002349 749 SLCVSK-SYTSTYIMGTIGYIDPEYARTS---RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETV 824 (933)
Q Consensus 749 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 824 (933)
.-..-. ......-.|..-|||||+++.. +|++++||||||+|+|||+||..||. ....+++.... ..+...
T Consensus 537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIifmV-GrG~l~--- 611 (678)
T KOG0193|consen 537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIFMV-GRGYLM--- 611 (678)
T ss_pred eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEEEe-cccccC---
Confidence 532111 1111223477889999999753 68999999999999999999999998 33333333222 222111
Q ss_pred CccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCCC
Q 002349 825 DPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPA 872 (933)
Q Consensus 825 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 872 (933)
++.... ...+++++.+++..||..++++||.+.+|+..|+.+.+.
T Consensus 612 -pd~s~~--~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 612 -PDLSKI--RSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred -ccchhh--hccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 111111 224567899999999999999999999999988877664
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=344.25 Aligned_cols=260 Identities=28% Similarity=0.380 Sum_probs=211.5
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEe
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
+.|+....||.|..++||+|+.. .++.||||++.-+. ....+.+.+|+..++.++||||++++..|..+...|+||.|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 57888899999999999999954 57899999996543 33468899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS 755 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 755 (933)
|.+||+.+++.... ...+++..+..|.+++++||.|||++ |.||||||+.|||++.+|.|||+|||.+..+.....
T Consensus 106 Ma~GS~ldIik~~~-~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYY-PDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hcCCcHHHHHHHHc-cccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 99999999996533 34599999999999999999999977 999999999999999999999999998866533221
Q ss_pred ce--e-eeecccccccCcccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccc
Q 002349 756 YT--S-TYIMGTIGYIDPEYART--SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISA 830 (933)
Q Consensus 756 ~~--~-~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (933)
.. . ...+||+.|||||++.. ..|+.|+||||||++..|+.+|..||.....+..+............. ....
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t---~~~~ 258 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLT---SGLD 258 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCccc---ccCC
Confidence 11 1 45689999999999543 479999999999999999999999999877666655433322221110 0111
Q ss_pred cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002349 831 TCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSR 864 (933)
Q Consensus 831 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 864 (933)
...+......+.+++..|++.||++|||++++++
T Consensus 259 ~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 259 KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 1112233467889999999999999999999985
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=368.33 Aligned_cols=373 Identities=24% Similarity=0.273 Sum_probs=324.9
Q ss_pred CccEEEccCCcccccCCCCccCCCCCceecccccccCCCCCcccccccchhhhhhcccCccCCCCcccccCCCCceeeee
Q 002349 93 DLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLR 172 (933)
Q Consensus 93 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~ 172 (933)
.-+.||||+|+++..-+..|.++++|+.++|.+|.++ .||...+...+|+.|+|.+|.|+..-.+.++.++.|+.||||
T Consensus 79 ~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLS 157 (873)
T KOG4194|consen 79 QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLS 157 (873)
T ss_pred ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhh
Confidence 3457999999998777778899999999999999998 888877777779999999999987777788888999999999
Q ss_pred cCCCCCCcccccccCCCCcEEeccCccccCccCcCCcCCCCCcEEccccccccCcCCCCccccccceEeccccccccccC
Q 002349 173 GNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIP 252 (933)
Q Consensus 173 ~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p 252 (933)
.|.|+...-+.|..-.++++|+|++|+|+..-...|.++.+|..|.|+.|+++ ...+
T Consensus 158 rN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrit-----------------------tLp~ 214 (873)
T KOG4194|consen 158 RNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRIT-----------------------TLPQ 214 (873)
T ss_pred hchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCccc-----------------------ccCH
Confidence 99988665566777778888888888888777777777777777777777766 2344
Q ss_pred ccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcceEeeeccccccccCCcccccccc
Q 002349 253 SVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTD 332 (933)
Q Consensus 253 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~ 332 (933)
..|.+++.|+.|||..|+|...---.|.++++|+.|.|..|.|+..-...|..+.++++|+|+.|+++..-.+++.+|+.
T Consensus 215 r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~ 294 (873)
T KOG4194|consen 215 RSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTS 294 (873)
T ss_pred HHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccch
Confidence 56778899999999999998555678899999999999999999888888999999999999999999888889999999
Q ss_pred ccccccccccCCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCCccccccccccceeeccC
Q 002349 333 LFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSN 412 (933)
Q Consensus 333 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 412 (933)
|+.|+|++|.|..+-++.++.+++|++|+|++|+|+...+..|..+..|+.|+|++|.++......|..+++|+.|||++
T Consensus 295 L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~ 374 (873)
T KOG4194|consen 295 LEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRS 374 (873)
T ss_pred hhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcC
Confidence 99999999999988899999999999999999999988899999999999999999999987778899999999999999
Q ss_pred CccCCCCC---CCCCCccccccccccCcccccccccccccccccceEEccCCccccccchhhccccccceeeecCCCCcC
Q 002349 413 NKISGSIP---SPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSG 489 (933)
Q Consensus 413 N~l~~~~p---~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 489 (933)
|.|+..+- ..|.+|++|+.|.|.+|+|..+...+|.++.+|+.|||.+|.|..+.|.+|..+ .|++|-+..-.+-|
T Consensus 375 N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSssflC 453 (873)
T KOG4194|consen 375 NELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSSFLC 453 (873)
T ss_pred CeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcccceEE
Confidence 99986654 458889999999999999998888899999999999999999999999999999 89888777666654
Q ss_pred c
Q 002349 490 D 490 (933)
Q Consensus 490 ~ 490 (933)
+
T Consensus 454 D 454 (873)
T KOG4194|consen 454 D 454 (873)
T ss_pred e
Confidence 4
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=361.01 Aligned_cols=251 Identities=22% Similarity=0.277 Sum_probs=210.1
Q ss_pred HhhccCcceeeecccceeEEEEEEc-CCceEEEEEeccc----Cc-hhHHHHHHHHHHHhcCC-CCceeeeeeEEecCCc
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSH----YP-QCLKEFETELETVGSIK-HRNLVSLQGYSLSSSG 668 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 668 (933)
...+|..++.||+|+||+||.|.+. .++.||+|.+... .. ...+.+.+|+.++++++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 4568999999999999999999865 5799999977553 12 23456778999999998 9999999999999999
Q ss_pred cEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCC-CCeEEeecccc
Q 002349 669 NLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKD-FEAHLTDFGIA 747 (933)
Q Consensus 669 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~-~~~kl~DfGla 747 (933)
.++||||+.||+|.+++. ..+++.+.++..+++|++.|++|||++ ||+||||||+||+++.+ +++||+|||++
T Consensus 95 ~~ivmEy~~gGdL~~~i~---~~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIV---NKGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEEecCCccHHHHHH---HcCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 999999999999999994 478899999999999999999999955 99999999999999999 99999999999
Q ss_pred cccccCCCceeeeecccccccCccccccCC-CC-cchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccC
Q 002349 748 KSLCVSKSYTSTYIMGTIGYIDPEYARTSR-LT-EKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVD 825 (933)
Q Consensus 748 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (933)
.... .........+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||++.........+......++..+.
T Consensus 169 ~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~ 247 (370)
T KOG0583|consen 169 AISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLL 247 (370)
T ss_pred cccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcC
Confidence 8763 2334456679999999999999977 75 8899999999999999999999985544444332222222222211
Q ss_pred ccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 826 PEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 826 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
..++..++.+|+..||.+|+|+.+|+.+
T Consensus 248 ------------S~~~~~Li~~mL~~~P~~R~t~~~i~~h 275 (370)
T KOG0583|consen 248 ------------SPEARSLIEKMLVPDPSTRITLLEILEH 275 (370)
T ss_pred ------------CHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence 3567889999999999999999999943
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=365.08 Aligned_cols=371 Identities=23% Similarity=0.243 Sum_probs=298.6
Q ss_pred hhhhcccCccCCCCcccccCCCCceeeeecCCCCCCcccccccCCCCcEEeccCccccCccCcCCcCCCCCcEEcccccc
Q 002349 144 FLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQ 223 (933)
Q Consensus 144 ~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~ 223 (933)
.|||++|++...-+..|.++++|+.++|..|.++ .+|.......+|+.|+|.+|.|+..-.+.+.-++.|+.||||.|.
T Consensus 82 ~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~ 160 (873)
T KOG4194|consen 82 TLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNL 160 (873)
T ss_pred eeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhch
Confidence 3444444444444444445555555555555544 333333333445555555555554445556666666666666666
Q ss_pred ccCcCCCCccc-cccceEeccccccccccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCc
Q 002349 224 LSGEIPFNIGF-LQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPE 302 (933)
Q Consensus 224 l~~~~p~~~~~-~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~ 302 (933)
|+...-..+.. .++++|+|++|+|+..-...|..+.+|..|.|+.|+++...+..|.++++|+.|+|..|+|.-.---.
T Consensus 161 is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~lt 240 (873)
T KOG4194|consen 161 ISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLT 240 (873)
T ss_pred hhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhh
Confidence 66322233333 46777778888887777788999999999999999999888899999999999999999998544667
Q ss_pred cccCCcceEeeeccccccccCCccccccccccccccccccCCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccc
Q 002349 303 LGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMT 382 (933)
Q Consensus 303 l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 382 (933)
|.++++|+.|.|..|.|...-.+.|..+.++++|+|+.|+++..-.+++.+++.|+.|+||+|.|..+.++.+...++|+
T Consensus 241 FqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~ 320 (873)
T KOG4194|consen 241 FQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLK 320 (873)
T ss_pred hcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccce
Confidence 99999999999999999988888999999999999999999988889999999999999999999999999999999999
Q ss_pred eecCCcccccCCCccccccccccceeeccCCccCCCCCCCCCCccccccccccCccccccccc---ccccccccceEEcc
Q 002349 383 YLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPG---EFGNLRSVMEIDLS 459 (933)
Q Consensus 383 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~---~~~~l~~L~~L~Ls 459 (933)
+|+|++|+|+...+..|..+..|++|.|++|.|+..--..|..+.+|++|||++|.|+..+.+ .|.+|++|+.|+|.
T Consensus 321 ~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~ 400 (873)
T KOG4194|consen 321 ELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLT 400 (873)
T ss_pred eEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeec
Confidence 999999999999999999999999999999999987778899999999999999999977754 68899999999999
Q ss_pred CCccccccchhhccccccceeeecCCCCcCcccchhhccccc-eeecCCCCCCCccc
Q 002349 460 HNHLTGVIPEELSQLQNMFSLRLDYNNLSGDVMSLINCLSLS-VLFIGNPGLCGYWL 515 (933)
Q Consensus 460 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~-~~~~~N~~~C~~~l 515 (933)
+|+|..+.-.+|.+++.|+.|||.+|.+-..-+..+.-..+. +.+..-..+|||.+
T Consensus 401 gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m~Lk~Lv~nSssflCDCql 457 (873)
T KOG4194|consen 401 GNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPMELKELVMNSSSFLCDCQL 457 (873)
T ss_pred CceeeecchhhhccCcccceecCCCCcceeecccccccchhhhhhhcccceEEeccH
Confidence 999997777999999999999999999987655433222444 55666678999966
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=350.71 Aligned_cols=247 Identities=29% Similarity=0.381 Sum_probs=209.1
Q ss_pred hccCcceeeecccceeEEEEEEcC-CceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYD 674 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 674 (933)
++|.+.+.||+|+||.||||+.+. .+.||+|.+.+.. ....+.+.+|++++++++|||||.++++|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 578888899999999999999764 6789999886532 3456778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCC
Q 002349 675 FMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSK 754 (933)
Q Consensus 675 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 754 (933)
|+.| +|..++. ..+.++++.+..++.+++.||.|||.+ +|.|||+||.|||++..|.+|++|||+|+.+.. .
T Consensus 82 ~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST-N 153 (808)
T ss_pred hhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc-C
Confidence 9977 9999994 567899999999999999999999955 999999999999999999999999999998753 4
Q ss_pred CceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccC
Q 002349 755 SYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKD 834 (933)
Q Consensus 755 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (933)
....+.+.|||-|||||+..+.+|+..+|+||+||++||+++|++||.... ..+++.....+. +.+ .
T Consensus 154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s-i~~Lv~~I~~d~-----v~~-------p 220 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS-ITQLVKSILKDP-----VKP-------P 220 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH-HHHHHHHHhcCC-----CCC-------c
Confidence 445667899999999999999999999999999999999999999997543 222322221111 111 1
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 835 LGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 835 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
......+..++.-.+.+||.+|.|-.+++.+
T Consensus 221 ~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 221 STASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred ccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 1335678889999999999999999998864
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=354.96 Aligned_cols=247 Identities=28% Similarity=0.458 Sum_probs=206.0
Q ss_pred hccCcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecC
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFME 677 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 677 (933)
+.+.+.+-||.|+.|.||+|+.++ +.||||+++.- -+.+++-|++++||||+.+.|+|....-++||||||+
T Consensus 124 e~IsELeWlGSGaQGAVF~Grl~n-etVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa 195 (904)
T KOG4721|consen 124 EEISELEWLGSGAQGAVFLGRLHN-ETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCA 195 (904)
T ss_pred HHhhhhhhhccCcccceeeeeccC-ceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccc
Confidence 344556789999999999999877 78999987542 2457899999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCce
Q 002349 678 NGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYT 757 (933)
Q Consensus 678 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 757 (933)
.|-|..+| +.+.++.....+.+..+||.|+.|||.+ .|||||+|.-||||+.+..|||+|||-++..... ..
T Consensus 196 ~GqL~~VL---ka~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--ST 267 (904)
T KOG4721|consen 196 QGQLYEVL---KAGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--ST 267 (904)
T ss_pred cccHHHHH---hccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh--hh
Confidence 99999999 4677899999999999999999999977 9999999999999999999999999999876433 33
Q ss_pred eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHH
Q 002349 758 STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGA 837 (933)
Q Consensus 758 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 837 (933)
...+.||..|||||+++..+.++|+||||||||+|||+||..||.+...... +. +.-...+.-.++ ..+
T Consensus 268 kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI---Iw---GVGsNsL~LpvP-----stc 336 (904)
T KOG4721|consen 268 KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI---IW---GVGSNSLHLPVP-----STC 336 (904)
T ss_pred hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee---EE---eccCCcccccCc-----ccC
Confidence 4557899999999999999999999999999999999999999975432211 11 110111111222 245
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCC
Q 002349 838 VKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVP 871 (933)
Q Consensus 838 ~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 871 (933)
++.+.-+++.||+..|..||++++++.+|+-..+
T Consensus 337 P~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p 370 (904)
T KOG4721|consen 337 PDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASP 370 (904)
T ss_pred chHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence 6778889999999999999999999999986543
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=326.49 Aligned_cols=262 Identities=23% Similarity=0.264 Sum_probs=216.9
Q ss_pred hhccCcceeeecccceeEEEEEEcC-CceEEEEEecccCchh--HHHHHHHHHHHhcCCCCceeeeeeEEecC--CccEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHYPQC--LKEFETELETVGSIKHRNLVSLQGYSLSS--SGNLL 671 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l 671 (933)
.++|+..+.|++|+||.||+|+++. ++.||+|+++...... --...||+.+|.+++|||||.+..+.... +.+|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 3467778889999999999999764 6889999997654221 12347899999999999999999987643 56899
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccc
Q 002349 672 FYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLC 751 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 751 (933)
|||||+. +|...++. ...++...++.-++.|+++|++|||.+ .|+|||+|++|+|++..|.+||+|||+|+.++
T Consensus 155 VMe~~Eh-DLksl~d~--m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMET--MKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred eHHHHHh-hHHHHHHh--ccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhc
Confidence 9999987 89999974 447899999999999999999999966 89999999999999999999999999999986
Q ss_pred cCCCceeeeecccccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccc
Q 002349 752 VSKSYTSTYIMGTIGYIDPEYARTS-RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISA 830 (933)
Q Consensus 752 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (933)
.. ....+..+-|.+|+|||.+.+. .|+.+.|+||+|||+.||+++++-|.+....+++..+....+...+.++|.+..
T Consensus 229 sp-~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~ 307 (419)
T KOG0663|consen 229 SP-LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE 307 (419)
T ss_pred CC-cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence 44 3334566789999999999875 689999999999999999999999999999998887776666666665554432
Q ss_pred ccc----------------CHH---HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 831 TCK----------------DLG---AVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 831 ~~~----------------~~~---~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
... .+. ..+.-++++...+..||.+|.|++|.+++
T Consensus 308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 220 011 22567889999999999999999998875
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=360.03 Aligned_cols=427 Identities=30% Similarity=0.428 Sum_probs=334.1
Q ss_pred EEEEEcCCCCcCcccCCCCCCCCCccEEEccCCcccccCCCCccCCCCCceecccccccCCCCCcccccccchhhhhhcc
Q 002349 70 VIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKN 149 (933)
Q Consensus 70 v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~ 149 (933)
.+++++++|.+. ++|++++.+..++.|+.++|+++ .+|++++.+.+|+.|+.++|.+. ++|++++.+..|..|+..+
T Consensus 70 l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~ 146 (565)
T KOG0472|consen 70 LTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATN 146 (565)
T ss_pred eeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhccc
Confidence 567777787777 67778888888888888888887 78888888888888888888887 7788888888888888888
Q ss_pred cCccCCCCcccccCCCCceeeeecCCCCCCcccccccCCCCcEEeccCccccCccCcCCcCCCCCcEEccccccccCcCC
Q 002349 150 NQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIP 229 (933)
Q Consensus 150 n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p 229 (933)
|+++ ..|..++++.+|..|++.+|++....|..+ +++.|++||+..|.+. ++|..++.+.+|.-|+|..|++. .+|
T Consensus 147 N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i-~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP 222 (565)
T KOG0472|consen 147 NQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHI-AMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP 222 (565)
T ss_pred cccc-cCchHHHHHHHHHHhhccccchhhCCHHHH-HHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC
Confidence 8887 577788888888888888888884444444 4888888888888887 78888888888888899888887 667
Q ss_pred CCccccccceEeccccccccccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcc
Q 002349 230 FNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKL 309 (933)
Q Consensus 230 ~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L 309 (933)
..-+...|++|+++.|++.-...+....+.+|.+|||..|+++ ..|+.+.-+++|++||+++|.|+ .+|.+++++ .|
T Consensus 223 ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL 299 (565)
T KOG0472|consen 223 EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HL 299 (565)
T ss_pred CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-ee
Confidence 5556667888888888888444444458888889999999888 77888888888899999998888 578888888 88
Q ss_pred eEeeecccccccc--------------------------------------CCcc---ccccccccccccccccCCCCCC
Q 002349 310 HYLELNDNQLTGH--------------------------------------IPPA---LGKLTDLFDLNVANNHLEGPIP 348 (933)
Q Consensus 310 ~~L~L~~N~l~~~--------------------------------------~~~~---l~~l~~L~~L~L~~N~l~~~~p 348 (933)
+.|.+.+|.+..+ .+.. ...+.+.+.|+++.-+++ .+|
T Consensus 300 ~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VP 378 (565)
T KOG0472|consen 300 KFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLT-LVP 378 (565)
T ss_pred eehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccc-cCC
Confidence 8888888877520 0111 112345666777777776 455
Q ss_pred CCcccCCC---CCceeccCcccCCCCCcccccccccceecCCcccccCCCccccccccccceeeccCCccCCCCCCCCCC
Q 002349 349 DNLSSCTN---LNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGD 425 (933)
Q Consensus 349 ~~l~~l~~---L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 425 (933)
+....... ....+++.|++. .+|..+..+..+.+.-+..|+..+.+|..+..+++|..|+|++|.+. .+|..++.
T Consensus 379 dEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~ 456 (565)
T KOG0472|consen 379 DEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGS 456 (565)
T ss_pred HHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhh-hcchhhhh
Confidence 54433333 677888888888 67777777766655444444444488888888999999999999887 78888888
Q ss_pred ccccccccccCcccccccccccccccccceEEccCCccccccchhhccccccceeeecCCCCcCcccchhhccccc-eee
Q 002349 426 LEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDVMSLINCLSLS-VLF 504 (933)
Q Consensus 426 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~-~~~ 504 (933)
+..|+.||++.|++. .+|..+-.+..|+.+-.++|++....|..+.++.+|..|||.+|.+...||.+.+++.++ +.+
T Consensus 457 lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL 535 (565)
T KOG0472|consen 457 LVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLEL 535 (565)
T ss_pred hhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEe
Confidence 888999999999888 778888888888888888888887777778889999999999999988888888888887 778
Q ss_pred cCCCCC
Q 002349 505 IGNPGL 510 (933)
Q Consensus 505 ~~N~~~ 510 (933)
.|||+.
T Consensus 536 ~gNpfr 541 (565)
T KOG0472|consen 536 DGNPFR 541 (565)
T ss_pred cCCccC
Confidence 888875
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=345.17 Aligned_cols=248 Identities=25% Similarity=0.374 Sum_probs=210.5
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEe
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
..|+..+.||+|.||.||+|.+. .++.||+|++.-.. ....+++++|+.++..++++||.++++.+..+...+++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 35666788999999999999965 47889999997654 34567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS 755 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 755 (933)
|.||++.+.+. ....+++..+.-+++++..|+.|+|.+ +.+|||||+.||++..+|.||++|||.+..+.....
T Consensus 93 ~~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 99999999993 455568889999999999999999966 999999999999999999999999999988754444
Q ss_pred ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCH
Q 002349 756 YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDL 835 (933)
Q Consensus 756 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (933)
.. ...+||+.|||||++.+..|+.|+||||+|++.+||++|.+|+.+...+.. ...+.+..+|.+..
T Consensus 167 rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv-------lflIpk~~PP~L~~----- 233 (467)
T KOG0201|consen 167 RR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV-------LFLIPKSAPPRLDG----- 233 (467)
T ss_pred cc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE-------EEeccCCCCCcccc-----
Confidence 33 667899999999999999999999999999999999999999986554221 12233334444443
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002349 836 GAVKKVFQLALLCSKRQPTDRPTMHEVSR 864 (933)
Q Consensus 836 ~~~~~l~~li~~cl~~dP~~RPt~~evl~ 864 (933)
.....+.+++..|++.||+.||+|.++++
T Consensus 234 ~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 234 DFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 23467889999999999999999999975
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=334.05 Aligned_cols=248 Identities=20% Similarity=0.298 Sum_probs=210.0
Q ss_pred hccCcceeeecccceeEEEEEE-cCCceEEEEEecccCc---hhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVL-KNCKPVAIKRLYSHYP---QCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
.+|+..+.||+|.||+|-+|.. ..|+.||||.+++..- ++.-.+.+|+++|..++||||+.++.+|...+...+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 3677778899999999999994 6799999999977643 34445789999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
||..+|.|+|++ ...+.+++.++..+++||..|+.|+|.+ ++||||+|.+|||+|.++++||+|||++..+...
T Consensus 133 EYaS~GeLYDYi---Ser~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 133 EYASGGELYDYI---SERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EecCCccHHHHH---HHhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 999999999999 4678899999999999999999999976 9999999999999999999999999999887433
Q ss_pred CCceeeeecccccccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccc
Q 002349 754 KSYTSTYIMGTIGYIDPEYARTSRL-TEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATC 832 (933)
Q Consensus 754 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (933)
..-+.++|++-|.+||++.|.+| .+.+|-||+||++|.++.|..||++........ .+..+.+.+.-
T Consensus 207 --kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvr--QIs~GaYrEP~-------- 274 (668)
T KOG0611|consen 207 --KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVR--QISRGAYREPE-------- 274 (668)
T ss_pred --cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHH--HhhcccccCCC--------
Confidence 33456799999999999999988 589999999999999999999999765433322 22233333221
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 002349 833 KDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLG 867 (933)
Q Consensus 833 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 867 (933)
.+....-+|++|+..+|++|.|+.+|..+-+
T Consensus 275 ----~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 275 ----TPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred ----CCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 1234456899999999999999999987653
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=357.28 Aligned_cols=261 Identities=24% Similarity=0.413 Sum_probs=205.0
Q ss_pred hhccCcceeeecccceeEEEEEEc------CCceEEEEEecccC-chhHHHHHHHHHHHhcC-CCCceeeeeeEEecCC-
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK------NCKPVAIKRLYSHY-PQCLKEFETELETVGSI-KHRNLVSLQGYSLSSS- 667 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~- 667 (933)
.++|+..+.||+|+||.||+|.+. .++.||||++.... ....+.+.+|+++++++ +||||+++++++...+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 468999999999999999999742 24679999987543 23356789999999999 8999999999887654
Q ss_pred ccEEEEEecCCCCHHHHhcCCCC---------------------------------------------------------
Q 002349 668 GNLLFYDFMENGSLWDILHGPTK--------------------------------------------------------- 690 (933)
Q Consensus 668 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 690 (933)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 57899999999999999863211
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCc-eeeeecccccc
Q 002349 691 --KKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY-TSTYIMGTIGY 767 (933)
Q Consensus 691 --~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y 767 (933)
..++++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++........ ......+++.|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 13578899999999999999999965 9999999999999999999999999999865332222 12233467889
Q ss_pred cCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHHHHHHHHHHH
Q 002349 768 IDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLAL 846 (933)
Q Consensus 768 ~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 846 (933)
+|||++.+..++.++|||||||++|||++ |..||.+............ .+. ....+. ..+..+.+++.
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~-~~~-----~~~~~~-----~~~~~l~~li~ 311 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLK-DGT-----RMRAPE-----NATPEIYRIML 311 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHh-cCC-----CCCCCC-----CCCHHHHHHHH
Confidence 99999999999999999999999999997 9999976443222221111 111 111111 12357889999
Q ss_pred HccCCCCCCCCCHHHHHHHHccCCC
Q 002349 847 LCSKRQPTDRPTMHEVSRVLGSLVP 871 (933)
Q Consensus 847 ~cl~~dP~~RPt~~evl~~L~~~~~ 871 (933)
+||+.||++|||+.|+++.|+.+..
T Consensus 312 ~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 312 ACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=351.03 Aligned_cols=249 Identities=22% Similarity=0.257 Sum_probs=209.5
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
.-|+.++.||+|+.|.|-.|++. .|+.+|||++.... ......+++|+.+|+-+.||||+++++++.+..+.|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 45777888999999999999965 58999999997652 233567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
||+++|.|.+++ ...+++++.++++++.||+.|+.|||.. +|+|||+||+|+|+|..+++||+|||+|..-.
T Consensus 92 Eyv~gGELFdyl---v~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~-- 163 (786)
T KOG0588|consen 92 EYVPGGELFDYL---VRKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEV-- 163 (786)
T ss_pred EecCCchhHHHH---HhhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeeccc--
Confidence 999999999999 5688999999999999999999999955 99999999999999999999999999997532
Q ss_pred CCceeeeecccccccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccc
Q 002349 754 KSYTSTYIMGTIGYIDPEYARTSRL-TEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATC 832 (933)
Q Consensus 754 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (933)
....-...||++.|.+||++.|.+| +.++||||+|||+|.++||+.||+++.--.-+.........++..
T Consensus 164 ~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~--------- 234 (786)
T KOG0588|consen 164 PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSN--------- 234 (786)
T ss_pred CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCc---------
Confidence 2223445699999999999999988 579999999999999999999999654433333333222222221
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 002349 833 KDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLG 867 (933)
Q Consensus 833 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 867 (933)
.+.+..+++++|+..||++|.|++||+++..
T Consensus 235 ----Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 235 ----ISSEAQDLLRRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred ----CCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence 1345677899999999999999999998653
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=316.37 Aligned_cols=236 Identities=22% Similarity=0.276 Sum_probs=202.1
Q ss_pred hccCcceeeecccceeEEEEEEcC-CceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
++|+..+.||.|+||.|..++.+. |..+|+|++.... ..+.+....|..+|+.+.||+++++.+.+.+.+..++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 467778899999999999999764 7789999997653 233455678999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
||++||.|..+++ +.+++++..+.-++.||+.|++|||. .+|++||+||+|||+|.+|.+||+|||.|+.+..
T Consensus 124 eyv~GGElFS~Lr---k~~rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~- 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLR---KSGRFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG- 196 (355)
T ss_pred eccCCccHHHHHH---hcCCCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecC-
Confidence 9999999999994 67789999999999999999999994 5999999999999999999999999999998632
Q ss_pred CCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccccc
Q 002349 754 KSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCK 833 (933)
Q Consensus 754 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (933)
.....+|||.|+|||++..++|..++|-|||||++|||+.|..||.+.........+...+-.++..+
T Consensus 197 ---rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~f--------- 264 (355)
T KOG0616|consen 197 ---RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYF--------- 264 (355)
T ss_pred ---cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCccc---------
Confidence 24568999999999999999999999999999999999999999998777555544443333322222
Q ss_pred CHHHHHHHHHHHHHccCCCCCCC
Q 002349 834 DLGAVKKVFQLALLCSKRQPTDR 856 (933)
Q Consensus 834 ~~~~~~~l~~li~~cl~~dP~~R 856 (933)
...+.+++...+++|-.+|
T Consensus 265 ----s~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 265 ----SSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ----CHHHHHHHHHHHhhhhHhh
Confidence 2356678888999999888
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=311.07 Aligned_cols=250 Identities=23% Similarity=0.336 Sum_probs=212.2
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLF 672 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 672 (933)
.++|+.++.||+|.||.||.|+.+ ++-.||+|++.+.. .+...++.+|+++-+.++||||.+++++|.+....|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 467899999999999999999966 46779999996643 33456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccccc
Q 002349 673 YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV 752 (933)
Q Consensus 673 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 752 (933)
+||..+|++...|++ ....++++.....++.|+|.|+.|+|. ++|+||||||+|+|++..+..|++|||-+..-
T Consensus 101 lEya~~gel~k~L~~-~~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~-- 174 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQE-GRMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA-- 174 (281)
T ss_pred EEecCCchHHHHHHh-cccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeec--
Confidence 999999999999964 355679999999999999999999994 59999999999999999999999999998753
Q ss_pred CCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccc
Q 002349 753 SKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATC 832 (933)
Q Consensus 753 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (933)
........+||..|.|||...+..++..+|+|++|++.||++.|.+||......+....+......++. .
T Consensus 175 -p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~----~----- 244 (281)
T KOG0580|consen 175 -PSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPS----T----- 244 (281)
T ss_pred -CCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCc----c-----
Confidence 244456689999999999999999999999999999999999999999876644444333322222221 1
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 833 KDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 833 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
.+....++|.+|+..+|.+|.+..|++++-
T Consensus 245 ----is~~a~dlI~~ll~~~p~~r~~l~~v~~hp 274 (281)
T KOG0580|consen 245 ----ISGGAADLISRLLVKNPIERLALTEVMDHP 274 (281)
T ss_pred ----cChhHHHHHHHHhccCccccccHHHHhhhH
Confidence 234677899999999999999999998864
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=336.85 Aligned_cols=254 Identities=20% Similarity=0.218 Sum_probs=211.1
Q ss_pred HhhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEE
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLL 671 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 671 (933)
..++|+...+||+|+||.||.|+-+ .|+.+|+|++++.. ....+....|-.+|...++|.||+++-.|.+.+..|+
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4578999999999999999999965 48899999998764 3345567889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccc
Q 002349 672 FYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLC 751 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 751 (933)
||||++||++..+| ...+.+++..+..++.+++.|++.+|+. |+|||||||+|+|||..|.+||+|||+++-+.
T Consensus 219 iMEylPGGD~mTLL---~~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLL---MRKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHH---HhcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhh
Confidence 99999999999999 5678999999999999999999999976 99999999999999999999999999986331
Q ss_pred c----------------------CCCc-----ee-------------------eeecccccccCccccccCCCCcchhhH
Q 002349 752 V----------------------SKSY-----TS-------------------TYIMGTIGYIDPEYARTSRLTEKSDVY 785 (933)
Q Consensus 752 ~----------------------~~~~-----~~-------------------~~~~gt~~y~aPE~~~~~~~~~~~Dvw 785 (933)
. .... .. ...+|||.|||||++.+..|+..+|.|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 1 0000 00 124699999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCC---CHHHH
Q 002349 786 SFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRP---TMHEV 862 (933)
Q Consensus 786 SlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---t~~ev 862 (933)
|+|||+|||+.|.+||.++...+.+.....-...+...... ....+..++|.+|+. ||++|- .++||
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~---------~~s~eA~DLI~rll~-d~~~RLG~~G~~EI 442 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEV---------DLSDEAKDLITRLLC-DPENRLGSKGAEEI 442 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcC---------cccHHHHHHHHHHhc-CHHHhcCcccHHHH
Confidence 99999999999999999998888886654433322221111 123567789999999 999996 57777
Q ss_pred HHH
Q 002349 863 SRV 865 (933)
Q Consensus 863 l~~ 865 (933)
-++
T Consensus 443 K~H 445 (550)
T KOG0605|consen 443 KKH 445 (550)
T ss_pred hcC
Confidence 654
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=374.36 Aligned_cols=262 Identities=29% Similarity=0.466 Sum_probs=216.0
Q ss_pred hhccCcceeeecccceeEEEEEEcC--Cc----eEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCcc
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKN--CK----PVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGN 669 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~--~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 669 (933)
.++.+..+.||+|+||.||+|...+ +. .||||.+.+.. .+...+|.+|+.+|+.++|||||+++|++.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 3455667789999999999999654 32 48999997754 56678899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCC----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecc
Q 002349 670 LLFYDFMENGSLWDILHGPT----KKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFG 745 (933)
Q Consensus 670 ~lv~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfG 745 (933)
++++|||++|+|..+|+..+ ....++..+.+.++.|||+|++||+++ ++|||||.++|+|++....|||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccc
Confidence 99999999999999997532 145789999999999999999999955 99999999999999999999999999
Q ss_pred cccccccCCCceeee-ecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccc
Q 002349 746 IAKSLCVSKSYTSTY-IMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMET 823 (933)
Q Consensus 746 la~~~~~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 823 (933)
+|+.+.....+.... ..-+..|||||.+..+.++.|+|||||||++||++| |..||.+..+.+......... .
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-----R 922 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-----R 922 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-----c
Confidence 999554443333222 234568999999999999999999999999999999 778888766555444222211 1
Q ss_pred cCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCCCC
Q 002349 824 VDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAP 873 (933)
Q Consensus 824 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 873 (933)
++ ++..|++.++++|..||+.+|++||++..+++.+..+....
T Consensus 923 L~-------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 923 LD-------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred cC-------CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 11 13346788999999999999999999999999888776554
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=350.49 Aligned_cols=257 Identities=28% Similarity=0.404 Sum_probs=209.0
Q ss_pred ccCcceeeecccceeEEEEEEcC--C--ce-EEEEEeccc---CchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccE
Q 002349 599 NLSEKYIIGYGASSTVYKCVLKN--C--KP-VAIKRLYSH---YPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNL 670 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~~--~--~~-vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 670 (933)
+....++||+|+||.||+|.++. + .. ||||..+.. ......+|.+|+++++.++|||||+++|++.....++
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence 33445789999999999999653 2 23 899998852 3556788999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccc
Q 002349 671 LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSL 750 (933)
Q Consensus 671 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~ 750 (933)
+|||+|+||+|.++|+. ....++..++..++.++|+||+|||++ +++||||.++|+|++.++.+||+|||+++.-
T Consensus 238 ivmEl~~gGsL~~~L~k--~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKK--NKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred EEEEecCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCC
Confidence 99999999999999963 334699999999999999999999955 9999999999999999999999999999763
Q ss_pred ccCCCceee--eecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCcc
Q 002349 751 CVSKSYTST--YIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPE 827 (933)
Q Consensus 751 ~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 827 (933)
. .+... ...-+..|+|||.+...-|++++|||||||++||+++ |..||.+....+........... ...
T Consensus 313 ~---~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r--~~~--- 384 (474)
T KOG0194|consen 313 S---QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYR--MPI--- 384 (474)
T ss_pred c---ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCcc--CCC---
Confidence 2 11111 1235679999999999999999999999999999999 88899876655433332221111 111
Q ss_pred ccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCCCCC
Q 002349 828 ISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAPE 874 (933)
Q Consensus 828 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 874 (933)
+. ..+..+..++..||..+|++||+|.++.+.++.+.....
T Consensus 385 -~~-----~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 385 -PS-----KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred -CC-----CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 11 235678889999999999999999999999988766544
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=311.57 Aligned_cols=262 Identities=24% Similarity=0.314 Sum_probs=209.2
Q ss_pred hccCcceeeecccceeEEEEE-EcCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCC-----ccEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCV-LKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSS-----GNLL 671 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~l 671 (933)
++|.+.+.+|+|||+.||.++ ..+++.+|+|++.....++.+...+|++..++++||||++++++...+. ..|+
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yl 100 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYL 100 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEE
Confidence 588999999999999999999 4567889999998887778888999999999999999999999875443 4899
Q ss_pred EEEecCCCCHHHHhcCCCC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccc
Q 002349 672 FYDFMENGSLWDILHGPTK-KKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSL 750 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~ 750 (933)
+++|...|+|.+.+..... +..+++.+++.|+.++++||++||+. .++++||||||.||++.+.+.+++.|||.++..
T Consensus 101 l~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a 179 (302)
T KOG2345|consen 101 LLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQA 179 (302)
T ss_pred EeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcccc
Confidence 9999999999999965443 34799999999999999999999987 456999999999999999999999999999865
Q ss_pred ccCCCc--------eeeeecccccccCccccccC---CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccc
Q 002349 751 CVSKSY--------TSTYIMGTIGYIDPEYARTS---RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNA 819 (933)
Q Consensus 751 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 819 (933)
...... .......|..|+|||.+.-+ ..++++|||||||++|+|+.|..||+.... ..+.
T Consensus 180 ~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~---------~GgS 250 (302)
T KOG2345|consen 180 PIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ---------QGGS 250 (302)
T ss_pred ceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh---------cCCe
Confidence 321111 11223578999999988643 568999999999999999999999973211 1111
Q ss_pred c-ccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCC
Q 002349 820 V-METVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLV 870 (933)
Q Consensus 820 ~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 870 (933)
+ .....+.+.-+- +...++.+.+++.+|+++||.+||++.+++..++.+.
T Consensus 251 laLAv~n~q~s~P~-~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 251 LALAVQNAQISIPN-SSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred EEEeeeccccccCC-CCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 1 111111111111 1124678999999999999999999999999887653
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=339.11 Aligned_cols=246 Identities=22% Similarity=0.357 Sum_probs=199.4
Q ss_pred ceeeecccceeEEEEEEcCCceEEEEEecccCchh---HHHHHHHHHHHhcCCCCceeeeeeEEec----CCccEEEEEe
Q 002349 603 KYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQC---LKEFETELETVGSIKHRNLVSLQGYSLS----SSGNLLFYDF 675 (933)
Q Consensus 603 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~ 675 (933)
...||+|++|.||+|.+ +++.||||++....... .+.+.+|+.++++++||||+++++++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 36799999999999998 56899999997653322 4678899999999999999999999876 3467899999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS 755 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 755 (933)
+++|+|.++++ ....+++.....++.+++.|+.|||+. .+++||||||+||++++++.+||+|||+++......
T Consensus 104 ~~~g~L~~~l~---~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 104 CTRGYLREVLD---KEKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCCcHHHHHh---hCCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 99999999995 345789999999999999999999952 378899999999999999999999999998653221
Q ss_pred ceeeeecccccccCcccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccccc
Q 002349 756 YTSTYIMGTIGYIDPEYART--SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCK 833 (933)
Q Consensus 756 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (933)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||.+............... .+..+
T Consensus 178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~------~~~~~---- 244 (283)
T PHA02988 178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNN------SLKLP---- 244 (283)
T ss_pred ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCC------CCCCC----
Confidence 23468899999999976 6799999999999999999999999986543322211111111 11111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccC
Q 002349 834 DLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869 (933)
Q Consensus 834 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 869 (933)
...+..+.+++.+||+.||++|||++|+++.|+..
T Consensus 245 -~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 245 -LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred -CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 12346788999999999999999999999998764
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=317.88 Aligned_cols=253 Identities=23% Similarity=0.311 Sum_probs=208.0
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSH--YPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
.++|+..+.||+|.|+.||++.+. .|+.+|+|.+... .....+++++|+++-+.++|||||++.+.+.+....|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 467888889999999999999865 5788898887543 2446788999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCC---CCCeEEeeccccccc
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDK---DFEAHLTDFGIAKSL 750 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~---~~~~kl~DfGla~~~ 750 (933)
|+|.|++|..-+ ..+...++..+-..++||++||.|+|.+ +|||||+||+|+++.. ...+|++|||+|..+
T Consensus 90 e~m~G~dl~~eI---V~R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 90 DLVTGGELFEDI---VAREFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred ecccchHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 999999997655 2345578888889999999999999965 9999999999999953 356899999999987
Q ss_pred ccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccc
Q 002349 751 CVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISA 830 (933)
Q Consensus 751 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (933)
. ........+|||+|||||+.+..+|+..+|||+.||++|-++.|..||.++....-...+......+.....+.+.
T Consensus 164 ~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is- 240 (355)
T KOG0033|consen 164 N--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVT- 240 (355)
T ss_pred C--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCC-
Confidence 6 3344555789999999999999999999999999999999999999999865544444444444333332222222
Q ss_pred cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 831 TCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 831 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
+...+++++|+..||++|.|+.|.+.+-
T Consensus 241 --------~~Ak~LvrrML~~dP~kRIta~EAL~Hp 268 (355)
T KOG0033|consen 241 --------PEAKSLIRRMLTVNPKKRITADEALKHP 268 (355)
T ss_pred --------HHHHHHHHHHhccChhhhccHHHHhCCc
Confidence 3456789999999999999999987643
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=342.06 Aligned_cols=263 Identities=22% Similarity=0.343 Sum_probs=202.4
Q ss_pred hccCcceeeecccceeEEEEEEcC-----------------CceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeee
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKN-----------------CKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSL 659 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~ 659 (933)
++|...+.||+|+||.||+|.+++ +..||+|.+.... .....+|.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578888999999999999998643 2369999987653 3345679999999999999999999
Q ss_pred eeEEecCCccEEEEEecCCCCHHHHhcCCC----------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeee
Q 002349 660 QGYSLSSSGNLLFYDFMENGSLWDILHGPT----------------KKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIH 723 (933)
Q Consensus 660 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH 723 (933)
++++...+..++||||+++|+|.+++.... ....+++..+.+++.|++.||+|||+. +|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence 999999999999999999999999885311 113578899999999999999999965 9999
Q ss_pred ccCCCCceEeCCCCCeEEeecccccccccCCCce-eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh--CCCC
Q 002349 724 RDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYT-STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT--GRKA 800 (933)
Q Consensus 724 ~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt--g~~p 800 (933)
|||||+||+++.++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 9999999999999999999999998653322211 223345789999999998899999999999999999987 5567
Q ss_pred CCCCcchhHHHHhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcc
Q 002349 801 VDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGS 868 (933)
Q Consensus 801 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 868 (933)
|........................... ...++..+.+++.+||+.||++|||+.+|.+.|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELTDEQVIENAGEFFRDQGRQVYLFR-----PPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCCHHHHHHHHHHHhhhccccccccC-----CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 7654332222111100000000000000 11234678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=334.26 Aligned_cols=255 Identities=22% Similarity=0.357 Sum_probs=205.4
Q ss_pred hccCcceeeecccceeEEEEEEc----CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK----NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLF 672 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 672 (933)
++|+..+.||+|+||.||+|.++ .+..||+|.++... ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 56888999999999999999864 35689999987653 23346789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccccc
Q 002349 673 YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV 752 (933)
Q Consensus 673 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 752 (933)
|||+++|+|.+++.. ....+++..+..++.|++.||+|||++ +++||||||+||+++.++.+|++|||.+.....
T Consensus 85 ~e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 85 TEYMSNGALDSFLRK--HEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEeCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 999999999999963 345789999999999999999999965 999999999999999999999999998765422
Q ss_pred CCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCcccccc
Q 002349 753 SKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISAT 831 (933)
Q Consensus 753 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (933)
..........++..|+|||.+.+..++.++|||||||++||+++ |+.||.+........... ... ....+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~--~~~-----~~~~~-- 230 (266)
T cd05064 160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE--DGF-----RLPAP-- 230 (266)
T ss_pred cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH--CCC-----CCCCC--
Confidence 22222222345678999999999999999999999999999775 999997654333222111 110 01111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccC
Q 002349 832 CKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869 (933)
Q Consensus 832 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 869 (933)
...+..+.+++.+||+.+|++||+++++.+.|..+
T Consensus 231 ---~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 231 ---RNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ---CCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 12346788999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=330.17 Aligned_cols=251 Identities=25% Similarity=0.389 Sum_probs=204.8
Q ss_pred hccCcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecC
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFME 677 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 677 (933)
++|+..+.||+|+||.||+|.++++..+|+|.+.... ...+++.+|++++++++||||+++++++..+...++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 4677888999999999999999888889999886432 234678899999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCce
Q 002349 678 NGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYT 757 (933)
Q Consensus 678 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 757 (933)
+|+|.++++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+|++|||.++.........
T Consensus 83 ~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 83 NGCLLNYLRQ--RQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 9999999863 234689999999999999999999965 99999999999999999999999999998653322222
Q ss_pred eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCccccccccCHH
Q 002349 758 STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLG 836 (933)
Q Consensus 758 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (933)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||................ .. ..+. .
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~-~~---~~~~--------~ 225 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF-RL---YRPK--------L 225 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-CC---CCCC--------C
Confidence 222345678999999998889999999999999999999 899997654433322221111 00 0011 1
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 837 AVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 837 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
.+..+.+++.+||+.+|++||+++++++.|
T Consensus 226 ~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 226 ASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 135688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=340.55 Aligned_cols=262 Identities=21% Similarity=0.247 Sum_probs=204.9
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYD 674 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 674 (933)
++|++.+.||+|+||+||+|+++ +++.||+|++.... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36888999999999999999986 46789999986542 3345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCC
Q 002349 675 FMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSK 754 (933)
Q Consensus 675 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 754 (933)
|++++.+..+.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 999887765542 345789999999999999999999965 99999999999999999999999999998764333
Q ss_pred CceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccc-------------
Q 002349 755 SYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVM------------- 821 (933)
Q Consensus 755 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~------------- 821 (933)
........|++.|+|||++.+..++.++||||+||++|||++|+.||.+..............+...
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07848 155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF 234 (287)
T ss_pred cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence 3333345789999999999988899999999999999999999999986554443322111111000
Q ss_pred -cccCcccccccc-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 822 -ETVDPEISATCK-----DLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 822 -~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
....+....... ....+..+.+++.+|++.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000000 00124568999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=337.39 Aligned_cols=252 Identities=21% Similarity=0.255 Sum_probs=200.2
Q ss_pred ccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEE
Q 002349 599 NLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYD 674 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 674 (933)
.|+..+.||+|+||+||+|.+. +++.||+|.+.... ......+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3677889999999999999964 68899999986532 2233457889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCC
Q 002349 675 FMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSK 754 (933)
Q Consensus 675 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 754 (933)
|+++|+|.+++.. .....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++......
T Consensus 81 ~~~~g~L~~~~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYN-MGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHh-hCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 9999999988753 2234689999999999999999999965 99999999999999999999999999998653222
Q ss_pred CceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccC
Q 002349 755 SYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKD 834 (933)
Q Consensus 755 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (933)
......||..|+|||++.+..++.++||||+||++|||++|+.||..................... ....
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~---- 226 (285)
T cd05631 157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQE----EYSE---- 226 (285)
T ss_pred --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccc----cCCc----
Confidence 223457999999999999999999999999999999999999999864332111110000000000 0111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 002349 835 LGAVKKVFQLALLCSKRQPTDRPT-----MHEVSRV 865 (933)
Q Consensus 835 ~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 865 (933)
..+..+.+++.+||+.||++||+ +++++++
T Consensus 227 -~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 227 -KFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred -cCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 12356788999999999999997 7888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=340.65 Aligned_cols=246 Identities=22% Similarity=0.236 Sum_probs=203.0
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
++|+..+.||+|+||.||+|..+ +++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888899999999999999976 57899999986432 233456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
||+++|+|.+++. ..+.+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLR---NSGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 9999999999994 456789999999999999999999965 9999999999999999999999999999865321
Q ss_pred CCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccccc
Q 002349 754 KSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCK 833 (933)
Q Consensus 754 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (933)
.....|++.|+|||++.+..++.++||||+||++|+|++|+.||.+............... .++..
T Consensus 155 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~--------~~~~~-- 220 (291)
T cd05612 155 ----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKL--------EFPRH-- 220 (291)
T ss_pred ----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc--------CCCcc--
Confidence 1234699999999999999999999999999999999999999986544332222111111 11111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHH
Q 002349 834 DLGAVKKVFQLALLCSKRQPTDRPT-----MHEVSRVL 866 (933)
Q Consensus 834 ~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~L 866 (933)
....+.+++.+|++.||.+||+ +++++++-
T Consensus 221 ---~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 255 (291)
T cd05612 221 ---LDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR 255 (291)
T ss_pred ---CCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence 1346788999999999999995 88888653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=345.51 Aligned_cols=242 Identities=22% Similarity=0.259 Sum_probs=198.5
Q ss_pred eeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecCCC
Q 002349 604 YIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENG 679 (933)
Q Consensus 604 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 679 (933)
+.||+|+||.||+|..+ +++.||+|++.... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999975 57899999987542 233456788999999999999999999999999999999999999
Q ss_pred CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCceee
Q 002349 680 SLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTST 759 (933)
Q Consensus 680 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 759 (933)
+|.+++. ..+.+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.... ......
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~-~~~~~~ 153 (323)
T cd05571 81 ELFFHLS---RERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS-DGATMK 153 (323)
T ss_pred cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCccccc-CCCccc
Confidence 9999984 456789999999999999999999965 999999999999999999999999999875322 122233
Q ss_pred eecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHHHH
Q 002349 760 YIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVK 839 (933)
Q Consensus 760 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 839 (933)
...||+.|+|||++.+..++.++||||+||++|||++|+.||.+............... .++. ....
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~--------~~p~-----~~~~ 220 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI--------RFPR-----TLSP 220 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC--------CCCC-----CCCH
Confidence 45799999999999999999999999999999999999999976543332222111111 1111 1235
Q ss_pred HHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002349 840 KVFQLALLCSKRQPTDRP-----TMHEVSRV 865 (933)
Q Consensus 840 ~l~~li~~cl~~dP~~RP-----t~~evl~~ 865 (933)
.+.+++.+|++.||++|| ++.+++++
T Consensus 221 ~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 221 EAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred HHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 688899999999999999 79998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=345.68 Aligned_cols=245 Identities=20% Similarity=0.236 Sum_probs=203.1
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
++|+..+.||+|+||.||+|+++ +++.||+|++.... ....+.+.+|++++++++||||+++++++..++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 57888999999999999999976 47889999986532 234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
||+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLR---KAGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 9999999999994 456789999999999999999999965 9999999999999999999999999999865322
Q ss_pred CCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccccc
Q 002349 754 KSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCK 833 (933)
Q Consensus 754 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (933)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.+........... ... ..++..
T Consensus 172 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~--~~~------~~~p~~-- 237 (329)
T PTZ00263 172 ----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKIL--AGR------LKFPNW-- 237 (329)
T ss_pred ----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHh--cCC------cCCCCC--
Confidence 123579999999999999999999999999999999999999998655433322211 111 011111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 002349 834 DLGAVKKVFQLALLCSKRQPTDRPT-----MHEVSRV 865 (933)
Q Consensus 834 ~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 865 (933)
....+.+++.+||+.||++||+ +++++.+
T Consensus 238 ---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 238 ---FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ---CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1246788999999999999996 6777765
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=322.96 Aligned_cols=264 Identities=26% Similarity=0.298 Sum_probs=208.8
Q ss_pred HHhhccCcceeeecccceeEEEEEEc-CCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCceeeeeeEEec-----C
Q 002349 595 RMTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSH--YPQCLKEFETELETVGSIKHRNLVSLQGYSLS-----S 666 (933)
Q Consensus 595 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~ 666 (933)
.....|...+.||+|+||.|++|.++ +++.||+|++... ..-..++..+|+++++.++|+||+.+.+++.. -
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 34456666788999999999999966 5789999999743 34456778999999999999999999999865 2
Q ss_pred CccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccc
Q 002349 667 SGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGI 746 (933)
Q Consensus 667 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl 746 (933)
...|+|+|+| +.+|...++ .+..++...+..+++|+++||.|+| |.+|+|||+||+|++++.+...||+|||+
T Consensus 99 ~DvYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred ceeEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccc
Confidence 4679999999 569999994 4556999999999999999999999 45999999999999999999999999999
Q ss_pred ccccccC-CCceeeeecccccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccccccccc
Q 002349 747 AKSLCVS-KSYTSTYIMGTIGYIDPEYART-SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETV 824 (933)
Q Consensus 747 a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 824 (933)
|+..... .....+..+.|.+|+|||++.. ..|+.+.||||.||++.||++|+.-|.+.....++..+...-+...+..
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~ 251 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED 251 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH
Confidence 9987432 2223456678999999998754 5799999999999999999999999998877777654433322221111
Q ss_pred Cccc---------ccc----ccCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 825 DPEI---------SAT----CKDL-----GAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 825 ~~~~---------~~~----~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
...+ ... ..+. ......++++.+|+..||.+|+|++|.+++
T Consensus 252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 252 LQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000 000 0000 123567889999999999999999999874
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=321.24 Aligned_cols=264 Identities=23% Similarity=0.299 Sum_probs=211.9
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccCch--hHHHHHHHHHHHhcCCCCc-eeeeeeEEecCC-----
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQ--CLKEFETELETVGSIKHRN-LVSLQGYSLSSS----- 667 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~----- 667 (933)
.+.|...++||+|+||+||+|+.+ .|+.||+|+++-...+ .-....+|+.++++++|+| ||++++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 345666678999999999999965 5789999999765432 3345689999999999999 999999998877
Q ss_pred -ccEEEEEecCCCCHHHHhcCCCCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecc
Q 002349 668 -GNLLFYDFMENGSLWDILHGPTKK-KKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFG 745 (933)
Q Consensus 668 -~~~lv~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfG 745 (933)
..++||||++. +|.+++...... ..++...+..++.|+++||+|||++ +|+||||||.||+++++|.+||+|||
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccc
Confidence 67899999965 899999643221 4677889999999999999999966 99999999999999999999999999
Q ss_pred cccccccCCCceeeeecccccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccccccccc
Q 002349 746 IAKSLCVSKSYTSTYIMGTIGYIDPEYARTS-RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETV 824 (933)
Q Consensus 746 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 824 (933)
+|+....... ..+..++|.+|+|||++.+. .|+...||||+||+++||++++.-|.+..+..++..+...-+...+..
T Consensus 166 lAra~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 166 LARAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD 244 (323)
T ss_pred hHHHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence 9997653322 23445789999999999887 789999999999999999999999999888888776655544443333
Q ss_pred Cccccccc------------cCHH--H---HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 825 DPEISATC------------KDLG--A---VKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 825 ~~~~~~~~------------~~~~--~---~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
+|.+.... .+.. . .....+++.+|++.+|.+|.|++.++++
T Consensus 245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 33322110 0000 0 1367889999999999999999999886
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=330.31 Aligned_cols=256 Identities=23% Similarity=0.367 Sum_probs=208.7
Q ss_pred hhccCcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEec
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFM 676 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 676 (933)
.++|+..++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 35788899999999999999998888889999886543 23567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCc
Q 002349 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY 756 (933)
Q Consensus 677 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 756 (933)
++++|.++++. .....+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||+++........
T Consensus 84 ~~~~L~~~l~~-~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 84 AKGSLLDFLKS-DEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCcHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 99999999864 2345689999999999999999999965 9999999999999999999999999999876433222
Q ss_pred eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCccccccccCH
Q 002349 757 TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDL 835 (933)
Q Consensus 757 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (933)
......++..|+|||++.+..++.++|||||||++|+|++ |+.||............. ... ..... .
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~--~~~-----~~~~~-----~ 227 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQ--RGY-----RMPRM-----E 227 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHH--cCC-----CCCCC-----C
Confidence 2223346778999999998889999999999999999998 999997544332222111 110 00000 1
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccC
Q 002349 836 GAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869 (933)
Q Consensus 836 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 869 (933)
..+..+.+++.+|+..+|++||+++++.+.|+.+
T Consensus 228 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 228 NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 1245788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=341.32 Aligned_cols=242 Identities=23% Similarity=0.276 Sum_probs=198.1
Q ss_pred eeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecCCC
Q 002349 604 YIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENG 679 (933)
Q Consensus 604 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 679 (933)
+.||+|+||.||+|..+ +++.||+|++.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999965 57899999997542 234567888999999999999999999999999999999999999
Q ss_pred CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCceee
Q 002349 680 SLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTST 759 (933)
Q Consensus 680 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 759 (933)
+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~ 153 (328)
T cd05593 81 ELFFHLS---RERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATMK 153 (328)
T ss_pred CHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCc-ccccc
Confidence 9999884 345789999999999999999999965 9999999999999999999999999998753221 22233
Q ss_pred eecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHHHH
Q 002349 760 YIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVK 839 (933)
Q Consensus 760 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 839 (933)
...||+.|+|||++.+..++.++||||+||++|+|++|+.||................ ..++. ....
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~--------~~~p~-----~~~~ 220 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED--------IKFPR-----TLSA 220 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCC--------ccCCC-----CCCH
Confidence 4579999999999999899999999999999999999999997654332222111111 11111 1235
Q ss_pred HHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002349 840 KVFQLALLCSKRQPTDRP-----TMHEVSRV 865 (933)
Q Consensus 840 ~l~~li~~cl~~dP~~RP-----t~~evl~~ 865 (933)
.+.+++.+|++.||++|| ++.|++++
T Consensus 221 ~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 221 DAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 678899999999999997 89998875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=341.82 Aligned_cols=242 Identities=20% Similarity=0.260 Sum_probs=204.0
Q ss_pred hhccCcceeeecccceeEEEEEEcC-CceEEEEEecccC---chhHHHHHHHHHHHhcC-CCCceeeeeeEEecCCccEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHY---PQCLKEFETELETVGSI-KHRNLVSLQGYSLSSSGNLL 671 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 671 (933)
.++|....+||+|.||+|++|..++ ++.+|||++++.. ....+..+.|.+++... +||.++.++..|...++.|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 4678889999999999999999875 6789999998764 34456677888888777 59999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccc
Q 002349 672 FYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLC 751 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 751 (933)
||||+.||++..+. ..+.+++..+.-++..|+.||+|||++ +||+||||.+|||+|.+|.+||+|||+++..
T Consensus 447 vmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~- 518 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEG- 518 (694)
T ss_pred EEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccccccc-
Confidence 99999999954443 457899999999999999999999977 9999999999999999999999999999864
Q ss_pred cCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccc
Q 002349 752 VSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISAT 831 (933)
Q Consensus 752 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (933)
......+...+|||.|||||++.+..|+.++|-|||||++|||+.|..||.++...+....+...+..+ +.
T Consensus 519 m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~y--------P~- 589 (694)
T KOG0694|consen 519 MGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRY--------PR- 589 (694)
T ss_pred CCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCC--------CC-
Confidence 223335667899999999999999999999999999999999999999999776655554433322211 11
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCH
Q 002349 832 CKDLGAVKKVFQLALLCSKRQPTDRPTM 859 (933)
Q Consensus 832 ~~~~~~~~~l~~li~~cl~~dP~~RPt~ 859 (933)
..+.+...++++++.++|++|.-+
T Consensus 590 ----~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 590 ----FLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ----cccHHHHHHHHHHhccCcccccCC
Confidence 234678889999999999999755
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=335.16 Aligned_cols=261 Identities=21% Similarity=0.256 Sum_probs=201.2
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEe
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
++|+..+.||+|+||+||+|..+ +++.||+|+++... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56888999999999999999976 57889999986543 23345678999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS 755 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 755 (933)
+++ +|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 85 ~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~- 157 (288)
T cd07871 85 LDS-DLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT- 157 (288)
T ss_pred CCc-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC-
Confidence 975 89998852 334678999999999999999999965 99999999999999999999999999997643222
Q ss_pred ceeeeecccccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccc------
Q 002349 756 YTSTYIMGTIGYIDPEYART-SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEI------ 828 (933)
Q Consensus 756 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 828 (933)
.......|++.|+|||++.+ ..++.++||||+||++|+|++|+.||.+..............+.......+.+
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence 12233468999999998865 56899999999999999999999999865544333222111111000000000
Q ss_pred -----cccc-c-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 829 -----SATC-K-----DLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 829 -----~~~~-~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
+... . ......+..+++.+|++.||.+|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000 0 00123567899999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=339.11 Aligned_cols=251 Identities=25% Similarity=0.320 Sum_probs=210.9
Q ss_pred hccCcceeeecccceeEEEEEEcC-CceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCc-cEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSG-NLLFY 673 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~lv~ 673 (933)
++|...+.+|+|+||.++.++++. .+.+|+|++.-.. ....+...+|+.++++++|||||.+.+.|..++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 578888999999999999999764 6789999986543 3345578999999999999999999999999988 89999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
+||+||++.+.+.. +++..++++.+..++.|++.|++|||++ +|+|||||+.|||++.+..|||+|||+|+.+...
T Consensus 84 ~Y~eGg~l~~~i~~-~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKE-QKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHH-HhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 99999999999975 3356799999999999999999999965 9999999999999999999999999999988644
Q ss_pred CCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccccc
Q 002349 754 KSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCK 833 (933)
Q Consensus 754 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (933)
.. ....++||+.||.||.+.+.+|..|+||||+||++|||++-+.+|...... .++....... ...+ +
T Consensus 160 ~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~-~Li~ki~~~~--~~Pl----p---- 227 (426)
T KOG0589|consen 160 DS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS-ELILKINRGL--YSPL----P---- 227 (426)
T ss_pred hh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH-HHHHHHhhcc--CCCC----C----
Confidence 42 345578999999999999999999999999999999999999999865433 3332221111 1111 1
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 834 DLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 834 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.....++..++..|++.+|..||++.+++..
T Consensus 228 -~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 228 -SMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -ccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1234678899999999999999999999874
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=345.80 Aligned_cols=253 Identities=20% Similarity=0.240 Sum_probs=206.5
Q ss_pred ccCcceeeecccceeEEEEEEcC-CceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEE
Q 002349 599 NLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYD 674 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 674 (933)
+|+..+.||+|+||.||+|.+.. ++.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 68889999999999999999764 7899999987542 2334568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCC
Q 002349 675 FMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSK 754 (933)
Q Consensus 675 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 754 (933)
|+++|+|.++++ ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 82 ~~~g~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 82 YVPGGDFRTLLN---NLGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred CCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 999999999994 456789999999999999999999965 999999999999999999999999999976532
Q ss_pred CceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccC
Q 002349 755 SYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKD 834 (933)
Q Consensus 755 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (933)
......||+.|+|||++.+..++.++||||+||++|||++|+.||........+............ +.... ..
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~---~~~~~--~~ 226 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQR---PVYDD--PR 226 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccC---CCCCc--cc
Confidence 223457999999999999999999999999999999999999999865544333222111111110 11000 01
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 835 LGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 835 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
...+..+.+++.+|+..+|++||++++++++-
T Consensus 227 ~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~ 258 (333)
T cd05600 227 FNLSDEAWDLITKLINDPSRRFGSLEDIKNHP 258 (333)
T ss_pred cccCHHHHHHHHHHhhChhhhcCCHHHHHhCc
Confidence 12346788999999999999999999999763
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=347.88 Aligned_cols=259 Identities=22% Similarity=0.329 Sum_probs=204.1
Q ss_pred hhccCcceeeecccceeEEEEEEc------CCceEEEEEecccC-chhHHHHHHHHHHHhcC-CCCceeeeeeEEecCCc
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK------NCKPVAIKRLYSHY-PQCLKEFETELETVGSI-KHRNLVSLQGYSLSSSG 668 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 668 (933)
.++|+..+.||+|+||.||+|.+. .+..||||+++... ....+.+.+|+++++.+ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 357888999999999999999742 35679999987543 33456788999999999 89999999999999999
Q ss_pred cEEEEEecCCCCHHHHhcCCC-----------------------------------------------------------
Q 002349 669 NLLFYDFMENGSLWDILHGPT----------------------------------------------------------- 689 (933)
Q Consensus 669 ~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------- 689 (933)
.++||||+++|+|.++++...
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999999985321
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCc
Q 002349 690 -------------KKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY 756 (933)
Q Consensus 690 -------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 756 (933)
....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 012578899999999999999999965 9999999999999999999999999999866432221
Q ss_pred e-eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCccccccccC
Q 002349 757 T-STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKD 834 (933)
Q Consensus 757 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (933)
. .....++..|+|||.+.+..++.++|||||||++|||++ |..||.............. ... .+..+.
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~-~~~-----~~~~~~---- 340 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIK-EGY-----RMLSPE---- 340 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHH-hCc-----cCCCCC----
Confidence 1 122345678999999999999999999999999999998 8889875433222221111 110 011111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccC
Q 002349 835 LGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869 (933)
Q Consensus 835 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 869 (933)
..+.++.+++.+|++.||++||+++||++.|+..
T Consensus 341 -~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 341 -CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred -CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 1235788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=308.66 Aligned_cols=256 Identities=26% Similarity=0.359 Sum_probs=213.8
Q ss_pred HHHhhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC----ch----hHHHHHHHHHHHhcC-CCCceeeeeeEE
Q 002349 594 MRMTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY----PQ----CLKEFETELETVGSI-KHRNLVSLQGYS 663 (933)
Q Consensus 594 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~----~~~~~~~E~~~l~~l-~h~niv~~~~~~ 663 (933)
...-+.|...+.+|.|..++|-++.++ +++++|+|++.... .+ ..+.-.+|+.+|+++ .||+|+++.+++
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 344567888899999999999998866 57889999985432 11 223346799999999 699999999999
Q ss_pred ecCCccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEee
Q 002349 664 LSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTD 743 (933)
Q Consensus 664 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 743 (933)
..+...++|+|.|+.|.|.|++ ...-.+++.+..+|++|+.+|++|||.. +|||||+||+|||+|++.++||+|
T Consensus 93 es~sF~FlVFdl~prGELFDyL---ts~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYL---TSKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred cCcchhhhhhhhcccchHHHHh---hhheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEec
Confidence 9999999999999999999999 4556799999999999999999999965 999999999999999999999999
Q ss_pred cccccccccCCCceeeeecccccccCcccccc------CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcc
Q 002349 744 FGIAKSLCVSKSYTSTYIMGTIGYIDPEYART------SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTAN 817 (933)
Q Consensus 744 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~ 817 (933)
||.|+.+.. ...-...+|||+|+|||.++. ..|+..+|+|++||++|.++.|.+||.....+..+..+....
T Consensus 167 FGFa~~l~~--GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGk 244 (411)
T KOG0599|consen 167 FGFACQLEP--GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGK 244 (411)
T ss_pred cceeeccCC--chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcc
Confidence 999998743 334456899999999998864 357889999999999999999999999877777776666655
Q ss_pred cccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 818 NAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
..+...-+..+ .....++|.+|++.||.+|-|++|++++-
T Consensus 245 yqF~speWadi---------s~~~KdLIsrlLqVdp~~Ritake~LaHp 284 (411)
T KOG0599|consen 245 YQFRSPEWADI---------SATVKDLISRLLQVDPTKRITAKEALAHP 284 (411)
T ss_pred cccCCcchhhc---------cccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence 55544333222 34567789999999999999999998743
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=340.13 Aligned_cols=261 Identities=23% Similarity=0.333 Sum_probs=204.7
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEe
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
++|+..+.||+|+||.||+|+++ .+..||+|.+.... ....+.+.+|++++++++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 67889999999999999999976 47789999887543 33456799999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS 755 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 755 (933)
+++++|.+++. ....+++..+..++.|++.||.|||+. .+|+||||||+||+++.++.+||+|||++......
T Consensus 85 ~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 157 (331)
T cd06649 85 MDGGSLDQVLK---EAKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (331)
T ss_pred CCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence 99999999995 345689999999999999999999963 26999999999999999999999999999765322
Q ss_pred ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcc----cccccccCc-----
Q 002349 756 YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTAN----NAVMETVDP----- 826 (933)
Q Consensus 756 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~----- 826 (933)
......|++.|+|||++.+..++.++|||||||++|||++|+.||................ ........+
T Consensus 158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (331)
T cd06649 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP 236 (331)
T ss_pred -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccc
Confidence 2233568999999999999999999999999999999999999997543322111100000 000000000
Q ss_pred --------------------------cccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 827 --------------------------EISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 827 --------------------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
.............++.+++.+||+.||++|||+.|++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred cccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 0000000011346789999999999999999999999764
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=339.93 Aligned_cols=240 Identities=23% Similarity=0.256 Sum_probs=194.6
Q ss_pred eecccceeEEEEEEc-CCceEEEEEeccc---CchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecCCCCH
Q 002349 606 IGYGASSTVYKCVLK-NCKPVAIKRLYSH---YPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSL 681 (933)
Q Consensus 606 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 681 (933)
||+|+||.||+|... +++.||+|++... .......+.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999976 4788999998653 233456678899999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCceeeee
Q 002349 682 WDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYI 761 (933)
Q Consensus 682 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 761 (933)
.+++. ..+.+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..... .......
T Consensus 81 ~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~~ 153 (312)
T cd05585 81 FHHLQ---REGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD-DDKTNTF 153 (312)
T ss_pred HHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccC-CCccccc
Confidence 99995 356789999999999999999999965 9999999999999999999999999999754222 2223345
Q ss_pred cccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHHHHHH
Q 002349 762 MGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKV 841 (933)
Q Consensus 762 ~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 841 (933)
.||+.|+|||++.+..++.++||||+||++|||++|+.||.+.............. ..++. .....+
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~--------~~~~~-----~~~~~~ 220 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEP--------LRFPD-----GFDRDA 220 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC--------CCCCC-----cCCHHH
Confidence 79999999999999999999999999999999999999998654333222111110 11111 123567
Q ss_pred HHHHHHccCCCCCCCCC---HHHHHHH
Q 002349 842 FQLALLCSKRQPTDRPT---MHEVSRV 865 (933)
Q Consensus 842 ~~li~~cl~~dP~~RPt---~~evl~~ 865 (933)
.+++.+|++.||++||+ +.|++.+
T Consensus 221 ~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 221 KDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred HHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 88999999999999985 5555543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=325.00 Aligned_cols=259 Identities=20% Similarity=0.218 Sum_probs=205.0
Q ss_pred HHhhccCcceeeecccceeEEEEEEc-CCceEEEEEecccCc----------h----hHHHHHHHHHHHhcCCCCceeee
Q 002349 595 RMTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYP----------Q----CLKEFETELETVGSIKHRNLVSL 659 (933)
Q Consensus 595 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----------~----~~~~~~~E~~~l~~l~h~niv~~ 659 (933)
...++|+....||+|.||.|-+|+.. +++.||+|++.+... . ..++..+|+.+|++++|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 44578999999999999999999965 578899999965321 0 12467899999999999999999
Q ss_pred eeEEecC--CccEEEEEecCCCCHHHHhcCCCCCCC-CCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCC
Q 002349 660 QGYSLSS--SGNLLFYDFMENGSLWDILHGPTKKKK-LDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKD 736 (933)
Q Consensus 660 ~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~ 736 (933)
+.+..+. +..|+|+|||..|.+...- ..++ ++..++.++++++..||+|||-+ +|+||||||+|+|++++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCC
Confidence 9998765 5789999999988764432 3344 89999999999999999999965 99999999999999999
Q ss_pred CCeEEeecccccccccCCC----ceeeeecccccccCccccccCC----CCcchhhHHHHHHHHHHHhCCCCCCCCcchh
Q 002349 737 FEAHLTDFGIAKSLCVSKS----YTSTYIMGTIGYIDPEYARTSR----LTEKSDVYSFGIVLLELLTGRKAVDNECNLH 808 (933)
Q Consensus 737 ~~~kl~DfGla~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGv~l~elltg~~p~~~~~~~~ 808 (933)
|+|||+|||.+........ ..-...+|||.|+|||...++. .+.+.||||+||++|.|+.|+.||-++..++
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~ 326 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE 326 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH
Confidence 9999999999986622211 1122368999999999887732 3578999999999999999999998876665
Q ss_pred HHHHhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCC
Q 002349 809 HLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVP 871 (933)
Q Consensus 809 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 871 (933)
....+....-.++ .. .+..+.+.++|.+++.+||+.|.+..+|..+.+-...
T Consensus 327 l~~KIvn~pL~fP--------~~---pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 327 LFDKIVNDPLEFP--------EN---PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HHHHHhcCcccCC--------Cc---ccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 5443322211111 11 1234678889999999999999999999988765544
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=342.85 Aligned_cols=246 Identities=25% Similarity=0.253 Sum_probs=202.5
Q ss_pred hhccCcceeeecccceeEEEEEEcC--CceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKN--CKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLL 671 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 671 (933)
.++|+..+.||+|+||.||+|.++. +..||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3578889999999999999998654 3689999986432 2345668899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccc
Q 002349 672 FYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLC 751 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 751 (933)
||||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 109 v~Ey~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLR---RNKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 999999999999995 445789999999999999999999965 99999999999999999999999999998653
Q ss_pred cCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccc
Q 002349 752 VSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISAT 831 (933)
Q Consensus 752 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (933)
.. .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+............... ..++.
T Consensus 183 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~----~~p~~---- 250 (340)
T PTZ00426 183 TR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII----YFPKF---- 250 (340)
T ss_pred CC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCC----CCCCC----
Confidence 21 2345799999999999998899999999999999999999999986554332222111110 01111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002349 832 CKDLGAVKKVFQLALLCSKRQPTDRP-----TMHEVSRV 865 (933)
Q Consensus 832 ~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 865 (933)
....+.+++.+|++.||++|+ +++++.++
T Consensus 251 -----~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 251 -----LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -----CCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 124577899999999999995 89998875
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=336.97 Aligned_cols=262 Identities=22% Similarity=0.281 Sum_probs=200.3
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYD 674 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 674 (933)
.++|+..+.||+|+||.||+|..+ +++.||+|++.... ......+.+|++++++++||||+++++++..+...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999976 57899999986543 2234567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCC
Q 002349 675 FMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSK 754 (933)
Q Consensus 675 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 754 (933)
|++ ++|.+++. .....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMD--KHPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 996 57888775 2346689999999999999999999965 99999999999999999999999999997543221
Q ss_pred CceeeeecccccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhc-cccccc----------
Q 002349 755 SYTSTYIMGTIGYIDPEYART-SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTA-NNAVME---------- 822 (933)
Q Consensus 755 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~-~~~~~~---------- 822 (933)
.......|++.|+|||++.+ ..++.++||||+||++|+|++|+.||.+..+.......... ......
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T cd07869 158 -HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP 236 (303)
T ss_pred -ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcc
Confidence 22233568999999998865 45789999999999999999999999865443322111100 000000
Q ss_pred ccCcc-c--------cccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 823 TVDPE-I--------SATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 823 ~~~~~-~--------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
...+. . ............+.+++.+|++.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 00000 0 0000000112457789999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=339.30 Aligned_cols=244 Identities=25% Similarity=0.395 Sum_probs=202.1
Q ss_pred eeecccceeEEEEEEcC-CceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecCCCCHHH
Q 002349 605 IIGYGASSTVYKCVLKN-CKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWD 683 (933)
Q Consensus 605 ~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~ 683 (933)
+||+|.||+||-|++.+ ...+|||.+.....+..+.+.+|+...++++|.|||+++|.+.+++..-|+||-++||||.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 79999999999999776 45689999988777778889999999999999999999999999998899999999999999
Q ss_pred HhcCCCCCCCC--CHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCC-CCCeEEeecccccccccCCCceeee
Q 002349 684 ILHGPTKKKKL--DWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDK-DFEAHLTDFGIAKSLCVSKSYTSTY 760 (933)
Q Consensus 684 ~l~~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~~ 760 (933)
+++ .+=+++ .+.+.--+.+||++||.|||++ .|||||||-+|||++. .|.+||+|||-++++.. -......
T Consensus 662 LLr--skWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TET 735 (1226)
T KOG4279|consen 662 LLR--SKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTET 735 (1226)
T ss_pred HHH--hccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhcc-CCccccc
Confidence 996 344566 7888888999999999999977 9999999999999975 58899999999988743 2333455
Q ss_pred ecccccccCccccccC--CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHHH
Q 002349 761 IMGTIGYIDPEYARTS--RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAV 838 (933)
Q Consensus 761 ~~gt~~y~aPE~~~~~--~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (933)
..||..|||||++..+ .|..++|||||||++.||.||++||..-... +-.+.+....... |.++ .+..
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp-qAAMFkVGmyKvH----P~iP-----eels 805 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP-QAAMFKVGMYKVH----PPIP-----EELS 805 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh-hHhhhhhcceecC----CCCc-----HHHH
Confidence 7899999999999765 5899999999999999999999999743222 2222223222222 2222 2345
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHH
Q 002349 839 KKVFQLALLCSKRQPTDRPTMHEVSR 864 (933)
Q Consensus 839 ~~l~~li~~cl~~dP~~RPt~~evl~ 864 (933)
.+...+|.+|+.+||.+||++.++++
T Consensus 806 aeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 806 AEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHcCCCcccCccHHHhcc
Confidence 67778999999999999999999986
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=323.83 Aligned_cols=256 Identities=25% Similarity=0.306 Sum_probs=202.1
Q ss_pred ccCcceeeecccceeEEEEEEcC-CceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCc-----cEEE
Q 002349 599 NLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSG-----NLLF 672 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-----~~lv 672 (933)
.|...+++|.|+||.||+|+... ++.||||+...+.. .-.+|+++|+.++|||||++.-+|..... ..+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 56778899999999999999664 68999999865532 22579999999999999999998865332 3489
Q ss_pred EEecCCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCC-CCeEEeeccccccc
Q 002349 673 YDFMENGSLWDILHGP-TKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKD-FEAHLTDFGIAKSL 750 (933)
Q Consensus 673 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~-~~~kl~DfGla~~~ 750 (933)
||||+. +|.+.++.. ..+..++.-.+.-+..|+.+||+|||+. +|+||||||.|+|+|.+ |.+||||||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999986 899888532 2356788889999999999999999965 99999999999999977 89999999999987
Q ss_pred ccCCCceeeeecccccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccc--------
Q 002349 751 CVSKSYTSTYIMGTIGYIDPEYARTS-RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVM-------- 821 (933)
Q Consensus 751 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------- 821 (933)
...... .....|..|+|||.+.|. .|+.+.||||.|||+.||+-|++-|.++....++..+...-+...
T Consensus 177 ~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn 254 (364)
T KOG0658|consen 177 VKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN 254 (364)
T ss_pred ccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence 544433 344578899999999875 799999999999999999999999999888888765433322221
Q ss_pred ----cccCccccccc----cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002349 822 ----ETVDPEISATC----KDLGAVKKVFQLALLCSKRQPTDRPTMHEVSR 864 (933)
Q Consensus 822 ----~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 864 (933)
+...+.+.... -....+.+..+++.++++.+|.+|.++.|++.
T Consensus 255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 11112221111 01123467899999999999999999999985
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=324.26 Aligned_cols=252 Identities=23% Similarity=0.331 Sum_probs=204.0
Q ss_pred hccCcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecC
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFME 677 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 677 (933)
++|...+.||+|+||+||+|.++++..+|+|.+.... ....++.+|+.++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4677888999999999999998877789999887543 234678999999999999999999999999889999999999
Q ss_pred CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCce
Q 002349 678 NGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYT 757 (933)
Q Consensus 678 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 757 (933)
+|+|.+++.. ....+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||.++.........
T Consensus 83 ~~~l~~~i~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 83 NGCLLNYLRE--HGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 9999999863 234689999999999999999999965 99999999999999999999999999998654332222
Q ss_pred eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCccccccccCHH
Q 002349 758 STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLG 836 (933)
Q Consensus 758 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (933)
.....++..|+|||...+..++.++|||||||++|+|++ |+.||............. ... ...... .
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~--~~~-----~~~~~~-----~ 225 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS--QGL-----RLYRPH-----L 225 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHh--cCC-----CCCCCC-----C
Confidence 222345678999999998889999999999999999999 999997544322221111 110 000011 1
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 002349 837 AVKKVFQLALLCSKRQPTDRPTMHEVSRVLG 867 (933)
Q Consensus 837 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 867 (933)
.+..+.+++.+||+.+|++||++.++++.++
T Consensus 226 ~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 226 ASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 2367899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=339.50 Aligned_cols=242 Identities=21% Similarity=0.260 Sum_probs=197.5
Q ss_pred eeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecCCC
Q 002349 604 YIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENG 679 (933)
Q Consensus 604 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 679 (933)
+.||+|+||.||+|..+ +++.||+|++.... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36999999999999965 57899999997542 234456788999999999999999999999999999999999999
Q ss_pred CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCceee
Q 002349 680 SLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTST 759 (933)
Q Consensus 680 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 759 (933)
+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.... ......
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~-~~~~~~ 153 (323)
T cd05595 81 ELFFHLS---RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-DGATMK 153 (323)
T ss_pred cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccC-CCCccc
Confidence 9999884 345789999999999999999999965 999999999999999999999999999875322 122223
Q ss_pred eecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHHHH
Q 002349 760 YIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVK 839 (933)
Q Consensus 760 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 839 (933)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.................. ++. ..+.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~--------~p~-----~~~~ 220 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR--------FPR-----TLSP 220 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC--------CCC-----CCCH
Confidence 457999999999999999999999999999999999999999765433322221111111 111 1235
Q ss_pred HHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002349 840 KVFQLALLCSKRQPTDRP-----TMHEVSRV 865 (933)
Q Consensus 840 ~l~~li~~cl~~dP~~RP-----t~~evl~~ 865 (933)
.+.+++.+|++.||++|| ++.+++++
T Consensus 221 ~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 221 EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred HHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 678899999999999998 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=325.70 Aligned_cols=255 Identities=27% Similarity=0.397 Sum_probs=207.7
Q ss_pred hhccCcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEec
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFM 676 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 676 (933)
.++|+..+.||+|++|.||+|...+++.||+|.++... ...+++.+|++++++++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 45788899999999999999998888889999987543 23567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCc
Q 002349 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY 756 (933)
Q Consensus 677 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 756 (933)
++++|.+++... ....+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 84 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 84 KYGSLLEYLQGG-AGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred cCCcHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 999999999642 235689999999999999999999965 9999999999999999999999999999876432221
Q ss_pred eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCccccccccCH
Q 002349 757 TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDL 835 (933)
Q Consensus 757 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (933)
.......+..|+|||+..+..++.++||||||+++|||++ |+.||.+............ . .. .... .
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~--~-~~----~~~~-----~ 227 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQ--G-YR----MPCP-----P 227 (261)
T ss_pred ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc--C-CC----CCCC-----C
Confidence 1111223458999999999899999999999999999999 9999976543332222111 1 00 0001 1
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcc
Q 002349 836 GAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGS 868 (933)
Q Consensus 836 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 868 (933)
..+..+.+++.+|++.+|++||+++++.+.|+.
T Consensus 228 ~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 228 GCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred cCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 224678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=346.31 Aligned_cols=259 Identities=25% Similarity=0.385 Sum_probs=204.1
Q ss_pred hhccCcceeeecccceeEEEEEEc------CCceEEEEEecccC-chhHHHHHHHHHHHhcC-CCCceeeeeeEEecCCc
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK------NCKPVAIKRLYSHY-PQCLKEFETELETVGSI-KHRNLVSLQGYSLSSSG 668 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 668 (933)
.++|+..+.||+|+||.||+|++. +++.||+|+++... ......+.+|+++++.+ +|+|||++++++.....
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 357888999999999999999853 23579999997543 33456688999999999 89999999999999999
Q ss_pred cEEEEEecCCCCHHHHhcCCC-----------------------------------------------------------
Q 002349 669 NLLFYDFMENGSLWDILHGPT----------------------------------------------------------- 689 (933)
Q Consensus 669 ~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------- 689 (933)
.++||||+++|+|.++++...
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 999999999999999885311
Q ss_pred --------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCce-eee
Q 002349 690 --------KKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYT-STY 760 (933)
Q Consensus 690 --------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~-~~~ 760 (933)
...++++.++.+++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++......... ...
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 113578899999999999999999965 99999999999999999999999999998653322211 122
Q ss_pred ecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHHHH
Q 002349 761 IMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVK 839 (933)
Q Consensus 761 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 839 (933)
..++..|||||++.+..++.++|||||||++|||++ |+.||............. ... ..+..+.. .+.
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~-~~~-----~~~~~~~~-----~~~ 342 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMV-KRG-----YQMSRPDF-----APP 342 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHH-Hcc-----cCccCCCC-----CCH
Confidence 335678999999998899999999999999999997 999997543322221111 111 01111111 135
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHHHHccC
Q 002349 840 KVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869 (933)
Q Consensus 840 ~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 869 (933)
.+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 343 ~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 343 EIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=328.86 Aligned_cols=256 Identities=27% Similarity=0.402 Sum_probs=211.9
Q ss_pred HhhccCcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEe
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
...+|+..+.||+|+||.||+|...+++.+|+|.+..........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 45678889999999999999999988899999999876655567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS 755 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 755 (933)
+++++|.++++.. ....+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||.+........
T Consensus 84 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 84 MEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred cccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 9999999999642 345689999999999999999999965 999999999999999999999999999987643221
Q ss_pred ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCccccccccC
Q 002349 756 YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKD 834 (933)
Q Consensus 756 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (933)
......++..|+|||...+..++.++||||||+++|+|++ |+.||............. .. .....+
T Consensus 160 -~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~--~~-----~~~~~~----- 226 (261)
T cd05148 160 -LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT--AG-----YRMPCP----- 226 (261)
T ss_pred -cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH--hC-----CcCCCC-----
Confidence 1223346778999999988889999999999999999998 899997654333322221 11 011111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcc
Q 002349 835 LGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGS 868 (933)
Q Consensus 835 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 868 (933)
...+..+.+++.+|++.||++|||++++.+.|+.
T Consensus 227 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 227 AKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 1224578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=342.04 Aligned_cols=253 Identities=19% Similarity=0.241 Sum_probs=204.6
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
++|+..+.||+|+||+||+|... +++.||+|+++... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36888999999999999999976 57899999997542 234566889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
||+++|+|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNR--YEDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 99999999999963 335799999999999999999999965 9999999999999999999999999999876544
Q ss_pred CCceeeeecccccccCccccc------cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcc
Q 002349 754 KSYTSTYIMGTIGYIDPEYAR------TSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPE 827 (933)
Q Consensus 754 ~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 827 (933)
.........||+.|+|||++. +..++.++|||||||++|||++|+.||................. .. .
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~-~~-----~ 229 (330)
T cd05601 156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQR-FL-----K 229 (330)
T ss_pred CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCC-cc-----C
Confidence 333334457999999999986 45678999999999999999999999986654443322111110 00 0
Q ss_pred ccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 828 ISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 828 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
++. ....+..+.+++..|++ +|++|||+++++++
T Consensus 230 ~~~---~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 230 FPE---DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CCC---CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 010 11123567889999997 99999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=325.22 Aligned_cols=268 Identities=27% Similarity=0.393 Sum_probs=204.5
Q ss_pred hccCcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhc--CCCCceeeeeeEEecCC----ccEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGS--IKHRNLVSLQGYSLSSS----GNLL 671 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~----~~~l 671 (933)
...+..++||+|.||.||||++++ +.||||++... ..+.|..|-.+.+. ++|+||++++++-.... ++++
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~~-~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLDN-RLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhccC-ceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 445556789999999999999877 89999999653 45567666666554 58999999999876655 7899
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC------CCCeeeccCCCCceEeCCCCCeEEeecc
Q 002349 672 FYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDC------SPRIIHRDVKSSNILLDKDFEAHLTDFG 745 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------~~~ivH~Dikp~NIll~~~~~~kl~DfG 745 (933)
|+||.+.|+|.++|. ...++|....+|+..+++||+|||+.. .++|+|||||++||||..|+++.|+|||
T Consensus 286 Vt~fh~kGsL~dyL~----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLK----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred EeeeccCCcHHHHHH----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 999999999999994 567999999999999999999999753 5679999999999999999999999999
Q ss_pred cccccccCCCce-eeeecccccccCccccccCC-C-----CcchhhHHHHHHHHHHHhCCCCCC-CCcchhHHHHh-hhc
Q 002349 746 IAKSLCVSKSYT-STYIMGTIGYIDPEYARTSR-L-----TEKSDVYSFGIVLLELLTGRKAVD-NECNLHHLILS-KTA 816 (933)
Q Consensus 746 la~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~-~-----~~~~DvwSlGv~l~elltg~~p~~-~~~~~~~~~~~-~~~ 816 (933)
+|..+....... ....+||.+|||||++.+.- + -.+.||||+|.|+|||++....++ +..+..+..+. ...
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 999885443322 22368999999999998752 2 247899999999999998754442 11111111111 111
Q ss_pred ---------ccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCCCC
Q 002349 817 ---------NNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAP 873 (933)
Q Consensus 817 ---------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 873 (933)
...+.+..+|.++........+..+.+.+..||+.||+.|.|+.=|.+.+..+....
T Consensus 442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 442 NHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred CCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 111223344555544444455678899999999999999999999988887765433
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=334.13 Aligned_cols=241 Identities=24% Similarity=0.302 Sum_probs=192.1
Q ss_pred eeeecccceeEEEEEEcC-CceEEEEEecccC---chhHHHHHHHHHHHhcC-CCCceeeeeeEEecCCccEEEEEecCC
Q 002349 604 YIIGYGASSTVYKCVLKN-CKPVAIKRLYSHY---PQCLKEFETELETVGSI-KHRNLVSLQGYSLSSSGNLLFYDFMEN 678 (933)
Q Consensus 604 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 678 (933)
+.||+|+||.||+|.+++ ++.||+|+++... ....+.+..|..++... +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999999764 6789999987532 22344556677777654 899999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCcee
Q 002349 679 GSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTS 758 (933)
Q Consensus 679 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 758 (933)
|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~ 153 (316)
T cd05592 81 GDLMFHIQ---SSGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKA 153 (316)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccc
Confidence 99999984 345789999999999999999999965 99999999999999999999999999997643222 223
Q ss_pred eeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHHH
Q 002349 759 TYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAV 838 (933)
Q Consensus 759 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (933)
....||+.|+|||++.+..++.++||||+||++|||++|+.||.+............. .+.++. ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--------~~~~~~-----~~~ 220 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND--------RPHFPR-----WIS 220 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--------CCCCCC-----CCC
Confidence 4457999999999999999999999999999999999999999865443322211110 111111 123
Q ss_pred HHHHHHHHHccCCCCCCCCCHH-HHHH
Q 002349 839 KKVFQLALLCSKRQPTDRPTMH-EVSR 864 (933)
Q Consensus 839 ~~l~~li~~cl~~dP~~RPt~~-evl~ 864 (933)
..+.+++.+|++.||++||++. ++.+
T Consensus 221 ~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 221 KEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred HHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 5678899999999999999875 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=344.36 Aligned_cols=255 Identities=22% Similarity=0.235 Sum_probs=197.2
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEec
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFM 676 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 676 (933)
.+|++.+.||+|+||.||+|.+. .++.||+|+.. ...+.+|++++++++|||||++++++......++|||++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 57999999999999999999975 47889999653 235678999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCc
Q 002349 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY 756 (933)
Q Consensus 677 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 756 (933)
. ++|.+++. ....+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+|+........
T Consensus 166 ~-~~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 166 K-TDLYCYLA---AKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred C-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 5 68888884 345789999999999999999999965 9999999999999999999999999999754322222
Q ss_pred eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcc-------hhHHHHhhhccccccccc-----
Q 002349 757 TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECN-------LHHLILSKTANNAVMETV----- 824 (933)
Q Consensus 757 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~-------~~~~~~~~~~~~~~~~~~----- 824 (933)
......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ...+.......+......
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 33345799999999999999999999999999999999999988753211 011111000000000000
Q ss_pred ----------------Ccccc-ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 825 ----------------DPEIS-ATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 825 ----------------~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.+... ........+..+.+++.+|++.||++|||++|++++
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000 000011235678899999999999999999999964
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=328.91 Aligned_cols=249 Identities=31% Similarity=0.514 Sum_probs=194.7
Q ss_pred cceeeecccceeEEEEEEc-----CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEe
Q 002349 602 EKYIIGYGASSTVYKCVLK-----NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 602 ~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
..+.||.|.||.||+|.+. .+..|+||.+.... .+..+.|.+|++.+++++||||++++|++...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999987 24679999996643 33478899999999999999999999999988889999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS 755 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 755 (933)
+++|+|.++++.. ....+++..+..++.|+++||+|||++ +++|+||+++||+++.++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc-ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 9999999999742 256799999999999999999999966 899999999999999999999999999987622222
Q ss_pred -ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCcccccccc
Q 002349 756 -YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISATCK 833 (933)
Q Consensus 756 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (933)
.......+...|+|||.+.+..++.++||||||+++|||++ |+.||.+... ....... ....... .+.
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~-~~~~~~~-~~~~~~~-----~~~--- 228 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN-EEIIEKL-KQGQRLP-----IPD--- 228 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH-HHHHHHH-HTTEETT-----SBT---
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccc-cccccce-----ecc---
Confidence 12223457789999999999889999999999999999999 6788876533 2222221 1111111 111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 834 DLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 834 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
..+..+.+++..||+.||++|||++++++.|
T Consensus 229 --~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 229 --NCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp --TSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred --chhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1246788999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=324.81 Aligned_cols=256 Identities=27% Similarity=0.427 Sum_probs=206.9
Q ss_pred hhccCcceeeecccceeEEEEEEcC----CceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKN----CKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLL 671 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 671 (933)
.++|+..+.||+|+||+||+|.++. ...||||.+.... .....+|.+|+.++++++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 3578889999999999999999753 3579999987543 3345678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccc
Q 002349 672 FYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLC 751 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 751 (933)
||||+++++|.+++.. ..+.+++..+..++.|++.|++|||++ +|+||||||+||++++++.+|++|||+++...
T Consensus 83 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 83 ITEYMENGSLDKFLRE--NDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEcCCCCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 9999999999999963 345789999999999999999999965 99999999999999999999999999998764
Q ss_pred cCCC-ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCcccc
Q 002349 752 VSKS-YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEIS 829 (933)
Q Consensus 752 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (933)
.... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||............ ...... + .
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~--~~~~~~----~-~- 229 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV--EDGYRL----P-P- 229 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHH--HcCCCC----C-C-
Confidence 2222 22222345678999999998899999999999999999998 99999654333222111 111000 0 0
Q ss_pred ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccC
Q 002349 830 ATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869 (933)
Q Consensus 830 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 869 (933)
....+..+.+++.+|++.+|++||++.||+++|+.+
T Consensus 230 ----~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 230 ----PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 112346788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=325.08 Aligned_cols=255 Identities=26% Similarity=0.395 Sum_probs=206.2
Q ss_pred hccCcceeeecccceeEEEEEEcC-CceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEec
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFM 676 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 676 (933)
.+|+..+.||+|+||.||+|.++. ++.||+|++.... ....++.+|++++++++||||+++++++..+...++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 457888899999999999999764 7889999886543 33567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCc
Q 002349 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY 756 (933)
Q Consensus 677 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 756 (933)
++++|.+++.. .....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~-~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 85 TYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCcHHHHHHh-CCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 99999999853 2345689999999999999999999965 9999999999999999999999999999876432222
Q ss_pred eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCccccccccCH
Q 002349 757 TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDL 835 (933)
Q Consensus 757 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (933)
......++..|+|||.+.+..++.++|||||||++|||++ |..||.+......+.... .. ..+..+.
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~--~~-----~~~~~~~----- 228 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--KG-----YRMERPE----- 228 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH--CC-----CCCCCCC-----
Confidence 2222234678999999999999999999999999999998 899997643322221111 10 1111111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccC
Q 002349 836 GAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869 (933)
Q Consensus 836 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 869 (933)
..+..+.+++.+|++.||++||++.++.+.|+.+
T Consensus 229 ~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 229 GCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 1246788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=331.30 Aligned_cols=261 Identities=20% Similarity=0.254 Sum_probs=197.3
Q ss_pred hccCcceeeecccceeEEEEEEc--CCceEEEEEecccC--chhHHHHHHHHHHHhcC---CCCceeeeeeEEec-----
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK--NCKPVAIKRLYSHY--PQCLKEFETELETVGSI---KHRNLVSLQGYSLS----- 665 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~----- 665 (933)
++|+..+.||+|+||+||+|++. +++.||+|+++... ......+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999863 46789999886543 22234566777777665 69999999998852
Q ss_pred CCccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecc
Q 002349 666 SSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFG 745 (933)
Q Consensus 666 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfG 745 (933)
....++||||++ ++|.+++.. .....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHh-CCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEcccc
Confidence 345789999996 589998863 2234689999999999999999999965 99999999999999999999999999
Q ss_pred cccccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccc-ccc
Q 002349 746 IAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVM-ETV 824 (933)
Q Consensus 746 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~ 824 (933)
+++..... .......||+.|+|||.+.+..++.++||||+||++|||++|+.||.+.................. +..
T Consensus 156 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~ 233 (290)
T cd07862 156 LARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 233 (290)
T ss_pred ceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhc
Confidence 99865432 223345689999999999888999999999999999999999999987665544332221111000 000
Q ss_pred Ccc-------cc-ccccCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 825 DPE-------IS-ATCKDL-----GAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 825 ~~~-------~~-~~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
+.. +. ...... .....+.+++.+|++.||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 000 00 000000 123567789999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=342.23 Aligned_cols=261 Identities=23% Similarity=0.352 Sum_probs=206.2
Q ss_pred hhccCcceeeecccceeEEEEEEcC------CceEEEEEecccC-chhHHHHHHHHHHHhcCC-CCceeeeeeEEecCCc
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKN------CKPVAIKRLYSHY-PQCLKEFETELETVGSIK-HRNLVSLQGYSLSSSG 668 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 668 (933)
.++|.+.+.||+|+||.||+|.+.. +..||||++.... ....+.+.+|+++++++. |||||++++++.....
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 4688889999999999999998632 3469999997543 334567899999999996 9999999999999999
Q ss_pred cEEEEEecCCCCHHHHhcCCC-----------------------------------------------------------
Q 002349 669 NLLFYDFMENGSLWDILHGPT----------------------------------------------------------- 689 (933)
Q Consensus 669 ~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------- 689 (933)
.++||||+++|+|.++++...
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 999999999999999885321
Q ss_pred ----------------------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCC
Q 002349 690 ----------------------------------KKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDK 735 (933)
Q Consensus 690 ----------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~ 735 (933)
....+++..+..++.|++.||+|||+. +|+||||||+||+++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeC
Confidence 012478889999999999999999965 9999999999999999
Q ss_pred CCCeEEeecccccccccCCCc-eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHh
Q 002349 736 DFEAHLTDFGIAKSLCVSKSY-TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILS 813 (933)
Q Consensus 736 ~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~ 813 (933)
++.+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |..||...........
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~- 351 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN- 351 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH-
Confidence 999999999999865332221 1223456788999999999899999999999999999997 9999875432222111
Q ss_pred hhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCC
Q 002349 814 KTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVP 871 (933)
Q Consensus 814 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 871 (933)
..... ..... ....+..+.+++.+||+.||++||++.+|.++|+.+.+
T Consensus 352 ~~~~~-----~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 352 KIKSG-----YRMAK-----PDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHhcC-----CCCCC-----CccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 11111 01111 11234678899999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=338.20 Aligned_cols=253 Identities=21% Similarity=0.264 Sum_probs=197.5
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
++|+..+.||+|+||+||+|... .++.||+|++.... ......+.+|+.++.+++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47888999999999999999976 47899999996532 233456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
||+++|+|.+++. ..+.+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLM---KKDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 9999999999995 456799999999999999999999965 9999999999999999999999999999754321
Q ss_pred CC----------------------------------ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCC
Q 002349 754 KS----------------------------------YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRK 799 (933)
Q Consensus 754 ~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~ 799 (933)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 10 00123579999999999999999999999999999999999999
Q ss_pred CCCCCcchhHHHHhhhcccccccccCccccccccCHHHHHHHHHHHHHccC--CCCCCCCCHHHHHHH
Q 002349 800 AVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSK--RQPTDRPTMHEVSRV 865 (933)
Q Consensus 800 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~dP~~RPt~~evl~~ 865 (933)
||.+................. .+++.. .......+++.+++. .++..||+++|++++
T Consensus 235 Pf~~~~~~~~~~~i~~~~~~~--~~p~~~-------~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 235 PFCSETPQETYKKVMNWKETL--IFPPEV-------PISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCCHHHHHHHHHcCcCcc--cCCCcC-------CCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 998765444333222111111 111111 012345556655332 344457999999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=334.09 Aligned_cols=253 Identities=22% Similarity=0.271 Sum_probs=215.6
Q ss_pred hhccCcceeeecccceeEEEEEEcC-CceEEEEEecccCc---hhHHHHHHHHHHHhcCC-CCceeeeeeEEecCCccEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHYP---QCLKEFETELETVGSIK-HRNLVSLQGYSLSSSGNLL 671 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~l 671 (933)
.+.|+..+.||.|.||.||+|+.+. |+.+|+|.+..... .+...+.+|+++|+++. |||||.++++|.+....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 4578888999999999999999876 89999999976543 24568999999999998 9999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCC----CCeEEeecccc
Q 002349 672 FYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKD----FEAHLTDFGIA 747 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~----~~~kl~DfGla 747 (933)
|||++.||.|.+.+... .+++..+..++.|++.|++|||. .||+|||+||+|+|+... +.+|++|||+|
T Consensus 114 vmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 99999999999998532 39999999999999999999995 499999999999999643 57999999999
Q ss_pred cccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcc
Q 002349 748 KSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPE 827 (933)
Q Consensus 748 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 827 (933)
..... .......+||+.|+|||++....|+..+||||+||++|.|++|..||.+................+....++.
T Consensus 187 ~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~ 264 (382)
T KOG0032|consen 187 KFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDD 264 (382)
T ss_pred eEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccc
Confidence 98754 4556678999999999999999999999999999999999999999998877666654444333333222222
Q ss_pred ccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 002349 828 ISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLG 867 (933)
Q Consensus 828 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 867 (933)
......++++.++..||.+|+|+.+++++-+
T Consensus 265 ---------is~~akd~i~~ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 265 ---------ISESAKDFIRKLLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred ---------cCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence 2356778999999999999999999999743
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=336.15 Aligned_cols=242 Identities=24% Similarity=0.280 Sum_probs=196.7
Q ss_pred eeeecccceeEEEEEEc----CCceEEEEEecccC----chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEe
Q 002349 604 YIIGYGASSTVYKCVLK----NCKPVAIKRLYSHY----PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 604 ~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
+.||+|+||.||+|... .++.||+|++.... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 57999999999999853 46889999986532 22345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS 755 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 755 (933)
+++++|.+++. ..+.+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (323)
T cd05584 82 LSGGELFMHLE---REGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG- 154 (323)
T ss_pred CCCchHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence 99999999984 456788899999999999999999965 99999999999999999999999999987542222
Q ss_pred ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCH
Q 002349 756 YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDL 835 (933)
Q Consensus 756 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (933)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||................. .+++
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~----~~~~--------- 221 (323)
T cd05584 155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL----NLPP--------- 221 (323)
T ss_pred CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC----CCCC---------
Confidence 222345799999999999998899999999999999999999999986554333222111110 1111
Q ss_pred HHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002349 836 GAVKKVFQLALLCSKRQPTDRP-----TMHEVSRV 865 (933)
Q Consensus 836 ~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 865 (933)
.....+.+++.+|++.||++|| ++.+++++
T Consensus 222 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 222 YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 1135678999999999999999 78888764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=329.08 Aligned_cols=264 Identities=23% Similarity=0.379 Sum_probs=211.3
Q ss_pred hhccCcceeeecccceeEEEEEEcCCceEEEEEecccCc-hhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEe
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYP-QCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
...+..+++||+|.||.|..+...++..||||+++.... ..+++|.+|+++|.+++|||||+++|+|..++..++++||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 356677889999999999999999889999999988754 3458899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS 755 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 755 (933)
|++|+|..++..... .........+|+.|||.|++||. +.++||||+.++|+|+|.++++||+|||+++.+...+.
T Consensus 617 mEnGDLnqFl~ahea-pt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 617 MENGDLNQFLSAHEL-PTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HhcCcHHHHHHhccC-cccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCc
Confidence 999999999953211 22456677889999999999999 66999999999999999999999999999997654444
Q ss_pred ce-eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh--CCCCCCCCcchhHHHHhhhcccccccccCccccccc
Q 002349 756 YT-STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT--GRKAVDNECNLHHLILSKTANNAVMETVDPEISATC 832 (933)
Q Consensus 756 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (933)
+. ....+-+.+|||||.+.-++++.++|||+||+++||+++ ...||....+.+-.... +.+...-.+.. ...
T Consensus 693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~----~~~~~~~~~~~-~l~ 767 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENA----GEFFRDQGRQV-VLS 767 (807)
T ss_pred eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhh----hhhcCCCCcce-ecc
Confidence 44 334566789999999999999999999999999999754 67788644332222111 11111111111 011
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccC
Q 002349 833 KDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869 (933)
Q Consensus 833 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 869 (933)
.+.-++.++++++.+||.+|.++||+++++...|.+.
T Consensus 768 ~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 768 RPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred CCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1224567899999999999999999999999888653
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=340.95 Aligned_cols=255 Identities=21% Similarity=0.225 Sum_probs=202.3
Q ss_pred HhhccCcceeeecccceeEEEEEEcC-CceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEE
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLL 671 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 671 (933)
..++|+..+.||+|+||.||+|.++. ++.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 45789999999999999999999764 6889999986421 2234567899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccc
Q 002349 672 FYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLC 751 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 751 (933)
||||+++|+|.+++. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|....
T Consensus 121 v~Ey~~gg~L~~~l~----~~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 121 VMEYMPGGDLVNLMS----NYDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 999999999999984 23588999999999999999999965 99999999999999999999999999998764
Q ss_pred cCCCceeeeecccccccCccccccC----CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcc
Q 002349 752 VSKSYTSTYIMGTIGYIDPEYARTS----RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPE 827 (933)
Q Consensus 752 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 827 (933)
...........||+.|+|||++.+. .++.++||||+||++|||++|+.||................... .
T Consensus 194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~------~ 267 (370)
T cd05621 194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSL------N 267 (370)
T ss_pred cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccc------C
Confidence 3333333456799999999998754 37889999999999999999999998665443332222111111 0
Q ss_pred ccccccCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHH
Q 002349 828 ISATCKDLGAVKKVFQLALLCSKRQPTD--RPTMHEVSRVL 866 (933)
Q Consensus 828 ~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~L 866 (933)
++. +......+.+++.+|+..++.+ ||+++|++++-
T Consensus 268 ~p~---~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp 305 (370)
T cd05621 268 FPE---DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHP 305 (370)
T ss_pred CCC---cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCc
Confidence 111 1112355677888898755544 88999999863
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=339.05 Aligned_cols=250 Identities=24% Similarity=0.297 Sum_probs=198.6
Q ss_pred ccCcceeeecccceeEEEEEEc----CCceEEEEEecccC----chhHHHHHHHHHHHhcC-CCCceeeeeeEEecCCcc
Q 002349 599 NLSEKYIIGYGASSTVYKCVLK----NCKPVAIKRLYSHY----PQCLKEFETELETVGSI-KHRNLVSLQGYSLSSSGN 669 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 669 (933)
+|+..+.||+|+||+||+|+.. .++.||+|++.... ....+.+.+|+++++++ +||||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4778899999999999999853 47889999986432 22345678899999999 599999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccc
Q 002349 670 LLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKS 749 (933)
Q Consensus 670 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 749 (933)
++||||+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLY---QRDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 99999999999999984 456789999999999999999999965 999999999999999999999999999986
Q ss_pred cccCCCceeeeecccccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcch--hHHHHhhhcccccccccCc
Q 002349 750 LCVSKSYTSTYIMGTIGYIDPEYARTS-RLTEKSDVYSFGIVLLELLTGRKAVDNECNL--HHLILSKTANNAVMETVDP 826 (933)
Q Consensus 750 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~ 826 (933)
+............||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .......... .++
T Consensus 155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~------~~~ 228 (332)
T cd05614 155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK------CDP 228 (332)
T ss_pred ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc------CCC
Confidence 543333333446799999999999875 4789999999999999999999999643221 1111111100 111
Q ss_pred cccccccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002349 827 EISATCKDLGAVKKVFQLALLCSKRQPTDRP-----TMHEVSRV 865 (933)
Q Consensus 827 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 865 (933)
.++. ..+..+.+++.+|++.||++|| ++++++++
T Consensus 229 ~~~~-----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 229 PFPS-----FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCCC-----CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 1111 1235678899999999999999 67788764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=327.69 Aligned_cols=256 Identities=25% Similarity=0.445 Sum_probs=205.8
Q ss_pred hccCcceeeecccceeEEEEEEcCC------ceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKNC------KPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNL 670 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~~------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 670 (933)
++|+..+.||+|+||.||+|..... +.||+|.+.... .....++.+|++++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 4688889999999999999986532 579999987543 334567899999999999999999999999989999
Q ss_pred EEEEecCCCCHHHHhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCC
Q 002349 671 LFYDFMENGSLWDILHGPTK-------------KKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDF 737 (933)
Q Consensus 671 lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~ 737 (933)
++|||+++++|.+++..... ...+++.++..++.|++.||+|||+. +++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 99999999999999853211 15688999999999999999999965 999999999999999999
Q ss_pred CeEEeecccccccccCCC-ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhh
Q 002349 738 EAHLTDFGIAKSLCVSKS-YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKT 815 (933)
Q Consensus 738 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~ 815 (933)
.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+......... .
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~--i 239 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM--I 239 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH--H
Confidence 999999999976532221 11223456789999999988889999999999999999998 9999976443222111 1
Q ss_pred cccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcc
Q 002349 816 ANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGS 868 (933)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 868 (933)
..... +..+ ...+..+.+++.+||+.||.+||+++||++.|+.
T Consensus 240 ~~~~~-----~~~~-----~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 240 RSRQL-----LPCP-----EDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HcCCc-----CCCc-----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11111 1111 1235689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=341.47 Aligned_cols=253 Identities=19% Similarity=0.251 Sum_probs=198.4
Q ss_pred ccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEE
Q 002349 599 NLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYD 674 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 674 (933)
.|+..+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5778899999999999999965 46889999996532 2345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCC
Q 002349 675 FMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSK 754 (933)
Q Consensus 675 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 754 (933)
|+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLI---RMEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 999999999985 345689999999999999999999965 99999999999999999999999999976431100
Q ss_pred C----------------------------------------------ceeeeecccccccCccccccCCCCcchhhHHHH
Q 002349 755 S----------------------------------------------YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFG 788 (933)
Q Consensus 755 ~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG 788 (933)
. ......+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 001234799999999999988999999999999
Q ss_pred HHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHHHHHHHHHHHH--ccCCCCCCCCCHHHHHHHH
Q 002349 789 IVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALL--CSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 789 v~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~dP~~RPt~~evl~~L 866 (933)
|++|||++|+.||................... .++. ......++.+++.+ |+..+|..||++++++++-
T Consensus 236 ~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~------~~~~---~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp 306 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTETQLKVINWENTL------HIPP---QVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHP 306 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHHHHHHHcccccc------CCCC---CCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCc
Confidence 99999999999998655433322211111110 0110 00123456677776 5566777799999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=340.78 Aligned_cols=402 Identities=29% Similarity=0.444 Sum_probs=352.6
Q ss_pred EEEEEcCCCCcCcccCCCCCCCCCccEEEccCCcccccCCCCccCCCCCceecccccccCCCCCcccccccchhhhhhcc
Q 002349 70 VIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKN 149 (933)
Q Consensus 70 v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~ 149 (933)
...++.+.|++. .+|+.++.+.+|..|+.+.|.+. .+|+.++.+..|..||..+|+++ ..|.++.++.+|..|++.+
T Consensus 93 l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~ 169 (565)
T KOG0472|consen 93 LKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEG 169 (565)
T ss_pred HHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccc
Confidence 456778888888 89999999999999999999999 78999999999999999999998 8899999999999999999
Q ss_pred cCccCCCCcccccCCCCceeeeecCCCCCCcccccccCCCCcEEeccCccccCccCcCCcCCCCCcEEccccccccCcCC
Q 002349 150 NQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIP 229 (933)
Q Consensus 150 n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p 229 (933)
|+++...|. .-+++.|++||...|-+. .+|++++.+.+|..|+|.+|++. .+| +|..++.|++|+++.|+++ .+|
T Consensus 170 n~l~~l~~~-~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lp 244 (565)
T KOG0472|consen 170 NKLKALPEN-HIAMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLP 244 (565)
T ss_pred cchhhCCHH-HHHHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhH
Confidence 999955544 445999999999999986 89999999999999999999999 677 8999999999999999998 566
Q ss_pred CCcc--ccccceEeccccccccccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCC----------
Q 002349 230 FNIG--FLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTG---------- 297 (933)
Q Consensus 230 ~~~~--~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~---------- 297 (933)
.... ..++..|||++|+++ ..|..++.+.+|..||+|+|.|+ ..|.+++++ +|+.|-+.+|.+..
T Consensus 245 ae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT 321 (565)
T KOG0472|consen 245 AEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGT 321 (565)
T ss_pred HHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccH
Confidence 5543 347899999999999 68999999999999999999999 678899999 99999999998741
Q ss_pred ---------------------------C-CCC---ccccCCcceEeeeccccccccCCcccccccc---ccccccccccC
Q 002349 298 ---------------------------H-IPP---ELGNMTKLHYLELNDNQLTGHIPPALGKLTD---LFDLNVANNHL 343 (933)
Q Consensus 298 ---------------------------~-~p~---~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~---L~~L~L~~N~l 343 (933)
. .+. ....+.+.+.|++++-+++ .+|+......+ ....+++.|++
T Consensus 322 ~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL 400 (565)
T KOG0472|consen 322 QEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQL 400 (565)
T ss_pred HHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchH
Confidence 0 011 1123456889999999999 66766555544 78899999999
Q ss_pred CCCCCCCcccCCCCCc-eeccCcccCCCCCcccccccccceecCCcccccCCCccccccccccceeeccCCccCCCCCCC
Q 002349 344 EGPIPDNLSSCTNLNS-LNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSP 422 (933)
Q Consensus 344 ~~~~p~~l~~l~~L~~-L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~ 422 (933)
. ++|..+..++.+.+ +.+++|.+. .+|..++.+++|..|+|++|-+. .+|..++.+..|+.||+|+|++. .+|..
T Consensus 401 ~-elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~ 476 (565)
T KOG0472|consen 401 C-ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPEC 476 (565)
T ss_pred h-hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHH
Confidence 8 78888888876655 455555555 88999999999999999999998 78999999999999999999998 89999
Q ss_pred CCCccccccccccCcccccccccccccccccceEEccCCccccccchhhccccccceeeecCCCCc
Q 002349 423 LGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLS 488 (933)
Q Consensus 423 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 488 (933)
+..+..|+.+-.++|++..+.|..+.+|.+|.+|||.+|.|. .+|+.++++++|+.|.++||+|.
T Consensus 477 ~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 477 LYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred HhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 998999999989999999877777999999999999999999 78999999999999999999998
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=344.97 Aligned_cols=253 Identities=23% Similarity=0.270 Sum_probs=206.4
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
++|+..+.||+|+||+||+|... +++.||+|++.... ......+.+|+++++.++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888999999999999999976 57899999986532 234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
||+++++|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLI---RKDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 9999999999995 336799999999999999999999965 9999999999999999999999999999866433
Q ss_pred C----------------------------CceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCc
Q 002349 754 K----------------------------SYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNEC 805 (933)
Q Consensus 754 ~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~ 805 (933)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 112234569999999999999999999999999999999999999998765
Q ss_pred chhHHHHhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHHH
Q 002349 806 NLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPT-MHEVSRVL 866 (933)
Q Consensus 806 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~~L 866 (933)
................ . +... ..+..+.+++.+|+. ||.+||+ +++++++.
T Consensus 235 ~~~~~~~i~~~~~~~~--~-p~~~------~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp 286 (350)
T cd05573 235 LQETYNKIINWKESLR--F-PPDP------PVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP 286 (350)
T ss_pred HHHHHHHHhccCCccc--C-CCCC------CCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence 4333322211101110 0 0000 124578889999997 9999999 99999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=333.77 Aligned_cols=261 Identities=23% Similarity=0.340 Sum_probs=202.8
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYD 674 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 674 (933)
.++|+..+.||+|+||.||+|.++ +++.+|+|.+.... ......+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 368899999999999999999977 46788999886543 3345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCC
Q 002349 675 FMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSK 754 (933)
Q Consensus 675 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 754 (933)
|+++|+|.+++. ....+++..+..++.|++.|++|||+. .+|+||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 84 HMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (333)
T ss_pred cCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence 999999999995 345689999999999999999999953 27999999999999999999999999999765321
Q ss_pred CceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhh-ccccccc-cc--------
Q 002349 755 SYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKT-ANNAVME-TV-------- 824 (933)
Q Consensus 755 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~-~~~~~~~-~~-------- 824 (933)
......|+..|+|||++.+..++.++|||||||++|||++|+.||.............. ....... ..
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (333)
T cd06650 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPG 235 (333)
T ss_pred --ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCcc
Confidence 12334689999999999998899999999999999999999999975432211110000 0000000 00
Q ss_pred ------Cccc--------------ccc---ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 825 ------DPEI--------------SAT---CKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 825 ------~~~~--------------~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.+.. ... ........++.+++.+||+.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred chhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 0000 000 0000123568899999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=338.51 Aligned_cols=258 Identities=22% Similarity=0.331 Sum_probs=197.3
Q ss_pred ccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCC-----ccE
Q 002349 599 NLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSS-----GNL 670 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~ 670 (933)
+|+..+.||+|+||.||+|+.. +++.||||++.... .....++.+|++++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4788899999999999999965 57899999986532 233456889999999999999999999885432 479
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccc
Q 002349 671 LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSL 750 (933)
Q Consensus 671 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~ 750 (933)
+||||+. ++|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIK---ANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHH---hcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 68999884 445799999999999999999999965 9999999999999999999999999999764
Q ss_pred ccCCC--ceeeeecccccccCcccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccccc------
Q 002349 751 CVSKS--YTSTYIMGTIGYIDPEYART--SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAV------ 820 (933)
Q Consensus 751 ~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~------ 820 (933)
..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+..............+..
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 32211 11234579999999999876 578999999999999999999999997654433221111000000
Q ss_pred ----------cccc----CccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 821 ----------METV----DPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 821 ----------~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
...+ ........+ .....+.+++.+|++.||++|||++|++++
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFP--NADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcC--CCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000 000000000 123567899999999999999999999974
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=316.22 Aligned_cols=248 Identities=24% Similarity=0.358 Sum_probs=208.6
Q ss_pred cCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecCC
Q 002349 600 LSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMEN 678 (933)
Q Consensus 600 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 678 (933)
|.+.++||+|+||.||+|.++ .|+.||+|++... .+.+++..|+.++++++.|++|++||.+......|+|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 445568999999999999987 4889999988654 4578899999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCcee
Q 002349 679 GSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTS 758 (933)
Q Consensus 679 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 758 (933)
|++.|+++ ..+.++++.++..+++..++||+|||.- .-+|||||+.|||++.+|.+|++|||.|-.+.+.- ...
T Consensus 113 GSiSDI~R--~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-AKR 186 (502)
T KOG0574|consen 113 GSISDIMR--ARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-AKR 186 (502)
T ss_pred CcHHHHHH--HhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhH-Hhh
Confidence 99999997 4678899999999999999999999954 78999999999999999999999999998764322 223
Q ss_pred eeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHHH
Q 002349 759 TYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAV 838 (933)
Q Consensus 759 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (933)
..+.||+.|||||++..-.|+.++||||+|++..||..|++||.+-........+ +..-+|.+ .++....
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI-------PT~PPPTF---~KPE~WS 256 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI-------PTKPPPTF---KKPEEWS 256 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec-------cCCCCCCC---CChHhhh
Confidence 4578999999999999999999999999999999999999999865443332211 11111212 2234556
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 839 KKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 839 ~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.++-++++.|+-..|++|.|+.+++++
T Consensus 257 ~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 257 SEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred hHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 788899999999999999999998764
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=320.88 Aligned_cols=251 Identities=24% Similarity=0.345 Sum_probs=202.8
Q ss_pred hccCcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecC
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFME 677 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 677 (933)
.+|+..+.||+|+||.||+|.++++..+|+|++..... ...++.+|++++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 35778889999999999999988777899999865432 34578889999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCce
Q 002349 678 NGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYT 757 (933)
Q Consensus 678 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 757 (933)
+++|.++++. ....+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||+++.........
T Consensus 83 ~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 83 NGCLLNYLRE--RKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 9999999863 334789999999999999999999965 99999999999999999999999999997653222111
Q ss_pred eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCccccccccCHH
Q 002349 758 STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLG 836 (933)
Q Consensus 758 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (933)
.....++..|+|||.+.+..++.++||||||+++|+|++ |+.||............... .....+. .
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-------~~~~~~~-----~ 225 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG-------YRLYRPK-----L 225 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcC-------CcCCCCC-----C
Confidence 111224457999999998899999999999999999999 88999755443332221111 1111111 1
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 837 AVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 837 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
.+..+.+++.+|+..+|++|||+.|+++.|
T Consensus 226 ~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 226 APTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 346789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=350.86 Aligned_cols=251 Identities=20% Similarity=0.235 Sum_probs=203.9
Q ss_pred ccCcceeeecccceeEEEEEEcC--CceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEec
Q 002349 599 NLSEKYIIGYGASSTVYKCVLKN--CKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFM 676 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 676 (933)
.|...+.||+|+||.||+|.... ++.||+|++..........+.+|+++++.++|||||++++++..++..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 38888999999999999998553 5678888876555555567888999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCC
Q 002349 677 ENGSLWDILHGP-TKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS 755 (933)
Q Consensus 677 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 755 (933)
++|+|.++++.. ....++++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988532 2345789999999999999999999965 999999999999999999999999999987643222
Q ss_pred -ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccC
Q 002349 756 -YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKD 834 (933)
Q Consensus 756 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (933)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||................ . .+ .+.
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~--~----~~-~~~---- 293 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGK--Y----DP-FPC---- 293 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--C----CC-CCc----
Confidence 12334579999999999999999999999999999999999999997654332222111111 0 00 111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002349 835 LGAVKKVFQLALLCSKRQPTDRPTMHEVSR 864 (933)
Q Consensus 835 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 864 (933)
..+..+.+++.+|++.||++||++++++.
T Consensus 294 -~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 294 -PVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -cCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 12356889999999999999999999864
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=333.66 Aligned_cols=245 Identities=20% Similarity=0.256 Sum_probs=195.2
Q ss_pred cCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHH---hcCCCCceeeeeeEEecCCccEEE
Q 002349 600 LSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETV---GSIKHRNLVSLQGYSLSSSGNLLF 672 (933)
Q Consensus 600 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~~~~~~~~~~~~~lv 672 (933)
|+..+.||+|+||.||+|.++ +++.||||++.... ....+.+.+|++++ ++++||||+++++++..++..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 566789999999999999976 47899999996532 22344566666554 567899999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccccc
Q 002349 673 YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV 752 (933)
Q Consensus 673 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 752 (933)
|||+++++|...++ ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 99999999998884 35689999999999999999999965 999999999999999999999999999875322
Q ss_pred CCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccc
Q 002349 753 SKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATC 832 (933)
Q Consensus 753 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (933)
. ........|++.|+|||.+.+..++.++|||||||++|||++|+.||.+............... ..+.
T Consensus 154 ~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~--------~~p~-- 222 (324)
T cd05589 154 F-GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV--------RYPR-- 222 (324)
T ss_pred C-CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--------CCCC--
Confidence 1 1223345799999999999999999999999999999999999999986544332221111111 1111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002349 833 KDLGAVKKVFQLALLCSKRQPTDRP-----TMHEVSRV 865 (933)
Q Consensus 833 ~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 865 (933)
..+..+.+++.+|++.||++|| ++.+++++
T Consensus 223 ---~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 223 ---FLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred ---CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 1235678899999999999999 56676654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=337.10 Aligned_cols=249 Identities=25% Similarity=0.376 Sum_probs=193.7
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEe
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
++|+..+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|++++++++|+||+++++++...+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 34566788999999999999976 57899999986543 33456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS 755 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 755 (933)
+++|+|.+.. ..++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~- 222 (353)
T PLN00034 154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM- 222 (353)
T ss_pred CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccc-
Confidence 9999986532 346778889999999999999965 99999999999999999999999999998653221
Q ss_pred ceeeeecccccccCcccccc-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccc
Q 002349 756 YTSTYIMGTIGYIDPEYART-----SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISA 830 (933)
Q Consensus 756 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (933)
.......||..|+|||++.. ...+.++|||||||++|||++|+.||................. ...+...
T Consensus 223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~----~~~~~~~- 297 (353)
T PLN00034 223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICM----SQPPEAP- 297 (353)
T ss_pred ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhc----cCCCCCC-
Confidence 12234579999999998743 2345689999999999999999999973221111100000000 0001111
Q ss_pred cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 831 TCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 831 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
......+.+++.+||+.||++|||+.|++++-
T Consensus 298 ----~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp 329 (353)
T PLN00034 298 ----ATASREFRHFISCCLQREPAKRWSAMQLLQHP 329 (353)
T ss_pred ----CccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 12345788999999999999999999999864
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=341.29 Aligned_cols=255 Identities=21% Similarity=0.230 Sum_probs=204.4
Q ss_pred HhhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEE
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLL 671 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 671 (933)
..++|+..+.||+|+||.||+|+.+ +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.++...++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3568999999999999999999976 47889999986432 2234557889999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccc
Q 002349 672 FYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLC 751 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 751 (933)
||||+++|+|.++++ ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 121 v~Ey~~gg~L~~~l~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMS----NYDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 999999999999985 24588899999999999999999965 99999999999999999999999999998764
Q ss_pred cCCCceeeeecccccccCccccccC----CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcc
Q 002349 752 VSKSYTSTYIMGTIGYIDPEYARTS----RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPE 827 (933)
Q Consensus 752 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 827 (933)
...........||+.|+|||++.+. .++.++|||||||++|||++|+.||.+................. .
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~------~ 267 (370)
T cd05596 194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSL------T 267 (370)
T ss_pred CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcC------C
Confidence 3322223345799999999998653 47899999999999999999999998765443332221111110 0
Q ss_pred ccccccCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHH
Q 002349 828 ISATCKDLGAVKKVFQLALLCSKRQPTD--RPTMHEVSRVL 866 (933)
Q Consensus 828 ~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~L 866 (933)
++. ....+..+.+++.+|++.+|++ ||++++++++-
T Consensus 268 ~~~---~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 268 FPD---DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred CCC---cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 111 1112457788999999999988 99999998763
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=345.11 Aligned_cols=257 Identities=25% Similarity=0.358 Sum_probs=207.0
Q ss_pred hccCcceeeecccceeEEEEEEcCC-ceEEEEEecccCchhHHHHHHHHHHHhcCC-CCceeeeeeE-Eec------CCc
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKNC-KPVAIKRLYSHYPQCLKEFETELETVGSIK-HRNLVSLQGY-SLS------SSG 668 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~-~~~------~~~ 668 (933)
.++++.+.|.+|||+.||.|....+ .+||+|++...+....+...+|+++|++|+ |+|||.++|. ... .-+
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 3667788999999999999998776 999999998888888899999999999996 9999999993 221 134
Q ss_pred cEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccc
Q 002349 669 NLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAK 748 (933)
Q Consensus 669 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 748 (933)
+++.||||+||.|-|++... ....|++.++++|+.++++|+++||.. .++|||||||-+|||++.++..||||||.|+
T Consensus 117 vllLmEyC~gg~Lvd~mn~R-lq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTR-LQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred EEeehhhccCCcHHHHHHHH-HhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 67899999999999999642 334599999999999999999999976 7889999999999999999999999999997
Q ss_pred ccccCCCcee--------eeecccccccCcccc---ccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcc
Q 002349 749 SLCVSKSYTS--------TYIMGTIGYIDPEYA---RTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTAN 817 (933)
Q Consensus 749 ~~~~~~~~~~--------~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~ 817 (933)
..-....... -....|+.|+|||.+ .+...++|+|||++||+||-++....||++...+.-+ ...
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIl----ng~ 270 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAIL----NGN 270 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEE----ecc
Confidence 5422221100 012468999999966 5778999999999999999999999999865332211 011
Q ss_pred cccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCC
Q 002349 818 NAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVP 871 (933)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 871 (933)
..+ |.. ......+.+||+.||++||.+||++-+|+..+..+..
T Consensus 271 Y~~-----P~~------p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 271 YSF-----PPF------PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred ccC-----CCC------ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 111 111 1346789999999999999999999999988866544
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=321.40 Aligned_cols=255 Identities=27% Similarity=0.377 Sum_probs=205.5
Q ss_pred hhccCcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEec
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFM 676 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 676 (933)
.++|+..++||+|+||.||+|.+.++..||+|++..... ..+++.+|++++++++||||+++++++. ....++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 357889999999999999999987777899999875332 3467899999999999999999999875 45689999999
Q ss_pred CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCc
Q 002349 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY 756 (933)
Q Consensus 677 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 756 (933)
++|+|.++++.. ....+++..+..++.|++.||+|+|+. +++||||||+||++++++.+||+|||.++........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 999999999631 234689999999999999999999965 9999999999999999999999999999866433322
Q ss_pred eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCccccccccCH
Q 002349 757 TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDL 835 (933)
Q Consensus 757 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (933)
......++..|+|||+..+..++.++||||||+++|||++ |..||.+............ . ..... ..
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~--~-----~~~~~-----~~ 226 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER--G-----YRMPC-----PP 226 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhc--C-----CCCCC-----cc
Confidence 2223446778999999988889999999999999999999 8888876543332221111 0 00000 11
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccC
Q 002349 836 GAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869 (933)
Q Consensus 836 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 869 (933)
..+..+.+++.+|++.||++||+++++.+.|+..
T Consensus 227 ~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 227 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 2346788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=325.47 Aligned_cols=255 Identities=25% Similarity=0.426 Sum_probs=206.0
Q ss_pred hccCcceeeecccceeEEEEEEcC------CceEEEEEecccCch-hHHHHHHHHHHHhcCCCCceeeeeeEEecCCccE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKN------CKPVAIKRLYSHYPQ-CLKEFETELETVGSIKHRNLVSLQGYSLSSSGNL 670 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 670 (933)
++|...+.||+|+||.||+|.+.+ ++.||+|.+...... ..+.+.+|++++++++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 467788899999999999998643 478999998765443 4578999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCC-----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCe
Q 002349 671 LFYDFMENGSLWDILHGP-----------TKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEA 739 (933)
Q Consensus 671 lv~e~~~~gsL~~~l~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~ 739 (933)
+||||+++++|.++++.. .....+++..+..++.|++.|++|||++ +++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence 999999999999999632 1234588999999999999999999965 99999999999999999999
Q ss_pred EEeecccccccccCCC-ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcc
Q 002349 740 HLTDFGIAKSLCVSKS-YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTAN 817 (933)
Q Consensus 740 kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 817 (933)
||+|||+++....... .......+++.|+|||++.+..+++++||||+||++|||++ |..||.+........... .
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~--~ 239 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT--Q 239 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH--c
Confidence 9999999976432221 11223346788999999999999999999999999999998 999997554333222111 1
Q ss_pred cccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 002349 818 NAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLG 867 (933)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 867 (933)
.... ... ...+..+.+++.+||+.||++||++.||++.|+
T Consensus 240 ~~~~-----~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 240 GRLL-----QRP-----RTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred CCcC-----CCC-----CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1110 011 112467889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=337.69 Aligned_cols=243 Identities=21% Similarity=0.261 Sum_probs=197.3
Q ss_pred eeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecCCC
Q 002349 604 YIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENG 679 (933)
Q Consensus 604 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 679 (933)
+.||+|+||.||+|... +++.||+|++.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999965 57899999997532 233456788999999999999999999999999999999999999
Q ss_pred CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCceee
Q 002349 680 SLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTST 759 (933)
Q Consensus 680 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 759 (933)
+|.+++. ....+++..+..++.|++.||+|||++ .+|+||||||+||+++.++.+||+|||+++..... .....
T Consensus 81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~ 154 (325)
T cd05594 81 ELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-GATMK 154 (325)
T ss_pred cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC-Ccccc
Confidence 9999884 445789999999999999999999951 39999999999999999999999999998753222 12223
Q ss_pred eecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHHHH
Q 002349 760 YIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVK 839 (933)
Q Consensus 760 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 839 (933)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.+............... .++. ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~--------~~p~-----~~~~ 221 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI--------RFPR-----TLSP 221 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCC--------CCCC-----CCCH
Confidence 45799999999999999999999999999999999999999976543322222111111 1111 1135
Q ss_pred HHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002349 840 KVFQLALLCSKRQPTDRP-----TMHEVSRV 865 (933)
Q Consensus 840 ~l~~li~~cl~~dP~~RP-----t~~evl~~ 865 (933)
.+.+++.+|++.||++|+ ++++++++
T Consensus 222 ~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 222 EAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred HHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 678899999999999996 89999865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=320.47 Aligned_cols=254 Identities=28% Similarity=0.380 Sum_probs=204.8
Q ss_pred hhccCcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEec
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFM 676 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 676 (933)
.++|++.+.||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++|+|++++++++. ....++||||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 357888899999999999999988888899999876433 3467899999999999999999999885 45689999999
Q ss_pred CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCc
Q 002349 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY 756 (933)
Q Consensus 677 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 756 (933)
++++|.++++. .....+++.++..++.|++.|++|||++ +++||||||+||++++++.++|+|||++..+......
T Consensus 83 ~~~~L~~~~~~-~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 83 SKGSLLDFLKD-GEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 99999999964 2234689999999999999999999965 9999999999999999999999999999865432222
Q ss_pred eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCccccccccCH
Q 002349 757 TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDL 835 (933)
Q Consensus 757 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (933)
......++..|+|||...+..++.++||||||+++|+|++ |..||.+........... .. .....+ .
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~--~~-----~~~~~~-----~ 226 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE--RG-----YRMPCP-----Q 226 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH--cC-----CCCCCC-----C
Confidence 2222345678999999988889999999999999999999 888997654333222111 10 011111 1
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcc
Q 002349 836 GAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGS 868 (933)
Q Consensus 836 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 868 (933)
..+..+.+++.+|+..+|++|||++++.+.|+.
T Consensus 227 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 227 DCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred cCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 224578899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=342.96 Aligned_cols=252 Identities=19% Similarity=0.238 Sum_probs=201.3
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
++|+..+.||+|+||+||+|+.. .++.||||++.... ......+.+|+++++.++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 36888999999999999999976 47899999996532 234456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
||+++|+|.+++. ..+.+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~~g~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLM---KKDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 9999999999985 345799999999999999999999965 9999999999999999999999999998754221
Q ss_pred CCc-------------------------------------eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh
Q 002349 754 KSY-------------------------------------TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT 796 (933)
Q Consensus 754 ~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt 796 (933)
... .....+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 100 0112469999999999999999999999999999999999
Q ss_pred CCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 002349 797 GRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPT---MHEVSRV 865 (933)
Q Consensus 797 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~evl~~ 865 (933)
|+.||.+................. ..+ . .......+.+++.+|+. +|.+|++ ++|++++
T Consensus 235 G~~Pf~~~~~~~~~~~i~~~~~~~--~~~----~---~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 235 GYPPFCSDNPQETYRKIINWKETL--QFP----D---EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCCCHHHHHHHHHcCCCcc--CCC----C---CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 999998665443322211111000 000 0 11123567788888986 9999997 8888774
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=326.23 Aligned_cols=257 Identities=23% Similarity=0.390 Sum_probs=203.9
Q ss_pred HhhccCcceeeecccceeEEEEEEcC------CceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCc
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLKN------CKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSG 668 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 668 (933)
.+++|+..+.||+|+||.||+|.+++ ++.||+|++.... .....++.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 56789999999999999999998642 4679999986533 2345668899999999999999999999999999
Q ss_pred cEEEEEecCCCCHHHHhcCCCC-------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEE
Q 002349 669 NLLFYDFMENGSLWDILHGPTK-------KKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHL 741 (933)
Q Consensus 669 ~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl 741 (933)
.++||||+++++|.++++.... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+|+
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence 9999999999999999853211 23467889999999999999999965 9999999999999999999999
Q ss_pred eecccccccccCCCce-eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccc
Q 002349 742 TDFGIAKSLCVSKSYT-STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNA 819 (933)
Q Consensus 742 ~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 819 (933)
+|||+++......... .....+++.|+|||++.+..++.++|||||||++|||++ |..||.+........... ...
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~--~~~ 238 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM--EGG 238 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH--cCC
Confidence 9999997653322211 112345778999999998889999999999999999999 688887554332221111 111
Q ss_pred cccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 002349 820 VMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLG 867 (933)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 867 (933)
.. ..+. ..+..+.+++.+|++.||++|||+.|+++.|+
T Consensus 239 ~~-----~~~~-----~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 239 LL-----DKPD-----NCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred cC-----CCCC-----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 11 1111 12457889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=337.94 Aligned_cols=260 Identities=22% Similarity=0.225 Sum_probs=204.4
Q ss_pred HHHHHHhhccCcceeeecccceeEEEEEEcC-CceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecC
Q 002349 591 EDIMRMTENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSS 666 (933)
Q Consensus 591 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 666 (933)
.+.....++|+..+.||+|+||.||+|+++. ++.||+|++.... ....+.+.+|+.+++.++||||+++++++..+
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 3444556899999999999999999999764 6789999986421 22345678899999999999999999999999
Q ss_pred CccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccc
Q 002349 667 SGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGI 746 (933)
Q Consensus 667 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl 746 (933)
...++||||+++|+|.+++. ...++...+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMS----NYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 99999999999999999984 23588899999999999999999965 999999999999999999999999999
Q ss_pred ccccccCCCceeeeecccccccCccccccC----CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccccccc
Q 002349 747 AKSLCVSKSYTSTYIMGTIGYIDPEYARTS----RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVME 822 (933)
Q Consensus 747 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 822 (933)
++..............||+.|+|||++.+. .++.++||||+||++|||++|+.||....................
T Consensus 189 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~- 267 (371)
T cd05622 189 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT- 267 (371)
T ss_pred eeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCccc-
Confidence 987643333333456799999999998754 378999999999999999999999987654433322221111110
Q ss_pred ccCccccccccCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHH
Q 002349 823 TVDPEISATCKDLGAVKKVFQLALLCSKRQPTD--RPTMHEVSRVL 866 (933)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~L 866 (933)
++. .......+.+++..|+..++.+ ||++++++++.
T Consensus 268 -----~~~---~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 268 -----FPD---DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred -----CCC---cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 110 0112356778899999844433 78999998865
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=330.16 Aligned_cols=258 Identities=26% Similarity=0.376 Sum_probs=204.0
Q ss_pred hccCcceeeecccceeEEEEEEcC-Cc----eEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKN-CK----PVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLL 671 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 671 (933)
.+|+..+.||+|+||.||+|.+.. ++ .||+|++.... ....+++.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 468889999999999999998643 33 48999987543 34457789999999999999999999998765 5789
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccc
Q 002349 672 FYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLC 751 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 751 (933)
|+||+++|+|.++++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccccc
Confidence 9999999999999963 345688999999999999999999965 99999999999999999999999999998764
Q ss_pred cCCCce-eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCcccc
Q 002349 752 VSKSYT-STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEIS 829 (933)
Q Consensus 752 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (933)
...... .....++..|+|||.+.+..++.++|||||||++|||++ |+.||.+..... ........... + ..
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~-----~-~~ 233 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERL-----P-QP 233 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHhCCCCC-----C-CC
Confidence 332221 122234678999999999999999999999999999998 999997643322 11111111100 0 00
Q ss_pred ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCCCC
Q 002349 830 ATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAP 873 (933)
Q Consensus 830 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 873 (933)
. .+...+.+++.+||+.+|++||++.+++..+..+...+
T Consensus 234 ~-----~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 234 P-----ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred C-----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 1 12356888999999999999999999999988765443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=332.81 Aligned_cols=241 Identities=22% Similarity=0.259 Sum_probs=195.3
Q ss_pred ccCcceeeecccceeEEEEEEcC-CceEEEEEecccC---chhHHHHHHHHHHHhcCCCC-ceeeeeeEEecCCccEEEE
Q 002349 599 NLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHY---PQCLKEFETELETVGSIKHR-NLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~lv~ 673 (933)
+|+..+.||+|+||.||+|..++ ++.||+|++.... ....+.+..|+++++.++|+ +|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 47788999999999999999764 6789999986532 23456678899999999764 6889999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
||+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQ---QVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 9999999999984 445789999999999999999999965 9999999999999999999999999998753221
Q ss_pred CCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccccc
Q 002349 754 KSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCK 833 (933)
Q Consensus 754 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (933)
........||+.|+|||++.+..++.++||||+||++|||++|+.||.+.............. ..++.
T Consensus 155 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~--------~~~~~--- 222 (324)
T cd05587 155 -GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN--------VSYPK--- 222 (324)
T ss_pred -CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--------CCCCC---
Confidence 222344679999999999999999999999999999999999999998654433322221111 11111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCH
Q 002349 834 DLGAVKKVFQLALLCSKRQPTDRPTM 859 (933)
Q Consensus 834 ~~~~~~~l~~li~~cl~~dP~~RPt~ 859 (933)
.....+.+++.+|+..||.+|++.
T Consensus 223 --~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 223 --SLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred --CCCHHHHHHHHHHhhcCHHHcCCC
Confidence 123567889999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=326.95 Aligned_cols=252 Identities=22% Similarity=0.259 Sum_probs=201.2
Q ss_pred ccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEE
Q 002349 599 NLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYD 674 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 674 (933)
+|+..++||+|+||+||+|... +++.||+|++.... ......+.+|++++++++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4778899999999999999965 57899999986532 2223457789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCC
Q 002349 675 FMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSK 754 (933)
Q Consensus 675 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 754 (933)
|+++|+|.+++.. .....+++..+..++.|++.|++|||+. +|+||||||+||++++++.++|+|||+++......
T Consensus 81 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYN-MGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHh-cCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 9999999988853 2335689999999999999999999965 99999999999999999999999999998653222
Q ss_pred CceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccC
Q 002349 755 SYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKD 834 (933)
Q Consensus 755 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (933)
. .....|++.|+|||++.+..++.++||||+||++|||++|+.||.+............. ... ......
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~---~~~-~~~~~~----- 225 (285)
T cd05605 157 T--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERR---VKE-DQEEYS----- 225 (285)
T ss_pred c--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHH---hhh-cccccC-----
Confidence 1 22347899999999999888999999999999999999999999864432221111100 000 001111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002349 835 LGAVKKVFQLALLCSKRQPTDRP-----TMHEVSRV 865 (933)
Q Consensus 835 ~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 865 (933)
...+..+.+++.+|++.||++|| ++++++++
T Consensus 226 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 226 EKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 11245688999999999999999 88888765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=330.56 Aligned_cols=241 Identities=23% Similarity=0.299 Sum_probs=193.7
Q ss_pred eeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcC-CCCceeeeeeEEecCCccEEEEEecCC
Q 002349 604 YIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSI-KHRNLVSLQGYSLSSSGNLLFYDFMEN 678 (933)
Q Consensus 604 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 678 (933)
+.||+|+||.||+|.++ +++.||+|.++... ....+.+..|.+++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36999999999999976 47889999987542 23345567788888754 899999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCcee
Q 002349 679 GSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTS 758 (933)
Q Consensus 679 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 758 (933)
|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..... ....
T Consensus 81 g~L~~~i~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~ 153 (316)
T cd05620 81 GDLMFHIQ---DKGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNRA 153 (316)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCce
Confidence 99999984 346789999999999999999999965 9999999999999999999999999998753211 1223
Q ss_pred eeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHHH
Q 002349 759 TYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAV 838 (933)
Q Consensus 759 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (933)
....||+.|+|||++.+..++.++||||+||++|||++|+.||.+.............. +.++.. ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~--------~~~~~~-----~~ 220 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT--------PHYPRW-----IT 220 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--------CCCCCC-----CC
Confidence 44679999999999999999999999999999999999999998654433222211111 111111 23
Q ss_pred HHHHHHHHHccCCCCCCCCCHH-HHHH
Q 002349 839 KKVFQLALLCSKRQPTDRPTMH-EVSR 864 (933)
Q Consensus 839 ~~l~~li~~cl~~dP~~RPt~~-evl~ 864 (933)
.++.+++.+|++.||++||++. ++.+
T Consensus 221 ~~~~~li~~~l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 221 KESKDILEKLFERDPTRRLGVVGNIRG 247 (316)
T ss_pred HHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 5678899999999999999984 5653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=333.50 Aligned_cols=236 Identities=23% Similarity=0.286 Sum_probs=192.0
Q ss_pred eeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcC-CCCceeeeeeEEecCCccEEEEEecCC
Q 002349 604 YIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSI-KHRNLVSLQGYSLSSSGNLLFYDFMEN 678 (933)
Q Consensus 604 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 678 (933)
+.||+|+||+||+|+.+ +++.||+|++.... ....+.+..|.+++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999976 47889999986532 23455677888888876 699999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCcee
Q 002349 679 GSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTS 758 (933)
Q Consensus 679 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 758 (933)
|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..... ....
T Consensus 81 g~L~~~i~---~~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~-~~~~ 153 (320)
T cd05590 81 GDLMFHIQ---KSRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-GKTT 153 (320)
T ss_pred chHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC-CCcc
Confidence 99999984 446789999999999999999999965 9999999999999999999999999998754221 2223
Q ss_pred eeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHHH
Q 002349 759 TYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAV 838 (933)
Q Consensus 759 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (933)
....||+.|+|||++.+..++.++||||+||++|||++|+.||.............. ... ..+. ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~--~~~------~~~~-----~~~ 220 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN--DEV------VYPT-----WLS 220 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc--CCC------CCCC-----CCC
Confidence 345799999999999999999999999999999999999999986554333222111 110 0111 123
Q ss_pred HHHHHHHHHccCCCCCCCCCH
Q 002349 839 KKVFQLALLCSKRQPTDRPTM 859 (933)
Q Consensus 839 ~~l~~li~~cl~~dP~~RPt~ 859 (933)
..+.+++.+|++.||++||++
T Consensus 221 ~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 221 QDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred HHHHHHHHHHcccCHHHCCCC
Confidence 567889999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=333.96 Aligned_cols=242 Identities=21% Similarity=0.280 Sum_probs=196.5
Q ss_pred eeeecccceeEEEEEEcC-CceEEEEEecccC---chhHHHHHHHHHHHhcC-CCCceeeeeeEEecCCccEEEEEecCC
Q 002349 604 YIIGYGASSTVYKCVLKN-CKPVAIKRLYSHY---PQCLKEFETELETVGSI-KHRNLVSLQGYSLSSSGNLLFYDFMEN 678 (933)
Q Consensus 604 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 678 (933)
++||+|+||.||+|..+. ++.||+|++.... ....+.+..|.++++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 369999999999999764 6889999987532 23345677888998866 799999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCcee
Q 002349 679 GSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTS 758 (933)
Q Consensus 679 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 758 (933)
|+|.+.+. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..... ....
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~-~~~~ 153 (321)
T cd05591 81 GDLMFQIQ---RSRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN-GVTT 153 (321)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccC-Cccc
Confidence 99999884 456789999999999999999999965 9999999999999999999999999998754222 2223
Q ss_pred eeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHHH
Q 002349 759 TYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAV 838 (933)
Q Consensus 759 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (933)
....||+.|+|||++.+..++.++||||+||++|||++|+.||................. ..+. ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~--------~~p~-----~~~ 220 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV--------LYPV-----WLS 220 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--------CCCC-----CCC
Confidence 345799999999999998999999999999999999999999986654433322211110 0111 123
Q ss_pred HHHHHHHHHccCCCCCCCC-------CHHHHHHH
Q 002349 839 KKVFQLALLCSKRQPTDRP-------TMHEVSRV 865 (933)
Q Consensus 839 ~~l~~li~~cl~~dP~~RP-------t~~evl~~ 865 (933)
..+.+++.+|++.||++|| ++++++++
T Consensus 221 ~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 221 KEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred HHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 5678899999999999999 78888765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=318.20 Aligned_cols=254 Identities=27% Similarity=0.387 Sum_probs=206.0
Q ss_pred hhccCcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEec
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFM 676 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 676 (933)
.++|+..++||+|+||.||+|..++++.||+|.+..... ..+++.+|+.++++++|+||+++++++. .+..++||||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 457888999999999999999988889999999875443 3567899999999999999999999874 55689999999
Q ss_pred CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCc
Q 002349 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY 756 (933)
Q Consensus 677 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 756 (933)
++++|.+++.. .....+++.++..++.|++.||+|||+. +++||||||+||++++++.++++|||++.........
T Consensus 83 ~~~~L~~~~~~-~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 83 ENGSLVDFLKT-PEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 99999999864 2345789999999999999999999965 9999999999999999999999999999765432222
Q ss_pred eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCccccccccCH
Q 002349 757 TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDL 835 (933)
Q Consensus 757 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (933)
......++..|+|||++.+..++.++||||||+++||+++ |+.||.+........... .. .......
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~--~~-----~~~~~~~----- 226 (260)
T cd05067 159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE--RG-----YRMPRPD----- 226 (260)
T ss_pred cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH--cC-----CCCCCCC-----
Confidence 2223346778999999998889999999999999999999 999997554322221111 10 0011111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcc
Q 002349 836 GAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGS 868 (933)
Q Consensus 836 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 868 (933)
..+.++.+++.+|+..+|++||+++++...|+.
T Consensus 227 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 227 NCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 123578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=325.34 Aligned_cols=259 Identities=25% Similarity=0.424 Sum_probs=208.6
Q ss_pred hccCcceeeecccceeEEEEEEc------CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK------NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLL 671 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 671 (933)
++|...+.||+|+||.||+|... ++..+++|.+........+.+.+|++++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 46778889999999999999853 245689999876665556789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCC
Q 002349 672 FYDFMENGSLWDILHGPT-------------KKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFE 738 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~ 738 (933)
||||+++++|.+++.... ....+++..++.++.|++.|++|||++ +|+||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 999999999999985321 123589999999999999999999965 9999999999999999999
Q ss_pred eEEeecccccccccCCCc-eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhc
Q 002349 739 AHLTDFGIAKSLCVSKSY-TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTA 816 (933)
Q Consensus 739 ~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~ 816 (933)
+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||+| |+.||........... ..
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~--~~ 239 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC--IT 239 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH--Hh
Confidence 999999999765322211 1223456788999999999999999999999999999999 9999875543332211 11
Q ss_pred ccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCC
Q 002349 817 NNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVP 871 (933)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 871 (933)
...... .. ...+..+.+++.+|++.||++||++++|++.|+.+..
T Consensus 240 ~~~~~~-----~~-----~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 240 QGRVLE-----RP-----RVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred CCCCCC-----CC-----ccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 111111 11 1124578899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=345.02 Aligned_cols=372 Identities=31% Similarity=0.478 Sum_probs=234.7
Q ss_pred CCCCCccEEEccCCcccc-cCCCCccCCCCCceecccccccCCCCCcccccccchhhhhhcccCccCCCCcccccCCCCc
Q 002349 89 GDLKDLQSIDLRGNRLSG-QIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLK 167 (933)
Q Consensus 89 ~~l~~L~~L~Ls~n~l~~-~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~ 167 (933)
+-|+..+-.|+++|.|+| ..|.....+++++.|.|...++. .+|.+++.|.+|++|.+++|+++ .+-..++.|+.|+
T Consensus 4 gVLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LR 81 (1255)
T KOG0444|consen 4 GVLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLR 81 (1255)
T ss_pred cccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhH
Confidence 345566667777777763 56777777777777777777775 67777777777777777777776 3445666677777
Q ss_pred eeeeecCCCCC-CcccccccCCCCcEEeccCccccCccCcCCcCCCCCcEEccccccccCcCCCCccccccceEeccccc
Q 002349 168 VFGLRGNNLVG-TLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQ 246 (933)
Q Consensus 168 ~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~ 246 (933)
.+++..|++.. -+|+++..+..|..||||+|++. ..|..+..-+++-+|+||+|+|. .||..
T Consensus 82 sv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~--------------- 144 (1255)
T KOG0444|consen 82 SVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNS--------------- 144 (1255)
T ss_pred HHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCch---------------
Confidence 77777777653 35666666666666666666666 56666666666666666666665 33322
Q ss_pred cccccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcceEeeecccccc-ccCCc
Q 002349 247 LTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLT-GHIPP 325 (933)
Q Consensus 247 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~-~~~~~ 325 (933)
.|.+++.|-.||||+|++. .+|+.+..+..|++|.|++|.+...--..+..|++|+.|.+++.+-+ ..+|.
T Consensus 145 -------lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Pt 216 (1255)
T KOG0444|consen 145 -------LFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPT 216 (1255)
T ss_pred -------HHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCC
Confidence 2334445555555555554 44444555555555555555544332333444555666666655433 24566
Q ss_pred cccccccccccccccccCCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCCcccccccccc
Q 002349 326 ALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNL 405 (933)
Q Consensus 326 ~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 405 (933)
++..+.+|..++++.|.+. .+|+.+..+.+|+.|+||+|+|+ .+.-..+...+|+.|+||.|+++ ..|.++.++++|
T Consensus 217 sld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL 293 (1255)
T KOG0444|consen 217 SLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKL 293 (1255)
T ss_pred chhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHH
Confidence 6666666666666666666 56666666666666666666666 33444455566667777777776 666667777777
Q ss_pred ceeeccCCccCC-CCCCCCCCccccccccccCcccccccccccccccccceEEccCCccccccchhhccccccceeeecC
Q 002349 406 DTLDMSNNKISG-SIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDY 484 (933)
Q Consensus 406 ~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 484 (933)
+.|++.+|+++- -+|..++.+.+|+.+..++|.|. ..|+.+..+..|+.|.|++|+|- .+|+.+--|+.|+.|||..
T Consensus 294 ~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlre 371 (1255)
T KOG0444|consen 294 TKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRE 371 (1255)
T ss_pred HHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccC
Confidence 777777776652 36666777777777777777776 66777777777777777777766 5677777777777777777
Q ss_pred CCCcCccc
Q 002349 485 NNLSGDVM 492 (933)
Q Consensus 485 N~l~~~~~ 492 (933)
|+=---+|
T Consensus 372 NpnLVMPP 379 (1255)
T KOG0444|consen 372 NPNLVMPP 379 (1255)
T ss_pred CcCccCCC
Confidence 65333333
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=329.98 Aligned_cols=241 Identities=23% Similarity=0.312 Sum_probs=193.3
Q ss_pred eeeecccceeEEEEEEcC-CceEEEEEecccC---chhHHHHHHHHHHHhcC-CCCceeeeeeEEecCCccEEEEEecCC
Q 002349 604 YIIGYGASSTVYKCVLKN-CKPVAIKRLYSHY---PQCLKEFETELETVGSI-KHRNLVSLQGYSLSSSGNLLFYDFMEN 678 (933)
Q Consensus 604 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 678 (933)
+.||+|+||+||+|.+.. ++.||+|+++... ....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 369999999999999764 6789999987542 22345566788888764 899999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCcee
Q 002349 679 GSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTS 758 (933)
Q Consensus 679 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 758 (933)
|+|.+++. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (316)
T cd05619 81 GDLMFHIQ---SCHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKT 153 (316)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cce
Confidence 99999984 345789999999999999999999965 99999999999999999999999999987532211 223
Q ss_pred eeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHHH
Q 002349 759 TYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAV 838 (933)
Q Consensus 759 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (933)
....||+.|+|||++.+..++.++||||+||++|||++|+.||................ +..+. ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~--------~~~~~-----~~~ 220 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN--------PCYPR-----WLT 220 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--------CCCCc-----cCC
Confidence 34579999999999999899999999999999999999999998654332222111111 11111 123
Q ss_pred HHHHHHHHHccCCCCCCCCCHH-HHHH
Q 002349 839 KKVFQLALLCSKRQPTDRPTMH-EVSR 864 (933)
Q Consensus 839 ~~l~~li~~cl~~dP~~RPt~~-evl~ 864 (933)
..+.+++.+|++.||++||++. ++.+
T Consensus 221 ~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 221 REAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred HHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 5678899999999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=317.76 Aligned_cols=253 Identities=29% Similarity=0.403 Sum_probs=204.2
Q ss_pred hccCcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecC
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFME 677 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 677 (933)
++|...+.||+|++|.||+|.+..+..+|+|++.... ...+.+.+|++++++++|||++++++++. ....++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 5688889999999999999998887789999886543 23467889999999999999999999875 456899999999
Q ss_pred CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCce
Q 002349 678 NGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYT 757 (933)
Q Consensus 678 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 757 (933)
+++|.++++.. ....+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||.++.........
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence 99999999642 234589999999999999999999965 99999999999999999999999999997654322222
Q ss_pred eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCccccccccCHH
Q 002349 758 STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLG 836 (933)
Q Consensus 758 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (933)
.....++..|+|||...+..++.++||||||+++|||++ |+.||.+............ . . .+... ..
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~--~-~----~~~~~-----~~ 227 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVER--G-Y----RMPCP-----QG 227 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc--C-C----CCCCC-----cc
Confidence 222346778999999998889999999999999999999 8999976544333222111 1 0 01111 12
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHHcc
Q 002349 837 AVKKVFQLALLCSKRQPTDRPTMHEVSRVLGS 868 (933)
Q Consensus 837 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 868 (933)
.+..+.+++.+|+..||++||++++|.+.|+.
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 228 CPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 24678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=323.48 Aligned_cols=256 Identities=24% Similarity=0.417 Sum_probs=203.2
Q ss_pred hccCcceeeecccceeEEEEEEc-----CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-----NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLL 671 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 671 (933)
++|+..+.||+|+||+||+|.+. .++.||+|.+.... .+...++.+|++++++++||||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 46778889999999999999852 45789999997543 3344678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCC--------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCC
Q 002349 672 FYDFMENGSLWDILHGPT--------------KKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDF 737 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~ 737 (933)
||||+++++|.+++.... ....+++.++..++.|++.||+|||++ +|+||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 999999999999985211 123578999999999999999999965 999999999999999999
Q ss_pred CeEEeecccccccccCCC-ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhh
Q 002349 738 EAHLTDFGIAKSLCVSKS-YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKT 815 (933)
Q Consensus 738 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~ 815 (933)
.+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||.+......... .
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~--~ 239 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM--V 239 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH--H
Confidence 999999999986533221 11223345678999999988889999999999999999998 8889975433221111 1
Q ss_pred cccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcc
Q 002349 816 ANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGS 868 (933)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 868 (933)
...... .... ..+..+.+++.+|++.||++||++.+|.+.|..
T Consensus 240 ~~~~~~-----~~~~-----~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 240 RKRQLL-----PCSE-----DCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HcCCcC-----CCCC-----CCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111111 0111 123578889999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=339.77 Aligned_cols=253 Identities=22% Similarity=0.244 Sum_probs=199.4
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
++|+..+.||+|+||+||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46888999999999999999865 57899999986532 233466889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
||+++|+|.+++. ..+.+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLI---KYDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 9999999999994 356789999999999999999999965 9999999999999999999999999999643110
Q ss_pred CCc----------------------------------------------eeeeecccccccCccccccCCCCcchhhHHH
Q 002349 754 KSY----------------------------------------------TSTYIMGTIGYIDPEYARTSRLTEKSDVYSF 787 (933)
Q Consensus 754 ~~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSl 787 (933)
... .....+||+.|+|||++.+..++.++||||+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 000 0012469999999999999899999999999
Q ss_pred HHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCC---CCHHHHHH
Q 002349 788 GIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDR---PTMHEVSR 864 (933)
Q Consensus 788 Gv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Pt~~evl~ 864 (933)
||++|||++|+.||................... .++. .......+.+++.+|+. +|.+| +++.|+++
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~------~~p~---~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~ 304 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSHETYRKIINWRETL------YFPD---DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKS 304 (377)
T ss_pred chhhhhhhcCCCCCCCCCHHHHHHHHHccCCcc------CCCC---CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhc
Confidence 999999999999998655433322211111000 0111 01123567789999997 66665 69999887
Q ss_pred HH
Q 002349 865 VL 866 (933)
Q Consensus 865 ~L 866 (933)
+-
T Consensus 305 hp 306 (377)
T cd05629 305 HP 306 (377)
T ss_pred CC
Confidence 53
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=336.09 Aligned_cols=238 Identities=24% Similarity=0.289 Sum_probs=194.2
Q ss_pred eeeecccceeEEEEEE----cCCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecC
Q 002349 604 YIIGYGASSTVYKCVL----KNCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFME 677 (933)
Q Consensus 604 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 677 (933)
+.||+|+||.||+++. ..++.||+|++.... ......+.+|++++++++||||+++++++...+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999985 247889999997543 2234557789999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCce
Q 002349 678 NGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYT 757 (933)
Q Consensus 678 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 757 (933)
+|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 82 ~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~ 154 (318)
T cd05582 82 GGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KK 154 (318)
T ss_pred CCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cc
Confidence 999999984 345789999999999999999999965 99999999999999999999999999997653221 22
Q ss_pred eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHH
Q 002349 758 STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGA 837 (933)
Q Consensus 758 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 837 (933)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||.................. ++. ..
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~--------~p~-----~~ 221 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLG--------MPQ-----FL 221 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCC--------CCC-----CC
Confidence 33457999999999999888999999999999999999999999865443332221111111 111 12
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHH
Q 002349 838 VKKVFQLALLCSKRQPTDRPTMHE 861 (933)
Q Consensus 838 ~~~l~~li~~cl~~dP~~RPt~~e 861 (933)
+..+.+++.+|++.||++||++.+
T Consensus 222 ~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 222 SPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CHHHHHHHHHHhhcCHhHcCCCCC
Confidence 356788999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=324.17 Aligned_cols=259 Identities=25% Similarity=0.427 Sum_probs=207.5
Q ss_pred hccCcceeeecccceeEEEEEEc------CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK------NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLL 671 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 671 (933)
++|...+.||+|+||+||+|... ++..+|+|.+..........+.+|++++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 57888899999999999999852 235689999876655566789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCC----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEE
Q 002349 672 FYDFMENGSLWDILHGPT----------KKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHL 741 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl 741 (933)
||||+++++|.+++.... ....+++..+..++.|++.||+|||++ +++||||||+||++++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEe
Confidence 999999999999985321 223589999999999999999999965 9999999999999999999999
Q ss_pred eecccccccccCCCc-eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccc
Q 002349 742 TDFGIAKSLCVSKSY-TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNA 819 (933)
Q Consensus 742 ~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 819 (933)
+|||+++........ ......++..|+|||.+.+..++.++|||||||++|+|++ |..||............ ....
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i--~~~~ 239 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI--TQGR 239 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH--HcCC
Confidence 999999765322211 1122345778999999998889999999999999999998 89998755433222111 1111
Q ss_pred cccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCC
Q 002349 820 VMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVP 871 (933)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 871 (933)
.. .... ..+..+.+++.+|++.||.+|||+.++.+.|+.+..
T Consensus 240 ~~-----~~~~-----~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 240 VL-----QRPR-----TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred cC-----CCCC-----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 11 0111 123568999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=329.58 Aligned_cols=256 Identities=25% Similarity=0.379 Sum_probs=212.1
Q ss_pred HhhccCcceeeecccceeEEEEEEcC---Cc--eEEEEEeccc-CchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCcc
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLKN---CK--PVAIKRLYSH-YPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGN 669 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~~---~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 669 (933)
..+.....++||+|.||.||+|.+.+ |+ .||||.-+.+ .+...+.|..|+.+|+.++|||||+++|+|.+. ..
T Consensus 387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~ 465 (974)
T KOG4257|consen 387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PM 465 (974)
T ss_pred ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ce
Confidence 34556667789999999999999653 33 4888988774 456678899999999999999999999999754 68
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccc
Q 002349 670 LLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKS 749 (933)
Q Consensus 670 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 749 (933)
|+|||.++-|.|..+++ .+...++......++.|++.||+||| |..+|||||.++|||+.....||++|||+++.
T Consensus 466 WivmEL~~~GELr~yLq--~nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQ--QNKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred eEEEecccchhHHHHHH--hccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhh
Confidence 99999999999999997 45678999999999999999999999 56999999999999999999999999999999
Q ss_pred cccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCccc
Q 002349 750 LCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEI 828 (933)
Q Consensus 750 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 828 (933)
+.++..+......-+..|||||-+.-+.++.++|||.|||++||++. |..||.+-.+.+-+. .+...-+...
T Consensus 541 ~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~-------~iEnGeRlP~ 613 (974)
T KOG4257|consen 541 LEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG-------HIENGERLPC 613 (974)
T ss_pred ccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE-------EecCCCCCCC
Confidence 98777777666566778999999999999999999999999999876 889998644322211 1111111111
Q ss_pred cccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccC
Q 002349 829 SATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869 (933)
Q Consensus 829 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 869 (933)
+..|+..++.++.+||+.||.+||.+.|+...|..+
T Consensus 614 -----P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv 649 (974)
T KOG4257|consen 614 -----PPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV 649 (974)
T ss_pred -----CCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence 224567899999999999999999999998877554
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=330.70 Aligned_cols=242 Identities=21% Similarity=0.274 Sum_probs=196.4
Q ss_pred eeeecccceeEEEEEEcC-CceEEEEEecccC---chhHHHHHHHHHHHhcC-CCCceeeeeeEEecCCccEEEEEecCC
Q 002349 604 YIIGYGASSTVYKCVLKN-CKPVAIKRLYSHY---PQCLKEFETELETVGSI-KHRNLVSLQGYSLSSSGNLLFYDFMEN 678 (933)
Q Consensus 604 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 678 (933)
+.||+|+||+||+|.++. ++.||+|+++... ......+.+|.++++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999999764 6789999997542 23445677899999888 799999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCcee
Q 002349 679 GSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTS 758 (933)
Q Consensus 679 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 758 (933)
|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..... ....
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~ 153 (318)
T cd05570 81 GDLMFHIQ---RSGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG-GVTT 153 (318)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcC-CCcc
Confidence 99999884 345799999999999999999999965 9999999999999999999999999998753221 1222
Q ss_pred eeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHHH
Q 002349 759 TYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAV 838 (933)
Q Consensus 759 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (933)
....|++.|+|||++.+..++.++||||+||++|+|++|+.||.+............... .++. ..+
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~--------~~~~-----~~~ 220 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV--------RYPR-----WLS 220 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC--------CCCC-----cCC
Confidence 345799999999999999999999999999999999999999986543332221111110 1111 123
Q ss_pred HHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 002349 839 KKVFQLALLCSKRQPTDRPTM-----HEVSRV 865 (933)
Q Consensus 839 ~~l~~li~~cl~~dP~~RPt~-----~evl~~ 865 (933)
..+.+++.+||+.||++||++ .+++++
T Consensus 221 ~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 221 KEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred HHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 578899999999999999999 888764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=321.18 Aligned_cols=256 Identities=25% Similarity=0.373 Sum_probs=201.0
Q ss_pred hccCcceeeecccceeEEEEEEcC-Cc----eEEEEEecccCc-hhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKN-CK----PVAIKRLYSHYP-QCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLL 671 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 671 (933)
++|+..+.||+|+||+||+|.+.. ++ .+++|.+..... ....++..|+.++++++||||+++++++. +...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 467788899999999999999743 33 478888754332 23467888999999999999999999875 455788
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccc
Q 002349 672 FYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLC 751 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 751 (933)
++||+++|+|.++++. ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQ--HRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 9999999999999963 345789999999999999999999965 99999999999999999999999999998653
Q ss_pred cCCC-ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCcccc
Q 002349 752 VSKS-YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEIS 829 (933)
Q Consensus 752 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (933)
.... .......++..|+|||.+.+..++.++|||||||++||+++ |+.||.+......... ...+.... .+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~--~~~~~~~~--~~--- 233 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL--LEKGERLA--QP--- 233 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH--HHCCCcCC--CC---
Confidence 3222 12233457789999999998899999999999999999998 9999976433221111 11111100 01
Q ss_pred ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCC
Q 002349 830 ATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVP 871 (933)
Q Consensus 830 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 871 (933)
. .+...+.+++.+|+..||++|||+.|+++.|..+..
T Consensus 234 ~-----~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 234 Q-----ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred C-----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 1 123467889999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=320.04 Aligned_cols=258 Identities=20% Similarity=0.327 Sum_probs=207.1
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEeccc---CchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSH---YPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
++|+..+.||+|+||.||+|... +++.||||.+... .......+.+|++++++++||||+++++++...+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57888999999999999999965 5789999987542 2334557889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccccc
Q 002349 674 DFMENGSLWDILHGPT-KKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV 752 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 752 (933)
||+++++|.+++.... ....++...+..++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998884322 234588999999999999999999965 999999999999999999999999999886542
Q ss_pred CCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcch-hHHHHhhhcccccccccCcccccc
Q 002349 753 SKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNL-HHLILSKTANNAVMETVDPEISAT 831 (933)
Q Consensus 753 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 831 (933)
... ......|++.|+|||.+.+..++.++||||+|+++|||++|+.||...... ..... ...... .+...
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~-~~~~~~-----~~~~~-- 229 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQ-KIEQCD-----YPPLP-- 229 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHH-HHhcCC-----CCCCC--
Confidence 221 122346888999999998888999999999999999999999999654321 12111 111111 11111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccC
Q 002349 832 CKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869 (933)
Q Consensus 832 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 869 (933)
....+..+.+++.+||+.+|++||++.+|++.++.+
T Consensus 230 --~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 230 --TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred --hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 112346788999999999999999999999998865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=318.62 Aligned_cols=247 Identities=20% Similarity=0.286 Sum_probs=211.7
Q ss_pred ccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEe
Q 002349 599 NLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
=|...+.||+|.|++|-.|++- .|+.||||++.+.. .-....+.+|++.|+-++|||||++|++.......|+|.|.
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 4556678999999999999855 58999999997654 33456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEe-CCCCCeEEeecccccccccCC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILL-DKDFEAHLTDFGIAKSLCVSK 754 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll-~~~~~~kl~DfGla~~~~~~~ 754 (933)
-++|+|+|++- +....+.++-+.+++.||+.|+.|+|+- .|||||+||+||.+ ..-|-||++|||++..+...
T Consensus 99 GD~GDl~DyIm--KHe~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG- 172 (864)
T KOG4717|consen 99 GDGGDLFDYIM--KHEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG- 172 (864)
T ss_pred cCCchHHHHHH--hhhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCc-
Confidence 99999999994 4566899999999999999999999965 89999999999877 45689999999999876433
Q ss_pred CceeeeecccccccCccccccCCCC-cchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccccc
Q 002349 755 SYTSTYIMGTIGYIDPEYARTSRLT-EKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCK 833 (933)
Q Consensus 755 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (933)
..-...+|+..|-|||++.|..|+ +++||||+||++|-+++|+.||+...+.+.+.++..-++.++.
T Consensus 173 -~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPs----------- 240 (864)
T KOG4717|consen 173 -KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPS----------- 240 (864)
T ss_pred -chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCch-----------
Confidence 334557999999999999999886 7899999999999999999999988888877665544444332
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 834 DLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 834 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
....++.++|.+|+..||++|.+.+||+..
T Consensus 241 --hvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 241 --HVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred --hhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 234678899999999999999999999864
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=322.85 Aligned_cols=247 Identities=20% Similarity=0.241 Sum_probs=194.7
Q ss_pred eecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecCCCCH
Q 002349 606 IGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSL 681 (933)
Q Consensus 606 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 681 (933)
||+|+||+||+|.++ +++.||+|++.... ....+.+..|++++++++||||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999976 57899999986532 12335678899999999999999999999999999999999999999
Q ss_pred HHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCceeee
Q 002349 682 WDILHGP-TKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTY 760 (933)
Q Consensus 682 ~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 760 (933)
.+.+... .....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 9887432 2345789999999999999999999965 999999999999999999999999999976543222 2233
Q ss_pred ecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHHHHH
Q 002349 761 IMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKK 840 (933)
Q Consensus 761 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 840 (933)
..||+.|+|||++.+..++.++|||||||++|||++|+.||............. ....... ...+ ...+..
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~--~~~~~~~--~~~~-----~~~~~~ 227 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK--QRILNDS--VTYP-----DKFSPA 227 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHH--HhhcccC--CCCc-----ccCCHH
Confidence 578999999999999999999999999999999999999997543221111000 0000000 0011 112457
Q ss_pred HHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002349 841 VFQLALLCSKRQPTDRP-----TMHEVSRV 865 (933)
Q Consensus 841 l~~li~~cl~~dP~~RP-----t~~evl~~ 865 (933)
+.+++.+|++.||++|| ++++++++
T Consensus 228 ~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 228 SKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred HHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 88999999999999999 67777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=330.55 Aligned_cols=241 Identities=21% Similarity=0.258 Sum_probs=194.9
Q ss_pred ccCcceeeecccceeEEEEEEcC-CceEEEEEecccC---chhHHHHHHHHHHHhcC-CCCceeeeeeEEecCCccEEEE
Q 002349 599 NLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHY---PQCLKEFETELETVGSI-KHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 673 (933)
+|+..+.||+|+||.||+|+... ++.||+|++.... ....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 47788999999999999999764 6789999987542 22334567788888877 5899999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
||+++|+|.+.+. ....+++.++..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQ---QVGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 9999999999984 345789999999999999999999965 9999999999999999999999999999754221
Q ss_pred CCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccccc
Q 002349 754 KSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCK 833 (933)
Q Consensus 754 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (933)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.+............... .++.
T Consensus 155 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~--------~~p~--- 222 (323)
T cd05616 155 -GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNV--------AYPK--- 222 (323)
T ss_pred -CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--------CCCC---
Confidence 2223345799999999999999999999999999999999999999986554333222211111 1111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCH
Q 002349 834 DLGAVKKVFQLALLCSKRQPTDRPTM 859 (933)
Q Consensus 834 ~~~~~~~l~~li~~cl~~dP~~RPt~ 859 (933)
.....+.+++.+|++.||++|++.
T Consensus 223 --~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 223 --SMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred --cCCHHHHHHHHHHcccCHHhcCCC
Confidence 123567889999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=317.28 Aligned_cols=255 Identities=27% Similarity=0.397 Sum_probs=208.0
Q ss_pred hhccCcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEec
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFM 676 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 676 (933)
.++|...+.||+|+||.||+|..++++.||||.+..... ..+++.+|+.++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 467889999999999999999988888899999875432 3567899999999999999999999999888999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCc
Q 002349 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY 756 (933)
Q Consensus 677 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 756 (933)
++++|.+++.. .....+++.++..++.|++.|++|||++ +++|+||||+||++++++.+|++|||.++........
T Consensus 84 ~~~~L~~~i~~-~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 84 SKGSLLDFLKS-GEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT 159 (261)
T ss_pred CCCCHHHHHhc-cccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence 99999999964 2235689999999999999999999965 9999999999999999999999999999866432222
Q ss_pred eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCccccccccCH
Q 002349 757 TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDL 835 (933)
Q Consensus 757 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (933)
......++..|+|||.+.+..++.++||||+|+++|++++ |+.||.+............ . .. .... .
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~-~--~~----~~~~-----~ 227 (261)
T cd05034 160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVER-G--YR----MPRP-----P 227 (261)
T ss_pred hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-C--CC----CCCC-----C
Confidence 2222335678999999998889999999999999999998 9999976543332222111 0 00 0000 1
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcc
Q 002349 836 GAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGS 868 (933)
Q Consensus 836 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 868 (933)
..+..+.+++.+|++.+|++||+++++.+.|+.
T Consensus 228 ~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 228 NCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 124578899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=332.90 Aligned_cols=261 Identities=25% Similarity=0.398 Sum_probs=203.8
Q ss_pred hhccCcceeeecccceeEEEEEEcC------CceEEEEEecccCc-hhHHHHHHHHHHHhcC-CCCceeeeeeEEecC-C
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKN------CKPVAIKRLYSHYP-QCLKEFETELETVGSI-KHRNLVSLQGYSLSS-S 667 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-~ 667 (933)
.++|+..+.||+|+||.||+|...+ ++.||+|++..... ...+.+.+|+++++++ +|+||+++++++... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 3578999999999999999997432 46899999875432 2345678899999999 899999999988654 5
Q ss_pred ccEEEEEecCCCCHHHHhcCCCC---------------------------------------------------------
Q 002349 668 GNLLFYDFMENGSLWDILHGPTK--------------------------------------------------------- 690 (933)
Q Consensus 668 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 690 (933)
..+++|||+++++|.+++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 67899999999999998853111
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCce-eeeeccccccc
Q 002349 691 -KKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYT-STYIMGTIGYI 768 (933)
Q Consensus 691 -~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~ 768 (933)
..++++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++.+....... .....++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 13689999999999999999999965 99999999999999999999999999998763322221 22345677899
Q ss_pred CccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHHHHHHHHHHHH
Q 002349 769 DPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALL 847 (933)
Q Consensus 769 aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 847 (933)
|||++.+..++.++|||||||++|||++ |..||.+........... .... .+..+ ......+.+++.+
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~-----~~~~~-----~~~~~~~~~l~~~ 311 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRL-KEGT-----RMRAP-----EYATPEIYSIMLD 311 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHH-hccC-----CCCCC-----ccCCHHHHHHHHH
Confidence 9999999999999999999999999998 999997543322221111 1110 01111 1123578899999
Q ss_pred ccCCCCCCCCCHHHHHHHHccCCC
Q 002349 848 CSKRQPTDRPTMHEVSRVLGSLVP 871 (933)
Q Consensus 848 cl~~dP~~RPt~~evl~~L~~~~~ 871 (933)
|++.+|++||++.|++++|+.+..
T Consensus 312 cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 312 CWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=315.05 Aligned_cols=246 Identities=26% Similarity=0.392 Sum_probs=199.5
Q ss_pred eeecccceeEEEEEEcCCceEEEEEecccCc-hhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecCCCCHHH
Q 002349 605 IIGYGASSTVYKCVLKNCKPVAIKRLYSHYP-QCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWD 683 (933)
Q Consensus 605 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~ 683 (933)
+||+|+||.||+|...+++.||+|++..... .....+.+|++++++++||||+++++++......++||||+++++|.+
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence 6999999999999988888999999876543 334568899999999999999999999999999999999999999999
Q ss_pred HhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCceeeeecc
Q 002349 684 ILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMG 763 (933)
Q Consensus 684 ~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~g 763 (933)
++.. ....+++..+..++.|++.||.|+|++ +++||||||+||+++.++.+|++|||++...............+
T Consensus 82 ~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 82 FLRK--KKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred HHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 9853 345689999999999999999999965 99999999999999999999999999997643322222222244
Q ss_pred cccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHHHHHHH
Q 002349 764 TIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVF 842 (933)
Q Consensus 764 t~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 842 (933)
+..|+|||++.+..++.++||||||+++|++++ |..||............. ... ...... ..+..+.
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~--~~~-----~~~~~~-----~~~~~~~ 224 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE--KGY-----RMSCPQ-----KCPDDVY 224 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH--cCC-----CCCCCC-----CCCHHHH
Confidence 678999999998889999999999999999998 999997543332221111 110 111111 1246788
Q ss_pred HHHHHccCCCCCCCCCHHHHHHHHc
Q 002349 843 QLALLCSKRQPTDRPTMHEVSRVLG 867 (933)
Q Consensus 843 ~li~~cl~~dP~~RPt~~evl~~L~ 867 (933)
+++.+|++.+|++||++.|+++.|.
T Consensus 225 ~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 225 KVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHcccCcccCCCHHHHHHHhc
Confidence 9999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=334.22 Aligned_cols=261 Identities=23% Similarity=0.286 Sum_probs=200.0
Q ss_pred HHhhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCC----
Q 002349 595 RMTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSS---- 667 (933)
Q Consensus 595 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 667 (933)
...++|+..+.||+|+||.||+|... .++.||+|++.... ......+.+|+.+++.++||||+++++++...+
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 34578999999999999999999975 47899999986542 334567789999999999999999999986543
Q ss_pred --ccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecc
Q 002349 668 --GNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFG 745 (933)
Q Consensus 668 --~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfG 745 (933)
..++||||+++ ++.+.++ ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCC
Confidence 46899999975 5666663 2478899999999999999999965 99999999999999999999999999
Q ss_pred cccccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccccccc---
Q 002349 746 IAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVME--- 822 (933)
Q Consensus 746 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--- 822 (933)
+++..... .......||+.|+|||.+.+..++.++||||+||++|+|++|+.||.+......+.......+....
T Consensus 169 ~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 246 (359)
T cd07876 169 LARTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM 246 (359)
T ss_pred CccccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence 99764322 2223357899999999999999999999999999999999999999866544333211111000000
Q ss_pred -----------ccCcccc---------cc------ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 823 -----------TVDPEIS---------AT------CKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 823 -----------~~~~~~~---------~~------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
...+... .. ..+......+.+++.+|++.||++|||++|++++-
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 316 (359)
T cd07876 247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP 316 (359)
T ss_pred HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 0000000 00 00001235678999999999999999999999854
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=340.44 Aligned_cols=251 Identities=21% Similarity=0.260 Sum_probs=196.0
Q ss_pred ccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEE
Q 002349 599 NLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYD 674 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 674 (933)
.|+..+.||+|+||+||+|+.. +++.||+|++.... ....+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5788899999999999999975 47889999986532 2345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCC
Q 002349 675 FMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSK 754 (933)
Q Consensus 675 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 754 (933)
|+++|+|.+++. ..+.+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+|+.+....
T Consensus 82 ~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLI---RMGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 999999999985 345689999999999999999999965 99999999999999999999999999975321000
Q ss_pred ----------------------------------------------CceeeeecccccccCccccccCCCCcchhhHHHH
Q 002349 755 ----------------------------------------------SYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFG 788 (933)
Q Consensus 755 ----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlG 788 (933)
.......+||+.|+|||++.+..++.++||||+|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0001234699999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 002349 789 IVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPT---MHEVSRV 865 (933)
Q Consensus 789 v~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~evl~~ 865 (933)
|++|||++|+.||.................... .+.. ........+++.+++ .+|++|++ +++++++
T Consensus 236 vil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~------~p~~---~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 305 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPLETQMKVINWQTSLH------IPPQ---AKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH 305 (382)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcC------CCCc---ccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence 999999999999986654433322211111110 0000 011245566666655 59999987 8887754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=314.78 Aligned_cols=247 Identities=23% Similarity=0.354 Sum_probs=197.1
Q ss_pred eeeecccceeEEEEEEc-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecCCCCH
Q 002349 604 YIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSL 681 (933)
Q Consensus 604 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 681 (933)
+.||+|+||.||+|.+. +++.||+|.+.... ......+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36999999999999975 57889999886543 34456789999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCce-eee
Q 002349 682 WDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYT-STY 760 (933)
Q Consensus 682 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~-~~~ 760 (933)
.++++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+|++|||++.......... ...
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRT--EGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 999952 344689999999999999999999965 99999999999999999999999999987643211111 011
Q ss_pred ecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHHHH
Q 002349 761 IMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVK 839 (933)
Q Consensus 761 ~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 839 (933)
..++..|+|||.+.+..++.++||||+|+++|||++ |..||.............. . .....+. ..+.
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~--~-----~~~~~~~-----~~~~ 223 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQ--G-----VRLPCPE-----LCPD 223 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHc--C-----CCCCCcc-----cCCH
Confidence 123457999999998889999999999999999998 8888875433222211111 0 0111111 1245
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 002349 840 KVFQLALLCSKRQPTDRPTMHEVSRVLG 867 (933)
Q Consensus 840 ~l~~li~~cl~~dP~~RPt~~evl~~L~ 867 (933)
.+.+++.+|++.+|++|||++++.+.|.
T Consensus 224 ~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 224 AVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 7889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=341.21 Aligned_cols=251 Identities=20% Similarity=0.247 Sum_probs=198.0
Q ss_pred ccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEE
Q 002349 599 NLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYD 674 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 674 (933)
+|++.+.||+|+||.||+|+.. .++.||||++.... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 6888999999999999999965 47889999986532 2234568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCC
Q 002349 675 FMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSK 754 (933)
Q Consensus 675 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 754 (933)
|+++|+|.+++. ..+.+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+|..+....
T Consensus 82 ~~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 82 YIPGGDMMSLLI---RLGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred CCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 999999999995 345788999999999999999999965 99999999999999999999999999985321000
Q ss_pred ------------------------------------------CceeeeecccccccCccccccCCCCcchhhHHHHHHHH
Q 002349 755 ------------------------------------------SYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLL 792 (933)
Q Consensus 755 ------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ 792 (933)
.......+||+.|||||++.+..++.++||||+||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 00012347999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCC---CHHHHHHH
Q 002349 793 ELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRP---TMHEVSRV 865 (933)
Q Consensus 793 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---t~~evl~~ 865 (933)
||++|+.||.+................. . ++. .......+.+++.+|+ .+|.+|+ ++.+++++
T Consensus 236 ell~G~~Pf~~~~~~~~~~~i~~~~~~~--~----~~~---~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 236 EMLVGQPPFLADTPAETQLKVINWETTL--H----IPS---QAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred ehhhCCCCCCCCCHHHHHHHHhccCccc--c----CCC---CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 9999999998765443322211111100 0 000 0012345666777765 5999999 89999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=353.44 Aligned_cols=261 Identities=21% Similarity=0.264 Sum_probs=204.2
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
++|++.++||+|+||.||+|.+. .++.||+|++.... ....+++.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 47889999999999999999976 47899999997542 234567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCC--------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecc
Q 002349 674 DFMENGSLWDILHGPT--------KKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFG 745 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfG 745 (933)
||++||+|.++++... .....++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999885311 123466788899999999999999965 99999999999999999999999999
Q ss_pred cccccccCCC-----------------ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchh
Q 002349 746 IAKSLCVSKS-----------------YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLH 808 (933)
Q Consensus 746 la~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~ 808 (933)
+++....... ......+||+.|||||++.+..++.++||||+||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986521110 11123469999999999999999999999999999999999999997533221
Q ss_pred HHHHhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHccCCC
Q 002349 809 HLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRP-TMHEVSRVLGSLVP 871 (933)
Q Consensus 809 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~~~ 871 (933)
..... ..... .... +....+..+.+++.+|++.||++|| +++++.+.|+....
T Consensus 239 i~~~~-----~i~~P--~~~~---p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 239 ISYRD-----VILSP--IEVA---PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hhhhh-----hccCh--hhcc---ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 11110 00000 0000 0112345688899999999999996 56777777766543
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=321.20 Aligned_cols=254 Identities=24% Similarity=0.326 Sum_probs=202.9
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEec
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFM 676 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 676 (933)
++|++.+.||+|+||.||+|... +++.||+|++..........+.+|+.++++++||||+++++++...+..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 47889999999999999999964 57889999987655455567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCc
Q 002349 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY 756 (933)
Q Consensus 677 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 756 (933)
++++|.++++ ...++++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++..+.... .
T Consensus 89 ~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~ 161 (267)
T cd06646 89 GGGSLQDIYH---VTGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATI-A 161 (267)
T ss_pred CCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccc-c
Confidence 9999999985 345789999999999999999999965 99999999999999999999999999998653221 1
Q ss_pred eeeeecccccccCccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccccc
Q 002349 757 TSTYIMGTIGYIDPEYAR---TSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCK 833 (933)
Q Consensus 757 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (933)
......|++.|+|||.+. ...++.++||||+||++|||++|+.||............ ..... ..+....
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~--~~~~~---~~~~~~~--- 233 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM--SKSNF---QPPKLKD--- 233 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee--ecCCC---CCCCCcc---
Confidence 123346889999999874 345788999999999999999999999644322211110 00000 0111111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 834 DLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 834 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
....+..+.+++.+|++.+|++||+++++++++
T Consensus 234 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 234 KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 112246788999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=346.89 Aligned_cols=255 Identities=20% Similarity=0.266 Sum_probs=203.4
Q ss_pred HhhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCC-----
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSS----- 667 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 667 (933)
..++|...+.||+|+||+||+|... +++.||||++.... ......+.+|+.++..++|+||+++++.+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 3468999999999999999999865 58899999986542 344567889999999999999999988775432
Q ss_pred ---ccEEEEEecCCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEee
Q 002349 668 ---GNLLFYDFMENGSLWDILHGP-TKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTD 743 (933)
Q Consensus 668 ---~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 743 (933)
..++||||+++|+|.++++.. .....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEe
Confidence 257999999999999998532 2345789999999999999999999965 999999999999999999999999
Q ss_pred cccccccccCCC-ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccccccc
Q 002349 744 FGIAKSLCVSKS-YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVME 822 (933)
Q Consensus 744 fGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 822 (933)
||+++.+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+........... ... ..
T Consensus 187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~--~~~-~~ 263 (496)
T PTZ00283 187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTL--AGR-YD 263 (496)
T ss_pred cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh--cCC-CC
Confidence 999987543221 22334579999999999999999999999999999999999999998654322221111 111 11
Q ss_pred ccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 823 TVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.+++ ..+..+.+++.+||+.||++||++.+++++
T Consensus 264 ~~~~---------~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 264 PLPP---------SISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCC---------CCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1111 123578899999999999999999999864
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=323.33 Aligned_cols=255 Identities=22% Similarity=0.357 Sum_probs=202.6
Q ss_pred ccCcceeeecccceeEEEEEEcC------CceEEEEEecccCc-hhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEE
Q 002349 599 NLSEKYIIGYGASSTVYKCVLKN------CKPVAIKRLYSHYP-QCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLL 671 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 671 (933)
+|+..+.||+|+||+||+|.+.+ ++.||+|++..... ...+.+.+|+.+++.++||||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 46667789999999999998643 46799999975543 234678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCC-------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCC
Q 002349 672 FYDFMENGSLWDILHGP-------------TKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFE 738 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~ 738 (933)
++||+++++|.+++... .....+++..+..++.|++.||+|+|++ +|+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence 99999999999998421 1124588999999999999999999965 9999999999999999999
Q ss_pred eEEeecccccccccCCCc-eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhc
Q 002349 739 AHLTDFGIAKSLCVSKSY-TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTA 816 (933)
Q Consensus 739 ~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~ 816 (933)
+||+|||+++........ ......+++.|+|||.+.+..++.++||||+||++|||++ |..||.+............
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~- 241 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRN- 241 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc-
Confidence 999999998865332221 1223346789999999988889999999999999999998 8888876543322221111
Q ss_pred ccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcc
Q 002349 817 NNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGS 868 (933)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 868 (933)
.... ..+. ..+..+.+++..|++.+|++||++++|++.|+.
T Consensus 242 -~~~~-----~~~~-----~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 242 -RQVL-----PCPD-----DCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -CCcC-----CCCC-----CCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1100 0111 234678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=337.35 Aligned_cols=260 Identities=23% Similarity=0.287 Sum_probs=200.9
Q ss_pred ccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCC-----ccE
Q 002349 599 NLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSS-----GNL 670 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~ 670 (933)
+|+..+.||+|+||.||+|... +++.||+|++.... ....+++.+|+++++.++||||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999965 68899999986532 234567889999999999999999999998776 789
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccc
Q 002349 671 LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSL 750 (933)
Q Consensus 671 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~ 750 (933)
+||||+. ++|.+.+. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999996 57888873 456799999999999999999999965 9999999999999999999999999999865
Q ss_pred ccCCCceeeeecccccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccccc-c-------
Q 002349 751 CVSKSYTSTYIMGTIGYIDPEYARTS-RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAV-M------- 821 (933)
Q Consensus 751 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~-~------- 821 (933)
............+++.|+|||.+.+. .++.++||||+||++|||++|+.||.+..............+.. .
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 233 (372)
T cd07853 154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC 233 (372)
T ss_pred ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence 43333333344688999999998874 47899999999999999999999998665444332221110000 0
Q ss_pred ---------ccc-Cccccccc-cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 822 ---------ETV-DPEISATC-KDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 822 ---------~~~-~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
... .+...... ........+.+++.+|++.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000 00000000 000124578899999999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=328.76 Aligned_cols=237 Identities=26% Similarity=0.269 Sum_probs=189.0
Q ss_pred eeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHH-HHhcCCCCceeeeeeEEecCCccEEEEEecCC
Q 002349 604 YIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELE-TVGSIKHRNLVSLQGYSLSSSGNLLFYDFMEN 678 (933)
Q Consensus 604 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 678 (933)
+.||+|+||+||+|++. +++.||+|++.... ....+++.+|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999976 57899999986532 122334445544 56789999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCcee
Q 002349 679 GSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTS 758 (933)
Q Consensus 679 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 758 (933)
|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..... ....
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~ 153 (323)
T cd05575 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTT 153 (323)
T ss_pred CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCcc
Confidence 99999984 456789999999999999999999965 9999999999999999999999999998753221 2223
Q ss_pred eeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHHH
Q 002349 759 TYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAV 838 (933)
Q Consensus 759 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (933)
....||+.|+|||++.+..++.++|||||||++|||++|+.||................. ...+. .+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~----~~~~~---------~~ 220 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL----RLKPN---------IS 220 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC----CCCCC---------CC
Confidence 345799999999999999999999999999999999999999986543322211111100 11111 13
Q ss_pred HHHHHHHHHccCCCCCCCCCHH
Q 002349 839 KKVFQLALLCSKRQPTDRPTMH 860 (933)
Q Consensus 839 ~~l~~li~~cl~~dP~~RPt~~ 860 (933)
..+.+++.+|++.||++||++.
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 221 VSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHHHHHHHHhhcCHHhCCCCC
Confidence 5688899999999999999885
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=308.80 Aligned_cols=253 Identities=24% Similarity=0.257 Sum_probs=211.7
Q ss_pred hccCcceeeecccceeEEEEEEcC-CceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
+.|+..+.||+|.-|+||.|..++ +..+|+|++.+.. .....+.+.|-+||+.++||.++++|+.|..++..|+||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 356667789999999999999876 4789999997654 334456788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccccc-
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV- 752 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~- 752 (933)
|||+||+|...++. +..+.+++..+.-++..|+.||+|||. .|||.||+||+||||.++|.+.|+||.++.....
T Consensus 157 eyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 99999999999875 567789999999999999999999994 5999999999999999999999999998754311
Q ss_pred --------------------------------CCC----------------------ceeeeecccccccCccccccCCC
Q 002349 753 --------------------------------SKS----------------------YTSTYIMGTIGYIDPEYARTSRL 778 (933)
Q Consensus 753 --------------------------------~~~----------------------~~~~~~~gt~~y~aPE~~~~~~~ 778 (933)
... ..+...+||-.|.|||+++|...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 000 11123579999999999999999
Q ss_pred CcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCC
Q 002349 779 TEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPT 858 (933)
Q Consensus 779 ~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt 858 (933)
+.++|.|+|||++|||+.|..||.+....+.+.........+.+. ...+..+.++|++.+.+||++|..
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~-----------~~vs~~akDLIr~LLvKdP~kRlg 381 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEE-----------PEVSSAAKDLIRKLLVKDPSKRLG 381 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCC-----------CcchhHHHHHHHHHhccChhhhhc
Confidence 999999999999999999999999988877776655444333322 123467788999999999999987
Q ss_pred ----HHHHHHH
Q 002349 859 ----MHEVSRV 865 (933)
Q Consensus 859 ----~~evl~~ 865 (933)
++||-++
T Consensus 382 ~~rGA~eIK~H 392 (459)
T KOG0610|consen 382 SKRGAAEIKRH 392 (459)
T ss_pred cccchHHhhcC
Confidence 8888764
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=326.35 Aligned_cols=261 Identities=20% Similarity=0.264 Sum_probs=199.8
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEe
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
++|...+.||+|+||.||+|..+ .++.||+|++.... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888999999999999999976 46789999986543 22345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS 755 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 755 (933)
+++ +|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDD--CGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 975 88888752 344689999999999999999999965 999999999999999999999999999976432221
Q ss_pred ceeeeecccccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcc-------
Q 002349 756 YTSTYIMGTIGYIDPEYART-SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPE------- 827 (933)
Q Consensus 756 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 827 (933)
......+++.|+|||.+.+ ..++.++||||+||++|+|++|+.||.+..............+.......+.
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 160 -TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred -ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 2223467899999998865 4688999999999999999999999986544333222111110000000000
Q ss_pred ----ccccc------cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 828 ----ISATC------KDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 828 ----~~~~~------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
..... .......++.+++.+|++.||.+|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 00000 000123567899999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=317.42 Aligned_cols=251 Identities=24% Similarity=0.343 Sum_probs=203.9
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC-----chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY-----PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLL 671 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 671 (933)
++|...+.||+|++|.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++..++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57889999999999999999964 57899999886432 1224568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccc
Q 002349 672 FYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLC 751 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 751 (933)
||||+++++|.+++. ....+++..+..++.|++.|+.|||+. +|+||||+|+||+++.++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLK---AYGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHH---HhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 999999999999985 345688999999999999999999965 99999999999999999999999999997653
Q ss_pred cCCCcee--eeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccc
Q 002349 752 VSKSYTS--TYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEIS 829 (933)
Q Consensus 752 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (933)
....... ....|+..|+|||.+.+..++.++||||+|+++|||++|+.||.+.............. . .+.++
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~----~~~~~ 229 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP--T----NPQLP 229 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccC--C----CCCCC
Confidence 2221111 23467889999999999889999999999999999999999997654433322211110 0 11111
Q ss_pred ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 830 ATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 830 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
. .....+.+++.+|+..+|++|||+.+++++
T Consensus 230 ~-----~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 230 S-----HVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred c-----cCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 1 123568889999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=316.73 Aligned_cols=255 Identities=27% Similarity=0.444 Sum_probs=204.8
Q ss_pred hccCcceeeecccceeEEEEEEcC-C---ceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKN-C---KPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLF 672 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 672 (933)
++|+..+.||+|+||.||+|..+. + ..+|+|++.... ....+++..|++++++++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 467888999999999999999753 2 368999986553 33456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccccc
Q 002349 673 YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV 752 (933)
Q Consensus 673 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 752 (933)
|||+++++|.+++.. ..+.+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||++.....
T Consensus 85 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 85 TEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999999963 346789999999999999999999965 999999999999999999999999999986643
Q ss_pred CCCceee--eecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCcccc
Q 002349 753 SKSYTST--YIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEIS 829 (933)
Q Consensus 753 ~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (933)
....... ....+..|+|||++.+..++.++|||||||++|||++ |+.||............. ..... + .
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~-~~~~~-----~-~- 231 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIN-DGFRL-----P-A- 231 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHh-cCCCC-----C-C-
Confidence 2221111 1223457999999998889999999999999999997 999997544332222111 11000 0 0
Q ss_pred ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccC
Q 002349 830 ATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869 (933)
Q Consensus 830 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 869 (933)
....+..+.+++.+|++.+|++||++.+|++.|+++
T Consensus 232 ----~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 232 ----PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 112346789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=327.07 Aligned_cols=246 Identities=28% Similarity=0.369 Sum_probs=204.3
Q ss_pred ccCcceeeecccceeEEEEEEc-CCceEEEEEeccc---CchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEE
Q 002349 599 NLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSH---YPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYD 674 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 674 (933)
.|+..+.||.|+||.||-|++. +.+.||||++.-. +.+.+.++..|++.|++++|||+|.+.|+|......|+|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 3555667999999999999954 5678999999643 34457789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCC
Q 002349 675 FMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSK 754 (933)
Q Consensus 675 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 754 (933)
||- ||-.|++. ....++.+.++..|+.+++.||+|||++ +.||||||+.|||+++.|.||++|||.|.....
T Consensus 107 YCl-GSAsDlle--VhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-- 178 (948)
T KOG0577|consen 107 YCL-GSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP-- 178 (948)
T ss_pred HHh-ccHHHHHH--HHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCc--
Confidence 995 58888885 4567899999999999999999999955 999999999999999999999999999977643
Q ss_pred CceeeeecccccccCccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccc
Q 002349 755 SYTSTYIMGTIGYIDPEYAR---TSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISAT 831 (933)
Q Consensus 755 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (933)
...++|||.|||||++. .+.|+-++||||+|++..|+...++|.-+-..+..+..+...+ .|.+.
T Consensus 179 ---AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNe-------sPtLq-- 246 (948)
T KOG0577|consen 179 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-------SPTLQ-- 246 (948)
T ss_pred ---hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcC-------CCCCC--
Confidence 34468999999999885 4679999999999999999999999987655444443322211 12222
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 832 CKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 832 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
..+....+..++..|++.-|.+|||.++++++-
T Consensus 247 --s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 247 --SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHR 279 (948)
T ss_pred --CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence 224467889999999999999999999988754
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=315.50 Aligned_cols=259 Identities=21% Similarity=0.319 Sum_probs=208.8
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
++|+..+.||+|+||.||+|... +++.||+|.++... ....+.+.+|++++++++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57889999999999999999977 68899999886422 233567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccccc
Q 002349 674 DFMENGSLWDILHGP-TKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV 752 (933)
Q Consensus 674 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 752 (933)
||+++++|.+++... .....+++..+..++.+++.|++|||+. +|+||||||+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999988532 2345689999999999999999999965 999999999999999999999999999876533
Q ss_pred CCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcc-hhHHHHhhhcccccccccCcccccc
Q 002349 753 SKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECN-LHHLILSKTANNAVMETVDPEISAT 831 (933)
Q Consensus 753 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (933)
... ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||..... ..... ....... .+..+
T Consensus 159 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~~~-----~~~~~-- 229 (267)
T cd08224 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC-KKIEKCD-----YPPLP-- 229 (267)
T ss_pred CCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHH-hhhhcCC-----CCCCC--
Confidence 221 12334688999999999988899999999999999999999999964431 11111 1111110 11111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCC
Q 002349 832 CKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLV 870 (933)
Q Consensus 832 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 870 (933)
....+..+.+++.+|+..+|++|||+.+|++.++.+.
T Consensus 230 --~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 230 --ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred --hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 1123457889999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=313.62 Aligned_cols=251 Identities=27% Similarity=0.419 Sum_probs=203.0
Q ss_pred hccCcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecC
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFME 677 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 677 (933)
.+|+..+.||+|+||.||+|.+.+++.+|+|++..... ...++.+|++++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 46777889999999999999987778899998865432 34678999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCce
Q 002349 678 NGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYT 757 (933)
Q Consensus 678 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 757 (933)
+++|.+++.. ....++++.+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||+++.........
T Consensus 83 ~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 83 HGCLSDYLRA--QRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 9999999863 345689999999999999999999965 99999999999999999999999999997653322221
Q ss_pred eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCccccccccCHH
Q 002349 758 STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLG 836 (933)
Q Consensus 758 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (933)
.....++.+|+|||.+.+..++.++||||+|+++|||++ |+.||............. ... ....+. .
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~--~~~--~~~~~~--------~ 225 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETIN--AGF--RLYKPR--------L 225 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHh--CCC--CCCCCC--------C
Confidence 222335678999999998889999999999999999998 999997544322221111 100 000111 1
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 837 AVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 837 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
.+..+.+++.+|++.+|++|||+.++++.|
T Consensus 226 ~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 226 ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 235789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=326.73 Aligned_cols=256 Identities=21% Similarity=0.249 Sum_probs=199.7
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEeccc---CchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSH---YPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
++|+..+.||+|+||+||+|... +++.||+|++... .....+.+.+|+.+++.++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888999999999999999976 4789999998642 1223456889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
||+++|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 99999999999952 345789999999999999999999965 9999999999999999999999999999765433
Q ss_pred CCceeeeecccccccCcccccc-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccc
Q 002349 754 KSYTSTYIMGTIGYIDPEYART-----SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEI 828 (933)
Q Consensus 754 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 828 (933)
.........||+.|+|||++.. ..++.++||||+||++|||++|+.||.+................. .+++..
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~~ 233 (331)
T cd05597 156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHF--QFPPDV 233 (331)
T ss_pred CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcc--cCCCcc
Confidence 3333334579999999999863 457889999999999999999999998654443332221111100 111111
Q ss_pred cccccCHHHHHHHHHHHHHccCCCC--CCCCCHHHHHHHH
Q 002349 829 SATCKDLGAVKKVFQLALLCSKRQP--TDRPTMHEVSRVL 866 (933)
Q Consensus 829 ~~~~~~~~~~~~l~~li~~cl~~dP--~~RPt~~evl~~L 866 (933)
. ..+..+.+++.+|+..++ ..||++.+++++-
T Consensus 234 ~------~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp 267 (331)
T cd05597 234 T------DVSEEAKDLIRRLICSPETRLGRNGLQDFKDHP 267 (331)
T ss_pred C------CCCHHHHHHHHHHccCcccccCCCCHHHHhcCC
Confidence 0 123466778888765443 3478999998763
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=343.67 Aligned_cols=258 Identities=21% Similarity=0.295 Sum_probs=194.9
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecC--------C
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSS--------S 667 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--------~ 667 (933)
.++|+..+.||+|+||.||+|... .++.||||++.... ....+|+.++++++|||||++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 457999999999999999999975 57899999885432 2345799999999999999999987432 1
Q ss_pred ccEEEEEecCCCCHHHHhcC-CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCC-CeEEeecc
Q 002349 668 GNLLFYDFMENGSLWDILHG-PTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDF-EAHLTDFG 745 (933)
Q Consensus 668 ~~~lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~-~~kl~DfG 745 (933)
..++||||+++ ++.+++.. ......+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccc
Confidence 35689999975 67766632 12456789999999999999999999965 999999999999999665 79999999
Q ss_pred cccccccCCCceeeeecccccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccc---
Q 002349 746 IAKSLCVSKSYTSTYIMGTIGYIDPEYARTS-RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVM--- 821 (933)
Q Consensus 746 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~--- 821 (933)
+|+.+.... ......||+.|+|||++.+. .++.++||||+||++|||++|..||.+..............+...
T Consensus 217 la~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~ 294 (440)
T PTZ00036 217 SAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQ 294 (440)
T ss_pred cchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 998764322 22335689999999998764 689999999999999999999999987665544433221111000
Q ss_pred ---------cccCccc-----cccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 822 ---------ETVDPEI-----SATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 822 ---------~~~~~~~-----~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
+...+.+ .... +...+.++.+++.+||+.||.+|||+.|++++
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~l~~~~-p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 295 LKEMNPNYADIKFPDVKPKDLKKVF-PKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHhchhhhcccCCccCchhHHHHh-ccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0000000 0000 00123578899999999999999999999864
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=321.91 Aligned_cols=262 Identities=23% Similarity=0.343 Sum_probs=200.7
Q ss_pred hccCcceeeecccceeEEEEEEcC---------------CceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeee
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKN---------------CKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQG 661 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~ 661 (933)
++|+..+.||+|+||.||+|...+ ...||+|+++... ......+.+|++++++++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578889999999999999988643 1248999987643 334567899999999999999999999
Q ss_pred EEecCCccEEEEEecCCCCHHHHhcCCC---------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceE
Q 002349 662 YSLSSSGNLLFYDFMENGSLWDILHGPT---------KKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNIL 732 (933)
Q Consensus 662 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIl 732 (933)
++......++||||+++++|.+++.... ....+++..+..++.|++.|++|||+. +++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEE
Confidence 9999999999999999999999985321 112478899999999999999999965 9999999999999
Q ss_pred eCCCCCeEEeecccccccccCCCce-eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh--CCCCCCCCcchhH
Q 002349 733 LDKDFEAHLTDFGIAKSLCVSKSYT-STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT--GRKAVDNECNLHH 809 (933)
Q Consensus 733 l~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt--g~~p~~~~~~~~~ 809 (933)
+++++.+||+|||+++......... .....++..|+|||...+..++.++|||||||++|+|++ |..||........
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~ 241 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence 9999999999999997653222111 122345778999999988889999999999999999998 5667765433222
Q ss_pred HHHhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 002349 810 LILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLG 867 (933)
Q Consensus 810 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 867 (933)
................... ....+..+.+++.+|++.||++||++++|++.|.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 242 IENTGEFFRNQGRQIYLSQ-----TPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHhhhhccccccCCC-----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 1111000000000000000 0112457999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=314.94 Aligned_cols=246 Identities=24% Similarity=0.363 Sum_probs=196.9
Q ss_pred eeecccceeEEEEEEc---CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecCCC
Q 002349 605 IIGYGASSTVYKCVLK---NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENG 679 (933)
Q Consensus 605 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 679 (933)
.||+|+||.||+|.++ +++.+|+|+++... ....+++.+|+.++++++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999753 46789999986543 334567899999999999999999999875 45678999999999
Q ss_pred CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCce--
Q 002349 680 SLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYT-- 757 (933)
Q Consensus 680 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~-- 757 (933)
+|.+++. ....+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQ---KNKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 9999994 345789999999999999999999965 99999999999999999999999999998764332221
Q ss_pred eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCccccccccCHH
Q 002349 758 STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLG 836 (933)
Q Consensus 758 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (933)
.....++..|+|||.+....++.++|||||||++|||++ |+.||............. .... +..+. .
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~--~~~~-----~~~~~-----~ 222 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE--SGER-----MECPQ-----R 222 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH--CCCC-----CCCCC-----C
Confidence 112234578999999988889999999999999999998 999997654332222211 1111 11111 1
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHHccC
Q 002349 837 AVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869 (933)
Q Consensus 837 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 869 (933)
.+..+.+++.+|++.||++||++++|.+.|+..
T Consensus 223 ~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 223 CPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 245788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=329.26 Aligned_cols=244 Identities=23% Similarity=0.316 Sum_probs=192.7
Q ss_pred eeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcC-CCCceeeeeeEEecCCccEEEEEecCC
Q 002349 604 YIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSI-KHRNLVSLQGYSLSSSGNLLFYDFMEN 678 (933)
Q Consensus 604 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 678 (933)
+.||+|+||.||+|..+ +++.||+|++.... ....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36999999999999976 46789999997542 23445678899988877 799999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCcee
Q 002349 679 GSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTS 758 (933)
Q Consensus 679 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 758 (933)
|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..... ....
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~-~~~~ 153 (329)
T cd05618 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTT 153 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCC-CCcc
Confidence 99999884 446799999999999999999999965 9999999999999999999999999999753221 1222
Q ss_pred eeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcc-------hhHHHHhhhcccccccccCcccccc
Q 002349 759 TYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECN-------LHHLILSKTANNAVMETVDPEISAT 831 (933)
Q Consensus 759 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (933)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ............. ..++.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~------~~~p~- 226 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ------IRIPR- 226 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC------CCCCC-
Confidence 345799999999999999999999999999999999999999952110 1111111111110 11111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCC------HHHHHHH
Q 002349 832 CKDLGAVKKVFQLALLCSKRQPTDRPT------MHEVSRV 865 (933)
Q Consensus 832 ~~~~~~~~~l~~li~~cl~~dP~~RPt------~~evl~~ 865 (933)
.....+.+++.+|++.||++||+ +++++++
T Consensus 227 ----~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 227 ----SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred ----CCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 12356788999999999999998 4676654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=321.81 Aligned_cols=250 Identities=26% Similarity=0.355 Sum_probs=204.9
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEec
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFM 676 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 676 (933)
.+|+..+.||+|+||.||+|+.. +++.||+|.+........+.+.+|+.+++.++|+||+++++++..+...++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 47888899999999999999964 57899999987665555677899999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCc
Q 002349 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY 756 (933)
Q Consensus 677 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 756 (933)
++++|.++++ ...+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 100 ~~~~L~~~~~----~~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~- 171 (296)
T cd06654 100 AGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (296)
T ss_pred CCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc-
Confidence 9999999984 24578999999999999999999965 999999999999999999999999999876532221
Q ss_pred eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHH
Q 002349 757 TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLG 836 (933)
Q Consensus 757 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (933)
......|++.|+|||.+.+..++.++|||||||++|+|++|+.||........+...... .. +.... ...
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~-~~------~~~~~---~~~ 241 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GT------PELQN---PEK 241 (296)
T ss_pred ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-CC------CCCCC---ccc
Confidence 122346889999999999888999999999999999999999999866543333221111 00 00000 112
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 837 AVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 837 ~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
....+.+++.+|+..||++||++.+++++
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred cCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 23567889999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=328.47 Aligned_cols=237 Identities=24% Similarity=0.255 Sum_probs=188.1
Q ss_pred eeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHH-HHHhcCCCCceeeeeeEEecCCccEEEEEecCC
Q 002349 604 YIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETEL-ETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMEN 678 (933)
Q Consensus 604 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 678 (933)
++||+|+||.||+|++. +++.||+|++.... ......+.+|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999976 47889999986532 12233455554 467889999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCcee
Q 002349 679 GSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTS 758 (933)
Q Consensus 679 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 758 (933)
|+|.+.+. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..... ....
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~ 153 (321)
T cd05603 81 GELFFHLQ---RERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EETT 153 (321)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCC-CCcc
Confidence 99998884 356788999999999999999999965 9999999999999999999999999998753222 2223
Q ss_pred eeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHHH
Q 002349 759 TYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAV 838 (933)
Q Consensus 759 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (933)
....||+.|+|||.+.+..++.++||||+||++|||++|+.||............. ... ..++. ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~--~~~------~~~~~-----~~~ 220 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNIL--HKP------LQLPG-----GKT 220 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHh--cCC------CCCCC-----CCC
Confidence 34579999999999999899999999999999999999999998654322221111 110 01111 123
Q ss_pred HHHHHHHHHccCCCCCCCCCHH
Q 002349 839 KKVFQLALLCSKRQPTDRPTMH 860 (933)
Q Consensus 839 ~~l~~li~~cl~~dP~~RPt~~ 860 (933)
..+.+++.+|++.||.+||++.
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 221 VAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHHHHHHHHccCCHhhcCCCC
Confidence 5678899999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=328.83 Aligned_cols=244 Identities=23% Similarity=0.313 Sum_probs=194.1
Q ss_pred eeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcC-CCCceeeeeeEEecCCccEEEEEecCC
Q 002349 604 YIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSI-KHRNLVSLQGYSLSSSGNLLFYDFMEN 678 (933)
Q Consensus 604 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 678 (933)
++||+|+||.||+|.++ +++.||+|+++... ....+.+.+|..++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36999999999999976 47889999997532 23345678899999998 799999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCcee
Q 002349 679 GSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTS 758 (933)
Q Consensus 679 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 758 (933)
|+|.+++. ..+.+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.... .....
T Consensus 81 g~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~-~~~~~ 153 (329)
T cd05588 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR-PGDTT 153 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCcccccccc-CCCcc
Confidence 99999884 456799999999999999999999965 999999999999999999999999999875321 12223
Q ss_pred eeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcc-------hhHHHHhhhcccccccccCcccccc
Q 002349 759 TYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECN-------LHHLILSKTANNAVMETVDPEISAT 831 (933)
Q Consensus 759 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (933)
....||+.|+|||++.+..++.++||||+||++|+|++|+.||+.... ............ ...++.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~------~~~~p~- 226 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK------QIRIPR- 226 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC------CCCCCC-
Confidence 345799999999999999999999999999999999999999963211 111111111111 011111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCC------HHHHHHH
Q 002349 832 CKDLGAVKKVFQLALLCSKRQPTDRPT------MHEVSRV 865 (933)
Q Consensus 832 ~~~~~~~~~l~~li~~cl~~dP~~RPt------~~evl~~ 865 (933)
..+..+.+++.+|++.||.+||+ +++++++
T Consensus 227 ----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 227 ----SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred ----CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 12356788999999999999997 6777654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=313.58 Aligned_cols=246 Identities=23% Similarity=0.363 Sum_probs=195.8
Q ss_pred eecccceeEEEEEEc---CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecCCCCH
Q 002349 606 IGYGASSTVYKCVLK---NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSL 681 (933)
Q Consensus 606 lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 681 (933)
||+|+||.||+|.+. .+..||+|++.... ....+.+.+|+.++++++||||+++++++. ....++||||+++++|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L 81 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPL 81 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCH
Confidence 899999999999864 34569999987654 334567899999999999999999999885 4568999999999999
Q ss_pred HHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCceee--
Q 002349 682 WDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTST-- 759 (933)
Q Consensus 682 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~-- 759 (933)
.+++.. ....+++..+.+++.|++.|++|||++ +++||||||+||+++.++.+||+|||++............
T Consensus 82 ~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 82 NKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 999863 345789999999999999999999965 9999999999999999999999999999765433222111
Q ss_pred eecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHHH
Q 002349 760 YIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAV 838 (933)
Q Consensus 760 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (933)
...++..|+|||.+.+..++.++|||||||++||+++ |+.||.+........... ... .+..+ ...+
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~--~~~-----~~~~~-----~~~~ 224 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE--QGK-----RLDCP-----AECP 224 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH--CCC-----CCCCC-----CCCC
Confidence 1223578999999988889999999999999999996 999997654333221111 111 01111 1234
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHHHccC
Q 002349 839 KKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869 (933)
Q Consensus 839 ~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 869 (933)
.++.+++.+||+.+|++||++.+|.+.|+..
T Consensus 225 ~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 225 PEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 6788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=318.97 Aligned_cols=255 Identities=24% Similarity=0.400 Sum_probs=204.0
Q ss_pred hccCcceeeecccceeEEEEEEc------CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK------NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLL 671 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 671 (933)
.+|+..++||+|+||.||+|... .+..+|+|.+..........+.+|++++++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46778889999999999999742 245789998877666667789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCC------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCe
Q 002349 672 FYDFMENGSLWDILHGPTK------------KKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEA 739 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~ 739 (933)
||||+++++|.++++.... ...+++..+..++.|++.|++|||+. +++||||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCE
Confidence 9999999999999863211 13588999999999999999999965 99999999999999999999
Q ss_pred EEeecccccccccCCCce-eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcc
Q 002349 740 HLTDFGIAKSLCVSKSYT-STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTAN 817 (933)
Q Consensus 740 kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 817 (933)
||+|||+++......... .....+++.|+|||.+.+..++.++|||||||++|||++ |+.||............. .
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~--~ 239 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT--Q 239 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH--c
Confidence 999999997653222111 122345678999999999999999999999999999998 899986544333221111 1
Q ss_pred cccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 002349 818 NAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLG 867 (933)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 867 (933)
... ...+. ..+..+.+++.+||+.||.+||++++|.+.|+
T Consensus 240 ~~~-----~~~~~-----~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 240 GRE-----LERPR-----TCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred Ccc-----CCCCC-----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 100 01111 12356889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=320.95 Aligned_cols=258 Identities=24% Similarity=0.391 Sum_probs=204.5
Q ss_pred ccCcceeeecccceeEEEEEEcC------CceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEE
Q 002349 599 NLSEKYIIGYGASSTVYKCVLKN------CKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLL 671 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 671 (933)
+|+..+.||+|+||.||+|.... ...+|+|.+.... .....++.+|+.+++.++||||+++++++...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 46778899999999999998542 3568888886543 2345678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCC---------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCc
Q 002349 672 FYDFMENGSLWDILHGPT---------------------KKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSN 730 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~N 730 (933)
||||+++++|.+++.... ....+++..+..++.|++.||+|||++ +++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 999999999999885321 123588999999999999999999965 99999999999
Q ss_pred eEeCCCCCeEEeecccccccccCCCce-eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchh
Q 002349 731 ILLDKDFEAHLTDFGIAKSLCVSKSYT-STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLH 808 (933)
Q Consensus 731 Ill~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~ 808 (933)
|++++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||.+.....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999999997653322211 222345778999999988889999999999999999998 999997654333
Q ss_pred HHHHhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCC
Q 002349 809 HLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVP 871 (933)
Q Consensus 809 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 871 (933)
.+.... .. ...... ...+..+.+++.+|++.+|++||+++++++.|+.+..
T Consensus 238 ~~~~~~--~~-----~~~~~~-----~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 238 LFNLLK--TG-----YRMERP-----ENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHHHh--CC-----CCCCCC-----CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 222111 11 011111 1123578899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=317.92 Aligned_cols=256 Identities=25% Similarity=0.392 Sum_probs=202.0
Q ss_pred hhccCcceeeecccceeEEEEEEcC------CceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCcc
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKN------CKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGN 669 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 669 (933)
+++|...+.||+|+||.||+|.+.. +..||+|.+.... ......|.+|+.++++++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4678899999999999999999764 4678899886543 33345689999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCC----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCC---CeEEe
Q 002349 670 LLFYDFMENGSLWDILHGPT----KKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDF---EAHLT 742 (933)
Q Consensus 670 ~lv~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~---~~kl~ 742 (933)
++||||+++++|.++++... ....+++..+..++.|++.|++|||+. +++||||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEec
Confidence 99999999999999986422 123589999999999999999999965 999999999999998754 58999
Q ss_pred ecccccccccCCCce-eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhccccc
Q 002349 743 DFGIAKSLCVSKSYT-STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAV 820 (933)
Q Consensus 743 DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 820 (933)
|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||............. ....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~-~~~~- 239 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT-GGGR- 239 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-cCCc-
Confidence 999998753222111 112233568999999998899999999999999999997 999998654332221111 1100
Q ss_pred ccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 002349 821 METVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLG 867 (933)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 867 (933)
...+ ...+..+.+++.+|++.+|++||++.+|+++|.
T Consensus 240 -----~~~~-----~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 240 -----LDPP-----KGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred -----CCCC-----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 0111 112457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=329.38 Aligned_cols=241 Identities=24% Similarity=0.238 Sum_probs=190.7
Q ss_pred eeeecccceeEEEEEEcC-CceEEEEEecccC---chhHHHHHHHH-HHHhcCCCCceeeeeeEEecCCccEEEEEecCC
Q 002349 604 YIIGYGASSTVYKCVLKN-CKPVAIKRLYSHY---PQCLKEFETEL-ETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMEN 678 (933)
Q Consensus 604 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 678 (933)
+.||+|+||+||+|++.. ++.||+|++.... ......+.+|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 369999999999999764 6789999986532 12223444444 457888999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCcee
Q 002349 679 GSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTS 758 (933)
Q Consensus 679 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 758 (933)
|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..... ....
T Consensus 81 ~~L~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-~~~~ 153 (325)
T cd05602 81 GELFYHLQ---RERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NGTT 153 (325)
T ss_pred CcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccC-CCCc
Confidence 99999994 356688899999999999999999965 9999999999999999999999999999754222 2223
Q ss_pred eeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHHH
Q 002349 759 TYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAV 838 (933)
Q Consensus 759 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (933)
....||+.|+|||++.+..++.++||||+||++|+|++|+.||.+............... ...+ ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~----~~~~---------~~~ 220 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL----QLKP---------NIT 220 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCc----CCCC---------CCC
Confidence 445799999999999999999999999999999999999999986554433222111110 1111 123
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHH
Q 002349 839 KKVFQLALLCSKRQPTDRPTMHEVSR 864 (933)
Q Consensus 839 ~~l~~li~~cl~~dP~~RPt~~evl~ 864 (933)
..+.+++.+|++.||.+||++.+.+.
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 221 NSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred HHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 56788999999999999998875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=314.08 Aligned_cols=250 Identities=26% Similarity=0.365 Sum_probs=205.1
Q ss_pred ccCcceeeecccceeEEEEEEc-CCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEe
Q 002349 599 NLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSH--YPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
+|+..+.||+|++|.||+|..+ +++.|++|.+... ......++.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677889999999999999976 5788999988643 234567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS 755 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 755 (933)
+++++|.++++.. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++.......
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999999642 245789999999999999999999965 999999999999999999999999999987643222
Q ss_pred ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCH
Q 002349 756 YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDL 835 (933)
Q Consensus 756 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (933)
. .....|++.|+|||+..+..++.++||||||+++|+|++|+.||............ .... .+.+..
T Consensus 157 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--~~~~-----~~~~~~----- 223 (256)
T cd08529 157 F-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKI--IRGV-----FPPVSQ----- 223 (256)
T ss_pred h-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HcCC-----CCCCcc-----
Confidence 2 23346889999999999998999999999999999999999999865532222111 1111 111111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 836 GAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 836 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
..+..+.+++.+|++.+|++||++.++++.
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 224 MYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 224678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=323.15 Aligned_cols=259 Identities=24% Similarity=0.372 Sum_probs=203.4
Q ss_pred hccCcceeeecccceeEEEEEEcC-C--ceEEEEEecccC-chhHHHHHHHHHHHhcC-CCCceeeeeeEEecCCccEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKN-C--KPVAIKRLYSHY-PQCLKEFETELETVGSI-KHRNLVSLQGYSLSSSGNLLF 672 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~-~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 672 (933)
++|++.+.||+|+||.||+|..++ + ..+++|.++... ....+.+.+|+++++++ +||||+++++++......++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578889999999999999998754 3 247888887532 33456789999999999 799999999999999999999
Q ss_pred EEecCCCCHHHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCe
Q 002349 673 YDFMENGSLWDILHGPT-------------KKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEA 739 (933)
Q Consensus 673 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~ 739 (933)
|||+++++|.++++... ....+++..+..++.|++.|++|||++ +|+||||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 99999999999995321 123588999999999999999999965 99999999999999999999
Q ss_pred EEeecccccccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhccc
Q 002349 740 HLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANN 818 (933)
Q Consensus 740 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 818 (933)
||+|||++...... ........+..|+|||+..+..++.++|||||||++|||++ |..||.+.......... ...
T Consensus 159 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~--~~~ 234 (297)
T cd05089 159 KIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL--PQG 234 (297)
T ss_pred EECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH--hcC
Confidence 99999998643211 11111223567999999998889999999999999999997 99999765433222111 111
Q ss_pred ccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCCCC
Q 002349 819 AVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAP 873 (933)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 873 (933)
..+..+. ..+..+.+++.+|++.+|.+||+++++++.|+.+....
T Consensus 235 -----~~~~~~~-----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 235 -----YRMEKPR-----NCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred -----CCCCCCC-----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 1111111 12357889999999999999999999999988776543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=317.36 Aligned_cols=247 Identities=22% Similarity=0.244 Sum_probs=193.4
Q ss_pred eecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecCCCCH
Q 002349 606 IGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSL 681 (933)
Q Consensus 606 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 681 (933)
||+|+||.||++..+ +++.||+|++.... ....+.+..|++++++++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999976 48899999986432 12234556799999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCceeeee
Q 002349 682 WDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYI 761 (933)
Q Consensus 682 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 761 (933)
.+++.. .....+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||++...... ......
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~--~~~~~~ 154 (277)
T cd05607 81 KYHIYN-VGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG--KTITQR 154 (277)
T ss_pred HHHHHh-ccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCC--ceeecc
Confidence 988853 2334689999999999999999999965 9999999999999999999999999999765332 222345
Q ss_pred cccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHHHHHH
Q 002349 762 MGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKV 841 (933)
Q Consensus 762 ~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 841 (933)
.|+..|+|||++.+..++.++||||+||++|||++|+.||............ ............ ....+.++
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~------~~~~~~~~ 226 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEEL--KRRTLEDEVKFE------HQNFTEES 226 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHH--HHHhhccccccc------cccCCHHH
Confidence 6899999999999888999999999999999999999999753321111000 000000010000 00124568
Q ss_pred HHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 842 FQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 842 ~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
.+++.+|++.||++||+++|+++.+
T Consensus 227 ~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 227 KDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred HHHHHHHhccCHhhCCCCccchhhh
Confidence 8999999999999999997766433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=320.80 Aligned_cols=263 Identities=25% Similarity=0.365 Sum_probs=204.4
Q ss_pred hhccCcceeeecccceeEEEEEEcC-----------------CceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceee
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKN-----------------CKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVS 658 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 658 (933)
..+|+..+.||+|+||.||+|.... +..||+|++.... ....+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578889999999999999998653 2458999987653 334667899999999999999999
Q ss_pred eeeEEecCCccEEEEEecCCCCHHHHhcCCC--------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCc
Q 002349 659 LQGYSLSSSGNLLFYDFMENGSLWDILHGPT--------KKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSN 730 (933)
Q Consensus 659 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~N 730 (933)
+++++..++..++||||+++++|.+++.... ....+++..+..++.|++.||+|||+. +|+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 9999999999999999999999999986422 123689999999999999999999965 99999999999
Q ss_pred eEeCCCCCeEEeecccccccccCCCc-eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh--CCCCCCCCcch
Q 002349 731 ILLDKDFEAHLTDFGIAKSLCVSKSY-TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT--GRKAVDNECNL 807 (933)
Q Consensus 731 Ill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt--g~~p~~~~~~~ 807 (933)
|+++.++.++|+|||+++........ ......+++.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 99999999999999999765322211 1223456788999999988889999999999999999998 67788654333
Q ss_pred hHHHHhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 002349 808 HHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLG 867 (933)
Q Consensus 808 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 867 (933)
..+........... ....... ....+.++.+++.+|++.||++|||++||++.|.
T Consensus 241 ~~~~~~~~~~~~~~--~~~~~~~---~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 QVIENAGHFFRDDG--RQIYLPR---PPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHHHHHhcccccc--ccccCCC---ccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 32221111100000 0000000 1122467899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=319.38 Aligned_cols=259 Identities=18% Similarity=0.314 Sum_probs=207.3
Q ss_pred hhccCcceeeecccceeEEEEEEcC-----CceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEec-CCcc
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKN-----CKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLS-SSGN 669 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~ 669 (933)
.++|+..+.||+|+||.||+|.+.. +..|++|++.... ....+.+.+|+.++++++||||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4688889999999999999999776 6789999887543 3345678899999999999999999998766 4678
Q ss_pred EEEEEecCCCCHHHHhcCCCCC-----CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeec
Q 002349 670 LLFYDFMENGSLWDILHGPTKK-----KKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDF 744 (933)
Q Consensus 670 ~lv~e~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 744 (933)
++++||+++++|.+++...... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+|++||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999998643222 5689999999999999999999965 9999999999999999999999999
Q ss_pred ccccccccCCCce-eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhccccccc
Q 002349 745 GIAKSLCVSKSYT-STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVME 822 (933)
Q Consensus 745 Gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 822 (933)
|+++.+....... .....++..|+|||++.+..++.++||||||+++||+++ |+.||............. ...
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~---- 236 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLK-DGY---- 236 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHH-cCC----
Confidence 9998653322211 122345778999999998889999999999999999999 999997654332211111 111
Q ss_pred ccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCC
Q 002349 823 TVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLV 870 (933)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 870 (933)
.... ....+..+.+++.+|+..||++|||+.++++.|..+.
T Consensus 237 --~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 237 --RLAQ-----PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred --CCCC-----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 0000 1112457889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=323.33 Aligned_cols=260 Identities=25% Similarity=0.382 Sum_probs=206.7
Q ss_pred HhhccCcceeeecccceeEEEEEEcC------CceEEEEEecccC-chhHHHHHHHHHHHhcC-CCCceeeeeeEEecCC
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLKN------CKPVAIKRLYSHY-PQCLKEFETELETVGSI-KHRNLVSLQGYSLSSS 667 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 667 (933)
..++|+..+.||+|+||.||+|.+.. ...+|+|.+.... .+...++.+|+++++++ +|+||+++++++..++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 34578888999999999999998653 3578999987543 33456688999999999 8999999999999999
Q ss_pred ccEEEEEecCCCCHHHHhcCC-------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeC
Q 002349 668 GNLLFYDFMENGSLWDILHGP-------------TKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLD 734 (933)
Q Consensus 668 ~~~lv~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~ 734 (933)
..+++|||+++|+|.++++.. .....+++..+..++.|++.|++|||+. +|+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEc
Confidence 999999999999999998532 2245689999999999999999999965 999999999999999
Q ss_pred CCCCeEEeecccccccccCCCce-eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHH
Q 002349 735 KDFEAHLTDFGIAKSLCVSKSYT-STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLIL 812 (933)
Q Consensus 735 ~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~ 812 (933)
.++.+||+|||+++.+....... .....++..|+|||++.+..++.++|||||||++||+++ |..||...........
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 246 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 246 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 99999999999998764322211 122235678999999988889999999999999999997 8999875433222211
Q ss_pred hhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCC
Q 002349 813 SKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLV 870 (933)
Q Consensus 813 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 870 (933)
.. .... ... ....+..+.+++.+|++.||++|||+.|+++.|+.+.
T Consensus 247 ~~--~~~~-----~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 247 LK--EGYR-----MEK-----PQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HH--cCCc-----CCC-----CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11 1100 011 1122457889999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=316.50 Aligned_cols=254 Identities=22% Similarity=0.343 Sum_probs=197.7
Q ss_pred CcceeeecccceeEEEEEEcCCc---eEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecC------Ccc
Q 002349 601 SEKYIIGYGASSTVYKCVLKNCK---PVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSS------SGN 669 (933)
Q Consensus 601 ~~~~~lG~G~~g~Vy~~~~~~~~---~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~ 669 (933)
.+.+.||+|+||.||+|++.... .||+|.++... ....+.+.+|+++++.++||||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 45678999999999999976532 58999886542 34456789999999999999999999987432 246
Q ss_pred EEEEEecCCCCHHHHhcCC---CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccc
Q 002349 670 LLFYDFMENGSLWDILHGP---TKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGI 746 (933)
Q Consensus 670 ~lv~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl 746 (933)
+++|||+++|+|.+++... .....+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCc
Confidence 8999999999999887321 1234589999999999999999999965 999999999999999999999999999
Q ss_pred ccccccCCCce-eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhccccccccc
Q 002349 747 AKSLCVSKSYT-STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETV 824 (933)
Q Consensus 747 a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 824 (933)
++.+....... .....+++.|+|||...+..++.++||||||+++|||++ |+.||............ ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~--~~~~~~--- 233 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYL--RQGNRL--- 233 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH--HcCCCC---
Confidence 98764322211 122346678999999999999999999999999999999 78899764433222211 111110
Q ss_pred CccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccC
Q 002349 825 DPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869 (933)
Q Consensus 825 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 869 (933)
... ...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 234 --~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 234 --KQP-----PDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred --CCC-----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 001 11235688999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=331.93 Aligned_cols=262 Identities=22% Similarity=0.330 Sum_probs=206.1
Q ss_pred HHhhccCcceeeecccceeEEEEEEcC------CceEEEEEecccC-chhHHHHHHHHHHHhcCC-CCceeeeeeEEecC
Q 002349 595 RMTENLSEKYIIGYGASSTVYKCVLKN------CKPVAIKRLYSHY-PQCLKEFETELETVGSIK-HRNLVSLQGYSLSS 666 (933)
Q Consensus 595 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 666 (933)
...++|...+.||+|+||.||+|.+++ ++.||+|++.... ....+.+.+|++++.++. |||||++++++...
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 344678888999999999999998642 4679999997643 233457889999999997 99999999999999
Q ss_pred CccEEEEEecCCCCHHHHhcCCCC--------------------------------------------------------
Q 002349 667 SGNLLFYDFMENGSLWDILHGPTK-------------------------------------------------------- 690 (933)
Q Consensus 667 ~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 690 (933)
+..++||||+++|+|.++++....
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 999999999999999999964211
Q ss_pred ---------------------------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCce
Q 002349 691 ---------------------------------------KKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNI 731 (933)
Q Consensus 691 ---------------------------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NI 731 (933)
...+++..++.++.|++.||+|||+. +|+||||||+||
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~Ni 270 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNV 270 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceE
Confidence 12467888999999999999999954 999999999999
Q ss_pred EeCCCCCeEEeecccccccccCCC-ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhH
Q 002349 732 LLDKDFEAHLTDFGIAKSLCVSKS-YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHH 809 (933)
Q Consensus 732 ll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~ 809 (933)
++++++.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |+.||........
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~ 350 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ 350 (401)
T ss_pred EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH
Confidence 999999999999999986532221 11223357789999999998889999999999999999998 8889875433222
Q ss_pred HHHhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCC
Q 002349 810 LILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLV 870 (933)
Q Consensus 810 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 870 (933)
...... .+. .+..+. ..+..+.+++.+||..+|.+||++++|++.|+.+.
T Consensus 351 ~~~~~~-~~~-----~~~~p~-----~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 351 FYNAIK-RGY-----RMAKPA-----HASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHHHHH-cCC-----CCCCCC-----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 211111 110 111111 12357889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=325.85 Aligned_cols=255 Identities=20% Similarity=0.235 Sum_probs=200.1
Q ss_pred hccCcceeeecccceeEEEEEEcC-CceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
++|+..++||+|+||.||+|+++. ++.||+|++.... ......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 468889999999999999999765 6779999985421 223345788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
||+++|+|.++++. ....+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 81 ey~~~g~L~~~l~~--~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 99999999999962 345789999999999999999999965 9999999999999999999999999999765333
Q ss_pred CCceeeeecccccccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccc
Q 002349 754 KSYTSTYIMGTIGYIDPEYAR-----TSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEI 828 (933)
Q Consensus 754 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 828 (933)
.........||+.|+|||++. ...++.++|||||||++|||++|+.||................... ..+...
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~--~~p~~~ 233 (332)
T cd05623 156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF--QFPAQV 233 (332)
T ss_pred CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccc--cCCCcc
Confidence 333333457999999999986 3457899999999999999999999998765444433222111110 011100
Q ss_pred cccccCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 002349 829 SATCKDLGAVKKVFQLALLCSKRQPTD--RPTMHEVSRV 865 (933)
Q Consensus 829 ~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~ 865 (933)
...+..+.+++.+|+..++++ |++++|++++
T Consensus 234 ------~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 234 ------TDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ------ccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 112456778888888655544 6899999876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=344.67 Aligned_cols=266 Identities=19% Similarity=0.224 Sum_probs=199.1
Q ss_pred HHHHHHHhhccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCCC------CceeeeeeE
Q 002349 590 YEDIMRMTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIKH------RNLVSLQGY 662 (933)
Q Consensus 590 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~~~~~ 662 (933)
.+++...+++|++.++||+|+||+||+|.+. .++.||||+++... ...+++..|+++++.++| .++++++++
T Consensus 121 ~~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~ 199 (467)
T PTZ00284 121 GEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRY 199 (467)
T ss_pred CCccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence 3445556789999999999999999999975 46789999986432 223455667777777654 458999998
Q ss_pred EecC-CccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCC----
Q 002349 663 SLSS-SGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDF---- 737 (933)
Q Consensus 663 ~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~---- 737 (933)
+... .+.++|||++ +++|.+++. ..+.+++..+..++.|++.||+|||++ .+||||||||+|||++.++
T Consensus 200 ~~~~~~~~~iv~~~~-g~~l~~~l~---~~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~ 273 (467)
T PTZ00284 200 FQNETGHMCIVMPKY-GPCLLDWIM---KHGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVD 273 (467)
T ss_pred EEcCCceEEEEEecc-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccc
Confidence 8765 4678999988 678988884 346799999999999999999999952 3999999999999998765
Q ss_pred ------------CeEEeecccccccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCc
Q 002349 738 ------------EAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNEC 805 (933)
Q Consensus 738 ------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~ 805 (933)
.+||+|||.+.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||++..
T Consensus 274 ~~~~~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 274 PVTNRALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred cccccccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 49999999886432 22334679999999999999999999999999999999999999998766
Q ss_pred chhHHHHhhhccccccccc-------------------Ccccc-----c-----cccCHHHHHHHHHHHHHccCCCCCCC
Q 002349 806 NLHHLILSKTANNAVMETV-------------------DPEIS-----A-----TCKDLGAVKKVFQLALLCSKRQPTDR 856 (933)
Q Consensus 806 ~~~~~~~~~~~~~~~~~~~-------------------~~~~~-----~-----~~~~~~~~~~l~~li~~cl~~dP~~R 856 (933)
....+.......+.....+ .+... . ..........+.+++.+||+.||++|
T Consensus 350 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R 429 (467)
T PTZ00284 350 NLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR 429 (467)
T ss_pred hHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence 5544332222111111000 00000 0 00001113457799999999999999
Q ss_pred CCHHHHHHHH
Q 002349 857 PTMHEVSRVL 866 (933)
Q Consensus 857 Pt~~evl~~L 866 (933)
||++|++++-
T Consensus 430 ~ta~e~L~Hp 439 (467)
T PTZ00284 430 LNARQMTTHP 439 (467)
T ss_pred CCHHHHhcCc
Confidence 9999999853
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=313.52 Aligned_cols=239 Identities=23% Similarity=0.356 Sum_probs=189.9
Q ss_pred eeecccceeEEEEEEcC-------------CceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEE
Q 002349 605 IIGYGASSTVYKCVLKN-------------CKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLL 671 (933)
Q Consensus 605 ~lG~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 671 (933)
.||+|+||.||+|.+.. ...||+|.+..........+.+|+.+++.++||||+++++++..+...++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l 81 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence 58999999999998532 23588998876555556678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCC-------eEEeec
Q 002349 672 FYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFE-------AHLTDF 744 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~-------~kl~Df 744 (933)
||||+++|+|..+++ .....+++..+..++.|++.|++|||+. +|+||||||+||+++.++. +|++||
T Consensus 82 v~e~~~~~~l~~~~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 82 VEEFVEFGPLDLFMH--RKSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEecccCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 999999999999885 2345689999999999999999999965 9999999999999987664 899999
Q ss_pred ccccccccCCCceeeeecccccccCccccc-cCCCCcchhhHHHHHHHHHHH-hCCCCCCCCcchhHHHHhhhccccccc
Q 002349 745 GIAKSLCVSKSYTSTYIMGTIGYIDPEYAR-TSRLTEKSDVYSFGIVLLELL-TGRKAVDNECNLHHLILSKTANNAVME 822 (933)
Q Consensus 745 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGv~l~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~ 822 (933)
|++..... .....++..|+|||.+. +..++.++|||||||++|||+ +|+.||............ .... .
T Consensus 157 g~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~---~~~~-~ 227 (262)
T cd05077 157 GIPITVLS-----RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFY---EGQC-M 227 (262)
T ss_pred CCCccccC-----cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHH---hcCc-c
Confidence 99865421 12345788999999886 467899999999999999997 588887653322211110 0000 0
Q ss_pred ccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 002349 823 TVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLG 867 (933)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 867 (933)
. .. .....+.+++.+||+.||.+||++.+|++.++
T Consensus 228 -----~--~~---~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 228 -----L--VT---PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred -----C--CC---CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 0 00 11356889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=319.26 Aligned_cols=263 Identities=27% Similarity=0.420 Sum_probs=201.7
Q ss_pred hccCcceeeecccceeEEEEEEc-----CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecC--CccE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-----NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSS--SGNL 670 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~ 670 (933)
.+|+..+.||+|+||.||+|..+ .++.||+|++........+.+.+|++++++++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46778889999999999999853 4678999999776666677899999999999999999999987543 4578
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccc
Q 002349 671 LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSL 750 (933)
Q Consensus 671 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~ 750 (933)
+||||+++++|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++..
T Consensus 84 lv~e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQK--HRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 99999999999999953 345689999999999999999999965 9999999999999999999999999999876
Q ss_pred ccCCCcee--eeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccccc--------
Q 002349 751 CVSKSYTS--TYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAV-------- 820 (933)
Q Consensus 751 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~-------- 820 (933)
........ ....++..|+|||+..+..++.++|||||||++|||++|..++...... +... ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~ 235 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE--FMRM-MGNDKQGQMIVYHL 235 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh--hhhh-cccccccccchHHH
Confidence 43322211 1123445699999999888999999999999999999998776432211 0000 000000
Q ss_pred ccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccC
Q 002349 821 METVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869 (933)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 869 (933)
.+.+.... ........+..+.+++.+||+.+|++|||+.||++.|+.+
T Consensus 236 ~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 236 IELLKNNG-RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHhcCC-cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00000000 0000112346789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=317.62 Aligned_cols=258 Identities=26% Similarity=0.377 Sum_probs=203.3
Q ss_pred hccCcceeeecccceeEEEEEEc-CCc----eEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCK----PVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLL 671 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 671 (933)
++|+..+.||+|+||+||+|.+. +++ .||+|++.... ....+++.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEE
Confidence 56888899999999999999864 333 48999986543 33456788999999999999999999998754 5789
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccc
Q 002349 672 FYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLC 751 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 751 (933)
+|||+++|+|.++++. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 86 ~~~~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 86 VTQLMPYGCLLDYVRE--NKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEcCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 9999999999999963 345789999999999999999999965 99999999999999999999999999998764
Q ss_pred cCCCce-eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCcccc
Q 002349 752 VSKSYT-STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEIS 829 (933)
Q Consensus 752 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (933)
...... .....++..|+|||...+..++.++|||||||++|||++ |..||........... ....... ...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~--~~~~~~~-----~~~ 233 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDL--LEKGERL-----PQP 233 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH--HHCCCcC-----CCC
Confidence 322211 112235678999999998899999999999999999998 8899875432221111 1111000 000
Q ss_pred ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCCCC
Q 002349 830 ATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAP 873 (933)
Q Consensus 830 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 873 (933)
...+..+.+++.+||+.||++||++.++++.++.+...+
T Consensus 234 -----~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 234 -----PICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred -----ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 112457889999999999999999999999988765544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=329.47 Aligned_cols=258 Identities=20% Similarity=0.242 Sum_probs=206.7
Q ss_pred ccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCC-C-----CceeeeeeEEecCCccEE
Q 002349 599 NLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIK-H-----RNLVSLQGYSLSSSGNLL 671 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~~~~~~~~~~~~~l 671 (933)
+|.+.+.||+|+||.|-+|.+. .++.||||+++.... ...+...|+.+|..++ | -|+|++++||...++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 8999999999999999999965 488999999977543 3455678999999996 3 389999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCC--CCeEEeecccccc
Q 002349 672 FYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKD--FEAHLTDFGIAKS 749 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~--~~~kl~DfGla~~ 749 (933)
|+|.+. .+|+++++. .+..+++...+..++.||+.||.+||+. +|||+||||+|||+.+. ..+||+|||.|+.
T Consensus 266 VfELL~-~NLYellK~-n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELLS-TNLYELLKN-NKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhhh-hhHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccccc
Confidence 999995 599999976 3456799999999999999999999966 99999999999999754 4699999999987
Q ss_pred cccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccccccc-------
Q 002349 750 LCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVME------- 822 (933)
Q Consensus 750 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------- 822 (933)
... ... ..+.+..|+|||++.|.+|+.+.||||||||++||++|.+-|.++...+++..+....+....
T Consensus 341 ~~q---~vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~ 416 (586)
T KOG0667|consen 341 ESQ---RVY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAK 416 (586)
T ss_pred cCC---cce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 532 222 457889999999999999999999999999999999999999988887777544222111100
Q ss_pred -------c------------------------------cCccccccccC------HHHHHHHHHHHHHccCCCCCCCCCH
Q 002349 823 -------T------------------------------VDPEISATCKD------LGAVKKVFQLALLCSKRQPTDRPTM 859 (933)
Q Consensus 823 -------~------------------------------~~~~~~~~~~~------~~~~~~l~~li~~cl~~dP~~RPt~ 859 (933)
. .....+...+. ......+.+++.+|+..||.+|+|+
T Consensus 417 ~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp 496 (586)
T KOG0667|consen 417 KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP 496 (586)
T ss_pred ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH
Confidence 0 00000000000 0123568899999999999999999
Q ss_pred HHHHHHH
Q 002349 860 HEVSRVL 866 (933)
Q Consensus 860 ~evl~~L 866 (933)
.|.+++-
T Consensus 497 ~qal~Hp 503 (586)
T KOG0667|consen 497 AQALNHP 503 (586)
T ss_pred HHHhcCc
Confidence 9999854
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=327.06 Aligned_cols=240 Identities=26% Similarity=0.280 Sum_probs=190.7
Q ss_pred eeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHH-HHhcCCCCceeeeeeEEecCCccEEEEEecCC
Q 002349 604 YIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELE-TVGSIKHRNLVSLQGYSLSSSGNLLFYDFMEN 678 (933)
Q Consensus 604 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 678 (933)
+.||+|+||+||+|... +++.||+|++.... ......+..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 36999999999999965 57899999986532 223344555554 56778999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCcee
Q 002349 679 GSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTS 758 (933)
Q Consensus 679 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 758 (933)
|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.... .....
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~-~~~~~ 153 (325)
T cd05604 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA-QSDTT 153 (325)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCC-CCCCc
Confidence 99999884 456789999999999999999999965 999999999999999999999999999875321 12223
Q ss_pred eeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHHH
Q 002349 759 TYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAV 838 (933)
Q Consensus 759 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (933)
....||+.|+|||++.+..++.++||||+||++|||++|+.||................ ....+ ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~----~~~~~---------~~~ 220 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP----LVLRP---------GAS 220 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC----ccCCC---------CCC
Confidence 34579999999999999999999999999999999999999998654333222111110 01111 123
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHH
Q 002349 839 KKVFQLALLCSKRQPTDRPTMHEVS 863 (933)
Q Consensus 839 ~~l~~li~~cl~~dP~~RPt~~evl 863 (933)
..+.+++.+|++.+|.+||++.+.+
T Consensus 221 ~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 221 LTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred HHHHHHHHHHhccCHHhcCCCCCCH
Confidence 4677899999999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=316.83 Aligned_cols=259 Identities=20% Similarity=0.311 Sum_probs=207.3
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
++|+..+.||+|+||.||+|... +++.+|||.+.... .....++.+|+++++.++||||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 46788889999999999999964 68899999876432 234467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccccc
Q 002349 674 DFMENGSLWDILHGP-TKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV 752 (933)
Q Consensus 674 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 752 (933)
||+++++|.+++... .....+++..+..++.|++.|++|||++ +++|+||||+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999988532 2345689999999999999999999965 999999999999999999999999999876543
Q ss_pred CCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccc
Q 002349 753 SKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATC 832 (933)
Q Consensus 753 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (933)
... ......|+..|+|||.+.+..++.++||||||+++|+|++|..||.+............. ....+...
T Consensus 159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~--- 229 (267)
T cd08229 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE-----QCDYPPLP--- 229 (267)
T ss_pred CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhh-----cCCCCCCC---
Confidence 222 123346889999999999888999999999999999999999999754321111111111 11111111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccC
Q 002349 833 KDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869 (933)
Q Consensus 833 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 869 (933)
....+..+.+++.+|++.||++|||+.+|++.++++
T Consensus 230 -~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 230 -SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred -cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 112346788999999999999999999999988765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=315.26 Aligned_cols=255 Identities=26% Similarity=0.400 Sum_probs=204.3
Q ss_pred hccCcceeeecccceeEEEEEEcC----CceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKN----CKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLF 672 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 672 (933)
++|+..+.||+|+||.||+|.+.. +..+|+|.+.... ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 578888999999999999998642 3469999886543 33456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccccc
Q 002349 673 YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV 752 (933)
Q Consensus 673 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 752 (933)
|||+++++|.+++.. ....+++.++..++.|++.|++|||+. +++||||||+||+++.++.++++|||++.....
T Consensus 84 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRK--HDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 999999999999963 345689999999999999999999965 999999999999999999999999999987643
Q ss_pred CCCceee--eecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCcccc
Q 002349 753 SKSYTST--YIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEIS 829 (933)
Q Consensus 753 ~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (933)
....... ...++..|+|||.+.+..++.++||||||+++||+++ |+.||............. ... .....
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~--~~~-----~~~~~ 231 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE--EGY-----RLPAP 231 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHh--CCC-----cCCCC
Confidence 3222211 1223568999999998889999999999999999886 999997544332221111 110 00001
Q ss_pred ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccC
Q 002349 830 ATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869 (933)
Q Consensus 830 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 869 (933)
...+..+.+++.+|++.+|.+||++.++++.|..+
T Consensus 232 -----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 232 -----MDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -----CCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 11245788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=326.04 Aligned_cols=241 Identities=21% Similarity=0.267 Sum_probs=193.9
Q ss_pred ccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCC-CCceeeeeeEEecCCccEEEE
Q 002349 599 NLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIK-HRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 673 (933)
+|+..+.||+|+||.||+|..+ +++.||+|++.... ....+.+..|.++++.+. |++|+++++++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3667789999999999999976 57889999987532 233456778899998885 577888999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
||+++|+|.+++. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQ---QVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 9999999999984 446799999999999999999999965 9999999999999999999999999998754222
Q ss_pred CCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccccc
Q 002349 754 KSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCK 833 (933)
Q Consensus 754 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (933)
........||+.|+|||++.+..++.++||||+||++|||++|+.||.+............... ..+.
T Consensus 155 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~--------~~p~--- 222 (323)
T cd05615 155 -GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV--------SYPK--- 222 (323)
T ss_pred -CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--------CCCc---
Confidence 1223345699999999999999999999999999999999999999986544332222111110 1111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCH
Q 002349 834 DLGAVKKVFQLALLCSKRQPTDRPTM 859 (933)
Q Consensus 834 ~~~~~~~l~~li~~cl~~dP~~RPt~ 859 (933)
..+..+.+++.+|++.+|++|++.
T Consensus 223 --~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 223 --SLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred --cCCHHHHHHHHHHcccCHhhCCCC
Confidence 123567889999999999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=312.37 Aligned_cols=254 Identities=25% Similarity=0.405 Sum_probs=205.2
Q ss_pred hhccCcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEec
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFM 676 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 676 (933)
.++|+..+.||+|+||.||+|....+..+|+|.+.... ...+.+.+|++++++++|+||+++++++.. ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 46788999999999999999998777889999887543 235678899999999999999999999887 7789999999
Q ss_pred CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCc
Q 002349 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY 756 (933)
Q Consensus 677 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 756 (933)
++++|.+++... ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||.+.........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 83 AKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 999999999642 345688999999999999999999965 9999999999999999999999999999765432222
Q ss_pred eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCccccccccCH
Q 002349 757 TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDL 835 (933)
Q Consensus 757 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (933)
......++..|+|||++.+..++.++|||||||++|++++ |+.||............. ..... ... .
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~--~~~~~-----~~~-----~ 226 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE--RGYRM-----PRP-----E 226 (260)
T ss_pred cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh--CCCCC-----CCc-----c
Confidence 2222345678999999998889999999999999999999 899997644322221111 11000 000 1
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcc
Q 002349 836 GAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGS 868 (933)
Q Consensus 836 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 868 (933)
..+..+.+++.+|++.+|++||++.++.+.|+.
T Consensus 227 ~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 227 NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred cCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 124578899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=320.90 Aligned_cols=258 Identities=23% Similarity=0.355 Sum_probs=205.4
Q ss_pred hhccCcceeeecccceeEEEEEEc------CCceEEEEEecccC-chhHHHHHHHHHHHhcC-CCCceeeeeeEEecCCc
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK------NCKPVAIKRLYSHY-PQCLKEFETELETVGSI-KHRNLVSLQGYSLSSSG 668 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 668 (933)
.++|...+.||+|+||.||+|... .+..||||+++... ....+.+.+|+++++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 357889999999999999999742 24579999987543 33456789999999999 79999999999999999
Q ss_pred cEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccc
Q 002349 669 NLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAK 748 (933)
Q Consensus 669 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 748 (933)
.++||||+++|+|.++++.. ....+++.++..++.|++.||+|||++ +|+|+||||+||+++.++.+|++|||+++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRK-RESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccc
Confidence 99999999999999999632 223489999999999999999999965 99999999999999999999999999998
Q ss_pred ccccCCCc-eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCc
Q 002349 749 SLCVSKSY-TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDP 826 (933)
Q Consensus 749 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 826 (933)
........ ......++..|+|||.+.+..++.++||||+||++|||++ |..||............. ... . ..
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~-~~~-~----~~ 263 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLI-KEG-Y----RM 263 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHH-HcC-C----cC
Confidence 65432221 1222345778999999999889999999999999999998 999987544332221111 111 0 00
Q ss_pred cccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccC
Q 002349 827 EISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869 (933)
Q Consensus 827 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 869 (933)
.... ..+..+.+++.+|++.+|++|||+.|+++.|+++
T Consensus 264 ~~~~-----~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 264 AQPE-----HAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCCC-----CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0000 1235788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=318.73 Aligned_cols=251 Identities=22% Similarity=0.283 Sum_probs=201.8
Q ss_pred cCcceeeecccceeEEEEEEcC-CceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecCC
Q 002349 600 LSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMEN 678 (933)
Q Consensus 600 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 678 (933)
|++.+.||+|+||.||+|.... +..+++|.+........+.+.+|+++++.++||||+++++++..+...++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 5667789999999999999764 677889988765555667789999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCcee
Q 002349 679 GSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTS 758 (933)
Q Consensus 679 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 758 (933)
++|.+++.. ...++++..+..++.|++.||+|||+. +++||||||+||+++.++.+|++|||++...... ....
T Consensus 87 ~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~-~~~~ 160 (282)
T cd06643 87 GAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQRR 160 (282)
T ss_pred CcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccc-cccc
Confidence 999998752 345789999999999999999999965 9999999999999999999999999998764322 1222
Q ss_pred eeecccccccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccccc
Q 002349 759 TYIMGTIGYIDPEYAR-----TSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCK 833 (933)
Q Consensus 759 ~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (933)
....|+..|+|||++. +..++.++||||+||++|||++|+.||................. +....
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~-------~~~~~--- 230 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP-------PTLAQ--- 230 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCC-------CCCCC---
Confidence 3356899999999874 34578899999999999999999999976544333222111100 00000
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 834 DLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 834 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
+...+..+.+++.+||+.||.+||++.+++++-
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 231 PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 111245788999999999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=315.87 Aligned_cols=255 Identities=25% Similarity=0.403 Sum_probs=201.0
Q ss_pred cCcceeeecccceeEEEEEEcC----CceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCc-----
Q 002349 600 LSEKYIIGYGASSTVYKCVLKN----CKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSG----- 668 (933)
Q Consensus 600 ~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----- 668 (933)
|...+.||+|+||.||+|.... +..||+|+++... ......+.+|++.++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567889999999999998653 3679999987543 2345678999999999999999999998876554
Q ss_pred -cEEEEEecCCCCHHHHhcCCC---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeec
Q 002349 669 -NLLFYDFMENGSLWDILHGPT---KKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDF 744 (933)
Q Consensus 669 -~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 744 (933)
.++||||+++|+|.+++.... ....+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 789999999999999885321 234689999999999999999999965 9999999999999999999999999
Q ss_pred ccccccccCCCce-eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhccccccc
Q 002349 745 GIAKSLCVSKSYT-STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVME 822 (933)
Q Consensus 745 Gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 822 (933)
|+++.+....... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+......... . .....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~-~-~~~~~-- 233 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDY-L-RHGNR-- 233 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-H-HcCCC--
Confidence 9998764332221 112235678999999988889999999999999999999 8888876543322211 1 11111
Q ss_pred ccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccC
Q 002349 823 TVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869 (933)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 869 (933)
...+. ..+..+.+++.+|++.||++|||+.|+++.|+.+
T Consensus 234 ---~~~~~-----~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 234 ---LKQPE-----DCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ---CCCCc-----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11111 2346789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=319.80 Aligned_cols=262 Identities=25% Similarity=0.390 Sum_probs=199.2
Q ss_pred cCcceeeecccceeEEEEEE-----cCCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecC--CccEE
Q 002349 600 LSEKYIIGYGASSTVYKCVL-----KNCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSS--SGNLL 671 (933)
Q Consensus 600 ~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l 671 (933)
|+..+.||+|+||+||++.. .+++.||+|.+.... ......+.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37888999999999988653 246789999987653 23456788999999999999999999988654 35789
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccc
Q 002349 672 FYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLC 751 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 751 (933)
||||+++++|.+++.. ..+++..+..++.|++.|++|||++ +|+||||||+||++++++.+||+|||+++...
T Consensus 86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccC
Confidence 9999999999999852 4589999999999999999999965 99999999999999999999999999998664
Q ss_pred cCCCce--eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhc-c---cccccccC
Q 002349 752 VSKSYT--STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTA-N---NAVMETVD 825 (933)
Q Consensus 752 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~-~---~~~~~~~~ 825 (933)
...... .....++..|+|||...+..++.++||||||+++|||++|..||............... . ....+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence 322211 12234566799999998888999999999999999999999998643221110000000 0 00000000
Q ss_pred ccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccC
Q 002349 826 PEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869 (933)
Q Consensus 826 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 869 (933)
....... ....+..+.+++..|++.+|++|||++++++.|+.+
T Consensus 239 ~~~~~~~-~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 239 RGMRLPC-PKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred cCCCCCC-CCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 0000000 112346899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=338.78 Aligned_cols=367 Identities=26% Similarity=0.396 Sum_probs=288.9
Q ss_pred cEEEEEcCCCCcC-cccCCCCCCCCCccEEEccCCcccccCCCCccCCCCCceecccccccCCCCCcccccccchhhhhh
Q 002349 69 TVIALNLSGLNLD-GEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLIL 147 (933)
Q Consensus 69 ~v~~l~l~~~~l~-~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 147 (933)
-|..+|+++|.++ +.+|.....++.++.|-|...++. .+|++++.|.+|++|.+++|++. .+-.+++.|+.|+.+++
T Consensus 8 FVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~ 85 (1255)
T KOG0444|consen 8 FVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIV 85 (1255)
T ss_pred eeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhh
Confidence 5788999999999 589999999999999999999998 89999999999999999999998 67778999999999999
Q ss_pred cccCccC-CCCcccccCCCCceeeeecCCCCCCcccccccCCCCcEEeccCccccCccCc-CCcCCCCCcEEcccccccc
Q 002349 148 KNNQLIG-PIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQ-NIGNCTSFQVLDLSYNQLS 225 (933)
Q Consensus 148 ~~n~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~-~l~~l~~L~~L~L~~N~l~ 225 (933)
.+|++.. -+|..+-+|..|+.||||+|++. ..|..+...+++-.|+||+|+|. +||. .+-+++.|-.||||+|++.
T Consensus 86 R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe 163 (1255)
T KOG0444|consen 86 RDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE 163 (1255)
T ss_pred hccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh
Confidence 9999964 58889999999999999999998 77899999999999999999999 5665 4689999999999999998
Q ss_pred CcCCCCccccccceEeccccccccccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccC-CCCCCccc
Q 002349 226 GEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLT-GHIPPELG 304 (933)
Q Consensus 226 ~~~p~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~p~~l~ 304 (933)
. +|+.+..+.+|+.|+|++|.+.-.-...+-.+++|+.|.+++.+-+ ..+|.++.
T Consensus 164 ~------------------------LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld 219 (1255)
T KOG0444|consen 164 M------------------------LPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLD 219 (1255)
T ss_pred h------------------------cCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchh
Confidence 3 3444445555555555555544332233334455555555553322 34566666
Q ss_pred cCCcceEeeeccccccccCCccccccccccccccccccCCCCCCCCcccCCCCCceeccCcccCCCCCccccccccccee
Q 002349 305 NMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYL 384 (933)
Q Consensus 305 ~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L 384 (933)
.+.+|..+|+|.|.+. .+|+.+-++.+|+.|+|++|+|+ .+........+|++|+||.|+++ .+|.+++++++|+.|
T Consensus 220 ~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kL 296 (1255)
T KOG0444|consen 220 DLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKL 296 (1255)
T ss_pred hhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHH
Confidence 6677777777777776 66777777777777777777776 34444555667777777777777 677777778888888
Q ss_pred cCCccccc-CCCccccccccccceeeccCCccCCCCCCCCCCccccccccccCcccccccccccccccccceEEccCCcc
Q 002349 385 NLSLNNIR-GPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHL 463 (933)
Q Consensus 385 ~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 463 (933)
++.+|+++ .-+|..++++.+|+.+..++|++. ..|..++.+..|+.|.|++|+|- ..|+++.-|+.|+.|||..|.=
T Consensus 297 y~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpn 374 (1255)
T KOG0444|consen 297 YANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPN 374 (1255)
T ss_pred HhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcC
Confidence 88777766 247888888888888888888887 88888999999999999999888 6788888899999999999854
Q ss_pred ccccc
Q 002349 464 TGVIP 468 (933)
Q Consensus 464 ~~~~p 468 (933)
--..|
T Consensus 375 LVMPP 379 (1255)
T KOG0444|consen 375 LVMPP 379 (1255)
T ss_pred ccCCC
Confidence 42444
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=319.26 Aligned_cols=261 Identities=23% Similarity=0.367 Sum_probs=201.3
Q ss_pred hccCcceeeecccceeEEEEEEcC-----------------CceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeee
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKN-----------------CKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSL 659 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~ 659 (933)
++|+..+.||+|+||.||+|.+.+ ...||+|++.... .....++.+|++++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 468899999999999999986432 3468999987543 3345678999999999999999999
Q ss_pred eeEEecCCccEEEEEecCCCCHHHHhcCCC--------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCce
Q 002349 660 QGYSLSSSGNLLFYDFMENGSLWDILHGPT--------KKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNI 731 (933)
Q Consensus 660 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NI 731 (933)
++++...+..++||||+++++|.+++.... ....+++..+..++.|++.|++|||+. +++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence 999999999999999999999999986421 113478889999999999999999965 999999999999
Q ss_pred EeCCCCCeEEeecccccccccCCCce-eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh--CCCCCCCCcchh
Q 002349 732 LLDKDFEAHLTDFGIAKSLCVSKSYT-STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT--GRKAVDNECNLH 808 (933)
Q Consensus 732 ll~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt--g~~p~~~~~~~~ 808 (933)
+++.++.++|+|||+++.+....... .....++..|+|||...++.++.++|||||||++|||++ |..||.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 99999999999999998653322111 122334678999999888889999999999999999998 678886543322
Q ss_pred HHHHhhhcc-cccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 002349 809 HLILSKTAN-NAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLG 867 (933)
Q Consensus 809 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 867 (933)
......... ........+. ...++..+.+++.+|++.||++||++.+|.+.|+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 242 VIENTGEFFRDQGRQVYLPK------PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHHHHHhhccccccCCC------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 221110000 0000000000 1123467889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=317.35 Aligned_cols=256 Identities=24% Similarity=0.381 Sum_probs=205.5
Q ss_pred hhccCcceeeecccceeEEEEEEcC------CceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCcc
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKN------CKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGN 669 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 669 (933)
.++|+..+.||+|+||.||+|..++ ++.||+|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3578889999999999999998653 3679999986543 33456788999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCC-------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEe
Q 002349 670 LLFYDFMENGSLWDILHGPT-------KKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLT 742 (933)
Q Consensus 670 ~lv~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~ 742 (933)
++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence 99999999999999985321 123578999999999999999999965 99999999999999999999999
Q ss_pred ecccccccccCCCc-eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhccccc
Q 002349 743 DFGIAKSLCVSKSY-TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAV 820 (933)
Q Consensus 743 DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 820 (933)
|||+++.+...... ......++..|+|||.+.+..++.++|||||||++||+++ |..||............. ....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~--~~~~ 239 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI--DGGH 239 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh--cCCC
Confidence 99999865433221 1223356789999999988889999999999999999998 899987544333222211 1111
Q ss_pred ccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 002349 821 METVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLG 867 (933)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 867 (933)
...+. ..+..+.+++.+|++.+|++|||+.++++.|+
T Consensus 240 -----~~~~~-----~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 240 -----LDLPE-----NCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred -----CCCCC-----CCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 11111 12467889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=330.69 Aligned_cols=260 Identities=20% Similarity=0.253 Sum_probs=200.2
Q ss_pred HHhhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecC-----
Q 002349 595 RMTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSS----- 666 (933)
Q Consensus 595 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----- 666 (933)
...++|+..+.||+|+||.||+|... .++.||||++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 34578999999999999999999965 47889999987542 33456788999999999999999999987543
Q ss_pred -CccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecc
Q 002349 667 -SGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFG 745 (933)
Q Consensus 667 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfG 745 (933)
...++||||+++ +|.+.+. ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCC
Confidence 346999999975 7777763 2478899999999999999999965 99999999999999999999999999
Q ss_pred cccccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccc----
Q 002349 746 IAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVM---- 821 (933)
Q Consensus 746 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~---- 821 (933)
+++..... .......||..|+|||++.+..++.++|||||||++|+|++|+.||.+......+.......+...
T Consensus 172 ~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (364)
T cd07875 172 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 249 (364)
T ss_pred CccccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 99865322 222335689999999999999999999999999999999999999986655444322211100000
Q ss_pred cc----------------------cCcccccc---ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 822 ET----------------------VDPEISAT---CKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 822 ~~----------------------~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.. ..+..... .........+.+++.+|++.||++|||+.|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 00000000 0000113567899999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=325.49 Aligned_cols=255 Identities=19% Similarity=0.221 Sum_probs=200.3
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
++|+..+.||+|+||.||+|+.+ +++.||+|.+.... ......+.+|..++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47888999999999999999976 46789999986422 223455788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
||+++|+|.++++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 Ey~~gg~L~~~l~~--~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 99999999999963 245789999999999999999999965 9999999999999999999999999999876443
Q ss_pred CCceeeeecccccccCcccccc-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccc
Q 002349 754 KSYTSTYIMGTIGYIDPEYART-----SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEI 828 (933)
Q Consensus 754 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 828 (933)
.........||+.|+|||++.+ ..++.++||||+||++|||++|+.||................... .++...
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~--~~p~~~ 233 (331)
T cd05624 156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERF--QFPSHI 233 (331)
T ss_pred CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcc--cCCCcc
Confidence 3333334579999999999875 467889999999999999999999998655433332221111110 011111
Q ss_pred cccccCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 002349 829 SATCKDLGAVKKVFQLALLCSKRQPTD--RPTMHEVSRV 865 (933)
Q Consensus 829 ~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~ 865 (933)
. ..+..+.+++.+|+..++++ |+++++++++
T Consensus 234 ~------~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 234 T------DVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred c------cCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 1 12356778899988866544 4688888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=311.05 Aligned_cols=249 Identities=27% Similarity=0.425 Sum_probs=204.2
Q ss_pred hccCcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecC
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFME 677 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 677 (933)
++|+..+.||+|+||.||+|... ++.||+|.+..... ..+++.+|+.++++++|+||+++++++......++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 57888899999999999999876 68899999976644 46778999999999999999999999998999999999999
Q ss_pred CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCce
Q 002349 678 NGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYT 757 (933)
Q Consensus 678 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 757 (933)
+++|.+++.. .....+++..+..++.|++.|+.|||++ +++||||||+||+++.++.+||+|||.++.......
T Consensus 84 ~~~L~~~~~~-~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 84 KGSLVDYLRS-RGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CCcHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 9999999963 2223689999999999999999999965 999999999999999999999999999987532211
Q ss_pred eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCccccccccCHH
Q 002349 758 STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLG 836 (933)
Q Consensus 758 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (933)
...++..|+|||.+.+..++.++||||||+++|||++ |+.||....... ...... .. . ...... .
T Consensus 158 --~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-~~~~~~-~~-~----~~~~~~-----~ 223 (256)
T cd05039 158 --SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-VVPHVE-KG-Y----RMEAPE-----G 223 (256)
T ss_pred --cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH-HHHHHh-cC-C----CCCCcc-----C
Confidence 2345668999999998889999999999999999997 999987543222 111111 11 0 011111 1
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHHcc
Q 002349 837 AVKKVFQLALLCSKRQPTDRPTMHEVSRVLGS 868 (933)
Q Consensus 837 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 868 (933)
.+..+.+++.+|+..+|++||++.++++.|..
T Consensus 224 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 224 CPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 24678899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=315.64 Aligned_cols=256 Identities=24% Similarity=0.353 Sum_probs=204.8
Q ss_pred hccCcceeeecccceeEEEEEEcCC----ceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKNC----KPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLF 672 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 672 (933)
++|...+.||+|+||.||+|.+.+. ..||+|...... ....+.+.+|+.++++++||||+++++++.. ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 4577889999999999999986542 468999887654 4456689999999999999999999998875 557899
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccccc
Q 002349 673 YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV 752 (933)
Q Consensus 673 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 752 (933)
|||+++++|.+++.. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+|++|||+++....
T Consensus 85 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 85 MELAPLGELRSYLQV--NKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEcCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 999999999999953 234689999999999999999999965 999999999999999999999999999986643
Q ss_pred CCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCcccccc
Q 002349 753 SKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISAT 831 (933)
Q Consensus 753 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (933)
..........++..|+|||.+....++.++||||||+++||+++ |..||................ ......
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-------~~~~~~- 231 (270)
T cd05056 160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE-------RLPMPP- 231 (270)
T ss_pred ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-------cCCCCC-
Confidence 32222223345568999999988889999999999999999986 999997655433332211111 001111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCC
Q 002349 832 CKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVP 871 (933)
Q Consensus 832 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 871 (933)
..+..+.+++.+|+..+|++|||+.++++.|+.+..
T Consensus 232 ----~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 232 ----NCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred ----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 124578899999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=317.62 Aligned_cols=251 Identities=21% Similarity=0.251 Sum_probs=198.9
Q ss_pred cCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEe
Q 002349 600 LSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 600 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
|+..+.||+|+||+||+|.+. +++.||+|.+.... ......+.+|++++++++|+||+++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566788999999999999975 57899999986532 22334578899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS 755 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 755 (933)
+++++|.+++.. .....+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~-~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05632 82 MNGGDLKFHIYN-MGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE- 156 (285)
T ss_pred ccCccHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence 999999988853 2234699999999999999999999955 99999999999999999999999999997653222
Q ss_pred ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCH
Q 002349 756 YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDL 835 (933)
Q Consensus 756 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (933)
......|+..|+|||++.+..++.++||||+||++|||++|+.||..................... ....
T Consensus 157 -~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~----~~~~----- 226 (285)
T cd05632 157 -SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEE----VYSA----- 226 (285)
T ss_pred -cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcccc----ccCc-----
Confidence 223357899999999999889999999999999999999999999865432221111110000000 1111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 002349 836 GAVKKVFQLALLCSKRQPTDRPT-----MHEVSRV 865 (933)
Q Consensus 836 ~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 865 (933)
..+..+.+++.+|++.||++||+ +++++.+
T Consensus 227 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 227 KFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred cCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 12346788999999999999999 6677653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=318.93 Aligned_cols=260 Identities=22% Similarity=0.368 Sum_probs=204.3
Q ss_pred HhhccCcceeeecccceeEEEEEEcC------CceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCc
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLKN------CKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSG 668 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 668 (933)
.+++|++.+.||+|+||.||+|..++ +..||+|.+.... .....++.+|+.++++++||||+++++++.....
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 46789999999999999999997542 4579999886543 2334567889999999999999999999999999
Q ss_pred cEEEEEecCCCCHHHHhcCCC-------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEE
Q 002349 669 NLLFYDFMENGSLWDILHGPT-------KKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHL 741 (933)
Q Consensus 669 ~~lv~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl 741 (933)
.++||||+++|+|.++++... .....++..+..++.|++.||.|||++ +|+||||||+||++++++.+|+
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEE
Confidence 999999999999999996321 123457788999999999999999965 9999999999999999999999
Q ss_pred eecccccccccCCCce-eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccc
Q 002349 742 TDFGIAKSLCVSKSYT-STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNA 819 (933)
Q Consensus 742 ~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 819 (933)
+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+..... ..... ....
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~-~~~~~-~~~~ 238 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ-VLKFV-MDGG 238 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHH-HcCC
Confidence 9999998653222111 122345678999999998889999999999999999998 788887543222 11111 1111
Q ss_pred cccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCC
Q 002349 820 VMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLV 870 (933)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 870 (933)
.. ..+. ..+..+.+++.+|++.||++|||+.++++.++...
T Consensus 239 ~~-----~~~~-----~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 239 YL-----DQPD-----NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred CC-----CCCC-----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 10 1111 12357899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=317.89 Aligned_cols=262 Identities=22% Similarity=0.274 Sum_probs=200.3
Q ss_pred ccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEe
Q 002349 599 NLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
+|+..+.||+|++|.||+|..+ +++.||+|++.... ....+.+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778889999999999999976 57899999986532 22346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS 755 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 755 (933)
++ ++|.++++.......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 58988886433446789999999999999999999965 99999999999999999999999999997653221
Q ss_pred ceeeeecccccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccccccccc----------
Q 002349 756 YTSTYIMGTIGYIDPEYARTS-RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETV---------- 824 (933)
Q Consensus 756 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------- 824 (933)
.......+++.|+|||++.+. .++.++||||+||++|+|+||+.||.+..................+..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY 235 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence 112233578899999988654 578999999999999999999999986544333221111000000000
Q ss_pred Ccccccccc------CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 825 DPEISATCK------DLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 825 ~~~~~~~~~------~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.+....... ....+.++.+++.+|++.||++|||+.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000000 00123567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=349.51 Aligned_cols=256 Identities=21% Similarity=0.295 Sum_probs=201.0
Q ss_pred HHhhccCcceeeecccceeEEEEEEcC-CceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCceeeeeeEEecC--Ccc
Q 002349 595 RMTENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSH--YPQCLKEFETELETVGSIKHRNLVSLQGYSLSS--SGN 669 (933)
Q Consensus 595 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 669 (933)
...++|.+.+.||+|+||+||+|.+.. ++.||+|.+... .......+..|+.++++++|||||+++++|... ...
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 345689999999999999999999765 567889988643 233456789999999999999999999988543 568
Q ss_pred EEEEEecCCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhhcCC----CCCeeeccCCCCceEeCC---------
Q 002349 670 LLFYDFMENGSLWDILHGP-TKKKKLDWDTRLKIALGAAQGLAYLHHDC----SPRIIHRDVKSSNILLDK--------- 735 (933)
Q Consensus 670 ~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~----~~~ivH~Dikp~NIll~~--------- 735 (933)
++||||+++|+|.+++... .....+++..++.|+.||+.||+|||+.. ..+||||||||+|||++.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 8999999999999998632 12357999999999999999999999641 135999999999999964
Q ss_pred --------CCCeEEeecccccccccCCCceeeeecccccccCcccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCc
Q 002349 736 --------DFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYART--SRLTEKSDVYSFGIVLLELLTGRKAVDNEC 805 (933)
Q Consensus 736 --------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGv~l~elltg~~p~~~~~ 805 (933)
.+.+||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 2348999999998653222 2234579999999999864 458899999999999999999999998665
Q ss_pred chhHHHHhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002349 806 NLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSR 864 (933)
Q Consensus 806 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 864 (933)
............. .++. ...+..+.++|..||+.+|.+||++.|++.
T Consensus 248 ~~~qli~~lk~~p--------~lpi----~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 248 NFSQLISELKRGP--------DLPI----KGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred cHHHHHHHHhcCC--------CCCc----CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 5544432221111 1110 012357889999999999999999999984
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=313.24 Aligned_cols=250 Identities=24% Similarity=0.388 Sum_probs=205.5
Q ss_pred hccCcceeeecccceeEEEEEEcC-CceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEec
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFM 676 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 676 (933)
++|+..+.||+|+||.||+|.+.. ++.||+|.+..... .+++.+|++++++++||||+++++++..+...++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578888999999999999999875 78899999865432 678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCc
Q 002349 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY 756 (933)
Q Consensus 677 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 756 (933)
++++|.+++.. ....+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 81 GAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 99999999852 346789999999999999999999965 999999999999999999999999999987643221
Q ss_pred eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHH
Q 002349 757 TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLG 836 (933)
Q Consensus 757 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (933)
......|+..|+|||++.+..++.++||||||+++|+|++|+.||............... ..+... ....
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~-------~~~~~~---~~~~ 224 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK-------PPPTLS---DPEK 224 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC-------CCCCCC---chhh
Confidence 233456889999999999889999999999999999999999999765433322211110 000010 0112
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 837 AVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 837 ~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
....+.+++.+|++.||++|||+.|++++
T Consensus 225 ~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 225 WSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred cCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 23578899999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=331.64 Aligned_cols=260 Identities=21% Similarity=0.245 Sum_probs=199.7
Q ss_pred HHhhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCC----
Q 002349 595 RMTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSS---- 667 (933)
Q Consensus 595 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 667 (933)
...++|+..+.||+|+||.||+|... .++.||||++.... ....+.+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 45679999999999999999999965 47889999997543 234567788999999999999999999886432
Q ss_pred --ccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecc
Q 002349 668 --GNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFG 745 (933)
Q Consensus 668 --~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfG 745 (933)
..++||||+++ ++.+.+. ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence 46899999975 6777663 3478999999999999999999965 99999999999999999999999999
Q ss_pred cccccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccccc-----
Q 002349 746 IAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAV----- 820 (933)
Q Consensus 746 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~----- 820 (933)
+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+......+..........
T Consensus 165 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 165 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred ccccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 99865322 22234578999999999999999999999999999999999999998655433322111100000
Q ss_pred -----------------cc-ccCcccccc------ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 821 -----------------ME-TVDPEISAT------CKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 821 -----------------~~-~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.. ..+...... .........+.+++.+|++.||++|||+.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00 000000000 0000123567899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=317.73 Aligned_cols=252 Identities=23% Similarity=0.293 Sum_probs=203.5
Q ss_pred hccCcceeeecccceeEEEEEEcC-CceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEec
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFM 676 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 676 (933)
+.|++.+.||+|+||.||+|.... ++.||+|.+........+.+.+|+++++.++||||+++++++..+...++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 568888999999999999999764 7889999998766666778899999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCc
Q 002349 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY 756 (933)
Q Consensus 677 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 756 (933)
++++|..++.. ....+++..+..++.|++.|++|||++ +++||||||+||+++.++.+||+|||++...... ..
T Consensus 92 ~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-~~ 165 (292)
T cd06644 92 PGGAVDAIMLE--LDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-LQ 165 (292)
T ss_pred CCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccc-cc
Confidence 99999888752 345689999999999999999999965 9999999999999999999999999998754222 12
Q ss_pred eeeeecccccccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccc
Q 002349 757 TSTYIMGTIGYIDPEYAR-----TSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISAT 831 (933)
Q Consensus 757 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (933)
......+++.|+|||++. ...++.++|||||||++|||++|+.||............. ... .+....
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~--~~~-----~~~~~~- 237 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA--KSE-----PPTLSQ- 237 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHh--cCC-----CccCCC-
Confidence 223456889999999885 3456889999999999999999999997654332221111 110 011100
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 832 CKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 832 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.......+.+++.+|++.+|++||++.+++++
T Consensus 238 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 238 --PSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred --CcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 11223568889999999999999999999874
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=321.44 Aligned_cols=260 Identities=21% Similarity=0.357 Sum_probs=206.0
Q ss_pred hhccCcceeeecccceeEEEEEEc--------CCceEEEEEecccC-chhHHHHHHHHHHHhcC-CCCceeeeeeEEecC
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK--------NCKPVAIKRLYSHY-PQCLKEFETELETVGSI-KHRNLVSLQGYSLSS 666 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 666 (933)
.++|...+.||+|+||.||+|++. .+..||+|.+.... ....+++.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 467888899999999999999742 23469999886543 34457789999999999 899999999999999
Q ss_pred CccEEEEEecCCCCHHHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEe
Q 002349 667 SGNLLFYDFMENGSLWDILHGPT-------------KKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILL 733 (933)
Q Consensus 667 ~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll 733 (933)
...++||||+++|+|.+++.... ....+++.++..++.|++.||+|||++ +|+||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEE
Confidence 99999999999999999986421 123578899999999999999999965 99999999999999
Q ss_pred CCCCCeEEeecccccccccCCCce-eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHH
Q 002349 734 DKDFEAHLTDFGIAKSLCVSKSYT-STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLI 811 (933)
Q Consensus 734 ~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~ 811 (933)
++++.+||+|||+++......... .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+..... ..
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~ 249 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-LF 249 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH-HH
Confidence 999999999999998764322221 222345678999999998889999999999999999998 778886543322 22
Q ss_pred HhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCC
Q 002349 812 LSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVP 871 (933)
Q Consensus 812 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 871 (933)
.... .... .... ...+..+.+++.+|++.+|++||++.|+++.|+.+..
T Consensus 250 ~~~~-~~~~-----~~~~-----~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 250 KLLK-EGHR-----MDKP-----ANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred HHHH-cCCc-----CCCC-----CCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 1111 1110 0011 1234678899999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=319.56 Aligned_cols=250 Identities=25% Similarity=0.364 Sum_probs=206.0
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEec
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFM 676 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 676 (933)
.+|+..+.||.|+||.||+|... +++.||+|.+........+.+.+|+++++.++||||+++++++...+..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 46888899999999999999864 57899999997665555678899999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCc
Q 002349 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY 756 (933)
Q Consensus 677 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 756 (933)
++++|.+++. ...+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 170 (296)
T cd06655 99 AGGSLTDVVT----ETCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS- 170 (296)
T ss_pred CCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc-
Confidence 9999999984 34689999999999999999999965 999999999999999999999999999876533222
Q ss_pred eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHH
Q 002349 757 TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLG 836 (933)
Q Consensus 757 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (933)
......|+..|+|||.+.+..++.++|||||||++|+|++|+.||................. +.... ...
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~-------~~~~~---~~~ 240 (296)
T cd06655 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT-------PELQN---PEK 240 (296)
T ss_pred cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC-------cccCC---ccc
Confidence 12234688999999999988899999999999999999999999987655443322211110 00000 111
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 837 AVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 837 ~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.+..+.+++.+||..||++||++.+++.+
T Consensus 241 ~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 241 LSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred CCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 23567889999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=312.11 Aligned_cols=250 Identities=21% Similarity=0.293 Sum_probs=203.1
Q ss_pred ccCcceeeecccceeEEEEEEc-CCceEEEEEeccc-CchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEec
Q 002349 599 NLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSH-YPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFM 676 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 676 (933)
+|+..+.||+|+||.||++... +++.+|+|.++.. .....+.+.+|+.++++++|+||+++++++..++..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999976 4788999988643 2344567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCc
Q 002349 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY 756 (933)
Q Consensus 677 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 756 (933)
++++|.+++.. .....++...+..++.|++.||.|||++ +|+|+||||+||++++++.++++|||.++.......
T Consensus 81 ~~~~l~~~~~~-~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 81 DGGDLMQKIKL-QRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCcHHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence 99999998853 2345689999999999999999999965 999999999999999999999999999976543222
Q ss_pred eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHH
Q 002349 757 TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLG 836 (933)
Q Consensus 757 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (933)
......|++.|+|||++.+..++.++||||||+++|+|++|+.||............. .... ... +. .
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~--~~~~-~~~----~~-----~ 223 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVC--QGSY-KPL----PS-----H 223 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHh--cCCC-CCC----Cc-----c
Confidence 2234568999999999998889999999999999999999999998654322221111 1111 111 11 1
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 837 AVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 837 ~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.+..+.+++.+||+.||++||++.+++..
T Consensus 224 ~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 224 YSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred cCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 23467889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=315.01 Aligned_cols=256 Identities=23% Similarity=0.396 Sum_probs=204.6
Q ss_pred hccCcceeeecccceeEEEEEEcC------CceEEEEEecccCch-hHHHHHHHHHHHhcCCCCceeeeeeEEecCCccE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKN------CKPVAIKRLYSHYPQ-CLKEFETELETVGSIKHRNLVSLQGYSLSSSGNL 670 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 670 (933)
++|+....||+|+||.||+|+.+. .+.|++|.+...... ..+++.+|++++++++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 578888999999999999999652 357899988665433 4577999999999999999999999999989999
Q ss_pred EEEEecCCCCHHHHhcCCCCC------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeec
Q 002349 671 LFYDFMENGSLWDILHGPTKK------KKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDF 744 (933)
Q Consensus 671 lv~e~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 744 (933)
+||||+++|+|.++++..... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999643211 2689999999999999999999965 9999999999999999999999999
Q ss_pred ccccccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccc
Q 002349 745 GIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMET 823 (933)
Q Consensus 745 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 823 (933)
|++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||.............. ......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~--~~~~~~ 239 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQA--GKLELP 239 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHc--CCcCCC
Confidence 9987543332223333456788999999988889999999999999999999 7888865433222221111 111000
Q ss_pred cCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 002349 824 VDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLG 867 (933)
Q Consensus 824 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 867 (933)
.. ...+..+.+++.+|++.+|++||++.|+++.|.
T Consensus 240 ----~~-----~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 240 ----VP-----EGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred ----CC-----CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 01 122457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=314.49 Aligned_cols=255 Identities=26% Similarity=0.397 Sum_probs=202.9
Q ss_pred hccCcceeeecccceeEEEEEEcC-C---ceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKN-C---KPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLF 672 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 672 (933)
..|+..+.||+|+||.||+|.+.. + ..||+|.+.... ....++|..|+.++++++||||+++++++..+...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 357788999999999999999753 2 369999987643 34467899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccccc
Q 002349 673 YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV 752 (933)
Q Consensus 673 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 752 (933)
|||+++++|.+++.. ..+.+++.++..++.|++.|++|||++ +++||||||+||+++.++.+|++|||++.....
T Consensus 84 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 999999999999863 345689999999999999999999965 999999999999999999999999999876533
Q ss_pred CCCcee-e-ee--cccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCcc
Q 002349 753 SKSYTS-T-YI--MGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPE 827 (933)
Q Consensus 753 ~~~~~~-~-~~--~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 827 (933)
...... . .. ..+..|+|||.+.+..++.++||||+||++|||++ |..||............. ... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~-~~~------~~~ 231 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE-QDY------RLP 231 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH-cCC------cCC
Confidence 221111 1 11 12457999999999899999999999999999886 999997644332221111 100 000
Q ss_pred ccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccC
Q 002349 828 ISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869 (933)
Q Consensus 828 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 869 (933)
. ....+..+.+++.+|++.+|++||++.+++..|+.+
T Consensus 232 ~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 232 P-----PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred C-----cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 112345688899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=305.78 Aligned_cols=270 Identities=25% Similarity=0.377 Sum_probs=212.8
Q ss_pred HHHhhccCcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcC--CCCceeeeeeEEecCC----
Q 002349 594 MRMTENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSI--KHRNLVSLQGYSLSSS---- 667 (933)
Q Consensus 594 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~~---- 667 (933)
.....+....+.||+|.||.||+|.|++ +.||||++.... .+.+.+|.++.+.+ +|+||..+++.-..+.
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~wrG-e~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRWRG-EDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred HhhhheeEEEEEecCccccceeeccccC-CceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 3456788889999999999999999976 789999996543 45667788887775 9999999998765443
Q ss_pred ccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcC-----CCCCeeeccCCCCceEeCCCCCeEEe
Q 002349 668 GNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHD-----CSPRIIHRDVKSSNILLDKDFEAHLT 742 (933)
Q Consensus 668 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~Dikp~NIll~~~~~~kl~ 742 (933)
+.++|.+|.+.|||+|+|. +..++.+..++++..+|.||+|||.+ ..+.|+|||||+.||||..++.+-|+
T Consensus 283 QLwLvTdYHe~GSL~DyL~----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA 358 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLN----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 358 (513)
T ss_pred EEEEeeecccCCcHHHHHh----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence 4689999999999999994 47899999999999999999999943 36779999999999999999999999
Q ss_pred ecccccccccCCC---ceeeeecccccccCccccccC------CCCcchhhHHHHHHHHHHHhC----------CCCCCC
Q 002349 743 DFGIAKSLCVSKS---YTSTYIMGTIGYIDPEYARTS------RLTEKSDVYSFGIVLLELLTG----------RKAVDN 803 (933)
Q Consensus 743 DfGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGv~l~elltg----------~~p~~~ 803 (933)
|+|+|........ ......+||.+|||||++... +.-..+||||||.|+||++.. +.||.+
T Consensus 359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd 438 (513)
T KOG2052|consen 359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYD 438 (513)
T ss_pred eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCccc
Confidence 9999987644322 123456899999999998653 123469999999999999753 356653
Q ss_pred CcchhHHHHhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCCC
Q 002349 804 ECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPA 872 (933)
Q Consensus 804 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 872 (933)
-.+.+.- .....+-...+.++|.++...+..+....+.++++.||..+|..|-|+-.+-+.|.++...
T Consensus 439 ~Vp~DPs-~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 439 VVPSDPS-FEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS 506 (513)
T ss_pred CCCCCCC-HHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence 2211111 1111222344556777777777778889999999999999999999999999988877643
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=334.78 Aligned_cols=254 Identities=28% Similarity=0.423 Sum_probs=206.9
Q ss_pred cCcceeeecccceeEEEEEEc-CC----ceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 600 LSEKYIIGYGASSTVYKCVLK-NC----KPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 600 ~~~~~~lG~G~~g~Vy~~~~~-~~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
....++||+|+||+||+|.|- .| -+||+|++.... .+...++.+|+-+|.+++|||+++++|++..+. ..||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 445678999999999999963 33 468999887654 556788999999999999999999999998776 88999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
+||+.|+|.|+++ ..+..+-....+.|..|||+||.|||++ ++|||||.++||||..-..+||.|||+|+....+
T Consensus 777 q~mP~G~LlDyvr--~hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVR--EHRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HhcccchHHHHHH--HhhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 9999999999997 4677899999999999999999999976 9999999999999999999999999999987543
Q ss_pred -CCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCcccccc
Q 002349 754 -KSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISAT 831 (933)
Q Consensus 754 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (933)
..+......-.+.|||-|.++...|+.++|||||||++||++| |..|+++-.. +.+........ ++
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~-~eI~dlle~ge--------RL--- 919 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA-EEIPDLLEKGE--------RL--- 919 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH-HHhhHHHhccc--------cC---
Confidence 3333333445678999999999999999999999999999998 8888875322 22111111111 11
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCC
Q 002349 832 CKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVP 871 (933)
Q Consensus 832 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 871 (933)
.++.-+..+++.++.+||..|+..||+++++...+.++..
T Consensus 920 sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 920 SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 1233456789999999999999999999999987766543
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=332.65 Aligned_cols=252 Identities=21% Similarity=0.269 Sum_probs=198.4
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
++|+..+.||+|+||.||+|..+ .++.||+|++.... ......+.+|++++.+++||||+++++++.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888899999999999999976 47889999986432 234566888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
||+++|+|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 9999999999994 456789999999999999999999965 9999999999999999999999999998754211
Q ss_pred CC----------------------------------ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCC
Q 002349 754 KS----------------------------------YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRK 799 (933)
Q Consensus 754 ~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~ 799 (933)
.. ......+||+.|+|||++.+..++.++||||+||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 10 00113479999999999999999999999999999999999999
Q ss_pred CCCCCcchhHHHHhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 002349 800 AVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPT---MHEVSRV 865 (933)
Q Consensus 800 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~evl~~ 865 (933)
||.+................. .+++.. .....+.+++.+++ .||.+|++ ++++.++
T Consensus 235 Pf~~~~~~~~~~~i~~~~~~~--~~p~~~-------~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 235 PFCSETPQETYRKVMNWKETL--VFPPEV-------PISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCCCHHHHHHHHHcCCCce--ecCCCC-------CCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 998765544332221111100 011110 11245667777766 49999985 6666654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=320.84 Aligned_cols=262 Identities=24% Similarity=0.333 Sum_probs=203.0
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEe
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
++|+..+.||+|+||.||+|.+. +++.+|+|.+.... .....++.+|++++++++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888999999999999999976 46778889886543 33456688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS 755 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 755 (933)
+++++|.++++ ..+.+++..+..++.|++.||+|||+. .+++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 153 (308)
T cd06615 81 MDGGSLDQVLK---KAGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 153 (308)
T ss_pred cCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCccccccc--
Confidence 99999999995 346789999999999999999999952 38999999999999999999999999998754221
Q ss_pred ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccC--------c-
Q 002349 756 YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVD--------P- 826 (933)
Q Consensus 756 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------~- 826 (933)
......|+..|+|||.+.+..++.++||||||+++|+|++|+.||........................ .
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
T cd06615 154 -MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPD 232 (308)
T ss_pred -ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCC
Confidence 123356899999999998888999999999999999999999999744322111111000000000000 0
Q ss_pred ----------------cccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 002349 827 ----------------EISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLG 867 (933)
Q Consensus 827 ----------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 867 (933)
......+.......+.+++.+|++.+|++|||+.+++++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 289 (308)
T cd06615 233 SPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289 (308)
T ss_pred ccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 00000000112456889999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=313.88 Aligned_cols=250 Identities=25% Similarity=0.393 Sum_probs=202.4
Q ss_pred ccCcceeeecccceeEEEEEEcCCceEEEEEecccC------chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEE
Q 002349 599 NLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHY------PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLF 672 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 672 (933)
+|...+.||+|+||.||+|...+++.+|+|.+.... ....+.+.+|++++++++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999998888999999886432 12235688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccccc
Q 002349 673 YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV 752 (933)
Q Consensus 673 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 752 (933)
|||+++++|.+++. ...++++..+..++.|++.|++|||+. +|+|+||+|+||++++++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILN---RFGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 99999999999994 345688999999999999999999965 999999999999999999999999999876522
Q ss_pred CC-----CceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcc
Q 002349 753 SK-----SYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPE 827 (933)
Q Consensus 753 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 827 (933)
.. ........|+..|+|||++.+..++.++||||+||++|+|++|+.||................. . .+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~-~----~~~ 229 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRG-L----MPR 229 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccC-C----CCC
Confidence 11 1112234688999999999998899999999999999999999999976543333222111111 1 111
Q ss_pred ccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002349 828 ISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSR 864 (933)
Q Consensus 828 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 864 (933)
+.. .....+.+++.+|++.+|++||++.++++
T Consensus 230 ~~~-----~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 230 LPD-----SFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCC-----CCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 111 12456889999999999999999999876
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=318.66 Aligned_cols=258 Identities=22% Similarity=0.245 Sum_probs=194.8
Q ss_pred ccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcC---CCCceeeeeeEEecC-----C
Q 002349 599 NLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSI---KHRNLVSLQGYSLSS-----S 667 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~-----~ 667 (933)
+|+..+.||+|+||+||+|.++ +++.||+|.+.... ......+.+|+++++++ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778899999999999999976 47889999886532 22234556777777665 699999999988642 3
Q ss_pred ccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccc
Q 002349 668 GNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIA 747 (933)
Q Consensus 668 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla 747 (933)
..++||||+++ +|.+++.. .....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDK-VPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCcc
Confidence 47899999975 89888853 2234589999999999999999999965 9999999999999999999999999999
Q ss_pred cccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccc-----cccc
Q 002349 748 KSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANN-----AVME 822 (933)
Q Consensus 748 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~-----~~~~ 822 (933)
+...... ......||..|+|||++.+..++.++||||+||++|+|++|+.||................. .+..
T Consensus 156 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07863 156 RIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 233 (288)
T ss_pred ccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence 8653221 22335689999999999998999999999999999999999999976554433322111100 0000
Q ss_pred c-------cCcc----ccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 823 T-------VDPE----ISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 823 ~-------~~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
. ..+. ..... ......+.+++.+|++.||++|||+.|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 234 DVTLPRGAFSPRGPRPVQSVV--PEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred cccccccccCCCCCCchHHhC--cCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 0000 00000 0123567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=312.01 Aligned_cols=248 Identities=27% Similarity=0.395 Sum_probs=200.2
Q ss_pred eeeecccceeEEEEEEcC--C--ceEEEEEecccCc-hhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecCC
Q 002349 604 YIIGYGASSTVYKCVLKN--C--KPVAIKRLYSHYP-QCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMEN 678 (933)
Q Consensus 604 ~~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 678 (933)
++||+|++|.||+|.+.. + ..||+|.+..... ...+++.+|++++++++||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999999754 2 3689999987665 567789999999999999999999999988 888999999999
Q ss_pred CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCc--
Q 002349 679 GSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY-- 756 (933)
Q Consensus 679 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~-- 756 (933)
++|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.+......
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999964222 5789999999999999999999965 9999999999999999999999999999876432211
Q ss_pred eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCccccccccCH
Q 002349 757 TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDL 835 (933)
Q Consensus 757 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (933)
......++..|+|||.+.+..++.++|||||||++|||++ |+.||......+....... ..... .. ..
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~-----~~-----~~ 224 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK-EGERL-----ER-----PE 224 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh-cCCcC-----CC-----Cc
Confidence 1112457789999999998899999999999999999999 9999975543332221111 11000 00 11
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 002349 836 GAVKKVFQLALLCSKRQPTDRPTMHEVSRVLG 867 (933)
Q Consensus 836 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 867 (933)
..+..+.+++.+|++.+|++||+++++++.|.
T Consensus 225 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 225 ACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred cCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 22467889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=316.32 Aligned_cols=253 Identities=24% Similarity=0.340 Sum_probs=202.3
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEec
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFM 676 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 676 (933)
++|+..+.||+|+||.||+|... +++.||+|.++.........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46777888999999999999965 57889999987665555567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCc
Q 002349 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY 756 (933)
Q Consensus 677 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 756 (933)
++++|.+++. ..+.+++.++..++.|++.|++|||+. +++|+||||+||+++.++.+||+|||++...... ..
T Consensus 89 ~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-~~ 161 (267)
T cd06645 89 GGGSLQDIYH---VTGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITAT-IA 161 (267)
T ss_pred CCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCc-cc
Confidence 9999999984 456789999999999999999999965 9999999999999999999999999998765322 12
Q ss_pred eeeeecccccccCccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccccc
Q 002349 757 TSTYIMGTIGYIDPEYAR---TSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCK 833 (933)
Q Consensus 757 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (933)
......|+..|+|||++. ...++.++||||+||++|+|++|+.||.............. .... .+....
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~--~~~~---~~~~~~--- 233 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK--SNFQ---PPKLKD--- 233 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhc--cCCC---CCcccc---
Confidence 223457899999999874 45688999999999999999999999865433222211111 1100 111111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 834 DLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 834 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
....+..+.+++.+|++.+|++||++++++++
T Consensus 234 ~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 234 KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 01123467889999999999999999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=324.68 Aligned_cols=249 Identities=23% Similarity=0.361 Sum_probs=206.6
Q ss_pred cCcceeeecccceeEEEEEEcC--C--ceEEEEEecccCch-hHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEE
Q 002349 600 LSEKYIIGYGASSTVYKCVLKN--C--KPVAIKRLYSHYPQ-CLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYD 674 (933)
Q Consensus 600 ~~~~~~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 674 (933)
....++||+|.||+|++|.|+. | -.||||.++..... ...+|.+|+.+|.+++|||++++||+..+ ...++|||
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 3445679999999999999874 3 35899999887644 67889999999999999999999999987 67889999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCC
Q 002349 675 FMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSK 754 (933)
Q Consensus 675 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 754 (933)
.++.|||.+.|+. .....|.......++.|||.|+.||. ++++||||+.++|+++-....|||+|||+.+.++...
T Consensus 191 LaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred hcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 9999999999986 56778889999999999999999999 5599999999999999999999999999999886544
Q ss_pred Cceee--eecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCcccccc
Q 002349 755 SYTST--YIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISAT 831 (933)
Q Consensus 755 ~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (933)
.+... ...-...|+|||.++...++.++|||+|||++|||+| |..||-+......+.... .... +
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~~er--------L--- 334 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-AGER--------L--- 334 (1039)
T ss_pred cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-cccc--------C---
Confidence 43211 1234568999999999999999999999999999999 668888765544443322 1111 1
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 832 CKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 832 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.....|++++++++..||..+|++|||+..|.+.
T Consensus 335 pRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 335 PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred CCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 1133568899999999999999999999999743
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=317.47 Aligned_cols=251 Identities=23% Similarity=0.285 Sum_probs=198.8
Q ss_pred cCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEe
Q 002349 600 LSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 600 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
|+..+.||+|+||.||+|.+. .++.||+|.+.... ....+.+.+|+.++++++|++|+++++.+...+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999976 47899999986532 22234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS 755 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 755 (933)
+++++|.+++.. .....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05630 82 MNGGDLKFHIYH-MGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ- 156 (285)
T ss_pred cCCCcHHHHHHH-hcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence 999999998853 2234689999999999999999999955 99999999999999999999999999987643222
Q ss_pred ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCH
Q 002349 756 YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDL 835 (933)
Q Consensus 756 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (933)
......|+..|+|||++.+..++.++||||+||++|+|++|+.||............... ..........
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~----~~~~~~~~~~----- 226 (285)
T cd05630 157 -TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL----VKEVQEEYSE----- 226 (285)
T ss_pred -cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhh----hhhhhhhcCc-----
Confidence 122347899999999999989999999999999999999999999854322111100000 0000111111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 002349 836 GAVKKVFQLALLCSKRQPTDRPT-----MHEVSRV 865 (933)
Q Consensus 836 ~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 865 (933)
.....+.+++.+|++.||++||| ++|++++
T Consensus 227 ~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 227 KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred cCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 12346788999999999999999 8888864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=311.53 Aligned_cols=254 Identities=25% Similarity=0.347 Sum_probs=207.0
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEec
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFM 676 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 676 (933)
++|+..+.||+|+||.||+|... +++.+|+|.+........+.+.+|++++++++||||+++++++......+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57888999999999999999975 46789999997765556788999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCc
Q 002349 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY 756 (933)
Q Consensus 677 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 756 (933)
++++|.+++.. ....+++..+..++.|++.|++|||++ +++|+||||+||+++.++.+||+|||.+....... .
T Consensus 83 ~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~ 156 (262)
T cd06613 83 GGGSLQDIYQV--TRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-A 156 (262)
T ss_pred CCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh-h
Confidence 99999999852 336789999999999999999999965 99999999999999999999999999997653221 1
Q ss_pred eeeeecccccccCccccccC---CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccccc
Q 002349 757 TSTYIMGTIGYIDPEYARTS---RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCK 833 (933)
Q Consensus 757 ~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (933)
......++..|+|||.+.+. .++.++||||||+++|+|++|+.||................ .. ++... .
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~--~~---~~~~~---~ 228 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSN--FP---PPKLK---D 228 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--CC---Ccccc---c
Confidence 22335688899999998776 78999999999999999999999997654433322211110 00 00111 1
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 834 DLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 834 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
....+..+.+++.+|++.+|.+|||+.+|+.+
T Consensus 229 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 229 KEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred hhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 12235678899999999999999999999763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=314.54 Aligned_cols=239 Identities=23% Similarity=0.351 Sum_probs=188.9
Q ss_pred eeecccceeEEEEEEcC-------------------------CceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeee
Q 002349 605 IIGYGASSTVYKCVLKN-------------------------CKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSL 659 (933)
Q Consensus 605 ~lG~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 659 (933)
.||+|+||.||+|.+.. ...||+|++.........++.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999997521 13488998876555555678899999999999999999
Q ss_pred eeEEecCCccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCC--
Q 002349 660 QGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDF-- 737 (933)
Q Consensus 660 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~-- 737 (933)
++++......++||||+++|+|.+++.. ..+.+++..+..++.|+++||+|||+. +|+||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999999852 345789999999999999999999965 999999999999997643
Q ss_pred -----CeEEeecccccccccCCCceeeeecccccccCcccccc-CCCCcchhhHHHHHHHHHH-HhCCCCCCCCcchhHH
Q 002349 738 -----EAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYART-SRLTEKSDVYSFGIVLLEL-LTGRKAVDNECNLHHL 810 (933)
Q Consensus 738 -----~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~el-ltg~~p~~~~~~~~~~ 810 (933)
.+|++|||.+...... ....++..|+|||.+.+ ..++.++|||||||++||| ++|+.||.........
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~ 231 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE 231 (274)
T ss_pred cCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH
Confidence 3799999988643211 22357889999998865 5689999999999999998 4789999754332221
Q ss_pred HHhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 002349 811 ILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLG 867 (933)
Q Consensus 811 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 867 (933)
.... ... ..+.. ....+.+++.+||+.+|++|||+.+|++.|.
T Consensus 232 ~~~~-~~~--------~~~~~-----~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 232 RFYE-KKH--------RLPEP-----SCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHH-hcc--------CCCCC-----CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1110 000 01110 1246888999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=316.19 Aligned_cols=252 Identities=25% Similarity=0.363 Sum_probs=197.6
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEe
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
++|+..++||+|+||.||+|.+. +++.||+|.+.... ....+++.+|++++++++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 35778889999999999999964 57889999986542 33456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS 755 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 755 (933)
+++++|..+. .+++..+..++.|++.|++|||+. +|+|+||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-- 148 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-- 148 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence 9999986553 367889999999999999999965 9999999999999999999999999999765322
Q ss_pred ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCH
Q 002349 756 YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDL 835 (933)
Q Consensus 756 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (933)
......|+..|+|||++.+..++.++||||||+++|+|++|+.||........................+.... .
T Consensus 149 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~ 223 (279)
T cd06619 149 -IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPV----G 223 (279)
T ss_pred -cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCC----C
Confidence 12335789999999999998999999999999999999999999964221111000000000000001111111 1
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 836 GAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 836 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
.....+.+++.+|++.+|++||+++|++++.
T Consensus 224 ~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~ 254 (279)
T cd06619 224 QFSEKFVHFITQCMRKQPKERPAPENLMDHP 254 (279)
T ss_pred cCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence 1235688999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=313.90 Aligned_cols=255 Identities=23% Similarity=0.376 Sum_probs=200.9
Q ss_pred HHhhccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 595 RMTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 595 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
.+++++.....||+|+||.||+|.+. +++.||+|.+........+.+.+|++++++++|+||+++++++..++..++||
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 34566666778999999999999965 46789999987766666778999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCC--CHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCC-CCCeEEeeccccccc
Q 002349 674 DFMENGSLWDILHGPTKKKKL--DWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDK-DFEAHLTDFGIAKSL 750 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~-~~~~kl~DfGla~~~ 750 (933)
||+++++|.++++. ....+ ++..+..++.|++.|++|||+. +|+||||||+||+++. ++.+||+|||.+...
T Consensus 85 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 85 EQVPGGSLSALLRS--KWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred ecCCCCCHHHHHHH--hcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 99999999999963 22344 7888999999999999999965 9999999999999986 679999999998765
Q ss_pred ccCCCceeeeecccccccCccccccC--CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccc
Q 002349 751 CVSKSYTSTYIMGTIGYIDPEYARTS--RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEI 828 (933)
Q Consensus 751 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 828 (933)
..... ......|++.|+|||++.+. .++.++||||+|+++|+|++|+.||............ .... ...+.+
T Consensus 160 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~-~~~~----~~~~~~ 233 (268)
T cd06624 160 AGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK-VGMF----KIHPEI 233 (268)
T ss_pred ccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhh-hhhh----ccCCCC
Confidence 32221 12234588999999998664 3788999999999999999999999743222111110 0000 011111
Q ss_pred cccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 829 SATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 829 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
+. .....+.+++.+|++.+|++|||+.|++++
T Consensus 234 ~~-----~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 234 PE-----SLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred Cc-----ccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 11 123568889999999999999999999874
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=310.51 Aligned_cols=247 Identities=25% Similarity=0.388 Sum_probs=197.0
Q ss_pred eeeecccceeEEEEEEcC----CceEEEEEecccCc-hhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecCC
Q 002349 604 YIIGYGASSTVYKCVLKN----CKPVAIKRLYSHYP-QCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMEN 678 (933)
Q Consensus 604 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 678 (933)
+.||+|+||.||+|.+.. +..+|+|.+..... ...+++.+|++++++++||||+++++++. ....++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 369999999999998543 26899999876543 34567899999999999999999999876 4567999999999
Q ss_pred CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCcee
Q 002349 679 GSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTS 758 (933)
Q Consensus 679 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 758 (933)
++|.+++. ....+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLK---KRREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 99999995 334789999999999999999999965 999999999999999999999999999987643332211
Q ss_pred --eeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCccccccccCH
Q 002349 759 --TYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDL 835 (933)
Q Consensus 759 --~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (933)
....++..|+|||...+..++.++||||||+++|+|++ |+.||............. ..... ..+ .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~--~~~~~-----~~~-----~ 221 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE--SGERL-----PRP-----E 221 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH--cCCcC-----CCC-----C
Confidence 11223568999999998899999999999999999998 999997654332221111 11100 011 1
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccC
Q 002349 836 GAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869 (933)
Q Consensus 836 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 869 (933)
..+..+.+++.+|++.+|++||++.++.+.|+..
T Consensus 222 ~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 222 ECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 1235788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=317.09 Aligned_cols=257 Identities=25% Similarity=0.429 Sum_probs=203.8
Q ss_pred hhccCcceeeecccceeEEEEEEc------CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCcc
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK------NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGN 669 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 669 (933)
.++|+..+.||+|+||.||+|.+. .++.||+|++.... ....+++.+|+.++++++||||+++++++..+...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 457888999999999999999864 35789999987543 34456799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCc
Q 002349 670 LLFYDFMENGSLWDILHGPT-------------------KKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSN 730 (933)
Q Consensus 670 ~lv~e~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~N 730 (933)
++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+. +++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence 99999999999999985311 123578899999999999999999965 99999999999
Q ss_pred eEeCCCCCeEEeecccccccccCCCc-eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchh
Q 002349 731 ILLDKDFEAHLTDFGIAKSLCVSKSY-TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLH 808 (933)
Q Consensus 731 Ill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~ 808 (933)
|++++++.+||+|||++..+...... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+.....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999998765322211 1122345678999999998899999999999999999998 888886543322
Q ss_pred HHHHhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcc
Q 002349 809 HLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGS 868 (933)
Q Consensus 809 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 868 (933)
.... ........ .+ ...+..+.+++.+|++.||++|||+.|+++.|+.
T Consensus 241 ~~~~--~~~~~~~~-----~~-----~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 VIYY--VRDGNVLS-----CP-----DNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHH--HhcCCCCC-----CC-----CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 2111 11111110 01 1124678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=320.64 Aligned_cols=260 Identities=23% Similarity=0.380 Sum_probs=204.7
Q ss_pred hhccCcceeeecccceeEEEEEEcC--------CceEEEEEecccC-chhHHHHHHHHHHHhcC-CCCceeeeeeEEecC
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKN--------CKPVAIKRLYSHY-PQCLKEFETELETVGSI-KHRNLVSLQGYSLSS 666 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 666 (933)
.++|.+.+.||+|+||.||+|.+.+ ...+|+|.+.... .....++.+|+++++++ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 3678999999999999999998632 2469999987543 33456788899999999 799999999999999
Q ss_pred CccEEEEEecCCCCHHHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEe
Q 002349 667 SGNLLFYDFMENGSLWDILHGPT-------------KKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILL 733 (933)
Q Consensus 667 ~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll 733 (933)
+..++||||+++|+|.+++.... ....+++.+++.++.|++.||+|||+. +++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence 99999999999999999996421 123589999999999999999999965 99999999999999
Q ss_pred CCCCCeEEeecccccccccCCCce-eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHH
Q 002349 734 DKDFEAHLTDFGIAKSLCVSKSYT-STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLI 811 (933)
Q Consensus 734 ~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~ 811 (933)
+.++.+||+|||.++......... .....+++.|+|||.+.+..++.++||||+||++|||++ |..||.... .....
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~-~~~~~ 252 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELF 252 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC-HHHHH
Confidence 999999999999997653221111 111234568999999998889999999999999999998 888886533 22222
Q ss_pred HhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCC
Q 002349 812 LSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVP 871 (933)
Q Consensus 812 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 871 (933)
.... .... ...+. ..+..+.+++.+|++.+|++||++.+|++.|+.+.+
T Consensus 253 ~~~~-~~~~-----~~~~~-----~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 253 KLLK-EGHR-----MDKPS-----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred HHHH-cCCC-----CCCCC-----cCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 2111 1110 01111 124578889999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=309.82 Aligned_cols=249 Identities=25% Similarity=0.401 Sum_probs=199.4
Q ss_pred hccCcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEe-cCCccEEEEEec
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSL-SSSGNLLFYDFM 676 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~ 676 (933)
++|+..+.||+|+||.||+|..+ ++.||+|.+.... ..+.+.+|+.++++++|+|++++++++. .+...++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 47888899999999999999875 5789999886543 3467899999999999999999999764 456789999999
Q ss_pred CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCc
Q 002349 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY 756 (933)
Q Consensus 677 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 756 (933)
++++|.++++. .....+++..+..++.|++.||+|||++ +++||||||+||++++++.+|++|||+++......
T Consensus 83 ~~~~L~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 83 AKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCcHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 99999999863 2233589999999999999999999965 99999999999999999999999999987643221
Q ss_pred eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCccccccccCH
Q 002349 757 TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDL 835 (933)
Q Consensus 757 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (933)
....++..|+|||++.+..++.++|||||||++|+|++ |+.||..... ......... .. .+....
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~-~~~~~~~~~-~~-----~~~~~~----- 222 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVVPRVEK-GY-----KMDAPD----- 222 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHhc-CC-----CCCCCC-----
Confidence 22345678999999998889999999999999999998 9999875432 222111111 10 111111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccC
Q 002349 836 GAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869 (933)
Q Consensus 836 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 869 (933)
..+..+.+++.+|++.+|++|||++++++.|+.+
T Consensus 223 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 223 GCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 2246788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=317.29 Aligned_cols=253 Identities=24% Similarity=0.319 Sum_probs=205.0
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEe
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
.++|++.+.||+|+||.||+|.+. +++.||+|.+........+.+.+|++++++++||||+++++++..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 457888899999999999999975 5788999999776666667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS 755 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 755 (933)
+++++|.+++.. ....+++..+..++.|++.|+.|||+. +|+|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~- 157 (280)
T cd06611 84 CDGGALDSIMLE--LERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL- 157 (280)
T ss_pred cCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcccc-
Confidence 999999999852 345799999999999999999999965 99999999999999999999999999987653222
Q ss_pred ceeeeecccccccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccc
Q 002349 756 YTSTYIMGTIGYIDPEYAR-----TSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISA 830 (933)
Q Consensus 756 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (933)
.......|++.|+|||.+. +..++.++||||||+++|||++|+.||............. ... .+.+..
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~-----~~~~~~ 230 (280)
T cd06611 158 QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKIL--KSE-----PPTLDQ 230 (280)
T ss_pred cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHh--cCC-----CCCcCC
Confidence 1223456899999999875 3456789999999999999999999997654333222111 110 011100
Q ss_pred cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 831 TCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 831 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
....+..+.+++.+|++.+|++||++.+++++
T Consensus 231 ---~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 231 ---PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ---cccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 11123568889999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=320.73 Aligned_cols=258 Identities=24% Similarity=0.374 Sum_probs=201.9
Q ss_pred hhccCcceeeecccceeEEEEEEcC-Cc--eEEEEEecccC-chhHHHHHHHHHHHhcC-CCCceeeeeeEEecCCccEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKN-CK--PVAIKRLYSHY-PQCLKEFETELETVGSI-KHRNLVSLQGYSLSSSGNLL 671 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 671 (933)
.++|+..+.||+|+||.||+|.++. +. .+|+|.+.... ....+.+.+|++++.++ +||||+++++++..++..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 3578888999999999999999753 43 46778776533 33456788999999999 89999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCC
Q 002349 672 FYDFMENGSLWDILHGPT-------------KKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFE 738 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~ 738 (933)
||||+++++|.++++... ....+++.+++.++.|++.|++|||++ +|+||||||+||+++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCc
Confidence 999999999999986321 123688999999999999999999965 9999999999999999999
Q ss_pred eEEeecccccccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcc
Q 002349 739 AHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTAN 817 (933)
Q Consensus 739 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 817 (933)
+||+|||+++..... .......++..|+|||.+.+..++.++|||||||++|||+| |..||............ ..
T Consensus 163 ~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~--~~ 238 (303)
T cd05088 163 AKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL--PQ 238 (303)
T ss_pred EEeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHH--hc
Confidence 999999998643111 11111234668999999988889999999999999999998 99999754332221111 11
Q ss_pred cccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCC
Q 002349 818 NAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVP 871 (933)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 871 (933)
. ...... ...+..+.+++.+|++.+|++||+++++++.+..+..
T Consensus 239 ~-----~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~ 282 (303)
T cd05088 239 G-----YRLEKP-----LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282 (303)
T ss_pred C-----CcCCCC-----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0 011111 1123568899999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=325.87 Aligned_cols=244 Identities=23% Similarity=0.304 Sum_probs=193.2
Q ss_pred eeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcC-CCCceeeeeeEEecCCccEEEEEecCC
Q 002349 604 YIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSI-KHRNLVSLQGYSLSSSGNLLFYDFMEN 678 (933)
Q Consensus 604 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 678 (933)
+.||+|+||+||+|... +++.||+|++.... ....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999975 46889999997542 23345678899999888 699999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCcee
Q 002349 679 GSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTS 758 (933)
Q Consensus 679 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 758 (933)
|+|.+++. ..+.+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..... ....
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~ 153 (327)
T cd05617 81 GDLMFHMQ---RQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTT 153 (327)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCC-CCce
Confidence 99999884 345799999999999999999999965 9999999999999999999999999998753221 1223
Q ss_pred eeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcc-----hhHHHHhhhcccccccccCcccccccc
Q 002349 759 TYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECN-----LHHLILSKTANNAVMETVDPEISATCK 833 (933)
Q Consensus 759 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (933)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ............ ...++.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~------~~~~p~--- 224 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK------PIRIPR--- 224 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC------CCCCCC---
Confidence 346799999999999999999999999999999999999999963211 111111111110 011111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHH
Q 002349 834 DLGAVKKVFQLALLCSKRQPTDRPTM------HEVSRV 865 (933)
Q Consensus 834 ~~~~~~~l~~li~~cl~~dP~~RPt~------~evl~~ 865 (933)
..+..+.+++.+|++.||++|+++ .++.++
T Consensus 225 --~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 225 --FLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred --CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 113467789999999999999984 466543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=326.25 Aligned_cols=261 Identities=25% Similarity=0.376 Sum_probs=202.0
Q ss_pred hhccCcceeeecccceeEEEEEE------cCCceEEEEEecccC-chhHHHHHHHHHHHhcC-CCCceeeeeeEEecC-C
Q 002349 597 TENLSEKYIIGYGASSTVYKCVL------KNCKPVAIKRLYSHY-PQCLKEFETELETVGSI-KHRNLVSLQGYSLSS-S 667 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-~ 667 (933)
.++|+..+.||+|+||.||+|.+ ..++.||||+++... ......+.+|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35799999999999999999974 246789999997643 23356788999999999 689999999988654 4
Q ss_pred ccEEEEEecCCCCHHHHhcCCCC---------------------------------------------------------
Q 002349 668 GNLLFYDFMENGSLWDILHGPTK--------------------------------------------------------- 690 (933)
Q Consensus 668 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 690 (933)
..++||||+++|+|.++++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 57899999999999999853210
Q ss_pred -------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCc-eeeeec
Q 002349 691 -------KKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY-TSTYIM 762 (933)
Q Consensus 691 -------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~ 762 (933)
...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++........ ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 12468889999999999999999965 9999999999999999999999999999865322221 122234
Q ss_pred ccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHHHHHH
Q 002349 763 GTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKV 841 (933)
Q Consensus 763 gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 841 (933)
++..|+|||.+.+..++.++||||||+++|+|++ |..||............. .... ....+.. ....+
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~-----~~~~~~~-----~~~~~ 311 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL-KEGT-----RMRAPDY-----TTPEM 311 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHH-hccC-----CCCCCCC-----CCHHH
Confidence 5678999999988889999999999999999997 889987543222221111 1111 1111111 12468
Q ss_pred HHHHHHccCCCCCCCCCHHHHHHHHccCCC
Q 002349 842 FQLALLCSKRQPTDRPTMHEVSRVLGSLVP 871 (933)
Q Consensus 842 ~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 871 (933)
.+++.+||+.||++|||+.||+++|+.+..
T Consensus 312 ~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 312 YQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=319.97 Aligned_cols=263 Identities=25% Similarity=0.363 Sum_probs=214.0
Q ss_pred HHHHHhhccCcceeeecccceeEEEEEEcC-CceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccE
Q 002349 592 DIMRMTENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNL 670 (933)
Q Consensus 592 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 670 (933)
+++--..++...++||-|.||.||.|.|+. .-.||||.++.+. ...++|..|+.+|+.++|||+|+++|+|.....+|
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY 339 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY 339 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence 333334567778899999999999999986 4569999998764 34789999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccc
Q 002349 671 LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSL 750 (933)
Q Consensus 671 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~ 750 (933)
||.|||.+|+|.|+|+.. ++..++.-..+.++.||+.|++||..+ ++||||+.++|.|+.++..||++|||+++.+
T Consensus 340 IiTEfM~yGNLLdYLRec-nr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLREC-NRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred EEEecccCccHHHHHHHh-chhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhh
Confidence 999999999999999763 455678888899999999999999954 9999999999999999999999999999988
Q ss_pred ccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCcccc
Q 002349 751 CVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEIS 829 (933)
Q Consensus 751 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (933)
..+.........-.+.|.|||-+....++.|+|||+|||++||+.| |-.||.+-. ..+. +.....+. +.+
T Consensus 416 tgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid-lSqV-Y~LLEkgy-----RM~-- 486 (1157)
T KOG4278|consen 416 TGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQV-YGLLEKGY-----RMD-- 486 (1157)
T ss_pred cCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc-HHHH-HHHHhccc-----ccc--
Confidence 5444333333344678999999999999999999999999999998 556776532 2221 11111111 111
Q ss_pred ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCC
Q 002349 830 ATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVP 871 (933)
Q Consensus 830 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 871 (933)
...+|+..++++++.||+..|.+||+++|+-+.++.+..
T Consensus 487 ---~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 487 ---GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred ---CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 133567899999999999999999999999988876543
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=315.80 Aligned_cols=252 Identities=29% Similarity=0.396 Sum_probs=202.0
Q ss_pred cCcceeeecccceeEEEEEEcC-CceEEEEEecccCchhH--HHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEec
Q 002349 600 LSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHYPQCL--KEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFM 676 (933)
Q Consensus 600 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 676 (933)
|+..+.||+|+||+||+|.... ++.||+|++........ ....+|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 5677899999999999999775 56899999987653322 23456999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCc
Q 002349 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY 756 (933)
Q Consensus 677 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 756 (933)
++++|.+++. ....+++..+..++.|+++||+|||+. +|+|+||||+||+++.++.++|+|||.+.... ....
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~ 153 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNE 153 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTS
T ss_pred cccccccccc---ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-cccc
Confidence 9999999995 456789999999999999999999976 99999999999999999999999999997541 2223
Q ss_pred eeeeecccccccCccccc-cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcc-cccccccCccccccccC
Q 002349 757 TSTYIMGTIGYIDPEYAR-TSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTAN-NAVMETVDPEISATCKD 834 (933)
Q Consensus 757 ~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 834 (933)
......++..|+|||++. +..++.++||||+|+++|+|++|..||................ ....... .. .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~---~ 226 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSS----QQ---S 226 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHT----TS---H
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccc----cc---c
Confidence 344567899999999998 7889999999999999999999999998652222211111111 1110000 00 0
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 835 LGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 835 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
......+.+++.+|++.||++||++.+++++
T Consensus 227 ~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 227 REKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp TTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred chhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0112689999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=312.06 Aligned_cols=249 Identities=24% Similarity=0.400 Sum_probs=201.6
Q ss_pred ccCcceeeecccceeEEEEEEc-CCceEEEEEecccCch---------hHHHHHHHHHHHhcCCCCceeeeeeEEecCCc
Q 002349 599 NLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQ---------CLKEFETELETVGSIKHRNLVSLQGYSLSSSG 668 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 668 (933)
+|.....||+|++|.||+|... +++.||+|.+...... ..+.+.+|++++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4677889999999999999965 4788999988654321 23568899999999999999999999999999
Q ss_pred cEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccc
Q 002349 669 NLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAK 748 (933)
Q Consensus 669 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 748 (933)
.++||||+++++|.+++. ..+.+++..+..++.|++.|++|||+. +++||||+|+||++++++.+||+|||.++
T Consensus 81 ~~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLN---NYGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHH---hccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCc
Confidence 999999999999999994 346789999999999999999999965 99999999999999999999999999998
Q ss_pred ccccCCC-----ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccc
Q 002349 749 SLCVSKS-----YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMET 823 (933)
Q Consensus 749 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 823 (933)
....... .......|+..|+|||.+.+..++.++||||+||++|+|++|+.||............. . .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~-----~ 227 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG--E-----N 227 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHh--c-----c
Confidence 7642111 11122458899999999998889999999999999999999999998654433221111 1 1
Q ss_pred cCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 824 VDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 824 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
..+.+.. ..+..+.+++.+|++.||++||++.|++++
T Consensus 228 ~~~~~~~-----~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 228 ASPEIPS-----NISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred CCCcCCc-----ccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 1111111 124678899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=307.83 Aligned_cols=247 Identities=28% Similarity=0.399 Sum_probs=199.2
Q ss_pred eeeecccceeEEEEEEcCCceEEEEEecccCch-hHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecCCCCHH
Q 002349 604 YIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQ-CLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLW 682 (933)
Q Consensus 604 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 682 (933)
++||+|+||.||+|...+++.||+|++...... ....+.+|++++++++|+||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 369999999999999877899999998765443 5678899999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCcee-eee
Q 002349 683 DILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTS-TYI 761 (933)
Q Consensus 683 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~-~~~ 761 (933)
+++.. ....+++..+..++.+++.|++|||++ +++||||||+||+++.++.+||+|||++........... ...
T Consensus 81 ~~l~~--~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRK--KKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 99853 344688999999999999999999965 999999999999999999999999999976532111111 112
Q ss_pred cccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHHHHH
Q 002349 762 MGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKK 840 (933)
Q Consensus 762 ~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 840 (933)
.++..|+|||.+.+..++.++|||||||++|||++ |..||............. ... .... ....+..
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~--~~~-----~~~~-----~~~~~~~ 223 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIE--SGY-----RMPA-----PQLCPEE 223 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHh--cCC-----CCCC-----CccCCHH
Confidence 34567999999988889999999999999999999 788886544322221111 100 0000 1122467
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHHHHc
Q 002349 841 VFQLALLCSKRQPTDRPTMHEVSRVLG 867 (933)
Q Consensus 841 l~~li~~cl~~dP~~RPt~~evl~~L~ 867 (933)
+.+++.+|+..+|++|||+.|+++.|+
T Consensus 224 ~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 224 IYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=310.81 Aligned_cols=252 Identities=24% Similarity=0.339 Sum_probs=192.6
Q ss_pred eeecccceeEEEEEEcC---CceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecCCCC
Q 002349 605 IIGYGASSTVYKCVLKN---CKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGS 680 (933)
Q Consensus 605 ~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 680 (933)
.||+|+||.||+|.+.+ +..+|+|+++... ......+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 58999999999998654 3578999887654 2334578899999999999999999999999999999999999999
Q ss_pred HHHHhcCCC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCce-
Q 002349 681 LWDILHGPT--KKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYT- 757 (933)
Q Consensus 681 L~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~- 757 (933)
|.++++... .....++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||.++.........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 999986422 223567788889999999999999965 99999999999999999999999999997543222211
Q ss_pred eeeecccccccCccccccC-------CCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCcccc
Q 002349 758 STYIMGTIGYIDPEYARTS-------RLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEIS 829 (933)
Q Consensus 758 ~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (933)
.....|+..|+|||++.+. .++.++||||||+++|||++ |+.||............. . ........+.+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~-~-~~~~~~~~~~~~ 236 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTV-R-EQQLKLPKPRLK 236 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHh-h-cccCCCCCCccC
Confidence 1234578899999988642 35789999999999999996 999997554433222211 1 111111111111
Q ss_pred ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 002349 830 ATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLG 867 (933)
Q Consensus 830 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 867 (933)
. .....+.+++.+|+ .+|++|||++||++.|.
T Consensus 237 ~-----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 237 L-----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred C-----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1 12346778999998 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=318.87 Aligned_cols=250 Identities=26% Similarity=0.361 Sum_probs=204.5
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEec
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFM 676 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 676 (933)
.+|+..+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++|+||+++++++..++..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 67889999999999999999964 68899999997655555677889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCc
Q 002349 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY 756 (933)
Q Consensus 677 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 756 (933)
++++|.+++. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~----~~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~- 170 (297)
T cd06656 99 AGGSLTDVVT----ETCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170 (297)
T ss_pred CCCCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-
Confidence 9999999984 24578999999999999999999965 999999999999999999999999999876533222
Q ss_pred eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHH
Q 002349 757 TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLG 836 (933)
Q Consensus 757 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (933)
......+++.|+|||...+..++.++|||||||++|+|++|+.||.............. .. .+.... ...
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~------~~~~~~---~~~ 240 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NG------TPELQN---PER 240 (297)
T ss_pred CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CC------CCCCCC---ccc
Confidence 12234688999999999988899999999999999999999999976543222111100 00 000000 111
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 837 AVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 837 ~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.+..+.+++.+|++.+|++||++++++++
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 241 LSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 23567889999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=320.33 Aligned_cols=195 Identities=26% Similarity=0.375 Sum_probs=159.6
Q ss_pred ceeeecccceeEEEEEEc---CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEec--CCccEEEEEecC
Q 002349 603 KYIIGYGASSTVYKCVLK---NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLS--SSGNLLFYDFME 677 (933)
Q Consensus 603 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~ 677 (933)
..+||+|+||+||+|..+ .++.||+|.+.... ....+.+|++++++++||||+++++++.. +...++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 357999999999999965 35789999986542 23557889999999999999999998854 455789999996
Q ss_pred CCCHHHHhcCC------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEe----CCCCCeEEeecccc
Q 002349 678 NGSLWDILHGP------TKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILL----DKDFEAHLTDFGIA 747 (933)
Q Consensus 678 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll----~~~~~~kl~DfGla 747 (933)
++|.+++... .....+++..+..++.|++.||+|||++ +|+||||||+|||+ +..+.+||+|||+|
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 4888877421 1223589999999999999999999965 99999999999999 45678999999999
Q ss_pred cccccCCC--ceeeeecccccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 002349 748 KSLCVSKS--YTSTYIMGTIGYIDPEYART-SRLTEKSDVYSFGIVLLELLTGRKAVDN 803 (933)
Q Consensus 748 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~p~~~ 803 (933)
+.+..... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 87643221 12234578999999999877 4589999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=317.85 Aligned_cols=261 Identities=25% Similarity=0.412 Sum_probs=200.0
Q ss_pred ccCcceeeecccceeEEEEEEc-----CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecC--CccE
Q 002349 599 NLSEKYIIGYGASSTVYKCVLK-----NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSS--SGNL 670 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~ 670 (933)
.|++.+.||+|+||.||+|.+. .++.||+|.+.... ....+.+.+|++++++++||||+++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 4677889999999999999843 46789999987553 34456789999999999999999999998775 5678
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccc
Q 002349 671 LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSL 750 (933)
Q Consensus 671 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~ 750 (933)
+||||+++++|.+++.. ....+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++..
T Consensus 85 lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 85 LIMEFLPSGSLKEYLPR--NKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEccCCCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccccc
Confidence 99999999999999852 234689999999999999999999965 9999999999999999999999999999876
Q ss_pred ccCCCc--eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccc--------cc
Q 002349 751 CVSKSY--TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANN--------AV 820 (933)
Q Consensus 751 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~--------~~ 820 (933)
...... ......++..|+|||+..+..++.++|||||||++|||++++.|.................. ..
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL 239 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH
Confidence 432221 11234567789999999888899999999999999999998776532211000000000000 00
Q ss_pred ccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccC
Q 002349 821 METVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869 (933)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 869 (933)
........ ....+..+.+++.+|++.+|++|||++++++.++.+
T Consensus 240 ~~~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 240 EEGKRLPR-----PPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HcCccCCC-----CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 00000000 112346799999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=309.56 Aligned_cols=249 Identities=29% Similarity=0.430 Sum_probs=202.9
Q ss_pred eeeecccceeEEEEEEcC----CceEEEEEecccCch-hHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecCC
Q 002349 604 YIIGYGASSTVYKCVLKN----CKPVAIKRLYSHYPQ-CLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMEN 678 (933)
Q Consensus 604 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 678 (933)
+.||+|+||.||+|.... +..||+|.+...... ..+.+.+|++.+++++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 369999999999999764 778999999765433 367889999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCC------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccccc
Q 002349 679 GSLWDILHGPTK------KKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV 752 (933)
Q Consensus 679 gsL~~~l~~~~~------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 752 (933)
++|.+++..... ...+++..+..++.|++.|++|||++ +++||||||+||+++.++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999964211 37799999999999999999999965 999999999999999999999999999987643
Q ss_pred CCC-ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCccccc
Q 002349 753 SKS-YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISA 830 (933)
Q Consensus 753 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (933)
... .......++..|+|||.+.+..++.++||||+|+++|+|++ |..||............. ... ....+
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~--~~~-----~~~~~- 229 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR--KGY-----RLPKP- 229 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH--cCC-----CCCCC-
Confidence 321 12233467889999999988889999999999999999999 599998653322221111 110 11111
Q ss_pred cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 002349 831 TCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLG 867 (933)
Q Consensus 831 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 867 (933)
...+.++.+++.+|++.+|++|||+.|+++.|+
T Consensus 230 ----~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 230 ----EYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ----ccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 112467889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=332.34 Aligned_cols=258 Identities=22% Similarity=0.247 Sum_probs=198.9
Q ss_pred hhccCcceeeecccceeEEEEEEcC---CceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKN---CKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
..+|...+.||+|+||.||+|...+ ++.||+|.+... +...+|++++++++|||||++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 4579999999999999999998543 567999987643 33568999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
|++. ++|.+++ .....+++.++..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 166 e~~~-~~l~~~l---~~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYV---DRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9995 6888888 3456799999999999999999999965 9999999999999999999999999999765433
Q ss_pred CCc-eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcch---hHHHHhhhcccc----cc----
Q 002349 754 KSY-TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNL---HHLILSKTANNA----VM---- 821 (933)
Q Consensus 754 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~---~~~~~~~~~~~~----~~---- 821 (933)
... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.... ..+......... ..
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 221 223457999999999999999999999999999999999999999653321 111110000000 00
Q ss_pred -----------cccCccc--cccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 822 -----------ETVDPEI--SATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 822 -----------~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
....+.. +...........+.+++.+|+..||++|||+.|++.+-
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p 376 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLP 376 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 0000000 00000111235677899999999999999999999863
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=312.95 Aligned_cols=240 Identities=21% Similarity=0.345 Sum_probs=190.1
Q ss_pred eeeecccceeEEEEEEcC--------CceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEe
Q 002349 604 YIIGYGASSTVYKCVLKN--------CKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 604 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
+.||+|+||.||+|..+. ..+||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999998643 234888887655445567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCC--------eEEeecccc
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFE--------AHLTDFGIA 747 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~--------~kl~DfGla 747 (933)
+++|+|.++++. ....+++..+..++.|++.|++|||+. +|+||||||+||+++.++. ++++|||.+
T Consensus 81 ~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKK--NKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccccc
Confidence 999999999963 334689999999999999999999965 9999999999999987765 699999998
Q ss_pred cccccCCCceeeeecccccccCccccccC-CCCcchhhHHHHHHHHHHHhCC-CCCCCCcchhHHHHhhhcccccccccC
Q 002349 748 KSLCVSKSYTSTYIMGTIGYIDPEYARTS-RLTEKSDVYSFGIVLLELLTGR-KAVDNECNLHHLILSKTANNAVMETVD 825 (933)
Q Consensus 748 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (933)
..... .....++..|+|||++.+. .++.++||||||+++|||++|. .||........... ....
T Consensus 156 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~-~~~~-------- 221 (258)
T cd05078 156 ITVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF-YEDR-------- 221 (258)
T ss_pred cccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH-HHcc--------
Confidence 65432 1234678899999999874 5789999999999999999995 55543322221111 1100
Q ss_pred ccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 002349 826 PEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLG 867 (933)
Q Consensus 826 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 867 (933)
..++. ....++.+++.+|++.||++|||++++++.|+
T Consensus 222 ~~~~~-----~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 HQLPA-----PKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ccCCC-----CCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 01111 11256889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=318.34 Aligned_cols=261 Identities=21% Similarity=0.276 Sum_probs=200.5
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEe
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
++|...+.||+|+||.||+|..+ +++.||+|.+.... ......+.+|++++++++||||+++++++..+...++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 57888999999999999999976 47889999986443 33345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS 755 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 755 (933)
++ ++|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDD--CGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 97 589888853 345689999999999999999999965 999999999999999999999999999976432221
Q ss_pred ceeeeecccccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccC---------
Q 002349 756 YTSTYIMGTIGYIDPEYARTS-RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVD--------- 825 (933)
Q Consensus 756 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------- 825 (933)
......+++.|+|||.+.+. .++.++||||+||++|||++|+.||....................+...
T Consensus 160 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 160 -TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred -cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence 12234578899999988654 5788999999999999999999999865543333221111100000000
Q ss_pred -----ccccccc---cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 826 -----PEISATC---KDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 826 -----~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
+.....+ .....+..+.+++.+|++.||.+|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000000 001123567899999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=317.11 Aligned_cols=259 Identities=26% Similarity=0.348 Sum_probs=204.7
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEe
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
++|+..+.||+|+||+||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 56777889999999999999966 47889999876543 34467889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS 755 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 755 (933)
+++++|.+++. ..+.+++..+..++.+++.|+.|||+. .+++||||||+||+++.++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-- 157 (284)
T cd06620 85 MDCGSLDRIYK---KGGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-- 157 (284)
T ss_pred CCCCCHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhh--
Confidence 99999999984 345789999999999999999999952 38999999999999999999999999998654221
Q ss_pred ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHH-----HHhhhcccccccccCccccc
Q 002349 756 YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHL-----ILSKTANNAVMETVDPEISA 830 (933)
Q Consensus 756 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 830 (933)
......|+..|+|||++.+..++.++|||||||++|++++|+.||......... ........ ......+.+.
T Consensus 158 -~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~- 234 (284)
T cd06620 158 -IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQ-IVQEPPPRLP- 234 (284)
T ss_pred -ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHH-HhhccCCCCC-
Confidence 122357899999999998888999999999999999999999999754321100 00000000 0000011111
Q ss_pred cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccC
Q 002349 831 TCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869 (933)
Q Consensus 831 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 869 (933)
....+..+.+++.+|++.||++|||++|++++..-+
T Consensus 235 ---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~ 270 (284)
T cd06620 235 ---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI 270 (284)
T ss_pred ---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence 112346788999999999999999999999875443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=318.88 Aligned_cols=260 Identities=23% Similarity=0.380 Sum_probs=204.6
Q ss_pred hhccCcceeeecccceeEEEEEEc--------CCceEEEEEecccC-chhHHHHHHHHHHHhcC-CCCceeeeeeEEecC
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK--------NCKPVAIKRLYSHY-PQCLKEFETELETVGSI-KHRNLVSLQGYSLSS 666 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 666 (933)
.++|...+.||+|+||.||+|... ....||+|+++... .....++.+|+++++++ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 367888999999999999999853 23568999887543 33456788999999999 699999999999998
Q ss_pred CccEEEEEecCCCCHHHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEe
Q 002349 667 SGNLLFYDFMENGSLWDILHGPT-------------KKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILL 733 (933)
Q Consensus 667 ~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll 733 (933)
...++||||+++|+|.+++.... ....+++.++..++.|++.||+|||++ +++||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEE
Confidence 89999999999999999985321 124589999999999999999999965 99999999999999
Q ss_pred CCCCCeEEeecccccccccCCCce-eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHH
Q 002349 734 DKDFEAHLTDFGIAKSLCVSKSYT-STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLI 811 (933)
Q Consensus 734 ~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~ 811 (933)
+.++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||..........
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~ 247 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK 247 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999999998653222111 112234567999999998889999999999999999999 888987543322222
Q ss_pred HhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCC
Q 002349 812 LSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVP 871 (933)
Q Consensus 812 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 871 (933)
... .... .... ...+..+.+++.+|++.+|++|||+.++++.|..+..
T Consensus 248 ~~~--~~~~-----~~~~-----~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 248 LLR--EGHR-----MDKP-----SNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred HHH--cCCC-----CCCC-----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 111 1110 0111 1123578899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=311.25 Aligned_cols=248 Identities=25% Similarity=0.390 Sum_probs=194.9
Q ss_pred eeecccceeEEEEEEcC-Cc--eEEEEEecccC-chhHHHHHHHHHHHhcC-CCCceeeeeeEEecCCccEEEEEecCCC
Q 002349 605 IIGYGASSTVYKCVLKN-CK--PVAIKRLYSHY-PQCLKEFETELETVGSI-KHRNLVSLQGYSLSSSGNLLFYDFMENG 679 (933)
Q Consensus 605 ~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g 679 (933)
+||+|+||.||+|..++ +. .+|+|.++... ....+.+.+|+++++++ +||||+++++++......++||||+++|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 68999999999999764 33 46888887533 34456788999999999 7999999999999999999999999999
Q ss_pred CHHHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccc
Q 002349 680 SLWDILHGPT-------------KKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGI 746 (933)
Q Consensus 680 sL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl 746 (933)
+|.++++... ....+++..+..++.|++.|++|||+. +++||||||+||++++++.+|++|||+
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCCC
Confidence 9999986321 123578999999999999999999965 999999999999999999999999999
Q ss_pred ccccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccC
Q 002349 747 AKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVD 825 (933)
Q Consensus 747 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (933)
+..... .........+..|+|||++.+..++.++|||||||++|||++ |..||.+.......... .... .
T Consensus 159 ~~~~~~--~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~--~~~~-----~ 229 (270)
T cd05047 159 SRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL--PQGY-----R 229 (270)
T ss_pred ccccch--hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHH--hCCC-----C
Confidence 864211 111111234567999999988889999999999999999997 99999754332221111 1110 0
Q ss_pred ccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccC
Q 002349 826 PEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869 (933)
Q Consensus 826 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 869 (933)
.... ...+..+.+++.+|++.+|.+|||+.++++.|..+
T Consensus 230 ~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 230 LEKP-----LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred CCCC-----CcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 1111 11235788999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=323.04 Aligned_cols=251 Identities=23% Similarity=0.320 Sum_probs=206.3
Q ss_pred ccCcceeeecccceeEEEEEEcCCceE-EEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecC
Q 002349 599 NLSEKYIIGYGASSTVYKCVLKNCKPV-AIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFME 677 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~~~~~v-avK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 677 (933)
-|.+...||.|+||+||+|..+....+ |.|+|.....+..++|.-|+++|..++||+||++++.|...+..++..|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 455566799999999999998865444 5688877777788899999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCce
Q 002349 678 NGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYT 757 (933)
Q Consensus 678 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 757 (933)
||-++.++- .-.+.+.+.++..+++|++.||.|||++ +|+|||+|+.|||++-+|.++++|||.+.... .....
T Consensus 113 GGAVDaiml--EL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~-~t~qk 186 (1187)
T KOG0579|consen 113 GGAVDAIML--ELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNK-STRQK 186 (1187)
T ss_pred CchHhHHHH--HhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccch-hHHhh
Confidence 999988774 3567899999999999999999999955 99999999999999999999999999886432 12233
Q ss_pred eeeecccccccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccc
Q 002349 758 STYIMGTIGYIDPEYAR-----TSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATC 832 (933)
Q Consensus 758 ~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (933)
...+.|||+|||||+.. ..+|+.++||||||+++.||..+.+|-..-..+..+..+.... . |.+ .
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSe--P-----PTL---l 256 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE--P-----PTL---L 256 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcC--C-----Ccc---c
Confidence 45678999999999774 4589999999999999999999999987665554443332221 1 111 1
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 833 KDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 833 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.+......+.+++.+|+..||..||++++++++
T Consensus 257 qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 257 QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 222345778899999999999999999999764
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=309.66 Aligned_cols=250 Identities=24% Similarity=0.404 Sum_probs=192.7
Q ss_pred eeeecccceeEEEEEEcC----CceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEe-cCCccEEEEEecC
Q 002349 604 YIIGYGASSTVYKCVLKN----CKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSL-SSSGNLLFYDFME 677 (933)
Q Consensus 604 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~ 677 (933)
+.||+|+||.||+|.+.+ ...||+|++.... ....+.+.+|+.+++.++||||+++++++. .+...++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 368999999999998642 3569999885432 344567889999999999999999999775 4556789999999
Q ss_pred CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCce
Q 002349 678 NGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYT 757 (933)
Q Consensus 678 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 757 (933)
+|+|.++++. .....++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||+++.........
T Consensus 81 ~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRS--ETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 9999999963 234567888899999999999999965 99999999999999999999999999997653221111
Q ss_pred ---eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCC-CCCCCCcchhHHHHhhhcccccccccCcccccccc
Q 002349 758 ---STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGR-KAVDNECNLHHLILSKTANNAVMETVDPEISATCK 833 (933)
Q Consensus 758 ---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (933)
.....++..|+|||.+.+..++.++|||||||++|||++|+ .||...... .......... .+....
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~-~~~~~~~~~~------~~~~~~--- 225 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF-DITVYLLQGR------RLLQPE--- 225 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHHhcCC------CCCCCC---
Confidence 11234677899999998888999999999999999999964 556543322 2221111110 011111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCC
Q 002349 834 DLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLV 870 (933)
Q Consensus 834 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 870 (933)
..+..+.+++.+||+.+|++||++.++++.|+.+.
T Consensus 226 --~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 226 --YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred --cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 12357889999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=325.91 Aligned_cols=262 Identities=23% Similarity=0.283 Sum_probs=199.6
Q ss_pred HHHHHhhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecC--
Q 002349 592 DIMRMTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSS-- 666 (933)
Q Consensus 592 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-- 666 (933)
......++|+..+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++...
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07878 9 TVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATS 88 (343)
T ss_pred HHhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccc
Confidence 34456789999999999999999999965 57889999986543 22345677899999999999999999987543
Q ss_pred ----CccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEe
Q 002349 667 ----SGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLT 742 (933)
Q Consensus 667 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~ 742 (933)
...++++|++ +++|.+++. ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 89 ~~~~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~ 160 (343)
T cd07878 89 IENFNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRIL 160 (343)
T ss_pred ccccCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEc
Confidence 3468999988 779988874 35699999999999999999999965 99999999999999999999999
Q ss_pred ecccccccccCCCceeeeecccccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccc
Q 002349 743 DFGIAKSLCVSKSYTSTYIMGTIGYIDPEYART-SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVM 821 (933)
Q Consensus 743 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 821 (933)
|||+++..... .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+..............+...
T Consensus 161 Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 236 (343)
T cd07878 161 DFGLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPS 236 (343)
T ss_pred CCccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99999865322 223468999999999877 5689999999999999999999999976544333222111110000
Q ss_pred cc----cCc--------ccccccc-CH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 822 ET----VDP--------EISATCK-DL-----GAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 822 ~~----~~~--------~~~~~~~-~~-----~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.. +.. .+..... +. .....+.+++.+|++.||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 237 PEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 000 0000000 00 012356789999999999999999999975
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=323.56 Aligned_cols=243 Identities=25% Similarity=0.412 Sum_probs=198.5
Q ss_pred ceeeecccceeEEEEEEcC-CceEEEE--Eecc--cCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCc--cEEEEEe
Q 002349 603 KYIIGYGASSTVYKCVLKN-CKPVAIK--RLYS--HYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSG--NLLFYDF 675 (933)
Q Consensus 603 ~~~lG~G~~g~Vy~~~~~~-~~~vavK--~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--~~lv~e~ 675 (933)
..+||+|+|-+||+|.+.. |.+||=- ++.. ..+...++|..|+++|+.|+|||||+++++|.+... ..+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 3469999999999999754 6666521 1211 235566899999999999999999999999988765 6688999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCC-CCeEEeecccccccccCC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKD-FEAHLTDFGIAKSLCVSK 754 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~-~~~kl~DfGla~~~~~~~ 754 (933)
+..|+|..++ .+.+.++...+..|++||++||.|||.+ .++|+|||||.+||||+.. |.|||+|.|+|+.....
T Consensus 125 ~TSGtLr~Y~---kk~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s- 199 (632)
T KOG0584|consen 125 FTSGTLREYR---KKHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS- 199 (632)
T ss_pred ccCCcHHHHH---HHhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc-
Confidence 9999999999 4567899999999999999999999998 8999999999999999865 89999999999986432
Q ss_pred CceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccC
Q 002349 755 SYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKD 834 (933)
Q Consensus 755 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (933)
....++|||.|||||.+. ..|++.+||||||++++||+|+.+||......+++.. +...+..+..+. ..++
T Consensus 200 --~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYK-KV~SGiKP~sl~-----kV~d 270 (632)
T KOG0584|consen 200 --HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYK-KVTSGIKPAALS-----KVKD 270 (632)
T ss_pred --ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHH-HHHcCCCHHHhh-----ccCC
Confidence 233489999999999988 6799999999999999999999999987666665543 333333222221 1112
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002349 835 LGAVKKVFQLALLCSKRQPTDRPTMHEVSR 864 (933)
Q Consensus 835 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 864 (933)
.++.++|.+|+.. .++|||+.|++.
T Consensus 271 ----Pevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 271 ----PEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ----HHHHHHHHHHhcC-chhccCHHHHhh
Confidence 4678899999999 899999999986
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=314.80 Aligned_cols=254 Identities=23% Similarity=0.388 Sum_probs=201.8
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEe
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
++|+..+.||+|+||.||+|.+. .++.||+|.+.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36788889999999999999976 57899999886542 33456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS 755 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 755 (933)
+++++|.++++.......+++..+..++.|++.|+.|||+. .+|+||||||+||+++.++.+||+|||++..+...
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-- 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence 99999999986433345789999999999999999999952 38999999999999999999999999999765322
Q ss_pred ceeeeecccccccCccccccC------CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccc
Q 002349 756 YTSTYIMGTIGYIDPEYARTS------RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEIS 829 (933)
Q Consensus 756 ~~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (933)
......|+..|+|||.+.+. .++.++||||+||++|+|++|+.||................ ....+.+.
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~----~~~~~~~~ 231 (286)
T cd06622 157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIV----DGDPPTLP 231 (286)
T ss_pred -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHh----hcCCCCCC
Confidence 12234588899999988654 35789999999999999999999997543322111111000 01111111
Q ss_pred ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 830 ATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 830 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
. .....+.+++.+|++.+|++||++++++++
T Consensus 232 ~-----~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 232 S-----GYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred c-----ccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 1 134678899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=307.17 Aligned_cols=251 Identities=23% Similarity=0.320 Sum_probs=205.2
Q ss_pred ccCcceeeecccceeEEEEEEc-CCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEe
Q 002349 599 NLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSH--YPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
+|+..+.||+|+||.||.++.. +++.+++|++... .....+++.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4788899999999999999854 4788999988654 244556789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS 755 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 755 (933)
+++++|.+++... ....+++..+..++.|++.|++|||+. +++|+||+|+||++++++.+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQ-KGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 9999999999632 245689999999999999999999965 999999999999999999999999999986643322
Q ss_pred ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCH
Q 002349 756 YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDL 835 (933)
Q Consensus 756 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (933)
......|++.|+|||...+..++.++||||+|+++|||++|+.||.............. .... + .. .
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--~~~~----~-~~-----~ 223 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ--GNYT----P-VV-----S 223 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc--CCCC----C-Cc-----c
Confidence 23345689999999999888889999999999999999999999976543332222111 1111 1 00 1
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 836 GAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 836 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
..+..+.+++.+|+..+|++||++.++++++
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 224 VYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 2245788999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=313.89 Aligned_cols=259 Identities=22% Similarity=0.281 Sum_probs=204.4
Q ss_pred ccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEe
Q 002349 599 NLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
+|+..+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778899999999999999975 57899999987644 33456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS 755 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 755 (933)
+ +++|.+++.. ....+++.++..++.|++.||+|||+. +++|+||||+||+++.++.++++|||++........
T Consensus 81 ~-~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRD--EERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 9999999863 336799999999999999999999965 999999999999999999999999999987644332
Q ss_pred ceeeeecccccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcc-------
Q 002349 756 YTSTYIMGTIGYIDPEYARTS-RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPE------- 827 (933)
Q Consensus 756 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 827 (933)
.......|+..|+|||.+.+. .++.++||||+|+++|||++|+.||.+......+...............+.
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY 234 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence 223345689999999988654 468999999999999999999888876655443322211111000000000
Q ss_pred ------------ccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 828 ------------ISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 828 ------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
+.... ......+.+++.+|++.+|.+||++++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 235 NKITFPESKPIPLEEIF--PDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hcccCCCCCcchHHHhC--CCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000 0124788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=315.95 Aligned_cols=247 Identities=24% Similarity=0.372 Sum_probs=200.7
Q ss_pred CcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecCCC
Q 002349 601 SEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENG 679 (933)
Q Consensus 601 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 679 (933)
.....||+|+||.||+|... +++.||+|++........+.+.+|+.+++.++|+||+++++++..++..++||||++++
T Consensus 25 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~ 104 (292)
T cd06658 25 DSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGG 104 (292)
T ss_pred hhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCC
Confidence 33456999999999999965 57889999987655555677899999999999999999999999999999999999999
Q ss_pred CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCceee
Q 002349 680 SLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTST 759 (933)
Q Consensus 680 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 759 (933)
+|.+++. ...+++.++..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||++........ ...
T Consensus 105 ~L~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~ 176 (292)
T cd06658 105 ALTDIVT----HTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRK 176 (292)
T ss_pred cHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCc
Confidence 9999884 34589999999999999999999965 999999999999999999999999999876532221 223
Q ss_pred eecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHHHH
Q 002349 760 YIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVK 839 (933)
Q Consensus 760 ~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 839 (933)
...|+..|+|||...+..++.++||||||+++|||++|+.||.............. ...+.+... .....
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~-------~~~~~~~~~---~~~~~ 246 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRD-------NLPPRVKDS---HKVSS 246 (292)
T ss_pred eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------cCCCccccc---cccCH
Confidence 35689999999999888899999999999999999999999986554333221111 111111110 11234
Q ss_pred HHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 840 KVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 840 ~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.+.+++.+|+..||++|||+++++++
T Consensus 247 ~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 247 VLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHHHHHHccCChhHCcCHHHHhhC
Confidence 67789999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=329.71 Aligned_cols=256 Identities=18% Similarity=0.196 Sum_probs=194.0
Q ss_pred hccCcceeeecccceeEEEEEEcC-CceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEec
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFM 676 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 676 (933)
.+|.+.+.||+|+||.||+|.+.. ++.||||... ...+.+|++++++++|+|||++++++..++..++|||++
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 468889999999999999999765 6789999642 234578999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCc
Q 002349 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY 756 (933)
Q Consensus 677 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 756 (933)
. ++|.+++.. ....+++.++..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 243 ~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 243 R-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred C-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 5 688888852 345799999999999999999999965 9999999999999999999999999999865332211
Q ss_pred -eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcc-------hhHHHHhhhcccccccccCc--
Q 002349 757 -TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECN-------LHHLILSKTANNAVMETVDP-- 826 (933)
Q Consensus 757 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~-- 826 (933)
......||+.|+|||++.+..++.++|||||||++|||++|..|+..... ..+..............+.+
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 12345799999999999999999999999999999999998865532110 01111111100000000000
Q ss_pred ------------------cccc--cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 827 ------------------EISA--TCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 827 ------------------~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.... ..........+.+++.+||+.||.+|||+.|++++
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0000 00000112367789999999999999999999986
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=313.67 Aligned_cols=261 Identities=25% Similarity=0.316 Sum_probs=202.2
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYD 674 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 674 (933)
++|+....||+|+||.||+|..+ +++.||+|++.... ....+.+.+|++++++++||||+++++++..+...++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999976 47899999886432 2234568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCC
Q 002349 675 FMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSK 754 (933)
Q Consensus 675 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 754 (933)
|++++++..+.. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 999998888773 345689999999999999999999965 99999999999999999999999999998764322
Q ss_pred CceeeeecccccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccccc-------------
Q 002349 755 SYTSTYIMGTIGYIDPEYART-SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAV------------- 820 (933)
Q Consensus 755 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~------------- 820 (933)
. ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.................
T Consensus 155 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07847 155 D-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF 233 (286)
T ss_pred c-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccc
Confidence 1 1223457889999999876 457899999999999999999999998655443332211110000
Q ss_pred ccc-cCcccccccc----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 821 MET-VDPEISATCK----DLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 821 ~~~-~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
... ..+......+ ....+..+.+++.+|++.+|++||++.|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 000 0000000000 00124678899999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=312.79 Aligned_cols=254 Identities=25% Similarity=0.352 Sum_probs=200.3
Q ss_pred HHhhccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcC-CCCceeeeeeEEecC------
Q 002349 595 RMTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSI-KHRNLVSLQGYSLSS------ 666 (933)
Q Consensus 595 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~------ 666 (933)
.+.+.|+..+.||+|+||.||+|... .++.||+|++.... .....+.+|+.+++++ +||||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 35667888899999999999999976 47889999886543 3356788999999998 799999999998653
Q ss_pred CccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccc
Q 002349 667 SGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGI 746 (933)
Q Consensus 667 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl 746 (933)
...++||||+++++|.+++.. .....+++..+..++.|++.|++|||++ +|+||||||+||++++++.+||+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~-~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKN-TKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCC
Confidence 357899999999999999864 2345689999999999999999999965 999999999999999999999999999
Q ss_pred ccccccCCCceeeeecccccccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccc
Q 002349 747 AKSLCVSKSYTSTYIMGTIGYIDPEYAR-----TSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVM 821 (933)
Q Consensus 747 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 821 (933)
++...... .......|+..|+|||++. +..++.++||||+||++|||++|+.||.............. ..
T Consensus 158 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~--~~-- 232 (272)
T cd06637 158 SAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR--NP-- 232 (272)
T ss_pred ceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc--CC--
Confidence 97653221 1223456899999999886 33578899999999999999999999975443332221111 00
Q ss_pred cccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 822 ETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.+... ....+..+.+++.+|+..+|.+|||+++++++
T Consensus 233 ---~~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 233 ---APRLK----SKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred ---CCCCC----CCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 00000 11224578899999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=307.57 Aligned_cols=238 Identities=25% Similarity=0.381 Sum_probs=189.6
Q ss_pred eeeecccceeEEEEEEcCCc-----------eEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEE
Q 002349 604 YIIGYGASSTVYKCVLKNCK-----------PVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLF 672 (933)
Q Consensus 604 ~~lG~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 672 (933)
+.||+|+||.||+|.+.+.. .|++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 36999999999999986533 4777876554333 6788999999999999999999999988 778999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCC-------CeEEeecc
Q 002349 673 YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDF-------EAHLTDFG 745 (933)
Q Consensus 673 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~-------~~kl~DfG 745 (933)
|||+++|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++ .+|++|||
T Consensus 79 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHR--EKNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 999999999999963 233789999999999999999999965 999999999999999887 79999999
Q ss_pred cccccccCCCceeeeecccccccCccccccC--CCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhccccccc
Q 002349 746 IAKSLCVSKSYTSTYIMGTIGYIDPEYARTS--RLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVME 822 (933)
Q Consensus 746 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 822 (933)
++..... .....++..|+|||++.+. .++.++||||||+++|+|++ |..||............. .. .
T Consensus 154 ~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~--~~---~ 223 (259)
T cd05037 154 IPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ--DQ---H 223 (259)
T ss_pred ccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh--cC---C
Confidence 9986532 2233567889999999876 78999999999999999999 577776543221111111 00 0
Q ss_pred ccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 002349 823 TVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLG 867 (933)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 867 (933)
. .+. .....+.+++.+|+..+|++|||+.++++.|+
T Consensus 224 ~----~~~-----~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 224 R----LPM-----PDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred C----CCC-----CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 000 01157889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=315.62 Aligned_cols=262 Identities=24% Similarity=0.350 Sum_probs=204.3
Q ss_pred HHHHHHHhhccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcC-CCCceeeeeeEEe---
Q 002349 590 YEDIMRMTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSI-KHRNLVSLQGYSL--- 664 (933)
Q Consensus 590 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~--- 664 (933)
++.+..+.++|+..+.||+|+||.||+|... .++.+|+|++.... .....+.+|+.+++++ +||||+++++++.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 3455667889999999999999999999975 47889999876432 2245688899999999 6999999999874
Q ss_pred --cCCccEEEEEecCCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEE
Q 002349 665 --SSSGNLLFYDFMENGSLWDILHGP-TKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHL 741 (933)
Q Consensus 665 --~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl 741 (933)
.+...++||||+++++|.++++.. .....+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+|+
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEE
Confidence 345679999999999999987532 2345689999999999999999999965 9999999999999999999999
Q ss_pred eecccccccccCCCceeeeecccccccCcccccc-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhc
Q 002349 742 TDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYART-----SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTA 816 (933)
Q Consensus 742 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~ 816 (933)
+|||+++...... .......|++.|+|||++.. ..++.++||||+||++|||++|+.||.............
T Consensus 166 ~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~-- 242 (286)
T cd06638 166 VDFGVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIP-- 242 (286)
T ss_pred ccCCceeecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcc--
Confidence 9999998653322 22233468999999998753 447889999999999999999999997654433322111
Q ss_pred ccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 817 NNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
... .+.... .......+.+++.+|++.||++|||+.|++++.
T Consensus 243 ~~~-----~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 243 RNP-----PPTLHQ---PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred ccC-----CCcccC---CCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 100 001000 001235688999999999999999999998864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=325.51 Aligned_cols=241 Identities=23% Similarity=0.233 Sum_probs=188.6
Q ss_pred eecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcC---CCCceeeeeeEEecCCccEEEEEecCC
Q 002349 606 IGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSI---KHRNLVSLQGYSLSSSGNLLFYDFMEN 678 (933)
Q Consensus 606 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~ 678 (933)
||+|+||+||+|+.+ +++.||||++.... ......+..|..++.+. +||||+++++++......++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999976 47899999986432 12233445666777665 699999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCcee
Q 002349 679 GSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTS 758 (933)
Q Consensus 679 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 758 (933)
|+|.+++. ..+.+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~ 153 (330)
T cd05586 81 GELFWHLQ---KEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTT 153 (330)
T ss_pred ChHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCc
Confidence 99999984 456789999999999999999999965 99999999999999999999999999987542221 223
Q ss_pred eeecccccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHH
Q 002349 759 TYIMGTIGYIDPEYARTS-RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGA 837 (933)
Q Consensus 759 ~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 837 (933)
....||+.|+|||++.+. .++.++||||+||++|+|++|+.||.................. ++. ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~--------~~~----~~~ 221 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVR--------FPK----NVL 221 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCC--------CCC----ccC
Confidence 345799999999998764 5899999999999999999999999865443322222111111 110 012
Q ss_pred HHHHHHHHHHccCCCCCCCC----CHHHHHHH
Q 002349 838 VKKVFQLALLCSKRQPTDRP----TMHEVSRV 865 (933)
Q Consensus 838 ~~~l~~li~~cl~~dP~~RP----t~~evl~~ 865 (933)
...+.+++.+|++.||++|| ++.+++++
T Consensus 222 ~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 222 SDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred CHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 35677899999999999998 56666653
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=310.72 Aligned_cols=249 Identities=27% Similarity=0.414 Sum_probs=204.1
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEe
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
++|+..+.||.|++|.||+|... +++.||+|.+.... ......+.+|+++++.++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36788889999999999999976 57889999986543 34456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS 755 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 755 (933)
+++++|.++++. .++++..+..++.|++.|+.|||++ +++||||+|+||++++++.++++|||+++......
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 152 (274)
T cd06609 81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM- 152 (274)
T ss_pred eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence 999999999852 3789999999999999999999965 99999999999999999999999999998764332
Q ss_pred ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCH
Q 002349 756 YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDL 835 (933)
Q Consensus 756 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (933)
.......|++.|+|||++.+..++.++||||||+++|+|++|+.||............. .. ..+.+...
T Consensus 153 ~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~--~~-----~~~~~~~~---- 221 (274)
T cd06609 153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIP--KN-----NPPSLEGN---- 221 (274)
T ss_pred cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhh--hc-----CCCCCccc----
Confidence 22233468889999999998889999999999999999999999997544322211111 11 11111111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 836 GAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 836 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
..+..+.+++.+|+..+|++|||+++++++
T Consensus 222 ~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 222 KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 124568889999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=308.02 Aligned_cols=258 Identities=27% Similarity=0.425 Sum_probs=207.1
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEe
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
++|+..+.||.|+||+||+|... ++..+|+|++.... ....+.+.+|+++++.++|+||+++++.+..++..++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888999999999999999965 57889999986543 33567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS 755 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 755 (933)
+++++|.++++.......+++..+..++.|++.|++|||+. +++||||||+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 99999999996422335789999999999999999999965 999999999999999999999999999976643322
Q ss_pred c---eeeeecccccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccc
Q 002349 756 Y---TSTYIMGTIGYIDPEYARTS-RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISAT 831 (933)
Q Consensus 756 ~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (933)
. ......|+..|+|||.+... .++.++|||||||++|+|++|+.||................ ++.....
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~-------~~~~~~~ 230 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND-------PPSLETG 230 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCC-------CCCcCCc
Confidence 2 22334689999999998776 78999999999999999999999998654433222211111 1111111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 832 CKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 832 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
......+..+.+++.+|++.||++||++.+++++
T Consensus 231 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 231 ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred cccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 1111234678899999999999999999999874
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=309.43 Aligned_cols=252 Identities=23% Similarity=0.336 Sum_probs=189.6
Q ss_pred eeecccceeEEEEEEcC---CceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecCCCC
Q 002349 605 IIGYGASSTVYKCVLKN---CKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGS 680 (933)
Q Consensus 605 ~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 680 (933)
.||+|+||+||+|...+ ...+|+|.+.... ......+.+|+++++.++||||+++++++......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 3468888776543 2334568899999999999999999999999999999999999999
Q ss_pred HHHHhcCCCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCce-
Q 002349 681 LWDILHGPTK--KKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYT- 757 (933)
Q Consensus 681 L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~- 757 (933)
|.+++..... ....++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999964221 23456788899999999999999965 99999999999999999999999999987543221111
Q ss_pred eeeecccccccCcccccc-------CCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCcccc
Q 002349 758 STYIMGTIGYIDPEYART-------SRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEIS 829 (933)
Q Consensus 758 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (933)
.....+++.|+|||+... ..++.++||||+||++|||++ |..||.............. .. ..+...+...
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~-~~-~~~~~~~~~~ 236 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVR-EQ-DIKLPKPQLD 236 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhh-cc-CccCCCCccc
Confidence 122345678999998743 356889999999999999999 7788875544332222111 11 1111111111
Q ss_pred ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 002349 830 ATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLG 867 (933)
Q Consensus 830 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 867 (933)
. ..+..+.+++..|+ .||++|||+++|++.|.
T Consensus 237 ~-----~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 237 L-----KYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred c-----cCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1 22356677888898 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=305.74 Aligned_cols=250 Identities=24% Similarity=0.322 Sum_probs=200.7
Q ss_pred ccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecC-CccEEEEE
Q 002349 599 NLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSS-SGNLLFYD 674 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e 674 (933)
+|+..+.||+|++|.||+|..+ +++.||+|++.... ....+.+.+|++++++++|+|++++++.+... ...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788899999999999999966 46889999986532 33456788999999999999999999987644 45789999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCC
Q 002349 675 FMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSK 754 (933)
Q Consensus 675 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 754 (933)
|+++++|.+++.. .....+++.++..++.+++.|++|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~-~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKE-QKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 9999999999864 2345689999999999999999999965 99999999999999999999999999998663322
Q ss_pred CceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccC
Q 002349 755 SYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKD 834 (933)
Q Consensus 755 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (933)
.......|++.|+|||+..+..++.++||||+|+++++|++|+.||....... ...... .... +..+
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~-~~~~~~-~~~~-----~~~~----- 223 (257)
T cd08223 157 -DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS-LVYRII-EGKL-----PPMP----- 223 (257)
T ss_pred -CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHH-hcCC-----CCCc-----
Confidence 22234568899999999999999999999999999999999999997543222 211111 1111 1111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 835 LGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 835 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
......+.+++.+|++.+|++||++.+++++
T Consensus 224 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 224 KDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred cccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1234578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=312.90 Aligned_cols=247 Identities=25% Similarity=0.377 Sum_probs=200.7
Q ss_pred ccCcceeeecccceeEEEEEEc-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEec
Q 002349 599 NLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFM 676 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 676 (933)
.|+..+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|++++++++||||+++++++..+...++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4556678999999999999865 46789999886443 344567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCc
Q 002349 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY 756 (933)
Q Consensus 677 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 756 (933)
++++|.+++. ...+++..+..++.|++.|+.|||++ +++|+||+|+||++++++.++++|||++....... .
T Consensus 85 ~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~ 156 (277)
T cd06642 85 GGGSALDLLK----PGPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-I 156 (277)
T ss_pred CCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcc-h
Confidence 9999999984 35689999999999999999999965 99999999999999999999999999997654322 1
Q ss_pred eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHH
Q 002349 757 TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLG 836 (933)
Q Consensus 757 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (933)
......|+..|+|||++.+..++.++|||||||++|||++|+.||........... . .....+.+. ..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~--~-----~~~~~~~~~-----~~ 224 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFL--I-----PKNSPPTLE-----GQ 224 (277)
T ss_pred hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhh--h-----hcCCCCCCC-----cc
Confidence 22234688899999999998899999999999999999999999875432221111 0 111111111 12
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 837 AVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 837 ~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.+..+.+++.+|++.+|++||++.+++++
T Consensus 225 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 225 YSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 34578899999999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=312.90 Aligned_cols=260 Identities=24% Similarity=0.244 Sum_probs=200.8
Q ss_pred ccCcceeeecccceeEEEEEEc-CCceEEEEEecccCch-----hHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEE
Q 002349 599 NLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQ-----CLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLF 672 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 672 (933)
+|+..+.||+|+||.||+|... +++.||+|++...... ....+..|++++++++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4777889999999999999975 5789999999754322 345577899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccccc
Q 002349 673 YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV 752 (933)
Q Consensus 673 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 752 (933)
|||+ +++|.+++.. ....+++..+..++.|+++||+|||++ +|+|+||||+||+++.++.+||+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKD--KSIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 8999999963 223799999999999999999999965 999999999999999999999999999987643
Q ss_pred CCCceeeeecccccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCc-----
Q 002349 753 SKSYTSTYIMGTIGYIDPEYART-SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDP----- 826 (933)
Q Consensus 753 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----- 826 (933)
... ......+++.|+|||.+.+ ..++.++|||||||++|||++|..||.+......................+
T Consensus 155 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (298)
T cd07841 155 PNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSL 233 (298)
T ss_pred CCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccc
Confidence 221 1222356788999998865 467899999999999999999988887665544332221110000000000
Q ss_pred ----------cccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 827 ----------EISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 827 ----------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
..............+.+++.+|++.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 234 PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000001224678899999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=305.67 Aligned_cols=250 Identities=30% Similarity=0.478 Sum_probs=200.9
Q ss_pred CcceeeecccceeEEEEEEcC-----CceEEEEEecccCch-hHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEE
Q 002349 601 SEKYIIGYGASSTVYKCVLKN-----CKPVAIKRLYSHYPQ-CLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYD 674 (933)
Q Consensus 601 ~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 674 (933)
+..+.||.|+||.||+|.+.. +..||+|++...... ..+.+.+|++++++++|+||+++++++...+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 456789999999999999764 378999999765433 56789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCC
Q 002349 675 FMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSK 754 (933)
Q Consensus 675 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 754 (933)
|+++++|.+++... ....+++..+..++.|++.|++|||+. +++||||||+||+++.++.++++|||+++......
T Consensus 82 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 82 YMEGGDLLDYLRKN-RPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred ccCCCCHHHHHHhh-hhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 99999999999631 112289999999999999999999965 99999999999999999999999999998765432
Q ss_pred CceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCcccccccc
Q 002349 755 SYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISATCK 833 (933)
Q Consensus 755 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (933)
........+++.|+|||.+.+..++.++||||+|+++++|++ |+.||............. ..... ....
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~--~~~~~-----~~~~--- 227 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLK--KGYRL-----PKPE--- 227 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh--cCCCC-----CCCC---
Confidence 322222347789999999988889999999999999999998 788887533322221111 11110 0111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 834 DLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 834 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
..+.++.+++.+|+..||++|||+.|+++.|
T Consensus 228 --~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 228 --NCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred --cCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 1346788999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=305.97 Aligned_cols=248 Identities=23% Similarity=0.361 Sum_probs=201.9
Q ss_pred ccCcceeeecccceeEEEEEEc-CCceEEEEEecccC-----chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEE
Q 002349 599 NLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY-----PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLF 672 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 672 (933)
+|+..+.||+|+||.||+|... +++.|++|.+.... .+..+.+.+|++++++++|+||+++++++..+...++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4777889999999999999976 68899999886533 23456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccccc
Q 002349 673 YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV 752 (933)
Q Consensus 673 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 752 (933)
|||+++++|.+++. ....+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLK---KYGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 99999999999995 345689999999999999999999965 999999999999999999999999999876533
Q ss_pred CCCceeeeecccccccCccccccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccc
Q 002349 753 SKSYTSTYIMGTIGYIDPEYARTSR-LTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISAT 831 (933)
Q Consensus 753 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (933)
.. ......|+..|+|||.+.... ++.++|+||||+++|+|++|+.||.............. .... +.++.
T Consensus 155 ~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~--~~~~----~~~~~- 225 (258)
T cd06632 155 FS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGR--SKEL----PPIPD- 225 (258)
T ss_pred cc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHh--cccC----CCcCC-
Confidence 22 223456889999999987766 89999999999999999999999976543322221111 0001 11111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 832 CKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 832 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.....+.+++.+|++.+|++||++.+++++
T Consensus 226 ----~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 226 ----HLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred ----CcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 123567889999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=308.31 Aligned_cols=256 Identities=28% Similarity=0.382 Sum_probs=203.6
Q ss_pred hccCcceeeecccceeEEEEEEcC-C----ceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKN-C----KPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLL 671 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~-~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 671 (933)
.+|+..+.||+|+||.||+|.++. + ..||+|.+.... .....++.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 567888999999999999999653 2 258999886654 3345678999999999999999999999987 78899
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccc
Q 002349 672 FYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLC 751 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 751 (933)
||||+++|+|.++++. ....+++..+..++.|++.|++|||++ +++||||||+||+++.++.+||+|||+++...
T Consensus 86 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRN--HKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 9999999999999963 345689999999999999999999965 99999999999999999999999999998764
Q ss_pred cCCCce-eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCcccc
Q 002349 752 VSKSYT-STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEIS 829 (933)
Q Consensus 752 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (933)
...... .....++..|+|||.+....++.++||||||+++||+++ |+.||.+.... ............ ..+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~~~~~~~~~~~~------~~~ 233 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV-EIPDLLEKGERL------PQP 233 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH-HHHHHHhCCCCC------CCC
Confidence 322211 111223568999999988889999999999999999998 99999765332 222111111100 000
Q ss_pred ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCC
Q 002349 830 ATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVP 871 (933)
Q Consensus 830 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 871 (933)
. .+...+.+++.+||..+|++||++.++++.|..+..
T Consensus 234 ~-----~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 234 P-----ICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred C-----CCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0 123467889999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=313.72 Aligned_cols=262 Identities=23% Similarity=0.315 Sum_probs=204.2
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYD 674 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 674 (933)
++|+..+.||+|+||.||+|.++ +++.||+|+++... ....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999976 47889999886532 3345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCC
Q 002349 675 FMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSK 754 (933)
Q Consensus 675 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 754 (933)
|++++.+..+.. ....+++.++..++.|++.|++|||++ +++||||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 999877766653 345689999999999999999999966 99999999999999999999999999998765433
Q ss_pred CceeeeecccccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccc----c--Cc-
Q 002349 755 SYTSTYIMGTIGYIDPEYARTS-RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMET----V--DP- 826 (933)
Q Consensus 755 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----~--~~- 826 (933)
........++..|+|||++.+. .++.++||||||+++|+|++|+.||.+..............+..... . .+
T Consensus 155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07833 155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR 234 (288)
T ss_pred cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence 3233345688999999999888 78999999999999999999999998654433322211110000000 0 00
Q ss_pred ----cccccc--------cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 827 ----EISATC--------KDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 827 ----~~~~~~--------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
...... .....+..+.+++.+|+..+|++||++++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 000000 000125778999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=318.63 Aligned_cols=259 Identities=24% Similarity=0.374 Sum_probs=204.7
Q ss_pred hccCcceeeecccceeEEEEEEcC--------CceEEEEEecccC-chhHHHHHHHHHHHhcC-CCCceeeeeeEEecCC
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKN--------CKPVAIKRLYSHY-PQCLKEFETELETVGSI-KHRNLVSLQGYSLSSS 667 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 667 (933)
.+|.+.+.||+|+||.||+|.+.. ...||+|.+.... ....+++.+|+++++++ +||||+++++++...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 468889999999999999998532 2368999887543 33456789999999999 7999999999999999
Q ss_pred ccEEEEEecCCCCHHHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeC
Q 002349 668 GNLLFYDFMENGSLWDILHGPT-------------KKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLD 734 (933)
Q Consensus 668 ~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~ 734 (933)
..+++|||+++|+|.+++.... ....+++.++..++.|++.||+|||++ +++||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEc
Confidence 9999999999999999985321 123588999999999999999999965 999999999999999
Q ss_pred CCCCeEEeecccccccccCCCce-eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHH
Q 002349 735 KDFEAHLTDFGIAKSLCVSKSYT-STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLIL 812 (933)
Q Consensus 735 ~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~ 812 (933)
.++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||.+.........
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 248 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 248 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 99999999999998654322211 122234568999999999999999999999999999998 8888875433222211
Q ss_pred hhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCC
Q 002349 813 SKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVP 871 (933)
Q Consensus 813 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 871 (933)
.. ... ....+. ..+..+.+++.+|++.+|++||++.|+++.|+.+..
T Consensus 249 ~~--~~~-----~~~~~~-----~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 249 LK--EGH-----RMDKPA-----NCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred HH--cCC-----CCCCCC-----CCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 11 110 011111 124578899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=313.20 Aligned_cols=257 Identities=28% Similarity=0.409 Sum_probs=200.8
Q ss_pred hccCcceeeecccceeEEEEEEc-CCc----eEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCK----PVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLL 671 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 671 (933)
++|+..+.||+|+||.||+|.+. +++ .||+|.+.... .....++.+|+.++++++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 46778889999999999999864 333 47888886543 23345688999999999999999999998754 4678
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccc
Q 002349 672 FYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLC 751 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 751 (933)
++||+++|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 86 VTQLMPHGCLLDYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eehhcCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccccccc
Confidence 9999999999999862 344689999999999999999999965 99999999999999999999999999998764
Q ss_pred cCCCc-eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCcccc
Q 002349 752 VSKSY-TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEIS 829 (933)
Q Consensus 752 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (933)
..... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||.+........... ..... + ..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~--~~~~~----~-~~ 233 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE--KGERL----P-QP 233 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH--CCCCC----C-CC
Confidence 32221 1222345678999999999999999999999999999997 899997543222111111 11100 0 00
Q ss_pred ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCCC
Q 002349 830 ATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPA 872 (933)
Q Consensus 830 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 872 (933)
. .++..+.+++.+|+..+|++||+++++++.++.+...
T Consensus 234 ~-----~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 234 P-----ICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred C-----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0 1235688899999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=315.94 Aligned_cols=253 Identities=23% Similarity=0.261 Sum_probs=204.3
Q ss_pred hccCcceeeecccceeEEEEEEcC-CceEEEEEecccCc---hhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHYP---QCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
++|+..+.||+|+||.||+|...+ ++.||+|.+..... ...+.+.+|++++++++||||+++++++......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 368888999999999999999765 88999999976432 24567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
||+++++|.+++.. .....+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQR-QPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHh-CCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 99999999999863 2345789999999999999999999965 9999999999999999999999999998754321
Q ss_pred CCc----------------------------eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCc
Q 002349 754 KSY----------------------------TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNEC 805 (933)
Q Consensus 754 ~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~ 805 (933)
... ......|+..|+|||+..+..++.++||||||+++|+|++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 110 1112368889999999999889999999999999999999999998665
Q ss_pred chhHHHHhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCC----HHHHHHH
Q 002349 806 NLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPT----MHEVSRV 865 (933)
Q Consensus 806 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt----~~evl~~ 865 (933)
....+......... ... ....+..+.+++.+|+..||++||+ ++|++++
T Consensus 237 ~~~~~~~~~~~~~~--------~~~---~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 237 RDETFSNILKKEVT--------FPG---SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred hHHHHHHHhcCCcc--------CCC---ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 44433222111110 110 1113467899999999999999999 7777763
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=317.39 Aligned_cols=257 Identities=22% Similarity=0.278 Sum_probs=193.4
Q ss_pred ceeeecc--cceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecC
Q 002349 603 KYIIGYG--ASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFME 677 (933)
Q Consensus 603 ~~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 677 (933)
.++||+| +|++||++..+ +++.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++||||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 4679999 78899999865 57899999997543 2334567889999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCC--
Q 002349 678 NGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS-- 755 (933)
Q Consensus 678 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~-- 755 (933)
+|+|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.++++|||.+........
T Consensus 83 ~~~l~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 83 YGSAKDLICTH-FMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCcHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 99999998531 234589999999999999999999965 999999999999999999999999986543311100
Q ss_pred ----ceeeeecccccccCcccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccC----
Q 002349 756 ----YTSTYIMGTIGYIDPEYART--SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVD---- 825 (933)
Q Consensus 756 ----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---- 825 (933)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||............. ........+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~ 236 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL--NGTVPCLLDTTTI 236 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHh--cCCccccccccch
Confidence 01122356788999999876 468999999999999999999999997543222111110 000000000
Q ss_pred ---------------ccc----------c------ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 826 ---------------PEI----------S------ATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 826 ---------------~~~----------~------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
... . ...........+.+++.+|++.||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 000 0 000011224578899999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=308.11 Aligned_cols=249 Identities=24% Similarity=0.367 Sum_probs=203.4
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEe
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
+.|+..+.||+|+||.||+|.++ .++.||+|.+.... ......+.+|++++++++||||+++++++.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35667788999999999999976 47889999886543 34456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS 755 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 755 (933)
+++++|.+++. ..++++..+..++.|++.|++|+|+. +++|+||+|+||+++.++.++++|||++........
T Consensus 84 ~~~~~L~~~i~----~~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 84 LGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 99999999984 34688999999999999999999965 999999999999999999999999999976543221
Q ss_pred ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCH
Q 002349 756 YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDL 835 (933)
Q Consensus 756 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (933)
......++..|+|||++.+..++.++|||||||++|||++|+.||............. ....+.+ ..
T Consensus 157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~-------~~~~~~~-----~~ 223 (277)
T cd06640 157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP-------KNNPPTL-----TG 223 (277)
T ss_pred -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhh-------cCCCCCC-----ch
Confidence 2233468889999999988889999999999999999999999997543322211110 0001111 12
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 836 GAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 836 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
..+..+.+++.+|++.+|++||++.+++++-
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06640 224 EFSKPFKEFIDACLNKDPSFRPTAKELLKHK 254 (277)
T ss_pred hhhHHHHHHHHHHcccCcccCcCHHHHHhCh
Confidence 3456788999999999999999999998753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=316.39 Aligned_cols=195 Identities=26% Similarity=0.378 Sum_probs=159.2
Q ss_pred ceeeecccceeEEEEEEcC---CceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEec--CCccEEEEEecC
Q 002349 603 KYIIGYGASSTVYKCVLKN---CKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLS--SSGNLLFYDFME 677 (933)
Q Consensus 603 ~~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~ 677 (933)
..+||+|+||+||+|..++ ++.||+|.+.... ....+.+|++++++++||||+++++++.. +...++||||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 3579999999999999753 4689999886543 23567889999999999999999998854 456789999986
Q ss_pred CCCHHHHhcCC------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEe----CCCCCeEEeecccc
Q 002349 678 NGSLWDILHGP------TKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILL----DKDFEAHLTDFGIA 747 (933)
Q Consensus 678 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll----~~~~~~kl~DfGla 747 (933)
+ +|.+++... .....+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 787776421 1223588999999999999999999965 99999999999999 56678999999999
Q ss_pred cccccCCCc--eeeeecccccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 002349 748 KSLCVSKSY--TSTYIMGTIGYIDPEYART-SRLTEKSDVYSFGIVLLELLTGRKAVDN 803 (933)
Q Consensus 748 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~p~~~ 803 (933)
+........ ......||+.|+|||++.+ ..++.++||||+||++|||+||+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 876432221 1234568999999999876 4589999999999999999999999974
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=314.13 Aligned_cols=255 Identities=21% Similarity=0.244 Sum_probs=201.5
Q ss_pred hccCcceeeecccceeEEEEEEcC-CceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
++|+..+.||+|+||.||+|.+.. ++.||+|.+.... ....+.+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 368888999999999999999764 6789999886543 233457889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
||+++++|.+++. ..+.+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||+++.....
T Consensus 81 e~~~g~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLK---NIGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 9999999999994 346789999999999999999999965 9999999999999999999999999998642110
Q ss_pred CC--------------ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccc
Q 002349 754 KS--------------YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNA 819 (933)
Q Consensus 754 ~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 819 (933)
.. .......|+..|+|||.+.+..++.++|||||||++|||++|+.||.+............ ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~--~~ 232 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS--DD 232 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--cc
Confidence 00 011124578899999999888899999999999999999999999976543222211111 10
Q ss_pred cccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcc
Q 002349 820 VMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGS 868 (933)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 868 (933)
.. .+... ...+..+.+++.+|++.||++||++.++.+.++.
T Consensus 233 ~~---~~~~~-----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 233 IE---WPEGD-----EALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred cC---CCCcc-----ccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 00 01100 0124568899999999999999997666666654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=314.93 Aligned_cols=245 Identities=22% Similarity=0.344 Sum_probs=200.0
Q ss_pred ceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecCCCCH
Q 002349 603 KYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSL 681 (933)
Q Consensus 603 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 681 (933)
...||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 446999999999999965 5789999998665444566788999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCceeeee
Q 002349 682 WDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYI 761 (933)
Q Consensus 682 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 761 (933)
.+++. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++....... ......
T Consensus 106 ~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~~ 177 (297)
T cd06659 106 TDIVS----QTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKSL 177 (297)
T ss_pred HHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccccce
Confidence 99873 35689999999999999999999965 99999999999999999999999999987653222 222345
Q ss_pred cccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHHHHHH
Q 002349 762 MGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKV 841 (933)
Q Consensus 762 ~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 841 (933)
.|+..|+|||++.+..++.++|||||||++|||++|+.||................. +.... .......+
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-------~~~~~---~~~~~~~l 247 (297)
T cd06659 178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP-------PKLKN---AHKISPVL 247 (297)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC-------CCccc---cCCCCHHH
Confidence 689999999999988899999999999999999999999976544433322111100 00000 00123567
Q ss_pred HHHHHHccCCCCCCCCCHHHHHHH
Q 002349 842 FQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 842 ~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.+++.+|++.+|++||++++++++
T Consensus 248 ~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 248 RDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHHHHHhcCCcccCcCHHHHhhC
Confidence 889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=324.38 Aligned_cols=192 Identities=24% Similarity=0.336 Sum_probs=164.4
Q ss_pred HhhccCcceeeecccceeEEEEEEcC-CceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEE
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYD 674 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 674 (933)
...+|++.+.||+|+||.||+|.... ++.||+|+.... ....|+.++++++||||+++++++......++|||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 34579999999999999999999764 578899875432 23568999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCC
Q 002349 675 FMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSK 754 (933)
Q Consensus 675 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 754 (933)
|+. ++|.+++. .....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 138 ~~~-~~l~~~l~--~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 210 (357)
T PHA03209 138 HYS-SDLYTYLT--KRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA- 210 (357)
T ss_pred ccC-CcHHHHHH--hccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccC-
Confidence 995 58888885 3456789999999999999999999965 9999999999999999999999999999753221
Q ss_pred CceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCC
Q 002349 755 SYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAV 801 (933)
Q Consensus 755 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~ 801 (933)
.......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 211 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 -PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred -cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1223456999999999999999999999999999999999866554
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=314.83 Aligned_cols=261 Identities=25% Similarity=0.346 Sum_probs=202.2
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYD 674 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 674 (933)
++|+..+.||+|+||.||+|.++ +++.||+|++.... ....+.+.+|++++++++||||+++++++..+...++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888899999999999999986 47899999886533 2234568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCC
Q 002349 675 FMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSK 754 (933)
Q Consensus 675 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 754 (933)
|++++++.++.. ....+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEK---YPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 999999988774 334589999999999999999999965 99999999999999999999999999998653322
Q ss_pred CceeeeecccccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccc----------
Q 002349 755 SYTSTYIMGTIGYIDPEYART-SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMET---------- 823 (933)
Q Consensus 755 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 823 (933)
.......++..|+|||+..+ ..++.++||||||+++|||++|+.||......................
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07846 155 -EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL 233 (286)
T ss_pred -cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchH
Confidence 22233467899999998875 347889999999999999999999997655443322211111110000
Q ss_pred ----cCccccccc----cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 824 ----VDPEISATC----KDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 824 ----~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
..+...... .....+..+.+++.+|++.+|++||++++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 000000000 001224678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=305.93 Aligned_cols=250 Identities=24% Similarity=0.356 Sum_probs=195.9
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC-----chhHHHHHHHHHHHhcCCCCceeeeeeEEecC--Ccc
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY-----PQCLKEFETELETVGSIKHRNLVSLQGYSLSS--SGN 669 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 669 (933)
.+|+..+.||+|+||.||+|... .++.||+|++.... .+..+.+.+|+.++++++||||+++++++... ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36888999999999999999975 47899999886432 22345688999999999999999999988653 567
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccc
Q 002349 670 LLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKS 749 (933)
Q Consensus 670 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 749 (933)
+++|||+++++|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLK---AYGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 89999999999999995 345689999999999999999999955 999999999999999999999999999976
Q ss_pred cccCC--CceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcc
Q 002349 750 LCVSK--SYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPE 827 (933)
Q Consensus 750 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 827 (933)
..... ........++..|+|||.+.+..++.++||||+||++|||++|+.||.............. . ...+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~-~-----~~~~~ 229 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT-Q-----PTNPQ 229 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhc-C-----CCCCC
Confidence 53211 1112234588999999999988899999999999999999999999976543332221111 1 11111
Q ss_pred ccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 828 ISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 828 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
++. .....+..++ +|+..+|++||+++||+++
T Consensus 230 ~~~-----~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 230 LPS-----HISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred Cch-----hcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 111 1224455666 6888999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=305.27 Aligned_cols=250 Identities=26% Similarity=0.347 Sum_probs=203.0
Q ss_pred ccCcceeeecccceeEEEEEEc-CCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEe
Q 002349 599 NLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSH--YPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
+|+..+.||+|+||.||++... +++.||+|++... .....+++.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4788899999999999999965 5789999998643 233456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS 755 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 755 (933)
+++++|.+.+.. .....+++..+..++.|++.|+.|||++ +++|+||+|+||+++.++.++++|||++........
T Consensus 81 ~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINA-QRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 999999999853 2234678999999999999999999965 999999999999999999999999999976533221
Q ss_pred ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCH
Q 002349 756 YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDL 835 (933)
Q Consensus 756 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (933)
......|++.|+|||+..+..++.++|||||||++++|++|+.||............. .+.. +... .
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~--~~~~-----~~~~-----~ 223 (256)
T cd08218 157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKII--RGSY-----PPVS-----S 223 (256)
T ss_pred -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHh--cCCC-----CCCc-----c
Confidence 1223468889999999998889999999999999999999999997544332221111 1111 1111 1
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 836 GAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 836 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.....+.+++.+|++.+|++||++.+|+++
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 224 HYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred cCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 224578899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=304.95 Aligned_cols=251 Identities=27% Similarity=0.418 Sum_probs=203.0
Q ss_pred ccCcceeeecccceeEEEEEEc-CCceEEEEEecccCc--hhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEe
Q 002349 599 NLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYP--QCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
+|+..+.||+|+||.||+|... +++.||+|.++.... ...+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5778899999999999999965 578999999876543 3567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS 755 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 755 (933)
+++++|.++++ ....+++..+..++.|++.|++|||+. +|+|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLE---HGRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHh---hcCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 99999999995 345688999999999999999999965 999999999999999999999999999987643332
Q ss_pred ceee---eecccccccCccccccCC---CCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccc
Q 002349 756 YTST---YIMGTIGYIDPEYARTSR---LTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEIS 829 (933)
Q Consensus 756 ~~~~---~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (933)
.... ...++..|+|||++.+.. ++.++||||||+++|++++|+.||............... . ..+.++
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~--~----~~~~~~ 228 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA--G----HKPPIP 228 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc--C----CCCCCC
Confidence 2211 346788999999998766 889999999999999999999999754332222221111 1 111111
Q ss_pred ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002349 830 ATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSR 864 (933)
Q Consensus 830 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 864 (933)
.. ......+.+++.+|++.+|++||++.+++.
T Consensus 229 ~~---~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 229 DS---LQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred cc---cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11 112456788999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=310.95 Aligned_cols=245 Identities=23% Similarity=0.262 Sum_probs=201.9
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
++|+..+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|++++++++||||+++++++..+...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36888899999999999999976 47899999986532 234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
||+++++|.+++. ....+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~---~~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLR---KSGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 9999999999995 346789999999999999999999965 9999999999999999999999999999875433
Q ss_pred CCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccccc
Q 002349 754 KSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCK 833 (933)
Q Consensus 754 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (933)
.....|++.|+|||.+.+...+.++||||||+++|+|++|+.||............. ... ..++..
T Consensus 155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~------~~~~~~-- 220 (290)
T cd05580 155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL--EGK------VRFPSF-- 220 (290)
T ss_pred ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--cCC------ccCCcc--
Confidence 233468999999999988888999999999999999999999997655322222111 111 111111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002349 834 DLGAVKKVFQLALLCSKRQPTDRP-----TMHEVSRV 865 (933)
Q Consensus 834 ~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 865 (933)
....+.+++.+|+..||.+|+ +++|++++
T Consensus 221 ---~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 221 ---FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred ---CCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 135778899999999999999 77777654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=306.21 Aligned_cols=254 Identities=25% Similarity=0.373 Sum_probs=201.8
Q ss_pred ccCcceeeecccceeEEEEEEcC--CceEEEEEecccC----------chhHHHHHHHHHHHhc-CCCCceeeeeeEEec
Q 002349 599 NLSEKYIIGYGASSTVYKCVLKN--CKPVAIKRLYSHY----------PQCLKEFETELETVGS-IKHRNLVSLQGYSLS 665 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~ 665 (933)
+|+..+.||+|+||.||+|.++. ++.+|+|.+.... .....++.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 46778899999999999999765 6789999885321 2234557788888875 799999999999999
Q ss_pred CCccEEEEEecCCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeec
Q 002349 666 SSGNLLFYDFMENGSLWDILHGP-TKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDF 744 (933)
Q Consensus 666 ~~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 744 (933)
++..++||||+++++|.+++... .....+++..++.++.|++.|+.|||+. .+++|+||+|+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999987431 2345689999999999999999999952 38999999999999999999999999
Q ss_pred ccccccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccccccccc
Q 002349 745 GIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETV 824 (933)
Q Consensus 745 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 824 (933)
|.+....... ......|+..|+|||...+..++.++||||||+++|+|++|+.||............ ......
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~--~~~~~~--- 231 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKI--VEAVYE--- 231 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHH--hhccCC---
Confidence 9998754332 233456899999999999888999999999999999999999999754332221111 111110
Q ss_pred CccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 002349 825 DPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLG 867 (933)
Q Consensus 825 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 867 (933)
+ .. ....+..+.+++.+|++.||++||++.|+.++++
T Consensus 232 -~-~~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 232 -P-LP----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred -c-CC----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 0 00 0012357889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=310.53 Aligned_cols=263 Identities=21% Similarity=0.253 Sum_probs=198.5
Q ss_pred HhhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
++++|...+.||+|+||.||+|... +++.||+|++.... ......+.+|+++++.++|+||+++++++..+...++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4578999999999999999999865 57899999986543 223346788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
||+. +++.+.+. .....+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~--~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMI--QHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9996 67777664 2335678889999999999999999965 9999999999999999999999999999764322
Q ss_pred CCceeeeecccccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhc-cc-------------
Q 002349 754 KSYTSTYIMGTIGYIDPEYARTS-RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTA-NN------------- 818 (933)
Q Consensus 754 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~-~~------------- 818 (933)
.. ......+++.|+|||.+.+. .++.++|||||||++|+|++|+.||............... .+
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07870 157 SQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL 235 (291)
T ss_pred CC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhc
Confidence 21 12234578999999998764 5788999999999999999999999754432221111100 00
Q ss_pred -cccccc-----CccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 819 -AVMETV-----DPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 819 -~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
...+.. ................+.+++.+|+..||++|||++|++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 000000 00000001111123567889999999999999999998763
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=308.73 Aligned_cols=266 Identities=26% Similarity=0.409 Sum_probs=203.2
Q ss_pred hccCcceeeecccceeEEEEEEc-----CCceEEEEEecccCch-hHHHHHHHHHHHhcCCCCceeeeeeEEec--CCcc
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-----NCKPVAIKRLYSHYPQ-CLKEFETELETVGSIKHRNLVSLQGYSLS--SSGN 669 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~ 669 (933)
+.|+..+.||+|+||.||+|.+. .++.||||.+...... ..+.+.+|++++++++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35677789999999999999864 3578999999765443 46789999999999999999999999877 5578
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccc
Q 002349 670 LLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKS 749 (933)
Q Consensus 670 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 749 (933)
++||||+++++|.+++.. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++|||.+..
T Consensus 84 ~lv~e~~~~~~l~~~l~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQR--HRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHh--CccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 999999999999999963 334689999999999999999999965 999999999999999999999999999987
Q ss_pred cccCCCce--eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhc----ccccccc
Q 002349 750 LCVSKSYT--STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTA----NNAVMET 823 (933)
Q Consensus 750 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~----~~~~~~~ 823 (933)
........ .....++..|+|||...+..++.++||||||+++|||++|+.|+............... .....+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 64222211 11224556799999998888999999999999999999999998643221100000000 0000000
Q ss_pred cCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccC
Q 002349 824 VDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869 (933)
Q Consensus 824 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 869 (933)
+..... ......++.++.+++.+|++.+|++|||+.||+++|+.+
T Consensus 239 ~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEGER-LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcCCc-CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 000000 000112346789999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=310.60 Aligned_cols=262 Identities=22% Similarity=0.288 Sum_probs=198.4
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccCc-hhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYP-QCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYD 674 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 674 (933)
.++|+..+.||+|++|.||+|..+ +++.||+|.+..... .....+.+|++++++++|+||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 367888999999999999999976 578999999865432 223456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCC
Q 002349 675 FMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSK 754 (933)
Q Consensus 675 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 754 (933)
|+++ +|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 84 ~~~~-~L~~~~~~--~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 84 YLDT-DLKQYMDD--CGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred cCCC-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 9985 89998863 334789999999999999999999965 99999999999999999999999999987543221
Q ss_pred CceeeeecccccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHH-hhhcccccccccC-------
Q 002349 755 SYTSTYIMGTIGYIDPEYART-SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLIL-SKTANNAVMETVD------- 825 (933)
Q Consensus 755 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~------- 825 (933)
. ......++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||.+......... .........+...
T Consensus 158 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07844 158 K-TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP 236 (291)
T ss_pred c-cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcc
Confidence 1 1122346889999998875 4588999999999999999999999975542221111 1000000000000
Q ss_pred ------------ccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 826 ------------PEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 826 ------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
..+............+.+++.+|++.+|++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0000000111112567899999999999999999998764
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=311.55 Aligned_cols=263 Identities=26% Similarity=0.336 Sum_probs=204.9
Q ss_pred cCHHHHHHHhhccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcC-CCCceeeeeeEEec
Q 002349 588 HVYEDIMRMTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSI-KHRNLVSLQGYSLS 665 (933)
Q Consensus 588 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 665 (933)
+..+++..++++|+..+.||+|+||.||+|... +++.+|+|.+.... .....+.+|+.+++++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 334555566889999999999999999999975 57889999886532 2346678899999999 89999999999875
Q ss_pred C-----CccEEEEEecCCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCe
Q 002349 666 S-----SGNLLFYDFMENGSLWDILHGP-TKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEA 739 (933)
Q Consensus 666 ~-----~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~ 739 (933)
. ...++||||+++++|.++++.. .....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCE
Confidence 4 3579999999999999988532 2345789999999999999999999965 99999999999999999999
Q ss_pred EEeecccccccccCCCceeeeecccccccCccccccC-----CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhh
Q 002349 740 HLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTS-----RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSK 814 (933)
Q Consensus 740 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~ 814 (933)
||+|||++........ ......|+..|+|||.+... .++.++|||||||++|||++|+.||.............
T Consensus 168 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~ 246 (291)
T cd06639 168 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIP 246 (291)
T ss_pred EEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHh
Confidence 9999999876532221 22234688999999987653 36889999999999999999999997654433322211
Q ss_pred hcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 815 TANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
. ... +.+.. .......+.+++.+|++.+|++||++.|++++
T Consensus 247 ~--~~~-----~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 247 R--NPP-----PTLLH---PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred c--CCC-----CCCCc---ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1 100 11110 01123568899999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=307.76 Aligned_cols=248 Identities=28% Similarity=0.432 Sum_probs=197.1
Q ss_pred eeecccceeEEEEEEcC-------CceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEec
Q 002349 605 IIGYGASSTVYKCVLKN-------CKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFM 676 (933)
Q Consensus 605 ~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 676 (933)
.||+|+||.||+|.+.+ ++.+|+|.+.... .....++.+|+.++++++||||+++++++...+..++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 59999999999998653 2578999886543 344667899999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCC----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCC-----CeEEeecccc
Q 002349 677 ENGSLWDILHGPT----KKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDF-----EAHLTDFGIA 747 (933)
Q Consensus 677 ~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~-----~~kl~DfGla 747 (933)
++++|.++++... ....+++.++..++.|++.|++|||+. +++|+||||+||+++.++ .++++|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 9999999986321 223578999999999999999999965 999999999999999887 8999999999
Q ss_pred cccccCCCc-eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccC
Q 002349 748 KSLCVSKSY-TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVD 825 (933)
Q Consensus 748 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (933)
+........ ......++..|+|||++.+..++.++|||||||++|||++ |+.||.............. .. .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~-~~------~ 231 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTA-GG------R 231 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhc-CC------c
Confidence 765322211 1122345678999999999999999999999999999998 9999975544332222111 00 0
Q ss_pred ccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 002349 826 PEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLG 867 (933)
Q Consensus 826 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 867 (933)
... ....+..+.+++.+|+..+|++||++++|.+.|.
T Consensus 232 ~~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 232 LQK-----PENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred cCC-----cccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 000 1123467889999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=311.83 Aligned_cols=260 Identities=20% Similarity=0.235 Sum_probs=196.4
Q ss_pred ccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEe
Q 002349 599 NLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
+|+..+.||+|+||.||+|.+. +|+.||+|++.... ......+.+|++++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4777889999999999999976 57899999986532 22345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS 755 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 755 (933)
++ ++|.+++.. ....+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CD-QDLKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 97 478887752 345789999999999999999999965 999999999999999999999999999986533221
Q ss_pred ceeeeecccccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhc-ccc-----------ccc
Q 002349 756 YTSTYIMGTIGYIDPEYARTS-RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTA-NNA-----------VME 822 (933)
Q Consensus 756 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~-~~~-----------~~~ 822 (933)
......++..|+|||.+.+. .++.++||||+||++|+|++|+.|+............... ... ...
T Consensus 155 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07839 155 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD 233 (284)
T ss_pred -CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccc
Confidence 12234578899999988765 4789999999999999999999986533332221111000 000 000
Q ss_pred -ccCccccccc----cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 823 -TVDPEISATC----KDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 823 -~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
...+...... ........+.+++.+|++.||.+|||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0000000000 000123567889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=303.65 Aligned_cols=249 Identities=25% Similarity=0.359 Sum_probs=201.3
Q ss_pred ccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEe
Q 002349 599 NLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
+|+..+.||+|+||.||+|... +++.+|+|++.... ....+.+.+|++++++++||||+++++++..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4778899999999999999975 57889999986542 33466789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCC-CCeEEeecccccccccCC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKD-FEAHLTDFGIAKSLCVSK 754 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~-~~~kl~DfGla~~~~~~~ 754 (933)
+++++|.+++.. .....+++..+..++.+++.|++|||++ +++|+||||+||+++++ +.+|++|||.+.......
T Consensus 81 ~~~~~L~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQK-RCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHH-hcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 999999999963 2234689999999999999999999965 99999999999999865 457999999998764322
Q ss_pred CceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccC
Q 002349 755 SYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKD 834 (933)
Q Consensus 755 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (933)
......|+..|+|||.+.+..++.++||||||+++|+|++|+.||................ ... +..
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~---~~~----~~~---- 223 (256)
T cd08220 157 --KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGT---FAP----ISD---- 223 (256)
T ss_pred --cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcC---CCC----CCC----
Confidence 2223468899999999998889999999999999999999999997654332222111110 001 111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 835 LGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 835 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
..+..+.+++.+|++.+|++|||+.|++++
T Consensus 224 -~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 224 -RYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred -CcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 124578899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=304.32 Aligned_cols=250 Identities=23% Similarity=0.311 Sum_probs=197.2
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC-----chhHHHHHHHHHHHhcCCCCceeeeeeEEecC--Ccc
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY-----PQCLKEFETELETVGSIKHRNLVSLQGYSLSS--SGN 669 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 669 (933)
++|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47888999999999999999975 47899999885321 22345788999999999999999999998764 457
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccc
Q 002349 670 LLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKS 749 (933)
Q Consensus 670 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 749 (933)
++||||+++++|.+++. ....+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLK---SYGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccc
Confidence 79999999999999984 335688999999999999999999965 999999999999999999999999999976
Q ss_pred cccCCC--ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcc
Q 002349 750 LCVSKS--YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPE 827 (933)
Q Consensus 750 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 827 (933)
...... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||............. ... ..+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~--~~~----~~~~ 229 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA--TQP----TNPV 229 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHh--cCC----CCCC
Confidence 532111 11233468899999999988889999999999999999999999997543333222111 110 0111
Q ss_pred ccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 828 ISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 828 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
. .......+.+++.+|+. +|++||++++|+++
T Consensus 230 ~-----~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 230 L-----PPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred C-----chhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 1 11233567788899984 99999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=304.79 Aligned_cols=252 Identities=20% Similarity=0.313 Sum_probs=189.2
Q ss_pred eeecccceeEEEEEEcCC---ceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecCCCC
Q 002349 605 IIGYGASSTVYKCVLKNC---KPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGS 680 (933)
Q Consensus 605 ~lG~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 680 (933)
.||+|+||+||+|...++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++++......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999985543 345667665433 3345678999999999999999999999999999999999999999
Q ss_pred HHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCC-Ccee
Q 002349 681 LWDILHGPT-KKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSK-SYTS 758 (933)
Q Consensus 681 L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~-~~~~ 758 (933)
|.++++... .....++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++....... ....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999996422 223567778889999999999999965 99999999999999999999999999986432111 1122
Q ss_pred eeecccccccCcccccc-------CCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCccccc
Q 002349 759 TYIMGTIGYIDPEYART-------SRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISA 830 (933)
Q Consensus 759 ~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (933)
....|+..|+|||+... ..++.++|||||||++|||++ |..||............. ........++.+..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 236 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVI--KDQQVKLFKPQLEL 236 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH--hhcccccCCCccCC
Confidence 33467889999998753 245789999999999999997 466786544333222211 11111222222222
Q ss_pred cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 002349 831 TCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLG 867 (933)
Q Consensus 831 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 867 (933)
. ....+.+++..|+ .+|++||++++|++.|.
T Consensus 237 ~-----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 237 P-----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred C-----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 1 2356778899999 67999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=302.51 Aligned_cols=247 Identities=26% Similarity=0.419 Sum_probs=198.1
Q ss_pred hccCcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecC
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFME 677 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 677 (933)
++|+..+.||+|+||.||+|.. .++.||+|.+.... ....+.+|+.++++++||||+++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4688899999999999999975 56789999986543 346788999999999999999999998654 5799999999
Q ss_pred CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCce
Q 002349 678 NGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYT 757 (933)
Q Consensus 678 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 757 (933)
+++|.+++... ....+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||.+......
T Consensus 82 ~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---- 153 (254)
T cd05083 82 KGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---- 153 (254)
T ss_pred CCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence 99999999642 234689999999999999999999965 9999999999999999999999999998754221
Q ss_pred eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCccccccccCHH
Q 002349 758 STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLG 836 (933)
Q Consensus 758 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (933)
......+..|+|||.+.+..++.++|||||||++|||++ |+.||......... .... ... .+... ..
T Consensus 154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~-~~~~-~~~-----~~~~~-----~~ 221 (254)
T cd05083 154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVK-ECVE-KGY-----RMEPP-----EG 221 (254)
T ss_pred CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHH-HHHh-CCC-----CCCCC-----Cc
Confidence 112234678999999988889999999999999999998 99999754432221 1111 110 01111 12
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHHcc
Q 002349 837 AVKKVFQLALLCSKRQPTDRPTMHEVSRVLGS 868 (933)
Q Consensus 837 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 868 (933)
.+..+.+++.+|++.+|++||+++++++.|+.
T Consensus 222 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 222 CPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 24678899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=305.67 Aligned_cols=254 Identities=24% Similarity=0.401 Sum_probs=200.3
Q ss_pred ccCcceeeecccceeEEEEEEc-CCceEEEEEecccCc----------hhHHHHHHHHHHHhcCCCCceeeeeeEEecCC
Q 002349 599 NLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYP----------QCLKEFETELETVGSIKHRNLVSLQGYSLSSS 667 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 667 (933)
+|...+.||+|+||.||+|... +++.||+|.++.... ...+.+.+|++++++++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4677889999999999999865 578999998853211 12346788999999999999999999999999
Q ss_pred ccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccc
Q 002349 668 GNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIA 747 (933)
Q Consensus 668 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla 747 (933)
..++||||+++++|.++++ ....+++..+..++.|++.|+.|||++ +++||||+|+||+++.++.++++|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLR---TYGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccc
Confidence 9999999999999999995 336789999999999999999999965 9999999999999999999999999999
Q ss_pred cccccCCC-ceeeeecccccccCccccccCC--CCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccccccccc
Q 002349 748 KSLCVSKS-YTSTYIMGTIGYIDPEYARTSR--LTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETV 824 (933)
Q Consensus 748 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 824 (933)
+....... .......|+..|+|||.+.... ++.++||||+|+++|++++|..||.............. ......+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~ 233 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGN--KRSAPPI 233 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhc--cccCCcC
Confidence 76532211 1123346889999999987654 78999999999999999999999975544333221111 1111111
Q ss_pred CccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 825 DPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 825 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
+.... ...+..+.+++.+|+..+|++||++++|+++
T Consensus 234 ~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 234 PPDVS-----MNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred Ccccc-----ccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 11111 1224678889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=310.39 Aligned_cols=250 Identities=26% Similarity=0.364 Sum_probs=203.9
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEec
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFM 676 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 676 (933)
++|...+.||+|+||.||+|... +++.||+|.+........+.+.+|+.++++++||||+++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 57888999999999999999864 57889999986555455677899999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCc
Q 002349 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY 756 (933)
Q Consensus 677 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 756 (933)
++++|.+++. ...+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~- 170 (293)
T cd06647 99 AGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170 (293)
T ss_pred CCCcHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-
Confidence 9999999984 24578999999999999999999965 999999999999999999999999999876533222
Q ss_pred eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHH
Q 002349 757 TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLG 836 (933)
Q Consensus 757 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (933)
......|++.|+|||.+.+..++.++||||||+++|++++|+.||............... . .+... ....
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~-~------~~~~~---~~~~ 240 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-G------TPELQ---NPEK 240 (293)
T ss_pred ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcC-C------CCCCC---Cccc
Confidence 223346889999999998888999999999999999999999999865443322111100 0 00110 0112
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 837 AVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 837 ~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.+..+.+++.+||+.+|++||++.+++.+
T Consensus 241 ~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 241 LSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 24568889999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=310.66 Aligned_cols=252 Identities=23% Similarity=0.312 Sum_probs=197.8
Q ss_pred hccCcceeeecccceeEEEEEEcCCceEEEEEecc--cCchhHHHHHHHHHHHhcC-CCCceeeeeeEEecCCccEEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYS--HYPQCLKEFETELETVGSI-KHRNLVSLQGYSLSSSGNLLFYD 674 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 674 (933)
..|+..+.||+||.+.||++...+.+.+|+|++.. .+.+...-|..|+..|.++ .|.+||++++|-..++..|+|||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 46778889999999999999988888899988754 3456677899999999999 49999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCC
Q 002349 675 FMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSK 754 (933)
Q Consensus 675 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 754 (933)
|- ..+|..+|.. ....++.-.+..+..|++.|+.++|++ ||||.|+||.|+|+-. |++||+|||+|..+..+.
T Consensus 441 ~G-d~DL~kiL~k--~~~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 441 CG-DIDLNKILKK--KKSIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDT 513 (677)
T ss_pred cc-cccHHHHHHh--ccCCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCccc
Confidence 87 4599999963 233333237788999999999999988 9999999999999876 699999999998875443
Q ss_pred Cce-eeeecccccccCccccccC-----------CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccccccc
Q 002349 755 SYT-STYIMGTIGYIDPEYARTS-----------RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVME 822 (933)
Q Consensus 755 ~~~-~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 822 (933)
... ....+||+.||+||.+... ..++++||||+||++|+|+.|+.||..-....... ..
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl---------~a 584 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKL---------HA 584 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHH---------Hh
Confidence 322 4456899999999987532 25689999999999999999999997533221111 11
Q ss_pred ccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 823 TVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
..+|...-.+++.....++.++++.|++.||++||++.+++++
T Consensus 585 I~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 585 ITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred hcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 1222221112222223348999999999999999999999975
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=302.61 Aligned_cols=251 Identities=27% Similarity=0.406 Sum_probs=206.2
Q ss_pred ccCcceeeecccceeEEEEEEcC-CceEEEEEecccCc-hhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEec
Q 002349 599 NLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHYP-QCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFM 676 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 676 (933)
+|+..+.||+|++|.||+|.... ++.||+|++..... ...+.+.+|++++++++|+||+++++++..+...++||||+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 67888999999999999999775 88999999876543 45678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCc
Q 002349 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY 756 (933)
Q Consensus 677 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 756 (933)
++++|.+++. ....+++..+..++.|+++|++|||+ ..+++||||+|+||+++.++.++|+|||.+.........
T Consensus 82 ~~~~L~~~l~---~~~~l~~~~~~~~~~~l~~~l~~lh~--~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 82 DGGSLADLLK---KVGKIPEPVLAYIARQILKGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred CCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHhc--cCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 9999999995 34678999999999999999999995 049999999999999999999999999999876432222
Q ss_pred eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCc--chhHHHHhhhcccccccccCccccccccC
Q 002349 757 TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNEC--NLHHLILSKTANNAVMETVDPEISATCKD 834 (933)
Q Consensus 757 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (933)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||.... .......... . ...+.....
T Consensus 157 -~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~--~----~~~~~~~~~--- 226 (264)
T cd06623 157 -CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC--D----GPPPSLPAE--- 226 (264)
T ss_pred -ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh--c----CCCCCCCcc---
Confidence 224468899999999998889999999999999999999999997654 2222211111 1 011111111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 835 LGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 835 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
..+..+.+++.+|+..+|++||++.+++++
T Consensus 227 -~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 227 -EFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred -cCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 034678999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=287.18 Aligned_cols=268 Identities=24% Similarity=0.281 Sum_probs=202.8
Q ss_pred HHhhccCcceeeecccceeEEEEEEcC-----CceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEec-C
Q 002349 595 RMTENLSEKYIIGYGASSTVYKCVLKN-----CKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLS-S 666 (933)
Q Consensus 595 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~ 666 (933)
.....|+....||+|.||.||+|.-++ .+.+|+|+++... +.......+|+..++.++||||+.+..++.+ +
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 345678999999999999999997443 2478999997653 2234567899999999999999999999877 7
Q ss_pred CccEEEEEecCCCCHHHHhcC--CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCC----CCeE
Q 002349 667 SGNLLFYDFMENGSLWDILHG--PTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKD----FEAH 740 (933)
Q Consensus 667 ~~~~lv~e~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~----~~~k 740 (933)
..+++++||.+. +|..+++. ....+.++...+..|+.||+.|+.|||++ =|+|||+||.|||+..+ |+||
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeE
Confidence 788999999987 89888852 23446789999999999999999999976 68999999999999877 9999
Q ss_pred EeecccccccccCCC--ceeeeecccccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCc---------chh
Q 002349 741 LTDFGIAKSLCVSKS--YTSTYIMGTIGYIDPEYARTS-RLTEKSDVYSFGIVLLELLTGRKAVDNEC---------NLH 808 (933)
Q Consensus 741 l~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~p~~~~~---------~~~ 808 (933)
|+|||+|+.+...-. .....++-|.+|+|||.+.|. .||++.||||.||++.||+|-++-|.+.. ...
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~d 256 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHD 256 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHH
Confidence 999999998854322 234457789999999999886 58999999999999999999887775321 112
Q ss_pred HHHHhhhcccccccccCccccccccC------HH------------------HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002349 809 HLILSKTANNAVMETVDPEISATCKD------LG------------------AVKKVFQLALLCSKRQPTDRPTMHEVSR 864 (933)
Q Consensus 809 ~~~~~~~~~~~~~~~~~~~~~~~~~~------~~------------------~~~~l~~li~~cl~~dP~~RPt~~evl~ 864 (933)
++..+...-+...+..+|.+...... .. ....-++++.+++..||.+|-|+++.++
T Consensus 257 Ql~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle 336 (438)
T KOG0666|consen 257 QLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE 336 (438)
T ss_pred HHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence 22222222222222222222111100 00 0123678999999999999999999887
Q ss_pred HH
Q 002349 865 VL 866 (933)
Q Consensus 865 ~L 866 (933)
+.
T Consensus 337 h~ 338 (438)
T KOG0666|consen 337 HP 338 (438)
T ss_pred cc
Confidence 64
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=307.39 Aligned_cols=249 Identities=23% Similarity=0.338 Sum_probs=202.5
Q ss_pred ccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecC
Q 002349 599 NLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFME 677 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 677 (933)
.|...+.||+|++|.||+|... +++.+|+|++........+.+.+|+.++++++||||+++++++...+..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 3445578999999999999965 578899999865554455678899999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCce
Q 002349 678 NGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYT 757 (933)
Q Consensus 678 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 757 (933)
+++|.+++.. .++++..+..++.|++.|++|||++ +++||||+|+||+++.++.++++|||.+....... ..
T Consensus 100 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~-~~ 171 (285)
T cd06648 100 GGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-PR 171 (285)
T ss_pred CCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCC-cc
Confidence 9999999852 5689999999999999999999965 99999999999999999999999999887653222 12
Q ss_pred eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHH
Q 002349 758 STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGA 837 (933)
Q Consensus 758 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 837 (933)
.....|++.|+|||...+..++.++|||||||++|+|++|+.||............... . .+.... ....
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~--~-----~~~~~~---~~~~ 241 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN--L-----PPKLKN---LHKV 241 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc--C-----CCCCcc---cccC
Confidence 23356899999999998888999999999999999999999999765443332221111 0 111111 0112
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 838 VKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 838 ~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
+..+.+++.+|++.+|++||++.+++++
T Consensus 242 ~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 242 SPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 3578999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=309.07 Aligned_cols=261 Identities=22% Similarity=0.285 Sum_probs=199.5
Q ss_pred ccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEe
Q 002349 599 NLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
+|+..+.||+|++|.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778899999999999999975 57899999886543 22345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS 755 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 755 (933)
+. ++|.+++.. .....+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+|++|||++........
T Consensus 81 ~~-~~l~~~~~~-~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDA-SPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHh-CCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 96 589888864 2345789999999999999999999965 999999999999999999999999999876532221
Q ss_pred ceeeeecccccccCccccccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCc--------
Q 002349 756 YTSTYIMGTIGYIDPEYARTSR-LTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDP-------- 826 (933)
Q Consensus 756 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 826 (933)
......+++.|+|||.+.+.. ++.++||||||+++|+|+||+.||................+.......+
T Consensus 156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07860 156 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY 234 (284)
T ss_pred -ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence 122335688999999887654 6889999999999999999999997655443332211111110000000
Q ss_pred --ccccc-ccC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 827 --EISAT-CKD-----LGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 827 --~~~~~-~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.+... ... ......+.+++.+|++.||++|||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 00000 000 0113567789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=305.69 Aligned_cols=250 Identities=28% Similarity=0.409 Sum_probs=202.1
Q ss_pred ccCcceeeecccceeEEEEEEc-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEec
Q 002349 599 NLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFM 676 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 676 (933)
+|+..+.||+|+||.||+|.++ +++.||+|++.... ....+++.+|++++++++||||+++++++..+...++|+||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5777788999999999999977 47889999987653 344567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCc
Q 002349 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY 756 (933)
Q Consensus 677 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 756 (933)
++++|.+++.. ....+++..+..++.|++.|++|+|+ ..+++|+||||+||+++.++.++|+|||.+.........
T Consensus 82 ~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 157 (265)
T cd06605 82 DGGSLDKILKE--VQGRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK 157 (265)
T ss_pred CCCcHHHHHHH--ccCCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence 99999999963 22678999999999999999999995 149999999999999999999999999998765322211
Q ss_pred eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCc----chhHHHHhhhcccccccccCccccccc
Q 002349 757 TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNEC----NLHHLILSKTANNAVMETVDPEISATC 832 (933)
Q Consensus 757 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (933)
...++..|+|||...+..++.++||||+|+++|+|++|+.||.... .......... ....+.+...
T Consensus 158 ---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~- 227 (265)
T cd06605 158 ---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIV------NEPPPRLPSG- 227 (265)
T ss_pred ---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHh------cCCCCCCChh-
Confidence 1568899999999999899999999999999999999999997542 1111111111 0011111110
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 833 KDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 833 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.....+.+++.+|+..||++|||+.+++.+
T Consensus 228 ---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 228 ---KFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred ---hcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 134578899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=299.12 Aligned_cols=250 Identities=28% Similarity=0.394 Sum_probs=206.7
Q ss_pred ccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecC
Q 002349 599 NLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFME 677 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 677 (933)
.|+..+.||+|++|.||+|... +++.+++|++........+.+.+|++++++++|+||+++++++..+...++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3677889999999999999976 578899999977655566789999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCce
Q 002349 678 NGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYT 757 (933)
Q Consensus 678 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 757 (933)
+++|.+++.. ....+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKS--TNQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 9999999853 225789999999999999999999965 999999999999999999999999999987643322
Q ss_pred eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHH
Q 002349 758 STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGA 837 (933)
Q Consensus 758 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 837 (933)
.....|+..|+|||.+.+..++.++||||||+++|+|++|+.||.............. .. . +.... ....
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~-~----~~~~~---~~~~ 223 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT--NG-P----PGLRN---PEKW 223 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh--cC-C----CCcCc---cccc
Confidence 3345688999999999888899999999999999999999999986543333322221 00 0 11111 1111
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 838 VKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 838 ~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
+..+.+++.+|++.||++|||+.+++++
T Consensus 224 ~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 224 SDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 4578899999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=319.99 Aligned_cols=198 Identities=28% Similarity=0.395 Sum_probs=174.2
Q ss_pred cCcceeeecccceeEEEEEEc-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecC------CccEE
Q 002349 600 LSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSS------SGNLL 671 (933)
Q Consensus 600 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~l 671 (933)
|...+.||+|+||.||+|+++ .|+.||||.+.... ....+...+|++++++++|+|||+++++-... ....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 444567999999999999955 69999999997643 44567788999999999999999999986543 35789
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeC--CCCC--eEEeecccc
Q 002349 672 FYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLD--KDFE--AHLTDFGIA 747 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~--~~~~--~kl~DfGla 747 (933)
|||||.+|||...+..+.+...+++.+.+.++.+++.||.|||++ +||||||||.||++- .+|. .||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 999999999999999998999999999999999999999999987 999999999999994 3343 699999999
Q ss_pred cccccCCCceeeeecccccccCccccc-cCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 002349 748 KSLCVSKSYTSTYIMGTIGYIDPEYAR-TSRLTEKSDVYSFGIVLLELLTGRKAVD 802 (933)
Q Consensus 748 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGv~l~elltg~~p~~ 802 (933)
+.++++. .....+||..|.+||.+. .+.|+..+|.|||||++|+++||..||.
T Consensus 172 rel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~ 225 (732)
T KOG4250|consen 172 RELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFI 225 (732)
T ss_pred ccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCC
Confidence 9885444 567789999999999998 5889999999999999999999999996
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=286.77 Aligned_cols=249 Identities=25% Similarity=0.351 Sum_probs=197.2
Q ss_pred cCcceeeecccceeEEEEEEcC-CceEEEEEecccC-chhHHHHHHHHHHHhcCC-CCceeeeeeEEecCCccEEEEEec
Q 002349 600 LSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHY-PQCLKEFETELETVGSIK-HRNLVSLQGYSLSSSGNLLFYDFM 676 (933)
Q Consensus 600 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~ 676 (933)
++....||.|..|.||+++++. |..+|||.+.+.. .+..+++.+.+.++..-+ +|+||+.+|||..+..+++.||.|
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM 173 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM 173 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence 3344569999999999999775 7889999997653 455677777787776654 899999999999999999999998
Q ss_pred CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCc
Q 002349 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY 756 (933)
Q Consensus 677 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 756 (933)
.. .++.++. ...+++++..+-++...++.||.||.++ .+|+|||+||+|||+|+.|.+|+||||++-++.++..+
T Consensus 174 s~-C~ekLlk--rik~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh 248 (391)
T KOG0983|consen 174 ST-CAEKLLK--RIKGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH 248 (391)
T ss_pred HH-HHHHHHH--HhcCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeeccccc
Confidence 53 5666665 3456789888899999999999999875 39999999999999999999999999999877544333
Q ss_pred eeeeecccccccCcccccc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCc-chhHHHHhhhcccccccccCccccccc
Q 002349 757 TSTYIMGTIGYIDPEYART---SRLTEKSDVYSFGIVLLELLTGRKAVDNEC-NLHHLILSKTANNAVMETVDPEISATC 832 (933)
Q Consensus 757 ~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGv~l~elltg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (933)
+...|.+.|||||.+.. ..|+-++||||||++++|+.||+.||.+.. +.+.+.. ... ..+|.++..
T Consensus 249 --trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltk--vln-----~ePP~L~~~- 318 (391)
T KOG0983|consen 249 --TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTK--VLN-----EEPPLLPGH- 318 (391)
T ss_pred --ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHH--HHh-----cCCCCCCcc-
Confidence 44579999999998864 468899999999999999999999998532 3333222 111 112222221
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 833 KDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 833 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
......+.+++..|+..|+.+||...+++++
T Consensus 319 --~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 319 --MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred --cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 1235678899999999999999999999875
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=345.21 Aligned_cols=253 Identities=26% Similarity=0.340 Sum_probs=203.3
Q ss_pred hhccCcceeeecccceeEEEEEE-cCCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVL-KNCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
+-+++....||.|.||.||.|.. .+|+-.|||-++... ........+|+.++..++|||+|+++|+-.+.+..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 34677778999999999999995 457889999886543 334556789999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
|||++|+|.+.+. .++-.++.....+..|++.|++|||++ |||||||||.||+++.+|.+|++|||.|..+...
T Consensus 1314 EyC~~GsLa~ll~---~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHhccCcHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 9999999999993 455566777777899999999999987 9999999999999999999999999999887543
Q ss_pred CCce---eeeecccccccCccccccC---CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcc
Q 002349 754 KSYT---STYIMGTIGYIDPEYARTS---RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPE 827 (933)
Q Consensus 754 ~~~~---~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 827 (933)
.... -...+||+.|||||++.+. ....++||||+|||+.||+||+.||..-.+..++.+.... +.. |.
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~-gh~-----Pq 1461 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAA-GHK-----PQ 1461 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhc-cCC-----CC
Confidence 2111 2346899999999999764 4567999999999999999999999865444443332222 211 11
Q ss_pred ccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 828 ISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 828 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
++. ....+-.+++..|+..||++|-++.|++++=
T Consensus 1462 ~P~-----~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1462 IPE-----RLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred Cch-----hhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 111 1345667899999999999999999888763
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=304.38 Aligned_cols=253 Identities=26% Similarity=0.417 Sum_probs=200.5
Q ss_pred ccCcceeeecccceeEEEEEE-cCCceEEEEEecccC------chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEE
Q 002349 599 NLSEKYIIGYGASSTVYKCVL-KNCKPVAIKRLYSHY------PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLL 671 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 671 (933)
+|+..+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477788999999999999996 457899999986433 1234678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCC-CeEEeeccccccc
Q 002349 672 FYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDF-EAHLTDFGIAKSL 750 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~-~~kl~DfGla~~~ 750 (933)
||||+++++|.+++. ...++++..+..++.|++.||+|||+. +++|+||||+||+++.++ .+||+|||.+...
T Consensus 81 v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLS---KYGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHH---HhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 999999999999995 345789999999999999999999965 999999999999998776 5999999999776
Q ss_pred ccCCC---ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcc
Q 002349 751 CVSKS---YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPE 827 (933)
Q Consensus 751 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 827 (933)
..... .......|+..|+|||.+.+..++.++||||+|+++|+|++|..||................. ....+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~ 231 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIAS---ATTAPS 231 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhc---cCCCCC
Confidence 43211 112234688999999999888899999999999999999999999975432222111110000 000111
Q ss_pred ccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 828 ISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 828 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
+ +......+.+++.+|++.+|++||++.+++.+
T Consensus 232 ~-----~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 232 I-----PEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred C-----chhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 1 11234678889999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=333.71 Aligned_cols=255 Identities=25% Similarity=0.342 Sum_probs=195.3
Q ss_pred HHHhhccCcceeeecccceeEEEEEEc-CCceEEEEEeccc-CchhHHHHHHHHHHHhcCCCCceeeeeeEEecCC----
Q 002349 594 MRMTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSH-YPQCLKEFETELETVGSIKHRNLVSLQGYSLSSS---- 667 (933)
Q Consensus 594 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 667 (933)
.+...+|++..+||+||||.||+++.+ +|+.||||+|.-. +......+.+|++.+++++|||||+++..|.+..
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 567788999999999999999999976 7899999999654 3445677899999999999999999876542100
Q ss_pred --------------------------------------------------------------------------------
Q 002349 668 -------------------------------------------------------------------------------- 667 (933)
Q Consensus 668 -------------------------------------------------------------------------------- 667 (933)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred -----------------------------------ccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 002349 668 -----------------------------------GNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAY 712 (933)
Q Consensus 668 -----------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~ 712 (933)
..||=||||+...+.+++++... .-.....++++++|++||.|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~--~~~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHF--NSQRDEAWRLFREILEGLAY 712 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhccc--chhhHHHHHHHHHHHHHHHH
Confidence 03677999999888888863211 11578899999999999999
Q ss_pred hhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccc-----------------cCCCceeeeecccccccCcccccc
Q 002349 713 LHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLC-----------------VSKSYTSTYIMGTIGYIDPEYART 775 (933)
Q Consensus 713 LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~ 775 (933)
+|++ |||||||||.||++|++..|||+|||+|+... .......+..+||.-|+|||++.+
T Consensus 713 IH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 713 IHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 9966 99999999999999999999999999998721 011113345689999999999976
Q ss_pred CC---CCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCC
Q 002349 776 SR---LTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQ 852 (933)
Q Consensus 776 ~~---~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 852 (933)
.. |+.|+|+||+|||++||+. ||.....-....... ..+.++.. +.+ ..+....=.++|++++++|
T Consensus 790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~L-R~g~iP~~--~~f-----~~~~~~~e~slI~~Ll~hd 858 (1351)
T KOG1035|consen 790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNL-RKGSIPEP--ADF-----FDPEHPEEASLIRWLLSHD 858 (1351)
T ss_pred cccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhc-ccCCCCCC--ccc-----ccccchHHHHHHHHHhcCC
Confidence 54 9999999999999999985 676544333332222 23333322 111 1122344567899999999
Q ss_pred CCCCCCHHHHHH
Q 002349 853 PTDRPTMHEVSR 864 (933)
Q Consensus 853 P~~RPt~~evl~ 864 (933)
|.+||||.|++.
T Consensus 859 P~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 859 PSKRPTATELLN 870 (1351)
T ss_pred CccCCCHHHHhh
Confidence 999999999986
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=302.65 Aligned_cols=247 Identities=26% Similarity=0.402 Sum_probs=200.8
Q ss_pred ccCcceeeecccceeEEEEEEc-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEec
Q 002349 599 NLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFM 676 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 676 (933)
-|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++..+...++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4667788999999999999865 57889999886443 334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCc
Q 002349 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY 756 (933)
Q Consensus 677 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 756 (933)
++++|.+++. ...+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++++|||++....... .
T Consensus 85 ~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~ 156 (277)
T cd06641 85 GGGSALDLLE----PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-I 156 (277)
T ss_pred CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccch-h
Confidence 9999999984 34689999999999999999999965 99999999999999999999999999987653221 1
Q ss_pred eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHH
Q 002349 757 TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLG 836 (933)
Q Consensus 757 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (933)
......|+..|+|||...+..++.++|||||||++|+|++|..||............ ... ..+.+.. .
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~--~~~-----~~~~~~~-----~ 224 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI--PKN-----NPPTLEG-----N 224 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHH--hcC-----CCCCCCc-----c
Confidence 223346888999999998888899999999999999999999999754332211111 111 0111111 1
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 837 AVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 837 ~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.+..+.+++.+|++.+|++||++.+++++
T Consensus 225 ~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 225 YSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 24568889999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=302.75 Aligned_cols=255 Identities=23% Similarity=0.389 Sum_probs=198.0
Q ss_pred cCcceeeecccceeEEEEEEc----CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCC------
Q 002349 600 LSEKYIIGYGASSTVYKCVLK----NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSS------ 667 (933)
Q Consensus 600 ~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 667 (933)
|...+.||+|+||.||+|.++ .++.||+|++.... ....+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456778999999999999864 35789999986543 334567889999999999999999999886542
Q ss_pred ccEEEEEecCCCCHHHHhcCC---CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeec
Q 002349 668 GNLLFYDFMENGSLWDILHGP---TKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDF 744 (933)
Q Consensus 668 ~~~lv~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 744 (933)
..++++||+++|+|.+++... .....+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+|++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 237889999999999887421 1223578999999999999999999965 9999999999999999999999999
Q ss_pred ccccccccCCCce-eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhccccccc
Q 002349 745 GIAKSLCVSKSYT-STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVME 822 (933)
Q Consensus 745 Gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 822 (933)
|.++......... .....+++.|++||.+.+..++.++||||||+++|+|++ |+.||.+........... .....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~--~~~~~- 234 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLI--KGNRL- 234 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHH--cCCcC-
Confidence 9998654322211 122345678999999998889999999999999999999 888887544322221111 11100
Q ss_pred ccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccC
Q 002349 823 TVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869 (933)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 869 (933)
... ...+..+.+++.+|++.+|++||++.++++.|+.+
T Consensus 235 ----~~~-----~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 235 ----KQP-----PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ----CCC-----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000 11245789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=306.56 Aligned_cols=260 Identities=24% Similarity=0.339 Sum_probs=203.0
Q ss_pred CHHHHHHHhhccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcC-CCCceeeeeeEEec-
Q 002349 589 VYEDIMRMTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSI-KHRNLVSLQGYSLS- 665 (933)
Q Consensus 589 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~- 665 (933)
+..++....+.|+..+.||+|+||.||+|.+. .++.||+|.+.... ....++..|+.+++++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 34555667788999999999999999999975 47889999885543 2346688899999999 69999999999853
Q ss_pred -----CCccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeE
Q 002349 666 -----SSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAH 740 (933)
Q Consensus 666 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~k 740 (933)
....+++|||+++|+|.+++.. .....+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKN-TKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHH-ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEE
Confidence 3567999999999999999863 2234688889999999999999999965 999999999999999999999
Q ss_pred EeecccccccccCCCceeeeecccccccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhh
Q 002349 741 LTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYAR-----TSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKT 815 (933)
Q Consensus 741 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~ 815 (933)
|+|||++........ ......|++.|+|||.+. ...++.++|||||||++|||++|+.||.............
T Consensus 162 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~- 239 (282)
T cd06636 162 LVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIP- 239 (282)
T ss_pred EeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHh-
Confidence 999999876532211 223356899999999875 3457889999999999999999999997544332221110
Q ss_pred cccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 816 ANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
....+... ....+..+.+++.+||+.||.+|||+.|++++
T Consensus 240 ------~~~~~~~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 240 ------RNPPPKLK----SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred ------hCCCCCCc----ccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 00011111 11234678999999999999999999999763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=307.67 Aligned_cols=263 Identities=25% Similarity=0.297 Sum_probs=202.2
Q ss_pred HHhhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCC----
Q 002349 595 RMTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSS---- 667 (933)
Q Consensus 595 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 667 (933)
+..++|+..+.||+|+||.||+|.++ +++.||+|+++... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999976 47889999986543 223456788999999999999999999987654
Q ss_pred ------ccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEE
Q 002349 668 ------GNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHL 741 (933)
Q Consensus 668 ------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl 741 (933)
..++|+||+++ ++.+.+.. ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEe
Confidence 68999999986 77777752 345789999999999999999999965 9999999999999999999999
Q ss_pred eecccccccccCCCceeeeecccccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccccc
Q 002349 742 TDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYART-SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAV 820 (933)
Q Consensus 742 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 820 (933)
+|||++...............++..|+|||.+.+ ..++.++||||+||++|||++|+.||...................
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 237 (302)
T cd07864 158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSP 237 (302)
T ss_pred CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 9999998764333222222346788999998865 357899999999999999999999998665544433222211111
Q ss_pred ccccCcccc-------------------ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 821 METVDPEIS-------------------ATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 821 ~~~~~~~~~-------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.....+.+. .... ..+..+.+++.+|++.||++||++.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFS--FIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred ChhhcccccccccccccccccccccchhhhcC--CCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111000000 0000 124678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=307.10 Aligned_cols=261 Identities=20% Similarity=0.252 Sum_probs=199.6
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecC--CccEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSS--SGNLLF 672 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv 672 (933)
++|+..+.||+|+||.||+|.+. +++.+|+|.++... ......+.+|+.++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57888899999999999999976 47889999986543 22234567899999999999999999998877 789999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccccc
Q 002349 673 YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV 752 (933)
Q Consensus 673 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 752 (933)
|||+++ +|.+++.. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 85 ~e~~~~-~L~~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVEH-DLKSLMET--MKQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcCc-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 999974 99998853 234689999999999999999999965 999999999999999999999999999987643
Q ss_pred CCCceeeeecccccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccccc-----------
Q 002349 753 SKSYTSTYIMGTIGYIDPEYARTS-RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAV----------- 820 (933)
Q Consensus 753 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~----------- 820 (933)
.. .......+++.|+|||.+.+. .++.++||||+|+++|+|++|+.||...................
T Consensus 159 ~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (293)
T cd07843 159 PL-KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL 237 (293)
T ss_pred Cc-cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence 32 122334578899999988764 46899999999999999999999998655433322111100000
Q ss_pred --------ccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 821 --------METVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 821 --------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.......+....+.......+.+++.+|++.+|++|||+.|++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000000001111111124568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=300.69 Aligned_cols=254 Identities=22% Similarity=0.302 Sum_probs=202.0
Q ss_pred ccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEec--CCccEEEE
Q 002349 599 NLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLS--SSGNLLFY 673 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~ 673 (933)
+|+..+.||.|+||.||+|... +++.||+|++.... ....+++..|++++++++||||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4777889999999999999965 57889999886432 3345678899999999999999999998764 34578999
Q ss_pred EecCCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhhcCC--CCCeeeccCCCCceEeCCCCCeEEeeccccccc
Q 002349 674 DFMENGSLWDILHGP-TKKKKLDWDTRLKIALGAAQGLAYLHHDC--SPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSL 750 (933)
Q Consensus 674 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~ 750 (933)
||+++++|.+++... ....++++..++.++.|++.||+|||..+ +.+++|+||||+||+++.++.+|++|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998532 22467899999999999999999999332 348999999999999999999999999999876
Q ss_pred ccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccc
Q 002349 751 CVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISA 830 (933)
Q Consensus 751 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (933)
...... .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ..... ...... .+.++.
T Consensus 161 ~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~-~~~~~~-----~~~~~~ 232 (265)
T cd08217 161 GHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ-LQLAS-KIKEGK-----FRRIPY 232 (265)
T ss_pred cCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH-HHHHH-HHhcCC-----CCCCcc
Confidence 433321 2334689999999999988899999999999999999999999986542 22211 111111 111111
Q ss_pred cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 831 TCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 831 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
..+..+.+++.+|++.+|++||++.+|+++
T Consensus 233 -----~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 233 -----RYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -----ccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 234678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=304.98 Aligned_cols=253 Identities=28% Similarity=0.380 Sum_probs=206.2
Q ss_pred HhhccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEE
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYD 674 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 674 (933)
.++.|+....||+|++|.||+|.++ +++.||+|++..... ..+.+.+|++++++++|+||+++++++......++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4567888889999999999999987 578899999976544 46778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCC
Q 002349 675 FMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSK 754 (933)
Q Consensus 675 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 754 (933)
|+++++|.+++.. ....+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 96 ~~~~~~L~~~l~~--~~~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 96 YMDGGSLTDIITQ--NFVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred ccCCCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 9999999999963 223799999999999999999999965 99999999999999999999999999987653221
Q ss_pred CceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccC
Q 002349 755 SYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKD 834 (933)
Q Consensus 755 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (933)
.......++..|+|||.+.+..++.++|||||||++|+|++|+.||............... ... .... .
T Consensus 171 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~--~~~-----~~~~---~ 239 (286)
T cd06614 171 -SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK--GIP-----PLKN---P 239 (286)
T ss_pred -hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--CCC-----CCcc---h
Confidence 1223345788999999998888999999999999999999999999865444332221111 100 0000 1
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 835 LGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 835 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
...+..+.+++.+|++.+|.+||++.+++++
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 240 EKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred hhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1134678899999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=306.60 Aligned_cols=247 Identities=28% Similarity=0.370 Sum_probs=198.3
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
+.|+..+.||+|+||.||+|... +++.||+|++.... .+..+++.+|+++++.++||||+++++++..++..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45788889999999999999975 57899999886432 234467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
||++ |++.+.+. .....+++..+..++.|++.||.|||+. +|+||||+|+||+++.++.+||+|||++......
T Consensus 95 e~~~-g~l~~~~~--~~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 95 EYCL-GSASDILE--VHKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HhhC-CCHHHHHH--HcccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 9997 57777764 2345689999999999999999999965 9999999999999999999999999998764322
Q ss_pred CCceeeeecccccccCccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccc
Q 002349 754 KSYTSTYIMGTIGYIDPEYAR---TSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISA 830 (933)
Q Consensus 754 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (933)
....|+..|+|||++. ...++.++||||||+++|||++|+.||.+............ .. .+...
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~--~~-----~~~~~- 235 (307)
T cd06607 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--ND-----SPTLS- 235 (307)
T ss_pred -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc--CC-----CCCCC-
Confidence 2346788999999874 35688999999999999999999999976543332221111 00 01110
Q ss_pred cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 831 TCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 831 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
....+..+.+++.+||+.+|++||++.+++.+.
T Consensus 236 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 236 ---SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred ---chhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 112346789999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=303.80 Aligned_cols=258 Identities=30% Similarity=0.372 Sum_probs=200.6
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecC--CccEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSS--SGNLLFY 673 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 673 (933)
++|...+.||.|++|.||+|... .++.+|+|.+.... .....++.+|++++++++||||+++++++... ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 36788899999999999999975 47889999887543 23456789999999999999999999988654 4679999
Q ss_pred EecCCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccccc
Q 002349 674 DFMENGSLWDILHGP-TKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV 752 (933)
Q Consensus 674 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 752 (933)
||+++++|.+++... .....++...+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999887421 2345689999999999999999999965 999999999999999999999999999875432
Q ss_pred CCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcc----hhHHHHhhhcccccccccCccc
Q 002349 753 SKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECN----LHHLILSKTANNAVMETVDPEI 828 (933)
Q Consensus 753 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 828 (933)
.. .....++..|+|||.+.+..++.++||||+|+++|+|++|+.||..... ......... ...........
T Consensus 158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 232 (287)
T cd06621 158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV--NMPNPELKDEP 232 (287)
T ss_pred cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh--cCCchhhccCC
Confidence 21 1234578899999999988999999999999999999999999985521 111111100 00000111000
Q ss_pred cccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 829 SATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 829 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
..+...+..+.+++.+|++.+|++|||+.|++++-
T Consensus 233 ---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~ 267 (287)
T cd06621 233 ---GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP 267 (287)
T ss_pred ---CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence 00112356789999999999999999999999853
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=304.43 Aligned_cols=259 Identities=24% Similarity=0.294 Sum_probs=200.7
Q ss_pred cCcceeeecccceeEEEEEEcC-CceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecC--CccEEEEE
Q 002349 600 LSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSS--SGNLLFYD 674 (933)
Q Consensus 600 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e 674 (933)
|+..+.||+|+||.||+|...+ ++.+|+|++.... ....+.+.+|++++++++|+|++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 5667899999999999999764 7899999997653 33456788999999999999999999999888 78999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCC
Q 002349 675 FMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSK 754 (933)
Q Consensus 675 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 754 (933)
|+++ +|.+++.. ....+++..+..++.|++.|++|||+. +++|+||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDS--PEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9975 89888853 235789999999999999999999965 99999999999999999999999999998765433
Q ss_pred CceeeeecccccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcc------
Q 002349 755 SYTSTYIMGTIGYIDPEYART-SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPE------ 827 (933)
Q Consensus 755 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 827 (933)
........++..|+|||.+.+ ..++.++||||||+++|||++|+.||........................+.
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence 222333457889999998765 4578999999999999999999999986554333222111110000000000
Q ss_pred -------------ccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 828 -------------ISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 828 -------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
+...... .++..+.+++.+|++.+|.+||++.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKH-LIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhccccccchhHHHHHhcc-cCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0000000 025678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=302.71 Aligned_cols=248 Identities=23% Similarity=0.263 Sum_probs=201.8
Q ss_pred ccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEE
Q 002349 599 NLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYD 674 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 674 (933)
+|+..++||.|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++..+...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999976 47899999986543 2346788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCC
Q 002349 675 FMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSK 754 (933)
Q Consensus 675 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 754 (933)
|+++++|.+++. ...++++..+..++.|+++||.|||++ +++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~~L~~~l~---~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLS---QKVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHH---hcCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 999999999995 336789999999999999999999965 99999999999999999999999999987653322
Q ss_pred CceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccC
Q 002349 755 SYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKD 834 (933)
Q Consensus 755 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (933)
......|+..|+|||.+.+..++.++||||+|+++|+|++|+.||................. .....++
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~-------- 223 (258)
T cd05578 155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET-ADVLYPA-------- 223 (258)
T ss_pred --cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc-ccccCcc--------
Confidence 22345688899999999888899999999999999999999999986543211111111110 1111111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCH--HHHHH
Q 002349 835 LGAVKKVFQLALLCSKRQPTDRPTM--HEVSR 864 (933)
Q Consensus 835 ~~~~~~l~~li~~cl~~dP~~RPt~--~evl~ 864 (933)
..+..+.+++.+|++.||.+||++ +|+++
T Consensus 224 -~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 224 -TWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred -cCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 123678899999999999999999 66553
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=303.56 Aligned_cols=262 Identities=23% Similarity=0.306 Sum_probs=200.8
Q ss_pred ccCcceeeecccceeEEEEEEc-CCceEEEEEecccCc-hhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEec
Q 002349 599 NLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYP-QCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFM 676 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 676 (933)
+|+..+.||+|++|.||+|... +++.||+|++..... .....+.+|++++++++||||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4788899999999999999976 578899999875432 23456778999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCc
Q 002349 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY 756 (933)
Q Consensus 677 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 756 (933)
++ +|.+++........+++..+..++.|++.||+|||+. +++||||||+||++++++.++++|||+++.......
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 8888886433345789999999999999999999965 999999999999999999999999999976533211
Q ss_pred eeeeecccccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccccc----------ccccC
Q 002349 757 TSTYIMGTIGYIDPEYARTS-RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAV----------METVD 825 (933)
Q Consensus 757 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~----------~~~~~ 825 (933)
......++..|+|||.+.+. .++.++||||+||++|+|++|+.||.+................. .....
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 12234578899999988664 56889999999999999999999998665443322211100000 00000
Q ss_pred ccccccc----c--CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 826 PEISATC----K--DLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 826 ~~~~~~~----~--~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
...+... . ....+..+.+++.+|++.||.+||++++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000000 0 01124567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=303.22 Aligned_cols=248 Identities=22% Similarity=0.361 Sum_probs=200.1
Q ss_pred ccCcceeeecccceeEEEEEEc-CCceEEEEEecccC-chhHHHHHHHHHHHhcCC---CCceeeeeeEEecCCccEEEE
Q 002349 599 NLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY-PQCLKEFETELETVGSIK---HRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~ 673 (933)
.|+..+.||+|+||.||+|.+. +++.||+|.+.... ....+++.+|++++++++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 3667788999999999999964 57899999986543 344567889999999996 999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
||+++++|.++++. ..+++..+..++.|++.|+.|||+. +|+|+||+|+||+++.++.++++|||++..+...
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999999842 3789999999999999999999965 9999999999999999999999999999876433
Q ss_pred CCceeeeecccccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccc
Q 002349 754 KSYTSTYIMGTIGYIDPEYARTS-RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATC 832 (933)
Q Consensus 754 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (933)
. .......|+..|+|||.+.++ .++.++|||||||++|+|++|+.||............ . ....+.+...
T Consensus 155 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~--~-----~~~~~~~~~~- 225 (277)
T cd06917 155 S-SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI--P-----KSKPPRLEDN- 225 (277)
T ss_pred c-cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcc--c-----cCCCCCCCcc-
Confidence 2 222334689999999988654 5689999999999999999999999765332221110 0 0011111111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 833 KDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 833 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
..+..+.+++.+|++.||++||++.+++++
T Consensus 226 ---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 226 ---GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred ---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 124578899999999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=303.94 Aligned_cols=252 Identities=27% Similarity=0.347 Sum_probs=194.6
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC-chhHHHHHHHHHH-HhcCCCCceeeeeeEEecCCccEEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY-PQCLKEFETELET-VGSIKHRNLVSLQGYSLSSSGNLLFYD 674 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e 674 (933)
++|+..+.||+|+||.||+|.++ +++.||+|++.... .....++..|+.. ++..+||||+++++++..+...++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36888899999999999999976 58899999987543 2233455556665 666789999999999999999999999
Q ss_pred ecCCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 675 FMENGSLWDILHGP-TKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 675 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
|++ |+|.+++... .....+++..+..++.|++.|++|||++ .+++||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 996 6888877532 2345789999999999999999999953 38999999999999999999999999999865322
Q ss_pred CCceeeeecccccccCcccccc----CCCCcchhhHHHHHHHHHHHhCCCCCCCCcc-hhHHHHhhhcccccccccCccc
Q 002349 754 KSYTSTYIMGTIGYIDPEYART----SRLTEKSDVYSFGIVLLELLTGRKAVDNECN-LHHLILSKTANNAVMETVDPEI 828 (933)
Q Consensus 754 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwSlGv~l~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 828 (933)
.......|+..|+|||.+.+ ..++.++||||+||++|+|++|+.||..... ........ . ...+.+
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~-----~~~~~~ 228 (283)
T cd06617 158 --VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV--E-----EPSPQL 228 (283)
T ss_pred --cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHH--h-----cCCCCC
Confidence 12223468899999998865 4568899999999999999999999974322 22211111 0 111111
Q ss_pred cccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 829 SATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 829 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
+. ...+..+.+++.+|+..+|++||++++++++
T Consensus 229 ~~----~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 229 PA----EKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred Cc----cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11 1124578899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=308.00 Aligned_cols=263 Identities=22% Similarity=0.279 Sum_probs=200.1
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccCc--hhHHHHHHHHHHHhcCCCCceeeeeeEEecC--CccEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYP--QCLKEFETELETVGSIKHRNLVSLQGYSLSS--SGNLL 671 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l 671 (933)
.++|+..+.||+|+||.||+|..+ +++.||+|+++.... .....+.+|++++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467899999999999999999975 488999999865432 2233567899999999999999999998765 45799
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccc
Q 002349 672 FYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLC 751 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 751 (933)
||||+++ +|.+++.. ....+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 86 v~e~~~~-~l~~~l~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCEQ-DLASLLDN--MPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999975 88888853 346789999999999999999999965 99999999999999999999999999998764
Q ss_pred cCCCceeeeecccccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcc---
Q 002349 752 VSKSYTSTYIMGTIGYIDPEYART-SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPE--- 827 (933)
Q Consensus 752 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 827 (933)
... .......++..|+|||.+.+ ..++.++||||+||++|||++|+.||................+.......+.
T Consensus 160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07845 160 LPA-KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSD 238 (309)
T ss_pred Ccc-CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhc
Confidence 322 12222346788999998865 4578999999999999999999999986655544332222111111110000
Q ss_pred --------cccc-ccC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 828 --------ISAT-CKD-----LGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 828 --------~~~~-~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
.... ... ......+.+++.+|++.||++|||+.+++++-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~ 291 (309)
T cd07845 239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESS 291 (309)
T ss_pred ccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 0000 000 01245678899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=328.26 Aligned_cols=266 Identities=18% Similarity=0.233 Sum_probs=190.4
Q ss_pred HHhhccCcceeeecccceeEEEEEEcC--CceEEEE------------------EecccCchhHHHHHHHHHHHhcCCCC
Q 002349 595 RMTENLSEKYIIGYGASSTVYKCVLKN--CKPVAIK------------------RLYSHYPQCLKEFETELETVGSIKHR 654 (933)
Q Consensus 595 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~h~ 654 (933)
...++|++.+.||+|+||+||+|.++. +..++.| ++. ........+.+|++++++++||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCC
Confidence 345789999999999999999987543 1112222 111 1122345688999999999999
Q ss_pred ceeeeeeEEecCCccEEEEEecCCCCHHHHhcCCC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceE
Q 002349 655 NLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPT--KKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNIL 732 (933)
Q Consensus 655 niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIl 732 (933)
|||++++++...+..++|+|++. +++.+++.... .........+..++.|++.||+|||++ +|+||||||+|||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NIL 299 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIF 299 (501)
T ss_pred CcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEE
Confidence 99999999999999999999985 57777764321 122344667888999999999999965 9999999999999
Q ss_pred eCCCCCeEEeecccccccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCC-CCc--chhH
Q 002349 733 LDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVD-NEC--NLHH 809 (933)
Q Consensus 733 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~-~~~--~~~~ 809 (933)
++.++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|..++. ... ...+
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred ECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 9999999999999998765443333344679999999999999999999999999999999999886443 221 1111
Q ss_pred HHHhhhcccccccccCc-------------------cccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 810 LILSKTANNAVMETVDP-------------------EISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 810 ~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
............+.++. .+.........+..+.+++.+|++.||++|||+.|++++
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 11111100000000000 000000011123456778999999999999999999875
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=305.76 Aligned_cols=263 Identities=18% Similarity=0.224 Sum_probs=197.8
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCC-CCceeeeeeEEecCCc-----
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIK-HRNLVSLQGYSLSSSG----- 668 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~----- 668 (933)
++|+..+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.++++++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999976 57899999886543 223457888999999995 6999999999877665
Q ss_pred cEEEEEecCCCCHHHHhcCCCC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCC-CCCeEEeecc
Q 002349 669 NLLFYDFMENGSLWDILHGPTK--KKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDK-DFEAHLTDFG 745 (933)
Q Consensus 669 ~~lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~-~~~~kl~DfG 745 (933)
.++||||+++ +|.+++..... ...+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 89888753221 34689999999999999999999965 9999999999999998 8899999999
Q ss_pred cccccccCCCceeeeecccccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccccccccc
Q 002349 746 IAKSLCVSKSYTSTYIMGTIGYIDPEYART-SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETV 824 (933)
Q Consensus 746 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 824 (933)
+++.+..... ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||.+.....................
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV 235 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 9976532211 1122356889999998865 4578999999999999999999999986655444322111100000000
Q ss_pred Ccc---------ccccc------cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 825 DPE---------ISATC------KDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 825 ~~~---------~~~~~------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.+. ..... ........+.+++.+|+++||++||+++|++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000 00000 001134668899999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=302.11 Aligned_cols=255 Identities=28% Similarity=0.372 Sum_probs=201.7
Q ss_pred HhhccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcC-CCCceeeeeeEEecCC------
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSI-KHRNLVSLQGYSLSSS------ 667 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~------ 667 (933)
.+++|+..+.||+|++|.||+|..+ +++.+++|++..... ..+.+.+|+++++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4678999999999999999999976 467899998865443 346789999999999 7999999999997644
Q ss_pred ccEEEEEecCCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccc
Q 002349 668 GNLLFYDFMENGSLWDILHGPT-KKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGI 746 (933)
Q Consensus 668 ~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl 746 (933)
..++||||+++++|.++++... ....+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||.
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcc
Confidence 4799999999999999985321 246789999999999999999999965 999999999999999999999999999
Q ss_pred ccccccCCCceeeeecccccccCcccccc-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccc
Q 002349 747 AKSLCVSKSYTSTYIMGTIGYIDPEYART-----SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVM 821 (933)
Q Consensus 747 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 821 (933)
+....... .......|+..|+|||++.. ..++.++||||+||++|+|++|+.||.............. .
T Consensus 160 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~--- 233 (275)
T cd06608 160 SAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPR--N--- 233 (275)
T ss_pred ceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhc--c---
Confidence 87653221 22233568899999998754 3467899999999999999999999975443333222111 1
Q ss_pred cccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 822 ETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
..+.... .......+.+++.+|+..||++|||+.+++++
T Consensus 234 --~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 234 --PPPTLKS---PENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred --CCCCCCc---hhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1111111 11234678899999999999999999999864
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=310.02 Aligned_cols=260 Identities=24% Similarity=0.317 Sum_probs=199.2
Q ss_pred HhhccCcceeeecccceeEEEEEEc-CCceEEEEEeccc--CchhHHHHHHHHHHHhcC-CCCceeeeeeEEecC--Ccc
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSH--YPQCLKEFETELETVGSI-KHRNLVSLQGYSLSS--SGN 669 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~~~ 669 (933)
..++|+..+.||+|+||.||+|.+. +++.||+|++... .......+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4578888999999999999999976 5788999988543 223345678899999999 999999999998654 357
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccc
Q 002349 670 LLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKS 749 (933)
Q Consensus 670 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 749 (933)
++||||++ ++|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999997 599998842 2788999999999999999999965 999999999999999999999999999986
Q ss_pred cccCCC----ceeeeecccccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccc---
Q 002349 750 LCVSKS----YTSTYIMGTIGYIDPEYART-SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVM--- 821 (933)
Q Consensus 750 ~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~--- 821 (933)
...... .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+..............+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 643221 12233568999999998765 4578999999999999999999999976544433222111111000
Q ss_pred -------------ccc----CccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 822 -------------ETV----DPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 822 -------------~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
+.. ........+ ..+..+.+++.+|++.||++|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLP--KASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhcc--CCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000 000000000 124678999999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=311.35 Aligned_cols=261 Identities=24% Similarity=0.308 Sum_probs=197.4
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCC-----cc
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSS-----GN 669 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~ 669 (933)
.++|+..+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.++++++||||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999965 57899999986432 334566888999999999999999999876543 47
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccc
Q 002349 670 LLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKS 749 (933)
Q Consensus 670 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 749 (933)
++|+||+++ ++.+.+. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceee
Confidence 899999964 8888773 35689999999999999999999965 999999999999999999999999999976
Q ss_pred cccCCCce--eeeecccccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccc-ccc---
Q 002349 750 LCVSKSYT--STYIMGTIGYIDPEYART-SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNA-VME--- 822 (933)
Q Consensus 750 ~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~--- 822 (933)
........ .....|+..|+|||.+.+ ..++.++||||+||++|+|++|+.||.+......+......... ..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLN 235 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 53322211 123468899999998754 46889999999999999999999999765433222111100000 000
Q ss_pred ------------ccC--ccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 823 ------------TVD--PEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 823 ------------~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
..+ +..............+.+++.+|++.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 0000000000124568899999999999999999999986
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=304.82 Aligned_cols=251 Identities=28% Similarity=0.354 Sum_probs=200.0
Q ss_pred ccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEE
Q 002349 599 NLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYD 674 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 674 (933)
.|+..+.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++|||++++++++..+...++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 3666788999999999999965 57889999986432 2334578899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCC
Q 002349 675 FMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSK 754 (933)
Q Consensus 675 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 754 (933)
|+++ ++.+.+. ....++++..+..++.|++.|+.|||+. +|+||||+|+||+++.++.+||+|||++......
T Consensus 106 ~~~g-~l~~~~~--~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 106 YCLG-SASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CCCC-CHHHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 9975 7877774 2355689999999999999999999965 9999999999999999999999999998754321
Q ss_pred CceeeeecccccccCccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccc
Q 002349 755 SYTSTYIMGTIGYIDPEYAR---TSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISAT 831 (933)
Q Consensus 755 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (933)
....|++.|+|||.+. ++.++.++|||||||++|||++|+.||................. +...
T Consensus 179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~-------~~~~-- 245 (317)
T cd06635 179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-------PTLQ-- 245 (317)
T ss_pred ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccC-------CCCC--
Confidence 2346888999999874 45688999999999999999999999976543332222111110 0000
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCC
Q 002349 832 CKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVP 871 (933)
Q Consensus 832 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 871 (933)
....+..+.+++.+|++.+|.+||++.+++++......
T Consensus 246 --~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 246 --SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred --CccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 11224568899999999999999999999987765543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=308.57 Aligned_cols=249 Identities=20% Similarity=0.258 Sum_probs=206.3
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
...|.....||+|.|++|..|.+. .+..||+|.+.+.. ....+.+.+|+++|..++|||||+++.+.......|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 456788889999999999999965 47899999997754 334456899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
||+.+|.+.+++. +.+.+....+..++.|+.+|++|||++ .|||||||++|||++.+..+||+|||++..+.
T Consensus 135 eya~~ge~~~yl~---~~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~-- 206 (596)
T KOG0586|consen 135 EYASGGELFDYLV---KHGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD-- 206 (596)
T ss_pred EeccCchhHHHHH---hcccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec--
Confidence 9999999999994 566777789999999999999999965 99999999999999999999999999999874
Q ss_pred CCceeeeecccccccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccc
Q 002349 754 KSYTSTYIMGTIGYIDPEYARTSRL-TEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATC 832 (933)
Q Consensus 754 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (933)
........+|++.|.|||++.+.+| .+++|+||+|+++|.|+.|..||++..-..-..........+
T Consensus 207 ~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rI------------ 274 (596)
T KOG0586|consen 207 YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRI------------ 274 (596)
T ss_pred ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecc------------
Confidence 3444566799999999999999876 589999999999999999999998643221111111111111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 833 KDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 833 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
+.....++.+++++++-.+|.+|++.+++.+.-
T Consensus 275 -p~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~ 307 (596)
T KOG0586|consen 275 -PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDR 307 (596)
T ss_pred -cceeechhHHHHHHhhccCccccCCHHHhhhhc
Confidence 111234567789999999999999999998643
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=301.89 Aligned_cols=260 Identities=23% Similarity=0.287 Sum_probs=197.7
Q ss_pred cCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEec
Q 002349 600 LSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFM 676 (933)
Q Consensus 600 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 676 (933)
|+..+.||.|++|.||+|.+. +++.||+|++.... ....+.+.+|++++++++|||++++++++..++..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567789999999999999975 68899999986543 223456888999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCc
Q 002349 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY 756 (933)
Q Consensus 677 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 756 (933)
+ ++|.+++... ....+++..+..++.|+++||+|||++ +++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 81 D-LDLKKYMDSS-PLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred C-cCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 5 6899998531 224689999999999999999999965 999999999999999999999999999976532211
Q ss_pred eeeeecccccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccccccccc----------C
Q 002349 757 TSTYIMGTIGYIDPEYARTS-RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETV----------D 825 (933)
Q Consensus 757 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----------~ 825 (933)
......++..|+|||++.+. .++.++||||||+++|+|++|+.||....................+.. .
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK 234 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence 11223568899999988664 578899999999999999999999976554433222111100000000 0
Q ss_pred ccccccc-c-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 826 PEISATC-K-----DLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 826 ~~~~~~~-~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
..+.... . ....+..+.+++.+|++.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000000 0 00123578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=312.73 Aligned_cols=260 Identities=21% Similarity=0.235 Sum_probs=199.4
Q ss_pred HHhhccCcceeeecccceeEEEEEEc-CCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCceeeeeeEEecC-----
Q 002349 595 RMTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSH--YPQCLKEFETELETVGSIKHRNLVSLQGYSLSS----- 666 (933)
Q Consensus 595 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----- 666 (933)
...++|+..+.||+|+||.||+|... +++.||+|++... ......++.+|++++++++||||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 34578999999999999999999965 5789999998643 233445678899999999999999999988644
Q ss_pred -CccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecc
Q 002349 667 -SGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFG 745 (933)
Q Consensus 667 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfG 745 (933)
...++||||+. ++|.+.+.. .++...+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence 34699999996 488888742 288999999999999999999965 99999999999999999999999999
Q ss_pred cccccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccc----
Q 002349 746 IAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVM---- 821 (933)
Q Consensus 746 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~---- 821 (933)
+++...... ......++..|+|||.+.+..++.++||||+||++|+|++|+.||........+.......+...
T Consensus 164 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 164 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred cceeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 998653321 22334688999999999999999999999999999999999999976544333221111000000
Q ss_pred -----------------------cccCccc-ccc--ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 822 -----------------------ETVDPEI-SAT--CKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 822 -----------------------~~~~~~~-~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
+...... ... ......+..+.+++.+|++.||++|||+.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000 000 0011234567899999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=297.08 Aligned_cols=242 Identities=25% Similarity=0.308 Sum_probs=195.6
Q ss_pred eecccceeEEEEEEcC-CceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecCCCCH
Q 002349 606 IGYGASSTVYKCVLKN-CKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSL 681 (933)
Q Consensus 606 lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 681 (933)
||.|+||.||+|.... ++.||+|++.... ....+.+.+|++++++++||||+++++++.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6999999999999764 7899999986543 23456789999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCceeeee
Q 002349 682 WDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYI 761 (933)
Q Consensus 682 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 761 (933)
.+++. ....+++..+..++.|++.||+|+|++ +++|+||+|+||+++.++.++|+|||.+....... .....
T Consensus 81 ~~~l~---~~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~ 152 (262)
T cd05572 81 WTILR---DRGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTF 152 (262)
T ss_pred HHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccc
Confidence 99995 345689999999999999999999965 99999999999999999999999999998764332 22334
Q ss_pred cccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHHHHHH
Q 002349 762 MGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKV 841 (933)
Q Consensus 762 ~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 841 (933)
.|+..|+|||.+.+..++.++|+||+|+++|+|++|..||.................. .....+. ..+..+
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~-----~~~~~~ 223 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGN----GKLEFPN-----YIDKAA 223 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccC----CCCCCCc-----ccCHHH
Confidence 6889999999998888999999999999999999999999765421111111111000 0111111 114678
Q ss_pred HHHHHHccCCCCCCCCC-----HHHHHH
Q 002349 842 FQLALLCSKRQPTDRPT-----MHEVSR 864 (933)
Q Consensus 842 ~~li~~cl~~dP~~RPt-----~~evl~ 864 (933)
.+++.+||+.+|++||+ ++|+++
T Consensus 224 ~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 224 KDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 99999999999999999 777776
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=305.28 Aligned_cols=263 Identities=24% Similarity=0.300 Sum_probs=197.4
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCc-----
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSG----- 668 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----- 668 (933)
.++|+..+.||+|+||.||+|... +++.||||++.... ......+.+|++++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357899999999999999999976 57899999886532 2223456789999999999999999999876543
Q ss_pred ---cEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecc
Q 002349 669 ---NLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFG 745 (933)
Q Consensus 669 ---~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfG 745 (933)
.++||||+.+ ++.+.+.. ....+++.++..++.|++.||+|||++ +++|+||||+||+++.++.+||+|||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCC
Confidence 4999999964 88888752 334789999999999999999999966 99999999999999999999999999
Q ss_pred cccccccCCCc---eeeeecccccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccc
Q 002349 746 IAKSLCVSKSY---TSTYIMGTIGYIDPEYARTS-RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVM 821 (933)
Q Consensus 746 la~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 821 (933)
++......... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||................+...
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99765332211 11234578899999988664 478899999999999999999999986654433322222111111
Q ss_pred cccCccc-----------ccc--------ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 822 ETVDPEI-----------SAT--------CKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 822 ~~~~~~~-----------~~~--------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
....+.. +.. .........+.+++.+|+..||++|||++|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 1110000 000 0000112456789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=303.10 Aligned_cols=244 Identities=24% Similarity=0.358 Sum_probs=198.8
Q ss_pred eeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecCCCCHH
Q 002349 604 YIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLW 682 (933)
Q Consensus 604 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 682 (933)
.+||+|+||.||+|..+ +++.||+|++..........+.+|+.++++++|+||+++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 46999999999999875 57899999986555555677899999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCceeeeec
Q 002349 683 DILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIM 762 (933)
Q Consensus 683 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 762 (933)
+++. ...+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||++....... .......
T Consensus 106 ~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~~ 177 (292)
T cd06657 106 DIVT----HTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLV 177 (292)
T ss_pred HHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccc-ccccccc
Confidence 9873 34689999999999999999999965 99999999999999999999999999987653322 2223356
Q ss_pred ccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHHHHHHH
Q 002349 763 GTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVF 842 (933)
Q Consensus 763 gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 842 (933)
|++.|+|||...+..++.++||||+|+++|+|++|+.||.............. ..++.+... ...+..+.
T Consensus 178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~-------~~~~~~~~~---~~~~~~l~ 247 (292)
T cd06657 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD-------NLPPKLKNL---HKVSPSLK 247 (292)
T ss_pred cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------hCCcccCCc---ccCCHHHH
Confidence 88999999999888889999999999999999999999976544333222111 111111110 01234678
Q ss_pred HHHHHccCCCCCCCCCHHHHHHH
Q 002349 843 QLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 843 ~li~~cl~~dP~~RPt~~evl~~ 865 (933)
+++.+|++.+|.+||++.+++++
T Consensus 248 ~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 248 GFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred HHHHHHHhCCcccCcCHHHHhcC
Confidence 89999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=294.74 Aligned_cols=251 Identities=27% Similarity=0.403 Sum_probs=205.2
Q ss_pred ccCcceeeecccceeEEEEEEc-CCceEEEEEecccCc--hhHHHHHHHHHHHhcCCCCceeeeeeEEecC--CccEEEE
Q 002349 599 NLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYP--QCLKEFETELETVGSIKHRNLVSLQGYSLSS--SGNLLFY 673 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 673 (933)
+|+..+.||+|++|.||+|... +++.|++|++..... ...+.+.+|++++++++||||+++++++... ...++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677889999999999999977 578999999876542 4567889999999999999999999999988 8899999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
||+++++|.+++. ....+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLK---KFGKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999995 334899999999999999999999965 9999999999999999999999999999876433
Q ss_pred CCc-eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccc
Q 002349 754 KSY-TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATC 832 (933)
Q Consensus 754 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (933)
... ......++..|+|||...+...+.++||||||+++++|++|+.||............... ... .+.++.
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~----~~~~~~-- 227 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS-SGE----PPEIPE-- 227 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccc-cCC----CcCCCc--
Confidence 221 123456889999999999888999999999999999999999999865422222211111 000 111111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 833 KDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 833 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
..+..+.+++.+|++.+|++||++.+++++
T Consensus 228 ---~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 228 ---HLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred ---ccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 124678899999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=296.50 Aligned_cols=250 Identities=24% Similarity=0.344 Sum_probs=200.6
Q ss_pred ccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEe
Q 002349 599 NLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
+|+..+.||+|+||.||+|..+ ++..||+|.+.... ....+.+.+|++++++++|+||+++++++......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999976 47889999986532 23446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCC-eEEeecccccccccCC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFE-AHLTDFGIAKSLCVSK 754 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~-~kl~DfGla~~~~~~~ 754 (933)
+++++|.+++.. .....+++..+..++.|++.|++|||+. +++|+||||+||++++++. +|++|||.+.......
T Consensus 81 ~~~~~L~~~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINR-QRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 999999999853 2234579999999999999999999965 9999999999999998864 6999999997664322
Q ss_pred CceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccC
Q 002349 755 SYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKD 834 (933)
Q Consensus 755 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (933)
.......|++.|+|||+..+..++.++||||||+++|||++|+.||....... ...... .... ....+
T Consensus 157 -~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~-~~~~-~~~~~-------- 224 (257)
T cd08225 157 -ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ-LVLKIC-QGYF-APISP-------- 224 (257)
T ss_pred -ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH-HHHHHh-cccC-CCCCC--------
Confidence 12233468899999999988889999999999999999999999997543322 222111 1111 11111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 835 LGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 835 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
..+..+.+++.+|++.+|++|||+.+++++
T Consensus 225 -~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 225 -NFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -CCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 123578899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=302.99 Aligned_cols=262 Identities=20% Similarity=0.256 Sum_probs=197.1
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYD 674 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 674 (933)
++|+..+.||+|++|+||+|..+ +++.||+|++.... ....+.+.+|++++++++||||+++++++..+...++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 47888999999999999999976 57899999886543 2234668899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCC-CCCeEEeecccccccccC
Q 002349 675 FMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDK-DFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 675 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~-~~~~kl~DfGla~~~~~~ 753 (933)
|++ +++.+++.. .....+++..+..++.|++.||+|||++ +++||||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDS-SPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHh-CCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 996 578887743 2233468888999999999999999965 9999999999999985 567999999999765332
Q ss_pred CCceeeeecccccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccC-------
Q 002349 754 KSYTSTYIMGTIGYIDPEYARTS-RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVD------- 825 (933)
Q Consensus 754 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------- 825 (933)
.. ......+++.|+|||++.+. .++.++||||+||++|+|+||+.||....................+...
T Consensus 157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (294)
T PLN00009 157 VR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLP 235 (294)
T ss_pred cc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccch
Confidence 11 12233578899999988764 5789999999999999999999999765544333221110000000000
Q ss_pred ------ccccccc---cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 826 ------PEISATC---KDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 826 ------~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
+...... ........+.+++.+|++.+|++||++.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 000123567889999999999999999999863
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=299.56 Aligned_cols=244 Identities=23% Similarity=0.244 Sum_probs=191.8
Q ss_pred eecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecCCCCH
Q 002349 606 IGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSL 681 (933)
Q Consensus 606 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 681 (933)
||+|+||+||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999865 57899999986532 22345567899999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCceeeee
Q 002349 682 WDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYI 761 (933)
Q Consensus 682 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 761 (933)
.+++... ....+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.+||+|||.+..... .......
T Consensus 81 ~~~l~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~--~~~~~~~ 154 (277)
T cd05577 81 KYHIYNV-GEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG--GKKIKGR 154 (277)
T ss_pred HHHHHHc-CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhcc--CCccccc
Confidence 9998632 224689999999999999999999965 999999999999999999999999999876532 2222334
Q ss_pred cccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHHHHHH
Q 002349 762 MGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKV 841 (933)
Q Consensus 762 ~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 841 (933)
.++..|+|||.+.+..++.++||||+|+++|+|++|+.||.............. .... .....+. .....+
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~--~~~~~~~-----~~~~~~ 225 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR--RTLE--MAVEYPD-----KFSPEA 225 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh--cccc--ccccCCc-----cCCHHH
Confidence 678899999999888899999999999999999999999975433111110000 0000 0111111 124578
Q ss_pred HHHHHHccCCCCCCCC-----CHHHHHH
Q 002349 842 FQLALLCSKRQPTDRP-----TMHEVSR 864 (933)
Q Consensus 842 ~~li~~cl~~dP~~RP-----t~~evl~ 864 (933)
.+++.+|++.||++|| ++.++++
T Consensus 226 ~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 226 KDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred HHHHHHHccCChhHccCCCcccHHHHHh
Confidence 8999999999999999 6666765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=283.58 Aligned_cols=258 Identities=20% Similarity=0.323 Sum_probs=202.4
Q ss_pred CHHHHHHHhhccCcceeeecccceeEEEEE-EcCCceEEEEEecccCchhHHHHHHHHHHHhcC-CCCceeeeeeEEecC
Q 002349 589 VYEDIMRMTENLSEKYIIGYGASSTVYKCV-LKNCKPVAIKRLYSHYPQCLKEFETELETVGSI-KHRNLVSLQGYSLSS 666 (933)
Q Consensus 589 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 666 (933)
.++|+...|+ +.||+|+|+.|-.++ ..++.++|||++.+.....+.+..+|++++.+. .|+||+.++++|+++
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 4677777776 469999999999988 678899999999888777888999999999999 599999999999999
Q ss_pred CccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCC---CeEEee
Q 002349 667 SGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDF---EAHLTD 743 (933)
Q Consensus 667 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~---~~kl~D 743 (933)
+..|+|||.|.||+|..+++ ++..+++.++.+++++|+.||.+||.+ ||.|||+||+|||..... -|||+|
T Consensus 149 ~~FYLVfEKm~GGplLshI~---~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCD 222 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQ---KRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICD 222 (463)
T ss_pred ceEEEEEecccCchHHHHHH---HhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeec
Confidence 99999999999999999995 567899999999999999999999955 999999999999997543 479999
Q ss_pred cccccccccC------CCceeeeecccccccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchh----
Q 002349 744 FGIAKSLCVS------KSYTSTYIMGTIGYIDPEYAR-----TSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLH---- 808 (933)
Q Consensus 744 fGla~~~~~~------~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~---- 808 (933)
|.++.-.... .+..-...+|+..|||||+.. ...|+.++|.||+||++|-|++|..||.+.....
T Consensus 223 fDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWd 302 (463)
T KOG0607|consen 223 FDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWD 302 (463)
T ss_pred cccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCcc
Confidence 9877543211 112223457899999999763 2358899999999999999999999997543310
Q ss_pred ---------H--HHHhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 809 ---------H--LILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 809 ---------~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
. +..+......+++.-+. ....+..+++...+..|+.+|.++.+++.+-
T Consensus 303 rGe~Cr~CQ~~LFesIQEGkYeFPdkdWa---------hIS~eakdlisnLlvrda~~rlsa~~vlnhP 362 (463)
T KOG0607|consen 303 RGEVCRVCQNKLFESIQEGKYEFPDKDWA---------HISSEAKDLISNLLVRDAKQRLSAAQVLNHP 362 (463)
T ss_pred CCCccHHHHHHHHHHHhccCCcCChhhhH---------HhhHHHHHHHHHHHhccHHhhhhhhhccCCc
Confidence 0 01111111111211111 1234455678888889999999999998744
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=310.46 Aligned_cols=263 Identities=25% Similarity=0.328 Sum_probs=201.0
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEec----CCcc
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLS----SSGN 669 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~ 669 (933)
.++|+..+.||+|+||.||+|..+ +++.||+|++.... ....+.+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 468899999999999999999965 48899999987543 2345667889999999999999999998763 3457
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccc
Q 002349 670 LLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKS 749 (933)
Q Consensus 670 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 749 (933)
++||||+. ++|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIH---SDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccccee
Confidence 89999996 58999884 345699999999999999999999965 999999999999999999999999999976
Q ss_pred cccCCCc---eeeeecccccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccccccc---
Q 002349 750 LCVSKSY---TSTYIMGTIGYIDPEYART-SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVME--- 822 (933)
Q Consensus 750 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--- 822 (933)
....... ......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.+..............+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 5332211 1223478899999998765 46889999999999999999999999765544332221111111000
Q ss_pred -------------ccCcccccccc--CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 823 -------------TVDPEISATCK--DLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 823 -------------~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
........... ....+..+.+++.+|++.+|++||++++++.+-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 00000000000 011246789999999999999999999998754
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=304.62 Aligned_cols=255 Identities=28% Similarity=0.339 Sum_probs=195.2
Q ss_pred ccCcceeeecccceeEEEEEEc-CCceEEEEEecccC-chhHHHHHHHHHHHhcCC-CCceeeeeeEEecCCccEEEEEe
Q 002349 599 NLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY-PQCLKEFETELETVGSIK-HRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
+|...+.||+|+||.||++.+. +++.||+|++.... ......+.+|+.++.++. ||||+++++++..+...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4555678999999999999976 47899999986543 334567889999999996 99999999999999899999999
Q ss_pred cCCCCHHHHhcC--CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 676 MENGSLWDILHG--PTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 676 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
+.. ++.++... ......+++..+..++.|++.||+|||+. .+++||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 864 55554321 02346789999999999999999999952 38999999999999999999999999999765332
Q ss_pred CCceeeeecccccccCccccccC---CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccc
Q 002349 754 KSYTSTYIMGTIGYIDPEYARTS---RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISA 830 (933)
Q Consensus 754 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (933)
. ......|+..|+|||.+.+. .++.++||||+||++|+|++|+.||.............. .. ..+.+..
T Consensus 162 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~-----~~~~~~~ 233 (288)
T cd06616 162 I--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVV-KG-----DPPILSN 233 (288)
T ss_pred C--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhc-CC-----CCCcCCC
Confidence 2 12233688999999998776 688999999999999999999999975432111111110 00 0111111
Q ss_pred cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 831 TCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 831 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.. ....+..+.+++.+|++.+|++|||+.+|+++
T Consensus 234 ~~-~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 234 SE-EREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred cC-CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11 11235678999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=299.47 Aligned_cols=245 Identities=24% Similarity=0.297 Sum_probs=197.6
Q ss_pred eecccceeEEEEEEcC-CceEEEEEecccCc---hhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecCCCCH
Q 002349 606 IGYGASSTVYKCVLKN-CKPVAIKRLYSHYP---QCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSL 681 (933)
Q Consensus 606 lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 681 (933)
||+|+||.||+|.+.. ++.+|+|.+..... ...+.+.+|++++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999874 88999999865432 3456788999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCC------
Q 002349 682 WDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS------ 755 (933)
Q Consensus 682 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~------ 755 (933)
.++++. .+.+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~---~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLEN---VGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 999953 34789999999999999999999965 999999999999999999999999999876432211
Q ss_pred -ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccC
Q 002349 756 -YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKD 834 (933)
Q Consensus 756 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (933)
.......++..|+|||...+..++.++||||||+++|++++|+.||.............. ... ..+. .
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~------~~~~---~ 223 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN--GKI------EWPE---D 223 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CCc------CCCc---c
Confidence 122345688899999999888899999999999999999999999976543332221111 100 0000 0
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 002349 835 LGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLG 867 (933)
Q Consensus 835 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 867 (933)
...+..+.+++.+|++.+|++|||+.++.+.++
T Consensus 224 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 224 VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 012467889999999999999999966666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=300.90 Aligned_cols=259 Identities=23% Similarity=0.291 Sum_probs=202.1
Q ss_pred cCcceeeecccceeEEEEEEc-CCceEEEEEecccCc--hhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEec
Q 002349 600 LSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYP--QCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFM 676 (933)
Q Consensus 600 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 676 (933)
|+..+.||+|++|.||+|... +++.+|+|++..... .....+.+|++++++++|+||+++++++..+...++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 556788999999999999975 578899999865432 24567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCc
Q 002349 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY 756 (933)
Q Consensus 677 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 756 (933)
++ ++.+++.. ....+++..+..++.|++.|++|||+. +|+|+||||+||+++.++.+||+|||.+....... .
T Consensus 81 ~~-~l~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~ 153 (283)
T cd05118 81 DT-DLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-R 153 (283)
T ss_pred CC-CHHHHHHh--hcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-c
Confidence 75 88888853 336789999999999999999999965 99999999999999999999999999997764332 1
Q ss_pred eeeeecccccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccc-----
Q 002349 757 TSTYIMGTIGYIDPEYARTS-RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISA----- 830 (933)
Q Consensus 757 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 830 (933)
......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||................+.......+....
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY 233 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhh
Confidence 22234578899999998776 789999999999999999999999976655443322211111100000000000
Q ss_pred ------------cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 831 ------------TCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 831 ------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.......+.++.+++.+|++.||.+||++.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00001235678999999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=307.52 Aligned_cols=263 Identities=23% Similarity=0.267 Sum_probs=195.7
Q ss_pred ccCcceeeecccceeEEEEEEcC---CceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecC--CccE
Q 002349 599 NLSEKYIIGYGASSTVYKCVLKN---CKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSS--SGNL 670 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~ 670 (933)
+|+..+.||+|+||.||+|..+. ++.||+|.+.... ....+.+.+|++++++++||||+++++++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47778899999999999999754 6899999997633 33446678899999999999999999999888 7889
Q ss_pred EEEEecCCCCHHHHhcCCC--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCC----CCCeEEeec
Q 002349 671 LFYDFMENGSLWDILHGPT--KKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDK----DFEAHLTDF 744 (933)
Q Consensus 671 lv~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~----~~~~kl~Df 744 (933)
+||||+++ ++.+.+.... ....+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 6777664211 223789999999999999999999965 9999999999999999 899999999
Q ss_pred ccccccccCCC--ceeeeecccccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchh---------HHHH
Q 002349 745 GIAKSLCVSKS--YTSTYIMGTIGYIDPEYARTS-RLTEKSDVYSFGIVLLELLTGRKAVDNECNLH---------HLIL 812 (933)
Q Consensus 745 Gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~---------~~~~ 812 (933)
|+++....... .......++..|+|||++.+. .++.++|||||||++|+|++|+.||....... ....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99986533222 122334678999999988764 57899999999999999999999997443221 0000
Q ss_pred h--hhc------------cccccc----ccCccccc-cccC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 813 S--KTA------------NNAVME----TVDPEISA-TCKD-----LGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 813 ~--~~~------------~~~~~~----~~~~~~~~-~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
. ... ...... ........ .... ......+.+++.+|++.||++|||+.|++++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0 000 000000 00000000 0000 0123568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=300.38 Aligned_cols=257 Identities=21% Similarity=0.249 Sum_probs=194.1
Q ss_pred cCcceeeecccceeEEEEEEc-CCceEEEEEecccC-chhHHHHHHHHHHHhcCC-CCceeeeeeEEecC--CccEEEEE
Q 002349 600 LSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY-PQCLKEFETELETVGSIK-HRNLVSLQGYSLSS--SGNLLFYD 674 (933)
Q Consensus 600 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e 674 (933)
|+..+.||+|+||.||+|... +++.||+|+++... ........+|+.+++++. |+||+++++++.++ +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 566788999999999999965 57889999987542 222334457899999885 99999999999887 88999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCC
Q 002349 675 FMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSK 754 (933)
Q Consensus 675 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 754 (933)
|++ +++.+.+.. ....+++.++..++.|++.||+|||+. +++||||||+||+++. +.+||+|||+++......
T Consensus 81 ~~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKG--RKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 997 588888752 335789999999999999999999965 9999999999999999 999999999998653322
Q ss_pred CceeeeecccccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccccccc----------c
Q 002349 755 SYTSTYIMGTIGYIDPEYART-SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVME----------T 823 (933)
Q Consensus 755 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------~ 823 (933)
. .....++..|+|||.+.+ ..++.++||||+||++|||++|+.||.+..............+...+ .
T Consensus 154 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07831 154 P--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH 231 (282)
T ss_pred C--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence 2 123457889999997654 45788999999999999999999999765543322211111000000 0
Q ss_pred cCccccccc------cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 824 VDPEISATC------KDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 824 ~~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.....+... .....+..+.+++.+|++.+|++||++++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 000000000 001235789999999999999999999999874
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=293.17 Aligned_cols=247 Identities=30% Similarity=0.420 Sum_probs=204.0
Q ss_pred ccCcceeeecccceeEEEEEEc-CCceEEEEEecccCc--hhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEe
Q 002349 599 NLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYP--QCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
+|+..+.||+|++|.||+|... .++.||+|.+..... ...+.+.+|++++++++|||++++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999876 478899999976543 4567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS 755 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 755 (933)
+++++|.+++. ....+++..+..++.|++.|+.|||+. +|+||||||+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~L~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIK---KFGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 99999999985 346799999999999999999999955 999999999999999999999999999987643322
Q ss_pred ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCH
Q 002349 756 YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDL 835 (933)
Q Consensus 756 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (933)
. .....++..|+|||...+..++.++||||+|+++|+|++|+.||.............. . .. +.++.
T Consensus 155 ~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~-~~----~~~~~----- 221 (254)
T cd06627 155 D-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ--D-DH----PPLPE----- 221 (254)
T ss_pred c-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc--c-CC----CCCCC-----
Confidence 1 2334688999999999888889999999999999999999999976554333222111 1 01 11111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002349 836 GAVKKVFQLALLCSKRQPTDRPTMHEVSR 864 (933)
Q Consensus 836 ~~~~~l~~li~~cl~~dP~~RPt~~evl~ 864 (933)
..+..+.+++.+|+..+|++|||+.+++.
T Consensus 222 ~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 222 GISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 12357889999999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=299.36 Aligned_cols=243 Identities=23% Similarity=0.265 Sum_probs=186.7
Q ss_pred eeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHh---cCCCCceeeeeeEEecCCccEEEEEecC
Q 002349 605 IIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVG---SIKHRNLVSLQGYSLSSSGNLLFYDFME 677 (933)
Q Consensus 605 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~---~l~h~niv~~~~~~~~~~~~~lv~e~~~ 677 (933)
.||+|+||.||+|... +++.+|+|.+.... ......+.+|..+++ ..+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999975 47899999886532 112233444544443 3479999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCce
Q 002349 678 NGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYT 757 (933)
Q Consensus 678 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 757 (933)
+++|.+++. ..+.+++..+..++.|++.||+|||+. +|+||||||+||++++++.++++|||++.......
T Consensus 81 ~~~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLS---QHGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 999999984 345799999999999999999999965 99999999999999999999999999987553221
Q ss_pred eeeecccccccCccccc-cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHH
Q 002349 758 STYIMGTIGYIDPEYAR-TSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLG 836 (933)
Q Consensus 758 ~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (933)
.....|+..|+|||... +..++.++||||+||++|+|++|+.||.............. .. .....++. .
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~-~~----~~~~~~~~-----~ 221 (279)
T cd05633 152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-TL----TVNVELPD-----S 221 (279)
T ss_pred ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH-hh----cCCcCCcc-----c
Confidence 12346899999999886 45688999999999999999999999974322111111110 00 01111111 1
Q ss_pred HHHHHHHHHHHccCCCCCCCC-----CHHHHHHHH
Q 002349 837 AVKKVFQLALLCSKRQPTDRP-----TMHEVSRVL 866 (933)
Q Consensus 837 ~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L 866 (933)
.+.++.+++.+|++.||++|| +++|++++.
T Consensus 222 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~ 256 (279)
T cd05633 222 FSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHV 256 (279)
T ss_pred cCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence 245788999999999999999 699998863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=301.34 Aligned_cols=255 Identities=22% Similarity=0.287 Sum_probs=199.7
Q ss_pred ccCcceeeecccceeEEEEEEc----CCceEEEEEecccC----chhHHHHHHHHHHHhcC-CCCceeeeeeEEecCCcc
Q 002349 599 NLSEKYIIGYGASSTVYKCVLK----NCKPVAIKRLYSHY----PQCLKEFETELETVGSI-KHRNLVSLQGYSLSSSGN 669 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 669 (933)
+|+..+.||+|+||.||+|... +++.||||.++... ....+.+.+|++++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 3677889999999999999853 46789999986432 22345688999999999 599999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccc
Q 002349 670 LLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKS 749 (933)
Q Consensus 670 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 749 (933)
++||||+++++|.+++. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLY---QREHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHh---hcCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccc
Confidence 99999999999999984 345789999999999999999999965 999999999999999999999999999976
Q ss_pred cccCCCceeeeecccccccCccccccCC--CCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcc
Q 002349 750 LCVSKSYTSTYIMGTIGYIDPEYARTSR--LTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPE 827 (933)
Q Consensus 750 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 827 (933)
.............|+..|+|||...+.. .+.++||||||+++|||++|+.||.............. . .... .+.
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~--~-~~~~-~~~ 230 (288)
T cd05583 155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR--R-ILKS-KPP 230 (288)
T ss_pred cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHH--H-HHcc-CCC
Confidence 5433332233456899999999987654 78899999999999999999999964322111110000 0 0000 011
Q ss_pred ccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcc
Q 002349 828 ISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGS 868 (933)
Q Consensus 828 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 868 (933)
.+. .....+.+++.+|++.||++|||+.++.+.|+.
T Consensus 231 ~~~-----~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 231 FPK-----TMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred CCc-----ccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 111 123567889999999999999999888887765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=294.56 Aligned_cols=244 Identities=21% Similarity=0.189 Sum_probs=190.2
Q ss_pred eeeecccceeEEEEEEc-CCceEEEEEecccCc---hhHHHHHHHHHHH-hcCCCCceeeeeeEEecCCccEEEEEecCC
Q 002349 604 YIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYP---QCLKEFETELETV-GSIKHRNLVSLQGYSLSSSGNLLFYDFMEN 678 (933)
Q Consensus 604 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 678 (933)
+.||+|+||.||+|... .++.||+|.+..... .....+..|..++ ...+|+||+++++++..++..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999975 478999999865421 2223344555444 445899999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCcee
Q 002349 679 GSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTS 758 (933)
Q Consensus 679 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 758 (933)
++|.+++. ....+++..+..++.|++.||.|||+. +++||||+|+||+++.++.+||+|||+++.... .
T Consensus 82 ~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~ 150 (260)
T cd05611 82 GDCASLIK---TLGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----N 150 (260)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----c
Confidence 99999994 345789999999999999999999965 999999999999999999999999999875432 2
Q ss_pred eeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHHH
Q 002349 759 TYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAV 838 (933)
Q Consensus 759 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (933)
....|+..|+|||...+..++.++||||+|+++|+|++|..||........+.......... ..... ...+
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~-----~~~~ 221 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINW----PEEVK-----EFCS 221 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCC----CCccc-----ccCC
Confidence 23468899999999988888999999999999999999999997654433222111111000 11111 1234
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 002349 839 KKVFQLALLCSKRQPTDRPTMHEVSRVLG 867 (933)
Q Consensus 839 ~~l~~li~~cl~~dP~~RPt~~evl~~L~ 867 (933)
..+.+++.+|++.+|++||++.++.+.+.
T Consensus 222 ~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 222 PEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred HHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 67889999999999999998766655543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=302.10 Aligned_cols=256 Identities=16% Similarity=0.204 Sum_probs=184.4
Q ss_pred hccCcceeeecccceeEEEEEEcCC----ceEEEEEecccCchhH-----------HHHHHHHHHHhcCCCCceeeeeeE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKNC----KPVAIKRLYSHYPQCL-----------KEFETELETVGSIKHRNLVSLQGY 662 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~~~~~ 662 (933)
++|...++||+|+||+||+|.+.++ ..+|+|+......... .....+...+..+.|++|++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 5789999999999999999997653 4556665432221110 112234455667789999999997
Q ss_pred EecCC----ccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCC
Q 002349 663 SLSSS----GNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFE 738 (933)
Q Consensus 663 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~ 738 (933)
+.... ..++++|++. .++.+.+. .....++..+..++.|++.||+|||+. +|+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLV-ENTKEIFK---RIKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNR 164 (294)
T ss_pred eeEecCCceEEEEEEehhc-cCHHHHHH---hhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCc
Confidence 65543 2367778764 36766663 233467888999999999999999965 9999999999999999999
Q ss_pred eEEeecccccccccCCCc------eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHH
Q 002349 739 AHLTDFGIAKSLCVSKSY------TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLIL 812 (933)
Q Consensus 739 ~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~ 812 (933)
++|+|||+|+.+...... ......||+.|+|||+..+..++.++|||||||++|||++|+.||.+.........
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 999999999876322111 11224699999999999999999999999999999999999999986533222211
Q ss_pred hhhcccccccccC-ccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 813 SKTANNAVMETVD-PEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 813 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
.... .....+. .... ....+..+.+++..|++.+|++||+++++.+.+
T Consensus 245 ~~~~--~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 245 AAKC--DFIKRLHEGKIK----IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HhHH--HHHHHhhhhhhc----cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 1110 0001100 0000 012246788999999999999999999999876
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=295.23 Aligned_cols=252 Identities=22% Similarity=0.246 Sum_probs=199.2
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
+.|+.-++||+||||.||-++.+ .|+.+|.|++.+.. .........|-.++.+++.+.||.+--.|..++..++|+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 46788899999999999999966 58889999875432 223344678999999999999999988899999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
..|+||+|.-+|... ....+++..++-++.+|+.||++||+. +||.||+||+|||+|+.|.++|+|.|+|..+...
T Consensus 265 tlMNGGDLkfHiyn~-g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNH-GNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EeecCCceeEEeecc-CCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 999999999888642 335799999999999999999999976 9999999999999999999999999999987544
Q ss_pred CCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccccc
Q 002349 754 KSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCK 833 (933)
Q Consensus 754 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (933)
... ...+||.+|||||++..+.|+...|-||+||++|||+.|+.||........+.... ..+.+ .+.+++.
T Consensus 341 ~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvd---rr~~~-~~~ey~~--- 411 (591)
T KOG0986|consen 341 KPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVD---RRTLE-DPEEYSD--- 411 (591)
T ss_pred Ccc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHH---HHHhc-chhhccc---
Confidence 433 33489999999999999999999999999999999999999997543322221100 00000 0111111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 002349 834 DLGAVKKVFQLALLCSKRQPTDRP-----TMHEVSR 864 (933)
Q Consensus 834 ~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 864 (933)
...++...+.+..+..||++|. .+++|-+
T Consensus 412 --kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~ 445 (591)
T KOG0986|consen 412 --KFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKE 445 (591)
T ss_pred --ccCHHHHHHHHHHHccCHHHhccCCCcCcchhhh
Confidence 1234566677788999999996 4556654
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=294.22 Aligned_cols=250 Identities=23% Similarity=0.326 Sum_probs=198.3
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEeccc-----CchhHHHHHHHHHHHhcCCCCceeeeeeEEecC--Ccc
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSH-----YPQCLKEFETELETVGSIKHRNLVSLQGYSLSS--SGN 669 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 669 (933)
++|+..+.||+|+||.||+|... +++.||+|.+... ..+....+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47888999999999999999965 4789999987432 123456788999999999999999999998764 457
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccc
Q 002349 670 LLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKS 749 (933)
Q Consensus 670 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 749 (933)
++||||+++++|.+++. ....+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~---~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLK---AYGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccc
Confidence 89999999999999984 345688999999999999999999965 999999999999999999999999999986
Q ss_pred cccCC--CceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcc
Q 002349 750 LCVSK--SYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPE 827 (933)
Q Consensus 750 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 827 (933)
..... ........|+..|+|||.+.+..++.++|||||||++|++++|+.||............. ... ..+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~----~~~~ 229 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA--TQP----TKPM 229 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHH--cCC----CCCC
Confidence 53211 111223568899999999998889999999999999999999999997654333322111 111 1111
Q ss_pred ccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 828 ISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 828 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
++. ...+.+.+++.+|++ +|.+||++.+++.+
T Consensus 230 ~p~-----~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 230 LPD-----GVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred CCc-----ccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 111 123568889999999 57999999988764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=307.02 Aligned_cols=260 Identities=24% Similarity=0.298 Sum_probs=197.8
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCC------
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSS------ 667 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 667 (933)
.++|.....||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 378999999999999999999965 57899999986532 223456789999999999999999999986543
Q ss_pred ccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccc
Q 002349 668 GNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIA 747 (933)
Q Consensus 668 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla 747 (933)
..++|+||+.. ++.++. ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 35899999964 777765 23589999999999999999999965 9999999999999999999999999999
Q ss_pred cccccCCCceeeeecccccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccc-----
Q 002349 748 KSLCVSKSYTSTYIMGTIGYIDPEYART-SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVM----- 821 (933)
Q Consensus 748 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~----- 821 (933)
+..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+..............+...
T Consensus 165 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07879 165 RHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ 240 (342)
T ss_pred cCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 764321 123457889999999876 4688999999999999999999999986554333322111100000
Q ss_pred -----------cccC----ccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HccCCC
Q 002349 822 -----------ETVD----PEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV--LGSLVP 871 (933)
Q Consensus 822 -----------~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~~~ 871 (933)
.... .......+ .....+.+++.+|++.||++||++++++.+ ++...+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 241 KLEDKAAKSYIKSLPKYPRKDFSTLFP--KASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HhcccchHHHHhhcCCcccchHHHHhc--CCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 0000 00000000 123567899999999999999999999964 666544
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=305.75 Aligned_cols=260 Identities=25% Similarity=0.288 Sum_probs=202.8
Q ss_pred ccCcceeeecccceeEEEEEEcC-CceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCC-----ccE
Q 002349 599 NLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSS-----GNL 670 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~ 670 (933)
+|+..+.||+|++|.||+|+... ++.||+|++.... ....+.+.+|+++++.++||||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 47788999999999999999764 8899999987643 344567899999999999999999999988775 789
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccc
Q 002349 671 LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSL 750 (933)
Q Consensus 671 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~ 750 (933)
+||||++ ++|.++++ ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~---~~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIK---SPQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999997 48999885 344899999999999999999999965 9999999999999999999999999999876
Q ss_pred ccCCC--ceeeeecccccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccC--
Q 002349 751 CVSKS--YTSTYIMGTIGYIDPEYARTS-RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVD-- 825 (933)
Q Consensus 751 ~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 825 (933)
..... .......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||.+..............+.......
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence 44321 112334678899999999887 7899999999999999999999999866544332221111111000000
Q ss_pred ---ccc----c---cc-cc-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 826 ---PEI----S---AT-CK-----DLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 826 ---~~~----~---~~-~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
... . .. .. ....+..+.+++.+||+.+|++||++++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 000 0 00 00 00124678899999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=293.03 Aligned_cols=251 Identities=23% Similarity=0.322 Sum_probs=205.5
Q ss_pred ccCcceeeecccceeEEEEEEc-CCceEEEEEecccCc--hhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEe
Q 002349 599 NLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYP--QCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
+|+..+.||.|+||.||+|.+. +++.||+|++..... ...+.+.+|++++++++|||++++++.+..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778889999999999999976 478899999876532 4567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCC
Q 002349 676 MENGSLWDILHGPT-KKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSK 754 (933)
Q Consensus 676 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 754 (933)
+++++|.+++.... ....+++..+..++.+++.|+.|||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999986421 246799999999999999999999965 99999999999999999999999999998764332
Q ss_pred CceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccC
Q 002349 755 SYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKD 834 (933)
Q Consensus 755 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (933)
.......|++.|+|||...+..++.++||||+|+++++|++|+.||........... .. ... . +.++.
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~-~~-~~~-~----~~~~~---- 225 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALK-IL-KGQ-Y----PPIPS---- 225 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHH-Hh-cCC-C----CCCCC----
Confidence 223345788999999999888899999999999999999999999975542221111 11 111 1 11111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 835 LGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 835 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
..+..+.+++.+|+..+|++|||+.+++++
T Consensus 226 -~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 226 -QYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred -CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 124678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=307.77 Aligned_cols=259 Identities=23% Similarity=0.273 Sum_probs=198.7
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCceeeeeeEEecC-----Cc
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSH--YPQCLKEFETELETVGSIKHRNLVSLQGYSLSS-----SG 668 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~ 668 (933)
.++|...+.||+|+||+||+|... +++.||||++... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457889999999999999999965 5789999998653 233345678899999999999999999988654 34
Q ss_pred cEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccc
Q 002349 669 NLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAK 748 (933)
Q Consensus 669 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 748 (933)
.++||||+. ++|.+++. ..+.+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999996 68988884 456799999999999999999999965 99999999999999999999999999998
Q ss_pred ccccCCCceeeeecccccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccc------
Q 002349 749 SLCVSKSYTSTYIMGTIGYIDPEYART-SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVM------ 821 (933)
Q Consensus 749 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~------ 821 (933)
...... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||.+..............+...
T Consensus 157 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07858 157 TTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF 235 (337)
T ss_pred ccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence 653322 22233467889999998765 4688999999999999999999999976543222211111000000
Q ss_pred --------------cccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 822 --------------ETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 822 --------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
...++...... ...+..+.+++.+|++.+|++|||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFARLF--PHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred cCchhhhHHHHhcCcccccCHHHHc--ccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 00000000000 1234668899999999999999999999986
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=300.31 Aligned_cols=249 Identities=27% Similarity=0.322 Sum_probs=202.8
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCC-CCceeeeeeEEecCCccEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIK-HRNLVSLQGYSLSSSGNLLF 672 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv 672 (933)
++|...+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++ ||||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36888899999999999999976 58899999986532 233467889999999998 99999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccccc
Q 002349 673 YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV 752 (933)
Q Consensus 673 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 752 (933)
|||+++++|.+++. ..+.+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++++|||++.....
T Consensus 81 ~e~~~~~~L~~~l~---~~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIR---KYGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 99999999999995 345799999999999999999999965 999999999999999999999999999986543
Q ss_pred CCC-------------------ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHh
Q 002349 753 SKS-------------------YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILS 813 (933)
Q Consensus 753 ~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~ 813 (933)
... .......|+..|+|||...+..++.++||||+|++++++++|+.||............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 234 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKI 234 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 221 1122346789999999998888999999999999999999999999865533322211
Q ss_pred hhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCH----HHHHHH
Q 002349 814 KTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTM----HEVSRV 865 (933)
Q Consensus 814 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~----~evl~~ 865 (933)
..... .++. ..+..+.+++.+|++.+|++||++ ++++++
T Consensus 235 ~~~~~--------~~~~-----~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 235 LKLEY--------SFPP-----NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HhcCC--------CCCC-----ccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 11000 0111 114578899999999999999999 777653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=283.12 Aligned_cols=248 Identities=25% Similarity=0.302 Sum_probs=201.9
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchh---HHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQC---LKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLF 672 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 672 (933)
.++|...++||+|.||+|-.++-+ .++.+|+|++++...-. ...-..|-++|+..+||.+..+.-.|...++.|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 367888899999999999999966 57889999998764322 23335688999999999999999899999999999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccccc
Q 002349 673 YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV 752 (933)
Q Consensus 673 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 752 (933)
|||..||.|.-++ ...+.+++....-+...|+.||.|||+ .+||.||+|.+|.|+|.+|.+||+|||+++.- .
T Consensus 247 MeyanGGeLf~HL---srer~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~-I 319 (516)
T KOG0690|consen 247 MEYANGGELFFHL---SRERVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEE-I 319 (516)
T ss_pred EEEccCceEeeeh---hhhhcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhc-c
Confidence 9999999999888 356678999999999999999999995 49999999999999999999999999999853 2
Q ss_pred CCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccc
Q 002349 753 SKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATC 832 (933)
Q Consensus 753 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (933)
.........+|||.|+|||++....|..++|-|.+||++|||++|+.||.+......+..+...+-.++..+.
T Consensus 320 ~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls------- 392 (516)
T KOG0690|consen 320 KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLS------- 392 (516)
T ss_pred cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCC-------
Confidence 3334456789999999999999999999999999999999999999999876554444443333322222221
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 002349 833 KDLGAVKKVFQLALLCSKRQPTDRP-----TMHEVSR 864 (933)
Q Consensus 833 ~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 864 (933)
.+...++.-.+..||++|. .+.||.+
T Consensus 393 ------~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 393 ------PEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred ------HHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 2344567778889999995 4666664
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=256.81 Aligned_cols=260 Identities=21% Similarity=0.243 Sum_probs=201.9
Q ss_pred ccCcceeeecccceeEEEEEEcC-CceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEe
Q 002349 599 NLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
+|...++||+|.||+||+|+.++ ++.||+|+++-+. ...-....+|+-+++.++|.|||+++++...+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 45566789999999999999654 6889999986543 33345678999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS 755 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 755 (933)
|.. +|..+.. .-++.++.+.+..++.|+++|+.++|.+ ++.|||+||.|.+++.+|+.|++|||+|+.++....
T Consensus 83 cdq-dlkkyfd--slng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 CDQ-DLKKYFD--SLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hhH-HHHHHHH--hcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 965 8888876 4567899999999999999999999965 999999999999999999999999999998865543
Q ss_pred ceeeeecccccccCccccccCC-CCcchhhHHHHHHHHHHHhCC-CCCCCCcchhHHHHhhhcccccccccCccccccc-
Q 002349 756 YTSTYIMGTIGYIDPEYARTSR-LTEKSDVYSFGIVLLELLTGR-KAVDNECNLHHLILSKTANNAVMETVDPEISATC- 832 (933)
Q Consensus 756 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGv~l~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 832 (933)
..+ ..+-|.+|++|+++.+.. |+...|+||-||++.|+.... +.|.+..-..++..+...-+...+..+|.+....
T Consensus 157 cys-aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpd 235 (292)
T KOG0662|consen 157 CYS-AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD 235 (292)
T ss_pred eee-ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCC
Confidence 333 335689999999998864 789999999999999998754 4566655555555444444444333333222111
Q ss_pred -------cC-H-------HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 833 -------KD-L-------GAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 833 -------~~-~-------~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
+. . .....-.+++...+.-+|.+|.++++.+++
T Consensus 236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 00 0 111334567777888899999999887764
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=302.73 Aligned_cols=256 Identities=23% Similarity=0.284 Sum_probs=192.1
Q ss_pred eeecc--cceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecCCC
Q 002349 605 IIGYG--ASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENG 679 (933)
Q Consensus 605 ~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 679 (933)
.||+| +||+||+|.+. .++.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++||||++++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 99999999975 68999999986533 234567899999999999999999999999999999999999999
Q ss_pred CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCce--
Q 002349 680 SLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYT-- 757 (933)
Q Consensus 680 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~-- 757 (933)
++.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|||.+..........
T Consensus 85 ~l~~~l~~~-~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 85 SANSLLKTY-FPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 999998642 234589999999999999999999955 99999999999999999999999998654321111000
Q ss_pred ----eeeecccccccCccccccC--CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccc----------
Q 002349 758 ----STYIMGTIGYIDPEYARTS--RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVM---------- 821 (933)
Q Consensus 758 ----~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~---------- 821 (933)
.....++..|+|||++.+. .++.++||||+||++|||++|+.||....................
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE 240 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence 1112356679999999764 478999999999999999999999976543333221111100000
Q ss_pred -------------------------cccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 822 -------------------------ETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 822 -------------------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
........ ..........+.+++++|++.||++|||++|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLR-TPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhccchhhhhcccccchhcccccccccccccc-chhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 00000000 00112345678999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=298.91 Aligned_cols=252 Identities=23% Similarity=0.296 Sum_probs=195.8
Q ss_pred ccCcceeeecccceeEEEEEEc----CCceEEEEEecccC----chhHHHHHHHHHHHhcC-CCCceeeeeeEEecCCcc
Q 002349 599 NLSEKYIIGYGASSTVYKCVLK----NCKPVAIKRLYSHY----PQCLKEFETELETVGSI-KHRNLVSLQGYSLSSSGN 669 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 669 (933)
+|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4677889999999999999863 57889999986532 22346678899999999 599999999999999899
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccc
Q 002349 670 LLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKS 749 (933)
Q Consensus 670 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 749 (933)
++||||+++++|.+++. ....+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLS---QRERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 99999999999999984 345788999999999999999999965 999999999999999999999999999987
Q ss_pred cccCCCceeeeecccccccCccccccC--CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcc
Q 002349 750 LCVSKSYTSTYIMGTIGYIDPEYARTS--RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPE 827 (933)
Q Consensus 750 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 827 (933)
.............|+..|+|||...+. .++.++||||||+++|+|++|+.||.............. ..... .+.
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~---~~~~~-~~~ 230 (290)
T cd05613 155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISR---RILKS-EPP 230 (290)
T ss_pred cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHH---Hhhcc-CCC
Confidence 543332233345689999999998753 467899999999999999999999964322111100000 00000 011
Q ss_pred ccccccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002349 828 ISATCKDLGAVKKVFQLALLCSKRQPTDRP-----TMHEVSRV 865 (933)
Q Consensus 828 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 865 (933)
.+. .....+.+++.+|++.||++|| ++.+++.+
T Consensus 231 ~~~-----~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 231 YPQ-----EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred CCc-----cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 111 1235678899999999999997 66666653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=291.72 Aligned_cols=250 Identities=22% Similarity=0.266 Sum_probs=190.9
Q ss_pred HHHHHHhhccCcceee--ecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcC-CCCceeeeeeEEecC
Q 002349 591 EDIMRMTENLSEKYII--GYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSI-KHRNLVSLQGYSLSS 666 (933)
Q Consensus 591 ~~~~~~~~~~~~~~~l--G~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 666 (933)
.+.....++|+..+.+ |+|+||.||++..+ +++.+|+|.+...... .. |+.....+ +||||+++++++...
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~~--e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN---AI--EPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc---hh--hHHHHHHhhcCCCEEEEEEEEecC
Confidence 4455556677777766 99999999999965 5778999988653221 11 22222222 799999999999999
Q ss_pred CccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCC-CeEEeecc
Q 002349 667 SGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDF-EAHLTDFG 745 (933)
Q Consensus 667 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~-~~kl~DfG 745 (933)
+..++||||+++++|.+++. ....+++..+..++.|+++|++|||+. +++||||||+||+++.++ .++|+|||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg 155 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLK---KEGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYG 155 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCc
Confidence 99999999999999999995 334899999999999999999999965 999999999999999998 99999999
Q ss_pred cccccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccC
Q 002349 746 IAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVD 825 (933)
Q Consensus 746 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (933)
+++...... ...|+..|+|||++.+..++.++||||+|+++|||++|+.||........ ......... ...
T Consensus 156 ~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~-~~~-- 226 (267)
T PHA03390 156 LCKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL-DLESLLKRQ-QKK-- 226 (267)
T ss_pred cceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh-hHHHHHHhh-ccc--
Confidence 987653221 23588999999999998899999999999999999999999974432211 000000000 000
Q ss_pred ccccccccCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHH
Q 002349 826 PEISATCKDLGAVKKVFQLALLCSKRQPTDRPT-MHEVSRV 865 (933)
Q Consensus 826 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~~ 865 (933)
.... ...+..+.+++.+|++.+|.+||+ ++|++++
T Consensus 227 ~~~~-----~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 227 LPFI-----KNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred CCcc-----cccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 0000 023467889999999999999996 6888753
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=301.33 Aligned_cols=256 Identities=21% Similarity=0.239 Sum_probs=190.2
Q ss_pred eeecccceeEEEEEEcCCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecCCCCHH
Q 002349 605 IIGYGASSTVYKCVLKNCKPVAIKRLYSH--YPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLW 682 (933)
Q Consensus 605 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 682 (933)
.+|.|+++.||++.. +++.||||++... .....+.+.+|++++++++|+||+++++++...+..+++|||+++|+|.
T Consensus 9 ~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 87 (314)
T cd08216 9 CFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE 87 (314)
T ss_pred hhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHH
Confidence 344555555555544 5789999998754 3445678999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCC------c
Q 002349 683 DILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS------Y 756 (933)
Q Consensus 683 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~------~ 756 (933)
++++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+|++|||.+..+..... .
T Consensus 88 ~~l~~~-~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~ 163 (314)
T cd08216 88 DLLKTH-FPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163 (314)
T ss_pred HHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence 999642 234688999999999999999999966 999999999999999999999999998875532111 1
Q ss_pred eeeeecccccccCcccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcc-cccc-----c------
Q 002349 757 TSTYIMGTIGYIDPEYART--SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTAN-NAVM-----E------ 822 (933)
Q Consensus 757 ~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~-~~~~-----~------ 822 (933)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||................ .... .
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (314)
T cd08216 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSM 243 (314)
T ss_pred ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCc
Confidence 1123457788999999876 358899999999999999999999998654333222111000 0000 0
Q ss_pred ------ccCcccc---ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 823 ------TVDPEIS---ATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 823 ------~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
...+... ..........++.+++.+||+.||++|||+++++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 244 SQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred CcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0000000 000011234578899999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=281.30 Aligned_cols=253 Identities=25% Similarity=0.287 Sum_probs=196.1
Q ss_pred HhhccCcc-eeeecccceeEEEEEEcC-CceEEEEEecccCchhHHHHHHHHHHHhcC-CCCceeeeeeEEecC----Cc
Q 002349 596 MTENLSEK-YIIGYGASSTVYKCVLKN-CKPVAIKRLYSHYPQCLKEFETELETVGSI-KHRNLVSLQGYSLSS----SG 668 (933)
Q Consensus 596 ~~~~~~~~-~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~----~~ 668 (933)
.+++|++. ++||-|-.|+|-.+.++. ++.+|+|++... ....+|++..-.. .|||||.++++|... .-
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45566554 479999999999999764 788999998543 4456777776655 699999999998653 34
Q ss_pred cEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCC---CCCeEEeecc
Q 002349 669 NLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDK---DFEAHLTDFG 745 (933)
Q Consensus 669 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~---~~~~kl~DfG 745 (933)
..+|||.|+||.|...+++ +....+++.++..|++||+.|+.|||. .+|.||||||+|+|... +..+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~-~g~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQD-RGDQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHH-cccccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEecccc
Confidence 5789999999999999965 345579999999999999999999994 59999999999999964 5678999999
Q ss_pred cccccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhH----HHHhhhcccccc
Q 002349 746 IAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHH----LILSKTANNAVM 821 (933)
Q Consensus 746 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~----~~~~~~~~~~~~ 821 (933)
+|+.... .......+-|+.|.|||++...+|+..+|+||+||++|-|++|.+||........ ...+......++
T Consensus 210 FAK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP 287 (400)
T KOG0604|consen 210 FAKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFP 287 (400)
T ss_pred cccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCC
Confidence 9987532 2334455789999999999999999999999999999999999999975433211 111111112221
Q ss_pred cccCccccccccCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHHHccC
Q 002349 822 ETVDPEISATCKDLG-AVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869 (933)
Q Consensus 822 ~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 869 (933)
+. ... .++...++|+.++..+|++|.|+.+++++-+-.
T Consensus 288 ~p----------EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~ 326 (400)
T KOG0604|consen 288 EP----------EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWIN 326 (400)
T ss_pred Ch----------hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhc
Confidence 11 122 245567889999999999999999999865443
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=292.41 Aligned_cols=249 Identities=22% Similarity=0.279 Sum_probs=203.0
Q ss_pred ccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEe
Q 002349 599 NLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
+|+..+.||+|+||.||+|... +++.+|+|++.... .....++.+|++++++++|+||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778889999999999999865 57889999986543 33456778899999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCC
Q 002349 676 MENGSLWDILHGPT-KKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSK 754 (933)
Q Consensus 676 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 754 (933)
+++++|.+++.... ....+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.+|++|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 99999999885321 235689999999999999999999955 9999999999999999999999999999876433
Q ss_pred CceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccC
Q 002349 755 SYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKD 834 (933)
Q Consensus 755 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (933)
......++..|+|||...+..++.++|+||+|+++|+|++|+.||............ .... .+.+.
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~--~~~~-----~~~~~----- 222 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV--QRGK-----YPPIP----- 222 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--hcCC-----CCCCc-----
Confidence 222345889999999999988999999999999999999999999765432211111 1111 11111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 835 LGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 835 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
......+.+++.+|++.+|++||++.+++++
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 223 PIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred hhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1334678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=295.04 Aligned_cols=259 Identities=23% Similarity=0.251 Sum_probs=196.3
Q ss_pred cCcceeeecccceeEEEEEEcC-CceEEEEEecccCc--hhHHHHHHHHHHHhcC---CCCceeeeeeEEecCCc-----
Q 002349 600 LSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHYP--QCLKEFETELETVGSI---KHRNLVSLQGYSLSSSG----- 668 (933)
Q Consensus 600 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~----- 668 (933)
|++.+.||+|+||.||+|.++. ++.||+|++..... .....+.+|+.+++++ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5677899999999999999875 88999999974322 2234566788777666 59999999999988776
Q ss_pred cEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccc
Q 002349 669 NLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAK 748 (933)
Q Consensus 669 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 748 (933)
.+++|||+++ +|.+++... ....+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||.+.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~-~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKC-PKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999975 898888532 234689999999999999999999965 99999999999999999999999999997
Q ss_pred ccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccccc-----c--
Q 002349 749 SLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAV-----M-- 821 (933)
Q Consensus 749 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~-----~-- 821 (933)
....... .....++..|+|||.+.+..++.++|||||||++|||++|+.||................... .
T Consensus 156 ~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07838 156 IYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRN 233 (287)
T ss_pred eccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCC
Confidence 7643221 123357889999999999899999999999999999999999998665443332211100000 0
Q ss_pred -----cccCcccccccc--CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 822 -----ETVDPEISATCK--DLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 822 -----~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
............ .......+.+++.+|++.||++||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 234 VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 000000000000 01224667899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=297.71 Aligned_cols=253 Identities=27% Similarity=0.370 Sum_probs=195.7
Q ss_pred hccCcceeeecccceeEEEEEEcC-CceEEEEEecccC-chhHHHHHHHHHHHhcCC-CCceeeeeeEEecCCccEEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHY-PQCLKEFETELETVGSIK-HRNLVSLQGYSLSSSGNLLFYD 674 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 674 (933)
++|+..+.||+|+||.||+|.++. ++.||||++.... .....++.+|+.++.+.. ||||+++++++..+...++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 568888999999999999999875 7899999987543 233456677887776664 9999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCC
Q 002349 675 FMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSK 754 (933)
Q Consensus 675 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 754 (933)
|+. +++.+.+.. ....+++..+..++.|++.|++|||+. .+|+||||+|+||++++++.+||+|||++..+....
T Consensus 95 ~~~-~~l~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 95 LMS-TCLDKLLKR--IQGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred ccC-cCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 985 477777642 235789999999999999999999952 389999999999999999999999999997653322
Q ss_pred CceeeeecccccccCccccccCC----CCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccc
Q 002349 755 SYTSTYIMGTIGYIDPEYARTSR----LTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISA 830 (933)
Q Consensus 755 ~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (933)
. .....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||................. .+..+.
T Consensus 170 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~------~~~~~~ 241 (296)
T cd06618 170 A--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE------PPSLPP 241 (296)
T ss_pred c--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC------CCCCCC
Confidence 2 22335788999999987653 78899999999999999999999975322211111111110 011111
Q ss_pred cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 831 TCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 831 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
. ...+.++.+++.+|++.||++||++.+++++.
T Consensus 242 ~---~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 242 N---EGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred C---CCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 0 01245788999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=301.25 Aligned_cols=261 Identities=22% Similarity=0.274 Sum_probs=196.4
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccCc--hhHHHHHHHHHHHhcCCCCceeeeeeEEecCC------
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYP--QCLKEFETELETVGSIKHRNLVSLQGYSLSSS------ 667 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 667 (933)
.++|+..+.||+|+||.||+|.++ +++.||+|++..... .....+.+|++++++++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999976 478899998865432 22345778999999999999999999875543
Q ss_pred --ccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecc
Q 002349 668 --GNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFG 745 (933)
Q Consensus 668 --~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfG 745 (933)
..++||||+.+ ++.+.+.. ....+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCc
Confidence 35899999965 67777752 345799999999999999999999965 99999999999999999999999999
Q ss_pred cccccccCCC----------ceeeeecccccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhh
Q 002349 746 IAKSLCVSKS----------YTSTYIMGTIGYIDPEYARTS-RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSK 814 (933)
Q Consensus 746 la~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~ 814 (933)
+++....... .......|++.|+|||.+.+. .++.++|||||||++|||++|+.||.+...........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9976532211 111234678889999987654 58899999999999999999999998655543322211
Q ss_pred hcccccc-------------------cccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 815 TANNAVM-------------------ETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 815 ~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
....... ...++...... ......+.+++.+|++.||++|||+.|++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERF--GKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHc--ccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 1110000 00000000000 0112568899999999999999999998764
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=332.77 Aligned_cols=398 Identities=29% Similarity=0.403 Sum_probs=251.6
Q ss_pred cEEEEEcCCCCcCcccCCCCCCCCCccEEEccCCcccccCCCCccCCCCCceecccccccCCCCCcccccccchhhhhhc
Q 002349 69 TVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILK 148 (933)
Q Consensus 69 ~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~ 148 (933)
+...||+++|.+. .+|..+..+.+|+.|+++.|.|. ..|.+.+++.+|++|+|..|.+. ..|.++..+++|++|+++
T Consensus 46 ~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS 122 (1081)
T KOG0618|consen 46 KLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLS 122 (1081)
T ss_pred eeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccc
Confidence 4678888877665 77888888888888888888888 67888888888888888888887 788888888888888888
Q ss_pred ccCccCCCCcccccCCCCceeeeecC-------------------CCCCCcccccccCCCCcEEeccCccccCccCcCCc
Q 002349 149 NNQLIGPIPSTLSQLPNLKVFGLRGN-------------------NLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIG 209 (933)
Q Consensus 149 ~n~l~~~~p~~l~~l~~L~~L~L~~N-------------------~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~ 209 (933)
.|++. .+|..+..++.++.+..++| .+.+.++.++..++. .|||++|.+.. ..+.
T Consensus 123 ~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~~---~dls 196 (1081)
T KOG0618|consen 123 FNHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEMEV---LDLS 196 (1081)
T ss_pred hhccC-CCchhHHhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcchhhhhe--eeecccchhhh---hhhh
Confidence 88887 67766666666666666666 333333333333333 34444444431 1133
Q ss_pred CCCCCcEEccccccccCcCCCCccccccceEeccccccccccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEE
Q 002349 210 NCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLY 289 (933)
Q Consensus 210 ~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 289 (933)
++.+|+.|....|+++.. .....+++.|+.++|.++...+ .....+|+.+|+++|++++ +|++++.+.+|+.|.
T Consensus 197 ~~~~l~~l~c~rn~ls~l---~~~g~~l~~L~a~~n~l~~~~~--~p~p~nl~~~dis~n~l~~-lp~wi~~~~nle~l~ 270 (1081)
T KOG0618|consen 197 NLANLEVLHCERNQLSEL---EISGPSLTALYADHNPLTTLDV--HPVPLNLQYLDISHNNLSN-LPEWIGACANLEALN 270 (1081)
T ss_pred hccchhhhhhhhcccceE---EecCcchheeeeccCcceeecc--ccccccceeeecchhhhhc-chHHHHhcccceEec
Confidence 333344444333333210 1122345556666666552221 1233566677777777763 346666777777777
Q ss_pred eeCCccCCCCCCccccCCcceEeeeccccccccCCccccccccccccccccccCCCCCCCC-cc----------------
Q 002349 290 LHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDN-LS---------------- 352 (933)
Q Consensus 290 L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~-l~---------------- 352 (933)
..+|++. .+|..+..+++|+.|++.+|.++ .+|....+++.|++|+|..|+|. ..|+. +.
T Consensus 271 ~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l 347 (1081)
T KOG0618|consen 271 ANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKL 347 (1081)
T ss_pred ccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccc
Confidence 7777764 55666666666666666666666 55555666666666666666665 22221 11
Q ss_pred ---------cCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCCccccccccccceeeccCCccCCCCCCCC
Q 002349 353 ---------SCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPL 423 (933)
Q Consensus 353 ---------~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 423 (933)
....|+.|++.+|.++...-..+.++..|+.|+|++|++.......+.++..|+.|+||+|+++ .+|..+
T Consensus 348 ~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tv 426 (1081)
T KOG0618|consen 348 STLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTV 426 (1081)
T ss_pred cccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHH
Confidence 2334566677777776665566666677777777777776555555666777777777777776 566777
Q ss_pred CCccccccccccCcccccccccccccccccceEEccCCccccccchhhccccccceeeecCCCC
Q 002349 424 GDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNL 487 (933)
Q Consensus 424 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l 487 (933)
..+..|+.|...+|+|. ..| .+..+++|+.+|+|.|+|+...-.....-++|++|||+||..
T Consensus 427 a~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 427 ANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred HhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence 77777777777777777 445 667777777777777777654333333336777777777764
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=303.53 Aligned_cols=266 Identities=24% Similarity=0.274 Sum_probs=201.4
Q ss_pred CHHHHHHHhhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEec
Q 002349 589 VYEDIMRMTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLS 665 (933)
Q Consensus 589 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 665 (933)
..+++..++++|...+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 34566778899999999999999999999864 57899999987542 2234567889999999999999999998864
Q ss_pred C------CccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCe
Q 002349 666 S------SGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEA 739 (933)
Q Consensus 666 ~------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~ 739 (933)
. ...+++++++ +++|.+++. ...+++..+..++.|++.|++|||+. +|+||||||+||++++++.+
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCE
Confidence 3 3357788876 789988874 24689999999999999999999965 99999999999999999999
Q ss_pred EEeecccccccccCCCceeeeecccccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccc
Q 002349 740 HLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYART-SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANN 818 (933)
Q Consensus 740 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 818 (933)
||+|||+++.... ......|+..|+|||.+.+ ..++.++||||+||++|+|++|+.||.................
T Consensus 160 kl~dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 235 (345)
T cd07877 160 KILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 235 (345)
T ss_pred EEecccccccccc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 9999999876432 1233468889999998866 4678999999999999999999999975544332221111111
Q ss_pred ccccccCccc---------------cc-ccc--CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 819 AVMETVDPEI---------------SA-TCK--DLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 819 ~~~~~~~~~~---------------~~-~~~--~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
.......+.+ .. ... .......+.+++.+|++.||.+||++.+++++-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 301 (345)
T cd07877 236 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301 (345)
T ss_pred CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence 0000000000 00 000 001235678999999999999999999998753
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=298.49 Aligned_cols=249 Identities=29% Similarity=0.360 Sum_probs=196.7
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEeccc---CchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSH---YPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
+.|+..+.||+|+||.||+|+.. +++.+|+|.+... .....+++.+|+++++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34666778999999999999975 4678999988642 2233456888999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
||+. |++.+.+.. ....+++.++..++.|++.|+.|||+. +++||||||+||+++.++.+|++|||++......
T Consensus 95 e~~~-~~l~~~~~~--~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 95 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EccC-CCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 9996 588877742 345689999999999999999999965 9999999999999999999999999998765321
Q ss_pred CCceeeeecccccccCccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccc
Q 002349 754 KSYTSTYIMGTIGYIDPEYAR---TSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISA 830 (933)
Q Consensus 754 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (933)
....|++.|+|||.+. ...++.++|||||||++|+|++|+.||............ ..... +...
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~--~~~~~-----~~~~- 235 (308)
T cd06634 169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--AQNES-----PALQ- 235 (308)
T ss_pred -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHH--hhcCC-----CCcC-
Confidence 2345888999999874 356788999999999999999999998754322221111 11111 1111
Q ss_pred cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcc
Q 002349 831 TCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGS 868 (933)
Q Consensus 831 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 868 (933)
.......+.+++.+||+.+|++||++.+++.+...
T Consensus 236 ---~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~ 270 (308)
T cd06634 236 ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270 (308)
T ss_pred ---cccccHHHHHHHHHHhhCCcccCCCHHHHhhCccc
Confidence 11234568899999999999999999999987544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=302.72 Aligned_cols=260 Identities=23% Similarity=0.232 Sum_probs=198.2
Q ss_pred hccCc-ceeeecccceeEEEEEEc-CCceEEEEEecccCchh--------------HHHHHHHHHHHhcCCCCceeeeee
Q 002349 598 ENLSE-KYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQC--------------LKEFETELETVGSIKHRNLVSLQG 661 (933)
Q Consensus 598 ~~~~~-~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~~~~ 661 (933)
++|.. .+.||+|+||+||+|... .++.||||++....... ...+.+|++++++++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45553 467999999999999966 57899999986543211 124778999999999999999999
Q ss_pred EEecCCccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEE
Q 002349 662 YSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHL 741 (933)
Q Consensus 662 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl 741 (933)
++...+..++||||++ |+|.+++. ....+++..+..++.|++.||+|||+. +|+||||+|+||+++.++.+|+
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVD---RKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEE
Confidence 9999999999999997 58999984 455689999999999999999999965 9999999999999999999999
Q ss_pred eecccccccccCC-------------CceeeeecccccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcch
Q 002349 742 TDFGIAKSLCVSK-------------SYTSTYIMGTIGYIDPEYARTS-RLTEKSDVYSFGIVLLELLTGRKAVDNECNL 807 (933)
Q Consensus 742 ~DfGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~p~~~~~~~ 807 (933)
+|||+++...... ........++..|+|||.+.+. .++.++||||+||++|+|++|+.||.+....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999997654110 1111223468899999998764 4689999999999999999999999876655
Q ss_pred hHHHHhhhcccccccc-----------------cCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 808 HHLILSKTANNAVMET-----------------VDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 808 ~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
................ .++...... ......+.+++.+|++.+|++||+++|++.+-
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~ 314 (335)
T PTZ00024 241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIF--PNASDDAIDLLQSLLKLNPLERISAKEALKHE 314 (335)
T ss_pred HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhC--cCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence 4433221111100000 000000000 01245688999999999999999999999754
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=303.03 Aligned_cols=255 Identities=24% Similarity=0.309 Sum_probs=196.6
Q ss_pred HhhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCC-----
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSS----- 667 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 667 (933)
..++|+..+.||+|+||.||+|... +++.||||++.... ......+.+|++++++++||||+++++++..+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4678999999999999999999855 58899999986432 223456889999999999999999999987654
Q ss_pred -ccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccc
Q 002349 668 -GNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGI 746 (933)
Q Consensus 668 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl 746 (933)
..++||||+ +++|.+++. ...+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+|++|||+
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~ 164 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 164 (343)
T ss_pred ceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeccc
Confidence 358999999 779988874 35689999999999999999999965 999999999999999999999999999
Q ss_pred ccccccCCCceeeeecccccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccc--
Q 002349 747 AKSLCVSKSYTSTYIMGTIGYIDPEYART-SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMET-- 823 (933)
Q Consensus 747 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-- 823 (933)
+...... .....+++.|+|||.+.+ ..++.++||||+|+++|++++|+.||.+....................
T Consensus 165 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 240 (343)
T cd07880 165 ARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFV 240 (343)
T ss_pred ccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 9765321 123457889999998876 458899999999999999999999998654433222111111000000
Q ss_pred --------------cC----ccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002349 824 --------------VD----PEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSR 864 (933)
Q Consensus 824 --------------~~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 864 (933)
+. ..+.... ......+.+++.+|++.||++|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 241 QKLQSEDAKNYVKKLPRFRKKDFRSLL--PNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HhhcchhHHHHHHhccccCcchHHHhc--cCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 0000000 012346889999999999999999999985
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=295.53 Aligned_cols=259 Identities=21% Similarity=0.288 Sum_probs=196.5
Q ss_pred cCcceeeecccceeEEEEEEcC-CceEEEEEecccCc-hhHHHHHHHHHHHhcCC-CCceeeeeeEEecCCccEEEEEec
Q 002349 600 LSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHYP-QCLKEFETELETVGSIK-HRNLVSLQGYSLSSSGNLLFYDFM 676 (933)
Q Consensus 600 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~ 676 (933)
|+..+.||+|++|+||+|...+ ++.||+|++..... .......+|+..+++++ ||||+++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 5667889999999999999764 78899999865432 22334567999999999 999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCc
Q 002349 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY 756 (933)
Q Consensus 677 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 756 (933)
+|+|.+.+... ....+++..+..++.|++.||.|||++ +++|+||+|+||++++++.++|+|||.++.......
T Consensus 81 -~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 81 -EGNLYQLMKDR-KGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred -CCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 78999988632 234789999999999999999999965 999999999999999999999999999986533222
Q ss_pred eeeeecccccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccccc-----------cccc
Q 002349 757 TSTYIMGTIGYIDPEYART-SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAV-----------METV 824 (933)
Q Consensus 757 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~-----------~~~~ 824 (933)
.....++..|+|||.+.+ ..++.++||||||++++||++|+.||................+.. ....
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07830 155 -YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233 (283)
T ss_pred -cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence 223467889999998754 457899999999999999999999997554333221111000000 0000
Q ss_pred Cccccccc-cCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 825 DPEISATC-KDL-----GAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 825 ~~~~~~~~-~~~-----~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
...++... ... .....+.+++++|++.+|++|||+.|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00000000 000 113678899999999999999999999764
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=292.81 Aligned_cols=242 Identities=23% Similarity=0.257 Sum_probs=187.2
Q ss_pred eeecccceeEEEEEEc-CCceEEEEEecccCc---hhHHHHHHHH---HHHhcCCCCceeeeeeEEecCCccEEEEEecC
Q 002349 605 IIGYGASSTVYKCVLK-NCKPVAIKRLYSHYP---QCLKEFETEL---ETVGSIKHRNLVSLQGYSLSSSGNLLFYDFME 677 (933)
Q Consensus 605 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~---~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 677 (933)
.||+|+||.||+|... .++.||+|.+..... .....+..|. +.++...||+|+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999965 478999998865321 1122233443 34445579999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCce
Q 002349 678 NGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYT 757 (933)
Q Consensus 678 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 757 (933)
+++|.+++. ....+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 999999884 456799999999999999999999965 99999999999999999999999999987653221
Q ss_pred eeeecccccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHH
Q 002349 758 STYIMGTIGYIDPEYARTS-RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLG 836 (933)
Q Consensus 758 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (933)
.....|+..|+|||.+.++ .++.++||||+||++|+|++|+.||................ ...+.++. .
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~-----~ 221 (278)
T cd05606 152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-----TMAVELPD-----S 221 (278)
T ss_pred CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhh-----ccCCCCCC-----c
Confidence 1234689999999998754 68999999999999999999999997543221111111000 01111111 1
Q ss_pred HHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002349 837 AVKKVFQLALLCSKRQPTDRP-----TMHEVSRV 865 (933)
Q Consensus 837 ~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 865 (933)
.+..+.+++.+|+..+|.+|| ++.+++++
T Consensus 222 ~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 222 FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 235788999999999999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=303.91 Aligned_cols=260 Identities=22% Similarity=0.301 Sum_probs=195.3
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecC----------
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSS---------- 666 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---------- 666 (933)
.+|...+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 57888999999999999999975 4789999998766555667789999999999999999999876544
Q ss_pred ----CccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCC-CCCeEE
Q 002349 667 ----SGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDK-DFEAHL 741 (933)
Q Consensus 667 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~-~~~~kl 741 (933)
...++||||++ ++|.+++. ...+++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+|+
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEE
Confidence 24689999997 58988874 34689999999999999999999965 9999999999999985 557899
Q ss_pred eecccccccccCCCce--eeeecccccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccc
Q 002349 742 TDFGIAKSLCVSKSYT--STYIMGTIGYIDPEYART-SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANN 818 (933)
Q Consensus 742 ~DfGla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 818 (933)
+|||+++......... .....|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.................
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 236 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 9999997653221111 122357889999997654 5678899999999999999999999976554333222111100
Q ss_pred cccc--------ccCcc----ccccccC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 819 AVME--------TVDPE----ISATCKD-----LGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 819 ~~~~--------~~~~~----~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.... ..... ....... .....++.+++.+|++.||++|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 0000 00000 0000000 0123567889999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=283.00 Aligned_cols=253 Identities=28% Similarity=0.352 Sum_probs=195.8
Q ss_pred cCcceeeecccceeEEEEEEc-CCceEEEEEecccCc-hhHHHHHHHHHHHhcC-CCCceeeeeeEEecCCccEEEEEec
Q 002349 600 LSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYP-QCLKEFETELETVGSI-KHRNLVSLQGYSLSSSGNLLFYDFM 676 (933)
Q Consensus 600 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 676 (933)
++....||.|+||+|+|-.++ .|+..|||+++.... ...+++..|.++..+- +.||||+++|....++..|+.||.|
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM 145 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM 145 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence 334456999999999999977 588999999987653 4567788888775554 7999999999999999999999999
Q ss_pred CCCCHHHHh---cCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 677 ENGSLWDIL---HGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 677 ~~gsL~~~l---~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
+ .|++.+- +. .....+++...-.|...++.||.||-+. ..|+||||||+|||++..|.+|+||||++-.+..+
T Consensus 146 d-~SlDklYk~vy~-vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 146 D-ISLDKLYKRVYS-VQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS 221 (361)
T ss_pred h-hhHHHHHHHHHH-HHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence 5 4665432 22 2456789999999999999999999874 48999999999999999999999999999776332
Q ss_pred CCceeeeecccccccCcccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCcch-hHHHHhhhcccccccccCccccc
Q 002349 754 KSYTSTYIMGTIGYIDPEYART--SRLTEKSDVYSFGIVLLELLTGRKAVDNECNL-HHLILSKTANNAVMETVDPEISA 830 (933)
Q Consensus 754 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 830 (933)
...+.-.|...|||||.+.. ..|+-++||||+|+++||+.||+.|+.+-.+. +++....... +|.+..
T Consensus 222 --iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gd-------pp~l~~ 292 (361)
T KOG1006|consen 222 --IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGD-------PPILLF 292 (361)
T ss_pred --HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCC-------CCeecC
Confidence 22333468999999998864 35889999999999999999999999753332 2222111111 122222
Q ss_pred cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 831 TCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 831 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.....+....+.++|..|+..|-..||+.+++.++
T Consensus 293 ~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 293 DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 22233456788999999999999999999998763
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=299.78 Aligned_cols=259 Identities=22% Similarity=0.311 Sum_probs=198.5
Q ss_pred HHHHhhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEec-CCc
Q 002349 593 IMRMTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLS-SSG 668 (933)
Q Consensus 593 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~ 668 (933)
+...+++|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.. ...
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 3456789999999999999999999966 68899999885432 2345678899999999999999999999865 457
Q ss_pred cEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccc
Q 002349 669 NLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAK 748 (933)
Q Consensus 669 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 748 (933)
.++||||+ +++|.++++ ..++++..+..++.|++.||+|||+. +|+||||+|+||++++++.+||+|||.++
T Consensus 85 ~~lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 85 IYFVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 88999998 568988884 34678888999999999999999965 99999999999999999999999999987
Q ss_pred ccccCCCceeeeecccccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccc------
Q 002349 749 SLCVSKSYTSTYIMGTIGYIDPEYART-SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVM------ 821 (933)
Q Consensus 749 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~------ 821 (933)
..... .....++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||................+...
T Consensus 157 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 157 IQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred ccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 54221 123457889999998766 5689999999999999999999999975543222211110000000
Q ss_pred -------c---ccC----ccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 822 -------E---TVD----PEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 822 -------~---~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
+ ... .......+ ..+..+.+++.+|++.+|++|||+++++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFK--NADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcC--CCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 000 00000000 123678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-32 Score=295.87 Aligned_cols=244 Identities=27% Similarity=0.374 Sum_probs=194.6
Q ss_pred cCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEe
Q 002349 600 LSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 600 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
|...+.||+|+||+||+|... +++.||+|++.... ....+.+.+|++++++++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 566678999999999999965 57889999986432 23345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS 755 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 755 (933)
+. |++.+.+. ....++++.++..++.|++.|++|||+. +++||||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~--~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CL-GSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CC-CCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 96 57888775 2345789999999999999999999965 999999999999999999999999999864321
Q ss_pred ceeeeecccccccCccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccc
Q 002349 756 YTSTYIMGTIGYIDPEYAR---TSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATC 832 (933)
Q Consensus 756 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (933)
.....|+..|+|||++. ...++.++|||||||++|+|++|..||............... .. +...
T Consensus 174 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~--~~-----~~~~--- 241 (313)
T cd06633 174 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DS-----PTLQ--- 241 (313)
T ss_pred --CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc--CC-----CCCC---
Confidence 22346889999999874 456888999999999999999999999765443333221111 11 1111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 833 KDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 833 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
....+..+.+++.+|++.+|.+||++.+++++
T Consensus 242 -~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 242 -SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01123467889999999999999999999865
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=295.14 Aligned_cols=259 Identities=23% Similarity=0.289 Sum_probs=200.2
Q ss_pred cCcceeeecccceeEEEEEEcC-CceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEec
Q 002349 600 LSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFM 676 (933)
Q Consensus 600 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 676 (933)
|+..+.||+|++|.||+|.... ++.||+|++.... ....+.+..|++++++++|+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 4566789999999999999764 8899999987653 333467788999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCc
Q 002349 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY 756 (933)
Q Consensus 677 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 756 (933)
+ ++|.+++.. ....+++..+..++.|++.||+|||++ +|+||||+|+||++++++.+||+|||.++.......
T Consensus 81 ~-~~l~~~i~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 81 D-MDLKKYLDK--RPGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred C-cCHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 7 589999963 225799999999999999999999966 999999999999999999999999999986543222
Q ss_pred eeeeecccccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccc----------cC
Q 002349 757 TSTYIMGTIGYIDPEYARTS-RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMET----------VD 825 (933)
Q Consensus 757 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------~~ 825 (933)
......++..|+|||.+.+. .++.++|||||||++|||++|+.||....................+. ..
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK 233 (282)
T ss_pred ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence 12223467789999998776 78999999999999999999999998665443332211100000000 00
Q ss_pred cccccc---cc---CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 826 PEISAT---CK---DLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 826 ~~~~~~---~~---~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
...+.. .. -......+.+++.+|++.||++||++.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 000000 00 00114678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=319.59 Aligned_cols=260 Identities=28% Similarity=0.402 Sum_probs=207.9
Q ss_pred HhhccCcceeeecccceeEEEEEEcC--------CceEEEEEecccC-chhHHHHHHHHHHHhcC-CCCceeeeeeEEec
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLKN--------CKPVAIKRLYSHY-PQCLKEFETELETVGSI-KHRNLVSLQGYSLS 665 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 665 (933)
..+++...+.+|+|.||.||+|.... ...||||.++... ....+.+..|+++++.+ +|+||+.++|++..
T Consensus 294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~ 373 (609)
T KOG0200|consen 294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ 373 (609)
T ss_pred chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence 34455566699999999999998441 3569999997654 34677899999999999 69999999999999
Q ss_pred CCccEEEEEecCCCCHHHHhcCCC-----CC--------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceE
Q 002349 666 SSGNLLFYDFMENGSLWDILHGPT-----KK--------KKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNIL 732 (933)
Q Consensus 666 ~~~~~lv~e~~~~gsL~~~l~~~~-----~~--------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIl 732 (933)
++..++|+||+..|+|.++++..+ .. ..++..+.+.++.|||.|++||++. ++||||+.++|||
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVL 450 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVL 450 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEE
Confidence 999999999999999999996432 00 2389999999999999999999954 9999999999999
Q ss_pred eCCCCCeEEeecccccccccCCCceeeeecc--cccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhH
Q 002349 733 LDKDFEAHLTDFGIAKSLCVSKSYTSTYIMG--TIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHH 809 (933)
Q Consensus 733 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~ 809 (933)
+.++..+||+|||+|+.......+......| +..|||||.+....|+.++|||||||++|||+| |..|+.+-.....
T Consensus 451 i~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~ 530 (609)
T KOG0200|consen 451 ITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEE 530 (609)
T ss_pred ecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHH
Confidence 9999999999999999765555554343333 346999999999999999999999999999999 6678876322233
Q ss_pred HHHhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccC
Q 002349 810 LILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869 (933)
Q Consensus 810 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 869 (933)
. ......+... .. +..+..+++++++.||+.+|++||++.++.+.++..
T Consensus 531 l-~~~l~~G~r~-----~~-----P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 531 L-LEFLKEGNRM-----EQ-----PEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred H-HHHHhcCCCC-----CC-----CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 2 2222222111 11 223457899999999999999999999999998874
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=304.25 Aligned_cols=257 Identities=25% Similarity=0.301 Sum_probs=199.4
Q ss_pred HHhhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCc---
Q 002349 595 RMTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSG--- 668 (933)
Q Consensus 595 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--- 668 (933)
...++|+....||+|++|.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34678999999999999999999976 47889999886532 2334567889999999999999999998876554
Q ss_pred ---cEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecc
Q 002349 669 ---NLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFG 745 (933)
Q Consensus 669 ---~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfG 745 (933)
.++|+||+ +++|.+++. ..++++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVK----CQKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred cccEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence 79999998 669999984 25689999999999999999999965 99999999999999999999999999
Q ss_pred cccccccCCCceeeeecccccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccccccccc
Q 002349 746 IAKSLCVSKSYTSTYIMGTIGYIDPEYART-SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETV 824 (933)
Q Consensus 746 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 824 (933)
++...... .....++..|+|||...+ ..++.++||||+||++|+|++|+.||.+..............+...+.+
T Consensus 164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 239 (343)
T cd07851 164 LARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL 239 (343)
T ss_pred cccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence 99865322 223467889999998865 3678999999999999999999999976554433322111111000000
Q ss_pred ----------------C----ccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 825 ----------------D----PEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 825 ----------------~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
. +.+.... ......+.+++.+|++.||++|||+.+|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 240 LQKISSESARNYIQSLPQMPKKDFKEVF--SGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HhhccchhHHHHHHhccccCCCCHHHHh--ccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0 0000000 0124678899999999999999999999874
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.6e-32 Score=298.10 Aligned_cols=258 Identities=22% Similarity=0.274 Sum_probs=193.0
Q ss_pred ccCcceeeecccceeEEEEEEcC---CceEEEEEecccC--chhHHHHHHHHHHHhcC-CCCceeeeeeEEecC----Cc
Q 002349 599 NLSEKYIIGYGASSTVYKCVLKN---CKPVAIKRLYSHY--PQCLKEFETELETVGSI-KHRNLVSLQGYSLSS----SG 668 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~----~~ 668 (933)
+|+..+.||+|+||.||+|.... ++.||+|++.... ....+.+.+|+++++++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 47778899999999999999763 6789999986532 22346678899999999 599999999875432 45
Q ss_pred cEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccc
Q 002349 669 NLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAK 748 (933)
Q Consensus 669 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 748 (933)
.++++||+. ++|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 678889886 68999884 456789999999999999999999965 99999999999999999999999999998
Q ss_pred ccccCCCc---eeeeecccccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccccccc--
Q 002349 749 SLCVSKSY---TSTYIMGTIGYIDPEYART-SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVME-- 822 (933)
Q Consensus 749 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-- 822 (933)
........ ......|+..|+|||...+ ..++.++||||+||++|+|++|+.||................+...+
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 65322111 1223468999999998766 46899999999999999999999999765433222111110000000
Q ss_pred -----------------cc-CccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 823 -----------------TV-DPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 823 -----------------~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.. ...+.... ......+.+++.+|++.||++|||+.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIF--PNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhC--CCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00 00000000 0113578899999999999999999999853
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-34 Score=274.67 Aligned_cols=265 Identities=25% Similarity=0.316 Sum_probs=208.4
Q ss_pred ccCcceeeecccceeEEEEEEcC-CceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecC--------C
Q 002349 599 NLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSS--------S 667 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--------~ 667 (933)
.|....+||+|.||.||+|+.++ ++.||+|++.-.. ...-....+|+++|..++|+|++.+++.|... .
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 45555789999999999999765 6778998764322 22234568899999999999999999987542 3
Q ss_pred ccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccc
Q 002349 668 GNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIA 747 (933)
Q Consensus 668 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla 747 (933)
..|+||++|+. +|.-++. ....+++..++.+++.++..||.|+|.. .|+|||+||.|||++.+|.+||+|||+|
T Consensus 98 t~ylVf~~ceh-DLaGlLs--n~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLS--NRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred eeeeeHHHhhh-hHHHHhc--CccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccc
Confidence 47999999976 8888884 2346799999999999999999999965 8999999999999999999999999999
Q ss_pred cccccCCC---ceeeeecccccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccc
Q 002349 748 KSLCVSKS---YTSTYIMGTIGYIDPEYARTS-RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMET 823 (933)
Q Consensus 748 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 823 (933)
+.+..... ...+..+-|.+|++||.+.|. .|+++.|||+-||++.||+||.+-+.+.....++..+....+.....
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 87643221 223345669999999998874 79999999999999999999999999998888887776666666555
Q ss_pred cCccccccc----------------------cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccC
Q 002349 824 VDPEISATC----------------------KDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869 (933)
Q Consensus 824 ~~~~~~~~~----------------------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 869 (933)
++|...... ++........+++..++..||.+|+++++++.+....
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~ 319 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFW 319 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhh
Confidence 554332110 0000113567899999999999999999999865443
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.4e-32 Score=288.29 Aligned_cols=250 Identities=22% Similarity=0.296 Sum_probs=195.7
Q ss_pred ccCcceeeecccceeEEEEEEcC-CceEEEEEeccc-----CchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEE
Q 002349 599 NLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSH-----YPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLF 672 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 672 (933)
+|...+.||+|+||.||+|.+.. +..+++|.++.. .......+.+|+.++++++||||+++++++......++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47788999999999999998764 344555555432 122334577899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccc
Q 002349 673 YDFMENGSLWDILHGP-TKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLC 751 (933)
Q Consensus 673 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 751 (933)
|||+++++|.++++.. .....+++..+..++.|++.|+.|||+. +++|+||||+||+++. +.+|++|||.++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999988532 2345789999999999999999999965 9999999999999975 569999999987653
Q ss_pred cCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccc
Q 002349 752 VSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISAT 831 (933)
Q Consensus 752 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (933)
... .......|++.|+|||...+..++.++||||||+++|+|++|..||............ ... ..+..+
T Consensus 157 ~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~--~~~-----~~~~~~-- 226 (260)
T cd08222 157 GSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRI--VEG-----PTPSLP-- 226 (260)
T ss_pred CCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH--HcC-----CCCCCc--
Confidence 322 2223346888999999998888899999999999999999999999754432222111 111 111111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 832 CKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 832 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
...+..+.+++.+|++.+|++||++.+++++
T Consensus 227 ---~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 227 ---ETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred ---chhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 1234678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=314.74 Aligned_cols=260 Identities=21% Similarity=0.212 Sum_probs=211.1
Q ss_pred HHHHHHhhccCcceeeecccceeEEEEEEcC-CceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecC
Q 002349 591 EDIMRMTENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSS 666 (933)
Q Consensus 591 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 666 (933)
.++.-..++|.+.++||+|+||.|..++++. ++.||+|++.+.. .....-|..|-.+|..-+.+=||.++-.|.+.
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 4444556899999999999999999999875 6778999987632 33456688899999988999999999999999
Q ss_pred CccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccc
Q 002349 667 SGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGI 746 (933)
Q Consensus 667 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl 746 (933)
.+.|+|||||+||+|-.++. +..++++..+.-++..|+.||..+|+ .|+|||||||+|||+|..|.+||+|||.
T Consensus 148 ~~LYlVMdY~pGGDlltLlS---k~~~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADFGs 221 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLS---KFDRLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADFGS 221 (1317)
T ss_pred cceEEEEecccCchHHHHHh---hcCCChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccchh
Confidence 99999999999999999994 44589999999999999999999994 5999999999999999999999999999
Q ss_pred ccccccCCCceeeeecccccccCcccccc-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccc
Q 002349 747 AKSLCVSKSYTSTYIMGTIGYIDPEYART-----SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVM 821 (933)
Q Consensus 747 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 821 (933)
+..+..+..-.+...+|||-|++||+++. +.|++.+|-||+||++|||+.|..||..+.-..++..+......+.
T Consensus 222 Clkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~ 301 (1317)
T KOG0612|consen 222 CLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLS 301 (1317)
T ss_pred HHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcC
Confidence 98887666666677899999999998852 5689999999999999999999999998776666655444332221
Q ss_pred cccCccccccccCHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHHH
Q 002349 822 ETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPT---MHEVSRVL 866 (933)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~evl~~L 866 (933)
- +. +...++...++|++.+. +|+.|.. +.++-.+.
T Consensus 302 F--P~-------~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~Hp 339 (1317)
T KOG0612|consen 302 F--PD-------ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHP 339 (1317)
T ss_pred C--Cc-------ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCc
Confidence 1 10 11123445556665444 7888887 88887654
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=284.65 Aligned_cols=236 Identities=26% Similarity=0.282 Sum_probs=192.3
Q ss_pred eecccceeEEEEEEcC-CceEEEEEecccCc---hhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecCCCCH
Q 002349 606 IGYGASSTVYKCVLKN-CKPVAIKRLYSHYP---QCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSL 681 (933)
Q Consensus 606 lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 681 (933)
||+|+||.||+|.... ++.+|+|.+..... .....+..|++++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 6999999999999764 78999999866432 2456789999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCceeeee
Q 002349 682 WDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYI 761 (933)
Q Consensus 682 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~ 761 (933)
.+++. ....+++..+..++.|++.|+.|+|+. +++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~ 153 (250)
T cd05123 81 FSHLS---KEGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTF 153 (250)
T ss_pred HHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCC
Confidence 99995 344689999999999999999999965 99999999999999999999999999997653321 122345
Q ss_pred cccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHHHHHH
Q 002349 762 MGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKV 841 (933)
Q Consensus 762 ~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 841 (933)
.++..|+|||...+...+.++|+||||+++|++++|+.||......... ..... . ...++.. .+..+
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~-~~~~~-~------~~~~~~~-----~~~~l 220 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIY-EKILK-D------PLRFPEF-----LSPEA 220 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHH-HHHhc-C------CCCCCCC-----CCHHH
Confidence 6888999999998888899999999999999999999999755432211 11111 0 0111111 13578
Q ss_pred HHHHHHccCCCCCCCCCHHH
Q 002349 842 FQLALLCSKRQPTDRPTMHE 861 (933)
Q Consensus 842 ~~li~~cl~~dP~~RPt~~e 861 (933)
.+++.+|+..||++||++.+
T Consensus 221 ~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 221 RDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHhcCCHhhCCCccc
Confidence 89999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8e-33 Score=283.75 Aligned_cols=260 Identities=21% Similarity=0.274 Sum_probs=207.3
Q ss_pred HhhccCcceeeecccceeEEEEEEcC-CceEEEEEecccCchhHHHHHHHHHHHhcCC--CC----ceeeeeeEEecCCc
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHYPQCLKEFETELETVGSIK--HR----NLVSLQGYSLSSSG 668 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~----niv~~~~~~~~~~~ 668 (933)
.+++|.+...+|+|.||.|-.+.+.. +..||||+++... ...+...-|+++++++. .| -+|.+.++|.-.++
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 37899999999999999999999664 5789999986543 33455677999999993 33 37888899999999
Q ss_pred cEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCC-------------
Q 002349 669 NLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDK------------- 735 (933)
Q Consensus 669 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~------------- 735 (933)
.++|+|.+ |-|+.|++.. .+-.+++...+..++.|+++++++||+. +++|.|+||+||++.+
T Consensus 166 iCivfell-G~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred eEEEEecc-ChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCcc
Confidence 99999998 6699999964 3456899999999999999999999955 9999999999999931
Q ss_pred -------CCCeEEeecccccccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchh
Q 002349 736 -------DFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLH 808 (933)
Q Consensus 736 -------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~ 808 (933)
...++++|||.|+..... ...++.|..|+|||++.+-.++.++||||+|||++|+.||...|+...+.+
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e~----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHEH----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred ceeccCCCcceEEEecCCcceeccC----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 345899999999864322 255788999999999999999999999999999999999999999777777
Q ss_pred HHHHhhhcccccccccCccc-------------------------cccc--------cCHHHHHHHHHHHHHccCCCCCC
Q 002349 809 HLILSKTANNAVMETVDPEI-------------------------SATC--------KDLGAVKKVFQLALLCSKRQPTD 855 (933)
Q Consensus 809 ~~~~~~~~~~~~~~~~~~~~-------------------------~~~~--------~~~~~~~~l~~li~~cl~~dP~~ 855 (933)
++.+....-+..+..+-... ...+ .+-.+..++++++++|+..||.+
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 76655444333222111000 0011 11245578999999999999999
Q ss_pred CCCHHHHHHH
Q 002349 856 RPTMHEVSRV 865 (933)
Q Consensus 856 RPt~~evl~~ 865 (933)
|+|+.|++.+
T Consensus 397 RiTl~EAL~H 406 (415)
T KOG0671|consen 397 RITLREALSH 406 (415)
T ss_pred cccHHHHhcC
Confidence 9999999874
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=320.56 Aligned_cols=145 Identities=28% Similarity=0.350 Sum_probs=130.5
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
++|.+.++||+|+||+||+|.+. .++.||+|+++... ......+.+|+.+++.++||||+++++++......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57889999999999999999977 57899999986542 233467889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccc
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAK 748 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 748 (933)
||+++++|.++++ ..+.+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~---~~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLH---IYGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999995 345688999999999999999999965 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.4e-33 Score=292.10 Aligned_cols=244 Identities=19% Similarity=0.260 Sum_probs=198.2
Q ss_pred ceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecCCC
Q 002349 603 KYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENG 679 (933)
Q Consensus 603 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 679 (933)
.++||+|.||+||-|+++ +|+.||||++.+.. +.....+..|+.+|++++||.||.+...|+..+..++|||.+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 468999999999999976 58999999996542 445577899999999999999999999999999999999999765
Q ss_pred CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCC---CCeEEeecccccccccCCCc
Q 002349 680 SLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKD---FEAHLTDFGIAKSLCVSKSY 756 (933)
Q Consensus 680 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~---~~~kl~DfGla~~~~~~~~~ 756 (933)
-|.-++. ...+++++....-++.||+.||.|||.+ +|||+|+||+|||+... ..+||||||.|+.++.. .
T Consensus 649 MLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk--s 721 (888)
T KOG4236|consen 649 MLEMILS--SEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK--S 721 (888)
T ss_pred HHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchh--h
Confidence 5554554 4567899998899999999999999965 99999999999999644 57999999999997543 3
Q ss_pred eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHH
Q 002349 757 TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLG 836 (933)
Q Consensus 757 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (933)
....++||+.|+|||+++.+.|...-|+||+||++|--++|..||..+.+..+.+....-. ++..- ..+
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFM--yPp~P---------W~e 790 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFM--YPPNP---------WSE 790 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccc--cCCCc---------hhh
Confidence 3456899999999999999999999999999999999999999998776665544322111 11111 112
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002349 837 AVKKVFQLALLCSKRQPTDRPTMHEVSR 864 (933)
Q Consensus 837 ~~~~l~~li~~cl~~dP~~RPt~~evl~ 864 (933)
.....+++|...++..-.+|-+.+.-+.
T Consensus 791 is~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 791 ISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred cCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 2345678888888888889988877654
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-34 Score=324.07 Aligned_cols=397 Identities=28% Similarity=0.385 Sum_probs=287.1
Q ss_pred cEEEEEcCCCCcCcccCCCCCCCCCccEEEccCCcccccCCCCccCCCCCceecccccccCCCCCcccccccchhhhhhc
Q 002349 69 TVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILK 148 (933)
Q Consensus 69 ~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~ 148 (933)
+...|+++.|.+. ..|.+.+++.+|++|+|.+|.+. ..|..+..+++|++||+|+|++. .+|..+..+..+..+..+
T Consensus 69 ~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s 145 (1081)
T KOG0618|consen 69 HLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAAS 145 (1081)
T ss_pred HHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhh
Confidence 5677888888887 67788999999999999999998 78999999999999999999997 888887777666666666
Q ss_pred cc-------------------CccCCCCcccccCCCCceeeeecCCCCCCcccccccCCCCcEEeccCccccCccCcCCc
Q 002349 149 NN-------------------QLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIG 209 (933)
Q Consensus 149 ~n-------------------~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~ 209 (933)
+| .+.+.++..+..++. .|+|..|.+. .-++.++.+|+.+....|+++... -
T Consensus 146 ~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l~----~ 216 (1081)
T KOG0618|consen 146 NNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSELE----I 216 (1081)
T ss_pred cchhhhhhccccchhhhhhhhhcccchhcchhhhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceEE----e
Confidence 55 445555555655555 6999999987 234566667777777777665211 1
Q ss_pred CCCCCcEEccccccccCcCCCCccccccceEeccccccccccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEE
Q 002349 210 NCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLY 289 (933)
Q Consensus 210 ~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 289 (933)
..++|+.|+.++|.++ .+........++++++++|++++ +|++++.+.+|+.|+..+|.|+ .+|..+....+|+.|.
T Consensus 217 ~g~~l~~L~a~~n~l~-~~~~~p~p~nl~~~dis~n~l~~-lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~ 293 (1081)
T KOG0618|consen 217 SGPSLTALYADHNPLT-TLDVHPVPLNLQYLDISHNNLSN-LPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLS 293 (1081)
T ss_pred cCcchheeeeccCcce-eeccccccccceeeecchhhhhc-chHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHH
Confidence 2345556666666555 22222223345556666666553 3355555666666666665554 4444444445555555
Q ss_pred eeCCccCCCCCCccccCCcceEeeeccccccc------------------------cCC-ccccccccccccccccccCC
Q 002349 290 LHSNKLTGHIPPELGNMTKLHYLELNDNQLTG------------------------HIP-PALGKLTDLFDLNVANNHLE 344 (933)
Q Consensus 290 L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~------------------------~~~-~~l~~l~~L~~L~L~~N~l~ 344 (933)
+..|.+. .+|.....++.|++|+|..|+|.. ..| -.=..++.|+.|++.+|.++
T Consensus 294 ~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Lt 372 (1081)
T KOG0618|consen 294 AAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLT 372 (1081)
T ss_pred hhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCccc
Confidence 5555554 344444445555555555555441 112 11123567889999999999
Q ss_pred CCCCCCcccCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCCccccccccccceeeccCCccCCCCCCCCC
Q 002349 345 GPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLG 424 (933)
Q Consensus 345 ~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 424 (933)
...-..+.+..+|+.|+|++|+|.......+.+++.|+.|+||+|+++ .+|..+..++.|++|...+|+|. ..| .+.
T Consensus 373 d~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~ 449 (1081)
T KOG0618|consen 373 DSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELA 449 (1081)
T ss_pred ccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhh
Confidence 877778899999999999999999666668899999999999999999 78899999999999999999998 777 899
Q ss_pred CccccccccccCcccccc-cccccccccccceEEccCCccccccchhhccccccceeeecCC
Q 002349 425 DLEHLLKLNLSRNQLTGF-IPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYN 485 (933)
Q Consensus 425 ~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N 485 (933)
.++.|+.+|+|.|+|+.. +|..... ++|++|||++|.-.-..-..|..++++...+++-|
T Consensus 450 ~l~qL~~lDlS~N~L~~~~l~~~~p~-p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~~i~~~ 510 (1081)
T KOG0618|consen 450 QLPQLKVLDLSCNNLSEVTLPEALPS-PNLKYLDLSGNTRLVFDHKTLKVLKSLSQMDITLN 510 (1081)
T ss_pred hcCcceEEecccchhhhhhhhhhCCC-cccceeeccCCcccccchhhhHHhhhhhheecccC
Confidence 999999999999999944 3443333 89999999999855566778888888888888777
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-32 Score=302.81 Aligned_cols=255 Identities=24% Similarity=0.342 Sum_probs=207.9
Q ss_pred HHhhccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcC-CCCceeeeeeEEec-----CC
Q 002349 595 RMTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSI-KHRNLVSLQGYSLS-----SS 667 (933)
Q Consensus 595 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~-----~~ 667 (933)
..++.|++.+.||.|.+|.||+++.+ +++..|||+...... ..++++.|.++++.. +|||++.++|++.. ++
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D 94 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD 94 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence 34567888899999999999999954 577888998866543 356778899999988 69999999999853 56
Q ss_pred ccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccc
Q 002349 668 GNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIA 747 (933)
Q Consensus 668 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla 747 (933)
..|+|||||.+||..|+++... +..+.|+.+..|++.++.|+.+||++ .++|||||-.|||++.++.||++|||.+
T Consensus 95 qLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvS 170 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVS 170 (953)
T ss_pred eEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeee
Confidence 7899999999999999998644 77899999999999999999999976 8999999999999999999999999999
Q ss_pred cccccCCCceeeeecccccccCccccccC-----CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccccccc
Q 002349 748 KSLCVSKSYTSTYIMGTIGYIDPEYARTS-----RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVME 822 (933)
Q Consensus 748 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 822 (933)
..+.... ......+||+.|||||++... .|+..+|+||+|++..||..|.+|+.+-.....+..+- .
T Consensus 171 aQldsT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~Ip-------R 242 (953)
T KOG0587|consen 171 AQLDSTV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP-------R 242 (953)
T ss_pred eeeeccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCC-------C
Confidence 8874322 334456899999999998653 47789999999999999999999997655544433211 1
Q ss_pred ccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 823 TVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.-+|.+. ......+++.++|..|+..|-.+||++.+++++
T Consensus 243 NPPPkLk---rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 243 NPPPKLK---RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred CCCcccc---chhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 1112221 133456789999999999999999999988753
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=274.27 Aligned_cols=265 Identities=19% Similarity=0.322 Sum_probs=214.0
Q ss_pred HHHHHHHhhccCcceeeecccceeEEEEEEcC------CceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeE
Q 002349 590 YEDIMRMTENLSEKYIIGYGASSTVYKCVLKN------CKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGY 662 (933)
Q Consensus 590 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~ 662 (933)
.+++....++++...++-+|.||.||+|.|++ .+.|-||.++... +-+...+..|.-.+..+.|||+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 34555566778888889999999999998664 4567788887654 3456778899999999999999999998
Q ss_pred Eec-CCccEEEEEecCCCCHHHHhc-----CCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCC
Q 002349 663 SLS-SSGNLLFYDFMENGSLWDILH-----GPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKD 736 (933)
Q Consensus 663 ~~~-~~~~~lv~e~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~ 736 (933)
+.+ ...+++.|.++.-|+|..++. ++...+.++..+...++.|++.|++|||.+ +|||.||.++|.++|+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhh
Confidence 765 456788899999999999997 445556788889999999999999999976 99999999999999999
Q ss_pred CCeEEeecccccccccCCCce-eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhh
Q 002349 737 FEAHLTDFGIAKSLCVSKSYT-STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSK 814 (933)
Q Consensus 737 ~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~ 814 (933)
-+|||+|=.+++.+-..+.+- ......+..||+||.+....|+.++|||||||++|||+| |+.|+.+-.+.+...+.+
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk 512 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK 512 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh
Confidence 999999999998764333222 222345678999999999999999999999999999988 888887655554443322
Q ss_pred hcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccC
Q 002349 815 TANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869 (933)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 869 (933)
...+ ..++.+++.+++.++..||..+|++||+++|++.-|.+.
T Consensus 513 dGyR------------laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 513 DGYR------------LAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred ccce------------ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 1111 123456788999999999999999999999999887654
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=279.07 Aligned_cols=256 Identities=23% Similarity=0.281 Sum_probs=196.7
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--c-----hhHHHHHHHHHHHhcCCCCceeeeeeEEecC-Cc
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--P-----QCLKEFETELETVGSIKHRNLVSLQGYSLSS-SG 668 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~ 668 (933)
++|-..++||+|||+.||+|.+- ..+.||||+-.-.. . ...+...+|.++.+.++||.||++++||.-+ +.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 45666678999999999999954 45678888754321 1 1123467899999999999999999999755 56
Q ss_pred cEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCC---CCCeEEeecc
Q 002349 669 NLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDK---DFEAHLTDFG 745 (933)
Q Consensus 669 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~---~~~~kl~DfG 745 (933)
+|-|.|||+|.+|+-+|. ....+++.++..|+.||+.||.||.+. +++|+|-|+||.|||+.. -|.+||+|||
T Consensus 543 FCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 789999999999999994 466789999999999999999999987 889999999999999954 4789999999
Q ss_pred cccccccCCCce------eeeecccccccCccccccC----CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhh
Q 002349 746 IAKSLCVSKSYT------STYIMGTIGYIDPEYARTS----RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKT 815 (933)
Q Consensus 746 la~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~----~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~ 815 (933)
+++.+..+.... .....||.+|++||.+.-+ ..+.|+||||+||++|+++.|+.||........+.....
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNT 698 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENT 698 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhc
Confidence 999886543321 2345799999999987533 468899999999999999999999987655555433222
Q ss_pred cccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002349 816 ANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSR 864 (933)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 864 (933)
.-....-.+++ ......+...+|++|+++--++|....++..
T Consensus 699 IlkAtEVqFP~-------KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 699 ILKATEVQFPP-------KPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred hhcceeccCCC-------CCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 11111111111 1112345667899999999999998877753
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=291.60 Aligned_cols=244 Identities=22% Similarity=0.251 Sum_probs=193.9
Q ss_pred HhhccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcC-CCCceeeeeeEEecCCccEEEE
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSI-KHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 673 (933)
.++.|.....+|.|+|+.|-.+.+. .++..+||++.... .+-.+|+.++.+. +||||+++.+.+.++.+.|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 3677888888999999999999865 46789999997652 2334567666665 7999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEe-CCCCCeEEeeccccccccc
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILL-DKDFEAHLTDFGIAKSLCV 752 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll-~~~~~~kl~DfGla~~~~~ 752 (933)
|++.|+-+.+.+. ....+. .++..|+.+++.|+.|||++ ||||||+||+|||+ +..+.++|+|||.++....
T Consensus 396 e~l~g~ell~ri~---~~~~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 396 ELLDGGELLRRIR---SKPEFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hhccccHHHHHHH---hcchhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 9999998888774 223333 77888999999999999966 99999999999999 5889999999999987644
Q ss_pred CCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccc
Q 002349 753 SKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATC 832 (933)
Q Consensus 753 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (933)
. ...-+-|..|.|||+.....|++++|+||+|+++|+|++|+.||......... ......+...
T Consensus 469 ~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei-~~~i~~~~~s----------- 532 (612)
T KOG0603|consen 469 S----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEI-HTRIQMPKFS----------- 532 (612)
T ss_pred h----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHH-HHhhcCCccc-----------
Confidence 3 22234578999999999999999999999999999999999999855443211 1122111111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcc
Q 002349 833 KDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGS 868 (933)
Q Consensus 833 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 868 (933)
...+....+++..|++.||.+||+++++..+-..
T Consensus 533 --~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 533 --ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred --cccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 1123456778999999999999999999876544
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=273.91 Aligned_cols=240 Identities=23% Similarity=0.262 Sum_probs=194.8
Q ss_pred hccCcceeeecccceeEEEEEEcC-CceEEEEEecccCch---hHHHHHHHHHHHhcC-CCCceeeeeeEEecCCccEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHYPQ---CLKEFETELETVGSI-KHRNLVSLQGYSLSSSGNLLF 672 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 672 (933)
.+|....+||+|+||+|..|..++ .+-+|||+++++..- +.+--..|-++|+-. +-|.++.++.+|..-+..|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 468888999999999999999775 456899999776421 222224566677665 578999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccccc
Q 002349 673 YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV 752 (933)
Q Consensus 673 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 752 (933)
|||+.||+|.-+++ .-+++.+..++-++..||-||-+||++ ||+.||+|.+|||+|.+|.+||+|||+++.--
T Consensus 429 MEyvnGGDLMyhiQ---Q~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni- 501 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQ---QVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI- 501 (683)
T ss_pred EEEecCchhhhHHH---HhcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccc-
Confidence 99999999988884 567788899999999999999999954 99999999999999999999999999997532
Q ss_pred CCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccc
Q 002349 753 SKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATC 832 (933)
Q Consensus 753 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (933)
-........+|||.|+|||++...+|..++|.|||||++|||+.|+.||+++...+....+......++..
T Consensus 502 ~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKs--------- 572 (683)
T KOG0696|consen 502 FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKS--------- 572 (683)
T ss_pred cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCccc---------
Confidence 23344566899999999999999999999999999999999999999999877665554443333322222
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCC
Q 002349 833 KDLGAVKKVFQLALLCSKRQPTDRP 857 (933)
Q Consensus 833 ~~~~~~~~l~~li~~cl~~dP~~RP 857 (933)
.+.+...+....+...|.+|.
T Consensus 573 ----lSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 573 ----LSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred ----ccHHHHHHHHHHhhcCCcccc
Confidence 234556677777888999985
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=249.80 Aligned_cols=206 Identities=27% Similarity=0.322 Sum_probs=168.6
Q ss_pred HHHHhhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC-chhHHHHHHHHHHHhcC-CCCceeeeeeEEecCCcc
Q 002349 593 IMRMTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY-PQCLKEFETELETVGSI-KHRNLVSLQGYSLSSSGN 669 (933)
Q Consensus 593 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 669 (933)
+....+.+.....||+|+||.|-+-++. +|+..|||++.... .+..++..+|+.+..+- .+|.+|.++|........
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 3444455666677999999999888854 68899999997654 34456678888886665 799999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccc
Q 002349 670 LLFYDFMENGSLWDILHGP-TKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAK 748 (933)
Q Consensus 670 ~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 748 (933)
++.||.|+ .||+.+-... ..++.+++...-+|+..+.+||.|||++ ..|+|||+||+|||++.+|+||+||||.+-
T Consensus 121 wIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccce
Confidence 99999995 4776553221 3567899999999999999999999985 589999999999999999999999999998
Q ss_pred ccccCCCceeeeecccccccCcccccc----CCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 002349 749 SLCVSKSYTSTYIMGTIGYIDPEYART----SRLTEKSDVYSFGIVLLELLTGRKAVDN 803 (933)
Q Consensus 749 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwSlGv~l~elltg~~p~~~ 803 (933)
.+.++-.. +.-.|...|||||.+.. ..|+-++||||+|+++.||.+++.|++.
T Consensus 198 ~L~dSiAk--t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 198 YLVDSIAK--TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred eehhhhHH--HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 76433222 22358889999998854 3688999999999999999999999974
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=294.20 Aligned_cols=265 Identities=20% Similarity=0.257 Sum_probs=182.0
Q ss_pred HhhccCcceeeecccceeEEEEEE-----------------cCCceEEEEEecccCchhHHH--------------HHHH
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVL-----------------KNCKPVAIKRLYSHYPQCLKE--------------FETE 644 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E 644 (933)
..++|++.++||+|+||+||+|.. ..++.||||++........++ +..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 356899999999999999999974 234679999986543322222 3447
Q ss_pred HHHHhcCCCCce-----eeeeeEEec--------CCccEEEEEecCCCCHHHHhcCCC---------------------C
Q 002349 645 LETVGSIKHRNL-----VSLQGYSLS--------SSGNLLFYDFMENGSLWDILHGPT---------------------K 690 (933)
Q Consensus 645 ~~~l~~l~h~ni-----v~~~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~---------------------~ 690 (933)
+.++.+++|.++ ++++++|.. .+..++||||+++++|.++++... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777778876654 677777653 346799999999999999987421 1
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCceeeeecccccccCc
Q 002349 691 KKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDP 770 (933)
Q Consensus 691 ~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aP 770 (933)
...+++..+..++.|++.||.|+|+. +|+||||||+||+++.++.+||+|||+++..............+++.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 12356788899999999999999965 999999999999999999999999999976543322222233458899999
Q ss_pred cccccCCC----------------------CcchhhHHHHHHHHHHHhCCC-CCCCCcchhHHHHhhhcc-ccc--cccc
Q 002349 771 EYARTSRL----------------------TEKSDVYSFGIVLLELLTGRK-AVDNECNLHHLILSKTAN-NAV--METV 824 (933)
Q Consensus 771 E~~~~~~~----------------------~~~~DvwSlGv~l~elltg~~-p~~~~~~~~~~~~~~~~~-~~~--~~~~ 824 (933)
|.+..... ..+.||||+||++++|++|.. ||.+.............. ..+ ....
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 98754321 234799999999999999885 665321111100000000 000 0000
Q ss_pred CccccccccCHHHHHHHHHHHHHccCCCC---CCCCCHHHHHHHH
Q 002349 825 DPEISATCKDLGAVKKVFQLALLCSKRQP---TDRPTMHEVSRVL 866 (933)
Q Consensus 825 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPt~~evl~~L 866 (933)
...+.... .......+++.+++..+| .+|+|++|++++-
T Consensus 460 ~~~~~~~d---~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp 501 (507)
T PLN03224 460 KYDFSLLD---RNKEAGWDLACKLITKRDQANRGRLSVGQALSHR 501 (507)
T ss_pred CCCccccc---ccChHHHHHHHHHhccCCCCcccCCCHHHHhCCC
Confidence 01111100 123567888999998766 6899999999864
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=273.85 Aligned_cols=219 Identities=25% Similarity=0.255 Sum_probs=175.1
Q ss_pred ccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecCCCCHHHHhcC
Q 002349 609 GASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHG 687 (933)
Q Consensus 609 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 687 (933)
|.+|.||+|++. +++.||+|++.... .+.+|...+....||||+++++++...+..++||||+++|+|.+++.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~- 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS- 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH-
Confidence 899999999975 57889999986542 23445555556679999999999999999999999999999999984
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCceeeeecccccc
Q 002349 688 PTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGY 767 (933)
Q Consensus 688 ~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y 767 (933)
....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|||.+...... .....++..|
T Consensus 78 --~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y 148 (237)
T cd05576 78 --KFLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMY 148 (237)
T ss_pred --HhcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccc
Confidence 345689999999999999999999965 9999999999999999999999999988665321 1223457789
Q ss_pred cCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHHHHHHHHHHHH
Q 002349 768 IDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALL 847 (933)
Q Consensus 768 ~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 847 (933)
+|||...+..++.++||||+|+++|||++|+.|+....... .......++. .....+.+++.+
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~~~~~~~~~-----~~~~~~~~li~~ 211 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NTHTTLNIPE-----WVSEEARSLLQQ 211 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------ccccccCCcc-----cCCHHHHHHHHH
Confidence 99999988889999999999999999999998875321100 0000001111 123568889999
Q ss_pred ccCCCCCCCCCH
Q 002349 848 CSKRQPTDRPTM 859 (933)
Q Consensus 848 cl~~dP~~RPt~ 859 (933)
|++.||++||++
T Consensus 212 ~l~~dp~~R~~~ 223 (237)
T cd05576 212 LLQFNPTERLGA 223 (237)
T ss_pred HccCCHHHhcCC
Confidence 999999999996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=267.90 Aligned_cols=238 Identities=28% Similarity=0.365 Sum_probs=194.4
Q ss_pred cceeEEEEEEcC-CceEEEEEecccCchh-HHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecCCCCHHHHhcC
Q 002349 610 ASSTVYKCVLKN-CKPVAIKRLYSHYPQC-LKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHG 687 (933)
Q Consensus 610 ~~g~Vy~~~~~~-~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 687 (933)
+||.||+|...+ ++.+|+|++....... .+.+.+|++.+++++|+||+++++++......+++|||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999875 8899999997765444 68899999999999999999999999999999999999999999999853
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCceeeeecccccc
Q 002349 688 PTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGY 767 (933)
Q Consensus 688 ~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y 767 (933)
...+++..+..++.+++.++.|||+. +++|+||+|+||+++.++.++++|||.+....... ......++..|
T Consensus 81 ---~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~ 152 (244)
T smart00220 81 ---RGRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEY 152 (244)
T ss_pred ---ccCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCC
Confidence 23389999999999999999999965 99999999999999999999999999998764332 23345688899
Q ss_pred cCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHHHHHHHHHHHH
Q 002349 768 IDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALL 847 (933)
Q Consensus 768 ~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 847 (933)
++||...+..++.++||||+|++++++++|..||..................... .. ....+..+.+++.+
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~-------~~--~~~~~~~~~~~i~~ 223 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFP-------PP--EWKISPEAKDLIRK 223 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc-------cc--cccCCHHHHHHHHH
Confidence 9999998888999999999999999999999999763333332221111110000 00 00034678899999
Q ss_pred ccCCCCCCCCCHHHHHH
Q 002349 848 CSKRQPTDRPTMHEVSR 864 (933)
Q Consensus 848 cl~~dP~~RPt~~evl~ 864 (933)
|+..+|++||++.++++
T Consensus 224 ~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 224 LLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HccCCchhccCHHHHhh
Confidence 99999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=299.57 Aligned_cols=261 Identities=20% Similarity=0.195 Sum_probs=171.0
Q ss_pred HhhccCcceeeecccceeEEEEEEcC-----CceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeE------Ee
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLKN-----CKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGY------SL 664 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~------~~ 664 (933)
..++|+..+.||+|+||.||+|.+.+ +..||+|++...... +....| .+++..+.+++.++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 45789999999999999999999764 588999988643211 111111 1122222233222221 23
Q ss_pred cCCccEEEEEecCCCCHHHHhcCCCCC-----------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCC
Q 002349 665 SSSGNLLFYDFMENGSLWDILHGPTKK-----------------KKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVK 727 (933)
Q Consensus 665 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik 727 (933)
.+...++||||+++++|.++++..... .......+..++.|++.||+|||++ +|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 456789999999999999998632100 0112334567999999999999965 99999999
Q ss_pred CCceEeCC-CCCeEEeecccccccccCCCceeeeecccccccCccccccC----------------------CCCcchhh
Q 002349 728 SSNILLDK-DFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTS----------------------RLTEKSDV 784 (933)
Q Consensus 728 p~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~Dv 784 (933)
|+|||++. ++.+||+|||+|+.+.....+......+++.|||||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999986 57999999999987644444444556899999999965322 23456799
Q ss_pred HHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccc----ccccccCccc----cccccCH-HHHHHHHHHHHHccCCCCCC
Q 002349 785 YSFGIVLLELLTGRKAVDNECNLHHLILSKTANN----AVMETVDPEI----SATCKDL-GAVKKVFQLALLCSKRQPTD 855 (933)
Q Consensus 785 wSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~----~~~~~~~-~~~~~l~~li~~cl~~dP~~ 855 (933)
||+||++|||+++..+++.. ...+........ .+.....+.. ....... ......++++.+|++.||++
T Consensus 363 wSlGviL~el~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~k 440 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSN--LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQ 440 (566)
T ss_pred HHHHHHHHHHHhCcCCCchH--HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCccc
Confidence 99999999999987765432 111111100000 0000011110 0000000 01234568999999999999
Q ss_pred CCCHHHHHHH
Q 002349 856 RPTMHEVSRV 865 (933)
Q Consensus 856 RPt~~evl~~ 865 (933)
|||++|++++
T Consensus 441 R~ta~e~L~H 450 (566)
T PLN03225 441 RISAKAALAH 450 (566)
T ss_pred CCCHHHHhCC
Confidence 9999999986
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-31 Score=259.69 Aligned_cols=259 Identities=22% Similarity=0.311 Sum_probs=198.9
Q ss_pred CcceeeecccceeEEEEEEc-CCceEEEEEecccCc--hhHHHHHHHHHHHhcCCCCceeeeeeEEecC-----CccEEE
Q 002349 601 SEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYP--QCLKEFETELETVGSIKHRNLVSLQGYSLSS-----SGNLLF 672 (933)
Q Consensus 601 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv 672 (933)
+..+.||.|+||.||.+.+. +|+.||.|++..... ...+++.+|++++..++|.|+...+++..-. ++.|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 34567999999999999854 689999999865432 3467889999999999999999998876543 246788
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccccc
Q 002349 673 YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV 752 (933)
Q Consensus 673 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 752 (933)
.|.|.. +|..++ .....++...+.-+.+||++||+|||. .+|.||||||.|.|++.+...||||||+|+.-..
T Consensus 136 TELmQS-DLHKII---VSPQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 136 TELMQS-DLHKII---VSPQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHh-hhhhee---ccCCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccch
Confidence 898854 788887 466789999999999999999999995 4999999999999999999999999999997655
Q ss_pred CCCceeeeecccccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccccc-cc--------
Q 002349 753 SKSYTSTYIMGTIGYIDPEYARTS-RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAV-ME-------- 822 (933)
Q Consensus 753 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~-~~-------- 822 (933)
+.....+..+-|..|+|||++.|. .|+.+.||||.||++.|++..+..|......+++..+...-+.. .+
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence 555556666778999999999886 68999999999999999999998898777666654432211110 00
Q ss_pred ----cc-----Cccccccc---cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 823 ----TV-----DPEISATC---KDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 823 ----~~-----~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
.+ .|.++... .......+-..+...++..||++|.+..+.+.++
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 00 11111110 0001123445667788999999999999888755
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-30 Score=273.01 Aligned_cols=251 Identities=23% Similarity=0.283 Sum_probs=205.5
Q ss_pred hccCcceeeecccceeEEEEEEcCCc-eEEEEEeccc---CchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKNCK-PVAIKRLYSH---YPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~~~-~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
.+++....||-|+||.|=.+..++.. .+|+|.+++. .+.+.+.+..|-.+|...+.|.||++|..|.+.+.+|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 44555667999999999998876543 3788877653 3445566788999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
|-|-||.++..+ +.++.++.....-++..+.+|++|||.+ +||.||+||+|.++|.+|-+||.|||.|+.+...
T Consensus 500 EaClGGElWTiL---rdRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 500 EACLGGELWTIL---RDRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HhhcCchhhhhh---hhcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 999999999999 5678899999999999999999999955 9999999999999999999999999999987543
Q ss_pred CCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccccc
Q 002349 754 KSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCK 833 (933)
Q Consensus 754 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (933)
. ..-..+|||.|.|||++..+..+.++|.||+|+++||+++|.+||.+..++.....+...-..+ .++..+
T Consensus 574 ~--KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i--~~Pr~I----- 644 (732)
T KOG0614|consen 574 R--KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI--EFPRRI----- 644 (732)
T ss_pred C--ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh--hccccc-----
Confidence 3 3445799999999999999999999999999999999999999999887776654433221111 111222
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHHc
Q 002349 834 DLGAVKKVFQLALLCSKRQPTDRPT-----MHEVSRVLG 867 (933)
Q Consensus 834 ~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~L~ 867 (933)
.+...++|++....+|.+|.. +.+|-++-+
T Consensus 645 ----~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~W 679 (732)
T KOG0614|consen 645 ----TKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRW 679 (732)
T ss_pred ----chhHHHHHHHHHhcCcHhhhccccCChHHHHhhhh
Confidence 244566788888899999974 677766543
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-30 Score=288.12 Aligned_cols=246 Identities=28% Similarity=0.385 Sum_probs=188.2
Q ss_pred cCcceeeeccccee-EEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcC-CCCceeeeeeEEecCCccEEEEEecC
Q 002349 600 LSEKYIIGYGASST-VYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSI-KHRNLVSLQGYSLSSSGNLLFYDFME 677 (933)
Q Consensus 600 ~~~~~~lG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~ 677 (933)
|...+++|.|+.|+ ||+|...+ +.||||++-.. ......+|+..|+.- +|||||++++.-.++...||..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye~-R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYEG-REVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeCC-ceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 44456799999996 79999865 79999998543 345668999999988 59999999999889999999999995
Q ss_pred CCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCC---C--CCeEEeecccccccc
Q 002349 678 NGSLWDILHGP-TKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDK---D--FEAHLTDFGIAKSLC 751 (933)
Q Consensus 678 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~---~--~~~kl~DfGla~~~~ 751 (933)
.+|.|++... .......-...+.+..|+++||++|| +.+|||||+||.||||+. + .+++|+|||+++.+.
T Consensus 587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 5999999642 11111111456788999999999999 569999999999999975 3 578999999999886
Q ss_pred cCCCce--eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhC-CCCCCCCcchhHHHHhhhcccccccccCccc
Q 002349 752 VSKSYT--STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTG-RKAVDNECNLHHLILSKTANNAVMETVDPEI 828 (933)
Q Consensus 752 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 828 (933)
.+.... .....||.+|+|||.+....-+.++||||+||++|+.++| .+||.+. .++...+.......... .+
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~--~~R~~NIl~~~~~L~~L-~~-- 737 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS--LERQANILTGNYTLVHL-EP-- 737 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch--HHhhhhhhcCccceeee-cc--
Confidence 543322 3456799999999999998888999999999999999987 8999753 22222222222211111 10
Q ss_pred cccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 829 SATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 829 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
..++ ...++|.+|+++||..||+|.+|+.+
T Consensus 738 -----~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 738 -----LPDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred -----CchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 1111 56789999999999999999999753
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=252.04 Aligned_cols=199 Identities=25% Similarity=0.362 Sum_probs=171.3
Q ss_pred hhccCcceeeecccceeEEEEEEcC-CceEEEEEecccC---chhHHHHHHHHHHHhcC-CCCceeeeeeEEecCCccEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHY---PQCLKEFETELETVGSI-KHRNLVSLQGYSLSSSGNLL 671 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 671 (933)
..+|...++||+|+|++|-.++++. .+.+|+|++++.- .++..=.+.|-.+.... +||.+|.++.+|......++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 3578888999999999999999765 5678999887642 22233345566666555 79999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccc
Q 002349 672 FYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLC 751 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 751 (933)
|.||++||+|.-++ +..++++++.+.-+...|..||.|||+. ||+.||+|.+|||+|.+|.+|++|+|+++.-
T Consensus 329 vieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~- 401 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG- 401 (593)
T ss_pred EEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcC-
Confidence 99999999997776 4567899999999999999999999965 9999999999999999999999999999863
Q ss_pred cCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 002349 752 VSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVD 802 (933)
Q Consensus 752 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~ 802 (933)
..........+|||.|+|||++++..|...+|.|++||+++||+.|+.||+
T Consensus 402 l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfd 452 (593)
T KOG0695|consen 402 LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 452 (593)
T ss_pred CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcc
Confidence 223334556799999999999999999999999999999999999999997
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=262.82 Aligned_cols=131 Identities=22% Similarity=0.331 Sum_probs=111.7
Q ss_pred hccCcceeeecccceeEEEEEEcC-CceEEEEEecccCchhHHHHHHHHHHHhcCC-----C---CceeeeeeEEec---
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHYPQCLKEFETELETVGSIK-----H---RNLVSLQGYSLS--- 665 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~~~~~~~~--- 665 (933)
.+|.+.++||.|.|++||+|.+.. .+.||+|+.+.... ..+....|+++|++++ | .+||+++++|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh-YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH-YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH-HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 688899999999999999999654 57799999876532 3456688999999984 3 379999999964
Q ss_pred -CCccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEe
Q 002349 666 -SSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILL 733 (933)
Q Consensus 666 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll 733 (933)
+.++++|+|++ |.+|..++.. ..-+.++...+.+|++||+.||.|||++| ||+|.||||+|||+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~-s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKY-SNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHH-hCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 56789999999 6789888864 34567999999999999999999999976 99999999999998
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=241.10 Aligned_cols=255 Identities=18% Similarity=0.254 Sum_probs=196.9
Q ss_pred hhccCcceeeecccceeEEEEE-EcCCceEEEEEecccCchhHHHHHHHHHHHhcCC-CCceeeeeeEEecC--CccEEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCV-LKNCKPVAIKRLYSHYPQCLKEFETELETVGSIK-HRNLVSLQGYSLSS--SGNLLF 672 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~lv 672 (933)
.++|++.+++|+|.|+.||.|. ..+.+.++||++++. ..+.+.+|+++|+.++ ||||++++++..++ ..+.+|
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 3678888999999999999999 456788999999764 3578899999999997 99999999998775 457899
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCC-CCeEEeecccccccc
Q 002349 673 YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKD-FEAHLTDFGIAKSLC 751 (933)
Q Consensus 673 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~-~~~kl~DfGla~~~~ 751 (933)
+||+++.+...+- ..++..++..++.++++||.||| |.||+|||+||.||++|.. ...+++|+|+|..+.
T Consensus 114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcC
Confidence 9999997766554 35777889999999999999999 5599999999999999965 458999999999886
Q ss_pred cCCCceeeeecccccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCC-CCcchhHHHHhhhcccc---------c
Q 002349 752 VSKSYTSTYIMGTIGYIDPEYART-SRLTEKSDVYSFGIVLLELLTGRKAVD-NECNLHHLILSKTANNA---------V 820 (933)
Q Consensus 752 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~p~~-~~~~~~~~~~~~~~~~~---------~ 820 (933)
....+. -.+.+..|..||.+.. ..|+..-|+|||||++..|+..+.||- +..+..+++.+...-+. .
T Consensus 185 p~~eYn--VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY 262 (338)
T KOG0668|consen 185 PGKEYN--VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKY 262 (338)
T ss_pred CCceee--eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHH
Confidence 554443 2356778899998865 468899999999999999999999975 55555555543222111 0
Q ss_pred ccccCccccccc---------------cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 821 METVDPEISATC---------------KDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 821 ~~~~~~~~~~~~---------------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.-.++|.+.... ...-...+..+++.+.+..|-.+|||++|.+++
T Consensus 263 ~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 263 QIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred ccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 011222221100 000112677889999999999999999998764
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=269.90 Aligned_cols=205 Identities=22% Similarity=0.288 Sum_probs=171.3
Q ss_pred ccCcceeeecccceeEEEEEEcC-CceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEE
Q 002349 599 NLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYD 674 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 674 (933)
-|...+.||-|+||.|.++.-.+ ...+|.|.+++.+ .......+.|-.||..-+.+=||+++-.|.+++..|+|||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 35566789999999999998443 4568999887654 2344556789999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccc---
Q 002349 675 FMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLC--- 751 (933)
Q Consensus 675 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~--- 751 (933)
|++||++..+|. .-+-|++.-+.-++..+.+|+++.|. .|+|||||||+|||||.+|.+||+|||+++-+.
T Consensus 710 YIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 710 YIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred ccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccccccceecc
Confidence 999999999984 45678888888899999999999995 499999999999999999999999999987441
Q ss_pred ------cCCC--------------------------------ceeeeecccccccCccccccCCCCcchhhHHHHHHHHH
Q 002349 752 ------VSKS--------------------------------YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLE 793 (933)
Q Consensus 752 ------~~~~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~e 793 (933)
..+. ......+||+.|+|||++....|+..+|.||.||++||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 0000 00012469999999999999999999999999999999
Q ss_pred HHhCCCCCCCCcchhH
Q 002349 794 LLTGRKAVDNECNLHH 809 (933)
Q Consensus 794 lltg~~p~~~~~~~~~ 809 (933)
|+.|+.||.+......
T Consensus 864 m~~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPGET 879 (1034)
T ss_pred HhhCCCCccCCCCCcc
Confidence 9999999986655443
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.8e-29 Score=247.87 Aligned_cols=258 Identities=22% Similarity=0.260 Sum_probs=200.2
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCC------
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSS------ 667 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 667 (933)
..+|.....+|.|+- .|-.|.+. .+++||+|+..... ....++..+|..++..+.|+||++++.+|.-.+
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 346777788999998 56566543 47889999885542 345677899999999999999999999986543
Q ss_pred ccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccc
Q 002349 668 GNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIA 747 (933)
Q Consensus 668 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla 747 (933)
..|+|||||. .+|...++ -.++-+.+..+..|+++|++|||.. +|+|||+||+||++..+..+||.|||+|
T Consensus 95 e~y~v~e~m~-~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 95 EVYLVMELMD-ANLCQVIL-----MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred hHHHHHHhhh-hHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhh
Confidence 4699999995 48888874 3467788999999999999999954 9999999999999999999999999999
Q ss_pred cccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccC--
Q 002349 748 KSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVD-- 825 (933)
Q Consensus 748 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 825 (933)
+.-+. ....+..+.|..|+|||++.+..+.+.+||||+||++.||++|+.-|.+.....+|......-+...+.+.
T Consensus 166 r~e~~--~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 166 RTEDT--DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred cccCc--ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence 86432 24556678899999999999988999999999999999999999999988888877654332222111000
Q ss_pred ---------------------cc-----cccccc-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 826 ---------------------PE-----ISATCK-DLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 826 ---------------------~~-----~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
.. ++.... ..-......+++.+|+..||++|-++++++++-
T Consensus 244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HP 311 (369)
T KOG0665|consen 244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHP 311 (369)
T ss_pred hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCC
Confidence 00 000000 001224566789999999999999999999853
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.1e-29 Score=264.56 Aligned_cols=196 Identities=22% Similarity=0.346 Sum_probs=168.7
Q ss_pred hccCcceeeecccceeEEEEEEcC-CceEEEEEecccC---chh-----HHHHHHHHHHHhcCC---CCceeeeeeEEec
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHY---PQC-----LKEFETELETVGSIK---HRNLVSLQGYSLS 665 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~-----~~~~~~E~~~l~~l~---h~niv~~~~~~~~ 665 (933)
.+|...+.+|+|+||.|+.|.++. ...|+||.+.+.. ..+ ....-.|+++|.+++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 468888999999999999999875 5678999886643 111 223567999999997 9999999999999
Q ss_pred CCccEEEEEec-CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeec
Q 002349 666 SSGNLLFYDFM-ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDF 744 (933)
Q Consensus 666 ~~~~~lv~e~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 744 (933)
++.+|++||.. ++.+|.+++. ....+++.++..|++||+.|+++||++ +|||||||-+||.++.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE---~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIE---FKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhh---ccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeec
Confidence 99999999975 5679999994 567899999999999999999999965 9999999999999999999999999
Q ss_pred ccccccccCCCceeeeecccccccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCC
Q 002349 745 GIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRL-TEKSDVYSFGIVLLELLTGRKAVD 802 (933)
Q Consensus 745 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGv~l~elltg~~p~~ 802 (933)
|.|...... .....+||..|.|||++.|.+| ....|||++|+++|.++....||.
T Consensus 715 gsaa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999765332 2344689999999999999887 567899999999999999888875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-29 Score=271.45 Aligned_cols=252 Identities=23% Similarity=0.311 Sum_probs=209.5
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEec
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFM 676 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 676 (933)
++|.....+|.|.||.||||+++ .++..|||+++-......+-+++|+-+++..+|||||.++|.+...+..++.||||
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEyc 94 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYC 94 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEec
Confidence 57888899999999999999965 57889999998877777888899999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCc
Q 002349 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY 756 (933)
Q Consensus 677 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 756 (933)
.+|+|+|.-| -.+++++.++..+++..++|++|||. .+=+|||||-.||++++.|.+|++|||.+..+...- .
T Consensus 95 gggslQdiy~---~TgplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitati-~ 167 (829)
T KOG0576|consen 95 GGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI-A 167 (829)
T ss_pred CCCcccceee---ecccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhhh-h
Confidence 9999999875 46789999999999999999999994 488999999999999999999999999997764322 2
Q ss_pred eeeeecccccccCcccc---ccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccccc
Q 002349 757 TSTYIMGTIGYIDPEYA---RTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCK 833 (933)
Q Consensus 757 ~~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (933)
......||+.|||||+. +.+.|...+|||+.|++..|+-.-+.|..+-..+............... +....
T Consensus 168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~-----lkDk~- 241 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPT-----LKDKT- 241 (829)
T ss_pred hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCc-----ccCCc-
Confidence 34557899999999976 4567999999999999999999888887666555555444333322222 22111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002349 834 DLGAVKKVFQLALLCSKRQPTDRPTMHEVSR 864 (933)
Q Consensus 834 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 864 (933)
.....+-++++.|+..+|++||++..+++
T Consensus 242 --kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 242 --KWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred --cchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 12355678999999999999999987764
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-26 Score=239.31 Aligned_cols=210 Identities=37% Similarity=0.529 Sum_probs=182.7
Q ss_pred eecccceeEEEEEEcC-CceEEEEEecccCch-hHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecCCCCHHH
Q 002349 606 IGYGASSTVYKCVLKN-CKPVAIKRLYSHYPQ-CLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWD 683 (933)
Q Consensus 606 lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~ 683 (933)
||+|++|.||++.... ++.+++|++...... ..+.+.+|++.++.++|++|+++++++......+++|||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999765 789999999766432 45779999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCC-CCCeEEeecccccccccCCCceeeeec
Q 002349 684 ILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDK-DFEAHLTDFGIAKSLCVSKSYTSTYIM 762 (933)
Q Consensus 684 ~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~-~~~~kl~DfGla~~~~~~~~~~~~~~~ 762 (933)
++.. ....+++..+..++.+++++++|||+. +++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus 81 ~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~ 154 (215)
T cd00180 81 LLKE--NEGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIV 154 (215)
T ss_pred HHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhccc
Confidence 9853 124689999999999999999999965 9999999999999999 89999999999986543221 123345
Q ss_pred ccccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHHHHHH
Q 002349 763 GTIGYIDPEYARTS-RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKV 841 (933)
Q Consensus 763 gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 841 (933)
+...|++||..... .++.++|+|++|+++++| ..+
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------~~~ 190 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------PEL 190 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------------HHH
Confidence 78899999999887 788999999999999998 357
Q ss_pred HHHHHHccCCCCCCCCCHHHHHHH
Q 002349 842 FQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 842 ~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.+++..|++.+|++||++.++++.
T Consensus 191 ~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 191 KDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHHHHHhhCCcccCcCHHHHhhC
Confidence 789999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-27 Score=231.54 Aligned_cols=250 Identities=16% Similarity=0.244 Sum_probs=186.3
Q ss_pred HhhccCcceeeecccceeEEEEEEcC-CceEEEEEecccCchhHHHHHHHHHHHhcC-CCCceeeeeeE-EecCCccEEE
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHYPQCLKEFETELETVGSI-KHRNLVSLQGY-SLSSSGNLLF 672 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~-~~~~~~~~lv 672 (933)
..+.|.+.+.+|+|.||.+-.|.++. .+.+|+|.+..... ..++|.+|...--.+ .|.||+.-+++ |...+.++++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 34678888999999999999999886 56788888866543 368899998876666 58999988775 5666778899
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeC--CCCCeEEeeccccccc
Q 002349 673 YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLD--KDFEAHLTDFGIAKSL 750 (933)
Q Consensus 673 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~--~~~~~kl~DfGla~~~ 750 (933)
+||++.|+|.+.+. ...+-+....+++.|+++|+.|+| ++++||||||.+|||+- +..+||+||||+.+..
T Consensus 101 qE~aP~gdL~snv~----~~GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVE----AAGIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred eccCccchhhhhcC----cccccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeeccccccc
Confidence 99999999999884 356788899999999999999999 55999999999999993 4468999999998765
Q ss_pred ccCCCceeeeecccccccCccccccC-----CCCcchhhHHHHHHHHHHHhCCCCCCCCcc--hhHHHHhhhcccccccc
Q 002349 751 CVSKSYTSTYIMGTIGYIDPEYARTS-----RLTEKSDVYSFGIVLLELLTGRKAVDNECN--LHHLILSKTANNAVMET 823 (933)
Q Consensus 751 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGv~l~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~ 823 (933)
+.. .....-+..|.|||..... ...+.+|||.||++++.++||+.||+.... ...+.+.....+...
T Consensus 174 g~t----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~-- 247 (378)
T KOG1345|consen 174 GTT----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP-- 247 (378)
T ss_pred Cce----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc--
Confidence 322 2223345679999966432 357889999999999999999999983221 122222222222221
Q ss_pred cCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002349 824 VDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSR 864 (933)
Q Consensus 824 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 864 (933)
.++..... ..+...++.++-+.++|++|-...++.+
T Consensus 248 ---~~P~~F~~--fs~~a~r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 248 ---ALPKKFNP--FSEKALRLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred ---cCchhhcc--cCHHHHHHHHHhcCCcccccchhHHHHH
Confidence 22222222 1356778888999999999966655544
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-26 Score=237.71 Aligned_cols=198 Identities=30% Similarity=0.386 Sum_probs=172.7
Q ss_pred cCcceeeecccceeEEEEEEcC-CceEEEEEecccCch-hHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecC
Q 002349 600 LSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHYPQ-CLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFME 677 (933)
Q Consensus 600 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 677 (933)
|+..+.||+|++|.||+|...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567889999999999999875 789999999876554 67789999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCC-CCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCc
Q 002349 678 NGSLWDILHGPTKKKK-LDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY 756 (933)
Q Consensus 678 ~gsL~~~l~~~~~~~~-l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 756 (933)
+++|.+++.. ... +++..+..++.+++.++.+||+. +++|+||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 81 GGDLFDYLRK---KGGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 9999999953 233 89999999999999999999965 9999999999999999999999999999876443211
Q ss_pred eeeeecccccccCcccc-ccCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 002349 757 TSTYIMGTIGYIDPEYA-RTSRLTEKSDVYSFGIVLLELLTGRKAVDN 803 (933)
Q Consensus 757 ~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGv~l~elltg~~p~~~ 803 (933)
......++..|++||.. ....++.++|||+||+++++|++|+.||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 22334678899999998 666788899999999999999999999975
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-27 Score=252.10 Aligned_cols=262 Identities=21% Similarity=0.180 Sum_probs=206.5
Q ss_pred HhhccCcceeeecccceeEEEEEEcC-CceEEEEEecccCchhHHHHHHHHHHHhcCC------CCceeeeeeEEecCCc
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHYPQCLKEFETELETVGSIK------HRNLVSLQGYSLSSSG 668 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~~~~~~~ 668 (933)
.-.+|.+....|+|-|++|.+|.+.. |..||||+|.... -..+.-.+|+++|+++. --|+++++..|....+
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 34688888899999999999999664 7899999997653 34556678999999995 3489999999999999
Q ss_pred cEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCC-CCeEEeecccc
Q 002349 669 NLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKD-FEAHLTDFGIA 747 (933)
Q Consensus 669 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~-~~~kl~DfGla 747 (933)
.|+|||-+. .+|.++|......-.+....+..++.|+..||..|-. .+|+|.||||+||||++. ...||||||.|
T Consensus 509 LClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 509 LCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred eEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEeccCcceeeeccCccc
Confidence 999999884 5899999765666678999999999999999999994 499999999999999976 45799999999
Q ss_pred cccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccccccccc---
Q 002349 748 KSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETV--- 824 (933)
Q Consensus 748 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--- 824 (933)
........ +.+.-+..|.|||++.|-+|+...|+||+||++||+.||+..|.+..+.+++.......+.++..+
T Consensus 585 ~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRK 661 (752)
T KOG0670|consen 585 SFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRK 661 (752)
T ss_pred cccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhh
Confidence 76543221 223346689999999999999999999999999999999999998887777654433333222110
Q ss_pred --------C--------------------------c------cccc----cccCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 002349 825 --------D--------------------------P------EISA----TCKDLGAVKKVFQLALLCSKRQPTDRPTMH 860 (933)
Q Consensus 825 --------~--------------------------~------~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 860 (933)
+ | .+.. ...+......+.+++..|+..||++|.|..
T Consensus 662 gqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~n 741 (752)
T KOG0670|consen 662 GQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVN 741 (752)
T ss_pred cchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHH
Confidence 0 0 0000 001223346788899999999999999999
Q ss_pred HHHHH
Q 002349 861 EVSRV 865 (933)
Q Consensus 861 evl~~ 865 (933)
+.+++
T Consensus 742 qAL~H 746 (752)
T KOG0670|consen 742 QALKH 746 (752)
T ss_pred HHhcC
Confidence 98865
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.3e-28 Score=247.33 Aligned_cols=374 Identities=24% Similarity=0.240 Sum_probs=212.6
Q ss_pred cEEEccCCcccccCCCCccCCCCCceecccccccCCCCCcccccccchhhhhhcc-cCccCCCCcccccCCCCceeeeec
Q 002349 95 QSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKN-NQLIGPIPSTLSQLPNLKVFGLRG 173 (933)
Q Consensus 95 ~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~-n~l~~~~p~~l~~l~~L~~L~L~~ 173 (933)
..|+|..|+|+...|.+|+.+++|+.||||+|.|+.+-|++|.+|++|..|-+.+ |+|+......|++|..|+.|.+.-
T Consensus 70 veirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNa 149 (498)
T KOG4237|consen 70 VEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNA 149 (498)
T ss_pred eEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcCh
Confidence 3445555555532233455555555555555555545555555555544444333 455433333455555555555555
Q ss_pred CCCCCCcccccccCCCCcEEeccCccccCccCc-CCcCCCCCcEEcccccc-----------------------------
Q 002349 174 NNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQ-NIGNCTSFQVLDLSYNQ----------------------------- 223 (933)
Q Consensus 174 N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~-~l~~l~~L~~L~L~~N~----------------------------- 223 (933)
|++.....+.|..+++|..|.+.+|.+. .++. .|..+.+++.+.+..|.
T Consensus 150 n~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p 228 (498)
T KOG4237|consen 150 NHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSP 228 (498)
T ss_pred hhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecch
Confidence 5555444445555555555555555554 2222 44555555555555554
Q ss_pred -------ccCcCCCCcccc--cc-ceEeccccccccccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCC
Q 002349 224 -------LSGEIPFNIGFL--QI-ATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSN 293 (933)
Q Consensus 224 -------l~~~~p~~~~~~--~L-~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 293 (933)
+...-+.-+... .+ ..+....+.........|+.+++|++|+|++|+|+++-+.+|..+..+++|+|..|
T Consensus 229 ~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N 308 (498)
T KOG4237|consen 229 YRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRN 308 (498)
T ss_pred HHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcc
Confidence 221111111100 11 11111222222122234778888888888888888888888888888888888888
Q ss_pred ccCCCCCCccccCCcceEeeeccccccccCCccccccccccccccccccCCCC-CCCCcccCCCCCceeccCcccCCCCC
Q 002349 294 KLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGP-IPDNLSSCTNLNSLNVHGNKLNGTIP 372 (933)
Q Consensus 294 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~-~p~~l~~l~~L~~L~l~~N~l~~~~~ 372 (933)
+|...-...|.++..|+.|+|++|+|+...|.+|..+.+|.+|.|-.|.+.-. --.|+.. .|..++-.|..|
T Consensus 309 ~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~-------Wlr~~~~~~~~~ 381 (498)
T KOG4237|consen 309 KLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGE-------WLRKKSVVGNPR 381 (498)
T ss_pred hHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHH-------HHhhCCCCCCCC
Confidence 88876677788888888888888888888888888888888888888876410 0001110 122222111111
Q ss_pred cccccccccceecCCccccc---CCCcccc---------ccccccce-eeccCCccCCCCCCCCCCccccccccccCccc
Q 002349 373 PAFQRLESMTYLNLSLNNIR---GPIPVEL---------SRIGNLDT-LDMSNNKISGSIPSPLGDLEHLLKLNLSRNQL 439 (933)
Q Consensus 373 ~~~~~l~~L~~L~L~~N~l~---~~~~~~~---------~~l~~L~~-L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 439 (933)
-+....++.+.++.+.+. ...|++. ...+-+.+ ...|++.++ .+|..+.. .-.+|++.+|.+
T Consensus 382 --Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-~lp~~iP~--d~telyl~gn~~ 456 (498)
T KOG4237|consen 382 --CQSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK-LLPRGIPV--DVTELYLDGNAI 456 (498)
T ss_pred --CCCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchh-hcCCCCCc--hhHHHhcccchh
Confidence 111223444444444332 1122221 11222332 334444444 66665542 467899999999
Q ss_pred ccccccccccccccceEEccCCccccccchhhccccccceeeecCC
Q 002349 440 TGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYN 485 (933)
Q Consensus 440 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N 485 (933)
+ .+|.+ .+.+| .+|+|+|+++..--..|.+++.|.+|-|++|
T Consensus 457 ~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 457 T-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred c-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 9 66766 67788 8999999998777788889999998888876
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-26 Score=238.71 Aligned_cols=202 Identities=27% Similarity=0.356 Sum_probs=167.7
Q ss_pred HHHHHHHhhccCcceeeecccceeEEEEEEcC----CceEEEEEecccCchhHHHHHHHHHHHhcC-CCCceeeeeeEEe
Q 002349 590 YEDIMRMTENLSEKYIIGYGASSTVYKCVLKN----CKPVAIKRLYSHYPQCLKEFETELETVGSI-KHRNLVSLQGYSL 664 (933)
Q Consensus 590 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 664 (933)
++++....+.|...++||+|.|++||+|.+.. .+.||+|.+...+. -.++..|+++|..+ .+.||+++.+++.
T Consensus 28 ~q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~r 105 (418)
T KOG1167|consen 28 RQDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFR 105 (418)
T ss_pred HhhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhc
Confidence 34455566788999999999999999998543 57899999976543 36688999999999 5899999999999
Q ss_pred cCCccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCC-CCeEEee
Q 002349 665 SSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKD-FEAHLTD 743 (933)
Q Consensus 665 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~-~~~kl~D 743 (933)
..+...+|+||++.....++.. .++..++..+++.+..||+++|.+ |||||||||+|++.+.. ++-.|.|
T Consensus 106 nnd~v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvD 176 (418)
T KOG1167|consen 106 NNDQVAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVD 176 (418)
T ss_pred cCCeeEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEe
Confidence 9999999999999988888873 367899999999999999999955 99999999999999864 6789999
Q ss_pred cccccccccCC---------------------------------C----------ceeeeecccccccCcccccc-CCCC
Q 002349 744 FGIAKSLCVSK---------------------------------S----------YTSTYIMGTIGYIDPEYART-SRLT 779 (933)
Q Consensus 744 fGla~~~~~~~---------------------------------~----------~~~~~~~gt~~y~aPE~~~~-~~~~ 779 (933)
||+|....... . .......||++|+|||++.. ...+
T Consensus 177 FgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qt 256 (418)
T KOG1167|consen 177 FGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQT 256 (418)
T ss_pred chhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcC
Confidence 99997321000 0 00112359999999998754 5678
Q ss_pred cchhhHHHHHHHHHHHhCCCCCC
Q 002349 780 EKSDVYSFGIVLLELLTGRKAVD 802 (933)
Q Consensus 780 ~~~DvwSlGv~l~elltg~~p~~ 802 (933)
+++||||.||++..+++++.||-
T Consensus 257 taiDiws~GVI~Lslls~~~PFf 279 (418)
T KOG1167|consen 257 TAIDIWSAGVILLSLLSRRYPFF 279 (418)
T ss_pred Cccceeeccceeehhhccccccc
Confidence 99999999999999999999985
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=274.80 Aligned_cols=344 Identities=19% Similarity=0.243 Sum_probs=237.9
Q ss_pred CCCCCCCCccEEEccCCc------ccccCCCCccCCC-CCceecccccccCCCCCcccccccchhhhhhcccCccCCCCc
Q 002349 86 PAVGDLKDLQSIDLRGNR------LSGQIPDEIGDCS-SLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPS 158 (933)
Q Consensus 86 ~~l~~l~~L~~L~Ls~n~------l~~~~p~~l~~l~-~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~ 158 (933)
.+|..+++|+.|.+..+. +...+|..|..++ +|+.|++.+|.+. .+|..| ...+|++|+|++|++. .+|.
T Consensus 552 ~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~ 628 (1153)
T PLN03210 552 NAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWD 628 (1153)
T ss_pred HHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cccc
Confidence 468889999999997653 3446788887774 6999999999987 888887 5789999999999988 5788
Q ss_pred ccccCCCCceeeeecCCCCCCcccccccCCCCcEEeccCccccCccCcCCcCCCCCcEEccccccccCcCCCCccccccc
Q 002349 159 TLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIA 238 (933)
Q Consensus 159 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~ 238 (933)
.+..+++|+.|+|++|.....+| .++.+++|++|+|++|.....+|..++++++|+.|++++|..-..+|..+...+|+
T Consensus 629 ~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i~l~sL~ 707 (1153)
T PLN03210 629 GVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGINLKSLY 707 (1153)
T ss_pred ccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcCCCCCCC
Confidence 88999999999999887655665 58889999999999988777899999999999999999876555666655555666
Q ss_pred eEeccccccccccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcceEeeecccc
Q 002349 239 TLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQ 318 (933)
Q Consensus 239 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~ 318 (933)
.|+|++|.....+|.. ..+|+.|+|++|.+. .+|..+ .+++|++|++.++.... +.. .
T Consensus 708 ~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~-l~~----------------~ 765 (1153)
T PLN03210 708 RLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEK-LWE----------------R 765 (1153)
T ss_pred EEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhh-ccc----------------c
Confidence 6666666544344432 245556666666554 333332 34555555554422110 000 0
Q ss_pred ccccCCccccccccccccccccccCCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCCccc
Q 002349 319 LTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVE 398 (933)
Q Consensus 319 l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 398 (933)
+....+..+...++|+.|++++|...+.+|..+.++++|+.|++++|...+.+|..+ .+++|+.|++++|.....+|..
T Consensus 766 ~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~ 844 (1153)
T PLN03210 766 VQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI 844 (1153)
T ss_pred ccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc
Confidence 111111122234567777777776666667777777777777777765444555544 5677777777776544344432
Q ss_pred cccccccceeeccCCccCCCCCCCCCCccccccccccCc-ccccccccccccccccceEEccCC
Q 002349 399 LSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRN-QLTGFIPGEFGNLRSVMEIDLSHN 461 (933)
Q Consensus 399 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N 461 (933)
.++|+.|+|++|.|+ .+|.++..+++|+.|+|++| +|+ .+|..+..+++|+.|+++++
T Consensus 845 ---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C 903 (1153)
T PLN03210 845 ---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDC 903 (1153)
T ss_pred ---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCC
Confidence 356778888888887 67777888888888888874 555 56667778888888888877
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.9e-24 Score=269.92 Aligned_cols=337 Identities=19% Similarity=0.261 Sum_probs=250.8
Q ss_pred ccccccchhhhhhcccC------ccCCCCcccccCC-CCceeeeecCCCCCCcccccccCCCCcEEeccCccccCccCcC
Q 002349 135 SISKLKQLEFLILKNNQ------LIGPIPSTLSQLP-NLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQN 207 (933)
Q Consensus 135 ~~~~l~~L~~L~L~~n~------l~~~~p~~l~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~ 207 (933)
.|.++++|+.|.+..+. +...+|..+..++ +|+.|++.+|.+. .+|..| ...+|++|+|++|.+. .+|..
T Consensus 553 aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~ 629 (1153)
T PLN03210 553 AFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDG 629 (1153)
T ss_pred HHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccc
Confidence 45566666666665443 2234566666654 4777777777765 555555 4577778888877776 46666
Q ss_pred CcCCCCCcEEccccccccCcCCCCccccccceEeccccccccccCccccccccccEEeccCCcCcCCCCCCCCCCCCccE
Q 002349 208 IGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEK 287 (933)
Q Consensus 208 l~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 287 (933)
+..+++|+.|+|++|.....+|......+|++|+|++|.....+|..++.+++|+.|++++|..-+.+|..+ ++++|+.
T Consensus 630 ~~~l~~Lk~L~Ls~~~~l~~ip~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~ 708 (1153)
T PLN03210 630 VHSLTGLRNIDLRGSKNLKEIPDLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYR 708 (1153)
T ss_pred cccCCCCCEEECCCCCCcCcCCccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCE
Confidence 777788888888776654566654445577888888877666788888899999999999875444666655 7889999
Q ss_pred EEeeCCccCCCCCCccccCCcceEeeeccccccccCCccccccccccccccccccCC-------CCCCCCcccCCCCCce
Q 002349 288 LYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLE-------GPIPDNLSSCTNLNSL 360 (933)
Q Consensus 288 L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~-------~~~p~~l~~l~~L~~L 360 (933)
|+|++|...+.+|.. .++|++|+|++|.++ .+|..+ .+++|+.|++.++... ...+......++|+.|
T Consensus 709 L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L 783 (1153)
T PLN03210 709 LNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRL 783 (1153)
T ss_pred EeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhccccchhe
Confidence 999988766566643 467889999999987 566654 5788888888774432 1122223345789999
Q ss_pred eccCcccCCCCCcccccccccceecCCcccccCCCccccccccccceeeccCCccCCCCCCCCCCccccccccccCcccc
Q 002349 361 NVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLT 440 (933)
Q Consensus 361 ~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 440 (933)
++++|...+.+|..++++++|+.|++++|...+.+|..+ .+++|+.|+|++|..-..+|.. .++|+.|+|++|.++
T Consensus 784 ~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~ 859 (1153)
T PLN03210 784 FLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE 859 (1153)
T ss_pred eCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc
Confidence 999998888899999999999999999986555677666 7899999999998655455543 357889999999998
Q ss_pred cccccccccccccceEEccC-CccccccchhhccccccceeeecCCC
Q 002349 441 GFIPGEFGNLRSVMEIDLSH-NHLTGVIPEELSQLQNMFSLRLDYNN 486 (933)
Q Consensus 441 ~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~l~~N~ 486 (933)
.+|.++..+++|++|+|++ |+|+ .+|..+..+++|+.++++++.
T Consensus 860 -~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 860 -EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred -cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence 6788999999999999998 4666 577788899999999998873
|
syringae 6; Provisional |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.6e-25 Score=271.43 Aligned_cols=197 Identities=19% Similarity=0.240 Sum_probs=140.9
Q ss_pred cCCC-CceeeeeeEE-------ecCCccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 002349 650 SIKH-RNLVSLQGYS-------LSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRI 721 (933)
Q Consensus 650 ~l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 721 (933)
+++| +||++++++| ...+.++.++||+ +++|.++++. ....+++.++..+++||++||+|||++ +|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---gI 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHSQ---GI 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 4455 6888888887 2234567788987 5699999963 345699999999999999999999965 99
Q ss_pred eeccCCCCceEeCC-------------------CCCeEEeecccccccccCCC---------------ceeeeecccccc
Q 002349 722 IHRDVKSSNILLDK-------------------DFEAHLTDFGIAKSLCVSKS---------------YTSTYIMGTIGY 767 (933)
Q Consensus 722 vH~Dikp~NIll~~-------------------~~~~kl~DfGla~~~~~~~~---------------~~~~~~~gt~~y 767 (933)
+||||||+|||++. ++.+|++|||+++....... ......+||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 44566677777654211000 001124588999
Q ss_pred cCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHHHHHHHHHHHH
Q 002349 768 IDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALL 847 (933)
Q Consensus 768 ~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 847 (933)
||||++.+..++.++|||||||++|||++|..|+.......... ... ..++... ........++.+
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~----~~~----~~~~~~~------~~~~~~~~~~~~ 247 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSL----RHR----VLPPQIL------LNWPKEASFCLW 247 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHH----HHh----hcChhhh------hcCHHHHHHHHH
Confidence 99999999999999999999999999999988875322111100 000 0111110 112345678889
Q ss_pred ccCCCCCCCCCHHHHHHHH
Q 002349 848 CSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 848 cl~~dP~~RPt~~evl~~L 866 (933)
|++.+|.+||++.|++++-
T Consensus 248 ~L~~~P~~Rps~~eil~h~ 266 (793)
T PLN00181 248 LLHPEPSCRPSMSELLQSE 266 (793)
T ss_pred hCCCChhhCcChHHHhhch
Confidence 9999999999999998743
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.8e-24 Score=213.99 Aligned_cols=169 Identities=25% Similarity=0.281 Sum_probs=127.0
Q ss_pred CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCcee
Q 002349 679 GSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTS 758 (933)
Q Consensus 679 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 758 (933)
|+|.++++. ...++++.+++.++.|++.||+|||++ + ||+||+++.++.+|+ ||.++......
T Consensus 1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc----
Confidence 689999952 345799999999999999999999975 4 999999999999999 99997653321
Q ss_pred eeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHHH
Q 002349 759 TYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAV 838 (933)
Q Consensus 759 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (933)
..||+.|||||++.+..+++++|||||||++|||++|+.||.................. .. .+............
T Consensus 64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~~~~~~~~ 138 (176)
T smart00750 64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMP--AD-DPRDRSNLESVSAA 138 (176)
T ss_pred --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhc--cC-CccccccHHHHHhh
Confidence 25899999999999999999999999999999999999999765443332222111110 00 00000000011111
Q ss_pred HHHHHHHHHccCCCCCCCCCHHHHHHHHccC
Q 002349 839 KKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869 (933)
Q Consensus 839 ~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 869 (933)
..+.+++.+|++.+|++||++.|+++++...
T Consensus 139 ~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 139 RSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred hhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 2689999999999999999999999987654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.1e-26 Score=232.01 Aligned_cols=366 Identities=21% Similarity=0.208 Sum_probs=268.0
Q ss_pred CCceecccccccCCCCCcccccccchhhhhhcccCccCCCCcccccCCCCceeeeec-CCCCCCcccccccCCCCcEEec
Q 002349 117 SLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRG-NNLVGTLSPDMCQLSGLWYFDV 195 (933)
Q Consensus 117 ~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L 195 (933)
.-..++|..|.|+...|.+|+.+++|+.||||+|+|+.+-|+.|.++.+|..|-+.+ |+|+...-..|.++..|+.|.+
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll 147 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL 147 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence 456899999999977778899999999999999999999999999999998887777 9999766678999999999999
Q ss_pred cCccccCccCcCCcCCCCCcEEccccccccCcCCCCcc-ccccceEecccccc------------ccccCcccccccccc
Q 002349 196 RNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIG-FLQIATLSLQGNQL------------TGKIPSVIGLMQALA 262 (933)
Q Consensus 196 ~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~-~~~L~~L~L~~n~l------------~~~~p~~~~~l~~L~ 262 (933)
.-|++.-...+.|..+++|..|.+..|.+...--..+. ...++++.+..|.+ ....|..++...-..
T Consensus 148 Nan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~ 227 (498)
T KOG4237|consen 148 NANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVS 227 (498)
T ss_pred ChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecc
Confidence 99999988888999999999999999998743333443 33678888888872 233445555555555
Q ss_pred EEeccCCcCcCCCCCCCCCC-CCc-cEEEeeCCccCCCCC-CccccCCcceEeeeccccccccCCccccccccccccccc
Q 002349 263 VLDLSCNMLSGPIPPILGNL-SYT-EKLYLHSNKLTGHIP-PELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVA 339 (933)
Q Consensus 263 ~L~Ls~N~l~~~~~~~~~~l-~~L-~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~ 339 (933)
-..+.++++..+.+..|..- ..+ ..+....+ ..+..| ..|..+++|+.|+|++|+|+++.+.+|..+.++++|.|.
T Consensus 228 p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~-~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~ 306 (498)
T KOG4237|consen 228 PYRLYYKRINQEDARKFLCSLESLPSRLSSEDF-PDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLT 306 (498)
T ss_pred hHHHHHHHhcccchhhhhhhHHhHHHhhccccC-cCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcC
Confidence 55666666665555555432 111 11222222 222333 358889999999999999998888999999999999999
Q ss_pred cccCCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCCc-----cc-----------ccccc
Q 002349 340 NNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIP-----VE-----------LSRIG 403 (933)
Q Consensus 340 ~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-----~~-----------~~~l~ 403 (933)
.|+|...-...|.++..|+.|+|.+|+|+..-|.+|..+.+|..|+|-.|.+...-. .+ -....
T Consensus 307 ~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~~~~~~~Cq~p~ 386 (498)
T KOG4237|consen 307 RNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKSVVGNPRCQSPG 386 (498)
T ss_pred cchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHhhCCCCCCCCCCCCc
Confidence 999987667778899999999999999998888899999999999988887642110 01 11233
Q ss_pred ccceeeccCCccCC---CCCCCCC---------Cccccc-cccccCcccccccccccccccccceEEccCCccccccchh
Q 002349 404 NLDTLDMSNNKISG---SIPSPLG---------DLEHLL-KLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEE 470 (933)
Q Consensus 404 ~L~~L~Ls~N~l~~---~~p~~~~---------~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 470 (933)
.++.++++++.+.. ..|++.+ .++-+. ....|++.++ .+|..+. ....+|++.+|.++ .+|.+
T Consensus 387 ~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-~lp~~iP--~d~telyl~gn~~~-~vp~~ 462 (498)
T KOG4237|consen 387 FVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK-LLPRGIP--VDVTELYLDGNAIT-SVPDE 462 (498)
T ss_pred hhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchh-hcCCCCC--chhHHHhcccchhc-ccCHH
Confidence 56677777766542 1222221 223333 3344555555 5555432 35678999999999 56666
Q ss_pred hccccccceeeecCCCCcCc
Q 002349 471 LSQLQNMFSLRLDYNNLSGD 490 (933)
Q Consensus 471 ~~~l~~L~~L~l~~N~l~~~ 490 (933)
.+.+| .+|+++|+|+..
T Consensus 463 --~~~~l-~~dls~n~i~~L 479 (498)
T KOG4237|consen 463 --LLRSL-LLDLSNNRISSL 479 (498)
T ss_pred --HHhhh-hcccccCceehh
Confidence 66777 899999999753
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.4e-23 Score=241.15 Aligned_cols=263 Identities=28% Similarity=0.371 Sum_probs=107.9
Q ss_pred CceeeeecCCCCCCcccccccCCCCcEEeccCccccCccCcCCcCCCCCcEEccccccccCcCCCCccccccceEecccc
Q 002349 166 LKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGN 245 (933)
Q Consensus 166 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n 245 (933)
-..|+|++|.|+ .+|+.+. ++|+.|++++|+|+ .+|.. +++|++|+|++|+|+ .+|.. ..+|+.|+|++|
T Consensus 203 ~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lt-sLP~l--p~sL~~L~Ls~N 272 (788)
T PRK15387 203 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT-SLPVL--PPGLLELSIFSN 272 (788)
T ss_pred CcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccC-cccCc--ccccceeeccCC
Confidence 334555555554 3444432 24555555555555 23321 345555555555555 22321 123444444444
Q ss_pred ccccccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcceEeeeccccccccCCc
Q 002349 246 QLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPP 325 (933)
Q Consensus 246 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~ 325 (933)
+++. +|.. .++|+.|+|++|+++. +|.. .++|+.|+|++|+|++ +|.. ..+|+.|++++|+|++ +|.
T Consensus 273 ~L~~-Lp~l---p~~L~~L~Ls~N~Lt~-LP~~---p~~L~~LdLS~N~L~~-Lp~l---p~~L~~L~Ls~N~L~~-LP~ 339 (788)
T PRK15387 273 PLTH-LPAL---PSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQLTS-LPT 339 (788)
T ss_pred chhh-hhhc---hhhcCEEECcCCcccc-cccc---ccccceeECCCCcccc-CCCC---cccccccccccCcccc-ccc
Confidence 4432 2221 1334455555555542 2221 2345555555555543 2221 1234444455555542 222
Q ss_pred cccccccccccccccccCCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCCcccccccccc
Q 002349 326 ALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNL 405 (933)
Q Consensus 326 ~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 405 (933)
. ..+|+.|+|++|+|++ +|.. ..+|+.|++++|+|+. +|.. ..+|+.|+|++|+|++ +|.. .++|
T Consensus 340 l---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~-LP~l---~s~L 404 (788)
T PRK15387 340 L---PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LPVL---PSEL 404 (788)
T ss_pred c---ccccceEecCCCccCC-CCCC---Ccccceehhhcccccc-Cccc---ccccceEEecCCcccC-CCCc---ccCC
Confidence 1 1244444444444442 2221 1234444444444442 2221 1234444444444442 2221 1234
Q ss_pred ceeeccCCccCCCCCCCCCCccccccccccCcccccccccccccccccceEEccCCccccccchhh
Q 002349 406 DTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEEL 471 (933)
Q Consensus 406 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 471 (933)
+.|++++|+|+ .+|..+ .+|+.|+|++|+|+ .+|..+.++++|+.|+|++|+|++..|..+
T Consensus 405 ~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L 465 (788)
T PRK15387 405 KELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL 465 (788)
T ss_pred CEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHH
Confidence 44444444444 233221 23344444444444 334444444444444444444444444333
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.1e-23 Score=243.28 Aligned_cols=375 Identities=21% Similarity=0.321 Sum_probs=185.0
Q ss_pred HHHHHHhhcCCCChHHHHHHHHHHHhCCCCCCCcCC----CCCCCCCCCCCccc----------------eEecCCCCcE
Q 002349 11 LVFLFCLSFGSVDSEDGATLLKIKKSFRDVDNVLYD----WTDSPSSDYCVWRG----------------ITCDNVTFTV 70 (933)
Q Consensus 11 ~~~~~~~~~~~~~~~d~~all~~k~~~~~~~~~l~~----w~~~~~~~~c~w~g----------------v~C~~~~~~v 70 (933)
++.-+|--.+.+.++|..+++++.+.+..| +.+.+ |++ .+++|.-.. |.|.. ..|
T Consensus 49 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~p-~~~~~~~~~~~~--~~~fc~~~~~~~~~l~~~~~~~~~tv~~~~--~~v 123 (754)
T PRK15370 49 CIAYLCHPPETASPEEIKSKFECLRMLAFP-AYADNIQYSRGG--ADQYCILSENSQEILSIVFNTEGYTVEGGG--KSV 123 (754)
T ss_pred HHHHHhCCCCCCCHHHHHHHHHHHHHhcCC-chhhccccccCC--CCcccccCCcchhhheeeecCCceEEecCC--Ccc
Confidence 334455556678899999999999999777 34555 876 468885433 55543 234
Q ss_pred EEEEcCCCCcCcccCCCCCCCCCccEEEccC-----CcccccCC---CCc-----cCCCCCceecccccccCCCCCcccc
Q 002349 71 IALNLSGLNLDGEISPAVGDLKDLQSIDLRG-----NRLSGQIP---DEI-----GDCSSLKSLDLSFNELYGDIPFSIS 137 (933)
Q Consensus 71 ~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~-----n~l~~~~p---~~l-----~~l~~L~~L~Ls~n~l~~~~p~~~~ 137 (933)
+.+..-|...... -..-..-..-+..+ +.-.+.-+ ..+ .-..+...|+|+++.++ .+|..+.
T Consensus 124 t~l~~~g~~~~~~----~~~~~~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~Lt-sLP~~Ip 198 (754)
T PRK15370 124 TYTRVTESEQASS----ASGSKDAVNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLT-TIPACIP 198 (754)
T ss_pred ccccccccccccc----CCCCCChhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcC-cCCcccc
Confidence 4443333111100 00000000000000 00000000 001 11134566777777766 4565543
Q ss_pred cccchhhhhhcccCccCCCCcccccCCCCceeeeecCCCCCCcccccccCCCCcEEeccCccccCccCcCCcCCCCCcEE
Q 002349 138 KLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVL 217 (933)
Q Consensus 138 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L 217 (933)
++|+.|+|++|+++ .+|..+. ++|+.|+|++|+++ .+|..+. .+|+.|+|++|.+. .+|..+. ++|+.|
T Consensus 199 --~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L 267 (754)
T PRK15370 199 --EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSL 267 (754)
T ss_pred --cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEE
Confidence 35777777777776 3555443 46777777777776 3454432 36777777777776 5565543 367777
Q ss_pred ccccccccCcCCCCccccccceEeccccccccccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCC
Q 002349 218 DLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTG 297 (933)
Q Consensus 218 ~L~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 297 (933)
++++|+++ .+|..+. .+|+.|+|++|++++ +|..+. ++|+.|++++|.++. +|..+. ++
T Consensus 268 ~Ls~N~L~-~LP~~l~-~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~-LP~~l~--~s------------- 326 (754)
T PRK15370 268 DLFHNKIS-CLPENLP-EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTA-LPETLP--PG------------- 326 (754)
T ss_pred ECcCCccC-ccccccC-CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCcccc-CCcccc--cc-------------
Confidence 77777776 3443332 234444444444442 222221 244455555555542 222211 33
Q ss_pred CCCCccccCCcceEeeeccccccccCCccccccccccccccccccCCCCCCCCcccCCCCCceeccCcccCCCCCccccc
Q 002349 298 HIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQR 377 (933)
Q Consensus 298 ~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~ 377 (933)
|+.|++++|.+++ +|..+. ++|+.|++++|++. .+|..+ .++|+.|++++|+|+. +|..+.
T Consensus 327 -----------L~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~l--p~~L~~LdLs~N~Lt~-LP~~l~- 387 (754)
T PRK15370 327 -----------LKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETL--PPTITTLDVSRNALTN-LPENLP- 387 (754)
T ss_pred -----------ceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhh--cCCcCEEECCCCcCCC-CCHhHH-
Confidence 4444444444442 333222 34455555555444 233322 1355555666665552 333332
Q ss_pred ccccceecCCcccccCCCcccc----ccccccceeeccCCccCCCCCCCCCCccccccccccCccccc-ccccccccccc
Q 002349 378 LESMTYLNLSLNNIRGPIPVEL----SRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTG-FIPGEFGNLRS 452 (933)
Q Consensus 378 l~~L~~L~L~~N~l~~~~~~~~----~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~ 452 (933)
.+|+.|++++|++. .+|..+ ..++++..|+|.+|.++ ...+++|+.| ++.+.+.| .++...+.+.+
T Consensus 388 -~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls------~~tl~~L~~L-l~s~~~~gp~i~~~~~~~~~ 458 (754)
T PRK15370 388 -AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS------ERTIQNMQRL-MSSVGYQGPRVLFAMGDFSI 458 (754)
T ss_pred -HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc------HHHHHHHHHh-hhcccccCCccccccccccc
Confidence 24666666666665 333322 33456677777777765 2345555555 34444433 22333333444
Q ss_pred cce
Q 002349 453 VME 455 (933)
Q Consensus 453 L~~ 455 (933)
++.
T Consensus 459 l~~ 461 (754)
T PRK15370 459 VRV 461 (754)
T ss_pred ccc
Confidence 443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.6e-23 Score=222.32 Aligned_cols=164 Identities=19% Similarity=0.178 Sum_probs=128.5
Q ss_pred HhhccCcceeeecccceeEEEEEEc--CCceEEEEEeccc-----CchhHHHHHHHHHHHhcCCCCceee-eeeEEecCC
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLK--NCKPVAIKRLYSH-----YPQCLKEFETELETVGSIKHRNLVS-LQGYSLSSS 667 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~-~~~~~~~~~ 667 (933)
..++|...+.||+|+||+||+|+++ +++.||||++... .....+.|.+|++++++++|+|+++ ++++ +
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~ 91 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----G 91 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----C
Confidence 4568999999999999999999875 4677899987533 1223566899999999999999985 4432 4
Q ss_pred ccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccC-CCCceEeCCCCCeEEeeccc
Q 002349 668 GNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDV-KSSNILLDKDFEAHLTDFGI 746 (933)
Q Consensus 668 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Di-kp~NIll~~~~~~kl~DfGl 746 (933)
..++||||++|++|.... ... ...++.++++||+|||++ ||+|||| ||+||+++.++.+||+|||+
T Consensus 92 ~~~LVmE~~~G~~L~~~~----~~~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLAR----PHG------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred CcEEEEEccCCCCHHHhC----ccc------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 579999999999997321 111 146788999999999965 9999999 99999999999999999999
Q ss_pred ccccccCCCce-------eeeecccccccCccccccC
Q 002349 747 AKSLCVSKSYT-------STYIMGTIGYIDPEYARTS 776 (933)
Q Consensus 747 a~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~ 776 (933)
|+.+....... -....+++.|+|||.+...
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 98764322111 1345788899999988654
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.2e-23 Score=240.09 Aligned_cols=263 Identities=29% Similarity=0.366 Sum_probs=150.8
Q ss_pred EEEcCCCCcCcccCCCCCCCCCccEEEccCCcccccCCCCccCCCCCceecccccccCCCCCcccccccchhhhhhcccC
Q 002349 72 ALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQ 151 (933)
Q Consensus 72 ~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~ 151 (933)
.|||++++|+ .+|+.+. ++|+.|++++|+|+ .+|.. +++|++|+|++|+|+ .+|.. .++|+.|+|++|.
T Consensus 205 ~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~N~ 273 (788)
T PRK15387 205 VLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT-SLPVL---PPGLLELSIFSNP 273 (788)
T ss_pred EEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccC-cccCc---ccccceeeccCCc
Confidence 3455555555 4454443 24555555555555 34431 345555555555555 33422 2344555555555
Q ss_pred ccCCCCcccccCCCCceeeeecCCCCCCcccccccCCCCcEEeccCccccCccCcCCcCCCCCcEEccccccccCcCCCC
Q 002349 152 LIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFN 231 (933)
Q Consensus 152 l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~ 231 (933)
++ .+|..+ ++|+.|+|++|++ + .+|.. +++|+.|+|++|++++ +|..
T Consensus 274 L~-~Lp~lp---~~L~~L~Ls~N~L------------------------t-~LP~~---p~~L~~LdLS~N~L~~-Lp~l 320 (788)
T PRK15387 274 LT-HLPALP---SGLCKLWIFGNQL------------------------T-SLPVL---PPGLQELSVSDNQLAS-LPAL 320 (788)
T ss_pred hh-hhhhch---hhcCEEECcCCcc------------------------c-ccccc---ccccceeECCCCcccc-CCCC
Confidence 54 233221 3344445555544 4 23321 2345555555555543 2221
Q ss_pred ccccccceEeccccccccccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcceE
Q 002349 232 IGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHY 311 (933)
Q Consensus 232 ~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 311 (933)
..+|+.|++++|++++ +|.. ..+|+.|+|++|+|++ +|... ++|+.|++++|+|+. +|.. ..+|+.
T Consensus 321 --p~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~-LP~lp---~~L~~L~Ls~N~L~~-LP~l---~~~L~~ 386 (788)
T PRK15387 321 --PSELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLAS-LPTLP---SELYKLWAYNNRLTS-LPAL---PSGLKE 386 (788)
T ss_pred --cccccccccccCcccc-cccc---ccccceEecCCCccCC-CCCCC---cccceehhhcccccc-Cccc---ccccce
Confidence 1134455555555553 3321 2467777777777774 34332 456677777777773 5543 246788
Q ss_pred eeeccccccccCCccccccccccccccccccCCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccceecCCcccc
Q 002349 312 LELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNI 391 (933)
Q Consensus 312 L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 391 (933)
|+|++|+|++ +|.. .++|+.|++++|++.+ +|.. ..+|+.|++++|+|+ .+|..|.++++|+.|+|++|+|
T Consensus 387 LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~L 457 (788)
T PRK15387 387 LIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPL 457 (788)
T ss_pred EEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCC
Confidence 8888888874 4443 2567888888888874 5543 246778888888888 6788888888888999999988
Q ss_pred cCCCcccccc
Q 002349 392 RGPIPVELSR 401 (933)
Q Consensus 392 ~~~~~~~~~~ 401 (933)
++..+..+..
T Consensus 458 s~~~~~~L~~ 467 (788)
T PRK15387 458 SERTLQALRE 467 (788)
T ss_pred CchHHHHHHH
Confidence 8777766533
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.8e-22 Score=219.95 Aligned_cols=260 Identities=18% Similarity=0.194 Sum_probs=195.2
Q ss_pred ccCcceeeecccceeEEEEEEcCC--ceEEEEEecccCchhHHHHHHHHHHHhcCCC----CceeeeeeEE-ecCCccEE
Q 002349 599 NLSEKYIIGYGASSTVYKCVLKNC--KPVAIKRLYSHYPQCLKEFETELETVGSIKH----RNLVSLQGYS-LSSSGNLL 671 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~~~~~~-~~~~~~~l 671 (933)
+|.+.++||+|+||.||.|..... +.+|+|............+..|..++..+.. +++..+++.+ ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999997663 4788888766543323367889999988863 6899999998 47778899
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCC-----CCeEEeeccc
Q 002349 672 FYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKD-----FEAHLTDFGI 746 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~-----~~~kl~DfGl 746 (933)
||+.+ |.+|.++..... .+.++..++.+|+.|++.+|+++|+. |++||||||+|+++... ..+++.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99988 789999885422 57899999999999999999999955 99999999999999865 4589999999
Q ss_pred cc--ccccCCC----ce---eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcc
Q 002349 747 AK--SLCVSKS----YT---STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTAN 817 (933)
Q Consensus 747 a~--~~~~~~~----~~---~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~ 817 (933)
|+ .+..... .. .....||..|.+++...+.+.+++.|+||++.++.|+..|..||................
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 99 3321111 11 123569999999999999999999999999999999999999997544322211111111
Q ss_pred cccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCC
Q 002349 818 NAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVP 871 (933)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 871 (933)
... .... .. ...+..+.++...+-..+..++|....+...+.....
T Consensus 254 ~~~--~~~~-~~-----~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~ 299 (322)
T KOG1164|consen 254 RKL--LTDR-FG-----DLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD 299 (322)
T ss_pred hhh--cccc-cc-----CCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence 000 0000 00 0123455666666666899999999999988766544
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.5e-23 Score=202.35 Aligned_cols=246 Identities=20% Similarity=0.342 Sum_probs=188.4
Q ss_pred ceeeecccceeEEEEEEcCCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecCCCC
Q 002349 603 KYIIGYGASSTVYKCVLKNCKPVAIKRLYSH--YPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGS 680 (933)
Q Consensus 603 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 680 (933)
.-+|.+...|..|+|+|++. .+++|++... .+...++|..|.-.++-+.||||..++|.|..+.+..++..||+.||
T Consensus 195 ~tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 34688999999999999875 4566766432 34556789999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEe--ecccccccccCCCcee
Q 002349 681 LWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLT--DFGIAKSLCVSKSYTS 758 (933)
Q Consensus 681 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~--DfGla~~~~~~~~~~~ 758 (933)
|+..+|+ ...-..+..++.+++.++|+|++|||.- .+-|..--+.+..|++|++.+++|+ |--++. ..
T Consensus 274 lynvlhe-~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsf--------qe 343 (448)
T KOG0195|consen 274 LYNVLHE-QTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSF--------QE 343 (448)
T ss_pred HHHHHhc-CccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeee--------ec
Confidence 9999986 3344578889999999999999999975 3334455789999999999888774 221111 11
Q ss_pred eeecccccccCccccccCCC---CcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCH
Q 002349 759 TYIMGTIGYIDPEYARTSRL---TEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDL 835 (933)
Q Consensus 759 ~~~~gt~~y~aPE~~~~~~~---~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (933)
....-.+.||+||.++..+- -.++|+|||++++||+.|...||.+-.+.+--. ++ ..+.+++.++..
T Consensus 344 ~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm--ki----aleglrv~ippg---- 413 (448)
T KOG0195|consen 344 VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM--KI----ALEGLRVHIPPG---- 413 (448)
T ss_pred cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh--hh----hhccccccCCCC----
Confidence 11234689999999877653 368999999999999999999998654433211 11 123333333322
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCC
Q 002349 836 GAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLV 870 (933)
Q Consensus 836 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 870 (933)
....+.+++.-|+..||.+||.++.|+.+|+.+.
T Consensus 414 -is~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 414 -ISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred -ccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 2356788999999999999999999999998753
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.3e-22 Score=191.33 Aligned_cols=258 Identities=20% Similarity=0.248 Sum_probs=192.8
Q ss_pred HhhccCcceeeecccceeEEEEE-EcCCceEEEEEecccCchhHHHHHHHHHHHhcCC-CCceeeeeeEEecCCccEEEE
Q 002349 596 MTENLSEKYIIGYGASSTVYKCV-LKNCKPVAIKRLYSHYPQCLKEFETELETVGSIK-HRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 673 (933)
...+|...++||.|+||.+|.|. ..+|+.||+|.-..... ...+..|.++.+.++ ...|..+..|+.+...-.+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 34689999999999999999999 56799999998765432 244677888888886 467888888889999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCC---CCeEEeeccccccc
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKD---FEAHLTDFGIAKSL 750 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~---~~~kl~DfGla~~~ 750 (933)
|.. |.||.+.+. -..+.++..+++-++-|++.-++|+|.+ +++||||||+|+|..-+ ..+.++|||+|+.+
T Consensus 91 dLL-GPsLEdLfn--fC~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 91 DLL-GPSLEDLFN--FCSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ecc-CccHHHHHH--HHhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhh
Confidence 998 789999986 3456789999999999999999999966 99999999999999744 46899999999987
Q ss_pred ccCCCc------eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHH-hhhcccccccc
Q 002349 751 CVSKSY------TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLIL-SKTANNAVMET 823 (933)
Q Consensus 751 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~-~~~~~~~~~~~ 823 (933)
.+..+. ......||.+|.+-....+...+.+.|+-|+|.++.++--|..||++-........ .++.+....
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s-- 242 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMS-- 242 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcC--
Confidence 433221 23346799999988888888888999999999999999999999986433322211 111111110
Q ss_pred cCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 002349 824 VDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLG 867 (933)
Q Consensus 824 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 867 (933)
..+...++ +.|.++.-.+..|-..--++-|...-+-+.++
T Consensus 243 --~~ie~LC~--G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr 282 (341)
T KOG1163|consen 243 --TPIEVLCK--GFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFR 282 (341)
T ss_pred --CCHHHHhC--CCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence 11111111 12456666677777777777787665555443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=196.85 Aligned_cols=199 Identities=22% Similarity=0.287 Sum_probs=169.3
Q ss_pred hccCcceeeecccceeEEEEE-EcCCceEEEEEecccCchhHHHHHHHHHHHhcC-CCCceeeeeeEEecCCccEEEEEe
Q 002349 598 ENLSEKYIIGYGASSTVYKCV-LKNCKPVAIKRLYSHYPQCLKEFETELETVGSI-KHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
-.|.++++||+|.||+++.|. .-++++||||.-...+. .-++..|.+..+.+ ..++|..++-|..++.+-.+|+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 368899999999999999999 45789999997654432 34566777777777 578999999888888889999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCC-----CCeEEeeccccccc
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKD-----FEAHLTDFGIAKSL 750 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~-----~~~kl~DfGla~~~ 750 (933)
+ |.||.|++.- ..+.|+..+++.+|.|++.-++|+|++ .+|.|||||+|+||... ..+.++|||+|+.+
T Consensus 106 L-GPSLEDLFD~--CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 106 L-GPSLEDLFDL--CGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred h-CcCHHHHHHH--hcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 8 7799999863 567899999999999999999999966 99999999999999743 35899999999988
Q ss_pred ccCCCce------eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 002349 751 CVSKSYT------STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNE 804 (933)
Q Consensus 751 ~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~ 804 (933)
.+..+.. .....||.+||+-....|.+.+.+.|+-|+|-++++.+-|..||.+-
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL 239 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 239 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence 5543322 34567999999999999999999999999999999999999999853
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.7e-20 Score=206.31 Aligned_cols=256 Identities=29% Similarity=0.370 Sum_probs=197.7
Q ss_pred cCcceeeecccceeEEEEEEcCCceEEEEEecccCch---hHHHHHHHHHHHhcCCCC-ceeeeeeEEecCCccEEEEEe
Q 002349 600 LSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQ---CLKEFETELETVGSIKHR-NLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 600 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~ 675 (933)
|.....||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +|+++.+++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566788999999999999987 78899998765432 467899999999999988 799999999777778999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCC-CeEEeecccccccccCC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDF-EAHLTDFGIAKSLCVSK 754 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~-~~kl~DfGla~~~~~~~ 754 (933)
+.++++.+++........++......++.|++.+++|+|+. +++|||+||+||+++..+ .++++|||.++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999997774211113789999999999999999999965 899999999999999998 69999999998654333
Q ss_pred Cc-----eeeeecccccccCcccccc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCcc---hhH-HHHhhhcccc-cc
Q 002349 755 SY-----TSTYIMGTIGYIDPEYART---SRLTEKSDVYSFGIVLLELLTGRKAVDNECN---LHH-LILSKTANNA-VM 821 (933)
Q Consensus 755 ~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGv~l~elltg~~p~~~~~~---~~~-~~~~~~~~~~-~~ 821 (933)
.. ......|+..|+|||...+ ..+....|+||+|++++++++|..||..... ... .......... ..
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccc
Confidence 22 2355689999999999987 5788999999999999999999999876543 111 1111111111 11
Q ss_pred cccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 822 ETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
........ ......+.+++..|+..+|..|.+..+....
T Consensus 237 ~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 237 SPLSPSNP-----ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cccCcccc-----chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 11111000 1123567889999999999999998887654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-22 Score=233.89 Aligned_cols=253 Identities=19% Similarity=0.199 Sum_probs=186.8
Q ss_pred CcceeeecccceeEEEEEEcC-CceEEEEEec----cc-Cchh-HHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 601 SEKYIIGYGASSTVYKCVLKN-CKPVAIKRLY----SH-YPQC-LKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 601 ~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~----~~-~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
....++|.|++|.|+.+.... .+.++.|..+ .. .... ...+..|+.+-.+++|||++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 345689999999888777442 3334444432 21 1111 122667888889999999999888887777666679
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
|||++ +|...+. ....+...++-.+++|++.|++|+|.. ||.|||+|++|++++..|.+||+|||.+..+..+
T Consensus 401 E~~~~-Dlf~~~~---~~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVM---SNGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHh---cccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 9999983 445789999999999999999999955 9999999999999999999999999999766433
Q ss_pred CC---ceeeeecccccccCccccccCCCCc-chhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccc
Q 002349 754 KS---YTSTYIMGTIGYIDPEYARTSRLTE-KSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEIS 829 (933)
Q Consensus 754 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (933)
.. ......+|+..|+|||++.+.+|.+ ..||||.|++++.|.+|+.||.......+................+
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~--- 550 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGP--- 550 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccCh---
Confidence 22 3455678999999999999998875 6899999999999999999997443332221000000000000000
Q ss_pred ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002349 830 ATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSR 864 (933)
Q Consensus 830 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 864 (933)
..--...+.....++.++++.||.+|.|+++|++
T Consensus 551 -~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 551 -NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred -HHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0001133567778999999999999999999986
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-21 Score=231.91 Aligned_cols=256 Identities=23% Similarity=0.395 Sum_probs=155.5
Q ss_pred CccceEecCCCCcEEEEEcCCCCcCcccCCCCCCCCCccEEEccCCcccccCCCCccCCCCCceecccccccCCCCCccc
Q 002349 57 VWRGITCDNVTFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSI 136 (933)
Q Consensus 57 ~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~ 136 (933)
.|+-..|-.. .++.|++++++++ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|++|+|++|.|+ .+|..+
T Consensus 169 ~~r~~~Cl~~--~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l 239 (754)
T PRK15370 169 VQRMRDCLKN--NKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATL 239 (754)
T ss_pred HHHHHhhccc--CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhh
Confidence 3444566432 4577888888888 4565553 47888888888888 5776554 57888888888887 567655
Q ss_pred ccccchhhhhhcccCccCCCCcccccCCCCceeeeecCCCCCCcccccccCCCCcEEeccCccccCccCcCCcCCCCCcE
Q 002349 137 SKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQV 216 (933)
Q Consensus 137 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~ 216 (933)
. .+|+.|+|++|+++ .+|..+. ++|+.|+|++|+++ .+|..+. .+|+.|++++|+|++ +|..+. ++|+.
T Consensus 240 ~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~ 308 (754)
T PRK15370 240 P--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITH 308 (754)
T ss_pred h--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHH
Confidence 3 36777888888777 5666553 46777777777776 3455443 356666666666663 443332 24555
Q ss_pred EccccccccCcCCCCccccccceEeccccccccccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccC
Q 002349 217 LDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLT 296 (933)
Q Consensus 217 L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 296 (933)
|++++|+++ . +|..+ .++|+.|++++|.+++ +|..+. ++|+.|+|++|+|+
T Consensus 309 L~Ls~N~Lt-----------------------~-LP~~l--~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~ 359 (754)
T PRK15370 309 LNVQSNSLT-----------------------A-LPETL--PPGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT 359 (754)
T ss_pred HHhcCCccc-----------------------c-CCccc--cccceeccccCCcccc-CChhhc--CcccEEECCCCCCC
Confidence 555555554 2 22222 1466777777777764 444432 56777777777776
Q ss_pred CCCCCccccCCcceEeeeccccccccCCccccccccccccccccccCCCCCCCCc----ccCCCCCceeccCcccC
Q 002349 297 GHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNL----SSCTNLNSLNVHGNKLN 368 (933)
Q Consensus 297 ~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l----~~l~~L~~L~l~~N~l~ 368 (933)
.+|..+. ++|+.|+|++|+|+ .+|..+. ..|+.|++++|++. .+|..+ ..++++..|++.+|.++
T Consensus 360 -~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 360 -VLPETLP--PTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred -cCChhhc--CCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence 3554442 56777777777777 3444433 25666666666665 333322 22344455555555544
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.4e-21 Score=192.55 Aligned_cols=171 Identities=13% Similarity=0.185 Sum_probs=133.7
Q ss_pred HhhccCcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHH---------HHHHHHHHhcCCCCceeeeeeEEecC
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKE---------FETELETVGSIKHRNLVSLQGYSLSS 666 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h~niv~~~~~~~~~ 666 (933)
...+|+..+++|.|+||.||.+.. ++..+|+|.++.......+. +++|++.+.++.|++|..+.+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 357999999999999999999766 56789999997654332222 68999999999999999999986533
Q ss_pred --------CccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCC
Q 002349 667 --------SGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFE 738 (933)
Q Consensus 667 --------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~ 738 (933)
...++||||++|.+|.++.. ++. ....+++.++..+|+. |++|||+||+||++++++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-
Confidence 35789999999999988741 222 3456999999999966 999999999999999988
Q ss_pred eEEeecccccccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHH
Q 002349 739 AHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELL 795 (933)
Q Consensus 739 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ell 795 (933)
++++|||..+........ ..+.....+..++|+|+||+++....
T Consensus 173 i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999988654211111 11344455677999999999987654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.2e-20 Score=187.39 Aligned_cols=139 Identities=18% Similarity=0.158 Sum_probs=108.6
Q ss_pred ceeeecccceeEEEEEEcCCceEEEEEecccCch--h-------HH-----------------HHHHHHHHHhcCCCCce
Q 002349 603 KYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQ--C-------LK-----------------EFETELETVGSIKHRNL 656 (933)
Q Consensus 603 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~-------~~-----------------~~~~E~~~l~~l~h~ni 656 (933)
...||+|+||.||+|...+|+.||||+++..... . .. ...+|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3579999999999999888999999999754211 1 11 22459999999988776
Q ss_pred eeeeeEEecCCccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCCeeeccCCCCceEeCC
Q 002349 657 VSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYL-HHDCSPRIIHRDVKSSNILLDK 735 (933)
Q Consensus 657 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~Dikp~NIll~~ 735 (933)
.....+.. ...++||||++++++..... ...+++...+..++.|++.+|+|+ |+. +|+||||||+||+++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-
Confidence 44333322 23489999999887765431 235789999999999999999999 654 999999999999998
Q ss_pred CCCeEEeeccccccc
Q 002349 736 DFEAHLTDFGIAKSL 750 (933)
Q Consensus 736 ~~~~kl~DfGla~~~ 750 (933)
++.++|+|||+|...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.3e-20 Score=216.40 Aligned_cols=251 Identities=24% Similarity=0.268 Sum_probs=183.8
Q ss_pred ccCcceeeecccceeEEEEEEcCCceEEEEEecccC-chhHHHHHHHHHH--HhcCCCCceeeeeeEEecCCccEEEEEe
Q 002349 599 NLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHY-PQCLKEFETELET--VGSIKHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
++...+.||.+.|=+|.+|+++.|. |+||++.+.. .-..+.|.++++- ...++|||.+++.-+-...+..|+|-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5677788999999999999999887 9999987655 3345555554443 4445899999998887788888999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccc--ccC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSL--CVS 753 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~--~~~ 753 (933)
... +|+|.+ ..+.-+...+..-|+.|++.|+.-+|+. ||+|||||.+|||++.=.-+.|+||..-+.. ..+
T Consensus 103 vkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 865 899998 3455678888889999999999999965 9999999999999999999999999866532 222
Q ss_pred CCceeeee----cccccccCccccccC----------C-CCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcc
Q 002349 754 KSYTSTYI----MGTIGYIDPEYARTS----------R-LTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTAN 817 (933)
Q Consensus 754 ~~~~~~~~----~gt~~y~aPE~~~~~----------~-~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 817 (933)
+....... ..-..|+|||.+... . .+++.||||+||+++|+++ |+++|. +.++...+...
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~----LSQL~aYr~~~ 251 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT----LSQLLAYRSGN 251 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc----HHHHHhHhccC
Confidence 22222222 233479999977431 2 5789999999999999988 577775 22332222221
Q ss_pred cccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccC
Q 002349 818 NAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869 (933)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 869 (933)
....+..-..+ ++ ..+..++..|++.||++|-++++.++.-+..
T Consensus 252 ~~~~e~~Le~I----ed----~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 252 ADDPEQLLEKI----ED----VSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred ccCHHHHHHhC----cC----ccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 11111111111 11 3578899999999999999999999875443
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.3e-21 Score=176.27 Aligned_cols=176 Identities=24% Similarity=0.434 Sum_probs=121.1
Q ss_pred cccccccccccccCCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCCccccccccccceee
Q 002349 330 LTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLD 409 (933)
Q Consensus 330 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 409 (933)
+..++.|.|++|+++ .+|..+..+.+|+.|++++|+|. ..|..++.+++|+.|+++-|++. ..|..|+.++.|+.||
T Consensus 32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levld 108 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLD 108 (264)
T ss_pred hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhh
Confidence 344444455555554 34444555555555555555555 34555555555555555555555 5556666666666666
Q ss_pred ccCCccCC-CCCCCCCCccccccccccCcccccccccccccccccceEEccCCccccccchhhccccccceeeecCCCCc
Q 002349 410 MSNNKISG-SIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLS 488 (933)
Q Consensus 410 Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 488 (933)
|.+|++.. .+|..|..++.|+.|+|++|.+. .+|..++++++|+.|.+..|.+- .+|.+++.++.|++|.+++|+++
T Consensus 109 ltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~ 186 (264)
T KOG0617|consen 109 LTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT 186 (264)
T ss_pred ccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee
Confidence 66666542 57788888888888888888888 78888888888888888888887 67888899999999999999998
Q ss_pred Ccccchhhccccc----eeecCCCCC
Q 002349 489 GDVMSLINCLSLS----VLFIGNPGL 510 (933)
Q Consensus 489 ~~~~~~~~~~~~~----~~~~~N~~~ 510 (933)
-.+|++.++.... .-+..|||.
T Consensus 187 vlppel~~l~l~~~k~v~r~E~NPwv 212 (264)
T KOG0617|consen 187 VLPPELANLDLVGNKQVMRMEENPWV 212 (264)
T ss_pred ecChhhhhhhhhhhHHHHhhhhCCCC
Confidence 8888887765432 346788885
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.1e-19 Score=180.00 Aligned_cols=140 Identities=17% Similarity=0.165 Sum_probs=111.3
Q ss_pred ceeeecccceeEEEEEEcCCceEEEEEecccCchh--------------------------HHHHHHHHHHHhcCCCCce
Q 002349 603 KYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQC--------------------------LKEFETELETVGSIKHRNL 656 (933)
Q Consensus 603 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~E~~~l~~l~h~ni 656 (933)
...||+|+||.||+|...+|+.||||+++...... ...+.+|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 45799999999999998789999999987642110 1124679999999999987
Q ss_pred eeeeeEEecCCccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeeeccCCCCceEeCC
Q 002349 657 VSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHH-DCSPRIIHRDVKSSNILLDK 735 (933)
Q Consensus 657 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dikp~NIll~~ 735 (933)
.....+... ..++||||++|+++..... ....++..+...++.|++.++.++|+ . ||+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-
Confidence 555444333 3489999999885543321 23467888999999999999999996 5 999999999999999
Q ss_pred CCCeEEeecccccccc
Q 002349 736 DFEAHLTDFGIAKSLC 751 (933)
Q Consensus 736 ~~~~kl~DfGla~~~~ 751 (933)
++.++|+|||+|+...
T Consensus 153 ~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCEEEEEcccceecC
Confidence 8899999999998653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.9e-19 Score=183.21 Aligned_cols=233 Identities=21% Similarity=0.278 Sum_probs=149.8
Q ss_pred ccCcceeeecccceeEEEEEEcC-CceEEEEEecccC---chhHHHHHHHHHHHhcCCC----------CceeeeeeEEe
Q 002349 599 NLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHY---PQCLKEFETELETVGSIKH----------RNLVSLQGYSL 664 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h----------~niv~~~~~~~ 664 (933)
.+..++.||.|+++.||.+.+.. ++++|||++.... ....+++++|.-....+.+ -.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 45667889999999999999875 7899999885433 3356677777766666432 12222222211
Q ss_pred ---------cCC--------ccEEEEEecCCCCHHHHhcC----CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeee
Q 002349 665 ---------SSS--------GNLLFYDFMENGSLWDILHG----PTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIH 723 (933)
Q Consensus 665 ---------~~~--------~~~lv~e~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH 723 (933)
... ..+++|+-+ .++|.+++.. ......+....++.+..|+++.+++||.. |+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEe
Confidence 111 235677777 4588887631 11122344556677889999999999966 9999
Q ss_pred ccCCCCceEeCCCCCeEEeecccccccccCCCceeeeecccccccCccccccC--------CCCcchhhHHHHHHHHHHH
Q 002349 724 RDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTS--------RLTEKSDVYSFGIVLLELL 795 (933)
Q Consensus 724 ~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~DvwSlGv~l~ell 795 (933)
+||||+|++++.+|.++|+||+.....+.. ... ...+..|.|||..... .++.+.|.|++|+++|.|+
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~--~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTR--YRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEE--EEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCce--eec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 999999999999999999999987664321 111 2455789999976442 4789999999999999999
Q ss_pred hCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCC
Q 002349 796 TGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDR 856 (933)
Q Consensus 796 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 856 (933)
+|+.||+........ . ..+. .|. +.++.+..+|..+++++|.+|
T Consensus 245 C~~lPf~~~~~~~~~-------~-------~~f~-~C~--~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADP-------E-------WDFS-RCR--DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTS-------G-------GGGT-TSS-----HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCccccc-------c-------ccch-hcC--CcCHHHHHHHHHHccCCcccC
Confidence 999999743211100 0 0122 232 457889999999999999988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.8e-19 Score=173.12 Aligned_cols=185 Identities=14% Similarity=0.067 Sum_probs=138.1
Q ss_pred CcceeeecccceeEEEEEEcCCceEEEEEecccCc----hhHHHHHHHHHHHhcCC-CCceeeeeeEEecCCccEEEEEe
Q 002349 601 SEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYP----QCLKEFETELETVGSIK-HRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 601 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
.+...|++|+||+||.+.. .+.+++.+.+..... -....+.+|+++|+++. |++|++++++ ...+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3456899999999997765 567777776654322 11235889999999995 5889999886 356999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccC-CCCceEeCCCCCeEEeecccccccccCC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDV-KSSNILLDKDFEAHLTDFGIAKSLCVSK 754 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Di-kp~NIll~~~~~~kl~DfGla~~~~~~~ 754 (933)
++|.+|.+... . ....++.|++.+++++|++ ||+|||| ||+||+++.++.++|+|||+|.......
T Consensus 80 I~G~~L~~~~~----~------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 80 LAGAAMYQRPP----R------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred ecCccHHhhhh----h------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 99999876541 1 1135778999999999966 9999999 7999999999999999999998653222
Q ss_pred Cc----e--------eeeecccccccCcccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 002349 755 SY----T--------STYIMGTIGYIDPEYART--SRLTEKSDVYSFGIVLLELLTGRKAVDN 803 (933)
Q Consensus 755 ~~----~--------~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGv~l~elltg~~p~~~ 803 (933)
.. . ......++.|++|+...- ..--.+.+-++-|.-+|.++|++.+..+
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 10 0 011236778888875433 2223577889999999999999988754
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.1e-20 Score=172.92 Aligned_cols=184 Identities=32% Similarity=0.544 Sum_probs=141.1
Q ss_pred ccCCcceEeeeccccccccCCccccccccccccccccccCCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccce
Q 002349 304 GNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTY 383 (933)
Q Consensus 304 ~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~ 383 (933)
.++.+.+.|.|++|+++ .+|..+..+.+|+.|++.+|+|+ ..|..++.+++|+.|+++-|++. ..|..|+.++.|+.
T Consensus 30 f~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~lev 106 (264)
T KOG0617|consen 30 FNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEV 106 (264)
T ss_pred cchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhh
Confidence 34556666667777776 56666777777777777777776 66777777777777777777777 67777888888888
Q ss_pred ecCCcccccC-CCccccccccccceeeccCCccCCCCCCCCCCccccccccccCcccccccccccccccccceEEccCCc
Q 002349 384 LNLSLNNIRG-PIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNH 462 (933)
Q Consensus 384 L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 462 (933)
|||++|++.. ..|..|..++.|+.|+|++|.+. .+|..++++++|+.|.+..|.+- ..|..++.+..|++|.+.+|+
T Consensus 107 ldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnr 184 (264)
T KOG0617|consen 107 LDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNR 184 (264)
T ss_pred hhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccce
Confidence 8888877763 56777888888888888888887 78888888888888888888888 678888888888888888888
Q ss_pred cccccchhhcccccc---ceeeecCCCCcCcccc
Q 002349 463 LTGVIPEELSQLQNM---FSLRLDYNNLSGDVMS 493 (933)
Q Consensus 463 l~~~~p~~~~~l~~L---~~L~l~~N~l~~~~~~ 493 (933)
++ .+|.+++++.-+ +.+.+.+|+|-..+.+
T Consensus 185 l~-vlppel~~l~l~~~k~v~r~E~NPwv~pIae 217 (264)
T KOG0617|consen 185 LT-VLPPELANLDLVGNKQVMRMEENPWVNPIAE 217 (264)
T ss_pred ee-ecChhhhhhhhhhhHHHHhhhhCCCCChHHH
Confidence 88 777777776533 5577888988766543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=7.2e-20 Score=201.41 Aligned_cols=232 Identities=25% Similarity=0.240 Sum_probs=177.5
Q ss_pred eeecccceeEEEEE----EcCCceEEEEEecccCc--hhHHHHHHHHHHHhcCC-CCceeeeeeEEecCCccEEEEEecC
Q 002349 605 IIGYGASSTVYKCV----LKNCKPVAIKRLYSHYP--QCLKEFETELETVGSIK-HRNLVSLQGYSLSSSGNLLFYDFME 677 (933)
Q Consensus 605 ~lG~G~~g~Vy~~~----~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~ 677 (933)
.+|+|.||.|+.+. .+.++-+|.|..+.... ........|..++..++ ||.+|++.-.+..+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999765 33466788887765431 11224456888888886 9999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCce
Q 002349 678 NGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYT 757 (933)
Q Consensus 678 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 757 (933)
+|.+...+ .....++......+...++-|++++|+. +|+|||+|++||+++.+|.+++.|||+++..-.....
T Consensus 81 gg~lft~l---~~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 81 GGDLFTRL---SKEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred cchhhhcc---ccCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence 99998888 4556678888888889999999999954 9999999999999999999999999999875322221
Q ss_pred eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHH
Q 002349 758 STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGA 837 (933)
Q Consensus 758 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 837 (933)
+||..|||||++. ....++|-||||++++||+||..||..+ ....+...+... +.+.
T Consensus 154 ----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~----~~~~Il~~~~~~-------------p~~l 210 (612)
T KOG0603|consen 154 ----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD----TMKRILKAELEM-------------PREL 210 (612)
T ss_pred ----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH----HHHHHhhhccCC-------------chhh
Confidence 8999999999998 5678999999999999999999999861 111111111111 1122
Q ss_pred HHHHHHHHHHccCCCCCCCCCH--HHHHHHH
Q 002349 838 VKKVFQLALLCSKRQPTDRPTM--HEVSRVL 866 (933)
Q Consensus 838 ~~~l~~li~~cl~~dP~~RPt~--~evl~~L 866 (933)
......++..++..+|..|.-. ..+.++.
T Consensus 211 ~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik 241 (612)
T KOG0603|consen 211 SAEARSLFRQLFKRNPENRLGAGPDGVDEIK 241 (612)
T ss_pred hHHHHHHHHHHHhhCHHHHhccCcchhHHHh
Confidence 3455667888889999999644 3444433
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=9.7e-19 Score=180.34 Aligned_cols=196 Identities=23% Similarity=0.283 Sum_probs=135.7
Q ss_pred CCCceeeeeeEEec---------------------------CCccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHH
Q 002349 652 KHRNLVSLQGYSLS---------------------------SSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIAL 704 (933)
Q Consensus 652 ~h~niv~~~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 704 (933)
+|||||++.++|.+ +...|+||.-.+ .+|..++. ....+.....-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~----~~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLW----TRHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHh----cCCCchHHHHHHHH
Confidence 59999999988743 123588998775 48999884 34466777888999
Q ss_pred HHHHHHHHhhcCCCCCeeeccCCCCceEeC--CCC--CeEEeeccccccccc---CCCcee--eeecccccccCcccccc
Q 002349 705 GAAQGLAYLHHDCSPRIIHRDVKSSNILLD--KDF--EAHLTDFGIAKSLCV---SKSYTS--TYIMGTIGYIDPEYART 775 (933)
Q Consensus 705 ~i~~~l~~LH~~~~~~ivH~Dikp~NIll~--~~~--~~kl~DfGla~~~~~---~~~~~~--~~~~gt~~y~aPE~~~~ 775 (933)
|+++|+.|||++ ||.|||+|++|||+. +|+ ...|+|||.+-.-.. .-.+.+ ...-|.-.-||||+...
T Consensus 349 QlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 999999999987 999999999999994 443 358999998753211 011111 12346778899998865
Q ss_pred CC------CCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHHHHHHHHHHHHcc
Q 002349 776 SR------LTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCS 849 (933)
Q Consensus 776 ~~------~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 849 (933)
.+ -..|+|.|+.|.+.||+++...||.+.....--. ..+.+..-|.+++. ++..+.+++...+
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~------r~Yqe~qLPalp~~-----vpp~~rqlV~~lL 494 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT------RTYQESQLPALPSR-----VPPVARQLVFDLL 494 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheech------hhhhhhhCCCCccc-----CChHHHHHHHHHh
Confidence 32 2368999999999999999999998532211110 11111112222222 2345778899999
Q ss_pred CCCCCCCCCHHHHHHHH
Q 002349 850 KRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 850 ~~dP~~RPt~~evl~~L 866 (933)
++||++|++..-....+
T Consensus 495 ~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 495 KRDPSKRVSPNIAANVL 511 (598)
T ss_pred cCCccccCCccHHHhHH
Confidence 99999999865544433
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.3e-18 Score=170.84 Aligned_cols=137 Identities=20% Similarity=0.205 Sum_probs=106.9
Q ss_pred cCcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcC-----CCCceeeeeeEEecCC---ccE-
Q 002349 600 LSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSI-----KHRNLVSLQGYSLSSS---GNL- 670 (933)
Q Consensus 600 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~---~~~- 670 (933)
++....||+|+||.||. +......+||++........+.+.+|+++++.+ .||||++++|++.++. ..+
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 45567899999999996 443333479988765444567899999999999 5799999999998874 223
Q ss_pred EEEEe--cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHH-HHhhcCCCCCeeeccCCCCceEeCC----CCCeEEee
Q 002349 671 LFYDF--MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGL-AYLHHDCSPRIIHRDVKSSNILLDK----DFEAHLTD 743 (933)
Q Consensus 671 lv~e~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l-~~LH~~~~~~ivH~Dikp~NIll~~----~~~~kl~D 743 (933)
+|+|| +.+++|.+++.. ..+++. ..++.+++.++ +|||++ +|+||||||+||+++. ++.++|+|
T Consensus 82 ~I~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EEecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 78999 557999999942 235555 35678888787 999976 9999999999999974 34799999
Q ss_pred cccc
Q 002349 744 FGIA 747 (933)
Q Consensus 744 fGla 747 (933)
|+-+
T Consensus 153 g~G~ 156 (210)
T PRK10345 153 NIGE 156 (210)
T ss_pred CCCC
Confidence 5433
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.8e-18 Score=188.77 Aligned_cols=215 Identities=28% Similarity=0.438 Sum_probs=163.4
Q ss_pred HhcCCCCceeeeeeEEecCCccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCC
Q 002349 648 VGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVK 727 (933)
Q Consensus 648 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik 727 (933)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.|.+. .....+++.-...++++++.||+|+|.- +-..|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~--~~~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILS--NEDIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHh--ccccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeeec
Confidence 457899999999999999999999999999999999996 3456789999999999999999999963 334899999
Q ss_pred CCceEeCCCCCeEEeecccccccccC-CCceeeeecccccccCccccccCC-------CCcchhhHHHHHHHHHHHhCCC
Q 002349 728 SSNILLDKDFEAHLTDFGIAKSLCVS-KSYTSTYIMGTIGYIDPEYARTSR-------LTEKSDVYSFGIVLLELLTGRK 799 (933)
Q Consensus 728 p~NIll~~~~~~kl~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DvwSlGv~l~elltg~~ 799 (933)
++|.++|....+|++|||+....... .........-..-|.|||.+++.. .+.+.||||||++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 99999999999999999998765321 111111122345799999987641 4678999999999999999999
Q ss_pred CCCCCcchh---HHHHhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCC
Q 002349 800 AVDNECNLH---HLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVP 871 (933)
Q Consensus 800 p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 871 (933)
||+...... ..+..... .......|.+.... +....+..++..||..+|.+||++++|-..++.+..
T Consensus 157 ~~~~~~~~~~~~eii~~~~~--~~~~~~rP~i~~~~---e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKK--GGSNPFRPSIELLN---ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred ccccccccCChHHHHHHHHh--cCCCCcCcchhhhh---hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 998532222 22222111 12222334333221 334478899999999999999999999888876654
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.1e-20 Score=208.49 Aligned_cols=57 Identities=33% Similarity=0.362 Sum_probs=28.4
Q ss_pred EEcCCCCcCc-ccCCCCCCCCCccEEEccCCcccc----cCCCCccCCCCCceecccccccC
Q 002349 73 LNLSGLNLDG-EISPAVGDLKDLQSIDLRGNRLSG----QIPDEIGDCSSLKSLDLSFNELY 129 (933)
Q Consensus 73 l~l~~~~l~~-~~~~~l~~l~~L~~L~Ls~n~l~~----~~p~~l~~l~~L~~L~Ls~n~l~ 129 (933)
|+|.++.+++ .....+..++.|++|+++++.++. .+++.+...++|++|+++++.+.
T Consensus 3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~ 64 (319)
T cd00116 3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETG 64 (319)
T ss_pred cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccC
Confidence 4455555542 223334445556666666665532 23444445555555555555544
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.5e-17 Score=196.49 Aligned_cols=198 Identities=21% Similarity=0.226 Sum_probs=159.1
Q ss_pred HHHHhhccCcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCC---CCceeeeeeEEecCCcc
Q 002349 593 IMRMTENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIK---HRNLVSLQGYSLSSSGN 669 (933)
Q Consensus 593 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~ 669 (933)
...-.+.|.+.+.||+|+||+||+|...+|+.||+|+-+.... -+|.-=.+++.||+ -+-|..+...+...+.-
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 3344568889999999999999999988899999998876542 11111123334444 23455555556667788
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeC-------CCCCeEEe
Q 002349 670 LLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLD-------KDFEAHLT 742 (933)
Q Consensus 670 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~-------~~~~~kl~ 742 (933)
++|+||.+.|+|.+++. ..+.+++.-+..++.|+++.+++||.. +|||+||||+|.++. +...++|+
T Consensus 770 ~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred eeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEE
Confidence 99999999999999994 667899999999999999999999966 999999999999994 23468999
Q ss_pred eccccccccc-CCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCC
Q 002349 743 DFGIAKSLCV-SKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRK 799 (933)
Q Consensus 743 DfGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~ 799 (933)
|||.+..+.- .+.......++|-.+-.+|...|.++++++|-|.++.+++-|+.|++
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 9999865532 23345566789999999999999999999999999999999999975
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.3e-20 Score=203.75 Aligned_cols=276 Identities=23% Similarity=0.274 Sum_probs=123.2
Q ss_pred EEeccCcccc-CccCcCCcCCCCCcEEccccccccCcCCCCccccccceEeccccccccccCccccccccccEEeccCCc
Q 002349 192 YFDVRNNSLT-GSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNM 270 (933)
Q Consensus 192 ~L~L~~n~l~-~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~ 270 (933)
.|+|..+.++ ......+..+..|+.|+++++.++..-.. .++..+...++|+.|+++.+.
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~-------------------~i~~~l~~~~~l~~l~l~~~~ 62 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAK-------------------ALASALRPQPSLKELCLSLNE 62 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHH-------------------HHHHHHhhCCCceEEeccccc
Confidence 3556666665 23334445555666666666665421000 122233334445555555444
Q ss_pred CcC------CCCCCCCCCCCccEEEeeCCccCCCCCCccccCCc---ceEeeeccccccc----cCCcccccc-cccccc
Q 002349 271 LSG------PIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTK---LHYLELNDNQLTG----HIPPALGKL-TDLFDL 336 (933)
Q Consensus 271 l~~------~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~---L~~L~L~~N~l~~----~~~~~l~~l-~~L~~L 336 (933)
+.+ .++..+.++++|+.|++++|.+.+..+..+..+.+ |++|++++|++++ .+...+..+ ++|+.|
T Consensus 63 ~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L 142 (319)
T cd00116 63 TGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKL 142 (319)
T ss_pred cCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEE
Confidence 431 11223344445555555555554333333333333 5555555555542 111223333 445555
Q ss_pred ccccccCCCC----CCCCcccCCCCCceeccCcccCCC----CCcccccccccceecCCcccccCCC----ccccccccc
Q 002349 337 NVANNHLEGP----IPDNLSSCTNLNSLNVHGNKLNGT----IPPAFQRLESMTYLNLSLNNIRGPI----PVELSRIGN 404 (933)
Q Consensus 337 ~L~~N~l~~~----~p~~l~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~ 404 (933)
++++|.+++. ++..+..+.+|+.|++++|.+++. ++..+..+++|++|++++|.+++.. ...+..+++
T Consensus 143 ~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~ 222 (319)
T cd00116 143 VLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKS 222 (319)
T ss_pred EcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCC
Confidence 5555554421 122333444555555555555421 1222333345555555555554222 222334455
Q ss_pred cceeeccCCccCCCCCCCCC-----CccccccccccCcccc----cccccccccccccceEEccCCccccc----cchhh
Q 002349 405 LDTLDMSNNKISGSIPSPLG-----DLEHLLKLNLSRNQLT----GFIPGEFGNLRSVMEIDLSHNHLTGV----IPEEL 471 (933)
Q Consensus 405 L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~Ls~N~l~----~~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~ 471 (933)
|+.|++++|.+++.....+. ..+.|+.|++++|.++ ..+...+..+++|+.+++++|.++.. ....+
T Consensus 223 L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~ 302 (319)
T cd00116 223 LEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESL 302 (319)
T ss_pred CCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHH
Confidence 55555555555432111111 1245555555555554 11223344445555556665555533 22333
Q ss_pred ccc-cccceeeecCCC
Q 002349 472 SQL-QNMFSLRLDYNN 486 (933)
Q Consensus 472 ~~l-~~L~~L~l~~N~ 486 (933)
... +.|+++++.+|+
T Consensus 303 ~~~~~~~~~~~~~~~~ 318 (319)
T cd00116 303 LEPGNELESLWVKDDS 318 (319)
T ss_pred hhcCCchhhcccCCCC
Confidence 333 445555555554
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.2e-17 Score=170.23 Aligned_cols=141 Identities=16% Similarity=0.156 Sum_probs=110.7
Q ss_pred ccCcceeeecccceeEEEEE--EcCCceEEEEEecccCch------------------------hHHHHHHHHHHHhcCC
Q 002349 599 NLSEKYIIGYGASSTVYKCV--LKNCKPVAIKRLYSHYPQ------------------------CLKEFETELETVGSIK 652 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 652 (933)
-|+..+.||+|+||.||+|. ..+|+.||+|+++..... ....+.+|++.+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47778899999999999998 457899999998753210 1123578999999997
Q ss_pred CCc--eeeeeeEEecCCccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC-eeeccCCCC
Q 002349 653 HRN--LVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPR-IIHRDVKSS 729 (933)
Q Consensus 653 h~n--iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-ivH~Dikp~ 729 (933)
+.. +.+++++ ...++||||++++++..... ....+...+...++.|++.++++||++ + |+||||||+
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~ 178 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEY 178 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChh
Confidence 533 3344443 23589999999988876542 234566667789999999999999966 8 999999999
Q ss_pred ceEeCCCCCeEEeeccccccc
Q 002349 730 NILLDKDFEAHLTDFGIAKSL 750 (933)
Q Consensus 730 NIll~~~~~~kl~DfGla~~~ 750 (933)
||+++ ++.++++|||.|...
T Consensus 179 NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred hEEEE-CCCEEEEEChhhhcc
Confidence 99999 889999999998754
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.9e-17 Score=194.38 Aligned_cols=156 Identities=31% Similarity=0.525 Sum_probs=124.8
Q ss_pred CCCChHHHHHHHHHHHhCCCCCCCcCCCCCCCC-CCCCCccceEecC--CC--CcEEEEEcCCCCcCcccCCCCCCCCCc
Q 002349 20 GSVDSEDGATLLKIKKSFRDVDNVLYDWTDSPS-SDYCVWRGITCDN--VT--FTVIALNLSGLNLDGEISPAVGDLKDL 94 (933)
Q Consensus 20 ~~~~~~d~~all~~k~~~~~~~~~l~~w~~~~~-~~~c~w~gv~C~~--~~--~~v~~l~l~~~~l~~~~~~~l~~l~~L 94 (933)
.++.++|.+||+++|+++.++.. .+|++++- ..+|.|.||.|+. .. .+|+.|+|++++++|.+|+.++++++|
T Consensus 367 ~~t~~~~~~aL~~~k~~~~~~~~--~~W~g~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L 444 (623)
T PLN03150 367 SKTLLEEVSALQTLKSSLGLPLR--FGWNGDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHL 444 (623)
T ss_pred cccCchHHHHHHHHHHhcCCccc--CCCCCCCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCC
Confidence 34567899999999999977643 48975320 0112799999953 22 358899999999999999999999999
Q ss_pred cEEEccCCcccccCCCCccCCCCCceecccccccCCCCCcccccccchhhhhhcccCccCCCCcccccC-CCCceeeeec
Q 002349 95 QSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQL-PNLKVFGLRG 173 (933)
Q Consensus 95 ~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l-~~L~~L~L~~ 173 (933)
+.|+|++|+++|.+|..++.+++|+.|||++|+++|.+|..+++|++|++|+|++|+++|.+|..++.+ .++..+++.+
T Consensus 445 ~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~ 524 (623)
T PLN03150 445 QSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTD 524 (623)
T ss_pred CEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecC
Confidence 999999999999999889999999999999999998899888888889999998888888888887753 4566677776
Q ss_pred CCCC
Q 002349 174 NNLV 177 (933)
Q Consensus 174 N~l~ 177 (933)
|...
T Consensus 525 N~~l 528 (623)
T PLN03150 525 NAGL 528 (623)
T ss_pred Cccc
Confidence 6543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.6e-17 Score=191.45 Aligned_cols=207 Identities=24% Similarity=0.286 Sum_probs=147.9
Q ss_pred hccCcceeeecccceeEEEEEEcC-CceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEec
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFM 676 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 676 (933)
.+|...+.|..|+||.||.++++. .+++|.| +.+.. .+.+- ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~-----lilRn--ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN-----LILRN--ILTFAGNPFVV------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-ccccc-----hhhhc--cccccCCccee-------------------
Confidence 478888999999999999999885 4668884 33221 01110 22222333333
Q ss_pred CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC---
Q 002349 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS--- 753 (933)
Q Consensus 677 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~--- 753 (933)
|+=.+.+ +..++++... +.+++|+| +.+|+|||+||+|.+|+.-|.+|++|||+++..-..
T Consensus 136 --gDc~tll---k~~g~lPvdm--------vla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 --GDCATLL---KNIGPLPVDM--------VLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred --chhhhhc---ccCCCCcchh--------hHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 3334444 3334555333 78899999 559999999999999999999999999998754211
Q ss_pred -----------CCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccccccc
Q 002349 754 -----------KSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVME 822 (933)
Q Consensus 754 -----------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 822 (933)
.......++||+.|+|||++.-..|...+|.|++|+++||.+.|..||.++...+-+.........+.+
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE 279 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 279 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccc
Confidence 112234578999999999999999999999999999999999999999988666555443333333333
Q ss_pred ccCccccccccCHHHHHHHHHHHHHccCCCCCCCC
Q 002349 823 TVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRP 857 (933)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 857 (933)
. +. ..+.+..+++.+.++.+|.+|-
T Consensus 280 ~-de---------a~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 280 E-DE---------ALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred c-Cc---------CCCHHHHHHHHHHHHhChHhhc
Confidence 3 21 2235667788899999999995
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.7e-16 Score=162.16 Aligned_cols=134 Identities=19% Similarity=0.273 Sum_probs=112.6
Q ss_pred eeeecccceeEEEEEEcCCceEEEEEecccCch--------hHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEe
Q 002349 604 YIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQ--------CLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 604 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
+.||+|++|.||+|.+ .+..|++|+....... ....+.+|++++..++|++|+....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4699999999999987 5577999987543211 124578899999999999998877777777888999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccc
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKS 749 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 749 (933)
++|++|.+.+.. . .+ .+..++.+++.++.++|+. +++|||++|+||+++ ++.++++|||.+..
T Consensus 81 ~~G~~L~~~~~~---~---~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINS---N---GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHh---c---cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999999842 1 12 8889999999999999965 999999999999999 78999999998864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.2e-16 Score=159.48 Aligned_cols=138 Identities=17% Similarity=0.166 Sum_probs=109.5
Q ss_pred hccCcceeeecccceeEEEEEEcCCceEEEEEecccCch----------------------hHHHHHHHHHHHhcCCCCc
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQ----------------------CLKEFETELETVGSIKHRN 655 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~l~h~n 655 (933)
..|...+.||+|+||.||+|..++++.||||++...... ....+.+|+.++..+.|++
T Consensus 15 ~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 15 VVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred chhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 347778899999999999999888999999987543210 1123677899999998774
Q ss_pred --eeeeeeEEecCCccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEe
Q 002349 656 --LVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILL 733 (933)
Q Consensus 656 --iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll 733 (933)
+...++ ....++||||+++++|.+... ......++.+++.++.++|+. +|+||||||+||++
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill 158 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILV 158 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEE
Confidence 444443 245689999999999876542 134567889999999999965 99999999999999
Q ss_pred CCCCCeEEeecccccccc
Q 002349 734 DKDFEAHLTDFGIAKSLC 751 (933)
Q Consensus 734 ~~~~~~kl~DfGla~~~~ 751 (933)
++++.++|+|||++....
T Consensus 159 ~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 159 DDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred cCCCcEEEEECCccccCC
Confidence 999999999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.4e-17 Score=178.24 Aligned_cols=174 Identities=26% Similarity=0.410 Sum_probs=132.4
Q ss_pred ccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccc
Q 002349 668 GNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIA 747 (933)
Q Consensus 668 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla 747 (933)
..||.|++|.-.+|.+++.+.......++...+.++.|++.|++| + +.+|||+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 468999999999999999766666778899999999999999999 3 8999999999999999999999999999
Q ss_pred cccccCC-----CceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHH-Hhhhccccc
Q 002349 748 KSLCVSK-----SYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLI-LSKTANNAV 820 (933)
Q Consensus 748 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~-~~~~~~~~~ 820 (933)
....... ....+...||..||+||.+.+..|+.|+||||+|++++|++. =..+++ ... ......+.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e------r~~t~~d~r~g~- 476 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE------RIATLTDIRDGI- 476 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH------HHHhhhhhhcCC-
Confidence 8765443 223455689999999999999999999999999999999997 122221 111 01111111
Q ss_pred ccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 002349 821 METVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVS 863 (933)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 863 (933)
++|.+.... ..=+.++.+++...|.+||++.++.
T Consensus 477 ---ip~~~~~d~------p~e~~ll~~lls~~p~~RP~~~~~~ 510 (516)
T KOG1033|consen 477 ---IPPEFLQDY------PEEYTLLQQLLSPSPEERPSAIEVA 510 (516)
T ss_pred ---CChHHhhcC------cHHHHHHHHhcCCCcccCchHHHHh
Confidence 111222111 2234578899999999999655543
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.5e-16 Score=158.85 Aligned_cols=130 Identities=20% Similarity=0.322 Sum_probs=105.9
Q ss_pred eeecccceeEEEEEEcCCceEEEEEecccC---ch-----hHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEec
Q 002349 605 IIGYGASSTVYKCVLKNCKPVAIKRLYSHY---PQ-----CLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFM 676 (933)
Q Consensus 605 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 676 (933)
.||+|+||.||+|.+ .++.|++|+..... .+ ...++.+|+++++.++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999995 45789999865432 11 1356778999999999887666555666677789999999
Q ss_pred CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccc
Q 002349 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKS 749 (933)
Q Consensus 677 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 749 (933)
+|++|.+.+.. ... .++.+++.+|.++|+. +++|||++|+||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~---~~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEE---GND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhh---cHH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999998742 111 7899999999999965 999999999999999 88999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.65 E-value=5.6e-16 Score=181.83 Aligned_cols=137 Identities=20% Similarity=0.282 Sum_probs=112.2
Q ss_pred hhccCcceeeecccceeEEEEEEcCCceEEEEEe-cccC-c------hhHHHHHHHHHHHhcCCCCceeeeeeEEecCCc
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRL-YSHY-P------QCLKEFETELETVGSIKHRNLVSLQGYSLSSSG 668 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~-~~~~-~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 668 (933)
...|...+.||+|+||+||+|.+.+.. +++|+. .... . ...+++.+|++++++++|++++....++.....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 445567889999999999999876644 444432 2111 1 123568899999999999999988888877778
Q ss_pred cEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccc
Q 002349 669 NLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAK 748 (933)
Q Consensus 669 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 748 (933)
.++||||+++++|.+++. ....++.+++.++.|||+. +++||||||+||++ .++.++|+|||+++
T Consensus 411 ~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred CEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 899999999999999883 4578999999999999965 99999999999999 67899999999997
Q ss_pred c
Q 002349 749 S 749 (933)
Q Consensus 749 ~ 749 (933)
.
T Consensus 476 ~ 476 (535)
T PRK09605 476 Y 476 (535)
T ss_pred c
Confidence 5
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.57 E-value=2e-14 Score=139.56 Aligned_cols=135 Identities=20% Similarity=0.166 Sum_probs=114.1
Q ss_pred cceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCCC--CceeeeeeEEecCCccEEEEEecCCC
Q 002349 602 EKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKH--RNLVSLQGYSLSSSGNLLFYDFMENG 679 (933)
Q Consensus 602 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~g 679 (933)
+.+.||+|.++.||++...+ +.+++|....... ...+.+|+.+++.++| .++++++++...++..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35679999999999999866 7899998865433 4678999999999976 58999999888888899999999887
Q ss_pred CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccc
Q 002349 680 SLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKS 749 (933)
Q Consensus 680 sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 749 (933)
.+... +......++.+++.+++++|.....+++|+|++|+||++++.+.++++|||.++.
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 55432 5667788999999999999975335799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.4e-14 Score=146.16 Aligned_cols=136 Identities=19% Similarity=0.221 Sum_probs=97.7
Q ss_pred ceeeecccceeEEEEEEcCCceEEEEEecccCch--hHHH----------------------HHHHHHHHhcCCCCc--e
Q 002349 603 KYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQ--CLKE----------------------FETELETVGSIKHRN--L 656 (933)
Q Consensus 603 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~h~n--i 656 (933)
.+.||+|+||.||+|...+++.||||++...... .... ...|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4579999999999999888899999998654311 1111 135666666664433 3
Q ss_pred eeeeeEEecCCccEEEEEecCCCCHHH-HhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCC
Q 002349 657 VSLQGYSLSSSGNLLFYDFMENGSLWD-ILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDK 735 (933)
Q Consensus 657 v~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~ 735 (933)
.+.+++ ...++||||++++.+.. .+.. .... .+...++.+++.++.++|.. .+|+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~----~~~~-~~~~~~~~~~~~~l~~lh~~--~~ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKD----VRLL-EDPEELYDQILELMRKLYRE--AGLVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhh----hhhc-ccHHHHHHHHHHHHHHHhhc--cCcCcCCCChhhEEEE-
Confidence 344432 24689999999854321 1110 0011 66788999999999999961 4999999999999999
Q ss_pred CCCeEEeeccccccc
Q 002349 736 DFEAHLTDFGIAKSL 750 (933)
Q Consensus 736 ~~~~kl~DfGla~~~ 750 (933)
++.++++|||.+...
T Consensus 150 ~~~~~liDfg~a~~~ 164 (187)
T cd05119 150 DGKVYIIDVPQAVEI 164 (187)
T ss_pred CCcEEEEECcccccc
Confidence 899999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.9e-14 Score=148.52 Aligned_cols=136 Identities=17% Similarity=0.154 Sum_probs=105.6
Q ss_pred cceeee-cccceeEEEEEEcCCceEEEEEecccC-------------chhHHHHHHHHHHHhcCCCCce--eeeeeEEec
Q 002349 602 EKYIIG-YGASSTVYKCVLKNCKPVAIKRLYSHY-------------PQCLKEFETELETVGSIKHRNL--VSLQGYSLS 665 (933)
Q Consensus 602 ~~~~lG-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~ 665 (933)
....|| .||.|+||.+... +..+|||.+.... .....++.+|++++.+++|++| ++.+++...
T Consensus 35 ~~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 35 QARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred cCceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 346798 9999999999875 5678999874311 1223567889999999998875 667776443
Q ss_pred CCc----cEEEEEecCC-CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeE
Q 002349 666 SSG----NLLFYDFMEN-GSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAH 740 (933)
Q Consensus 666 ~~~----~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~k 740 (933)
... .++||||++| .+|.+++.. ..++.. .+.+++.++.+||++ ||+||||||+|||++.++.++
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence 322 2599999997 699988842 344543 357899999999966 999999999999999999999
Q ss_pred Eeecccccc
Q 002349 741 LTDFGIAKS 749 (933)
Q Consensus 741 l~DfGla~~ 749 (933)
|+|||.++.
T Consensus 183 LIDfg~~~~ 191 (239)
T PRK01723 183 LIDFDRGEL 191 (239)
T ss_pred EEECCCccc
Confidence 999998865
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.2e-15 Score=177.76 Aligned_cols=254 Identities=23% Similarity=0.246 Sum_probs=188.3
Q ss_pred ccCcceeeecccceeEEEEEEcC--CceEEEEEecccC--chhHHHHHHHHHHHhcCC-CCceeeeeeEEecCCccEEEE
Q 002349 599 NLSEKYIIGYGASSTVYKCVLKN--CKPVAIKRLYSHY--PQCLKEFETELETVGSIK-HRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 673 (933)
.|...+.||+|+|+.|-.+.... ...+|+|.+.... .........|..+-..+. |+|++.+++.....+..+++.
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 45566679999999998877543 3446666665432 233344556888888886 999999999999999999999
Q ss_pred EecCCCCHHHHh-cCCCCCCCCCHHHHHHHHHHHHHHHHHhh-cCCCCCeeeccCCCCceEeCCCC-CeEEeeccccccc
Q 002349 674 DFMENGSLWDIL-HGPTKKKKLDWDTRLKIALGAAQGLAYLH-HDCSPRIIHRDVKSSNILLDKDF-EAHLTDFGIAKSL 750 (933)
Q Consensus 674 e~~~~gsL~~~l-~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~ivH~Dikp~NIll~~~~-~~kl~DfGla~~~ 750 (933)
||..++++.+.+ +. .....+......++.|+..++.|+| +. ++.||||||+|.+++..+ ..+++|||+|..+
T Consensus 101 ~~s~g~~~f~~i~~~--~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHP--DSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred CcccccccccccccC--CccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccc
Confidence 999999999888 42 2225667778889999999999999 65 999999999999999999 9999999999987
Q ss_pred cc--CCCceeeeecc-cccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCc
Q 002349 751 CV--SKSYTSTYIMG-TIGYIDPEYARTS-RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDP 826 (933)
Q Consensus 751 ~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 826 (933)
.. .........+| ++.|+|||...+. ...+..|+||.|+++..+++|..|++......... ......... .
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~-~~~~~~~~~--~-- 250 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY-SSWKSNKGR--F-- 250 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc-eeecccccc--c--
Confidence 65 33444555678 9999999999884 55788999999999999999999997543322111 111111000 0
Q ss_pred cccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 827 EISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 827 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.. ... ........++..+++..+|..|.+.+++...
T Consensus 251 ~~-~~~--~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 251 TQ-LPW--NSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred cc-Ccc--ccCChhhhhcccccccCCchhcccccccccc
Confidence 00 000 0112455667888888999999999888653
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.50 E-value=2.9e-14 Score=169.01 Aligned_cols=117 Identities=39% Similarity=0.594 Sum_probs=92.9
Q ss_pred ccceeeccCCccCCCCCCCCCCccccccccccCcccccccccccccccccceEEccCCccccccchhhccccccceeeec
Q 002349 404 NLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLD 483 (933)
Q Consensus 404 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 483 (933)
.++.|+|++|.++|.+|..+..+++|+.|+|++|+|+|.+|..++++++|+.|||++|+++|.+|..+..+++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 36778888888888888888888888888888888888888888888888888888888888888888888888888888
Q ss_pred CCCCcCcccchhhc--ccc-ceeecCCCCCCCcccCCccc
Q 002349 484 YNNLSGDVMSLINC--LSL-SVLFIGNPGLCGYWLHSACR 520 (933)
Q Consensus 484 ~N~l~~~~~~~~~~--~~~-~~~~~~N~~~C~~~l~~~~~ 520 (933)
+|+++|.+|....- ..+ ...+.+|+++|+.+....|.
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C~ 538 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACG 538 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCCCCCCCc
Confidence 88888877653221 112 26688999999987667784
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.3e-15 Score=162.67 Aligned_cols=191 Identities=36% Similarity=0.495 Sum_probs=148.3
Q ss_pred EEcCCCCcCcccC--CCCCCCCCccEEEccCCcccccCCCCccCCCCCceecccccccCCCCCcccccccchhhhhhccc
Q 002349 73 LNLSGLNLDGEIS--PAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNN 150 (933)
Q Consensus 73 l~l~~~~l~~~~~--~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n 150 (933)
|.|++..+. .+| ..=-.++.-...||+.|++. .+|..+..+..|+.|.|..|.+. .||..+.+|..|++|||+.|
T Consensus 55 l~Ls~rrlk-~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~N 131 (722)
T KOG0532|consen 55 LLLSGRRLK-EFPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSN 131 (722)
T ss_pred cccccchhh-cCCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccc
Confidence 455555555 222 12256777888999999998 89999999999999999999998 89999999999999999999
Q ss_pred CccCCCCcccccCCCCceeeeecCCCCCCcccccccCCCCcEEeccCccccCccCcCCcCCCCCcEEccccccccCcCCC
Q 002349 151 QLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPF 230 (933)
Q Consensus 151 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~ 230 (933)
+++ .+|..++.|+ |+.|-+++|+++ .+|+.++.+..|.+||.+.|++. .+|..++.+.+|+.|.+..|++. .+|.
T Consensus 132 qlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~ 206 (722)
T KOG0532|consen 132 QLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPE 206 (722)
T ss_pred hhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCH
Confidence 998 6788888774 899999999997 78888888899999999999998 68888999999999999999887 4555
Q ss_pred CccccccceEeccccccccccCccccccccccEEeccCCcCc
Q 002349 231 NIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLS 272 (933)
Q Consensus 231 ~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 272 (933)
.+..+.|..||++.|+++ .+|-.|.+|+.|++|-|.+|.|.
T Consensus 207 El~~LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 207 ELCSLPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred HHhCCceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC
Confidence 554555555666666555 45555555555555555555554
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.47 E-value=3.3e-15 Score=161.40 Aligned_cols=173 Identities=28% Similarity=0.504 Sum_probs=85.8
Q ss_pred EeeeccccccccCCccccccccccccccccccCCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccceecCCccc
Q 002349 311 YLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNN 390 (933)
Q Consensus 311 ~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 390 (933)
..||+.|++. .+|..+..+..|+.+.|..|.+. .+|..++++..|+.|+|+.|+++ ..|..++.++ |+.|.+++|+
T Consensus 79 ~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNk 154 (722)
T KOG0532|consen 79 FADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNK 154 (722)
T ss_pred hhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCc
Confidence 3344444444 34444444444444444444444 34444444444444444444444 3344444333 4445555555
Q ss_pred ccCCCccccccccccceeeccCCccCCCCCCCCCCccccccccccCcccccccccccccccccceEEccCCccccccchh
Q 002349 391 IRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEE 470 (933)
Q Consensus 391 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 470 (933)
++ .+|..++.+..|..||.+.|.+. .+|..++++.+|+.|++..|++. ..|..+..| .|..||+|+|+++ .+|-.
T Consensus 155 l~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~iPv~ 229 (722)
T KOG0532|consen 155 LT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-YLPVD 229 (722)
T ss_pred cc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-ecchh
Confidence 54 44444445555555555555555 45555555555555555555555 334444422 3555555555555 45555
Q ss_pred hccccccceeeecCCCCcCccc
Q 002349 471 LSQLQNMFSLRLDYNNLSGDVM 492 (933)
Q Consensus 471 ~~~l~~L~~L~l~~N~l~~~~~ 492 (933)
|.+|..|++|-|.+|+|+..+.
T Consensus 230 fr~m~~Lq~l~LenNPLqSPPA 251 (722)
T KOG0532|consen 230 FRKMRHLQVLQLENNPLQSPPA 251 (722)
T ss_pred hhhhhhheeeeeccCCCCCChH
Confidence 5555555555555555555443
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.42 E-value=7.5e-13 Score=149.96 Aligned_cols=140 Identities=21% Similarity=0.236 Sum_probs=100.6
Q ss_pred ceeeecccceeEEEEEEcCCceEEEEEecccCchhH----------------------------------------HHHH
Q 002349 603 KYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCL----------------------------------------KEFE 642 (933)
Q Consensus 603 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~ 642 (933)
.+.||+|++|.||+|+.++|+.||||+.++...... -+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 368999999999999999999999999866431100 0245
Q ss_pred HHHHHHhcCC-----CCceeeeeeEE-ecCCccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHH-HHHHhhc
Q 002349 643 TELETVGSIK-----HRNLVSLQGYS-LSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQ-GLAYLHH 715 (933)
Q Consensus 643 ~E~~~l~~l~-----h~niv~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~-~l~~LH~ 715 (933)
+|++.+.+++ +++| .+-.++ ...+..++||||++|++|.+.... ..... .+.+++..++. .+..+|+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~--~~~~~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAAL--DEAGL---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHH--HhcCC---CHHHHHHHHHHHHHHHHHh
Confidence 5666666662 3443 333333 334567999999999999887642 11122 23456666655 4677885
Q ss_pred CCCCCeeeccCCCCceEeCCCCCeEEeecccccccc
Q 002349 716 DCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLC 751 (933)
Q Consensus 716 ~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 751 (933)
. |++|+|+||.||+++.+++++++|||++..+.
T Consensus 276 ~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 276 D---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred C---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 5 99999999999999999999999999997653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.38 E-value=5.7e-13 Score=151.31 Aligned_cols=150 Identities=34% Similarity=0.536 Sum_probs=62.6
Q ss_pred cccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcceEeeeccccccccCCccccccccccccccc
Q 002349 260 ALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVA 339 (933)
Q Consensus 260 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~ 339 (933)
+|+.|++++|.+. .+|..++++++|+.|++++|+++ .+|...+..++|+.|++++|+++ .+|.....+..|++|.++
T Consensus 141 nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~ 217 (394)
T COG4886 141 NLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLS 217 (394)
T ss_pred hcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhc
Confidence 4444444444444 22233444444444444444444 23333334444444444444444 333333333334444444
Q ss_pred cccCCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCCccccccccccceeeccCCccC
Q 002349 340 NNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKIS 416 (933)
Q Consensus 340 ~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 416 (933)
+|++. ..+..+..+.++..+.+.+|++. ..+..+..++++++|++++|.++.... +..+.+++.|++++|.+.
T Consensus 218 ~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~ 290 (394)
T COG4886 218 NNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLS 290 (394)
T ss_pred CCcce-ecchhhhhcccccccccCCceee-eccchhccccccceecccccccccccc--ccccCccCEEeccCcccc
Confidence 44322 23333444444444444444443 123333444444444444444442211 344444444444444444
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.38 E-value=4.2e-13 Score=152.40 Aligned_cols=82 Identities=34% Similarity=0.567 Sum_probs=35.3
Q ss_pred ccEEEeeCCccCCCCCCccccCCcceEeeeccccccccCCccccccccccccccccccCCCCCCCCcccCCCCCceeccC
Q 002349 285 TEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHG 364 (933)
Q Consensus 285 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~ 364 (933)
|++|++++|.+. ..+..+.++.++..|.+.+|++. ..+..++.+++++.|++++|.++...+ +..+.+|+.|++++
T Consensus 211 L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~ 286 (394)
T COG4886 211 LEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSG 286 (394)
T ss_pred hhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccchhccccccceecccccccccccc--ccccCccCEEeccC
Confidence 444444444322 23334444444444444444444 223344444444444444444442211 44444444555554
Q ss_pred cccCCC
Q 002349 365 NKLNGT 370 (933)
Q Consensus 365 N~l~~~ 370 (933)
|.+...
T Consensus 287 n~~~~~ 292 (394)
T COG4886 287 NSLSNA 292 (394)
T ss_pred cccccc
Confidence 444433
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.31 E-value=2.4e-12 Score=142.93 Aligned_cols=245 Identities=22% Similarity=0.185 Sum_probs=179.5
Q ss_pred ccCcceeeec--ccceeEEEEEE--c-CCceEEEEEeccc--CchhHHHHHHHHHHHhcC-CCCceeeeeeEEecCCccE
Q 002349 599 NLSEKYIIGY--GASSTVYKCVL--K-NCKPVAIKRLYSH--YPQCLKEFETELETVGSI-KHRNLVSLQGYSLSSSGNL 670 (933)
Q Consensus 599 ~~~~~~~lG~--G~~g~Vy~~~~--~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 670 (933)
.+.....+|. |.+|.||.+.. . ++..+|+|+-+.. .+.....=.+|+....++ .|+|.++.+..+...+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4455667999 99999999986 2 4677899874332 223333345677777777 4999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHH----HHHHhhcCCCCCeeeccCCCCceEeCCC-CCeEEeecc
Q 002349 671 LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQ----GLAYLHHDCSPRIIHRDVKSSNILLDKD-FEAHLTDFG 745 (933)
Q Consensus 671 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~----~l~~LH~~~~~~ivH~Dikp~NIll~~~-~~~kl~DfG 745 (933)
+-.|++. .++.++.+. ....++....+.+..+... |+.++| +.+++|-|+||.||+...+ ...+++|||
T Consensus 195 iqtE~~~-~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeecccc-chhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCcc
Confidence 9999995 688888863 3344777888888888888 999999 4599999999999999999 889999999
Q ss_pred cccccccCCCce----eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCC--cchhHHHHhhhcccc
Q 002349 746 IAKSLCVSKSYT----STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNE--CNLHHLILSKTANNA 819 (933)
Q Consensus 746 la~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~--~~~~~~~~~~~~~~~ 819 (933)
+...+....... .....|...|++||..++. ++.+.|+|++|.++.+..++......+ ....+... ..
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~-----~~ 342 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ-----GY 342 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc-----cc
Confidence 998775443211 1223678899999988765 788999999999999999988766533 11111100 00
Q ss_pred cccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002349 820 VMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSR 864 (933)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 864 (933)
+..++.. ....++...+..+++.+|-.|++.+.+..
T Consensus 343 ----ip~e~~~-----~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 343 ----IPLEFCE-----GGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ----Cchhhhc-----CcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 1111111 11244555788999999999999887764
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.1e-12 Score=131.08 Aligned_cols=204 Identities=20% Similarity=0.261 Sum_probs=140.7
Q ss_pred HHHhcCCCCceeeeeeEEecCC-----ccEEEEEecCCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 002349 646 ETVGSIKHRNLVSLQGYSLSSS-----GNLLFYDFMENGSLWDILHGPT-KKKKLDWDTRLKIALGAAQGLAYLHHDCSP 719 (933)
Q Consensus 646 ~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~ 719 (933)
.-+-++.|.|||+++.|+.+.+ ...++.|||..|++..+|++.+ ....+....-.+++.||..||.|||.- .+
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence 3445557999999999987643 4678999999999999997533 334677788889999999999999975 89
Q ss_pred CeeeccCCCCceEeCCCCCeEEeeccccccc---ccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh
Q 002349 720 RIIHRDVKSSNILLDKDFEAHLTDFGIAKSL---CVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT 796 (933)
Q Consensus 720 ~ivH~Dikp~NIll~~~~~~kl~DfGla~~~---~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt 796 (933)
.|+|+++..+-|++..+|-+|+.--.-.... ............+-++|.+||.-.....+.++|||+||+...||..
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 9999999999999999999998532111000 0001111112346789999998888888899999999999999988
Q ss_pred CCCCC-CCCcchhHHHHhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 797 GRKAV-DNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 797 g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
+..-- ..+....... .....+..... ..=+.++..|++..|..||+|.+++.+.
T Consensus 278 lEiq~tnseS~~~~ee-----------~ia~~i~~len-----~lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEE-----------NIANVIIGLEN-----GLQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred heeccCCCcceeehhh-----------hhhhheeeccC-----ccccCcCcccccCCCCCCcchhhhhcCc
Confidence 76432 1111111000 00000000000 0112358899999999999999987643
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.27 E-value=3e-11 Score=138.14 Aligned_cols=143 Identities=15% Similarity=0.129 Sum_probs=96.8
Q ss_pred hhccCcceeeecccceeEEEEEEcC-CceEEEEEecccCch------------------------------h----H---
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHYPQ------------------------------C----L--- 638 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~------------------------------~----~--- 638 (933)
...|+. +.||+|++|.||+|++++ |+.||||+.++...+ . .
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345666 789999999999999987 999999999754211 0 0
Q ss_pred ---HHHHHHHHHHhcCC----CCceeeeeeEEec-CCccEEEEEecCCCCHHHHhcCCCCCC----CCCHHHHHHHHHHH
Q 002349 639 ---KEFETELETVGSIK----HRNLVSLQGYSLS-SSGNLLFYDFMENGSLWDILHGPTKKK----KLDWDTRLKIALGA 706 (933)
Q Consensus 639 ---~~~~~E~~~l~~l~----h~niv~~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~----~l~~~~~~~i~~~i 706 (933)
-++.+|+..+.+++ +...+.+-.++.+ ....++||||++|+.+.++-.- ...+ .+....+..++.|+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l-~~~g~d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAAL-RAAGTDMKLLAERGVEVFFTQV 276 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHH-HhcCCCHHHHHHHHHHHHHHHH
Confidence 12445665555552 4444444444433 4567899999999999874210 1111 23333333344444
Q ss_pred HHHHHHhhcCCCCCeeeccCCCCceEeCCCC----CeEEeecccccccc
Q 002349 707 AQGLAYLHHDCSPRIIHRDVKSSNILLDKDF----EAHLTDFGIAKSLC 751 (933)
Q Consensus 707 ~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~----~~kl~DfGla~~~~ 751 (933)
.. | |++|+|+||.||+++.++ ++++.|||++..+.
T Consensus 277 f~-----~-----GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 FR-----D-----GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred Hh-----C-----CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 32 2 999999999999999888 99999999998764
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.22 E-value=2.5e-12 Score=128.68 Aligned_cols=134 Identities=26% Similarity=0.364 Sum_probs=107.4
Q ss_pred cCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCCccccccccccceeeccCCccCCCCCCCCCCccccccc
Q 002349 353 SCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKL 432 (933)
Q Consensus 353 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 432 (933)
-...|+.+|||+|.|+ .+.+...-+|.++.|++|+|.+... ..+..+.+|+.||||+|.++ .+-.+--.+-+++.|
T Consensus 282 TWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL 357 (490)
T KOG1259|consen 282 TWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTL 357 (490)
T ss_pred hHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeee
Confidence 3456888888888888 5666777788889999999988743 33778889999999999888 555666677888999
Q ss_pred cccCcccccccccccccccccceEEccCCccccccc-hhhccccccceeeecCCCCcCccc
Q 002349 433 NLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIP-EELSQLQNMFSLRLDYNNLSGDVM 492 (933)
Q Consensus 433 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~~ 492 (933)
.|++|.|... ..+..+-+|..||+++|+|..... ..+++||-|+.+.|.+|++.+.+.
T Consensus 358 ~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd 416 (490)
T KOG1259|consen 358 KLAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD 416 (490)
T ss_pred ehhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence 9999988843 356778889999999999986543 678899999999999999998764
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.21 E-value=3.9e-11 Score=118.93 Aligned_cols=131 Identities=20% Similarity=0.132 Sum_probs=96.0
Q ss_pred ceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCcee-eeeeEEecCCccEEEEEecCCCCH
Q 002349 603 KYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLV-SLQGYSLSSSGNLLFYDFMENGSL 681 (933)
Q Consensus 603 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~gsL 681 (933)
.+.++.|.++.||++... ++.|++|....... ....+.+|+++++.+.+.+++ +++.+. ....++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 357899999999999876 57899998765432 233567899999988655544 444443 3345899999999876
Q ss_pred HHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC--CCCeeeccCCCCceEeCCCCCeEEeecccccc
Q 002349 682 WDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDC--SPRIIHRDVKSSNILLDKDFEAHLTDFGIAKS 749 (933)
Q Consensus 682 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 749 (933)
.+.- .....++.+++++++.||+.. ..+++|+|++|.||+++ ++.++++|||.+..
T Consensus 79 ~~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 5420 111345678999999999651 12369999999999999 66899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.2e-10 Score=113.64 Aligned_cols=135 Identities=16% Similarity=0.137 Sum_probs=98.4
Q ss_pred eeeecccceeEEEEEEcC-------CceEEEEEecccCc----------------------hhHHHH----HHHHHHHhc
Q 002349 604 YIIGYGASSTVYKCVLKN-------CKPVAIKRLYSHYP----------------------QCLKEF----ETELETVGS 650 (933)
Q Consensus 604 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~----------------------~~~~~~----~~E~~~l~~ 650 (933)
..||.|.-+.||.|...+ +..+|||+.+.... ...+.+ ++|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 469999999999998543 47899998753210 012223 389999999
Q ss_pred CCC--CceeeeeeEEecCCccEEEEEecCCCCHHH-HhcCCCCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCCeeeccC
Q 002349 651 IKH--RNLVSLQGYSLSSSGNLLFYDFMENGSLWD-ILHGPTKKKKLDWDTRLKIALGAAQGLAYL-HHDCSPRIIHRDV 726 (933)
Q Consensus 651 l~h--~niv~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~Di 726 (933)
+.. -++.+++++ ...++||||+.++.+.. .+. ...++.++...+..+++.++.++ |+. ++||||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence 853 455566654 56789999997654422 221 22345566778889999999999 754 9999999
Q ss_pred CCCceEeCCCCCeEEeeccccccc
Q 002349 727 KSSNILLDKDFEAHLTDFGIAKSL 750 (933)
Q Consensus 727 kp~NIll~~~~~~kl~DfGla~~~ 750 (933)
++.||+++ ++.++++|||.|...
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeC
Confidence 99999997 468999999988754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.17 E-value=5.8e-12 Score=143.17 Aligned_cols=174 Identities=29% Similarity=0.350 Sum_probs=103.4
Q ss_pred ccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcceEeeeccccccccCC-ccccccccc
Q 002349 255 IGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIP-PALGKLTDL 333 (933)
Q Consensus 255 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~-~~l~~l~~L 333 (933)
+..+++|++|+|++|.|+.+. .+..++.|+.|++.+|.|+.. ..+..+++|+.+++++|++....+ . ...+.++
T Consensus 114 l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l 188 (414)
T KOG0531|consen 114 LSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISL 188 (414)
T ss_pred hhhhhcchheecccccccccc--chhhccchhhheeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccch
Confidence 445566666666666665432 244555577777777777632 345557777777777777775433 2 4667777
Q ss_pred cccccccccCCCCCCCCcccCCCCCceeccCcccCCCCCccccccc--ccceecCCcccccCCCccccccccccceeecc
Q 002349 334 FDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLE--SMTYLNLSLNNIRGPIPVELSRIGNLDTLDMS 411 (933)
Q Consensus 334 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~--~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 411 (933)
+.+++.+|.+. ....+..+..+..+++..|+++..-+ +..+. .|+.+++++|.+. ..+..+..+.++..|++.
T Consensus 189 ~~l~l~~n~i~--~i~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~ 263 (414)
T KOG0531|consen 189 EELDLGGNSIR--EIEGLDLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLS 263 (414)
T ss_pred HHHhccCCchh--cccchHHHHHHHHhhcccccceeccC--cccchhHHHHHHhcccCccc-cccccccccccccccchh
Confidence 77777777775 22345555566666777777763222 11122 2667777777776 333455566667777777
Q ss_pred CCccCCCCCCCCCCccccccccccCcccc
Q 002349 412 NNKISGSIPSPLGDLEHLLKLNLSRNQLT 440 (933)
Q Consensus 412 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 440 (933)
+|++... ..+.....+..+.++.|.+.
T Consensus 264 ~n~~~~~--~~~~~~~~~~~~~~~~~~~~ 290 (414)
T KOG0531|consen 264 SNRISNL--EGLERLPKLSELWLNDNKLA 290 (414)
T ss_pred hcccccc--ccccccchHHHhccCcchhc
Confidence 7766532 23444455566666666655
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.4e-10 Score=127.94 Aligned_cols=166 Identities=15% Similarity=0.200 Sum_probs=126.7
Q ss_pred EcCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecCCCCHHHHhcCCCCCCCCCHHH
Q 002349 619 LKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDT 698 (933)
Q Consensus 619 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~ 698 (933)
..++.+|.|+..+...........+-++.++.+|||||+++++.+...+..|+|+|-+. -|..++.. +....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHH
Confidence 34577888888877665556667888999999999999999999999999999999884 46667642 23566
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCceeeeecccccccCccccccCCC
Q 002349 699 RLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRL 778 (933)
Q Consensus 699 ~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 778 (933)
+..-+.||+.||.+||+. .+++|++|..+.|+|+..|..||++|-++........ ......---.|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc-
Confidence 777889999999999975 4999999999999999999999999988755322111 111111122456666544332
Q ss_pred CcchhhHHHHHHHHHHHhC
Q 002349 779 TEKSDVYSFGIVLLELLTG 797 (933)
Q Consensus 779 ~~~~DvwSlGv~l~elltg 797 (933)
-..|.|.||++++|++.|
T Consensus 182 -~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred -cchhhhhHHHHHHHHhCc
Confidence 246999999999999999
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.5e-12 Score=133.91 Aligned_cols=233 Identities=26% Similarity=0.300 Sum_probs=162.2
Q ss_pred cccccccEEeccCCcCcCC----CCCCCCCCCCccEEEeeCC---ccCCCCCC-------ccccCCcceEeeeccccccc
Q 002349 256 GLMQALAVLDLSCNMLSGP----IPPILGNLSYTEKLYLHSN---KLTGHIPP-------ELGNMTKLHYLELNDNQLTG 321 (933)
Q Consensus 256 ~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N---~l~~~~p~-------~l~~l~~L~~L~L~~N~l~~ 321 (933)
..+.+++.|+||+|.+... +...+.+.++|+..++++= ++...+|+ ++...++|++|+||+|-+..
T Consensus 27 ~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~ 106 (382)
T KOG1909|consen 27 EPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGP 106 (382)
T ss_pred cccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCc
Confidence 3445566666666666432 3334455556666665541 22223333 34455688888888888875
Q ss_pred cCCcc----ccccccccccccccccCCCCC-------------CCCcccCCCCCceeccCcccCCCC----Ccccccccc
Q 002349 322 HIPPA----LGKLTDLFDLNVANNHLEGPI-------------PDNLSSCTNLNSLNVHGNKLNGTI----PPAFQRLES 380 (933)
Q Consensus 322 ~~~~~----l~~l~~L~~L~L~~N~l~~~~-------------p~~l~~l~~L~~L~l~~N~l~~~~----~~~~~~l~~ 380 (933)
..+.. +...+.|++|.|.+|.+...- .....+-++|+++..++|++.... ...|...+.
T Consensus 107 ~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~ 186 (382)
T KOG1909|consen 107 KGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHPT 186 (382)
T ss_pred cchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhccc
Confidence 44443 345678888899888876321 123445678999999999987432 245777789
Q ss_pred cceecCCcccccCC----CccccccccccceeeccCCccCCC----CCCCCCCccccccccccCccccccccccc-----
Q 002349 381 MTYLNLSLNNIRGP----IPVELSRIGNLDTLDMSNNKISGS----IPSPLGDLEHLLKLNLSRNQLTGFIPGEF----- 447 (933)
Q Consensus 381 L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~----- 447 (933)
|+.+.+++|.|... ....+..++.|+.|||.+|.++.. +...+..+++|+.|++++|.+...-..+|
T Consensus 187 leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~ 266 (382)
T KOG1909|consen 187 LEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALK 266 (382)
T ss_pred cceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHHh
Confidence 99999999998632 234567899999999999998743 34567778899999999999985433332
Q ss_pred ccccccceEEccCCcccc----ccchhhccccccceeeecCCCCc
Q 002349 448 GNLRSVMEIDLSHNHLTG----VIPEELSQLQNMFSLRLDYNNLS 488 (933)
Q Consensus 448 ~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~ 488 (933)
...++|+.|.|.+|.++. .+...+...+.|..|+|++|.+.
T Consensus 267 ~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 267 ESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred ccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 336899999999999874 34455667899999999999984
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.3e-11 Score=130.37 Aligned_cols=187 Identities=22% Similarity=0.241 Sum_probs=119.0
Q ss_pred cccCCcceEeeeccccccccC--CccccccccccccccccccCCCCCCCCc-ccCCCCCceeccCcccCCCC-Ccccccc
Q 002349 303 LGNMTKLHYLELNDNQLTGHI--PPALGKLTDLFDLNVANNHLEGPIPDNL-SSCTNLNSLNVHGNKLNGTI-PPAFQRL 378 (933)
Q Consensus 303 l~~l~~L~~L~L~~N~l~~~~--~~~l~~l~~L~~L~L~~N~l~~~~p~~l-~~l~~L~~L~l~~N~l~~~~-~~~~~~l 378 (933)
...+++++.|||+.|-+.... .....++++|+.|+|+.|++........ ..++.|+.|.|+.|.++... ......+
T Consensus 142 ~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~f 221 (505)
T KOG3207|consen 142 SKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTF 221 (505)
T ss_pred hhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhC
Confidence 344555666666666555321 1234456777777777777653222221 24567888888888887322 2234567
Q ss_pred cccceecCCcccccCCCccccccccccceeeccCCccCCCC-CCCCCCccccccccccCccccccc-ccc-----ccccc
Q 002349 379 ESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSI-PSPLGDLEHLLKLNLSRNQLTGFI-PGE-----FGNLR 451 (933)
Q Consensus 379 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~-p~~-----~~~l~ 451 (933)
|+|+.|+|..|............+..|+.|||++|++.... -...+.++.|..|+++.+.++.+- |+. -..++
T Consensus 222 Psl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~ 301 (505)
T KOG3207|consen 222 PSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFP 301 (505)
T ss_pred CcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhccccCcchhcCCCccchhhhcccc
Confidence 88888999888643344444556778899999998886322 145677888999999999888543 222 35677
Q ss_pred ccceEEccCCcccccc-chhhccccccceeeecCCCCcC
Q 002349 452 SVMEIDLSHNHLTGVI-PEELSQLQNMFSLRLDYNNLSG 489 (933)
Q Consensus 452 ~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~ 489 (933)
+|++|+++.|++...- -..+..+++|+.|....|.|+.
T Consensus 302 kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~ 340 (505)
T KOG3207|consen 302 KLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNK 340 (505)
T ss_pred cceeeecccCccccccccchhhccchhhhhhcccccccc
Confidence 8889999999886321 1345556677777777776654
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=2.2e-12 Score=132.64 Aligned_cols=247 Identities=24% Similarity=0.275 Sum_probs=133.2
Q ss_pred CcEEEEEcCCCCcCc----ccCCCCCCCCCccEEEccCC---cccccCCC-------CccCCCCCceecccccccCCCCC
Q 002349 68 FTVIALNLSGLNLDG----EISPAVGDLKDLQSIDLRGN---RLSGQIPD-------EIGDCSSLKSLDLSFNELYGDIP 133 (933)
Q Consensus 68 ~~v~~l~l~~~~l~~----~~~~~l~~l~~L~~L~Ls~n---~l~~~~p~-------~l~~l~~L~~L~Ls~n~l~~~~p 133 (933)
..++.++|+||.+.- .+.+.+.+.++|+..++|+- ++...+|+ .+..+++|++||||+|-|.-..+
T Consensus 30 ~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g~ 109 (382)
T KOG1909|consen 30 DSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKGI 109 (382)
T ss_pred CceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccch
Confidence 357899999998864 35567778889999999863 22224554 34567799999999999875555
Q ss_pred ccc----ccccchhhhhhcccCccCCCCcccccCCCCceeeeecCCCCCCcccccccCCCCcEEeccCccccCc----cC
Q 002349 134 FSI----SKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGS----IP 205 (933)
Q Consensus 134 ~~~----~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~----~p 205 (933)
..| .++..|++|+|.+|.+.-.--..+++ .|..|. .|+ ....-++|+.+...+|++... +.
T Consensus 110 ~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~--~~k-------k~~~~~~Lrv~i~~rNrlen~ga~~~A 178 (382)
T KOG1909|consen 110 RGLEELLSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELA--VNK-------KAASKPKLRVFICGRNRLENGGATALA 178 (382)
T ss_pred HHHHHHHHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHH--HHh-------ccCCCcceEEEEeeccccccccHHHHH
Confidence 554 45688999999998875211111111 111111 111 112223445555555544321 12
Q ss_pred cCCcCCCCCcEEccccccccCcCCCCccccccceEeccccccccccCccccccccccEEeccCCcCcCC----CCCCCCC
Q 002349 206 QNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGP----IPPILGN 281 (933)
Q Consensus 206 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~ 281 (933)
..|...+.|+.+.++.|.+...--. .+...+..+++|++|||.+|.++.. +...+..
T Consensus 179 ~~~~~~~~leevr~~qN~I~~eG~~-------------------al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s 239 (382)
T KOG1909|consen 179 EAFQSHPTLEEVRLSQNGIRPEGVT-------------------ALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSS 239 (382)
T ss_pred HHHHhccccceEEEecccccCchhH-------------------HHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcc
Confidence 2334445555555555554311000 1122334444555555555544321 2233444
Q ss_pred CCCccEEEeeCCccCCCCCCcc-----ccCCcceEeeeccccccc----cCCccccccccccccccccccCC
Q 002349 282 LSYTEKLYLHSNKLTGHIPPEL-----GNMTKLHYLELNDNQLTG----HIPPALGKLTDLFDLNVANNHLE 344 (933)
Q Consensus 282 l~~L~~L~L~~N~l~~~~p~~l-----~~l~~L~~L~L~~N~l~~----~~~~~l~~l~~L~~L~L~~N~l~ 344 (933)
+++|+.|++++|.++..-..+| ...++|+.|.|.+|.|+. .+..++...+.|..|+|++|.+.
T Consensus 240 ~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 240 WPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred cchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 4555555555555543222221 224667777777777762 12233445677777777777773
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.1e-11 Score=140.86 Aligned_cols=247 Identities=26% Similarity=0.342 Sum_probs=133.3
Q ss_pred CCCCccEEEccCCcccccCCCCccCCCCCceecccccccCCCCCcccccccchhhhhhcccCccCCCCcccccCCCCcee
Q 002349 90 DLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVF 169 (933)
Q Consensus 90 ~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L 169 (933)
.+..++.+++..|.+. .+-..++.+++|..|+|.+|.|. .+...+..+.+|++|+|++|.|+.. ..+..++.|+.|
T Consensus 70 ~l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L 145 (414)
T KOG0531|consen 70 SLTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKEL 145 (414)
T ss_pred HhHhHHhhccchhhhh-hhhcccccccceeeeeccccchh-hcccchhhhhcchheeccccccccc--cchhhccchhhh
Confidence 3445555556666555 22334555666666666666665 2332255556666666666666543 234455556666
Q ss_pred eeecCCCCCCcccccccCCCCcEEeccCccccCccC-cCCcCCCCCcEEccccccccCcCCCCccccccceEeccccccc
Q 002349 170 GLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIP-QNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLT 248 (933)
Q Consensus 170 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~l~ 248 (933)
++++|.|+.. ..+..+.+|+.+++++|+++..-+ . +..+.+|+.+++.+|.+.
T Consensus 146 ~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~----------------------- 199 (414)
T KOG0531|consen 146 NLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIR----------------------- 199 (414)
T ss_pred eeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchh-----------------------
Confidence 6666665422 333335555555555555553222 1 344445555555555443
Q ss_pred cccCccccccccccEEeccCCcCcCCCCCCCCCCC--CccEEEeeCCccCCCCCCccccCCcceEeeeccccccccCCcc
Q 002349 249 GKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLS--YTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPA 326 (933)
Q Consensus 249 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~--~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~ 326 (933)
....+..+..+..+++..|.++..-+ +..+. +|+.+++.+|.+. ..+..+..+.++..|++.+|++... ..
T Consensus 200 --~i~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~ 272 (414)
T KOG0531|consen 200 --EIEGLDLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL--EG 272 (414)
T ss_pred --cccchHHHHHHHHhhcccccceeccC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccc--cc
Confidence 11223333444555666666653221 11122 3677777777776 3335566677777788887777743 23
Q ss_pred ccccccccccccccccCCCC---CCCC-cccCCCCCceeccCcccCCCCCc
Q 002349 327 LGKLTDLFDLNVANNHLEGP---IPDN-LSSCTNLNSLNVHGNKLNGTIPP 373 (933)
Q Consensus 327 l~~l~~L~~L~L~~N~l~~~---~p~~-l~~l~~L~~L~l~~N~l~~~~~~ 373 (933)
+.....+..+....|.+... .... .....+++.+.+..|.+....+.
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (414)
T KOG0531|consen 273 LERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISSL 323 (414)
T ss_pred ccccchHHHhccCcchhcchhhhhccccccccccccccccccCcccccccc
Confidence 44556667777777776521 1111 45667788888888887755443
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.08 E-value=2e-11 Score=122.22 Aligned_cols=133 Identities=24% Similarity=0.285 Sum_probs=89.4
Q ss_pred CCCCCCccEEEeeCCccCCCCCCccccCCcceEeeeccccccccCCccccccccccccccccccCCCCCCCCcccCCCCC
Q 002349 279 LGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLN 358 (933)
Q Consensus 279 ~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~ 358 (933)
......|++|+|++|.|+ .+.++..-+++++.|++++|.|... +.+..+++|+.|||++|.++ .+-.|=.++-|++
T Consensus 280 ~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIK 355 (490)
T KOG1259|consen 280 ADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIK 355 (490)
T ss_pred cchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEe
Confidence 334455666666666666 5566666667777777777777633 23666777777777777766 3444555666777
Q ss_pred ceeccCcccCCCCCcccccccccceecCCcccccCCC-ccccccccccceeeccCCccCC
Q 002349 359 SLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPI-PVELSRIGNLDTLDMSNNKISG 417 (933)
Q Consensus 359 ~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~ 417 (933)
.|.|++|.|.. -..++.+.+|.+||+++|+|.... -..+++++-|+.|.|.+|.|.+
T Consensus 356 tL~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~ 413 (490)
T KOG1259|consen 356 TLKLAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG 413 (490)
T ss_pred eeehhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence 77777777752 234666777888888888876432 2457788888888888888874
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.1e-09 Score=113.89 Aligned_cols=142 Identities=17% Similarity=0.199 Sum_probs=111.1
Q ss_pred eeeecccceeEEEEEEcCCceEEEEEecccCc-hhHHHHHHHHHHHhcCCCC--ceeeeeeEEecCC---ccEEEEEecC
Q 002349 604 YIIGYGASSTVYKCVLKNCKPVAIKRLYSHYP-QCLKEFETELETVGSIKHR--NLVSLQGYSLSSS---GNLLFYDFME 677 (933)
Q Consensus 604 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~~~---~~~lv~e~~~ 677 (933)
+.||.|.++.||++...+|+.+++|....... .....+.+|+++++.+++. .+.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999987778899998765432 2356789999999999763 4566777765542 5689999999
Q ss_pred CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC----------------------------------------
Q 002349 678 NGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDC---------------------------------------- 717 (933)
Q Consensus 678 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---------------------------------------- 717 (933)
|.++.+.+. ...++..+...++.++++++.+||+..
T Consensus 84 G~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLL----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCC----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 988877652 145778888889999999999998521
Q ss_pred -------------CCCeeeccCCCCceEeCC--CCCeEEeecccccc
Q 002349 718 -------------SPRIIHRDVKSSNILLDK--DFEAHLTDFGIAKS 749 (933)
Q Consensus 718 -------------~~~ivH~Dikp~NIll~~--~~~~kl~DfGla~~ 749 (933)
...++|+|+++.||+++. ++.+.++||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 56689999998754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=2e-10 Score=138.96 Aligned_cols=105 Identities=24% Similarity=0.305 Sum_probs=64.5
Q ss_pred CccEEEccCCc--ccccCCCCccCCCCCceecccccccCCCCCcccccccchhhhhhcccCccCCCCcccccCCCCceee
Q 002349 93 DLQSIDLRGNR--LSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFG 170 (933)
Q Consensus 93 ~L~~L~Ls~n~--l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ 170 (933)
.|++|-+..|. +....++.|..++.|++||||+|.=-+.+|.+++.|.+|++|+|+...++ .+|..+++|..|.+|+
T Consensus 546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Ln 624 (889)
T KOG4658|consen 546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLN 624 (889)
T ss_pred ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheec
Confidence 46666666664 33222234556666666666666555566666666666666666666666 5666666666666666
Q ss_pred eecCCCCCCcccccccCCCCcEEeccCc
Q 002349 171 LRGNNLVGTLSPDMCQLSGLWYFDVRNN 198 (933)
Q Consensus 171 L~~N~l~~~~~~~~~~l~~L~~L~L~~n 198 (933)
+..+.-...+|..+..+++|++|.+..-
T Consensus 625 l~~~~~l~~~~~i~~~L~~Lr~L~l~~s 652 (889)
T KOG4658|consen 625 LEVTGRLESIPGILLELQSLRVLRLPRS 652 (889)
T ss_pred cccccccccccchhhhcccccEEEeecc
Confidence 6666555455555555666666666443
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.3e-10 Score=129.26 Aligned_cols=249 Identities=21% Similarity=0.188 Sum_probs=176.6
Q ss_pred HHHHhhccCcceeeecccceeEEEEEEc--CCceEEEEEecccCchhHHH--HHHHHHHHhcC-CCCceeeeeeEEecCC
Q 002349 593 IMRMTENLSEKYIIGYGASSTVYKCVLK--NCKPVAIKRLYSHYPQCLKE--FETELETVGSI-KHRNLVSLQGYSLSSS 667 (933)
Q Consensus 593 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~h~niv~~~~~~~~~~ 667 (933)
....+.+|.....||.|.|+.||+...+ ++..+++|...........+ -..|+.+...+ .|.+++.....|..-+
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 4455678999999999999999998744 46788999876654332222 24566666666 5889998888888888
Q ss_pred ccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCC-CCeEEeeccc
Q 002349 668 GNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKD-FEAHLTDFGI 746 (933)
Q Consensus 668 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~-~~~kl~DfGl 746 (933)
+.++--|||+++++.... .....+++..++++..|++.++.++| ++.++|+|+||+||++..+ +..++.|||.
T Consensus 340 ~~~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~ 413 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGC 413 (524)
T ss_pred cccCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhcccccc
Confidence 888889999999887766 33456788889999999999999999 5599999999999999886 7789999999
Q ss_pred ccccccCCCceeeeeccccccc--CccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccccccccc
Q 002349 747 AKSLCVSKSYTSTYIMGTIGYI--DPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETV 824 (933)
Q Consensus 747 a~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 824 (933)
++.+.... ....+.-+++ +|+......+..++|++|||..+.+.++|..--........ +....
T Consensus 414 ~t~~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~----------i~~~~ 479 (524)
T KOG0601|consen 414 WTRLAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLT----------IRSGD 479 (524)
T ss_pred ccccceec----ccccccccccccchhhccccccccccccccccccccccccCcccCccccccee----------eeccc
Confidence 87532111 1112233444 55555667788999999999999999998753332211111 11111
Q ss_pred CccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 002349 825 DPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLG 867 (933)
Q Consensus 825 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 867 (933)
-+..+. ....+..+...+...++..||.+.+...+.+
T Consensus 480 ~p~~~~------~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 480 TPNLPG------LKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred ccCCCc------hHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 111111 1134555667788899999999988766543
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.01 E-value=5.2e-11 Score=125.80 Aligned_cols=183 Identities=23% Similarity=0.261 Sum_probs=83.4
Q ss_pred ccCCCCcEEeccCccccCc--cCcCCcCCCCCcEEccccccccCcCCCCc--cccccceEeccccccccc-cCccccccc
Q 002349 185 CQLSGLWYFDVRNNSLTGS--IPQNIGNCTSFQVLDLSYNQLSGEIPFNI--GFLQIATLSLQGNQLTGK-IPSVIGLMQ 259 (933)
Q Consensus 185 ~~l~~L~~L~L~~n~l~~~--~p~~l~~l~~L~~L~L~~N~l~~~~p~~~--~~~~L~~L~L~~n~l~~~-~p~~~~~l~ 259 (933)
..+++++.|||++|-+... +-.....|++|+.|+|+.|++........ ...+++.|.|+.|.++.. +-.....++
T Consensus 143 k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fP 222 (505)
T KOG3207|consen 143 KILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFP 222 (505)
T ss_pred hhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCC
Confidence 3445555555555544422 22334566777777777777653222211 122444555555554421 111222344
Q ss_pred cccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcceEeeeccccccccCC--ccccccccccccc
Q 002349 260 ALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIP--PALGKLTDLFDLN 337 (933)
Q Consensus 260 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~--~~l~~l~~L~~L~ 337 (933)
+|..|+|..|.....-......+ ..|+.|||++|++-. .+ ...+.++.|..|+
T Consensus 223 sl~~L~L~~N~~~~~~~~~~~i~------------------------~~L~~LdLs~N~li~-~~~~~~~~~l~~L~~Ln 277 (505)
T KOG3207|consen 223 SLEVLYLEANEIILIKATSTKIL------------------------QTLQELDLSNNNLID-FDQGYKVGTLPGLNQLN 277 (505)
T ss_pred cHHHhhhhcccccceecchhhhh------------------------hHHhhccccCCcccc-cccccccccccchhhhh
Confidence 45555555553222222223333 444444444444431 11 2234445555555
Q ss_pred cccccCCCC-CCCC-----cccCCCCCceeccCcccCCCC-CcccccccccceecCCccccc
Q 002349 338 VANNHLEGP-IPDN-----LSSCTNLNSLNVHGNKLNGTI-PPAFQRLESMTYLNLSLNNIR 392 (933)
Q Consensus 338 L~~N~l~~~-~p~~-----l~~l~~L~~L~l~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~ 392 (933)
++.+.+... .|+. ....++|++|+++.|++...- -..+..+++|+.|....|.++
T Consensus 278 ls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln 339 (505)
T KOG3207|consen 278 LSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLN 339 (505)
T ss_pred ccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhccccccc
Confidence 555544321 1111 234456666666666664211 123344566666666666665
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.00 E-value=1.2e-10 Score=113.17 Aligned_cols=17 Identities=18% Similarity=0.253 Sum_probs=5.5
Q ss_pred ccccccceEEccCCccc
Q 002349 448 GNLRSVMEIDLSHNHLT 464 (933)
Q Consensus 448 ~~l~~L~~L~Ls~N~l~ 464 (933)
..+++|+.|+|.+|.++
T Consensus 110 ~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 110 SSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp GG-TT--EEE-TT-GGG
T ss_pred HcCCCcceeeccCCccc
Confidence 33444444444444444
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.99 E-value=3.5e-09 Score=100.88 Aligned_cols=130 Identities=21% Similarity=0.347 Sum_probs=98.2
Q ss_pred eeecccceeEEEEEEcCCceEEEEE-ecccC--chh-----HHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEec
Q 002349 605 IIGYGASSTVYKCVLKNCKPVAIKR-LYSHY--PQC-----LKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFM 676 (933)
Q Consensus 605 ~lG~G~~g~Vy~~~~~~~~~vavK~-~~~~~--~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 676 (933)
.+++|+-+.+|.+.+.+.. +++|. +.+.. ++- ..+-.+|++++++++--.|...+-|..+.....++|||+
T Consensus 3 ~i~~GAEa~i~~~~~~g~~-av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLP-AVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeeccCcc-eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 5789999999999876544 55553 22221 221 233467999999987666666666667788889999999
Q ss_pred CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccc
Q 002349 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKS 749 (933)
Q Consensus 677 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 749 (933)
+|..|.+.+... ...++..+-.-+.-||.+ +|+|+|+.++||.+..+. +.++|||++..
T Consensus 82 ~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999999998531 245666777777889966 999999999999998875 99999999964
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=3e-10 Score=137.51 Aligned_cols=132 Identities=23% Similarity=0.347 Sum_probs=100.5
Q ss_pred CCCCCCccEEEccCCcccccCCCCccCCCCCceecccccc--cCCCCCc-ccccccchhhhhhcccCccCCCCcccccCC
Q 002349 88 VGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNE--LYGDIPF-SISKLKQLEFLILKNNQLIGPIPSTLSQLP 164 (933)
Q Consensus 88 l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~--l~~~~p~-~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~ 164 (933)
..+....+...+.+|++. .++.... +++|++|-+..|. +. .++. .|..++.|+.|||++|.=-+.+|..++.|-
T Consensus 519 ~~~~~~~rr~s~~~~~~~-~~~~~~~-~~~L~tLll~~n~~~l~-~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li 595 (889)
T KOG4658|consen 519 VKSWNSVRRMSLMNNKIE-HIAGSSE-NPKLRTLLLQRNSDWLL-EISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELV 595 (889)
T ss_pred ccchhheeEEEEeccchh-hccCCCC-CCccceEEEeecchhhh-hcCHHHHhhCcceEEEECCCCCccCcCChHHhhhh
Confidence 344567788888888886 4554443 3478888888886 44 3444 477888999999998877778888888888
Q ss_pred CCceeeeecCCCCCCcccccccCCCCcEEeccCccccCccCcCCcCCCCCcEEcccccc
Q 002349 165 NLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQ 223 (933)
Q Consensus 165 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~ 223 (933)
+|++|+|++..+. .+|..+.++.+|.+||+..+.-...+|.....+++|++|.+..-.
T Consensus 596 ~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~ 653 (889)
T KOG4658|consen 596 HLRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA 653 (889)
T ss_pred hhhcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccc
Confidence 9999998888887 778888888888888888877665666666778888888775443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.97 E-value=1.7e-10 Score=134.36 Aligned_cols=249 Identities=19% Similarity=0.160 Sum_probs=168.9
Q ss_pred HhhccCcceeeecccceeEEEEEEcC-CceEEEEEeccc---CchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEE
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSH---YPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLL 671 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 671 (933)
..+.+...+.+-+|.++.++.+.-.. +...+.|..... .....+...++-.+.-..++|.+++..--+.-....++
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 34566777788999999998876332 333333332211 11222333344444444566777766655556677899
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccc
Q 002349 672 FYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLC 751 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 751 (933)
|++|..+++|...+|. .+..+.+........+..+.+|||. ..+.|||++|.|.+...++..+++|||.....+
T Consensus 882 ~~~~~~~~~~~Skl~~---~~~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHN---SGCLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred hhHHhccCCchhhhhc---CCCcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCccccccccc
Confidence 9999999999999963 3455666666677778889999994 368999999999999999999999998443321
Q ss_pred cC------------------------------CCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCC
Q 002349 752 VS------------------------------KSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAV 801 (933)
Q Consensus 752 ~~------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~ 801 (933)
.- .........||+.|.+||...+......+|.|+.|++++|.++|..||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 10 001122356899999999999999999999999999999999999999
Q ss_pred CCCcchhHHHHhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 002349 802 DNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMH 860 (933)
Q Consensus 802 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 860 (933)
...........+...... ++.. .........+++...+..+|.+|-.+.
T Consensus 1036 na~tpq~~f~ni~~~~~~-----~p~g-----~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQQIFENILNRDIP-----WPEG-----PEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCcchhhhhhccccCCCC-----CCCC-----ccccChhhhhhhhhhhccCchhccCcc
Confidence 876654443221111111 1111 111223455567777888999997665
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.93 E-value=5.1e-10 Score=108.86 Aligned_cols=107 Identities=31% Similarity=0.397 Sum_probs=39.2
Q ss_pred ccccceecCCcccccCCCccccc-cccccceeeccCCccCCCCCCCCCCccccccccccCccccccccccc-ccccccce
Q 002349 378 LESMTYLNLSLNNIRGPIPVELS-RIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEF-GNLRSVME 455 (933)
Q Consensus 378 l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~ 455 (933)
..+++.|+|++|.|+.. ..++ .+.+|+.|||++|.|+.. +.+..++.|+.|++++|+|+.. +..+ ..+++|++
T Consensus 18 ~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i-~~~l~~~lp~L~~ 92 (175)
T PF14580_consen 18 PVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSI-SEGLDKNLPNLQE 92 (175)
T ss_dssp --------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S--CHHHHHH-TT--E
T ss_pred ccccccccccccccccc--cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCcc-ccchHHhCCcCCE
Confidence 34556666666666632 2343 466777788888877743 3467788888888888888854 3334 46888999
Q ss_pred EEccCCccccccc-hhhccccccceeeecCCCCcC
Q 002349 456 IDLSHNHLTGVIP-EELSQLQNMFSLRLDYNNLSG 489 (933)
Q Consensus 456 L~Ls~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~ 489 (933)
|+|++|+|..... ..++.+++|+.|+|.+|+++.
T Consensus 93 L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~ 127 (175)
T PF14580_consen 93 LYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCE 127 (175)
T ss_dssp EE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGG
T ss_pred EECcCCcCCChHHhHHHHcCCCcceeeccCCcccc
Confidence 9999998876433 567788899999999888763
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.3e-08 Score=96.34 Aligned_cols=143 Identities=22% Similarity=0.339 Sum_probs=102.4
Q ss_pred cceeeecccceeEEEEEEcCCceEEEE-EecccC--c-----hhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 602 EKYIIGYGASSTVYKCVLKNCKPVAIK-RLYSHY--P-----QCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 602 ~~~~lG~G~~g~Vy~~~~~~~~~vavK-~~~~~~--~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
....+-+|+-+.|+++.+.+ +..+|| ++.+.. + -..++-.+|++.+.+++--.|.-..-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~G-e~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSG-EAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccCC-ceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 34678999999999999876 444454 332221 1 12345678999999987556555555666777778999
Q ss_pred EecCC-CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCC---CeEEeecccccc
Q 002349 674 DFMEN-GSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDF---EAHLTDFGIAKS 749 (933)
Q Consensus 674 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~---~~kl~DfGla~~ 749 (933)
||++| .++.+++...... ....+.....+..+-+.+.-||.+ +|+|+|+..+||++..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~-~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMED-ESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccC-cccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99977 4777777532222 222233367888999999999965 999999999999997654 358999999854
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.87 E-value=2.4e-09 Score=78.19 Aligned_cols=41 Identities=46% Similarity=0.892 Sum_probs=30.8
Q ss_pred hHHHHHHHHHHHhCC-CCCCCcCCCCCCCCCCCCCccceEec
Q 002349 24 SEDGATLLKIKKSFR-DVDNVLYDWTDSPSSDYCVWRGITCD 64 (933)
Q Consensus 24 ~~d~~all~~k~~~~-~~~~~l~~w~~~~~~~~c~w~gv~C~ 64 (933)
.+|++||++||+++. +|.+.+.+|+.+...+||+|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 579999999999998 56789999986533799999999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.83 E-value=6.5e-08 Score=102.34 Aligned_cols=259 Identities=16% Similarity=0.141 Sum_probs=154.1
Q ss_pred cCcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcC-CCCceeeeeeE------Eec-CCccEE
Q 002349 600 LSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSI-KHRNLVSLQGY------SLS-SSGNLL 671 (933)
Q Consensus 600 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~------~~~-~~~~~l 671 (933)
....+.||+|+-+.+|-.---. .-+.|+.+...+....+ .++.|... .||-+-.-+.+ .-+ +....+
T Consensus 13 i~~gr~LgqGgea~ly~l~e~~--d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLGEVR--DQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred cCCCccccCCccceeeecchhh--chhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 3445679999999999643211 23457776554332222 22333333 56543321111 111 222567
Q ss_pred EEEecCCCC-HHHHhc---CCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccc
Q 002349 672 FYDFMENGS-LWDILH---GPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIA 747 (933)
Q Consensus 672 v~e~~~~gs-L~~~l~---~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla 747 (933)
.|..+.+.- ..++.. ..+.-....|.-.+++++.+|.+.+.||++ |.+-+|+.++|+|+++++.|.+.|=..-
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccce
Confidence 788776642 222221 112233578999999999999999999987 8999999999999999999999874432
Q ss_pred cccccCCCceeeeecccccccCccccc-----cCCCCcchhhHHHHHHHHHHHhC-CCCCCCCc-------chh-HHHHh
Q 002349 748 KSLCVSKSYTSTYIMGTIGYIDPEYAR-----TSRLTEKSDVYSFGIVLLELLTG-RKAVDNEC-------NLH-HLILS 813 (933)
Q Consensus 748 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGv~l~elltg-~~p~~~~~-------~~~-~~~~~ 813 (933)
... .......--+|...|.+||.-. +...++..|-|.+||++++++.| ++||.+-. ..+ ++...
T Consensus 165 qi~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g 242 (637)
T COG4248 165 QIN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG 242 (637)
T ss_pred eec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence 221 2222333347899999999654 44567889999999999999887 89997321 111 11110
Q ss_pred hhccccc--ccccCccccccccCHHHHHHHHHHHHHccCCC--CCCCCCHHHHHHHHccCC
Q 002349 814 KTANNAV--METVDPEISATCKDLGAVKKVFQLALLCSKRQ--PTDRPTMHEVSRVLGSLV 870 (933)
Q Consensus 814 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d--P~~RPt~~evl~~L~~~~ 870 (933)
....... .....+... .+-.-.+..+..+..+|+... +.-|||++..+..|..+.
T Consensus 243 ~f~ya~~~~~g~~p~P~~--~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~ 301 (637)
T COG4248 243 RFAYASDQRRGLKPPPRS--IPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALR 301 (637)
T ss_pred eeeechhccCCCCCCCCC--CChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHH
Confidence 0000000 000000000 000112355666777887643 567999999988776543
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.81 E-value=3e-09 Score=84.97 Aligned_cols=59 Identities=42% Similarity=0.620 Sum_probs=32.6
Q ss_pred ccccccccCcccccccccccccccccceEEccCCccccccchhhccccccceeeecCCC
Q 002349 428 HLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNN 486 (933)
Q Consensus 428 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~ 486 (933)
+|++|++++|+|+.+.+..|.++++|++|++++|+++...|..|..+++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 45555555555554444555555555555555555555555555555555555555554
|
... |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.80 E-value=2.9e-08 Score=98.39 Aligned_cols=125 Identities=18% Similarity=0.251 Sum_probs=82.4
Q ss_pred eEEEEEEcCCceEEEEEecccCc-------------h-------------hHHHHHHHHHHHhcCCCC--ceeeeeeEEe
Q 002349 613 TVYKCVLKNCKPVAIKRLYSHYP-------------Q-------------CLKEFETELETVGSIKHR--NLVSLQGYSL 664 (933)
Q Consensus 613 ~Vy~~~~~~~~~vavK~~~~~~~-------------~-------------~~~~~~~E~~~l~~l~h~--niv~~~~~~~ 664 (933)
.||.|...++..+|||..+.... . ......+|++.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999998899999998753210 0 112357899999999765 466666552
Q ss_pred cCCccEEEEEecC--CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCCeeeccCCCCceEeCCCCCeEE
Q 002349 665 SSSGNLLFYDFME--NGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYL-HHDCSPRIIHRDVKSSNILLDKDFEAHL 741 (933)
Q Consensus 665 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~Dikp~NIll~~~~~~kl 741 (933)
..++||||++ |..+..+... .++.+....++.+++..+..+ |. .||+|+|+.+.||+++++ .+.+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~-----~~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDV-----DLSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHC-----GGGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhc-----cccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEEE
Confidence 4689999998 6555444321 112345566777777766654 64 499999999999999988 9999
Q ss_pred eeccccccc
Q 002349 742 TDFGIAKSL 750 (933)
Q Consensus 742 ~DfGla~~~ 750 (933)
+|||.+...
T Consensus 148 IDf~qav~~ 156 (188)
T PF01163_consen 148 IDFGQAVDS 156 (188)
T ss_dssp --GTTEEET
T ss_pred EecCcceec
Confidence 999988654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.80 E-value=3.4e-09 Score=84.68 Aligned_cols=61 Identities=43% Similarity=0.655 Sum_probs=52.4
Q ss_pred cccceeeccCCccCCCCCCCCCCccccccccccCcccccccccccccccccceEEccCCcc
Q 002349 403 GNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHL 463 (933)
Q Consensus 403 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 463 (933)
++|++|++++|+|+...+..|.++++|++|++++|+++.+.|..|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4678888888888877777888899999999999999888888899999999999999875
|
... |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.77 E-value=2.6e-07 Score=100.55 Aligned_cols=169 Identities=20% Similarity=0.294 Sum_probs=128.4
Q ss_pred cceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEec----CCccEEEEEecCC-CCHHH
Q 002349 610 ASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLS----SSGNLLFYDFMEN-GSLWD 683 (933)
Q Consensus 610 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~-gsL~~ 683 (933)
...+.|||... +|..|++|+++.........-..-+++++++.|+|||++.++|.. +...++||+|.++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 34578999854 789999999966544434344566889999999999999998863 3457899999885 57777
Q ss_pred HhcCC------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccc
Q 002349 684 ILHGP------------TKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLC 751 (933)
Q Consensus 684 ~l~~~------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 751 (933)
.-... ..+...+++..+.++.|+..||.++|.. |..-+-+.+.+|+++.+.+++|+..|....+.
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence 54321 2234578899999999999999999955 99999999999999999999999888765543
Q ss_pred cCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCC
Q 002349 752 VSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRK 799 (933)
Q Consensus 752 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~ 799 (933)
.+.. |-+. --.+-|.-.||.+++.+.||..
T Consensus 445 ~d~~---------------~~le---~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 445 EDPT---------------EPLE---SQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCCC---------------cchh---HHhhhhHHHHHHHHHHHhhccc
Confidence 2220 1111 1246789999999999999964
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.75 E-value=9.7e-08 Score=100.56 Aligned_cols=141 Identities=13% Similarity=0.066 Sum_probs=100.3
Q ss_pred eeeecccceeEEEEEEcCCceEEEEEecccCch-----------hHHHHHHHHHHHhcCCCCce--eeeeeEEec-----
Q 002349 604 YIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQ-----------CLKEFETELETVGSIKHRNL--VSLQGYSLS----- 665 (933)
Q Consensus 604 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~----- 665 (933)
+.+-+.....|+++.+ +|+.|.||+....... ....+.+|+..+.++...+| ++++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3455444555777665 4578999977443211 11247899999988854433 344555543
Q ss_pred CCccEEEEEecCCC-CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCC-------CC
Q 002349 666 SSGNLLFYDFMENG-SLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDK-------DF 737 (933)
Q Consensus 666 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~-------~~ 737 (933)
...-++|+|++++. +|.+++.... ..+.+...+..++.+++..+.-||++ ||+|+|++++|||++. ++
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCc
Confidence 23468999999886 8998874211 24456677889999999999999976 9999999999999975 46
Q ss_pred CeEEeecccccc
Q 002349 738 EAHLTDFGIAKS 749 (933)
Q Consensus 738 ~~kl~DfGla~~ 749 (933)
.+.++||+.+..
T Consensus 183 ~~~LIDl~r~~~ 194 (268)
T PRK15123 183 KLSVIDLHRAQI 194 (268)
T ss_pred eEEEEECCcccc
Confidence 799999998753
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.75 E-value=5.2e-08 Score=98.54 Aligned_cols=135 Identities=19% Similarity=0.196 Sum_probs=95.3
Q ss_pred CcceeeecccceeEEEEEEcCCceEEEEEecccCc----------------------hhHHHHHHHHHHHhcCCCC--ce
Q 002349 601 SEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYP----------------------QCLKEFETELETVGSIKHR--NL 656 (933)
Q Consensus 601 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~h~--ni 656 (933)
..+..||.|.-+.||.|....|.++|||.=+...+ -.....++|.++|.++.-. .|
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 34578999999999999999999999995422111 0123467899999999654 66
Q ss_pred eeeeeEEecCCccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCC
Q 002349 657 VSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKD 736 (933)
Q Consensus 657 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~ 736 (933)
.+.++ .+.+.+||||++|--|...- ++.+..-.++..|++-+...-. .||||+|+++-||+++++
T Consensus 174 P~P~~----~nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~~d 238 (304)
T COG0478 174 PKPIA----WNRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVTED 238 (304)
T ss_pred CCccc----cccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEecC
Confidence 66655 35678999999986554332 1233333344444444433332 289999999999999999
Q ss_pred CCeEEeeccccccc
Q 002349 737 FEAHLTDFGIAKSL 750 (933)
Q Consensus 737 ~~~kl~DfGla~~~ 750 (933)
|.+.++||--+...
T Consensus 239 g~~~vIDwPQ~v~~ 252 (304)
T COG0478 239 GDIVVIDWPQAVPI 252 (304)
T ss_pred CCEEEEeCcccccC
Confidence 99999999877543
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.74 E-value=3.1e-10 Score=126.40 Aligned_cols=130 Identities=31% Similarity=0.359 Sum_probs=102.7
Q ss_pred CCCceeccCcccCCCCCcccccccccceecCCcccccCCCccccccccccceeeccCCccCCCCCC-CCCCccccccccc
Q 002349 356 NLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPS-PLGDLEHLLKLNL 434 (933)
Q Consensus 356 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L 434 (933)
.|...+.++|++. .....+.-++.|+.|+|++|+++.. ..+..++.|+.|||++|.+. .+|. ....+ .|+.|+|
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc-~L~~L~l 239 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGC-KLQLLNL 239 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhh-hheeeee
Confidence 5778888899888 5667788888999999999999855 37888999999999999998 4443 33334 4999999
Q ss_pred cCcccccccccccccccccceEEccCCccccccc-hhhccccccceeeecCCCCcCccc
Q 002349 435 SRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIP-EELSQLQNMFSLRLDYNNLSGDVM 492 (933)
Q Consensus 435 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~~ 492 (933)
++|.++.. ..+.+|++|+.|||++|-|.+--. .-++.|..|..|+|.||++.|-+.
T Consensus 240 rnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p~ 296 (1096)
T KOG1859|consen 240 RNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAPW 296 (1096)
T ss_pred cccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCHH
Confidence 99999854 357889999999999998876432 335677888999999999987664
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.68 E-value=5.2e-10 Score=124.71 Aligned_cols=131 Identities=27% Similarity=0.379 Sum_probs=105.7
Q ss_pred cccceecCCcccccCCCccccccccccceeeccCCccCCCCCCCCCCccccccccccCcccccccccccccccccceEEc
Q 002349 379 ESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDL 458 (933)
Q Consensus 379 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 458 (933)
..|...+.+.|.+. .....+.-++.|+.|||++|+++... .+..+++|++|||++|.|+.+.--...+++ |+.|.|
T Consensus 164 n~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~l 239 (1096)
T KOG1859|consen 164 NKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNL 239 (1096)
T ss_pred hhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-heeeee
Confidence 46888999999998 66777888999999999999998553 889999999999999999955444555565 999999
Q ss_pred cCCccccccchhhccccccceeeecCCCCcCc--ccchhhccccc-eeecCCCCCCCccc
Q 002349 459 SHNHLTGVIPEELSQLQNMFSLRLDYNNLSGD--VMSLINCLSLS-VLFIGNPGLCGYWL 515 (933)
Q Consensus 459 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~--~~~~~~~~~~~-~~~~~N~~~C~~~l 515 (933)
++|.++.. ..+.+|.+|+.|||++|-|++. ...+..+..+. +.+.|||.-|..+-
T Consensus 240 rnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p~h 297 (1096)
T KOG1859|consen 240 RNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAPWH 297 (1096)
T ss_pred cccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCHHH
Confidence 99999854 4578999999999999999874 22233444444 67899999998654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.62 E-value=2e-07 Score=106.12 Aligned_cols=141 Identities=20% Similarity=0.225 Sum_probs=99.0
Q ss_pred eeeecccceeEEEEEEcCCceEEEEEecccCchh------------------------------HH----------HHHH
Q 002349 604 YIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQC------------------------------LK----------EFET 643 (933)
Q Consensus 604 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------------------------------~~----------~~~~ 643 (933)
..|+.++-|.||+|++++|+.||||+.++...+. .+ ++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 5899999999999999999999999987543211 01 1345
Q ss_pred HHHHHhcCC-----CCceeeeeeEEecCCccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCC
Q 002349 644 ELETVGSIK-----HRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCS 718 (933)
Q Consensus 644 E~~~l~~l~-----h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~ 718 (933)
|+..+.+++ .+++.-..=|+.-.+...++|||++|..+.+... .+....+...+.....++.--.-+-|
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~--l~~~g~d~k~ia~~~~~~f~~q~~~d---- 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAA--LKSAGIDRKELAELLVRAFLRQLLRD---- 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHH--HHhcCCCHHHHHHHHHHHHHHHHHhc----
Confidence 666666652 3444333333344567799999999998888742 12245665555544444333333335
Q ss_pred CCeeeccCCCCceEeCCCCCeEEeecccccccc
Q 002349 719 PRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLC 751 (933)
Q Consensus 719 ~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 751 (933)
|++|.|.+|.||+++.+|++.+.|||+...+.
T Consensus 285 -gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 285 -GFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred -CccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 99999999999999999999999999987653
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.55 E-value=2.9e-08 Score=112.09 Aligned_cols=150 Identities=19% Similarity=0.314 Sum_probs=103.2
Q ss_pred HHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCceee--------eecccccccCcccccc
Q 002349 704 LGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTST--------YIMGTIGYIDPEYART 775 (933)
Q Consensus 704 ~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~--------~~~gt~~y~aPE~~~~ 775 (933)
.+++.|+.|+|+ +.++||++|.|++|.++..+..||+.|+.+........+... -..-...|.|||++.+
T Consensus 106 ~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 344599999997 579999999999999999999999999988654321111111 1234568999999999
Q ss_pred CCCCcchhhHHHHHHHHHHH-hCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCC
Q 002349 776 SRLTEKSDVYSFGIVLLELL-TGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPT 854 (933)
Q Consensus 776 ~~~~~~~DvwSlGv~l~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 854 (933)
.-.+.++|+||+||++|.+. .|+.-+................+.-.... .-..+.++.+-+.+++..++.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~---------s~~~p~el~~~l~k~l~~~~~ 254 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGY---------SNNLPSELRESLKKLLNGDSA 254 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccc---------cccCcHHHHHHHHHHhcCCcc
Confidence 88899999999999999999 45544443322221111111111100000 112356788889999999999
Q ss_pred CCCCHHHHHH
Q 002349 855 DRPTMHEVSR 864 (933)
Q Consensus 855 ~RPt~~evl~ 864 (933)
-||++.++..
T Consensus 255 ~rp~~~~l~~ 264 (700)
T KOG2137|consen 255 VRPTLDLLLS 264 (700)
T ss_pred cCcchhhhhc
Confidence 9998877754
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.47 E-value=8.9e-07 Score=90.33 Aligned_cols=106 Identities=23% Similarity=0.261 Sum_probs=82.7
Q ss_pred HHHHHHHHHHHhcCCCC--ceeeeeeEEecCC----ccEEEEEecCCC-CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHH
Q 002349 638 LKEFETELETVGSIKHR--NLVSLQGYSLSSS----GNLLFYDFMENG-SLWDILHGPTKKKKLDWDTRLKIALGAAQGL 710 (933)
Q Consensus 638 ~~~~~~E~~~l~~l~h~--niv~~~~~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l 710 (933)
..+..+|...+.++... .+.+.+++..... ..++|+|++++. +|.+++.. ....+......++.+++..+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~---~~~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQ---WEQLDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHh---hcccchhhHHHHHHHHHHHH
Confidence 34678888888887533 3445566655432 347999999874 89998853 22266778889999999999
Q ss_pred HHhhcCCCCCeeeccCCCCceEeCCCC---CeEEeecccccc
Q 002349 711 AYLHHDCSPRIIHRDVKSSNILLDKDF---EAHLTDFGIAKS 749 (933)
Q Consensus 711 ~~LH~~~~~~ivH~Dikp~NIll~~~~---~~kl~DfGla~~ 749 (933)
.-||++ ||+|+|+++.|||++.+. .+.++||+-++.
T Consensus 132 ~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 132 AKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999976 999999999999999887 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.47 E-value=2.9e-08 Score=100.09 Aligned_cols=84 Identities=23% Similarity=0.287 Sum_probs=47.5
Q ss_pred CCCcEEeccCccccC--ccCcCCcCCCCCcEEccccccccCcCCCC-ccccccceEeccccccccc-cCccccccccccE
Q 002349 188 SGLWYFDVRNNSLTG--SIPQNIGNCTSFQVLDLSYNQLSGEIPFN-IGFLQIATLSLQGNQLTGK-IPSVIGLMQALAV 263 (933)
Q Consensus 188 ~~L~~L~L~~n~l~~--~~p~~l~~l~~L~~L~L~~N~l~~~~p~~-~~~~~L~~L~L~~n~l~~~-~p~~~~~l~~L~~ 263 (933)
+.++++||.+|.|+. .+-..+.+++.|+.|+|+.|++...|... +...+|+.|.|.+..+.-. ....+..++.++.
T Consensus 71 ~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vte 150 (418)
T KOG2982|consen 71 TDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVTE 150 (418)
T ss_pred hhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhhh
Confidence 445555555555542 23334567777777777777776555433 3444566666666655421 2233445566666
Q ss_pred EeccCCcC
Q 002349 264 LDLSCNML 271 (933)
Q Consensus 264 L~Ls~N~l 271 (933)
|++|.|.+
T Consensus 151 lHmS~N~~ 158 (418)
T KOG2982|consen 151 LHMSDNSL 158 (418)
T ss_pred hhhccchh
Confidence 66666643
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.42 E-value=4.4e-08 Score=98.77 Aligned_cols=86 Identities=22% Similarity=0.266 Sum_probs=52.3
Q ss_pred ccchhhhhhcccCccC--CCCcccccCCCCceeeeecCCCCCCcccccccCCCCcEEeccCccccC-ccCcCCcCCCCCc
Q 002349 139 LKQLEFLILKNNQLIG--PIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTG-SIPQNIGNCTSFQ 215 (933)
Q Consensus 139 l~~L~~L~L~~n~l~~--~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~p~~l~~l~~L~ 215 (933)
.+.+++|||.+|+|+. .+-..+.+||.|+.|+|+.|++...|...-..+.+|+.|-|.+..+.- ..-..+..++.++
T Consensus 70 ~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vt 149 (418)
T KOG2982|consen 70 VTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVT 149 (418)
T ss_pred hhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhh
Confidence 3456666666666653 233344566777777777777664443222455667777666666542 2334567788888
Q ss_pred EEccccccc
Q 002349 216 VLDLSYNQL 224 (933)
Q Consensus 216 ~L~L~~N~l 224 (933)
+|++|.|.+
T Consensus 150 elHmS~N~~ 158 (418)
T KOG2982|consen 150 ELHMSDNSL 158 (418)
T ss_pred hhhhccchh
Confidence 888888854
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 933 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-53 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 7e-53 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-50 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-50 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 7e-43 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 7e-43 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-33 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-33 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-33 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-31 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-25 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-24 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-24 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 1e-04 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-21 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-21 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-20 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-19 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-19 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-19 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-19 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-19 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 9e-19 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 9e-19 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-18 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-18 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-18 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-18 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-18 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-18 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-18 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-17 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-17 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-17 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-17 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-17 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-17 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-17 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-17 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 7e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 7e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 7e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 8e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-17 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 9e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-16 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-16 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-16 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-16 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-16 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-15 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-15 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-15 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 8e-15 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 8e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 8e-15 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 8e-15 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 8e-15 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 9e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 9e-15 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 9e-15 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 9e-15 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-14 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-14 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-14 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-14 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-14 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 6e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 7e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 8e-14 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 8e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 9e-14 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 9e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 9e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 9e-14 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-14 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 9e-14 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 9e-14 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 9e-14 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 9e-14 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 9e-14 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-13 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-13 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-13 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-13 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-13 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-13 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-13 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-13 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-13 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-13 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-13 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-13 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-13 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-13 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-13 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-13 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-13 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-13 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-13 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-13 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 6e-13 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-13 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-12 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 8e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 8e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 9e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 9e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-11 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-11 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-11 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-11 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-11 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-11 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-11 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-11 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-11 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-11 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-11 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-11 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-11 | ||
| 3zyj_A | 440 | Netring1 In Complex With Ngl1 Length = 440 | 3e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-11 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 3e-11 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 9e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-11 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-11 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-11 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-11 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-11 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-11 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 4e-11 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 6e-09 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-11 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 6e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 6e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-11 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 7e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 8e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 8e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 8e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 9e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 9e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 9e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 9e-11 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 1e-10 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 3e-09 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-10 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-10 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-10 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-10 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-10 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 1e-10 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 8e-07 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-10 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-10 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 3e-10 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 6e-07 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 3e-10 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 3e-07 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 7e-10 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 7e-10 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 2e-07 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 8e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 8e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 9e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 9e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-09 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-09 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-09 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 5e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 7e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 7e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 7e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 7e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 7e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 7e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 7e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 7e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 7e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 7e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 9e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 9e-09 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 9e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 9e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 9e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 9e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-08 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-08 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-08 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-08 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-08 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-08 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-08 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-08 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-08 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-08 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-08 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-08 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-08 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-08 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 6e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 6e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 7e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 7e-08 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 7e-08 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 3e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-08 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 7e-08 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 7e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-08 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 7e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 7e-08 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 8e-08 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 8e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 8e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 8e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 8e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 9e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 9e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 9e-08 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 9e-08 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 9e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 9e-08 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-07 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-07 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-07 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-07 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-07 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-07 | ||
| 3zyn_A | 321 | Crystal Structure Of The N-Terminal Leucine Rich Re | 1e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-07 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-07 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-07 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-07 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-07 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-07 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-07 | ||
| 3zyo_A | 411 | Crystal Structure Of The N-Terminal Leucine Rich Re | 2e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-07 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-07 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-07 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-07 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-07 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-07 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-07 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-07 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-07 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-07 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-07 | ||
| 2z7x_B | 520 | Crystal Structure Of The Tlr1-Tlr2 Heterodimer Indu | 3e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-07 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-07 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-07 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-07 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-07 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-07 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-07 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-07 | ||
| 3zyi_A | 452 | Netring2 In Complex With Ngl2 Length = 452 | 4e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-07 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-07 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-07 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-07 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-07 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-07 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-07 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-07 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-07 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-07 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-07 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-07 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-07 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-07 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-07 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-07 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-07 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-07 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-07 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-07 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-07 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-07 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 6e-07 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-07 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 7e-07 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-07 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-07 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 7e-07 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 7e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 7e-07 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 7e-07 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 8e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 8e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 9e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 9e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 9e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 9e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 9e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 9e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 9e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 9e-07 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 9e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-06 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-06 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-06 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-06 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-06 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-06 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-06 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-06 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-06 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-06 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-06 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-06 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-06 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-06 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-06 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-06 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-06 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-06 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-06 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-06 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-06 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-06 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-06 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-06 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-06 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 5e-06 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-06 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 6e-06 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 6e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 7e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 7e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 7e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 7e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 7e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 7e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 7e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-06 | ||
| 3rfs_A | 272 | Design Of A Binding Scaffold Based On Variable Lymp | 8e-06 | ||
| 3rfs_A | 272 | Design Of A Binding Scaffold Based On Variable Lymp | 1e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 8e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 8e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 8e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-06 | ||
| 3kj4_A | 286 | Structure Of Rat Nogo Receptor Bound To 1d9 Antagon | 8e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 8e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 9e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-05 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-05 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-05 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-05 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-05 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-05 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-05 | ||
| 3rfj_A | 279 | Design Of A Binding Scaffold Based On Variable Lymp | 3e-05 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-05 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-05 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-05 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-05 | ||
| 3v47_A | 455 | Crystal Structure Of The N-Tetminal Fragment Of Zeb | 3e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-05 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-05 | ||
| 3m18_A | 251 | Crystal Structure Of Variable Lymphocyte Receptor V | 3e-05 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-05 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-05 | ||
| 3m19_A | 251 | Crystal Structure Of Variable Lymphocyte Receptor V | 4e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 4e-05 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-05 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-05 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-05 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 6e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 7e-05 | ||
| 1p8t_A | 285 | Crystal Structure Of Nogo-66 Receptor Length = 285 | 7e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 7e-05 | ||
| 1ozn_A | 285 | 1.5a Crystal Structure Of The Nogo Receptor Ligand | 7e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 8e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 8e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 9e-05 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-04 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-04 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-04 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-04 | ||
| 3e6j_A | 229 | Crystal Structure Of Variable Lymphocyte Receptor ( | 1e-04 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-04 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-04 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-04 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-04 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-04 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-04 | ||
| 2z63_A | 570 | Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 A | 2e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-04 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-04 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-04 | ||
| 2id5_A | 477 | Crystal Structure Of The Lingo-1 Ectodomain Length | 4e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-04 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-04 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-04 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-04 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-04 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-04 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-04 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-04 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-04 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-04 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-04 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-04 | ||
| 3cig_A | 697 | Crystal Structure Of Mouse Tlr3 Ectodomain Length = | 4e-04 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-04 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-04 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-04 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-04 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-04 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-04 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-04 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-04 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-04 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-04 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-04 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-04 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-04 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-04 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-04 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-04 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-04 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-04 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-04 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3ZYJ|A Chain A, Netring1 In Complex With Ngl1 Length = 440 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3ZYN|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats Of Netrin-G Ligand-3 Length = 321 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3ZYO|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats And Immunoglobulin Domain Of Netrin-G Ligand-3 Length = 411 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2Z7X|B Chain B, Crystal Structure Of The Tlr1-Tlr2 Heterodimer Induced By Binding Of A Tri-Acylated Lipopeptide Length = 520 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3ZYI|A Chain A, Netring2 In Complex With Ngl2 Length = 452 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272 | Back alignment and structure |
|
| >pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3KJ4|A Chain A, Structure Of Rat Nogo Receptor Bound To 1d9 Antagonist Antibody Length = 286 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3RFJ|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 279 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3V47|A Chain A, Crystal Structure Of The N-Tetminal Fragment Of Zebrafish Tlr5 In Complex With Salmonella Flagellin Length = 455 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3M18|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor Vlra.R2.1 In Complex With Hen Egg Lysozyme Length = 251 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3M19|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor Vlra.R5.1 Length = 251 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor Length = 285 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1OZN|A Chain A, 1.5a Crystal Structure Of The Nogo Receptor Ligand Binding Domain Reveals A Convergent Recognition Scaffold Mediating Inhibition Of Myelination Length = 285 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3E6J|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor (Vlr) Rbc36 In Complex With H-Trisaccharide Length = 229 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2Z63|A Chain A, Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 570 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2ID5|A Chain A, Crystal Structure Of The Lingo-1 Ectodomain Length = 477 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3CIG|A Chain A, Crystal Structure Of Mouse Tlr3 Ectodomain Length = 697 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 933 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-139 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-129 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-129 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-129 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 2e-35 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 4e-04 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 1e-110 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 1e-107 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-103 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-89 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-64 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 5e-99 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 1e-93 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 2e-93 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 2e-33 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 6e-17 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 2e-86 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 2e-82 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-72 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 2e-58 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 3e-80 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-72 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-65 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 1e-09 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-79 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-77 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-72 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 7e-71 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 3e-46 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-34 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-30 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 4e-75 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 7e-75 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 6e-66 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 1e-34 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 4e-14 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 6e-74 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 7e-69 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 6e-64 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 6e-63 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 7e-58 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 2e-42 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 2e-65 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 8e-62 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 5e-59 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 3e-10 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 3e-07 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 4e-65 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 2e-63 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 1e-42 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 1e-20 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 2e-60 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 3e-60 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 4e-56 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 9e-56 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 1e-55 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 5e-55 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 6e-54 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 1e-53 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 1e-52 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 5e-41 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 1e-39 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-39 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 3e-53 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 2e-50 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 2e-46 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 9e-23 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 8e-53 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-52 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-39 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-31 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-30 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-25 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 3e-52 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 1e-51 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 5e-51 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 3e-46 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 1e-44 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 5e-51 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 6e-51 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 4e-50 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 6e-50 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 4e-49 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-48 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-45 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-43 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 2e-42 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 3e-30 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 1e-48 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 1e-46 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 7e-46 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 2e-44 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 7e-44 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 5e-36 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 3e-46 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 1e-41 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 2e-39 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 2e-31 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 2e-22 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 7e-11 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 5e-46 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 4e-44 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 1e-40 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 1e-32 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 3e-44 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 3e-41 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 1e-29 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 3e-20 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 5e-44 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 3e-43 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 7e-14 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 2e-42 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 6e-33 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 3e-30 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 8e-16 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 1e-41 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 4e-41 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 1e-20 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 3e-39 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 1e-38 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 3e-38 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 2e-33 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 9e-27 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 2e-11 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 4e-38 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 5e-38 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 1e-37 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 8e-37 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 3e-36 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 1e-35 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 2e-34 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 4e-33 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 4e-22 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 8e-10 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 1e-37 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 6e-36 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 1e-32 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 3e-31 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 3e-30 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 4e-16 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 2e-08 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 1e-36 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 2e-36 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 4e-24 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 1e-23 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 3e-23 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 2e-11 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 4e-36 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 4e-24 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 1e-22 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 1e-13 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 8e-36 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 2e-35 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 3e-35 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 7e-33 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 3e-32 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 7e-35 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 9e-26 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 1e-24 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 2e-10 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 7e-35 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 3e-34 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 5e-34 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 8e-32 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 2e-30 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 1e-28 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 3e-04 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 6e-34 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 1e-33 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 3e-33 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 8e-33 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 1e-32 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 4e-32 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 7e-32 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 4e-26 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 3e-21 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 1e-31 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 2e-31 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 3e-22 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 3e-15 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 3e-31 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 3e-31 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 5e-31 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 6e-31 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 7e-31 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 3e-29 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 9e-21 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 7e-31 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 1e-30 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 1e-30 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 2e-30 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 3e-30 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 3e-30 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 3e-27 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 1e-20 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 3e-20 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 3e-11 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 7e-07 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 4e-30 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 4e-30 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 5e-30 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 5e-30 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 7e-30 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 8e-30 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 9e-30 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 2e-29 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 2e-29 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 4e-29 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 4e-29 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 9e-29 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 1e-25 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 4e-25 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 3e-23 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 4e-21 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 9e-17 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 1e-28 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 1e-28 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 1e-28 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 2e-28 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 2e-28 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 2e-28 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 3e-28 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 3e-28 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 4e-28 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 5e-28 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 9e-27 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-19 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 5e-12 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-10 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 5e-28 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 6e-28 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 7e-28 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 8e-28 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 1e-27 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 1e-27 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 5e-27 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 2e-23 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 8e-10 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 5e-06 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 1e-27 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 1e-27 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 1e-27 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 2e-27 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 2e-27 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 2e-27 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 2e-27 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 3e-27 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 4e-27 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 7e-27 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 9e-27 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 1e-26 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 5e-24 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 7e-24 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 6e-21 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 1e-19 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 2e-08 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 6e-04 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 9e-27 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 9e-27 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 1e-26 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 2e-26 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 2e-26 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 3e-26 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 3e-26 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 9e-26 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 1e-25 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 1e-25 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 2e-25 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 2e-25 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 2e-25 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 3e-25 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 3e-25 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 5e-25 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 9e-25 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 1e-24 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 2e-24 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 2e-24 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 6e-24 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 2e-23 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 3e-22 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 7e-19 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 2e-24 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 3e-24 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 7e-24 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 8e-24 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 4e-20 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 5e-17 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 1e-13 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 2e-12 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 2e-23 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 3e-23 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 9e-23 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 1e-20 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 9e-19 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 5e-18 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 7e-18 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 1e-17 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 7e-17 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 1e-22 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 4e-18 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 7e-17 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 1e-22 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 2e-22 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 3e-22 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 3e-22 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 5e-22 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 1e-21 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 1e-21 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 2e-21 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 3e-21 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 3e-21 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 3e-14 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 4e-14 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 1e-07 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 4e-21 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 5e-21 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 5e-21 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 6e-21 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 9e-21 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 1e-20 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 6e-17 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 2e-16 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 5e-15 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 7e-15 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 2e-07 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 6e-07 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 2e-20 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 9e-16 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 2e-07 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-20 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 2e-20 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 3e-20 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 3e-20 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 2e-17 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 2e-16 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 1e-08 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 3e-07 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 2e-05 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 3e-20 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 5e-20 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 6e-20 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 7e-20 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 7e-20 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 1e-19 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 1e-19 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 1e-19 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 3e-19 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 4e-19 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 5e-19 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 5e-19 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 5e-19 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 7e-19 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 1e-18 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 1e-18 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-18 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 2e-18 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 3e-15 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 1e-13 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 1e-12 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 1e-11 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 2e-09 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 1e-05 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 2e-18 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 4e-18 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 7e-18 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 9e-18 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 1e-17 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 2e-17 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 2e-17 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 2e-17 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 2e-17 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 3e-17 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 3e-17 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 4e-17 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 7e-17 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 5e-13 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 3e-07 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 9e-17 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 1e-16 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 1e-16 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 8e-16 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 2e-15 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 8e-12 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 1e-11 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 1e-16 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 2e-16 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 2e-16 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 2e-16 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 2e-16 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 2e-16 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 4e-16 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 5e-16 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 3e-15 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 7e-14 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 4e-11 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 1e-10 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 1e-06 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 1e-04 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 7e-16 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 8e-16 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 2e-15 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 2e-15 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 3e-15 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 4e-15 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 5e-15 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 6e-15 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 6e-13 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 2e-12 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 6e-08 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 6e-06 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 8e-05 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 7e-15 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 1e-14 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 1e-14 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 2e-13 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 5e-11 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 3e-07 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 4e-05 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 8e-05 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 1e-14 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 3e-14 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 3e-14 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 5e-09 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 1e-13 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 3e-06 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 6e-06 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 1e-05 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 1e-13 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 2e-13 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 3e-13 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 4e-13 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 5e-13 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 8e-13 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 8e-04 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 5e-13 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 5e-13 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 9e-13 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 1e-12 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 1e-12 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 1e-12 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 2e-12 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 3e-12 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 3e-12 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 4e-12 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 4e-12 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 1e-11 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 4e-11 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 3e-09 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 1e-05 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 3e-05 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 8e-12 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 1e-11 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 1e-11 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 1e-11 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 2e-11 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 9e-07 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 1e-06 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 5e-05 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 2e-11 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 2e-11 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 2e-11 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 2e-11 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 2e-11 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 2e-11 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 4e-10 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 9e-09 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 2e-08 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 6e-08 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 3e-11 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 3e-11 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 3e-11 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 3e-11 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 4e-11 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 5e-11 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 7e-11 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 9e-11 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 1e-10 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 1e-10 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 1e-10 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 2e-10 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 2e-10 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 3e-10 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 3e-10 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 3e-10 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 4e-10 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 5e-10 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 8e-10 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 4e-09 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 2e-05 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 5e-04 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 7e-10 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 9e-10 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 1e-09 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 1e-09 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 3e-09 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 3e-09 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 1e-07 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 8e-07 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 9e-07 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 2e-06 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 2e-05 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 1e-09 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 2e-09 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 2e-09 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 8e-09 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 4e-08 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 7e-08 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 9e-08 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 3e-05 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 2e-09 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 3e-09 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 8e-09 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 4e-06 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 2e-04 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 3e-09 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 4e-07 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 5e-07 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-06 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 3e-06 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 8e-06 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 3e-09 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 4e-09 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-07 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 3e-07 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 4e-07 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-06 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 5e-05 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 4e-09 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 4e-09 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 7e-07 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 2e-06 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 2e-06 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 9e-06 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 8e-05 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 4e-09 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 4e-09 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 6e-09 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 9e-09 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 2e-08 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 2e-08 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 3e-08 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 3e-08 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 3e-08 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 6e-08 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 7e-08 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 9e-08 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 1e-07 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 1e-07 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 2e-07 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 6e-07 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 2e-06 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 4e-04 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 6e-07 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 2e-06 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 7e-07 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 8e-07 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 1e-06 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 1e-06 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 1e-06 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 5e-06 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 1e-06 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 2e-06 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 2e-06 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 3e-06 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 3e-06 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 1e-05 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 4e-06 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 5e-06 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 4e-05 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 1e-04 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 2e-04 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 432 bits (1112), Expect = e-139
Identities = 153/461 (33%), Positives = 226/461 (49%), Gaps = 12/461 (2%)
Query: 73 LNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDE-IGDCSSLKSLDLSFNELYGD 131
L+LSG + G + P G L+S+ L N SG++P + + LK LDLSFNE G+
Sbjct: 299 LDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGE 358
Query: 132 IPFSISKLK-QLEFLILKNNQLIGPIPSTL--SQLPNLKVFGLRGNNLVGTLSPDMCQLS 188
+P S++ L L L L +N GPI L + L+ L+ N G + P + S
Sbjct: 359 LPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCS 418
Query: 189 GLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFL-QIATLSLQGNQL 247
L + N L+G+IP ++G+ + + L L N L GEIP + ++ + TL L N L
Sbjct: 419 ELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDL 478
Query: 248 TGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMT 307
TG+IPS + L + LS N L+G IP +G L L L +N +G+IP ELG+
Sbjct: 479 TGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCR 538
Query: 308 KLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGN-- 365
L +L+LN N G IP A+ K + +A N + G + + + GN
Sbjct: 539 SLIWLDLNTNLFNGTIPAAMFKQS----GKIAANFIAGKRYVYIKNDGMKKECHGAGNLL 594
Query: 366 KLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGD 425
+ G RL + N++ G G++ LDMS N +SG IP +G
Sbjct: 595 EFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGS 654
Query: 426 LEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYN 485
+ +L LNL N ++G IP E G+LR + +DLS N L G IP+ +S L + + L N
Sbjct: 655 MPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNN 714
Query: 486 NLSGDVMSLINCLSLSVL-FIGNPGLCGYWLHSACRDSHPT 525
NLSG + + + F+ NPGLCGY L +
Sbjct: 715 NLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPSNADG 755
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 407 bits (1049), Expect = e-129
Identities = 136/496 (27%), Positives = 215/496 (43%), Gaps = 45/496 (9%)
Query: 25 EDGATLLKIKKSFRDVDNVLYDWTDSPSSDYCVWRGITCDNVTFTVIALNLSGLNLDGEI 84
+ L+ K D N+L DW S + + C + G+TC + V +++LS L+
Sbjct: 12 REIHQLISFKDVLPD-KNLLPDW--SSNKNPCTFDGVTCRDDK--VTSIDLSSKPLNVGF 66
Query: 85 SPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEF 144
+ + + L+SL LS + + G + L
Sbjct: 67 ---------------------SAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTS 104
Query: 145 LILKNNQLIGPIPS--TLSQLPNLKVFGLRGNNLVGTLS-PDMCQLSGLWYFDVRNNSLT 201
L L N L GP+ + +L LK + N L +L+ L D+ NS++
Sbjct: 105 LDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSIS 164
Query: 202 GSIPQNI---GNCTSFQVLDLSYNQLSGEIPF-NIGFLQIATLSLQGNQLTGKIPSVIGL 257
G+ C + L +S N++SG++ L+ L + N + IP +G
Sbjct: 165 GANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLE--FLDVSSNNFSTGIPF-LGD 221
Query: 258 MQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDN 317
AL LD+S N LSG + + + L + SN+ G IPP + L YL L +N
Sbjct: 222 CSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAEN 279
Query: 318 QLTGHIPPAL-GKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPP-AF 375
+ TG IP L G L L+++ NH G +P SC+ L SL + N +G +P
Sbjct: 280 KFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTL 339
Query: 376 QRLESMTYLNLSLNNIRGPIPVELSRI-GNLDTLDMSNNKISGSIPSPLGD--LEHLLKL 432
++ + L+LS N G +P L+ + +L TLD+S+N SG I L L +L
Sbjct: 340 LKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQEL 399
Query: 433 NLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDV- 491
L N TG IP N ++ + LS N+L+G IP L L + L+L N L G++
Sbjct: 400 YLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIP 459
Query: 492 MSLINCLSLSVLFIGN 507
L+ +L L +
Sbjct: 460 QELMYVKTLETLILDF 475
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 407 bits (1048), Expect = e-129
Identities = 141/439 (32%), Positives = 211/439 (48%), Gaps = 16/439 (3%)
Query: 73 LNLSGLNLDGEIS-PAVGDLKDLQSIDLRGNRLSGQIPDEI---GDCSSLKSLDLSFNEL 128
LN+S LD L L+ +DL N +SG C LK L +S N++
Sbjct: 131 LNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKI 190
Query: 129 YGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLS 188
GD+ +S+ LEFL + +N IP L L+ + GN L G S + +
Sbjct: 191 SGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCT 247
Query: 189 GLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFL--QIATLSLQGNQ 246
L ++ +N G IP S Q L L+ N+ +GEIP + + L L GN
Sbjct: 248 ELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNH 305
Query: 247 LTGKIPSVIGLMQALAVLDLSCNMLSGPIPP-ILGNLSYTEKLYLHSNKLTGHIPPELGN 305
G +P G L L LS N SG +P L + + L L N+ +G +P L N
Sbjct: 306 FYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTN 365
Query: 306 MT-KLHYLELNDNQLTGHIPPALGK--LTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNV 362
++ L L+L+ N +G I P L + L +L + NN G IP LS+C+ L SL++
Sbjct: 366 LSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHL 425
Query: 363 HGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSP 422
N L+GTIP + L + L L LN + G IP EL + L+TL + N ++G IPS
Sbjct: 426 SFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSG 485
Query: 423 LGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRL 482
L + +L ++LS N+LTG IP G L ++ + LS+N +G IP EL +++ L L
Sbjct: 486 LSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDL 545
Query: 483 DYNNLSGDV-MSLINCLSL 500
+ N +G + ++
Sbjct: 546 NTNLFNGTIPAAMFKQSGK 564
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 406 bits (1047), Expect = e-129
Identities = 144/435 (33%), Positives = 216/435 (49%), Gaps = 17/435 (3%)
Query: 73 LNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDI 132
L +SG + G++ V +L+ +D+ N S IP +GDCS+L+ LD+S N+L GD
Sbjct: 183 LAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDF 239
Query: 133 PFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMC-QLSGLW 191
+IS +L+ L + +NQ +GPIP L +L+ L N G + + L
Sbjct: 240 SRAISTCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLT 297
Query: 192 YFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFN-IGFL-QIATLSLQGNQLTG 249
D+ N G++P G+C+ + L LS N SGE+P + + + + L L N+ +G
Sbjct: 298 GLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSG 357
Query: 250 KIPSVIG-LMQALAVLDLSCNMLSGPIPPILGN--LSYTEKLYLHSNKLTGHIPPELGNM 306
++P + L +L LDLS N SGPI P L + ++LYL +N TG IPP L N
Sbjct: 358 ELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNC 417
Query: 307 TKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNK 366
++L L L+ N L+G IP +LG L+ L DL + N LEG IP L L +L + N
Sbjct: 418 SELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFND 477
Query: 367 LNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDL 426
L G IP ++ +++LS N + G IP + R+ NL L +SNN SG+IP+ LGD
Sbjct: 478 LTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDC 537
Query: 427 EHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYN- 485
L+ L+L+ N G IP ++ N + G + N
Sbjct: 538 RSLIWLDLNTNLFNGTIPAAMFKQSG----KIAANFIAGKRYVYIKNDGMKKECHGAGNL 593
Query: 486 -NLSGDVMSLINCLS 499
G +N LS
Sbjct: 594 LEFQGIRSEQLNRLS 608
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-35
Identities = 43/183 (23%), Positives = 61/183 (33%), Gaps = 24/183 (13%)
Query: 63 CDNVTFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLD 122
++ + L G S + L ++ G + S+ LD
Sbjct: 579 KNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLD 638
Query: 123 LSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSP 182
+S+N L G IP I + L L L +N + G IP + L L
Sbjct: 639 MSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLN--------------- 683
Query: 183 DMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSL 242
D+ +N L G IPQ + T +DLS N LSG IP F
Sbjct: 684 ---------ILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKF 734
Query: 243 QGN 245
N
Sbjct: 735 LNN 737
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 4e-04
Identities = 18/67 (26%), Positives = 26/67 (38%), Gaps = 3/67 (4%)
Query: 449 NLRSVMEIDLSHNHLT---GVIPEELSQLQNMFSLRLDYNNLSGDVMSLINCLSLSVLFI 505
V IDLS L + L L + SL L ++++G V SL+ L +
Sbjct: 48 RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDL 107
Query: 506 GNPGLCG 512
L G
Sbjct: 108 SRNSLSG 114
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 342 bits (879), Expect = e-110
Identities = 111/286 (38%), Positives = 172/286 (60%), Gaps = 10/286 (3%)
Query: 590 YEDIMRMTENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLK-EFETELETV 648
++ ++N S K I+G G VYK L + VA+KRL Q + +F+TE+E +
Sbjct: 22 LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMI 81
Query: 649 GSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTK-KKKLDWDTRLKIALGAA 707
HRNL+ L+G+ ++ + LL Y +M NGS+ L + + LDW R +IALG+A
Sbjct: 82 SMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSA 141
Query: 708 QGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGY 767
+GLAYLH C P+IIHRDVK++NILLD++FEA + DFG+AK + ++ +T + GTIG+
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 201
Query: 768 IDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDN-------ECNLHHLILSKTANNAV 820
I PEY T + +EK+DV+ +G++LLEL+TG++A D + L + +
Sbjct: 202 IAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 261
Query: 821 METVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866
VD ++ V+++ Q+ALLC++ P +RP M EV R+L
Sbjct: 262 EALVDVDLQGNY-KDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 333 bits (856), Expect = e-107
Identities = 115/284 (40%), Positives = 163/284 (57%), Gaps = 11/284 (3%)
Query: 590 YEDIMRMTENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVG 649
D+ T N K++IG+G VYK VL++ VA+KR Q ++EFETE+ET+
Sbjct: 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLS 90
Query: 650 SIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKK-LDWDTRLKIALGAAQ 708
+H +LVSL G+ + +L Y +MENG+L L+G + W+ RL+I +GAA+
Sbjct: 91 FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150
Query: 709 GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKS-LCVSKSYTSTYIMGTIGY 767
GL YLH IIHRDVKS NILLD++F +TDFGI+K + +++ ST + GT+GY
Sbjct: 151 GLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGY 207
Query: 768 IDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVD-----NECNLHHLILSKTANNAVME 822
IDPEY RLTEKSDVYSFG+VL E+L R A+ NL + N + +
Sbjct: 208 IDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ 267
Query: 823 TVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866
VDP ++ +++K A+ C DRP+M +V L
Sbjct: 268 IVDPNLADKI-RPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 333 bits (855), Expect = e-103
Identities = 99/541 (18%), Positives = 176/541 (32%), Gaps = 65/541 (12%)
Query: 23 DSEDGATLLKIKKSFRDVDNVLYDWTDS--------------------PSSDYCVWR--- 59
D L + L + D+ + + +W
Sbjct: 14 DDAIVPIKLSRTAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQP 73
Query: 60 GITCDNVTFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQ----IPDEIGDC 115
G++ ++ V L+L G G + A+G L +L+ + L + P I
Sbjct: 74 GVSLNSNGR-VTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISAN 132
Query: 116 SSLKSLDLSFNELYGDIPFSISKLK--QLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRG 173
S + + L + ++ I + G
Sbjct: 133 MSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLS 192
Query: 174 NNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIG 233
NN+ +S + +L+ L F + N+ + Y Q
Sbjct: 193 NNI-TFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENEN-----SEYAQQYKTEDLKWD 246
Query: 234 FLQ-IATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNML--------SGPIPPILGNLSY 284
L+ + + + K+P+ + + + +++++CN
Sbjct: 247 NLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEK 306
Query: 285 TEKLYLHSNKL-TGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHL 343
+ +Y+ N L T + L M KL LE NQL G PA G L LN+A N +
Sbjct: 307 IQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQI 365
Query: 344 EGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQ--RLESMTYLNLSLNNIRG-------P 394
+ + +L+ NKL IP F + M+ ++ S N I P
Sbjct: 366 TEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDP 424
Query: 395 IPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGF-------IPGEF 447
+ + N+ ++++SNN+IS L +NL N LT F
Sbjct: 425 LDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENF 484
Query: 448 GNLRSVMEIDLSHNHLTGVIPE-ELSQLQNMFSLRLDYNNLSGDVMSLINCLSLSVLFIG 506
N + IDL N LT + + + L + + L YN+ S +N +L I
Sbjct: 485 KNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFGIR 544
Query: 507 N 507
N
Sbjct: 545 N 545
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 297 bits (762), Expect = 2e-89
Identities = 74/449 (16%), Positives = 154/449 (34%), Gaps = 45/449 (10%)
Query: 73 LNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDI 132
+ N+ +S AV L L+ + + + C + ++ + + + Y
Sbjct: 188 IGQLSNNI-TFVSKAVMRLTKLRQFYMGNSPFVAENI-----CEAWENENSEYAQQYKTE 241
Query: 133 PFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLV--------GTLSPDM 184
LK L + + N + +P+ L LP +++ + N + D
Sbjct: 242 DLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADA 301
Query: 185 CQLSGLWYFDVRNNSL-TGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQ-IATLSL 242
+ + N+L T + ++ +L+ YNQL G++P G +A+L+L
Sbjct: 302 PVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNL 360
Query: 243 QGNQLTGKIPSVIGLMQALAVLDLSCNMLSG-PIPPILGNLSYTEKLYLHSNKLTG---- 297
NQ+T + G + + L + N L P ++S + N++
Sbjct: 361 AYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGK 420
Query: 298 ---HIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEG-------PI 347
+ P + + L++NQ++ + L +N+ N L
Sbjct: 421 NFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDE 480
Query: 348 PDNLSSCTNLNSLNVHGNKLNGTIPPAFQ--RLESMTYLNLSLNNIRGPIPVELSRIGNL 405
+N + L S+++ NKL + F+ L + ++LS N+ P + L
Sbjct: 481 NENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTL 538
Query: 406 DTLDMSN------NKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLS 459
+ N N+ P + L +L + N + N+ +D+
Sbjct: 539 KGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKITPNISV---LDIK 595
Query: 460 HNHLTGVIPEELSQLQNMFSLRLDYNNLS 488
N + + L Y+
Sbjct: 596 DNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 228 bits (582), Expect = 2e-64
Identities = 58/356 (16%), Positives = 115/356 (32%), Gaps = 32/356 (8%)
Query: 73 LNLSGLNLDGEISPAVGDLKDLQSIDLRGNRL-SGQIPDEIGDCSSLKSLDLSFNELYGD 131
++ L D + + +Q I + N L + + + L L+ +N+L G
Sbjct: 286 ISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGK 345
Query: 132 IPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSP-DMCQLSGL 190
+P + +L L L NQ+ + ++ N L + D +S +
Sbjct: 346 LP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVM 404
Query: 191 WYFDVRNNSLTG-------SIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFL-QIATLSL 242
D N + + + ++LS NQ+S +++++L
Sbjct: 405 SAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINL 464
Query: 243 QGNQLTG-------KIPSVIGLMQALAVLDLSCNMLSGPIPPI-LGNLSYTEKLYLHSNK 294
GN LT L +DL N L+ L Y + L N
Sbjct: 465 MGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNS 524
Query: 295 LTGHIPPELGNMTKL------HYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIP 348
+ P + N + L + + N+ P + L L + +N + +
Sbjct: 525 FSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VN 582
Query: 349 DNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNN---IRGPIPVELSR 401
+ + N++ L++ N L + IRG +++ R
Sbjct: 583 EKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQDIRGCDALDIKR 636
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 311 bits (800), Expect = 5e-99
Identities = 93/298 (31%), Positives = 154/298 (51%), Gaps = 26/298 (8%)
Query: 590 YEDIMRMTENLSEKY------IIGYGASSTVYKCVLKNCKPVAIKRLYSHYP----QCLK 639
+ ++ +T N E+ +G G VYK + N VA+K+L + + +
Sbjct: 17 FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEELKQ 75
Query: 640 EFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTR 699
+F+ E++ + +H NLV L G+S L Y +M NGSL D L L W R
Sbjct: 76 QFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMR 135
Query: 700 LKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV-SKSYTS 758
KIA GAA G+ +LH + IHRD+KS+NILLD+ F A ++DFG+A++ +++ +
Sbjct: 136 CKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMT 192
Query: 759 TYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHL------IL 812
+ I+GT Y+ PE +T KSD+YSFG+VLLE++TG AVD L I
Sbjct: 193 SRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIE 251
Query: 813 SKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLV 870
+ + + +D +++ +V+ ++ +A C + RP + +V ++L +
Sbjct: 252 DE--EKTIEDYIDKKMNDADST--SVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 297 bits (763), Expect = 1e-93
Identities = 95/340 (27%), Positives = 146/340 (42%), Gaps = 37/340 (10%)
Query: 23 DSEDGATLLKIKKSFRDVDNVLYDWTDSPSSDYCVWRGITCDNVT--FTVIALNLSGLNL 80
+ +D LL+IKK + L W + W G+ CD T + V L+LSGLNL
Sbjct: 4 NPQDKQALLQIKKDLGN-PTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNL 62
Query: 81 DGE--ISPAVGDLKDLQSIDLRG-NRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSIS 137
I ++ +L L + + G N L G IP I + L L ++ + G IP +S
Sbjct: 63 PKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLS 122
Query: 138 KLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRN 197
++K L L N L G +P ++S LPNL
Sbjct: 123 QIKTLVTLDFSYNALSGTLPPSISSLPNLV------------------------GITFDG 158
Query: 198 NSLTGSIPQNIGNCTS-FQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIG 256
N ++G+IP + G+ + F + +S N+L+G+IP L +A + L N L G + G
Sbjct: 159 NRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFG 218
Query: 257 LMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELND 316
+ + L+ N L+ + +G L L +N++ G +P L + LH L ++
Sbjct: 219 SDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSF 277
Query: 317 NQLTGHIPPALGKLTDLFDLNVA-NNHLEGPIPDNLSSCT 355
N L G I P G L A N L G L +CT
Sbjct: 278 NNLCGEI-PQGGNLQRFDVSAYANNKCLCGSP---LPACT 313
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 297 bits (762), Expect = 2e-93
Identities = 85/282 (30%), Positives = 140/282 (49%), Gaps = 7/282 (2%)
Query: 239 TLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSG--PIPPILGNLSYTEKLYLHS-NKL 295
T G + + LDLS L PIP L NL Y LY+ N L
Sbjct: 30 TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNL 89
Query: 296 TGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCT 355
G IPP + +T+LHYL + ++G IP L ++ L L+ + N L G +P ++SS
Sbjct: 90 VGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLP 149
Query: 356 NLNSLNVHGNKLNGTIPPAFQRLESM-TYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNK 414
NL + GN+++G IP ++ + T + +S N + G IP + + NL +D+S N
Sbjct: 150 NLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNM 208
Query: 415 ISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQL 474
+ G G ++ K++L++N L + + G +++ +DL +N + G +P+ L+QL
Sbjct: 209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQL 267
Query: 475 QNMFSLRLDYNNLSGDVMSLINCLSLSVL-FIGNPGLCGYWL 515
+ + SL + +NNL G++ N V + N LCG L
Sbjct: 268 KFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPL 309
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-33
Identities = 41/164 (25%), Positives = 75/164 (45%), Gaps = 8/164 (4%)
Query: 347 IPDNLSSCTNLNS----LNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRG--PIPVELS 400
I +L + T L+S + G + + + L+LS N+ PIP L+
Sbjct: 14 IKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLA 73
Query: 401 RIGNLDTLDMSN-NKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLS 459
+ L+ L + N + G IP + L L L ++ ++G IP +++++ +D S
Sbjct: 74 NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFS 133
Query: 460 HNHLTGVIPEELSQLQNMFSLRLDYNNLSGDV-MSLINCLSLSV 502
+N L+G +P +S L N+ + D N +SG + S + L
Sbjct: 134 YNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFT 177
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 6e-17
Identities = 25/106 (23%), Positives = 41/106 (38%), Gaps = 4/106 (3%)
Query: 406 DTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTG--FIPGEFGNLRSVMEIDLSH-NH 462
T D N G + + L+LS L IP NL + + + N+
Sbjct: 29 PTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINN 88
Query: 463 LTGVIPEELSQLQNMFSLRLDYNNLSGDV-MSLINCLSLSVLFIGN 507
L G IP +++L + L + + N+SG + L +L L
Sbjct: 89 LVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSY 134
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 290 bits (744), Expect = 2e-86
Identities = 99/458 (21%), Positives = 174/458 (37%), Gaps = 26/458 (5%)
Query: 73 LNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDI 132
+ S L L ++ + ++ ++L N+L S L SLD+ FN +
Sbjct: 9 ADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLE 65
Query: 133 PFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWY 192
P KL L+ L L++N+L T + NL L N++ + + L
Sbjct: 66 PELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLIT 125
Query: 193 FDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFL---QIATLSLQGNQLTG 249
D+ +N L+ + + Q L LS N++ + + L L NQ+
Sbjct: 126 LDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKE 185
Query: 250 KIPSVIGLMQALAVLDLSCNMLSGPIPPILG---NLSYTEKLYLHSNKLTGHIPPELGNM 306
P + L L L+ L + L + L L +++L+ +
Sbjct: 186 FSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGL 245
Query: 307 --TKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHG 364
T L L+L+ N L + L L + N+++ +L N+ LN+
Sbjct: 246 KWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKR 305
Query: 365 N---------KLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKI 415
+ L +FQ L+ + +LN+ N+I G + + NL L +SN+
Sbjct: 306 SFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFT 365
Query: 416 SGSIPSP--LGDLEH--LLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIP-EE 470
S + L H L LNL++N+++ F L + +DL N + + +E
Sbjct: 366 SLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQE 425
Query: 471 LSQLQNMFSLRLDYNNLSG-DVMSLINCLSLSVLFIGN 507
L+N+F + L YN S SL L +
Sbjct: 426 WRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRR 463
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 279 bits (715), Expect = 2e-82
Identities = 85/449 (18%), Positives = 161/449 (35%), Gaps = 31/449 (6%)
Query: 73 LNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGD---CSSLKSLDLSFNELY 129
L LS + + L + L +L + +++ +S+++L LS ++L
Sbjct: 176 LELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLS 235
Query: 130 GDIPFSISKLK--QLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQL 187
+ LK L L L N L + + LP L+ F L NN+ S + L
Sbjct: 236 TTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGL 295
Query: 188 SGLWYFDVRNN---------SLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFL-QI 237
+ Y +++ + SL + + L++ N + G L +
Sbjct: 296 FNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINL 355
Query: 238 ATLSLQGNQLTGKIPSVIGLMQ----ALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSN 293
LSL + + + + + L +L+L+ N +S L + E L L N
Sbjct: 356 KYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLN 415
Query: 294 KLTGHIPP-ELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEG--PIPDN 350
++ + E + + + L+ N+ + + L L + L+ P
Sbjct: 416 EIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSP 475
Query: 351 LSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNI--------RGPIPVELSRI 402
NL L++ N + + LE + L+L NN+ G L +
Sbjct: 476 FQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGL 535
Query: 403 GNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNH 462
+L L++ +N DL L ++L N L F N S+ ++L N
Sbjct: 536 SHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNL 595
Query: 463 LTGVIPEELS-QLQNMFSLRLDYNNLSGD 490
+T V + +N+ L + +N
Sbjct: 596 ITSVEKKVFGPAFRNLTELDMRFNPFDCT 624
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 252 bits (646), Expect = 1e-72
Identities = 82/438 (18%), Positives = 154/438 (35%), Gaps = 50/438 (11%)
Query: 117 SLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNL 176
S + D S +L +P + + L L +NQL + ++ L + N +
Sbjct: 5 SHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 177 VGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFL- 235
+L L ++++N L+ + CT+ L L N +
Sbjct: 62 SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121
Query: 236 QIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYT--EKLYLHSN 293
+ TL L N L+ ++ L L LS N + L + + +KL L SN
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSN 181
Query: 294 KLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALG---KLTDLFDLNVANNHLEGPIPDN 350
++ P + +L L LN+ QL + L T + +L+++N+ L
Sbjct: 182 QIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTT 241
Query: 351 LSSC--TNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTL 408
TNL L++ N LN +F L + Y L NNI+ L + N+ L
Sbjct: 242 FLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYL 301
Query: 409 DMSNN---------KISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLS 459
++ + + L+ L LN+ N + G F L ++ + LS
Sbjct: 302 NLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLS 361
Query: 460 H----------------------------NHLTGVIPEELSQLQNMFSLRLDYNNLSGDV 491
+ N ++ + + S L ++ L L N + ++
Sbjct: 362 NSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQEL 421
Query: 492 --MSLINCLSLSVLFIGN 507
++ +++
Sbjct: 422 TGQEWRGLENIFEIYLSY 439
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 2e-58
Identities = 75/306 (24%), Positives = 124/306 (40%), Gaps = 11/306 (3%)
Query: 211 CT-SFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCN 269
CT S +V D S+ +L+ ++P ++ I L+L NQL + L LD+ N
Sbjct: 2 CTVSHEVADCSHLKLT-QVPDDL-PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFN 59
Query: 270 MLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGK 329
+S P + L + L L N+L+ T L L L N + K
Sbjct: 60 TISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVK 119
Query: 330 LTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLE--SMTYLNLS 387
+L L++++N L NL L + NK+ S+ L LS
Sbjct: 120 QKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELS 179
Query: 388 LNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGD---LEHLLKLNLSRNQLTGFIP 444
N I+ P IG L L ++N ++ S+ L + L+LS +QL+
Sbjct: 180 SNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSN 239
Query: 445 GEFGNLR--SVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSG-DVMSLINCLSLS 501
F L+ ++ +DLS+N+L V + + L + L+YNN+ SL ++
Sbjct: 240 TTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVR 299
Query: 502 VLFIGN 507
L +
Sbjct: 300 YLNLKR 305
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 271 bits (694), Expect = 3e-80
Identities = 88/483 (18%), Positives = 158/483 (32%), Gaps = 42/483 (8%)
Query: 64 DNVTFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDL 123
DN+ F+ L+LS L S + +LQ +DL + S L +L L
Sbjct: 24 DNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLIL 83
Query: 124 SFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPD 183
+ N + + S L L+ L+ L + L LK + N + P+
Sbjct: 84 TGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPE 143
Query: 184 M-CQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQV----LDLSYNQLSGEIPFNIGFLQIA 238
L+ L + D+ +N + ++ + LDLS N ++ P +++
Sbjct: 144 YFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLH 203
Query: 239 TLSLQGNQLTGKIPSVIGL-MQALAVLDLS------CNMLSGPIPPILGNLSYTEKLYLH 291
L+L+ N + + + L V L L L L
Sbjct: 204 KLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFR 263
Query: 292 SNKL---TGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIP 348
L I +T + L + L + N
Sbjct: 264 LAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPT 321
Query: 349 DNLSS-------------------CTNLNSLNVHGNKLN--GTIPPAFQRLESMTYLNLS 387
L S +L L++ N L+ G + S+ YL+LS
Sbjct: 322 LKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLS 381
Query: 388 LNNIRGPIPVELSRIGNLDTLDMSNNKISGSIP-SPLGDLEHLLKLNLSRNQLTGFIPGE 446
N + + + L+ LD ++ + S L +L+ L++S G
Sbjct: 382 FNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI 440
Query: 447 FGNLRSVMEIDLSHNHLTGVI-PEELSQLQNMFSLRLDYNNLSG-DVMSLINCLSLSVLF 504
F L S+ + ++ N P+ ++L+N+ L L L + + SL VL
Sbjct: 441 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 500
Query: 505 IGN 507
+ +
Sbjct: 501 MSH 503
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 249 bits (639), Expect = 2e-72
Identities = 86/457 (18%), Positives = 156/457 (34%), Gaps = 42/457 (9%)
Query: 73 LNLSGLNLDG-EISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLK----SLDLSFNE 127
LN++ + ++ +L +L+ +DL N++ ++ + SLDLS N
Sbjct: 129 LNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188
Query: 128 LYGDIPFSISKLKQLEFLILKNNQLIGPIPST-LSQLPNLKVFGLRGNNLVGT---LSPD 183
+ I K +L L L+NN + T + L L+V L D
Sbjct: 189 MNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFD 247
Query: 184 MCQLSGLWYFDVRNNSLT------GSIPQNIGNCTSFQVLDLSYNQLSGEIPF------- 230
L GL + L I T+ L + F
Sbjct: 248 KSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQ 307
Query: 231 ----------NIGFLQIATL-SLQGNQLTGKIPSVIGLMQALAVLDLSCNMLS--GPIPP 277
L++ +L L G + +L LDLS N LS G
Sbjct: 308 HLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQ 367
Query: 278 ILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPP-ALGKLTDLFDL 336
+ + L L N + + + +L +L+ + L L +L L
Sbjct: 368 SDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYL 426
Query: 337 NVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPP-AFQRLESMTYLNLSLNNIRGPI 395
++++ H + ++L L + GN P F L ++T+L+LS +
Sbjct: 427 DISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLS 486
Query: 396 PVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNL-RSVM 454
P + + +L L+MS+N P L L L+ S N + E + S+
Sbjct: 487 PTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLA 546
Query: 455 EIDLSHNHLTGVIPEE--LSQLQNMFSLRLDYNNLSG 489
++L+ N + L +++ L ++ +
Sbjct: 547 FLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMEC 583
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 2e-65
Identities = 88/442 (19%), Positives = 160/442 (36%), Gaps = 33/442 (7%)
Query: 86 PAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFL 145
P V + ++ + +IPD + S K+LDLSFN L +S +L+ L
Sbjct: 2 PCVEVVPNI-TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVL 57
Query: 146 ILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIP 205
L ++ L +L L GN + LS L +L
Sbjct: 58 DLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLEN 117
Query: 206 QNIGNCTSFQVLDLSYNQL-SGEIPFNIGFL-QIATLSLQGNQLTGKIPSVIGLMQAL-- 261
IG+ + + L++++N + S ++P L + L L N++ + + ++ +
Sbjct: 118 FPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPL 177
Query: 262 --AVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPE-LGNMTKLHYLELNDNQ 318
LDLS N ++ P + KL L +N + ++ + + L L +
Sbjct: 178 LNLSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGE 236
Query: 319 LTGHI---PPALGKLTDLFDLNVANNHLE------GPIPDNLSSCTNLNSLNVHGNKLNG 369
L L +L + L I D + TN++S ++ +
Sbjct: 237 FRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER 296
Query: 370 TIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHL 429
F +L L ++L +L L ++NK DL L
Sbjct: 297 VKD--FSYNFGWQHLELVNCKFGQFPTLKLK---SLKRLTFTSNKGGN--AFSEVDLPSL 349
Query: 430 LKLNLSRNQLT--GFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNL 487
L+LSRN L+ G S+ +DLS N + + L+ + L ++NL
Sbjct: 350 EFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNL 408
Query: 488 SG--DVMSLINCLSLSVLFIGN 507
+ ++ +L L I +
Sbjct: 409 KQMSEFSVFLSLRNLIYLDISH 430
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-09
Identities = 21/95 (22%), Positives = 37/95 (38%), Gaps = 3/95 (3%)
Query: 73 LNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDC-SSLKSLDLSFNELYGD 131
LN+S N + L LQ +D N + E+ SSL L+L+ N+
Sbjct: 499 LNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 558
Query: 132 IPFS--ISKLKQLEFLILKNNQLIGPIPSTLSQLP 164
+ +K L+++ ++ PS +P
Sbjct: 559 CEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMP 593
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 268 bits (688), Expect = 2e-79
Identities = 81/450 (18%), Positives = 153/450 (34%), Gaps = 17/450 (3%)
Query: 73 LNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDI 132
L+L+ + L ++ L N L + +LK L +
Sbjct: 62 LDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSID 121
Query: 133 PFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGL-- 190
+ K LE L L +N + LKV + N + DM L
Sbjct: 122 FIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATN 181
Query: 191 WYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIA---TLSLQGNQL 247
++ N + I + FQ L+ Q I + I + +
Sbjct: 182 LSLNLNGNDIA-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDD 240
Query: 248 TGKIPSVIGLMQALAV--LDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGN 305
P+V + ++V ++L + S ++L L + L+ +P L
Sbjct: 241 EDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVG 299
Query: 306 MTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDN-LSSCTNLNSLNVHG 364
++ L L L+ N+ + L L++ N + L + NL L++
Sbjct: 300 LSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSH 359
Query: 365 NKLN--GTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIP-S 421
+ + + L + LNLS N L+ LD++ ++ S
Sbjct: 360 DDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQS 419
Query: 422 PLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLR 481
P +L L LNLS + L F L ++ ++L NH ++ + LQ + L
Sbjct: 420 PFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLE 479
Query: 482 ---LDYNNLSG-DVMSLINCLSLSVLFIGN 507
L + +LS D + + ++ + + +
Sbjct: 480 ILVLSFCDLSSIDQHAFTSLKMMNHVDLSH 509
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 264 bits (676), Expect = 1e-77
Identities = 87/474 (18%), Positives = 159/474 (33%), Gaps = 44/474 (9%)
Query: 73 LNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDI 132
N L L+ EI + + ++ N L +L LDL+ ++Y
Sbjct: 17 YNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73
Query: 133 PFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWY 192
+ +L+ L+L N LI + LS LK + + L
Sbjct: 74 EDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLES 133
Query: 193 FDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFL---QIATLSLQGNQLTG 249
+ +N ++ +VLD N + ++ L +L+L GN + G
Sbjct: 134 LYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG 193
Query: 250 KIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYT------------------------ 285
I L+ I L N +
Sbjct: 194 -IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLC 252
Query: 286 ----EKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANN 341
E + L + + L L+L L+ +P L L+ L L ++ N
Sbjct: 253 EMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSAN 311
Query: 342 HLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPP-AFQRLESMTYLNLSLNNIR--GPIPVE 398
E + S+ +L L++ GN + + LE++ L+LS ++I ++
Sbjct: 312 KFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQ 371
Query: 399 LSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIP-GEFGNLRSVMEID 457
L + +L +L++S N+ + L L+L+ +L F NL + ++
Sbjct: 372 LRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLN 431
Query: 458 LSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDVMSLINCL----SLSVLFIGN 507
LSH+ L + L + L L N+ + N L L +L +
Sbjct: 432 LSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSF 485
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 250 bits (640), Expect = 2e-72
Identities = 91/452 (20%), Positives = 150/452 (33%), Gaps = 19/452 (4%)
Query: 73 LNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDI 132
L + + + K L+S+ L N +S + LK LD N ++
Sbjct: 110 LFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLS 169
Query: 133 PFSISKLKQLE--FLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDM--CQLS 188
+S L+Q L L N I I + G + + + +
Sbjct: 170 KEDMSSLQQATNLSLNLNGND-IAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQ 228
Query: 189 GLWYFDVRNNSLTGSIPQNIGNC--TSFQVLDLSYNQLSGEIPFNIGFL-QIATLSLQGN 245
LW + P S + ++L + + L L
Sbjct: 229 SLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTAT 288
Query: 246 QLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPE-LG 304
L+ ++PS + + L L LS N N L + N + L
Sbjct: 289 HLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLE 347
Query: 305 NMTKLHYLELNDNQLT--GHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNV 362
N+ L L+L+ + + L L+ L LN++ N + C L L++
Sbjct: 348 NLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDL 407
Query: 363 HGNKLNGTIPP-AFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPS 421
+L FQ L + LNLS + + + L L++ N
Sbjct: 408 AFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQ 467
Query: 422 P---LGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMF 478
L L L L LS L+ F +L+ + +DLSHN LT E LS L+ ++
Sbjct: 468 KTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY 527
Query: 479 SLRLDYNNLSG-DVMSLINCLSLSVLFI-GNP 508
L L N++S L + + NP
Sbjct: 528 -LNLASNHISIILPSLLPILSQQRTINLRQNP 558
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 245 bits (628), Expect = 7e-71
Identities = 79/432 (18%), Positives = 159/432 (36%), Gaps = 17/432 (3%)
Query: 73 LNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLK--SLDLSFNELYG 130
L L ++ P + L+ +D + N + +++ SL+L+ N++
Sbjct: 134 LYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI-A 192
Query: 131 DIPFSISKLKQLEFLILKNNQLIGPIPSTLS--QLPNLKVFGLRGNNL--VGTLSPDMCQ 186
I + L Q + I L + +L + + + +
Sbjct: 193 GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLC 252
Query: 187 LSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFL-QIATLSLQGN 245
+ +++ + + Q LDL+ LS E+P + L + L L N
Sbjct: 253 EMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSAN 311
Query: 246 QLTGKIPSVIGLMQALAVLDLSCNMLSGPIPP-ILGNLSYTEKLYLHSNKLT--GHIPPE 302
+ +L L + N + L NL +L L + + +
Sbjct: 312 KFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQ 371
Query: 303 LGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDN-LSSCTNLNSLN 361
L N++ L L L+ N+ A + L L++A L+ + + L LN
Sbjct: 372 LRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLN 431
Query: 362 VHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVE---LSRIGNLDTLDMSNNKISGS 418
+ + L+ + F L ++ +LNL N+ + L +G L+ L +S +S
Sbjct: 432 LSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSI 491
Query: 419 IPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMF 478
L+ + ++LS N+LT +L+ + ++L+ NH++ ++P L L
Sbjct: 492 DQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQR 550
Query: 479 SLRLDYNNLSGD 490
++ L N L
Sbjct: 551 TINLRQNPLDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 3e-46
Identities = 53/299 (17%), Positives = 90/299 (30%), Gaps = 9/299 (3%)
Query: 215 QVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGP 274
+ + L+ EIP + L N L + + L LDL+ +
Sbjct: 15 KTYNCENLGLN-EIPGTL-PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI 72
Query: 275 IPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLF 334
+ + L L +N L L L +L ++ L L
Sbjct: 73 HEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLE 132
Query: 335 DLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMT--YLNLSLNNIR 392
L + +NH+ L L+ N ++ L+ T LNL+ N+I
Sbjct: 133 SLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA 192
Query: 393 GPIPVELSRIGNLDTLDMSNNKISGSIPSPLG--DLEHLLKLNLSRNQLTGFIPGEFGNL 450
G I +L+ + I L ++ L P F L
Sbjct: 193 G-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251
Query: 451 R--SVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDVMSLINCLSLSVLFIGN 507
SV I+L ++ + + L L +LS L+ +L L +
Sbjct: 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSA 310
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-34
Identities = 39/221 (17%), Positives = 73/221 (33%), Gaps = 6/221 (2%)
Query: 285 TEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLE 344
+ + L IP L N LE + N L +L +L L++ +
Sbjct: 14 NKTYNCENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIY 70
Query: 345 GPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGN 404
D S L++L + N L A +++ +L I + L
Sbjct: 71 WIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKT 130
Query: 405 LDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRS--VMEIDLSHNH 462
L++L + +N IS E L L+ N + + +L+ + ++L+ N
Sbjct: 131 LESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGND 190
Query: 463 LTGVIPEELSQLQNMFSLRLDYNNLSGDVMSLINCLSLSVL 503
+ G I SL + + ++ L
Sbjct: 191 IAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSL 230
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-30
Identities = 54/254 (21%), Positives = 98/254 (38%), Gaps = 10/254 (3%)
Query: 73 LNLSG--LNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYG 130
L+LS + + + +L LQS++L N + +C L+ LDL+F L
Sbjct: 355 LDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKV 414
Query: 131 DIPFSI-SKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGT---LSPDMCQ 186
S L L+ L L ++ L LP L+ L+GN+ + +
Sbjct: 415 KDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQT 474
Query: 187 LSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQ 246
L L + L+ + +DLS+N+L+ + L+ L+L N
Sbjct: 475 LGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNH 534
Query: 247 LTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNM 306
++ +PS++ ++ ++L N L N+ + E + KL N
Sbjct: 535 ISIILPSLLPILSQQRTINLRQNPLDC----TCSNIYFLEWYKENMQKLEDTEDTLCENP 590
Query: 307 TKLHYLELNDNQLT 320
L + L+D L+
Sbjct: 591 PLLRGVRLSDVTLS 604
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 263 bits (674), Expect = 4e-75
Identities = 87/576 (15%), Positives = 177/576 (30%), Gaps = 108/576 (18%)
Query: 25 EDGATLLKIKKSFRDVDNVLYDWTDSPSSDYCVWR------------GITCDNVTFTVIA 72
+D L I ++ + Y T + + W G+ DN V
Sbjct: 269 KDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNG-RVTG 327
Query: 73 LNLSGLNLDGEISPAVGDLKDLQSID------------------------LRGNRLSGQI 108
L+L+G G + A+G L +L+ + R +R+
Sbjct: 328 LSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHY 387
Query: 109 PDEIGDC-SSLKSLDLS------FNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLS 161
D L DL E+ S LK + L N I I +
Sbjct: 388 KKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNR--ITFISKAIQ 445
Query: 162 QLPNLKVFGLRGNNLVG-------------------TLSPDMCQLSGLWYFDVRNNSLTG 202
+L L++ + L L ++ N
Sbjct: 446 RLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMT 505
Query: 203 SIPQNIGNCTSFQVLDLSYNQLSG---------EIPFNIGFL-QIATLSLQGNQLTG-KI 251
+P + + Q L+++ N+ + + +I + N L
Sbjct: 506 QLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPA 565
Query: 252 PSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELG-NMTKLH 310
+ + M L +LD N + G L L N++ IP + ++
Sbjct: 566 SASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVE 622
Query: 311 YLELNDNQLTGHIPPA--LGKLTDLFDLNVANNHLEGPIPDNLSS-----CTNLNSLNVH 363
L + N+L IP + + ++ + N + + S N +++ +
Sbjct: 623 GLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLS 681
Query: 364 GNKLNGTIPPAFQRLESMTYLNLSLNNIR-------GPIPVELSRIGNLDTLDMSNNKIS 416
N++ F ++ + LS N + P L T+D+ NK++
Sbjct: 682 YNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT 741
Query: 417 GSIPSPL--GDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSH------NHLTGVIP 468
S+ L +L +++S N + P + N + + H N + P
Sbjct: 742 -SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWP 799
Query: 469 EELSQLQNMFSLRLDYNNLSG---DVMSLINCLSLS 501
++ ++ L++ N++ + + L ++
Sbjct: 800 TGITTCPSLIQLQIGSNDIRKVDEKLTPQLYILDIA 835
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 262 bits (672), Expect = 7e-75
Identities = 71/474 (14%), Positives = 153/474 (32%), Gaps = 62/474 (13%)
Query: 73 LNLSGLNLDG------EISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFN 126
++L + IS A+ L LQ I + + + + +
Sbjct: 423 ISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNI-----AVDWEDANSDYA 477
Query: 127 ELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQ 186
+ Y + S S LK L + L N + +P L LP L+ + N +
Sbjct: 478 KQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQ----- 532
Query: 187 LSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQ---IATLSLQ 243
+ + + Q+ + YN L E P + + + L
Sbjct: 533 ----------LKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCV 581
Query: 244 GNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPP-- 301
N++ + + G L L L N + E L NKL IP
Sbjct: 582 HNKVR-HLEA-FGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKY-IPNIF 638
Query: 302 ELGNMTKLHYLELNDNQLTGHIP-----PALGKLTDLFDLNVANNHLEGPIPDNLSSCTN 356
++ + ++ + N++ K + + ++ N ++ + ++ +
Sbjct: 639 NAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSP 698
Query: 357 LNSLNVHGNKL-------NGTIPPAFQRLESMTYLNLSLNNIRG-PIPVELSRIGNLDTL 408
++++ + N + ++ +T ++L N + + + L +
Sbjct: 699 ISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNM 758
Query: 409 DMSNNKISGSIPSPLGDLEHLLKLNLSR------NQLTGFIPGEFGNLRSVMEIDLSHNH 462
D+S N S S P+ + L + N++ P S++++ + N
Sbjct: 759 DVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSND 817
Query: 463 LTGVIPEELSQLQNMFSLRLDYNNL-SGDVMSLINCLSLSVLFI---GNPGLCG 512
+ V + QL L + N S DV S+ + + + + G
Sbjct: 818 IRKVDEKLTPQLY---ILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRG 868
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 237 bits (605), Expect = 6e-66
Identities = 73/415 (17%), Positives = 143/415 (34%), Gaps = 45/415 (10%)
Query: 61 ITCDNVTFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKS 120
T DN+ N + +LKDL ++L Q+PD + D L+S
Sbjct: 460 FTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQS 519
Query: 121 LDLSFNELYG---------DIPFSISKLKQLEFLILKNNQLIG-PIPSTLSQLPNLKVFG 170
L+++ N + +++ + N L P ++L ++ L +
Sbjct: 520 LNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLD 579
Query: 171 LRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSF-QVLDLSYNQLSGEIP 229
N + L + N + IP++ T + L S+N+L IP
Sbjct: 580 CVHNKV--RHLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIP 635
Query: 230 FNIGF---LQIATLSLQGNQLTGKIPSVIGLMQA-----LAVLDLSCNMLSGPIPPILGN 281
+ ++ N++ + ++ M + + LS N + +
Sbjct: 636 NIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFAT 695
Query: 282 LSYTEKLYLHSNKLT-------GHIPPELGNMTKLHYLELNDNQLTGHIPP--ALGKLTD 332
S + L +N +T N L ++L N+LT + L
Sbjct: 696 GSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPY 754
Query: 333 LFDLNVANNHLEGPIPDNLSSCTNLNSLN------VHGNKLNGTIPPAFQRLESMTYLNL 386
L +++V+ N P + + L + GN++ P S+ L +
Sbjct: 755 LSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQI 813
Query: 387 SLNNIRGPIPVELSRIGNLDTLDMSNNKI-SGSIPSPLGDLE-HLLKLNLSRNQL 439
N+IR + +L+ L LD+++N S + S +E + L + Q
Sbjct: 814 GSNDIRK-VDEKLTP--QLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQD 865
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-34
Identities = 35/254 (13%), Positives = 77/254 (30%), Gaps = 14/254 (5%)
Query: 264 LDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHI 323
+ +M L N L L G +P +G +T+L L + T
Sbjct: 304 FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSG 363
Query: 324 PPALGKLTDLFDLNVANNHLEGPIPDN-LSSCTNLNSLNVHGNKLNGTIPPAFQRLESMT 382
+ + + L LN ++ + +N P + ++ +
Sbjct: 364 RLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRN--PEMKPIKKDS 421
Query: 383 YLNLSLNNIRG------PIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSR 436
++L I I + R+ L + +N+ + + N
Sbjct: 422 RISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIA-----VDWEDANSDY 476
Query: 437 NQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDVMSLIN 496
+ + NL+ + +++L + +P+ L L + SL + N +
Sbjct: 477 AKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKAD 536
Query: 497 CLSLSVLFIGNPGL 510
L+ P +
Sbjct: 537 WTRLADDEDTGPKI 550
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 4e-14
Identities = 30/225 (13%), Positives = 66/225 (29%), Gaps = 18/225 (8%)
Query: 288 LYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPI 347
+S E ++ + + DN+LT ++ + I
Sbjct: 221 YTTYSQSGIKRSELETQSV-RGESFTVIDNKLTKDA-----------NVPIQLKETAEYI 268
Query: 348 PDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDT 407
D + +L+ + + N L+ V+L G +
Sbjct: 269 KDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWN-FNKELDMWGDQPGVDLDNNGRVTG 327
Query: 408 LDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVI 467
L ++ G +P +G L L L+ + T + + + +
Sbjct: 328 LSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHY 387
Query: 468 PEE-LSQLQNMFSLRLDYNNLSGD----VMSLINCLSLSVLFIGN 507
+ L Q + L + ++ + + + +SL IGN
Sbjct: 388 KKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGN 432
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 245 bits (626), Expect = 6e-74
Identities = 73/307 (23%), Positives = 117/307 (38%), Gaps = 33/307 (10%)
Query: 590 YEDIMRMTENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVG 649
E++ + L + G V+K L N + VA+K Q + E E+ ++
Sbjct: 16 TENLYFQSMPLQLLEVKARGRFGCVWKAQLLN-EYVAVKIFPIQDKQS-WQNEYEVYSLP 73
Query: 650 SIKHRNLVSLQGYSLSSSGN----LLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALG 705
+KH N++ G + L F E GSL D L + W+ IA
Sbjct: 74 GMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV----VSWNELCHIAET 129
Query: 706 AAQGLAYLHHD-------CSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY-T 757
A+GLAYLH D P I HRD+KS N+LL + A + DFG+A KS
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189
Query: 758 STYIMGTIGYIDPEYARTS-----RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLIL 812
+ +GT Y+ PE + + D+Y+ G+VL EL + A D + + L
Sbjct: 190 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249
Query: 813 SKTANNA----------VMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
+ V + P + + + + + C R + V
Sbjct: 250 EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCV 309
Query: 863 SRVLGSL 869
+ +
Sbjct: 310 GERITQM 316
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 239 bits (613), Expect = 7e-69
Identities = 89/474 (18%), Positives = 149/474 (31%), Gaps = 43/474 (9%)
Query: 73 LNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDI 132
L+LS ++ A L L ++ L GN + P +SL++L +L
Sbjct: 61 LDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLE 120
Query: 133 PFSISKLKQLEFLILKNNQLIG-PIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGL- 190
F I +L L+ L + +N + +P+ S L NL L N + D+ L
Sbjct: 121 SFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENP 180
Query: 191 ---WYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIP----FNIGFLQIATLS-- 241
D+ N + I L L N S I N+ L + L
Sbjct: 181 QVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILG 239
Query: 242 --LQGNQLTGKIPSVIGLMQALAV--LDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTG 297
L PS++ + + + L+ L+ + L +
Sbjct: 240 EFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY 299
Query: 298 HIPPELGNMTKLHYLELNDNQLT-------------------GHIPPALGKLTDLFDLNV 338
++ K L + QL G I L L L++
Sbjct: 300 --LEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDL 357
Query: 339 ANNHLEGPIPDNLS--SCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIP 396
+ N L + S +L L++ N + F LE + +L+ + ++
Sbjct: 358 SRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTE 416
Query: 397 VE-LSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIP-GEFGNLRSVM 454
+ L LD+S L L L ++ N F N ++
Sbjct: 417 FSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLT 476
Query: 455 EIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSG-DVMSLINCLSLSVLFIGN 507
+DLS L + L + L + +NNL D SLS L
Sbjct: 477 FLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSF 530
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 226 bits (577), Expect = 6e-64
Identities = 86/454 (18%), Positives = 159/454 (35%), Gaps = 27/454 (5%)
Query: 73 LNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDI 132
++LS L S + + +LQ +DL + L +L L+ N +
Sbjct: 37 IDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFS 96
Query: 133 PFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVG-TLSPDMCQLSGLW 191
P S S L LE L+ +L + QL LK + N + L L+ L
Sbjct: 97 PGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLV 156
Query: 192 YFDVRNNSLTGSIPQNIGN----CTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQL 247
+ D+ N + ++ LD+S N + +++ L+L+GN
Sbjct: 157 HVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFN 216
Query: 248 TGKIPSVIGL-MQALAVLDLSCNMLSG------PIPPILGNLS--YTEKLYLHSNKLTGH 298
+ I + L V L P I+ L ++ L
Sbjct: 217 SSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSD 276
Query: 299 IPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLN 358
+ + + + L + + K L++ L+ +L L
Sbjct: 277 DIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQFPTLDLP---FLK 331
Query: 359 SLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIR--GPIPVELSRIGNLDTLDMSNNKIS 416
SL + NK +I L S++YL+LS N + G +L LD+S N
Sbjct: 332 SLTLTMNKG--SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI 389
Query: 417 GSIPSPLGDLEHLLKLNLSRNQLTGFIP-GEFGNLRSVMEIDLSHNHLTGVIPEELSQLQ 475
+ + LE L L+ + L F +L ++ +D+S+ + L
Sbjct: 390 -IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLT 448
Query: 476 NMFSLRLDYNNLSGDVMS--LINCLSLSVLFIGN 507
++ +L++ N+ + +S N +L+ L +
Sbjct: 449 SLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSK 482
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 6e-63
Identities = 80/435 (18%), Positives = 145/435 (33%), Gaps = 28/435 (6%)
Query: 73 LNLSGLNLDG-EISPAVGDLKDLQSIDLRGNRLSGQIPDEIGD----CSSLKSLDLSFNE 127
LN++ + ++ +L +L +DL N + +++ SLD+S N
Sbjct: 133 LNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNP 192
Query: 128 LYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQ-LPNLKVFGLRGNNLVG-----TLS 181
+ I + +L L L+ N I T Q L L V L
Sbjct: 193 I-DFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFE 251
Query: 182 PD----MCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQI 237
P +C ++ F + + + + L+ + + +
Sbjct: 252 PSIMEGLCDVTID-EFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK-YLEDVPKHFKW 309
Query: 238 ATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLT- 296
+LS+ QL P+ + L L L+ N S I L L L N L+
Sbjct: 310 QSLSIIRCQLKQ-FPT--LDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSF 364
Query: 297 -GHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIP-DNLSSC 354
G L +L+L+ N + L +L L+ ++ L+ S
Sbjct: 365 SGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSL 423
Query: 355 TNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVE-LSRIGNLDTLDMSNN 413
L L++ F L S+ L ++ N+ + + NL LD+S
Sbjct: 424 EKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKC 483
Query: 414 KISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQ 473
++ L L LN+S N L + L S+ +D S N +
Sbjct: 484 QLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHF 543
Query: 474 LQNMFSLRLDYNNLS 488
+++ L N+++
Sbjct: 544 PKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 7e-58
Identities = 83/446 (18%), Positives = 164/446 (36%), Gaps = 34/446 (7%)
Query: 82 GEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQ 141
G ++P + + ++ + +LS ++PD+I SS K++DLSFN L +S S +
Sbjct: 2 GSLNPCIEVVPNI-TYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSE 57
Query: 142 LEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLT 201
L++L L ++ L +L L GN + L+ L L
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 202 GSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIA---TLSLQGNQLTGKIPSVIGLM 258
IG + + L++++N + F + + L N + + + +
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHS-CKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFL 176
Query: 259 QALA----VLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPE-LGNMTKLHYLE 313
+ LD+S N + I +L L N + +I L N+ LH
Sbjct: 177 RENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHR 235
Query: 314 LNDNQLTGHI------PPALGKLTDLF--DLNVANNHLEGPIPDNLSSCTNLNSLNVHGN 365
L + P + L D+ + + + N++++++ G
Sbjct: 236 LILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGV 295
Query: 366 KLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGD 425
+ + L++ ++ ++L L +L ++ NK SI
Sbjct: 296 SI--KYLEDVPKHFKWQSLSIIRCQLKQFPTLDLP---FLKSLTLTMNKG--SISFKKVA 348
Query: 426 LEHLLKLNLSRNQLTGFIPGEFGNL--RSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLD 483
L L L+LSRN L+ + +L S+ +DLS N ++ L+ + L
Sbjct: 349 LPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQ 407
Query: 484 YNNLSG--DVMSLINCLSLSVLFIGN 507
++ L + + ++ L L I
Sbjct: 408 HSTLKRVTEFSAFLSLEKLLYLDISY 433
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 2e-42
Identities = 63/326 (19%), Positives = 112/326 (34%), Gaps = 31/326 (9%)
Query: 69 TVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNEL 128
T+ L+ N + L ++ ++ L G + + D +SL + +L
Sbjct: 262 TIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK-YLEDVPK-HFKWQSLSIIRCQL 319
Query: 129 YGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLS 188
P L L+ L L N+ I LP+L L N L
Sbjct: 320 -KQFPT--LDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNAL-SFSGCCSYSDL 373
Query: 189 GLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLT 248
G S + LDLS+N +G ++ L Q + L
Sbjct: 374 GT---------------------NSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLK 412
Query: 249 GKIP-SVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPE-LGNM 306
S ++ L LD+S I L+ L + N + N
Sbjct: 413 RVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANT 472
Query: 307 TKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNK 366
T L +L+L+ QL L L LN+++N+L + + +L++L+ N+
Sbjct: 473 TNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNR 532
Query: 367 LNGTIPPAFQRLESMTYLNLSLNNIR 392
+ + +S+ + NL+ N++
Sbjct: 533 IETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 2e-65
Identities = 107/442 (24%), Positives = 179/442 (40%), Gaps = 33/442 (7%)
Query: 69 TVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNEL 128
+ + ++ +I L + L ++ + D + +L +
Sbjct: 2 PLGSATITQDTPINQIFT-DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI 58
Query: 129 YGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLS 188
I + L L + NNQL P L L L + N + + L+
Sbjct: 59 -KSID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD--ITPLANLT 112
Query: 189 GLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLT 248
L + NN +T P + N T+ L+LS N +S + G + LS GNQ+T
Sbjct: 113 NLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALS-GLTSLQQLSF-GNQVT 168
Query: 249 GKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTK 308
P + + L LD+S N +S +L L+ E L +N+++ P LG +T
Sbjct: 169 DLKP--LANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTN 222
Query: 309 LHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLN 368
L L LN NQL L LT+L DL++ANN + P LS T L L + N+++
Sbjct: 223 LDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQIS 278
Query: 369 GTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEH 428
P L ++T L L+ N + P +S + NL L + N IS SP+ L
Sbjct: 279 NISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDI--SPVSSLTK 332
Query: 429 LLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLS 488
L +L N+++ NL ++ + HN ++ + P L+ L + L L+ +
Sbjct: 333 LQRLFFYNNKVSDVSS--LANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWT 388
Query: 489 GDVMSLINCLSLSVLFIGNPGL 510
++ +S+ G
Sbjct: 389 NAPVNYKANVSIPNTVKNVTGA 410
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 8e-62
Identities = 94/438 (21%), Positives = 177/438 (40%), Gaps = 48/438 (10%)
Query: 70 VIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELY 129
+ L N+ +S DL + ++ + D + ++L ++ S N+L
Sbjct: 26 KMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQINFSNNQLT 81
Query: 130 GDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSG 189
P + L +L +++ NNQ+ P L+ L NL L N + T + L+
Sbjct: 82 DITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQI--TDIDPLKNLTN 135
Query: 190 LWYFDVRNNSLTG-------------------SIPQNIGNCTSFQVLDLSYNQLSGEIPF 230
L ++ +N+++ + + + N T+ + LD+S N++S
Sbjct: 136 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 195
Query: 231 NIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYL 290
+ +L NQ++ P +G++ L L L+ N L L +L+ L L
Sbjct: 196 A-KLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDL 250
Query: 291 HSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDN 350
+N+++ P L +TKL L+L NQ++ L LT L +L + N LE P
Sbjct: 251 ANNQISNLAP--LSGLTKLTELKLGANQISN--ISPLAGLTALTNLELNENQLEDISP-- 304
Query: 351 LSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDM 410
+S+ NL L ++ N ++ P L + L N + L+ + N++ L
Sbjct: 305 ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDVSS--LANLTNINWLSA 360
Query: 411 SNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEE 470
+N+IS +PL +L + +L L+ T N+ + L + P
Sbjct: 361 GHNQISD--LTPLANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGAL--IAPAT 416
Query: 471 LSQLQNMFSLRLDYNNLS 488
+S + + +N S
Sbjct: 417 ISDGGSYTEPDITWNLPS 434
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 5e-59
Identities = 99/442 (22%), Positives = 172/442 (38%), Gaps = 53/442 (11%)
Query: 73 LNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDI 132
L L + + V L +L I+ N+L+ P + + + L + ++ N++
Sbjct: 51 LQADRLGI--KSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADIT 106
Query: 133 PFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWY 192
P ++ L L L L NNQ+ P L L NL L N + + + L+ L
Sbjct: 107 P--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTI--SDISALSGLTSLQQ 160
Query: 193 FDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIP 252
N + + N T+ + LD+S N++S + +L NQ++ P
Sbjct: 161 LSFGNQVTD---LKPLANLTTLERLDISSNKVSDISVLA-KLTNLESLIATNNQISDITP 216
Query: 253 SVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYL 312
+G++ L L L+ N L L +L+ L L +N+++ P L +TKL L
Sbjct: 217 --LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTEL 270
Query: 313 ELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIP 372
+L NQ++ L LT L +L + N LE P +S+ NL L ++ N ++ P
Sbjct: 271 KLGANQISN--ISPLAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP 326
Query: 373 PAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKL 432
L + L N + L+ + N++ L +N+IS +PL +L + +L
Sbjct: 327 --VSSLTKLQRLFFYNNKVSDVSS--LANLTNINWLSAGHNQISD--LTPLANLTRITQL 380
Query: 433 NLSRNQLTGFI----------------------PGEFGNLRSVMEIDLSHNHLTGVIPEE 470
L+ T P + S E D++ N + E
Sbjct: 381 GLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLPSY-TNEV 439
Query: 471 LSQLQNMFSLRLDYNNLSGDVM 492
++ SG V
Sbjct: 440 SYTFSQPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-10
Identities = 18/138 (13%), Positives = 46/138 (33%), Gaps = 8/138 (5%)
Query: 74 NLSGLNLDG-EIS--PAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYG 130
L L ++S ++ +L ++ + N++S P + + + + L L+
Sbjct: 332 KLQRLFFYNNKVSDVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN 389
Query: 131 DIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGL 190
+ + + LI P+T+S + + N + S
Sbjct: 390 APVNYKANVSIPNTVKNVTGALI--APATISDGGSYTEPDITWNLP-SYTNEVSYTFSQP 446
Query: 191 WYFDVRNNSLTGSIPQNI 208
+ +G++ Q +
Sbjct: 447 VTIGKGTTTFSGTVTQPL 464
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 3e-07
Identities = 18/106 (16%), Positives = 37/106 (34%), Gaps = 8/106 (7%)
Query: 403 GNLDTLDM-SNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHN 461
G L + + + I+ L +K L + +T + +L V +
Sbjct: 1 GPLGSATITQDTPINQI--FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRL 56
Query: 462 HLTGVIPEELSQLQNMFSLRLDYNNLSGDVMSLINCLSLSVLFIGN 507
+ + + L N+ + N L+ D+ L N L + + N
Sbjct: 57 GIK--SIDGVEYLNNLTQINFSNNQLT-DITPLKNLTKLVDILMNN 99
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 4e-65
Identities = 82/371 (22%), Positives = 148/371 (39%), Gaps = 26/371 (7%)
Query: 118 LKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLV 177
+L + I F + L + +L+ + + +L ++ + G +
Sbjct: 2 AATLATLPAPI-NQI-FPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKV- 56
Query: 178 GTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQI 237
+ L+ L Y ++ N +T P + N L + N+++ +I +
Sbjct: 57 -ASIQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT-DISALQNLTNL 112
Query: 238 ATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTG 297
L L + ++ P + + + L+L N + P L N++ L + +K+
Sbjct: 113 RELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKD 169
Query: 298 HIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNL 357
+ N+T L+ L LN NQ+ P L LT L N + P +++ T L
Sbjct: 170 --VTPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRL 223
Query: 358 NSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISG 417
NSL + NK+ P L +T+L + N I + + L L++ +N+IS
Sbjct: 224 NSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDINA--VKDLTKLKMLNVGSNQISD 279
Query: 418 SIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNM 477
S L +L L L L+ NQL G L ++ + LS NH+T + P L+ L M
Sbjct: 280 --ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKM 335
Query: 478 FSLRLDYNNLS 488
S +
Sbjct: 336 DSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 2e-63
Identities = 78/371 (21%), Positives = 152/371 (40%), Gaps = 26/371 (7%)
Query: 94 LQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLI 153
++ ++ PD D + L + + +L+ + L++ ++
Sbjct: 2 AATLATLPAPINQIFPDA--DLAEGIRAVLQKASVTDVVTQ--EELESITKLVVAGEKVA 57
Query: 154 GPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTS 213
+ L NL+ L GN + T + L L + N +T + N T+
Sbjct: 58 SIQG--IEYLTNLEYLNLNGNQI--TDISPLSNLVKLTNLYIGTNKIT--DISALQNLTN 111
Query: 214 FQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSG 273
+ L L+ + +S P ++ +L+L N S + M L L ++ + +
Sbjct: 112 LRELYLNEDNISDISPLA-NLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKD 169
Query: 274 PIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDL 333
P + NL+ L L+ N++ P L ++T LHY NQ+T P + +T L
Sbjct: 170 VTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRL 223
Query: 334 FDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRG 393
L + NN + P L++ + L L + N++ + A + L + LN+ N I
Sbjct: 224 NSLKIGNNKITDLSP--LANLSQLTWLEIGTNQI--SDINAVKDLTKLKMLNVGSNQISD 279
Query: 394 PIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSV 453
L+ + L++L ++NN++ +G L +L L LS+N +T P +L +
Sbjct: 280 ISV--LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKM 335
Query: 454 MEIDLSHNHLT 464
D ++ +
Sbjct: 336 DSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 1e-42
Identities = 60/274 (21%), Positives = 119/274 (43%), Gaps = 19/274 (6%)
Query: 74 NLSGLNLDG---EISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYG 130
L+ L + A+ +L +L+ + L + +S + + + + SL+L N
Sbjct: 89 KLTNLYIGTNKITDISALQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLS 146
Query: 131 DIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGL 190
D+ +S + L +L + +++ P ++ L +L L N + + L+ L
Sbjct: 147 DLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQI--EDISPLASLTSL 201
Query: 191 WYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGK 250
YF N +T P + N T L + N+++ P Q+ L + NQ++
Sbjct: 202 HYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSPLA-NLSQLTWLEIGTNQISD- 257
Query: 251 IPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLH 310
+ + + L +L++ N +S +L NLS L+L++N+L +G +T L
Sbjct: 258 -INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLT 314
Query: 311 YLELNDNQLTGHIPPALGKLTDLFDLNVANNHLE 344
L L+ N +T P L L+ + + AN ++
Sbjct: 315 TLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 1e-20
Identities = 38/178 (21%), Positives = 75/178 (42%), Gaps = 15/178 (8%)
Query: 330 LTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLN 389
L L N + + + + + + LES+T L ++
Sbjct: 2 AATLATLPAPINQIF-----PDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGE 54
Query: 390 NIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGN 449
+ + + NL+ L+++ N+I+ SPL +L L L + N++T N
Sbjct: 55 KVASIQG--IEYLTNLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTNKIT--DISALQN 108
Query: 450 LRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDVMSLINCLSLSVLFIGN 507
L ++ E+ L+ ++++ + P L+ L M+SL L N+ D+ L N L+ L +
Sbjct: 109 LTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTE 164
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 2e-60
Identities = 78/287 (27%), Positives = 135/287 (47%), Gaps = 16/287 (5%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYP--QCLKEFETELETVGSIKHRN 655
+L+ K IG G+ TV++ VA+K L + + EF E+ + ++H N
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAEWHG-SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95
Query: 656 LVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHH 715
+V G + +++ GSL+ +LH +++LD RL +A A+G+ YLH+
Sbjct: 96 IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155
Query: 716 DCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYART 775
+P I+HR++KS N+L+DK + + DFG+++ S +S GT ++ PE R
Sbjct: 156 -RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA-STFLSSKSAAGTPEWMAPEVLRD 213
Query: 776 SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDL 835
EKSDVYSFG++L EL T ++ N L ++ + EI
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQPWGN------LNPAQVVAAVGFKCKRLEIPRNLN-- 265
Query: 836 GAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAPEPQKQPTSI 882
+V + C +P RP+ + +L L+ + P + +
Sbjct: 266 ---PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRSDL 309
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 3e-60
Identities = 80/291 (27%), Positives = 124/291 (42%), Gaps = 30/291 (10%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLV 657
+ + + ++G GA V K + K VAIK++ K F EL + + H N+V
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKWRA-KDVAIKQI--ESESERKAFIVELRQLSRVNHPNIV 64
Query: 658 SLQGYSLSSSGNLLFY---DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLH 714
L G L+ ++ E GSL+++LHG + L +QG+AYLH
Sbjct: 65 KLYGACLNP-----VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 119
Query: 715 HDCSPRIIHRDVKSSNILLDKDFE-AHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYA 773
+IHRD+K N+LL + DFG A T G+ ++ PE
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAPEVF 175
Query: 774 RTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCK 833
S +EK DV+S+GI+L E++T RK D I+ AV P +
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM-----WAVHNGTRPPLIKNLP 230
Query: 834 DLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL----GSLVPAPEPQKQPT 880
K + L C + P+ RP+M E+ +++ A EP + P
Sbjct: 231 -----KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPC 276
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 4e-56
Identities = 70/287 (24%), Positives = 122/287 (42%), Gaps = 33/287 (11%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLY-------SHYPQCLKEFETELETVG 649
+ + IG G V+K L + VAIK L + + +EF+ E+ +
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 650 SIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQG 709
++ H N+V L G + + +F+ G L+ L K + W +L++ L A G
Sbjct: 79 NLNHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALG 134
Query: 710 LAYLHHDCSPRIIHRDVKSSNILLDKDFE-----AHLTDFGIAKSLCVSKSYTSTYIMGT 764
+ Y+ + +P I+HRD++S NI L E A + DFG+++ ++ + ++G
Sbjct: 135 IEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLGN 189
Query: 765 IGYIDPE--YARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVME 822
++ PE A TEK+D YSF ++L +LTG D ++
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE---- 245
Query: 823 TVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869
+ P I C ++ + LC P RP + + L L
Sbjct: 246 GLRPTIPEDCP-----PRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 9e-56
Identities = 74/284 (26%), Positives = 122/284 (42%), Gaps = 31/284 (10%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQ----CLKEFETELETVGSIKH 653
L+ + IIG G VY+ VA+K + ++ E + +KH
Sbjct: 7 AELTLEEIIGIGGFGKVYRAFWIG-DEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65
Query: 654 RNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYL 713
N+++L+G L L +F G L +L K++ D + A+ A+G+ YL
Sbjct: 66 PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYL 121
Query: 714 HHDCSPRIIHRDVKSSNILLDKDFEAH--------LTDFGIAKSLCVSKSYTSTYIMGTI 765
H + IIHRD+KSSNIL+ + E +TDFG+A+ + ++ G
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA---GAY 178
Query: 766 GYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVD 825
++ PE R S ++ SDV+S+G++L ELLTG + A M +
Sbjct: 179 AWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRG------IDGLAVAYGVAMNKLA 232
Query: 826 PEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869
I +TC + +L C P RP+ + L ++
Sbjct: 233 LPIPSTCP-----EPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 195 bits (496), Expect = 1e-55
Identities = 69/333 (20%), Positives = 118/333 (35%), Gaps = 44/333 (13%)
Query: 590 YEDIMRMTENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVG 649
+ +NL +IG G VYK L +PVA+K Q E + V
Sbjct: 5 ASEPSLDLDNLKLLELIGRGRYGAVYKGSLDE-RPVAVKVFSFANRQNFIN-EKNIYRVP 62
Query: 650 SIKHRNLVSLQGYSLSSSGN-----LLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIAL 704
++H N+ + + LL ++ NGSL L DW + ++A
Sbjct: 63 LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS----LHTSDWVSSCRLAH 118
Query: 705 GAAQGLAYLHHD------CSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSK---- 754
+GLAYLH + P I HRD+ S N+L+ D ++DFG++ L ++
Sbjct: 119 SVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRP 178
Query: 755 ---SYTSTYIMGTIGYIDPEYARTS-------RLTEKSDVYSFGIVLLELLTGRKAVDN- 803
+ +GTI Y+ PE + ++ D+Y+ G++ E+ +
Sbjct: 179 GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238
Query: 804 -----------ECNLHHLILSKTANNAVMETVDPEISATCK-DLGAVKKVFQLALLCSKR 851
+H E P+ K + AV+ + + C +
Sbjct: 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQ 298
Query: 852 QPTDRPTMHEVSRVLGSLVPAPEPQKQPTSIPS 884
R T + L+ E K +
Sbjct: 299 DAEARLTAQXAEERMAELMMIWERNKSVSPTAH 331
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 5e-55
Identities = 56/276 (20%), Positives = 107/276 (38%), Gaps = 27/276 (9%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRN 655
+ L+ + S ++K + + +K L + ++F E + H N
Sbjct: 10 KQLNFLTKLNENHSGELWKGRWQG-NDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 656 LVSLQGYSLSSSGNLLFY--DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYL 713
++ + G S +M GSL+++LH +D +K AL A+G+A+L
Sbjct: 69 VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFL 127
Query: 714 HHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPE-- 771
H P I + S ++++D+D A ++ V S+ S M ++ PE
Sbjct: 128 HT-LEPLIPRHALNSRSVMIDEDMTARISMAD------VKFSFQSPGRMYAPAWVAPEAL 180
Query: 772 -YARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISA 830
+D++SF ++L EL+T +L ++ + +E + P I
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVPFA---DLSNM---EIGMKVALEGLRPTIPP 234
Query: 831 TCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866
V +L +C P RP + +L
Sbjct: 235 GI-----SPHVSKLMKICMNEDPAKRPKFDMIVPIL 265
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 6e-54
Identities = 77/424 (18%), Positives = 140/424 (33%), Gaps = 23/424 (5%)
Query: 73 LNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDI 132
++ +L ++ +++ +DL GN LS ++ + L+ L+LS N LY +
Sbjct: 15 EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ET 73
Query: 133 PFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWY 192
+ L L L L NN + L P+++ NN+ +S G
Sbjct: 74 L-DLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNI-SRVSCSR--GQGKKN 124
Query: 193 FDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSG-EIPFNIGFLQ-IATLSLQGNQLTGK 250
+ NN +T + G + Q LDL N++ + L+LQ N +
Sbjct: 125 IYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-D 183
Query: 251 IPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLH 310
+ + L LDLS N L+ + P + + + L +NKL I L L
Sbjct: 184 VKGQVVF-AKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLE 240
Query: 311 YLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGT 370
+ +L N + VA ++ N CT +
Sbjct: 241 HFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDL 299
Query: 371 IPPAFQRLESMTYLNLSLNNIRG----PIPVELSRIGNLDTLDMSNNKISGSIPSPLGDL 426
P RL ++ +L + +G + E +D + I
Sbjct: 300 PAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRK 359
Query: 427 EHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGV--IPEELSQLQNMFSLRLDY 484
+ + L + L + + + EE S LQ + ++ Y
Sbjct: 360 QAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRY 419
Query: 485 NNLS 488
+
Sbjct: 420 EEMY 423
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 1e-53
Identities = 66/389 (16%), Positives = 124/389 (31%), Gaps = 25/389 (6%)
Query: 108 IPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLK 167
I + + + K ++ + L + ++ L L N L + L+ L+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 168 VFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGE 227
+ L N L + D+ LS L D+ NN + + S + L + N +S
Sbjct: 62 LLNLSSNVL--YETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-R 113
Query: 228 IPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSG-PIPPILGNLSYTE 286
+ + + L N++T G + LDL N + + + E
Sbjct: 114 VSCSR-GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLE 172
Query: 287 KLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGP 346
L L N + + ++ KL L+L+ N+L + P + +++ NN L
Sbjct: 173 HLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL- 228
Query: 347 IPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLD 406
I L NL ++ GN + F ++ ++ ++
Sbjct: 229 IEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEECTVPT 287
Query: 407 TLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLT-------GFIPGEFGNLRSVMEIDLS 459
P + L+ L + L + E N EID
Sbjct: 288 LGHYGAYCCE---DLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDAL 344
Query: 460 HNHLTGVIPEELSQLQNMFSLRLDYNNLS 488
VI + + Q +L L
Sbjct: 345 KEQYRTVIDQVTLRKQAKITLEQKKKALD 373
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 1e-52
Identities = 60/405 (14%), Positives = 129/405 (31%), Gaps = 21/405 (5%)
Query: 89 GDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILK 148
+ + + + L + ++K LDLS N L ++ +LE L L
Sbjct: 7 QNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLS 66
Query: 149 NNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNI 208
+N L + L L L+ L N + L + NN+++ + +
Sbjct: 67 SNVLYETLD--LESLSTLRTLDLNNNYV-QELLV----GPSIETLHAANNNIS-RVSCSR 118
Query: 209 GNCTSFQVLDLSYNQLSGEIPFNIGFL-QIATLSLQGNQLTG-KIPSVIGLMQALAVLDL 266
G + + L+ N+++ + G ++ L L+ N++ + L L+L
Sbjct: 119 G--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176
Query: 267 SCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPA 326
N + + + + + L L SNKL + PE + + ++ L +N+L I A
Sbjct: 177 QYNFIYD-VKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKA 232
Query: 327 LGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNL 386
L +L ++ N + S N V + + T +
Sbjct: 233 LRFSQNLEHFDLRGNGFHCGTLRDFFS-KNQRVQTVAKQTVKKLTGQNEEECTVPTLGHY 291
Query: 387 SLNNIRGPIPVELSRIGNLDTLDMSNNKISGS----IPSPLGDLEHLLKLNLSRNQLTGF 442
R+ L + + GS + + +++ + Q
Sbjct: 292 GAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTV 351
Query: 443 IPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNL 487
I ++ + ++ L + +
Sbjct: 352 IDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQ 396
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 5e-41
Identities = 65/285 (22%), Positives = 108/285 (37%), Gaps = 17/285 (5%)
Query: 227 EIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTE 286
EI N +I + + L + S+ + LDLS N LS L + E
Sbjct: 4 EIKQNGNRYKI--EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 287 KLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGP 346
L L SN L +L +++ L L+LN+N + L + L+ ANN++
Sbjct: 62 LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR- 113
Query: 347 IPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRG-PIPVELSRIGNL 405
+ S ++ + NK+ + YL+L LN I + L
Sbjct: 114 VS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 406 DTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTG 465
+ L++ N I + + L L+LS N+L F+ EF + V I L +N L
Sbjct: 172 EHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV- 227
Query: 466 VIPEELSQLQNMFSLRLDYNNLSGDVMSLINCLSLSVLFIGNPGL 510
+I + L QN+ L N + + V + +
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTV 272
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 153 bits (387), Expect = 1e-39
Identities = 51/309 (16%), Positives = 118/309 (38%), Gaps = 20/309 (6%)
Query: 203 SIPQNIGNCTSFQVLDLSYNQLSGEIPFNI--GFLQIATLSLQGNQLTGKIPSVIGLMQA 260
+I + N +++ ++ + L + ++ + L L GN L+ + +
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTK 59
Query: 261 LAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLT 320
L +L+LS N+L + L +LS L L++N + EL + L +N ++
Sbjct: 60 LELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS 112
Query: 321 GHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAF-QRLE 379
+ + ++ +ANN + + + + L++ N+++ +
Sbjct: 113 -RVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169
Query: 380 SMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQL 439
++ +LNL N I + ++ L TLD+S+NK++ + + ++L N+L
Sbjct: 170 TLEHLNLQYNFIYD-VKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL 226
Query: 440 TGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSG-DVMSLINCL 498
I +++ DL N + +N + + + C
Sbjct: 227 V-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEECT 284
Query: 499 SLSVLFIGN 507
++ G
Sbjct: 285 VPTLGHYGA 293
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-39
Identities = 58/427 (13%), Positives = 125/427 (29%), Gaps = 26/427 (6%)
Query: 74 NLSGLNLDG-EIS--PAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYG 130
L LNL + + L L+++DL N + E+ S+++L + N +
Sbjct: 59 KLELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-S 112
Query: 131 DIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDM-CQLSG 189
+ S + + + L NN++ ++ L+ N + ++
Sbjct: 113 RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 190 LWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFL-QIATLSLQGNQLT 248
L + +++ N + + + + LDLS N+L+ + + +SL+ N+L
Sbjct: 171 LEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227
Query: 249 GKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTK 308
I + Q L DL N + + T
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEECTV 285
Query: 309 LHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEG----PIPDNLSSCTNLNSLNVHG 364
P +L L A +G + + ++
Sbjct: 286 PTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALK 345
Query: 365 NKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLG 424
+ I R ++ L + + LD +
Sbjct: 346 EQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVG-QIELQHATE 404
Query: 425 DLEHLLKLNLSRNQLT-GFIPGEFGNLRSVMEIDLSHNHLTGVIPE--ELSQLQNMFSLR 481
+ L L + ++ + ++ + D+ + T + E L +L L
Sbjct: 405 EQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQLAEENARLKKLNGEADLA 464
Query: 482 LDYNNLS 488
L N +
Sbjct: 465 LASANAT 471
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 3e-53
Identities = 91/418 (21%), Positives = 153/418 (36%), Gaps = 63/418 (15%)
Query: 84 ISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLE 143
I+P LQ + L+ ++P E + S +++E + P + +++
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 144 FLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGS 203
L++ L L +L L L NSLT
Sbjct: 62 VSRLRDC-----------LDRQAHELELNNLGLS-SLPELPPHLESL---VASCNSLT-E 105
Query: 204 IPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAV 263
+P+ + S V + + LS P + L + NQL K+P + L +
Sbjct: 106 LPELPQSLKSLLVDNNNLKALSDLPP------LLEYLGVSNNQLE-KLPE-LQNSSFLKI 157
Query: 264 LDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHI 323
+D+ N L +P + +L E + +N+L PEL N+ L + ++N L +
Sbjct: 158 IDVDNNSLKK-LPDLPPSL---EFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLK-KL 210
Query: 324 PPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTY 383
P L + NN LE L + L ++ N L T+P LE++
Sbjct: 211 PDLPLSLE---SIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALNV 264
Query: 384 LNLSLNNIRGPIP--VEL-----------SRIGNLDTLDMSNNKISGSIPSPLGDLEHLL 430
+ L ++ L NL L+ S+N+I S+ LE
Sbjct: 265 RDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIR-SLCDLPPSLEE-- 321
Query: 431 KLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLS 488
LN+S N+L +P L + S NHL +PE L+ L ++YN L
Sbjct: 322 -LNVSNNKLI-ELPALPPRLE---RLIASFNHLA-EVPELPQNLK---QLHVEYNPLR 370
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 2e-50
Identities = 90/416 (21%), Positives = 155/416 (37%), Gaps = 62/416 (14%)
Query: 73 LNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDI 132
L L+ L L + L+S+ N L+ ++P+ SL + + L
Sbjct: 76 LELNNLGLS-SLPE---LPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLP 130
Query: 133 PFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWY 192
P LE+L + NNQL +P L LK+ + N+L L L +
Sbjct: 131 P-------LLEYLGVSNNQLEK-LPE-LQNSSFLKIIDVDNNSLK-KLPDLPPSLEFI-- 178
Query: 193 FDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIP 252
NN L +P + N + N L ++P L+ ++ N L
Sbjct: 179 -AAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK-KLPDLPLSLE--SIVAGNNILE--EL 230
Query: 253 SVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYL 312
+ + L + N+L +P + +L E L + N LT +P ++T L
Sbjct: 231 PELQNLPFLTTIYADNNLLKT-LPDLPPSL---EALNVRDNYLT-DLPELPQSLTFLDVS 285
Query: 313 ELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIP 372
E + L+ P +L+ LN ++N + + D +L LNV NKL +P
Sbjct: 286 ENIFSGLSELPP-------NLYYLNASSNEIRS-LCDLP---PSLEELNVSNNKLI-ELP 333
Query: 373 PAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKL 432
RLE L S N++ +P NL L + N + P +E L
Sbjct: 334 ALPPRLE---RLIASFNHLAE-VPEL---PQNLKQLHVEYNPLR-EFPDIPESVEDLRMN 385
Query: 433 NLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLS 488
+ +P NL+ ++ + N L P+ +++ LR++ +
Sbjct: 386 SHLAE-----VPELPQNLK---QLHVETNPLR-EFPDIPESVED---LRMNSERVV 429
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 2e-46
Identities = 89/407 (21%), Positives = 149/407 (36%), Gaps = 64/407 (15%)
Query: 73 LNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIP---------------DEIGDCSS 117
L S +L E+ LK L + LS P E+ + S
Sbjct: 96 LVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSF 154
Query: 118 LKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLV 177
LK +D+ N L +P LEF+ NNQL L LP L N+L
Sbjct: 155 LKIIDVDNNSL-KKLP---DLPPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLK 208
Query: 178 GTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQI 237
L L + NN L +P+ + N + N L +P L+
Sbjct: 209 -KLPDLPLSLESI---VAGNNILE-ELPE-LQNLPFLTTIYADNNLLK-TLPDLPPSLE- 260
Query: 238 ATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTG 297
L+++ N LT +P + +L LD+S N+ SG + + NL L SN++
Sbjct: 261 -ALNVRDNYLT-DLPELPQ---SLTFLDVSENIFSG-LSELPPNL---YYLNASSNEIR- 310
Query: 298 HIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNL 357
+ ++ +L+ +++N+L +P +L L + NHL +P+ NL
Sbjct: 311 SLCDLPPSLEELN---VSNNKLI-ELPALPPRLERL---IASFNHLAE-VPELP---QNL 359
Query: 358 NSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISG 417
L+V N L P + +E +L +N+ +P NL L + N +
Sbjct: 360 KQLHVEYNPLR-EFPDIPESVE-----DLRMNSHLAEVP---ELPQNLKQLHVETNPLR- 409
Query: 418 SIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLT 464
P +E L ++ ++ + + H+H
Sbjct: 410 EFPDIPESVEDL---RMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-23
Identities = 44/223 (19%), Positives = 79/223 (35%), Gaps = 33/223 (14%)
Query: 298 HIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSS---- 353
I P + T L + + LT +P + + A + E P
Sbjct: 2 FINPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREM 60
Query: 354 ---------CTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGN 404
+ L ++ L+ ++P LES L S N++ +P + +
Sbjct: 61 AVSRLRDCLDRQAHELELNNLGLS-SLPELPPHLES---LVASCNSLT-ELPELPQSLKS 115
Query: 405 LDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLT 464
L + + +S P L L +S NQL +P E N + ID+ +N L
Sbjct: 116 LLVDNNNLKALSDLPPL-------LEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK 166
Query: 465 GVIPEELSQLQNMFSLRLDYNNLSGDVMSLINCLSLSVLFIGN 507
+P+ L+ + N L ++ L N L+ ++ N
Sbjct: 167 -KLPDLPPSLE---FIAAGNNQLE-ELPELQNLPFLTAIYADN 204
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 8e-53
Identities = 86/457 (18%), Positives = 160/457 (35%), Gaps = 43/457 (9%)
Query: 73 LNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNEL-YGD 131
L L+G + A L LQ + L+ IG +LK L+++ N +
Sbjct: 81 LILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFK 140
Query: 132 IPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLR---GNNLVGTLSPDMCQLS 188
+P S L LE L L +N++ + L L + + L N + + P +
Sbjct: 141 LPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI 200
Query: 189 GLWYFDVRNNSLTGSIPQN-IGNCTSFQVLDLSYNQLSGEIPF---------NIGFLQIA 238
L +RNN + ++ + I +V L + E + L I
Sbjct: 201 RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE 260
Query: 239 TLSLQGNQLTG-KIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTE----------- 286
L I + + ++ L + + N +
Sbjct: 261 EFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNFGWQHLELVNCKFGQF 319
Query: 287 ---------KLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLT--GHIPPALGKLTDLFD 335
+L SNK ++ L +L+L+ N L+ G + T L
Sbjct: 320 PTLKLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKY 377
Query: 336 LNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPP-AFQRLESMTYLNLSLNNIRGP 394
L+++ N + + N L L+ + L F L ++ YL++S + R
Sbjct: 378 LDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVA 436
Query: 395 IPVELSRIGNLDTLDMSNNKISGSIPS-PLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSV 453
+ + +L+ L M+ N + +L +L L+LS+ QL P F +L S+
Sbjct: 437 FNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSL 496
Query: 454 MEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGD 490
++++ N L V +L ++ + L N
Sbjct: 497 QVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 533
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 193 bits (491), Expect = 1e-52
Identities = 87/455 (19%), Positives = 157/455 (34%), Gaps = 44/455 (9%)
Query: 93 DLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQL 152
+++DL N L L+ LDLS E+ + L L LIL N +
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88
Query: 153 IGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLT-GSIPQNIGNC 211
S L +L+ NL + + L L +V +N + +P+ N
Sbjct: 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL 148
Query: 212 TSFQVLDLSYNQLSGEIPFNIGFLQ-----IATLSLQGNQLTGKIPSVIGLMQALAVLDL 266
T+ + LDLS N++ ++ L +L L N + I L L L
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTL 207
Query: 267 SCNMLSGPIPP-ILGNLSYTEKLYLHSNKLTGH---IPPELGNMTKLHYLELNDNQLTG- 321
N S + + L+ E L + + + L L + + +L
Sbjct: 208 RNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 267
Query: 322 -----HIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNG------- 369
I LT++ ++ + +E + S L + K
Sbjct: 268 DYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQFPTLKLK 325
Query: 370 ------------TIPPAFQRLESMTYLNLSLNNIR--GPIPVELSRIGNLDTLDMSNNKI 415
+ L S+ +L+LS N + G +L LD+S N +
Sbjct: 326 SLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGV 385
Query: 416 SGSIPSPLGDLEHLLKLNLSRNQLTGFIP-GEFGNLRSVMEIDLSHNHLTGVIPEELSQL 474
++ S LE L L+ + L F +LR+++ +D+SH H + L
Sbjct: 386 I-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGL 444
Query: 475 QNMFSLRLDYNNLSGDVMSLI--NCLSLSVLFIGN 507
++ L++ N+ + + I +L+ L +
Sbjct: 445 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 479
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-39
Identities = 75/372 (20%), Positives = 129/372 (34%), Gaps = 24/372 (6%)
Query: 65 NVTFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDE-IGDCSSLKSLDL 123
+ ++L+LS ++ I P L + LR N S + I + L+ L
Sbjct: 174 QMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRL 232
Query: 124 SFNELYGD---IPFSISKLKQLEFLILKNNQL------IGPIPSTLSQLPNLKVFGLRGN 174
E + F S L+ L L ++ +L + I + L N+ F L
Sbjct: 233 VLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSV 292
Query: 175 NLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGF 234
+ D G + ++ N P S + L + N+ +
Sbjct: 293 TI--ERVKDFSYNFGWQHLELVNCKFG-QFPTL--KLKSLKRLTFTSNKGG-NAFSEVDL 346
Query: 235 LQIATLSLQGNQLT--GKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHS 292
+ L L N L+ G +L LDLS N + + L E L
Sbjct: 347 PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQH 405
Query: 293 NKLTGHIPPE--LGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHL-EGPIPD 349
+ L + ++ L YL+++ L+ L L +A N E +PD
Sbjct: 406 SNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPD 464
Query: 350 NLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLD 409
+ NL L++ +L P AF L S+ LN++ N ++ R+ +L +
Sbjct: 465 IFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIW 524
Query: 410 MSNNKISGSIPS 421
+ N S P
Sbjct: 525 LHTNPWDCSCPR 536
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-31
Identities = 54/263 (20%), Positives = 86/263 (32%), Gaps = 18/263 (6%)
Query: 239 TLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGH 298
T KIP L + LDLS N L + + L L ++
Sbjct: 11 TYQCMELNFY-KIPD--NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-T 66
Query: 299 IPPE-LGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNL 357
I +++ L L L N + A L+ L L +L + L
Sbjct: 67 IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTL 126
Query: 358 NSLNVHGNKLN-GTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLD----TLDMSN 412
LNV N + +P F L ++ +L+LS N I+ +L + + +LD+S
Sbjct: 127 KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186
Query: 413 NKISGSIPSPLGDLEHLLKLNLSRNQLTGFIP-GEFGNLRSVMEIDL------SHNHLTG 465
N ++ I L KL L N + + L + L + +L
Sbjct: 187 NPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEK 245
Query: 466 VIPEELSQLQNMFSLRLDYNNLS 488
L L N+ L
Sbjct: 246 FDKSALEGLCNLTIEEFRLAYLD 268
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-30
Identities = 47/214 (21%), Positives = 86/214 (40%), Gaps = 7/214 (3%)
Query: 283 SYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNH 342
T+ L L N L + +L L+L+ ++ A L+ L L + N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 343 LEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIR-GPIPVELSR 401
++ S ++L L L L+++ LN++ N I+ +P S
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 402 IGNLDTLDMSNNKISGSIPSPLGDLEHL----LKLNLSRNQLTGFIPGEFGNLRSVMEID 457
+ NL+ LD+S+NKI + L L + L L+LS N + PG F + + ++
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLT 206
Query: 458 LSHNHLTGVIPEE-LSQLQNMFSLRLDYNNLSGD 490
L +N + + + + L + RL +
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNE 240
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-25
Identities = 45/199 (22%), Positives = 81/199 (40%), Gaps = 8/199 (4%)
Query: 314 LNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPP 373
+ IP L +L+++ N L + S L L++ ++
Sbjct: 14 CMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 70
Query: 374 AFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLN 433
A+Q L ++ L L+ N I+ S + +L L ++ P+G L+ L +LN
Sbjct: 71 AYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 130
Query: 434 LSRNQLTGF-IPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNM----FSLRLDYNNLS 488
++ N + F +P F NL ++ +DLS N + + +L L M SL L N ++
Sbjct: 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190
Query: 489 GDVMSLINCLSLSVLFIGN 507
+ L L + N
Sbjct: 191 FIQPGAFKEIRLHKLTLRN 209
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 3e-52
Identities = 66/291 (22%), Positives = 114/291 (39%), Gaps = 31/291 (10%)
Query: 606 IGYGASSTVYKCVLKNC-KPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSL 664
+G G K + + + +K L + + F E++ + ++H N++ G L
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG-VL 76
Query: 665 SSSGNLLFY-DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIH 723
L F ++++ G+L I+ + + W R+ A A G+AYLH S IIH
Sbjct: 77 YKDKRLNFITEYIKGGTLRGIIK--SMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIH 131
Query: 724 RDVKSSNILLDKDFEAHLTDFGIA-------------KSLCVSKSYTSTYIMGTIGYIDP 770
RD+ S N L+ ++ + DFG+A +SL ++G ++ P
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 771 EYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISA 830
E EK DV+SFGIVL E++ A + +L + V +D
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD-----YLPRTMDFGLNVRGFLDRYCPP 246
Query: 831 TCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAPEPQKQPTS 881
C F + + C P RP+ ++ L +L
Sbjct: 247 NCPP-----SFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGP 292
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 1e-51
Identities = 81/277 (29%), Positives = 136/277 (49%), Gaps = 25/277 (9%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRN 655
++ IG G+ TVYK VA+K L PQ L+ F+ E+ + +H N
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 656 LVSLQGYSLSSSGNL-LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLH 714
++ GYS ++ L + + E SL+ LH + K + + IA A+G+ YLH
Sbjct: 82 ILLFMGYS--TAPQLAIVTQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLH 137
Query: 715 HDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIA--KSLCVSKSYTSTYIMGTIGYIDPE- 771
+ IIHRD+KS+NI L +D + DFG+A KS S S+ + G+I ++ PE
Sbjct: 138 ---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW-SGSHQFEQLSGSILWMAPEV 193
Query: 772 --YARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEIS 829
++ + +SDVY+FGIVL EL+TG+ N N I+ ++ + ++
Sbjct: 194 IRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-IIEMVGRGSLSPDL-SKVR 251
Query: 830 ATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866
+ C K++ +L C K++ +RP+ + +
Sbjct: 252 SNCP-----KRMKRLMAECLKKKRDERPSFPRILAEI 283
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 5e-51
Identities = 81/340 (23%), Positives = 142/340 (41%), Gaps = 43/340 (12%)
Query: 185 CQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQG 244
C +G +V + LT ++P + L + N L+ +P L+ TL + G
Sbjct: 37 CLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPALPPELR--TLEVSG 90
Query: 245 NQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELG 304
NQLT +P + + L++ L P + L KL++ N+LT +P
Sbjct: 91 NQLT-SLPVLPPGLLELSIFSNPLTHL----PALPSGL---CKLWIFGNQLT-SLPVLPP 141
Query: 305 NMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHG 364
L L ++DNQL +P +L L NN L +P + L L+V
Sbjct: 142 G---LQELSVSDNQLA-SLPALPSELCKL---WAYNNQLTS-LPMLP---SGLQELSVSD 190
Query: 365 NKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLG 424
N+L ++P L + N L ++ + L L +S N+++ S+P
Sbjct: 191 NQLA-SLPTLPSELYKLWAYNNRLTSLP-------ALPSGLKELIVSGNRLT-SLPVLPS 241
Query: 425 DLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDY 484
+L+ +L +S N+LT +P L S + + N LT +PE L L + ++ L+
Sbjct: 242 ELK---ELMVSGNRLTS-LPMLPSGLLS---LSVYRNQLT-RLPESLIHLSSETTVNLEG 293
Query: 485 NNLSGDVMSLINCLSLSVLFIGNPGLCGYWLHSACRDSHP 524
N LS + + ++ + + G SA R++
Sbjct: 294 NPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRA 333
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 3e-46
Identities = 76/388 (19%), Positives = 138/388 (35%), Gaps = 72/388 (18%)
Query: 102 NRLSGQIPDEIGDC--SSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPST 159
+R + ++ C + L++ + L +P + + L++ +N L +P+
Sbjct: 24 SRGRAAVVQKMRACLNNGNAVLNVGESGL-TTLPDCL--PAHITTLVIPDNNLTS-LPAL 79
Query: 160 LSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDL 219
+L L +V N LT S+P +
Sbjct: 80 PPELRTL---------------------------EVSGNQLT-SLPVLPPGLLELSIFSN 111
Query: 220 SYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPIL 279
L + L + GNQLT +P + L L +S N L+ +P +
Sbjct: 112 PLTHLPALPS------GLCKLWIFGNQLT-SLPVLPP---GLQELSVSDNQLAS-LPALP 160
Query: 280 GNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVA 339
L KL+ ++N+LT +P + +L ++DNQL +P +L L
Sbjct: 161 SEL---CKLWAYNNQLT-SLPMLPSGLQELS---VSDNQLA-SLPTLPSELY---KLWAY 209
Query: 340 NNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVEL 399
NN L +P + + L L V GN+L ++P L L +S N + +P+
Sbjct: 210 NNRLT-SLP---ALPSGLKELIVSGNRLT-SLPVLPSEL---KELMVSGNRLTS-LPML- 259
Query: 400 SRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLS 459
L +L + N+++ +P L L +NL N L+ + S
Sbjct: 260 --PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSA---PGY 313
Query: 460 HNHLTGVIPEELSQLQNMFSLRLDYNNL 487
+ S + +L L +
Sbjct: 314 SGPIIRFDMAGASAPRETRALHLAAADW 341
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 1e-44
Identities = 80/418 (19%), Positives = 152/418 (36%), Gaps = 48/418 (11%)
Query: 73 LNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDI 132
LN+ L + + + ++ + N L+ +P L++L++S N+L +
Sbjct: 45 LNVGESGL-TTLPDCLP--AHITTLVIPDNNLT-SLPALPP---ELRTLEVSGNQLT-SL 96
Query: 133 PFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWY 192
P L +L L + L + GN L +L L L
Sbjct: 97 PVLPPGLLELSIFSNPLTHLP-------ALPSGLCKLWIFGNQL-TSLPVLPPGLQEL-- 146
Query: 193 FDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIP 252
V +N L S+P L NQL+ +P LQ LS+ NQL +P
Sbjct: 147 -SVSDNQLA-SLPALPSELCK---LWAYNNQLT-SLPMLPSGLQ--ELSVSDNQLA-SLP 197
Query: 253 SVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYL 312
++ + L + L P + L ++L + N+LT +P + +L
Sbjct: 198 TLPSELYKLWAYNNRLTSL----PALPSGL---KELIVSGNRLT-SLPVLPSELKELM-- 247
Query: 313 ELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIP 372
++ N+LT +P L L +V N L +P++L ++ ++N+ GN L+
Sbjct: 248 -VSGNRLT-SLPMLPSGLLSL---SVYRNQLTR-LPESLIHLSSETTVNLEGNPLSERTL 301
Query: 373 PAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKL 432
A + + S + + R L ++ +P+ G+ +
Sbjct: 302 QALREITSAPGYSGPIIRFD-MAGASAPRETRALHLAAADWL----VPAREGEPAPADRW 356
Query: 433 NLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGD 490
++ + F + S E + I L+QL +LR + ++ +
Sbjct: 357 HMFGQEDNADAFSLFLDRLSETENFIKDAGFKAQISSWLAQLAEDEALRANTFAMATE 414
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 5e-51
Identities = 65/303 (21%), Positives = 119/303 (39%), Gaps = 37/303 (12%)
Query: 596 MTENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEF--ETELETVGSIKH 653
+ +++ +G G V++ + + VA+K S + K + ETEL ++H
Sbjct: 6 VARDITLLECVGKGRYGEVWRGSWQG-ENVAVKIFSS---RDEKSWFRETELYNTVMLRH 61
Query: 654 RNLVSLQGYSLSSSGNLLFY----DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQG 709
N++ ++S + + E GSL+D L LD + L+I L A G
Sbjct: 62 ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASG 117
Query: 710 LAYLHHD-----CSPRIIHRDVKSSNILLDKDFEAHLTDFGIAK---SLCVSKSYTSTYI 761
LA+LH + P I HRD+KS NIL+ K+ + + D G+A +
Sbjct: 118 LAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR 177
Query: 762 MGTIGYIDPE------YARTSRLTEKSDVYSFGIVLLELLTGRKAVDN---------ECN 806
+GT Y+ PE ++ D+++FG+VL E+ + +
Sbjct: 178 VGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237
Query: 807 LHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866
+ ++ P I + + +L C + P+ R T + + L
Sbjct: 238 PNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297
Query: 867 GSL 869
+
Sbjct: 298 TKI 300
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 6e-51
Identities = 67/310 (21%), Positives = 123/310 (39%), Gaps = 38/310 (12%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRN 655
E L +IG G VY VAI+ + LK F+ E+ +H N
Sbjct: 33 EQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHEN 90
Query: 656 LVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHH 715
+V G +S + + +L+ ++ K LD + +IA +G+ YLH
Sbjct: 91 VVLFMGACMSPPHLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLH- 147
Query: 716 DCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIM----GTIGYIDPE 771
+ I+H+D+KS N+ D + +TDFG+ V ++ + G + ++ PE
Sbjct: 148 --AKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPE 204
Query: 772 YARTSRL---------TEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVME 822
R ++ SDV++ G + EL ++ +
Sbjct: 205 IIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT-------QPAEAIIWQMGT 257
Query: 823 TVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAPEPQKQPTSI 882
+ P +S +G K++ + L C + +RPT ++ +L L P+ ++ S
Sbjct: 258 GMKPNLS----QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKL---PKRNRRL-SH 309
Query: 883 PSALLSSAKV 892
P SA++
Sbjct: 310 PGHFWKSAEL 319
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 4e-50
Identities = 63/308 (20%), Positives = 115/308 (37%), Gaps = 37/308 (12%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELE--TVGSIKHRN 655
+ + IG G V+ + + VA+K ++ + E E ++H N
Sbjct: 37 KQIQMVKQIGKGRYGEVWMGKWRG-EKVAVKVFFT---TEEASWFRETEIYQTVLMRHEN 92
Query: 656 LVSLQGYSLSSSGNLLFY----DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLA 711
++ + +G+ D+ ENGSL+D L LD + LK+A + GL
Sbjct: 93 ILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLK----STTLDAKSMLKLAYSSVSGLC 148
Query: 712 YLH-----HDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS---YTSTYIMG 763
+LH P I HRD+KS NIL+ K+ + D G+A + +G
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVG 208
Query: 764 TIGYIDPE------YARTSRLTEKSDVYSFGIVLLELLTGRKAVD---------NECNLH 808
T Y+ PE + +D+YSFG++L E+ + ++
Sbjct: 209 TKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPS 268
Query: 809 HLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGS 868
++ + P ++++ +L C P R T V + L
Sbjct: 269 DPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328
Query: 869 LVPAPEPQ 876
+ + + +
Sbjct: 329 MSESQDIK 336
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 1e-48
Identities = 92/472 (19%), Positives = 164/472 (34%), Gaps = 48/472 (10%)
Query: 73 LNLSGLNLDGEISP-AVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGD 131
L L I A +L +L+ +DL +++ PD L L L F L
Sbjct: 53 LELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDA 112
Query: 132 I--PFSISKLKQLEFLILKNNQLIG-PIPSTLSQLPNLKVFGLRGNNLVGTLSPDM---C 185
+ LK L L L NQ+ + + +L +LK N + +
Sbjct: 113 VLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF-LVCEHELEPL 171
Query: 186 QLSGLWYFDVRNNSLTGSIPQNIGNC------TSFQVLDLSYNQLSGEIPFN-------- 231
Q L +F + NSL + + G C ++LD+S N + +I N
Sbjct: 172 QGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKS 231
Query: 232 -----IGFLQIATLSLQGNQLTGKIPSVIGLMQ--ALAVLDLSCNMLSGPIPPILGNLSY 284
I I + + + + ++ LDLS + + L
Sbjct: 232 QAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKD 291
Query: 285 TEKLYLHSNKLTGHIPPE-LGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHL 343
+ L L NK+ I E + L L L+ N L L + +++ NH+
Sbjct: 292 LKVLNLAYNKIN-KIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHI 350
Query: 344 EGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIG 403
L +L++ N L + S+ + LS N + + L+
Sbjct: 351 AIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVTLPKINLT--- 402
Query: 404 NLDTLDMSNNKISG-SIPSPLGDLEHLLKLNLSRNQLTGFIP-GEFGNLRSVMEIDLSHN 461
+ + +S N++ I L + HL L L++N+ + S+ ++ L N
Sbjct: 403 -ANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGEN 461
Query: 462 HLTGVIPEEL-----SQLQNMFSLRLDYNNLSG-DVMSLINCLSLSVLFIGN 507
L EL L ++ L L++N L+ + +L L + +
Sbjct: 462 MLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNS 513
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 1e-45
Identities = 81/448 (18%), Positives = 147/448 (32%), Gaps = 34/448 (7%)
Query: 73 LNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDI 132
NL ++ L + + L N + L+ L+L I
Sbjct: 9 AFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTI 64
Query: 133 PF-SISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNL-VGTLSPDMCQ-LSG 189
+ L L L L ++++ P L +L L L L + L
Sbjct: 65 DKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKA 124
Query: 190 LWYFDVRNNSLTG-SIPQNIGNCTSFQVLDLSYNQLSGEIPF----NIGFLQIATLSLQG 244
L D+ N + + + G S + +D S NQ+ + + ++ SL
Sbjct: 125 LTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF-LVCEHELEPLQGKTLSFFSLAA 183
Query: 245 NQLTGKIPSVI-GLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPEL 303
N L ++ M + L +S GN + SN ++ L
Sbjct: 184 NSLYSRVSVDWGKCMNPFRNMVLEILDVS-------GNGWTVDITGNFSNAISKSQAFSL 236
Query: 304 GNMTKLHYLELNDNQLTGHIPPALGKL--TDLFDLNVANNHLEGPIPDNLSSCTNLNSLN 361
+ + + L + + L++++ + + +L LN
Sbjct: 237 ILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLN 296
Query: 362 VHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPS 421
+ NK+N AF L+++ LNLS N + + + +D+ N I+
Sbjct: 297 LAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQ 356
Query: 422 PLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLR 481
LE L L+L N LT + S+ +I LS N L + L+ +
Sbjct: 357 TFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVTLPKINLTANL----IH 407
Query: 482 LDYNNLSG--DVMSLINCLSLSVLFIGN 507
L N L + L+ L +L +
Sbjct: 408 LSENRLENLDILYFLLRVPHLQILILNQ 435
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 1e-43
Identities = 98/475 (20%), Positives = 174/475 (36%), Gaps = 51/475 (10%)
Query: 73 LNLSGLNLDGEISP--AVGDLKDLQSIDLRGNRLSG-QIPDEIGDCSSLKSLDLSFNELY 129
L L L + +LK L +DL N++ + G +SLKS+D S N+++
Sbjct: 102 LRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF 161
Query: 130 GDIPFSISKLKQ--LEFLILKNNQLIGPIPSTLSQLPN------LKVFGLRGNNLV---- 177
+ L+ L F L N L + + N L++ + GN
Sbjct: 162 LVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDIT 221
Query: 178 --------GTLSPDMCQLSGLWYFDVRNNSLTGSIPQNI---GNCTSFQVLDLSYNQLSG 226
+ + + + +++ QN +S + LDLS+ +
Sbjct: 222 GNFSNAISKSQAFSLILAHHIMGAGFGFHNIK-DPDQNTFAGLARSSVRHLDLSHGFVF- 279
Query: 227 EIPFNI--GFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSY 284
+ + + L+L N++ + L VL+LS N+L L
Sbjct: 280 SLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPK 339
Query: 285 TEKLYLHSNKLTGHIPPE-LGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHL 343
+ L N + I + + KL L+L DN LT + + + D+ ++ N L
Sbjct: 340 VAYIDLQKNHIA-IIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKL 393
Query: 344 EGPIPDNLSSCTNLNSLNVHGNKLNG-TIPPAFQRLESMTYLNLSLNNIRG-PIPVELSR 401
NL+ N +++ N+L I R+ + L L+ N S
Sbjct: 394 VTLPKINLT----ANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSE 449
Query: 402 IGNLDTLDMSNNKISGSIPSPL-----GDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEI 456
+L+ L + N + + + L L HL L L+ N L PG F +L ++ +
Sbjct: 450 NPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGL 509
Query: 457 DLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDVMSLINCLSLSVLFIGNPGLC 511
L+ N LT + +L N+ L + N L + LS + N +C
Sbjct: 510 SLNSNRLTVLSHNDL--PANLEILDISRNQLLAPNPDVFVSLS-VLDITHNKFIC 561
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 2e-42
Identities = 77/408 (18%), Positives = 155/408 (37%), Gaps = 30/408 (7%)
Query: 93 DLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQL 152
D + R L+ Q+P + ++ + L LSFN + S L+QL+ L L +
Sbjct: 5 DGRIAFYRFCNLT-QVPQVL---NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYT 60
Query: 153 IGPI-PSTLSQLPNLKVFGLRGNNLVGTLSPDM-CQLSGLWYFDVRNNSLTGSIPQN--I 208
I LPNL++ L + + L PD L L+ + L+ ++ ++
Sbjct: 61 PLTIDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYF 119
Query: 209 GNCTSFQVLDLSYNQLSGEIPFNIGFLQIA---TLSLQGNQLTGKIPSVIGLMQA--LAV 263
N + LDLS NQ+ + + F ++ ++ NQ+ + +Q L+
Sbjct: 120 RNLKALTRLDLSKNQIR-SLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSF 178
Query: 264 LDLSCNMLSGPIPPILGN-LSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGH 322
L+ N L + G ++ + L ++G N + N ++
Sbjct: 179 FSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSG-------NGWTVDITGNFSNAISKS 231
Query: 323 IPPALGKLTDLFDLNVANNHLEGPIPDNLSS--CTNLNSLNVHGNKLNGTIPPAFQRLES 380
+L + ++++ P + + +++ L++ + F+ L+
Sbjct: 232 QAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKD 291
Query: 381 MTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLT 440
+ LNL+ N I + NL L++S N + S L + ++L +N +
Sbjct: 292 LKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIA 351
Query: 441 GFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLS 488
F L + +DL N LT + + ++ + L N L
Sbjct: 352 IIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLV 394
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-30
Identities = 89/463 (19%), Positives = 149/463 (32%), Gaps = 78/463 (16%)
Query: 73 LNLSGLNLDGEISPAV-GDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGD 131
L+LS + ++ V LKDL+ ++L N+++ + +L+ L+LS+N L
Sbjct: 271 LDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGEL 329
Query: 132 IPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLW 191
+ L ++ ++ L+ N + T L L+ LR N L
Sbjct: 330 YSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL--------------- 374
Query: 192 YFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTG-K 250
I S + LS N+L L + L N+L
Sbjct: 375 --------------TTIHFIPSIPDIFLSGNKLVT---LPKINLTANLIHLSENRLENLD 417
Query: 251 IPSVIGLMQALAVLDLSCNMLSG-PIPPILGNLSYTEKLYLHSNKLTGHIPPEL-----G 304
I + + L +L L+ N S E+L+L N L EL
Sbjct: 418 ILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFE 477
Query: 305 NMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHG 364
++ L L LN N L P LT L L++ +N L LS +L
Sbjct: 478 GLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-----VLSHNDLPANL---- 528
Query: 365 NKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLG 424
L++S N + P P +L LD+++NK
Sbjct: 529 -----------------EILDISRNQLLAPNPDVFV---SLSVLDITHNKFICEC----- 563
Query: 425 DLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDY 484
+L + N I G ++ V S L + E + + + SL+
Sbjct: 564 ELSTFINWLNHTNVT---IAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSL 620
Query: 485 NNLSGDVMSLINCLSLSVLFIGNPGLCGYWLHSACRDSHPTER 527
+ ++L L+V Y +
Sbjct: 621 FIVCTVTLTLFLMTILTVTKFRGFCFICYKTAQRLVFKDHPQG 663
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 1e-48
Identities = 61/294 (20%), Positives = 115/294 (39%), Gaps = 37/294 (12%)
Query: 605 IIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELE--TVGSIKHRNLVSLQGY 662
IG G V++ + + VA+K S + + + E E ++H N++
Sbjct: 49 SIGKGRFGEVWRGKWRG-EEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 663 SLSSSGNLLFY----DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHD-- 716
+G D+ E+GSL+D L+ + + + +K+AL A GLA+LH +
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEIV 160
Query: 717 ---CSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS---YTSTYIMGTIGYIDP 770
P I HRD+KS NIL+ K+ + D G+A + + +GT Y+ P
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220
Query: 771 E------YARTSRLTEKSDVYSFGIVLLELLTGRKAVDN---------ECNLHHLILSKT 815
E + +++D+Y+ G+V E+ + + +
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 280
Query: 816 ANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869
+ + P I + A++ + ++ C R T + + L L
Sbjct: 281 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 1e-46
Identities = 49/315 (15%), Positives = 103/315 (32%), Gaps = 22/315 (6%)
Query: 186 QLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGN 245
SG + ++ + D + + N QI + G
Sbjct: 10 HSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA-NSNNPQI--ETRTGR 66
Query: 246 QLTGKIPSVIGL--MQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPEL 303
L ++ L+L L P LS+ + + + + L +P +
Sbjct: 67 ALK-ATADLLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAGLM-ELPDTM 123
Query: 304 GNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVA-NNHLE--------GPIPDNLSSC 354
L L L N L +P ++ L L +L++ L
Sbjct: 124 QQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGL 182
Query: 355 TNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNK 414
NL SL + + ++P + L+++ L + + + + + + L+ LD+
Sbjct: 183 VNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCT 240
Query: 415 ISGSIPSPLGDLEHLLKLNLS-RNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQ 473
+ P G L +L L + L +P + L + ++DL +P ++Q
Sbjct: 241 ALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQ 299
Query: 474 LQNMFSLRLDYNNLS 488
L + + + +
Sbjct: 300 LPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 7e-46
Identities = 48/330 (14%), Positives = 102/330 (30%), Gaps = 30/330 (9%)
Query: 91 LKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNN 150
+++ +G+ D + + D + + + +
Sbjct: 11 SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIETRTGR 66
Query: 151 QLIGPIPSTLSQL--PNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNI 208
L L P LR L +LS L + + L +P +
Sbjct: 67 ALKA-TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTM 123
Query: 209 GNCTSFQVLDLSYNQLSGEIPFNIGFLQ-IATLSLQGNQLTGKIPSVIGLMQALAVLDLS 267
+ L L+ N L +P +I L + LS++ ++P +
Sbjct: 124 QQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTD-------- 174
Query: 268 CNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPAL 327
L + L L + +P + N+ L L++ ++ L+ + PA+
Sbjct: 175 -------ASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAI 225
Query: 328 GKLTDLFDLNVA-NNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNL 386
L L +L++ L P L L + T+P RL + L+L
Sbjct: 226 HHLPKLEELDLRGCTALRN-YPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDL 284
Query: 387 SLNNIRGPIPVELSRIGNLDTLDMSNNKIS 416
+P ++++ + + + +
Sbjct: 285 RGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 2e-44
Identities = 51/343 (14%), Positives = 104/343 (30%), Gaps = 28/343 (8%)
Query: 135 SISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFD 194
E L + + + P LSQ + +
Sbjct: 7 HHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQ----ANSNNPQIET 62
Query: 195 VRNNSLTGSIPQNIGNCTSF--QVLDLSYNQLSGEIPFNIGFL-QIATLSLQGNQLTGKI 251
+L + + + T L+L L + P L + +++ L ++
Sbjct: 63 RTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-EL 119
Query: 252 PSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHY 311
P + L L L+ N L +P + +L+ +L + + +P L +
Sbjct: 120 PDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTD---- 174
Query: 312 LELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTI 371
L +L L + + +P ++++ NL SL + + L+ +
Sbjct: 175 -----------ASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLS-AL 221
Query: 372 PPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLK 431
PA L + L+L P L L + + ++P + L L K
Sbjct: 222 GPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEK 281
Query: 432 LNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQL 474
L+L +P L + I + + +
Sbjct: 282 LDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 7e-44
Identities = 51/320 (15%), Positives = 105/320 (32%), Gaps = 49/320 (15%)
Query: 74 NLSGLNLDGEISP-AVGDLKDLQSIDLRGNRLSGQIPDEIGDCSS--LKSLDLSFNELYG 130
+ + S + + Q G L D + D + +L+L L
Sbjct: 37 RHYNADRNRWHSAWRQANSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPL-P 94
Query: 131 DIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGL 190
P +L L+ + + L+ +P T+ Q L+ L N L
Sbjct: 95 QFPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARNPLR------------- 140
Query: 191 WYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGK 250
++P +I + + L + E+P +
Sbjct: 141 ------------ALPASIASLNRLRELSIRACPELTELPEPLASTD-------------- 174
Query: 251 IPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLH 310
+ L L L + +P + NL + L + ++ L+ + P + ++ KL
Sbjct: 175 ASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLE 232
Query: 311 YLELNDNQLTGHIPPALGKLTDLFDLNVAN-NHLEGPIPDNLSSCTNLNSLNVHGNKLNG 369
L+L + PP G L L + + ++L +P ++ T L L++ G
Sbjct: 233 ELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT-LPLDIHRLTQLEKLDLRGCVNLS 291
Query: 370 TIPPAFQRLESMTYLNLSLN 389
+P +L + + + +
Sbjct: 292 RLPSLIAQLPANCIILVPPH 311
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 5e-36
Identities = 49/248 (19%), Positives = 91/248 (36%), Gaps = 17/248 (6%)
Query: 73 LNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDI 132
L L + L + L LQ + + L ++PD + + L++L L+ N L +
Sbjct: 86 LELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPL-RAL 142
Query: 133 PFSISKLKQLEFLILKNNQLIGPIPSTLSQ---------LPNLKVFGLRGNNLVGTLSPD 183
P SI+ L +L L ++ + +P L+ L NL+ L + +L
Sbjct: 143 PASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPAS 201
Query: 184 MCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQ-IATLSL 242
+ L L +RN+ L+ ++ I + + LDL P G + L L
Sbjct: 202 IANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLIL 260
Query: 243 QG-NQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPP 301
+ + L +P I + L LDL + +P ++ L + + +
Sbjct: 261 KDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQH 319
Query: 302 ELGNMTKL 309
Sbjct: 320 RPVARPAE 327
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 3e-46
Identities = 57/319 (17%), Positives = 113/319 (35%), Gaps = 16/319 (5%)
Query: 108 IPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLK 167
I + + + K ++ + L + ++ L L N L + L+ L+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 168 VFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGE 227
+ L N L + D+ LS L D+ NN + + S + L + N +S
Sbjct: 62 LLNLSSNVL--YETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-R 113
Query: 228 IPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSG-PIPPILGNLSYTE 286
+ + + L N++T G + LDL N + + + E
Sbjct: 114 VSCSR-GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLE 172
Query: 287 KLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGP 346
L L N + + ++ KL L+L+ N+L + P + +++ NN L
Sbjct: 173 HLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL- 228
Query: 347 IPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLD 406
I L NL ++ GN + F ++ ++ ++ + + +
Sbjct: 229 IEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKK-LTGQNEEECTVP 286
Query: 407 TLDMSNNKISGSIPSPLGD 425
TL +P+P D
Sbjct: 287 TLGHYGAYCCEDLPAPFAD 305
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-41
Identities = 48/288 (16%), Positives = 110/288 (38%), Gaps = 17/288 (5%)
Query: 203 SIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFL-QIATLSLQGNQLTGKIPSVIGLMQAL 261
+I + N +++ ++ + L + + L L GN L+ + + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 262 AVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTG 321
+L+LS N+L + +LS L L++N + EL + L +N ++
Sbjct: 61 ELLNLSSNVLYE-TLDL-ESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112
Query: 322 HIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAF-QRLES 380
+ + ++ +ANN + + + + L++ N+++ ++
Sbjct: 113 RVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 381 MTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLT 440
+ +LNL N I + ++ L TLD+S+NK++ + + ++L N+L
Sbjct: 171 LEHLNLQYNFIYD-VKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227
Query: 441 GFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLS 488
I +++ DL N + +N + +
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVK 273
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-39
Identities = 57/277 (20%), Positives = 100/277 (36%), Gaps = 31/277 (11%)
Query: 251 IPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLH 310
I + + ++ + L + + + ++L L N L+ +L TKL
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 311 YLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEG-PIPDNL---------------SSC 354
L L+ N L L L+ L L++ NN+++ + ++ S
Sbjct: 62 LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRG 119
Query: 355 TNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRG-PIPVELSRIGNLDTLDMSNN 413
++ + NK+ + YL+L LN I + L+ L++ N
Sbjct: 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179
Query: 414 KISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQ 473
I + L L+LS N+L F+ EF + V I L +N L +I + L
Sbjct: 180 FIY-DVK-GQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRF 235
Query: 474 LQNMFSLRLDYNNLSGDVMSLINCLSLSVLFIGNPGL 510
QN+ L N C +L F N +
Sbjct: 236 SQNLEHFDLRGNGFH--------CGTLRDFFSKNQRV 264
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 50/267 (18%), Positives = 94/267 (35%), Gaps = 15/267 (5%)
Query: 73 LNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDI 132
L+LSG L + + L+ ++L N L + D + S+L++LDL+ N +
Sbjct: 39 LDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYV---- 92
Query: 133 PFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWY 192
+ +E L NN I + S+ K L N + D S + Y
Sbjct: 93 -QELLVGPSIETLHAANNN-ISRVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQY 148
Query: 193 FDVRNNSLTG-SIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKI 251
D++ N + + + + + + L+L YN + ++ + F ++ TL L N+L +
Sbjct: 149 LDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVFAKLKTLDLSSNKLA-FM 206
Query: 252 PSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLT-GHIPPELGNMTKLH 310
+ + L N L I L E L N G + ++
Sbjct: 207 GPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQ 265
Query: 311 YLELNDNQLTGHIPPALGKLTDLFDLN 337
+ + + L
Sbjct: 266 TVAKQTVKKLTGQNEEECTVPTLGHYG 292
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 43/218 (19%), Positives = 79/218 (36%), Gaps = 14/218 (6%)
Query: 74 NLSGLNLDG----EISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELY 129
++ L+ +S + ++I L N+++ + G S ++ LDL NE+
Sbjct: 100 SIETLHAANNNISRVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157
Query: 130 G-DIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLS 188
+ + LE L L+ N + + LK L N L + P+ +
Sbjct: 158 TVNFAELAASSDTLEHLNLQYNFIYD-VKG-QVVFAKLKTLDLSSNKLA-FMGPEFQSAA 214
Query: 189 GLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIP--FNIGFLQIATLSLQGNQ 246
G+ + +RNN L I + + + + DL N F ++ T++ Q +
Sbjct: 215 GVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK 273
Query: 247 -LTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLS 283
LTG+ + C L P L L
Sbjct: 274 KLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALG 311
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 7e-11
Identities = 18/90 (20%), Positives = 37/90 (41%), Gaps = 1/90 (1%)
Query: 418 SIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNM 477
+I + ++ + L + + +V E+DLS N L+ + +L+ +
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 478 FSLRLDYNNLSGDVMSLINCLSLSVLFIGN 507
L L N L + + L + +L L + N
Sbjct: 61 ELLNLSSNVLY-ETLDLESLSTLRTLDLNN 89
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 5e-46
Identities = 71/398 (17%), Positives = 135/398 (33%), Gaps = 23/398 (5%)
Query: 73 LNLSGLNLDGEISPAV-GDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGD 131
L + + EI L L ++++ L + + L L +E
Sbjct: 128 LRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFL 187
Query: 132 IPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLW 191
+ L + +L L++ L S L +L L
Sbjct: 188 LEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLL 247
Query: 192 YFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSG-EIPFNIGFLQIATLSLQGNQLTGK 250
+ + + + +CT + D + ++ + + I L + L
Sbjct: 248 RYILELSEVE------FDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYD 301
Query: 251 IPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPE---LGNMT 307
+ +V L++ + + + + + +L E L L N + G
Sbjct: 302 LSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWP 361
Query: 308 KLHYLELNDNQLT--GHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGN 365
L L L+ N L L L +L L+++ N P+PD+ + LN+
Sbjct: 362 SLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSST 420
Query: 366 KLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGD 425
+ + +++ L++S NN+ + L L L +S NK+ ++P
Sbjct: 421 GIR-VVKTCI--PQTLEVLDVSNNNLDS-FSLFLP---RLQELYISRNKLK-TLP-DASL 471
Query: 426 LEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHL 463
LL + +SRNQL G F L S+ +I L N
Sbjct: 472 FPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 4e-44
Identities = 78/434 (17%), Positives = 154/434 (35%), Gaps = 20/434 (4%)
Query: 64 DNVTFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEI-GDCSSLKSLD 122
+T + +L+LS + + +LQ + L+ +R++ I + SL+ LD
Sbjct: 22 SGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLD 80
Query: 123 LSFNELYGDIPFSISKLKQLEFLILKNNQLIG-PIPSTLSQLPNLKVFGLRGNNLVGTLS 181
LS N L L L++L L N + S L NL+ + +
Sbjct: 81 LSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIR 140
Query: 182 PDMCQ-LSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFL-QIAT 239
L+ L +++ SL Q++ + L L ++ + + L +
Sbjct: 141 RIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRY 200
Query: 240 LSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHI 299
L L+ L S + + + + + S L + L +++
Sbjct: 201 LELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEV---- 256
Query: 300 PPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNS 359
E + T + N ++ + + L++ +L + S +
Sbjct: 257 --EFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKR 314
Query: 360 LNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIG---NLDTLDMSNNKIS 416
+ V +K+ Q L+S+ +L+LS N + + G +L TL +S N +
Sbjct: 315 ITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR 374
Query: 417 --GSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQL 474
L L++L L++SRN +P + ++LS + V L
Sbjct: 375 SMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTL 433
Query: 475 QNMFSLRLDYNNLS 488
+ L + NNL
Sbjct: 434 E---VLDVSNNNLD 444
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-40
Identities = 57/382 (14%), Positives = 127/382 (33%), Gaps = 19/382 (4%)
Query: 115 CSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGN 174
C + D IP ++ ++ L L N++ L NL+V L+ +
Sbjct: 4 CDASGVCDGRSRSFT-SIPSGLTA--AMKSLDLSFNKITYIGHGDLRACANLQVLILKSS 60
Query: 175 NLVGTLSPDMCQ-LSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIG 233
+ T+ D L L + D+ +N L+ G +S + L+L N +
Sbjct: 61 RI-NTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ-TLGVTSL 118
Query: 234 FLQIA---TLSLQGNQLTGKIP-SVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLY 289
F + TL + + +I + +L L++ L L ++ L
Sbjct: 119 FPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLT 178
Query: 290 LHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPD 349
LH ++ + ++ + YLEL D L L + +
Sbjct: 179 LHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDE 238
Query: 350 NLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLD 409
+ + L + +++ F + + + + + L
Sbjct: 239 SFNELLKLLRYILELSEVE------FDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLH 292
Query: 410 MSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPE 469
+ + + + LE + ++ + +++ +L+S+ +DLS N + +
Sbjct: 293 IPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLK 352
Query: 470 E---LSQLQNMFSLRLDYNNLS 488
++ +L L N+L
Sbjct: 353 NSACKGAWPSLQTLVLSQNHLR 374
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-32
Identities = 50/301 (16%), Positives = 107/301 (35%), Gaps = 11/301 (3%)
Query: 210 NCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCN 269
+C + V D + IP + + +L L N++T + L VL L +
Sbjct: 3 SCDASGVCDGRSRSFT-SIPSGL-TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSS 60
Query: 270 MLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPE-LGNMTKLHYLELNDNQLTG-HIPPAL 327
++ +L E L L N L+ + G ++ L YL L N +
Sbjct: 61 RINTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLF 119
Query: 328 GKLTDLFDLNVANNHLEGPIPDN-LSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNL 386
LT+L L + N I + T+LN L + L + + + + +L L
Sbjct: 120 PNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTL 179
Query: 387 SLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGE 446
L+ + + + ++ L++ + ++ SPL E + + +
Sbjct: 180 HLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDES 239
Query: 447 FGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDVMSLINCLSLSVLFIG 506
F L ++ L + + + L + +++ ++ + +++ L I
Sbjct: 240 FNELLKLLRYILELSEVE----FDDCTLNGLGDFNPSESDVVSELGKV-ETVTIRRLHIP 294
Query: 507 N 507
Sbjct: 295 Q 295
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 3e-44
Identities = 75/423 (17%), Positives = 152/423 (35%), Gaps = 40/423 (9%)
Query: 73 LNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDI 132
+ + + + L L S+D + ++ I + L L + N + +
Sbjct: 23 EVAAAFEMQATDTISEEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNNI-TTL 79
Query: 133 PFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWY 192
S + L +L +N+L + ++ L L N L D+ Q L Y
Sbjct: 80 DLS--QNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNCDTNKLT---KLDVSQNPLLTY 131
Query: 193 FDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIP 252
+ N+LT I + + T LD N+ ++ Q+ TL N++T ++
Sbjct: 132 LNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLDVT-PQTQLTTLDCSFNKIT-ELD 186
Query: 253 SVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYL 312
+ + L L+ N ++ + L L SNKLT I + +T+L Y
Sbjct: 187 --VSQNKLLNRLNCDTNNITK-LD--LNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYF 238
Query: 313 ELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIP 372
+ + N LT + + L+ L L+ L +L+ T L G + +
Sbjct: 239 DCSVNPLT-ELD--VSTLSKLTTLHCIQTDLLE---IDLTHNTQLIYFQAEGCRKIKELD 292
Query: 373 PAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKL 432
+ L+ I ++LS+ L L ++N +++ + + L L
Sbjct: 293 --VTHNTQLYLLDCQAAGIT---ELDLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSL 344
Query: 433 NLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDVM 492
+ + F G + ++ + + E L+ ++ D + G+ M
Sbjct: 345 SCVNAHIQDFSS--VGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPM 402
Query: 493 SLI 495
++
Sbjct: 403 NIE 405
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 3e-41
Identities = 75/414 (18%), Positives = 145/414 (35%), Gaps = 40/414 (9%)
Query: 94 LQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLI 153
S + ++L SLD + + D+ I KL L LI +N +
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSI-TDMT-GIEKLTGLTKLICTSNNIT 77
Query: 154 GPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTS 213
+ LSQ NL N L + D+ L+ L Y + N LT ++
Sbjct: 78 T-LD--LSQNTNLTYLACDSNKLT---NLDVTPLTKLTYLNCDTNKLTKL---DVSQNPL 128
Query: 214 FQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSG 273
L+ + N L+ EI + Q+ L N+ K+ + L LD S N ++
Sbjct: 129 LTYLNCARNTLT-EIDVS-HNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITE 184
Query: 274 PIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDL 333
+ + +L +N +T +L +L +L+ + N+LT I + LT L
Sbjct: 185 -LD--VSQNKLLNRLNCDTNNITK---LDLNQNIQLTFLDCSSNKLT-EID--VTPLTQL 235
Query: 334 FDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRG 393
+ + N L ++S+ + L +L+ L I + Y
Sbjct: 236 TYFDCSVNPLTEL---DVSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKIK 289
Query: 394 PIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSV 453
+ +++ L LD I+ + L L+ L L+ +LT + + +
Sbjct: 290 EL--DVTHNTQLYLLDCQAAGIT-EL--DLSQNPKLVYLYLNNTELTEL---DVSHNTKL 341
Query: 454 MEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDVMSLINCLSLSVLFIGN 507
+ + H+ + ++ + + + SL++ +
Sbjct: 342 KSLSCVNAHIQDF--SSVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPD 393
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-29
Identities = 69/360 (19%), Positives = 124/360 (34%), Gaps = 66/360 (18%)
Query: 164 PNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQ 223
N + T + QL+ L D N+S+T + I T L + N
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNN 75
Query: 224 LSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLS 283
++ + + + L+ N+LT + + + L L+ N L+ + +
Sbjct: 76 IT-TLDLS-QNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLD--VSQNP 127
Query: 284 YTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHL 343
L N LT I + + T+L L+ + N+ + T L L+ + N +
Sbjct: 128 LLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKIT--KLDVTPQTQLTTLDCSFNKI 182
Query: 344 EGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIG 403
++S LN LN N + T L+L+ N
Sbjct: 183 TE---LDVSQNKLLNRLNCDTNNI--------------TKLDLNQNI------------- 212
Query: 404 NLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVM-------EI 456
L LD S+NK++ I + L L + S N LT L ++ EI
Sbjct: 213 QLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEI 269
Query: 457 DLSHN---------HLTGVIPEELSQLQNMFSLRLDYNNLSGDVMSLINCLSLSVLFIGN 507
DL+HN + +++ ++ L ++ + L L L++ N
Sbjct: 270 DLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGITE--LDLSQNPKLVYLYLNN 327
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 3e-20
Identities = 47/278 (16%), Positives = 93/278 (33%), Gaps = 30/278 (10%)
Query: 88 VGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLIL 147
V K L ++ N ++ ++ + L LD S N+L ++ L QL +
Sbjct: 187 VSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTE---IDVTPLTQLTYFDC 240
Query: 148 KNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQN 207
N L + +S L L +L+ + D+ + L YF + +
Sbjct: 241 SVNPLT-ELD--VSTLSKLTTLHCIQTDLL-EI--DLTHNTQLIYFQAEGCRKIKEL--D 292
Query: 208 IGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLS 267
+ + T +LD ++ E+ + ++ L L +LT ++ + L L
Sbjct: 293 VTHNTQLYLLDCQAAGIT-ELDLS-QNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCV 347
Query: 268 CNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHY------LELNDNQLTG 321
+ + G + + + +P E L L+ N +
Sbjct: 348 NAHIQD-FSSV-GKIPALNNNFEAEGQTI-TMPKETLTNNSLTIAVSPDLLDQFGNPMN- 403
Query: 322 HIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNS 359
I P G + D + +L P + T+ N
Sbjct: 404 -IEPGDGGVYDQATNTITWENLSTDNPAVTYTFTSENG 440
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 5e-44
Identities = 70/423 (16%), Positives = 144/423 (34%), Gaps = 53/423 (12%)
Query: 108 IPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLK 167
I + + + F L + + KN+ + + L ++
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72
Query: 168 VFGLRGNNLVGTLSPDM-CQLSGLWYFDVRNNSLTGSIPQNI-GNCTSFQVLDLSYNQLS 225
+ L + + + + N++ +P ++ N VL L N LS
Sbjct: 73 LLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS 130
Query: 226 GEIPFNI--GFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLS 283
+P I ++ TLS+ N L +I +
Sbjct: 131 -SLPRGIFHNTPKLTTLSMSNNNLE-RIE-----------------------DDTFQATT 165
Query: 284 YTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHL 343
+ L L SN+LT H+ + L + ++ N L+ L + +L+ ++N +
Sbjct: 166 SLQNLQLSSNRLT-HVDL--SLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSI 217
Query: 344 EGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIG 403
+ + L L + N L T + ++LS N + + ++
Sbjct: 218 NV-VRGPV--NVELTILKLQHNNL--TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQ 272
Query: 404 NLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHL 463
L+ L +SNN++ ++ + L L+LS N L + + + L HN +
Sbjct: 273 RLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSI 330
Query: 464 TGVIPEELSQLQNMFSLRLDYNNLSGDVMSLI--NCLSLSVLFIGNPGLCGYWLHS--AC 519
+ +LS + +L L +N+ + + + N +V Y L C
Sbjct: 331 VTL---KLSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCC 387
Query: 520 RDS 522
++S
Sbjct: 388 KES 390
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 3e-43
Identities = 68/371 (18%), Positives = 134/371 (36%), Gaps = 47/371 (12%)
Query: 73 LNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEI-GDCSSLKSLDLSFNELYGD 131
+++ D L + + + + + + ++P + ++ L+L+ ++
Sbjct: 26 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEI 84
Query: 132 IPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDM-CQLSGL 190
++ + ++ L + N + P +P L V L N+L +L + L
Sbjct: 85 DTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKL 143
Query: 191 WYFDVRNNSLTGSIPQNI-GNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTG 249
+ NN+L I + TS Q L LS N+L+ + + + ++ N L+
Sbjct: 144 TTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLS-LIPSLFHANVSYNLLS- 199
Query: 250 KIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKL 309
+ + A+ LD S N ++ P+ L L L N LT L N L
Sbjct: 200 ----TLAIPIAVEELDASHNSINVVRGPVNVEL---TILKLQHNNLTD--TAWLLNYPGL 250
Query: 310 HYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNG 369
++L+ N+L I L L + N+L
Sbjct: 251 VEVDLSYNELE-KIM-----------------------YHPFVKMQRLERLYISNNRLV- 285
Query: 370 TIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHL 429
+ Q + ++ L+LS N++ + + L+ L + +N I ++ L L
Sbjct: 286 ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV-TL--KLSTHHTL 341
Query: 430 LKLNLSRNQLT 440
L LS N
Sbjct: 342 KNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 7e-14
Identities = 18/119 (15%), Positives = 41/119 (34%)
Query: 370 TIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHL 429
I Q +++ + E + N + N+ + + L +
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71
Query: 430 LKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLS 488
LNL+ Q+ F ++ ++ + N + + P + + L L+ N+LS
Sbjct: 72 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 130
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 2e-42
Identities = 67/299 (22%), Positives = 118/299 (39%), Gaps = 7/299 (2%)
Query: 194 DVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNI--GFLQIATLSLQGNQLTGKI 251
D+ N + + + L+L+ N +S + + TL L+ N+L
Sbjct: 38 DLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSNRLKLIP 96
Query: 252 PSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPE-LGNMTKLH 310
V + L LD+S N + + + +L + L + N L +I + L
Sbjct: 97 LGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLE 155
Query: 311 YLELNDNQLTGHIPP-ALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNG 369
L L LT IP AL L L L + + ++ + L L +
Sbjct: 156 QLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLD 214
Query: 370 TIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHL 429
T+ P ++T L+++ N+ + + + L L++S N IS S L +L L
Sbjct: 215 TMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRL 274
Query: 430 LKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLS 488
++ L QL P F L + +++S N LT + + N+ +L LD N L+
Sbjct: 275 QEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 6e-33
Identities = 71/360 (19%), Positives = 124/360 (34%), Gaps = 48/360 (13%)
Query: 51 PSSDYCVWRGIT--CDNVTFTVIALNLSG----LNLDG----EISPAV-GDLKDLQSIDL 99
P C + C F + + L+L ++ L+ ++L
Sbjct: 4 PPRCECSAQDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELEL 63
Query: 100 RGNRLSGQIPDEI-GDCSSLKSLDLSFNELYGDIPFSI-SKLKQLEFLILKNNQLIGPIP 157
N +S + + +L++L L N L IP + + L L L + N+++ +
Sbjct: 64 NENIVS-AVEPGAFNNLFNLRTLGLRSNRL-KLIPLGVFTGLSNLTKLDISENKIVILLD 121
Query: 158 STLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVL 217
L NLK + N+LV +S SGL S + L
Sbjct: 122 YMFQDLYNLKSLEVGDNDLV-YISHRA--FSGL---------------------NSLEQL 157
Query: 218 DLSYNQLSGEIPFNI--GFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPI 275
L L+ IP + L L+ + + L VL++S +
Sbjct: 158 TLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTM 216
Query: 276 PPILGNLSYTEKLYLHSNKLTGHIPPE-LGNMTKLHYLELNDNQLTGHIPP-ALGKLTDL 333
P L + LT +P + ++ L +L L+ N ++ I L +L L
Sbjct: 217 TPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRL 274
Query: 334 FDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPP-AFQRLESMTYLNLSLNNIR 392
++ + L P L LNV GN+L T+ F + ++ L L N +
Sbjct: 275 QEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-30
Identities = 49/231 (21%), Positives = 95/231 (41%), Gaps = 13/231 (5%)
Query: 263 VLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPE-LGNMTKLHYLELNDNQLTG 321
+ +P + + T L L N++ + + + L LELN+N ++
Sbjct: 15 AVLCHRKRFVA-VPEGI--PTETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIVS- 69
Query: 322 HIPP-ALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPP-AFQRLE 379
+ P A L +L L + +N L+ + +NL L++ NK+ + FQ L
Sbjct: 70 AVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLY 128
Query: 380 SMTYLNLSLNNIRGPIPVE-LSRIGNLDTLDMSNNKISGSIPSP-LGDLEHLLKLNLSRN 437
++ L + N++ I S + +L+ L + ++ SIP+ L L L+ L L
Sbjct: 129 NLKSLEVGDNDLVY-ISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHL 186
Query: 438 QLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLS 488
+ F L + +++SH + N+ SL + + NL+
Sbjct: 187 NINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT 237
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 8e-16
Identities = 31/137 (22%), Positives = 59/137 (43%), Gaps = 4/137 (2%)
Query: 353 SCT-NLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMS 411
C+ ++ H + +P L+L N I+ E + +L+ L+++
Sbjct: 8 ECSAQDRAVLCHRKRFV-AVPEGIPT--ETRLLDLGKNRIKTLNQDEFASFPHLEELELN 64
Query: 412 NNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEEL 471
N +S P +L +L L L N+L G F L ++ ++D+S N + ++
Sbjct: 65 ENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMF 124
Query: 472 SQLQNMFSLRLDYNNLS 488
L N+ SL + N+L
Sbjct: 125 QDLYNLKSLEVGDNDLV 141
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-41
Identities = 68/371 (18%), Positives = 134/371 (36%), Gaps = 47/371 (12%)
Query: 73 LNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEI-GDCSSLKSLDLSFNELYGD 131
+++ D L + + + + + + ++P + ++ L+L+ ++
Sbjct: 32 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEI 90
Query: 132 IPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDM-CQLSGL 190
++ + ++ L + N + P +P L V L N+L +L + L
Sbjct: 91 DTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKL 149
Query: 191 WYFDVRNNSLTGSIPQNI-GNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTG 249
+ NN+L I + TS Q L LS N+L+ + + + ++ N L+
Sbjct: 150 TTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLS-LIPSLFHANVSYNLLS- 205
Query: 250 KIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKL 309
+ + A+ LD S N ++ P+ L L L N LT L N L
Sbjct: 206 ----TLAIPIAVEELDASHNSINVVRGPVNVEL---TILKLQHNNLTD--TAWLLNYPGL 256
Query: 310 HYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNG 369
++L+ N+L I L L + N+L
Sbjct: 257 VEVDLSYNELE-KIMYHP-----------------------FVKMQRLERLYISNNRLV- 291
Query: 370 TIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHL 429
+ Q + ++ L+LS N++ + + L+ L + +N I ++ L L
Sbjct: 292 ALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIV-TL--KLSTHHTL 347
Query: 430 LKLNLSRNQLT 440
L LS N
Sbjct: 348 KNLTLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 4e-41
Identities = 70/426 (16%), Positives = 140/426 (32%), Gaps = 52/426 (12%)
Query: 108 IPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLK 167
I + + + F L + + KN+ + + L ++
Sbjct: 19 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 78
Query: 168 VFGLRGNNLVGTLSPDM-CQLSGLWYFDVRNNSLTGSIPQNI-GNCTSFQVLDLSYNQLS 225
+ L + + + + N++ +P ++ N VL L N LS
Sbjct: 79 LLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS 136
Query: 226 GEIPFNI--GFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLS 283
+P I ++ TLS+ N L +I +
Sbjct: 137 -SLPRGIFHNTPKLTTLSMSNNNLE-RIE-----------------------DDTFQATT 171
Query: 284 YTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHL 343
+ L L SN+LT H+ + L + ++ N L+ L + +L+ ++N +
Sbjct: 172 SLQNLQLSSNRLT-HVDL--SLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSI 223
Query: 344 EGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIG 403
+ + L L + N L T + ++LS N + + ++
Sbjct: 224 NV-VRGPV--NVELTILKLQHNNL--TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQ 278
Query: 404 NLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHL 463
L+ L +SNN++ ++ + L L+LS N L + + + L HN +
Sbjct: 279 RLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSI 336
Query: 464 TGVIPEELSQLQNMFSLRLDYNNLSGDVMSLI--NCLSLSVLFIGNPGLCGYWL-HSACR 520
+ L+N L L +N+ + + + N +V Y L H C
Sbjct: 337 VTLKLSTHHTLKN---LTLSHNDWDCNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCC 393
Query: 521 DSHPTE 526
Sbjct: 394 KESDKP 399
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 1e-20
Identities = 31/182 (17%), Positives = 61/182 (33%), Gaps = 2/182 (1%)
Query: 308 KLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKL 367
+ Y I L +D+++ + + N + + +
Sbjct: 4 QQRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTM 63
Query: 368 NGTIPP-AFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDL 426
+P + LNL+ I + + L M N I P ++
Sbjct: 64 R-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNV 122
Query: 427 EHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNN 486
L L L RN L+ G F N + + +S+N+L + + ++ +L+L N
Sbjct: 123 PLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNR 182
Query: 487 LS 488
L+
Sbjct: 183 LT 184
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 3e-39
Identities = 85/329 (25%), Positives = 140/329 (42%), Gaps = 51/329 (15%)
Query: 594 MRMTENLSEKY----IIGYGASSTVYKCV-LKNCKPVAIKRLYSHY---PQCLKEFETEL 645
M +LS++Y I+G+G S V+ L++ + VA+K L + P F E
Sbjct: 4 MTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREA 63
Query: 646 ETVGSIKHRNLVSL--QGYSLSSSGNLLFYDFME--NG-SLWDILHGPTKKKKLDWDTRL 700
+ ++ H +V++ G + + +G L Y ME +G +L DI+H + + +
Sbjct: 64 QNAAALNHPAIVAVYDTGEAETPAGPL-PYIVMEYVDGVTLRDIVH---TEGPMTPKRAI 119
Query: 701 KIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLC-VSKSYTST 759
++ A Q L + H + IIHRDVK +NI++ + DFGIA+++ S T T
Sbjct: 120 EVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 760 -YIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECN----LHHLILSK 814
++GT Y+ PE AR + +SDVYS G VL E+LTG + H+
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV---- 232
Query: 815 TANNAV--METVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPT-----MHEVSRVLG 867
+SA + V AL + P +R ++ RV
Sbjct: 233 --REDPIPPSARHEGLSA------DLDAVVLKAL---AKNPENRYQTAAEMRADLVRVHN 281
Query: 868 SL---VPAPEPQKQPTSIPSALLSSAKVP 893
P + TS+ S+ + P
Sbjct: 282 GEPPEAPKVLTDAERTSLLSSAAGNLSGP 310
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-38
Identities = 78/419 (18%), Positives = 156/419 (37%), Gaps = 30/419 (7%)
Query: 96 SIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGP 155
+D N L +P ++ L++S N + I L +L LI+ +N++
Sbjct: 4 LVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYL 60
Query: 156 IPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQN--IGNCTS 213
S L+ L N L +S L + D+ N+ ++P GN +
Sbjct: 61 DISVFKFNQELEYLDLSHNKL-VKISCH--PTVNLKHLDLSFNAFD-ALPICKEFGNMSQ 116
Query: 214 FQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGL-------MQALAVLDL 266
+ L LS L I L I+ + L + G+ GL + + +
Sbjct: 117 LKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNK 176
Query: 267 SCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHY---LELNDNQLTGHI 323
+ + + NL + + + + L + L LN+ + T +
Sbjct: 177 EFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNS 236
Query: 324 PPALGKL---TDLFDLNVANNHLEGPIPDNLSSCTN-----LNSLNVHGNKLNGTIPPAF 375
+ +L T ++ +++N L+G + + L+ V + +
Sbjct: 237 FIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIY 296
Query: 376 QRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLS 435
+ +M N +++ R + S+I LD SNN ++ ++ G L L L L
Sbjct: 297 EIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQ 356
Query: 436 RNQLT--GFIPGEFGNLRSVMEIDLSHNHLTGVIPEEL-SQLQNMFSLRLDYNNLSGDV 491
NQL I ++S+ ++D+S N ++ + S +++ SL + N L+ +
Sbjct: 357 MNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTI 415
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 3e-38
Identities = 88/442 (19%), Positives = 153/442 (34%), Gaps = 63/442 (14%)
Query: 74 NLSGLNLDG----EISPAV-GDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNEL 128
L L + + +V ++L+ +DL N+L +LK LDLSFN
Sbjct: 46 KLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCHPT---VNLKHLDLSFNAF 102
Query: 129 YGDIPFS--ISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQ 186
+P + QL+FL L L ++ L KV + G P+
Sbjct: 103 -DALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPE--G 159
Query: 187 LSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFN--------------- 231
L + T I + + V +L + + + N
Sbjct: 160 LQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTN 219
Query: 232 -----------------------------IGFLQIATLSLQGNQLTGKIPSVIGLMQALA 262
+ + I+ + LQG ++AL+
Sbjct: 220 PKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALS 279
Query: 263 VLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGH 322
+ + ++ P I S + ++ +L+ ++N LT
Sbjct: 280 IHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDT 339
Query: 323 IPPALGKLTDLFDLNVANNHLE--GPIPDNLSSCTNLNSLNVHGNKLNGTIPP-AFQRLE 379
+ G LT+L L + N L+ I + + +L L++ N ++ +
Sbjct: 340 VFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTK 399
Query: 380 SMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQL 439
S+ LN+S N + I L + LD+ +NKI SIP + LE L +LN++ NQL
Sbjct: 400 SLLSLNMSSNILTDTIFRCLPP--RIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQL 456
Query: 440 TGFIPGEFGNLRSVMEIDLSHN 461
G F L S+ +I L N
Sbjct: 457 KSVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-33
Identities = 78/468 (16%), Positives = 157/468 (33%), Gaps = 31/468 (6%)
Query: 64 DNVTFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDL 123
+++ LN+S + + + L L+ + + NR+ L+ LDL
Sbjct: 17 KDLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDL 76
Query: 124 SFNELYGDIPFSISKLKQLEFLILKNNQLIG-PIPSTLSQLPNLKVFGLRGNNLVGTLSP 182
S N+L I L+ L L N PI + LK GL +L +
Sbjct: 77 SHNKL-VKISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVL 133
Query: 183 DMCQLSGLWYFDVRNNSLTGSIP----QNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIA 238
+ L+ V + Q+ S ++ + + + ++ +
Sbjct: 134 PIAHLNISKVLLVLGETYGEKEDPEGLQDFNT-ESLHIVFPTNKEFHFILDVSVKTVANL 192
Query: 239 TLS-----LQGNQLTGKIPSVIGLMQALAVLDLS---CNMLSGPIPPILGNLSYTEKLYL 290
LS L+ N+ + + + L + +L+ IL + +T Y
Sbjct: 193 ELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYF 252
Query: 291 HSNKLTGHIPPELG-------NMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHL 343
+ + + ++ L ++ + +++ N +
Sbjct: 253 SISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGT 312
Query: 344 EGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIR--GPIPVELSR 401
S + L+ N L T+ L + L L +N ++ I ++
Sbjct: 313 RMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQ 372
Query: 402 IGNLDTLDMSNNKISGSIPSPLGD-LEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSH 460
+ +L LD+S N +S + LL LN+S N LT I + +DL
Sbjct: 373 MKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHS 430
Query: 461 NHLTGVIPEELSQLQNMFSLRLDYNNLSG-DVMSLINCLSLSVLFIGN 507
N + IP+++ +L+ + L + N L SL +++
Sbjct: 431 NKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHT 477
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 9e-27
Identities = 70/393 (17%), Positives = 131/393 (33%), Gaps = 33/393 (8%)
Query: 73 LNLSGLNLDGEISPAV-GDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGD 131
L+LS D G++ L+ + L L I + K L +
Sbjct: 95 LDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEK 154
Query: 132 IPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMC------ 185
L+ L + + V L +N+ L + C
Sbjct: 155 EDPE--GLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSI 212
Query: 186 -----QLSGLWYFDVRNNSLTGSIPQNIGNC---TSFQVLDLSYNQLSGEI---PFNIGF 234
L + N T + I T+ +S +L G++ F+
Sbjct: 213 LAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSG 272
Query: 235 LQIATLS---LQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLH 291
+ LS + + + + + + + + + +S L
Sbjct: 273 TSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFS 332
Query: 292 SNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALG---KLTDLFDLNVANNHLEGPIP 348
+N LT + G++T+L L L NQL + ++ L L+++ N +
Sbjct: 333 NNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEK 391
Query: 349 DNL-SSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDT 407
S +L SLN+ N L TI + L+L N I+ IP ++ ++ L
Sbjct: 392 KGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIKS-IPKQVVKLEALQE 448
Query: 408 LDMSNNKISGSIP-SPLGDLEHLLKLNLSRNQL 439
L++++N++ S+P L L K+ L N
Sbjct: 449 LNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 2e-11
Identities = 34/153 (22%), Positives = 62/153 (40%), Gaps = 7/153 (4%)
Query: 356 NLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKI 415
+ ++ N L +P + T LN+S N I ++ + L L +S+N+I
Sbjct: 1 SEFLVDRSKNGLI-HVPKDL--SQKTTILNISQNYISELWTSDILSLSKLRILIISHNRI 57
Query: 416 SGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGV-IPEELSQL 474
S + L L+LS N+L I ++ +DLS N + I +E +
Sbjct: 58 QYLDISVFKFNQELEYLDLSHNKLVK-IS--CHPTVNLKHLDLSFNAFDALPICKEFGNM 114
Query: 475 QNMFSLRLDYNNLSGDVMSLINCLSLSVLFIGN 507
+ L L +L + I L++S + +
Sbjct: 115 SQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVL 147
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-38
Identities = 68/211 (32%), Positives = 103/211 (48%), Gaps = 22/211 (10%)
Query: 600 LSEKY----IIGYGASSTVYKCV-LKNCKPVAIKRLYSHY---PQCLKEFETELETVGSI 651
++E+Y +G G STVY VAIK ++ + LK FE E+ +
Sbjct: 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL 68
Query: 652 KHRNLVSLQGYSLSSSGNLLFYDFME--NG-SLWDILHGPTKKKKLDWDTRLKIALGAAQ 708
H+N+VS+ + + +Y ME G +L + + L DT +
Sbjct: 69 SHQNIVSM--IDVDEEDDC-YYLVMEYIEGPTLSEYIE---SHGPLSVDTAINFTNQILD 122
Query: 709 GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTST-YIMGTIGY 767
G+ + H RI+HRD+K NIL+D + + DFGIAK+L S T T +++GT+ Y
Sbjct: 123 GIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKAL-SETSLTQTNHVLGTVQY 178
Query: 768 IDPEYARTSRLTEKSDVYSFGIVLLELLTGR 798
PE A+ E +D+YS GIVL E+L G
Sbjct: 179 FSPEQAKGEATDECTDIYSIGIVLYEMLVGE 209
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-37
Identities = 68/318 (21%), Positives = 128/318 (40%), Gaps = 28/318 (8%)
Query: 182 PDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFN--IGFLQIAT 239
P CQ + L +P+++ T +LDL N+++ EI + T
Sbjct: 26 PFRCQCHLR-VVQCSDLGLE-KVPKDLPPDT--ALLDLQNNKIT-EIKDGDFKNLKNLHT 80
Query: 240 LSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHI 299
L L N+++ P + L L LS N L + L ++L +H N++T +
Sbjct: 81 LILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTL---QELRVHENEIT-KV 136
Query: 300 PPE-LGNMTKLHYLELNDNQLT-GHIPP-ALGKLTDLFDLNVANNHLEGPIPDNLSSCTN 356
+ ++ +EL N L I A + L + +A+ ++ IP L +
Sbjct: 137 RKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGLPP--S 193
Query: 357 LNSLNVHGNKLNGTIPP-AFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKI 415
L L++ GNK+ + + + L ++ L LS N+I L+ +L L ++NNK+
Sbjct: 194 LTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL 252
Query: 416 SGSIPSPLGDLEHLLKLNLSRNQLTGF------IPGEFGNLRSVMEIDLSHNHL--TGVI 467
+P L D +++ + L N ++ PG S + L N + +
Sbjct: 253 V-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQ 311
Query: 468 PEELSQLQNMFSLRLDYN 485
P + +++L
Sbjct: 312 PSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 6e-36
Identities = 66/254 (25%), Positives = 110/254 (43%), Gaps = 16/254 (6%)
Query: 239 TLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGH 298
+ L K+P L A+LDL N ++ NL L L +NK++
Sbjct: 35 VVQCSDLGLE-KVPK--DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-K 90
Query: 299 IPPE-LGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNL 357
I P + KL L L+ NQL +P + L +L V N + + +
Sbjct: 91 ISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQM 147
Query: 358 NSLNVHGNKL-NGTIPP-AFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKI 415
+ + N L + I AFQ ++ ++Y+ ++ NI IP L +L L + NKI
Sbjct: 148 IVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGLPP--SLTELHLDGNKI 204
Query: 416 SGSIPSP-LGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQL 474
+ + + L L +L KL LS N ++ G N + E+ L++N L +P L+
Sbjct: 205 T-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADH 262
Query: 475 QNMFSLRLDYNNLS 488
+ + + L NN+S
Sbjct: 263 KYIQVVYLHNNNIS 276
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-32
Identities = 64/334 (19%), Positives = 122/334 (36%), Gaps = 47/334 (14%)
Query: 93 DLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQL 152
L+ + L ++P ++ LDL N++ LK L LIL NN++
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 153 IGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNI-GNC 211
P + L L+ L N L L M L V N +T + +++
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEIT-KVRKSVFNGL 144
Query: 212 TSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNML 271
V++L N L + ++ G M+ L+ + ++ +
Sbjct: 145 NQMIVVELGTNPLK-------------SSGIENGAFQG--------MKKLSYIRIADTNI 183
Query: 272 SGPIPPILGNLSYTEKLYLHSNKLTGHIPPE-LGNMTKLHYLELNDNQLTGHIPP-ALGK 329
+ IP G +L+L NK+T + L + L L L+ N ++ + +L
Sbjct: 184 TT-IPQ--GLPPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSIS-AVDNGSLAN 238
Query: 330 LTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPP-------AFQRLESMT 382
L +L++ NN L +P L+ + + +H N ++ I + S +
Sbjct: 239 TPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYS 296
Query: 383 YLNLSLNNIR-GPIPVEL-SRIGNLDTLDMSNNK 414
++L N ++ I + + + N K
Sbjct: 297 GVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-31
Identities = 62/252 (24%), Positives = 109/252 (43%), Gaps = 17/252 (6%)
Query: 261 LAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPE-LGNMTKLHYLELNDNQL 319
L V+ S L +P L T L L +NK+T I N+ LH L L +N++
Sbjct: 33 LRVVQCSDLGLEK-VPKDLP--PDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKI 88
Query: 320 TGHIPP-ALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPP-AFQR 377
+ I P A L L L ++ N L+ +P+ + L L VH N++ + F
Sbjct: 89 S-KISPGAFAPLVKLERLYLSKNQLKE-LPEKMPK--TLQELRVHENEIT-KVRKSVFNG 143
Query: 378 LESMTYLNLSLNNIR-GPIPVE-LSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLS 435
L M + L N ++ I + L + +++ I+ +IP L L +L+L
Sbjct: 144 LNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLD 200
Query: 436 RNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDVMSLI 495
N++T L ++ ++ LS N ++ V L+ ++ L L+ N L L
Sbjct: 201 GNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLA 260
Query: 496 NCLSLSVLFIGN 507
+ + V+++ N
Sbjct: 261 DHKYIQVVYLHN 272
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 58/305 (19%), Positives = 121/305 (39%), Gaps = 34/305 (11%)
Query: 92 KDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQ 151
D +DL+ N+++ + + +L +L L N++ P + + L +LE L L NQ
Sbjct: 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 111
Query: 152 LIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDM-CQLSGLWYFDVRNNSLT-GSIPQNI- 208
L +P + L+ + N + + + L+ + ++ N L I
Sbjct: 112 LKE-LPEKM--PKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAF 167
Query: 209 GNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPS-VIGLMQALAVLDLS 267
+ ++ ++ IP + + L L GN++T K+ + + + LA L LS
Sbjct: 168 QGMKKLSYIRIADTNIT-TIPQGL-PPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLS 224
Query: 268 CNMLSGPIPP-ILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPA 326
N +S + L N + +L+L++NKL +P L + + + L++N ++ I
Sbjct: 225 FNSISA-VDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGS- 280
Query: 327 LGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGT-IPP-AFQRLESMTYL 384
+ F N + + +++ N + I P F+ + +
Sbjct: 281 -----NDFCPPGYNTKK-----------ASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAV 324
Query: 385 NLSLN 389
L
Sbjct: 325 QLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 4e-16
Identities = 39/160 (24%), Positives = 57/160 (35%), Gaps = 10/160 (6%)
Query: 352 SSCT-NLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDM 410
C +L + L +P L+L N I + + NL TL +
Sbjct: 27 FRCQCHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLIL 83
Query: 411 SNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEE 470
NNKIS P L L +L LS+NQL L+ E+ + N +T V
Sbjct: 84 INNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQ---ELRVHENEITKVRKSV 140
Query: 471 LSQLQNMFSLRLDYNNLSGDVMS---LINCLSLSVLFIGN 507
+ L M + L N L + LS + I +
Sbjct: 141 FNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIAD 180
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 28/138 (20%), Positives = 56/138 (40%), Gaps = 14/138 (10%)
Query: 74 NLSGLNLDG----EISPAV-GDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNEL 128
+L+ L+LDG ++ A L +L + L N +S + + L+ L L+ N+L
Sbjct: 193 SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL 252
Query: 129 YGDIPFSISKLKQLEFLILKNNQL--IGP----IPSTLSQLPNLKVFGLRGNNL-VGTLS 181
+P ++ K ++ + L NN + IG P ++ + L N + +
Sbjct: 253 V-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQ 311
Query: 182 PDMCQ-LSGLWYFDVRNN 198
P + + + N
Sbjct: 312 PSTFRCVYVRAAVQLGNY 329
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-36
Identities = 57/204 (27%), Positives = 85/204 (41%), Gaps = 24/204 (11%)
Query: 606 IGYGASSTVYK--CVLKNCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQ 660
+G G VY+ ++ + VA+K + P + E T G ++ ++V +
Sbjct: 42 VGRGGMGDVYEAEDTVRE-RIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI- 99
Query: 661 GYSLSSSGNLLFYDFME--NG-SLWDIL--HGPTKKKKLDWDTRLKIALGAAQGLAYLHH 715
+ L+ D M NG L +L GP L + I L H
Sbjct: 100 -HDFGEIDGQLYVD-MRLINGVDLAAMLRRQGP-----LAPPRAVAIVRQIGSALDAAHA 152
Query: 716 DCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTST-YIMGTIGYIDPEYAR 774
HRDVK NIL+ D A+L DFGIA + + T +GT+ Y+ PE
Sbjct: 153 A---GATHRDVKPENILVSADDFAYLVDFGIASAT-TDEKLTQLGNTVGTLYYMAPERFS 208
Query: 775 TSRLTEKSDVYSFGIVLLELLTGR 798
S T ++D+Y+ VL E LTG
Sbjct: 209 ESHATYRADIYALTCVLYECLTGS 232
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-36
Identities = 68/255 (26%), Positives = 116/255 (45%), Gaps = 10/255 (3%)
Query: 236 QIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKL 295
Q + + L+ ++P G+ L+L N + +L + E L L N +
Sbjct: 55 QFSKVVCTRRGLS-EVPQ--GIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 296 TGHIPPE-LGNMTKLHYLELNDNQLTGHIPP-ALGKLTDLFDLNVANNHLEGPIPDNLSS 353
I + L+ LEL DN LT IP A L+ L +L + NN +E +
Sbjct: 112 R-QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNR 169
Query: 354 CTNLNSLNVHGNKLNGTIPP-AFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSN 412
+L L++ K I AF+ L ++ YLNL + NI+ +P L+ + L+ L+MS
Sbjct: 170 VPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSG 227
Query: 413 NKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELS 472
N P L L KL + +Q++ F L S++E++L+HN+L+ + + +
Sbjct: 228 NHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFT 287
Query: 473 QLQNMFSLRLDYNNL 487
L+ + L L +N
Sbjct: 288 PLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-24
Identities = 57/304 (18%), Positives = 93/304 (30%), Gaps = 59/304 (19%)
Query: 93 DLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQL 152
+ LS ++P I S+ + L+L N + + L LE L L N +
Sbjct: 55 QFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 153 IGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCT 212
+ L +L L N L + L +
Sbjct: 112 RQIEVGAFNGLASLNTLELFDNWLT-VIPSGA--FEYL---------------------S 147
Query: 213 SFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLS-CNML 271
+ L L N + S+ + +L LDL L
Sbjct: 148 KLRELWLRNNPIE---------------SIPSYAFNR--------VPSLMRLDLGELKKL 184
Query: 272 SGPIPP-ILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPP-ALGK 329
I L + L L + +P L + L LE++ N I P +
Sbjct: 185 EY-ISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFP-EIRPGSFHG 240
Query: 330 LTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPP-AFQRLESMTYLNLSL 388
L+ L L V N+ + + +L LN+ N L+ ++P F L + L+L
Sbjct: 241 LSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHH 299
Query: 389 NNIR 392
N
Sbjct: 300 NPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-23
Identities = 47/205 (22%), Positives = 80/205 (39%), Gaps = 12/205 (5%)
Query: 288 LYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPP-ALGKLTDLFDLNVANNHLEGP 346
+ L+ +P + + YL L +N + I L L L + N +
Sbjct: 59 VVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNSIRQI 114
Query: 347 IPDNLSSCTNLNSLNVHGNKLNGTIPP-AFQRLESMTYLNLSLNNIRGPIPVE-LSRIGN 404
+ +LN+L + N L IP AF+ L + L L N I IP +R+ +
Sbjct: 115 EVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIES-IPSYAFNRVPS 172
Query: 405 LDTLDMSN-NKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHL 463
L LD+ K+ L +L LNL + +P L + E+++S NH
Sbjct: 173 LMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHF 230
Query: 464 TGVIPEELSQLQNMFSLRLDYNNLS 488
+ P L ++ L + + +S
Sbjct: 231 PEIRPGSFHGLSSLKKLWVMNSQVS 255
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-23
Identities = 58/290 (20%), Positives = 98/290 (33%), Gaps = 50/290 (17%)
Query: 62 TCDNVTFTVIALNLSGLNLD---GEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSL 118
+C N V + L I + + ++L N + +
Sbjct: 51 SCSNQFSKV---VCTRRGLSEVPQGIPS------NTRYLNLMENNI-----------QMI 90
Query: 119 KSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVG 178
++ L LE L L N + + L +L L N L
Sbjct: 91 QADTF-------------RHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLT- 136
Query: 179 TLSPDM-CQLSGLWYFDVRNNSLTGSIPQNI-GNCTSFQVLDLS-YNQLSGEIPFNI--G 233
+ LS L +RNN + SIP S LDL +L I G
Sbjct: 137 VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLE-YISEGAFEG 194
Query: 234 FLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSN 293
+ L+L + +P++ L L L++S N P LS +KL++ ++
Sbjct: 195 LFNLKYLNLGMCNIK-DMPNLTPL-VGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNS 252
Query: 294 KLTGHIPPE-LGNMTKLHYLELNDNQLTGHIPP-ALGKLTDLFDLNVANN 341
+++ I + L L L N L+ +P L L +L++ +N
Sbjct: 253 QVS-LIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 28/114 (24%), Positives = 41/114 (35%), Gaps = 3/114 (2%)
Query: 395 IPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVM 454
+P + N L++ N I L HL L L RN + G F L S+
Sbjct: 69 VPQGIPS--NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLN 126
Query: 455 EIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSG-DVMSLINCLSLSVLFIGN 507
++L N LT + L + L L N + + SL L +G
Sbjct: 127 TLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGE 180
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 4e-36
Identities = 74/258 (28%), Positives = 125/258 (48%), Gaps = 10/258 (3%)
Query: 236 QIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKL 295
Q + + L ++P G+ +L+L N + +L + E L L N +
Sbjct: 44 QFSKVICVRKNLR-EVPD--GISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100
Query: 296 TGHIPPE-LGNMTKLHYLELNDNQLTGHIPP-ALGKLTDLFDLNVANNHLEGPIPDNLSS 353
I + L+ LEL DN+LT IP A L+ L +L + NN +E +
Sbjct: 101 R-TIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNR 158
Query: 354 CTNLNSLNVHGNKLNGTIPP-AFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSN 412
+L L++ K I AF+ L ++ YLNL++ N+R IP L+ + LD LD+S
Sbjct: 159 IPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IP-NLTPLIKLDELDLSG 216
Query: 413 NKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELS 472
N +S P L HL KL + ++Q+ F NL+S++EI+L+HN+LT + + +
Sbjct: 217 NHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFT 276
Query: 473 QLQNMFSLRLDYNNLSGD 490
L ++ + L +N + +
Sbjct: 277 PLHHLERIHLHHNPWNCN 294
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-24
Identities = 69/290 (23%), Positives = 104/290 (35%), Gaps = 50/290 (17%)
Query: 62 TCDNVTFTVIALNLSGLNLD---GEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSL 118
+C N V NL IS + + ++L N++ +
Sbjct: 40 SCSNQFSKV---ICVRKNLREVPDGIST------NTRLLNLHENQI-----------QII 79
Query: 119 KSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVG 178
K L+ LE L L N + + L NL L N L
Sbjct: 80 KVNSF-------------KHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT- 125
Query: 179 TLSPDM-CQLSGLWYFDVRNNSLTGSIPQNI-GNCTSFQVLDLS-YNQLSGEIPFNI--G 233
T+ LS L +RNN + SIP S + LDL +LS I G
Sbjct: 126 TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLS-YISEGAFEG 183
Query: 234 FLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSN 293
+ L+L L +IP++ L L LDLS N LS P L + +KL++ +
Sbjct: 184 LSNLRYLNLAMCNLR-EIPNLTPL-IKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQS 241
Query: 294 KLTGHIPPE-LGNMTKLHYLELNDNQLTGHIPP-ALGKLTDLFDLNVANN 341
++ I N+ L + L N LT +P L L +++ +N
Sbjct: 242 QIQ-VIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-22
Identities = 59/260 (22%), Positives = 103/260 (39%), Gaps = 18/260 (6%)
Query: 114 DCSS-LKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLR 172
CS+ + L ++P IS L L NQ+ ++ L +L++ L
Sbjct: 40 SCSNQFSKVICVRKNL-REVPDGIST--NTRLLNLHENQIQIIKVNSFKHLRHLEILQLS 96
Query: 173 GNNLVGTLSPDM-CQLSGLWYFDVRNNSLTGSIPQNI-GNCTSFQVLDLSYNQLSGEIPF 230
N++ T+ L+ L ++ +N LT +IP + + L L N + IP
Sbjct: 97 RNHI-RTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPS 153
Query: 231 NI--GFLQIATLSLQG-NQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEK 287
+ L L +L+ + L L+L+ L IP L L ++
Sbjct: 154 YAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IPN-LTPLIKLDE 211
Query: 288 LYLHSNKLTGHIPPE-LGNMTKLHYLELNDNQLTGHIPP-ALGKLTDLFDLNVANNHLEG 345
L L N L+ I P + L L + +Q+ I A L L ++N+A+N+L
Sbjct: 212 LDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLTL 269
Query: 346 PIPDNLSSCTNLNSLNVHGN 365
D + +L +++H N
Sbjct: 270 LPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 1e-13
Identities = 46/185 (24%), Positives = 70/185 (37%), Gaps = 17/185 (9%)
Query: 74 NLSGLNLDG----EISP-AVGDLKDLQSIDLRGNRLSGQIPDEI-GDCSSLKSLDLS-FN 126
NL+ L L I A L L+ + LR N + IP SL+ LDL
Sbjct: 113 NLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELK 171
Query: 127 ELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDM-C 185
L + L L +L L L IP L+ L L L GN+L + P
Sbjct: 172 RLSYISEGAFEGLSNLRYLNLAMCNLRE-IP-NLTPLIKLDELDLSGNHLS-AIRPGSFQ 228
Query: 186 QLSGLWYFDVRNNSLTGSIPQN-IGNCTSFQVLDLSYNQLSGEIPFNI--GFLQIATLSL 242
L L + + + I +N N S ++L++N L+ +P ++ + + L
Sbjct: 229 GLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHL 286
Query: 243 QGNQL 247
N
Sbjct: 287 HHNPW 291
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 8e-36
Identities = 49/203 (24%), Positives = 80/203 (39%), Gaps = 27/203 (13%)
Query: 606 IGYGASSTVYKC---VLKNCKPVAIKRL-YSHYPQCLKEFETELETVGSIKHRNLVSL-- 659
I +G +Y + N +PV +K L +S + E + + + H ++V +
Sbjct: 88 IAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 660 QGYSLSSSGNLLFYDFME--NG-SLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHD 716
G+ + Y ME G SL L + L L+YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSYLH-- 199
Query: 717 CSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTST-YIMGTIGYIDPEYART 775
S +++ D+K NI+L ++ + L D G + S Y+ GT G+ PE RT
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI------NSFGYLYGTPGFQAPEIVRT 251
Query: 776 SRLTEKSDVYSFGIVLLELLTGR 798
T +D+Y+ G L L
Sbjct: 252 -GPTVATDIYTVGRTLAALTLDL 273
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-35
Identities = 72/307 (23%), Positives = 123/307 (40%), Gaps = 39/307 (12%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLK-----NCKPVAIKRLYSHYPQCLKEFETELETVGSIK 652
+L +G G +V C VA+K+L P ++F+ E++ + ++
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82
Query: 653 HRNLVSLQGYSLSSSGNLLFY--DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGL 710
+V +G S L +++ +G L D L + +LD L + +G+
Sbjct: 83 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGM 140
Query: 711 AYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYI-- 768
YL S R +HRD+ + NIL++ + + DFG+AK L + K Y Y++ G
Sbjct: 141 EYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY---YVVREPGQSPI 194
Query: 769 ---DPEYARTSRLTEKSDVYSFGIVLLELLT-GRK---AVDNECNLHHLILSKTANNAVM 821
PE + + +SDV+SFG+VL EL T K + A + ++
Sbjct: 195 FWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL 254
Query: 822 ETVD-------PEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAPE 874
E ++ P C +V +L LC P DRP+ + L L
Sbjct: 255 ELLEEGQRLPAPP---ACPA-----EVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306
Query: 875 PQKQPTS 881
+
Sbjct: 307 GCETHAF 313
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 3e-35
Identities = 67/382 (17%), Positives = 122/382 (31%), Gaps = 69/382 (18%)
Query: 120 SLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGT 179
S + +N + G S + E L N V
Sbjct: 14 SQNSFYNTISGTYADYFSAWDKWEKQALPGENR---------------------NEAVSL 52
Query: 180 LSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIAT 239
C ++ + +L+ S+P N+ VL+++ N L +P L+
Sbjct: 53 --LKECLINQFSELQLNRLNLS-SLPDNLP--PQITVLEITQNALI-SLPELPASLE--Y 104
Query: 240 LSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHI 299
L N+L+ +P + ++ LD+ N L+ +P + L E + +N+LT +
Sbjct: 105 LDACDNRLS-TLPELPASLK---HLDVDNNQLTM-LPELPALL---EYINADNNQLT-ML 155
Query: 300 PPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNS 359
P + L L + +NQLT +P L L+V+ N LE +P +
Sbjct: 156 PELPTS---LEVLSVRNNQLT-FLPELPESLE---ALDVSTNLLES-LPAVPVRNHHSEE 207
Query: 360 LNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSI 419
+ N I IP + + T+ + +N +S I
Sbjct: 208 TEIF--------------------FRCRENRITH-IPENILSLDPTCTIILEDNPLSSRI 246
Query: 420 PSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFS 479
L + R + + N D ++SQ+ + F
Sbjct: 247 RESLSQQTAQPDYHGPRIYFSMSDGQQ--NTLHRPLADAVTAWFPENKQSDVSQIWHAFE 304
Query: 480 LRLDYNNLSGDVMSLINCLSLS 501
N S + L + +S
Sbjct: 305 HEEHANTFSAFLDRLSDTVSAR 326
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 7e-33
Identities = 56/270 (20%), Positives = 105/270 (38%), Gaps = 34/270 (12%)
Query: 245 NQLTG---KIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPP 301
N ++G S + A+ + N + L ++ +L L+ L+ +P
Sbjct: 20 NTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSELQLNRLNLS-SLPD 76
Query: 302 ELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLN 361
L ++ LE+ N L +P L L + +N L +P+ + +L L+
Sbjct: 77 NLP--PQITVLEITQNALI-SLPELPASLEYL---DACDNRLST-LPELPA---SLKHLD 126
Query: 362 VHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPS 421
V N+L +P LE Y+N N + +P +L+ L + NN+++ +P
Sbjct: 127 VDNNQLT-MLPELPALLE---YINADNNQLTM-LP---ELPTSLEVLSVRNNQLT-FLPE 177
Query: 422 PLGDLEHLLKLNLSRNQLTGFIPGEFGNLRS----VMEIDLSHNHLTGVIPEELSQLQNM 477
LE L++S N L +P + N +T IPE + L
Sbjct: 178 LPESLE---ALDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPT 232
Query: 478 FSLRLDYNNLSGDVMSLINCLSLSVLFIGN 507
++ L+ N LS + ++ + + G
Sbjct: 233 CTIILEDNPLSSRIRESLSQQTAQPDYHGP 262
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-32
Identities = 74/390 (18%), Positives = 133/390 (34%), Gaps = 70/390 (17%)
Query: 73 LNLSGLNLDGEIS-PAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGD 131
L G N + +S + + L LS +PD + + L+++ N L
Sbjct: 39 QALPGENRNEAVSLLKECLINQFSELQLNRLNLS-SLPDNLP--PQITVLEITQNAL-IS 94
Query: 132 IPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLW 191
+P + LE+L +N+L +P + L +L
Sbjct: 95 LPELPA---SLEYLDACDNRLST-LPELPASLKHL------------------------- 125
Query: 192 YFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKI 251
DV NN LT +P+ + ++ NQL+ +P L+ LS++ NQLT +
Sbjct: 126 --DVDNNQLT-MLPELPALL---EYINADNNQLT-MLPELPTSLE--VLSVRNNQLT-FL 175
Query: 252 PSVIGLMQALAVLDLSCNMLSGPIPPILGNL----SYTEKLYLHSNKLTGHIPPELGNMT 307
P L ++L LD+S N+L +P + N++T HIP + ++
Sbjct: 176 PE---LPESLEALDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLD 230
Query: 308 KLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNL-----NSLNV 362
+ L DN L+ I +L + T D + + + L
Sbjct: 231 PTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPE 290
Query: 363 HGNKLNGTIPPAFQRLESMTYLNLSLNNIRGP------------IPVELSRIGNLDTLDM 410
+ I AF+ E + L+ + + L ++ L
Sbjct: 291 NKQSDVSQIWHAFEHEEHANTFSAFLDRLSDTVSARNTSGFREQVAAWLEKLSASAELRQ 350
Query: 411 SNNKISGSIPSPLGDLEHLLKLNLSRNQLT 440
+ ++ D L NL + L
Sbjct: 351 QSFAVAADATESCEDRVALTWNNLRKTLLV 380
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 7e-35
Identities = 53/302 (17%), Positives = 110/302 (36%), Gaps = 19/302 (6%)
Query: 199 SLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLM 258
S S Q +C + S L+ IP + + +L L N++T S +
Sbjct: 18 SKEESSNQASLSCDRNGICKGSSGSLN-SIPSGL-TEAVKSLDLSNNRITYISNSDLQRC 75
Query: 259 QALAVLDLSCNMLSGPIPP-ILGNLSYTEKLYLHSNKLTGHIPPEL-GNMTKLHYLELND 316
L L L+ N ++ I +L E L L N L+ ++ ++ L +L L
Sbjct: 76 VNLQALVLTSNGINT-IEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLG 133
Query: 317 NQLTGHIPP--ALGKLTDLFDLNVANNHLEGPIPDN-LSSCTNLNSLNVHGNKLNGTIPP 373
N + LT L L V N I + T L L + + L P
Sbjct: 134 NPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPK 192
Query: 374 AFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISG----SIPS----PLGD 425
+ + ++++++L L + + + + +++ L++ + + + + L
Sbjct: 193 SLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIK 252
Query: 426 LEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYN 485
+ ++ L + + ++E++ S N L V +L ++ + L N
Sbjct: 253 KFTFRNVKITDESLFQ-VMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTN 311
Query: 486 NL 487
Sbjct: 312 PW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 9e-26
Identities = 62/335 (18%), Positives = 110/335 (32%), Gaps = 43/335 (12%)
Query: 71 IALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYG 130
+ + L+ + + A L+ IP + ++KSLDLS N +
Sbjct: 10 VLGVIISLSKEESSNQASLSCDRNGICKGSSGSLN-SIPSGL--TEAVKSLDLSNNRITY 66
Query: 131 DIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGL 190
+ + L+ L+L +N + + S L +L+ L N L LS
Sbjct: 67 ISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS-NLSSSW------ 119
Query: 191 WYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLS--GEIPFNIGFLQIATLSLQGNQLT 248
F +S L+L N GE ++ L +
Sbjct: 120 --FK---------------PLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTF 162
Query: 249 GKIPS-VIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPEL-GNM 306
KI + L L++ + L P L ++ L LH + +
Sbjct: 163 TKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVT 221
Query: 307 TKLHYLELNDNQLTG----HIPP----ALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLN 358
+ + LEL D L + +L K ++ + + L + L+ + L
Sbjct: 222 SSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLL 280
Query: 359 SLNVHGNKLNGTIPP-AFQRLESMTYLNLSLNNIR 392
L N+L ++P F RL S+ + L N
Sbjct: 281 ELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 44/237 (18%), Positives = 86/237 (36%), Gaps = 18/237 (7%)
Query: 285 TEKLYLHSNKLTGHIPPE-LGNMTKLHYLELNDNQLTGHIPP-ALGKLTDLFDLNVANNH 342
+ L L +N++T +I L L L L N + I + L L L+++ N+
Sbjct: 54 VKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNY 111
Query: 343 LEGPIPDNL-SSCTNLNSLNVHGNKLNGTIPP--AFQRLESMTYLNLSLNNIRGPIPVE- 398
L + + ++L LN+ GN T+ F L + L + + I +
Sbjct: 112 LSN-LSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKD 169
Query: 399 LSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDL 458
+ + L+ L++ + + P L ++++ L L Q + SV ++L
Sbjct: 170 FAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLEL 229
Query: 459 SHNHLTGVIPEELS--------QLQNMFSLRLDYNNLSGDVMSLINCLSLSVLFIGN 507
L ELS + ++++ +L + L L L
Sbjct: 230 RDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSR 286
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 32/133 (24%), Positives = 55/133 (41%), Gaps = 14/133 (10%)
Query: 385 NLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIP 444
+ SLN+I + + +LD+SNN+I+ S L +L L L+ N +
Sbjct: 40 SGSLNSIPSGLTE------AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEE 93
Query: 445 GEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDVMSLINCLSLSVLF 504
F +L S+ +DLS+N+L+ + L ++ L L N L + LF
Sbjct: 94 DSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK--------TLGETSLF 145
Query: 505 IGNPGLCGYWLHS 517
L + +
Sbjct: 146 SHLTKLQILRVGN 158
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 7e-35
Identities = 56/266 (21%), Positives = 104/266 (39%), Gaps = 28/266 (10%)
Query: 605 IIGYGASSTVYKCV-LKNCKPVAIK--RLYSHYPQCLKEFETELETVGSIKHRNLVSLQG 661
IG G+ TVYK + + VA + + F+ E E + ++H N+V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 662 YSLSSS---GNLLFY-DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDC 717
S+ ++ + M +G+L L + K + +GL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLH-TR 148
Query: 718 SPRIIHRDVKSSNILLD-KDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTS 776
+P IIHRD+K NI + + D G+A S + ++GT ++ PE
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA---VIGTPEFMAPEMY-EE 204
Query: 777 RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEI-SATCKDL 835
+ E DVY+FG+ +LE+ T N + + + V ++ K+
Sbjct: 205 KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY--RRVTSGVKPASFDKVAIPEVKE- 261
Query: 836 GAVKKVFQLALLCSKRQPTDRPTMHE 861
+ C ++ +R ++ +
Sbjct: 262 --------IIEGCIRQNKDERYSIKD 279
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-34
Identities = 75/346 (21%), Positives = 131/346 (37%), Gaps = 31/346 (8%)
Query: 153 IGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCT 212
T S +P+L + + P C + L ++P+ I
Sbjct: 3 EASGAETTSGIPDLDSLPPTYSAMC----PFGCHCHLR-VVQCSDLGLK-AVPKEIS--P 54
Query: 213 SFQVLDLSYNQLSGEIPFN--IGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNM 270
+LDL N +S E+ + G + L L N+++ ++ L L +S N
Sbjct: 55 DTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNH 113
Query: 271 LSGPIPPILGNLSYTEKLYLHSNKLTGHIPPE-LGNMTKLHYLELNDNQLT-GHIPPALG 328
L P + +L +L +H N++ +P + ++ +E+ N L P
Sbjct: 114 LVEIPPNLPSSL---VELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAF 169
Query: 329 KLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPP-AFQRLESMTYLNLS 387
L L ++ L G IP +L LN L++ NK+ I R + L L
Sbjct: 170 DGLKLNYLRISEAKLTG-IPKDLPE--TLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLG 225
Query: 388 LNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEF 447
N IR LS + L L + NNK+S +P+ L DL+ L + L N +T +F
Sbjct: 226 HNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDF 284
Query: 448 GNLRSVM------EIDLSHNHLT--GVIPEELSQLQNMFSLRLDYN 485
+ + I L +N + V P + + +++
Sbjct: 285 CPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 5e-34
Identities = 70/284 (24%), Positives = 114/284 (40%), Gaps = 41/284 (14%)
Query: 210 NCT-SFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSC 268
C +V+ S L +P I L LQ N ++ ++
Sbjct: 30 GCHCHLRVVQCSDLGLK-AVPKEI-SPDTTLLDLQNNDIS-ELR---------------- 70
Query: 269 NMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPE-LGNMTKLHYLELNDNQLTGHIPPAL 327
L + L L +NK++ I + + KL L ++ N L IPP L
Sbjct: 71 -------KDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISKNHLV-EIPPNL 121
Query: 328 GKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKL-NGTIPP-AFQRLESMTYLN 385
+ L +L + +N + S N+N + + GN L N P AF L + YL
Sbjct: 122 --PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLR 178
Query: 386 LSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSP-LGDLEHLLKLNLSRNQLTGFIP 444
+S + G IP +L L+ L + +NKI +I L L +L L NQ+
Sbjct: 179 ISEAKLTG-IPKDLPE--TLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIEN 234
Query: 445 GEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLS 488
G L ++ E+ L +N L+ +P L L+ + + L NN++
Sbjct: 235 GSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT 277
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 8e-32
Identities = 70/334 (20%), Positives = 119/334 (35%), Gaps = 48/334 (14%)
Query: 93 DLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQL 152
L+ + L +P EI LDL N++ L+ L L+L NN++
Sbjct: 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 153 IGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNI-GNC 211
S L L+ + N+LV + P++ S L + +N + +P+ +
Sbjct: 91 SKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIR-KVPKGVFSGL 146
Query: 212 TSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNML 271
+ +++ N L F G L L L +S L
Sbjct: 147 RNMNCIEMGGNPLE-NSGFEPGAFD--GLKLN-------------------YLRISEAKL 184
Query: 272 SGPIPPILGNLSYTEKLYLHSNKLTGHIPPE-LGNMTKLHYLELNDNQLTGHIPP-ALGK 329
+G IP +L+L NK+ I E L +KL+ L L NQ+ I +L
Sbjct: 185 TG-IPK--DLPETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSF 239
Query: 330 LTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPP-AFQRLE------SMT 382
L L +L++ NN L +P L L + +H N + + F +
Sbjct: 240 LPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYN 297
Query: 383 YLNLSLNNIRGPI--PVELSRIGNLDTLDMSNNK 414
++L N + P + + + N K
Sbjct: 298 GISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 62/251 (24%), Positives = 105/251 (41%), Gaps = 16/251 (6%)
Query: 261 LAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPE-LGNMTKLHYLELNDNQL 319
L V+ S L +P + T L L +N ++ + + + L+ L L +N++
Sbjct: 35 LRVVQCSDLGLKA-VPKEIS--PDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKI 90
Query: 320 TGHIPP-ALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPP-AFQR 377
+ I A L L L ++ NHL IP NL S +L L +H N++ +P F
Sbjct: 91 S-KIHEKAFSPLRKLQKLYISKNHLVE-IPPNLPS--SLVELRIHDNRIR-KVPKGVFSG 145
Query: 378 LESMTYLNLSLNNIR-GPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSR 436
L +M + + N + L+ L +S K++ IP L E L +L+L
Sbjct: 146 LRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDH 202
Query: 437 NQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDVMSLIN 496
N++ + + + L HN + + LS L + L LD N LS L +
Sbjct: 203 NKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVPAGLPD 262
Query: 497 CLSLSVLFIGN 507
L V+++
Sbjct: 263 LKLLQVVYLHT 273
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 62/346 (17%), Positives = 120/346 (34%), Gaps = 49/346 (14%)
Query: 51 PSSDYCVWRGITCDNVTFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPD 110
P +C R + C ++ + +S D +DL+ N +S D
Sbjct: 28 PFGCHCHLRVVQCSDLGLKAVPKEIS---------------PDTTLLDLQNNDISELRKD 72
Query: 111 EIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFG 170
+ L +L L N++ + S L++L+ L + N L+ IP L +L
Sbjct: 73 DFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLVE-IPPNL--PSSLVELR 129
Query: 171 LRGNNLVGTLSPDMCQ-LSGLWYFDVRNNSLT-GSIPQNIGNCTSFQVLDLSYNQLSGEI 228
+ N + + + L + ++ N L + L +S +L+ I
Sbjct: 130 IHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GI 187
Query: 229 PFNIGFLQIATLSLQGNQLTGKIPS-VIGLMQALAVLDLSCNMLSGPIPP-ILGNLSYTE 286
P ++ + L L N++ I + L L L N + I L L
Sbjct: 188 PKDL-PETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRM-IENGSLSFLPTLR 244
Query: 287 KLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGP 346
+L+L +NKL+ +P L ++ L + L+ N +T + + F
Sbjct: 245 ELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGV------NDFCPVGFGVKR--- 293
Query: 347 IPDNLSSCTNLNSLNVHGNKL-NGTIPP-AFQRLESMTYLNLSLNN 390
N +++ N + + P F+ + + N
Sbjct: 294 --------AYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFG-NY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 3e-04
Identities = 15/91 (16%), Positives = 32/91 (35%), Gaps = 14/91 (15%)
Query: 74 NLSGLNLDG----EISPAVGDLKDLQSIDLRGNRLSGQIPDEI-------GDCSSLKSLD 122
L L+LD + + DLK LQ + L N ++ ++ + +
Sbjct: 242 TLRELHLDNNKLSRVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGIS 300
Query: 123 LSFNEL-YGDIPFSI-SKLKQLEFLILKNNQ 151
L N + Y ++ + + + N +
Sbjct: 301 LFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 6e-34
Identities = 69/304 (22%), Positives = 121/304 (39%), Gaps = 42/304 (13%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLKNCK-----PVAIKRLYSHY-PQCLKEFETELETVGSI 651
L + +G G V VA+K L + PQ ++ E++ + ++
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 652 KHRNLVSLQGYSLSSSGN--LLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQG 709
H +++ +G + L +++ GSL D L + + L A +G
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEG 146
Query: 710 LAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYI- 768
+AYLH + IHRD+ + N+LLD D + DFG+AK++ Y Y + G
Sbjct: 147 MAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY---YRVREDGDSP 200
Query: 769 ----DPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLIL---SKTANNAV 820
PE + + SDV+SFG+ L ELLT + LI + +
Sbjct: 201 VFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRL 260
Query: 821 METVD-------PEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAP 873
E ++ P+ C +V+ L C + + + RPT + +L ++
Sbjct: 261 TELLERGERLPRPD---KCPA-----EVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312
Query: 874 EPQK 877
+ Q
Sbjct: 313 QGQA 316
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 68/301 (22%), Positives = 126/301 (41%), Gaps = 40/301 (13%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLKNCK-----PVAIKRLYSHYPQCLKEFETELETVGSIK 652
+L +G G +V C + VA+K+L + L++FE E+E + S++
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69
Query: 653 HRNLVSLQGYSLSSSGNLLFY--DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGL 710
H N+V +G S+ L +++ GSL D L K+++D L+ +G+
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 127
Query: 711 AYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYI-- 768
YL + R IHRD+ + NIL++ + + DFG+ K L K + + + G
Sbjct: 128 EYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF---FKVKEPGESPI 181
Query: 769 ---DPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKT-----ANNAV 820
PE S+ + SDV+SFG+VL EL T + + ++ +
Sbjct: 182 FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 241
Query: 821 METVD-------PEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAP 873
+E + P+ C D +++ + C RP+ +++ + +
Sbjct: 242 IELLKNNGRLPRPD---GCPD-----EIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293
Query: 874 E 874
Sbjct: 294 A 294
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-33
Identities = 72/269 (26%), Positives = 118/269 (43%), Gaps = 26/269 (9%)
Query: 602 EKY----IIGYGASSTVYKCV-LKNCKPVAIK--RLYSHYPQCLKEFETELETVGSIKHR 654
EKY IG G+ ++ + IK + + +E E+ + ++KH
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 655 NLVSLQGYSLSSSGNLLFY-DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYL 713
N+V + S +G+L D+ E G L+ ++ K D L + L ++
Sbjct: 84 NIVQYRE-SFEENGSLYIVMDYCEGGDLFKRIN-AQKGVLFQEDQILDWFVQICLALKHV 141
Query: 714 HHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYA 773
H +I+HRD+KS NI L KD L DFGIA+ L + I GT Y+ PE
Sbjct: 142 H---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEIC 197
Query: 774 RTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCK 833
KSD+++ G VL EL T + A + ++ +L+L + V S +
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLKHAFEAG-SMKNLVLK--IISGSFPPVSLHYSYDLR 254
Query: 834 DLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
L V ++F+ R P DRP+++ +
Sbjct: 255 SL--VSQLFK-------RNPRDRPSVNSI 274
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 8e-33
Identities = 71/297 (23%), Positives = 124/297 (41%), Gaps = 40/297 (13%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLKNCK-----PVAIKRLYSHY-PQCLKEFETELETVGSI 651
L +G G V C VA+K L + + + E+E + ++
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 652 KHRNLVSLQGYSLSSSGNLLF--YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQG 709
H N+V +G GN + +F+ +GSL + L P K K++ +LK A+ +G
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKG 138
Query: 710 LAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYI- 768
+ YL S + +HRD+ + N+L++ + + + DFG+ K++ K Y Y +
Sbjct: 139 MDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY---YTVKDDRDSP 192
Query: 769 ----DPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILS---KTANNAV 820
PE S+ SDV+SFG+ L ELLT +I + +
Sbjct: 193 VFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL 252
Query: 821 METVD-------PEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLV 870
+ T+ P C D +V+QL C + QP++R + + +L+
Sbjct: 253 VNTLKEGKRLPCPP---NCPD-----EVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 70/301 (23%), Positives = 126/301 (41%), Gaps = 40/301 (13%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLKNCK-----PVAIKRLYSHYPQCLKEFETELETVGSIK 652
+L +G G +V C + VA+K+L + L++FE E+E + S++
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100
Query: 653 HRNLVSLQGYSLSSSGNLLF--YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGL 710
H N+V +G S+ L +++ GSL D L K+++D L+ +G+
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 158
Query: 711 AYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYI-- 768
YL + R IHRD+ + NIL++ + + DFG+ K L K Y Y + G
Sbjct: 159 EYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEY---YKVKEPGESPI 212
Query: 769 ---DPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKT-----ANNAV 820
PE S+ + SDV+SFG+VL EL T + + ++ +
Sbjct: 213 FWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 272
Query: 821 METVD-------PEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAP 873
+E + P+ C D +++ + C RP+ +++ + +
Sbjct: 273 IELLKNNGRLPRPD---GCPD-----EIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324
Query: 874 E 874
Sbjct: 325 A 325
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-32
Identities = 73/295 (24%), Positives = 113/295 (38%), Gaps = 33/295 (11%)
Query: 606 IGYGASSTVYKCV-LKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSL 664
+G G S V L + A+KR+ H Q +E + E + H N++ L Y L
Sbjct: 37 LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCL 96
Query: 665 SSSGN-----LLFYDFMENGSLWDIL-HGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCS 718
G LL F + G+LW+ + K L D L + LG +GL +H +
Sbjct: 97 RERGAKHEAWLLL-PFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---A 152
Query: 719 PRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIM--------GTIGYIDP 770
HRD+K +NILL + + L D G C+ + + TI Y P
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 771 E---YARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPE 827
E + E++DV+S G VL ++ G D ++ N + P
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMV-FQKGDSVALAVQNQLSIPQSPR 271
Query: 828 ISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAPEPQKQPTSI 882
S+ L + + P RP + + L +L P P P + T I
Sbjct: 272 HSSALWQL--LNSMMT-------VDPHQRPHIPLLLSQLEALQP-PAPGQHTTQI 316
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 7e-32
Identities = 47/209 (22%), Positives = 87/209 (41%), Gaps = 7/209 (3%)
Query: 285 TEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLT-GHIPP-ALGKLTDLFDLNVANNH 342
+L L SNKL +T+L L L+ N L+ + T L L+++ N
Sbjct: 30 ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNG 89
Query: 343 LEGPIPDNLSSCTNLNSLNVHGNKLNGTIPP--AFQRLESMTYLNLSLNNIRGPIPVELS 400
+ + N L L+ + L + F L ++ YL++S + R +
Sbjct: 90 VIT-MSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFN 147
Query: 401 RIGNLDTLDMSNNKISGSIPS-PLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLS 459
+ +L+ L M+ N + +L +L L+LS+ QL P F +L S+ +++S
Sbjct: 148 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMS 207
Query: 460 HNHLTGVIPEELSQLQNMFSLRLDYNNLS 488
HN+ + L ++ L N++
Sbjct: 208 HNNFFSLDTFPYKCLNSLQVLDYSLNHIM 236
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 55/258 (21%), Positives = 92/258 (35%), Gaps = 16/258 (6%)
Query: 93 DLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQL 152
I L+ +P I SS L+L N+L KL QL L L +N L
Sbjct: 8 SGTEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGL 64
Query: 153 --IGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNI-G 209
G + +LK L N ++ T+S + L L + D ++++L ++
Sbjct: 65 SFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 123
Query: 210 NCTSFQVLDLSYNQLSGEIPFNI--GFLQIATLSLQGNQLTGKIPS-VIGLMQALAVLDL 266
+ + LD+S+ I G + L + GN + ++ L LDL
Sbjct: 124 SLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 182
Query: 267 SCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPE-LGNMTKLHYLELNDNQLTGHIPP 325
S L P +LS + L + N + + L L+ + N +
Sbjct: 183 SQCQLEQLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIM-TSKK 240
Query: 326 AL--GKLTDLFDLNVANN 341
+ L LN+ N
Sbjct: 241 QELQHFPSSLAFLNLTQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-21
Identities = 53/232 (22%), Positives = 81/232 (34%), Gaps = 13/232 (5%)
Query: 73 LNLSGLNLDGEISPAV-GDLKDLQSIDLRGNRLSGQ--IPDEIGDCSSLKSLDLSFNELY 129
L L L + V L L + L N LS + +SLK LDLSFN +
Sbjct: 33 LELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGV- 90
Query: 130 GDIPFSISKLKQLEFLILKNNQLIG-PIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQ-L 187
+ + L+QLE L +++ L S L NL + + + L
Sbjct: 91 ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGL 149
Query: 188 SGLWYFDVRNNSLTGSIPQNI-GNCTSFQVLDLSYNQLSGEIPFNI--GFLQIATLSLQG 244
S L + NS + +I + LDLS QL ++ + L++
Sbjct: 150 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSH 208
Query: 245 NQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYT-EKLYLHSNKL 295
N + +L VLD S N + L + + L L N
Sbjct: 209 NNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 260
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-31
Identities = 76/285 (26%), Positives = 119/285 (41%), Gaps = 33/285 (11%)
Query: 605 IIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSL 664
+G G V+ VAIK L + F E + + ++H LV L +
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAV-V 248
Query: 665 SSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHR 724
S + ++M GSL D L G K L + +A A G+AY+ +HR
Sbjct: 249 SEEPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 304
Query: 725 DVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDV 784
D++++NIL+ ++ + DFG+A+ + ++ I + PE A R T KSDV
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 785 YSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVD-------PEISATCKDLG 836
+SFGI+L EL T GR N V++ V+ P C +
Sbjct: 365 WSFGILLTELTTKGRVPYPG-----------MVNREVLDQVERGYRMPCPP---ECPE-- 408
Query: 837 AVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAPEPQKQPTS 881
+ L C +++P +RPT + L + EPQ QP
Sbjct: 409 ---SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGE 450
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-31
Identities = 79/381 (20%), Positives = 134/381 (35%), Gaps = 34/381 (8%)
Query: 116 SSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPS-TLSQLPNLKVFGLRGN 174
+ + +DLS N + S S+L+ L+FL ++ I + T L +L + L N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 175 NLVGTLSPDMCQ-LSGLWYFDVRNNSLTGS-IPQNI-GNCTSFQVLDLSYNQLSGEIPFN 231
+ L L+ L + +L G+ + N TS ++L L N + +I
Sbjct: 90 QFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK-KIQPA 147
Query: 232 IGFL---QIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKL 288
FL + L L N++ + Q L LS
Sbjct: 148 SFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLL--------------RLSSITLQ 193
Query: 289 YLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIP 348
++ L T + L+L+ N + + +
Sbjct: 194 DMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMG 253
Query: 349 DNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTL 408
+ + N L + + +LS + I + S +L+ L
Sbjct: 254 SSFGHTNFKDPDNFTFKGLEAS---------GVKTCDLSKSKIFALLKSVFSHFTDLEQL 304
Query: 409 DMSNNKISGSIPSPLGD-LEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVI 467
++ N+I+ I L HLLKLNLS+N L F NL + +DLS+NH+ +
Sbjct: 305 TLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALG 363
Query: 468 PEELSQLQNMFSLRLDYNNLS 488
+ L N+ L LD N L
Sbjct: 364 DQSFLGLPNLKELALDTNQLK 384
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-22
Identities = 62/313 (19%), Positives = 108/313 (34%), Gaps = 45/313 (14%)
Query: 90 DLKDLQSIDLRGNRLSGQIPDEIGDC-SSLKSLDLSFNELYGDIP---FSISKLKQLEFL 145
L L+ + LR N + P LDL+FN++ I + K L
Sbjct: 127 PLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKV-KSICEEDLLNFQGKHFTLL 185
Query: 146 ILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIP 205
L + L + + + N + + D+ N S+
Sbjct: 186 RLSSIT--------LQDMNEYWLGWEKCGNPFK--------NTSITTLDLSGNGFKESMA 229
Query: 206 Q---NIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALA 262
+ + T Q L LS + G + F + +G + +G +
Sbjct: 230 KRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASG-----------VK 278
Query: 263 VLDLSCNMLSGPIPP-ILGNLSYTEKLYLHSNKLTGHIPPE-LGNMTKLHYLELNDNQLT 320
DLS + + + + + + E+L L N++ I +T L L L+ N L
Sbjct: 279 TCDLSKSKIFA-LLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLG 336
Query: 321 GHIPP-ALGKLTDLFDLNVANNHLEGPIPDNL-SSCTNLNSLNVHGNKLNGTIPP-AFQR 377
I L L L+++ NH+ + D NL L + N+L ++P F R
Sbjct: 337 -SIDSRMFENLDKLEVLDLSYNHIRA-LGDQSFLGLPNLKELALDTNQLK-SVPDGIFDR 393
Query: 378 LESMTYLNLSLNN 390
L S+ + L N
Sbjct: 394 LTSLQKIWLHTNP 406
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 3e-15
Identities = 47/240 (19%), Positives = 91/240 (37%), Gaps = 28/240 (11%)
Query: 90 DLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIP---FSISKLKQLEFLI 146
L + D+ L + +S+ +LDLS N + F +++ LI
Sbjct: 186 RLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLI 245
Query: 147 LKNNQLIGP--IPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSI 204
L N+ +G + N GL + + D+ + + ++
Sbjct: 246 LSNSYNMGSSFGHTNFKDPDNFTFKGLEASG--------------VKTCDLSKSKIF-AL 290
Query: 205 PQNI-GNCTSFQVLDLSYNQLSGEIPFNI--GFLQIATLSLQGNQLTGKIPSVIGLMQAL 261
+++ + T + L L+ N+++ +I N G + L+L N L + + L
Sbjct: 291 LKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKL 349
Query: 262 AVLDLSCNMLSGPIPP-ILGNLSYTEKLYLHSNKLTGHIPPE-LGNMTKLHYLELNDNQL 319
VLDLS N + + L ++L L +N+L +P +T L + L+ N
Sbjct: 350 EVLDLSYNHIRA-LGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-31
Identities = 67/282 (23%), Positives = 118/282 (41%), Gaps = 33/282 (11%)
Query: 605 IIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSL 664
+G G V+ VA+K + ++ F E + +++H LV L
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVV- 252
Query: 665 SSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHR 724
+ + +FM GSL D L + K + + A+G+A++ IHR
Sbjct: 253 TKEPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHR 308
Query: 725 DVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDV 784
D++++NIL+ + DFG+A+ + ++ I + PE T KSDV
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 368
Query: 785 YSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVD-------PEISATCKDLG 836
+SFGI+L+E++T GR +N V+ ++ PE C +
Sbjct: 369 WSFGILLMEIVTYGRIPYPG-----------MSNPEVIRALERGYRMPRPE---NCPE-- 412
Query: 837 AVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAPEPQKQ 878
+++ + + C K +P +RPT + VL A E Q +
Sbjct: 413 ---ELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQYE 451
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 60/273 (21%), Positives = 105/273 (38%), Gaps = 25/273 (9%)
Query: 602 EKY----IIGYGASSTVYKCV-LKNCKPVAIK--RLYSHYPQCLKEFETELETVGSIKHR 654
E Y IG G+ K + K + K S + +E+ + +KH
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 655 NLVSLQGYSLSSSGNLLFY--DFMENGSLWD-ILHGPTKKKKLDWDTRLKIALGAAQGLA 711
N+V + + L+ ++ E G L I G +++ LD + L++ L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 712 YLH--HDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYID 769
H D ++HRD+K +N+ LD L DFG+A+ L S+ T++ GT Y+
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMS 184
Query: 770 PEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEIS 829
PE EKSD++S G +L EL + L + S
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF-SQKELAGK--IREGKFRRIPYRYS 241
Query: 830 ATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
++ + ++ + RP++ E+
Sbjct: 242 DELNEI--ITRMLN-------LKDYHRPSVEEI 265
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 5e-31
Identities = 69/340 (20%), Positives = 120/340 (35%), Gaps = 41/340 (12%)
Query: 606 IGYGASSTVYKCVLKNCKPVAIKR--LYSHYPQCLKEFETELETVGSIKHRNL--VSLQG 661
IG G SS V++ + + + AIK L Q L + E+ + ++ + + L
Sbjct: 17 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76
Query: 662 YSLSSSGNLLFYDFME--NGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSP 719
Y ++ Y ME N L L KKK +D R + + +H
Sbjct: 77 YEITDQ---YIYMVMECGNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIH---QH 127
Query: 720 RIIHRDVKSSNILLDKDFEAHLTDFGIAKSL-CVSKSYTSTYIMGTIGYIDPE------- 771
I+H D+K +N L+ L DFGIA + + S +GT+ Y+ PE
Sbjct: 128 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 772 ----YARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPE 827
S+++ KSDV+S G +L + G+ N + + N +E
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE-FPDI 245
Query: 828 ISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSR---VLGSLVPAPEPQKQPTSIPS 884
+D+ +K + R P R ++ E+ V P + K T
Sbjct: 246 PEKDLQDV--LKCCLK-------RDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMK 296
Query: 885 ALLSSAKVPCYKDEYANLKTPHMLNCPSMSTSDAQLFLKF 924
+L + + + ++ F
Sbjct: 297 YVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTF 336
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 6e-31
Identities = 84/439 (19%), Positives = 144/439 (32%), Gaps = 59/439 (13%)
Query: 74 NLSGLNLDG----EISPAVGD-LKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNEL 128
L L L + V +DL+ +D+ NRL I +SL+ LDLSFN+
Sbjct: 77 ELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQN-ISC--CPMASLRHLDLSFNDF 133
Query: 129 YGDIPFS--ISKLKQLEFLILKNNQL------------------------IGPIPSTLSQ 162
+P L +L FL L + I + Q
Sbjct: 134 -DVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQ 192
Query: 163 LPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTG-------SIPQNIGNCTSFQ 215
+PN V L + ++ L + + N L + + +
Sbjct: 193 IPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLL 252
Query: 216 VLDLSYNQLSGEIPFNI---------GFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDL 266
+ L + + + + + +L I L++ + +++L + +
Sbjct: 253 NVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHV 312
Query: 267 SCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPA 326
+ + + L + + + +L N T +
Sbjct: 313 KNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQG 372
Query: 327 LGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLN----GTIPPAFQRLESMT 382
L L L + N L+ N++SL LN ES+
Sbjct: 373 CSTLKRLQTLILQRNGLKN-FFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESIL 431
Query: 383 YLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGF 442
LNLS N + G + L + LD+ NN+I SIP + L+ L +LN++ NQL
Sbjct: 432 VLNLSSNMLTGSVFRCLPP--KVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSV 488
Query: 443 IPGEFGNLRSVMEIDLSHN 461
G F L S+ I L N
Sbjct: 489 PDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 7e-31
Identities = 76/418 (18%), Positives = 137/418 (32%), Gaps = 30/418 (7%)
Query: 96 SIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGP 155
+D L+ +P ++ K+L LS N + IS L +L L L +N++
Sbjct: 35 MVDYSNRNLT-HVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSL 91
Query: 156 IPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQN--IGNCTS 213
+L+ + N L +S ++ L + D+ N +P GN T
Sbjct: 92 DFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDLSFNDFD-VLPVCKEFGNLTK 147
Query: 214 FQVLDLSYNQLSGEIPFNIGFLQIAT--LSLQGNQLTGKIPSVIGLMQALAVLDLSCNML 271
L LS + + L ++ L L + G + + VL L +
Sbjct: 148 LTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPN-TTVLHLVFHPN 206
Query: 272 SGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGK-- 329
S + +++ L L + KL L +T K
Sbjct: 207 SLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCS 266
Query: 330 --------LTDLFDLNVANNHLEGPIPDNLSSCTN-----LNSLNVHGNKLNGTIPPAFQ 376
+ LN+ N + I + + L +V + +
Sbjct: 267 VKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYS 326
Query: 377 RLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSR 436
M LS+++ V + L+ + N + S+ L+ L L L R
Sbjct: 327 VFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQR 386
Query: 437 NQLT--GFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQL-QNMFSLRLDYNNLSGDV 491
N L + N+ S+ +D+S N L + +++ L L N L+G V
Sbjct: 387 NGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSV 444
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-29
Identities = 89/488 (18%), Positives = 171/488 (35%), Gaps = 41/488 (8%)
Query: 49 DSPSSDYCVWRGITC--DNVTFTVIALNLSGLNLDGEISPAVGD-LKDLQSIDLRGNRLS 105
+ S R +T ++ AL+LS N E+ L +L+ + L NR+
Sbjct: 31 ELESMVDYSNRNLTHVPKDLPPRTKALSLSQ-NSISELRMPDISFLSELRVLRLSHNRIR 89
Query: 106 GQIPDEIGDC-SSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIG-PIPSTLSQL 163
+ + L+ LD+S N L +I + L L L N P+ L
Sbjct: 90 -SLDFHVFLFNQDLEYLDVSHNRL-QNISCC--PMASLRHLDLSFNDFDVLPVCKEFGNL 145
Query: 164 PNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQN-----IGNCTSFQVLD 218
L GL D+ ++ L + + ++ I T+ L
Sbjct: 146 TKLTFLGLSAAKF---RQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLV 202
Query: 219 LSYNQLSGEIPF----NIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGP 274
N L +G LQ++ + L + + L + +L+++ +
Sbjct: 203 FHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETT 262
Query: 275 IPPILGNLSYT-----EKLYLHSNKLTGHIPPELGNMTK-----LHYLELNDNQLTGHIP 324
+ + E L +++ +T I E ++ L + +
Sbjct: 263 WKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKE 322
Query: 325 PALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYL 384
++ ++ + S ++ LN N ++ L+ + L
Sbjct: 323 ALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTL 382
Query: 385 NLSLNNIR--GPIPVELSRIGNLDTLDMSNNKI-SGSIPSPLGDLEHLLKLNLSRNQLTG 441
L N ++ + + + +L+TLD+S N + S + E +L LNLS N LT
Sbjct: 383 ILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLT- 441
Query: 442 FIPGEFGNL-RSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNL-SGDVMSLINCLS 499
F L V +DL +N + IP++++ LQ + L + N L S S
Sbjct: 442 --GSVFRCLPPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTS 498
Query: 500 LSVLFIGN 507
L +++ +
Sbjct: 499 LQYIWLHD 506
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 9e-21
Identities = 69/381 (18%), Positives = 127/381 (33%), Gaps = 51/381 (13%)
Query: 32 KIKK-SFRDVDNVLYDWTDSPSSDYCVWRGITCDNVTFTVIALNLSGLNLDGEISPAVGD 90
K ++ V ++ Y + G T L+L
Sbjct: 157 KFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMS 216
Query: 91 LKDLQSIDLRGNRLSGQ-------IPDEIGDCSSLKSLDLSFNELYGDIPFSISKL---K 140
+ L + L +L+ + E+ +L ++ L E + + +
Sbjct: 217 VNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPR 276
Query: 141 QLEFLILKNNQLIGPIP-----STLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDV 195
+E+L + N + I + + L +L + ++ + + + + +
Sbjct: 277 PVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKML 336
Query: 196 RNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFL-QIATLSLQGNQLTGKIPSV 254
+ + +SF L+ + N + + L ++ TL LQ N L V
Sbjct: 337 SISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKV 395
Query: 255 IGL---MQALAVLDLSCNML-SGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLH 310
+ M +L LD+S N L S L L SN LTG + L K+
Sbjct: 396 ALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVK 453
Query: 311 YLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGT 370
L+L++N++ IP + L L LNV N+L +
Sbjct: 454 VLDLHNNRIM-SIPKDVTHLQ------------------------ALQELNVASNQLK-S 487
Query: 371 IPP-AFQRLESMTYLNLSLNN 390
+P F RL S+ Y+ L N
Sbjct: 488 VPDGVFDRLTSLQYIWLHDNP 508
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 7e-31
Identities = 75/282 (26%), Positives = 118/282 (41%), Gaps = 27/282 (9%)
Query: 605 IIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSL 664
+G G V+ VAIK L + F E + + ++H LV L +
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAV-V 331
Query: 665 SSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHR 724
S + ++M GSL D L G K L + +A A G+AY+ +HR
Sbjct: 332 SEEPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 387
Query: 725 DVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDV 784
D++++NIL+ ++ + DFG+A+ + ++ I + PE A R T KSDV
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 447
Query: 785 YSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDP----EISATCKDLGAVK 839
+SFGI+L EL T GR N V++ V+ C +
Sbjct: 448 WSFGILLTELTTKGRVPYPG-----------MVNREVLDQVERGYRMPCPPECPE----- 491
Query: 840 KVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAPEPQKQPTS 881
+ L C +++P +RPT + L + EPQ QP
Sbjct: 492 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGE 533
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 55/274 (20%), Positives = 103/274 (37%), Gaps = 24/274 (8%)
Query: 602 EKY----IIGYGASSTVYKCV-LKNCKPVAIK--RLYSHY-PQCLKEFETELETVGSIKH 653
+ IG G S VY+ L + PVA+K +++ + + E++ + + H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 654 RNLVSLQGYSLSSSGNLLFY-DFMENGSLWDILHGPTKKKK-LDWDTRLKIALGAAQGLA 711
N++ S L + + G L ++ K+K+ + T K + L
Sbjct: 92 PNVIKYYA-SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 712 YLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPE 771
++H S R++HRD+K +N+ + L D G+ + + + + GT Y+ PE
Sbjct: 151 HMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPE 206
Query: 772 YARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISAT 831
+ KSD++S G +L E+ + + + + K S
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE 266
Query: 832 CKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865
+ L V P RP + V V
Sbjct: 267 LRQL--VNMCIN-------PDPEKRPDVTYVYDV 291
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-30
Identities = 42/339 (12%), Positives = 83/339 (24%), Gaps = 72/339 (21%)
Query: 605 IIGYGASSTVYKCV-LKNCKPVAIKRLYSHY---PQCLKEFETE---------------- 644
++G + + + + Y +K+ + E
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 645 ------LETVGSIKHRNLVSL----QGYSLSSSGNLLFYDFMENGSLWD----ILHGPTK 690
+ +K + + F +L +L +
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 691 KKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSL 750
K L RL++ L + LA LH ++H ++ +I+LD+ LT F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 751 CVSKSYTSTYIMGTIGYIDPEYAR-----TSRLTEKSDVYSFGIVLLELLTGRK--AVDN 803
S + +T D ++ G+ + + D
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDA 321
Query: 804 ECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVS 863
I I + L ++ L DR +
Sbjct: 322 ALGGSEWIFRS----------CKNIPQPVRAL--LEG-----FLR--YPKEDRLLPLQAM 362
Query: 864 R---------VLGSLVPAPEPQKQPTSIPSALLSSAKVP 893
L + +P + +PT A S P
Sbjct: 363 ETPEYEQLRTELSAALPLYQTDGEPTREGGAPPSGTSQP 401
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-30
Identities = 65/287 (22%), Positives = 106/287 (36%), Gaps = 35/287 (12%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLKNCK-PVAIKRLYSHY-PQCLKEFETELETVGSIKHRN 655
E+L IG G V+ L+ VA+K P +F E + H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 656 LVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHH 715
+V L G + + ++ G L T+ +L T L++ AA G+ YL
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLR--TEGARLRVKTLLQMVGDAAAGMEYLE- 230
Query: 716 DCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYI-----DP 770
S IHRD+ + N L+ + ++DFG+++ + G + + P
Sbjct: 231 --SKCCIHRDLAARNCLVTEKNVLKISDFGMSREE----ADGVYAASGGLRQVPVKWTAP 284
Query: 771 EYARTSRLTEKSDVYSFGIVLLELLT-GRK---AVDNECNLHHLILSKTANNAVMETVDP 826
E R + +SDV+SFGI+L E + G + N + P
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN-----QQTREFVEKGGRLPC--P 337
Query: 827 EISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAP 873
E VF+L C +P RP+ + + L S+
Sbjct: 338 E--------LCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 63/275 (22%), Positives = 107/275 (38%), Gaps = 38/275 (13%)
Query: 606 IGYGASSTVYKCVLKNCKPVAIKR--LYSHYPQCLKEFETELETVGSIKHRNL--VSLQG 661
IG G SS V++ + + + AIK L Q L + E+ + ++ + + L
Sbjct: 36 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 662 YSLSSSGNLLFYDFME--NGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSP 719
Y ++ Y ME N L L KKK +D R + + +H
Sbjct: 96 YEITDQ---YIYMVMECGNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIH---QH 146
Query: 720 RIIHRDVKSSNILLDKDFEAHLTDFGIAKSL-CVSKSYTSTYIMGTIGYIDPE------- 771
I+H D+K +N L+ L DFGIA + + S +GT+ Y+ PE
Sbjct: 147 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 772 ----YARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPE 827
S+++ KSDV+S G +L + G+ N + + N +E
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE-FPDI 264
Query: 828 ISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
+D+ +K + R P R ++ E+
Sbjct: 265 PEKDLQDV--LKCCLK-------RDPKQRISIPEL 290
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 53/210 (25%), Positives = 98/210 (46%), Gaps = 9/210 (4%)
Query: 283 SYTEKLYLHSNKLTGHIPPE-LGNMTKLHYLELNDNQLTGHIPP-ALGKLTDLFDLNVAN 340
+ +++++LH N+++ H+P L L L+ N L I A L L L++++
Sbjct: 32 AASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSD 89
Query: 341 NHLEGPIPDN-LSSCTNLNSLNVHGNKLNGTIPP-AFQRLESMTYLNLSLNNIRGPIPVE 398
N + L++L++ L + P F+ L ++ YL L N ++ +P +
Sbjct: 90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQA-LPDD 147
Query: 399 -LSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEID 457
+GNL L + N+IS L L +L L +N++ P F +L +M +
Sbjct: 148 TFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLY 207
Query: 458 LSHNHLTGVIPEELSQLQNMFSLRLDYNNL 487
L N+L+ + E L+ L+ + LRL+ N
Sbjct: 208 LFANNLSALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 57/227 (25%), Positives = 93/227 (40%), Gaps = 9/227 (3%)
Query: 217 LDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIP 276
L +P I + L GN+++ + + L +L L N+L+
Sbjct: 16 TSCPQQGLQ-AVPVGI-PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDA 73
Query: 277 PILGNLSYTEKLYLHSNKLTGHIPPE-LGNMTKLHYLELNDNQLTGHIPP-ALGKLTDLF 334
L+ E+L L N + P + +LH L L+ L + P L L
Sbjct: 74 AAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQ 132
Query: 335 DLNVANNHLEGPIPDN-LSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRG 393
L + +N L+ +PD+ NL L +HGN+++ AF+ L S+ L L N +
Sbjct: 133 YLYLQDNALQA-LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191
Query: 394 PIPVELSRIGNLDTLDMSNNKISGSIPS-PLGDLEHLLKLNLSRNQL 439
P +G L TL + N +S ++P+ L L L L L+ N
Sbjct: 192 VHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 59/232 (25%), Positives = 90/232 (38%), Gaps = 32/232 (13%)
Query: 93 DLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQL 152
Q I L GNR+S C +L L L N L + + L LE L L +N
Sbjct: 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92
Query: 153 IGPIPS-TLSQLPNLKVFGLRGNNLVGTLSPDM-CQLSGLWYFDVRNNSLTGSIPQNI-G 209
+ + T L L L L L P + L+ L Y +++N+L ++P +
Sbjct: 93 LRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFR 150
Query: 210 NCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCN 269
+ + L L N++S S+ G + +L L L N
Sbjct: 151 DLGNLTHLFLHGNRIS---------------SVPERAFRG--------LHSLDRLLLHQN 187
Query: 270 MLSGPIPP-ILGNLSYTEKLYLHSNKLTGHIPPE-LGNMTKLHYLELNDNQL 319
++ + P +L LYL +N L+ +P E L + L YL LNDN
Sbjct: 188 RVAH-VHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-20
Identities = 37/177 (20%), Positives = 62/177 (35%), Gaps = 8/177 (4%)
Query: 315 NDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPP- 373
L +P + + + N + + +C NL L +H N L I
Sbjct: 19 PQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVL-ARIDAA 74
Query: 374 AFQRLESMTYLNLSLNNIRGPIPVE-LSRIGNLDTLDMSNNKISGSIPSP-LGDLEHLLK 431
AF L + L+LS N + +G L TL + + + L L
Sbjct: 75 AFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQY 133
Query: 432 LNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLS 488
L L N L F +L ++ + L N ++ V L ++ L L N ++
Sbjct: 134 LYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA 190
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 34/161 (21%), Positives = 58/161 (36%), Gaps = 14/161 (8%)
Query: 74 NLSGLNLDG-----EISPAV-GDLKDLQSIDLRGNRLSGQIPDEI-GDCSSLKSLDLSFN 126
L L+L + PA L L ++ L L ++ + ++L+ L L N
Sbjct: 81 LLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDN 139
Query: 127 ELYGDIPFSI-SKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMC 185
L +P L L L L N++ L +L L N + + P
Sbjct: 140 AL-QALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAF 197
Query: 186 Q-LSGLWYFDVRNNSLTGSIPQNI-GNCTSFQVLDLSYNQL 224
+ L L + N+L+ ++P + Q L L+ N
Sbjct: 198 RDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 7e-07
Identities = 30/110 (27%), Positives = 41/110 (37%), Gaps = 7/110 (6%)
Query: 74 NLSGLNLDG----EISPAV-GDLKDLQSIDLRGNRLSGQIPDEI-GDCSSLKSLDLSFNE 127
L L L + DL +L + L GNR+S +P+ SL L L N
Sbjct: 130 ALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNR 188
Query: 128 LYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLV 177
+ P + L +L L L N L L+ L L+ L N V
Sbjct: 189 VAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-30
Identities = 69/297 (23%), Positives = 113/297 (38%), Gaps = 50/297 (16%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLKNCK-----PVAIKRLYSHY-PQCLKEFETELETVGSI 651
+ ++G GA TVYK + PVAIK L P+ KE E + S+
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 652 KHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLA 711
+ ++ L G L+S+ L M G L D + K + L + A+G+
Sbjct: 75 DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 131
Query: 712 YLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGT---IGYI 768
YL R++HRD+ + N+L+ +TDFG+AK L + G I ++
Sbjct: 132 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIKWM 186
Query: 769 DPEYARTSRLTEKSDVYSFGIVLLELLT-GRK---AVDNECNLHHLILSKTANNAVMETV 824
E T +SDV+S+G+ + EL+T G K + + + +
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--------------ASEISSIL 232
Query: 825 D-------PEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAPE 874
+ P I C V+ + C RP E+ + P+
Sbjct: 233 EKGERLPQPPI---CTI-----DVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQ 281
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 61/294 (20%), Positives = 114/294 (38%), Gaps = 45/294 (15%)
Query: 602 EKYIIGYGASSTVYKCVLKNCK---PVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLV 657
+G G +V + V + K VAIK L +E E + + + + +V
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 658 SLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDC 717
L G + + +L + G L L G K++++ ++ + G+ YL
Sbjct: 74 RLIGVCQAEA-LMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYL---E 127
Query: 718 SPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYI-----DPEY 772
+HRD+ + N+LL A ++DFG++K+L SY Y + G PE
Sbjct: 128 EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY---YTARSAGKWPLKWYAPEC 184
Query: 773 ARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVD------ 825
+ + +SDV+S+G+ + E L+ G+K VM ++
Sbjct: 185 INFRKFSSRSDVWSYGVTMWEALSYGQKPYKK-----------MKGPEVMAFIEQGKRME 233
Query: 826 -PEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAPEPQKQ 878
P C +++ L C + DRP V + + + + + +
Sbjct: 234 CPP---ECPP-----ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 279
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 77/287 (26%), Positives = 128/287 (44%), Gaps = 39/287 (13%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLV 657
L+ IG G V+ N VAIK + ++F E E + + H LV
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLV 66
Query: 658 SLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDC 717
L G L + L +FME+G L D L T++ +T L + L +G+AYL
Sbjct: 67 QLYGVCLEQAPICLVTEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCEGMAYL---E 121
Query: 718 SPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGT---IGYIDPEYAR 774
+IHRD+ + N L+ ++ ++DFG+ + + + YTS+ GT + + PE
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFV-LDDQYTSS--TGTKFPVKWASPEVFS 178
Query: 775 TSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVD-------P 826
SR + KSDV+SFG+++ E+ + G+ +N +N+ V+E + P
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFSEGKIPYEN-----------RSNSEVVEDISTGFRLYKP 227
Query: 827 EISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAP 873
A V+Q+ C + +P DRP + R L + +
Sbjct: 228 R--------LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESG 266
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 5e-30
Identities = 60/297 (20%), Positives = 114/297 (38%), Gaps = 45/297 (15%)
Query: 603 KYIIGYGASSTVYKCVLKNCK---PVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVS 658
+G G +V + V + K VAIK L +E E + + + + +V
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 659 LQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCS 718
L G + + +L + G L L K++++ ++ + G+ YL
Sbjct: 401 LIGVCQAEA-LMLVMEMAGGGPLHKFLV--GKREEIPVSNVAELLHQVSMGMKYL---EE 454
Query: 719 PRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYI-----DPEYA 773
+HR++ + N+LL A ++DFG++K+L SY Y + G PE
Sbjct: 455 KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY---YTARSAGKWPLKWYAPECI 511
Query: 774 RTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVD------- 825
+ + +SDV+S+G+ + E L+ G+K VM ++
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKK-----------MKGPEVMAFIEQGKRMEC 560
Query: 826 PEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAPEPQKQPTSI 882
P C +++ L C + DRP V + + + + + + S
Sbjct: 561 PP---ECPP-----ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGGSA 609
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 7e-30
Identities = 68/340 (20%), Positives = 119/340 (35%), Gaps = 41/340 (12%)
Query: 606 IGYGASSTVYKCVLKNCKPVAIKR--LYSHYPQCLKEFETELETVGSIKHRNL--VSLQG 661
IG G SS V++ + + + AIK L Q L + E+ + ++ + + L
Sbjct: 64 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 662 YSLSSSGNLLFYDFME--NGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSP 719
Y ++ Y ME N L L KKK +D R + + +H
Sbjct: 124 YEITDQ---YIYMVMECGNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIH---QH 174
Query: 720 RIIHRDVKSSNILLDKDFEAHLTDFGIAKSL-CVSKSYTSTYIMGTIGYIDPE------- 771
I+H D+K +N L+ L DFGIA + + S +G + Y+ PE
Sbjct: 175 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233
Query: 772 ----YARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPE 827
S+++ KSDV+S G +L + G+ N + + N +E
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE-FPDI 292
Query: 828 ISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSR---VLGSLVPAPEPQKQPTSIPS 884
+D+ +K + R P R ++ E+ V P + K T
Sbjct: 293 PEKDLQDV--LKCCLK-------RDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMK 343
Query: 885 ALLSSAKVPCYKDEYANLKTPHMLNCPSMSTSDAQLFLKF 924
+L + + + ++ F
Sbjct: 344 YVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTF 383
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 8e-30
Identities = 79/279 (28%), Positives = 123/279 (44%), Gaps = 25/279 (8%)
Query: 605 IIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSL 664
+G G V+ VA+K L F E + ++H+ LV L +
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYA-VV 77
Query: 665 SSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHR 724
+ + ++MENGSL D L P KL + L +A A+G+A++ IHR
Sbjct: 78 TQEPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHR 133
Query: 725 DVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDV 784
D++++NIL+ + DFG+A+ + ++ I + PE T KSDV
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 785 YSFGIVLLELLT-GRK---AVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKK 840
+SFGI+L E++T GR + N + +L M P+ C + +
Sbjct: 194 WSFGILLTEIVTHGRIPYPGMTNPEVIQNLE-----RGYRMVR--PD---NCPE-----E 238
Query: 841 VFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAPEPQKQP 879
++QL LC K +P DRPT + VL A E Q QP
Sbjct: 239 LYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQP 277
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 9e-30
Identities = 66/284 (23%), Positives = 117/284 (41%), Gaps = 33/284 (11%)
Query: 605 IIGYGASSTVYKCVLKNCK-PVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYS 663
+G G VY+ V K VA+K L + ++EF E + IKH NLV L G
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 285
Query: 664 LSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIH 723
+ +FM G+L D L ++++ L +A + + YL IH
Sbjct: 286 TREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 341
Query: 724 RDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSD 783
R++ + N L+ ++ + DFG+++ + I + PE ++ + KSD
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 401
Query: 784 VYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVD-------PEISATCKDL 835
V++FG++L E+ T G + V E ++ PE
Sbjct: 402 VWAFGVLLWEIATYGMSPYPG-----------IDLSQVYELLEKDYRMERPE-------- 442
Query: 836 GAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAPEPQKQP 879
G +KV++L C + P+DRP+ E+ + ++ +
Sbjct: 443 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 486
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-29
Identities = 41/319 (12%), Positives = 84/319 (26%), Gaps = 69/319 (21%)
Query: 605 IIGYGASSTVYKCV-LKNCKPVAIKRLYSHYPQCLKE----------------------- 640
++G + + + + Y
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 641 -----FETELETVGSIKHRNLVSLQG-YSLSSSGNLLFYDFMENGSLWD----ILHGPTK 690
F + V + + ++ ++ + F +L +L +
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 691 KKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAK-- 748
K L RL++ L + LA LH ++H ++ +I+LD+ LT F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 749 ----SLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRK--AVD 802
VS+ + + I R + +T D ++ G+V+ + D
Sbjct: 257 GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKD 316
Query: 803 NECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
I I + L ++ L DR +
Sbjct: 317 AALGGSEWIFRS----------CKNIPQPVRAL--LEG-----FLR--YPKEDRLLPLQA 357
Query: 863 S-----RVLGSLVPAPEPQ 876
L + + A P
Sbjct: 358 METPEYEQLRTELSAALPL 376
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 57/293 (19%), Positives = 107/293 (36%), Gaps = 42/293 (14%)
Query: 595 RMTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRL-YSHYPQCLKEFETELETVGSIK 652
R + +G G V++ K + AIKR+ + ++ E++ + ++
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 653 HRNLVSL---------QGYSLSSSGNLLFYDFME---NGSLWDILHGPTKKKKLDWDTRL 700
H +V SS + Y M+ +L D ++G ++ + L
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 701 KIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSL---------- 750
I L A+ + +LH S ++HRD+K SNI D + DFG+ ++
Sbjct: 122 HIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 751 -CVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHH 809
+ T +GT Y+ PE + + K D++S G++L ELL
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQ----MERV 234
Query: 810 LILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
L+ N + + + V+ + P +RP +
Sbjct: 235 RTLTD-VRNLKFPPLFTQKYPCEYVM--VQDMLS-------PSPMERPEAINI 277
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 4e-29
Identities = 30/319 (9%), Positives = 70/319 (21%), Gaps = 61/319 (19%)
Query: 605 IIGYGASSTVYKCV-LKNCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQ 660
+ G S V+ ++ + A+K L+ + + +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 661 GY-----------------------SLSSSGNLLFYDFME--NGSLWDIL----HGPTKK 691
+ M + L + +
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 692 KKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLC 751
+ + A L S ++H N+ + D L D +
Sbjct: 189 GDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKV- 244
Query: 752 VSKSYTSTYIMGTIGYIDPEY--ARTSRLTEKSDVYSFGIVLLELLTGR-----KAVDNE 804
+ Y E+ A T+ T + + G+ + + +
Sbjct: 245 ---GTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK 301
Query: 805 CNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVS- 863
+ L +++ + K L + + L R E
Sbjct: 302 GSWKRPSLRVPGTDSLAFGSCTPLPDFVKTL--IGR-----FLN--FDRRRRLLPLEAME 352
Query: 864 ----RVLGSLVPAPEPQKQ 878
L + + + Q
Sbjct: 353 TPEFLQLQNEISSSLSTGQ 371
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 63/275 (22%), Positives = 110/275 (40%), Gaps = 44/275 (16%)
Query: 605 IIGYGASSTVYKCV-LKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGY- 662
+IG G V+K + K IKR+ ++ E E++ + + H N+V G
Sbjct: 18 LIGSGGFGQVFKAKHRIDGKTYVIKRV----KYNNEKAEREVKALAKLDHVNIVHYNGCW 73
Query: 663 ------------SLSSSGNLLFYDFME---NGSLWDILHGPTKKKKLDWDTRLKIALGAA 707
+ S S + ME G+L + + +KLD L++
Sbjct: 74 DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK-RRGEKLDKVLALELFEQIT 132
Query: 708 QGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGY 767
+G+ Y+H S ++I+RD+K SNI L + + DFG+ SL T + GT+ Y
Sbjct: 133 KGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS--KGTLRY 187
Query: 768 IDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPE 827
+ PE + ++ D+Y+ G++L ELL + +
Sbjct: 188 MSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDG--------IISDI 239
Query: 828 ISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
K L ++K+ ++P DRP E+
Sbjct: 240 FDKKEKTL--LQKLLS-------KKPEDRPNTSEI 265
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 9e-29
Identities = 50/273 (18%), Positives = 88/273 (32%), Gaps = 23/273 (8%)
Query: 187 LSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNI----GFLQIATLSL 242
S + + +I S + L + ++ I F G + L+L
Sbjct: 43 RSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTL 102
Query: 243 QGNQLTGKIPSVIGLMQALAVLDLSCNMLS----GPIPPILGNLSYT--EKLYLHSNKLT 296
+ ++TG P + + L+ +S L + L +
Sbjct: 103 ENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSL 162
Query: 297 GHIPPELGNMTKLHYLELNDNQLTGHIP----PALGKLTDLFDLNVANNHLE---GPIPD 349
++ L L+L+DN G K L L + N +E G
Sbjct: 163 NFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSA 222
Query: 350 NLSSCTNLNSLNVHGNKLNGTIPP-AFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTL 408
++ L L++ N L + + LNLS ++ +P L L L
Sbjct: 223 LAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGLPA--KLSVL 279
Query: 409 DMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTG 441
D+S N++ PSP L + L+L N
Sbjct: 280 DLSYNRLD-RNPSPDE-LPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 65/295 (22%), Positives = 105/295 (35%), Gaps = 25/295 (8%)
Query: 211 CTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNM 270
++F L + +L G L+ Q T I S+ ++ L V
Sbjct: 25 SSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLS--LKRLTVRAARIPS 82
Query: 271 LSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMT--KLHYLELNDNQLTGHIPPALG 328
+ +S ++L L + ++TG PP L T L+ L L + L
Sbjct: 83 RILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT-RDAWLA 141
Query: 329 KL-----TDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTI-------PPAFQ 376
+L L L++A H + + L++L++ N G P F
Sbjct: 142 ELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFP 201
Query: 377 RLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGD-LEHLLKLNLS 435
L+ + N + G + L LD+S+N + + +P D L LNLS
Sbjct: 202 TLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLS 261
Query: 436 RNQLTGFIPGEFGNLRSVMEIDLSHNHLTGV-IPEELSQLQNMFSLRLDYNNLSG 489
L G L +DLS+N L P+EL Q+ +L L N
Sbjct: 262 FTGLKQVPKGLPAKLS---VLDLSYNRLDRNPSPDELPQVG---NLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 4e-25
Identities = 54/288 (18%), Positives = 93/288 (32%), Gaps = 39/288 (13%)
Query: 73 LNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPD---EIGDCSSLKSLDLSFNELY 129
L D + L+ + +R R+ +I + S L+ L L E+
Sbjct: 49 LKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT 108
Query: 130 GDIPFSISKL--KQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQL 187
G P + + L L L+N + L++L GL+ ++
Sbjct: 109 GTAPPPLLEATGPDLNILNLRNVSWAT-RDAWLAELQQWLKPGLKVLSI----------- 156
Query: 188 SGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPF-----NIGFLQIATLSL 242
+ + + LDLS N GE + F + L+L
Sbjct: 157 --------AQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLAL 208
Query: 243 QGNQLT---GKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYT-EKLYLHSNKLTGH 298
+ + G ++ L LDLS N L + L L L
Sbjct: 209 RNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-Q 267
Query: 299 IPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGP 346
+P L KL L+L+ N+L P+ +L + +L++ N
Sbjct: 268 VPKGLP--AKLSVLDLSYNRLDR--NPSPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 54/298 (18%), Positives = 98/298 (32%), Gaps = 42/298 (14%)
Query: 113 GDCSSLKSLDLSFNELYGDIPFS-ISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGL 171
G SL+ L + F+ I K L+ L ++ ++ I ++ +
Sbjct: 40 GGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGI----- 94
Query: 172 RGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCT--SFQVLDLSYNQLSGEIP 229
SGL + N +TG+ P + T +L+L +
Sbjct: 95 ----------------SGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDA 138
Query: 230 F-----NIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPI----LG 280
+ + LS+ + + AL+ LDLS N G I
Sbjct: 139 WLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPL 198
Query: 281 NLSYTEKLYLHSNKLT---GHIPPELGNMTKLHYLELNDNQLTGHIPPAL-GKLTDLFDL 336
+ L L + + G +L L+L+ N L + L L
Sbjct: 199 KFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSL 258
Query: 337 NVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGP 394
N++ L+ +P L + L+ L++ N+L+ P+ L + L+L N
Sbjct: 259 NLSFTGLKQ-VPKGLPA--KLSVLDLSYNRLDRN--PSPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 94.6 bits (235), Expect = 4e-21
Identities = 50/263 (19%), Positives = 85/263 (32%), Gaps = 36/263 (13%)
Query: 257 LMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPP---ELGNMTKLHYLE 313
L L +D + G I+ +LS ++L + + ++ I + ++ L L
Sbjct: 45 LEYLLKRVDTEAD--LGQFTDIIKSLS-LKRLTVRAARIPSRILFGALRVLGISGLQELT 101
Query: 314 LNDNQLTGHIPPALGKLT--DLFDLNVANNHLEGPIPDNLS----SCTNLNSLNVHGNKL 367
L + ++TG PP L + T DL LN+ N L L++
Sbjct: 102 LENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHS 161
Query: 368 NGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLE 427
+ +++ L+LS N G + + P L+
Sbjct: 162 LNFSCEQVRVFPALSTLDLSDNPELGERGLISA-----------------LCPLKFPTLQ 204
Query: 428 HLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQ-LQNMFSLRLDYNN 486
L N +G + +DLSHN L + SL L +
Sbjct: 205 VLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTG 264
Query: 487 LSGDVMSLINCL--SLSVLFIGN 507
L + L LSVL +
Sbjct: 265 LK----QVPKGLPAKLSVLDLSY 283
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 9e-17
Identities = 37/186 (19%), Positives = 56/186 (30%), Gaps = 36/186 (19%)
Query: 72 ALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDC----SSLKSLDLSFNE 127
L+++ + V L ++DL N G+ C +L+ L L
Sbjct: 153 VLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAG 212
Query: 128 ---LYGDIPFSISKLKQLEFLILKNNQLIG-PIPSTLSQLPNLKVFGLRGNNLVGTLSPD 183
G + QL+ L L +N L + L L L
Sbjct: 213 METPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGL------- 265
Query: 184 MCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQ 243
+ +P + VLDLSYN+L P Q+ LSL+
Sbjct: 266 --------------KQVPKGLPAKL------SVLDLSYNRLD-RNPSPDELPQVGNLSLK 304
Query: 244 GNQLTG 249
GN
Sbjct: 305 GNPFLD 310
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 67/290 (23%), Positives = 112/290 (38%), Gaps = 48/290 (16%)
Query: 605 IIGYGASSTVYKCVLKNCK----PVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSL 659
IG G V++ + + + VAIK + ++F E T+ H ++V L
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 660 QGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSP 719
G + + + G L L +K LD + + A + LAYL S
Sbjct: 82 IGVITENP-VWIIMELCTLGELRSFLQ--VRKYSLDLASLILYAYQLSTALAYLE---SK 135
Query: 720 RIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYI-----DPEYAR 774
R +HRD+ + N+L+ + L DFG+++ + STY + G + PE
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-----EDSTYYKASKGKLPIKWMAPESIN 190
Query: 775 TSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVD-------P 826
R T SDV+ FG+ + E+L G K NN V+ ++ P
Sbjct: 191 FRRFTSASDVWMFGVCMWEILMHGVKPFQG-----------VKNNDVIGRIENGERLPMP 239
Query: 827 EISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAPEPQ 876
C ++ L C P+ RP E+ L +++ + Q
Sbjct: 240 PN---CPP-----TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQ 281
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 62/261 (23%), Positives = 104/261 (39%), Gaps = 24/261 (9%)
Query: 605 IIGYGASSTVYKCV-LKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYS 663
++G G VY L N +AIK + + + E+ +KH+N+V G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 664 LSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIH 723
+ +F + + GSL +L K + T +GL YLH +I+H
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVH 145
Query: 724 RDVKSSNILLD-KDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRL--TE 780
RD+K N+L++ ++DFG +K L T T+ GT+ Y+ PE +
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT-GTLQYMAPEIIDKGPRGYGK 204
Query: 781 KSDVYSFGIVLLELLTGRK---AVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGA 837
+D++S G ++E+ TG+ + + K V + +SA K
Sbjct: 205 AADIWSLGCTIIEMATGKPPFYELGEPQA----AMFKVGMFKVHPEIPESMSAEAKA--- 257
Query: 838 VKKVFQLALLCSKRQPTDRPT 858
F L C + P R
Sbjct: 258 ----F--ILKCFEPDPDKRAC 272
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 69/317 (21%), Positives = 114/317 (35%), Gaps = 48/317 (15%)
Query: 606 IGYGASSTVYKCV-LKNCKPVAIKRLYSHYPQCLKEFETELETVGSIK-HRNLVSL---- 659
+ G + VY+ + + + A+KRL S+ + + E+ + + H N+V
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 660 -QGYSLSSSGNLLFYDFME--NGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHD 716
G S +G F E G L + L + L DT LKI + + ++H
Sbjct: 96 SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR- 154
Query: 717 CSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIM-----------GTI 765
P IIHRD+K N+LL L DFG A ++ Y+ + T
Sbjct: 155 QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTP 214
Query: 766 GYIDPE---YARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVME 822
Y PE + EK D+++ G +L L + ++ L + N
Sbjct: 215 MYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL------RIVNGKYSI 268
Query: 823 TVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL---------VPAP 873
L ++ + Q+ P +R ++ EV L + P
Sbjct: 269 PPHDTQYTVFHSL--IRAMLQV-------NPEERLSIAEVVHQLQEIAAARNVNPKSPIT 319
Query: 874 EPQKQPTSIPSALLSSA 890
E +Q SA LS
Sbjct: 320 ELLEQNGGYGSATLSRG 336
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-28
Identities = 55/196 (28%), Positives = 95/196 (48%), Gaps = 12/196 (6%)
Query: 606 IGYGASSTVYKCVLKNCK-PVAIKRLY-SHYPQCLKEFETELETVGSIKHRNLVSLQGYS 663
+G G V+K K +A K ++ P + EL+ + +V G +
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG-A 99
Query: 664 LSSSGNLLFY-DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRII 722
S G + + M+ GSL +L K ++ K+++ +GL YL +I+
Sbjct: 100 FYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLREKH--KIM 154
Query: 723 HRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKS 782
HRDVK SNIL++ E L DFG++ L S ++++ GT Y+ PE + + + +S
Sbjct: 155 HRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFV-GTRSYMSPERLQGTHYSVQS 211
Query: 783 DVYSFGIVLLELLTGR 798
D++S G+ L+E+ GR
Sbjct: 212 DIWSMGLSLVEMAVGR 227
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 67/324 (20%), Positives = 118/324 (36%), Gaps = 58/324 (17%)
Query: 605 IIGYGASSTVYKCVLKNCK-----PVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVS 658
++G G TV+K V PV IK + Q + + +GS+ H ++V
Sbjct: 20 VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 79
Query: 659 LQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCS 718
L G SS L ++ GSL D + + L L + A+G+ YL
Sbjct: 80 LLGLCPGSS-LQLVTQYLPLGSLLDHVR--QHRGALGPQLLLNWGVQIAKGMYYLE---E 133
Query: 719 PRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGT---IGYIDPEYART 775
++HR++ + N+LL + + DFG+A L I ++ E
Sbjct: 134 HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY--SEAKTPIKWMALESIHF 191
Query: 776 SRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVD-------PE 827
+ T +SDV+S+G+ + EL+T G + V + ++ P+
Sbjct: 192 GKYTHQSDVWSYGVTVWELMTFGAEPYAG-----------LRLAEVPDLLEKGERLAQPQ 240
Query: 828 ISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLV--------------PAP 873
I C V+ + + C RPT E++ + P
Sbjct: 241 I---CTI-----DVYMVMVKCWMIDENIRPTFKELANEFTRMARDPPRYLVIKRESGPGI 292
Query: 874 EPQKQPTSIPSALLSSAKVPCYKD 897
P +P + + L ++ D
Sbjct: 293 APGPEPHGLTNKKLEEVELEPELD 316
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 69/285 (24%), Positives = 118/285 (41%), Gaps = 35/285 (12%)
Query: 605 IIGYGASSTVYKCVLKNCK-PVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYS 663
+G G VY+ V K VA+K L + ++EF E + IKH NLV L G
Sbjct: 20 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 664 LSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIH 723
+ +FM G+L D L ++++ L +A + + YL IH
Sbjct: 79 TREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 134
Query: 724 RDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYI-----DPEYARTSRL 778
RD+ + N L+ ++ + DFG+++ + TY PE ++
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLM-----TGDTYTAHAGAKFPIKWTAPESLAYNKF 189
Query: 779 TEKSDVYSFGIVLLELLT-GRK---AVDNECNLHHLILSKTANNAVMETVDPEISATCKD 834
+ KSDV++FG++L E+ T G +D + + ME PE C +
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQVYELLEKDYRMER--PE---GCPE 239
Query: 835 LGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAPEPQKQP 879
KV++L C + P+DRP+ E+ + ++ +
Sbjct: 240 -----KVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 279
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-28
Identities = 78/372 (20%), Positives = 148/372 (39%), Gaps = 43/372 (11%)
Query: 520 RDSHPTERVTISKAAILGIALGALVILLMILVAACRPHNPTHFPDGSLDKPVNYSTPKLV 579
R + + + + + + ++ L L N ++ ++ P+L
Sbjct: 17 RRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPEL- 75
Query: 580 ILHMNMALHVYEDIMRMTENLSEKYIIGYGASSTVYKCVLKNCK----PVAIKRLYSHYP 635
+ HV + + +E +IG G VY L + A+K L
Sbjct: 76 ---VQAVQHVVIGPSSLIVHFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD 130
Query: 636 QC-LKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLF-YDFMENGSLWDILHGPTKKKK 693
+ +F TE + H N++SL G L S G+ L +M++G L + + +
Sbjct: 131 IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR--NETHN 188
Query: 694 LDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753
+ L A+G+ +L S + +HRD+ + N +LD+ F + DFG+A+ +
Sbjct: 189 PTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDM-YD 244
Query: 754 KSYTSTYIMGTIGYI-----DPEYARTSRLTEKSDVYSFGIVLLELLT-GRK---AVDNE 804
K + S + T + E +T + T KSDV+SFG++L EL+T G V+
Sbjct: 245 KEFDSVH-NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 303
Query: 805 CNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSR 864
+L+ + PE C D ++++ L C + RP+ E+
Sbjct: 304 DITVYLL-----QGRRLLQ--PE---YCPD-----PLYEVMLKCWHPKAEMRPSFSELVS 348
Query: 865 VLGSLVPAPEPQ 876
+ ++ +
Sbjct: 349 RISAIFSTFIGE 360
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 75/296 (25%), Positives = 124/296 (41%), Gaps = 45/296 (15%)
Query: 605 IIGYGASSTVYKCVLK----NCKPVAIKRLYSHYPQCLK-EFETELETVGSIKHRNLVSL 659
IIG G S V L+ PVAIK L + Y + + +F +E +G H N++ L
Sbjct: 56 IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 660 QGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSP 719
+G ++ ++MENGSL L T + + + G G+ YL
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFLR--THDGQFTIMQLVGMLRGVGAGMRYLS---DL 170
Query: 720 RIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYI-----DPEYAR 774
+HRD+ + N+L+D + ++DFG+++ L + T G I PE
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVL---EDDPDAAYTTTGGKIPIRWTAPEAIA 227
Query: 775 TSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVD-------P 826
+ SDV+SFG+V+ E+L G + N N V+ +V+ P
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLAYGERPYWN-----------MTNRDVISSVEEGYRLPAP 276
Query: 827 EISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAPEPQKQPTSI 882
C + QL L C + RP ++ VL +L+ +PE + ++
Sbjct: 277 M---GCPH-----ALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRATATV 324
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 67/291 (23%), Positives = 113/291 (38%), Gaps = 55/291 (18%)
Query: 605 IIGYGASSTVYKCVLKNCK----PVAIKRL---YSHYPQCLKEFETELETVGSIKHRNLV 657
+G G+ V + VA+K L P+ + +F E+ + S+ HRNL+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 658 SLQGYSLSSSGNLLFY---DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLH 714
L G L+ + GSL D L + T + A+ A+G+ YL
Sbjct: 85 RLYGVVLTPP----MKMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLE 138
Query: 715 HDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYI-----D 769
S R IHRD+ + N+LL + DFG+ ++L + + Y+M +
Sbjct: 139 ---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH---YVMQEHRKVPFAWCA 192
Query: 770 PEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVD--- 825
PE +T + SD + FG+ L E+ T G++ + ++ +D
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG-----------LNGSQILHKIDKEG 241
Query: 826 -----PEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVP 871
PE C ++ + + C +P DRPT + L P
Sbjct: 242 ERLPRPED---CPQ-----DIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 67/270 (24%), Positives = 97/270 (35%), Gaps = 54/270 (20%)
Query: 196 RNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVI 255
+ IP N+ S + LDLS+N L L
Sbjct: 15 MELNFY-KIPDNLP--FSTKNLDLSFNPLR---------------HLG--------SYSF 48
Query: 256 GLMQALAVLDLSCNMLSGPIPP-ILGNLSYTEKLYLHSNKLTGHIPPEL-GNMTKLHYLE 313
L VLDLS + I +LS+ L L N + + ++ L L
Sbjct: 49 FSFPELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLV 106
Query: 314 LNDNQLTGHIPPALGKLTDLFDLNVANNHL-EGPIPDNLSSCTNLNSLNVHGNKLNGTIP 372
+ L +G L L +LNVA+N + +P+ S+ TNL L++ NK+ +I
Sbjct: 107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIY 165
Query: 373 P-AFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLK 431
+ L M LNLSL D+S N ++ I L +
Sbjct: 166 CTDLRVLHQMPLLNLSL--------------------DLSLNPMN-FIQPGAFKEIRLKE 204
Query: 432 LNLSRNQLTGFIPGEFGNLRSVMEIDLSHN 461
L L NQL G F L S+ +I L N
Sbjct: 205 LALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 9e-27
Identities = 56/212 (26%), Positives = 92/212 (43%), Gaps = 18/212 (8%)
Query: 285 TEKLYLHSNKLTGHIPPE-LGNMTKLHYLELNDNQLTGHIPP-ALGKLTDLFDLNVANNH 342
T+ L L N L H+ + +L L+L+ ++ I A L+ L L + N
Sbjct: 30 TKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNP 87
Query: 343 LEGPIPDNLSSCTNLNSLNVHGNKLNGTIPP-AFQRLESMTYLNLSLNNIRG-PIPVELS 400
++ S ++L L L ++ L+++ LN++ N I+ +P S
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146
Query: 401 RIGNLDTLDMSNNKISGSIPSPLGDLEHL-------LKLNLSRNQLTGFIPGEFGNLRSV 453
+ NL+ LD+S+NKI SI DL L L L+LS N + PG F +R +
Sbjct: 147 NLTNLEHLDLSSNKIQ-SIYC--TDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-L 202
Query: 454 MEIDLSHNHLTGVIPEELSQLQNMFSLRLDYN 485
E+ L N L V +L ++ + L N
Sbjct: 203 KELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 4e-19
Identities = 53/253 (20%), Positives = 88/253 (34%), Gaps = 36/253 (14%)
Query: 96 SIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGP 155
+ +IPD + S K+LDLSFN L +S +L+ L L ++
Sbjct: 11 TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTI 67
Query: 156 IPSTLSQLPNLKVFGLRGNNLVGTLSPDM-CQLSGLWYFDVRNNSLTGSIPQNI-GNCTS 213
L +L L GN + +L+ LS L +L S+ G+ +
Sbjct: 68 EDGAYQSLSHLSTLILTGNPI-QSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKT 125
Query: 214 FQVLDLSYNQLSGEIPFNIGFL---QIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNM 270
+ L++++N + F + L L N++ + C
Sbjct: 126 LKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQ----------------SIYCTD 168
Query: 271 LSGPIPPILGNLSYTE-KLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPP-ALG 328
L L + L L N + I P +L L L+ NQL +P
Sbjct: 169 LRV-----LHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK-SVPDGIFD 221
Query: 329 KLTDLFDLNVANN 341
+LT L + + N
Sbjct: 222 RLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 5e-12
Identities = 36/165 (21%), Positives = 59/165 (35%), Gaps = 13/165 (7%)
Query: 90 DLKDLQSIDLRGNRLSGQIPDEI-GDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILK 148
L L ++ L GN + + SSL+ L L F I LK L+ L +
Sbjct: 74 SLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVA 132
Query: 149 NNQLIG-PIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQ-LSGLWYFDVR----NNSLTG 202
+N + +P S L NL+ L N + ++ + L + ++ N +
Sbjct: 133 HNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN- 190
Query: 203 SIPQNIGNCTSFQVLDLSYNQLSGEIPFNI--GFLQIATLSLQGN 245
I + L L NQL +P I + + L N
Sbjct: 191 FIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 3e-10
Identities = 26/110 (23%), Positives = 44/110 (40%), Gaps = 2/110 (1%)
Query: 380 SMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGD-LEHLLKLNLSRNQ 438
S L+LS N +R L LD+S +I +I L HL L L+ N
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNP 87
Query: 439 LTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLS 488
+ G F L S+ ++ +L + + L+ + L + +N +
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 5e-28
Identities = 89/361 (24%), Positives = 145/361 (40%), Gaps = 55/361 (15%)
Query: 565 GSLDKPVNYSTP--KLVILHMNMALHVYEDIMRMT---------ENLSEKYIIGYGASST 613
GS +K +++ KL L + H +ED + N+S ++G G
Sbjct: 1 GSDEKRLHFGNGHLKLPGLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGE 60
Query: 614 VYKCVLK----NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSG 668
V LK VAIK L Y + ++F E +G H N++ L+G S
Sbjct: 61 VCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP 120
Query: 669 NLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKS 728
++ ++MENGSL L + + + G A G+ YL +HRD+ +
Sbjct: 121 VMIVTEYMENGSLDSFLR--KHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAA 175
Query: 729 SNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGT---IGYIDPEYARTSRLTEKSDVY 785
NIL++ + ++DFG+ + L + G I + PE + T SDV+
Sbjct: 176 RNILINSNLVCKVSDFGLGRVL-EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVW 234
Query: 786 SFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVD-------PEISATCKDLGA 837
S+GIVL E+++ G + +N V++ VD P C
Sbjct: 235 SYGIVLWEVMSYGERPYWE-----------MSNQDVIKAVDEGYRLPPPM---DCPA--- 277
Query: 838 VKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAPEPQKQPTSI---PSALLSSAKVPC 894
++QL L C ++ +RP ++ +L L+ P K TS PS LL
Sbjct: 278 --ALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNLLLDQSNVD 335
Query: 895 Y 895
Sbjct: 336 I 336
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 6e-28
Identities = 72/298 (24%), Positives = 117/298 (39%), Gaps = 35/298 (11%)
Query: 593 IMRMTENLSEKYIIGYGASSTVYKCVLKNCK----PVAIKRLYSHYPQC-LKEFETELET 647
I +IG G VY + AIK L ++ F E
Sbjct: 16 IPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLL 75
Query: 648 VGSIKHRNLVSLQGYSLSSSG-NLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGA 706
+ + H N+++L G L G + +M +G L + P ++ + L
Sbjct: 76 MRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQV 133
Query: 707 AQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGT-- 764
A+G+ YL + +HRD+ + N +LD+ F + DFG+A+ + + + Y S
Sbjct: 134 ARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDI-LDREYYSVQQHRHAR 189
Query: 765 --IGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRK---AVDNECNLHHLILSKTANN 818
+ + E +T R T KSDV+SFG++L ELLT G +D H L
Sbjct: 190 LPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA-----QG 244
Query: 819 AVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAPEPQ 876
+ PE C D ++Q+ C + P RPT + + +V A
Sbjct: 245 RRLPQ--PE---YCPD-----SLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD 292
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 7e-28
Identities = 60/259 (23%), Positives = 100/259 (38%), Gaps = 27/259 (10%)
Query: 606 IGYGASSTVYKCV-LKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSL 664
+G G+ V++ + A+K++ E EL + +V L G
Sbjct: 66 VGRGSFGEVHRMKDKQTGFQCAVKKV--RLEVFRVE---ELVACAGLSSPRIVPLYGAVR 120
Query: 665 SSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHR 724
+F + +E GSL ++ + L D L A +GL YLH + RI+H
Sbjct: 121 EGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLH---TRRILHG 174
Query: 725 DVKSSNILLDKD-FEAHLTDFGIAKSLCVSKSYTST----YIMGTIGYIDPEYARTSRLT 779
DVK+ N+LL D A L DFG A L S YI GT ++ PE
Sbjct: 175 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 234
Query: 780 EKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVK 839
K D++S ++L +L G + L L + + + P + ++
Sbjct: 235 AKVDIWSSCCMMLHMLNGCHPW-TQYFRGPLCLKIASEPPPIREIPPSCAPLTAQA--IQ 291
Query: 840 KVFQLALLCSKRQPTDRPT 858
+ + ++P R +
Sbjct: 292 EGLR-------KEPVHRAS 303
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 8e-28
Identities = 66/282 (23%), Positives = 110/282 (39%), Gaps = 55/282 (19%)
Query: 605 IIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSL 664
IG G V + VA+K + + + F E + ++H NLV L G +
Sbjct: 200 TIGKGEFGDVMLGDYRG-NKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIV 256
Query: 665 SSSGNLLFY---DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRI 721
G Y ++M GSL D L + L D LK +L + + YL
Sbjct: 257 EEKGG--LYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE---GNNF 310
Query: 722 IHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGT---IGYIDPEYARTSRL 778
+HRD+ + N+L+ +D A ++DFG+ K ++ + + PE R +
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQD--TGKLPVKWTAPEALREKKF 363
Query: 779 TEKSDVYSFGIVLLELLT-GRK---AVDNECNLHHLILSKTANNAVMETVD-------PE 827
+ KSDV+SFGI+L E+ + GR + + V+ V+ P+
Sbjct: 364 STKSDVWSFGILLWEIYSFGRVPYPRIPLK--------------DVVPRVEKGYKMDAPD 409
Query: 828 ISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869
C V+ + C RPT ++ L +
Sbjct: 410 ---GCPP-----AVYDVMKNCWHLDAATRPTFLQLREQLEHI 443
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 65/300 (21%), Positives = 113/300 (37%), Gaps = 50/300 (16%)
Query: 600 LSEKYIIGYGASSTVYKCVLKNCK---PVAIKRLYSHY--PQCLKEFETELETVGSIKHR 654
L +K +G G TV K + K VA+K L + P E E + + +
Sbjct: 20 LEDK-ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNP 78
Query: 655 NLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLH 714
+V + G + S L+ + E G L L + + + +++ + G+ YL
Sbjct: 79 YIVRMIGICEAESWMLVM-EMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLE 134
Query: 715 HDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYI-----D 769
+HRD+ + N+LL A ++DFG++K+L ++Y Y T G
Sbjct: 135 ---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY---YKAQTHGKWPVKWYA 188
Query: 770 PEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVD--- 825
PE + + KSDV+SFG+++ E + G+K + V ++
Sbjct: 189 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG-----------MKGSEVTAMLEKGE 237
Query: 826 ----PEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLV--PAPEPQKQP 879
P C +++ L LC +RP V L + E
Sbjct: 238 RMGCPA---GCPR-----EMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHHHH 289
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 60/293 (20%), Positives = 123/293 (41%), Gaps = 24/293 (8%)
Query: 134 FSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYF 193
F L + + + T + L + G + T + L+ L
Sbjct: 13 FPDPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGV--TTIEGVQYLNNLIGL 68
Query: 194 DVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPS 253
++++N +T + + N T L+LS N L + G I TL L Q+T P
Sbjct: 69 ELKDNQIT-DLA-PLKNLTKITELELSGNPLK-NVSAIAGLQSIKTLDLTSTQITDVTP- 124
Query: 254 VIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLE 313
+ + L VL L N ++ I P L L+ + L + + +++ + P L N++KL L+
Sbjct: 125 -LAGLSNLQVLYLDLNQITN-ISP-LAGLTNLQYLSIGNAQVS-DLTP-LANLSKLTTLK 179
Query: 314 LNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPP 373
+DN+++ I P L L +L ++++ NN + P L++ +NL + + +
Sbjct: 180 ADDNKIS-DISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVF 235
Query: 374 AFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDL 426
L + N ++GP ++ D ++ ++ ++ S + ++
Sbjct: 236 YNNNL-------VVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFINNV 281
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 67/295 (22%), Positives = 116/295 (39%), Gaps = 27/295 (9%)
Query: 202 GSIPQN--------IGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPS 253
GSI Q + + + ++ + I TLS G +T I
Sbjct: 1 GSITQPTAINVIFPDPALANAIKIAAGKSNVTDTVTQA-DLDGITTLSAFGTGVT-TIEG 58
Query: 254 VIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLE 313
+ + L L+L N ++ + P L NL+ +L L N L ++ + + + L+
Sbjct: 59 -VQYLNNLIGLELKDNQITD-LAP-LKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLD 113
Query: 314 LNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPP 373
L Q+T L L++L L + N + I L+ TNL L++ +++ + P
Sbjct: 114 LTSTQITD--VTPLAGLSNLQVLYLDLNQITN-IS-PLAGLTNLQYLSIGNAQVS-DLTP 168
Query: 374 AFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLN 433
L +T L N I P L+ + NL + + NN+IS SPL + +L +
Sbjct: 169 -LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDV--SPLANTSNLFIVT 223
Query: 434 LSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLS 488
L+ +T NL V+ + + P +S S L +N S
Sbjct: 224 LTNQTITNQPVFYNNNL--VVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTS 276
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 49/251 (19%), Positives = 96/251 (38%), Gaps = 17/251 (6%)
Query: 70 VIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELY 129
I + N+ ++ DL + ++ G ++ I + ++L L+L N++
Sbjct: 21 AIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQI- 75
Query: 130 GDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSG 189
D+ + L ++ L L N L S ++ L ++K L + T + LS
Sbjct: 76 TDLA-PLKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQI--TDVTPLAGLSN 130
Query: 190 LWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTG 249
L + N +T +I + T+ Q L + Q+S P ++ TL N+++
Sbjct: 131 LQVLYLDLNQIT-NIS-PLAGLTNLQYLSIGNAQVSDLTPLA-NLSKLTTLKADDNKIS- 186
Query: 250 KIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKL 309
I + L L + L N +S P L N S + L + +T N+
Sbjct: 187 DISPLASL-PNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVP 243
Query: 310 HYLELNDNQLT 320
+ ++
Sbjct: 244 NVVKGPSGAPI 254
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 8e-10
Identities = 43/182 (23%), Positives = 73/182 (40%), Gaps = 13/182 (7%)
Query: 74 NLSGLNLDG----EISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELY 129
NL L LD ISP + L +LQ + + ++S + + S L +L N++
Sbjct: 130 NLQVLYLDLNQITNISP-LAGLTNLQYLSIGNAQVSD--LTPLANLSKLTTLKADDNKI- 185
Query: 130 GDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSG 189
DI ++ L L + LKNNQ+ P L+ NL + L + T P +
Sbjct: 186 SDIS-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTI--TNQPVFYNNNL 240
Query: 190 LWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTG 249
+ V+ S P I + ++ +L++N S + F Q T +G
Sbjct: 241 VVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFINNVSYTFNQSVTFKNTTVPFSG 300
Query: 250 KI 251
+
Sbjct: 301 TV 302
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 5e-06
Identities = 17/97 (17%), Positives = 39/97 (40%), Gaps = 7/97 (7%)
Query: 411 SNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEE 470
I+ + P L + +K+ ++ +T + +L + + +T + E
Sbjct: 5 QPTAIN--VIFPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EG 58
Query: 471 LSQLQNMFSLRLDYNNLSGDVMSLINCLSLSVLFIGN 507
+ L N+ L L N ++ D+ L N ++ L +
Sbjct: 59 VQYLNNLIGLELKDNQIT-DLAPLKNLTKITELELSG 94
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 69/285 (24%), Positives = 123/285 (43%), Gaps = 33/285 (11%)
Query: 605 IIGYGASSTVYKCVLKNCK----PVAIKRLYSHYPQC-LKEFETELETVGSIKHRNLVSL 659
+IG G VY L + A+K L + +F TE + H N++SL
Sbjct: 32 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 660 QGYSLSSSGNLLF-YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCS 718
G L S G+ L +M++G L + + + + L A+G+ YL S
Sbjct: 92 LGICLRSEGSPLVVLPYMKHGDLRNFIR--NETHNPTVKDLIGFGLQVAKGMKYLA---S 146
Query: 719 PRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGT---IGYIDPEYART 775
+ +HRD+ + N +LD+ F + DFG+A+ + + Y+ G + ++ E +T
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 206
Query: 776 SRLTEKSDVYSFGIVLLELLT-GRK---AVDNECNLHHLILSKTANNAVMETVDPEISAT 831
+ T KSDV+SFG++L EL+T G V+ +L+ + PE
Sbjct: 207 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-----QGRRLLQ--PE---Y 256
Query: 832 CKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAPEPQ 876
C D ++++ L C + RP+ E+ + ++ +
Sbjct: 257 CPD-----PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 296
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 57/279 (20%), Positives = 94/279 (33%), Gaps = 37/279 (13%)
Query: 595 RMTENLSEKY----IIGYGASSTVYKCVLKNC-KPVAIKRLYSHYPQCLKEFETELETVG 649
R + + +G+G+ V+K K + A+KR S + + K+ +L VG
Sbjct: 50 RPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPF-RGPKDRARKLAEVG 108
Query: 650 SI----KHRNLVSLQGYSLSSSGNLLFYDFME--NGSLWDILHGPTKKKKLDWDTRLKIA 703
S +H V L+ + G L Y E SL L
Sbjct: 109 SHEKVGQHPCCVRLEQ-AWEEGGIL--YLQTELCGPSLQQHCE--AWGASLPEAQVWGYL 163
Query: 704 LGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMG 763
LA+LH S ++H DVK +NI L L DFG+ L + G
Sbjct: 164 RDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL-GTAGAGEVQE-G 218
Query: 764 TIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMET 823
Y+ PE + +DV+S G+ +LE+ + L +
Sbjct: 219 DPRYMAPELLQ-GSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLR-----QGYLPPE 272
Query: 824 VDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
+S+ + + + + P R T +
Sbjct: 273 FTAGLSSELRSV--LVM-------MLEPDPKLRATAEAL 302
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 66/283 (23%), Positives = 118/283 (41%), Gaps = 39/283 (13%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLV 657
E ++ +G G V K VA+K + EF E +T+ + H LV
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLV 66
Query: 658 SLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDC 717
G + +++ NG L + L + K L+ L++ +G+A+L
Sbjct: 67 KFYGVCSKEYPIYIVTEYISNGCLLNYLR--SHGKGLEPSQLLEMCYDVCEGMAFLE--- 121
Query: 718 SPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGT---IGYIDPEYAR 774
S + IHRD+ + N L+D+D ++DFG+ + + + Y S+ +GT + + PE
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYV-LDDQYVSS--VGTKFPVKWSAPEVFH 178
Query: 775 TSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVD-------P 826
+ + KSDV++FGI++ E+ + G+ D N+ V+ V P
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFSLGKMPYDL-----------YTNSEVVLKVSQGHRLYRP 227
Query: 827 EISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869
D ++Q+ C P RPT ++ + L
Sbjct: 228 H---LASD-----TIYQIMYSCWHELPEKRPTFQQLLSSIEPL 262
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 64/302 (21%), Positives = 113/302 (37%), Gaps = 54/302 (17%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLKNCK----PVAIKRLYSHYPQCLK-EFETELETVGSIK 652
E++ I+G G VY+ V N K VA+K K +F +E + ++
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 653 HRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAY 712
H ++V L G + + G L L K L T + +L + +AY
Sbjct: 72 HPHIVKLIGIIEEEP-TWIIMELYPYGELGHYLE--RNKNSLKVLTLVLYSLQICKAMAY 128
Query: 713 LHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYI---- 768
L S +HRD+ NIL+ L DFG+++ + Y ++ +
Sbjct: 129 LE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYI-----EDEDYYKASVTRLPIKW 180
Query: 769 -DPEYARTSRLTEKSDVYSFGIVLLELLT-GRK---AVDNECNLHHLILSKTANNAVMET 823
PE R T SDV+ F + + E+L+ G++ ++N+ V+
Sbjct: 181 MSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK--------------DVIGV 226
Query: 824 VD-------PEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAPEPQ 876
++ P++ C ++ L C P+DRP E+ L + +
Sbjct: 227 LEKGDRLPKPDL---CPP-----VLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDI 278
Query: 877 KQ 878
Sbjct: 279 AM 280
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 70/297 (23%), Positives = 114/297 (38%), Gaps = 44/297 (14%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLKNCK-----PVAIKRLYSHY-PQCLKEFETELETVGSI 651
+ ++G GA TVYK + PVAIK L P+ KE E + S+
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 652 KHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLA 711
+ ++ L G L+S+ L M G L D + K + L + A+G+
Sbjct: 75 DNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMN 131
Query: 712 YLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGT---IGYI 768
YL R++HRD+ + N+L+ +TDFG+AK L + G I ++
Sbjct: 132 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIKWM 186
Query: 769 DPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVD-- 825
E T +SDV+S+G+ + EL+T G K D + + ++
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-----------IPASEISSILEKG 235
Query: 826 -----PEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAPEPQK 877
P I C V+ + + C RP E+ + P+
Sbjct: 236 ERLPQPPI---CTI-----DVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYL 284
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 66/298 (22%), Positives = 119/298 (39%), Gaps = 47/298 (15%)
Query: 594 MRMTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIK 652
+R + E ++G GA V K + + AIK++ H + L +E+ + S+
Sbjct: 2 LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLN 60
Query: 653 HRNLVSL-----------QGYSLSSSGNLLFY--DFMENGSLWDILHGPTKKKKLDWDTR 699
H+ +V + + + LF ++ ENG+L+D++H ++ D
Sbjct: 61 HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH--SENLNQQRDEY 118
Query: 700 LKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSL--------- 750
++ + L+Y+H S IIHRD+K NI +D+ + DFG+AK++
Sbjct: 119 WRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 751 -----CVSKSYTSTYIMGTIGYIDPE-YARTSRLTEKSDVYSFGIVLLELLTGRKAVDNE 804
S ++ I GT Y+ E T EK D+YS GI+ E++
Sbjct: 176 DSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMER 234
Query: 805 CNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
N+ + S + D K + ++ L+ P RP +
Sbjct: 235 VNILKKLRSVSIEF--PPDFDDNKMKVEKKI--IRL-----LID--HDPNKRPGARTL 281
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 56/284 (19%), Positives = 117/284 (41%), Gaps = 39/284 (13%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLV 657
++L+ +G G V + VAIK + EF E + + ++ H LV
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLV 82
Query: 658 SLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDC 717
L G + ++M NG L + L + + L++ + + YL
Sbjct: 83 QLYGVCTKQRPIFIITEYMANGCLLNYLR--EMRHRFQTQQLLEMCKDVCEAMEYLE--- 137
Query: 718 SPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGT---IGYIDPEYAR 774
S + +HRD+ + N L++ ++DFG+++ + + YTS+ +G+ + + PE
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSS--VGSKFPVRWSPPEVLM 194
Query: 775 TSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVD-------P 826
S+ + KSD+++FG+++ E+ + G+ + N+ E + P
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIYSLGKMPYER-----------FTNSETAEHIAQGLRLYRP 243
Query: 827 EISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLV 870
+ KV+ + C + +RPT + + ++
Sbjct: 244 H---LASE-----KVYTIMYSCWHEKADERPTFKILLSNILDVM 279
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 77/297 (25%), Positives = 131/297 (44%), Gaps = 42/297 (14%)
Query: 605 IIGYGASSTVYKCVLKNCK-----PVAIKRLYSHYPQCLK-EFETELETVGSIKHRNLVS 658
+IG G VYK +LK PVAIK L + Y + + +F E +G H N++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 659 LQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCS 718
L+G ++ ++MENG+L L K + + + G A G+ YL +
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLR--EKDGEFSVLQLVGMLRGIAAGMKYLA---N 165
Query: 719 PRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGT---IGYIDPEYART 775
+HRD+ + NIL++ + ++DFG+++ L + G I + PE
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVL-EDDPEATYTTSGGKIPIRWTAPEAISY 224
Query: 776 SRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVD-------PE 827
+ T SDV+SFGIV+ E++T G + LS N+ VM+ ++ P
Sbjct: 225 RKFTSASDVWSFGIVMWEVMTYGERPYWE--------LS---NHEVMKAINDGFRLPTPM 273
Query: 828 ISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAPEPQKQPTSIPS 884
C ++QL + C +++ RP ++ +L L+ AP+ K
Sbjct: 274 ---DCPS-----AIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTLADFDP 322
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-27
Identities = 72/315 (22%), Positives = 115/315 (36%), Gaps = 45/315 (14%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLKNCKP------VAIKRLYSHY-PQCLKEFETELETVGS 650
+N++ +G+GA VY+ + VA+K L Q +F E +
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 651 IKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDIL----HGPTKKKKLDWDTRLKIALGA 706
H+N+V G SL S + + M G L L P++ L L +A
Sbjct: 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 707 AQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHL---TDFGIAKSLCVSKSYTSTYIMG 763
A G YL IHRD+ + N LL + DFG+A+ + S Y G
Sbjct: 150 ACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI----YRASYYRKG 202
Query: 764 TIGYI-----DPEYARTSRLTEKSDVYSFGIVLLELLT-GRK---AVDNECNLHHLILSK 814
+ PE T K+D +SFG++L E+ + G + N+ L +
Sbjct: 203 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT--- 259
Query: 815 TANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAPE 874
+ M+ P+ C V+++ C + QP DRP + + P+
Sbjct: 260 --SGGRMDP--PK---NCPG-----PVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 307
Query: 875 PQKQPTSIPSALLSS 889
I L
Sbjct: 308 VINTALPIEYGPLVE 322
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-27
Identities = 66/282 (23%), Positives = 112/282 (39%), Gaps = 55/282 (19%)
Query: 605 IIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSL 664
IG G V + VA+K + + + F E + ++H NLV L G +
Sbjct: 28 TIGKGEFGDVMLGDYRG-NKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 665 SSSGNLLFY---DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRI 721
G L Y ++M GSL D L + L D LK +L + + YL
Sbjct: 85 EEKGGL--YIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE---GNNF 138
Query: 722 IHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGT---IGYIDPEYARTSRL 778
+HRD+ + N+L+ +D A ++DFG+ K ++ + + PE R +
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQD--TGKLPVKWTAPEALREKKF 191
Query: 779 TEKSDVYSFGIVLLELLT-GRK---AVDNECNLHHLILSKTANNAVMETVD-------PE 827
+ KSDV+SFGI+L E+ + GR + + V+ V+ P+
Sbjct: 192 STKSDVWSFGILLWEIYSFGRVPYPRIPLK--------------DVVPRVEKGYKMDAPD 237
Query: 828 ISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869
C V+++ C RP+ ++ L +
Sbjct: 238 ---GCPP-----AVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 9e-27
Identities = 52/258 (20%), Positives = 97/258 (37%), Gaps = 17/258 (6%)
Query: 207 NIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDL 266
+L ++ + N I + + + + I + + L L
Sbjct: 16 PDDAFAETIKDNLKKKSVTDAVTQN-ELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFL 72
Query: 267 SCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPA 326
+ N L+ I P L NL L+L NK+ + L ++ KL L L N ++ I
Sbjct: 73 NGNKLTD-IKP-LTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS-DING- 126
Query: 327 LGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNL 386
L L L L + NN + LS T L++L++ N+++ I P L + L L
Sbjct: 127 LVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYL 182
Query: 387 SLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGE 446
S N+I L+ + NLD L++ + + + +L + + L P
Sbjct: 183 SKNHISDLRA--LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--VTPEI 238
Query: 447 FGNLRSVMEIDLSHNHLT 464
+ + ++ +
Sbjct: 239 ISDDGDYEKPNVKWHLPE 256
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-26
Identities = 51/251 (20%), Positives = 97/251 (38%), Gaps = 18/251 (7%)
Query: 237 IATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLT 296
+ + +I +L ++ + L+ +++ +++ +
Sbjct: 1 MGETITVSTPIK-QIFPDDAF-AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56
Query: 297 GHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTN 356
+ + + + L LN N+LT I P L L +L L + N ++ +L
Sbjct: 57 -SVQG-IQYLPNVTKLFLNGNKLT-DIKP-LTNLKNLGWLFLDENKIK--DLSSLKDLKK 110
Query: 357 LNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKIS 416
L SL++ N ++ I L + L L N I LSR+ LDTL + +N+IS
Sbjct: 111 LKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQIS 166
Query: 417 GSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQN 476
I PL L L L LS+N ++ L+++ ++L S L
Sbjct: 167 -DI-VPLAGLTKLQNLYLSKNHISDLRA--LAGLKNLDVLELFSQECLNKPINHQSNLVV 222
Query: 477 MFSLRLDYNNL 487
+++ +L
Sbjct: 223 PNTVKNTDGSL 233
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-24
Identities = 60/280 (21%), Positives = 108/280 (38%), Gaps = 21/280 (7%)
Query: 142 LEFLILKNNQL--IGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNS 199
+ I + + I P L+ ++ T + +L+ + N+
Sbjct: 1 MGETITVSTPIKQIFP----DDAFAETIKDNLKKKSV--TDAVTQNELNSIDQIIANNSD 54
Query: 200 LTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQ 259
+ S+ Q I + L L+ N+L+ +I + L L N++ + S+ L +
Sbjct: 55 IK-SV-QGIQYLPNVTKLFLNGNKLT-DIKPLTNLKNLGWLFLDENKIK-DLSSLKDL-K 109
Query: 260 ALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQL 319
L L L N +S I L +L E LYL +NK+T I L +TKL L L DNQ+
Sbjct: 110 KLKSLSLEHNGISD-ING-LVHLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQI 165
Query: 320 TGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLE 379
+ I P L LT L +L ++ NH+ L+ NL+ L + + L
Sbjct: 166 S-DIVP-LAGLTKLQNLYLSKNHIS--DLRALAGLKNLDVLELFSQECLNKPINHQSNLV 221
Query: 380 SMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSI 419
+ + ++ P + + + + +
Sbjct: 222 VPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEV 261
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 7e-24
Identities = 52/307 (16%), Positives = 116/307 (37%), Gaps = 22/307 (7%)
Query: 118 LKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLV 177
+ + I F + LK + + ++L ++ +++
Sbjct: 1 MGETITVSTPI-KQI-FPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56
Query: 178 GTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQI 237
++ + L + + N LT I + + N + L L N++ ++ ++
Sbjct: 57 -SVQG-IQYLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDENKIK-DLSSLKDLKKL 111
Query: 238 ATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTG 297
+LSL+ N ++ I + + + L L L N ++ L L+ + L L N+++
Sbjct: 112 KSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQIS- 166
Query: 298 HIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNL 357
I P L +TKL L L+ N ++ + L L +L L + + ++ S+
Sbjct: 167 DIVP-LAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVP 223
Query: 358 NSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGN-LDTLDMSNNKIS 416
N++ +G++ + Y ++ E+S I T+ + +
Sbjct: 224 NTV----KNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFH 279
Query: 417 GSIPSPL 423
G + PL
Sbjct: 280 GRVTQPL 286
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 97.1 bits (241), Expect = 6e-21
Identities = 52/253 (20%), Positives = 93/253 (36%), Gaps = 17/253 (6%)
Query: 70 VIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELY 129
I NL ++ ++ +L + I + + + I ++ L L+ N+L
Sbjct: 23 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKL- 77
Query: 130 GDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSG 189
DI ++ LK L +L L N+ I + S+L L LK L N + ++ + L
Sbjct: 78 TDI-KPLTNLKNLGWLFLDENK-IKDL-SSLKDLKKLKSLSLEHNGIS-DING-LVHLPQ 132
Query: 190 LWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTG 249
L + NN +T + T L L NQ+S +I G ++ L L N ++
Sbjct: 133 LESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS-DIVPLAGLTKLQNLYLSKNHIS- 188
Query: 250 KIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKL 309
+ ++ GL L VL+L NL + L P + +
Sbjct: 189 DLRALAGLKN-LDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--VTPEIISDDGDY 245
Query: 310 HYLELNDNQLTGH 322
+ +
Sbjct: 246 EKPNVKWHLPEFT 258
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 93.2 bits (231), Expect = 1e-19
Identities = 42/194 (21%), Positives = 84/194 (43%), Gaps = 15/194 (7%)
Query: 314 LNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPP 373
+ I P + N+ + + + +++ + + + + ++
Sbjct: 6 TVSTPIK-QIFP-DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG 60
Query: 374 AFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLN 433
Q L ++T L L+ N + P L+ + NL L + NKI + S L DL+ L L+
Sbjct: 61 -IQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLS 115
Query: 434 LSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDVMS 493
L N ++ I G +L + + L +N +T + LS+L + +L L+ N +S D++
Sbjct: 116 LEHNGISD-ING-LVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQIS-DIVP 170
Query: 494 LINCLSLSVLFIGN 507
L L L++
Sbjct: 171 LAGLTKLQNLYLSK 184
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 57.4 bits (138), Expect = 2e-08
Identities = 23/103 (22%), Positives = 43/103 (41%), Gaps = 7/103 (6%)
Query: 405 LDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLT 464
+ + I I P +K NL + +T + L S+ +I +++ +
Sbjct: 1 MGETITVSTPIK-QI-FPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56
Query: 465 GVIPEELSQLQNMFSLRLDYNNLSGDVMSLINCLSLSVLFIGN 507
V + + L N+ L L+ N L+ D+ L N +L LF+
Sbjct: 57 SV--QGIQYLPNVTKLFLNGNKLT-DIKPLTNLKNLGWLFLDE 96
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 42.4 bits (99), Expect = 6e-04
Identities = 25/133 (18%), Positives = 45/133 (33%), Gaps = 12/133 (9%)
Query: 74 NLSGLNLDG-EIS--PAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYG 130
L L+L+ +IS + L LQ++ L N +S + +L L+L E
Sbjct: 154 KLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHIS--DLRALAGLKNLDVLELFSQECLN 211
Query: 131 DIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGL 190
S L + + L P +S + + N+ L ++S +
Sbjct: 212 KPINHQSNLVVPNTVKNTDGSL--VTPEIISDDGDYE-----KPNVKWHLPEFTNEVSFI 264
Query: 191 WYFDVRNNSLTGS 203
+Y V
Sbjct: 265 FYQPVTIGKAKAR 277
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 9e-27
Identities = 75/300 (25%), Positives = 122/300 (40%), Gaps = 45/300 (15%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLKNCK----PVAIKRL--YSHYPQCLKEFETELETVGSI 651
L I+G G +V + LK VA+K + + + ++EF +E +
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 652 KHRNLVSLQGYSL--SSSGNLLFY---DFMENGSLWDIL---HGPTKKKKLDWDTRLKIA 703
H N++ L G + SS G FM+ G L L T K + T LK
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153
Query: 704 LGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMG 763
+ A G+ YL + +HRD+ + N +L D + DFG++K + S Y Y G
Sbjct: 154 VDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKI-YSGDY---YRQG 206
Query: 764 TIGYI-----DPEYARTSRLTEKSDVYSFGIVLLELLT-GRK---AVDNECNLHHLILSK 814
I + E T KSDV++FG+ + E+ T G V N +L+
Sbjct: 207 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL--- 263
Query: 815 TANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAPE 874
+ ++ PE C D +++++ C + P DRPT + L L+ +
Sbjct: 264 --HGHRLKQ--PE---DCLD-----ELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 9e-27
Identities = 66/309 (21%), Positives = 116/309 (37%), Gaps = 46/309 (14%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLKNCK----PVAIKRL--YSHYPQCLKEFETELETVGSI 651
+ + ++G G +V + LK VA+K L ++EF E +
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 652 KHRNLVSLQGYSLSSSGNLLFYD------FMENGSLWDIL---HGPTKKKKLDWDTRLKI 702
H ++ L G SL S FM++G L L L T ++
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 703 ALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIM 762
+ A G+ YL S IHRD+ + N +L +D + DFG+++ + S Y Y
Sbjct: 143 MVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKI-YSGDY---YRQ 195
Query: 763 GTIGYI-----DPEYARTSRLTEKSDVYSFGIVLLELLT-GRK---AVDNECNLHHLILS 813
G + E + T SDV++FG+ + E++T G+ ++N ++LI
Sbjct: 196 GCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI-- 253
Query: 814 KTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAP 873
++ P C + +V+ L C P RP+ + L +++
Sbjct: 254 ---GGNRLKQ--PP---ECME-----EVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300
Query: 874 EPQKQPTSI 882
Sbjct: 301 SVLSTSQDP 309
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-26
Identities = 58/271 (21%), Positives = 108/271 (39%), Gaps = 33/271 (12%)
Query: 605 IIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETV-GSIKHRNLVSLQGYS 663
++G+GA T+ + + + VA+KR+ P+C + E++ + S +H N++
Sbjct: 31 VLGHGAEGTIVYRGMFDNRDVAVKRI---LPECFSFADREVQLLRESDEHPNVIRYFC-- 85
Query: 664 LSSSGNLLFYDFME--NGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRI 721
+ Y +E +L + + K + + GLA+LH S I
Sbjct: 86 -TEKDRQFQYIAIELCAATLQEYVE--QKDFAHLGLEPITLLQQTTSGLAHLH---SLNI 139
Query: 722 IHRDVKSSNILLDKDFE-----AHLTDFGIAKSLCVSKSYTSTY--IMGTIGYIDPEY-- 772
+HRD+K NIL+ A ++DFG+ K L V + S + GT G+I PE
Sbjct: 140 VHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLS 199
Query: 773 -ARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISAT 831
T D++S G V +++ + + A + +
Sbjct: 200 EDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVI 259
Query: 832 CKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
++L ++K ++ P RP+ V
Sbjct: 260 AREL--IEK-----MIA--MDPQKRPSAKHV 281
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-26
Identities = 76/356 (21%), Positives = 130/356 (36%), Gaps = 64/356 (17%)
Query: 555 RPHNPTHFPDGSLDKPVNYSTPKLVILHMNMA-------LHVYEDIMRMT---------E 598
RP S+ K N + ++++ + ED M E
Sbjct: 331 RPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRE 390
Query: 599 NLSEKYIIGYGASSTVYKCVLKNCK----PVAIKRLYSHY-PQCLKEFETELETVGSIKH 653
+ IG G V++ + + + VAIK + ++F E T+ H
Sbjct: 391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 450
Query: 654 RNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYL 713
++V L G + + + G L L +K LD + + A + LAYL
Sbjct: 451 PHIVKLIGVITENP-VWIIMELCTLGELRSFLQ--VRKFSLDLASLILYAYQLSTALAYL 507
Query: 714 HHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYI----- 768
S R +HRD+ + N+L+ + L DFG+++ + STY + G +
Sbjct: 508 E---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-----EDSTYYKASKGKLPIKWM 559
Query: 769 DPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVD-- 825
PE R T SDV+ FG+ + E+L G K + NN V+ ++
Sbjct: 560 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG--------VK---NNDVIGRIENG 608
Query: 826 -----PEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAPEPQ 876
P C ++ L C P+ RP E+ L +++ + Q
Sbjct: 609 ERLPMPPN---CPP-----TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKLQ 656
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-26
Identities = 71/315 (22%), Positives = 114/315 (36%), Gaps = 45/315 (14%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLKNCKP------VAIKRLYSHY-PQCLKEFETELETVGS 650
+N++ +G+GA VY+ + VA+K L Q +F E +
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 651 IKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDIL----HGPTKKKKLDWDTRLKIALGA 706
H+N+V G SL S + + M G L L P++ L L +A
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 707 AQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHL---TDFGIAKSLCVSKSYTSTYIMG 763
A G YL IHRD+ + N LL + DFG+A+ + Y G
Sbjct: 191 ACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI----YRAGYYRKG 243
Query: 764 TIGYI-----DPEYARTSRLTEKSDVYSFGIVLLELLT-GRK---AVDNECNLHHLILSK 814
+ PE T K+D +SFG++L E+ + G + N+ L +
Sbjct: 244 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT--- 300
Query: 815 TANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAPE 874
+ M+ P+ C V+++ C + QP DRP + + P+
Sbjct: 301 --SGGRMDP--PK---NCPG-----PVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 348
Query: 875 PQKQPTSIPSALLSS 889
I L
Sbjct: 349 VINTALPIEYGPLVE 363
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 60/233 (25%), Positives = 104/233 (44%), Gaps = 23/233 (9%)
Query: 568 DKPVNYSTPKLVILHMNMALHVYEDIMRMTENLSEKYIIGYGASSTVYKCV-LKNCKPVA 626
PV P + L + ++ + + IG G+ V+K + + K VA
Sbjct: 3 HSPVQSGLPGMQNLKADPE-ELFTKLEK----------IGKGSFGEVFKGIDNRTQKVVA 51
Query: 627 IKRL-YSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNL-LFYDFMENGSLWDI 684
IK + +++ + E+ + + G S L + +++ GS D+
Sbjct: 52 IKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG-SYLKDTKLWIIMEYLGGGSALDL 110
Query: 685 LHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDF 744
L + LD I +GL YLH S + IHRD+K++N+LL + E L DF
Sbjct: 111 L----EPGPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADF 163
Query: 745 GIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTG 797
G+A L ++ +T++ GT ++ PE + S K+D++S GI +EL G
Sbjct: 164 GVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARG 215
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 71/305 (23%), Positives = 126/305 (41%), Gaps = 49/305 (16%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLKNCKP------VAIKRLYSHYPQCLKEFETELETVGSI 651
++ K+ +G GA V+ N P VA+K L ++F+ E E + +
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100
Query: 652 KHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDIL--HGPTKKKKLDWDTR---------- 699
+H+++V G L+ +++M +G L L HGP K +
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 700 LKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTST 759
L +A A G+ YL +HRD+ + N L+ + + DFG+++ + T
Sbjct: 161 LAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI----YSTDY 213
Query: 760 YIMGTIGYI-----DPEYARTSRLTEKSDVYSFGIVLLELLT-GRK---AVDNECNLHHL 810
Y +G + PE + T +SDV+SFG+VL E+ T G++ + N + +
Sbjct: 214 YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI 273
Query: 811 ILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLV 870
+E P C +V+ + C +R+P R ++ +V L +L
Sbjct: 274 T-----QGRELER--PR---ACPP-----EVYAIMRGCWQREPQQRHSIKDVHARLQALA 318
Query: 871 PAPEP 875
AP
Sbjct: 319 QAPPV 323
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-26
Identities = 64/204 (31%), Positives = 93/204 (45%), Gaps = 18/204 (8%)
Query: 606 IGYGASSTVYKCVLK-NCKPVAIKRL-YSHYPQCLKEFETELETV-GSIKHRNLVSLQGY 662
IG GA +V K V K + + +A+KR+ + + K+ +L+ V S +V G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG- 88
Query: 663 SLSSSGNLLFYDFME--NGSLWDILH--GPTKKKKLDWDTRLKIALGAAQGLAYLHHDCS 718
+L G+ + ME + S + + KI L + L +L +
Sbjct: 89 ALFREGDC--WICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL- 145
Query: 719 PRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPE----YAR 774
+IIHRD+K SNILLD+ L DFGI+ L S + T G Y+ PE A
Sbjct: 146 -KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD--AGCRPYMAPERIDPSAS 202
Query: 775 TSRLTEKSDVYSFGIVLLELLTGR 798
+SDV+S GI L EL TGR
Sbjct: 203 RQGYDVRSDVWSLGITLYELATGR 226
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 54/203 (26%), Positives = 90/203 (44%), Gaps = 17/203 (8%)
Query: 606 IGYGASSTVYKCVLK-NCKPVAIKRL-YSHYPQCLKEFETELETV-GSIKHRNLVSLQGY 662
+G GA V K + + +A+KR+ + Q K +L+ ++ V+ G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG- 73
Query: 663 SLSSSGNLLFYDFME--NGSLWDILHGPTKKKK-LDWDTRLKIALGAAQGLAYLHHDCSP 719
+L G++ + ME + SL K + + D KIA+ + L +LH
Sbjct: 74 ALFREGDV--WICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL-- 129
Query: 720 RIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPE----YART 775
+IHRDVK SN+L++ + + DFGI+ L + G Y+ PE
Sbjct: 130 SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKD-IDA-GCKPYMAPERINPELNQ 187
Query: 776 SRLTEKSDVYSFGIVLLELLTGR 798
+ KSD++S GI ++EL R
Sbjct: 188 KGYSVKSDIWSLGITMIELAILR 210
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 54/203 (26%), Positives = 87/203 (42%), Gaps = 19/203 (9%)
Query: 606 IGYGASSTVYKCVLKNCKPV-AIKRL-YSHYPQCLKEFETELETV-GSIKHRNLVSLQGY 662
+G G V+K + V A+K++ S + K +L+ V S +V G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG- 91
Query: 663 SLSSSGNLLFYDFME--NGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPR 720
+ ++ ++ + ME + + + K+ + + L YL
Sbjct: 92 TFITNTDV--FIAMELMGTCAEKLKK--RMQGPIPERILGKMTVAIVKALYYLKEK--HG 145
Query: 721 IIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGY-----IDPEYART 775
+IHRDVK SNILLD+ + L DFGI+ L K+ + G Y IDP
Sbjct: 146 VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS--AGCAAYMAPERIDPPDPTK 203
Query: 776 SRLTEKSDVYSFGIVLLELLTGR 798
++DV+S GI L+EL TG+
Sbjct: 204 PDYDIRADVWSLGISLVELATGQ 226
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 11/203 (5%)
Query: 597 TENLSEKYIIGYGASSTVYKCV-LKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRN 655
E +G G+ +VYK + + + VAIK++ L+E E+ + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDLQEIIKEISIMQQCDSPH 85
Query: 656 LVSLQGYSLSSSGNL-LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLH 714
+V G S + +L + ++ GS+ DI+ + K L D I +GL YLH
Sbjct: 86 VVKYYG-SYFKNTDLWIVMEYCGAGSVSDIIR--LRNKTLTEDEIATILQSTLKGLEYLH 142
Query: 715 HDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYAR 774
R IHRD+K+ NILL+ + A L DFG+A L + + +T I GT ++ PE +
Sbjct: 143 ---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQ 198
Query: 775 TSRLTEKSDVYSFGIVLLELLTG 797
+D++S GI +E+ G
Sbjct: 199 EIGYNCVADIWSLGITAIEMAEG 221
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 67/302 (22%), Positives = 118/302 (39%), Gaps = 45/302 (14%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLKNCKP------VAIKRLYSHY-PQCLKEFETELETVGS 650
E ++ +G G+ VY+ V K VAIK + + EF E +
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 651 IKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDIL-------HGPTKKKKLDWDTRLKIA 703
++V L G L+ + M G L L +++A
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 704 LGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMG 763
A G+AYL+ + + +HRD+ + N ++ +DF + DFG+ + + T Y G
Sbjct: 145 GEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI----YETDYYRKG 197
Query: 764 TIGYI-----DPEYARTSRLTEKSDVYSFGIVLLELLT-GRK---AVDNECNLHHLILSK 814
G + PE + T SDV+SFG+VL E+ T + + NE L ++
Sbjct: 198 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM--- 254
Query: 815 TANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAPE 874
+++ P+ C D +F+L +C + P RP+ E+ + +
Sbjct: 255 --EGGLLDK--PD---NCPD-----MLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 302
Query: 875 PQ 876
+
Sbjct: 303 RE 304
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 74/313 (23%), Positives = 129/313 (41%), Gaps = 68/313 (21%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLKNCKP------VAIKRLYSHYPQCLKEFETELETVGSI 651
++ K +G GA V+ N P VA+K L K+F+ E E + ++
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74
Query: 652 KHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDIL--HGPT-----------KKKKLDWDT 698
+H ++V G ++ +++M++G L L HGP K +L
Sbjct: 75 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 699 RLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTS 758
L IA A G+ YL S +HRD+ + N L+ + + DFG+++ + Y++
Sbjct: 135 MLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDV-----YST 186
Query: 759 -TYIMGTIGYI-----DPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLIL 812
Y +G + PE + T +SDV+SFG++L E+ T
Sbjct: 187 DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT---------------Y 231
Query: 813 SKT-----ANNAVMETVD-------PEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMH 860
K +N V+E + P C +V+ + L C +R+P R +
Sbjct: 232 GKQPWFQLSNTEVIECITQGRVLERPR---VCPK-----EVYDVMLGCWQREPQQRLNIK 283
Query: 861 EVSRVLGSLVPAP 873
E+ ++L +L A
Sbjct: 284 EIYKILHALGKAT 296
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 3e-25
Identities = 73/311 (23%), Positives = 125/311 (40%), Gaps = 60/311 (19%)
Query: 591 EDIMRMTENLSEKY----IIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELE 646
+I ++L I+GYG+S TV +PVA+KR+ E++
Sbjct: 4 ANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRM---LIDFCDIALMEIK 60
Query: 647 T-VGSIKHRNLVSLQGYSLSSSGNLLFYDFME--NGSLWDILHGPTKKKKLDWDTRLKIA 703
S H N++ Y ++ L Y +E N +L D++ K D + +L+
Sbjct: 61 LLTESDDHPNVIRY--YCSETTDRFL-YIALELCNLNLQDLV---ESKNVSDENLKLQKE 114
Query: 704 LGAA-------QGLAYLHHDCSPRIIHRDVKSSNILLD-------------KDFEAHLTD 743
G+A+LH S +IIHRD+K NIL+ ++ ++D
Sbjct: 115 YNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 171
Query: 744 FGIAKSLCVSKSYTSTYIM---GTIGYIDPE-------YARTSRLTEKSDVYSFGIVLLE 793
FG+ K L +S T + GT G+ PE RLT D++S G V
Sbjct: 172 FGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYY 231
Query: 794 LLT-GRKAVDNECNLHHLILSKTAN-NAVMETVDPEISATCKDLGAVKKVFQLALLCSKR 851
+L+ G+ ++ + I+ + + + D + A DL + + ++
Sbjct: 232 ILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDL--ISQ-----MID--H 282
Query: 852 QPTDRPTMHEV 862
P RPT +V
Sbjct: 283 DPLKRPTAMKV 293
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 60/300 (20%), Positives = 115/300 (38%), Gaps = 62/300 (20%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLKNCK--------PVAIKRLYSHYPQCLKEFETELETVG 649
E+L +G G + ++K V + V +K L + + F +
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 650 SIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQG 709
+ H++LV G + N+L +F++ GSL L K ++ +L++A A
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLK--KNKNCINILWKLEVAKQLAAA 125
Query: 710 LAYLHHDCSPRIIHRDVKSSNILLDKDFEAH--------LTDFGIAKSLCVSKSYTSTYI 761
+ +L +IH +V + NILL ++ + L+D GI+ ++ +
Sbjct: 126 MHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV-----LPKDIL 177
Query: 762 MGTIGYIDPEYARTSRL-TEKSDVYSFGIVLLELLT-GRK---AVDNECNLHHLILSKTA 816
I ++ PE + +D +SFG L E+ + G K A+D++
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ------------ 225
Query: 817 NNAVMETVD-------PEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869
++ + P+ ++ L C +P RP+ + R L SL
Sbjct: 226 --RKLQFYEDRHQLPAPKA---A-------ELANLINNCMDYEPDHRPSFRAIIRDLNSL 273
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-25
Identities = 57/194 (29%), Positives = 93/194 (47%), Gaps = 11/194 (5%)
Query: 606 IGYGASSTVYKCV-LKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSL 664
IG GAS TVY + + + VAI+++ + E+ + K+ N+V+ S
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD-SY 86
Query: 665 SSSGNL-LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIH 723
L + +++ GSL D++ + +D + Q L +LH S ++IH
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVV----TETCMDEGQIAAVCRECLQALEFLH---SNQVIH 139
Query: 724 RDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSD 783
RD+KS NILL D LTDFG + +S ST + GT ++ PE K D
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 198
Query: 784 VYSFGIVLLELLTG 797
++S GI+ +E++ G
Sbjct: 199 IWSLGIMAIEMIEG 212
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 67/305 (21%), Positives = 123/305 (40%), Gaps = 52/305 (17%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLKNCK---PVAIKRLYSHYPQC-LKEFETELETVGSI-K 652
++ + +IG G V K +K AIKR+ + + ++F ELE + +
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 653 HRNLVSLQGYSLSSSGNLLFYDFMENGSLWDIL-------------HGPTKKKKLDWDTR 699
H N+++L G L ++ +G+L D L + L
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 700 LKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTST 759
L A A+G+ YL + IHRD+ + NIL+ +++ A + DFG+++
Sbjct: 145 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRG-------QEV 194
Query: 760 YIMGTIGYI-----DPEYARTSRLTEKSDVYSFGIVLLELLT-GRK---AVDNECNLHHL 810
Y+ T+G + E S T SDV+S+G++L E+++ G + L
Sbjct: 195 YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 254
Query: 811 ILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLV 870
+E P C D +V+ L C + +P +RP+ ++ L ++
Sbjct: 255 P-----QGYRLEK--PL---NCDD-----EVYDLMRQCWREKPYERPSFAQILVSLNRML 299
Query: 871 PAPEP 875
+
Sbjct: 300 EERKT 304
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 51/194 (26%), Positives = 92/194 (47%), Gaps = 11/194 (5%)
Query: 606 IGYGASSTVYKCV-LKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSL 664
IG G++ V + + VA+K + Q + E+ + +H N+V + S
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYK-SY 111
Query: 665 SSSGNL-LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIH 723
L + +F++ G+L DI+ + +L+ + + Q LAYLH + +IH
Sbjct: 112 LVGEELWVLMEFLQGGALTDIV----SQVRLNEEQIATVCEAVLQALAYLH---AQGVIH 164
Query: 724 RDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSD 783
RD+KS +ILL D L+DFG + + + GT ++ PE S + D
Sbjct: 165 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSLYATEVD 223
Query: 784 VYSFGIVLLELLTG 797
++S GI+++E++ G
Sbjct: 224 IWSLGIMVIEMVDG 237
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 51/240 (21%), Positives = 95/240 (39%), Gaps = 18/240 (7%)
Query: 250 KIPSVIGL--MQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMT 307
I + +L ++ + L+ +++ +++ + + + +
Sbjct: 13 PIKQIFSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLP 68
Query: 308 KLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKL 367
+ L LN N+LT I P L L +L L + N ++ +L L SL++ N +
Sbjct: 69 NVTKLFLNGNKLT-DIKP-LANLKNLGWLFLDENKVK--DLSSLKDLKKLKSLSLEHNGI 124
Query: 368 NGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLE 427
+ I L + L L N I LSR+ LDTL + +N+IS I PL L
Sbjct: 125 S-DING-LVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQIS-DI-VPLAGLT 178
Query: 428 HLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNL 487
L L LS+N ++ L+++ ++L S L +++ +L
Sbjct: 179 KLQNLYLSKNHISDLRA--LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 51/234 (21%), Positives = 92/234 (39%), Gaps = 15/234 (6%)
Query: 207 NIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDL 266
+ +L ++ + N I + + + + I + + L L
Sbjct: 19 SDDAFAETIKDNLKKKSVTDAVTQN-ELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFL 75
Query: 267 SCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPA 326
+ N L+ I P L NL L+L NK+ + L ++ KL L L N ++ I
Sbjct: 76 NGNKLTD-IKP-LANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGIS-DING- 129
Query: 327 LGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNL 386
L L L L + NN + LS T L++L++ N+++ I P L + L L
Sbjct: 130 LVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYL 185
Query: 387 SLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLT 440
S N+I L+ + NLD L++ + + + +L + + L
Sbjct: 186 SKNHISDLRA--LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV 237
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 46/210 (21%), Positives = 86/210 (40%), Gaps = 16/210 (7%)
Query: 279 LGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNV 338
+ T K L +T + + + N++ + + + L ++ L +
Sbjct: 20 DDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFL 75
Query: 339 ANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVE 398
N L I L++ NL L + NK+ + + L+ + L+L N I
Sbjct: 76 NGNKLTD-IK-PLANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGISDING-- 129
Query: 399 LSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDL 458
L + L++L + NNKI+ + L L L L+L NQ++ +P L + + L
Sbjct: 130 LVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYL 185
Query: 459 SHNHLTGVIPEELSQLQNMFSLRLDYNNLS 488
S NH++ + L+ L+N+ L L
Sbjct: 186 SKNHISDL--RALAGLKNLDVLELFSQECL 213
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 46/221 (20%), Positives = 89/221 (40%), Gaps = 17/221 (7%)
Query: 287 KLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGP 346
+ + I + L +T +L + + N+ ++
Sbjct: 6 ETITVPTPIK-QIFS-DDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIK-- 59
Query: 347 IPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLD 406
+ N+ L ++GNKL I P L+++ +L L N ++ L + L
Sbjct: 60 SVQGIQYLPNVTKLFLNGNKLT-DIKP-LANLKNLGWLFLDENKVKDLSS--LKDLKKLK 115
Query: 407 TLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGV 466
+L + +N IS I + L L L L L N++T L + + L N ++ +
Sbjct: 116 SLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQISDI 171
Query: 467 IPEELSQLQNMFSLRLDYNNLSGDVMSLINCLSLSVLFIGN 507
+P L+ L + +L L N++S D+ +L +L VL + +
Sbjct: 172 VP--LAGLTKLQNLYLSKNHIS-DLRALAGLKNLDVLELFS 209
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 7e-19
Identities = 52/282 (18%), Positives = 101/282 (35%), Gaps = 45/282 (15%)
Query: 91 LKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNN 150
+ +L+ ++ + + +S+ + + +++ + I L + L L N
Sbjct: 23 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI-KSVQG-IQYLPNVTKLFLNGN 78
Query: 151 QL--IGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNI 208
+L I P L+ L NL L N V LS + L L + +N ++ I +
Sbjct: 79 KLTDIKP----LANLKNLGWLFL-DENKVKDLSS-LKDLKKLKSLSLEHNGIS-DIN-GL 130
Query: 209 GNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSC 268
+ + L L N+++ +I ++ TLSL+ NQ++ D+
Sbjct: 131 VHLPQLESLYLGNNKIT-DITVLSRLTKLDTLSLEDNQIS----------------DIVP 173
Query: 269 NMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALG 328
L L+ + LYL N ++ + L + L LEL +
Sbjct: 174 ----------LAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQS 221
Query: 329 KLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGT 370
L + + L P+ +S + NV + T
Sbjct: 222 NLVVPNTVKNTDGSLVT--PEIISDDGDYEKPNVKWHLPEFT 261
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 48/207 (23%), Positives = 81/207 (39%), Gaps = 19/207 (9%)
Query: 606 IGYGASS--TVYKCV-LKNCKPVAIKR--LYSHYPQCLKEFETELETVGSIKHRNLVSLQ 660
IG G TV + V ++R L + + + + EL H N+V +
Sbjct: 33 IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92
Query: 661 GYSLSSSGNL-LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSP 719
+ + L + FM GS D++ ++ I G + L Y+HH
Sbjct: 93 A-TFIADNELWVVTSFMAYGSAKDLIC-THFMDGMNELAIAYILQGVLKALDYIHHM--- 147
Query: 720 RIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTST------YIMGTIGYIDPEYA 773
+HR VK+S+IL+ D + +L+ S+ Y + + ++ PE
Sbjct: 148 GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVL 207
Query: 774 RTSRL--TEKSDVYSFGIVLLELLTGR 798
+ + KSD+YS GI EL G
Sbjct: 208 QQNLQGYDAKSDIYSVGITACELANGH 234
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 59/298 (19%), Positives = 107/298 (35%), Gaps = 51/298 (17%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLKNCKP------VAIKRLYSHY-PQCLKEFETELETVGS 650
+ +G VYK L P VAIK L +EF E
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR 68
Query: 651 IKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILH-------------GPTKKKKLDWD 697
++H N+V L G + + + +G L + L T K L+
Sbjct: 69 LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 698 TRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYT 757
+ + A G+ YL S ++H+D+ + N+L+ ++D G+ + +
Sbjct: 129 DFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREV----YAA 181
Query: 758 STYIMGTIGYI-----DPEYARTSRLTEKSDVYSFGIVLLELLT-GRK---AVDNECNLH 808
Y + + PE + + SD++S+G+VL E+ + G + N+ +
Sbjct: 182 DYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 241
Query: 809 HLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866
+ N V+ P+ C V+ L + C P+ RP ++ L
Sbjct: 242 MIR-----NRQVLPC--PD---DCPA-----WVYALMIECWNEFPSRRPRFKDIHSRL 284
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 81/276 (29%), Positives = 118/276 (42%), Gaps = 34/276 (12%)
Query: 606 IGYGASSTVYKCV-LKNCKPVAIKRLYSHYPQC-LKEFETELETVGSIKHRNLVSLQGYS 663
IG GA++ V + VAIKR+ Q + E E++ + H N+VS S
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT-S 81
Query: 664 LSSSGNL-LFYDFMENGSLWDIL-----HGPTKKKKLDWDTRLKIALGAAQGLAYLHHDC 717
L L + GS+ DI+ G K LD T I +GL YLH
Sbjct: 82 FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH--- 138
Query: 718 SPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTS-----TYIMGTIGYIDPE- 771
IHRDVK+ NILL +D + DFG++ L T T++ GT ++ PE
Sbjct: 139 KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV-GTPCWMAPEV 197
Query: 772 YARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHL-ILSKTANNAVMETVDPEISA 830
+ K+D++SFGI +EL TG + +L T N P +
Sbjct: 198 MEQVRGYDFKADIWSFGITAIELATGAA---PYHKYPPMKVLMLTLQNDP-----PSLET 249
Query: 831 TCKDLGAVKK---VFQ--LALLCSKRQPTDRPTMHE 861
+D +KK F+ ++ LC ++ P RPT E
Sbjct: 250 GVQDKEMLKKYGKSFRKMIS-LCLQKDPEKRPTAAE 284
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 53/200 (26%), Positives = 88/200 (44%), Gaps = 11/200 (5%)
Query: 264 LDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHI 323
++ L+ +PP T L+L N L L T+L L L+ +LT
Sbjct: 15 VNCDKRNLTA-LPP--DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT--K 69
Query: 324 PPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPP-AFQRLESMT 382
G L L L++++N L+ +P + L L+V N+L ++P A + L +
Sbjct: 70 LQVDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQ 127
Query: 383 YLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGD-LEHLLKLNLSRNQLTG 441
L L N ++ P L+ L+ L ++NN ++ +P+ L + LE+L L L N L
Sbjct: 128 ELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT 186
Query: 442 FIPGEFGNLRSVMEIDLSHN 461
G FG+ + L N
Sbjct: 187 IPKGFFGSH-LLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 4e-20
Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 9/209 (4%)
Query: 305 NMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHG 364
+ + + LT +PP L D L+++ N L L T L LN+
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 365 NKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLG 424
+L T L + L+LS N ++ +P+ + L LD+S N+++ S+P
Sbjct: 65 AEL--TKLQVDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLT-SLPLGAL 120
Query: 425 D-LEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLD 483
L L +L L N+L PG + ++ L++N+LT + L+ L+N+ +L L
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ 180
Query: 484 YNNLSGDVMSLINCLSLSVLFI-GNPGLC 511
N+L L F+ GNP LC
Sbjct: 181 ENSLYTIPKGFFGSHLLPFAFLHGNPWLC 209
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 5e-17
Identities = 53/227 (23%), Positives = 87/227 (38%), Gaps = 36/227 (15%)
Query: 94 LQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLI 153
++ L+ +P ++ L LS N LY ++ +L L L +
Sbjct: 12 HLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE-- 66
Query: 154 GPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTS 213
L++L V G L L D+ +N L S+P +
Sbjct: 67 ------LTKLQ---VDG---------------TLPVLGTLDLSHNQLQ-SLPLLGQTLPA 101
Query: 214 FQVLDLSYNQLSGEIPFNI--GFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNML 271
VLD+S+N+L+ +P G ++ L L+GN+L P ++ L L L+ N L
Sbjct: 102 LTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL 160
Query: 272 SGPIPP-ILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDN 317
+ +P +L L + L L N L IP L + L+ N
Sbjct: 161 TE-LPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 47/181 (25%), Positives = 66/181 (36%), Gaps = 11/181 (6%)
Query: 93 DLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQL 152
D + L N L + + L L+L EL L L L L +NQL
Sbjct: 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLGTLDLSHNQL 89
Query: 153 IGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDM-CQLSGLWYFDVRNNSLTGSIPQNI-GN 210
+P LP L V + N L +L L L ++ N L ++P +
Sbjct: 90 QS-LPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTP 146
Query: 211 CTSFQVLDLSYNQLSGEIPFNI--GFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSC 268
+ L L+ N L+ E+P + G + TL LQ N L IP L L
Sbjct: 147 TPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHG 204
Query: 269 N 269
N
Sbjct: 205 N 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 50/177 (28%), Positives = 70/177 (39%), Gaps = 11/177 (6%)
Query: 73 LNLSGLNLDGEISPAVGD-LKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGD 131
L+LS NL S A L ++L L+ ++ G L +LDLS N+L
Sbjct: 36 LHLSE-NLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQL-QS 91
Query: 132 IPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQ-LSGL 190
+P L L L + N+L L L L+ L+GN L TL P + L
Sbjct: 92 LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKL 150
Query: 191 WYFDVRNNSLTGSIPQNI-GNCTSFQVLDLSYNQLSGEIPFNI-GFLQIATLSLQGN 245
+ NN+LT +P + + L L N L IP G + L GN
Sbjct: 151 EKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 19/205 (9%)
Query: 606 IGYGASSTVYKCV-LKNCKPVAIKRLYSHYPQCLKEFETELETVGSI-KHRNLVS----- 658
+G G VYK +K + AIK + +E + E+ + HRN+ +
Sbjct: 32 VGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 90
Query: 659 LQGYSLSSSGNL-LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDC 717
++ L L +F GS+ D++ TK L + I +GL++LH
Sbjct: 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIK-NTKGNTLKEEWIAYICREILRGLSHLH--- 146
Query: 718 SPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSR 777
++IHRD+K N+LL ++ E L DFG++ L + +T+I GT ++ PE
Sbjct: 147 QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDE 205
Query: 778 LTE-----KSDVYSFGIVLLELLTG 797
+ KSD++S GI +E+ G
Sbjct: 206 NPDATYDFKSDLWSLGITAIEMAEG 230
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 16/200 (8%)
Query: 606 IGYGASSTVYKCV-LKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSL 664
+G GA VYK + A K + + + L+++ E+E + + H +V L G +
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLG-AY 85
Query: 665 SSSGNL-LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIH 723
G L + +F G++ I+ + L + + L +LH S RIIH
Sbjct: 86 YHDGKLWIMIEFCPGGAVDAIML--ELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIH 140
Query: 724 RDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGY------IDPEYARTSR 777
RD+K+ N+L+ + + L DFG++ + ++I GT Y + E + +
Sbjct: 141 RDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GT-PYWMAPEVVMCETMKDTP 198
Query: 778 LTEKSDVYSFGIVLLELLTG 797
K+D++S GI L+E+
Sbjct: 199 YDYKADIWSLGITLIEMAQI 218
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 9e-23
Identities = 33/186 (17%), Positives = 69/186 (37%), Gaps = 10/186 (5%)
Query: 281 NLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVAN 340
L + M L Y+ L + +T + + ++ DL + N
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINN 75
Query: 341 NHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELS 400
H + +S +NL L + G + P L S+T L++S + I +++
Sbjct: 76 IHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 401 RIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSH 460
+ ++++D+S N I PL L L LN+ + + + + + ++
Sbjct: 134 TLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFS 190
Query: 461 NHLTGV 466
+ G
Sbjct: 191 QTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-20
Identities = 28/160 (17%), Positives = 66/160 (41%), Gaps = 7/160 (4%)
Query: 258 MQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDN 317
M +L + L+ ++ + + + L +++ T + P + ++ L L +
Sbjct: 43 MNSLTYITLANINVTD-LTG-IEYAHNIKDLTINNIHAT-NYNP-ISGLSNLERLRIMGK 98
Query: 318 QLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQR 377
+T P L LT L L+++++ + I +++ +NS+++ N I P +
Sbjct: 99 DVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKT 157
Query: 378 LESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISG 417
L + LN+ + + + L+ L + I G
Sbjct: 158 LPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 9e-19
Identities = 34/161 (21%), Positives = 64/161 (39%), Gaps = 9/161 (5%)
Query: 347 IPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLD 406
IPD + + + T ++ S+TY+ L+ N+ + N+
Sbjct: 17 IPD-----STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTG--IEYAHNIK 69
Query: 407 TLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGV 466
L ++N + +P+ L +L +L + +T L S+ +D+SH+
Sbjct: 70 DLTINNIHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDS 127
Query: 467 IPEELSQLQNMFSLRLDYNNLSGDVMSLINCLSLSVLFIGN 507
I +++ L + S+ L YN D+M L L L I
Sbjct: 128 ILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQF 168
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 5e-18
Identities = 27/166 (16%), Positives = 59/166 (35%), Gaps = 14/166 (8%)
Query: 208 IGNCTSFQVLDLSYNQLSGEIPFNIGFLQIAT----LSLQGNQLTGKIPSVIGLMQALAV 263
S + L+ ++ ++ ++ A L++ T + I + L
Sbjct: 40 EAQMNSLTYITLANINVT-----DLTGIEYAHNIKDLTINNIHATN--YNPISGLSNLER 92
Query: 264 LDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHI 323
L + ++ P L L+ L + + I ++ + K++ ++L+ N I
Sbjct: 93 LRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI 152
Query: 324 PPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNG 369
P L L +L LN+ + + + LN L + G
Sbjct: 153 MP-LKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 7e-18
Identities = 28/153 (18%), Positives = 59/153 (38%), Gaps = 6/153 (3%)
Query: 355 TNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNK 414
+L + + + + ++ L ++ + P +S + NL+ L +
Sbjct: 44 NSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKD 99
Query: 415 ISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQL 474
++ L L L L++S + I + L V IDLS+N I L L
Sbjct: 100 VTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTL 158
Query: 475 QNMFSLRLDYNNLSGDVMSLINCLSLSVLFIGN 507
+ SL + ++ + D + + L+ L+ +
Sbjct: 159 PELKSLNIQFDGVH-DYRGIEDFPKLNQLYAFS 190
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-17
Identities = 23/155 (14%), Positives = 62/155 (40%), Gaps = 7/155 (4%)
Query: 73 LNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDI 132
+ L+ +N+ +++ + +++ + + + P I S+L+ L + ++ D
Sbjct: 49 ITLANINVT-DLTG-IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDK 104
Query: 133 PFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWY 192
++S L L L + ++ I + ++ LP + L N + + P + L L
Sbjct: 105 IPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKS 163
Query: 193 FDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGE 227
+++ + + I + L + G+
Sbjct: 164 LNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 7e-17
Identities = 32/183 (17%), Positives = 68/183 (37%), Gaps = 9/183 (4%)
Query: 91 LKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNN 150
K + L + + +SL + L+ + D+ I ++ L + N
Sbjct: 22 FKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINV-TDLTG-IEYAHNIKDLTINNI 76
Query: 151 QLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGN 210
+ +S L NL+ + G ++ P++ L+ L D+ +++ SI I
Sbjct: 77 HATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINT 134
Query: 211 CTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNM 270
+DLSYN +I ++ +L++Q + + + + L L
Sbjct: 135 LPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVH-DYRGIEDFPK-LNQLYAFSQT 192
Query: 271 LSG 273
+ G
Sbjct: 193 IGG 195
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 1e-22
Identities = 55/255 (21%), Positives = 93/255 (36%), Gaps = 19/255 (7%)
Query: 239 TLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPP-ILGNLSYTEKLYLHSNKLTG 297
Q +++T +IPS L + L L I EK+ + N +
Sbjct: 13 VFLCQESKVT-EIPS--DLPRNAIELRFVLTKLRV-IQKGAFSGFGDLEKIEISQNDVLE 68
Query: 298 HIPPE-LGNMTKLHYLEL-NDNQLTGHIPP-ALGKLTDLFDLNVANNHLEGPIPDNL-SS 353
I + N+ KLH + + N L +I P A L +L L ++N ++ +PD
Sbjct: 69 VIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIKH-LPDVHKIH 126
Query: 354 CTNLNSLNVHGNKLNGTIPP-AFQRLESMT-YLNLSLNNIRGPIPVELSRIGNLDTLD-M 410
L++ N TI +F L + L L+ N I+ I LD L+
Sbjct: 127 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLS 185
Query: 411 SNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEE 470
NN + + L++SR ++ NL+ + S +L +
Sbjct: 186 DNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRA--RSTYNLKKLPT-- 241
Query: 471 LSQLQNMFSLRLDYN 485
L +L + L Y
Sbjct: 242 LEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 4e-18
Identities = 32/231 (13%), Positives = 62/231 (26%), Gaps = 35/231 (15%)
Query: 264 LDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPE-LGNMTKLHYLELNDNQLTGH 322
+ ++ IP L +L KL I L +E++ N +
Sbjct: 14 FLCQESKVTE-IPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEV 69
Query: 323 IPP-ALGKLTDLFDLNVAN-NHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPP-AFQRLE 379
I L L ++ + N+L P+ + NL L + + +P
Sbjct: 70 IEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSL 128
Query: 380 SMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPS-PLGDLEHLLK-LNLSRN 437
L++ N I +I L L L++N
Sbjct: 129 QKVLLDIQ-----------------------DNINIH-TIERNSFVGLSFESVILWLNKN 164
Query: 438 QLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLS 488
+ F + +N+L + + L + +
Sbjct: 165 GIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH 215
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 7e-17
Identities = 44/256 (17%), Positives = 82/256 (32%), Gaps = 35/256 (13%)
Query: 92 KDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSI-SKLKQLEFL-ILKN 149
++ + +L L+ +++S N++ I + S L +L + I K
Sbjct: 30 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 89
Query: 150 NQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNI- 208
N L+ P LPNL+ + + D+++N +I +N
Sbjct: 90 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSF 149
Query: 209 -GNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLS 267
G +L L+ N + EI S Q +
Sbjct: 150 VGLSFESVILWLNKNGIQ-EIH----------------------NSAFNGTQLDELNLSD 186
Query: 268 CNMLSGPIPP-ILGNLSYTEKLYLHSNKLTGHIPPE-LGNMTKLHYLELNDNQLTGHIPP 325
N L +P + S L + ++ +P L N+ KL + + P
Sbjct: 187 NNNLEE-LPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLKKL----P 240
Query: 326 ALGKLTDLFDLNVANN 341
L KL L + ++
Sbjct: 241 TLEKLVALMEASLTYP 256
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 68/319 (21%), Positives = 118/319 (36%), Gaps = 70/319 (21%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLKN------CKPVAIKRLYSHYPQC-LKEFETELETVGS 650
+ L +G GA V + C+ VA+K L + +EL+ +
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 651 I-KHRNLVSLQGYSLSSSG-NLLFYDFMENGSLWDIL-------------HGPTKKKKLD 695
I H N+V+L G G ++ +F + G+L L K L
Sbjct: 87 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 696 WDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS 755
+ + + A+G+ +L S + IHRD+ + NILL + + DFG+A+ +
Sbjct: 147 LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDI----Y 199
Query: 756 YTSTYIMGTIGYI-----DPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHL 810
Y+ + PE T +SDV+SFG++L E+ +
Sbjct: 200 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-------------- 245
Query: 811 ILSKT------ANNAVMETVD-------PEISATCKDLGAVKKVFQLALLCSKRQPTDRP 857
L + + + P+ +++Q L C +P+ RP
Sbjct: 246 -LGASPYPGVKIDEEFCRRLKEGTRMRAPD---YTTP-----EMYQTMLDCWHGEPSQRP 296
Query: 858 TMHEVSRVLGSLVPAPEPQ 876
T E+ LG+L+ A Q
Sbjct: 297 TFSELVEHLGNLLQANAQQ 315
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 2e-22
Identities = 41/215 (19%), Positives = 77/215 (35%), Gaps = 31/215 (14%)
Query: 662 YSLSSSGNLLFYDFME---NGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCS 718
SS + Y M+ +L D ++ + + L I + A+ + +LH S
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---S 182
Query: 719 PRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIM-----------GTIGY 767
++HRD+K SNI D + DFG+ ++ + + GT Y
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 768 IDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPE 827
+ PE + + K D++S G++L ELL + +
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--------RVRIITDVRNLKFPLL 294
Query: 828 ISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
+ + + + S PT+RP ++
Sbjct: 295 FTQKYPQEHMM-----VQDMLSPS-PTERPEATDI 323
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 3e-22
Identities = 69/316 (21%), Positives = 124/316 (39%), Gaps = 61/316 (19%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLKNCKP------VAIKRLYSHY-PQCLKEFETELETVGS 650
N+ IG GA V++ P VA+K L +F+ E +
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 651 IKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDIL--HGPTKKKKLDWDTR--------- 699
+ N+V L G L +++M G L + L P L
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 700 ----------LKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKS 749
L IA A G+AYL + +HRD+ + N L+ ++ + DFG++++
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRN 223
Query: 750 LCVSKSYTS-TYIMGTIGYI-----DPEYARTSRLTEKSDVYSFGIVLLELLT-GRK--- 799
+ Y++ Y I PE +R T +SDV+++G+VL E+ + G +
Sbjct: 224 I-----YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278
Query: 800 AVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTM 859
+ +E ++++ + ++ PE C +++ L LC + P DRP+
Sbjct: 279 GMAHEEVIYYVR-----DGNILAC--PE---NCPL-----ELYNLMRLCWSKLPADRPSF 323
Query: 860 HEVSRVLGSLVPAPEP 875
+ R+L + E
Sbjct: 324 CSIHRILQRMCERAEG 339
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 3e-22
Identities = 69/265 (26%), Positives = 108/265 (40%), Gaps = 34/265 (12%)
Query: 606 IGYGASSTVYKCVLKNCK-PVAIKRLYSHYPQCLKE-----FETELETVGSIKHRNLVSL 659
+G G VY K K +A+K L+ Q K E+E ++H N++ L
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 660 QGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSP 719
GY ++ L ++ G+++ L K K D A L+Y H S
Sbjct: 75 YGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCH---SK 128
Query: 720 RIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLT 779
R+IHRD+K N+LL E + DFG + S+ GT+ Y+ PE
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC---GTLDYLPPEMIEGRMHD 185
Query: 780 EKSDVYSFGIVLLELLTGRK--AVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGA 837
EK D++S G++ E L G+ + + I V T ++ +DL
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR------VEFTFPDFVTEGARDL-- 237
Query: 838 VKKVFQLALLCSKRQPTDRPTMHEV 862
+ + LL K P+ RP + EV
Sbjct: 238 ISR-----LL--KHNPSQRPMLREV 255
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 5e-22
Identities = 48/301 (15%), Positives = 93/301 (30%), Gaps = 58/301 (19%)
Query: 594 MRMTENLSEKY----IIGYGASSTVYKCV-LKNCKPVAIKR--LYSHYPQCLKEFETELE 646
M M + ++ IG G +V+KCV + AIKR + E+
Sbjct: 3 MGMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVY 62
Query: 647 TVGSI-KHRNLVSLQGYSLSSSGNLLFYDFME---NGSLWDILHGPTKKKK-LDWDTRLK 701
+ +H ++V Y + + + E GSL D + +
Sbjct: 63 AHAVLGQHSHVVR---YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD 119
Query: 702 IALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKD-------------------FEAHLT 742
+ L +GL Y+H S ++H D+K SNI + + +
Sbjct: 120 LLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIG 176
Query: 743 DFGIAKSLCVSKSYTSTYIMGTIGYIDPE-YARTSRLTEKSDVYSFGIVLLELLTGRKAV 801
D G + + G ++ E K+D+++ + ++
Sbjct: 177 DLGHVTRISSPQVEE-----GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP 231
Query: 802 DNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHE 861
N H + + + +S +L +K P RP+
Sbjct: 232 RNGDQWHEI------RQGRLPRIPQVLSQEFTEL--LKV-------MIHPDPERRPSAMA 276
Query: 862 V 862
+
Sbjct: 277 L 277
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 1e-21
Identities = 68/311 (21%), Positives = 118/311 (37%), Gaps = 54/311 (17%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLKNCK--------PVAIKRLY-SHYPQCLKEFETELETV 648
+ L +G GA V VA+K L + L + +E+E +
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 649 GSI-KHRNLVSLQGYSLSSSGNLLFYDFMENGSL-------------WDILHGPTKKKKL 694
I KH+N+++L G + ++ G+L + +++L
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 695 DWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSK 754
+ A A+G+ YL S + IHRD+ + N+L+ +D + DFG+A+ +
Sbjct: 189 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDI---- 241
Query: 755 SYTSTYIMGTIGYI-----DPEYARTSRLTEKSDVYSFGIVLLELLT-GRK---AVDNEC 805
+ Y T G + PE T +SDV+SFG++L E+ T G V E
Sbjct: 242 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301
Query: 806 NLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865
L M+ P C + +++ + C P+ RPT ++
Sbjct: 302 LFKLLK-----EGHRMDK--PS---NCTN-----ELYMMMRDCWHAVPSQRPTFKQLVED 346
Query: 866 LGSLVPAPEPQ 876
L +V Q
Sbjct: 347 LDRIVALTSNQ 357
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 97.0 bits (241), Expect = 1e-21
Identities = 37/231 (16%), Positives = 71/231 (30%), Gaps = 29/231 (12%)
Query: 593 IMRMTENLSEKYII----GYGASSTVYKCVLKNC------KPVAIKRLYSHYPQCLKEFE 642
+ S+ + G GA + VY+ + + +K P
Sbjct: 56 PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGT 115
Query: 643 TELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDIL--HGPTKKKKLDWDTRL 700
+E + + L +G++L + G+L + + + T +K + +
Sbjct: 116 QLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVI 175
Query: 701 KIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAH-----------LTDFG--IA 747
A+ + +H IIH D+K N +L F L D G I
Sbjct: 176 SFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSID 232
Query: 748 KSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGR 798
L + + T G+ E + D + + +L G
Sbjct: 233 MKLFPKGTIFTAKC-ETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-21
Identities = 62/311 (19%), Positives = 120/311 (38%), Gaps = 54/311 (17%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLKNCK--------PVAIKRLY-SHYPQCLKEFETELETV 648
+ L+ +G GA V VA+K L + L + +E+E +
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 649 GSI-KHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDIL-------------HGPTKKKKL 694
I KH+N+++L G + ++ G+L + L ++++
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 695 DWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSK 754
+ + A+G+ YL S + IHRD+ + N+L+ ++ + DFG+A+ +
Sbjct: 155 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDI---- 207
Query: 755 SYTSTYIMGTIGYI-----DPEYARTSRLTEKSDVYSFGIVLLELLT-GRK---AVDNEC 805
+ Y T G + PE T +SDV+SFG+++ E+ T G + E
Sbjct: 208 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267
Query: 806 NLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865
L M+ P C + +++ + C P+ RPT ++
Sbjct: 268 LFKLLK-----EGHRMDK--PA---NCTN-----ELYMMMRDCWHAVPSQRPTFKQLVED 312
Query: 866 LGSLVPAPEPQ 876
L ++ +
Sbjct: 313 LDRILTLTTNE 323
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 3e-21
Identities = 32/294 (10%), Positives = 72/294 (24%), Gaps = 57/294 (19%)
Query: 606 IGYGASSTVYKCV-LKNCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQG 661
G ++ + + VA+ + L+E + + I + +
Sbjct: 39 HGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV-- 96
Query: 662 YSLSSSGNLLFY--DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSP 719
+ + +++ GSL ++ ++ A H
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRA--- 148
Query: 720 RIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLT 779
+ S + + D + L
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYPATM----------------------------PDAN 180
Query: 780 EKSDVYSFGIVLLELLTGRKAVDNECNLHHL-ILSKTANNAVME--TVDPEISATCKDLG 836
+ D+ G L LL R + L + +E +D +I +
Sbjct: 181 PQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPF---QIS 237
Query: 837 AVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAPEPQKQPTSIPSALLSSA 890
AV A + R + ++ + + I A +S+A
Sbjct: 238 AV------AARSVQGDGGIRSAS-TLLNLMQQATAVADRTEVLGPIDEAPVSAA 284
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 3e-21
Identities = 58/204 (28%), Positives = 85/204 (41%), Gaps = 30/204 (14%)
Query: 285 TEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLE 344
T+KL L SNKL+ +TKL L LNDN+L +P
Sbjct: 39 TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAG------------------ 79
Query: 345 GPIPDNLSSCTNLNSLNVHGNKLNGTIPP-AFQRLESMTYLNLSLNNIRGPIPVEL-SRI 402
I L NL +L V NKL +P F +L ++ L L N ++ +P + +
Sbjct: 80 --IFKEL---KNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKS-LPPRVFDSL 132
Query: 403 GNLDTLDMSNNKISGSIPSPLGD-LEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHN 461
L L + N++ S+P + D L L +L L NQL G F L + + L +N
Sbjct: 133 TKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNN 191
Query: 462 HLTGVIPEELSQLQNMFSLRLDYN 485
L V L+ + L+L N
Sbjct: 192 QLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 52/205 (25%), Positives = 78/205 (38%), Gaps = 10/205 (4%)
Query: 93 DLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQL 152
+ S+D +L+ IP I + K LDL N+L + +L +L L L +N+L
Sbjct: 17 NKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKL 73
Query: 153 IGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDM-CQLSGLWYFDVRNNSLTGSIPQNI-GN 210
+L NL+ + N L L + QL L + N L S+P + +
Sbjct: 74 QTLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDS 131
Query: 211 CTSFQVLDLSYNQLSGEIPFNI--GFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSC 268
T L L YN+L +P + + L L NQL + L L L
Sbjct: 132 LTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDN 190
Query: 269 NMLSGPIPPILGNLSYTEKLYLHSN 293
N L +L + L L N
Sbjct: 191 NQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 53/210 (25%), Positives = 88/210 (41%), Gaps = 13/210 (6%)
Query: 114 DCS-SLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLR 172
C+ + S+D S +L IP +I + L L++N+L +L L++ L
Sbjct: 13 SCNNNKNSVDCSSKKL-TAIPSNIPA--DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLN 69
Query: 173 GNNLVGTLSPDMC-QLSGLWYFDVRNNSLTGSIPQNI-GNCTSFQVLDLSYNQLSGEIPF 230
N L TL + +L L V +N L ++P + + L L NQL +P
Sbjct: 70 DNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPP 126
Query: 231 NI--GFLQIATLSLQGNQLTGKIPS-VIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEK 287
+ ++ LSL N+L +P V + +L L L N L L+ +
Sbjct: 127 RVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKT 185
Query: 288 LYLHSNKLTGHIPPELGNMTKLHYLELNDN 317
L L +N+L ++ KL L+L +N
Sbjct: 186 LKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 26/97 (26%), Positives = 42/97 (43%), Gaps = 12/97 (12%)
Query: 395 IPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVM 454
IP + LD+ +NK+S L L L L+ N+L G F L+++
Sbjct: 35 IPA------DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLE 88
Query: 455 EIDLSHNHLTGV---IPEELSQLQNMFSLRLDYNNLS 488
+ ++ N L + + ++L L LRLD N L
Sbjct: 89 TLWVTDNKLQALPIGVFDQLVNLAE---LRLDRNQLK 122
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 4e-21
Identities = 75/296 (25%), Positives = 118/296 (39%), Gaps = 44/296 (14%)
Query: 590 YEDIMRMTENLSEKYII----GYGASSTVYKCVLKN-CKPVAIKRL--------YSHYPQ 636
+D + L ++YI+ G GA V + CK VAI+ + +
Sbjct: 123 VDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREAD 182
Query: 637 CLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWD-ILHGPTKKKKLD 695
ETE+E + + H ++ ++ + + ++ + ME G L+D + K+L
Sbjct: 183 PALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVL-ELMEGGELFDKV----VGNKRLK 237
Query: 696 WDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILL---DKDFEAHLTDFGIAKSLCV 752
T + YLH IIHRD+K N+LL ++D +TDFG +K +
Sbjct: 238 EATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-ILG 293
Query: 753 SKSYTSTYIMGTIGYIDPE---YARTSRLTEKSDVYSFGIVLLELLTGRK---AVDNECN 806
S T + GT Y+ PE T+ D +S G++L L+G + +
Sbjct: 294 ETSLMRT-LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS 352
Query: 807 LHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
L I S + V E+S DL VKK LL P R T E
Sbjct: 353 LKDQITS--GKYNFIPEVWAEVSEKALDL--VKK-----LLV--VDPKARFTTEEA 397
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 5e-21
Identities = 61/311 (19%), Positives = 119/311 (38%), Gaps = 54/311 (17%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLKNCK--------PVAIKRLYSHYPQC-LKEFETELETV 648
+ L+ +G G V VA+K L + L + +E+E +
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 649 GSI-KHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDIL-------------HGPTKKKKL 694
I KH+N+++L G + ++ G+L + L ++++
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 695 DWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSK 754
+ + A+G+ YL S + IHRD+ + N+L+ ++ + DFG+A+ +
Sbjct: 201 TFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDI---- 253
Query: 755 SYTSTYIMGTIGYI-----DPEYARTSRLTEKSDVYSFGIVLLELLT-GRK---AVDNEC 805
+ Y T G + PE T +SDV+SFG+++ E+ T G + E
Sbjct: 254 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 313
Query: 806 NLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865
L M+ P C + +++ + C P+ RPT ++
Sbjct: 314 LFKLLK-----EGHRMDK--PA---NCTN-----ELYMMMRDCWHAVPSQRPTFKQLVED 358
Query: 866 LGSLVPAPEPQ 876
L ++ +
Sbjct: 359 LDRILTLTTNE 369
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 5e-21
Identities = 58/295 (19%), Positives = 107/295 (36%), Gaps = 47/295 (15%)
Query: 605 IIGYGASSTVYKCVLKNC-KPVAIKRLY-SHYPQCLKEFETELETVGSIKHRNLVSL-QG 661
I+G GA++ V++ K AIK + + + E E + + H+N+V L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 662 YSLSSSGNL-LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPR 720
+++ + L +F GSL+ +L P+ L L + G+ +L
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENG 132
Query: 721 IIHRDVKSSNILLDKDFEAH----LTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTS 776
I+HR++K NI+ + LTDFG A+ L + + S Y GT Y+ P+ +
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--GTEEYLHPDMYERA 190
Query: 777 RL--------TEKSDVYSFGIVLLELLTGR------KAVDNECNLHHLILSKTANNAVME 822
L D++S G+ TG + + + I++ + A+
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISG 250
Query: 823 T---------------VDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
V +S + L + V L + +
Sbjct: 251 VQKAENGPIDWSGDMPVSCSLSRGLQVL--LTPVLANIL---EADQEKCWGFDQF 300
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 6e-21
Identities = 67/309 (21%), Positives = 125/309 (40%), Gaps = 59/309 (19%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLKNCK------PVAIKRLYSHYPQC-LKEFETELETVGS 650
+NL +G G V K + K VA+K L + L++ +E +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 651 IKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDIL---------------------HGPT 689
+ H +++ L G LL ++ + GSL L
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 690 KKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKS 749
++ L + A +QG+ YL +++HRD+ + NIL+ + + ++DFG+++
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRD 199
Query: 750 LCVSKSYTSTYIMGTIGYI-----DPEYARTSRLTEKSDVYSFGIVLLELLT-GRK---A 800
+ +Y+ + G I E T +SDV+SFG++L E++T G
Sbjct: 200 V----YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255
Query: 801 VDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMH 860
+ E + L ME P+ C + ++++L L C K++P RP
Sbjct: 256 IPPERLFNLLK-----TGHRMER--PD---NCSE-----EMYRLMLQCWKQEPDKRPVFA 300
Query: 861 EVSRVLGSL 869
++S+ L +
Sbjct: 301 DISKDLEKM 309
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 9e-21
Identities = 70/310 (22%), Positives = 113/310 (36%), Gaps = 40/310 (12%)
Query: 569 KPVNYSTPKLVILHMNMALHVYEDIMRMTENLSEKY----IIGYGASSTVYKCVLKNC-K 623
+ S + + ++ I +LSE Y +G GA V C K
Sbjct: 4 HHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHV 63
Query: 624 PVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSL 681
AIK + + E+ + + H N++ L + L + + G L
Sbjct: 64 ERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL 123
Query: 682 WD-ILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILL---DKDF 737
+D I+ + K + I G+ YLH I+HRD+K N+LL +KD
Sbjct: 124 FDEII----HRMKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDA 176
Query: 738 EAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTG 797
+ DFG++ K +GT YI PE R + EK DV+S G++L LL G
Sbjct: 177 LIKIVDFGLSAVFENQKKMKE--RLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAG 233
Query: 798 RK--AVDNECNLHHLILSKTANNAVMETVDPE---ISATCKDLGAVKKVFQLALLCSKRQ 852
+ + + PE +S KDL +K+ +L
Sbjct: 234 YPPFGGQTDQEILRKVE-----KGKYTFDSPEWKNVSEGAKDL--IKQ-----MLQ--FD 279
Query: 853 PTDRPTMHEV 862
R + +
Sbjct: 280 SQRRISAQQA 289
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 45/218 (20%), Positives = 84/218 (38%), Gaps = 19/218 (8%)
Query: 279 LGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNV 338
L+ K L +T + ++ + +++ + + + T+L +L++
Sbjct: 15 DPGLANAVKQNLGKQSVT-DLVS-QKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKELHL 70
Query: 339 ANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVE 398
++N + L T L L+V+ N+L L L L N +R
Sbjct: 71 SHNQISDL--SPLKDLTKLEELSVNRNRLKNLNGIPSACLS---RLFLDNNELRDTDS-- 123
Query: 399 LSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDL 458
L + NL+ L + NNK+ SI LG L L L+L N++T L+ V IDL
Sbjct: 124 LIHLKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDL 179
Query: 459 SHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDVMSLIN 496
+ + +L +++ + G +S
Sbjct: 180 TGQKCVNEPVKYQPELYITNTVK----DPDGRWISPYY 213
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 6e-17
Identities = 41/199 (20%), Positives = 83/199 (41%), Gaps = 18/199 (9%)
Query: 239 TLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGH 298
+L +T + S + + + + + + + + ++L+L N+++
Sbjct: 23 KQNLGKQSVT-DLVS-QKELSGVQNFNGDNSNIQS-LAG-MQFFTNLKELHLSHNQIS-D 77
Query: 299 IPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLN 358
+ P L ++TKL L +N N+L ++ + L L + NN L D+L NL
Sbjct: 78 LSP-LKDLTKLEELSVNRNRLK-NLNG-IPSAC-LSRLFLDNNELRDT--DSLIHLKNLE 131
Query: 359 SLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGS 418
L++ NKL +I L + L+L N I L+R+ ++ +D++ K
Sbjct: 132 ILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQKCV-- 185
Query: 419 IPSPLGDLEHLLKLNLSRN 437
P+ L N ++
Sbjct: 186 -NEPVKYQPELYITNTVKD 203
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 42/244 (17%), Positives = 86/244 (35%), Gaps = 19/244 (7%)
Query: 174 NNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIG 233
+ + PD L+ ++ S+T + + Q + + + +
Sbjct: 6 PTPINQVFPD-PGLANAVKQNLGKQSVTD--LVSQKELSGVQNFNGDNSNIQ-SLAGMQF 61
Query: 234 FLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSN 293
F + L L NQ++ + + L L L ++ N L L +L+L +N
Sbjct: 62 FTNLKELHLSHNQIS-DLSPLKDL-TKLEELSVNRNRLKNLNGIPSACL---SRLFLDNN 116
Query: 294 KLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSS 353
+L L ++ L L + +N+L I LG L+ L L++ N + L+
Sbjct: 117 ELR-DTDS-LIHLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEITN--TGGLTR 170
Query: 354 CTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPI-PVELSRIGNLDTLDMSN 412
+N +++ G K + + + N + I P +S G+ +
Sbjct: 171 LKKVNWIDLTGQKC---VNEPVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGCVLW 227
Query: 413 NKIS 416
Sbjct: 228 ELPV 231
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 5e-15
Identities = 37/158 (23%), Positives = 63/158 (39%), Gaps = 12/158 (7%)
Query: 350 NLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLD 409
N N+ + + + L + N +NI+ + NL L
Sbjct: 14 PDPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQSLAG--MQFFTNLKELH 69
Query: 410 MSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPE 469
+S+N+IS + SPL DL L +L+++RN+L L + L +N L +
Sbjct: 70 LSHNQIS-DL-SPLKDLTKLEELSVNRNRLKNLNGIPSACLS---RLFLDNNELRDT--D 122
Query: 470 ELSQLQNMFSLRLDYNNLSGDVMSLINCLSLSVLFIGN 507
L L+N+ L + N L ++ L L VL +
Sbjct: 123 SLIHLKNLEILSIRNNKLK-SIVMLGFLSKLEVLDLHG 159
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 7e-15
Identities = 38/238 (15%), Positives = 82/238 (34%), Gaps = 17/238 (7%)
Query: 83 EISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQL 142
++ P L + +L ++ + + S +++ + + + + + L
Sbjct: 11 QVFP-DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNI-QSLA-GMQFFTNL 65
Query: 143 EFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTG 202
+ L L +NQ I + S L L L+ + N L LS L+ + NN L
Sbjct: 66 KELHLSHNQ-ISDL-SPLKDLTKLEELSVNRNRLKNLNGIPSACLSRLF---LDNNELRD 120
Query: 203 SIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALA 262
++ + + ++L + N+L I ++ L L GN++T + L + +
Sbjct: 121 --TDSLIHLKNLEILSIRNNKLK-SIVMLGFLSKLEVLDLHGNEIT-NTGGLTRL-KKVN 175
Query: 263 VLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLT 320
+DL+ L T + + P + N +
Sbjct: 176 WIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWIS--PYYISNGGSYVDGCVLWELPV 231
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 39/134 (29%), Positives = 60/134 (44%), Gaps = 18/134 (13%)
Query: 74 NLSGLNLDG----EISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELY 129
NL L+L ++SP + DL L+ + + NRL + + L L L NEL
Sbjct: 64 NLKELHLSHNQISDLSP-LKDLTKLEELSVNRNRLK-NL--NGIPSACLSRLFLDNNELR 119
Query: 130 GDIPFSISKLKQLEFLILKNNQL--IGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQL 187
D S+ LK LE L ++NN+L I L L L+V L GN + T + + +L
Sbjct: 120 -DTD-SLIHLKNLEILSIRNNKLKSIVM----LGFLSKLEVLDLHGNEI--TNTGGLTRL 171
Query: 188 SGLWYFDVRNNSLT 201
+ + D+
Sbjct: 172 KKVNWIDLTGQKCV 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 6e-07
Identities = 18/97 (18%), Positives = 38/97 (39%), Gaps = 7/97 (7%)
Query: 411 SNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEE 470
I+ + P L + +K NL + +T + L V + ++++ +
Sbjct: 5 RPTPIN-QV-FPDPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQSL--AG 58
Query: 471 LSQLQNMFSLRLDYNNLSGDVMSLINCLSLSVLFIGN 507
+ N+ L L +N +S D+ L + L L +
Sbjct: 59 MQFFTNLKELHLSHNQIS-DLSPLKDLTKLEELSVNR 94
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-20
Identities = 88/465 (18%), Positives = 152/465 (32%), Gaps = 80/465 (17%)
Query: 116 SSLKSLDLSFNELYGDIPFS--ISKLKQLEFLILKNNQL----IGPIPSTLSQLPNLKVF 169
++SLD+ EL D ++ + L+Q + + L + L I S L P L
Sbjct: 3 LDIQSLDIQCEEL-SDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 61
Query: 170 GLRGNN--------LVGTLSPDMCQLSGLWYFDVRNNSLT----GSIPQNIGNCTSFQVL 217
LR N ++ L C++ L ++N LT G + + + Q L
Sbjct: 62 NLRSNELGDVGVHCVLQGLQTPSCKIQKL---SLQNCCLTGAGCGVLSSTLRTLPTLQEL 118
Query: 218 DLSYNQLSGEIPFNIGFLQIA-----------TLSLQGNQLTGK----IPSVIGLMQALA 262
LS N L G + L L+ L+ + SV+
Sbjct: 119 HLSDNLLGDA-----GLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFK 173
Query: 263 VLDLSCNMLSGP----IPPILGNLSYT-EKLYLHSNKLT----GHIPPELGNMTKLHYLE 313
L +S N ++ + L + E L L S +T + + + L L
Sbjct: 174 ELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELA 233
Query: 314 LNDNQLTG----HIPPALGK-LTDLFDLNVANNHLEGP----IPDNLSSCTNLNSLNVHG 364
L N+L + P L + L L + + + L + +L L++ G
Sbjct: 234 LGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAG 293
Query: 365 NKLNGT-----IPPAFQRLESMTYLNLSLNNIRGPIPVE-----LSRIGNLDTLDMSNNK 414
N+L + + L + + L++ L L +SNN+
Sbjct: 294 NELGDEGARLLCETLLEPGCQLESLWVKSCSF-TAACCSHFSSVLAQNRFLLELQISNNR 352
Query: 415 ISGSIPSPLGD-LEH----LLKLNLSRNQLT----GFIPGEFGNLRSVMEIDLSHNHLTG 465
+ + L L L L L+ ++ + S+ E+DLS+N L
Sbjct: 353 LEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD 412
Query: 466 VIPEELSQLQNMFSLRLDYNNLSGDVMSLINCLSLSVLFIGNPGL 510
+L + L+ L S L L P L
Sbjct: 413 AGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSL 457
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 9e-16
Identities = 68/376 (18%), Positives = 123/376 (32%), Gaps = 75/376 (19%)
Query: 94 LQSIDLRGNRLSGQ----IPDEIGDCSSLKSLDLSFNELYGDIPFSI------SKLKQLE 143
+Q + L+ L+G + + +L+ L LS N L GD + +LE
Sbjct: 87 IQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLL-GDAGLQLLCEGLLDPQCRLE 145
Query: 144 FLILKNNQL----IGPIPSTLSQLPNLKVFGLRGNN--------LVGTLSPDMCQLSGLW 191
L L+ L P+ S L P+ K + N+ L L CQL L
Sbjct: 146 KLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEAL- 204
Query: 192 YFDVRNNSLT----GSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQL 247
+ + +T + + + S + L L N+L G ++ L +
Sbjct: 205 --KLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV-----GMAELCPGLLHPS-- 255
Query: 248 TGKIPSVIGLMQALAVLDLSCNMLSGP----IPPILGNLSYTEKLYLHSNKLTGHIPPEL 303
L L + ++ + +L ++L L N+L L
Sbjct: 256 -----------SRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLL 304
Query: 304 GNM-----TKLHYLELNDNQLTG----HIPPALGKLTDLFDLNVANNHLEGP----IPDN 350
+L L + T H L + L +L ++NN LE +
Sbjct: 305 CETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQG 364
Query: 351 LSSC-TNLNSLNVHGNKLN----GTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRI--- 402
L + L L + ++ ++ S+ L+LS N + ++L
Sbjct: 365 LGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQ 424
Query: 403 --GNLDTLDMSNNKIS 416
L+ L + + S
Sbjct: 425 PGCLLEQLVLYDIYWS 440
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 2e-07
Identities = 45/258 (17%), Positives = 84/258 (32%), Gaps = 47/258 (18%)
Query: 307 TKLHYLELNDNQLT-GHIPPALGKLTDLFDLNVANNHL--EG--PIPDNLSSCTNLNSLN 361
+ L++ +L+ L L + + + L I L L LN
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 362 VHGNKLNGTIPPAFQRLESM--------TYLNLSLNNIR----GPIPVELSRIGNLDTLD 409
+ N+L + L+L + G + L + L L
Sbjct: 63 LRSNELG---DVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELH 119
Query: 410 MSNNKISGSIPSPLGDLE-----HLLKLNLSRNQLT----GFIPGEFGNLRSVMEIDLSH 460
+S+N + + L + L KL L L+ + E+ +S+
Sbjct: 120 LSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSN 179
Query: 461 NHL--TGV--IPEELSQLQ-NMFSLRLDYNNLSGDVMS-----LINCLSLSVL-----FI 505
N + GV + + L + +L+L+ ++ D + + SL L +
Sbjct: 180 NDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKL 239
Query: 506 GNPG---LCGYWLHSACR 520
G+ G LC LH + R
Sbjct: 240 GDVGMAELCPGLLHPSSR 257
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 2e-20
Identities = 65/289 (22%), Positives = 118/289 (40%), Gaps = 45/289 (15%)
Query: 593 IMRMTENLSEKY----IIGYGASSTVYKCVLKN------CKPVAIKRLYSHYPQCLKEFE 642
+ T S++Y ++G G+ V C K K ++ +++ +
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQ--KTDKESLL 74
Query: 643 TELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWD-ILHGPTKKKKLDWDTRLK 701
E++ + + H N++ L + L + G L+D I+ +K+ +
Sbjct: 75 REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII----SRKRFSEVDAAR 130
Query: 702 IALGAAQGLAYLHHDCSPRIIHRDVKSSNILL-DKDFEAHL--TDFGIAKSLCVSKSYTS 758
I G+ Y+H +I+HRD+K N+LL K +A++ DFG++ SK
Sbjct: 131 IIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD 187
Query: 759 TYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRK--AVDNECNLHHLILSKTA 816
+GT YI PE EK DV+S G++L LL+G NE ++ +
Sbjct: 188 --KIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVE---- 240
Query: 817 NNAVMETVDPE---ISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
P+ +S + KDL ++K +L P+ R + +
Sbjct: 241 -KGKYTFELPQWKKVSESAKDL--IRK-----MLT--YVPSMRISARDA 279
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 66/311 (21%), Positives = 115/311 (36%), Gaps = 53/311 (17%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLKNCK------PVAIKRLY-SHYPQCLKEFETELETVGS 650
LS +G GA V + VA+K L S + + +EL+ +
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 651 I-KHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDIL---------------HGPTKKKKL 694
+ H N+V+L G L+ ++ G L + L + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 695 DWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSK 754
D + L + A+G+A+L S IHRD+ + NILL + DFG+A+ +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDI---- 195
Query: 755 SYTSTYIMGTIGYI-----DPEYARTSRLTEKSDVYSFGIVLLELLT-GRK---AVDNEC 805
S Y++ + PE T +SDV+S+GI L EL + G + +
Sbjct: 196 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255
Query: 806 NLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865
+ +I M + PE +++ + C P RPT ++ ++
Sbjct: 256 KFYKMIKE----GFRMLS--PE---HAPA-----EMYDIMKTCWDADPLKRPTFKQIVQL 301
Query: 866 LGSLVPAPEPQ 876
+ +
Sbjct: 302 IEKQISESTNH 312
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 3e-20
Identities = 66/310 (21%), Positives = 112/310 (36%), Gaps = 53/310 (17%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLK------NCKPVAIKRLY-SHYPQCLKEFETELETVGS 650
NL +G GA V + VA+K L + + + +EL+ +
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 651 I-KHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDIL-----------HGPTKKKKLDWDT 698
+ +H N+V+L G L+ ++ G L + L
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 699 RLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTS 758
L + AQG+A+L S IHRDV + N+LL A + DFG+A+ + S
Sbjct: 166 LLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI----MNDS 218
Query: 759 TYIMGTIGYI-----DPEYARTSRLTEKSDVYSFGIVLLELLT-GR-----KAVDNECNL 807
YI+ + PE T +SDV+S+GI+L E+ + G V+++
Sbjct: 219 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK--- 275
Query: 808 HHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLG 867
+ M P ++ + C +PT RPT ++ L
Sbjct: 276 ---FYKLVKDGYQMAQ--PA---FAPK-----NIYSIMQACWALEPTHRPTFQQICSFLQ 322
Query: 868 SLVPAPEPQK 877
++
Sbjct: 323 EQAQEDRRER 332
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 3e-20
Identities = 42/231 (18%), Positives = 82/231 (35%), Gaps = 19/231 (8%)
Query: 264 LDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPE-LGNMTKLHYLELNDNQLTGH 322
++C + IP + + T+ L L L IP N+ + + ++ +
Sbjct: 16 FRVTCKDIQR-IPSLPPS---TQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQ 70
Query: 323 IPP-ALGKLTDLFDLNVANNHLEGPIPDN-LSSCTNLNSLNVHGNKLNGTIPP--AFQRL 378
+ + L+ + + + N I + L L L + L P
Sbjct: 71 LESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYST 129
Query: 379 ESMTYLNLSLNNIRGPIPVEL--SRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSR 436
+ L ++ N IPV TL + NN + S+ + L + L++
Sbjct: 130 DIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNK 188
Query: 437 NQ-LTGFIPGEFGNLRSVMEI-DLSHNHLTGVIPEELSQLQNMFSLRLDYN 485
N+ LT FG + S + D+S +T +P + L+++ L
Sbjct: 189 NKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKG--LEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-17
Identities = 43/222 (19%), Positives = 77/222 (34%), Gaps = 19/222 (8%)
Query: 182 PDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFN--IGFLQIAT 239
C+ F V + IP S Q L L L IP + I+
Sbjct: 5 SPPCECHQEEDFRVTCKDIQ-RIPSLP---PSTQTLKLIETHLR-TIPSHAFSNLPNISR 59
Query: 240 LSLQGNQLTGKIPSVI--GLMQALAVLDLSCNMLSGPIPP-ILGNLSYTEKLYLHSNKLT 296
+ + + ++ S L + +++ I P L L + L + + L
Sbjct: 60 IYVSIDVTLQQLESHSFYNL-SKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK 118
Query: 297 GHIPPE--LGNMTKLHYLELNDNQLTGHIPP-ALGKLT-DLFDLNVANNHLEGPIPDNLS 352
P + + LE+ DN IP A L + L + NN +
Sbjct: 119 -MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTS-VQGYAF 176
Query: 353 SCTNLNSLNVHGNKLNGTIPP-AFQRLES-MTYLNLSLNNIR 392
+ T L+++ ++ NK I AF + S + L++S ++
Sbjct: 177 NGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT 218
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 37/212 (17%), Positives = 80/212 (37%), Gaps = 18/212 (8%)
Query: 93 DLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSI-SKLKQLEFLILKNNQ 151
Q++ L L + ++ + +S + + L ++ + ++N +
Sbjct: 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91
Query: 152 LIGPIPS-TLSQLPNLKVFGLRGNNLVGTLSPDMCQLSG---LWYFDVRNNSLTGSIPQN 207
+ I L +LP LK G+ L + PD+ ++ + ++ +N SIP N
Sbjct: 92 NLTYIDPDALKELPLLKFLGIFNTGL--KMFPDLTKVYSTDIFFILEITDNPYMTSIPVN 149
Query: 208 I--GNCTSFQVLDLSYNQLSGEIPFNIGF--LQIATLSLQGNQLTGKIPSVI--GLMQAL 261
G C L L N + + F ++ + L N+ I G+
Sbjct: 150 AFQGLCNETLTLKLYNNGFT-SVQGYA-FNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGP 207
Query: 262 AVLDLSCNMLSGPIPPILGNLSYTEKLYLHSN 293
++LD+S ++ +P L + ++L +
Sbjct: 208 SLLDVSQTSVTA-LPS--KGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 29/181 (16%), Positives = 58/181 (32%), Gaps = 12/181 (6%)
Query: 73 LNLSGLNLDGEISPAV-GDLKDLQSIDLRGNRLSGQIPDEI-GDCSSLKSLDLSFNELYG 130
+ +S ++ +L + I++R R I + + LK L + L
Sbjct: 60 IYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGL-K 118
Query: 131 DIP--FSISKLKQLEFLILKNNQLIGPIPS-TLSQLPN-LKVFGLRGNNLVGTLSPDMCQ 186
P + L + +N + IP L N L N ++
Sbjct: 119 MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGF-TSVQGYAFN 177
Query: 187 LSGLWYFDVRNNSLTGSIPQNI--GNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQG 244
+ L + N I ++ G + +LD+S ++ +P G + L +
Sbjct: 178 GTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSK-GLEHLKELIARN 235
Query: 245 N 245
Sbjct: 236 T 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 3e-07
Identities = 20/88 (22%), Positives = 40/88 (45%), Gaps = 4/88 (4%)
Query: 404 NLDTLDMSNNKISGSIPSP-LGDLEHLLKLNLSRN-QLTGFIPGEFGNLRSVMEIDLSHN 461
+ TL + + +IPS +L ++ ++ +S + L F NL V I++ +
Sbjct: 32 STQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNT 90
Query: 462 -HLTGVIPEELSQLQNMFSLRLDYNNLS 488
+LT + P+ L +L + L + L
Sbjct: 91 RNLTYIDPDALKELPLLKFLGIFNTGLK 118
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 14/84 (16%), Positives = 26/84 (30%), Gaps = 5/84 (5%)
Query: 404 NLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHN-H 462
+ ++ I IPS + L L L F NL ++ I +S +
Sbjct: 12 QEEDFRVTCKDIQ-RIPSLPPSTQTL---KLIETHLRTIPSHAFSNLPNISRIYVSIDVT 67
Query: 463 LTGVIPEELSQLQNMFSLRLDYNN 486
L + L + + +
Sbjct: 68 LQQLESHSFYNLSKVTHIEIRNTR 91
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 3e-20
Identities = 69/303 (22%), Positives = 108/303 (35%), Gaps = 63/303 (20%)
Query: 593 IMRMTENLSEKYII----GYGASSTVYKCVLK-NCKPVAIKRL-------------YSHY 634
+ + + E Y G GA V C K AIK + +
Sbjct: 27 VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86
Query: 635 PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWD-ILHGPTKKKK 693
+ +E E+ + S+ H N++ L L +F E G L++ I+ + K
Sbjct: 87 EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQII----NRHK 142
Query: 694 LDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILL-DKDFEAHL--TDFGIAKSL 750
D I G+ YLH I+HRD+K NILL +K+ ++ DFG++
Sbjct: 143 FDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF 199
Query: 751 CVSKSYTSTYIMGTIGYIDPE-----YARTSRLTEKSDVYSFGIVLLELLTGR---KAVD 802
+GT YI PE Y EK DV+S G+++ LL G
Sbjct: 200 SKDYKLRD--RLGTAYYIAPEVLKKKY------NEKCDVWSCGVIMYILLCGYPPFGG-Q 250
Query: 803 NECNLHHLILSKTANNAVMETVDPE---ISATCKDLGAVKKVFQLALLCSKRQPTDRPTM 859
N+ ++ + + IS K+L +K +L R T
Sbjct: 251 NDQDIIKKVE-----KGKYYFDFNDWKNISDEAKEL--IKL-----MLT--YDYNKRCTA 296
Query: 860 HEV 862
E
Sbjct: 297 EEA 299
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 5e-20
Identities = 67/291 (23%), Positives = 112/291 (38%), Gaps = 50/291 (17%)
Query: 597 TENLSEKY----IIGYGASSTVYKCVLKN------CKPVAIKRLYSHYPQCLKEFETELE 646
+ Y +IG G S V +C+ + K V + + S ++ + E
Sbjct: 19 DVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREAS 78
Query: 647 TVGSIKHRNLVSLQGYSLSSSGNL-LFYDFMENGSLWDILHGPTKKKKLDW-----DTR- 699
+KH ++V L SS G L + ++FM+ L + K+ +
Sbjct: 79 ICHMLKHPHIVELLET-YSSDGMLYMVFEFMDGADLCFEI---VKRADAGFVYSEAVASH 134
Query: 700 -LKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILL---DKDFEAHLTDFGIAKSLCVSKS 755
++ L A L Y H IIHRDVK +LL + L FG+A L S
Sbjct: 135 YMRQILEA---LRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL 188
Query: 756 YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKA-VDNECNLHHLILSK 814
+GT ++ PE + + DV+ G++L LL+G + L I+
Sbjct: 189 VAGG-RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIK- 246
Query: 815 TANNAVMETVDPE---ISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
+ + IS + KDL V++ +L P +R T++E
Sbjct: 247 ----GKYKMNPRQWSHISESAKDL--VRR-----MLM--LDPAERITVYEA 284
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 6e-20
Identities = 51/211 (24%), Positives = 84/211 (39%), Gaps = 23/211 (10%)
Query: 605 IIGYGASSTVYKCVLKNC-KPVAIKRLY-SHYPQCLKEFETELETVGSIKHRNLVSLQGY 662
I+G GA++ V++ K AIK + + + E E + + H+N+V L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 663 SLSSSGNLLFYDFME---NGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSP 719
+ ME GSL+ +L P+ L L + G+ +L
Sbjct: 76 -EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---EN 131
Query: 720 RIIHRDVKSSNILLDKDFEAH----LTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYART 775
I+HR++K NI+ + LTDFG A+ L + + S Y GT Y+ P+
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--GTEEYLHPDMYER 189
Query: 776 SRL--------TEKSDVYSFGIVLLELLTGR 798
+ L D++S G+ TG
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 7e-20
Identities = 54/326 (16%), Positives = 94/326 (28%), Gaps = 74/326 (22%)
Query: 595 RMTENLSEKYII----GYGASSTVYKCVLKN------CKPVAIKRLYSHYPQCLKEFETE 644
L +KY + G G+ V + K + ++ P+ ++ +TE
Sbjct: 19 GSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTE 78
Query: 645 LETVGSIKHRNLVSLQGYSLSSSGNL-LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIA 703
+ + + H N+ L + L + G L D L+ +
Sbjct: 79 VRLMKKLHHPNIARLYEV-YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKT 137
Query: 704 LGAA-------------------------------------QGLAYLHHDCSPRIIHRDV 726
L YLH + I HRD+
Sbjct: 138 QICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDI 194
Query: 727 KSSNILLDKDFEAHL--TDFGIAKSLCVSKSYTSTYIM---GTIGYIDPE--YARTSRLT 779
K N L + + DFG++K + + GT ++ PE
Sbjct: 195 KPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYG 254
Query: 780 EKSDVYSFGIVLLELLTGR---KAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLG 836
K D +S G++L LL G N+ + +L+ +S +DL
Sbjct: 255 PKCDAWSAGVLLHLLLMGAVPFPG-VNDADTISQVLN--KKLCFENPNYNVLSPLARDL- 310
Query: 837 AVKKVFQLALLCSKRQPTDRPTMHEV 862
+ LL R +R
Sbjct: 311 -LSN-----LLN--RNVDERFDAMRA 328
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 7e-20
Identities = 59/298 (19%), Positives = 107/298 (35%), Gaps = 57/298 (19%)
Query: 606 IGYGASSTVYKCVLKNCKPVAIKRLY-----------------SHYPQCLKEFETELETV 648
+ G + + C K+ K A+K+ +F+ EL+ +
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 649 GSIKHRNLVSLQGYSLSSSGNL-LFYDFMENGSLWDILH-----GPTKKKKLDWDTRLKI 702
IK+ ++ +G +++ + + Y++MEN S+ + I
Sbjct: 98 TDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 703 ALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIM 762
+Y+H++ I HRDVK SNIL+DK+ L+DFG ++ + K S
Sbjct: 157 IKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS---R 211
Query: 763 GTIGYIDPE--YARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHL---------- 810
GT ++ PE +S K D++S GI L + + +L L
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIE 271
Query: 811 ------ILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
N + +S D +K L ++ P +R T +
Sbjct: 272 YPLDRNHFLYPLTNKKSTCSNNFLSNEDIDF--LKL-----FL--RKNPAERITSEDA 320
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 67/292 (22%), Positives = 119/292 (40%), Gaps = 54/292 (18%)
Query: 597 TENLSEKYII----GYGASSTVYKCVLKN------CKPVAIKRL-YSHYPQCLKEFETEL 645
+ + + Y I G G + V KC K+ K + ++ S +E E E+
Sbjct: 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66
Query: 646 ETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALG 705
+ + H N+++L + + +L + + G L+D L +K+ L + +
Sbjct: 67 SILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL---AQKESL---SEEEATSF 120
Query: 706 AAQ---GLAYLHHDCSPRIIHRDVKSSNILL-DKDFEAH---LTDFGIAKSLCVSKSYTS 758
Q G+ YLH + +I H D+K NI+L DK+ L DFG+A + + +
Sbjct: 121 IKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN 177
Query: 759 TYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRK--AVDNECNLHHLILSKTA 816
I GT ++ PE L ++D++S G++ LL+G D + +T
Sbjct: 178 --IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------QETL 227
Query: 817 NNAVMETVD------PEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
N + D S KD ++K LL ++ R T+ E
Sbjct: 228 ANITSVSYDFDEEFFSHTSELAKDF--IRK-----LLV--KETRKRLTIQEA 270
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 1e-19
Identities = 68/292 (23%), Positives = 121/292 (41%), Gaps = 54/292 (18%)
Query: 597 TENLSEKYII----GYGASSTVYKCVLKN------CKPVAIKRL-YSHYPQCLKEFETEL 645
+ + + Y I G G + V KC K+ K + ++ S C +E E E+
Sbjct: 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREV 66
Query: 646 ETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALG 705
+ + H N+++L + + +L + + G L+D L +K+ L + +
Sbjct: 67 SILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL---AQKESL---SEEEATSF 120
Query: 706 AAQ---GLAYLHHDCSPRIIHRDVKSSNILL-DKDFEAH---LTDFGIAKSLCVSKSYTS 758
Q G+ YLH + +I H D+K NI+L DK+ L DFG+A + + +
Sbjct: 121 IKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN 177
Query: 759 TYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRK--AVDNECNLHHLILSKTA 816
I GT ++ PE L ++D++S G++ LL+G D + +T
Sbjct: 178 --IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------QETL 227
Query: 817 NNAVMETVD------PEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
N + D + S KD ++K LL ++ R T+ E
Sbjct: 228 ANITAVSYDFDEEFFSQTSELAKDF--IRK-----LLV--KETRKRLTIQEA 270
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 1e-19
Identities = 60/200 (30%), Positives = 92/200 (46%), Gaps = 20/200 (10%)
Query: 606 IGYGASSTVYKCV-LKNCKPVAIKRLYSHYPQC---LKEFETELETVGSIKHRNLVSLQG 661
IG+G+ VY ++N + VAIK++ Q ++ E+ + ++H N + +G
Sbjct: 62 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 662 YSLSSSGNL-LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPR 720
L ++ GS D+L KK L + GA QGLAYLH S
Sbjct: 122 -CYLREHTAWLVMEYCL-GSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLH---SHN 174
Query: 721 IIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPE---YARTSR 777
+IHRDVK+ NILL + L DFG A + + + + +GT ++ PE +
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFGSASIM--APANS---FVGTPYWMAPEVILAMDEGQ 229
Query: 778 LTEKSDVYSFGIVLLELLTG 797
K DV+S GI +EL
Sbjct: 230 YDGKVDVWSLGITCIELAER 249
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 92.4 bits (229), Expect = 3e-19
Identities = 52/205 (25%), Positives = 84/205 (40%), Gaps = 16/205 (7%)
Query: 605 IIGYGASSTVYKCV-LKNCKPVAIKRLYSH-YPQCLKEFETELETVGSIKHRNLVSL--- 659
+G G V + + + VAIK+ P+ + + E++ + + H N+VS
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 660 ---QGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHD 716
+ LL ++ E G L L+ L + + L YLH
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH-- 138
Query: 717 CSPRIIHRDVKSSNILLDKDFEAH---LTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYA 773
RIIHRD+K NI+L + + D G AK L + ++ GT+ Y+ PE
Sbjct: 139 -ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEFV-GTLQYLAPELL 195
Query: 774 RTSRLTEKSDVYSFGIVLLELLTGR 798
+ T D +SFG + E +TG
Sbjct: 196 EQKKYTVTVDYWSFGTLAFECITGF 220
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 78/295 (26%), Positives = 118/295 (40%), Gaps = 50/295 (16%)
Query: 595 RMTENLSEKY----IIGYGASSTVYKCVLKN------CKPVAIKRLYSHYPQCLKEFETE 644
T E Y I+G G SS V +C+ K K + + S + ++E
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 645 LETVGSI-----KHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLD-WDT 698
I H N++ L+ +++ L +D M+ G L+D L T+K L +T
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKET 126
Query: 699 RLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTS 758
R KI + + LH I+HRD+K NILLD D LTDFG + L +
Sbjct: 127 R-KIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE 182
Query: 759 TYIMGTIGYIDPE------YARTSRLTEKSDVYSFGIVLLELLTGRK--AVDNECNLHHL 810
+ GT Y+ PE ++ D++S G+++ LL G + + +
Sbjct: 183 --VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM 240
Query: 811 ILSKTANNAVMETVDPE---ISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
I+S + PE S T KDL V + L QP R T E
Sbjct: 241 IMS-----GNYQFGSPEWDDYSDTVKDL--VSR-----FLV--VQPQKRYTAEEA 281
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 5e-19
Identities = 70/265 (26%), Positives = 104/265 (39%), Gaps = 40/265 (15%)
Query: 605 IIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFE---TELETVGSIKHRNLVSLQ 660
I+G G+ STV + AIK L + + E + + + H V L
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 96
Query: 661 GYSLSSSGNLLF-YDFMENGSLWDILHGPTKKKKLDWD-TRLKIA-LGAAQGLAYLHHDC 717
++ L F + +NG L + K D TR A + +A L YLH
Sbjct: 97 -FTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSA--LEYLH--- 147
Query: 718 SPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIM-GTIGYIDPEYARTS 776
IIHRD+K NILL++D +TDFG AK L GT Y+ PE
Sbjct: 148 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 207
Query: 777 RLTEKSDVYSFGIVLLELLTGR---KAVDNECNLHHLILSKTANNAVMETVD--PEISAT 831
+ SD+++ G ++ +L+ G +A NE + I+ D +
Sbjct: 208 SACKSSDLWALGCIIYQLVAGLPPFRA-GNEYLIFQKIIK--------LEYDFPEKFFPK 258
Query: 832 CKDLGAVKKVFQLALLCSKRQPTDR 856
+DL V+K LL T R
Sbjct: 259 ARDL--VEK-----LL--VLDATKR 274
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 5e-19
Identities = 63/314 (20%), Positives = 112/314 (35%), Gaps = 58/314 (18%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLKN------CKPVAIKRLY-SHYPQCLKEFETELETVGS 650
ENL ++G GA V VA+K L + +EL+ +
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 651 I-KHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDIL--HGPTKKKKLDWDTR-------- 699
+ H N+V+L G S L +++ G L + L +
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 700 ----------LKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKS 749
L A A+G+ +L +HRD+ + N+L+ + DFG+A+
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARD 221
Query: 750 LCVSKSYTSTYIMGTIGYI-----DPEYARTSRLTEKSDVYSFGIVLLELLT-GRK---A 800
+ S Y++ + PE T KSDV+S+GI+L E+ + G
Sbjct: 222 I----MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277
Query: 801 VDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMH 860
+ + N + LI + M+ P + +++ + C RP+
Sbjct: 278 IPVDANFYKLIQN----GFKMDQ--PF---YATE-----EIYIIMQSCWAFDSRKRPSFP 323
Query: 861 EVSRVLGSLVPAPE 874
++ LG + E
Sbjct: 324 NLTSFLGCQLADAE 337
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 5e-19
Identities = 68/292 (23%), Positives = 120/292 (41%), Gaps = 54/292 (18%)
Query: 597 TENLSEKYII----GYGASSTVYKCVLKN------CKPVAIKRL-YSHYPQCLKEFETEL 645
EN+ + Y G G + V KC K+ K + +R S ++ E E+
Sbjct: 6 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 646 ETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALG 705
+ I+H N+++L + + +L + + G L+D L +K+ L T +
Sbjct: 66 SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESL---TEEEATEF 119
Query: 706 AAQ---GLAYLHHDCSPRIIHRDVKSSNILL-DKDFEAH---LTDFGIAKSLCVSKSYTS 758
Q G+ YLH S +I H D+K NI+L D++ + DFG+A + + +
Sbjct: 120 LKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 176
Query: 759 TYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRK--AVDNECNLHHLILSKTA 816
I GT ++ PE L ++D++S G++ LL+G D + +T
Sbjct: 177 --IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------QETL 226
Query: 817 NNAVMETVD------PEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
N + SA KD +++ LL + P R T+ +
Sbjct: 227 ANVSAVNYEFEDEYFSNTSALAKDF--IRR-----LLV--KDPKKRMTIQDS 269
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 7e-19
Identities = 69/283 (24%), Positives = 112/283 (39%), Gaps = 40/283 (14%)
Query: 595 RMTENLSEKY----IIGYGASSTVYKCVLKN-CKPVAIKRLYSHYPQCLKEFETELETVG 649
T N+ + + ++G GA S V+ + K A+K + E E+ +
Sbjct: 2 MQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLK 61
Query: 650 SIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWD-ILHGPTKKKKL-DWDTRLKIALGAA 707
IKH N+V+L+ S++ L + G L+D IL ++ + D +
Sbjct: 62 KIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRIL----ERGVYTEKDAS-LVIQQVL 116
Query: 708 QGLAYLHHDCSPRIIHRDVKSSNILL-DKDFEAHL--TDFGIAKSLCVSKSYTSTYIMGT 764
+ YLH I+HRD+K N+L + + + TDFG++K ST GT
Sbjct: 117 SAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK--MEQNGIMST-ACGT 170
Query: 765 IGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRK--AVDNECNLHHLILSKTANNAVME 822
GY+ PE ++ D +S G++ LL G + E L I E
Sbjct: 171 PGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIK-----EGYYE 225
Query: 823 TVDPE---ISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
P IS + KD + LL + P +R T +
Sbjct: 226 FESPFWDDISESAKDF--ICH-----LLE--KDPNERYTCEKA 259
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 65/263 (24%), Positives = 101/263 (38%), Gaps = 30/263 (11%)
Query: 606 IGYGASSTVYKCVLKNCK-PVAIKRLY-SHYPQC--LKEFETELETVGSIKHRNLVSLQG 661
+G G VY K K +A+K L+ S + + E+E ++H N++ +
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 662 YSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRI 721
Y L +F G L+ L K + D A L Y H ++
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFMEELADALHYCH---ERKV 135
Query: 722 IHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEK 781
IHRD+K N+L+ E + DFG + + T GT+ Y+ PE EK
Sbjct: 136 IHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC---GTLDYLPPEMIEGKTHDEK 192
Query: 782 SDVYSFGIVLLELLTGRKAVD--NECNLHHLILSKTANNAVMETVDPEISATCKDLGAVK 839
D++ G++ E L G D + H I++ V P +S KDL +
Sbjct: 193 VDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN------VDLKFPPFLSDGSKDL--IS 244
Query: 840 KVFQLALLCSKRQPTDRPTMHEV 862
K LL + P R + V
Sbjct: 245 K-----LL--RYHPPQRLPLKGV 260
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 71/290 (24%), Positives = 118/290 (40%), Gaps = 54/290 (18%)
Query: 599 NLSEKYII----GYGASSTVYKCVLKN------CKPVAIKRLYS-HYPQCLKEFETELET 647
+ + Y + G G + V KC K K + +RL S +E E E+
Sbjct: 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61
Query: 648 VGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAA 707
+ I+H N+++L + + +L + + G L+D L +K+ L T +
Sbjct: 62 LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL---AEKESL---TEDEATQFLK 115
Query: 708 Q---GLAYLHHDCSPRIIHRDVKSSNILL-DKDFEAH---LTDFGIAKSLCVSKSYTSTY 760
Q G+ YLH S RI H D+K NI+L DK+ L DFGIA + + +
Sbjct: 116 QILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN-- 170
Query: 761 IMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRK--AVDNECNLHHLILSKTANN 818
I GT ++ PE L ++D++S G++ LL+G + + +T N
Sbjct: 171 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK--------QETLTN 222
Query: 819 AVMETVD------PEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
D S KD +++ LL + P R T+ +
Sbjct: 223 ISAVNYDFDEEYFSNTSELAKDF--IRR-----LLV--KDPKRRMTIAQS 263
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-18
Identities = 68/292 (23%), Positives = 113/292 (38%), Gaps = 60/292 (20%)
Query: 597 TENLSEKY----IIGYGASSTVYKCVLKN------CKPVAIKRLYSHYPQCLKEFETELE 646
+E+Y ++G G+ V KC + K + + E+E
Sbjct: 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD---TSTILREVE 73
Query: 647 TVGSIKHRNLVSLQGYSLSSSGNL-LFYDFMENGSLWD-ILHGPTKKKKLDWDTRLKIAL 704
+ + H N++ L L S + + + G L+D I+ K+K+ +I
Sbjct: 74 LLKKLDHPNIMKLFEI-LEDSSSFYIVGELYTGGELFDEII----KRKRFSEHDAARIIK 128
Query: 705 GAAQGLAYLHHDCSPRIIHRDVKSSNILL-DKDFEAHL--TDFGIAKSLCVSKSYTSTYI 761
G+ Y+H I+HRD+K NILL K+ + + DFG++ +
Sbjct: 129 QVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD--R 183
Query: 762 MGTIGYIDPE-----YARTSRLTEKSDVYSFGIVLLELLTGR---KAVDNECNLHHLILS 813
+GT YI PE Y EK DV+S G++L LL+G NE ++ +
Sbjct: 184 IGTAYYIAPEVLRGTY------DEKCDVWSAGVILYILLSGTPPFYG-KNEYDILKRVE- 235
Query: 814 KTANNAVMETVDPE---ISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
P+ IS KDL ++K +L P+ R T +
Sbjct: 236 ----TGKYAFDLPQWRTISDDAKDL--IRK-----MLT--FHPSLRITATQC 274
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 2e-18
Identities = 43/203 (21%), Positives = 79/203 (38%), Gaps = 19/203 (9%)
Query: 347 IPDNLSSCTNLNSLNVHGNKLNGTIPP--AFQRLESMTYLNLSLNNIRGPIPVE-LSRIG 403
+P +L + L++ N L + RL ++ L LS N++ I E +
Sbjct: 33 VPQSLP--SYTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLNF-ISSEAFVPVP 88
Query: 404 NLDTLDMSNNKISGSIPSP-LGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNH 462
NL LD+S+N + ++ DL+ L L L N + F ++ + ++ LS N
Sbjct: 89 NLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQ 147
Query: 463 LTGVIPE---ELSQLQNMFSLRLDYNNLS----GDVMSLINCLSLSVLFIGNPGLC---G 512
++ E + ++L + L L N L D+ L + + NP C
Sbjct: 148 ISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDCKL 207
Query: 513 YWLHSACRDSHPTERVTISKAAI 535
Y L S + + + +
Sbjct: 208 YQLFSHWQYRQLSSVMDFQEDLY 230
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 3e-15
Identities = 46/185 (24%), Positives = 72/185 (38%), Gaps = 17/185 (9%)
Query: 239 TLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPP--ILGNLSYTEKLYLHSNKLT 296
LS QL +P L A+LDLS N LS + L+ L L N L
Sbjct: 22 ILSCSKQQLP-NVPQ--SLPSYTALLDLSHNNLSR-LRAEWTPTRLTNLHSLLLSHNHLN 77
Query: 297 GHIPPE-LGNMTKLHYLELNDNQLTGHIPP-ALGKLTDLFDLNVANNHLEGPIPDNLSSC 354
I E + L YL+L+ N L + L L L + NNH+ +
Sbjct: 78 -FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDM 135
Query: 355 TNLNSLNVHGNKLNGTIPP-AFQ---RLESMTYLNLSLNNIRGPIPVELSRIGNL--DTL 408
L L + N+++ P + +L + L+LS N ++ +L ++ + L
Sbjct: 136 AQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGL 194
Query: 409 DMSNN 413
+ NN
Sbjct: 195 YLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 1e-13
Identities = 34/141 (24%), Positives = 62/141 (43%), Gaps = 9/141 (6%)
Query: 352 SSCT-NLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIG--NLDTL 408
++C N L+ +L +P + L+LS NN+ + E + NL +L
Sbjct: 14 ANCLCASNILSCSKQQLP-NVPQSLPS--YTALLDLSHNNLSR-LRAEWTPTRLTNLHSL 69
Query: 409 DMSNNKISGSIPSP-LGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVI 467
+S+N ++ I S + +L L+LS N L F +L+++ + L +NH+ V
Sbjct: 70 LLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVD 128
Query: 468 PEELSQLQNMFSLRLDYNNLS 488
+ + L L N +S
Sbjct: 129 RNAFEDMAQLQKLYLSQNQIS 149
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 52/206 (25%), Positives = 77/206 (37%), Gaps = 34/206 (16%)
Query: 95 QSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIP--FSISKLKQLEFLILKNNQL 152
+ +L +P + S LDLS N L + ++ ++L L L+L +N
Sbjct: 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNH- 75
Query: 153 IGPIPS-TLSQLPNLKVFGLRGNNLVGTLSPDMCQ-LSGLWYFDVRNNSLTGSIPQNI-G 209
+ I S +PNL+ L N+L TL + L L + NN + + +N
Sbjct: 76 LNFISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFE 133
Query: 210 NCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCN 269
+ Q L LS NQ+S P + L L +LDLS N
Sbjct: 134 DMAQLQKLYLSQNQIS-RFPVEL-IKDGNKLP------------------KLMLLDLSSN 173
Query: 270 MLSGPIPPILGNLS--YTEKLYLHSN 293
L L L LYLH+N
Sbjct: 174 KLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 46/198 (23%), Positives = 73/198 (36%), Gaps = 39/198 (19%)
Query: 156 IPSTLSQLPNLKVFGLRGNNLVGTLSPDM--CQLSGLWYFDVRNNSLTGSIPQNI-GNCT 212
+P +L + L NNL L + +L+ L + +N L I
Sbjct: 33 VPQSLP--SYTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVP 88
Query: 213 SFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLS 272
+ + LDLS N L +L + +QAL VL L N +
Sbjct: 89 NLRYLDLSSNHLH---------------TLDEFLFSD--------LQALEVLLLYNNHIV 125
Query: 273 GPIPP-ILGNLSYTEKLYLHSNKLTGHIPPE----LGNMTKLHYLELNDNQLTGHIPPAL 327
+ +++ +KLYL N+++ P E + KL L+L+ N+L L
Sbjct: 126 V-VDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDL 183
Query: 328 GKLTDL--FDLNVANNHL 343
KL L + NN L
Sbjct: 184 QKLPAWVKNGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 41/183 (22%), Positives = 64/183 (34%), Gaps = 31/183 (16%)
Query: 73 LNLSGLNLDGEISP--AVGDLKDLQSIDLRGNRLSGQIPDEI-GDCSSLKSLDLSFNELY 129
L+LS NL + L +L S+ L N L+ I E +L+ LDLS N L
Sbjct: 44 LDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHL- 100
Query: 130 GDIPFSI-SKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLS 188
+ + S L+ LE L+L NN ++ + + L+ L N + ++
Sbjct: 101 HTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVEL---- 155
Query: 189 GLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLS---GEIPFNIGFLQIATLSLQGN 245
+ +LDLS N+L + L L N
Sbjct: 156 ----IK------------DGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
Query: 246 QLT 248
L
Sbjct: 200 PLE 202
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 32/135 (23%), Positives = 51/135 (37%), Gaps = 14/135 (10%)
Query: 90 DLKDLQSIDLRGNRLSGQIPDEI-GDCSSLKSLDLSFNELYGDIPF----SISKLKQLEF 144
DL+ L+ + L N + + D + L+ L LS N++ P +KL +L
Sbjct: 110 DLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLML 167
Query: 145 LILKNNQLIGPIPSTLSQLPNLKVFGLR--GNNLVGTLSPDMCQLSGLWYFDVRNNSLTG 202
L L +N+L + L +LP GL N L C+L L+ +
Sbjct: 168 LDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECD-----CKLYQLFSHWQYRQLSSV 222
Query: 203 SIPQNIGNCTSFQVL 217
Q C + L
Sbjct: 223 MDFQEDLYCMHSKKL 237
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 70/264 (26%), Positives = 114/264 (43%), Gaps = 29/264 (10%)
Query: 606 IGYGASSTVYKCV-LKNCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQG 661
+G G+ + VY+ + VAIK + ++ + E++ +KH +++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 662 YSLSSSGNLLFYDFME---NGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCS 718
Y S + Y +E NG + L + K + G+ YLH S
Sbjct: 79 Y-FEDSNYV--YLVLEMCHNGEMNRYLK--NRVKPFSENEARHFMHQIITGMLYLH---S 130
Query: 719 PRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRL 778
I+HRD+ SN+LL ++ + DFG+A L + T + GT YI PE A S
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRSAH 189
Query: 779 TEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAV 838
+SDV+S G + LL GR D + + + L+K + +S KDL +
Sbjct: 190 GLESDVWSLGCMFYTLLIGRPPFDTD-TVKNT-LNKVVLADY--EMPSFLSIEAKDL--I 243
Query: 839 KKVFQLALLCSKRQPTDRPTMHEV 862
+ LL +R P DR ++ V
Sbjct: 244 HQ-----LL--RRNPADRLSLSSV 260
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 4e-18
Identities = 66/294 (22%), Positives = 107/294 (36%), Gaps = 45/294 (15%)
Query: 588 HVYEDIMRMTENLSEKY----IIGYGASSTVYKCVLKNC-KPVAIKRLYSHYPQCLKEFE 642
+ + + R + ++ Y IG G+ S +C+ K A+K + +E E
Sbjct: 8 SIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIE 67
Query: 643 TELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWD-ILHGPTKKKKLD-WDTRL 700
L H N+++L+ + + M+ G L D I ++K +
Sbjct: 68 ILLRYGQ---HPNIITLKDVYDDGKYVYVVTELMKGGELLDKI----LRQKFFSEREAS- 119
Query: 701 KIALGAAQGLAYLHHDCSPRIIHRDVKSSNILL-DKDFEAH---LTDFGIAKSLCVSKSY 756
+ + + YLH + ++HRD+K SNIL D+ + DFG AK L
Sbjct: 120 AVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL 176
Query: 757 TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTG-----RKAVDNECNLHHLI 811
T T ++ PE D++S G++L +LTG D + I
Sbjct: 177 LMT-PCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI 235
Query: 812 LSKTANNAVMETVDPE---ISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
S +S T KDL V K +L P R T V
Sbjct: 236 GS-----GKFSLSGGYWNSVSDTAKDL--VSK-----MLH--VDPHQRLTAALV 275
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 7e-18
Identities = 58/266 (21%), Positives = 108/266 (40%), Gaps = 34/266 (12%)
Query: 606 IGYGASSTVYKCV-LKNCKPVAIK-----RLYSHYPQCLKEFETELETVGSIKHRNLVSL 659
+G G + ++ + A K L + + ++ E+ S+ H+++V
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQR--EKMSMEISIHRSLAHQHVVGF 80
Query: 660 QGYSLSSSGNLLFYDFME---NGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHD 716
G+ + + + +E SL ++ ++K L G YLH
Sbjct: 81 HGF-FEDNDFV--FVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLGCQYLH-- 132
Query: 717 CSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTS 776
R+IHRD+K N+ L++D E + DFG+A + + GT YI PE
Sbjct: 133 -RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKK 190
Query: 777 RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLG 836
+ + DV+S G ++ LL G+ + L + N ++ I+ L
Sbjct: 191 GHSFEVDVWSIGCIMYTLLVGKPPFETS-CLKET-YLRIKKNEY--SIPKHINPVAASL- 245
Query: 837 AVKKVFQLALLCSKRQPTDRPTMHEV 862
++K +L + PT RPT++E+
Sbjct: 246 -IQK-----ML--QTDPTARPTINEL 263
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 9e-18
Identities = 64/327 (19%), Positives = 121/327 (37%), Gaps = 49/327 (14%)
Query: 555 RPHNPTHFPDGSLDKPVNYSTPKLVILHMNMALHVYEDIMRMTENLSEKYII----GYGA 610
H+ G D P K + + + ++ + Y I G GA
Sbjct: 6 HHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVP--QPVEVKQGSVYDYYDILEELGSGA 63
Query: 611 SSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGN 669
V++CV K + K + + YP + E+ + + H L++L
Sbjct: 64 FGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM 123
Query: 670 LLFYDFMENGSLWD-ILHGPTKKKKLDWDTRLKIALGAAQ---GLAYLHHDCSPRIIHRD 725
+L +F+ G L+D I + K+ + ++ Q GL ++H I+H D
Sbjct: 124 VLILEFLSGGELFDRIA---AEDYKM---SEAEVINYMRQACEGLKHMH---EHSIVHLD 174
Query: 726 VKSSNILLDKDFEAHL--TDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSD 783
+K NI+ + + + DFG+A L + T + PE + +D
Sbjct: 175 IKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV--TTATAEFAAPEIVDREPVGFYTD 232
Query: 784 VYSFGIVLLELLTGRK--AVDNECNLHHLILSKTANNAVMETVD------PEISATCKDL 835
+++ G++ LL+G A +++ +T N + +S KD
Sbjct: 233 MWAIGVLGYVLLSGLSPFAGEDD--------LETLQNVKRCDWEFDEDAFSSVSPEAKDF 284
Query: 836 GAVKKVFQLALLCSKRQPTDRPTMHEV 862
+K LL ++P R T+H+
Sbjct: 285 --IKN-----LLQ--KEPRKRLTVHDA 302
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 58/266 (21%), Positives = 108/266 (40%), Gaps = 34/266 (12%)
Query: 606 IGYGASSTVYKCV-LKNCKPVAIK-----RLYSHYPQCLKEFETELETVGSIKHRNLVSL 659
+G G + ++ + A K L + + ++ E+ S+ H+++V
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQR--EKMSMEISIHRSLAHQHVVGF 106
Query: 660 QGYSLSSSGNLLFYDFME---NGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHD 716
G+ + + + +E SL ++ ++K L G YLH
Sbjct: 107 HGF-FEDNDFV--FVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLGCQYLH-- 158
Query: 717 CSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTS 776
R+IHRD+K N+ L++D E + DFG+A + + GT YI PE
Sbjct: 159 -RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKK 216
Query: 777 RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLG 836
+ + DV+S G ++ LL G+ + C + N ++ I+ L
Sbjct: 217 GHSFEVDVWSIGCIMYTLLVGKPPFETSC--LKETYLRIKKNEY--SIPKHINPVAASL- 271
Query: 837 AVKKVFQLALLCSKRQPTDRPTMHEV 862
++K +L + PT RPT++E+
Sbjct: 272 -IQK-----ML--QTDPTARPTINEL 289
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 76/284 (26%), Positives = 118/284 (41%), Gaps = 46/284 (16%)
Query: 597 TENLSEKYII----GYGASSTVYKCVLKN-CKPVAIKRLYSHYPQCLKEFETELETVGSI 651
+ LS+ + + G GA+S VY+C K KP A+K L K TE+ + +
Sbjct: 48 RDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRL 105
Query: 652 KHRNLVSLQGYSLSSSGNLLFYDFMENGSLWD-ILHGPTKKKKL---DWDTRLKIALGAA 707
H N++ L+ + + L + + G L+D I+ +K D +K L A
Sbjct: 106 SHPNIIKLKEIFETPTEISLVLELVTGGELFDRIV----EKGYYSERDAADAVKQILEA- 160
Query: 708 QGLAYLHHDCSPRIIHRDVKSSNILL-DKDFEAHL--TDFGIAKSLCVSKSYTSTYIMGT 764
+AYLH I+HRD+K N+L +A L DFG++K + + + GT
Sbjct: 161 --VAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT--VCGT 213
Query: 765 IGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGR---KAVDNECNLHHLILSKTANNAVM 821
GY PE R + D++S GI+ LL G + + IL N
Sbjct: 214 PGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRIL-----NCEY 268
Query: 822 ETVDPE---ISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
+ P +S KDL V+K L+ P R T +
Sbjct: 269 YFISPWWDEVSLNAKDL--VRK-----LIV--LDPKKRLTTFQA 303
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 50/232 (21%), Positives = 95/232 (40%), Gaps = 26/232 (11%)
Query: 585 MALHVYEDIMRMTENLSEKY----IIGYGASSTVYKCVLKNC-KPVAIKRLYSHYPQCLK 639
M+L+ + +++ + G G TV K+ VAIK++ +
Sbjct: 6 MSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNR 65
Query: 640 EFETELETVGSIKHRNLVSLQGYSLSSSGN-------LLFYDFMENGSLWDIL-HGPTKK 691
E + ++ + + H N+V LQ Y + + +++ + +L + ++
Sbjct: 66 ELQ-IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQ 123
Query: 692 KKLDWDTRLKIALGAAQ---GLAYLHHDCSPRIIHRDVKSSNILLDK-DFEAHLTDFGIA 747
I + Q + LH S + HRD+K N+L+++ D L DFG A
Sbjct: 124 VAPPPIL---IKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSA 179
Query: 748 KSLCVSKSYTSTYIMGTIGYIDPEYARTSRL-TEKSDVYSFGIVLLELLTGR 798
K L S+ + YI + Y PE ++ T D++S G + E++ G
Sbjct: 180 KKLSPSEPNVA-YIC-SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 62/281 (22%), Positives = 113/281 (40%), Gaps = 36/281 (12%)
Query: 597 TENLSEKYI----IGYGASSTVYKCVLK-NCKPVAIKRLY-SHYPQCLKEFETELETVGS 650
+ + +I +G GA V+ + + IK + +++ E E+E + S
Sbjct: 17 QGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKS 76
Query: 651 IKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWD-ILHGPTKKKKLDWDTRLKIALGAAQG 709
+ H N++ + + + E G L + I+ + K L ++
Sbjct: 77 LDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNA 136
Query: 710 LAYLHHDCSPRIIHRDVKSSNILL-DKDFEAHL--TDFGIAKSLCVSKSYTSTYIMGTIG 766
LAY H S ++H+D+K NIL D + + DFG+A+ + T+ GT
Sbjct: 137 LAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN--AAGTAL 191
Query: 767 YIDPEYARTSRLTEKSDVYSFGIVLLELLTGRK--AVDNECNLHHLILSKTANNAVMETV 824
Y+ PE + +T K D++S G+V+ LLTG + + K N
Sbjct: 192 YMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPN------Y 244
Query: 825 DPE---ISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
E ++ DL +K+ +L + P RP+ +V
Sbjct: 245 AVECRPLTPQAVDL--LKQ-----MLT--KDPERRPSAAQV 276
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 74/288 (25%), Positives = 116/288 (40%), Gaps = 44/288 (15%)
Query: 598 ENLSEKYII----GYGASSTVYKCVLKN-CKPVAIKRL--------YSHYPQCLKEFETE 644
+ L ++YI+ G GA V + CK VAIK + + ETE
Sbjct: 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 645 LETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWD-ILHGPTKKKKLDWDTRLKIA 703
+E + + H ++ ++ + + ++ + ME G L+D + K+L T
Sbjct: 66 IEILKKLNHPCIIKIKNFFDAEDYYIVL-ELMEGGELFDKV----VGNKRLKEATCKLYF 120
Query: 704 LGAAQGLAYLHHDCSPRIIHRDVKSSNILLD-KDFEAHL--TDFGIAKSLCVSKSYTSTY 760
+ YLH IIHRD+K N+LL ++ + + TDFG +K + S T
Sbjct: 121 YQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-ILGETSLMRT- 175
Query: 761 IMGTIGYIDPE---YARTSRLTEKSDVYSFGIVLLELLTGR---KAVDNECNLHHLILSK 814
+ GT Y+ PE T+ D +S G++L L+G + +L I S
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS- 234
Query: 815 TANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
+ V E+S DL VKK LL P R T E
Sbjct: 235 -GKYNFIPEVWAEVSEKALDL--VKK-----LLV--VDPKARFTTEEA 272
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 72/303 (23%), Positives = 120/303 (39%), Gaps = 50/303 (16%)
Query: 581 LHMNMALHVYEDIMRMTENLSEKYII----GYGASSTVYKCVLK-NCKPVAIKRL--YSH 633
+H + + + +E+Y I G G+ V KC + + A+K + S
Sbjct: 1 MHHHHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA 60
Query: 634 YPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWD-ILHGPTKKK 692
+ E+E + + H N++ L SS + + G L+D I K+K
Sbjct: 61 KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI----IKRK 116
Query: 693 KLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILL-DKDFEAHL--TDFGIAKS 749
+ +I G+ Y+H I+HRD+K NILL K+ + + DFG++
Sbjct: 117 RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173
Query: 750 LCVSKSYTSTYIMGTIGYIDPE-----YARTSRLTEKSDVYSFGIVLLELLTGRK--AVD 802
+ +GT YI PE Y EK DV+S G++L LL+G
Sbjct: 174 FQQNTKMKD--RIGTAYYIAPEVLRGTY------DEKCDVWSAGVILYILLSGTPPFYGK 225
Query: 803 NECNLHHLILSKTANNAVMETVDPE---ISATCKDLGAVKKVFQLALLCSKRQPTDRPTM 859
NE ++ + + P+ IS KDL ++K +L P+ R T
Sbjct: 226 NEYDILKRVET-----GKYAFDLPQWRTISDDAKDL--IRK-----MLT--FHPSLRITA 271
Query: 860 HEV 862
+
Sbjct: 272 TQC 274
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 3e-17
Identities = 60/294 (20%), Positives = 114/294 (38%), Gaps = 47/294 (15%)
Query: 588 HVYEDIMRMTENLSEKYII----GYGASSTVYKCVLKN-CKPVAIKRLYSHYPQCLKEFE 642
+ + + +++ + Y I G GA V++ + A K + + + +
Sbjct: 143 YYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVR 202
Query: 643 TELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWD-ILHGPTKKKKLDWDTRLK 701
E++T+ ++H LV+L + ++ Y+FM G L++ + + K+ + +
Sbjct: 203 KEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA---DEHNKM---SEDE 256
Query: 702 IALGAAQ---GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHL--TDFGIAKSLCVSKSY 756
Q GL ++H +H D+K NI+ L DFG+ L +S
Sbjct: 257 AVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 313
Query: 757 TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRK--AVDNECNLHHLILSK 814
GT + PE A + +D++S G++ LL+G +N+ +
Sbjct: 314 KV--TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--------DE 363
Query: 815 TANNAVMETVD------PEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
T N + IS KD ++K LL P R T+H+
Sbjct: 364 TLRNVKSCDWNMDDSAFSGISEDGKDF--IRK-----LLL--ADPNTRMTIHQA 408
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 4e-17
Identities = 66/287 (22%), Positives = 116/287 (40%), Gaps = 49/287 (17%)
Query: 597 TENLSEKY----IIGYGASSTVYKCVLKN------CKPVAIKRLYSHYPQCLKEFETELE 646
+ S+ Y +G GA S V +CV K K + K+L + Q L E E
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKL---EREAR 57
Query: 647 TVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGA 706
++H N+V L S + L +D + G L++ + ++
Sbjct: 58 ICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI---VAREFYSEADASHCIQQI 114
Query: 707 AQGLAYLHHDCSPRIIHRDVKSSNILL-DKDFEAHL--TDFGIAKSLCVSKSYTSTYIMG 763
+ +AY H S I+HR++K N+LL K A + DFG+A + S+++ G
Sbjct: 115 LESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG--FAG 169
Query: 764 TIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAV-----DNECNLHHLILSKTANN 818
T GY+ PE + ++ D+++ G++L LL G +++ L+ I +
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG---YPPFWDEDQHRLYAQIKA----- 221
Query: 819 AVMETVDPE---ISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
+ PE ++ K L + +L P R T +
Sbjct: 222 GAYDYPSPEWDTVTPEAKSL--IDS-----MLT--VNPKKRITADQA 259
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 7e-17
Identities = 45/185 (24%), Positives = 82/185 (44%), Gaps = 12/185 (6%)
Query: 285 TEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLE 344
T K L +T + + + + N++ + + L ++ L + N L
Sbjct: 21 TIKANLKKKSVT-DAVTQNE-LNSIDQIIANNSDIKS--VQGIQYLPNVRYLALGGNKLH 76
Query: 345 G-PIPDNLSSCTNLNSLNVHGNKLNGTIPP-AFQRLESMTYLNLSLNNIRGPIPVELSRI 402
L TNL L + GN+L ++P F +L ++ L L N ++ ++
Sbjct: 77 DISALKEL---TNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKL 132
Query: 403 GNLDTLDMSNNKISGSIPSPLGD-LEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHN 461
NL L++++N++ S+P + D L +L +L+LS NQL G F L + ++ L N
Sbjct: 133 TNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQN 191
Query: 462 HLTGV 466
L V
Sbjct: 192 QLKSV 196
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 5e-13
Identities = 46/182 (25%), Positives = 71/182 (39%), Gaps = 12/182 (6%)
Query: 182 PDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLS 241
+L+ + N+ + S+ I + + L L N+L + L
Sbjct: 35 VTQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVRYLALGGNKLHDISALK-ELTNLTYLI 91
Query: 242 LQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPP 301
L GNQL V + L L L N L + L+ L L N+L +P
Sbjct: 92 LTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQS-LPK 150
Query: 302 EL-GNMTKLHYLELNDNQLTGHIPP-ALGKLTDLFDLNVANNHLEGPIP----DNLSSCT 355
+ +T L L+L+ NQL +P KLT L DL + N L+ +P D L+S
Sbjct: 151 GVFDKLTNLTELDLSYNQLQS-LPEGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQ 208
Query: 356 NL 357
+
Sbjct: 209 YI 210
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 33/144 (22%), Positives = 61/144 (42%), Gaps = 14/144 (9%)
Query: 347 IPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLD 406
PD+ N+ + T L S+ + + ++I+ ++ + N+
Sbjct: 13 FPDDAF--AETIKANLKKKSV--TDAVTQNELNSIDQIIANNSDIKSVQGIQ--YLPNVR 66
Query: 407 TLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGV 466
L + NK+ I + L +L +L L L+ NQL G F L ++ E+ L N L +
Sbjct: 67 YLALGGNKLH-DISA-LKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSL 124
Query: 467 ---IPEELSQLQNMFSLRLDYNNL 487
+ ++L+ L L L +N L
Sbjct: 125 PDGVFDKLTNLTY---LNLAHNQL 145
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 9e-17
Identities = 68/289 (23%), Positives = 117/289 (40%), Gaps = 52/289 (17%)
Query: 597 TENLSEKY----IIGYGASSTVYKCVLKN------CKPVAIKRLYSHYPQCLKEFETELE 646
+E+Y +G GA S V +CV + K+L + Q L+ E
Sbjct: 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLE---REAR 62
Query: 647 TVGSIKHRNLVSLQGYSLSSSGNL-LFYDFMENGSLWD-ILHGPTKKKKL---DWDTRLK 701
+KH N+V L +S G+ L +D + G L++ I ++ D ++
Sbjct: 63 ICRLLKHPNIVRLHDS-ISEEGHHYLIFDLVTGGELFEDI----VAREYYSEADASHCIQ 117
Query: 702 IALGAAQGLAYLHHDCSPRIIHRDVKSSNILL-DKDFEAHL--TDFGIAKSLCVSKSYTS 758
L A + + H ++HR++K N+LL K A + DFG+A + +
Sbjct: 118 QILEA---VLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF 171
Query: 759 TYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRK--AVDNECNLHHLILSKTA 816
GT GY+ PE R + D+++ G++L LL G +++ L+ I +
Sbjct: 172 G-FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKA--- 227
Query: 817 NNAVMETVDPE---ISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
+ PE ++ KDL + K +L P+ R T E
Sbjct: 228 --GAYDFPSPEWDTVTPEAKDL--INK-----MLT--INPSKRITAAEA 265
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 1e-16
Identities = 63/298 (21%), Positives = 118/298 (39%), Gaps = 49/298 (16%)
Query: 586 ALHVYEDIMRMTENLSEKYII------GYGASSTVYKCVLKN-CKPVAIKRLYSHYPQCL 638
A + + ++ Y + G G V+KC +A K + + +
Sbjct: 71 APFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK 130
Query: 639 KEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWD-ILHGPTKKKKLDWD 697
+E + E+ + + H NL+ L S + +L ++++ G L+D I+ + L
Sbjct: 131 EEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRII---DESYNL--- 184
Query: 698 TRLKIALGAAQ---GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHL--TDFGIAKSLCV 752
T L L Q G+ ++H I+H D+K NIL + DFG+A+
Sbjct: 185 TELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP 241
Query: 753 SKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRK--AVDNECNLHHL 810
+ GT ++ PE ++ +D++S G++ LL+G DN+
Sbjct: 242 REKLKV--NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND------ 293
Query: 811 ILSKTANNAVMETVD------PEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
++T NN + D +IS K+ + K LL ++ + R + E
Sbjct: 294 --AETLNNILACRWDLEDEEFQDISEEAKEF--ISK-----LLI--KEKSWRISASEA 340
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 83.3 bits (205), Expect = 1e-16
Identities = 39/231 (16%), Positives = 81/231 (35%), Gaps = 17/231 (7%)
Query: 252 PSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHY 311
+ L +LS + + L + ++L + I + + L Y
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY 400
Query: 312 LE---LNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLN 368
+ + L P L D + ++ L++ L
Sbjct: 401 EKETLQYFSTLKAVDPMRAAYLDD------LRSKFLLENSVLKMEYADVRVLHLAHKDL- 453
Query: 369 GTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEH 428
T+ ++L +T+L+LS N +R +P L+ + L+ L S+N + ++ + +L
Sbjct: 454 -TVLCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE-NVD-GVANLPR 509
Query: 429 LLKLNLSRNQLTGF-IPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMF 478
L +L L N+L + ++ ++L N L +L M
Sbjct: 510 LQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEML 559
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 80.6 bits (198), Expect = 8e-16
Identities = 53/276 (19%), Positives = 90/276 (32%), Gaps = 34/276 (12%)
Query: 93 DLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQL 152
DL + L S K L + + +QL L +
Sbjct: 303 DLPAASLNDQLPQHTFRVIWTGSDSQKECVLL-KDRPECWCRDSATDEQLFRCELSVEKS 361
Query: 153 IGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCT 212
+ S L L+ + T+ M L L Y + + +
Sbjct: 362 T-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY-----------EKETLQYFS 409
Query: 213 SFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLS 272
+ + +D ++ A L ++ + + + VL L+ L+
Sbjct: 410 TLKAVD---------------PMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT 454
Query: 273 GPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTD 332
+ L L L L N+L +PP L + L L+ +DN L ++ + L
Sbjct: 455 --VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPR 509
Query: 333 LFDLNVANNHLEG-PIPDNLSSCTNLNSLNVHGNKL 367
L +L + NN L+ L SC L LN+ GN L
Sbjct: 510 LQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 79.4 bits (195), Expect = 2e-15
Identities = 39/217 (17%), Positives = 80/217 (36%), Gaps = 22/217 (10%)
Query: 300 PPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNS 359
+ +L EL+ + T + L +L +L N L+ + +
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENK------WCLLTIILLMRA 394
Query: 360 LNVHGNKLNGTIPPAFQRLESMTYLNLSL-----NNIRGPIPVELSRIGNLDTLDMSNNK 414
L+ + F L+++ + + + V ++ L +++
Sbjct: 395 LDPLLYEKETL--QYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKD 452
Query: 415 ISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQL 474
++ + L L + L+LS N+L +P LR + + S N L V + ++ L
Sbjct: 453 LT-VLCH-LEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALENV--DGVANL 507
Query: 475 QNMFSLRLDYNNLSG--DVMSLINCLSLSVLFI-GNP 508
+ L L N L + L++C L +L + GN
Sbjct: 508 PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNS 544
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 67.9 bits (165), Expect = 8e-12
Identities = 30/124 (24%), Positives = 52/124 (41%), Gaps = 6/124 (4%)
Query: 55 YCVWRGITCDNVTFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGD 114
+ V L+L+ +L + + L + +DL NRL +P +
Sbjct: 428 KFLLENSVLKMEYADVRVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLR-ALPPALAA 484
Query: 115 CSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIG-PIPSTLSQLPNLKVFGLRG 173
L+ L S N L ++ ++ L +L+ L+L NN+L L P L + L+G
Sbjct: 485 LRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQG 542
Query: 174 NNLV 177
N+L
Sbjct: 543 NSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 67.5 bits (164), Expect = 1e-11
Identities = 48/280 (17%), Positives = 86/280 (30%), Gaps = 16/280 (5%)
Query: 236 QIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKL 295
+S + L+ + + + L L + + + +
Sbjct: 246 CCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLP 305
Query: 296 TGHIPPELGNMTKLHYLELNDNQLTGHI--------PPALGKLTDLFDLNVANNHLEGPI 347
+ +L T +D+Q + LF ++ +
Sbjct: 306 AASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST-VL 364
Query: 348 PDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDT 407
L SC L L TI + L+ + Y +L V+ R LD
Sbjct: 365 QSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD- 423
Query: 408 LDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVI 467
+K + + L+L+ LT + L V +DLSHN L +
Sbjct: 424 --DLRSKFLLENSVLKMEYADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-AL 478
Query: 468 PEELSQLQNMFSLRLDYNNLSGDVMSLINCLSLSVLFIGN 507
P L+ L+ + L+ N L +V + N L L + N
Sbjct: 479 PPALAALRCLEVLQASDNALE-NVDGVANLPRLQELLLCN 517
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 1e-16
Identities = 78/333 (23%), Positives = 131/333 (39%), Gaps = 49/333 (14%)
Query: 556 PHNPTHFPDGSLDKPVNYSTPKLVILHMNMALHVYEDIMRMTENLSEKY----IIGYGAS 611
P + + + +M + +KY +IG G S
Sbjct: 48 PSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVS 107
Query: 612 STVYKCVLK-NCKPVAIK-------RLYSHYPQCLKE-FETELETVGSIK-HRNLVSLQG 661
S V +CV + A+K RL + ++E E + + H ++++L
Sbjct: 108 SVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167
Query: 662 YSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLD-WDTRLKIALGAAQGLAYLHHDCSPR 720
SSS L +D M G L+D L T+K L +TR I + +++LH +
Sbjct: 168 SYESSSFMFLVFDLMRKGELFDYL---TEKVALSEKETR-SIMRSLLEAVSFLH---ANN 220
Query: 721 IIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPE------YAR 774
I+HRD+K NILLD + + L+DFG + L + + GT GY+ PE
Sbjct: 221 IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE--LCGTPGYLAPEILKCSMDET 278
Query: 775 TSRLTEKSDVYSFGIVLLELLTGRK--AVDNECNLHHLILSKTANNAVMETVDPE---IS 829
++ D+++ G++L LL G + + +I+ + PE S
Sbjct: 279 HPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIME-----GQYQFSSPEWDDRS 333
Query: 830 ATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
+T KDL + + LL P R T +
Sbjct: 334 STVKDL--ISR-----LLQ--VDPEARLTAEQA 357
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 55/287 (19%), Positives = 107/287 (37%), Gaps = 48/287 (16%)
Query: 595 RMTENLSEKYII----GYGASSTVYKCVLKN-CKPVAIKRLYSHYPQCLKEFETELETVG 649
++++ Y + G G+ V V K A K++ ++ + + F+ E+E +
Sbjct: 2 STKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMK 61
Query: 650 SIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWD-ILHGPTKKKKLDWDTRLKIALGAAQ 708
S+ H N++ L ++ L + G L++ ++ K+ +I
Sbjct: 62 SLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVV----HKRVFRESDAARIMKDVLS 117
Query: 709 GLAYLHHDCSPRIIHRDVKSSNILL---DKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTI 765
+AY H + HRD+K N L D L DFG+A K + +GT
Sbjct: 118 AVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT--KVGTP 172
Query: 766 GYIDPE-----YARTSRLTEKSDVYSFGIVLLELLTGRK--AVDNECNLHHLILSKTANN 818
Y+ P+ Y + D +S G+++ LL G + + + I
Sbjct: 173 YYVSPQVLEGLY------GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIR-----E 221
Query: 819 AVMETVDPE---ISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
+ + +S + L +++ LL + P R T +
Sbjct: 222 GTFTFPEKDWLNVSPQAESL--IRR-----LLT--KSPKQRITSLQA 259
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-16
Identities = 63/225 (28%), Positives = 91/225 (40%), Gaps = 37/225 (16%)
Query: 643 TELETVGSIKHRNLVSLQGYSLSSSGNLLF-YDFMENGSLWDILHGPTKKKKLD-WDTRL 700
EL+ + ++H LV+L YS ++ D + G L L + +L
Sbjct: 64 KELQIMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQ---QNVHFKEETVKL 119
Query: 701 KIA-LGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTST 759
I L A L YL + RIIHRD+K NILLD+ H+TDF IA L T+
Sbjct: 120 FICELVMA--LDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT- 173
Query: 760 YIMGTIGYIDPEYARTSRLTEKS---DVYSFGIVLLELLTGR-----KAVDNECNLHHLI 811
+ GT Y+ PE + + S D +S G+ ELL GR ++ + + H
Sbjct: 174 -MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF 232
Query: 812 LSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDR 856
+ T S L +KK LL + P R
Sbjct: 233 ETTVV------TYPSAWSQEMVSL--LKK-----LL--EPNPDQR 262
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-16
Identities = 60/225 (26%), Positives = 92/225 (40%), Gaps = 43/225 (19%)
Query: 597 TENLSEKY----IIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFET-ELETVGSI 651
E Y +IG G+ V++ L VAIK++ K F+ EL+ + +
Sbjct: 35 GEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIV 89
Query: 652 KHRNLVSLQGYSLSSSGNL------LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALG 705
KH N+V L+ + S+ L +++ T + +LK +
Sbjct: 90 KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE----------TVYRASRHYAKLKQTMP 139
Query: 706 AA----------QGLAYLHHDCSPRIIHRDVKSSNILLDKD-FEAHLTDFGIAKSLCVSK 754
+ LAY+H S I HRD+K N+LLD L DFG AK L +
Sbjct: 140 MLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE 196
Query: 755 SYTSTYIMGTIGYIDPEYARTSRL-TEKSDVYSFGIVLLELLTGR 798
S YI + Y PE + T D++S G V+ EL+ G+
Sbjct: 197 PNVS-YIC-SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 62/297 (20%), Positives = 111/297 (37%), Gaps = 57/297 (19%)
Query: 593 IMRMTENLSEKYII-----GYGASSTVYKCVLKN------CKPVAIKRLYSHYPQCLKEF 641
+ EN + YI+ G G + V +C+ K+ K + +R C E
Sbjct: 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRG---QDCRAEI 75
Query: 642 ETELETVGSIKHR-NLVSLQGYSLSSSGNLLFYDFMENGSLWD-ILHGPTKKKKLDWDTR 699
E+ + K +++L ++S +L ++ G ++ L + + +
Sbjct: 76 LHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCL-----PELAEMVSE 130
Query: 700 LKIALGAAQ---GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAH---LTDFGIAKSLCVS 753
+ Q G+ YLH I+H D+K NILL + + DFG+++ + +
Sbjct: 131 NDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187
Query: 754 KSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRK--AVDNECNLHHLI 811
IMGT Y+ PE +T +D+++ GI+ LLT ++
Sbjct: 188 CELRE--IMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN------- 238
Query: 812 LSKTANNAVMETVD------PEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
+T N VD +S D ++ LL + P RPT
Sbjct: 239 -QETYLNISQVNVDYSEETFSSVSQLATDF--IQS-----LLV--KNPEKRPTAEIC 285
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 68/297 (22%), Positives = 122/297 (41%), Gaps = 57/297 (19%)
Query: 591 EDIMRMTENLSEKY----IIGYGASSTVYKCVLKN------CKPVAIKRLYSHYPQCLKE 640
E +M + S+ Y +G GA S V +CV K K + K+L + Q L+
Sbjct: 18 EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE- 76
Query: 641 FETELETVGSIKHRNLVSLQGYSLSSSGNL-LFYDFMENGSLWDILHGPTKKKKL---DW 696
E ++H N+V L + L +D + G L++ + ++ D
Sbjct: 77 --REARICRKLQHPNIVRLHDS-IQEESFHYLVFDLVTGGELFEDI---VAREFYSEADA 130
Query: 697 DTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILL-DKDFEAHL--TDFGIAKSLCVS 753
++ L + +AY H S I+HR++K N+LL K A + DFG+A + S
Sbjct: 131 SHCIQQILES---IAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184
Query: 754 KSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAV-----DNECNLH 808
+++ GT GY+ PE + ++ D+++ G++L LL G +++ L+
Sbjct: 185 EAWHG--FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG---YPPFWDEDQHRLY 239
Query: 809 HLILSKTANNAVMETVDPE---ISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
I + + PE ++ K L + +L P R T +
Sbjct: 240 AQIKA-----GAYDYPSPEWDTVTPEAKSL--IDS-----MLT--VNPKKRITADQA 282
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 4e-16
Identities = 64/287 (22%), Positives = 112/287 (39%), Gaps = 45/287 (15%)
Query: 597 TENLSEKY-----IIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGS 650
+++ Y ++G G + V +C + + A+K LY P+ +E + + G
Sbjct: 23 KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-PKARQEVDHHWQASG- 80
Query: 651 IKHRNLVSLQG-YSLSSSGNLLFY---DFMENGSLWD-ILHGPTKKKKLDWDTR--LKIA 703
++V + Y G + ME G L+ I ++ + R +I
Sbjct: 81 --GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQ----ERGDQAFTEREAAEIM 134
Query: 704 LGAAQGLAYLHHDCSPRIIHRDVKSSNILL-DKDFEAHL--TDFGIAKSLCVSKSYTSTY 760
+ +LH S I HRDVK N+L K+ +A L TDFG AK + T
Sbjct: 135 RDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT--- 188
Query: 761 IMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRK--AVDNECNLHHLILSKTANN 818
T Y+ PE + + D++S G+++ LL G + + + +
Sbjct: 189 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRI-RL 247
Query: 819 AVMETVDPE---ISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
+PE +S K L ++ LL PT+R T+ +
Sbjct: 248 GQYGFPNPEWSEVSEDAKQL--IRL-----LLK--TDPTERLTITQF 285
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 5e-16
Identities = 56/183 (30%), Positives = 77/183 (42%), Gaps = 36/183 (19%)
Query: 285 TEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPP-ALGKLTDLFDLNVANNHL 343
TEKL L S L +TKL +L L+ NQL + LT+L L +ANN L
Sbjct: 37 TEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQL 95
Query: 344 ---EGPIPDNLSSCTNLNSLNVHGNKLNGTIPP-AFQRLESMTYLNLSLNNIRGPIPVEL 399
+ D+L T L+ L + GN+L ++P F RL
Sbjct: 96 ASLPLGVFDHL---TQLDKLYLGGNQLK-SLPSGVFDRL--------------------- 130
Query: 400 SRIGNLDTLDMSNNKISGSIPSPLGD-LEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDL 458
L L ++ N++ SIP+ D L +L L+LS NQL G F L + I L
Sbjct: 131 ---TKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITL 186
Query: 459 SHN 461
N
Sbjct: 187 FGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 3e-15
Identities = 45/156 (28%), Positives = 69/156 (44%), Gaps = 12/156 (7%)
Query: 240 LSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHI 299
L LQ L + + L L+L N L + +L+ L L +N+L +
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS-L 98
Query: 300 PPEL-GNMTKLHYLELNDNQLTGHIPP-ALGKLTDLFDLNVANNHLEGPIP----DNLSS 353
P + ++T+L L L NQL +P +LT L +L + N L+ IP D L
Sbjct: 99 PLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQS-IPAGAFDKL-- 154
Query: 354 CTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLN 389
TNL +L++ N+L AF RL + + L N
Sbjct: 155 -TNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 7e-14
Identities = 53/173 (30%), Positives = 80/173 (46%), Gaps = 17/173 (9%)
Query: 194 DVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNI--GFLQIATLSLQGNQLTGKI 251
D + SL S+P I + LDL L+ + G ++ L+L NQL
Sbjct: 20 DCQGKSLD-SVPSGIP--ADTEKLDLQSTGLA-TLSDATFRGLTKLTWLNLDYNQLQTLS 75
Query: 252 PSVIGLMQALAVLDLSCNMLSGPIPP-ILGNLSYTEKLYLHSNKLTGHIPPEL-GNMTKL 309
V + L L L+ N L+ +P + +L+ +KLYL N+L +P + +TKL
Sbjct: 76 AGVFDDLTELGTLGLANNQLAS-LPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKL 133
Query: 310 HYLELNDNQLTGHIPP-ALGKLTDLFDLNVANNHLEGPIP----DNLSSCTNL 357
L LN NQL IP A KLT+L L+++ N L+ +P D L +
Sbjct: 134 KELRLNTNQLQS-IPAGAFDKLTNLQTLSLSTNQLQS-VPHGAFDRLGKLQTI 184
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 4e-11
Identities = 41/138 (29%), Positives = 62/138 (44%), Gaps = 10/138 (7%)
Query: 355 TNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNK 414
+ L++ L F+ L +T+LNL N ++ + L TL ++NN+
Sbjct: 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQ 94
Query: 415 ISGSIPSPLGD-LEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPE---- 469
++ S+P + D L L KL L NQL G F L + E+ L+ N L IP
Sbjct: 95 LA-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFD 152
Query: 470 ELSQLQNMFSLRLDYNNL 487
+L+ LQ L L N L
Sbjct: 153 KLTNLQT---LSLSTNQL 167
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 43/166 (25%), Positives = 69/166 (41%), Gaps = 7/166 (4%)
Query: 323 IPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPP-AFQRLESM 381
+P + T+ DL + L T L LN+ N+L T+ F L +
Sbjct: 29 VPSGIPADTEKLDLQ--STGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTEL 85
Query: 382 TYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGD-LEHLLKLNLSRNQLT 440
L L+ N + + LD L + N++ S+PS + D L L +L L+ NQL
Sbjct: 86 GTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ 144
Query: 441 GFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNN 486
G F L ++ + LS N L V +L + ++ L + N
Sbjct: 145 SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITL-FGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 44/179 (24%), Positives = 61/179 (34%), Gaps = 31/179 (17%)
Query: 119 KSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVG 178
+ LDL L + L +L +L L NQ L L VF
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQ--------LQTLSA-GVFD-------- 80
Query: 179 TLSPDMCQLSGLWYFDVRNNSLTGSIPQNI-GNCTSFQVLDLSYNQLSGEIPFNI--GFL 235
L+ L + NN L S+P + + T L L NQL +P +
Sbjct: 81 -------DLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLT 131
Query: 236 QIATLSLQGNQLTGKIPS-VIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSN 293
++ L L NQL IP+ + L L LS N L L + + L N
Sbjct: 132 KLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 39/135 (28%), Positives = 56/135 (41%), Gaps = 6/135 (4%)
Query: 93 DLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSI-SKLKQLEFLILKNNQ 151
D + +DL+ L+ + L L+L +N+L + + L +L L L NNQ
Sbjct: 36 DTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANNQ 94
Query: 152 LIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMC-QLSGLWYFDVRNNSLTGSIPQNI-G 209
L L L L GN L +L + +L+ L + N L SIP
Sbjct: 95 LASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFD 152
Query: 210 NCTSFQVLDLSYNQL 224
T+ Q L LS NQL
Sbjct: 153 KLTNLQTLSLSTNQL 167
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 7e-16
Identities = 49/222 (22%), Positives = 87/222 (39%), Gaps = 38/222 (17%)
Query: 645 LETVGSIKHRNLVSLQGYSLSSSGNLLF-YDFMENGSLWDILHGPTKKKKLDWDTRLKIA 703
L V + +V + Y+ + L F D M G L L + + ++
Sbjct: 243 LSLVSTGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFS-EADMRFY 297
Query: 704 LGAAQ---GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTY 760
AA+ GL ++H + +++RD+K +NILLD+ ++D G+A SK
Sbjct: 298 --AAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACD--FSKKKPHAS 350
Query: 761 IMGTIGYIDPE-YARTSRLTEKSDVYSFGIVLLELLTGR-----KAVDNECNLHHLILSK 814
+ GT GY+ PE + +D +S G +L +LL G ++ + + L+
Sbjct: 351 V-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 409
Query: 815 TANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDR 856
+ S + L ++ LL R R
Sbjct: 410 A------VELPDSFSPELRSL--LEG-----LLQ--RDVNRR 436
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 8e-16
Identities = 56/286 (19%), Positives = 101/286 (35%), Gaps = 40/286 (13%)
Query: 597 TENLSEKY-------IIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETV 648
+ Y +G G+ S KCV K + + A+K + + E+ +
Sbjct: 3 DSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITAL 59
Query: 649 GSIK-HRNLVSLQGYSLSSSGNLLFYDFMENGSLWD-ILHGPTKKKKLDWDTRLKIALGA 706
+ H N+V L L + + G L++ I KKK I
Sbjct: 60 KLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIK----KKKHFSETEASYIMRKL 115
Query: 707 AQGLAYLHHDCSPRIIHRDVKSSNILL-DKDFEAHL--TDFGIAKSLCVSKSYTSTYIMG 763
++++H ++HRD+K N+L D++ + DFG A+ T
Sbjct: 116 VSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT-PCF 171
Query: 764 TIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVME- 822
T+ Y PE + E D++S G++L +L+G+ + + + +
Sbjct: 172 TLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG 231
Query: 823 TVD------PEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
+S KDL ++ LL P R M +
Sbjct: 232 DFSFEGEAWKNVSQEAKDL--IQG-----LLT--VDPNKRLKMSGL 268
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 57/284 (20%), Positives = 105/284 (36%), Gaps = 48/284 (16%)
Query: 598 ENLSEKYII----GYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIK 652
+ L EKY+I G G V++CV + K K + + E+ + +
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIAR 59
Query: 653 HRNLVSLQGYSLSSSGNLLFYDFMENGSLWD-ILHGPTKKKKLDWDTRLKIALGAAQ--- 708
HRN++ L S ++ ++F+ +++ I T +L +I Q
Sbjct: 60 HRNILHLHESFESMEELVMIFEFISGLDIFERIN---TSAFEL---NEREIVSYVHQVCE 113
Query: 709 GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHL--TDFGIAKSLCVSKSYTSTYIMGTIG 766
L +LH S I H D++ NI+ + + +FG A+ L ++ +
Sbjct: 114 ALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL--LFTAPE 168
Query: 767 YIDPEYARTSRLTEKSDVYSFGIVLLELLTGRK--AVDNECNLHHLILSKTANNAVMETV 824
Y PE + ++ +D++S G ++ LL+G + + N +
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN--------QQIIENIMNAEY 220
Query: 825 D------PEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
EIS D V + LL ++ R T E
Sbjct: 221 TFDEEAFKEISIEAMDF--VDR-----LLV--KERKSRMTASEA 255
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 2e-15
Identities = 65/214 (30%), Positives = 92/214 (42%), Gaps = 40/214 (18%)
Query: 605 IIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFET-ELETVGSIKHRNLVSLQGY 662
+IG G+ VY+ L + + VAIK++ K F+ EL+ + + H N+V L+ +
Sbjct: 61 VIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYF 115
Query: 663 SLSSSGNL------LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAA--------- 707
SS L D++ T + +R K L
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPE----------TVYRVARHYSRAKQTLPVIYVKLYMYQL 165
Query: 708 -QGLAYLHHDCSPRIIHRDVKSSNILLDKD-FEAHLTDFGIAKSLCVSKSYTSTYIMGTI 765
+ LAY+H S I HRD+K N+LLD D L DFG AK L + S YI +
Sbjct: 166 FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS-YIC-SR 220
Query: 766 GYIDPEYARTSRL-TEKSDVYSFGIVLLELLTGR 798
Y PE + T DV+S G VL ELL G+
Sbjct: 221 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 3e-15
Identities = 52/203 (25%), Positives = 88/203 (43%), Gaps = 17/203 (8%)
Query: 605 IIGYGASSTVYKCVLKNCKPV-AIKRLYSHYPQCLKEFE---TELETVGSIKHRNLVSLQ 660
++G G V+ C +K + A K+L + K ++ E + + + R +VSL
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 661 GYSLSSSGNLLF-YDFMENGSL-WDILHGPTKKKKLDWDTRLKIALGAAQ---GLAYLHH 715
Y+ + +L M G + + I + + R AQ GL +LH
Sbjct: 252 -YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ-EPRAIFY--TAQIVSGLEHLH- 306
Query: 716 DCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYART 775
II+RD+K N+LLD D ++D G+A L ++ T Y GT G++ PE
Sbjct: 307 --QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPELLLG 363
Query: 776 SRLTEKSDVYSFGIVLLELLTGR 798
D ++ G+ L E++ R
Sbjct: 364 EEYDFSVDYFALGVTLYEMIAAR 386
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 4e-15
Identities = 62/245 (25%), Positives = 95/245 (38%), Gaps = 27/245 (11%)
Query: 605 IIGYGASSTVYKCVLKNCKPV-AIKRLYSHYPQCLKE---FETELETVGSIKHRNLVSLQ 660
+IG GA V K+ + V A+K L + F E + + +V L
Sbjct: 76 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135
Query: 661 GYSLSSSGNLLFY-DFMENGSLWDILHGPTKKKKLDWD-TRLKIA-LGAAQGLAYLHHDC 717
Y+ L ++M G L +++ + R A + A L +H
Sbjct: 136 -YAFQDDRYLYMVMEYMPGGDLVNLM----SNYDVPEKWARFYTAEVVLA--LDAIH--- 185
Query: 718 SPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSR 777
S IHRDVK N+LLDK L DFG + +GT YI PE ++
Sbjct: 186 SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 245
Query: 778 LTEK----SDVYSFGIVLLELLTGR---KAVDNECNLHHLILSKTANNAVMETVDPEISA 830
D +S G+ L E+L G A D+ + I++ N++ D +IS
Sbjct: 246 GDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTYSKIMN--HKNSLTFPDDNDISK 302
Query: 831 TCKDL 835
K+L
Sbjct: 303 EAKNL 307
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 5e-15
Identities = 63/304 (20%), Positives = 116/304 (38%), Gaps = 55/304 (18%)
Query: 597 TENLSEKY-----IIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGS 650
+ + Y ++G GA + V C+ + A+K + E+E +
Sbjct: 7 SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQ 66
Query: 651 IK-HRNLVSLQGYSLSSSGNLLFYDFMENGSLWD-ILHGPTKKKKLD-WDTRLKIALGAA 707
+ HRN++ L + L ++ M GS+ I K++ + + + A
Sbjct: 67 CQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHI----HKRRHFNELEAS-VVVQDVA 121
Query: 708 QGLAYLHHDCSPRIIHRDVKSSNILL---DKDFEAHLTDFGIAKSLCVSKSYT--STYIM 762
L +LH + I HRD+K NIL ++ + DF + + ++ + ST +
Sbjct: 122 SALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL 178
Query: 763 ----GTIGYIDPE-----YARTSRLTEKSDVYSFGIVLLELLTG----RKAVDNECNLHH 809
G+ Y+ PE S ++ D++S G++L LL+G ++C
Sbjct: 179 LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR 238
Query: 810 LILSKTANNAVMETV--------DPE---ISATCKDLGAVKKVFQLALLCSKRQPTDRPT 858
N + E++ D + IS KDL + K LL R R +
Sbjct: 239 GEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDL--ISK-----LLV--RDAKQRLS 289
Query: 859 MHEV 862
+V
Sbjct: 290 AAQV 293
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 6e-15
Identities = 34/152 (22%), Positives = 64/152 (42%), Gaps = 10/152 (6%)
Query: 194 DVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNI--GFLQIATLSLQGNQLTGKI 251
D R LT IP N+ + L N + IP + ++ + L NQ++
Sbjct: 17 DCRGKGLT-EIPTNLPETI--TEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISELA 72
Query: 252 PSVIGLMQALAVLDLSCNMLSGPIPP-ILGNLSYTEKLYLHSNKLTGHIPPEL-GNMTKL 309
P +++L L L N ++ +P + L + L L++NK+ + + ++ L
Sbjct: 73 PDAFQGLRSLNSLVLYGNKITE-LPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNL 130
Query: 310 HYLELNDNQLTGHIPPALGKLTDLFDLNVANN 341
+ L L DN+L L + +++A N
Sbjct: 131 NLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 6e-13
Identities = 42/174 (24%), Positives = 66/174 (37%), Gaps = 33/174 (18%)
Query: 291 HSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDN 350
LT IP L + L N + IPP F
Sbjct: 19 RGKGLT-EIPTNLPETIT--EIRLEQNTIK-VIPP------GAFS--------------- 53
Query: 351 LSSCTNLNSLNVHGNKLNGTIPP-AFQRLESMTYLNLSLNNIRGPIPVEL-SRIGNLDTL 408
L +++ N+++ + P AFQ L S+ L L N I +P L + +L L
Sbjct: 54 --PYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITE-LPKSLFEGLFSLQLL 109
Query: 409 DMSNNKISGSIPSPLGD-LEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHN 461
++ NKI+ + L +L L+L N+L G F LR++ + L+ N
Sbjct: 110 LLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 42/164 (25%), Positives = 70/164 (42%), Gaps = 8/164 (4%)
Query: 352 SSCT-NLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDM 410
++CT + N ++ G L IP E++T + L N I+ P S L +D+
Sbjct: 7 AACTCSNNIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDL 63
Query: 411 SNNKISGSIPSPLGD-LEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPE 469
SNN+IS + L L L L N++T F L S+ + L+ N + + +
Sbjct: 64 SNNQIS-ELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVD 122
Query: 470 ELSQLQNMFSLRLDYNNLSGDVMSLINCL-SLSVLFI-GNPGLC 511
L N+ L L N L + L ++ + + NP +C
Sbjct: 123 AFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC 166
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 6e-08
Identities = 35/155 (22%), Positives = 60/155 (38%), Gaps = 10/155 (6%)
Query: 95 QSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIG 154
+D RG L+ +IP + ++ + L N + P + S K+L + L NNQ+
Sbjct: 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE 70
Query: 155 PIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQ-LSGLWYFDVRNNSLTGSIPQNI-GNCT 212
P L +L L GN + L + + L L + N + + + +
Sbjct: 71 LAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLH 128
Query: 213 SFQVLDLSYNQLSGEIPFNI--GFLQIATLSLQGN 245
+ +L L N+L I I T+ L N
Sbjct: 129 NLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 6e-06
Identities = 27/107 (25%), Positives = 49/107 (45%), Gaps = 7/107 (6%)
Query: 74 NLSGLNLDG----EISPAVGD-LKDLQSIDLRGNRLSGQIPDEIGDC-SSLKSLDLSFNE 127
L ++L E++P L+ L S+ L GN+++ ++P + + SL+ L L+ N+
Sbjct: 57 KLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANK 115
Query: 128 LYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGN 174
+ + L L L L +N+L T S L ++ L N
Sbjct: 116 INCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 8e-05
Identities = 26/88 (29%), Positives = 42/88 (47%), Gaps = 4/88 (4%)
Query: 91 LKDLQSIDLRGNRLSGQIPDEIGDC-SSLKSLDLSFNELYGDIPFSI-SKLKQLEFLILK 148
K L+ IDL N++S ++ + SL SL L N++ ++P S+ L L+ L+L
Sbjct: 55 YKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKI-TELPKSLFEGLFSLQLLLLN 112
Query: 149 NNQLIGPIPSTLSQLPNLKVFGLRGNNL 176
N++ L NL + L N L
Sbjct: 113 ANKINCLRVDAFQDLHNLNLLSLYDNKL 140
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 7e-15
Identities = 51/245 (20%), Positives = 89/245 (36%), Gaps = 21/245 (8%)
Query: 605 IIGYGASSTVYKCVLKNCKPV-AIKRLYSHYPQCLKE---FETELETVGSIKHRNLVSLQ 660
+IG GA S V +K V A+K + E F E + + + R + L
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127
Query: 661 GYSLSSSGNLLFY-DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSP 719
++ L ++ G L +L ++ + R +A + +H
Sbjct: 128 -FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEM-ARFYLA-EIVMAIDSVH---RL 181
Query: 720 RIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLT 779
+HRD+K NILLD+ L DFG L + S +GT Y+ PE +
Sbjct: 182 GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGG 241
Query: 780 EKSDVY-------SFGIVLLELLTGRK--AVDNECNLHHLILSKTANNAVMETVDPEISA 830
+ Y + G+ E+ G+ D+ + I+ + + VD +
Sbjct: 242 PGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK-EHLSLPLVDEGVPE 300
Query: 831 TCKDL 835
+D
Sbjct: 301 EARDF 305
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 1e-14
Identities = 54/220 (24%), Positives = 91/220 (41%), Gaps = 34/220 (15%)
Query: 663 SLSSSGNLLFYDFMENGSLWDILH----GPTKKKKLDWDTRLKIALGAAQGLAYLHHDCS 718
S++SS + F+E SL D+ K L + + + A+G+ +L S
Sbjct: 155 SITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---AS 211
Query: 719 PRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYID-----PEYA 773
+ IHRD+ + NILL + + DFG+A+ + Y+ + PE
Sbjct: 212 RKCIHRDLAARNILLSEKNVVKICDFGLARDI----YKDPDYVRKGDARLPLKWMAPETI 267
Query: 774 RTSRLTEKSDVYSFGIVLLELLT-GRK---AVDNECNLHHLILSKTANNAVMETVDPEIS 829
T +SDV+SFG++L E+ + G V + + T M P+
Sbjct: 268 FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT----RMRA--PD-- 319
Query: 830 ATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869
+++Q L C +P+ RPT E+ LG+L
Sbjct: 320 ------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 1e-14
Identities = 31/142 (21%), Positives = 60/142 (42%), Gaps = 7/142 (4%)
Query: 347 IPDNLSSCTNLNSLNVHGNKLNGTIPP--AFQRLESMTYLNLSLNNIRGPIPVELSRIGN 404
IP+++ L ++ N+ + F++L + +N S N I
Sbjct: 26 IPEHIP--QYTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASG 82
Query: 405 LDTLDMSNNKISGSIPSPLGD-LEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHL 463
++ + +++N++ ++ + LE L L L N++T F L SV + L N +
Sbjct: 83 VNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQI 141
Query: 464 TGVIPEELSQLQNMFSLRLDYN 485
T V P L ++ +L L N
Sbjct: 142 TTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 2e-13
Identities = 28/136 (20%), Positives = 60/136 (44%), Gaps = 9/136 (6%)
Query: 283 SYTEKLYLHSNKLTGHIPPE--LGNMTKLHYLELNDNQLTGHIPP-ALGKLTDLFDLNVA 339
YT +L L++N+ T + + +L + ++N++T I A + + ++ +
Sbjct: 32 QYTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLT 89
Query: 340 NNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPP-AFQRLESMTYLNLSLNNIRGPIPVE 398
+N LE +L +L + N++ + +F L S+ L+L N I +
Sbjct: 90 SNRLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPG 147
Query: 399 -LSRIGNLDTLDMSNN 413
+ +L TL++ N
Sbjct: 148 AFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 5e-11
Identities = 23/110 (20%), Positives = 42/110 (38%), Gaps = 1/110 (0%)
Query: 380 SMTYLNLSLNNIRG-PIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQ 438
L L+ N ++ L ++ SNNKI+ + ++ L+ N+
Sbjct: 33 YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNR 92
Query: 439 LTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLS 488
L F L S+ + L N +T V + L ++ L L N ++
Sbjct: 93 LENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT 142
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 33/158 (20%), Positives = 52/158 (32%), Gaps = 33/158 (20%)
Query: 95 QSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSI-SKLKQLEFLILKNNQLI 153
++D +L+ +IP+ I L L+ NE I KL QL + NN++
Sbjct: 14 TTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT 70
Query: 154 GPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTS 213
+ L N L + M F S
Sbjct: 71 DIEEGAFEGASGVNEILLTSNRLE-NVQHKM--------FK---------------GLES 106
Query: 214 FQVLDLSYNQLSGEIP---FNIGFLQIATLSLQGNQLT 248
+ L L N+++ + F G + LSL NQ+T
Sbjct: 107 LKTLMLRSNRIT-CVGNDSFI-GLSSVRLLSLYDNQIT 142
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 25/107 (23%), Positives = 38/107 (35%), Gaps = 7/107 (6%)
Query: 74 NLSGLNLDG----EISPAVGD-LKDLQSIDLRGNRLSGQIPDEIGD-CSSLKSLDLSFNE 127
L +N +I + + I L NRL + ++ SLK+L L N
Sbjct: 58 QLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLEN-VQHKMFKGLESLKTLMLRSNR 116
Query: 128 LYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGN 174
+ S L + L L +NQ+ P L +L L N
Sbjct: 117 ITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 8e-05
Identities = 17/89 (19%), Positives = 43/89 (48%), Gaps = 4/89 (4%)
Query: 90 DLKDLQSIDLRGNRLSGQIPDEIGDC-SSLKSLDLSFNELYGDIPFSI-SKLKQLEFLIL 147
L L+ I+ N+++ I + + S + + L+ N L ++ + L+ L+ L+L
Sbjct: 55 KLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRL-ENVQHKMFKGLESLKTLML 112
Query: 148 KNNQLIGPIPSTLSQLPNLKVFGLRGNNL 176
++N++ + L ++++ L N +
Sbjct: 113 RSNRITCVGNDSFIGLSSVRLLSLYDNQI 141
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-14
Identities = 59/244 (24%), Positives = 96/244 (39%), Gaps = 21/244 (8%)
Query: 605 IIGYGASSTVYKCVLKNCKPV-AIKRLYSHYPQCLKE---FETELETVGSIKHRNLVSLQ 660
+IG GA V LKN V A+K L E F E + + + + + +L
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH 140
Query: 661 GYSLSSSGNLLFY-DFMENGSLWDILHGPTKKKKLDWDTRLKIA-LGAAQGLAYLHHDCS 718
Y+ NL D+ G L +L + + R +A + A + +H
Sbjct: 141 -YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEM-ARFYLAEMVIA--IDSVH---Q 193
Query: 719 PRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRL 778
+HRD+K NIL+D + L DFG L + S+ +GT YI PE +
Sbjct: 194 LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEG 253
Query: 779 TEKS-----DVYSFGIVLLELLTGRK--AVDNECNLHHLILSKTANNAVMETVDPEISAT 831
+ D +S G+ + E+L G ++ + I++ T ++S
Sbjct: 254 GKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK-ERFQFPTQVTDVSEN 312
Query: 832 CKDL 835
KDL
Sbjct: 313 AKDL 316
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 3e-14
Identities = 72/336 (21%), Positives = 115/336 (34%), Gaps = 66/336 (19%)
Query: 555 RPHNPTHFPDGSLDKPVNYSTPKLVILHMNMALHVYEDIMRMTENLSEKY-----IIGYG 609
+P P + P HV + + + Y ++G G
Sbjct: 22 QPPTPALPHPPAQPPPPPPQQFP--------QFHVKSGLQIKKNAIIDDYKVTSQVLGLG 73
Query: 610 ASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQG-YSLSSS 667
+ V + K + A+K L P+ +E E ++V + Y +
Sbjct: 74 INGKVLQIFNKRTQEKFALKML-QDCPKARREVELHWRASQ---CPHIVRIVDVYENLYA 129
Query: 668 GNLLFY---DFMENGSLWD-ILHGPTKKKKLDWDTR-----LKIALGAAQGLAYLHHDCS 718
G + ++ G L+ I + + R +K A + YLH S
Sbjct: 130 GRKCLLIVMECLDGGELFSRIQ----DRGDQAFTEREASEIMKSIGEA---IQYLH---S 179
Query: 719 PRIIHRDVKSSNILL-DKDFEAHL--TDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYART 775
I HRDVK N+L K A L TDFG AK S T+ T Y+ PE
Sbjct: 180 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPEVLGP 237
Query: 776 SRLTEKSDVYSFGIVLLELLTGR------KAVDNECNLHHLILSKTANNAVMETVDPE-- 827
+ + D++S G+++ LL G + + I E +PE
Sbjct: 238 EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM-----GQYEFPNPEWS 292
Query: 828 -ISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
+S K L ++ LL +PT R T+ E
Sbjct: 293 EVSEEVKML--IRN-----LLK--TEPTQRMTITEF 319
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 76.0 bits (186), Expect = 3e-14
Identities = 101/626 (16%), Positives = 186/626 (29%), Gaps = 196/626 (31%)
Query: 257 LMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLT-GHIP-PELGNMTKLHYLEL 314
LM + P + ++LY + ++ + + LEL
Sbjct: 94 LMSPIKT---EQR---QPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLEL 147
Query: 315 NDNQ-LTGHIPPALGK--LTDLFDLNVANNH-LEGPIPD-----NLSSCTNLNSLNVHGN 365
+ + GK + L+V ++ ++ + NL +C + ++
Sbjct: 148 RPAKNVLIDGVLGSGKTWVA----LDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQ 203
Query: 366 KLNGTIPPAF-QRLESMTYLNLSLNNIRGPIPVELSRIGN----------LDTLDMSNNK 414
KL I P + R + + + L +++I+ EL R+ L ++ N K
Sbjct: 204 KLLYQIDPNWTSRSDHSSNIKLRIHSIQA----ELRRLLKSKPYENCLLVLL--NVQNAK 257
Query: 415 ISGSIPSPLGDLEHL-LK---LNLSRN-QLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPE 469
L L +R Q+T F+ + I L H H + P+
Sbjct: 258 A----------WNAFNLSCKILLTTRFKQVTDFLSAA-----TTTHISLDH-HSMTLTPD 301
Query: 470 ELSQLQNMFS--LRLDYNNLSGDVMSLINCLSLSVLFIG-----NPGLCGYWLHSACRDS 522
E+ L L +L +V++ N LS+ I W H C
Sbjct: 302 EVKSL---LLKYLDCRPQDLPREVLT-TNPRRLSI--IAESIRDGLATWDNWKHVNC--- 352
Query: 523 HPTERVTISKAAILGIALGALVILLMILVAACRPHNPTH----------FPDGSLDKPVN 572
+++T I+ +L L P FP +
Sbjct: 353 ---DKLT----TIIESSLNVL--------------EPAEYRKMFDRLSVFPPS-----AH 386
Query: 573 YSTPKLVILHMNMALHVYEDIMRMTENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYS 632
T L ++ ++ + D+M + L + V K K I + S
Sbjct: 387 IPTILLSLIWFDV---IKSDVMVVVNKLHKY------------SLVEKQPKESTI-SIPS 430
Query: 633 HYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKK 692
Y + + E E HR++V Y+ + D++
Sbjct: 431 IYLELKVKLENEYA-----LHRSIVD-------------HYNIPKTFDSDDLI-----PP 467
Query: 693 KLD--WDTRLKIALGAAQGLAYL-HHDCSPRIIHRDVKSSNILLDKDF-EAHLTDFGIAK 748
LD + +++ HH + R + LD F E + A
Sbjct: 468 YLDQYF-------------YSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAW 514
Query: 749 SLCVS--------KSYTSTYIMGTIGYI---DPEYARTSRLTEKSDVYSFGIVLLELLTG 797
+ S K Y YI DP+Y R + + + F L +
Sbjct: 515 NASGSILNTLQQLKFYKP--------YICDNDPKYER--LV---NAILDF----LPKIEE 557
Query: 798 RKAVDNECNLHHLILSKTANNAVMET 823
+L + L + A+ E
Sbjct: 558 NLICSKYTDLLRIALM-AEDEAIFEE 582
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 59.5 bits (143), Expect = 5e-09
Identities = 85/583 (14%), Positives = 175/583 (30%), Gaps = 165/583 (28%)
Query: 4 RLEFILLLVFLFCLSFGSVDSEDGATLLKIKKSFRDVDNVLYDW--------TDSPSSD- 54
+ L L + + ++K +V + Y + PS
Sbjct: 60 AVSGTLRLFWTLLSKQEEM----------VQKFVEEVLRINYKFLMSPIKTEQRQPSMMT 109
Query: 55 --YCVWRGITC-DNVTFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDE 111
Y R DN F N+S L ++ A+ +L+ +++ + G SG+
Sbjct: 110 RMYIEQRDRLYNDNQVFA--KYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGK---- 163
Query: 112 IGDCSSLKSLDLSFNELYGDIPF-----SISKLKQLEFLILKNNQLIGPIPSTLSQLP-- 164
+ + ++ + F ++ E ++ +L+ I +
Sbjct: 164 ----TWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDH 219
Query: 165 --NLKVFGLRGNNLVGTLSPDMCQ---------LSGLW------YFDV--------RNNS 199
N+K LR +++ L + L + F++ R
Sbjct: 220 SSNIK---LRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQ 276
Query: 200 LTGSIPQN-------IGNCTSF----------QVLDLSYNQLSGEI----PFNIGFLQIA 238
+T + + + + LD L E+ P + IA
Sbjct: 277 VTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLS--IIA 334
Query: 239 TL------------SLQGNQLTGKIPSVI---------GLMQALAVLDLSCNMLSGPIPP 277
+ ++LT I S + + L+V S + IP
Sbjct: 335 ESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAH-----IPT 389
Query: 278 ----IL-GNLSYTEKLY----LHSNKLTGHIPPELGNMTKLH--YLEL---NDNQLTGHI 323
++ ++ ++ + LH L P E + + YLEL +N+ H
Sbjct: 390 ILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKE--STISIPSIYLELKVKLENEYALHR 447
Query: 324 PPALGKLTDLFDLNVA--NNHLEGPIPDNLSSCTNLNSLNVH-GNKLNGTIPPAFQRLES 380
+ D +++ ++ L P D + + H N + F+ +
Sbjct: 448 -----SIVDHYNIPKTFDSDDLIPPYLDQYF----YSHIGHHLKNIEHPERMTLFRMV-- 496
Query: 381 MTYLNLSL--NNIRGPIPVELSRIGNLDTL-DMSNNK--ISGSIPSP---LGDLEHLLKL 432
+L+ IR + L+TL + K I + P + + L
Sbjct: 497 --FLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLP- 553
Query: 433 NLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQ 475
+ N I ++ +L + I L + E Q+Q
Sbjct: 554 KIEEN----LICSKYTDL---LRIALMAED-EAIFEEAHKQVQ 588
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-13
Identities = 36/115 (31%), Positives = 59/115 (51%), Gaps = 15/115 (13%)
Query: 283 SYTEKLYLHSNKLTGHIPPE--LGNMTKLHYLELNDNQLTGHIPP-ALGKLTDLFDLNVA 339
+T +L L+ N+L I + G + L LEL NQLTG I P A + + +L +
Sbjct: 29 LHTTELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLTG-IEPNAFEGASHIQELQLG 86
Query: 340 NNHLEGPIP----DNLSSCTNLNSLNVHGNKLNGTIPP-AFQRLESMTYLNLSLN 389
N ++ I L L +LN++ N+++ + P +F+ L S+T LNL+ N
Sbjct: 87 ENKIKE-ISNKMFLGL---HQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 3e-06
Identities = 41/173 (23%), Positives = 59/173 (34%), Gaps = 54/173 (31%)
Query: 291 HSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDN 350
L IP ++ T L LNDN+L I LF
Sbjct: 16 TGRGLKE-IPRDIPLHTT--ELLLNDNELG-RISS-----DGLFG--------------- 51
Query: 351 LSSCTNLNSLNVHGNKLNGTIPP-AFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLD 409
+L L + N+L I P AF+ + L L
Sbjct: 52 --RLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQL----------------------- 85
Query: 410 MSNNKISGSIPSPLGD-LEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHN 461
NKI I + + L L LNL NQ++ +PG F +L S+ ++L+ N
Sbjct: 86 -GENKIK-EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 6e-06
Identities = 24/109 (22%), Positives = 47/109 (43%), Gaps = 4/109 (3%)
Query: 380 SMTYLNLSLNNIRG-PIPVELSRIGNLDTLDMSNNKISGSIPSPLGD-LEHLLKLNLSRN 437
T L L+ N + R+ +L L++ N+++ I + H+ +L L N
Sbjct: 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGEN 88
Query: 438 QLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNN 486
++ F L + ++L N ++ V+P L ++ SL L +N
Sbjct: 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNL-ASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 28/88 (31%), Positives = 39/88 (44%), Gaps = 9/88 (10%)
Query: 406 DTLDMSNNKISGSIPSPLGD-LEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLT 464
L +++N++ L L HL+KL L RNQLTG P F + E+ L N +
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK 91
Query: 465 GVIPE----ELSQLQNMFSLRLDYNNLS 488
I L QL+ L L N +S
Sbjct: 92 -EISNKMFLGLHQLKT---LNLYDNQIS 115
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 1e-13
Identities = 57/249 (22%), Positives = 106/249 (42%), Gaps = 27/249 (10%)
Query: 564 DGSLDKPVNYSTPKLVILHMNMALHVYEDIMRMTENLSEKY----IIGYGASSTVYKCV- 618
D +D + ++ + E + T + ++Y IG GA V
Sbjct: 25 DKQVDVSYIAKHYNMSKSKVDNQFYSVE-VGDSTFTVLKRYQNLKPIGSGAQGIVCAAYD 83
Query: 619 LKNCKPVAIKRLY---SHYPQCLKEFETELETVGSIKHRNLVSLQ-----GYSLSSSGNL 670
+ VAIK+L + + + EL + + H+N++SL +L ++
Sbjct: 84 AVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 142
Query: 671 -LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSS 729
L + M+ +L ++ + +LD + + G+ +LH S IIHRD+K S
Sbjct: 143 YLVMELMDA-NLCQVI-----QMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPS 193
Query: 730 NILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGI 789
NI++ D + DFG+A++ S T Y++ T Y PE E D++S G
Sbjct: 194 NIVVKSDCTLKILDFGLARTAGTSFMMTP-YVV-TRYYRAPEVILGMGYKENVDIWSVGC 251
Query: 790 VLLELLTGR 798
++ E++ +
Sbjct: 252 IMGEMVRHK 260
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 53/227 (23%), Positives = 89/227 (39%), Gaps = 48/227 (21%)
Query: 602 EKYIIGYGASSTVYKCVLKNCKP---VAIKRLYSHYPQCLKEFETELETVGSI------K 652
E +G G VYK K+ K A+K++ + + I K
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI--------EGTGISMSACREIALLRELK 76
Query: 653 HRNLVSLQGYSLSSSGNLLF--YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAA--- 707
H N++SLQ LS + ++ +D+ E+ LW I+ K +L + +
Sbjct: 77 HPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLY 135
Query: 708 ---QGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAH----LTDFGIAKSLCV-SKSYTS- 758
G+ YLH + ++HRD+K +NIL+ + + D G A+ K
Sbjct: 136 QILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 192
Query: 759 TYIMGTIGYIDPE-------YARTSRLTEKSDVYSFGIVLLELLTGR 798
++ T Y PE Y T+ D+++ G + ELLT
Sbjct: 193 DPVVVTFWYRAPELLLGARHY------TKAIDIWAIGCIFAELLTSE 233
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 50/201 (24%), Positives = 87/201 (43%), Gaps = 22/201 (10%)
Query: 606 IGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFE---TELETVGSIKHRNLVSLQG 661
+G G+ V K + A+K L LK+ E E + ++ LV L+
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE- 107
Query: 662 YSLSSSGNLLF-YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQ---GLAYLHHDC 717
+S + NL +++ G ++ L + + + + AAQ YLH
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFS-EPHARFY--AAQIVLTFEYLH--- 158
Query: 718 SPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSR 777
S +I+RD+K N+L+D+ +TDFG AK + K T T GT + PE +
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV---KGRTWTLC-GTPEALAPEIILSKG 214
Query: 778 LTEKSDVYSFGIVLLELLTGR 798
+ D ++ G+++ E+ G
Sbjct: 215 YNKAVDWWALGVLIYEMAAGY 235
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 49/307 (15%), Positives = 96/307 (31%), Gaps = 60/307 (19%)
Query: 261 LAVLDLSCNMLSG----PIPPILGNLSYTEKLYLHSNKLTG----HIPPELGNMTKLHYL 312
+ L + ++ + +L +++ L N + + + + L
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 313 ELNDNQL----------TGHIPPALGKLTDLFDLNVANNHL--EG--PIPDNLSSCTNLN 358
E +D + AL K L + +++N P+ D LS T L
Sbjct: 66 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 125
Query: 359 SLNVHGNKL-------------NGTIPPAFQRLESMTYLNLSLNNIRGP----IPVELSR 401
L +H N L + + + + N +
Sbjct: 126 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 185
Query: 402 IGNLDTLDMSNNKI-----SGSIPSPLGDLEHLLKLNLSRNQLTG----FIPGEFGNLRS 452
L T+ M N I + L + L L+L N T + + +
Sbjct: 186 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 245
Query: 453 VMEIDLSHNHLT--GV--IPEELSQLQN--MFSLRLDYNNLSGDVMSLI------NCLSL 500
+ E+ L+ L+ G + + S+L+N + +LRL YN + D + + L
Sbjct: 246 LRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDL 305
Query: 501 SVLFIGN 507
L +
Sbjct: 306 LFLELNG 312
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 5e-13
Identities = 53/361 (14%), Positives = 109/361 (30%), Gaps = 86/361 (23%)
Query: 117 SLKSLDLSFNELYGD-----IPFSISKLKQLEFLILKNNQLIGP-----IPSTLSQLPNL 166
S++ L + + + + + ++ ++L N IG + ++ +L
Sbjct: 5 SIEGKSLKLDAI-TTEDEKSVFAVLLEDDSVKEIVLSGNT-IGTEAARWLSENIASKKDL 62
Query: 167 KVFGLRGN--NLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQL 224
++ V P+ + + Q + C + LS N
Sbjct: 63 EIAEFSDIFTGRVKDEIPEALR----------------LLLQALLKCPKLHTVRLSDNAF 106
Query: 225 SGEIPFNIG-FLQ----IATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPIL 279
+ FL + L L N L + + +AL L ++ + P
Sbjct: 107 GPTAQEPLIDFLSKHTPLEHLYLHNNGLG--PQAGAKIARALQELAVNKKAKNAP----- 159
Query: 280 GNLSYTEKLYLHSNKLTG----HIPPELGNMTKLHYLELNDNQLTGH-IPPALGKLTDLF 334
L + N+L + LH +++ N + I L +
Sbjct: 160 -PL---RSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEG---- 211
Query: 335 DLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGT----IPPAFQRLESMTYLNLSLNN 390
L+ C L L++ N + A + ++ L L+
Sbjct: 212 ----------------LAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCL 255
Query: 391 IRGP----IPVELSRIGN--LDTLDMSNNKISGSIPSPLGD-----LEHLLKLNLSRNQL 439
+ + S++ N L TL + N+I L + LL L L+ N+
Sbjct: 256 LSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315
Query: 440 T 440
+
Sbjct: 316 S 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 8e-13
Identities = 53/366 (14%), Positives = 117/366 (31%), Gaps = 68/366 (18%)
Query: 92 KDLQSIDLRGNRLSGQ----IPDEIGDCSSLKSLDLSFNELYGD-----IPFSISKLKQL 142
++ L+ + ++ + + + + S+K + LS N + G + +I+ K L
Sbjct: 4 FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTI-GTEAARWLSENIASKKDL 62
Query: 143 EFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTG 202
E + G +K + L + + L + +N+
Sbjct: 63 EIAEFSDIF-TG----------RVKDEIPEA---LRLLLQALLKCPKLHTVRLSDNAFGP 108
Query: 203 SIPQNIG----NCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLM 258
+ + + T + L L N L + +IA +LQ +
Sbjct: 109 TAQEPLIDFLSKHTPLEHLYLHNNGLGPQ-----AGAKIAR-ALQELAVN----KKAKNA 158
Query: 259 QALAVLDLSCNMLSGP----IPPILGNLSYTEKLYLHSNKLTGH-----IPPELGNMTKL 309
L + N L + + + N + + L +L
Sbjct: 159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQEL 218
Query: 310 HYLELNDNQLTG----HIPPALGKLTDLFDLNVANNHL--EG--PIPDNLSSCTN--LNS 359
L+L DN T + AL +L +L + + L G + D S N L +
Sbjct: 219 KVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQT 278
Query: 360 LNVHGNKLNGTIPPAF-----QRLESMTYLNLSLNNIR--GPIPVELSRI----GNLDTL 408
L + N++ +++ + +L L+ N + E+ + G +
Sbjct: 279 LRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELD 338
Query: 409 DMSNNK 414
++ + +
Sbjct: 339 ELDDME 344
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 8e-04
Identities = 22/177 (12%), Positives = 50/177 (28%), Gaps = 48/177 (27%)
Query: 73 LNLSGLNLDGE----ISPAVGDLKDLQSIDLRGNRLSGQ-----IPDEIGDCSSLKSLDL 123
+ L+ + + L ++ + N + + + + + C LK LDL
Sbjct: 164 IICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDL 223
Query: 124 SFNELYGD-----IPFSISKLKQLEFLILKNNQLIGP-----IPSTLSQLPNLKVFGLRG 173
N + ++ L L L + + + S+L N+
Sbjct: 224 QDNTF-THLGSSALAIALKSWPNLRELGLNDCL-LSARGAAAVVDAFSKLENIG------ 275
Query: 174 NNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIG-----NCTSFQVLDLSYNQLS 225
L ++ N + + + L+L+ N+ S
Sbjct: 276 ----------------LQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 5e-13
Identities = 30/90 (33%), Positives = 47/90 (52%), Gaps = 5/90 (5%)
Query: 709 GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYI 768
GL LH RI++RD+K NILLD ++D G+A + + GT+GY+
Sbjct: 298 GLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHV-PEGQTIKGRV-GTVGYM 352
Query: 769 DPEYARTSRLTEKSDVYSFGIVLLELLTGR 798
PE + R T D ++ G +L E++ G+
Sbjct: 353 APEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 5e-13
Identities = 33/108 (30%), Positives = 54/108 (50%), Gaps = 5/108 (4%)
Query: 709 GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYI 768
L YLH + + +++RD+K N++LDKD +TDFG+ K + T+ GT Y+
Sbjct: 260 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYL 316
Query: 769 DPEYARTSRLTEKSDVYSFGIVLLELLTGRK--AVDNECNLHHLILSK 814
PE + D + G+V+ E++ GR + L LIL +
Sbjct: 317 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 364
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 9e-13
Identities = 58/227 (25%), Positives = 101/227 (44%), Gaps = 32/227 (14%)
Query: 589 VYEDIMRMTENLSEKY----IIGYGASSTVYKCV-LKNCKPVAIKRL---YSHYPQCLKE 640
+I T + ++Y IG GA V + VAIK+L + + +
Sbjct: 12 YSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRA 71
Query: 641 FETELETVGSIKHRNLVSLQ-----GYSLSSSGNL-LFYDFMENGSLWDILHGPTKKKKL 694
+ EL + + H+N++ L SL ++ + + M+ +L ++ + +L
Sbjct: 72 YR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI-----QMEL 124
Query: 695 DWDTRLKIALGAAQ---GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLC 751
D R+ L Q G+ +LH S IIHRD+K SNI++ D + DFG+A++
Sbjct: 125 D-HERMSYLL--YQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178
Query: 752 VSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGR 798
S T Y++ T Y PE E D++S G ++ E++ G
Sbjct: 179 TSFMMTP-YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 1e-12
Identities = 36/108 (33%), Positives = 57/108 (52%), Gaps = 6/108 (5%)
Query: 709 GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYI 768
L +LH S II+RD+K NILLD++ LTDFG++K + ++ GT+ Y+
Sbjct: 138 ALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYM 193
Query: 769 DPEYARTSRLTEKSDVYSFGIVLLELLTGRK--AVDNECNLHHLILSK 814
PE T+ +D +SFG+++ E+LTG + +IL
Sbjct: 194 APEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA 241
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 1e-12
Identities = 46/150 (30%), Positives = 66/150 (44%), Gaps = 21/150 (14%)
Query: 709 GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYI 768
L +LH II+RD+K NI+L+ LTDFG+ K + T T+ GTI Y+
Sbjct: 133 ALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC-GTIEYM 188
Query: 769 DPEYARTSRLTEKSDVYSFGIVLLELLTGRK--AVDNECNLHHLILSKTANNAVMETVDP 826
PE S D +S G ++ ++LTG +N IL N + P
Sbjct: 189 APEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLN------LPP 242
Query: 827 EISATCKDLGAVKKVFQLALLCSKRQPTDR 856
++ +DL +KK LL KR R
Sbjct: 243 YLTQEARDL--LKK-----LL--KRNAASR 263
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 50/246 (20%), Positives = 84/246 (34%), Gaps = 54/246 (21%)
Query: 598 ENLSEKY----IIGYGASSTVYKCVLKNC-KPVAIKRLYSHYPQCLKEFETELETVGSIK 652
E S+KY +G G+ V + K A+K++ +E L+ + +
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRE----LDIMKVLD 58
Query: 653 HRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTR------------- 699
H N++ L Y ++ +
Sbjct: 59 HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118
Query: 700 ---------LKIALGAAQ----------------GLAYLHHDCSPRIIHRDVKSSNILLD 734
LK + + + + ++H S I HRD+K N+L++
Sbjct: 119 YVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVN 175
Query: 735 -KDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRL-TEKSDVYSFGIVLL 792
KD L DFG AK L S+ + YI + Y PE + T D++S G V
Sbjct: 176 SKDNTLKLCDFGSAKKLIPSEPSVA-YIC-SRFYRAPELMLGATEYTPSIDLWSIGCVFG 233
Query: 793 ELLTGR 798
EL+ G+
Sbjct: 234 ELILGK 239
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 45/235 (19%), Positives = 84/235 (35%), Gaps = 35/235 (14%)
Query: 588 HVYEDIMRMTENLSEKY----IIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKE--F 641
D++ + Y I G+ V V PVAIKR+++
Sbjct: 8 AAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNIL 67
Query: 642 ET---------ELETVGSIKHRNLVSLQGYSLSSSGNL-----LFYDFMENGSLWDILHG 687
E+ + H N++ L+ + L + M L ++H
Sbjct: 68 SDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIH- 125
Query: 688 PTKKKKLDWDTRLKIALGAAQ---GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDF 744
++ + ++ + GL LH ++HRD+ NILL + + + DF
Sbjct: 126 -DQRIVIS-PQHIQYFM--YHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDF 178
Query: 745 GIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRL-TEKSDVYSFGIVLLELLTGR 798
+A+ + T Y+ Y PE + T+ D++S G V+ E+ +
Sbjct: 179 NLAREDTADANKTH-YVT-HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 3e-12
Identities = 36/90 (40%), Positives = 52/90 (57%), Gaps = 4/90 (4%)
Query: 709 GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYI 768
GL +LH S I++RD+K NILLDKD + DFG+ K + + T+T+ GT YI
Sbjct: 130 GLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYI 185
Query: 769 DPEYARTSRLTEKSDVYSFGIVLLELLTGR 798
PE + D +SFG++L E+L G+
Sbjct: 186 APEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 40/108 (37%), Positives = 51/108 (47%), Gaps = 6/108 (5%)
Query: 709 GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYI 768
L YLH S I++RD+K NILLD LTDFG+ K S TST+ GT Y+
Sbjct: 151 ALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC-GTPEYL 206
Query: 769 DPEYARTSRLTEKSDVYSFGIVLLELLTGRK--AVDNECNLHHLILSK 814
PE D + G VL E+L G N ++ IL+K
Sbjct: 207 APEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK 254
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 4e-12
Identities = 34/108 (31%), Positives = 53/108 (49%), Gaps = 6/108 (5%)
Query: 709 GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYI 768
L YLH S +++RD+K N++LDKD +TDFG+ K + T+ GT Y+
Sbjct: 117 ALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYL 172
Query: 769 DPEYARTSRLTEKSDVYSFGIVLLELLTGRK--AVDNECNLHHLILSK 814
PE + D + G+V+ E++ GR + L LIL +
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME 220
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 4e-12
Identities = 45/178 (25%), Positives = 63/178 (35%), Gaps = 51/178 (28%)
Query: 285 TEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLE 344
+ LYLH N++T P ++ L L L NQL L
Sbjct: 42 AQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA---------------------LP 80
Query: 345 GPIPDNLSSCTNLNSLNVHGNKLNGTIPP-AFQRLESMTYLNLSLNNIRGPIPVELSRIG 403
+ D+L T L L++ N+L +P F RL
Sbjct: 81 VGVFDSL---TQLTVLDLGTNQLT-VLPSAVFDRL------------------------V 112
Query: 404 NLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHN 461
+L L M NK++ +P + L HL L L +NQL G F L S+ L N
Sbjct: 113 HLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-11
Identities = 45/171 (26%), Positives = 72/171 (42%), Gaps = 38/171 (22%)
Query: 194 DVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNI--GFLQIATLSLQGNQLTGKI 251
D R+ S+P I T+ Q+L L NQ++ ++ + + + L L NQL +
Sbjct: 25 DCRSKRHA-SVPAGIP--TNAQILYLHDNQIT-KLEPGVFDSLINLKELYLGSNQLG-AL 79
Query: 252 PSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPEL-GNMTKLH 310
P V D +L+ L L +N+LT +P + + L
Sbjct: 80 PV--------GVFD---------------SLTQLTVLDLGTNQLTV-LPSAVFDRLVHLK 115
Query: 311 YLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIP----DNLSSCTNL 357
L + N+LT +P + +LT L L + N L+ IP D LSS T+
Sbjct: 116 ELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKS-IPHGAFDRLSSLTHA 164
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 4e-11
Identities = 41/129 (31%), Positives = 67/129 (51%), Gaps = 5/129 (3%)
Query: 263 VLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPEL-GNMTKLHYLELNDNQLTG 321
+L L N ++ P + +L ++LYL SN+L +P + ++T+L L+L NQLT
Sbjct: 44 ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-LPVGVFDSLTQLTVLDLGTNQLTV 102
Query: 322 HIPPAL-GKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLES 380
+P A+ +L L +L + N L +P + T+L L + N+L AF RL S
Sbjct: 103 -LPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSS 160
Query: 381 MTYLNLSLN 389
+T+ L N
Sbjct: 161 LTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 35/134 (26%), Positives = 61/134 (45%), Gaps = 6/134 (4%)
Query: 355 TNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVEL-SRIGNLDTLDMSNN 413
TN L +H N++ P F L ++ L L N + +PV + + L LD+ N
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-LPVGVFDSLTQLTVLDLGTN 98
Query: 414 KISGSIPSPLGD-LEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELS 472
+++ +PS + D L HL +L + N+LT +P L + + L N L +
Sbjct: 99 QLT-VLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHGAFD 156
Query: 473 QLQNMFSLRLDYNN 486
+L ++ L + N
Sbjct: 157 RLSSLTHAYL-FGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 37/133 (27%), Positives = 52/133 (39%), Gaps = 10/133 (7%)
Query: 95 QSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIG 154
++D R R + +P I ++ + L L N++ P L L+ L L +NQL
Sbjct: 22 TTVDCRSKRHAS-VPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA 78
Query: 155 PIPSTLSQLPNLKVFGLRGNNLVGTLSP---DMCQLSGLWYFDVRNNSLTGSIPQNIGNC 211
L L V L N L L D +L L + N LT +P+ I
Sbjct: 79 LPVGVFDSLTQLTVLDLGTNQLT-VLPSAVFD--RLVHLKELFMCCNKLT-ELPRGIERL 134
Query: 212 TSFQVLDLSYNQL 224
T L L NQL
Sbjct: 135 THLTHLALDQNQL 147
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 40/146 (27%), Positives = 59/146 (40%), Gaps = 31/146 (21%)
Query: 194 DVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNI--GFLQIATLSLQGNQLTGKI 251
+ +N +T P + + + L L NQL +P + Q+ L L NQLT +
Sbjct: 46 YLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT-VL 103
Query: 252 PSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHY 311
PS AV D L +L L++ NKLT +P + +T L +
Sbjct: 104 PS--------AVFDR------------LVHLKE---LFMCCNKLTE-LPRGIERLTHLTH 139
Query: 312 LELNDNQLTGHIPPA---LGKLTDLF 334
L L+ NQL A L LT +
Sbjct: 140 LALDQNQLKSIPHGAFDRLSSLTHAY 165
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 8e-12
Identities = 31/90 (34%), Positives = 47/90 (52%), Gaps = 4/90 (4%)
Query: 709 GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYI 768
GL +L S II+RD+K N++LD + + DFG+ K T T+ GT YI
Sbjct: 133 GLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDYI 188
Query: 769 DPEYARTSRLTEKSDVYSFGIVLLELLTGR 798
PE + D ++FG++L E+L G+
Sbjct: 189 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-11
Identities = 36/108 (33%), Positives = 54/108 (50%), Gaps = 6/108 (5%)
Query: 709 GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYI 768
L +LH II+RD+K N+LLD + L DFG+ K + T+T+ GT YI
Sbjct: 136 ALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC-GTPDYI 191
Query: 769 DPEYARTSRLTEKSDVYSFGIVLLELLTGRK--AVDNECNLHHLILSK 814
PE + D ++ G++L E+L G +NE +L IL+
Sbjct: 192 APEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND 239
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 48/190 (25%), Positives = 87/190 (45%), Gaps = 15/190 (7%)
Query: 651 IKHRNLVSL-QGYSLSSSGNL-LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQ 708
+ H N+V L + + +L + ++ + G + ++ K L D +
Sbjct: 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIK 148
Query: 709 GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYI 768
G+ YLH +IIHRD+K SN+L+ +D + DFG++ S + S + GT ++
Sbjct: 149 GIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTV-GTPAFM 204
Query: 769 DPEYARTSRLT---EKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVD 825
PE +R + DV++ G+ L + G+ +E + L SK + A+
Sbjct: 205 APESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE-RIMCL-HSKIKSQALEFPDQ 262
Query: 826 PEISATCKDL 835
P+I+ KDL
Sbjct: 263 PDIAEDLKDL 272
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 5/92 (5%)
Query: 709 GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYI 768
L +LH II+RD+K NILLD + LTDFG++K ++ + GTI Y+
Sbjct: 171 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 227
Query: 769 DPEYARTSRL--TEKSDVYSFGIVLLELLTGR 798
P+ R + D +S G+++ ELLTG
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-11
Identities = 34/110 (30%), Positives = 48/110 (43%), Gaps = 10/110 (9%)
Query: 285 TEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPAL-GKLTDLFDLNVANNHL 343
+L L SNKL +T+L L L+ NQ+ +P + KLT L L + N L
Sbjct: 30 ATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQS-LPDGVFDKLTKLTILYLHENKL 88
Query: 344 EGPIP----DNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLN 389
+ +P D L T L L + N+L F RL S+ + L N
Sbjct: 89 QS-LPNGVFDKL---TQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 9e-07
Identities = 34/128 (26%), Positives = 56/128 (43%), Gaps = 13/128 (10%)
Query: 291 HSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIP-- 348
+S LT +P + + LEL N+L KLT L L+++ N ++ +P
Sbjct: 15 NSKGLTS-VPTGIPSSAT--RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQS-LPDG 70
Query: 349 --DNLSSCTNLNSLNVHGNKLNGTIPP-AFQRLESMTYLNLSLNNIRGPIPVELSRIGNL 405
D L T L L +H NKL ++P F +L + L L N ++ R+ +L
Sbjct: 71 VFDKL---TKLTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSL 126
Query: 406 DTLDMSNN 413
+ + N
Sbjct: 127 QKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 1e-06
Identities = 41/151 (27%), Positives = 60/151 (39%), Gaps = 32/151 (21%)
Query: 194 DVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNI--GFLQIATLSLQGNQLTGKI 251
+ LT S+P I +S L+L N+L +P + Q+ LSL NQ+ +
Sbjct: 13 RCNSKGLT-SVPTGIP--SSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQ-SL 67
Query: 252 PSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPEL-GNMTKLH 310
P V D L L+ LYLH NKL +P + +T+L
Sbjct: 68 PD--------GVFDK------------LTKLTI---LYLHENKLQS-LPNGVFDKLTQLK 103
Query: 311 YLELNDNQLTGHIPPALGKLTDLFDLNVANN 341
L L+ NQL +LT L + + N
Sbjct: 104 ELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 5e-05
Identities = 29/106 (27%), Positives = 45/106 (42%), Gaps = 3/106 (2%)
Query: 382 TYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGD-LEHLLKLNLSRNQLT 440
T L L N ++ ++ L L +S N+I S+P + D L L L L N+L
Sbjct: 31 TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ 89
Query: 441 GFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNN 486
G F L + E+ L N L V +L ++ + L + N
Sbjct: 90 SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWL-HTN 134
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 2e-11
Identities = 33/90 (36%), Positives = 47/90 (52%), Gaps = 4/90 (4%)
Query: 709 GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYI 768
L YLH II+RD+K N+LLD + LTD+G+ K TST+ GT YI
Sbjct: 122 ALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYI 177
Query: 769 DPEYARTSRLTEKSDVYSFGIVLLELLTGR 798
PE R D ++ G+++ E++ GR
Sbjct: 178 APEILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 56/225 (24%), Positives = 99/225 (44%), Gaps = 28/225 (12%)
Query: 589 VYEDIMRMTENLSEKY----IIGYGASSTVYKCV-LKNCKPVAIKRL---YSHYPQCLKE 640
+++ + + Y +G GA V V + VAIK+L + +
Sbjct: 12 YRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRA 71
Query: 641 FETELETVGSIKHRNLVSLQ-----GYSLSSSGNL-LFYDFMENGSLWDILHGPTKKKKL 694
+ EL + ++H N++ L +L + L FM D L K +KL
Sbjct: 72 YR-ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT----D-LGKLMKHEKL 125
Query: 695 DWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSK 754
D + +GL Y+H + IIHRD+K N+ +++D E + DFG+A+ +
Sbjct: 126 GEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ---AD 179
Query: 755 SYTSTYIMGTIGYIDPEYARTSRL-TEKSDVYSFGIVLLELLTGR 798
S + Y++ T Y PE T+ D++S G ++ E++TG+
Sbjct: 180 SEMTGYVV-TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 67.0 bits (163), Expect = 2e-11
Identities = 31/90 (34%), Positives = 47/90 (52%), Gaps = 4/90 (4%)
Query: 709 GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYI 768
GL +L S II+RD+K N++LD + + DFG+ K T T+ GT YI
Sbjct: 454 GLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDYI 509
Query: 769 DPEYARTSRLTEKSDVYSFGIVLLELLTGR 798
PE + D ++FG++L E+L G+
Sbjct: 510 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 64.8 bits (159), Expect = 2e-11
Identities = 53/214 (24%), Positives = 94/214 (43%), Gaps = 34/214 (15%)
Query: 602 EKYI----IGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGS------- 650
EKY IG G VYK + A+K++ E E E + S
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKI---------RLEKEDEGIPSTTIREIS 52
Query: 651 ----IKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGA 706
+KH N+V L + +L ++ ++ L +L + L+ T L
Sbjct: 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLD--VCEGGLESVTAKSFLLQL 109
Query: 707 AQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV-SKSYTSTYIMGTI 765
G+AY H R++HRD+K N+L++++ E + DFG+A++ + + YT + T+
Sbjct: 110 LNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV--TL 164
Query: 766 GYIDPEYARTSRL-TEKSDVYSFGIVLLELLTGR 798
Y P+ S+ + D++S G + E++ G
Sbjct: 165 WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 2e-11
Identities = 56/206 (27%), Positives = 91/206 (44%), Gaps = 30/206 (14%)
Query: 606 IGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGS-----------IKHR 654
+G G VYK + VA+KR+ + E E + S + H
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRI---------RLDAEDEGIPSTAIREISLLKELHHP 79
Query: 655 NLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLH 714
N+VSL S L ++FME L +L K L +G+A+ H
Sbjct: 80 NIVSLIDVIHSERCLTLVFEFMEK-DLKKVLD--ENKTGLQDSQIKIYLYQLLRGVAHCH 136
Query: 715 HDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV-SKSYTSTYIMGTIGYIDPEYA 773
RI+HRD+K N+L++ D L DFG+A++ + +SYT + T+ Y P+
Sbjct: 137 QH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TLWYRAPDVL 191
Query: 774 RTSRL-TEKSDVYSFGIVLLELLTGR 798
S+ + D++S G + E++TG+
Sbjct: 192 MGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-11
Identities = 35/157 (22%), Positives = 59/157 (37%), Gaps = 35/157 (22%)
Query: 287 KLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGP 346
+L+ + + L + +L L+ N + K+
Sbjct: 29 ELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE--------KI---------------- 63
Query: 347 IPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVE-LSRIGNL 405
+LS NL L++ N + I +++ L +S N I + + ++ NL
Sbjct: 64 --SSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS---LSGIEKLVNL 117
Query: 406 DTLDMSNNKIS--GSIPSPLGDLEHLLKLNLSRNQLT 440
L MSNNKI+ G I L L+ L L L+ N L
Sbjct: 118 RVLYMSNNKITNWGEI-DKLAALDKLEDLLLAGNPLY 153
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 4e-10
Identities = 31/139 (22%), Positives = 61/139 (43%), Gaps = 7/139 (5%)
Query: 335 DLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGP 394
+L+ +E + LS+ L + N + I +E++ L+L N I+
Sbjct: 29 ELHGMIPPIEK-MDATLSTLKACKHLALSTNNI-EKISS-LSGMENLRILSLGRNLIKK- 84
Query: 395 IPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIP-GEFGNLRSV 453
I + L+ L +S N+I+ S+ S + L +L L +S N++T + + L +
Sbjct: 85 IENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKL 142
Query: 454 MEIDLSHNHLTGVIPEELS 472
++ L+ N L E +
Sbjct: 143 EDLLLAGNPLYNDYKENNA 161
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 9e-09
Identities = 36/158 (22%), Positives = 60/158 (37%), Gaps = 18/158 (11%)
Query: 120 SLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGT 179
L + + ++S LK + L L N I I S+LS + NL++ L N +
Sbjct: 29 ELHGMIPPI-EKMDATLSTLKACKHLALSTNN-IEKI-SSLSGMENLRILSLGRNLIK-K 84
Query: 180 LSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLS--GEIPFNIGFLQI 237
+ L + N + S+ I + +VL +S N+++ GEI ++
Sbjct: 85 IENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKL 142
Query: 238 ATLSLQGNQLTGKIPS----------VIGLMQALAVLD 265
L L GN L V+ + L LD
Sbjct: 143 EDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 31/131 (23%), Positives = 51/131 (38%), Gaps = 11/131 (8%)
Query: 240 LSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPI--LGNLSYTEKLYLHSNKLTG 297
L + K+ + + ++A L LS N I I L + L L N +
Sbjct: 30 LHGMIPPIE-KMDATLSTLKACKHLALSTNN----IEKISSLSGMENLRILSLGRNLIK- 83
Query: 298 HIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIP-DNLSSCTN 356
I L L ++ NQ+ + + KL +L L ++NN + D L++
Sbjct: 84 KIENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITNWGEIDKLAALDK 141
Query: 357 LNSLNVHGNKL 367
L L + GN L
Sbjct: 142 LEDLLLAGNPL 152
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 6e-08
Identities = 28/169 (16%), Positives = 53/169 (31%), Gaps = 29/169 (17%)
Query: 264 LDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHI 323
L + + L L + L L +N + I L M L L L N + I
Sbjct: 30 LHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KISS-LSGMENLRILSLGRNLIK-KI 85
Query: 324 PPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTY 383
L +L ++ N + + NL L + NK+
Sbjct: 86 ENLDAVADTLEELWISYNQIA--SLSGIEKLVNLRVLYMSNNKIT--------------- 128
Query: 384 LNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKL 432
+ I +L+ + L+ L ++ N + E+ +++
Sbjct: 129 ---NWGEID-----KLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEV 169
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 3e-11
Identities = 50/222 (22%), Positives = 83/222 (37%), Gaps = 53/222 (23%)
Query: 606 IGYGASSTVYKCVLKNCKP----VAIKRLYSHYPQCLKEFETE------------LETVG 649
IG GA V+K ++ K VA+KR+ + E L +
Sbjct: 19 IGEGAYGKVFKA--RDLKNGGRFVALKRV-------RVQTGEEGMPLSTIREVAVLRHLE 69
Query: 650 SIKHRNLVSL----QGYSLSSSGNL-LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIAL 704
+ +H N+V L L L ++ ++ D+ LD +
Sbjct: 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ----DL------TTYLDKVPEPGVPT 119
Query: 705 GAA--------QGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY 756
+GL +LH R++HRD+K NIL+ + L DFG+A+ +
Sbjct: 120 ETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL 176
Query: 757 TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGR 798
TS + T+ Y PE S D++S G + E+ +
Sbjct: 177 TSVVV--TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 3e-11
Identities = 56/214 (26%), Positives = 84/214 (39%), Gaps = 33/214 (15%)
Query: 602 EKY----IIGYGASSTVYKCV-LKNCKPVAIKRLYSHYPQCLKEFETELETVGSI----- 651
EKY IG G+ V+KC + VAIK+ L+ + + ++
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-------LESEDDPVIKKIALREIRM 55
Query: 652 ----KHRNLVSLQGYSLSSSGNL-LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGA 706
KH NLV+L L L +++ ++ ++ L ++ + I
Sbjct: 56 LKQLKHPNLVNLLEV-FRRKRRLHLVFEYCDH-TVLHELD--RYQRGVPEHLVKSITWQT 111
Query: 707 AQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV-SKSYTSTYIMGTI 765
Q + + H IHRDVK NIL+ K L DFG A+ L S Y + T
Sbjct: 112 LQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD-EVA-TR 166
Query: 766 GYIDPEYARTSRLTEKS-DVYSFGIVLLELLTGR 798
Y PE DV++ G V ELL+G
Sbjct: 167 WYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 3e-11
Identities = 55/216 (25%), Positives = 87/216 (40%), Gaps = 37/216 (17%)
Query: 602 EKY----IIGYGASSTVYKCV-LKNCKPVAIKRLYSHYPQCLKEFETELETVGSI----- 651
EKY ++G G+ V KC + VAIK+ + + V I
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFL---------ESDDDKMVKKIAMREI 75
Query: 652 ------KHRNLVSLQGYSLSSSGNL-LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIAL 704
+H NLV+L L ++F+++ ++ D L LD+ K
Sbjct: 76 KLLKQLRHENLVNLLEV-CKKKKRWYLVFEFVDH-TILDDLE--LFPNGLDYQVVQKYLF 131
Query: 705 GAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV-SKSYTSTYIMG 763
G+ + H S IIHRD+K NIL+ + L DFG A++L + Y +
Sbjct: 132 QIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDD-EVA- 186
Query: 764 TIGYIDPEYARTSRLTEKS-DVYSFGIVLLELLTGR 798
T Y PE K+ DV++ G ++ E+ G
Sbjct: 187 TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 3e-11
Identities = 33/90 (36%), Positives = 47/90 (52%), Gaps = 4/90 (4%)
Query: 709 GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYI 768
L YLH II+RD+K N+LLD + LTD+G+ K TST+ GT YI
Sbjct: 165 ALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYI 220
Query: 769 DPEYARTSRLTEKSDVYSFGIVLLELLTGR 798
PE R D ++ G+++ E++ GR
Sbjct: 221 APEILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 4e-11
Identities = 59/204 (28%), Positives = 92/204 (45%), Gaps = 28/204 (13%)
Query: 606 IGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFE---TELETVGSIKHRNLVSLQG 661
+G G+ V+ + N + A+K L LK+ E E + + H ++ +
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW- 72
Query: 662 YSLSSSGNLLF-YDFMENGSLWDILHGPTKKKKLDWDTRLK-----IALGAAQGLAYLHH 715
+ + + D++E G L+ +L K ++ + K + L L YLH
Sbjct: 73 GTFQDAQQIFMIMDYIEGGELFSLLR---KSQRFP-NPVAKFYAAEVCLA----LEYLH- 123
Query: 716 DCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIM-GTIGYIDPEYAR 774
S II+RD+K NILLDK+ +TDFG AK TY + GT YI PE
Sbjct: 124 --SKDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEVVS 176
Query: 775 TSRLTEKSDVYSFGIVLLELLTGR 798
T + D +SFGI++ E+L G
Sbjct: 177 TKPYNKSIDWWSFGILIYEMLAGY 200
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 5e-11
Identities = 49/222 (22%), Positives = 79/222 (35%), Gaps = 51/222 (22%)
Query: 606 IGYGASSTVYKCV-LKNCKPVAIKRL--------YSHYP-------QCLKEFETELETVG 649
IG GA TVYK + VA+K + P L+ E
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAF----- 71
Query: 650 SIKHRNLVSL----QGYSLSSSGNL-LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIAL 704
+H N+V L + L ++ ++ D+ + LD +
Sbjct: 72 --EHPNVVRLMDVCATSRTDREIKVTLVFEHVD----QDL------RTYLDKAPPPGLPA 119
Query: 705 GAA--------QGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY 756
+GL +LH + I+HRD+K NIL+ L DFG+A+ +
Sbjct: 120 ETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL 176
Query: 757 TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGR 798
T + T+ Y PE S D++S G + E+ +
Sbjct: 177 TPVVV--TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 7e-11
Identities = 54/232 (23%), Positives = 99/232 (42%), Gaps = 43/232 (18%)
Query: 589 VYEDIMRMTENLSEKY----IIGYGASSTVYKCV-LKNCKPVAIKRL---YSHYPQCLKE 640
+D+ + L + Y +G GA +V + ++ + VAIK+L + +
Sbjct: 11 YKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRA 70
Query: 641 FETELETVGSIKHRNLVSLQG--YSLSSSGNL----LFYDFMENGSLWDILHGPTKKKKL 694
+ EL + ++H N++ L SS N L FM+ L I+ K
Sbjct: 71 YR-ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIM-----GLKF 123
Query: 695 DWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSK 754
+ + +GL Y+H S ++HRD+K N+ +++D E + DFG+A+
Sbjct: 124 SEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM 180
Query: 755 S-YTST--Y-----IMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGR 798
+ Y T Y I+ + Y + D++S G ++ E+LTG+
Sbjct: 181 TGYVVTRWYRAPEVILSWMHY-----------NQTVDIWSVGCIMAEMLTGK 221
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 9e-11
Identities = 59/225 (26%), Positives = 97/225 (43%), Gaps = 28/225 (12%)
Query: 589 VYEDIMRMTENLSEKY----IIGYGASSTVYKCV-LKNCKPVAIKRL---YSHYPQCLKE 640
+++ + + E+Y +G GA +V K VA+K+L + +
Sbjct: 16 YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT 75
Query: 641 FETELETVGSIKHRNLVSLQG--YSLSSSGNL----LFYDFMENGSLWDILHGPTKKKKL 694
+ EL + +KH N++ L S L M D L+ K +KL
Sbjct: 76 YR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA----D-LNNIVKCQKL 129
Query: 695 DWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSK 754
D + +GL Y+H S IIHRD+K SN+ +++D E + DFG+A+ +
Sbjct: 130 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARH---TA 183
Query: 755 SYTSTYIMGTIGYIDPEYARTSRL-TEKSDVYSFGIVLLELLTGR 798
+ Y+ T Y PE + D++S G ++ ELLTGR
Sbjct: 184 DEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 57/228 (25%), Positives = 97/228 (42%), Gaps = 34/228 (14%)
Query: 591 EDIMRMTENLSEKY----IIGYGASSTVYKCV-LKNCKPVAIKRL--YSHYPQCLKEFET 643
E + ++ +Y IG GA V N VAIK++ + H C +
Sbjct: 16 EMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR- 74
Query: 644 ELETVGSIKHRNLVSLQGYSLSSSGNL-----LFYDFMENGSLWDILHGPTKKKKLDWDT 698
E++ + +H N++ + + + + D ME D L+ K + L +
Sbjct: 75 EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET----D-LYKLLKTQHL---S 126
Query: 699 RLKIALGAAQ---GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS 755
I Q GL Y+H S ++HRD+K SN+LL+ + + DFG+A+
Sbjct: 127 NDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARV--ADPD 181
Query: 756 YTSTYIM----GTIGYIDPEYARTSRL-TEKSDVYSFGIVLLELLTGR 798
+ T + T Y PE S+ T+ D++S G +L E+L+ R
Sbjct: 182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 62.5 bits (153), Expect = 1e-10
Identities = 48/209 (22%), Positives = 91/209 (43%), Gaps = 31/209 (14%)
Query: 606 IGYGASSTVYKCV-LKNCKPVAIKRLYSHYPQCLKEFETELETVGS-----------IKH 653
IG G TV+K + + VA+KR+ + + E V S +KH
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRV---------RLDDDDEGVPSSALREICLLKELKH 60
Query: 654 RNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYL 713
+N+V L S L ++F + L + LD + +GL +
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFD--SCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 714 HHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV-SKSYTSTYIMGTIGYIDPEY 772
H ++HRD+K N+L++++ E L +FG+A++ + + Y++ + T+ Y P+
Sbjct: 118 HSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV--TLWYRPPDV 172
Query: 773 ARTSRL-TEKSDVYSFGIVLLELLTGRKA 800
++L + D++S G + EL +
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 1e-10
Identities = 50/207 (24%), Positives = 92/207 (44%), Gaps = 32/207 (15%)
Query: 606 IGYGASSTVYKCVLK-NCKPVAIKRLYSHY----P-------QCLKEFETELETVGSIKH 653
+G G +TVYK K VA+K + + P LK+ +KH
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKD----------LKH 59
Query: 654 RNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYL 713
N+V+L + L +++++ L L ++ +GLAY
Sbjct: 60 ANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLD--DCGNIINMHNVKLFLFQLLRGLAYC 116
Query: 714 HHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV-SKSYTSTYIMGTIGYIDPEY 772
H +++HRD+K N+L+++ E L DFG+A++ + +K+Y + + T+ Y P+
Sbjct: 117 H---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWYRPPDI 171
Query: 773 ARTSRL-TEKSDVYSFGIVLLELLTGR 798
S + + D++ G + E+ TGR
Sbjct: 172 LLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 2e-10
Identities = 66/286 (23%), Positives = 107/286 (37%), Gaps = 46/286 (16%)
Query: 596 MTENLSEKYI----IGYGASSTVYKCV-LKNCKPVAIKRLY-SHYPQCLKEFETELETVG 649
M E + +G GA V V + VA+K + C + + E+
Sbjct: 1 MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINK 60
Query: 650 SIKHRNLVSLQGYSLSSSGNLLFYDFME---NGSLWDILHGPTKKKKLDWDTRLK----- 701
+ H N+V Y GN+ + F+E G L+D + + +
Sbjct: 61 MLNHENVVKF--YGHRREGNIQYL-FLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQL 114
Query: 702 IALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYI 761
+A G+ YLH I HRD+K N+LLD+ ++DFG+A V + +
Sbjct: 115 MA-----GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLAT---VFRYNNRERL 163
Query: 762 M----GTIGYIDPE-YARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTA 816
+ GT+ Y+ PE R E DV+S GIVL +L G D + S
Sbjct: 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWK 222
Query: 817 NNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
+I + L + K+ P+ R T+ ++
Sbjct: 223 EKKTYLNPWKKIDSAPLAL--LHKILVE-------NPSARITIPDI 259
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 64/304 (21%), Positives = 103/304 (33%), Gaps = 79/304 (25%)
Query: 587 LHVYEDIMRMTENLSEKY-----IIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKE 640
HV + + + Y ++G G + V + K + A+K L P+ +E
Sbjct: 2 PHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-QDCPKARRE 60
Query: 641 FETELETVGSIKHRNLVSLQG-YSLSSSGNLLFY---DFMENGSLWD-ILHGPTKKKKLD 695
E ++V + Y +G + ++ G L+ I +
Sbjct: 61 VELHWRASQ---CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ----DRGDQA 113
Query: 696 WDTR-----LKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILL-DKDFEAHL--TDFGIA 747
+ R +K A + YLH S I HRDVK N+L K A L TDFG A
Sbjct: 114 FTEREASEIMKSIGEA---IQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
Query: 748 KSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTG------RKAV 801
K + Y + D++S G+++ LL G +
Sbjct: 168 KET-TGEKY----------------------DKSCDMWSLGVIMYILLCGYPPFYSNHGL 204
Query: 802 DNECNLHHLILSKTANNAVMETVDPE---ISATCKDLGAVKKVFQLALLCSKRQPTDRPT 858
+ I E +PE +S K L ++ LL +PT R T
Sbjct: 205 AISPGMKTRIR-----MGQYEFPNPEWSEVSEEVKML--IRN-----LLK--TEPTQRMT 250
Query: 859 MHEV 862
+ E
Sbjct: 251 ITEF 254
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 3e-10
Identities = 52/218 (23%), Positives = 91/218 (41%), Gaps = 49/218 (22%)
Query: 606 IGYGASSTVYKCV-LKNCKPVAIKRLYSHYPQCLKEFETELETVGS-----------IKH 653
+G G VYK + + VAIKR+ E E E V ++H
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRI---------RLEHEEEGVPGTAIREVSLLKELQH 92
Query: 654 RNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAA------ 707
RN++ L+ + L +++ EN D+ KK +D + + + + +
Sbjct: 93 RNIIELKSVIHHNHRLHLIFEYAEN----DL------KKYMDKNPDVSMRVIKSFLYQLI 142
Query: 708 QGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAH-----LTDFGIAKSLCV-SKSYTSTYI 761
G+ + H S R +HRD+K N+LL + + DFG+A++ + + +T I
Sbjct: 143 NGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII 199
Query: 762 MGTIGYIDPEYARTSRL-TEKSDVYSFGIVLLELLTGR 798
T+ Y PE SR + D++S + E+L
Sbjct: 200 --TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 3e-10
Identities = 62/208 (29%), Positives = 93/208 (44%), Gaps = 30/208 (14%)
Query: 606 IGYGASSTVYKCVLKNC-KPVAIKRLYSHYPQCLKE-FET----ELETVGSIKHRNLVSL 659
+G G +TVYK KN + VAIK++ + K+ E++ + + H N++ L
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 660 QGYSLSSSGNL-LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCS 718
N+ L +DFME L I+ L L QGL YLH
Sbjct: 78 LDA-FGHKSNISLVFDFMET-DLEVIIK--DNSLVLTPSHIKAYMLMTLQGLEYLHQH-- 131
Query: 719 PRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV-SKSYTSTYIMGTIGYIDPE------ 771
I+HRD+K +N+LLD++ L DFG+AKS +++YT + T Y PE
Sbjct: 132 -WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV--TRWYRAPELLFGAR 188
Query: 772 -YARTSRLTEKSDVYSFGIVLLELLTGR 798
Y D+++ G +L ELL
Sbjct: 189 MY------GVGVDMWAVGCILAELLLRV 210
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 4e-10
Identities = 53/215 (24%), Positives = 95/215 (44%), Gaps = 43/215 (20%)
Query: 606 IGYGASSTVYKCV-LKNCKPVAIKRLYSH----YP-------QCLKEFETELETVGSIKH 653
+G G +TVYK + VA+K + P +KE +KH
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKE----------LKH 62
Query: 654 RNLVSLQGYSLSSSGNLLFYDFMEN--GSLWDILHGPTKKKKLDWDTRLKIALGAAQGLA 711
N+V L + + L ++FM+N D + L+ + QGLA
Sbjct: 63 ENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLA 122
Query: 712 YLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV-SKSYTSTYIMGTIGYIDP 770
+ H + +I+HRD+K N+L++K + L DFG+A++ + +++S + T+ Y P
Sbjct: 123 FCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV--TLWYRAP 177
Query: 771 E-------YARTSRLTEKSDVYSFGIVLLELLTGR 798
+ Y + D++S G +L E++TG+
Sbjct: 178 DVLMGSRTY------STSIDIWSCGCILAEMITGK 206
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 5e-10
Identities = 43/172 (25%), Positives = 65/172 (37%), Gaps = 39/172 (22%)
Query: 194 DVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNI--GFLQIATLSLQGNQLTGKI 251
+ + T S+P I LDL N L +P + + L L GN+L +
Sbjct: 13 ECYSQGRT-SVPTGIP--AQTTYLDLETNSLK-SLPNGVFDELTSLTQLYLGGNKLQ-SL 67
Query: 252 PSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPEL-GNMTKLH 310
P + L+ L L +N+L +P + +T+L
Sbjct: 68 P-----------------------NGVFNKLTSLTYLNLSTNQLQS-LPNGVFDKLTQLK 103
Query: 311 YLELNDNQLTGHIPP-ALGKLTDLFDLNVANNHLEGPIP----DNLSSCTNL 357
L LN NQL +P KLT L DL + N L+ +P D L+S +
Sbjct: 104 ELALNTNQLQS-LPDGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYI 153
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 8e-10
Identities = 42/179 (23%), Positives = 61/179 (34%), Gaps = 52/179 (29%)
Query: 285 TEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLE 344
T L L +N L +T L L L N+L L
Sbjct: 30 TTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS---------------------LP 68
Query: 345 GPIPDNLSSCTNLNSLNVHGNKLNGTIPP-AFQRLESMTYLNLSLNNIRGPIPVELSRIG 403
+ + L T+L LN+ N+L ++P F +L + L L
Sbjct: 69 NGVFNKL---TSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELAL----------------- 107
Query: 404 NLDTLDMSNNKISGSIPSPLGD-LEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHN 461
+ N++ S+P + D L L L L +NQL G F L S+ I L N
Sbjct: 108 -------NTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 4e-09
Identities = 33/121 (27%), Positives = 57/121 (47%), Gaps = 4/121 (3%)
Query: 347 IPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLD 406
+P + + T L++ N L F L S+T L L N ++ +++ +L
Sbjct: 22 VPTGIPAQTT--YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLT 79
Query: 407 TLDMSNNKISGSIPSPLGD-LEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTG 465
L++S N++ S+P+ + D L L +L L+ NQL G F L + ++ L N L
Sbjct: 80 YLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKS 138
Query: 466 V 466
V
Sbjct: 139 V 139
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 39/142 (27%), Positives = 67/142 (47%), Gaps = 14/142 (9%)
Query: 352 SSCT-NLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDM 410
S C+ + ++ + ++P TYL+L N+++ + +L L +
Sbjct: 3 SRCSCSGTTVECYSQGRT-SVPTGIP--AQTTYLDLETNSLKSLPNGVFDELTSLTQLYL 59
Query: 411 SNNKISGSIPSPLGD-LEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPE 469
NK+ S+P+ + + L L LNLS NQL G F L + E+ L+ N L +P+
Sbjct: 60 GGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQ-SLPD 117
Query: 470 ----ELSQLQNMFSLRLDYNNL 487
+L+QL++ LRL N L
Sbjct: 118 GVFDKLTQLKD---LRLYQNQL 136
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 31/132 (23%), Positives = 50/132 (37%), Gaps = 7/132 (5%)
Query: 95 QSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIG 154
+++ + +P I + LDL N L +L L L L N+L
Sbjct: 10 TTVECYSQGRTS-VPTGIP--AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS 66
Query: 155 PIPSTLSQLPNLKVFGLRGNNLVGTLSPDMC-QLSGLWYFDVRNNSLTGSIPQNI-GNCT 212
++L +L L N L +L + +L+ L + N L S+P + T
Sbjct: 67 LPNGVFNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLT 124
Query: 213 SFQVLDLSYNQL 224
+ L L NQL
Sbjct: 125 QLKDLRLYQNQL 136
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 7e-10
Identities = 51/236 (21%), Positives = 84/236 (35%), Gaps = 49/236 (20%)
Query: 591 EDIMRMTENLSEKYI----IGYGASSTVYKCV-LKNCKPVAIK-----RLYSHY---PQC 637
E + S+KY +G GA V+ V + K V +K ++
Sbjct: 13 EGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPK 72
Query: 638 LKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMEN--------------GSLWD 683
L + E+ + ++H N++ + D EN L+
Sbjct: 73 LGKVTLEIAILSRVEHANIIKV-------------LDIFENQGFFQLVMEKHGSGLDLFA 119
Query: 684 ILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTD 743
+ + +LD I + YL IIHRD+K NI++ +DF L D
Sbjct: 120 FI---DRHPRLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLID 173
Query: 744 FGIAKSLCVSKSYTSTYIMGTIGYIDPE-YARTSRLTEKSDVYSFGIVLLELLTGR 798
FG A + T+ GTI Y PE + +++S G+ L L+
Sbjct: 174 FGSA-AYLERGKLFYTFC-GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 9e-10
Identities = 65/291 (22%), Positives = 107/291 (36%), Gaps = 56/291 (19%)
Query: 596 MTENLSEKYI----IGYGASSTVYKCV-LKNCKPVAIKRLY-SHYPQCLKEFETELETVG 649
M E + +G GA V V + VA+K + C + + E+
Sbjct: 1 MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINK 60
Query: 650 SIKHRNLVSLQGYSLSSSGNLLFYDFME---NGSLWDILHGPTKKKKLDWDTRLK----- 701
+ H N+V Y GN+ + F+E G L+D + + +
Sbjct: 61 MLNHENVVKF--YGHRREGNIQYL-FLEYCSGGELFDRI---EPDIGMPEPDAQRFFHQL 114
Query: 702 IALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYI 761
+A G+ YLH I HRD+K N+LLD+ ++DFG+A V + +
Sbjct: 115 MA-----GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLAT---VFRYNNRERL 163
Query: 762 M----GTIGYIDPE------YARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLI 811
+ GT+ Y+ PE + E DV+S GIVL +L G D +
Sbjct: 164 LNKMCGTLPYVAPELLKRREFH-----AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE- 217
Query: 812 LSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
S +I + L + K+ P+ R T+ ++
Sbjct: 218 YSDWKEKKTYLNPWKKIDSAPLAL--LHKILVE-------NPSARITIPDI 259
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 49/222 (22%), Positives = 92/222 (41%), Gaps = 29/222 (13%)
Query: 599 NLSEKY----IIGYGASSTVYKCV-LKNCKPVAIKRL-YSHYPQCLKEFETELETVGSIK 652
+L +Y +G G + V+ V K VAIK++ + E++ + +
Sbjct: 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR-EIKIIRRLD 66
Query: 653 HRNLVSLQGYSLSSSGNLLFYDFMENGSLWDI----------LHGPTKKKKLDWDTRLKI 702
H N+V + L SG+ L D L + L ++ L +
Sbjct: 67 HDNIVKVFEI-LGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLF 125
Query: 703 ALGAAQGLAYLHHDCSPRIIHRDVKSSNILLD-KDFEAHLTDFGIAKSLCVSKSYTSTYI 761
+GL Y+H S ++HRD+K +N+ ++ +D + DFG+A+ + Y+
Sbjct: 126 MYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARI--MDPHYSHKGH 180
Query: 762 M----GTIGYIDPEYARTSRL-TEKSDVYSFGIVLLELLTGR 798
+ T Y P + T+ D+++ G + E+LTG+
Sbjct: 181 LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 24/119 (20%), Positives = 39/119 (32%), Gaps = 5/119 (4%)
Query: 412 NNKISGSIPSPLGDLEHLLKLNLSRNQ-LTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEE 470
+ L E+L +L + Q L + L + + + + L V P+
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 471 LSQLQNMFSLRLDYNNLSGDVMSLINCLSLSVLFI-GNPGLCG---YWLHSACRDSHPT 525
+ L L +N L + LSL L + GNP C WL +
Sbjct: 76 FHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGG 134
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 59.0 bits (142), Expect = 3e-09
Identities = 21/96 (21%), Positives = 37/96 (38%), Gaps = 4/96 (4%)
Query: 275 IPPILGNLSYTEKLYLHSNKLTGHIPPE-LGNMTKLHYLELNDNQLTGHIPP-ALGKLTD 332
L +LY+ + + H+ L + +L L + + L + P A
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPR 81
Query: 333 LFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLN 368
L LN++ N LE + +L L + GN L+
Sbjct: 82 LSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 59.0 bits (142), Expect = 3e-09
Identities = 21/94 (22%), Positives = 35/94 (37%), Gaps = 2/94 (2%)
Query: 395 IPVELSRIGNLDTLDMSNNKISGSIPS-PLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSV 453
L NL L + N + + L L L L + ++ L P F +
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82
Query: 454 MEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNL 487
++LS N L + + + L ++ L L N L
Sbjct: 83 SRLNLSFNALESLSWKTVQGL-SLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 53.6 bits (128), Expect = 1e-07
Identities = 24/102 (23%), Positives = 36/102 (35%), Gaps = 2/102 (1%)
Query: 292 SNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPP-ALGKLTDLFDLNVANNHLEGPIPDN 350
+ L L L + + Q H+ L L +L +L + + L PD
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 351 LSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIR 392
L+ LN+ N L Q L S+ L LS N +
Sbjct: 76 FHFTPRLSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 51.3 bits (122), Expect = 8e-07
Identities = 23/112 (20%), Positives = 40/112 (35%), Gaps = 5/112 (4%)
Query: 115 CSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPS-TLSQLPNLKVFGLRG 173
L + + D + + L L ++N Q + + L L L+ +
Sbjct: 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 174 NNLVGTLSPDM-CQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQL 224
+ L ++PD L ++ N+L S+ S Q L LS N L
Sbjct: 66 SGLR-FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 50.9 bits (121), Expect = 9e-07
Identities = 20/93 (21%), Positives = 36/93 (38%), Gaps = 4/93 (4%)
Query: 323 IPPALGKLTDLFDLNVANNHLEGPIPDN-LSSCTNLNSLNVHGNKLNGTIPP-AFQRLES 380
L +L +L + N + L L +L + + L + P AF
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPR 81
Query: 381 MTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNN 413
++ LNLS N + + + + +L L +S N
Sbjct: 82 LSRLNLSFNALES-LSWKTVQGLSLQELVLSGN 113
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 19/127 (14%), Positives = 38/127 (29%), Gaps = 7/127 (5%)
Query: 90 DLKDLQSIDLRGNRLSGQIPDE-IGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILK 148
++L + + + + + L++L + + L P + +L L L
Sbjct: 29 GAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88
Query: 149 NNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNI 208
N L + Q +L+ L GN L + C L L ++
Sbjct: 89 FNALES-LSWKTVQGLSLQELVLSGNPLHCS-----CALRWLQRWEEEGLGGVPEQKLQC 142
Query: 209 GNCTSFQ 215
Sbjct: 143 HGQGPLA 149
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 23/117 (19%), Positives = 37/117 (31%), Gaps = 4/117 (3%)
Query: 182 PDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFN--IGFLQIAT 239
PD C G + ++ + L + Q + G ++
Sbjct: 2 PDACCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60
Query: 240 LSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLT 296
L++ + L P L+ L+LS N L + LS E L L N L
Sbjct: 61 LTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQE-LVLSGNPLH 116
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 51/243 (20%), Positives = 94/243 (38%), Gaps = 49/243 (20%)
Query: 579 VILHMNMALHVYEDIMRMTENLSEKYI----IGYGASSTVYKCV-LKNCKPVAIKRLYSH 633
V H YE + + Y +G G S V++ + + N + V +K L
Sbjct: 14 VNTHRPREYWDYE-SHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL--- 69
Query: 634 YPQCLKEFETELETVGSIK-------HRNLVSLQG--YSLSSSGNLLFYDFMENGSLWDI 684
K + + + IK N+++L S L ++ + N +
Sbjct: 70 -----KPVKKK-KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL 123
Query: 685 LHGPTKKKKLDWDTR------LKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLD-KDF 737
T D+D R LK L Y H S I+HRDVK N+++D +
Sbjct: 124 YQTLT-----DYDIRFYMYEILK-------ALDYCH---SMGIMHRDVKPHNVMIDHEHR 168
Query: 738 EAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKS-DVYSFGIVLLELLT 796
+ L D+G+A+ + Y + + + PE ++ + S D++S G +L ++
Sbjct: 169 KLRLIDWGLAEFYHPGQEYN-VRV-ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 226
Query: 797 GRK 799
++
Sbjct: 227 RKE 229
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 53/251 (21%), Positives = 96/251 (38%), Gaps = 71/251 (28%)
Query: 595 RMTENLSEKY----IIGYGASSTVYKCV-LKNCKPVAIKRLY---SHYPQC--------- 637
R+ ++ KY +G GA V+K + + + VA+K+++ +
Sbjct: 2 RVDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMI 61
Query: 638 LKEFETELETVGSIKHRNLVSLQGYSLSSSGN--LLFYDFMENGSLWDILHGPTKKKKLD 695
L E H N+V+L + + L +D+ME D LH + L+
Sbjct: 62 LTELS---------GHENIVNLLNVLRADNDRDVYLVFDYMET----D-LHAVIRANILE 107
Query: 696 WDTR-------LKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAK 748
+ +K + YLH S ++HRD+K SNILL+ + + DFG+++
Sbjct: 108 PVHKQYVVYQLIK-------VIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSR 157
Query: 749 SLCVSKSYTSTYIMGTIGYIDPEYARTSRLTE---------------------KSDVYSF 787
S + T+ + + LT+ D++S
Sbjct: 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSL 217
Query: 788 GIVLLELLTGR 798
G +L E+L G+
Sbjct: 218 GCILGEILCGK 228
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 2e-09
Identities = 21/117 (17%), Positives = 48/117 (41%), Gaps = 4/117 (3%)
Query: 301 PELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSL 360
+ N + L+L ++ I L ++ ++N + + D L +L
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTL 69
Query: 361 NVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVE-LSRIGNLDTLDMSNNKIS 416
V+ N++ Q L +T L L+ N++ ++ L+ + +L L + N ++
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 8e-09
Identities = 28/128 (21%), Positives = 54/128 (42%), Gaps = 8/128 (6%)
Query: 384 LNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFI 443
+ L+ I + + LD+ KI I + L+ ++ S N++ +
Sbjct: 2 VKLTAELIEQ-AA-QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK-L 57
Query: 444 PGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLS--GDVMSLINCLSLS 501
G F LR + + +++N + + L ++ L L N+L GD+ L + SL+
Sbjct: 58 DG-FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLT 116
Query: 502 VL-FIGNP 508
L + NP
Sbjct: 117 YLCILRNP 124
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 4e-08
Identities = 26/152 (17%), Positives = 53/152 (34%), Gaps = 31/152 (20%)
Query: 216 VLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPI 275
++ L+ + + ++ L L+G ++ I ++ + +D S N I
Sbjct: 1 MVKLTAELIE-QAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNE----I 54
Query: 276 PPI--LGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDL 333
+ L + L +++N++ + L L L +N L +L
Sbjct: 55 RKLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNN-----------SLVEL 103
Query: 334 FDLNVANNHLEGPIPDNLSSCTNLNSLNVHGN 365
DL D L+S +L L + N
Sbjct: 104 GDL------------DPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 7e-08
Identities = 21/93 (22%), Positives = 37/93 (39%), Gaps = 5/93 (5%)
Query: 349 DNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVE-LSRIGNLDT 407
++ L++ G K+ I L+ ++ S N IR ++ + L T
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR---KLDGFPLLRRLKT 68
Query: 408 LDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLT 440
L ++NN+I L L +L L+ N L
Sbjct: 69 LLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 9e-08
Identities = 20/87 (22%), Positives = 39/87 (44%), Gaps = 3/87 (3%)
Query: 90 DLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKN 149
+ + +DLRG ++ I + ++D S NE+ + L++L+ L++ N
Sbjct: 17 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI-RKLDG-FPLLRRLKTLLVNN 73
Query: 150 NQLIGPIPSTLSQLPNLKVFGLRGNNL 176
N++ LP+L L N+L
Sbjct: 74 NRICRIGEGLDQALPDLTELILTNNSL 100
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 26/152 (17%), Positives = 46/152 (30%), Gaps = 14/152 (9%)
Query: 121 LDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNL--VG 178
+ L+ + + + L L+ + I I + + L N + +
Sbjct: 2 VKLTAELI-EQAA-QYTNAVRDRELDLRGYK-IPVIENLGATLDQFDAIDFSDNEIRKLD 58
Query: 179 TLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLS--GEIPFNIGFLQ 236
L L V NN + L L+ N L G++
Sbjct: 59 GFP----LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKS 114
Query: 237 IATLSLQGNQLTGKI---PSVIGLMQALAVLD 265
+ L + N +T K VI + + VLD
Sbjct: 115 LTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 146
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 58/307 (18%), Positives = 108/307 (35%), Gaps = 69/307 (22%)
Query: 606 IGYGASSTVYKCV-LKNCKPVAIKRL------YSHYPQCLKEFETELETVGSIKHR--NL 656
+G G +VY + + + PVAIK + E+ + + +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 657 VSLQGYSLSSSGNLLFYDFMEN--------------GSLWDILHGPTKKKKLDWDTRLKI 702
+ L D+ E L+D + T++ L +
Sbjct: 111 IRL-------------LDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSF 154
Query: 703 ALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKD-FEAHLTDFGIAKSLCVSKSYTSTYI 761
+ + + H + ++HRD+K NIL+D + E L DFG L +
Sbjct: 155 FWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-- 209
Query: 762 MGTIGYIDPEYARTSRLT-EKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAV 820
GT Y PE+ R R + V+S GI+L +++ G +++ I+
Sbjct: 210 -GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD----EEIIRGQV---- 260
Query: 821 METVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSR---VLGSLVPAPEPQK 877
+S+ C+ L ++ +P+DRPT E+ + L+P +
Sbjct: 261 --FFRQRVSSECQHL--IRWCLA-------LRPSDRPTFEEIQNHPWMQDVLLPQETAEI 309
Query: 878 QPTSIPS 884
S+
Sbjct: 310 HLHSLSP 316
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 65/341 (19%), Positives = 115/341 (33%), Gaps = 61/341 (17%)
Query: 210 NCTSFQVLDLSYNQLSGEIPFNIGFL------QIATLSLQGNQLTGKIPSVIGLMQALAV 263
LDLS N L + + +L+L GN L K + L+Q LA
Sbjct: 20 IPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFK--NSDELVQILAA 77
Query: 264 LDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNM-----TKLHYLELNDNQ 318
+ L L N L+ EL + L+L N
Sbjct: 78 -----------------IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWND 120
Query: 319 LTG----HIPPALGKL-TDLFDLNVANNHLEGP----IPDNLSSC-TNLNSLNVHGNKLN 368
+ A L + LN+ N L + L++ N+NSLN+ GN L
Sbjct: 121 FSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLA 180
Query: 369 GT----IPPAFQRL-ESMTYLNLSLNNIRGPIPVELSRI-----GNLDTLDMSNNKISGS 418
+ + S+T L+LS N + EL+ I ++ +L++ N + G
Sbjct: 181 SKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGP 240
Query: 419 ----IPSPLGDLEHLLKLNLSRNQLTGFIPGE-------FGNLRSVMEIDLSHNHLTGVI 467
+ L+HL + L + + + F N++ ++ +D + +
Sbjct: 241 SLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSH 300
Query: 468 PEELSQLQNMFSLRLDYNNLSGDVMSLINCLSLSVLFIGNP 508
+S L S + D +L + ++ + P
Sbjct: 301 SIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIP 341
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 8e-09
Identities = 65/375 (17%), Positives = 112/375 (29%), Gaps = 91/375 (24%)
Query: 115 CSSLKSLDLSFNELYGDIPFSISKL-----KQLEFLILKNNQLIGPIPSTLSQLPNLKVF 169
+ SLDLS N LY + + + L L N L L Q
Sbjct: 21 PHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQ------- 73
Query: 170 GLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIG-----NCTSFQVLDLSYNQL 224
L + + ++ N L+ + + VLDL +N
Sbjct: 74 ILAAIP------------ANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDF 121
Query: 225 SGEIPFNIG------FLQIATLSLQGNQLTGKIPSVIGLMQALA-------VLDLSCNML 271
S + I +L+L+GN L K S L+Q LA L+L N L
Sbjct: 122 SSKSSSEFKQAFSNLPASITSLNLRGNDLGIK--SSDELIQILAAIPANVNSLNLRGNNL 179
Query: 272 SGP----IPPILGNLSYT-EKLYLHSNKLTGHIPPELG-----NMTKLHYLELNDNQLTG 321
+ + L ++ + L L +N L EL + L L N L G
Sbjct: 180 ASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHG 239
Query: 322 HIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGT-------IPPA 374
L L S +L ++ + + + + A
Sbjct: 240 PSLENLKLL--------------------KDSLKHLQTVYLDYDIVKNMSKEQCKALGAA 279
Query: 375 FQRLESMTYLNLSLNNIRGPIPVELSRI-----GNLDTLDMSNNKIS-----GSIPSPLG 424
F ++ + ++ + I + +S + G D + N + + L
Sbjct: 280 FPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLN 339
Query: 425 DLEHLLKLNLSRNQL 439
+ L + + L
Sbjct: 340 IPDELRESIQTCKPL 354
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 4e-06
Identities = 64/368 (17%), Positives = 129/368 (35%), Gaps = 81/368 (22%)
Query: 69 TVIALNLSGLNLDGEISPAVGD-LKD----LQSIDLRGNRLSGQIPDEIGD-----CSSL 118
V +L+LS NL + + + + S++L GN L + DE+ +++
Sbjct: 23 GVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82
Query: 119 KSLDLSFNELYGDIPFSISKL-----KQLEFLILKNNQL----IGPIPSTLSQLP-NLKV 168
SL+LS N L + K + L L N S LP ++
Sbjct: 83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITS 142
Query: 169 FGLRGNN--------LVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIG-----NCTSFQ 215
LRGN+ L+ L+ ++ L ++R N+L + S
Sbjct: 143 LNLRGNDLGIKSSDELIQILAAIPANVNSL---NLRGNNLASKNCAELAKFLASIPASVT 199
Query: 216 VLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGP- 274
LDLS N L + + ++A + + L+L N L GP
Sbjct: 200 SLDLSANLLGLK-----SYAELAYI-FSSIPNH------------VVSLNLCLNCLHGPS 241
Query: 275 ---IPPILGNLSYTEKLYLHSNKLTGHIPPE--------LGNMTKLHYLELNDNQLTGHI 323
+ + +L + + +YL + + ++ E N+ K+ ++ N ++
Sbjct: 242 LENLKLLKDSLKHLQTVYLDYDIV-KNMSKEQCKALGAAFPNIQKIILVDKNGKEIH--- 297
Query: 324 PPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTY 383
P +++L + + + P +L + + + N + IP + +
Sbjct: 298 PSHSIPISNL--IRELSGKADVP---SLLNQCLIFAQKHQTNIEDLNIP------DELRE 346
Query: 384 LNLSLNNI 391
+ +
Sbjct: 347 SIQTCKPL 354
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 47/249 (18%), Positives = 88/249 (35%), Gaps = 40/249 (16%)
Query: 303 LGNMTKLHYLELNDNQLTG----HIPPALGKL-TDLFDLNVANNHLEGPIPDNLSS---- 353
+ L+L+ N L + A + LN++ N L D L
Sbjct: 18 TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77
Query: 354 -CTNLNSLNVHGNKLNGT----IPPAFQRL-ESMTYLNLSLNNIRGPIPVELSRI----- 402
N+ SLN+ GN L+ + + ++T L+L N+ E +
Sbjct: 78 IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLP 137
Query: 403 GNLDTLDMSNNKISGSIPSPLGDL-----EHLLKLNLSRNQLT----GFIPGEFGNL-RS 452
++ +L++ N + L + ++ LNL N L + ++ S
Sbjct: 138 ASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPAS 197
Query: 453 VMEIDLSHNHLTGVIPEELSQL-----QNMFSLRLDYNNLSGDVMSLI-----NCLSLSV 502
V +DLS N L EL+ + ++ SL L N L G + + + L
Sbjct: 198 VTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQT 257
Query: 503 LFIGNPGLC 511
+++ +
Sbjct: 258 VYLDYDIVK 266
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 3e-09
Identities = 27/111 (24%), Positives = 54/111 (48%), Gaps = 4/111 (3%)
Query: 308 KLHYLELNDNQLT-GHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNK 366
+ L L++ + G I + +L L++ N L NL L L + N+
Sbjct: 25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI--SVSNLPKLPKLKKLELSENR 82
Query: 367 LNGTIPPAFQRLESMTYLNLSLNNIRGPIPVE-LSRIGNLDTLDMSNNKIS 416
+ G + ++L ++T+LNLS N ++ +E L ++ L +LD+ N +++
Sbjct: 83 IFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 4e-07
Identities = 30/115 (26%), Positives = 53/115 (46%), Gaps = 6/115 (5%)
Query: 90 DLKDLQSIDLRGNRLS-GQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILK 148
++ + L + + G+I + +L+ L L L + ++ KL +L+ L L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGL-ISVS-NLPKLPKLKKLELS 79
Query: 149 NNQLIGPIPSTLSQLPNLKVFGLRGNNL--VGTLSPDMCQLSGLWYFDVRNNSLT 201
N++ G + +LPNL L GN L + TL P + +L L D+ N +T
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEP-LKKLECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 5e-07
Identities = 22/105 (20%), Positives = 36/105 (34%), Gaps = 6/105 (5%)
Query: 407 TLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGV 466
LD + G I + +L L+L L + L + +++LS N + G
Sbjct: 30 VLDNCKSND-GKIEGLTAEFVNLEFLSLINVGLIS-VSN-LPKLPKLKKLELSENRIFGG 86
Query: 467 IPEELSQLQNMFSLRLDYNNLS--GDVMSLINCLSLSVL-FIGNP 508
+ +L N+ L L N L + L L L
Sbjct: 87 LDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCE 131
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 1e-06
Identities = 27/112 (24%), Positives = 46/112 (41%), Gaps = 6/112 (5%)
Query: 356 NLNSLNVHGNKLN-GTIPPAFQRLESMTYLNLSLNNIRGPIPVE-LSRIGNLDTLDMSNN 413
+ L + K N G I ++ +L+L + V L ++ L L++S N
Sbjct: 25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS---VSNLPKLPKLKKLELSEN 81
Query: 414 KISGSIPSPLGDLEHLLKLNLSRNQLTGF-IPGEFGNLRSVMEIDLSHNHLT 464
+I G + L +L LNLS N+L L + +DL + +T
Sbjct: 82 RIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 3e-06
Identities = 28/136 (20%), Positives = 56/136 (41%), Gaps = 9/136 (6%)
Query: 135 SISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFD 194
+ + +++L K+N G I ++ NL+ L L+ ++S ++ +L L +
Sbjct: 22 TPAAVRELVLDNCKSN--DGKIEGLTAEFVNLEFLSLINVGLI-SVS-NLPKLPKLKKLE 77
Query: 195 VRNNSLTGSIPQNIGNCTSFQVLDLSYNQLS--GEIPFNIGFLQIATLSLQGNQLTGKI- 251
+ N + G + + L+LS N+L + + +L L ++T
Sbjct: 78 LSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLND 137
Query: 252 --PSVIGLMQALAVLD 265
SV L+ L LD
Sbjct: 138 YRESVFKLLPQLTYLD 153
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 8e-06
Identities = 28/133 (21%), Positives = 42/133 (31%), Gaps = 26/133 (19%)
Query: 234 FLQIATLSLQGNQLT-GKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHS 292
+ L L + GKI + L L L L L L +KL L
Sbjct: 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI--SVSNLPKLPKLKKLELSE 80
Query: 293 NKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLS 352
N++ G + + L +L L+ N KL D+ L + L
Sbjct: 81 NRIFGGLDMLAEKLPNLTHLNLSGN-----------KLKDISTL------------EPLK 117
Query: 353 SCTNLNSLNVHGN 365
L SL++
Sbjct: 118 KLECLKSLDLFNC 130
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 61/282 (21%), Positives = 105/282 (37%), Gaps = 54/282 (19%)
Query: 623 KPVAIKRL--YSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFME--- 677
+ VAIK + P L++ E+ + + H N+V L + + + L Y ME
Sbjct: 41 REVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL--FEVIETEKTL-YLIMEYAS 97
Query: 678 NGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDF 737
G ++D L ++ + Y H I+HRD+K+ N+LLD D
Sbjct: 98 GGEVFDYL---VAHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADM 151
Query: 738 EAHLTDFGIA---------KSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFG 788
+ DFG + + C + Y + + Y PE DV+S G
Sbjct: 152 NIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPE----------VDVWSLG 201
Query: 789 IVLLELLTGRKAVD--NECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLAL 846
++L L++G D N L +L + +S C++L +K+ L
Sbjct: 202 VILYTLVSGSLPFDGQNLKELRERVLRGKY------RIPFYMSTDCENL--LKRFLVL-- 251
Query: 847 LCSKRQPTDRPTMHEVSR----VLGSLVPAPEPQKQPTSIPS 884
P R T+ ++ + G +P +P S
Sbjct: 252 -----NPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDIS 288
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 4e-09
Identities = 27/114 (23%), Positives = 56/114 (49%), Gaps = 4/114 (3%)
Query: 305 NMTKLHYLELNDNQLT-GHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVH 363
+ + L L++++ G + + +L L+ N L NL L L +
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT--SIANLPKLNKLKKLELS 72
Query: 364 GNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVE-LSRIGNLDTLDMSNNKIS 416
N+++G + ++ ++T+LNLS N I+ +E L ++ NL +LD+ N +++
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 2e-07
Identities = 21/109 (19%), Positives = 42/109 (38%), Gaps = 6/109 (5%)
Query: 404 NLDTLDMSNNKIS-GSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNH 462
++ L + N++ + G + + E L L+ LT I L + +++LS N
Sbjct: 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS-IAN-LPKLNKLKKLELSDNR 75
Query: 463 LTGVIPEELSQLQNMFSLRLDYNNLS--GDVMSLINCLSLSVL-FIGNP 508
++G + + N+ L L N + + L +L L
Sbjct: 76 VSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCE 124
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-07
Identities = 22/115 (19%), Positives = 51/115 (44%), Gaps = 6/115 (5%)
Query: 353 SCTNLNSLNVHGNKLN-GTIPPAFQRLESMTYLNLSLNNIRGPIPVE-LSRIGNLDTLDM 410
+ +++ L + ++ N G + E + +L+ + + L ++ L L++
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS---IANLPKLNKLKKLEL 71
Query: 411 SNNKISGSIPSPLGDLEHLLKLNLSRNQLTGF-IPGEFGNLRSVMEIDLSHNHLT 464
S+N++SG + +L LNLS N++ L ++ +DL + +T
Sbjct: 72 SDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 4e-07
Identities = 21/88 (23%), Positives = 40/88 (45%), Gaps = 3/88 (3%)
Query: 90 DLKDLQSIDLRGNRLS-GQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILK 148
D++ + L +R + G++ + L+ L L I ++ KL +L+ L L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGL-TSIA-NLPKLNKLKKLELS 72
Query: 149 NNQLIGPIPSTLSQLPNLKVFGLRGNNL 176
+N++ G + + PNL L GN +
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKI 100
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 2e-06
Identities = 25/136 (18%), Positives = 56/136 (41%), Gaps = 9/136 (6%)
Query: 135 SISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFD 194
+ S +K+L ++N G + + L+ L +++ ++ +L+ L +
Sbjct: 15 TPSDVKELVLDNSRSN--EGKLEGLTDEFEELEFLSTINVGLT-SIA-NLPKLNKLKKLE 70
Query: 195 VRNNSLTGSIPQNIGNCTSFQVLDLSYNQLS--GEIPFNIGFLQIATLSLQGNQLTGKI- 251
+ +N ++G + C + L+LS N++ I + +L L ++T
Sbjct: 71 LSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLND 130
Query: 252 --PSVIGLMQALAVLD 265
+V L+ L LD
Sbjct: 131 YRENVFKLLPQLTYLD 146
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 5e-05
Identities = 26/134 (19%), Positives = 46/134 (34%), Gaps = 32/134 (23%)
Query: 236 QIATLSLQGNQLT-GKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYT---EKLYLH 291
+ L L ++ GK+ + + L L L+ + NL +KL L
Sbjct: 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-----SIANLPKLNKLKKLELS 72
Query: 292 SNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNL 351
N+++G + L +L L+ N K+ DL + + L
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGN-----------KIKDLSTI------------EPL 109
Query: 352 SSCTNLNSLNVHGN 365
NL SL++
Sbjct: 110 KKLENLKSLDLFNC 123
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 4e-09
Identities = 52/235 (22%), Positives = 91/235 (38%), Gaps = 75/235 (31%)
Query: 606 IGYGASSTVYKCV-LKNCKPVAIKRLYSHYPQCLKEFETELETVGS-----------IKH 653
IG G V+K K + VA+K++ E E E +KH
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKV---------LMENEKEGFPITALREIKILQLLKH 75
Query: 654 RNLVSLQG-------YSLSSSGNL-LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALG 705
N+V+L G++ L +DF E+ D+ L + +
Sbjct: 76 ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH----DL------AGLLS---NVLVKFT 122
Query: 706 AAQ----------GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV--- 752
++ GL Y+H + +I+HRD+K++N+L+ +D L DFG+A++ +
Sbjct: 123 LSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 179
Query: 753 --SKSYTSTYIMGTIGYIDPE-------YARTSRLTEKSDVYSFGIVLLELLTGR 798
YT+ + T+ Y PE Y D++ G ++ E+ T
Sbjct: 180 SQPNRYTNRVV--TLWYRPPELLLGERDY------GPPIDLWGAGCIMAEMWTRS 226
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 4e-09
Identities = 27/108 (25%), Positives = 49/108 (45%), Gaps = 3/108 (2%)
Query: 355 TNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNK 414
++ L + GN+ +P + +T ++LS N I S + L TL +S N+
Sbjct: 31 RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89
Query: 415 ISGSIPSPLGD-LEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHN 461
+ IP D L+ L L+L N ++ G F +L ++ + + N
Sbjct: 90 LR-CIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 7e-07
Identities = 31/131 (23%), Positives = 49/131 (37%), Gaps = 13/131 (9%)
Query: 194 DVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPS 253
N L +P+ I L L NQ + + + + L N+++
Sbjct: 16 RCSNKGLK-VLPKGIP--RDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQ 72
Query: 254 VIGLMQALAVLDLSCNMLSGPIPP----ILGNLSYTEKLYLHSNKLTGHIPPEL-GNMTK 308
M L L LS N L IPP L +L L LH N ++ +P +++
Sbjct: 73 SFSNMTQLLTLILSYNRLRC-IPPRTFDGLKSLRL---LSLHGNDISV-VPEGAFNDLSA 127
Query: 309 LHYLELNDNQL 319
L +L + N L
Sbjct: 128 LSHLAIGANPL 138
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 31/151 (20%), Positives = 51/151 (33%), Gaps = 58/151 (38%)
Query: 285 TEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLE 344
+LYL N+ T +P EL N L ++L++N+++
Sbjct: 33 VTELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRIS------------------------ 67
Query: 345 GPIPDNLSSCTNLNSLNVHGNKLNGTIPP-AFQRLESMTYLNLSLNNIRGPIPVEL-SRI 402
T+ +F + + L LS N +R IP +
Sbjct: 68 -------------------------TLSNQSFSNMTQLLTLILSYNRLRC-IPPRTFDGL 101
Query: 403 GNLDTLDMSNNKISGSIP----SPLGDLEHL 429
+L L + N IS +P + L L HL
Sbjct: 102 KSLRLLSLHGNDIS-VVPEGAFNDLSALSHL 131
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 34/102 (33%), Positives = 53/102 (51%), Gaps = 8/102 (7%)
Query: 382 TYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGD-LEHLLKLNLSRNQLT 440
T L L N +P ELS +L +D+SNN+IS ++ + + LL L LS N+L
Sbjct: 34 TELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR 91
Query: 441 GFIPGEFGNLRSVMEIDLSHNHLTGVIPE----ELSQLQNMF 478
P F L+S+ + L N ++ V+PE +LS L ++
Sbjct: 92 CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLA 132
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 9e-06
Identities = 21/81 (25%), Positives = 43/81 (53%), Gaps = 1/81 (1%)
Query: 408 LDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVI 467
L + N+ + +P L + +HL ++LS N+++ F N+ ++ + LS+N L +
Sbjct: 36 LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIP 94
Query: 468 PEELSQLQNMFSLRLDYNNLS 488
P L+++ L L N++S
Sbjct: 95 PRTFDGLKSLRLLSLHGNDIS 115
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 8e-05
Identities = 27/84 (32%), Positives = 43/84 (51%), Gaps = 1/84 (1%)
Query: 93 DLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQL 152
D+ + L GN+ + +P E+ + L +DLS N + S S + QL LIL N+L
Sbjct: 32 DVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL 90
Query: 153 IGPIPSTLSQLPNLKVFGLRGNNL 176
P T L +L++ L GN++
Sbjct: 91 RCIPPRTFDGLKSLRLLSLHGNDI 114
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 61/317 (19%), Positives = 103/317 (32%), Gaps = 79/317 (24%)
Query: 606 IGYGASSTVYKCV-LKNCKPVAIKRL----YSHYPQCLKEFETELETV------GSIKHR 654
+G G TV+ L + VAIK + + LE H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 655 NLVSLQGYSLSSSGNLLFYDFMEN--------------GSLWDILHGPTKKKKLDWDTRL 700
++ L D+ E L+D + T+K L
Sbjct: 99 GVIRL-------------LDWFETQEGFMLVLERPLPAQDLFDYI---TEKGPLGEGPSR 142
Query: 701 KIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKD-FEAHLTDFGIAKSLCVSKSYTST 759
+ + H S ++HRD+K NIL+D A L DFG L
Sbjct: 143 CFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD 199
Query: 760 YIMGTIGYIDPEYARTSRLT-EKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANN 818
GT Y PE+ + + V+S GI+L +++ G + +
Sbjct: 200 ---GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD-------------Q 243
Query: 819 AVME---TVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVS-----RVLGSLV 870
++E +S C L +++ C +P+ RP++ E+ + V
Sbjct: 244 EILEAELHFPAHVSPDCCAL--IRR-------CLAPKPSSRPSLEEILLDPWMQTPAEDV 294
Query: 871 PAPEPQKQPTSIPSALL 887
P + P + +LL
Sbjct: 295 PLNPSKGGPAPLAWSLL 311
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 4e-09
Identities = 43/212 (20%), Positives = 81/212 (38%), Gaps = 33/212 (15%)
Query: 606 IGYGASSTVYKCV-LKNCKPVAIK-----RLYSHYPQCLKEFETELETVGSIKHRNLVSL 659
+G G+ V + + + A+K +L P + E++ + ++H+N++ L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRI-PNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 660 -QGYSLSSSGNLLFYDFME--NGSLWDILHGPTKKKKLDWDTRLK----IALGAAQGLAY 712
+ Y ME + ++L +K+ I GL Y
Sbjct: 72 VDVLYNEEKQKM--YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLID-----GLEY 124
Query: 713 LHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIM----GTIGYI 768
LH S I+H+D+K N+LL ++ G+A+ + + G+ +
Sbjct: 125 LH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAE---ALHPFAADDTCRTSQGSPAFQ 178
Query: 769 DPEYARTSRLTE--KSDVYSFGIVLLELLTGR 798
PE A K D++S G+ L + TG
Sbjct: 179 PPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 6e-09
Identities = 47/242 (19%), Positives = 86/242 (35%), Gaps = 53/242 (21%)
Query: 605 IIGYGASSTVYKCV-LKNCKPVAIKRLYSH---YPQCLKEFETELETV--------GSIK 652
+G+G STV+ + N VA+K + E + L+ V S+
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKL-LQRVNDADNTKEDSMG 84
Query: 653 HRNLVSLQGYSLSSSGNLLFYDFMENG------------SLWDILHGPTKKKKLDWDTRL 700
+++ L + F NG +L ++ + + +
Sbjct: 85 ANHILKLLDH---------FNHKGPNGVHVVMVFEVLGENLLALIKK-YEHRGIPLIYVK 134
Query: 701 KIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAH------LTDFGIAKSLCVSK 754
+I+ GL Y+H C IIH D+K N+L++ + D G A C
Sbjct: 135 QISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA---CWYD 189
Query: 755 SYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTG------RKAVDNECNLH 808
+ + I T Y PE + +D++S ++ EL+TG + +
Sbjct: 190 EHYTNSIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 248
Query: 809 HL 810
H+
Sbjct: 249 HI 250
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 9e-09
Identities = 48/227 (21%), Positives = 90/227 (39%), Gaps = 41/227 (18%)
Query: 599 NLSEKY----IIGYGASSTVYKCV-LKNCKPVAIKRL--YSHYPQCLKEFETELETVGSI 651
N+S + ++G GA V + VAIK++ + L+ E++ +
Sbjct: 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHF 66
Query: 652 KHRNLVSLQGYSLSSSGNL-----LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGA 706
KH N++++ S + + M+ D LH + L D ++ +
Sbjct: 67 KHENIITIFNIQRPDSFENFNEVYIIQELMQT----D-LHRVISTQMLS-DDHIQYFI-- 118
Query: 707 AQ---GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMG 763
Q + LH +IHRD+K SN+L++ + + + DFG+A+ + +S
Sbjct: 119 YQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARI--IDESAADNSEPT 173
Query: 764 TIGYIDPEYART------------SRLTEKSDVYSFGIVLLELLTGR 798
E+ T ++ + DV+S G +L EL R
Sbjct: 174 GQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 2e-08
Identities = 44/210 (20%), Positives = 88/210 (41%), Gaps = 37/210 (17%)
Query: 606 IGYGASSTVYKCV-LKNCKPVAIK-----RLYSHYPQCLKEFETELETVGSIKHRNLVSL 659
+G G V VA+K ++ S + + + E++ + +H +++ L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSL--DVVGKIKREIQNLKLFRHPHIIKL 76
Query: 660 QGYSLSSSGNLLFY--DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDC 717
Y + S+ F +++ G L+D + K +++ ++ + Y H
Sbjct: 77 --YQVISTPTDFFMVMEYVSGGELFDYI---CKHGRVEEMEARRLFQQILSAVDYCH--- 128
Query: 718 SPRIIHRDVKSSNILLDKDFEAHLTDFGIA---------KSLCVSKSYTSTYIMGTIGYI 768
++HRD+K N+LLD A + DFG++ ++ C S +Y + ++ Y
Sbjct: 129 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYA 188
Query: 769 DPEYARTSRLTEKSDVYSFGIVLLELLTGR 798
PE D++S G++L LL G
Sbjct: 189 GPE----------VDIWSCGVILYALLCGT 208
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 55/242 (22%), Positives = 83/242 (34%), Gaps = 43/242 (17%)
Query: 593 IMRMTENLSEKYII----GYGASSTVYKCV-LKNCKPVAIKRLYSH---YPQCLKEFE-- 642
I++ E ++Y I G G+ V K + VAIK + + Q E
Sbjct: 45 IVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLL 104
Query: 643 TELETVGSIKHRNLVSLQGY------------SLSSSGNLLFYDFMENGSLWDILHGPTK 690
+ + +V L+ + LS NL YD + N T
Sbjct: 105 ELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY--NL--YDLLRN----------TN 150
Query: 691 KKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILL--DKDFEAHLTDFGIAK 748
+ + + K A L +L IIH D+K NILL K + DFG
Sbjct: 151 FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFG--- 206
Query: 749 SLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLH 808
S C YI + Y PE D++S G +L+E+ TG +
Sbjct: 207 SSCQLGQRIYQYIQ-SRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVD 265
Query: 809 HL 810
+
Sbjct: 266 QM 267
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 37/220 (16%), Positives = 73/220 (33%), Gaps = 69/220 (31%)
Query: 599 NLSEKY----IIGYGASSTVYKCV-LKNCKPVAIKRLYSHYPQCLKEFET---------E 644
+ ++Y +IG G+ V + + VAIK++ + FE E
Sbjct: 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL-------RVFEDLIDCKRILRE 102
Query: 645 LETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDW-------D 697
+ + + H ++V + DI+ +K + D
Sbjct: 103 IAILNRLNHDHVVKVL----------------------DIVIPKDVEKFDELYVVLEIAD 140
Query: 698 TRLKIALGAAQ----------------GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHL 741
+ K G+ Y+H S I+HRD+K +N L+++D +
Sbjct: 141 SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKV 197
Query: 742 TDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEK 781
DFG+A+++ ++ S + K
Sbjct: 198 CDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLK 237
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 49/246 (19%), Positives = 86/246 (34%), Gaps = 61/246 (24%)
Query: 599 NLSEKY----IIGYGASSTVYKCV-LKNCKPVAIKRLYSHYPQCLKEFET---------E 644
++ + Y +IG G+ VY K VAIK++ + FE E
Sbjct: 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN-------RMFEDLIDCKRILRE 75
Query: 645 LETVGSIKHRNLVSLQGYSLSSSGNL-----LFYDFMENGSLWDILHGPTKKKKLDWDTR 699
+ + +K ++ L + + + + D L K +
Sbjct: 76 ITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD----SD-LKKLFKTPIFLTEEH 130
Query: 700 LKIALGAAQ---GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY 756
+K L G ++H IIHRD+K +N LL++D + DFG+A+++ K
Sbjct: 131 IKTILY--NLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDT 185
Query: 757 TSTYIMGTIGYIDPEYARTSR-LTE--------------------KS-DVYSFGIVLLEL 794
+ P + LT KS D++S G + EL
Sbjct: 186 NIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245
Query: 795 LTGRKA 800
L ++
Sbjct: 246 LNMLQS 251
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 57/247 (23%), Positives = 87/247 (35%), Gaps = 55/247 (22%)
Query: 593 IMRMTENLSEKYII----GYGASSTVYKCV-LKNCKPVAIKRLYSH---YPQCLKEFETE 644
+ ++++ +Y + G G+ V K K + VA+K + + + Q +E
Sbjct: 88 VQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRI- 146
Query: 645 LETV---------------GSIKHRN---LVS-LQGYSLSSSGNLLFYDFMENGSLWDIL 685
LE + + RN + L +L Y+ ++
Sbjct: 147 LEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNL--------YELIKKNKF---- 194
Query: 686 HGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILL--DKDFEAHLTD 743
+ K A Q L LH RIIH D+K NILL + D
Sbjct: 195 ------QGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVID 245
Query: 744 FGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDN 803
FG S C TYI + Y PE +R D++S G +L ELLTG +
Sbjct: 246 FG---SSCYEHQRVYTYIQ-SRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPG 301
Query: 804 ECNLHHL 810
E L
Sbjct: 302 EDEGDQL 308
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 6e-08
Identities = 55/277 (19%), Positives = 93/277 (33%), Gaps = 85/277 (30%)
Query: 593 IMRMTENLSEKYII----GYGASSTVYKCV-LKNCKPVAIK--RLYSHYPQCLKEFETEL 645
++++ + + +Y + G+G STV+ ++ K VA+K + HY + + E+
Sbjct: 28 LVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD---EI 84
Query: 646 ETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENG---------------SLWDILHGPTK 690
+ S+++ + + + LL DF +G L + +
Sbjct: 85 RLLKSVRNSD-PNDPNREMVVQ--LLD-DFKISGVNGTHICMVFEVLGHHLLKWIIK-SN 139
Query: 691 KKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILL----------------- 733
+ L KI QGL YLH C RIIH D+K NILL
Sbjct: 140 YQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEW 197
Query: 734 --------------------------------DKDFEAHLTDFGIAKSLCVSKSYTSTYI 761
+ + + D G A C + + I
Sbjct: 198 QRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNA---CWVHKHFTEDI 254
Query: 762 MGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGR 798
T Y E S +D++S + EL TG
Sbjct: 255 Q-TRQYRSLEVLIGSGYNTPADIWSTACMAFELATGD 290
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 54.5 bits (130), Expect = 7e-08
Identities = 39/232 (16%), Positives = 60/232 (25%), Gaps = 54/232 (23%)
Query: 591 EDIMRMTENLSEKYI-----IGYGASSTVYKCVLKNCKPVAIKRLY--------SHYPQC 637
+ + + L + + IG G V++ + + PVAIK + + +
Sbjct: 8 KGPVPFSHCLPTEKLQRCEKIGEGVFGEVFQTIADH-TPVAIKIIAIEGPDLVNGSHQKT 66
Query: 638 LKEFETE---------LETVGSIKHRNLVSLQGYSL----SSSGNLLFYDFM--ENGSLW 682
+E E L + + L L +D GS
Sbjct: 67 FEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSAN 126
Query: 683 DILHGPTK--------------------KKKLDWDTRLKIALGAAQGLAYLHHDCSPRII 722
D K T I LA S R
Sbjct: 127 DRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFE 184
Query: 723 HRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYAR 774
HRD+ N+LL K L KS + + + I Y R
Sbjct: 185 HRDLHWGNVLLKKTSLKKLHYTLNGKSSTI---PSCGLQVSIIDYTLSRLER 233
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 9e-08
Identities = 51/210 (24%), Positives = 89/210 (42%), Gaps = 38/210 (18%)
Query: 606 IGYGASSTVYKCV-LKNCKPVAIK-----RLYSHYPQCLKEFETELETVGSIKHRNLVSL 659
+G G+ V K + VA+K L E E+ + ++H +++ L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKS--DMHMRVEREISYLKLLRHPHIIKL 74
Query: 660 QGYSLSSSGNLLFYDFME--NGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDC 717
Y + ++ + +E G L+D + +KK++ D + + Y H
Sbjct: 75 --YDVITTPTDIVM-VIEYAGGELFDYI---VEKKRMTEDEGRRFFQQIICAIEYCH--- 125
Query: 718 SPRIIHRDVKSSNILLDKDFEAHLTDFGIA---------KSLCVSKSYTSTYIMGTIGYI 768
+I+HRD+K N+LLD + + DFG++ K+ C S +Y + ++ Y
Sbjct: 126 RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYA 185
Query: 769 DPEYARTSRLTEKSDVYSFGIVLLELLTGR 798
PE DV+S GIVL +L GR
Sbjct: 186 GPE----------VDVWSCGIVLYVMLVGR 205
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 49/238 (20%), Positives = 79/238 (33%), Gaps = 43/238 (18%)
Query: 596 MTENLSEKYI----IGYGASSTVYKCVLKNCK------PVAIKRLYSHYPQCLKE--FET 643
+T+ + + IG G +Y + + + P +K S E F
Sbjct: 29 ITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQ 88
Query: 644 ELETVGSIKHRNLVSLQG--------YSLSSSGNLLFYDFME----NGSLWDILHGPTKK 691
I+ S N Y FM L I
Sbjct: 89 RAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYE--ANA 146
Query: 692 KKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFE--AHLTDFGIAKS 749
K+ T L+++L L Y+H +H D+K+SN+LL+ +L D+G+A
Sbjct: 147 KRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYR 203
Query: 750 LCVSKSYT------STYIMGTIGY--IDPEYART-SRLTEKSDVYSFGIVLLELLTGR 798
C + GTI + ID SR + D+ G +++ LTG
Sbjct: 204 YCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSR---RGDLEILGYCMIQWLTGH 258
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 53.4 bits (127), Expect = 2e-07
Identities = 29/193 (15%), Positives = 60/193 (31%), Gaps = 27/193 (13%)
Query: 56 CVWRGITCDNVTFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDC 115
+ ++SP + + L ++ ++G +
Sbjct: 136 EKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGT---NNLSIGKKPR 192
Query: 116 SSLKSLDLSFNELYGDIPFSISK-----LKQLEFLILKNNQLIGPIPSTLSQL------P 164
+LKSL++ L + I L++L + + + L P
Sbjct: 193 PNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFP 252
Query: 165 NLKVFGLRGNNLVGTL------SPDMCQLSGLWYFDVRNNSLTGS----IPQNIGNCTSF 214
NLK G+ + S + QL + D+ LT + ++
Sbjct: 253 NLKWLGIVDAEEQNVVVEMFLESDILPQLETM---DISAGVLTDEGARLLLDHVDKIKHL 309
Query: 215 QVLDLSYNQLSGE 227
+ +++ YN LS E
Sbjct: 310 KFINMKYNYLSDE 322
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 51.9 bits (123), Expect = 6e-07
Identities = 26/187 (13%), Positives = 66/187 (35%), Gaps = 25/187 (13%)
Query: 309 LHYLELNDNQLT----GHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHG 364
++ + +++ + P L + L +L + + NL SL +
Sbjct: 146 WGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGT---NNLSIGKKPRPNLKSLEIIS 202
Query: 365 NKLNGTIPPAFQ--RLESMTYLNLSL--NNIRGPIPVEL-------SRIGNLDTLDMSNN 413
L ++ L ++ L L + + + + R NL L + +
Sbjct: 203 GGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDA 262
Query: 414 KISGSIPSPLGD---LEHLLKLNLSRNQLTGF----IPGEFGNLRSVMEIDLSHNHLTGV 466
+ + + L L +++S LT + ++ + I++ +N+L+
Sbjct: 263 EEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322
Query: 467 IPEELSQ 473
+ +EL +
Sbjct: 323 MKKELQK 329
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 50.0 bits (118), Expect = 2e-06
Identities = 25/165 (15%), Positives = 53/165 (32%), Gaps = 17/165 (10%)
Query: 292 SNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNL 351
S + P L M L+ L++ L L ++
Sbjct: 157 SWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSL-EIISGGLPDSVVEDILG 215
Query: 352 SSCTNLNSLNVHGNKLN-------GTIPPAFQ--RLESMTYLNLSLNNIRGPIPVELSR- 401
S NL L ++ + P F R ++ +L + + +
Sbjct: 216 SDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLES 275
Query: 402 --IGNLDTLDMSNNKISGS----IPSPLGDLEHLLKLNLSRNQLT 440
+ L+T+D+S ++ + + ++HL +N+ N L+
Sbjct: 276 DILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 42.6 bits (99), Expect = 4e-04
Identities = 27/194 (13%), Positives = 60/194 (30%), Gaps = 27/194 (13%)
Query: 154 GPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIG--NC 211
+ L +P L ++G N LS L ++ + L S+ ++I +
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTN---NLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDL 218
Query: 212 TSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNML 271
+ + L L + F+ L ++ L L +
Sbjct: 219 PNLEKLVLYVG--VEDYGFDGDMNVFRPL-FSKDRFP-----------NLKWLGIVDAEE 264
Query: 272 SGPIPPILGNLSYT---EKLYLHSNKLTG----HIPPELGNMTKLHYLELNDNQLTGHIP 324
+ + E + + + LT + + + L ++ + N L+ +
Sbjct: 265 QNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMK 324
Query: 325 PALGK-LTDLFDLN 337
L K L D++
Sbjct: 325 KELQKSLPMKIDVS 338
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 6e-07
Identities = 30/78 (38%), Positives = 46/78 (58%), Gaps = 7/78 (8%)
Query: 285 TEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPP-ALGKLTDLFDLNVANNHL 343
T+ LYL+ N++T P +T+L L+L++NQLT +P KLT L L++ +N L
Sbjct: 32 TQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTV-LPAGVFDKLTQLTQLSLNDNQL 90
Query: 344 EGPIP----DNLSSCTNL 357
+ IP DNL S T++
Sbjct: 91 KS-IPRGAFDNLKSLTHI 107
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 2e-06
Identities = 35/107 (32%), Positives = 51/107 (47%), Gaps = 13/107 (12%)
Query: 288 LYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPI 347
+ L +P G T L L DNQ+T P +LT L L++ NN L +
Sbjct: 14 VDCSGKSLAS-VPT--GIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTV-L 69
Query: 348 P----DNLSSCTNLNSLNVHGNKLNGTIPP-AFQRLESMTYLNLSLN 389
P D L T L L+++ N+L +IP AF L+S+T++ L N
Sbjct: 70 PAGVFDKL---TQLTQLSLNDNQLK-SIPRGAFDNLKSLTHIWLLNN 112
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 7e-07
Identities = 47/210 (22%), Positives = 90/210 (42%), Gaps = 37/210 (17%)
Query: 606 IGYGASSTVYKCV-LKNCKPVAIK-----RLYSHYPQCLKEFETELETVGSIKHRNLVSL 659
+G G V VA+K ++ S + + E++ + +H +++ L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSL--DVVGKIRREIQNLKLFRHPHIIKL 81
Query: 660 QGYSLSSSGNLLFY--DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDC 717
Y + S+ + +F +++ G L+D + K +LD ++ G+ Y H
Sbjct: 82 --YQVISTPSDIFMVMEYVSGGELFDYI---CKNGRLDEKESRRLFQQILSGVDYCH--- 133
Query: 718 SPRIIHRDVKSSNILLDKDFEAHLTDFGIA---------KSLCVSKSYTSTYIMGTIGYI 768
++HRD+K N+LLD A + DFG++ ++ C S +Y + ++ Y
Sbjct: 134 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYA 193
Query: 769 DPEYARTSRLTEKSDVYSFGIVLLELLTGR 798
PE D++S G++L LL G
Sbjct: 194 GPE----------VDIWSSGVILYALLCGT 213
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 8e-07
Identities = 52/222 (23%), Positives = 80/222 (36%), Gaps = 55/222 (24%)
Query: 606 IGYGASSTVYKCV-LKNCKPVAIK--RLYSHYPQCLKEFETELETVGSIKHRNLVSLQGY 662
IG G+ +Y + + VAIK + + +PQ E + +QG
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKI------------YKMMQG- 63
Query: 663 SLSSSGNLLFYDFMENG------------SLWDILHGPTKKKKLDWDTRLKIALGAAQGL 710
G G SL D+ + +K T L +A +
Sbjct: 64 ---GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFN--FCSRKFSLKTVLLLADQMISRI 118
Query: 711 AYLHHDCSPRIIHRDVKSSNILL---DKDFEAHLTDFGIAKSLCVSKSYT------STYI 761
Y+H S IHRDVK N L+ K ++ DFG+AK ++++ + +
Sbjct: 119 EYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL 175
Query: 762 MGTIGYIDPEYA--RTSRLTEKS---DVYSFGIVLLELLTGR 798
GT YA T E+S D+ S G VL+ G
Sbjct: 176 TGT-----ARYASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 43/167 (25%), Positives = 66/167 (39%), Gaps = 35/167 (20%)
Query: 709 GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHL--TDFGIAKSLCVSKSYTSTYIMGTIG 766
G++Y H S +I HRD+K N LLD L DFG +K V S + + GT
Sbjct: 128 GVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTV-GTPA 182
Query: 767 YIDPE------YARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAV 820
YI PE Y + +DV+S G+ L +L G ++ + +
Sbjct: 183 YIAPEVLLRQEYD-----GKIADVWSCGVTLYVMLVGAYPFEDP---EEPRDYRKTIQRI 234
Query: 821 METV-----DPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
+ D IS C L + ++F P R ++ E+
Sbjct: 235 LSVKYSIPDDIRISPECCHL--ISRIFVA-------DPATRISIPEI 272
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 45/228 (19%), Positives = 83/228 (36%), Gaps = 25/228 (10%)
Query: 73 LNLSGLNL-DGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGD 131
++LS + + + LQ++ L G RLS I + + S+L L+LS + +
Sbjct: 98 MDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSE 157
Query: 132 IPFS--ISKLKQLEFLILKNNQLI---GPIPSTLSQLPNLKVFGLRG------NNLVGTL 180
+S +L+ L L + + L G + + TL
Sbjct: 158 FALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTL 217
Query: 181 SPDMCQLSGLWYFDVRN-NSLTGSIPQNIGNCTSFQVLDLSY-NQLSGEIPFNIGFLQIA 238
L L D+ + L Q Q L LS + L++
Sbjct: 218 VRRCPNLVHL---DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDII-----PETLLELG 269
Query: 239 TL-SLQGNQLTGKIP--SVIGLMQALAVLDLSCNMLSGPIPPILGNLS 283
+ +L+ Q+ G +P ++ L +AL L ++C+ + P +GN
Sbjct: 270 EIPTLKTLQVFGIVPDGTLQLLKEALPHLQINCSHFTTIARPTIGNKK 317
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 28/78 (35%), Positives = 44/78 (56%), Gaps = 7/78 (8%)
Query: 285 TEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPP-ALGKLTDLFDLNVANNHL 343
++L+L++N++T P ++ L L N N+LT IP KLT L L++ +NHL
Sbjct: 35 KQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTA-IPTGVFDKLTQLTQLDLNDNHL 93
Query: 344 EGPIP----DNLSSCTNL 357
+ IP DNL S T++
Sbjct: 94 KS-IPRGAFDNLKSLTHI 110
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 5e-06
Identities = 34/107 (31%), Positives = 50/107 (46%), Gaps = 13/107 (12%)
Query: 288 LYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPI 347
+ + +L +P G T L LN+NQ+T P L +L L +N L I
Sbjct: 17 VNCQNIRLAS-VPA--GIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTA-I 72
Query: 348 P----DNLSSCTNLNSLNVHGNKLNGTIPP-AFQRLESMTYLNLSLN 389
P D L T L L+++ N L +IP AF L+S+T++ L N
Sbjct: 73 PTGVFDKL---TQLTQLDLNDNHLK-SIPRGAFDNLKSLTHIYLYNN 115
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 30/135 (22%), Positives = 51/135 (37%), Gaps = 30/135 (22%)
Query: 680 SLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFE- 738
L I + T L++ + L Y+H +H D+K++N+LL
Sbjct: 137 DLQKIS---GQNGTFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPD 190
Query: 739 -AHLTDFGIAKSLCVSKSY------TSTYIMGTIGYIDPEYA--------RTSRLTEKSD 783
+L D+G++ C + ++ GTI E+ SR +SD
Sbjct: 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTI-----EFTSLDAHKGVALSR---RSD 242
Query: 784 VYSFGIVLLELLTGR 798
V G +L L G+
Sbjct: 243 VEILGYCMLRWLCGK 257
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 31/130 (23%), Positives = 53/130 (40%), Gaps = 18/130 (13%)
Query: 680 SLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEA 739
SL L + K L + L++A L +LH +H +V + NI +D + ++
Sbjct: 143 SLQSALD-VSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQS 198
Query: 740 --HLTDFGIAKSLCVSKS------YTSTYIMGTIGY--IDPEYART-SRLTEKSDVYSFG 788
L +G A C S + + G + + +D SR +SD+ S G
Sbjct: 199 QVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSR---RSDLQSLG 255
Query: 789 IVLLELLTGR 798
+L+ L G
Sbjct: 256 YCMLKWLYGF 265
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 46/213 (21%), Positives = 76/213 (35%), Gaps = 35/213 (16%)
Query: 606 IGYGASSTVYKCV-LKNCKPVAIK--RLYSHYPQCLKEFETELETVGSIKHRNLVSLQGY 662
IG G + L + VAIK + S PQ E+ + + + +
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGD---GIPQVYYF 73
Query: 663 SLSSSGNLLFYDFMENG-SLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRI 721
N + + + G SL D+ + T L IA+ + Y+H S +
Sbjct: 74 GPCGKYNAMVLELL--GPSLEDLFD--LCDRTFSLKTVLMIAIQLISRMEYVH---SKNL 126
Query: 722 IHRDVKSSNILLDKDFEA-----HLTDFGIAKSLCVSKSYT------STYIMGTIGYIDP 770
I+RDVK N L+ + H+ DF +AK ++ + GT
Sbjct: 127 IYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGT-----A 181
Query: 771 EYA--RTSRLTEKS---DVYSFGIVLLELLTGR 798
Y T E+S D+ + G + + L G
Sbjct: 182 RYMSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 54/222 (24%), Positives = 85/222 (38%), Gaps = 55/222 (24%)
Query: 606 IGYGASSTVYKCV-LKNCKPVAIK--RLYSHYPQCLKEFETELETVGSIKHRNLVSLQGY 662
IG G+ +Y ++ + VAIK + + +PQ L E + LQG
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKI------------YRILQG- 61
Query: 663 SLSSSGNLLFYDFMENG------------SLWDILHGPTKKKKLDWDTRLKIALGAAQGL 710
+G F G SL D+ + +KL T L +A +
Sbjct: 62 ---GTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFN--FCSRKLSLKTVLMLADQMINRV 116
Query: 711 AYLHHDCSPRIIHRDVKSSNILLDKDFEAH---LTDFGIAKSLCVSKSYT------STYI 761
++H S +HRD+K N L+ A+ + DFG+AK + ++ + +
Sbjct: 117 EFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNL 173
Query: 762 MGTIGYIDPEYA--RTSRLTEKS---DVYSFGIVLLELLTGR 798
GT YA T E+S D+ S G VL+ L G
Sbjct: 174 TGT-----ARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 3e-06
Identities = 47/280 (16%), Positives = 86/280 (30%), Gaps = 33/280 (11%)
Query: 73 LNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQ--IPDEIGDCSSLKSLDLSFNELYG 130
LN D + +L + + G G +P + ++ LDL + L
Sbjct: 248 FCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLET 307
Query: 131 DIPFS-ISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLS- 188
+ + I K LE L +N + LK + + + +S
Sbjct: 308 EDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQ 367
Query: 189 -GLWYF---------------DVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNI 232
GL D+ N SL SI + N F+++ L + ++P +
Sbjct: 368 RGLIALAQGCQELEYMAVYVSDITNESLE-SIGTYLKNLCDFRLVLLDREERITDLPLDN 426
Query: 233 GFLQIAT---------LSLQGNQLTGKIPSVIG-LMQALAVLDLSCNMLSGP-IPPILGN 281
G + L+ LT S IG + + L S +
Sbjct: 427 GVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRG 486
Query: 282 LSYTEKLYLHSNKLTGH-IPPELGNMTKLHYLELNDNQLT 320
+KL + + I + + L YL + + +
Sbjct: 487 CPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRAS 526
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 53/477 (11%), Positives = 144/477 (30%), Gaps = 50/477 (10%)
Query: 63 CDNVTFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEI--GDCSSLKS 120
+ G + ++ +L+ L+S+ R +S D + L++
Sbjct: 83 KPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLET 142
Query: 121 LDLSFNELYGDIPFS--ISKLKQLEFLILKNN-------QLIGPIPSTLSQLPNLKVFGL 171
L L + ++ ++++ L+++ + + + + + L L +
Sbjct: 143 LKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMT 202
Query: 172 RGNNL----VGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGE 227
+ + T++ + L + D L G + N F L+ + E
Sbjct: 203 EFAKISPKDLETIARNCRSLVSVKVGDFEILELVG-FFKAAANLEEFCGGSLNEDIGMPE 261
Query: 228 IPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLS-CNMLSGPIPPILGNLSYTE 286
N+ F + ++P + + LDL + + ++ E
Sbjct: 262 KYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLE 321
Query: 287 KLYLHSNKLTGHIPPELG-NMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEG 345
L N + L +L L + + G ++ + +A
Sbjct: 322 VLET-RNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQG---- 376
Query: 346 PIPDNLSSCTNLNSLNVHGNKLN----GTIPPAFQRLESMTYLNLSLNNIRGPIPVE--- 398
C L + V+ + + +I + L + L +P++
Sbjct: 377 --------CQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGV 428
Query: 399 ---LSRIGNLDTLDMSNN--KISGSIPSPLGDLEHLLK-LNLSRNQLTGF-IPGEFGNLR 451
L L ++ S +G ++ + L + +
Sbjct: 429 RSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCP 488
Query: 452 SVMEIDLSHNHLTGV-IPEELSQLQNMFSLRLDYNNLSGDVMSLI----NCLSLSVL 503
++ ++++ + I +++L ++ L + S L+ ++ ++
Sbjct: 489 NLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELI 545
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 47/213 (22%), Positives = 78/213 (36%), Gaps = 35/213 (16%)
Query: 606 IGYGASSTVYKCV-LKNCKPVAIK--RLYSHYPQCLKEFETELETVGSIKHRNLVSLQGY 662
IG G+ +++ L N + VAIK S PQ E+ T G + ++ +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCT---GIPNVYYF 74
Query: 663 SLSSSGNLLFYDFMENG-SLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRI 721
N+L D + G SL D+L +K T A + +H +
Sbjct: 75 GQEGLHNVLVIDLL--GPSLEDLLD--LCGRKFSVKTVAMAAKQMLARVQSIH---EKSL 127
Query: 722 IHRDVKSSNILLDKDFEA-----HLTDFGIAKSLCVSKSY------TSTYIMGTIGYIDP 770
++RD+K N L+ + ++ DFG+ K + + GT
Sbjct: 128 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT-----A 182
Query: 771 EYA--RTSRLTEKS---DVYSFGIVLLELLTGR 798
Y T E+S D+ + G V + L G
Sbjct: 183 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 5e-06
Identities = 62/399 (15%), Positives = 125/399 (31%), Gaps = 71/399 (17%)
Query: 73 LNLSGLNLDGEISPAVGDL----KDLQSIDLRGNRLSGQIPDE-----IGDCSSLKSLDL 123
L+L ++D + L S+++ L+ ++ + C +LKSL L
Sbjct: 161 LDLRESDVDDVSGHWLSHFPDTYTSLVSLNISC--LASEVSFSALERLVTRCPNLKSLKL 218
Query: 124 SFNELYGDIPFSISKLKQLEFLILK------NNQLIGPIPSTLSQLPNLKVFGLRGNNLV 177
+ + + + QLE L + + LS L+
Sbjct: 219 NRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRC--------- 269
Query: 178 GTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQI 237
LSG W +++ +P C+ L+LSY + +++
Sbjct: 270 ---------LSGFW------DAVPAYLPAVYSVCSRLTTLNLSYATVQSY-----DLVKL 309
Query: 238 ATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSN-KLT 296
+ +L + I L VL +C L L + +E + N LT
Sbjct: 310 LCQCPKLQRL--WVLDYIED-AGLEVLASTCKDLR-----EL-RVFPSEPFVMEPNVALT 360
Query: 297 GHIPPELG-NMTKLHYLELNDNQLTG----HIPPALGKLTDL---FDLNVANNHLEGPIP 348
+ KL + Q+T I +T A ++L
Sbjct: 361 EQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPL 420
Query: 349 DN-----LSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSR-I 402
D + C +L L++ G + + M L+++ +
Sbjct: 421 DIGFGAIVEHCKDLRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGC 480
Query: 403 GNLDTLDMSNNKISG-SIPSPLGDLEHLLKLNLSRNQLT 440
+L L++ + ++ + LE + L +S ++
Sbjct: 481 DSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVS 519
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 45/276 (16%), Positives = 77/276 (27%), Gaps = 95/276 (34%)
Query: 593 IMRMTENLSEKYII----GYGASSTVYKCV--LKNCKPVAIKRLYSH---YPQCLKEFET 643
+ R+ + L E+Y I G G V +C+ + VA+K + + E
Sbjct: 10 VCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINV 69
Query: 644 ELETVG---------------SIKHRN---LVS-LQGYSLSSSGNLLFYDFMENGSLWDI 684
L+ + + L G + ++F++
Sbjct: 70 -LKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNT--------FEFLKE------ 114
Query: 685 LHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLT-- 742
+ +A L +LH ++ H D+K NIL L
Sbjct: 115 ----NNFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNE 167
Query: 743 -----------------DFGIAKSLCVSKSYTSTY-----------IMGTIGYIDPEYAR 774
DFG S + +T I+ +G+
Sbjct: 168 HKSCEEKSVKNTSIRVADFG---SATFDHEHHTTIVATRHYRPPEVILE-LGW------- 216
Query: 775 TSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHL 810
+ DV+S G +L E G N HL
Sbjct: 217 ----AQPCDVWSIGCILFEYYRGFTLFQTHENREHL 248
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 53/276 (19%), Positives = 88/276 (31%), Gaps = 95/276 (34%)
Query: 593 IMRMTENLSEKYII----GYGASSTVYKCV--LKNCKPVAIKRLYSH---YPQCLKEFET 643
I + + LS +Y I G GA V +C+ + VA+K + + E +
Sbjct: 5 ICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQV 64
Query: 644 ELETVG---------------SIKHRN---LVS-LQGYSLSSSGNLLFYDFMENGSLWDI 684
LE + +H +V L G S YDF++
Sbjct: 65 -LEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLST--------YDFIKE------ 109
Query: 685 LHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLD---------- 734
D K+A + + +LH S ++ H D+K NIL
Sbjct: 110 ----NGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNP 162
Query: 735 ---------KDFEAHLTDFGIAKSLCVSKSYTSTY-----------IMGTIGYIDPEYAR 774
+ + + DFG S + ST I+ +G+
Sbjct: 163 KIKRDERTLINPDIKVVDFG---SATYDDEHHSTLVSTRHYRAPEVILA-LGW------- 211
Query: 775 TSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHL 810
++ DV+S G +L+E G + HL
Sbjct: 212 ----SQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL 243
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 2e-04
Identities = 46/280 (16%), Positives = 77/280 (27%), Gaps = 99/280 (35%)
Query: 593 IMRMTENLSEKYII----GYGASSTVYKCV-LKNCKPVAIKRLYSH---YPQCLKEFETE 644
+ L+ +++ G G V C + N K A+K + + E +
Sbjct: 26 SWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADI- 84
Query: 645 LETVG--------------SIKHRN---LVS-LQGYSLSSSGNLLFYDFMENGSLWDILH 686
L+ + + + L+ G SL Y+ +
Sbjct: 85 LKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSL--------YEIITR-------- 128
Query: 687 GPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLT---- 742
+ + + L YL + H D+K NILLD +
Sbjct: 129 --NNYNGFHIEDIKLYCIEILKALNYLR-KM--SLTHTDLKPENILLDDPYFEKSLITVR 183
Query: 743 ---------------------DFGIAKSLCVSKSYTSTY-----------IMGTIGYIDP 770
DFG Y + I+ +G+
Sbjct: 184 RVTDGKKIQIYRTKSTGIKLIDFG---CATFKSDYHGSIINTRQYRAPEVILN-LGW--- 236
Query: 771 EYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHL 810
SD++SFG VL EL TG ++ HL
Sbjct: 237 --------DVSSDMWSFGCVLAELYTGSLLFRTHEHMEHL 268
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 933 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.96 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.95 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.94 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.93 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.92 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.92 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.91 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.9 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.9 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.9 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.89 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.89 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.88 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.88 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.88 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.88 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.87 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.87 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.87 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.87 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.87 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.86 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.86 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.84 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.82 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.82 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.82 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.81 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.8 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.8 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.8 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.8 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.8 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.79 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.79 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.79 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.78 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.78 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.78 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.76 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.75 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.74 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.74 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.72 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.72 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.72 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.71 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.69 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.68 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.66 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.65 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.64 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.63 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.63 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.62 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.62 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.62 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.6 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.57 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.56 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.55 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.54 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.52 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.52 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.51 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.5 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.5 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.47 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.41 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.39 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.31 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.24 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.23 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.23 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.22 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.2 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.2 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.05 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.93 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.9 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.9 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.89 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.85 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.84 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.82 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.55 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.48 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.46 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.45 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.36 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.29 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.16 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.14 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.08 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.8 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.76 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.71 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.7 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.63 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.62 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.61 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.22 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.18 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.15 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.12 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.0 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.87 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.76 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.68 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.58 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.54 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.5 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.36 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.23 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.22 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.47 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.06 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 85.23 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 83.66 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-69 Score=667.62 Aligned_cols=501 Identities=35% Similarity=0.541 Sum_probs=392.6
Q ss_pred hcCCCChHHHHHHHHHHHhCCCCCCCcCCCCCCCCCCCCCccceEecCCCCcEEEEEcCCCCcCcc---cC---------
Q 002349 18 SFGSVDSEDGATLLKIKKSFRDVDNVLYDWTDSPSSDYCVWRGITCDNVTFTVIALNLSGLNLDGE---IS--------- 85 (933)
Q Consensus 18 ~~~~~~~~d~~all~~k~~~~~~~~~l~~w~~~~~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~---~~--------- 85 (933)
+++...++|++||++||+++.||. .+++|+. ++|||.|.||+|+ +++|++|||+++++.|. +|
T Consensus 5 ~~~~~~~~~~~all~~k~~~~~~~-~l~~W~~--~~~~C~w~gv~C~--~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L 79 (768)
T 3rgz_A 5 SPSQSLYREIHQLISFKDVLPDKN-LLPDWSS--NKNPCTFDGVTCR--DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGL 79 (768)
T ss_dssp ---CCHHHHHHHHHHHHTTCSCTT-SSTTCCT--TSCGGGSTTEEEE--TTEEEEEECTTSCCCEEHHHHHHHTTTCTTC
T ss_pred ccccCCHHHHHHHHHHHhhCCCcc-cccCCCC--CCCCcCCcceEEC--CCcEEEEECCCCCcCCccCccChhHhccCcc
Confidence 334446889999999999999998 9999974 5799999999998 68999999999999887 43
Q ss_pred --------------CCCCCCCCccEEEccCCcccccCCC--CccCCCCCceecccccccCCCCCccc-c-----------
Q 002349 86 --------------PAVGDLKDLQSIDLRGNRLSGQIPD--EIGDCSSLKSLDLSFNELYGDIPFSI-S----------- 137 (933)
Q Consensus 86 --------------~~l~~l~~L~~L~Ls~n~l~~~~p~--~l~~l~~L~~L~Ls~n~l~~~~p~~~-~----------- 137 (933)
+.++++++|++|||++|.++|.+|. .|+++++|++|||++|.+.+.+|..+ .
T Consensus 80 ~~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls 159 (768)
T 3rgz_A 80 ESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLS 159 (768)
T ss_dssp CEEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECC
T ss_pred cccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECC
Confidence 5788889999999999999988887 78888888888888777766655432 1
Q ss_pred --------------------------------------cccchhhhhhcccCccCCCCcccccCCCCceeeeecCCCCCC
Q 002349 138 --------------------------------------KLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGT 179 (933)
Q Consensus 138 --------------------------------------~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~ 179 (933)
.+++|++|+|++|.+++.+|. ++++++|++|+|++|++++.
T Consensus 160 ~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~ 238 (768)
T 3rgz_A 160 ANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGD 238 (768)
T ss_dssp SSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSC
T ss_pred CCccCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCc
Confidence 223333333444444433333 44444455555544444433
Q ss_pred cccccc----------------------------------------------cC-CCCcEEeccCccccCccCcCCcCCC
Q 002349 180 LSPDMC----------------------------------------------QL-SGLWYFDVRNNSLTGSIPQNIGNCT 212 (933)
Q Consensus 180 ~~~~~~----------------------------------------------~l-~~L~~L~L~~n~l~~~~p~~l~~l~ 212 (933)
+|..+. .. ++|++|+|++|.+++.+|..+++++
T Consensus 239 ~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~ 318 (768)
T 3rgz_A 239 FSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCS 318 (768)
T ss_dssp HHHHTTTCSSCCEEECCSSCCEESCCCCCCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCT
T ss_pred ccHHHhcCCCCCEEECCCCcccCccCccccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCC
Confidence 332222 22 4444444444444444455555555
Q ss_pred CCcEEccccccccCcC-------------------------CCCcc----------------------------ccccce
Q 002349 213 SFQVLDLSYNQLSGEI-------------------------PFNIG----------------------------FLQIAT 239 (933)
Q Consensus 213 ~L~~L~L~~N~l~~~~-------------------------p~~~~----------------------------~~~L~~ 239 (933)
+|++|+|++|++++.+ |..+. ..+|++
T Consensus 319 ~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~ 398 (768)
T 3rgz_A 319 LLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQE 398 (768)
T ss_dssp TCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCE
T ss_pred CccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccE
Confidence 5555555555554433 33221 123556
Q ss_pred EeccccccccccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcceEeeeccccc
Q 002349 240 LSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQL 319 (933)
Q Consensus 240 L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l 319 (933)
|++++|++++.+|..++.+++|++|+|++|.+++.+|..|+++++|+.|+|++|++++.+|..+..+++|++|++++|++
T Consensus 399 L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l 478 (768)
T 3rgz_A 399 LYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDL 478 (768)
T ss_dssp EECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCC
T ss_pred EECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcc
Confidence 66666666667777788888888888888888888888888888899999999988888888888899999999999999
Q ss_pred cccCCccccccccccccccccccCCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCCcccc
Q 002349 320 TGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVEL 399 (933)
Q Consensus 320 ~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 399 (933)
++.+|..+..+++|+.|++++|++.+.+|.++..+++|++|++++|++++.+|..+..+++|++|++++|.++|.+|..+
T Consensus 479 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~ 558 (768)
T 3rgz_A 479 TGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAM 558 (768)
T ss_dssp CSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGG
T ss_pred cCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHH
Confidence 98889999999999999999999998999999999999999999999999999999999999999999999887777543
Q ss_pred ----------------------------------------------------------------------ccccccceee
Q 002349 400 ----------------------------------------------------------------------SRIGNLDTLD 409 (933)
Q Consensus 400 ----------------------------------------------------------------------~~l~~L~~L~ 409 (933)
..+++|+.||
T Consensus 559 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~Ld 638 (768)
T 3rgz_A 559 FKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLD 638 (768)
T ss_dssp GTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEE
T ss_pred hcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEE
Confidence 2356789999
Q ss_pred ccCCccCCCCCCCCCCccccccccccCcccccccccccccccccceEEccCCccccccchhhccccccceeeecCCCCcC
Q 002349 410 MSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSG 489 (933)
Q Consensus 410 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 489 (933)
|++|+++|.+|..|++++.|+.|+|++|+++|.+|..|+++++|+.|||++|+++|.+|..+..+++|++|+|++|+++|
T Consensus 639 Ls~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g 718 (768)
T 3rgz_A 639 MSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSG 718 (768)
T ss_dssp CCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEE
T ss_pred CcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccchhhccccc-eeecCCCCCCCcccCCcccCCCCC
Q 002349 490 DVMSLINCLSLS-VLFIGNPGLCGYWLHSACRDSHPT 525 (933)
Q Consensus 490 ~~~~~~~~~~~~-~~~~~N~~~C~~~l~~~~~~~~~~ 525 (933)
.+|...++.++. ..|.|||++||.++. .|......
T Consensus 719 ~iP~~~~~~~~~~~~~~gN~~Lcg~~l~-~C~~~~~~ 754 (768)
T 3rgz_A 719 PIPEMGQFETFPPAKFLNNPGLCGYPLP-RCDPSNAD 754 (768)
T ss_dssp ECCSSSSGGGSCGGGGCSCTEEESTTSC-CCCSCC--
T ss_pred cCCCchhhccCCHHHhcCCchhcCCCCc-CCCCCccC
Confidence 999988888887 779999999999986 88655443
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-58 Score=552.09 Aligned_cols=451 Identities=20% Similarity=0.285 Sum_probs=251.1
Q ss_pred hHHHHHHHHHHHhCCCCC--------CCcCCCCCCCCCCCCCc---cceEecCCCCcEEEEEcCCCCcCcccCCCCCCCC
Q 002349 24 SEDGATLLKIKKSFRDVD--------NVLYDWTDSPSSDYCVW---RGITCDNVTFTVIALNLSGLNLDGEISPAVGDLK 92 (933)
Q Consensus 24 ~~d~~all~~k~~~~~~~--------~~l~~w~~~~~~~~c~w---~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~ 92 (933)
..|+.||.+|++++.++. ....+|+. +.+||.| .||+|+.. +||+.|+|++++++|.+|+++++|+
T Consensus 29 ~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~--~~~~c~w~~~~GV~C~~~-~~V~~L~L~~~~l~g~lp~~l~~L~ 105 (636)
T 4eco_A 29 IKDYLALKEIWDALNGKNWSQQGFGTQPGANWNF--NKELDMWGAQPGVSLNSN-GRVTGLSLEGFGASGRVPDAIGQLT 105 (636)
T ss_dssp HHHHHHHHHHHHHTTGGGCCCCC------CCCCC--SSCGGGTTCCTTEEECTT-CCEEEEECTTSCCEEEECGGGGGCT
T ss_pred HHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCC--CCCcccccCCCCeEEcCC-CCEEEEEecCcccCCcCChHHhcCc
Confidence 569999999999986542 12457975 4799999 99999764 8999999999999999999999999
Q ss_pred CccEEEccCCcc------cc------cCCCCccCCCCCceecccccccCCCCCccccc-ccchhhhhhc-----------
Q 002349 93 DLQSIDLRGNRL------SG------QIPDEIGDCSSLKSLDLSFNELYGDIPFSISK-LKQLEFLILK----------- 148 (933)
Q Consensus 93 ~L~~L~Ls~n~l------~~------~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~-l~~L~~L~L~----------- 148 (933)
+|++|+|++|++ .| .+|... +.+|+ +++++|.+.+.+|..+.. +..+..+++.
T Consensus 106 ~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~ 182 (636)
T 4eco_A 106 ELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRIT 182 (636)
T ss_dssp TCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCC
T ss_pred cceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccc
Confidence 999999999977 22 333322 34444 555555555555444432 1222222222
Q ss_pred ---------ccCccCCCCcccccCCCCceeeeecCCCCCC-----------------cccccc--cCCCCcEEeccCccc
Q 002349 149 ---------NNQLIGPIPSTLSQLPNLKVFGLRGNNLVGT-----------------LSPDMC--QLSGLWYFDVRNNSL 200 (933)
Q Consensus 149 ---------~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~-----------------~~~~~~--~l~~L~~L~L~~n~l 200 (933)
.|++++ +|..++++++|++|+|++|++++. +|..++ ++++|++|+|++|.+
T Consensus 183 l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l 261 (636)
T 4eco_A 183 LKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPN 261 (636)
T ss_dssp CCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTT
T ss_pred hhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcC
Confidence 344554 555555555555555555555543 455554 555555555555555
Q ss_pred cCccCcCCcCCCCCcEEcccccc-ccC-cCCCCccc-------cccceEeccccccccccCc--cccccccccEEeccCC
Q 002349 201 TGSIPQNIGNCTSFQVLDLSYNQ-LSG-EIPFNIGF-------LQIATLSLQGNQLTGKIPS--VIGLMQALAVLDLSCN 269 (933)
Q Consensus 201 ~~~~p~~l~~l~~L~~L~L~~N~-l~~-~~p~~~~~-------~~L~~L~L~~n~l~~~~p~--~~~~l~~L~~L~Ls~N 269 (933)
.+.+|..++++++|++|+|++|+ +++ .+|..++. .+|++|+|++|+++ .+|. .++.+++|++|++++|
T Consensus 262 ~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N 340 (636)
T 4eco_A 262 LTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYN 340 (636)
T ss_dssp CSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSC
T ss_pred CccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCC
Confidence 55555555555555555555554 554 44444433 34555555555555 4444 4555555555555555
Q ss_pred cCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCc-ceEeeeccccccccCCccccccc--cccccccccccCCCC
Q 002349 270 MLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTK-LHYLELNDNQLTGHIPPALGKLT--DLFDLNVANNHLEGP 346 (933)
Q Consensus 270 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~-L~~L~L~~N~l~~~~~~~l~~l~--~L~~L~L~~N~l~~~ 346 (933)
+++|.+| .|+++++|++|+|++|+++ .+|..+..+++ |++|++++|+++ .+|..+..++ +|+.|++++|++.+.
T Consensus 341 ~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~ 417 (636)
T 4eco_A 341 QLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSV 417 (636)
T ss_dssp CCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTT
T ss_pred cCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCc
Confidence 5554444 5555555555555555555 44555555555 555555555555 4444444433 455555555555555
Q ss_pred CCCCcc-------cCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCCccccccc-------cccceeeccC
Q 002349 347 IPDNLS-------SCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRI-------GNLDTLDMSN 412 (933)
Q Consensus 347 ~p~~l~-------~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-------~~L~~L~Ls~ 412 (933)
+|..+. .+++|+.|++++|+++...+..+..+++|++|+|++|+++...+..+... ++|+.|+|++
T Consensus 418 ~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~ 497 (636)
T 4eco_A 418 DGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRF 497 (636)
T ss_dssp TTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCS
T ss_pred chhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEECcC
Confidence 555444 44455555555555553333333445555555555555552222222211 1555555555
Q ss_pred CccCCCCCCCCC--CccccccccccCcccccccccccccccccceEEc------cCCccccccchhhccccccceeeecC
Q 002349 413 NKISGSIPSPLG--DLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDL------SHNHLTGVIPEELSQLQNMFSLRLDY 484 (933)
Q Consensus 413 N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L------s~N~l~~~~p~~~~~l~~L~~L~l~~ 484 (933)
|+|+ .+|..+. .+++|+.|+|++|+|++ +|..+.++++|+.|+| ++|++.+.+|..+..+++|+.|+|++
T Consensus 498 N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~ 575 (636)
T 4eco_A 498 NKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGS 575 (636)
T ss_dssp SCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCS
T ss_pred CcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCC
Confidence 5555 4444444 55555555555555554 4555555555555555 33445555555555555555555555
Q ss_pred CCC
Q 002349 485 NNL 487 (933)
Q Consensus 485 N~l 487 (933)
|++
T Consensus 576 N~l 578 (636)
T 4eco_A 576 NDI 578 (636)
T ss_dssp SCC
T ss_pred CcC
Confidence 555
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-57 Score=549.10 Aligned_cols=475 Identities=18% Similarity=0.270 Sum_probs=403.4
Q ss_pred CChHHHHHHHHHHHhCCCCCCCcCCCCCCC---CCCC--CCc------------cceEecCCCCcEEEEEcCCCCcCccc
Q 002349 22 VDSEDGATLLKIKKSFRDVDNVLYDWTDSP---SSDY--CVW------------RGITCDNVTFTVIALNLSGLNLDGEI 84 (933)
Q Consensus 22 ~~~~d~~all~~k~~~~~~~~~l~~w~~~~---~~~~--c~w------------~gv~C~~~~~~v~~l~l~~~~l~~~~ 84 (933)
...+|+.||++||+++.+| +|+.+. ..+| |.| .||+|+. ++||+.|+|++++++|.+
T Consensus 266 ~~~~d~~ALl~~k~~l~~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~-~~~V~~L~Ls~~~L~G~i 339 (876)
T 4ecn_A 266 EYIKDYKALKAIWEALDGK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRVTGLSLAGFGAKGRV 339 (876)
T ss_dssp HHHHHHHHHHHHHHHTTGG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT-TSCEEEEECTTTCCEEEE
T ss_pred cchHHHHHHHHHHHHcCCC-----CCCcCCCcccccCCccccccccccccccCcCceEecC-CCCEEEEECccCCCCCcC
Confidence 3467999999999999887 897653 2344 999 9999986 689999999999999999
Q ss_pred CCCCCCCCCccEEEc-cCCcccccCCCCc---------------------------------------------------
Q 002349 85 SPAVGDLKDLQSIDL-RGNRLSGQIPDEI--------------------------------------------------- 112 (933)
Q Consensus 85 ~~~l~~l~~L~~L~L-s~n~l~~~~p~~l--------------------------------------------------- 112 (933)
|++|++|++|++|+| ++|.++|..|-..
T Consensus 340 p~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~ 419 (876)
T 4ecn_A 340 PDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKK 419 (876)
T ss_dssp CGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCC
T ss_pred chHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcccccccc
Confidence 999999999999999 8999888744221
Q ss_pred cCCCCCceecccc--cccCCCCCcccccccchhhhhhcccCccC-----------------CCCcccc--cCCCCceeee
Q 002349 113 GDCSSLKSLDLSF--NELYGDIPFSISKLKQLEFLILKNNQLIG-----------------PIPSTLS--QLPNLKVFGL 171 (933)
Q Consensus 113 ~~l~~L~~L~Ls~--n~l~~~~p~~~~~l~~L~~L~L~~n~l~~-----------------~~p~~l~--~l~~L~~L~L 171 (933)
.....++.+.++. |.++| +|..|+++++|++|+|++|.+++ .+|..++ ++++|++|+|
T Consensus 420 ~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~L 498 (876)
T 4ecn_A 420 DSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVEL 498 (876)
T ss_dssp CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEE
T ss_pred ccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEEC
Confidence 1223445555554 88998 99999999999999999999998 3899988 9999999999
Q ss_pred ecCCCCCCcccccccCCCCcEEeccCcc-ccC-ccCcCCcCCC-------CCcEEccccccccCcCCC--Ccc-ccccce
Q 002349 172 RGNNLVGTLSPDMCQLSGLWYFDVRNNS-LTG-SIPQNIGNCT-------SFQVLDLSYNQLSGEIPF--NIG-FLQIAT 239 (933)
Q Consensus 172 ~~N~l~~~~~~~~~~l~~L~~L~L~~n~-l~~-~~p~~l~~l~-------~L~~L~L~~N~l~~~~p~--~~~-~~~L~~ 239 (933)
++|++.+.+|..|+++++|++|+|++|+ ++| .+|..+++++ +|++|+|++|+++ .+|. .+. ..+|++
T Consensus 499 s~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~ 577 (876)
T 4ecn_A 499 YNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGL 577 (876)
T ss_dssp ESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCE
T ss_pred cCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCE
Confidence 9999999999999999999999999998 998 8898777666 9999999999999 8887 554 457999
Q ss_pred EeccccccccccCccccccccccEEeccCCcCcCCCCCCCCCCCC-ccEEEeeCCccCCCCCCccccCCc--ceEeeecc
Q 002349 240 LSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSY-TEKLYLHSNKLTGHIPPELGNMTK--LHYLELND 316 (933)
Q Consensus 240 L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~p~~l~~l~~--L~~L~L~~ 316 (933)
|+|++|+++ .+| .|+.+++|+.|+|++|.++ .+|..+.++++ |+.|+|++|+++ .+|..+..++. |+.|+|++
T Consensus 578 L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~ 653 (876)
T 4ecn_A 578 LDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSY 653 (876)
T ss_dssp EECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCS
T ss_pred EECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcC
Confidence 999999999 778 8999999999999999999 88889999999 999999999999 78888887765 99999999
Q ss_pred ccccccCCccc---c--ccccccccccccccCCCCCCCCc-ccCCCCCceeccCcccCCCCCcc-ccc-------ccccc
Q 002349 317 NQLTGHIPPAL---G--KLTDLFDLNVANNHLEGPIPDNL-SSCTNLNSLNVHGNKLNGTIPPA-FQR-------LESMT 382 (933)
Q Consensus 317 N~l~~~~~~~l---~--~l~~L~~L~L~~N~l~~~~p~~l-~~l~~L~~L~l~~N~l~~~~~~~-~~~-------l~~L~ 382 (933)
|++++.+|... . .+++|+.|++++|++. .+|..+ ..+++|+.|+|++|+++ .+|.. +.. +++|+
T Consensus 654 N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~ 731 (876)
T 4ecn_A 654 NKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLT 731 (876)
T ss_dssp SCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCC
T ss_pred CcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCcc
Confidence 99998766432 2 3458999999999999 555554 58899999999999999 45544 432 33999
Q ss_pred eecCCcccccCCCccccc--cccccceeeccCCccCCCCCCCCCCccccccccccC------cccccccccccccccccc
Q 002349 383 YLNLSLNNIRGPIPVELS--RIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSR------NQLTGFIPGEFGNLRSVM 454 (933)
Q Consensus 383 ~L~L~~N~l~~~~~~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~------N~l~~~~p~~~~~l~~L~ 454 (933)
+|+|++|+++ .+|..+. .+++|+.|+|++|+|++ +|..+..+++|+.|+|++ |++.+.+|..|.++++|+
T Consensus 732 ~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~ 809 (876)
T 4ecn_A 732 TIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLI 809 (876)
T ss_dssp EEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCC
T ss_pred EEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCC
Confidence 9999999999 7788887 99999999999999997 799999999999999976 889999999999999999
Q ss_pred eEEccCCccccccchhhccccccceeeecCCCCcCcccchh-hccccc-eeecCCCCCC--Cccc
Q 002349 455 EIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDVMSLI-NCLSLS-VLFIGNPGLC--GYWL 515 (933)
Q Consensus 455 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~-~~~~~~-~~~~~N~~~C--~~~l 515 (933)
.|+|++|+| +.+|..+. ++|+.|+|++|++....+... ...... ..+.+|++.| ||+.
T Consensus 810 ~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~~~I~gC~~ 871 (876)
T 4ecn_A 810 QLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCDA 871 (876)
T ss_dssp EEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHTTCCEEECCTTSEEESCGG
T ss_pred EEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHccccccchheeecCCCccccCCCCC
Confidence 999999999 68888766 699999999999987654321 111222 4566776654 7764
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-54 Score=515.25 Aligned_cols=456 Identities=23% Similarity=0.223 Sum_probs=353.0
Q ss_pred ccceEecCC---------CCcEEEEEcCCCCcCcccCCCCCCCCCccEEEccCCcccccCCCCccCCCCCceeccccccc
Q 002349 58 WRGITCDNV---------TFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNEL 128 (933)
Q Consensus 58 w~gv~C~~~---------~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l 128 (933)
+.-+.|++. ...++.|+|++|.+++..|..|+++++|++|+|++|++++..|..|+++++|++|+|++|.+
T Consensus 14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l 93 (606)
T 3t6q_A 14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93 (606)
T ss_dssp TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcc
Confidence 556888653 24789999999999998899999999999999999999988899999999999999999999
Q ss_pred CCCCCcccccccchhhhhhcccCccCCCCcccccCCCCceeeeecCCCCCCcccccccCCCCcEEeccCccccCccCcCC
Q 002349 129 YGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNI 208 (933)
Q Consensus 129 ~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l 208 (933)
++..|..|+++++|++|+|++|++++..|..++++++|++|+|++|++.+...+.+..+++|++|++++|.+++..|..+
T Consensus 94 ~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 173 (606)
T 3t6q_A 94 IFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDM 173 (606)
T ss_dssp SEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHH
T ss_pred cccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhh
Confidence 98889999999999999999999998778889999999999999999998665666679999999999999998888889
Q ss_pred cCCCCCc--EEccccccccCcCCCCcccc---------------------------------------------------
Q 002349 209 GNCTSFQ--VLDLSYNQLSGEIPFNIGFL--------------------------------------------------- 235 (933)
Q Consensus 209 ~~l~~L~--~L~L~~N~l~~~~p~~~~~~--------------------------------------------------- 235 (933)
+.+++|+ .|++++|++++..|..+...
T Consensus 174 ~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~ 253 (606)
T 3t6q_A 174 SSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCE 253 (606)
T ss_dssp HTTTTCCSEEEECTTCCCCEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGG
T ss_pred hhhcccceeEEecCCCccCccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhc
Confidence 9999998 89999999887666543221
Q ss_pred -ccceEeccccccccccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccc----------
Q 002349 236 -QIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELG---------- 304 (933)
Q Consensus 236 -~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~---------- 304 (933)
+++.|++++|++++..+..|+.+++|++|++++|.++ .+|..+.++++|++|++++|++++..|..+.
T Consensus 254 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 332 (606)
T 3t6q_A 254 MSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSI 332 (606)
T ss_dssp SEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEEC
T ss_pred CceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEEC
Confidence 4555666666666666666666666666666666666 4555666666666666666666654444444
Q ss_pred ---------------cCCcceEeeeccccccccC--CccccccccccccccccccCCCCCCCCcccCCCCCceeccCccc
Q 002349 305 ---------------NMTKLHYLELNDNQLTGHI--PPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKL 367 (933)
Q Consensus 305 ---------------~l~~L~~L~L~~N~l~~~~--~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l 367 (933)
.+++|++|++++|.+++.. +..+..+++|+.|++++|++.+..|..+..+++|+.|++++|++
T Consensus 333 ~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 412 (606)
T 3t6q_A 333 KGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRL 412 (606)
T ss_dssp CSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCE
T ss_pred CCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcC
Confidence 4455555555555555433 44556666666666666666666666666677777777777777
Q ss_pred CCCCCc-ccccccccceecCCcccccCCCccccccccccceeeccCCccCCC---CCCCCCCccccccccccCccccccc
Q 002349 368 NGTIPP-AFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGS---IPSPLGDLEHLLKLNLSRNQLTGFI 443 (933)
Q Consensus 368 ~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~L~Ls~N~l~~~~ 443 (933)
++..+. .|..+++|++|++++|.+++..|..+..+++|++|+|++|++++. .+..+..+++|+.|+|++|++++..
T Consensus 413 ~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~ 492 (606)
T 3t6q_A 413 KVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSID 492 (606)
T ss_dssp ECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEEC
T ss_pred CCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccC
Confidence 655543 366777777777777777776777777777777777777777652 2355777788888888888888778
Q ss_pred ccccccccccceEEccCCccccccchhhccccccceeeecCCCCcCcccc-hhhccccc-eeecCCCCCCCccc
Q 002349 444 PGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDVMS-LINCLSLS-VLFIGNPGLCGYWL 515 (933)
Q Consensus 444 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~~~~~-~~~~~N~~~C~~~l 515 (933)
|..|.++++|++|+|++|++++..|..+..+++| .|++++|++++.++. +..+..+. +.+.+|||.|+|..
T Consensus 493 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~ 565 (606)
T 3t6q_A 493 QHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSN 565 (606)
T ss_dssp TTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGGG
T ss_pred hhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCCc
Confidence 8888888888888888888888888888888888 888888888887765 35566666 77899999999865
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-53 Score=529.12 Aligned_cols=454 Identities=21% Similarity=0.220 Sum_probs=359.4
Q ss_pred CCccceEecCCCCcEEEEEcCCCCcCcccCCCCCCCCCccEEEccCCcccccC-CCCccCCCCCceecccccccCCCCCc
Q 002349 56 CVWRGITCDNVTFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQI-PDEIGDCSSLKSLDLSFNELYGDIPF 134 (933)
Q Consensus 56 c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~-p~~l~~l~~L~~L~Ls~n~l~~~~p~ 134 (933)
|.|..|.+ ...+++.|||++|.+++..+..|.++++|++|+|++|.+.+.+ |..|+++++|++|+|++|.+.+..|.
T Consensus 14 ~~L~~vP~--lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~ 91 (844)
T 3j0a_A 14 CNLTQVPQ--VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPD 91 (844)
T ss_dssp CCSSCCCS--SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTT
T ss_pred CCCCCCCC--CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHh
Confidence 46777777 4568899999999999988999999999999999999777676 77899999999999999999988899
Q ss_pred ccccccchhhhhhcccCccCCCCcc--cccCCCCceeeeecCCCCCCcc-cccccCCCCcEEeccCccccCccCcCCcCC
Q 002349 135 SISKLKQLEFLILKNNQLIGPIPST--LSQLPNLKVFGLRGNNLVGTLS-PDMCQLSGLWYFDVRNNSLTGSIPQNIGNC 211 (933)
Q Consensus 135 ~~~~l~~L~~L~L~~n~l~~~~p~~--l~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l 211 (933)
.|+++++|++|+|++|.+++.+|.. |+++++|++|+|++|.+.+..+ ..|+++++|++|+|++|.+++..+..+..+
T Consensus 92 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l 171 (844)
T 3j0a_A 92 AFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPL 171 (844)
T ss_dssp SSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHH
T ss_pred HccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccc
Confidence 9999999999999999999877765 9999999999999999988765 578999999999999999998888888777
Q ss_pred --CCCcEEccccccccCcCCCCccc-------cccceEeccccccccccCccccc-------------------------
Q 002349 212 --TSFQVLDLSYNQLSGEIPFNIGF-------LQIATLSLQGNQLTGKIPSVIGL------------------------- 257 (933)
Q Consensus 212 --~~L~~L~L~~N~l~~~~p~~~~~-------~~L~~L~L~~n~l~~~~p~~~~~------------------------- 257 (933)
++|+.|++++|.+++..|..+.. ..|++|+|++|++++..+..+..
T Consensus 172 ~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~ 251 (844)
T 3j0a_A 172 QGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHN 251 (844)
T ss_dssp HHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSS
T ss_pred cCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccc
Confidence 77888888888877766654322 23677777777666554443322
Q ss_pred -------------cccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcceEeeeccccccccCC
Q 002349 258 -------------MQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIP 324 (933)
Q Consensus 258 -------------l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 324 (933)
.++|+.|+|++|.+.+..+..|..+++|+.|+|++|++++..|..|.++++|++|+|++|++++..|
T Consensus 252 l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 331 (844)
T 3j0a_A 252 IKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYS 331 (844)
T ss_dssp STTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCS
T ss_pred cCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCH
Confidence 1457777777777776667777777777777777777776666677777777777777777776667
Q ss_pred ccccccccccccccccccCCCCCCCCcccCCCCCceeccCcccCCCC------------------C--------------
Q 002349 325 PALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTI------------------P-------------- 372 (933)
Q Consensus 325 ~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~------------------~-------------- 372 (933)
..|..+++|+.|++++|++.+..+..|..+++|+.|++++|.+++.. |
T Consensus 332 ~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N 411 (844)
T 3j0a_A 332 SNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSEN 411 (844)
T ss_dssp CSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSC
T ss_pred HHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccCCCCcchhccCCCCcccccccccccceeecccC
Confidence 77777777777777777776666666777777777777777665321 1
Q ss_pred --------cccccccccceecCCcccccCCCcc-ccccccccceeeccCCccC-----CCCCCCCCCccccccccccCcc
Q 002349 373 --------PAFQRLESMTYLNLSLNNIRGPIPV-ELSRIGNLDTLDMSNNKIS-----GSIPSPLGDLEHLLKLNLSRNQ 438 (933)
Q Consensus 373 --------~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~ 438 (933)
..+..+++|++|+|++|++++..+. .+..+++|+.|+|++|.++ +..+..|.++++|+.|+|++|+
T Consensus 412 ~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~ 491 (844)
T 3j0a_A 412 RLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNY 491 (844)
T ss_dssp CCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHH
T ss_pred ccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCc
Confidence 1133677788888888888754433 3556788888888888886 4455678899999999999999
Q ss_pred cccccccccccccccceEEccCCccccccchhhccccccceeeecCCCCcCcccchhhccccc-eeecCCCCCCCccc
Q 002349 439 LTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDVMSLINCLSLS-VLFIGNPGLCGYWL 515 (933)
Q Consensus 439 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~-~~~~~N~~~C~~~l 515 (933)
|++..|..|.++++|+.|+|++|+|++..|..+. ++|+.|+|++|++++.+|... ..+. +.+.+|||.|+|.+
T Consensus 492 l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~--~~L~~l~l~~Np~~C~c~~ 565 (844)
T 3j0a_A 492 LNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVF--VSLSVLDITHNKFICECEL 565 (844)
T ss_dssp HTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCC--SSCCEEEEEEECCCCSSSC
T ss_pred ccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHh--CCcCEEEecCCCccccccc
Confidence 9999999999999999999999999988777766 899999999999999888643 3455 77899999999975
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-54 Score=527.62 Aligned_cols=420 Identities=37% Similarity=0.571 Sum_probs=341.4
Q ss_pred cEEEEEcCCCCcCcccCCCCCCCCCccEEEccCCcc----------------------cccCCCCccCC-CCCceecccc
Q 002349 69 TVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRL----------------------SGQIPDEIGDC-SSLKSLDLSF 125 (933)
Q Consensus 69 ~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l----------------------~~~~p~~l~~l-~~L~~L~Ls~ 125 (933)
.+..|+|++|.+++.+|..++++++|++|+|++|.+ +|.+|..+.++ ++|++|+|++
T Consensus 224 ~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~ 303 (768)
T 3rgz_A 224 ALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSG 303 (768)
T ss_dssp SCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCCCCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCS
T ss_pred CCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCccccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcC
Confidence 345556666666555555555555555555555544 44555555543 6666666666
Q ss_pred cccCCCCCcccccccchhhhhhcccCccCCCCcc-cccCCCCceeeeecCCCCCCcccccccCC-CCcEEeccCccccCc
Q 002349 126 NELYGDIPFSISKLKQLEFLILKNNQLIGPIPST-LSQLPNLKVFGLRGNNLVGTLSPDMCQLS-GLWYFDVRNNSLTGS 203 (933)
Q Consensus 126 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~-l~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~n~l~~~ 203 (933)
|.+++.+|..|+++++|++|+|++|.++|.+|.. ++++++|++|+|++|++++.+|..+..++ +|++|++++|.+++.
T Consensus 304 n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~ 383 (768)
T 3rgz_A 304 NHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGP 383 (768)
T ss_dssp SEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEE
T ss_pred CcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCC
Confidence 6666666666666666666666666666666654 66666666666666666666666666665 677777777777666
Q ss_pred cCcCCcC--CCCCcEEccccccccCcCCCCccc-cccceEeccccccccccCccccccccccEEeccCCcCcCCCCCCCC
Q 002349 204 IPQNIGN--CTSFQVLDLSYNQLSGEIPFNIGF-LQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILG 280 (933)
Q Consensus 204 ~p~~l~~--l~~L~~L~L~~N~l~~~~p~~~~~-~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 280 (933)
+|..+.. +++|++|++++|++++.+|..+.. .+|++|+|++|++++.+|..++.+++|+.|+|++|.+++.+|..+.
T Consensus 384 ~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~ 463 (768)
T 3rgz_A 384 ILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELM 463 (768)
T ss_dssp CCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGG
T ss_pred cChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHc
Confidence 6666655 677888888888888888877754 4799999999999999999999999999999999999999999999
Q ss_pred CCCCccEEEeeCCccCCCCCCccccCCcceEeeeccccccccCCccccccccccccccccccCCCCCCCCcccCCCCCce
Q 002349 281 NLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSL 360 (933)
Q Consensus 281 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 360 (933)
.+++|++|+|++|++++.+|..+.++++|++|+|++|++++.+|.+++.+++|+.|++++|++.+.+|..+..+++|+.|
T Consensus 464 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 543 (768)
T 3rgz_A 464 YVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWL 543 (768)
T ss_dssp GCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEE
T ss_pred CCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEE
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eccCcccCCCCCccc-----------------------------------------------------------------
Q 002349 361 NVHGNKLNGTIPPAF----------------------------------------------------------------- 375 (933)
Q Consensus 361 ~l~~N~l~~~~~~~~----------------------------------------------------------------- 375 (933)
++++|+++|.+|..+
T Consensus 544 ~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~ 623 (768)
T 3rgz_A 544 DLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGH 623 (768)
T ss_dssp ECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEE
T ss_pred ECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceeccc
Confidence 999999988777544
Q ss_pred -----ccccccceecCCcccccCCCccccccccccceeeccCCccCCCCCCCCCCccccccccccCcccccccccccccc
Q 002349 376 -----QRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNL 450 (933)
Q Consensus 376 -----~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 450 (933)
..+++|++|+|++|+++|.+|..++.+++|+.|+|++|+++|.+|..|+++++|+.|+|++|+++|.+|..++++
T Consensus 624 ~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l 703 (768)
T 3rgz_A 624 TSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSAL 703 (768)
T ss_dssp CCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGC
T ss_pred CchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCC
Confidence 335679999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccceEEccCCccccccchhhccccccceeeecCCCCcC
Q 002349 451 RSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSG 489 (933)
Q Consensus 451 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 489 (933)
++|++|||++|+++|.+|.. ..+.++....+.+|+.-|
T Consensus 704 ~~L~~L~ls~N~l~g~iP~~-~~~~~~~~~~~~gN~~Lc 741 (768)
T 3rgz_A 704 TMLTEIDLSNNNLSGPIPEM-GQFETFPPAKFLNNPGLC 741 (768)
T ss_dssp CCCSEEECCSSEEEEECCSS-SSGGGSCGGGGCSCTEEE
T ss_pred CCCCEEECcCCcccccCCCc-hhhccCCHHHhcCCchhc
Confidence 99999999999999999964 456667777788886433
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-53 Score=505.44 Aligned_cols=443 Identities=20% Similarity=0.195 Sum_probs=378.2
Q ss_pred CcEEEEEcCCCCcCcccCCCCCCCCCccEEEccCCcccccCCCCccCCCCCceecccccccCCCCCcccccccchhhhhh
Q 002349 68 FTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLIL 147 (933)
Q Consensus 68 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 147 (933)
.+++.|+|++|.+++..+..|.++++|++|+|++|++++..|..|+++++|++|+|++|.+++..|..|+++++|++|+|
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 111 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA 111 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence 57899999999999988889999999999999999999888999999999999999999999888999999999999999
Q ss_pred cccCccCCCCcccccCCCCceeeeecCCCCC-CcccccccCCCCcEEeccCccccCccCcCCcCCCCCc----EEccccc
Q 002349 148 KNNQLIGPIPSTLSQLPNLKVFGLRGNNLVG-TLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQ----VLDLSYN 222 (933)
Q Consensus 148 ~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~----~L~L~~N 222 (933)
++|.+++..|..++++++|++|+|++|++.+ .+|..|+++++|++|++++|++++..|..++.+++|+ +|++++|
T Consensus 112 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n 191 (606)
T 3vq2_A 112 VETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLN 191 (606)
T ss_dssp TTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTC
T ss_pred cCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCC
Confidence 9999998887899999999999999999986 5799999999999999999999998888888887765 7999999
Q ss_pred cccCcCCCCccccccceEeccccccc------------------------------------------------------
Q 002349 223 QLSGEIPFNIGFLQIATLSLQGNQLT------------------------------------------------------ 248 (933)
Q Consensus 223 ~l~~~~p~~~~~~~L~~L~L~~n~l~------------------------------------------------------ 248 (933)
++++..+..+...+|++|++++|.++
T Consensus 192 ~l~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~ 271 (606)
T 3vq2_A 192 PIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYT 271 (606)
T ss_dssp CCCEECTTTTTTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCC
T ss_pred CcceeCcccccCceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheecccc
Confidence 98876666666667777887777653
Q ss_pred ----cccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCC--------------------Cccc
Q 002349 249 ----GKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIP--------------------PELG 304 (933)
Q Consensus 249 ----~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p--------------------~~l~ 304 (933)
+.+|. +..+++|+.|++++|.+.. +| .+..+++|++|++++|.+ +.+| ..+.
T Consensus 272 ~~~~~~~~~-~~~l~~L~~L~l~~~~~~~-l~-~l~~~~~L~~L~l~~n~l-~~lp~~~l~~L~~L~l~~n~~~~~~~~~ 347 (606)
T 3vq2_A 272 NDFSDDIVK-FHCLANVSAMSLAGVSIKY-LE-DVPKHFKWQSLSIIRCQL-KQFPTLDLPFLKSLTLTMNKGSISFKKV 347 (606)
T ss_dssp TTCCGGGGS-CGGGTTCSEEEEESCCCCC-CC-CCCTTCCCSEEEEESCCC-SSCCCCCCSSCCEEEEESCSSCEECCCC
T ss_pred ccccccccc-cccCCCCCEEEecCccchh-hh-hccccccCCEEEcccccC-cccccCCCCccceeeccCCcCccchhhc
Confidence 12222 3444455555555555542 22 444444455555554444 2333 2456
Q ss_pred cCCcceEeeecccccccc--CCccccccccccccccccccCCCCCCCCcccCCCCCceeccCcccCCCCC-ccccccccc
Q 002349 305 NMTKLHYLELNDNQLTGH--IPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIP-PAFQRLESM 381 (933)
Q Consensus 305 ~l~~L~~L~L~~N~l~~~--~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L 381 (933)
.+++|++|++++|++++. .|..+..+++|++|++++|.+.+ +|..+..+++|+.|++++|++.+..| ..|..+++|
T Consensus 348 ~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L 426 (606)
T 3vq2_A 348 ALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKL 426 (606)
T ss_dssp CCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTC
T ss_pred cCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccC
Confidence 777888888888888865 37788889999999999999884 66889999999999999999998887 689999999
Q ss_pred ceecCCcccccCCCccccccccccceeeccCCccCC-CCCCCCCCccccccccccCcccccccccccccccccceEEccC
Q 002349 382 TYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISG-SIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSH 460 (933)
Q Consensus 382 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 460 (933)
++|++++|.+++..|..+..+++|++|+|++|.+++ .+|..|..+++|+.|+|++|++++..|..|.++++|++|+|++
T Consensus 427 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~ 506 (606)
T 3vq2_A 427 LYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSH 506 (606)
T ss_dssp CEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCC
Confidence 999999999999999999999999999999999997 4799999999999999999999999999999999999999999
Q ss_pred CccccccchhhccccccceeeecCCCCcCcccchhhccc-cc-eeecCCCCCCCccc
Q 002349 461 NHLTGVIPEELSQLQNMFSLRLDYNNLSGDVMSLINCLS-LS-VLFIGNPGLCGYWL 515 (933)
Q Consensus 461 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-~~-~~~~~N~~~C~~~l 515 (933)
|++++.+|..+..+++|+.|+|++|+++..+..+..+.. +. +.+.+|||.|+|++
T Consensus 507 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~c~~ 563 (606)
T 3vq2_A 507 NNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICEH 563 (606)
T ss_dssp SCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred CcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCcccCCcc
Confidence 999999999999999999999999999987777666653 66 78899999999975
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-52 Score=505.98 Aligned_cols=460 Identities=23% Similarity=0.217 Sum_probs=315.0
Q ss_pred CCccceEecCC---------CCcEEEEEcCCCCcCcccCCCCCCCCCccEEEccCCcccccCCCCccCCCCCceeccccc
Q 002349 56 CVWRGITCDNV---------TFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFN 126 (933)
Q Consensus 56 c~w~gv~C~~~---------~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n 126 (933)
|.++.|.|+.. ..+++.|+|++|++++..+..|+++++|++|+|++|.+++..|..|+++++|++|+|++|
T Consensus 4 ~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n 83 (680)
T 1ziw_A 4 VSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83 (680)
T ss_dssp CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSS
T ss_pred eECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCC
Confidence 45555666532 247889999999999877778999999999999999999888888999999999999999
Q ss_pred ccCCCCCcccccccchhhhhhcccCccCCCCcccccCCCCceeeeecCCCCCCcccccccCCCCcEEeccCccccCccCc
Q 002349 127 ELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQ 206 (933)
Q Consensus 127 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~ 206 (933)
.+++..+..|+++++|++|+|++|++++..|..|+++++|++|+|++|.+++..|..++++++|++|++++|.+++..+.
T Consensus 84 ~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 163 (680)
T 1ziw_A 84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSE 163 (680)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHH
T ss_pred ccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHH
Confidence 99865555799999999999999999887778899999999999999999988888888899999999999988876665
Q ss_pred CCc--CCCCCcEEccccccccCcCCCCcc---------------------------------------------------
Q 002349 207 NIG--NCTSFQVLDLSYNQLSGEIPFNIG--------------------------------------------------- 233 (933)
Q Consensus 207 ~l~--~l~~L~~L~L~~N~l~~~~p~~~~--------------------------------------------------- 233 (933)
.+. .+++|++|++++|++++..|..+.
T Consensus 164 ~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~ 243 (680)
T 1ziw_A 164 ELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFL 243 (680)
T ss_dssp HHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTG
T ss_pred HhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhh
Confidence 543 457788888888777765554321
Q ss_pred c---cccceEeccccccccccCccccccccccEEeccCCcCcCCCCCCCC------------------------------
Q 002349 234 F---LQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILG------------------------------ 280 (933)
Q Consensus 234 ~---~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~------------------------------ 280 (933)
. .+|++|+|++|++++..|..|+.+++|++|+|++|.+++..|..|.
T Consensus 244 ~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~ 323 (680)
T 1ziw_A 244 GLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDF 323 (680)
T ss_dssp GGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTT
T ss_pred ccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChh
Confidence 1 1256666666666666666666666666666666666554443332
Q ss_pred ---CCCCccEEEeeCCccCCCCCCccccCCcceEeeecc----------------------------ccccccCCccccc
Q 002349 281 ---NLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELND----------------------------NQLTGHIPPALGK 329 (933)
Q Consensus 281 ---~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~----------------------------N~l~~~~~~~l~~ 329 (933)
.+++|++|++++|++++..+..|.++++|++|++++ |++++..|..|..
T Consensus 324 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~ 403 (680)
T 1ziw_A 324 SFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSW 403 (680)
T ss_dssp TTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTT
T ss_pred hcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhC
Confidence 334444444444555544444444444444444333 2333333444555
Q ss_pred cccccccccccccCCCCCC-CCcccCCCCCceeccCcccCC--------------------------CCCcccccccccc
Q 002349 330 LTDLFDLNVANNHLEGPIP-DNLSSCTNLNSLNVHGNKLNG--------------------------TIPPAFQRLESMT 382 (933)
Q Consensus 330 l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~l~~N~l~~--------------------------~~~~~~~~l~~L~ 382 (933)
+++|+.|++++|++.+.+| ..+.++++|++|++++|++.+ .+|..|..+++|+
T Consensus 404 l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~ 483 (680)
T 1ziw_A 404 LGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLT 483 (680)
T ss_dssp CTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCC
T ss_pred CCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCC
Confidence 5555555555555544333 334444444444444444332 2344455555566
Q ss_pred eecCCcccccCCCccccccccccceeeccCCccCCCC--------CCCCCCccccccccccCcccccccccccccccccc
Q 002349 383 YLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSI--------PSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVM 454 (933)
Q Consensus 383 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~--------p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 454 (933)
+|+|++|++++..+..|..+++|++|+|++|++++.. +..|.++++|+.|+|++|+++.+.+..|.++++|+
T Consensus 484 ~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~ 563 (680)
T 1ziw_A 484 ILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELK 563 (680)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred EEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcc
Confidence 6666666666555555666666666666666665431 12356667777777777777755555788888888
Q ss_pred eEEccCCccccccchhhccccccceeeecCCCCcCcccchh--hccccc-eeecCCCCCCCccc
Q 002349 455 EIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDVMSLI--NCLSLS-VLFIGNPGLCGYWL 515 (933)
Q Consensus 455 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~--~~~~~~-~~~~~N~~~C~~~l 515 (933)
.|+|++|+|++..+..|..+++|+.|+|++|++++.++... .+..+. +.+.+|||.|+|..
T Consensus 564 ~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~ 627 (680)
T 1ziw_A 564 IIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627 (680)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred eeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence 88888888887777778888889999999998888877643 456666 77899999999974
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-52 Score=450.95 Aligned_cols=259 Identities=24% Similarity=0.402 Sum_probs=209.9
Q ss_pred hccCcceeeecccceeEEEEEEc------CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK------NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLL 671 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 671 (933)
++|...++||+|+||+||+|+++ +++.||||+++.......++|.+|++++++++|||||+++|+|.+++..++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 46777889999999999999975 367899999987777777889999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCe
Q 002349 672 FYDFMENGSLWDILHGPT------------KKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEA 739 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~ 739 (933)
|||||++|+|.++++... ...++++.+++.++.|+|+||+|||++ +||||||||+|||+++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcE
Confidence 999999999999996432 234699999999999999999999965 99999999999999999999
Q ss_pred EEeecccccccccCCCc-eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcc
Q 002349 740 HLTDFGIAKSLCVSKSY-TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTAN 817 (933)
Q Consensus 740 kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 817 (933)
||+|||+|+........ ......||+.|||||++.+..++.++|||||||++|||+| |+.||.+....+.......
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~-- 275 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ-- 275 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHH--
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHc--
Confidence 99999999876433322 2345679999999999999999999999999999999999 8999987655443322211
Q ss_pred cccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCC
Q 002349 818 NAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVP 871 (933)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 871 (933)
+. .+..+. .++.++.+++.+||+.||++||||+||+++|+.+..
T Consensus 276 g~-----~~~~p~-----~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 276 GR-----ELERPR-----ACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp TC-----CCCCCT-----TCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CC-----CCCCcc-----cccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 11 111111 234678999999999999999999999999988754
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-52 Score=445.65 Aligned_cols=258 Identities=25% Similarity=0.416 Sum_probs=214.3
Q ss_pred hccCcceeeecccceeEEEEEEc------CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK------NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLL 671 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 671 (933)
++|...+.||+|+||+||+|++. +++.||||+++.......++|.+|++++++++|||||+++|+|.+++..++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 57888899999999999999875 367899999987776777889999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCC----------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEE
Q 002349 672 FYDFMENGSLWDILHGP----------TKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHL 741 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl 741 (933)
|||||++|+|.++++.. .....+++.++..++.|+|+||+|||++ +||||||||+|||+++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEE
Confidence 99999999999999632 1245799999999999999999999966 9999999999999999999999
Q ss_pred eecccccccccCCCce-eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccc
Q 002349 742 TDFGIAKSLCVSKSYT-STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNA 819 (933)
Q Consensus 742 ~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 819 (933)
+|||+|+......... .....||+.|||||++.+..|+.++|||||||++|||+| |+.||.+....+...... .+.
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~--~~~ 247 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT--QGR 247 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH--HTC
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH--cCC
Confidence 9999998764433322 233569999999999999999999999999999999999 899998765443332221 111
Q ss_pred cccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCC
Q 002349 820 VMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLV 870 (933)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 870 (933)
. +..+. .++.++.+++.+||+.||++|||++||.+.|+.+.
T Consensus 248 ~-----~~~p~-----~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 248 V-----LQRPR-----TCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp C-----CCCCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C-----CCCCc-----cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1 11111 23467899999999999999999999999998764
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=440.27 Aligned_cols=258 Identities=29% Similarity=0.437 Sum_probs=206.2
Q ss_pred hccCcceeeecccceeEEEEEEcCCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEe
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
+++...+.||+|+||+||+|++++ .||||+++... .+..++|.+|++++++++|||||+++|++.+ +..++||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 577888999999999999998764 59999986543 4456789999999999999999999999864 568999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCC-
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSK- 754 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~- 754 (933)
|++|+|.++++. ...++++.++..|+.|+|+||+|||++ +||||||||+|||+++++.+||+|||+|+......
T Consensus 113 ~~gGsL~~~l~~--~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 113 CEGSSLYKHLHV--QETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp CSSCBHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred CCCCCHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 999999999973 456799999999999999999999965 99999999999999999999999999998764322
Q ss_pred CceeeeecccccccCcccccc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccc
Q 002349 755 SYTSTYIMGTIGYIDPEYART---SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISAT 831 (933)
Q Consensus 755 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (933)
.......+||+.|||||++.+ ..|+.++|||||||++|||+||+.||.+................ .|.....
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~-----~p~~~~~ 262 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYA-----SPDLSKL 262 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCC-----CCCSTTS
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCC-----CCCcccc
Confidence 223445689999999999864 35899999999999999999999999876554443332221111 1111111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCC
Q 002349 832 CKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLV 870 (933)
Q Consensus 832 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 870 (933)
. ..++..+.+++.+||+.||++||||+||++.|+.+.
T Consensus 263 ~--~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 263 Y--KNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299 (307)
T ss_dssp C--TTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred c--ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 1 123467899999999999999999999999887654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-51 Score=441.65 Aligned_cols=257 Identities=21% Similarity=0.346 Sum_probs=211.6
Q ss_pred ccCcceeeecccceeEEEEEEc------CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEE
Q 002349 599 NLSEKYIIGYGASSTVYKCVLK------NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLL 671 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 671 (933)
+++..+.||+|+||+||+|.+. .++.||||+++... ....++|.+|+.++++++|||||+++|+|.+++..++
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 4566788999999999999974 35789999997643 3456789999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCC
Q 002349 672 FYDFMENGSLWDILHGPT-------------KKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFE 738 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~ 738 (933)
|||||++|+|.++|+... ....+++.++..++.|||+||+|||++ +||||||||+|||+++++.
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCC
Confidence 999999999999996421 124689999999999999999999966 9999999999999999999
Q ss_pred eEEeecccccccccCCCc-eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhc
Q 002349 739 AHLTDFGIAKSLCVSKSY-TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTA 816 (933)
Q Consensus 739 ~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~ 816 (933)
+||+|||+|+........ ......||+.|||||++.++.|+.++|||||||++|||+| |+.||.+....+......
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~-- 261 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIR-- 261 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHH--
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH--
Confidence 999999999876433322 2345679999999999999999999999999999999998 899998765443322211
Q ss_pred ccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCC
Q 002349 817 NNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLV 870 (933)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 870 (933)
.+.. +..+. .++..+.+++.+||+.||++||||+||++.|+.+.
T Consensus 262 ~~~~-----~~~p~-----~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 262 NRQV-----LPCPD-----DCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp TTCC-----CCCCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred cCCC-----CCCcc-----cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 1111 11111 23567899999999999999999999999998753
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-50 Score=479.03 Aligned_cols=423 Identities=20% Similarity=0.208 Sum_probs=371.9
Q ss_pred cEEEEEcCCCCcCcccCCCCCCCCCccEEEccCCcccccCCCCccCCCCCceecccccccCCCCCcccccccchhhhhhc
Q 002349 69 TVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILK 148 (933)
Q Consensus 69 ~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~ 148 (933)
.+..|+|++|.+++..|..|+++++|++|+|++|++++..|..|+++++|++|+|++|.+++..|..++++++|++|+|+
T Consensus 58 ~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~ 137 (606)
T 3t6q_A 58 NLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLG 137 (606)
T ss_dssp TCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECC
T ss_pred cceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECC
Confidence 57789999999998888889999999999999999988888899999999999999999987667788899999999999
Q ss_pred ccCccCCCCcccccCCCCceeeeecCCCCCCcccccccCCCCc--EEeccCccccC------------------------
Q 002349 149 NNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLW--YFDVRNNSLTG------------------------ 202 (933)
Q Consensus 149 ~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~--~L~L~~n~l~~------------------------ 202 (933)
+|++++..+..+..+++|++|+|++|++++..+..++.+++|+ .|++++|.+++
T Consensus 138 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~~~ 217 (606)
T 3t6q_A 138 SNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLV 217 (606)
T ss_dssp SSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTTCEEEEEECTTCSCHHH
T ss_pred CCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCccChhHhhhccccccccCCchhHHH
Confidence 9998874434455588888888888888877676677766666 56666655543
Q ss_pred ---------------------------------------------------ccCcCCcCCCCCcEEccccccccCcCCCC
Q 002349 203 ---------------------------------------------------SIPQNIGNCTSFQVLDLSYNQLSGEIPFN 231 (933)
Q Consensus 203 ---------------------------------------------------~~p~~l~~l~~L~~L~L~~N~l~~~~p~~ 231 (933)
..+..|+++++|++|++++|+++ .+|..
T Consensus 218 ~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~ 296 (606)
T 3t6q_A 218 IFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSG 296 (606)
T ss_dssp HHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSS
T ss_pred HhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChh
Confidence 33444777889999999999998 66665
Q ss_pred cc-ccccceEeccccccccccCccccccccccEEeccCCcCcCCCCC-CCCCCCCccEEEeeCCccCCCC--CCccccCC
Q 002349 232 IG-FLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPP-ILGNLSYTEKLYLHSNKLTGHI--PPELGNMT 307 (933)
Q Consensus 232 ~~-~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~--p~~l~~l~ 307 (933)
+. ..+|++|++++|++++..|..+..+++|++|++++|.+.+.++. .+.++++|++|++++|.+++.. +..+..++
T Consensus 297 l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~ 376 (606)
T 3t6q_A 297 LVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLS 376 (606)
T ss_dssp CCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCT
T ss_pred hcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCC
Confidence 54 45799999999999988888999999999999999999866554 5999999999999999999766 78899999
Q ss_pred cceEeeeccccccccCCccccccccccccccccccCCCCCCC-CcccCCCCCceeccCcccCCCCCcccccccccceecC
Q 002349 308 KLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPD-NLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNL 386 (933)
Q Consensus 308 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~-~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L 386 (933)
+|++|++++|++++..|..+..+++|+.|++++|++.+..+. .+..+++|+.|++++|++++..|..|..+++|++|++
T Consensus 377 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L 456 (606)
T 3t6q_A 377 HLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNL 456 (606)
T ss_dssp TCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEEC
T ss_pred CCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEEC
Confidence 999999999999999999999999999999999999877654 4899999999999999999999999999999999999
Q ss_pred CcccccCC---CccccccccccceeeccCCccCCCCCCCCCCccccccccccCcccccccccccccccccceEEccCCcc
Q 002349 387 SLNNIRGP---IPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHL 463 (933)
Q Consensus 387 ~~N~l~~~---~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 463 (933)
++|.+++. .+..+..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++..|..|.++++| .|+|++|++
T Consensus 457 ~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l 535 (606)
T 3t6q_A 457 QGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHI 535 (606)
T ss_dssp TTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCC
T ss_pred CCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcc
Confidence 99999863 33678999999999999999999999999999999999999999999999999999999 999999999
Q ss_pred ccccchhhccccccceeeecCCCCcCcccc
Q 002349 464 TGVIPEELSQLQNMFSLRLDYNNLSGDVMS 493 (933)
Q Consensus 464 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~ 493 (933)
++.+|..+..+++|+.|++++|+|+|..+.
T Consensus 536 ~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~ 565 (606)
T 3t6q_A 536 SIILPSLLPILSQQRTINLRQNPLDCTCSN 565 (606)
T ss_dssp CCCCGGGHHHHHTSSEEECTTCCEECSGGG
T ss_pred cccCHhhcccCCCCCEEeCCCCCccccCCc
Confidence 999999999999999999999999997763
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-51 Score=441.73 Aligned_cols=250 Identities=24% Similarity=0.349 Sum_probs=212.6
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEec
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFM 676 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 676 (933)
+.|+..+.||+|+||+||+|+++ +|+.||||++........+.+.+|++++++++|||||++++++.+++..|+|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 46888999999999999999986 58899999997665555677899999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCc
Q 002349 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY 756 (933)
Q Consensus 677 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 756 (933)
+||+|.+++. ...+++.++..++.|++.||+|||++ +||||||||+|||++.++.+||+|||+|+.+.... .
T Consensus 154 ~gg~L~~~l~----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~ 225 (346)
T 4fih_A 154 EGGALTDIVT----HTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-P 225 (346)
T ss_dssp TTEEHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-C
T ss_pred CCCcHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCC-C
Confidence 9999999995 35699999999999999999999966 99999999999999999999999999998764332 2
Q ss_pred eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHH
Q 002349 757 TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLG 836 (933)
Q Consensus 757 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (933)
.....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+......+...... ..+.+... ..
T Consensus 226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~-------~~~~~~~~---~~ 295 (346)
T 4fih_A 226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN-------LPPRLKNL---HK 295 (346)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-------SCCCCSCG---GG
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC-------CCCCCCcc---cc
Confidence 344578999999999999999999999999999999999999999877655544332211 11111111 11
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 837 AVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 837 ~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.+..+.+++.+||+.||++|||++|++++
T Consensus 296 ~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 296 VSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 23578899999999999999999999875
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-51 Score=442.93 Aligned_cols=251 Identities=25% Similarity=0.342 Sum_probs=205.2
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYD 674 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 674 (933)
++|+..+.||+|+||+||+|+++ +++.||||++.... ....+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999976 58999999996543 3456779999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCC
Q 002349 675 FMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSK 754 (933)
Q Consensus 675 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 754 (933)
||+||+|.+++.. .....+++.++..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.+....
T Consensus 104 y~~gg~L~~~i~~-~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINA-QKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp CCTTCBHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred CCCCCcHHHHHHH-cCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 9999999999963 2345689999999999999999999966 99999999999999999999999999998764221
Q ss_pred CceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccC
Q 002349 755 SYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKD 834 (933)
Q Consensus 755 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (933)
......+||+.|||||++.+..|+.++||||+||++|||+||+.||.+............. .. +....
T Consensus 180 -~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~-----~~~~~---- 247 (350)
T 4b9d_A 180 -ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISG--SF-----PPVSL---- 247 (350)
T ss_dssp -HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT--CC-----CCCCT----
T ss_pred -ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC--CC-----CCCCc----
Confidence 2234468999999999999999999999999999999999999999876554443332221 11 11111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 835 LGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 835 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
..+.++.+++.+||+.||++|||++|++++
T Consensus 248 -~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 248 -HYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp -TSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -cCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 123578899999999999999999999863
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-50 Score=476.17 Aligned_cols=440 Identities=20% Similarity=0.201 Sum_probs=394.5
Q ss_pred CcEEEEEcCCCCcCcccCCCCCCCCCccEEEccCCcccccCCCCccCCCCCceecccccccCCCCCcccccccchhhhhh
Q 002349 68 FTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLIL 147 (933)
Q Consensus 68 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 147 (933)
.++..|+|++|.+++..+..|.++++|++|+|++|++++..|..|+++++|++|+|++|.+++..|..|+++++|++|+|
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence 46889999999999888889999999999999999999877889999999999999999999888889999999999999
Q ss_pred cccCccCCCCcccccCCCCceeeeecCCCCC-CcccccccCCCCcEEeccCccccCccCcCCcCCCCC----cEEccccc
Q 002349 148 KNNQLIGPIPSTLSQLPNLKVFGLRGNNLVG-TLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSF----QVLDLSYN 222 (933)
Q Consensus 148 ~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L----~~L~L~~N 222 (933)
++|++++..+..++++++|++|+|++|.+.+ .+|..|+++++|++|++++|.+++..|..++.+++| +.|++++|
T Consensus 108 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n 187 (570)
T 2z63_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187 (570)
T ss_dssp TTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTC
T ss_pred cccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCC
Confidence 9999997666679999999999999999987 478999999999999999999998888889999998 89999999
Q ss_pred cccCcCCCCccccccceEecccc---------------------------------------------------------
Q 002349 223 QLSGEIPFNIGFLQIATLSLQGN--------------------------------------------------------- 245 (933)
Q Consensus 223 ~l~~~~p~~~~~~~L~~L~L~~n--------------------------------------------------------- 245 (933)
.+++..|..+...+|++|++++|
T Consensus 188 ~l~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~ 267 (570)
T 2z63_A 188 PMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 267 (570)
T ss_dssp CCCEECTTTTTTCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEET
T ss_pred CceecCHHHhccCcceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcc
Confidence 99988887777667888887776
Q ss_pred -ccccccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcceEeeeccccccccCC
Q 002349 246 -QLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIP 324 (933)
Q Consensus 246 -~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 324 (933)
.+.+..|..+..+++|+.|++++|.++ .+|..+..+ +|++|++++|.+. .+|. ..+++|+.|++++|.+.+..+
T Consensus 268 ~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~~~~ 342 (570)
T 2z63_A 268 DYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGNAFS 342 (570)
T ss_dssp TEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-SCCB--CBCSSCCEEEEESCBSCCBCC
T ss_pred hhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCccc-ccCc--ccccccCEEeCcCCccccccc
Confidence 445566777888899999999999998 577788888 9999999999998 5554 478899999999999987665
Q ss_pred ccccccccccccccccccCCCCC--CCCcccCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCCc-ccccc
Q 002349 325 PALGKLTDLFDLNVANNHLEGPI--PDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIP-VELSR 401 (933)
Q Consensus 325 ~~l~~l~~L~~L~L~~N~l~~~~--p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~ 401 (933)
. ..+++|+.|++++|++.+.. +..+..+++|++|++++|++.+..+. |..+++|++|++++|.+.+..+ ..+..
T Consensus 343 ~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~ 419 (570)
T 2z63_A 343 E--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLS 419 (570)
T ss_dssp C--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTT
T ss_pred c--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhc
Confidence 5 78899999999999998654 66788999999999999999965444 9999999999999999998766 57889
Q ss_pred ccccceeeccCCccCCCCCCCCCCccccccccccCcccc-cccccccccccccceEEccCCccccccchhhcccccccee
Q 002349 402 IGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLT-GFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSL 480 (933)
Q Consensus 402 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 480 (933)
+++|++|++++|.+++..|..|..+++|+.|+|++|+++ +.+|..|.++++|++|+|++|++++..|..+..+++|++|
T Consensus 420 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 499 (570)
T 2z63_A 420 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 499 (570)
T ss_dssp CTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEE
Confidence 999999999999999999999999999999999999998 6899999999999999999999999999999999999999
Q ss_pred eecCCCCcCcccc-hhhccccc-eeecCCCCCCCccc
Q 002349 481 RLDYNNLSGDVMS-LINCLSLS-VLFIGNPGLCGYWL 515 (933)
Q Consensus 481 ~l~~N~l~~~~~~-~~~~~~~~-~~~~~N~~~C~~~l 515 (933)
++++|++++.++. +.++..+. +.+.+||+.|+|+.
T Consensus 500 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 536 (570)
T 2z63_A 500 NMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536 (570)
T ss_dssp ECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred eCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcc
Confidence 9999999998775 45666776 77899999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=438.26 Aligned_cols=252 Identities=25% Similarity=0.286 Sum_probs=206.0
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEec
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFM 676 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 676 (933)
+.|...++||+|+||+||+|+++ +++.||||+++.... ..+|++++++++|||||++++++.+++..|+|||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 56788889999999999999976 488999999975432 247999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCC-CeEEeecccccccccCCC
Q 002349 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDF-EAHLTDFGIAKSLCVSKS 755 (933)
Q Consensus 677 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~-~~kl~DfGla~~~~~~~~ 755 (933)
+||+|.++++ ..+.+++.++..++.|++.||+|||++ +||||||||+|||++.++ .+||+|||+|+.+.....
T Consensus 133 ~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 133 EGGSLGQLIK---QMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp TTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred CCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 9999999995 456799999999999999999999965 999999999999999987 699999999987643321
Q ss_pred c----eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccc
Q 002349 756 Y----TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISAT 831 (933)
Q Consensus 756 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (933)
. .....+||+.|||||++.+..|+.++||||+||++|||+||+.||.+................ ...+++
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~----- 280 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPP-IREIPP----- 280 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCG-GGGSCT-----
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCC-chhcCc-----
Confidence 1 223467999999999999999999999999999999999999999865443333222211111 111111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCC
Q 002349 832 CKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLV 870 (933)
Q Consensus 832 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 870 (933)
..+..+.+++.+||+.||++|||++|+++++....
T Consensus 281 ----~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l 315 (336)
T 4g3f_A 281 ----SCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKAL 315 (336)
T ss_dssp ----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----cCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 12457888999999999999999999999886654
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=432.06 Aligned_cols=247 Identities=23% Similarity=0.263 Sum_probs=210.3
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
++|+..+.||+|+||+||+|+++ +++.||||++.... ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999976 58899999996532 334677999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
|||+||+|.+++. ..+.+++.++..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~---~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 9999999999995 456799999999999999999999966 9999999999999999999999999999987533
Q ss_pred C-CceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccc
Q 002349 754 K-SYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATC 832 (933)
Q Consensus 754 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (933)
. .......+||+.|||||++.+..|+.++||||+||++|||++|+.||.+................+ +..
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~----p~~----- 256 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDF----PEK----- 256 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC----CTT-----
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC----Ccc-----
Confidence 2 233456789999999999999999999999999999999999999998765544433332222111 111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 002349 833 KDLGAVKKVFQLALLCSKRQPTDRPTMHEVS 863 (933)
Q Consensus 833 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 863 (933)
.+.++.+++.+|++.||++|||++|+.
T Consensus 257 ----~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 257 ----FFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp ----CCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred ----cCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 124678899999999999999999864
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-50 Score=425.58 Aligned_cols=247 Identities=23% Similarity=0.329 Sum_probs=200.3
Q ss_pred CcceeeecccceeEEEEEEcC-CceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEec----CCccEEEE
Q 002349 601 SEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLS----SSGNLLFY 673 (933)
Q Consensus 601 ~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~ 673 (933)
+..+.||+|+||+||+|.+.. ++.||+|++.... ....+.|.+|++++++++|||||+++++|.+ +...++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 556689999999999999764 7889999996542 3446779999999999999999999999865 34579999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCC-CCCeEEeeccccccccc
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDK-DFEAHLTDFGIAKSLCV 752 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~-~~~~kl~DfGla~~~~~ 752 (933)
|||++|+|.++++ ..+.+++..+..++.||+.||+|||++ .++||||||||+|||++. ++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 9999999999995 456799999999999999999999976 233999999999999985 79999999999986432
Q ss_pred CCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccc
Q 002349 753 SKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATC 832 (933)
Q Consensus 753 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (933)
......+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+............. .... +.+...
T Consensus 185 ---~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~-~~~~----~~~~~~- 254 (290)
T 3fpq_A 185 ---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKP----ASFDKV- 254 (290)
T ss_dssp ---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TCCC----GGGGGC-
T ss_pred ---CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHc-CCCC----CCCCcc-
Confidence 23445789999999999875 5999999999999999999999999866555444332221 1111 111111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 833 KDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 833 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.+.++.+++.+||+.||++|||++|++++
T Consensus 255 ----~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 255 ----AIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp ----CCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ----CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 12467889999999999999999999875
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=418.93 Aligned_cols=246 Identities=19% Similarity=0.282 Sum_probs=193.8
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
++|+..+.||+|+||+||+|+++ +++.||||++.... ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999975 58999999996542 334567999999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
||+ +|+|.+++. ..+++++.++..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIV---QRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHH---HSCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 679999984 456899999999999999999999976 9999999999999999999999999999875332
Q ss_pred CCceeeeecccccccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccc
Q 002349 754 KSYTSTYIMGTIGYIDPEYARTSRL-TEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATC 832 (933)
Q Consensus 754 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (933)
......+||+.|||||++.+..+ ++++||||+||++|||+||+.||.+................ ++..
T Consensus 166 --~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~--------~p~~- 234 (275)
T 3hyh_A 166 --NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYT--------LPKF- 234 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--------CCTT-
T ss_pred --CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC--------CCCC-
Confidence 23345689999999999998876 58999999999999999999999876544333222211111 1111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 833 KDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 833 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.+..+.+++.+|++.||++|||++|++++
T Consensus 235 ----~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 235 ----LSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp ----SCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred ----CCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 13567889999999999999999999974
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=443.24 Aligned_cols=250 Identities=24% Similarity=0.343 Sum_probs=213.2
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEec
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFM 676 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 676 (933)
+.|+..+.||+|+||+||+|+++ +|+.||||++........+.+.+|+++|++++|||||+++++|.+++..|+|||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56999999999999999999976 48999999997666556677899999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCc
Q 002349 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY 756 (933)
Q Consensus 677 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 756 (933)
+||+|.++++ ...+++.++..++.||+.||+|||++ +||||||||+|||++.+|.+||+|||+|+.+.... .
T Consensus 231 ~gG~L~~~i~----~~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-~ 302 (423)
T 4fie_A 231 EGGALTDIVT----HTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-P 302 (423)
T ss_dssp TTEEHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-C
T ss_pred CCCcHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCC-c
Confidence 9999999995 34699999999999999999999966 99999999999999999999999999998764332 2
Q ss_pred eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHH
Q 002349 757 TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLG 836 (933)
Q Consensus 757 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (933)
.....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+......+....... .+.+... ..
T Consensus 303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~-------~~~~~~~---~~ 372 (423)
T 4fie_A 303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-------PPRLKNL---HK 372 (423)
T ss_dssp CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-------CCCCSCT---TS
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-------CCCCccc---cc
Confidence 3445689999999999999999999999999999999999999998776655543332211 1111111 01
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 837 AVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 837 ~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.+..+.+++.+||+.||++|||++|++++
T Consensus 373 ~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 373 VSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 23578899999999999999999999875
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=430.47 Aligned_cols=268 Identities=23% Similarity=0.316 Sum_probs=205.1
Q ss_pred hccCcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCC----ccEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSS----GNLLFY 673 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv~ 673 (933)
++|...+.||+|+||+||+|+++ |+.||||++..... ....++.|+..+.+++|||||++++++.+++ ..++||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 46778899999999999999984 68999999965432 2223455677778899999999999997654 468999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-----CCCeeeccCCCCceEeCCCCCeEEeeccccc
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDC-----SPRIIHRDVKSSNILLDKDFEAHLTDFGIAK 748 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 748 (933)
|||++|+|.++++ ..+++++.+.+++.|+++||+|||+++ .++||||||||+|||++.++.+||+|||+|+
T Consensus 81 Ey~~~gsL~~~l~----~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 9999999999995 346899999999999999999999641 3489999999999999999999999999998
Q ss_pred ccccCCCc---eeeeecccccccCccccccC------CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHH-------
Q 002349 749 SLCVSKSY---TSTYIMGTIGYIDPEYARTS------RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLIL------- 812 (933)
Q Consensus 749 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~------- 812 (933)
........ .....+||+.|||||++.+. .++.++|||||||++|||+||+.||...........
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 76443322 22345799999999999764 367899999999999999999887753221110000
Q ss_pred --hhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCC
Q 002349 813 --SKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVP 871 (933)
Q Consensus 813 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 871 (933)
............+|.++......+.+..+.+++.+||+.||++||||+||++.|+.+..
T Consensus 237 ~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 00000011223344454444455677889999999999999999999999999987643
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=436.19 Aligned_cols=268 Identities=24% Similarity=0.334 Sum_probs=217.3
Q ss_pred HHHHHHHhhccCcceeeecccceeEEEEEEcC------CceEEEEEecccC-chhHHHHHHHHHHHhcCCC-Cceeeeee
Q 002349 590 YEDIMRMTENLSEKYIIGYGASSTVYKCVLKN------CKPVAIKRLYSHY-PQCLKEFETELETVGSIKH-RNLVSLQG 661 (933)
Q Consensus 590 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h-~niv~~~~ 661 (933)
.++++...++|+..+.||+|+||+||+|.+.+ ++.||||++.... ....+.|.+|++++++++| ||||+++|
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 34455556899999999999999999999754 3579999997654 3345779999999999965 89999999
Q ss_pred EEecC-CccEEEEEecCCCCHHHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCC
Q 002349 662 YSLSS-SGNLLFYDFMENGSLWDILHGPT-------------KKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVK 727 (933)
Q Consensus 662 ~~~~~-~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik 727 (933)
+|... +..++|||||++|+|.++|+... ....+++.++..++.|||+||+|||++ +|||||||
T Consensus 136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK 212 (353)
T 4ase_A 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLA 212 (353)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccC
Confidence 99764 56899999999999999996321 134589999999999999999999965 99999999
Q ss_pred CCceEeCCCCCeEEeecccccccccCCCc-eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCc
Q 002349 728 SSNILLDKDFEAHLTDFGIAKSLCVSKSY-TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNEC 805 (933)
Q Consensus 728 p~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~ 805 (933)
|+|||+++++.+||+|||+|+.+...... ......||+.|||||++.+..|+.++|||||||++|||+| |+.||.+..
T Consensus 213 ~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~ 292 (353)
T 4ase_A 213 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 292 (353)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred ccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999876544333 3345679999999999999999999999999999999998 899998654
Q ss_pred chhHHHHhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCC
Q 002349 806 NLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVP 871 (933)
Q Consensus 806 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 871 (933)
........... + ..+..+.. ++.++.+++.+||+.||++|||++||+++|+.+..
T Consensus 293 ~~~~~~~~i~~-g-----~~~~~p~~-----~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 293 IDEEFCRRLKE-G-----TRMRAPDY-----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp CSHHHHHHHHH-T-----CCCCCCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHc-C-----CCCCCCcc-----CCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 43333222111 1 11112221 24578899999999999999999999999987643
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=424.90 Aligned_cols=248 Identities=24% Similarity=0.291 Sum_probs=200.3
Q ss_pred hccCcceeeecccceeEEEEEEc----CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK----NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLL 671 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 671 (933)
++|+..+.||+|+||+||+|+.. .++.||||++.... .....++.+|++++++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999863 36789999996542 2234568899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccc
Q 002349 672 FYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLC 751 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 751 (933)
|||||+||+|.+++. ..+.+++.++..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 999999999999995 456799999999999999999999966 99999999999999999999999999998653
Q ss_pred cCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccc
Q 002349 752 VSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISAT 831 (933)
Q Consensus 752 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (933)
... ......+||+.|||||++.+..|+.++||||+||++|||+||+.||.+....+............ +..
T Consensus 178 ~~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~--------p~~ 248 (304)
T 3ubd_A 178 DHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGM--------PQF 248 (304)
T ss_dssp ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--------CTT
T ss_pred CCC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCC--------CCc
Confidence 322 22345689999999999999999999999999999999999999998766554443332221111 111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 002349 832 CKDLGAVKKVFQLALLCSKRQPTDRPTM-----HEVSRV 865 (933)
Q Consensus 832 ~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~~ 865 (933)
.+.++.+++.+||+.||++|||+ +|++++
T Consensus 249 -----~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 249 -----LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp -----SCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred -----CCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 23567889999999999999984 566653
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-49 Score=467.63 Aligned_cols=447 Identities=20% Similarity=0.251 Sum_probs=352.0
Q ss_pred CCCccceEecCC-----------CCcEEEEEcCCCCcCcccCCCCCCCCCccEEEccCCcccccCCCCccCCCCCceecc
Q 002349 55 YCVWRGITCDNV-----------TFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDL 123 (933)
Q Consensus 55 ~c~w~gv~C~~~-----------~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L 123 (933)
.|.|.|+ |+.. ...++.|+|++|.+++..+..+.++++|++|+|++|++++..|..|+++++|++|||
T Consensus 3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 81 (549)
T 2z81_A 3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDL 81 (549)
T ss_dssp EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEEC
Confidence 5999998 8642 137899999999999888899999999999999999999888899999999999999
Q ss_pred cccccCCCCCcccccccchhhhhhcccCccC-CCCcccccCCCCceeeeecCCCCCCcc-cccccCCCCcEEeccCcccc
Q 002349 124 SFNELYGDIPFSISKLKQLEFLILKNNQLIG-PIPSTLSQLPNLKVFGLRGNNLVGTLS-PDMCQLSGLWYFDVRNNSLT 201 (933)
Q Consensus 124 s~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~n~l~ 201 (933)
++|.+++..|..|+++++|++|+|++|.+++ .+|..++++++|++|+|++|++.+.+| ..|.++++|++|++++|.++
T Consensus 82 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~ 161 (549)
T 2z81_A 82 SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR 161 (549)
T ss_dssp TTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCC
T ss_pred CCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCccc
Confidence 9999998777779999999999999999987 467889999999999999999665665 57999999999999999999
Q ss_pred CccCcCCcCCCCCcEEccccccccCcCCCCc--cccccceEecccccccccc--C-cc----------------------
Q 002349 202 GSIPQNIGNCTSFQVLDLSYNQLSGEIPFNI--GFLQIATLSLQGNQLTGKI--P-SV---------------------- 254 (933)
Q Consensus 202 ~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~--~~~~L~~L~L~~n~l~~~~--p-~~---------------------- 254 (933)
+.+|..++++++|++|++++|.+. .+|..+ ...+|++|++++|++++.. | ..
T Consensus 162 ~~~~~~l~~l~~L~~L~l~~n~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~ 240 (549)
T 2z81_A 162 NYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESF 240 (549)
T ss_dssp EECTTTTTTCSEEEEEEEECSBST-THHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHH
T ss_pred ccChhhhhccccCceEecccCccc-ccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHH
Confidence 999999988888888888777765 233222 1346777777777776532 1 11
Q ss_pred ------ccccccccEEeccCCcCcCCC------CCCCCCCCCccEEEeeCCccCCC-----CCCccccCCcceEeeeccc
Q 002349 255 ------IGLMQALAVLDLSCNMLSGPI------PPILGNLSYTEKLYLHSNKLTGH-----IPPELGNMTKLHYLELNDN 317 (933)
Q Consensus 255 ------~~~l~~L~~L~Ls~N~l~~~~------~~~~~~l~~L~~L~L~~N~l~~~-----~p~~l~~l~~L~~L~L~~N 317 (933)
+..+++|+.|++++|.+.+.. ...+..+++|+.|++.++.+... ++..+...++|+.|++++|
T Consensus 241 ~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n 320 (549)
T 2z81_A 241 NELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENS 320 (549)
T ss_dssp HHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESS
T ss_pred HHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccC
Confidence 223344444555554443321 12334455566666666554421 1111233467899999999
Q ss_pred cccccCCccc-cccccccccccccccCCCCC---CCCcccCCCCCceeccCcccCCCCC--cccccccccceecCCcccc
Q 002349 318 QLTGHIPPAL-GKLTDLFDLNVANNHLEGPI---PDNLSSCTNLNSLNVHGNKLNGTIP--PAFQRLESMTYLNLSLNNI 391 (933)
Q Consensus 318 ~l~~~~~~~l-~~l~~L~~L~L~~N~l~~~~---p~~l~~l~~L~~L~l~~N~l~~~~~--~~~~~l~~L~~L~L~~N~l 391 (933)
+++ .+|..+ ..+++|+.|++++|++.+.+ +..+..+++|+.|++++|++++..+ ..+..+++|++|++++|++
T Consensus 321 ~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l 399 (549)
T 2z81_A 321 KVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTF 399 (549)
T ss_dssp CCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCC
T ss_pred ccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCC
Confidence 988 566665 57999999999999998765 3457888999999999999986533 4688999999999999999
Q ss_pred cCCCccccccccccceeeccCCccCCCCCCCCCCccccccccccCcccccccccccccccccceEEccCCccccccchhh
Q 002349 392 RGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEEL 471 (933)
Q Consensus 392 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 471 (933)
+ .+|..+..+++|++|+|++|.++ .+|..+. ++|+.|+|++|+|++.+ .++++|++|+|++|+|+ .+|. .
T Consensus 400 ~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~~--~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~ 469 (549)
T 2z81_A 400 H-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIP--QTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-A 469 (549)
T ss_dssp C-CCCSCCCCCTTCCEEECTTSCCS-CCCTTSC--TTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-G
T ss_pred c-cCChhhcccccccEEECCCCCcc-cccchhc--CCceEEECCCCChhhhc----ccCChhcEEECCCCccC-cCCC-c
Confidence 9 67888888999999999999998 4554442 58999999999999753 57899999999999999 5665 5
Q ss_pred ccccccceeeecCCCCcCcccc-hhhccccc-eeecCCCCCCCcc
Q 002349 472 SQLQNMFSLRLDYNNLSGDVMS-LINCLSLS-VLFIGNPGLCGYW 514 (933)
Q Consensus 472 ~~l~~L~~L~l~~N~l~~~~~~-~~~~~~~~-~~~~~N~~~C~~~ 514 (933)
..+++|+.|+|++|++++.++. +..+..+. +.+.+|||.|+|+
T Consensus 470 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 470 SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp GGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred ccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence 6899999999999999998876 56666776 7789999999986
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=465.22 Aligned_cols=418 Identities=21% Similarity=0.165 Sum_probs=356.1
Q ss_pred CcEEEEEcCCCCcCcccCCCCCCCCCccEEEccCCcccccCCCCccCCCCCceecccccccCCCCCcccccccchhhhhh
Q 002349 68 FTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLIL 147 (933)
Q Consensus 68 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 147 (933)
.++..|+|++|.+++..|..|+++++|++|+|++|++++..|..|+++++|++|+|++|.+++..|..|+++++|++|+|
T Consensus 56 ~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 135 (606)
T 3vq2_A 56 SELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNV 135 (606)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEEC
T ss_pred ccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeC
Confidence 36789999999999888889999999999999999999888999999999999999999999877788999999999999
Q ss_pred cccCccC-CCCcccccCCCCceeeeecCCCCCCcccccccCCCCc----EEeccCccccCccCcCCcCCCCCcEEccccc
Q 002349 148 KNNQLIG-PIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLW----YFDVRNNSLTGSIPQNIGNCTSFQVLDLSYN 222 (933)
Q Consensus 148 ~~n~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~----~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N 222 (933)
++|.+++ .+|..|+++++|++|+|++|++++..+..+..+++|+ +|++++|.+++..+..+... +|+.|++++|
T Consensus 136 ~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n 214 (606)
T 3vq2_A 136 AHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGN 214 (606)
T ss_dssp CSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESC
T ss_pred CCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCC
Confidence 9999986 6799999999999999999999988888787776655 78888888875444444333 6777777666
Q ss_pred cccC----------------------------------------------------------------------------
Q 002349 223 QLSG---------------------------------------------------------------------------- 226 (933)
Q Consensus 223 ~l~~---------------------------------------------------------------------------- 226 (933)
.+++
T Consensus 215 ~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~l~~L~~L~l~~ 294 (606)
T 3vq2_A 215 FNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAG 294 (606)
T ss_dssp CSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGSCGGGTTCSEEEEES
T ss_pred ccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccccccCCCCCEEEecC
Confidence 5431
Q ss_pred ----cCCCCccccccceEeccccccccccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCC--CC
Q 002349 227 ----EIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGH--IP 300 (933)
Q Consensus 227 ----~~p~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~p 300 (933)
.+|......+|++|++++|++ +.+| .+ .+++|+.|++++|...+.. .+..+++|++|++++|++++. .|
T Consensus 295 ~~~~~l~~l~~~~~L~~L~l~~n~l-~~lp-~~-~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~ 369 (606)
T 3vq2_A 295 VSIKYLEDVPKHFKWQSLSIIRCQL-KQFP-TL-DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCS 369 (606)
T ss_dssp CCCCCCCCCCTTCCCSEEEEESCCC-SSCC-CC-CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECC
T ss_pred ccchhhhhccccccCCEEEcccccC-cccc-cC-CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchh
Confidence 122111122455666666666 3455 23 5666666666666433322 566788899999999999865 37
Q ss_pred CccccCCcceEeeeccccccccCCccccccccccccccccccCCCCCC-CCcccCCCCCceeccCcccCCCCCccccccc
Q 002349 301 PELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIP-DNLSSCTNLNSLNVHGNKLNGTIPPAFQRLE 379 (933)
Q Consensus 301 ~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~ 379 (933)
..+..+++|++|++++|.+++ +|..+..+++|+.|++++|++.+..| ..+..+++|+.|++++|++++..|..|..++
T Consensus 370 ~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 448 (606)
T 3vq2_A 370 YSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLT 448 (606)
T ss_dssp HHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCT
T ss_pred hhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCC
Confidence 889999999999999999995 66899999999999999999998877 7899999999999999999999999999999
Q ss_pred ccceecCCcccccC-CCccccccccccceeeccCCccCCCCCCCCCCccccccccccCcccccccccccccccccceEEc
Q 002349 380 SMTYLNLSLNNIRG-PIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDL 458 (933)
Q Consensus 380 ~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 458 (933)
+|++|++++|.+++ .+|..+..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++..|..|.++++|++|+|
T Consensus 449 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l 528 (606)
T 3vq2_A 449 SLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDC 528 (606)
T ss_dssp TCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEEC
T ss_pred CCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEEC
Confidence 99999999999997 47889999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCccccccchhhcccc-ccceeeecCCCCcCcccc
Q 002349 459 SHNHLTGVIPEELSQLQ-NMFSLRLDYNNLSGDVMS 493 (933)
Q Consensus 459 s~N~l~~~~p~~~~~l~-~L~~L~l~~N~l~~~~~~ 493 (933)
++|+++ .+|..+..++ +|+.|++++|+|.|..+.
T Consensus 529 ~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~ 563 (606)
T 3vq2_A 529 SFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEH 563 (606)
T ss_dssp TTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred CCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCcc
Confidence 999999 6777799997 599999999999997653
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=464.51 Aligned_cols=303 Identities=19% Similarity=0.233 Sum_probs=215.5
Q ss_pred CcEEeccCccccCccCcCCcCCCCCcEEccccccccCcCCCCcc----------------------------------cc
Q 002349 190 LWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIG----------------------------------FL 235 (933)
Q Consensus 190 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~----------------------------------~~ 235 (933)
|++|++++|.+++..|..++.+++|++|++++|++++..|..+. ..
T Consensus 250 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~ 329 (680)
T 1ziw_A 250 LTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLK 329 (680)
T ss_dssp CCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCT
T ss_pred CCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCC
Confidence 55555555555555555555556666666666655544332221 12
Q ss_pred ccceEeccccccccccCccccccccccEEeccCC----------------------------cCcCCCCCCCCCCCCccE
Q 002349 236 QIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCN----------------------------MLSGPIPPILGNLSYTEK 287 (933)
Q Consensus 236 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N----------------------------~l~~~~~~~~~~l~~L~~ 287 (933)
+|++|++++|++++..+..|..+++|++|++++| ++++..|..|..+++|+.
T Consensus 330 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 409 (680)
T 1ziw_A 330 CLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEV 409 (680)
T ss_dssp TCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred CCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCE
Confidence 3455555555555555544544444444444333 333333444555555555
Q ss_pred EEeeCCccCCCCC-CccccCCcceEeeeccccccccCCccccccccccccccccccCC--CCCCCCcccCCCCCceeccC
Q 002349 288 LYLHSNKLTGHIP-PELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLE--GPIPDNLSSCTNLNSLNVHG 364 (933)
Q Consensus 288 L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~--~~~p~~l~~l~~L~~L~l~~ 364 (933)
|+|++|.+++.+| ..+.++++|++|++++|++++..+..|..+++|+.|++++|.+. +..|..+..+++|+.|++++
T Consensus 410 L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~ 489 (680)
T 1ziw_A 410 LDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSN 489 (680)
T ss_dssp EECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCS
T ss_pred EeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCC
Confidence 5555555544333 34555555555555555555555555566666666666666654 46788899999999999999
Q ss_pred cccCCCCCcccccccccceecCCcccccCCCc--------cccccccccceeeccCCccCCCCCCCCCCccccccccccC
Q 002349 365 NKLNGTIPPAFQRLESMTYLNLSLNNIRGPIP--------VELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSR 436 (933)
Q Consensus 365 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--------~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 436 (933)
|++++..+..|.++++|++|+|++|++++..+ ..+..+++|+.|+|++|+++...+..|.++++|+.|+|++
T Consensus 490 N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 569 (680)
T 1ziw_A 490 NNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGL 569 (680)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCC
Confidence 99998888899999999999999999986422 2478899999999999999965556799999999999999
Q ss_pred cccccccccccccccccceEEccCCccccccchhhc-cccccceeeecCCCCcCccc
Q 002349 437 NQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELS-QLQNMFSLRLDYNNLSGDVM 492 (933)
Q Consensus 437 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~~ 492 (933)
|+|++..+..|.++++|+.|+|++|+|++..|..+. .+++|+.|++++|+|.|..+
T Consensus 570 N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~ 626 (680)
T 1ziw_A 570 NNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626 (680)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCC
T ss_pred CCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCc
Confidence 999988888899999999999999999999988888 89999999999999999865
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=471.93 Aligned_cols=409 Identities=19% Similarity=0.268 Sum_probs=354.4
Q ss_pred CCccEEEccCCcccccCCCCccCCCCCceecc-cccccCCCCCcccc---------------------------------
Q 002349 92 KDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDL-SFNELYGDIPFSIS--------------------------------- 137 (933)
Q Consensus 92 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L-s~n~l~~~~p~~~~--------------------------------- 137 (933)
.+++.|+|++|+++|.+|++|++|++|++||| ++|.++|..|....
T Consensus 323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~ 402 (876)
T 4ecn_A 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402 (876)
T ss_dssp SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence 57899999999999999999999999999999 99998877553311
Q ss_pred ------------------cccchhhhhhcc--cCccCCCCcccccCCCCceeeeecCCCCC-----------------Cc
Q 002349 138 ------------------KLKQLEFLILKN--NQLIGPIPSTLSQLPNLKVFGLRGNNLVG-----------------TL 180 (933)
Q Consensus 138 ------------------~l~~L~~L~L~~--n~l~~~~p~~l~~l~~L~~L~L~~N~l~~-----------------~~ 180 (933)
....++.+.+.. |++++ +|..|+++++|+.|+|++|++++ .+
T Consensus 403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~i 481 (876)
T 4ecn_A 403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYE 481 (876)
T ss_dssp HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHT
T ss_pred HHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccC
Confidence 122344455544 88998 89999999999999999999998 38
Q ss_pred ccccc--cCCCCcEEeccCccccCccCcCCcCCCCCcEEcccccc-ccC-cCCCCcccc--------ccceEeccccccc
Q 002349 181 SPDMC--QLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQ-LSG-EIPFNIGFL--------QIATLSLQGNQLT 248 (933)
Q Consensus 181 ~~~~~--~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~-l~~-~~p~~~~~~--------~L~~L~L~~n~l~ 248 (933)
|..++ ++++|++|+|++|.+.+.+|..++++++|++|+|++|+ +++ .+|..++.. +|++|+|++|+++
T Consensus 482 P~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~ 561 (876)
T 4ecn_A 482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE 561 (876)
T ss_dssp TSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC
T ss_pred ChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC
Confidence 99988 99999999999999999999999999999999999998 998 788765543 7999999999999
Q ss_pred cccCc--cccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCc-ceEeeeccccccccCCc
Q 002349 249 GKIPS--VIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTK-LHYLELNDNQLTGHIPP 325 (933)
Q Consensus 249 ~~~p~--~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~-L~~L~L~~N~l~~~~~~ 325 (933)
.+|. .++.+++|+.|+|++|.++ .+| .|+++++|+.|+|++|+++ .+|..+.++++ |+.|+|++|+++ .+|.
T Consensus 562 -~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~ 636 (876)
T 4ecn_A 562 -EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPN 636 (876)
T ss_dssp -BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCS
T ss_pred -ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCch
Confidence 7888 8999999999999999999 777 9999999999999999999 88999999999 999999999999 7888
Q ss_pred ccccccc--ccccccccccCCCCCCCCc---c--cCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCCccc
Q 002349 326 ALGKLTD--LFDLNVANNHLEGPIPDNL---S--SCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVE 398 (933)
Q Consensus 326 ~l~~l~~--L~~L~L~~N~l~~~~p~~l---~--~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 398 (933)
.+..++. |+.|++++|++.+.+|... . .+++|+.|++++|+++...+..+..+++|+.|+|++|+++ .+|..
T Consensus 637 ~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~ 715 (876)
T 4ecn_A 637 IFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPEN 715 (876)
T ss_dssp CCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCS-CCCTT
T ss_pred hhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCC-ccChH
Confidence 8887765 9999999999998766433 2 3458999999999999544445568999999999999999 55554
Q ss_pred ccc--------ccccceeeccCCccCCCCCCCCC--CccccccccccCcccccccccccccccccceEEccC------Cc
Q 002349 399 LSR--------IGNLDTLDMSNNKISGSIPSPLG--DLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSH------NH 462 (933)
Q Consensus 399 ~~~--------l~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~------N~ 462 (933)
+.. +++|+.|+|++|+|+ .+|..+. .+++|+.|+|++|+|++ +|..+.++++|+.|+|++ |+
T Consensus 716 ~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~ 793 (876)
T 4ecn_A 716 SLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNR 793 (876)
T ss_dssp SSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCB
T ss_pred HhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCccccc
Confidence 433 339999999999999 7888887 99999999999999997 799999999999999977 88
Q ss_pred cccccchhhccccccceeeecCCCCcCcccchhhccccc-eeecCCCCCC
Q 002349 463 LTGVIPEELSQLQNMFSLRLDYNNLSGDVMSLINCLSLS-VLFIGNPGLC 511 (933)
Q Consensus 463 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~-~~~~~N~~~C 511 (933)
+.+.+|..+..+++|+.|+|++|++...+..+. ..+. +.+.+|++..
T Consensus 794 l~~~ip~~l~~L~~L~~L~Ls~N~L~~Ip~~l~--~~L~~LdLs~N~l~~ 841 (876)
T 4ecn_A 794 ILRQWPTGITTCPSLIQLQIGSNDIRKVDEKLT--PQLYILDIADNPNIS 841 (876)
T ss_dssp CCCCCCTTGGGCSSCCEEECCSSCCCBCCSCCC--SSSCEEECCSCTTCE
T ss_pred ccccChHHHhcCCCCCEEECCCCCCCccCHhhc--CCCCEEECCCCCCCc
Confidence 999999999999999999999999944444332 3555 6788998754
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=476.13 Aligned_cols=419 Identities=21% Similarity=0.247 Sum_probs=370.8
Q ss_pred cEEEEEcCCCCcCccc-CCCCCCCCCccEEEccCCcccccCCCCccCCCCCceecccccccCCCCCcc--cccccchhhh
Q 002349 69 TVIALNLSGLNLDGEI-SPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFS--ISKLKQLEFL 145 (933)
Q Consensus 69 ~v~~l~l~~~~l~~~~-~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~--~~~l~~L~~L 145 (933)
.+..|+|++|+..+.+ |.+|+++++|++|+|++|++++..|..|+++++|++|+|++|.+++.+|.. |+++++|++|
T Consensus 49 ~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L 128 (844)
T 3j0a_A 49 QLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRL 128 (844)
T ss_dssp SCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEE
T ss_pred cCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEE
Confidence 5678999999888888 568999999999999999999988999999999999999999999877776 9999999999
Q ss_pred hhcccCccCCCC-cccccCCCCceeeeecCCCCCCcccccccC--CCCcEEeccCccccCccCcCCcCCCC------CcE
Q 002349 146 ILKNNQLIGPIP-STLSQLPNLKVFGLRGNNLVGTLSPDMCQL--SGLWYFDVRNNSLTGSIPQNIGNCTS------FQV 216 (933)
Q Consensus 146 ~L~~n~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l--~~L~~L~L~~n~l~~~~p~~l~~l~~------L~~ 216 (933)
+|++|.+++..+ ..|+++++|++|+|++|.+++..+..+..+ ++|+.|++++|.+.+..|..++.+.+ |+.
T Consensus 129 ~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~ 208 (844)
T 3j0a_A 129 DLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEI 208 (844)
T ss_dssp EEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSE
T ss_pred ECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeE
Confidence 999999998755 579999999999999999999999999888 89999999999999988888877766 999
Q ss_pred EccccccccCcCCCCcc---------------------------------------ccccceEeccccccccccCccccc
Q 002349 217 LDLSYNQLSGEIPFNIG---------------------------------------FLQIATLSLQGNQLTGKIPSVIGL 257 (933)
Q Consensus 217 L~L~~N~l~~~~p~~~~---------------------------------------~~~L~~L~L~~n~l~~~~p~~~~~ 257 (933)
|++++|++++.++..+. ..++++|+|++|.+++..+..|..
T Consensus 209 L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~ 288 (844)
T 3j0a_A 209 LDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFET 288 (844)
T ss_dssp EBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSS
T ss_pred EecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhc
Confidence 99999988766654332 146889999999999988999999
Q ss_pred cccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcceEeeeccccccccCCccccccccccccc
Q 002349 258 MQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLN 337 (933)
Q Consensus 258 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~ 337 (933)
+++|+.|+|++|.+++..+..|.++++|++|+|++|++++..|..|..+++|++|++++|++++..+..|..+++|+.|+
T Consensus 289 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~ 368 (844)
T 3j0a_A 289 LKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLD 368 (844)
T ss_dssp CCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEE
T ss_pred CCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEE
Confidence 99999999999999988889999999999999999999988899999999999999999999988888899999999999
Q ss_pred cccccCCCCC------------------CC----------------------CcccCCCCCceeccCcccCCCCCc-ccc
Q 002349 338 VANNHLEGPI------------------PD----------------------NLSSCTNLNSLNVHGNKLNGTIPP-AFQ 376 (933)
Q Consensus 338 L~~N~l~~~~------------------p~----------------------~l~~l~~L~~L~l~~N~l~~~~~~-~~~ 376 (933)
+++|.+++.. |. .+..+++|+.|++++|++++..+. .+.
T Consensus 369 Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 448 (844)
T 3j0a_A 369 LRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPS 448 (844)
T ss_dssp EETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSC
T ss_pred CCCCCCCcccCCCCcchhccCCCCcccccccccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccc
Confidence 9998876421 11 123678999999999999976554 466
Q ss_pred cccccceecCCccccc-----CCCccccccccccceeeccCCccCCCCCCCCCCccccccccccCccccccccccccccc
Q 002349 377 RLESMTYLNLSLNNIR-----GPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLR 451 (933)
Q Consensus 377 ~l~~L~~L~L~~N~l~-----~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 451 (933)
.+++|++|+|++|.++ +..+..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..|..+. +
T Consensus 449 ~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~ 526 (844)
T 3j0a_A 449 ENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--A 526 (844)
T ss_dssp SCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--S
T ss_pred cCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--c
Confidence 7899999999999997 44556788999999999999999999999999999999999999999988888776 8
Q ss_pred ccceEEccCCccccccchhhccccccceeeecCCCCcCccc
Q 002349 452 SVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDVM 492 (933)
Q Consensus 452 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~ 492 (933)
+|+.|||++|+|++.+|..+ .+|+.|++++|++.|..+
T Consensus 527 ~L~~L~Ls~N~l~~~~~~~~---~~L~~l~l~~Np~~C~c~ 564 (844)
T 3j0a_A 527 NLEILDISRNQLLAPNPDVF---VSLSVLDITHNKFICECE 564 (844)
T ss_dssp CCCEEEEEEECCCCCCSCCC---SSCCEEEEEEECCCCSSS
T ss_pred cccEEECCCCcCCCCChhHh---CCcCEEEecCCCcccccc
Confidence 99999999999999999775 478899999999999765
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=411.12 Aligned_cols=252 Identities=20% Similarity=0.295 Sum_probs=191.5
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCC-------
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSS------- 667 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------- 667 (933)
.++|+..+.||+|+||+||+|+++ +++.||||++.... ....+.+.+|++++++++|||||++++++.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 357999999999999999999976 57899999997544 334567899999999999999999999986543
Q ss_pred -----ccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEe
Q 002349 668 -----GNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLT 742 (933)
Q Consensus 668 -----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~ 742 (933)
..|+|||||++|+|.+++.........++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEc
Confidence 3689999999999999997533334567778899999999999999966 99999999999999999999999
Q ss_pred ecccccccccCCCc-----------eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHH
Q 002349 743 DFGIAKSLCVSKSY-----------TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLI 811 (933)
Q Consensus 743 DfGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~ 811 (933)
|||+|+.+...... .....+||+.|||||++.+..|+.++||||+||++|||++ ||.+..+.....
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~ 237 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTL 237 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHH
Confidence 99999876432211 1234579999999999999999999999999999999996 776433221111
Q ss_pred HhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 812 LSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 812 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
. ...... .++... .......+++.+||+.||++|||+.|++++
T Consensus 238 ~-~~~~~~----~p~~~~------~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 238 T-DVRNLK----FPPLFT------QKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp H-HHHTTC----CCHHHH------HHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred H-HHhcCC----CCCCCc------ccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1 111111 111111 122456789999999999999999999874
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-48 Score=453.96 Aligned_cols=426 Identities=18% Similarity=0.174 Sum_probs=293.6
Q ss_pred EEcCCCCcCcccCCCCCCCCCccEEEccCCcccccCCCCccCCCCCceecccccccCCCCCcccccccchhhhhhcccCc
Q 002349 73 LNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQL 152 (933)
Q Consensus 73 l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l 152 (933)
+|+++++++ .+|..+. ++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|+++++|++|+|++|++
T Consensus 5 l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l 81 (520)
T 2z7x_B 5 VDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKL 81 (520)
T ss_dssp EECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCC
T ss_pred EecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCce
Confidence 455555555 3444443 4555555555555544444555555555555555555544455555555555555555555
Q ss_pred cCCCCcccccCCCCceeeeecCCCCC-CcccccccCCCCcEEeccCccccCccCcCCcCCCCC--cEEccccccc--cCc
Q 002349 153 IGPIPSTLSQLPNLKVFGLRGNNLVG-TLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSF--QVLDLSYNQL--SGE 227 (933)
Q Consensus 153 ~~~~p~~l~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L--~~L~L~~N~l--~~~ 227 (933)
+ .+|.. .+++|++|+|++|++++ .+|..|+++++|++|++++|.+++ ..+..+++| ++|++++|++ .+.
T Consensus 82 ~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~ 155 (520)
T 2z7x_B 82 V-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKE 155 (520)
T ss_dssp C-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSC
T ss_pred e-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeeccccccccc
Confidence 5 23433 45555555555555554 244555555555555555555543 223444444 5555555555 444
Q ss_pred CCCCccc---------------------------cccceEeccccc-------cccccCccccccccccEEeccCCcCcC
Q 002349 228 IPFNIGF---------------------------LQIATLSLQGNQ-------LTGKIPSVIGLMQALAVLDLSCNMLSG 273 (933)
Q Consensus 228 ~p~~~~~---------------------------~~L~~L~L~~n~-------l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 273 (933)
.|..+.. .+|+.|++++|. +.+.+| .++.+++|+.|++++|.+++
T Consensus 156 ~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l~~ 234 (520)
T 2z7x_B 156 DPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIETTW 234 (520)
T ss_dssp CTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEEEH
T ss_pred ccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhccccccccCH
Confidence 4443332 345666666665 555444 55666666667666666654
Q ss_pred CCCCCCC---CCCCccEEEeeCCccCCCCCCcc-----ccCCcceEeeeccccccccCC-cccccc---ccccccccccc
Q 002349 274 PIPPILG---NLSYTEKLYLHSNKLTGHIPPEL-----GNMTKLHYLELNDNQLTGHIP-PALGKL---TDLFDLNVANN 341 (933)
Q Consensus 274 ~~~~~~~---~l~~L~~L~L~~N~l~~~~p~~l-----~~l~~L~~L~L~~N~l~~~~~-~~l~~l---~~L~~L~L~~N 341 (933)
..+..+. ..++|++|++++|+++|.+|..+ ..+++|+.+++++|.+ .+| ..+..+ .+|+.|++++|
T Consensus 235 ~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n 312 (520)
T 2z7x_B 235 NSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGT 312 (520)
T ss_dssp HHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESS
T ss_pred HHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCC
Confidence 2211111 13478888888888888888887 8888888888888888 344 455554 67889999999
Q ss_pred cCCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccceecCCcccccC--CCccccccccccceeeccCCccCCCC
Q 002349 342 HLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRG--PIPVELSRIGNLDTLDMSNNKISGSI 419 (933)
Q Consensus 342 ~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~ 419 (933)
++.... .+..+++|++|++++|++++.+|..+..+++|++|++++|++++ .+|..+..+++|++|+|++|.+++.+
T Consensus 313 ~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l 390 (520)
T 2z7x_B 313 RMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDE 390 (520)
T ss_dssp CCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCG
T ss_pred cccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCccc
Confidence 886432 23688999999999999999899999999999999999999996 55677999999999999999999855
Q ss_pred CC-CCCCccccccccccCcccccccccccccccccceEEccCCccccccchhhccccccceeeecCCCCcCcccc-hhhc
Q 002349 420 PS-PLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDVMS-LINC 497 (933)
Q Consensus 420 p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~ 497 (933)
|. .+..+++|+.|++++|++++..|..+. ++|+.|+|++|+++ .+|..+..+++|+.|++++|+++..++. +..+
T Consensus 391 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l 467 (520)
T 2z7x_B 391 KKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRL 467 (520)
T ss_dssp GGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred ccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccC
Confidence 65 588899999999999999988887775 79999999999999 7888888999999999999999987665 5566
Q ss_pred cccc-eeecCCCCCCCccc
Q 002349 498 LSLS-VLFIGNPGLCGYWL 515 (933)
Q Consensus 498 ~~~~-~~~~~N~~~C~~~l 515 (933)
..+. +.+.+||+.|+|++
T Consensus 468 ~~L~~L~l~~N~~~c~c~~ 486 (520)
T 2z7x_B 468 TSLQKIWLHTNPWDCSCPR 486 (520)
T ss_dssp TTCCEEECCSSCBCCCHHH
T ss_pred CcccEEECcCCCCcccCCc
Confidence 6666 77899999999865
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=467.23 Aligned_cols=433 Identities=18% Similarity=0.253 Sum_probs=313.8
Q ss_pred cEEEEEcCCCCc------Cc------ccCCCCCCCCCccEEEccCCcccccCCCCccCC-------------------CC
Q 002349 69 TVIALNLSGLNL------DG------EISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDC-------------------SS 117 (933)
Q Consensus 69 ~v~~l~l~~~~l------~~------~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l-------------------~~ 117 (933)
+...|+|++|.+ .| .+|+.. +..|+ +++++|.+.+.+|..++.+ ..
T Consensus 106 ~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~ 182 (636)
T 4eco_A 106 ELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRIT 182 (636)
T ss_dssp TCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCC
T ss_pred cceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccc
Confidence 567899999976 23 333322 44556 6777776666666555421 12
Q ss_pred Cceeccc--ccccCCCCCcccccccchhhhhhcccCccCC-----------------CCcccc--cCCCCceeeeecCCC
Q 002349 118 LKSLDLS--FNELYGDIPFSISKLKQLEFLILKNNQLIGP-----------------IPSTLS--QLPNLKVFGLRGNNL 176 (933)
Q Consensus 118 L~~L~Ls--~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~-----------------~p~~l~--~l~~L~~L~L~~N~l 176 (933)
++.+.+. .|+++| +|.+|+++++|++|+|++|.+++. +|..++ ++++|++|+|++|++
T Consensus 183 l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l 261 (636)
T 4eco_A 183 LKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPN 261 (636)
T ss_dssp CCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTT
T ss_pred hhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcC
Confidence 2222222 567776 777777777777777777777765 777777 777777777777777
Q ss_pred CCCcccccccCCCCcEEeccCcc-ccC-ccCcCCcCC------CCCcEEccccccccCcCCC--Cccc-cccceEecccc
Q 002349 177 VGTLSPDMCQLSGLWYFDVRNNS-LTG-SIPQNIGNC------TSFQVLDLSYNQLSGEIPF--NIGF-LQIATLSLQGN 245 (933)
Q Consensus 177 ~~~~~~~~~~l~~L~~L~L~~n~-l~~-~~p~~l~~l------~~L~~L~L~~N~l~~~~p~--~~~~-~~L~~L~L~~n 245 (933)
.+.+|..|+++++|++|++++|+ ++| .+|..++++ ++|++|+|++|+++ .+|. .++. .+|++|+|++|
T Consensus 262 ~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N 340 (636)
T 4eco_A 262 LTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYN 340 (636)
T ss_dssp CSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSC
T ss_pred CccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCC
Confidence 77777777777777777777777 777 677777665 77777777777777 6666 4443 36777777777
Q ss_pred ccccccCccccccccccEEeccCCcCcCCCCCCCCCCCC-ccEEEeeCCccCCCCCCccccCC--cceEeeecccccccc
Q 002349 246 QLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSY-TEKLYLHSNKLTGHIPPELGNMT--KLHYLELNDNQLTGH 322 (933)
Q Consensus 246 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~p~~l~~l~--~L~~L~L~~N~l~~~ 322 (933)
+++|.+| .++.+++|++|+|++|+++ .+|..+.++++ |++|+|++|+++ .+|..+..++ +|++|++++|++++.
T Consensus 341 ~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~ 417 (636)
T 4eco_A 341 QLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSV 417 (636)
T ss_dssp CCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTT
T ss_pred cCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCc
Confidence 7777777 7777888888888888887 66777778877 888888888887 6777776654 788888888888877
Q ss_pred CCcccc-------ccccccccccccccCCCCCCCCcccCCCCCceeccCcccCCCCCccccccc-------ccceecCCc
Q 002349 323 IPPALG-------KLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLE-------SMTYLNLSL 388 (933)
Q Consensus 323 ~~~~l~-------~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~-------~L~~L~L~~ 388 (933)
+|..+. .+++|+.|++++|+++...+..+..+++|+.|++++|+++...+..+.... +|++|+|++
T Consensus 418 ~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~ 497 (636)
T 4eco_A 418 DGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRF 497 (636)
T ss_dssp TTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCS
T ss_pred chhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEECcC
Confidence 777777 677888888888888743333345578888888888888843333444332 888888888
Q ss_pred ccccCCCccccc--cccccceeeccCCccCCCCCCCCCCccccccccc------cCcccccccccccccccccceEEccC
Q 002349 389 NNIRGPIPVELS--RIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNL------SRNQLTGFIPGEFGNLRSVMEIDLSH 460 (933)
Q Consensus 389 N~l~~~~~~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L------s~N~l~~~~p~~~~~l~~L~~L~Ls~ 460 (933)
|+++ .+|..+. .+++|+.|+|++|+|++ +|..+..+++|+.|+| ++|++.+.+|..|.++++|++|+|++
T Consensus 498 N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~ 575 (636)
T 4eco_A 498 NKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGS 575 (636)
T ss_dssp SCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCS
T ss_pred CcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCC
Confidence 8888 6677765 88888888888888886 7888888888888888 56888999999999999999999999
Q ss_pred CccccccchhhccccccceeeecCCCCcCcccch--hhccc--cceeecCCCCCCCcc
Q 002349 461 NHLTGVIPEELSQLQNMFSLRLDYNNLSGDVMSL--INCLS--LSVLFIGNPGLCGYW 514 (933)
Q Consensus 461 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~~--~~~~~~~N~~~C~~~ 514 (933)
|++ +.+|..+. ++|+.|+|++|++.+..... ..... ....+..+...|+|+
T Consensus 576 N~l-~~ip~~~~--~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~C~ 630 (636)
T 4eco_A 576 NDI-RKVNEKIT--PNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQDIRGCD 630 (636)
T ss_dssp SCC-CBCCSCCC--TTCCEEECCSCTTCEEECTTTHHHHHTTCCEEECCTTSEEESCG
T ss_pred CcC-CccCHhHh--CcCCEEECcCCCCccccHHhcchhhhcccceeecCCccccCCCc
Confidence 999 57887766 89999999999988754321 11111 123445555666775
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-47 Score=450.19 Aligned_cols=417 Identities=21% Similarity=0.257 Sum_probs=375.7
Q ss_pred cEEEEEcCCCCcCcccCCCCCCCCCccEEEccCCcccccCCCCccCCCCCceecccccccCCCCCcccccccchhhhhhc
Q 002349 69 TVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILK 148 (933)
Q Consensus 69 ~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~ 148 (933)
.+..|+|++|.+++..+..|+++++|++|+|++|++++..|..|+++++|++|+|++|.+++..+..|+++++|++|+|+
T Consensus 53 ~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~ 132 (570)
T 2z63_A 53 ELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVA 132 (570)
T ss_dssp SCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECC
T ss_pred CceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccccccccccCCCccccccccccEEecC
Confidence 57899999999998888899999999999999999998888899999999999999999997666679999999999999
Q ss_pred ccCccC-CCCcccccCCCCceeeeecCCCCCCcccccccCCCC----cEEeccCccccCccCcCCcCCCCCcEEccccc-
Q 002349 149 NNQLIG-PIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGL----WYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYN- 222 (933)
Q Consensus 149 ~n~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L----~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N- 222 (933)
+|.+++ .+|..|+++++|++|++++|++++..+..+..+++| +.|++++|.+++..|..+..+ +|+.|++++|
T Consensus 133 ~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~ 211 (570)
T 2z63_A 133 HNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNF 211 (570)
T ss_dssp SSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCC
T ss_pred CCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCCceecCHHHhccC-cceeEeccccc
Confidence 999987 579999999999999999999998888889999998 899999999998888777766 7899988887
Q ss_pred ---------------------------------------------------------cccCcCCCCcc-ccccceEeccc
Q 002349 223 ---------------------------------------------------------QLSGEIPFNIG-FLQIATLSLQG 244 (933)
Q Consensus 223 ---------------------------------------------------------~l~~~~p~~~~-~~~L~~L~L~~ 244 (933)
.+.+.+|..+. ..+|++|++++
T Consensus 212 ~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~ 291 (570)
T 2z63_A 212 DSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVS 291 (570)
T ss_dssp SCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEES
T ss_pred ccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecC
Confidence 23333444443 34799999999
Q ss_pred cccccccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcceEeeeccccccccC-
Q 002349 245 NQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHI- 323 (933)
Q Consensus 245 n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~- 323 (933)
|.++ .+|..+..+ +|+.|++++|.+. .+|. ..+++|+.|++++|.+.+..+. ..+++|++|++++|++++..
T Consensus 292 ~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~ 364 (570)
T 2z63_A 292 VTIE-RVKDFSYNF-GWQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGC 364 (570)
T ss_dssp CEEC-SCCBCCSCC-CCSEEEEESCBCS-SCCB--CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEE
T ss_pred ccch-hhhhhhccC-CccEEeeccCccc-ccCc--ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCcccc
Confidence 9998 578888888 9999999999998 4444 4788999999999999877665 78899999999999999654
Q ss_pred -CccccccccccccccccccCCCCCCCCcccCCCCCceeccCcccCCCCC-cccccccccceecCCcccccCCCcccccc
Q 002349 324 -PPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIP-PAFQRLESMTYLNLSLNNIRGPIPVELSR 401 (933)
Q Consensus 324 -~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 401 (933)
+..+..+++|++|++++|.+.+..+. +..+++|+.|++++|++.+..+ ..|..+++|++|++++|.+.+..|..+..
T Consensus 365 ~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 443 (570)
T 2z63_A 365 CSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG 443 (570)
T ss_dssp EEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTT
T ss_pred ccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhc
Confidence 67889999999999999999865554 9999999999999999998766 57899999999999999999999999999
Q ss_pred ccccceeeccCCccC-CCCCCCCCCccccccccccCcccccccccccccccccceEEccCCccccccchhhcccccccee
Q 002349 402 IGNLDTLDMSNNKIS-GSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSL 480 (933)
Q Consensus 402 l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 480 (933)
+++|+.|+|++|.++ +.+|..+..+++|+.|+|++|++++..|..|.++++|++|+|++|++++..|..+..+++|+.|
T Consensus 444 l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 523 (570)
T 2z63_A 444 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKI 523 (570)
T ss_dssp CTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEE
T ss_pred CCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEE
Confidence 999999999999998 5799999999999999999999999999999999999999999999999988999999999999
Q ss_pred eecCCCCcCcccch
Q 002349 481 RLDYNNLSGDVMSL 494 (933)
Q Consensus 481 ~l~~N~l~~~~~~~ 494 (933)
++++|+++|..+..
T Consensus 524 ~l~~N~~~~~~~~~ 537 (570)
T 2z63_A 524 WLHTNPWDCSCPRI 537 (570)
T ss_dssp ECCSSCBCCCTTTT
T ss_pred EecCCcccCCCcch
Confidence 99999999988754
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=443.18 Aligned_cols=471 Identities=21% Similarity=0.196 Sum_probs=357.7
Q ss_pred CCCCCcCCCCCCC--CCCCCCc----cceEecCC---------CCcEEEEEcCCCCcCcccCCCCCCCCCccEEEccCCc
Q 002349 39 DVDNVLYDWTDSP--SSDYCVW----RGITCDNV---------TFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNR 103 (933)
Q Consensus 39 ~~~~~l~~w~~~~--~~~~c~w----~gv~C~~~---------~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~ 103 (933)
|+...+++|+.+. ..++|.| ..|.|.+. +..++.|||++|.|++..+.+|.++++|++|||++|+
T Consensus 8 ~~~~~~~~~~~~~p~~~~~c~~~~~~~~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~ 87 (635)
T 4g8a_A 8 DDDDKLAAANSSIPESWEPCVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCE 87 (635)
T ss_dssp -----------------CCSEEEETTTEEECTTSCCSSCCSSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred CCcchhhcccCCCCCCCCCccccCCCCEEECCCCCcCccCCCCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCc
Confidence 3344566665331 1234543 24678642 2468899999999998777889999999999999999
Q ss_pred ccccCCCCccCCCCCceecccccccCCCCCcccccccchhhhhhcccCccCCCCcccccCCCCceeeeecCCCCCC-ccc
Q 002349 104 LSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGT-LSP 182 (933)
Q Consensus 104 l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~-~~~ 182 (933)
|++..|.+|++|++|++|+|++|+|++..|..|.++++|++|+|++|++++..+..|+++++|++|+|++|++.+. +|.
T Consensus 88 i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~ 167 (635)
T 4g8a_A 88 IQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPE 167 (635)
T ss_dssp CCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCG
T ss_pred CCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCch
Confidence 9977777899999999999999999976667899999999999999999987777899999999999999999864 577
Q ss_pred ccccCCCCcEEeccCccccCccCcCCcCCCCCc----EEccccccccCcCCCCccccccceEecccccccccc-------
Q 002349 183 DMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQ----VLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKI------- 251 (933)
Q Consensus 183 ~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~----~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~------- 251 (933)
.++.+++|++|++++|++++..|..+..+.+++ .++++.|.++...+..+....+..+++.+|..+..+
T Consensus 168 ~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~ 247 (635)
T 4g8a_A 168 YFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQG 247 (635)
T ss_dssp GGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHT
T ss_pred hhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccccchhhhhhhhhcccccccccchhhcC
Confidence 889999999999999999988888877666544 577888888765555444444455555544322100
Q ss_pred ---------------------------------------------------Cc----------------------ccccc
Q 002349 252 ---------------------------------------------------PS----------------------VIGLM 258 (933)
Q Consensus 252 ---------------------------------------------------p~----------------------~~~~l 258 (933)
+. .+...
T Consensus 248 l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~ 327 (635)
T 4g8a_A 248 LAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYN 327 (635)
T ss_dssp TTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECGGGGSC
T ss_pred Ccccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhcccccccccccccccccccccc
Confidence 00 11222
Q ss_pred ccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcceEeeeccccccc--cCCcccccccccccc
Q 002349 259 QALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTG--HIPPALGKLTDLFDL 336 (933)
Q Consensus 259 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~--~~~~~l~~l~~L~~L 336 (933)
.+|+.|++++|.+.+..+. .+..|+.+++..|.+... .....+++|+.|++++|.+.. ..+..+..+.+|+.|
T Consensus 328 ~~L~~L~l~~~~~~~~~~~---~l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L 402 (635)
T 4g8a_A 328 FGWQHLELVNCKFGQFPTL---KLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYL 402 (635)
T ss_dssp CCCSEEEEESCEESSCCCC---BCTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEE
T ss_pred hhhhhhhcccccccCcCcc---cchhhhhcccccccCCCC--cccccccccccchhhccccccccccccchhhhhhhhhh
Confidence 3344444444444433222 234455555555554422 234467788888888888753 345556677788888
Q ss_pred ccccccCCCCCCCCcccCCCCCceeccCcccCCCCC-cccccccccceecCCcccccCCCccccccccccceeeccCCcc
Q 002349 337 NVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIP-PAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKI 415 (933)
Q Consensus 337 ~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 415 (933)
++..|.+.. .+..+..+++|+.+++++|+.....+ ..|..+.+++.++++.|.+.+..+..+..++.|+.|+|++|.+
T Consensus 403 ~~~~~~~~~-~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~ 481 (635)
T 4g8a_A 403 DLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSF 481 (635)
T ss_dssp ECCSCSEEE-ECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEE
T ss_pred hcccccccc-ccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhccc
Confidence 888888763 45678889999999999888775554 5688999999999999999999999999999999999999975
Q ss_pred -CCCCCCCCCCccccccccccCcccccccccccccccccceEEccCCccccccchhhccccccceeeecCCCCcCcccch
Q 002349 416 -SGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDVMSL 494 (933)
Q Consensus 416 -~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~ 494 (933)
.+..|..|..+++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|++++.++..
T Consensus 482 ~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 561 (635)
T 4g8a_A 482 QENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQE 561 (635)
T ss_dssp GGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSC
T ss_pred ccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHH
Confidence 4468889999999999999999999999999999999999999999999999999999999999999999999988764
Q ss_pred h-hc-cccc-eeecCCCCCCCccc
Q 002349 495 I-NC-LSLS-VLFIGNPGLCGYWL 515 (933)
Q Consensus 495 ~-~~-~~~~-~~~~~N~~~C~~~l 515 (933)
. .+ ..++ +.+.+|||.|+|.+
T Consensus 562 l~~l~~~L~~L~L~~Np~~C~C~~ 585 (635)
T 4g8a_A 562 LQHFPSSLAFLNLTQNDFACTCEH 585 (635)
T ss_dssp TTCCCTTCCEEECTTCCBCCSGGG
T ss_pred HHhhhCcCCEEEeeCCCCcccCCc
Confidence 3 33 3455 77899999999975
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=412.11 Aligned_cols=262 Identities=25% Similarity=0.352 Sum_probs=207.8
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEec------CCc
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLS------SSG 668 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~~ 668 (933)
++|+..+.||+|+||+||+|+++ +|+.||||++.... ....+.+.+|+++|++++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999976 58999999997543 3345678899999999999999999998764 356
Q ss_pred cEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccc
Q 002349 669 NLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAK 748 (933)
Q Consensus 669 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 748 (933)
.|+|||||+ |+|.+++. ..+++++.++..++.|++.||+|||++ +||||||||+|||++.++.+||+|||+|+
T Consensus 134 ~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp EEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceee
Confidence 799999996 68999994 467899999999999999999999966 99999999999999999999999999998
Q ss_pred ccccCC---CceeeeecccccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccccccccc
Q 002349 749 SLCVSK---SYTSTYIMGTIGYIDPEYARTS-RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETV 824 (933)
Q Consensus 749 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 824 (933)
.+.... .......+||+.|||||++.+. .++.++||||+||++|||++|+.||.+......+..+....+......
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~ 286 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV 286 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 764322 2223456899999999998875 569999999999999999999999998777666554433222221111
Q ss_pred Cccc------------ccc-ccCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 825 DPEI------------SAT-CKDL-----GAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 825 ~~~~------------~~~-~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
.... +.. .... .....+.+++.+||..||++|||++|++++-
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp 346 (398)
T 4b99_A 287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHP 346 (398)
T ss_dssp TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSG
T ss_pred hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCH
Confidence 1000 000 0000 1135678999999999999999999998753
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=440.70 Aligned_cols=412 Identities=18% Similarity=0.197 Sum_probs=358.6
Q ss_pred CcEEEEEcCCCCcCcccCCCCCCCCCccEEEccCCcccccCCCCccCCCCCceecccccccCCCCCcccccccchhhhhh
Q 002349 68 FTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLIL 147 (933)
Q Consensus 68 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 147 (933)
.+++.|+|++|.+++..+..|.++++|++|+|++|++++..|..|+++++|++|||++|+++ .+|.. .+++|++|+|
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 97 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDL 97 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEEC
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEec
Confidence 47889999999999888889999999999999999999888999999999999999999998 67776 8999999999
Q ss_pred cccCccC-CCCcccccCCCCceeeeecCCCCCCcccccccCCCC--cEEeccCccc--cCccCcCCcC------------
Q 002349 148 KNNQLIG-PIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGL--WYFDVRNNSL--TGSIPQNIGN------------ 210 (933)
Q Consensus 148 ~~n~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L--~~L~L~~n~l--~~~~p~~l~~------------ 210 (933)
++|++++ .+|..|+++++|++|+|++|++++ ..+..+++| ++|++++|.+ .+..|..+..
T Consensus 98 ~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~ 174 (520)
T 2z7x_B 98 SFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPT 174 (520)
T ss_dssp CSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCS
T ss_pred cCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccccccceEEEEecc
Confidence 9999997 578999999999999999999986 467778888 9999999999 6677766655
Q ss_pred --------------CCCCcEEcccccc-------ccCcCCCCccccccceEeccccccccccCcccc---ccccccEEec
Q 002349 211 --------------CTSFQVLDLSYNQ-------LSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIG---LMQALAVLDL 266 (933)
Q Consensus 211 --------------l~~L~~L~L~~N~-------l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~~~---~l~~L~~L~L 266 (933)
+++|+.|++++|+ +.+.+|......+|+.|++++|.+++..+..+. ..++|++|++
T Consensus 175 n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l 254 (520)
T 2z7x_B 175 NKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSI 254 (520)
T ss_dssp SSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEE
T ss_pred CcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEe
Confidence 7788999999987 666666444556899999999998865433322 2458999999
Q ss_pred cCCcCcCCCCCCC-----CCCCCccEEEeeCCccCCCCC-CccccC---CcceEeeeccccccccCCccccccccccccc
Q 002349 267 SCNMLSGPIPPIL-----GNLSYTEKLYLHSNKLTGHIP-PELGNM---TKLHYLELNDNQLTGHIPPALGKLTDLFDLN 337 (933)
Q Consensus 267 s~N~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~~~p-~~l~~l---~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~ 337 (933)
++|.++|.+|..+ +++++|+.+++++|.+ .+| ..+..+ .+|+.|++++|.+.... .+..+++|++|+
T Consensus 255 ~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~ 330 (520)
T 2z7x_B 255 SNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLD 330 (520)
T ss_dssp EEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEE
T ss_pred ecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEE
Confidence 9999999999988 9999999999999999 455 455554 67999999999997542 236889999999
Q ss_pred cccccCCCCCCCCcccCCCCCceeccCcccCC--CCCcccccccccceecCCcccccCCCcc-ccccccccceeeccCCc
Q 002349 338 VANNHLEGPIPDNLSSCTNLNSLNVHGNKLNG--TIPPAFQRLESMTYLNLSLNNIRGPIPV-ELSRIGNLDTLDMSNNK 414 (933)
Q Consensus 338 L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~ 414 (933)
+++|++.+..|..+..+++|+.|++++|++++ .+|..|..+++|++|++++|.+++.+|. .+..+++|+.|+|++|+
T Consensus 331 Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~ 410 (520)
T 2z7x_B 331 FSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNI 410 (520)
T ss_dssp CCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSC
T ss_pred eECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCC
Confidence 99999999899999999999999999999996 4567899999999999999999985665 48889999999999999
Q ss_pred cCCCCCCCCCCccccccccccCcccccccccccccccccceEEccCCccccccchhhccccccceeeecCCCCcCccc
Q 002349 415 ISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDVM 492 (933)
Q Consensus 415 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~ 492 (933)
+++..|..+. ++|+.|+|++|+|+ .+|..+.++++|++|+|++|++++..+..+..+++|++|++++|+++|..+
T Consensus 411 l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 485 (520)
T 2z7x_B 411 LTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 485 (520)
T ss_dssp CCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcccCC
Confidence 9988887765 78999999999999 788888899999999999999995444449999999999999999999765
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-45 Score=401.43 Aligned_cols=263 Identities=22% Similarity=0.302 Sum_probs=200.7
Q ss_pred HHHHHhhccCcceeeecccceeEEEEEEc----CCceEEEEEecccCchhHHHHHHHHHHHhcC-CCCceeeeeeEEecC
Q 002349 592 DIMRMTENLSEKYIIGYGASSTVYKCVLK----NCKPVAIKRLYSHYPQCLKEFETELETVGSI-KHRNLVSLQGYSLSS 666 (933)
Q Consensus 592 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 666 (933)
.+....++|++.+.||+|+||+||+|+++ .++.||+|++.... ...++.+|+++++.+ +|||||++++++.+.
T Consensus 15 ~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 15 AVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp HSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred hcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 33345678999999999999999999864 35789999986643 345688999999998 699999999999999
Q ss_pred CccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCC-CCeEEeecc
Q 002349 667 SGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKD-FEAHLTDFG 745 (933)
Q Consensus 667 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~-~~~kl~DfG 745 (933)
++.|+||||+++|+|.+++. .+++.++..++.|++.||+|||++ ||+||||||+|||++.+ +.+||+|||
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFG 163 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFG 163 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred CEEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCC
Confidence 99999999999999999983 489999999999999999999966 99999999999999877 799999999
Q ss_pred cccccccCCC---------------------------ceeeeecccccccCccccccC-CCCcchhhHHHHHHHHHHHhC
Q 002349 746 IAKSLCVSKS---------------------------YTSTYIMGTIGYIDPEYARTS-RLTEKSDVYSFGIVLLELLTG 797 (933)
Q Consensus 746 la~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg 797 (933)
+|+....... ......+||+.|||||++.+. .|+.++||||+||++|||++|
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G 243 (361)
T 4f9c_A 164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG 243 (361)
T ss_dssp TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence 9986532211 112335799999999999875 589999999999999999999
Q ss_pred CCCCCCCcc-hhHHHHhhhcccc-------------c------c--------------cccCcccccc----c----cCH
Q 002349 798 RKAVDNECN-LHHLILSKTANNA-------------V------M--------------ETVDPEISAT----C----KDL 835 (933)
Q Consensus 798 ~~p~~~~~~-~~~~~~~~~~~~~-------------~------~--------------~~~~~~~~~~----~----~~~ 835 (933)
+.||....+ ..++.......+. . . +...+..... . ...
T Consensus 244 ~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 323 (361)
T 4f9c_A 244 RYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWN 323 (361)
T ss_dssp CSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CT
T ss_pred CCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccc
Confidence 999964433 2222211110000 0 0 0000000000 0 000
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 836 GAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 836 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
..+.+..+++.+|++.||++|||++|++++
T Consensus 324 ~is~~a~DLl~~lL~~dP~~R~ta~eaL~H 353 (361)
T 4f9c_A 324 EVPDEAYDLLDKLLDLNPASRITAEEALLH 353 (361)
T ss_dssp TCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred cCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 113567899999999999999999999875
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=430.65 Aligned_cols=428 Identities=19% Similarity=0.198 Sum_probs=331.6
Q ss_pred EEEEcCCCCcCcccCCCCCCCCCccEEEccCCcccccCCCCccCCCCCceecccccccCCCCCcccccccchhhhhhccc
Q 002349 71 IALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNN 150 (933)
Q Consensus 71 ~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n 150 (933)
..+|++++++++ +|..+. ++|++|+|++|++++..|..|+++++|++|+|++|.+++..|..|+++++|++|+|++|
T Consensus 34 ~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 110 (562)
T 3a79_B 34 SMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN 110 (562)
T ss_dssp CEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred cEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCC
Confidence 578888998885 776654 78899999999998777778999999999999999998877888999999999999999
Q ss_pred CccCCCCcccccCCCCceeeeecCCCCC-CcccccccCCCCcEEeccCccccCccCcCCcCCCCC--cEEccccccc--c
Q 002349 151 QLIGPIPSTLSQLPNLKVFGLRGNNLVG-TLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSF--QVLDLSYNQL--S 225 (933)
Q Consensus 151 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L--~~L~L~~N~l--~ 225 (933)
+++ .+|.. .+++|++|+|++|++++ .+|..|+++++|++|++++|.+++. .+..+++| ++|++++|++ +
T Consensus 111 ~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~ 184 (562)
T 3a79_B 111 RLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIK 184 (562)
T ss_dssp CCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCC
T ss_pred cCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeeccccccc
Confidence 988 56666 78999999999999886 3467889999999999999998853 35555555 9999999988 7
Q ss_pred CcCCCCccccc--cceEeccccccccccCc-cccccccccEEeccCCcC-----cCCCCCCCCCC---------------
Q 002349 226 GEIPFNIGFLQ--IATLSLQGNQLTGKIPS-VIGLMQALAVLDLSCNML-----SGPIPPILGNL--------------- 282 (933)
Q Consensus 226 ~~~p~~~~~~~--L~~L~L~~n~l~~~~p~-~~~~l~~L~~L~Ls~N~l-----~~~~~~~~~~l--------------- 282 (933)
+..|..+.... ...+++++|.+.+.++. .+..+++|+.|++++|.. .+.+ ..+..+
T Consensus 185 ~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~-~~l~~l~~L~~L~L~~~~l~~ 263 (562)
T 3a79_B 185 GGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFL-SELTRGPTLLNVTLQHIETTW 263 (562)
T ss_dssp SSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHH-HHHHSCSSCEEEEEEEEEECH
T ss_pred ccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHH-HHHhccCcceEEEecCCcCcH
Confidence 77777766543 23456677777665543 345567777777777631 1000 111222
Q ss_pred ------------CCccEEEeeCCccCCCCCCcc-----ccCCcceEeeeccccccccCC-cccccc---ccccccccccc
Q 002349 283 ------------SYTEKLYLHSNKLTGHIPPEL-----GNMTKLHYLELNDNQLTGHIP-PALGKL---TDLFDLNVANN 341 (933)
Q Consensus 283 ------------~~L~~L~L~~N~l~~~~p~~l-----~~l~~L~~L~L~~N~l~~~~~-~~l~~l---~~L~~L~L~~N 341 (933)
++|++|++++|.++|.+|..+ .+++.|+.++++.|.+ .+| ..+..+ .+|+.|++++|
T Consensus 264 ~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~L~l~~n 341 (562)
T 3a79_B 264 KCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSKEALYSVFAEMNIKMLSISDT 341 (562)
T ss_dssp HHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCCCSEEEEESS
T ss_pred HHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhccccee--ecChhhhhhhhccCcceEEEccCC
Confidence 367777777777777677666 6666666666666665 233 222222 56888889988
Q ss_pred cCCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCC--ccccccccccceeeccCCccCCCC
Q 002349 342 HLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPI--PVELSRIGNLDTLDMSNNKISGSI 419 (933)
Q Consensus 342 ~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~ 419 (933)
++.... ....+++|++|++++|++++.+|..|..+++|++|+|++|++++.. |..+..+++|+.|+|++|++++.+
T Consensus 342 ~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 419 (562)
T 3a79_B 342 PFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHA 419 (562)
T ss_dssp CCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCC
T ss_pred Cccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCcc
Confidence 886322 1268899999999999999989999999999999999999999743 467889999999999999999845
Q ss_pred CC-CCCCccccccccccCcccccccccccccccccceEEccCCccccccchhhccccccceeeecCCCCcCcccc-hhhc
Q 002349 420 PS-PLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDVMS-LINC 497 (933)
Q Consensus 420 p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~ 497 (933)
|. .+..+++|+.|+|++|++++.+|..+. ++|++|+|++|+|+ .+|..+..+++|+.|+|++|++++.++. +..+
T Consensus 420 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l 496 (562)
T 3a79_B 420 YDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRL 496 (562)
T ss_dssp SSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTC
T ss_pred ChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcC
Confidence 54 588899999999999999988877665 78999999999999 6777777999999999999999987766 5666
Q ss_pred cccc-eeecCCCCCCCccc
Q 002349 498 LSLS-VLFIGNPGLCGYWL 515 (933)
Q Consensus 498 ~~~~-~~~~~N~~~C~~~l 515 (933)
..+. +.+.+|||.|+|++
T Consensus 497 ~~L~~L~l~~N~~~c~c~~ 515 (562)
T 3a79_B 497 TSLQYIWLHDNPWDCTCPG 515 (562)
T ss_dssp TTCCCEECCSCCBCCCHHH
T ss_pred CCCCEEEecCCCcCCCcch
Confidence 6666 77899999999865
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=419.66 Aligned_cols=253 Identities=20% Similarity=0.290 Sum_probs=215.6
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEe
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
.++|++.+.||+|+||+||+|+++ +|+.||+|++........+.+.+|+++|+.++|||||+++++|.++...++||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 468999999999999999999976 5889999999876666677889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCC--CCeEEeecccccccccC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKD--FEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~--~~~kl~DfGla~~~~~~ 753 (933)
|+||+|.+++. .....+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+.+...
T Consensus 236 ~~gg~L~~~i~--~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 236 MSGGELFEKVA--DEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCBHHHHHT--CTTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred cCCCcHHHHHH--HhCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 99999999985 2446799999999999999999999976 99999999999999854 89999999999987432
Q ss_pred CCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccccc
Q 002349 754 KSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCK 833 (933)
Q Consensus 754 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (933)
......+||+.|||||++.+..|+.++||||+||++|||++|+.||.+......................+.
T Consensus 311 --~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~------ 382 (573)
T 3uto_A 311 --QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG------ 382 (573)
T ss_dssp --SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTT------
T ss_pred --CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccC------
Confidence 334456899999999999999999999999999999999999999998766655544333222222211111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 834 DLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 834 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.+..+.+++.+||+.||++|||++|++++
T Consensus 383 ---~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 383 ---ISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp ---SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 13567889999999999999999999985
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=431.94 Aligned_cols=415 Identities=20% Similarity=0.263 Sum_probs=344.7
Q ss_pred CcEEEEEcCCCCcCcccCCCCCCCCCccEEEccCCcccccCCCCccCCCCCceecccccccCC-CCCcccccccchhhhh
Q 002349 68 FTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYG-DIPFSISKLKQLEFLI 146 (933)
Q Consensus 68 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~-~~p~~~~~l~~L~~L~ 146 (933)
.++..|+|++|.+++..+..|+++++|++|+|++|++++..|..|+++++|++|+|++|.+++ .+|..++++++|++|+
T Consensus 50 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~ 129 (549)
T 2z81_A 50 ANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLR 129 (549)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEE
T ss_pred CcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEE
Confidence 367899999999999888999999999999999999998777779999999999999999986 4678899999999999
Q ss_pred hcccCccCCCC-cccccCCCCceeeeecCCCCCCcccccccCCCCcEEeccCccccCccCcC-CcCCCCCcEEccccccc
Q 002349 147 LKNNQLIGPIP-STLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQN-IGNCTSFQVLDLSYNQL 224 (933)
Q Consensus 147 L~~n~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~-l~~l~~L~~L~L~~N~l 224 (933)
|++|.+.+.+| ..++++++|++|++++|++++..|..+..+++|++|++++|.+.. +|.. +..+++|++|++++|++
T Consensus 130 L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~-~~~~~~~~l~~L~~L~L~~n~l 208 (549)
T 2z81_A 130 IGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAF-LLEIFADILSSVRYLELRDTNL 208 (549)
T ss_dssp EEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTT-HHHHHHHSTTTBSEEEEESCBC
T ss_pred CCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCcccc-cchhhHhhcccccEEEccCCcc
Confidence 99999655555 689999999999999999999999999999999999999998863 4443 35688999999999998
Q ss_pred cCcC--CCCc--ccc----------------------------ccceEecccccccccc------CccccccccccEEec
Q 002349 225 SGEI--PFNI--GFL----------------------------QIATLSLQGNQLTGKI------PSVIGLMQALAVLDL 266 (933)
Q Consensus 225 ~~~~--p~~~--~~~----------------------------~L~~L~L~~n~l~~~~------p~~~~~l~~L~~L~L 266 (933)
++.. |..+ ... +++.|++++|.+.+.. ...+..+.+|+.|++
T Consensus 209 ~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l 288 (549)
T 2z81_A 209 ARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTI 288 (549)
T ss_dssp TTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEE
T ss_pred ccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccc
Confidence 8632 1111 112 3455555555554421 123566788999999
Q ss_pred cCCcCcCC-----CCCCCCCCCCccEEEeeCCccCCCCCCcc-ccCCcceEeeeccccccccCC---ccccccccccccc
Q 002349 267 SCNMLSGP-----IPPILGNLSYTEKLYLHSNKLTGHIPPEL-GNMTKLHYLELNDNQLTGHIP---PALGKLTDLFDLN 337 (933)
Q Consensus 267 s~N~l~~~-----~~~~~~~l~~L~~L~L~~N~l~~~~p~~l-~~l~~L~~L~L~~N~l~~~~~---~~l~~l~~L~~L~ 337 (933)
.++.+... .+..+...++|+.|++++|+++ .+|..+ ..+++|++|++++|++++.+| ..++.+++|+.|+
T Consensus 289 ~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~ 367 (549)
T 2z81_A 289 RRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLV 367 (549)
T ss_dssp ESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEE
T ss_pred cccccchhhhcccchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEE
Confidence 99887632 1112234578999999999998 667665 579999999999999998764 4478899999999
Q ss_pred cccccCCCCCC--CCcccCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCCccccccccccceeeccCCcc
Q 002349 338 VANNHLEGPIP--DNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKI 415 (933)
Q Consensus 338 L~~N~l~~~~p--~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 415 (933)
+++|++++..+ ..+..+++|++|++++|+++ .+|..+..+++|++|++++|+++. +|..+ .++|+.|+|++|+|
T Consensus 368 Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~-l~~~~--~~~L~~L~Ls~N~l 443 (549)
T 2z81_A 368 LSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV-VKTCI--PQTLEVLDVSNNNL 443 (549)
T ss_dssp CTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSC-CCTTS--CTTCSEEECCSSCC
T ss_pred ccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCccc-ccchh--cCCceEEECCCCCh
Confidence 99999986432 45889999999999999999 678889999999999999999984 44433 26899999999999
Q ss_pred CCCCCCCCCCccccccccccCcccccccccccccccccceEEccCCccccccchhhccccccceeeecCCCCcCcccch
Q 002349 416 SGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDVMSL 494 (933)
Q Consensus 416 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~ 494 (933)
++.+ ..+++|++|+|++|+|+ .+|. ...+++|++|+|++|++++.+|..+..+++|+.|++++|+|+|..+..
T Consensus 444 ~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~ 516 (549)
T 2z81_A 444 DSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 516 (549)
T ss_dssp SCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHHHH
T ss_pred hhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCccH
Confidence 9653 57899999999999999 5665 578999999999999999999999999999999999999999988743
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=414.67 Aligned_cols=391 Identities=20% Similarity=0.229 Sum_probs=303.6
Q ss_pred CCCCCccc--eEecCCCCcEEEEEcCCCCcCcccCCCCCCCCCccEEEccCCcccccCCCCccCCCCCceecccccccCC
Q 002349 53 SDYCVWRG--ITCDNVTFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYG 130 (933)
Q Consensus 53 ~~~c~w~g--v~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~ 130 (933)
.+.|.|.+ |.|++ ++++ .+|. +. ++|++|+|++|++++..|..|+++++|++|+|++|.+.+
T Consensus 5 ~~~c~~~~~~~~c~~------------~~l~-~lp~-l~--~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~ 68 (455)
T 3v47_A 5 TSECSVIGYNAICIN------------RGLH-QVPE-LP--AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGL 68 (455)
T ss_dssp --CCEEETTEEECCS------------SCCS-SCCC-CC--TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTC
T ss_pred cceeEEEccccCcCC------------CCcc-cCCC-CC--CccCEEEecCCccCcCChhHhccCccccEEECcCCcccc
Confidence 34566655 66653 3444 4444 22 789999999999998888999999999999999999986
Q ss_pred CC-CcccccccchhhhhhcccCccCCCCcccccCCCCceeeeecCCCCCCcccc--cccCCCCcEEeccCccccCccCcC
Q 002349 131 DI-PFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPD--MCQLSGLWYFDVRNNSLTGSIPQN 207 (933)
Q Consensus 131 ~~-p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~--~~~l~~L~~L~L~~n~l~~~~p~~ 207 (933)
.+ |..|.++++|++|+|++|++++..|..|+++++|++|+|++|++++..+.. +..+++|++|+|++|.+++..|..
T Consensus 69 ~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 148 (455)
T 3v47_A 69 VIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS 148 (455)
T ss_dssp EECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCG
T ss_pred eECcccccccccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCccc
Confidence 66 456899999999999999999888889999999999999999998766555 888899999999999998877766
Q ss_pred -CcCCCCCcEEccccccccCcCCCCccccccceEeccccccccccCccccccccccEEeccCCcCcCCCCCC--------
Q 002349 208 -IGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPI-------- 278 (933)
Q Consensus 208 -l~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~-------- 278 (933)
+.++++|++|++++|++++..|..+.... ..+|+.|++++|.+.+..+..
T Consensus 149 ~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~---------------------~~~L~~L~l~~n~l~~~~~~~~~~~~~~~ 207 (455)
T 3v47_A 149 FFLNMRRFHVLDLTFNKVKSICEEDLLNFQ---------------------GKHFTLLRLSSITLQDMNEYWLGWEKCGN 207 (455)
T ss_dssp GGGGCTTCCEEECTTCCBSCCCTTTSGGGT---------------------TCEEEEEECTTCBCTTCSTTCTTHHHHCC
T ss_pred ccCCCCcccEEeCCCCcccccChhhhhccc---------------------cccccccccccCcccccchhhcccccccc
Confidence 78888899998888888766665443210 134555555555555443332
Q ss_pred CCCCCCccEEEeeCCccCCCCCCccccC---CcceEeeeccccccccCCccccccccccccccccccCCCCCCCCcccC-
Q 002349 279 LGNLSYTEKLYLHSNKLTGHIPPELGNM---TKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSC- 354 (933)
Q Consensus 279 ~~~l~~L~~L~L~~N~l~~~~p~~l~~l---~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l- 354 (933)
+..+++|++|+|++|++++..|..+... ++|+.|++++|.+.+.. +..+.+.+..+..+..+
T Consensus 208 ~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~ 273 (455)
T 3v47_A 208 PFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSS--------------FGHTNFKDPDNFTFKGLE 273 (455)
T ss_dssp TTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCC--------------TTCCSSCCCCTTTTGGGT
T ss_pred ccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccc--------------cchhhhccCccccccccc
Confidence 2345667777777777776666655444 67777777777665321 12222333333334333
Q ss_pred -CCCCceeccCcccCCCCCcccccccccceecCCcccccCCCccccccccccceeeccCCccCCCCCCCCCCcccccccc
Q 002349 355 -TNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLN 433 (933)
Q Consensus 355 -~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 433 (933)
++|+.|++++|++++..|..|..+++|++|+|++|++++..|..|..+++|+.|+|++|.+++..|..|..+++|+.|+
T Consensus 274 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 353 (455)
T 3v47_A 274 ASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLD 353 (455)
T ss_dssp TSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEE
T ss_pred ccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEE
Confidence 6889999999999888888899999999999999999988888899999999999999999888888899999999999
Q ss_pred ccCcccccccccccccccccceEEccCCccccccchhhccccccceeeecCCCCcCcccch
Q 002349 434 LSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDVMSL 494 (933)
Q Consensus 434 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~ 494 (933)
|++|++++..|..|.++++|++|+|++|++++..+..+..+++|++|++++|+++|.+|..
T Consensus 354 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 414 (455)
T 3v47_A 354 LSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 414 (455)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred CCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCcc
Confidence 9999999888999999999999999999999877778899999999999999999988754
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=390.36 Aligned_cols=293 Identities=31% Similarity=0.495 Sum_probs=229.3
Q ss_pred CCChHHHHHHHHHHHhCCCCCCCcCCCCCCCCCCCCC--ccceEecCCC--CcEEEEEcCCCCcCc--ccCCCCCCCCCc
Q 002349 21 SVDSEDGATLLKIKKSFRDVDNVLYDWTDSPSSDYCV--WRGITCDNVT--FTVIALNLSGLNLDG--EISPAVGDLKDL 94 (933)
Q Consensus 21 ~~~~~d~~all~~k~~~~~~~~~l~~w~~~~~~~~c~--w~gv~C~~~~--~~v~~l~l~~~~l~~--~~~~~l~~l~~L 94 (933)
.|.++|++||++||+++.||. .+++|+. +.+||. |.||+|+..+ ++|+.|+|++++++| .+|+.++++++|
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~-~l~~W~~--~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L 78 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPT-TLSSWLP--TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYL 78 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GGTTCCT--TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTC
T ss_pred CCCHHHHHHHHHHHHhcCCcc-cccCCCC--CCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCC
Confidence 588999999999999999886 7899965 468998 9999998655 789999999999998 888888888888
Q ss_pred cEEEccC-CcccccCCCCccCCCCCceecccccccCCCCCcccccccchhhhhhcccCccCCCCcccccCCCCceeeeec
Q 002349 95 QSIDLRG-NRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRG 173 (933)
Q Consensus 95 ~~L~Ls~-n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~ 173 (933)
++|+|++ |++.+.+|..|+++++|++|+|++|.+++.+|..|.++++|++|+|++|.+++.+|..++.+++|++|+|++
T Consensus 79 ~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 158 (313)
T 1ogq_A 79 NFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG 158 (313)
T ss_dssp SEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCS
T ss_pred CeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcC
Confidence 8888884 888888888888888888888888888888888888888888888888888877777777777777777777
Q ss_pred CCCCCCcccccccCC-CCcEEeccCccccCccCcCCcCCCCCcEEccccccccCcCCCCccccccceEeccccccccccC
Q 002349 174 NNLVGTLSPDMCQLS-GLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIP 252 (933)
Q Consensus 174 N~l~~~~~~~~~~l~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p 252 (933)
|++++.+|..++.++ +|++|++++|++++.+|..+..++ |++|++++|+ +++..|
T Consensus 159 N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~-----------------------l~~~~~ 214 (313)
T 1ogq_A 159 NRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNM-----------------------LEGDAS 214 (313)
T ss_dssp SCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSE-----------------------EEECCG
T ss_pred CcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCc-----------------------ccCcCC
Confidence 777766666666665 666666666666666666555554 5555555444 444556
Q ss_pred ccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcceEeeeccccccccCCcccccccc
Q 002349 253 SVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTD 332 (933)
Q Consensus 253 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~ 332 (933)
..+..+++|+.|+|++|.+++.++. +..+++|++|+|++|++++.+|..+..+++|++|+|++|++++.+|.. ..+++
T Consensus 215 ~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~ 292 (313)
T 1ogq_A 215 VLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQR 292 (313)
T ss_dssp GGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGG
T ss_pred HHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-ccccc
Confidence 6677777888888888888765554 677778888888888887777777888888888888888887777765 67777
Q ss_pred cccccccccc
Q 002349 333 LFDLNVANNH 342 (933)
Q Consensus 333 L~~L~L~~N~ 342 (933)
|+.|++++|+
T Consensus 293 L~~l~l~~N~ 302 (313)
T 1ogq_A 293 FDVSAYANNK 302 (313)
T ss_dssp SCGGGTCSSS
T ss_pred cChHHhcCCC
Confidence 7777777776
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=410.41 Aligned_cols=248 Identities=23% Similarity=0.251 Sum_probs=199.5
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHH---HHHHHHHHHhcCCCCceeeeeeEEecCCccE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLK---EFETELETVGSIKHRNLVSLQGYSLSSSGNL 670 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~---~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 670 (933)
++|+..++||+|+||+||+|+++ +|+.||||++.... ..... ....++++++.++|||||+++++|.+.+..|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 67999999999999999999976 48899999996432 11122 2344577788889999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccc
Q 002349 671 LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSL 750 (933)
Q Consensus 671 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~ 750 (933)
+|||||+||+|.+++. ..+.+++..+..++.||+.||+|||++ +||||||||+|||++.+|.+||+|||+|+.+
T Consensus 269 lVmEy~~GGdL~~~l~---~~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEECCCCSCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeec
Confidence 9999999999999995 456799999999999999999999965 9999999999999999999999999999876
Q ss_pred ccCCCceeeeecccccccCccccc-cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHH-HhhhcccccccccCccc
Q 002349 751 CVSKSYTSTYIMGTIGYIDPEYAR-TSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLI-LSKTANNAVMETVDPEI 828 (933)
Q Consensus 751 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 828 (933)
.... ....+||+.|||||++. +..|+.++||||+||++|||++|+.||.+........ ........ ..+
T Consensus 343 ~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~------~~~ 413 (689)
T 3v5w_A 343 SKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA------VEL 413 (689)
T ss_dssp SSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCC------CCC
T ss_pred CCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC------CCC
Confidence 4332 33468999999999996 4579999999999999999999999997543222111 11111110 111
Q ss_pred cccccCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 002349 829 SATCKDLGAVKKVFQLALLCSKRQPTDRPT-----MHEVSRV 865 (933)
Q Consensus 829 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 865 (933)
+.. .+.++.+++.+||+.||++|++ ++||.++
T Consensus 414 p~~-----~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 414 PDS-----FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp CTT-----SCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred Ccc-----CCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 111 1356788999999999999998 7888764
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=383.58 Aligned_cols=285 Identities=39% Similarity=0.648 Sum_probs=233.3
Q ss_pred ccccCHHHHHHHhhccCcceeeecccceeEEEEEEcCCceEEEEEecccCc-hhHHHHHHHHHHHhcCCCCceeeeeeEE
Q 002349 585 MALHVYEDIMRMTENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYP-QCLKEFETELETVGSIKHRNLVSLQGYS 663 (933)
Q Consensus 585 ~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~ 663 (933)
...+.++++....++|+..+.||+|+||.||+|.+++++.||||++..... .....+.+|++++++++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 456778999999999999999999999999999988899999999976532 2334689999999999999999999999
Q ss_pred ecCCccEEEEEecCCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEe
Q 002349 664 LSSSGNLLFYDFMENGSLWDILHGPT-KKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLT 742 (933)
Q Consensus 664 ~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~ 742 (933)
...+..++||||+++|+|.++++... ....+++..+..++.|++.||+|||+++..+|+||||||+||+++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999997532 33459999999999999999999997555599999999999999999999999
Q ss_pred ecccccccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCC-------CcchhHHHHhhh
Q 002349 743 DFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDN-------ECNLHHLILSKT 815 (933)
Q Consensus 743 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~-------~~~~~~~~~~~~ 815 (933)
|||+++..............||+.|+|||++.+..++.++||||+|+++|+|++|+.||+. ......+.....
T Consensus 177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (326)
T 3uim_A 177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256 (326)
T ss_dssp CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred cCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence 9999987755555555556799999999999998999999999999999999999999961 112222222222
Q ss_pred cccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCC
Q 002349 816 ANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLV 870 (933)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 870 (933)
.........+....... ....+..+.+++.+|++.||++|||++||+++|+...
T Consensus 257 ~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 257 KEKKLEALVDVDLQGNY-KDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp SSCCSTTSSCTTCTTSC-CHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred hchhhhhhcChhhcccc-CHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 22222222233222222 3466789999999999999999999999999998743
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=419.83 Aligned_cols=410 Identities=18% Similarity=0.196 Sum_probs=336.2
Q ss_pred CcEEEEEcCCCCcCcccCCCCCCCCCccEEEccCCcccccCCCCccCCCCCceecccccccCCCCCcccccccchhhhhh
Q 002349 68 FTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLIL 147 (933)
Q Consensus 68 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 147 (933)
..++.|+|++|.+++..+..|.++++|++|+|++|++++..|..|+++++|++|||++|.++ .+|.. .+++|++|+|
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 128 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDL 128 (562)
T ss_dssp TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEEC
T ss_pred CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEEC
Confidence 47889999999999888889999999999999999999888999999999999999999998 77877 8999999999
Q ss_pred cccCccC-CCCcccccCCCCceeeeecCCCCCCcccccccCCCC--cEEeccCccc--cCccCcCCcCCC--CCcEEccc
Q 002349 148 KNNQLIG-PIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGL--WYFDVRNNSL--TGSIPQNIGNCT--SFQVLDLS 220 (933)
Q Consensus 148 ~~n~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L--~~L~L~~n~l--~~~~p~~l~~l~--~L~~L~L~ 220 (933)
++|++++ .+|..|+++++|++|+|++|++.+. .+..+++| ++|++++|.+ ++..|..+..+. .| .++++
T Consensus 129 s~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l-~l~l~ 204 (562)
T 3a79_B 129 SFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVL-HLVFH 204 (562)
T ss_dssp CSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEE-EEEEC
T ss_pred CCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccccccCcccccccCcceE-EEEec
Confidence 9999997 4578999999999999999999864 45555666 9999999999 888888777654 22 34555
Q ss_pred cccccCcCCCCc--cccccceEecccc----------------------------ccccc----cCccccccccccEEec
Q 002349 221 YNQLSGEIPFNI--GFLQIATLSLQGN----------------------------QLTGK----IPSVIGLMQALAVLDL 266 (933)
Q Consensus 221 ~N~l~~~~p~~~--~~~~L~~L~L~~n----------------------------~l~~~----~p~~~~~l~~L~~L~L 266 (933)
+|.+.+.++... ...+|+.|++++| .+++. ++..+ ..++|++|++
T Consensus 205 ~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~-~~~~L~~L~l 283 (562)
T 3a79_B 205 PNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFF-WPRPVEYLNI 283 (562)
T ss_dssp SSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHH-TTSSEEEEEE
T ss_pred CccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhh-hcccccEEEE
Confidence 666555443321 1123444444444 33221 11111 2248999999
Q ss_pred cCCcCcCCCCCCC-----CCCCCccEEEeeCCccCCCCC-CccccC---CcceEeeeccccccccCCccccccccccccc
Q 002349 267 SCNMLSGPIPPIL-----GNLSYTEKLYLHSNKLTGHIP-PELGNM---TKLHYLELNDNQLTGHIPPALGKLTDLFDLN 337 (933)
Q Consensus 267 s~N~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~~~p-~~l~~l---~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~ 337 (933)
++|.++|.+|..+ .+++.|+.+++..|.+ .+| ..+..+ .+|+.|++++|.+.... ....+++|++|+
T Consensus 284 ~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ 359 (562)
T 3a79_B 284 YNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLN 359 (562)
T ss_dssp EEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEE
T ss_pred eccEeeccccchhhhcccccchheehhhccccee--ecChhhhhhhhccCcceEEEccCCCccccc--CccCCCCceEEE
Confidence 9999999999887 7888888888888887 344 333322 67999999999997432 236889999999
Q ss_pred cccccCCCCCCCCcccCCCCCceeccCcccCCCC--CcccccccccceecCCcccccCCCc-cccccccccceeeccCCc
Q 002349 338 VANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTI--PPAFQRLESMTYLNLSLNNIRGPIP-VELSRIGNLDTLDMSNNK 414 (933)
Q Consensus 338 L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~ 414 (933)
+++|++++..|..+..+++|+.|++++|++++.. |..|..+++|++|++++|++++.+| ..+..+++|+.|+|++|+
T Consensus 360 l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~ 439 (562)
T 3a79_B 360 FTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNM 439 (562)
T ss_dssp CCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSC
T ss_pred CCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCC
Confidence 9999999989999999999999999999999643 4678999999999999999998455 458899999999999999
Q ss_pred cCCCCCCCCCCccccccccccCcccccccccccccccccceEEccCCccccccchh-hccccccceeeecCCCCcCcccc
Q 002349 415 ISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEE-LSQLQNMFSLRLDYNNLSGDVMS 493 (933)
Q Consensus 415 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~l~~N~l~~~~~~ 493 (933)
+++..|..+. ++|+.|+|++|+|+ .+|..+.++++|++|+|++|+|++ +|.. +..+++|+.|++++|+|+|..+.
T Consensus 440 l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N~~~c~c~~ 515 (562)
T 3a79_B 440 LTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKS-VPDGVFDRLTSLQYIWLHDNPWDCTCPG 515 (562)
T ss_dssp CCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCC-CCTTSTTTCTTCCCEECCSCCBCCCHHH
T ss_pred CCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCC-CCHHHHhcCCCCCEEEecCCCcCCCcch
Confidence 9988777665 78999999999999 677777799999999999999995 5554 99999999999999999998764
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=381.66 Aligned_cols=277 Identities=41% Similarity=0.630 Sum_probs=226.6
Q ss_pred HHHHHHhhccCcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccE
Q 002349 591 EDIMRMTENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNL 670 (933)
Q Consensus 591 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 670 (933)
.++...+++|+..+.||+|+||.||+|.+++++.||||++........+.+.+|++++++++||||+++++++...+..+
T Consensus 32 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 111 (321)
T 2qkw_B 32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI 111 (321)
T ss_dssp SCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred HHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence 34455678999999999999999999998889999999998776667788999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccc
Q 002349 671 LFYDFMENGSLWDILHGPT-KKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKS 749 (933)
Q Consensus 671 lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 749 (933)
+||||+++|+|.+++.... ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 188 (321)
T 2qkw_B 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKK 188 (321)
T ss_dssp EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecccccc
Confidence 9999999999999996432 223689999999999999999999976 999999999999999999999999999986
Q ss_pred cccCC-CceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchh-----HHHHhhhcccccccc
Q 002349 750 LCVSK-SYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLH-----HLILSKTANNAVMET 823 (933)
Q Consensus 750 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~-----~~~~~~~~~~~~~~~ 823 (933)
..... ........||+.|+|||++.+..++.++||||||+++|||++|+.||....... .+.............
T Consensus 189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (321)
T 2qkw_B 189 GTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQI 268 (321)
T ss_dssp CSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSS
T ss_pred cccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHh
Confidence 53222 222334568999999999999999999999999999999999999997543221 111111222222233
Q ss_pred cCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCC
Q 002349 824 VDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVP 871 (933)
Q Consensus 824 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 871 (933)
+++...... ....+..+.+++.+||+.||++|||++|+++.|+.+..
T Consensus 269 ~~~~~~~~~-~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 269 VDPNLADKI-RPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp SSSSCTTCS-CHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cChhhcccc-CHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 333332222 34677889999999999999999999999999987643
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=402.68 Aligned_cols=380 Identities=22% Similarity=0.236 Sum_probs=293.1
Q ss_pred CCCCccceEecC-CCCcEEEEEcCCCCcCcccCCCCCCCCCccEEEccCCcccccC-CCCccCCCCCceecccccccCCC
Q 002349 54 DYCVWRGITCDN-VTFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQI-PDEIGDCSSLKSLDLSFNELYGD 131 (933)
Q Consensus 54 ~~c~w~gv~C~~-~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~-p~~l~~l~~L~~L~Ls~n~l~~~ 131 (933)
-.|.+.|++.-. ...+++.|+|++|.+++..|..++++++|++|+|++|.+.+.+ |..|.++++|++|+|++|.+++.
T Consensus 15 ~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~ 94 (455)
T 3v47_A 15 AICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQL 94 (455)
T ss_dssp EECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEE
T ss_pred cCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCcc
Confidence 347777765422 3457899999999999988999999999999999999998766 46799999999999999999988
Q ss_pred CCcccccccchhhhhhcccCccCCCCcc--cccCCCCceeeeecCCCCCCcccc-cccCCCCcEEeccCccccCccCcCC
Q 002349 132 IPFSISKLKQLEFLILKNNQLIGPIPST--LSQLPNLKVFGLRGNNLVGTLSPD-MCQLSGLWYFDVRNNSLTGSIPQNI 208 (933)
Q Consensus 132 ~p~~~~~l~~L~~L~L~~n~l~~~~p~~--l~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~L~~n~l~~~~p~~l 208 (933)
.|..|+++++|++|+|++|++++.+|.. ++.+++|++|+|++|++++..|.. +.++++|++|++++|.+++..|..+
T Consensus 95 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l 174 (455)
T 3v47_A 95 ETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDL 174 (455)
T ss_dssp CTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTS
T ss_pred ChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhh
Confidence 8999999999999999999999866655 999999999999999999888876 8999999999999999999999988
Q ss_pred cCC--CCCcEEccccccccCcCCCCcc---------ccccceEeccccccccccCccccccccccEEeccCCcCcCCCCC
Q 002349 209 GNC--TSFQVLDLSYNQLSGEIPFNIG---------FLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPP 277 (933)
Q Consensus 209 ~~l--~~L~~L~L~~N~l~~~~p~~~~---------~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~ 277 (933)
..+ .+|+.|++++|.+++..+..+. ..+|++|++++|++++..|..+...
T Consensus 175 ~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~------------------- 235 (455)
T 3v47_A 175 LNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDA------------------- 235 (455)
T ss_dssp GGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHH-------------------
T ss_pred hccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhcc-------------------
Confidence 877 6899999999999865544332 1234555555555554444444332
Q ss_pred CCCCCCCccEEEeeCCccCCCCCCccccCCcceEeeeccccccccCCccccc--cccccccccccccCCCCCCCCcccCC
Q 002349 278 ILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGK--LTDLFDLNVANNHLEGPIPDNLSSCT 355 (933)
Q Consensus 278 ~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~--l~~L~~L~L~~N~l~~~~p~~l~~l~ 355 (933)
...++|+.|++++|.+.+.. +..+.+.+..+..+.. .++|+.|++++|++.+..|..+..++
T Consensus 236 --~~~~~L~~L~l~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~ 299 (455)
T 3v47_A 236 --IAGTKIQSLILSNSYNMGSS--------------FGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFT 299 (455)
T ss_dssp --TTTCCEEEEECTTCTTTSCC--------------TTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCT
T ss_pred --ccccceeeEeeccccccccc--------------cchhhhccCcccccccccccCceEEEecCccccccchhhcccCC
Confidence 00144555555555443211 0111111111222222 24666667777776666666777777
Q ss_pred CCCceeccCcccCCCCCcccccccccceecCCcccccCCCccccccccccceeeccCCccCCCCCCCCCCcccccccccc
Q 002349 356 NLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLS 435 (933)
Q Consensus 356 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 435 (933)
+|++|++++|++++..|..|..+++|++|+|++|.+++..+..+..+++|++|+|++|++++..|..|..+++|++|+|+
T Consensus 300 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 379 (455)
T 3v47_A 300 DLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALD 379 (455)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECC
Confidence 77777777777777777777778888888888888877777888888888888888888888888889999999999999
Q ss_pred CcccccccccccccccccceEEccCCccccccc
Q 002349 436 RNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIP 468 (933)
Q Consensus 436 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 468 (933)
+|+|++..+..|.++++|++|+|++|++++..|
T Consensus 380 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 380 TNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp SSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 999998777788999999999999999998777
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=375.94 Aligned_cols=265 Identities=28% Similarity=0.431 Sum_probs=206.3
Q ss_pred HhhccCcceeeecccceeEEEEEEcCCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
..++|+..+.||+|+||+||+|.+ .++.||||++.... ....+++.+|++++++++||||+++++++...+..++||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 457899999999999999999987 46889999987653 334567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--eeeccCCCCceEeCCCCCeEEeecccccccc
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPR--IIHRDVKSSNILLDKDFEAHLTDFGIAKSLC 751 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 751 (933)
||+++|+|.++++.......+++..++.++.|++.||+|||++ + |+||||||+||+++.++.+||+|||+++...
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 9999999999996422223499999999999999999999965 7 9999999999999999999999999997643
Q ss_pred cCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccc
Q 002349 752 VSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISAT 831 (933)
Q Consensus 752 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (933)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||.+................ ..++.
T Consensus 191 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~------~~~~~- 262 (309)
T 3p86_A 191 ST-FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR------LEIPR- 262 (309)
T ss_dssp ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCC------CCCCT-
T ss_pred cc-ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC------CCCCc-
Confidence 22 22234467999999999999999999999999999999999999999866544433222111111 11111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCCCCCCC
Q 002349 832 CKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAPEPQ 876 (933)
Q Consensus 832 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~ 876 (933)
..+..+.+++.+||+.||++|||++++++.|+.+.....|+
T Consensus 263 ----~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~ 303 (309)
T 3p86_A 263 ----NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303 (309)
T ss_dssp ----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred ----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence 12357889999999999999999999999999887655443
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=369.43 Aligned_cols=252 Identities=25% Similarity=0.332 Sum_probs=211.6
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEe
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
.++|+..+.||+|+||+||+|.+. +++.||||++........+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 358999999999999999999964 5889999999766555677889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS 755 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 755 (933)
+++|+|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.......
T Consensus 99 ~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 999999999952 3689999999999999999999976 999999999999999999999999999987643322
Q ss_pred ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCH
Q 002349 756 YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDL 835 (933)
Q Consensus 756 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (933)
......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.................. ..+ .
T Consensus 172 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-----~~~-----~ 240 (297)
T 3fxz_A 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL-----QNP-----E 240 (297)
T ss_dssp -CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC-----SCG-----G
T ss_pred -ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-----CCc-----c
Confidence 23446799999999999999999999999999999999999999987655444333222111100 000 1
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 836 GAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 836 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
..+..+.+++.+||+.||++|||++|++++-
T Consensus 241 ~~~~~~~~li~~~l~~dp~~Rps~~ell~h~ 271 (297)
T 3fxz_A 241 KLSAIFRDFLNRCLEMDVEKRGSAKELLQHQ 271 (297)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred ccCHHHHHHHHHHccCChhHCcCHHHHhhCh
Confidence 1235688999999999999999999998753
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=389.73 Aligned_cols=371 Identities=26% Similarity=0.320 Sum_probs=283.0
Q ss_pred CcEEEEEcCCCCcCcccCCCCCCCCCccEEEccCCcccccCCCCccCCCCC-------------ceecccccccCCCCCc
Q 002349 68 FTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSL-------------KSLDLSFNELYGDIPF 134 (933)
Q Consensus 68 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L-------------~~L~Ls~n~l~~~~p~ 134 (933)
.++..++++++++ |.+|++++++++|++|++++|+++|.+|..++++++| ++|++++|.+++ +|.
T Consensus 11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp~ 88 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LPE 88 (454)
T ss_dssp ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CCS
T ss_pred ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CCC
Confidence 3677899999999 8999999999999999999999999999999999875 999999999985 554
Q ss_pred ccccccchhhhhhcccCccCCCCcccccCCCCceeeeecCCCCCCcccccccCCCCcEEeccCccccCccCcCCcCCCCC
Q 002349 135 SISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSF 214 (933)
Q Consensus 135 ~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L 214 (933)
. .++|++|+|++|.+++ +|.. +++|++|++++|++++. +.. .++|++|++++|++++ +| .++++++|
T Consensus 89 ~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~l-~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L 155 (454)
T 1jl5_A 89 L---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKAL-SDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFL 155 (454)
T ss_dssp C---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSCC-CSC---CTTCCEEECCSSCCSS-CC-CCTTCTTC
T ss_pred C---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCcc-cCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCC
Confidence 2 3789999999999997 7754 48999999999999853 221 2799999999999996 77 59999999
Q ss_pred cEEccccccccCcCCCCccccccceEeccccccccccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCc
Q 002349 215 QVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNK 294 (933)
Q Consensus 215 ~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~ 294 (933)
++|++++|++++ +|... .+|++|++++|++++ +| .++.+++|++|++++|.+++ +|... ++|++|++++|+
T Consensus 156 ~~L~l~~N~l~~-lp~~~--~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l~~n~ 226 (454)
T 1jl5_A 156 KIIDVDNNSLKK-LPDLP--PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP---LSLESIVAGNNI 226 (454)
T ss_dssp CEEECCSSCCSC-CCCCC--TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC---TTCCEEECCSSC
T ss_pred CEEECCCCcCcc-cCCCc--ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc---CcccEEECcCCc
Confidence 999999999996 66544 489999999999997 55 68999999999999999996 44433 589999999999
Q ss_pred cCCCCCCccccCCcceEeeeccccccccCCccccccccccccccccccCCCCCCCCcccCCCCCceeccCcccCCCCCcc
Q 002349 295 LTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPA 374 (933)
Q Consensus 295 l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~ 374 (933)
++ .+| .+..+++|++|++++|++++ +|.. +++|+.|++++|++.+ +|.. .++|+.|++++|++++. |..
T Consensus 227 l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l-~~~ 295 (454)
T 1jl5_A 227 LE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGL-SEL 295 (454)
T ss_dssp CS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEE-SCC
T ss_pred CC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCcc-cCc
Confidence 99 677 49999999999999999995 5543 4799999999999996 5544 37899999999999862 211
Q ss_pred cccccccceecCCcccccCCCccccccc-cccceeeccCCccCCCCCCCCCCccccccccccCccccccccccccccccc
Q 002349 375 FQRLESMTYLNLSLNNIRGPIPVELSRI-GNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSV 453 (933)
Q Consensus 375 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 453 (933)
.++|++|++++|++++. + .+ ++|+.|++++|++++ +|.. +++|+.|++++|++++ +|. .+++|
T Consensus 296 ---~~~L~~L~l~~N~l~~i-~----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~-lp~---~l~~L 359 (454)
T 1jl5_A 296 ---PPNLYYLNASSNEIRSL-C----DLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAE-VPE---LPQNL 359 (454)
T ss_dssp ---CTTCCEEECCSSCCSEE-C----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTC
T ss_pred ---CCcCCEEECcCCcCCcc-c----CCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCcccc-ccc---hhhhc
Confidence 26899999999999852 2 23 589999999999996 6654 5789999999999994 666 47899
Q ss_pred ceEEccCCcccc--ccchhhccc-------------cccceeeecCCCCcC
Q 002349 454 MEIDLSHNHLTG--VIPEELSQL-------------QNMFSLRLDYNNLSG 489 (933)
Q Consensus 454 ~~L~Ls~N~l~~--~~p~~~~~l-------------~~L~~L~l~~N~l~~ 489 (933)
++|+|++|++++ .+|.++..+ ++|+.|++++|++++
T Consensus 360 ~~L~L~~N~l~~l~~ip~~l~~L~~n~~~~~i~~~~~~L~~L~ls~N~l~~ 410 (454)
T 1jl5_A 360 KQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLRE 410 (454)
T ss_dssp CEEECCSSCCSSCCCCCTTCCEEECCC------------------------
T ss_pred cEEECCCCCCCcCCCChHHHHhhhhcccccccccccCcCCEEECCCCcCCc
Confidence 999999999999 889999988 899999999999998
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=370.42 Aligned_cols=249 Identities=21% Similarity=0.292 Sum_probs=208.5
Q ss_pred hhccCcceeeecccceeEEEEEE-cCCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVL-KNCKPVAIKRLYSH--YPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
.++|+..+.||+|+||.||+|.+ .+++.||||++... .....+++.+|++++++++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 45899999999999999999997 46899999999654 2345667889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
||+++|+|.+++. ..+.+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 94 e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 94 EYASGGEVFDYLV---AHGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp CCCTTCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred ECCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 9999999999984 346799999999999999999999976 9999999999999999999999999999876432
Q ss_pred CCceeeeecccccccCccccccCCCC-cchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccc
Q 002349 754 KSYTSTYIMGTIGYIDPEYARTSRLT-EKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATC 832 (933)
Q Consensus 754 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (933)
. .....+||+.|+|||++.+..+. +++||||+||++|+|++|+.||.+................. +.
T Consensus 168 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~--------p~-- 235 (328)
T 3fe3_A 168 G--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI--------PF-- 235 (328)
T ss_dssp C--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--------CT--
T ss_pred C--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC--------CC--
Confidence 2 23445799999999999988765 89999999999999999999998765443332222211111 11
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 833 KDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 833 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
..+..+.+++.+|++.||.+|||++|++++-
T Consensus 236 ---~~s~~~~~li~~~L~~dP~~R~t~~eil~h~ 266 (328)
T 3fe3_A 236 ---YMSTDCENLLKRFLVLNPIKRGTLEQIMKDR 266 (328)
T ss_dssp ---TSCHHHHHHHHHHCCSSTTTSCCHHHHTTCT
T ss_pred ---CCCHHHHHHHHHHCCCChhHCcCHHHHhcCH
Confidence 1235678899999999999999999998753
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=368.10 Aligned_cols=263 Identities=22% Similarity=0.314 Sum_probs=218.4
Q ss_pred cccCHHHHHHHhhc----------cCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCC
Q 002349 586 ALHVYEDIMRMTEN----------LSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHR 654 (933)
Q Consensus 586 ~~~~~~~~~~~~~~----------~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 654 (933)
..++++++..+++. |+..+.||+|+||.||+|+.. +++.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 34678888888864 677789999999999999987 6899999999776666678899999999999999
Q ss_pred ceeeeeeEEecCCccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeC
Q 002349 655 NLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLD 734 (933)
Q Consensus 655 niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~ 734 (933)
||+++++++...+..++||||+++++|.+++. ...+++..+..++.|++.||+|||++ +|+||||||+||+++
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVS----QVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLT 175 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEC
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEC
Confidence 99999999999999999999999999999984 34699999999999999999999976 999999999999999
Q ss_pred CCCCeEEeecccccccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhh
Q 002349 735 KDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSK 814 (933)
Q Consensus 735 ~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~ 814 (933)
.++.+||+|||+++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.............
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~ 254 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKDV-PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR 254 (321)
T ss_dssp TTCCEEECCCTTCEECCSSS-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred CCCcEEEeeeeeeeecccCc-cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence 99999999999998764322 22344679999999999999999999999999999999999999998665444332221
Q ss_pred hcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 815 TANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
... .+.... ....+..+.+++.+|++.||++|||++|++++-
T Consensus 255 ~~~-------~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp 296 (321)
T 2c30_A 255 DSP-------PPKLKN---SHKVSPVLRDFLERMLVRDPQERATAQELLDHP 296 (321)
T ss_dssp HSS-------CCCCTT---GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred cCC-------CCCcCc---cccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 111 111111 011235688999999999999999999999854
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=372.02 Aligned_cols=260 Identities=27% Similarity=0.430 Sum_probs=212.1
Q ss_pred hccCcceeeecccceeEEEEEEc----CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK----NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLF 672 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 672 (933)
++|+..+.||+|+||.||+|.+. .+..||||++.... ....+.+.+|++++++++||||+++++++..++..++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 57888899999999999999975 34569999997653 44567799999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccccc
Q 002349 673 YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV 752 (933)
Q Consensus 673 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 752 (933)
|||+++|+|.++++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 129 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 129 TEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp EECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred eeCCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 999999999999963 446799999999999999999999966 999999999999999999999999999987643
Q ss_pred CCCc--eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCcccc
Q 002349 753 SKSY--TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEIS 829 (933)
Q Consensus 753 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (933)
.... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+............. . .....
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~-~------~~~~~ 276 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG-Y------RLPAP 276 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT-C------CCCCC
T ss_pred CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-C------CCCCC
Confidence 3222 2223456788999999999999999999999999999999 99999865544333222111 0 01111
Q ss_pred ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCCCCC
Q 002349 830 ATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAPE 874 (933)
Q Consensus 830 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 874 (933)
...+..+.+++.+||+.||++|||+++|++.|+.+...++
T Consensus 277 -----~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 277 -----MGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp -----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred -----CCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 1224678899999999999999999999999998765443
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=358.81 Aligned_cols=258 Identities=23% Similarity=0.345 Sum_probs=215.5
Q ss_pred hhccCcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEec
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFM 676 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 676 (933)
.++|+..+.||+|+||.||+|.++++..||+|++..... ..+++.+|++++++++||||+++++++......++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 468899999999999999999999888999999976543 3567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCc
Q 002349 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY 756 (933)
Q Consensus 677 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 756 (933)
++++|.+++.. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 86 ~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 86 SNGCLLNYLRS--HGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp TTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred CCCcHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 99999999952 344699999999999999999999966 9999999999999999999999999999876544333
Q ss_pred eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCccccccccCH
Q 002349 757 TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDL 835 (933)
Q Consensus 757 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (933)
......+|+.|+|||.+.+..++.++||||+|+++|+|++ |+.||.................. ..+.
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-------~~~~----- 228 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRL-------YRPH----- 228 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC-------CCCT-----
T ss_pred cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCC-------CCCC-----
Confidence 3344456788999999999889999999999999999999 99999865544433222211110 0011
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCCC
Q 002349 836 GAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPA 872 (933)
Q Consensus 836 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 872 (933)
..+..+.+++.+|++.||++|||++|+++.|+.+...
T Consensus 229 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 229 LASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp TSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred cChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 1135688999999999999999999999999988654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=369.97 Aligned_cols=259 Identities=23% Similarity=0.382 Sum_probs=211.2
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEec
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFM 676 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 676 (933)
++|...+.||+|+||+||+|.+. +++.||+|++........+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 57889999999999999999976 47899999997776677788999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCc
Q 002349 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY 756 (933)
Q Consensus 677 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 756 (933)
++|+|.++++. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++........
T Consensus 90 ~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 90 KGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp TTCBHHHHHHH--CCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred CCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 99999999963 356799999999999999999999966 9999999999999999999999999999876432221
Q ss_pred e-------------eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccc
Q 002349 757 T-------------STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMET 823 (933)
Q Consensus 757 ~-------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 823 (933)
. .....||+.|+|||++.+..++.++||||||+++|||++|..||........... ......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~-----~~~~~~ 239 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG-----LNVRGF 239 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS-----BCHHHH
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh-----hhhhcc
Confidence 1 1145799999999999999999999999999999999999999864322110000 000000
Q ss_pred cCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCC
Q 002349 824 VDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVP 871 (933)
Q Consensus 824 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 871 (933)
.+...+. ..+..+.+++.+|++.||++|||++++++.|+.+..
T Consensus 240 ~~~~~~~-----~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 240 LDRYCPP-----NCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp HHHTCCT-----TCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccccCCC-----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0000111 123468889999999999999999999999987653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=359.58 Aligned_cols=255 Identities=28% Similarity=0.387 Sum_probs=213.6
Q ss_pred hccCcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecC
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFME 677 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 677 (933)
++|+..+.||+|+||.||+|.+.+++.||+|++..... ..+++.+|++++++++||||+++++++.+++..++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 57888999999999999999998889999999976543 35679999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCce
Q 002349 678 NGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYT 757 (933)
Q Consensus 678 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 757 (933)
+++|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.........
T Consensus 89 ~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (269)
T 4hcu_A 89 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 163 (269)
T ss_dssp TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccccccc
Confidence 9999999963 445799999999999999999999976 99999999999999999999999999998764333333
Q ss_pred eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCccccccccCHH
Q 002349 758 STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLG 836 (933)
Q Consensus 758 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (933)
.....+|+.|+|||.+.+..++.++||||+|+++|+|++ |+.||................ ....+. .
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~-------~~~~~~-----~ 231 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF-------RLYKPR-----L 231 (269)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-------CCCCCT-----T
T ss_pred ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCc-------cCCCCC-----c
Confidence 334457888999999999999999999999999999999 999998655443332221110 111111 1
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCC
Q 002349 837 AVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLV 870 (933)
Q Consensus 837 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 870 (933)
.+..+.+++.+|++.||++|||+++++++|+.+.
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~ 265 (269)
T 4hcu_A 232 ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 265 (269)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence 2357889999999999999999999999998754
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=370.82 Aligned_cols=252 Identities=22% Similarity=0.316 Sum_probs=209.9
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccCch------hHHHHHHHHHHHhcCCCCceeeeeeEEecCCcc
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQ------CLKEFETELETVGSIKHRNLVSLQGYSLSSSGN 669 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 669 (933)
.++|...+.||+|+||+||+|.++ +++.||+|++...... ..+.+.+|+.++++++||||+++++++.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467999999999999999999976 4789999999764321 357799999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCC----CeEEeecc
Q 002349 670 LLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDF----EAHLTDFG 745 (933)
Q Consensus 670 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~----~~kl~DfG 745 (933)
++||||+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++ .+||+|||
T Consensus 91 ~lv~e~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 91 VLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEECCCSCBHHHHHT---TCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 99999999999999994 456799999999999999999999976 999999999999998877 79999999
Q ss_pred cccccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccC
Q 002349 746 IAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVD 825 (933)
Q Consensus 746 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (933)
+++...... ......||+.|+|||++.+..++.++||||+||++|+|++|..||.+..................
T Consensus 165 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~---- 238 (361)
T 2yab_A 165 LAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFD---- 238 (361)
T ss_dssp SCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC----
T ss_pred CceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC----
Confidence 998764322 23445799999999999999999999999999999999999999987655544433222211111
Q ss_pred ccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 826 PEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 826 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
+.... ..+..+.+++.+|+..||++|||++|++++
T Consensus 239 ~~~~~-----~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 239 EEFFS-----QTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp HHHHT-----TSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred chhcc-----CCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11111 113567889999999999999999999874
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=361.84 Aligned_cols=262 Identities=27% Similarity=0.410 Sum_probs=209.9
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
++|+..+.||+|+||.||+|.+. .++.||+|++.... ....+.+.+|+.++++++||||+++++++..++..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 57999999999999999999976 57899999985432 334567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
||+++++|.+++. ..+++++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 91 e~~~g~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 91 EYIEGPTLSEYIE---SHGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp ECCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred eCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 9999999999995 345799999999999999999999976 9999999999999999999999999999876544
Q ss_pred CCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccccc
Q 002349 754 KSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCK 833 (933)
Q Consensus 754 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (933)
.........||+.|+|||.+.+..++.++||||+|+++|+|++|+.||.+.............. ... ......
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~--~~~-~~~~~~---- 237 (294)
T 4eqm_A 165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDS--VPN-VTTDVR---- 237 (294)
T ss_dssp ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSC--CCC-HHHHSC----
T ss_pred cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhcc--CCC-cchhcc----
Confidence 4344445679999999999999999999999999999999999999998765444332211111 100 000111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHccCCCCC
Q 002349 834 DLGAVKKVFQLALLCSKRQPTDRP-TMHEVSRVLGSLVPAP 873 (933)
Q Consensus 834 ~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~~~~~ 873 (933)
...+..+.+++.+|++.||++|| +++++.+.|+.+....
T Consensus 238 -~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 238 -KDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp -TTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred -cCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 11246788999999999999998 8999999998876543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=363.44 Aligned_cols=280 Identities=33% Similarity=0.567 Sum_probs=226.1
Q ss_pred cccccCHHHHHHHhhccCcc------eeeecccceeEEEEEEcCCceEEEEEecccC----chhHHHHHHHHHHHhcCCC
Q 002349 584 NMALHVYEDIMRMTENLSEK------YIIGYGASSTVYKCVLKNCKPVAIKRLYSHY----PQCLKEFETELETVGSIKH 653 (933)
Q Consensus 584 ~~~~~~~~~~~~~~~~~~~~------~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h 653 (933)
....+.++++..++++|... +.||+|+||.||+|.+ +++.||||++.... ....+.+.+|++++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 34568899999999999888 8999999999999987 56889999986532 3346779999999999999
Q ss_pred CceeeeeeEEecCCccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEe
Q 002349 654 RNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILL 733 (933)
Q Consensus 654 ~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll 733 (933)
|||+++++++...+..++||||+++++|.+++........+++..+..++.|++.||+|||++ +|+||||||+||++
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEE
Confidence 999999999999999999999999999999997544456799999999999999999999966 99999999999999
Q ss_pred CCCCCeEEeecccccccccCCCc-eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchh---H
Q 002349 734 DKDFEAHLTDFGIAKSLCVSKSY-TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLH---H 809 (933)
Q Consensus 734 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~---~ 809 (933)
+.++.+||+|||+++........ ......||+.|+|||.+.+ .++.++||||||+++|+|++|+.||....... .
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 245 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD 245 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTH
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHH
Confidence 99999999999999876432222 2334579999999998875 48899999999999999999999997543221 1
Q ss_pred HHHhhhc-ccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCC
Q 002349 810 LILSKTA-NNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLV 870 (933)
Q Consensus 810 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 870 (933)
+...... .....+.+++.+.. .....+..+.+++.+|++.||++|||++++++.|+.+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 246 IKEEIEDEEKTIEDYIDKKMND--ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHHHHTTSCCHHHHSCSSCSC--CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHhhhhhhhhhhhccccccc--cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 1111111 11111122222211 23456788999999999999999999999999998764
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=372.62 Aligned_cols=268 Identities=26% Similarity=0.348 Sum_probs=208.8
Q ss_pred hhccCcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCc----cEEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSG----NLLF 672 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----~~lv 672 (933)
.++|+..+.||+|+||+||+|++. ++.||||++.... .....+.+|+.++++++||||+++++++..... .++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 368999999999999999999976 6899999996543 334556779999999999999999999987543 5999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-------CCCeeeccCCCCceEeCCCCCeEEeecc
Q 002349 673 YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDC-------SPRIIHRDVKSSNILLDKDFEAHLTDFG 745 (933)
Q Consensus 673 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-------~~~ivH~Dikp~NIll~~~~~~kl~DfG 745 (933)
|||+++|+|.++++. ..+++..+..++.|++.||+|||+.+ +.+|+||||||+||+++.++.+||+|||
T Consensus 101 ~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 101 TAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence 999999999999952 45999999999999999999999420 1299999999999999999999999999
Q ss_pred cccccccCCCc-eeeeecccccccCccccccC-----CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhh-----
Q 002349 746 IAKSLCVSKSY-TSTYIMGTIGYIDPEYARTS-----RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSK----- 814 (933)
Q Consensus 746 la~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~----- 814 (933)
+++........ ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+...........
T Consensus 177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 256 (322)
T 3soc_A 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH 256 (322)
T ss_dssp TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSS
T ss_pred cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccC
Confidence 99876433222 22335799999999999873 45678999999999999999999997543211110000
Q ss_pred -----hcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCC
Q 002349 815 -----TANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLV 870 (933)
Q Consensus 815 -----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 870 (933)
...........+.+.........+..+.+++.+||+.||++|||++||++.|+.+.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 257 PSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00000111222333333334456778999999999999999999999999998653
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=364.31 Aligned_cols=253 Identities=18% Similarity=0.215 Sum_probs=209.9
Q ss_pred hhccCcceeeecccceeEEEEEEcC-CceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEe
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
.++|+..+.||+|+||+||+|.+.. ++.||+|.+.... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 4689999999999999999999764 7889999987543 3456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCC--CCCeEEeecccccccccC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDK--DFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~--~~~~kl~DfGla~~~~~~ 753 (933)
+++|+|.+++. .....+++.++..++.|++.||+|||++ +|+||||||+||+++. ++.+||+|||+++.....
T Consensus 83 ~~g~~L~~~l~--~~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERIN--TSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHT--SSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 99999999995 2345799999999999999999999966 9999999999999987 789999999999876432
Q ss_pred CCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccccc
Q 002349 754 KSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCK 833 (933)
Q Consensus 754 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (933)
.......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+......................+
T Consensus 158 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~------- 228 (321)
T 1tki_A 158 --DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFK------- 228 (321)
T ss_dssp --CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHT-------
T ss_pred --CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhc-------
Confidence 23345679999999999999889999999999999999999999998765544333222211111110000
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 834 DLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 834 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
..+..+.+++.+|+..||++|||+.|++++-
T Consensus 229 --~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp 259 (321)
T 1tki_A 229 --EISIEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp --TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred --cCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence 1235788999999999999999999999844
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=365.06 Aligned_cols=250 Identities=21% Similarity=0.250 Sum_probs=208.5
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLF 672 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 672 (933)
.++|+..+.||+|+||+||+|+.+ +++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 368999999999999999999976 58899999996542 33456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccccc
Q 002349 673 YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV 752 (933)
Q Consensus 673 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 752 (933)
|||+++|+|.+++. ..+.+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 84 ~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 99999999999984 346789999999999999999999966 999999999999999999999999999986422
Q ss_pred CCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccc
Q 002349 753 SKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATC 832 (933)
Q Consensus 753 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (933)
. .......+||+.|+|||++.+..++.++||||+||++|||++|+.||.+................ ++.
T Consensus 158 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~--------~p~-- 226 (337)
T 1o6l_A 158 D-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR--------FPR-- 226 (337)
T ss_dssp T-TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--------CCT--
T ss_pred C-CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--------CCC--
Confidence 2 22334567999999999999999999999999999999999999999865543333222211111 111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHH
Q 002349 833 KDLGAVKKVFQLALLCSKRQPTDRP-----TMHEVSRVL 866 (933)
Q Consensus 833 ~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L 866 (933)
..+..+.+++.+|++.||++|| +++|++++-
T Consensus 227 ---~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~ 262 (337)
T 1o6l_A 227 ---TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 262 (337)
T ss_dssp ---TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred ---CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCC
Confidence 1235688899999999999999 899998753
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=373.28 Aligned_cols=259 Identities=22% Similarity=0.372 Sum_probs=211.0
Q ss_pred hhccCcceeeecccceeEEEEEEc--------CCceEEEEEecccC-chhHHHHHHHHHHHhcC-CCCceeeeeeEEecC
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK--------NCKPVAIKRLYSHY-PQCLKEFETELETVGSI-KHRNLVSLQGYSLSS 666 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 666 (933)
.++|...+.||+|+||.||+|.+. .+..||||+++... ....+++.+|+++++++ +||||+++++++...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 368899999999999999999863 34579999997654 33457799999999999 899999999999999
Q ss_pred CccEEEEEecCCCCHHHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEe
Q 002349 667 SGNLLFYDFMENGSLWDILHGPT-------------KKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILL 733 (933)
Q Consensus 667 ~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll 733 (933)
+..++||||+++|+|.+++.... ....+++.+++.++.|++.||+|||++ +|+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence 99999999999999999996422 124589999999999999999999976 99999999999999
Q ss_pred CCCCCeEEeecccccccccCCCc-eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHH
Q 002349 734 DKDFEAHLTDFGIAKSLCVSKSY-TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLI 811 (933)
Q Consensus 734 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~ 811 (933)
+.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+........
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~ 316 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 316 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 99999999999999866433222 1223457889999999999999999999999999999999 999998654333222
Q ss_pred HhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCC
Q 002349 812 LSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLV 870 (933)
Q Consensus 812 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 870 (933)
.... .. .+..+. ..+..+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 317 ~~~~--~~-----~~~~~~-----~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 317 LLKE--GH-----RMDKPA-----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp HHHT--TC-----CCCCCT-----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhc--CC-----CCCCCC-----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111 11 111111 22457889999999999999999999999998754
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=366.31 Aligned_cols=255 Identities=22% Similarity=0.317 Sum_probs=205.5
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYD 674 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 674 (933)
.++|+..+.||+|+||+||+|.+. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 368999999999999999999977 67899999986543 2334668899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCC
Q 002349 675 FMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSK 754 (933)
Q Consensus 675 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 754 (933)
|+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.+....
T Consensus 86 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 999999999994 456799999999999999999999966 99999999999999999999999999998653222
Q ss_pred C-ceeeeecccccccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccc
Q 002349 755 S-YTSTYIMGTIGYIDPEYARTSRL-TEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATC 832 (933)
Q Consensus 755 ~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (933)
. .......||+.|+|||++.+..+ +.++||||+||++|+|++|+.||...................... .
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~----~---- 231 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP----W---- 231 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTT----G----
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCc----c----
Confidence 1 22334679999999999988775 789999999999999999999998654432222211111111100 0
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 002349 833 KDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLG 867 (933)
Q Consensus 833 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 867 (933)
...+..+.+++.+|++.||++|||++|++++-.
T Consensus 232 --~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~ 264 (323)
T 3tki_A 232 --KKIDSAPLALLHKILVENPSARITIPDIKKDRW 264 (323)
T ss_dssp --GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred --ccCCHHHHHHHHHHccCChhhCcCHHHHhhChh
Confidence 112356788999999999999999999987643
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=363.61 Aligned_cols=253 Identities=21% Similarity=0.307 Sum_probs=210.1
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccCc------hhHHHHHHHHHHHhcCCCCceeeeeeEEecCCcc
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYP------QCLKEFETELETVGSIKHRNLVSLQGYSLSSSGN 669 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 669 (933)
.++|...+.||+|+||.||+|.++ +++.||+|++..... ...+.+.+|++++++++||||+++++++......
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 467999999999999999999976 478999999865432 1357899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCC----CeEEeecc
Q 002349 670 LLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDF----EAHLTDFG 745 (933)
Q Consensus 670 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~----~~kl~DfG 745 (933)
++||||+++++|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHT---TSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHH---hcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 99999999999999994 456799999999999999999999966 999999999999999887 89999999
Q ss_pred cccccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccC
Q 002349 746 IAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVD 825 (933)
Q Consensus 746 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (933)
+++...... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+...................
T Consensus 164 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~--- 238 (326)
T 2y0a_A 164 LAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED--- 238 (326)
T ss_dssp TCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCH---
T ss_pred CCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCc---
Confidence 998764322 223457999999999999999999999999999999999999999876554443332221111111
Q ss_pred ccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 826 PEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 826 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
.... ..+..+.+++.+|++.||++|||++|++++-
T Consensus 239 -~~~~-----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 273 (326)
T 2y0a_A 239 -EYFS-----NTSALAKDFIRRLLVKDPKKRMTIQDSLQHP 273 (326)
T ss_dssp -HHHT-----TSCHHHHHHHHHHSCSSGGGSCCHHHHHHST
T ss_pred -cccc-----cCCHHHHHHHHHHccCChhhCCCHHHHhcCC
Confidence 1000 1135678999999999999999999999863
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=374.75 Aligned_cols=258 Identities=26% Similarity=0.404 Sum_probs=200.5
Q ss_pred hccCcceeeecccceeEEEEEEc----CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK----NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLF 672 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 672 (933)
++|+..+.||+|+||.||+|+++ .+..||||+++... ....++|.+|++++++++||||+++++++...+..++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 58999999999999999999975 46789999997653 34567899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccccc
Q 002349 673 YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV 752 (933)
Q Consensus 673 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 752 (933)
|||+++|+|.++++. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 125 ~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 125 TEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp EECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 999999999999963 445799999999999999999999976 999999999999999999999999999987643
Q ss_pred CCCc--eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCcccc
Q 002349 753 SKSY--TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEIS 829 (933)
Q Consensus 753 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (933)
.... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||............. ... . ...
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~--~~~-~----~~~- 271 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD--EGY-R----LPP- 271 (373)
T ss_dssp --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHH--TTE-E----CCC-
T ss_pred CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH--cCC-C----CCC-
Confidence 3221 1222345778999999999999999999999999999998 999997654433222111 110 0 000
Q ss_pred ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCCC
Q 002349 830 ATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPA 872 (933)
Q Consensus 830 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 872 (933)
....+..+.+++.+||+.||++||++++|++.|+.+...
T Consensus 272 ----~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 272 ----PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp ----CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ----CccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 112346789999999999999999999999999877543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=368.08 Aligned_cols=253 Identities=23% Similarity=0.323 Sum_probs=209.2
Q ss_pred HhhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEE
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLF 672 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 672 (933)
..++|+..+.||+|+||.||+|.++ +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4578999999999999999999976 47899999996543 33456789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCC---CCeEEeecccccc
Q 002349 673 YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKD---FEAHLTDFGIAKS 749 (933)
Q Consensus 673 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~---~~~kl~DfGla~~ 749 (933)
|||+++|+|.+.+. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.+ +.+||+|||+++.
T Consensus 107 ~e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 107 FDLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp ECCCCSCBHHHHHT---TCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 99999999999994 456799999999999999999999976 99999999999999865 4599999999987
Q ss_pred cccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccc
Q 002349 750 LCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEIS 829 (933)
Q Consensus 750 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (933)
..... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.................... ...
T Consensus 181 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~---~~~ 255 (362)
T 2bdw_A 181 VNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP---EWD 255 (362)
T ss_dssp CTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT---GGG
T ss_pred ecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcc---ccc
Confidence 64322 2234579999999999999999999999999999999999999998765444333222221111111 000
Q ss_pred ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 830 ATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 830 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
..+..+.+++.+|++.||++|||+.|++++
T Consensus 256 ------~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 256 ------TVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp ------GSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ------CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 123568899999999999999999999864
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=357.41 Aligned_cols=256 Identities=20% Similarity=0.303 Sum_probs=210.6
Q ss_pred hhccCcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEec
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFM 676 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 676 (933)
.++|+..+.||+|+||.||+|.+++++.||+|++..... ..+++.+|++++++++||||+++++++.+.+..++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 468899999999999999999999888999999976543 3467899999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCc
Q 002349 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY 756 (933)
Q Consensus 677 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 756 (933)
++++|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++........
T Consensus 102 ~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 176 (283)
T 3gen_A 102 ANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 176 (283)
T ss_dssp TTCBHHHHHHC--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH
T ss_pred CCCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccccccc
Confidence 99999999963 345799999999999999999999976 9999999999999999999999999999876433322
Q ss_pred eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCccccccccCH
Q 002349 757 TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDL 835 (933)
Q Consensus 757 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (933)
......+|+.|+|||.+.+..++.++||||+|+++|+|++ |+.||................ ....+.
T Consensus 177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~-------~~~~~~----- 244 (283)
T 3gen_A 177 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL-------RLYRPH----- 244 (283)
T ss_dssp STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-------CCCCCT-----
T ss_pred cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhccc-------CCCCCC-----
Confidence 2333457788999999999999999999999999999998 999998655443332222111 111111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCC
Q 002349 836 GAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLV 870 (933)
Q Consensus 836 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 870 (933)
..+..+.+++.+||+.||++|||+++++++|..+.
T Consensus 245 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 245 LASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 11357889999999999999999999999997653
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=376.22 Aligned_cols=255 Identities=22% Similarity=0.255 Sum_probs=209.8
Q ss_pred HHhhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEE
Q 002349 595 RMTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLL 671 (933)
Q Consensus 595 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 671 (933)
...++|+..+.||+|+||+||+|.+. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 35678999999999999999999975 57899999987644 3345678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeC---CCCCeEEeeccccc
Q 002349 672 FYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLD---KDFEAHLTDFGIAK 748 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~---~~~~~kl~DfGla~ 748 (933)
||||+++|+|.+.+. ....+++..+..++.|++.||+|||++ +|+||||||+||+++ .++.+||+|||+++
T Consensus 88 v~E~~~gg~L~~~i~---~~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 88 IFDLVTGGELFEDIV---AREYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp EECCCBCCBHHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEEeCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 999999999999985 356799999999999999999999966 999999999999998 46789999999998
Q ss_pred ccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccc
Q 002349 749 SLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEI 828 (933)
Q Consensus 749 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 828 (933)
...... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+......................+
T Consensus 162 ~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~-- 238 (444)
T 3soa_A 162 EVEGEQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWD-- 238 (444)
T ss_dssp CCCTTC-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTT--
T ss_pred EecCCC-ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccc--
Confidence 764322 22334679999999999999999999999999999999999999998765544443332222211111111
Q ss_pred cccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 829 SATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 829 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
..+..+.+++.+|++.||++|||++|++++
T Consensus 239 -------~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 239 -------TVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp -------TSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -------cCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 123578899999999999999999999985
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=361.44 Aligned_cols=262 Identities=23% Similarity=0.272 Sum_probs=205.5
Q ss_pred hhccCcceeeecccceeEEEEEEcCCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYD 674 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 674 (933)
.++|+..+.||+|+||+||+|.+.+++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 46899999999999999999999889999999996543 2335678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCC
Q 002349 675 FMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSK 754 (933)
Q Consensus 675 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 754 (933)
|+++ +|.+.+. .....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 100 ~~~~-~l~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 100 FMEK-DLKKVLD--ENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp CCSE-EHHHHHH--TCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred CCCC-CHHHHHH--hccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 9985 8888886 3445699999999999999999999966 99999999999999999999999999998764322
Q ss_pred CceeeeecccccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccc---
Q 002349 755 SYTSTYIMGTIGYIDPEYART-SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISA--- 830 (933)
Q Consensus 755 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 830 (933)
.......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+..............+.......+....
T Consensus 174 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 252 (311)
T 3niz_A 174 -RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPL 252 (311)
T ss_dssp -C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHH
T ss_pred -ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccch
Confidence 22334578999999999876 5689999999999999999999999986555444433222111111000000000
Q ss_pred --------cc-cC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 831 --------TC-KD-----LGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 831 --------~~-~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.. .. .....++.+++.+|++.||++|||++|++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp HHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00 00 0123578899999999999999999999974
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=368.20 Aligned_cols=254 Identities=20% Similarity=0.301 Sum_probs=211.8
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEe
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
.++|+..+.||+|+||.||+|.++ +++.||+|++..........+.+|++++++++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 467999999999999999999976 5788999999776655667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCC--CCCeEEeecccccccccC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDK--DFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~--~~~~kl~DfGla~~~~~~ 753 (933)
+++|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++. .+.+||+|||+++.....
T Consensus 130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999999952 345799999999999999999999966 9999999999999974 477999999999876433
Q ss_pred CCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccccc
Q 002349 754 KSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCK 833 (933)
Q Consensus 754 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (933)
. ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.................... ...
T Consensus 205 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~----~~~--- 275 (387)
T 1kob_A 205 E--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDED----AFS--- 275 (387)
T ss_dssp S--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSS----TTT---
T ss_pred c--ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcc----ccc---
Confidence 2 2334579999999999999999999999999999999999999998766544443322221111111 100
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 834 DLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 834 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
..+..+.+++.+||+.||++|||++|++++-
T Consensus 276 --~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp 306 (387)
T 1kob_A 276 --SVSPEAKDFIKNLLQKEPRKRLTVHDALEHP 306 (387)
T ss_dssp --TSCHHHHHHHHTTSCSSGGGSCCHHHHHTST
T ss_pred --cCCHHHHHHHHHHcCCChhHCcCHHHHhhCc
Confidence 1235788999999999999999999999853
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=383.25 Aligned_cols=261 Identities=25% Similarity=0.398 Sum_probs=214.9
Q ss_pred hhccCcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEec
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFM 676 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 676 (933)
.++|...+.||+|+||.||+|.+++++.||||+++... ...+.|.+|++++++++|||||++++++. .+..++||||+
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~ 264 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM 264 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence 46888899999999999999999888999999997654 34678999999999999999999999986 66789999999
Q ss_pred CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCc
Q 002349 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY 756 (933)
Q Consensus 677 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 756 (933)
++|+|.++++.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 265 ~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 340 (454)
T 1qcf_A 265 AKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 340 (454)
T ss_dssp TTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHH
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCcee
Confidence 999999999631 123689999999999999999999966 9999999999999999999999999999876432222
Q ss_pred eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCccccccccCH
Q 002349 757 TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDL 835 (933)
Q Consensus 757 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (933)
......+++.|+|||++.+..++.++|||||||++|||++ |+.||.+............ .. ....+ .
T Consensus 341 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~-~~------~~~~~-----~ 408 (454)
T 1qcf_A 341 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER-GY------RMPRP-----E 408 (454)
T ss_dssp TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHH-TC------CCCCC-----T
T ss_pred ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CC------CCCCC-----C
Confidence 2233456789999999999999999999999999999999 9999986544333222111 11 11111 1
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCCCCCC
Q 002349 836 GAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAPEP 875 (933)
Q Consensus 836 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~ 875 (933)
.++..+.+++.+||+.||++|||+++|++.|+.+..+...
T Consensus 409 ~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~ 448 (454)
T 1qcf_A 409 NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATES 448 (454)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCC
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcccc
Confidence 2346789999999999999999999999999998765543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=376.36 Aligned_cols=261 Identities=22% Similarity=0.212 Sum_probs=212.2
Q ss_pred HHHHHHhhccCcceeeecccceeEEEEEEcC-CceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecC
Q 002349 591 EDIMRMTENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSS 666 (933)
Q Consensus 591 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 666 (933)
.++....++|+..+.||+|+||+||+|+++. ++.||+|++.... ....+.+.+|+.+++.++|||||++++++.++
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 3444556899999999999999999999874 7889999986532 12234578999999999999999999999999
Q ss_pred CccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccc
Q 002349 667 SGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGI 746 (933)
Q Consensus 667 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl 746 (933)
+..++||||+++|+|.++++ ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~----~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMS----NYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccce
Confidence 99999999999999999995 24689999999999999999999966 999999999999999999999999999
Q ss_pred ccccccCCCceeeeecccccccCccccccCC----CCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccccccc
Q 002349 747 AKSLCVSKSYTSTYIMGTIGYIDPEYARTSR----LTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVME 822 (933)
Q Consensus 747 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 822 (933)
|+.............+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+..................-
T Consensus 215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~ 294 (410)
T 3v8s_A 215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF 294 (410)
T ss_dssp CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCC
T ss_pred eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccC
Confidence 9876544333444678999999999998765 789999999999999999999999876554443332221111110
Q ss_pred ccCccccccccCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHHc
Q 002349 823 TVDPEISATCKDLGAVKKVFQLALLCSKRQPTD--RPTMHEVSRVLG 867 (933)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~L~ 867 (933)
.... ..+..+.+++.+|+..+|.+ ||+++||+++-.
T Consensus 295 p~~~---------~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~ 332 (410)
T 3v8s_A 295 PDDN---------DISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 332 (410)
T ss_dssp CTTC---------CCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGG
T ss_pred CCcc---------cccHHHHHHHHHHccChhhhCCCCCHHHHhcCcc
Confidence 0000 12356888999999999988 999999998643
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=381.33 Aligned_cols=265 Identities=28% Similarity=0.398 Sum_probs=212.0
Q ss_pred hhccCcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEec
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFM 676 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 676 (933)
.++|+..+.||+|+||.||+|.++++..||||+++... ...++|.+|++++++++||||+++++++.. +..++||||+
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~ 260 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 260 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence 46788899999999999999999988889999997654 235789999999999999999999999876 6789999999
Q ss_pred CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCc
Q 002349 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY 756 (933)
Q Consensus 677 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 756 (933)
++|+|.++++. .....+++.++..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 261 ~~gsL~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 336 (452)
T 1fmk_A 261 SKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 336 (452)
T ss_dssp TTCBHHHHHSH-HHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred cCCCHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCcee
Confidence 99999999952 1234689999999999999999999966 9999999999999999999999999999876433333
Q ss_pred eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCccccccccCH
Q 002349 757 TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDL 835 (933)
Q Consensus 757 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (933)
......+++.|+|||.+.+..++.++|||||||++|||++ |+.||.+............ + .....+ .
T Consensus 337 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~--~-----~~~~~~-----~ 404 (452)
T 1fmk_A 337 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER--G-----YRMPCP-----P 404 (452)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT--T-----CCCCCC-----T
T ss_pred cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc--C-----CCCCCC-----C
Confidence 3334567889999999999999999999999999999999 9999986554333222111 1 011111 1
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCCCCCCCCCC
Q 002349 836 GAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAPEPQKQP 879 (933)
Q Consensus 836 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~~ 879 (933)
.++..+.+++.+||+.||++|||++++++.|+.+.....++.++
T Consensus 405 ~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~~~ 448 (452)
T 1fmk_A 405 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 448 (452)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCC
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCccccc
Confidence 23467889999999999999999999999999988766665543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=356.91 Aligned_cols=261 Identities=21% Similarity=0.285 Sum_probs=204.1
Q ss_pred hccCcceeeecccceeEEEEEEcCCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEe
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
++|+..+.||+|+||+||+|....++.||+|++.... ....+.+.+|++++++++||||+++++++..++..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5788999999999999999999888999999996543 22347788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS 755 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 755 (933)
+++ +|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV- 154 (288)
T ss_dssp CSE-EHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc-
Confidence 985 89998863 346799999999999999999999966 99999999999999999999999999998754322
Q ss_pred ceeeeecccccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccccccc----------cc
Q 002349 756 YTSTYIMGTIGYIDPEYARTS-RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVME----------TV 824 (933)
Q Consensus 756 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------~~ 824 (933)
.......||+.|+|||++.+. .++.++||||+||++|||++|+.||.+..............+.... ..
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T 1ob3_A 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccc
Confidence 222345789999999999764 5899999999999999999999999876554443332211110000 00
Q ss_pred Cccccccc------cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 825 DPEISATC------KDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 825 ~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
++.+.... .....+..+.+++.+|++.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 01000000 000124678899999999999999999999874
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=395.77 Aligned_cols=417 Identities=22% Similarity=0.204 Sum_probs=347.3
Q ss_pred cEEEEEcCCCCcCcccCCCCCCCCCccEEEccCCcccccCCCCccCCCCCceecccccccCCCCCcccccccchhhhhhc
Q 002349 69 TVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILK 148 (933)
Q Consensus 69 ~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~ 148 (933)
..+.|||++|.|++..+.+|.++++|++|+|++|+|++..+..|+++++|++|+|++|++++..+..|+++++|++|+|+
T Consensus 77 ~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls 156 (635)
T 4g8a_A 77 ELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVA 156 (635)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECC
T ss_pred CCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccc
Confidence 67899999999998778899999999999999999997666789999999999999999998777789999999999999
Q ss_pred ccCccC-CCCcccccCCCCceeeeecCCCCCCcccccccCCCCc----EEeccCccccCccCcCCcCCCCCcEEcccccc
Q 002349 149 NNQLIG-PIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLW----YFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQ 223 (933)
Q Consensus 149 ~n~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~----~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~ 223 (933)
+|.+++ .+|..++.+++|++|+|++|++++..+..+..+.+++ .++++.|.++...+..+ ....++.+++++|.
T Consensus 157 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~-~~~~~~~l~l~~n~ 235 (635)
T 4g8a_A 157 HNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF-KEIRLHKLTLRNNF 235 (635)
T ss_dssp SSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTT-TTCEEEEEEEESCC
T ss_pred cCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccc-cchhhhhhhhhccc
Confidence 999976 4688899999999999999999988888887665543 57778887764333322 22233334443332
Q ss_pred ccC-----------------------------------------------------------------------------
Q 002349 224 LSG----------------------------------------------------------------------------- 226 (933)
Q Consensus 224 l~~----------------------------------------------------------------------------- 226 (933)
.+.
T Consensus 236 ~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~ 315 (635)
T 4g8a_A 236 DSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVS 315 (635)
T ss_dssp SSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEES
T ss_pred ccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhcccccccccc
Confidence 110
Q ss_pred ----cCCCCccccccceEeccccccccccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCC--CCC
Q 002349 227 ----EIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTG--HIP 300 (933)
Q Consensus 227 ----~~p~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~p 300 (933)
.++.......++.|++.+|.+....+. .+..|+.++++.|.+... ....++++|+.|++++|.+.. ..+
T Consensus 316 ~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~---~l~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~ 390 (635)
T 4g8a_A 316 VTIERVKDFSYNFGWQHLELVNCKFGQFPTL---KLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCS 390 (635)
T ss_dssp CEEEECGGGGSCCCCSEEEEESCEESSCCCC---BCTTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECC
T ss_pred cccccccccccchhhhhhhcccccccCcCcc---cchhhhhcccccccCCCC--cccccccccccchhhccccccccccc
Confidence 000000112467788888887755443 467889999999987743 345578999999999999863 445
Q ss_pred CccccCCcceEeeeccccccccCCccccccccccccccccccCCCCC-CCCcccCCCCCceeccCcccCCCCCccccccc
Q 002349 301 PELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPI-PDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLE 379 (933)
Q Consensus 301 ~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~-p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~ 379 (933)
..+..+.+|++|++..|.+. ..+..+..+++|+.+++..|+..... +..+..+.+++.+++++|++.+..+..+..++
T Consensus 391 ~~~~~~~~L~~L~~~~~~~~-~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~ 469 (635)
T 4g8a_A 391 QSDFGTISLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS 469 (635)
T ss_dssp HHHHSCSCCCEEECCSCSEE-EECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCT
T ss_pred cchhhhhhhhhhhccccccc-cccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccch
Confidence 66778899999999999998 45667889999999999988876544 45688999999999999999999999999999
Q ss_pred ccceecCCcccc-cCCCccccccccccceeeccCCccCCCCCCCCCCccccccccccCcccccccccccccccccceEEc
Q 002349 380 SMTYLNLSLNNI-RGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDL 458 (933)
Q Consensus 380 ~L~~L~L~~N~l-~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 458 (933)
+|+.|+|++|.+ .+..|..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|.++++|++|||
T Consensus 470 ~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L 549 (635)
T 4g8a_A 470 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDY 549 (635)
T ss_dssp TCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEEC
T ss_pred hhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEEC
Confidence 999999999985 4467888999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCccccccchhhccc-cccceeeecCCCCcCccc
Q 002349 459 SHNHLTGVIPEELSQL-QNMFSLRLDYNNLSGDVM 492 (933)
Q Consensus 459 s~N~l~~~~p~~~~~l-~~L~~L~l~~N~l~~~~~ 492 (933)
++|+|++..|..+..+ ++|+.|+|++|+|+|...
T Consensus 550 s~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 550 SLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 584 (635)
T ss_dssp TTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred CCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence 9999999999999998 689999999999999754
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=367.72 Aligned_cols=250 Identities=22% Similarity=0.256 Sum_probs=203.2
Q ss_pred HhhccCcceeeecccceeEEEEEEcC-CceEEEEEecccC---chhHHHHHHHHHHHhcC-CCCceeeeeeEEecCCccE
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHY---PQCLKEFETELETVGSI-KHRNLVSLQGYSLSSSGNL 670 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 670 (933)
..++|+..+.||+|+||+||+|+++. ++.||||++.... ....+.+.+|.++++.+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 34789999999999999999999764 7899999997542 23456678899999988 7999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccc
Q 002349 671 LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSL 750 (933)
Q Consensus 671 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~ 750 (933)
+||||+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+..
T Consensus 101 lv~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQ---KSRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeec
Confidence 9999999999999995 346799999999999999999999976 9999999999999999999999999999854
Q ss_pred ccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccc
Q 002349 751 CVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISA 830 (933)
Q Consensus 751 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (933)
.. ........+||+.|+|||++.+..++.++||||+||++|||++|+.||.+................. +.
T Consensus 175 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~--------p~ 245 (353)
T 3txo_A 175 IC-NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY--------PT 245 (353)
T ss_dssp CC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--------CT
T ss_pred cc-CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC--------CC
Confidence 22 2223445689999999999999899999999999999999999999998765544433332221111 11
Q ss_pred cccCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHH
Q 002349 831 TCKDLGAVKKVFQLALLCSKRQPTDRPTM------HEVSRV 865 (933)
Q Consensus 831 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~------~evl~~ 865 (933)
. ....+.+++.+|++.||++||++ +|++++
T Consensus 246 ~-----~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 246 W-----LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp T-----SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred C-----CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 1 13567889999999999999998 777753
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=372.55 Aligned_cols=257 Identities=24% Similarity=0.346 Sum_probs=209.5
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYD 674 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 674 (933)
.++|...+.||+|+||.||+|.++ +++.||||+++... ....++|.+|++++++++||||+++++++..++..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 357888999999999999999987 67899999987653 2334568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCC
Q 002349 675 FMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSK 754 (933)
Q Consensus 675 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 754 (933)
|+++|+|.++++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 193 ~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 193 LVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp CCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred cCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 9999999999962 345689999999999999999999966 99999999999999999999999999998643221
Q ss_pred Ccee-eeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCccccccc
Q 002349 755 SYTS-TYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISATC 832 (933)
Q Consensus 755 ~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (933)
.... ....+++.|+|||.+.+..++.++|||||||++|||++ |+.||.+............ .. ....+.
T Consensus 268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~--~~-----~~~~~~-- 338 (377)
T 3cbl_A 268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK--GG-----RLPCPE-- 338 (377)
T ss_dssp EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHT--TC-----CCCCCT--
T ss_pred eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc--CC-----CCCCCC--
Confidence 1111 11235778999999999899999999999999999998 9999986544333222111 11 011111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCC
Q 002349 833 KDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLV 870 (933)
Q Consensus 833 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 870 (933)
.++..+.+++.+||+.||++|||++++++.|+.+.
T Consensus 339 ---~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 339 ---LCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp ---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 12457889999999999999999999999997653
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=356.62 Aligned_cols=254 Identities=22% Similarity=0.323 Sum_probs=206.6
Q ss_pred hccCcceeeecccceeEEEEEEcC-C-------ceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCcc
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKN-C-------KPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGN 669 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 669 (933)
++|...+.||+|+||+||+|.+.. + +.||+|++........+.+.+|++++++++||||+++++++..++..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 578899999999999999999664 2 46999999776666778899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCC--------eEE
Q 002349 670 LLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFE--------AHL 741 (933)
Q Consensus 670 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~--------~kl 741 (933)
++||||+++|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++. +||
T Consensus 88 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKK--NKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp EEEEECCTTCBHHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred EEEEECCCCCCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeee
Confidence 999999999999999963 334599999999999999999999966 9999999999999998887 999
Q ss_pred eecccccccccCCCceeeeecccccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccccc
Q 002349 742 TDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYART-SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAV 820 (933)
Q Consensus 742 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 820 (933)
+|||++...... ....||+.|+|||++.+ ..++.++||||+|+++|||++|..|+...................
T Consensus 163 ~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 237 (289)
T 4fvq_A 163 SDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQL 237 (289)
T ss_dssp CCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC
T ss_pred ccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCCC
Confidence 999999764321 23458899999999987 678999999999999999999665554443333322222111111
Q ss_pred ccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCCCCC
Q 002349 821 METVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAPE 874 (933)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 874 (933)
.. .. +..+.+++.+||+.||++|||++|+++.|+.+.....
T Consensus 238 ~~----~~---------~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~ 278 (289)
T 4fvq_A 238 PA----PK---------AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL 278 (289)
T ss_dssp CC----CS---------SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred CC----CC---------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence 11 11 2357789999999999999999999999999876443
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=362.94 Aligned_cols=257 Identities=24% Similarity=0.384 Sum_probs=198.9
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCcc---
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGN--- 669 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~--- 669 (933)
.++|+..+.||+|+||.||+|++. +++.||||++.... ......+.+|++++++++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 368999999999999999999974 57899999997643 23456789999999999999999999998766544
Q ss_pred -EEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccc
Q 002349 670 -LLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAK 748 (933)
Q Consensus 670 -~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 748 (933)
++||||+++++|.++++ ..+.+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 91 ~~lv~e~~~g~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 99999999999999995 345799999999999999999999976 99999999999999999999999999998
Q ss_pred ccccCCC--ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCc
Q 002349 749 SLCVSKS--YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDP 826 (933)
Q Consensus 749 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 826 (933)
....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.+.....................
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-- 242 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR-- 242 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHH--
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccc--
Confidence 7643222 223345799999999999999999999999999999999999999987654443322221111111000
Q ss_pred cccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH-HHcc
Q 002349 827 EISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSR-VLGS 868 (933)
Q Consensus 827 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~-~L~~ 868 (933)
....+..+.+++.+||+.||++||++.++++ .+..
T Consensus 243 -------~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 278 (311)
T 3ork_A 243 -------HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 278 (311)
T ss_dssp -------STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred -------cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence 0112457889999999999999997666554 4433
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=350.17 Aligned_cols=253 Identities=28% Similarity=0.427 Sum_probs=197.2
Q ss_pred hccCcceeeecccceeEEEEEEcCCceEEEEEecccC----chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHY----PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
++|+..+.||+|+||.||+|.+. ++.||||+++... ....+.+.+|+++++.++||||+++++++..++..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 57889999999999999999976 6889999986543 233567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCC--------CCCeEEeecc
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDK--------DFEAHLTDFG 745 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~--------~~~~kl~DfG 745 (933)
||+++++|.+++. ...+++..+..++.|++.||+|||++...+|+||||||+||+++. ++.+||+|||
T Consensus 86 e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 86 EFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp ECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 9999999999984 457999999999999999999999761122999999999999986 6789999999
Q ss_pred cccccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccC
Q 002349 746 IAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVD 825 (933)
Q Consensus 746 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (933)
+++...... .....||+.|+|||.+.+..+++++||||+|+++|+|++|+.||.+.............. . .
T Consensus 162 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~----~ 232 (271)
T 3dtc_A 162 LAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK--L----A 232 (271)
T ss_dssp C----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSC--C----C
T ss_pred ccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCC--C----C
Confidence 998653322 224579999999999999999999999999999999999999998655443332221111 1 1
Q ss_pred ccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccC
Q 002349 826 PEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869 (933)
Q Consensus 826 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 869 (933)
...+. ..+..+.+++.+|++.||++|||++|++++|+.+
T Consensus 233 ~~~~~-----~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 233 LPIPS-----TCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CCCCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CCCCc-----ccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 11111 1235788999999999999999999999999753
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=354.06 Aligned_cols=256 Identities=24% Similarity=0.345 Sum_probs=198.0
Q ss_pred hhccCcceeeecccceeEEEEEEcC----CceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKN----CKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLL 671 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 671 (933)
.++|+..+.||+|+||.||+|.+.. +..||+|++.... ....+.+.+|+.++++++||||+++++++. .+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 4688999999999999999999753 4569999987643 344567899999999999999999999984 567899
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccc
Q 002349 672 FYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLC 751 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 751 (933)
||||+++++|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 93 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 93 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccC
Confidence 9999999999999963 345799999999999999999999976 99999999999999999999999999998765
Q ss_pred cCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCccccc
Q 002349 752 VSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISA 830 (933)
Q Consensus 752 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (933)
...........+|+.|+|||.+.+..++.++||||||+++|||++ |..||.+.............. . .....
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~--~-----~~~~~ 240 (281)
T 1mp8_A 168 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE--R-----LPMPP 240 (281)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC--C-----CCCCT
T ss_pred cccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCC--C-----CCCCC
Confidence 443333444567889999999999999999999999999999997 999998655443332221111 0 11111
Q ss_pred cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCC
Q 002349 831 TCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLV 870 (933)
Q Consensus 831 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 870 (933)
..+..+.+++.+|++.||++|||+.|+++.|+.+.
T Consensus 241 -----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 241 -----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp -----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 12467889999999999999999999999987653
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=349.47 Aligned_cols=255 Identities=28% Similarity=0.377 Sum_probs=212.1
Q ss_pred hccCcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecC
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFME 677 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 677 (933)
++|+..+.||+|+||.||+|.+.+++.||+|++..... ..+.+.+|++++++++||||+++++++..++..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 57888999999999999999998888999999976543 34678999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCce
Q 002349 678 NGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYT 757 (933)
Q Consensus 678 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 757 (933)
+++|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.........
T Consensus 87 ~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 161 (267)
T 3t9t_A 87 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 161 (267)
T ss_dssp TCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CCcHHHHHhh--CcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccccc
Confidence 9999999963 345789999999999999999999966 99999999999999999999999999998754322222
Q ss_pred eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCccccccccCHH
Q 002349 758 STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLG 836 (933)
Q Consensus 758 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (933)
.....+++.|+|||++.+..++.++||||+|+++|+|++ |+.||................ ....+. .
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~-------~~~~~~-----~ 229 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF-------RLYKPR-----L 229 (267)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-------CCCCCT-----T
T ss_pred cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC-------cCCCCc-----c
Confidence 233457889999999999999999999999999999999 899998654433322211110 011111 1
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCC
Q 002349 837 AVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLV 870 (933)
Q Consensus 837 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 870 (933)
.+..+.+++.+|++.||++|||++++++.|+.+.
T Consensus 230 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 230 ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 2357889999999999999999999999998754
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=356.51 Aligned_cols=257 Identities=25% Similarity=0.364 Sum_probs=201.2
Q ss_pred hhccCcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhc--CCCCceeeeeeEEec----CCccE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGS--IKHRNLVSLQGYSLS----SSGNL 670 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~----~~~~~ 670 (933)
.++|+..+.||+|+||+||+|.+ +++.||||++... ....+.+|.+++.. ++||||+++++++.. ....+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46899999999999999999998 5789999998653 23455666666666 799999999998654 34578
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhh--------cCCCCCeeeccCCCCceEeCCCCCeEEe
Q 002349 671 LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLH--------HDCSPRIIHRDVKSSNILLDKDFEAHLT 742 (933)
Q Consensus 671 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~ivH~Dikp~NIll~~~~~~kl~ 742 (933)
+||||+++|+|.++++ ...+++..+..++.|++.||+||| +. +|+||||||+||+++.++.+||+
T Consensus 83 lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEEC
T ss_pred EehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEe
Confidence 9999999999999994 357999999999999999999999 55 99999999999999999999999
Q ss_pred ecccccccccCCCce---eeeecccccccCccccccC------CCCcchhhHHHHHHHHHHHhC----------CCCCCC
Q 002349 743 DFGIAKSLCVSKSYT---STYIMGTIGYIDPEYARTS------RLTEKSDVYSFGIVLLELLTG----------RKAVDN 803 (933)
Q Consensus 743 DfGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~DvwSlGv~l~elltg----------~~p~~~ 803 (933)
|||+|+......... .....||+.|+|||++.+. .+++++|||||||++|||++| +.||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 999998664333222 2234799999999999876 455799999999999999999 888864
Q ss_pred Ccc----hhHHHHhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccC
Q 002349 804 ECN----LHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869 (933)
Q Consensus 804 ~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 869 (933)
... ......... .....+..+........+..+.+++.+||+.||++|||++||++.|+.+
T Consensus 236 ~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 236 VVPNDPSFEDMRKVVC-----VDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TSCSSCCHHHHHHHHT-----TSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCcchhhhhHHHh-----ccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 221 111111111 1111222222222234678899999999999999999999999998753
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=355.53 Aligned_cols=266 Identities=19% Similarity=0.242 Sum_probs=209.3
Q ss_pred hccCcceeeecccceeEEEEEEcC-CceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCC--ccEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSS--GNLLFY 673 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~ 673 (933)
++|...+.||+|+||+||+|.+.. ++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 578999999999999999999875 7899999997543 334677889999999999999999999988765 679999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEe----CCCCCeEEeecccccc
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILL----DKDFEAHLTDFGIAKS 749 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll----~~~~~~kl~DfGla~~ 749 (933)
||+++++|.+++........+++..+..++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 9999999999997544444599999999999999999999976 99999999999999 7888899999999987
Q ss_pred cccCCCceeeeecccccccCccccc--------cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcch---hHHHHhhhccc
Q 002349 750 LCVSKSYTSTYIMGTIGYIDPEYAR--------TSRLTEKSDVYSFGIVLLELLTGRKAVDNECNL---HHLILSKTANN 818 (933)
Q Consensus 750 ~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~---~~~~~~~~~~~ 818 (933)
..... ......||+.|+|||++. +..++.++|||||||++|||++|+.||...... ......... .
T Consensus 166 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-~ 242 (319)
T 4euu_A 166 LEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT-G 242 (319)
T ss_dssp CCTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH-H
T ss_pred cCCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc-C
Confidence 64332 223457999999999886 567899999999999999999999999632221 111111111 0
Q ss_pred cccc---c----------cCccccc-cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccC
Q 002349 819 AVME---T----------VDPEISA-TCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869 (933)
Q Consensus 819 ~~~~---~----------~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 869 (933)
.... . ....++. ..........+.+++.+|++.||++|||++|++++..+.
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 0000 0 0001110 011235567888999999999999999999999988654
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=356.36 Aligned_cols=257 Identities=30% Similarity=0.463 Sum_probs=200.7
Q ss_pred hccCcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecC
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFME 677 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 677 (933)
++|+..+.||+|+||+||+|.+. ++.||||++... ...+.+.+|++++++++||||+++++++. +..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 57888999999999999999986 588999998654 34578999999999999999999999886 45899999999
Q ss_pred CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCC-eEEeecccccccccCCCc
Q 002349 678 NGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFE-AHLTDFGIAKSLCVSKSY 756 (933)
Q Consensus 678 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~-~kl~DfGla~~~~~~~~~ 756 (933)
+|+|.++++.......+++..++.++.|+++||+|||+....+|+||||||+||+++.++. +||+|||+++.....
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 9999999975333345789999999999999999999732258999999999999998887 799999999765321
Q ss_pred eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHH
Q 002349 757 TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLG 836 (933)
Q Consensus 757 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (933)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||.................. .+.... .
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-----~~~~~~-----~ 228 (307)
T 2eva_A 160 -MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT-----RPPLIK-----N 228 (307)
T ss_dssp ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTC-----CCCCBT-----T
T ss_pred -cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCC-----CCCccc-----c
Confidence 22346999999999999999999999999999999999999999754322211111111111 111111 1
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCCCC
Q 002349 837 AVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAP 873 (933)
Q Consensus 837 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 873 (933)
.+..+.+++.+|++.||++|||++++++.|+.+....
T Consensus 229 ~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 229 LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 2357889999999999999999999999998765433
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=356.20 Aligned_cols=246 Identities=24% Similarity=0.302 Sum_probs=207.3
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLF 672 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 672 (933)
.++|+..+.||+|+||+||+|+.+ +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 367899999999999999999976 58899999996542 23456788999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccccc
Q 002349 673 YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV 752 (933)
Q Consensus 673 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 752 (933)
|||+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 99999999999995 356799999999999999999999965 999999999999999999999999999987532
Q ss_pred CCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccc
Q 002349 753 SKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATC 832 (933)
Q Consensus 753 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (933)
.....+||+.|+|||++.+..++.++||||+||++|||++|+.||.+................ ++.
T Consensus 159 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~--------~p~-- 224 (318)
T 1fot_A 159 ----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELR--------FPP-- 224 (318)
T ss_dssp ----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCC--------CCT--
T ss_pred ----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--------CCC--
Confidence 123457999999999999999999999999999999999999999876554443322221111 111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002349 833 KDLGAVKKVFQLALLCSKRQPTDRP-----TMHEVSRV 865 (933)
Q Consensus 833 ~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 865 (933)
..+..+.+++.+|++.||++|| ++++++++
T Consensus 225 ---~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 225 ---FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp ---TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 1135688899999999999999 89999864
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=374.22 Aligned_cols=264 Identities=20% Similarity=0.227 Sum_probs=214.0
Q ss_pred HHHHHHHhhccCcceeeecccceeEEEEEEcC-CceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEec
Q 002349 590 YEDIMRMTENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLS 665 (933)
Q Consensus 590 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 665 (933)
+.++....++|+..++||+|+||+||+|+++. ++.||+|++.... ....+.+.+|+.++..++||||+++++++.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 44455567899999999999999999999875 6889999996532 1223348899999999999999999999999
Q ss_pred CCccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecc
Q 002349 666 SSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFG 745 (933)
Q Consensus 666 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfG 745 (933)
++..++||||+++|+|.++++. ....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~--~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSK--FEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEecCCCCcHHHHHHH--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchh
Confidence 9999999999999999999963 356799999999999999999999966 99999999999999999999999999
Q ss_pred cccccccCCCceeeeecccccccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccccc
Q 002349 746 IAKSLCVSKSYTSTYIMGTIGYIDPEYAR-----TSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAV 820 (933)
Q Consensus 746 la~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 820 (933)
+|+.............+||+.|+|||++. ...++.++||||+||++|||++|+.||.+.................
T Consensus 221 la~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~ 300 (437)
T 4aw2_A 221 SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF 300 (437)
T ss_dssp TCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC
T ss_pred hhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccc
Confidence 99876544444445568999999999987 4578999999999999999999999998766554443322111110
Q ss_pred ccccCccccccccCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHH
Q 002349 821 METVDPEISATCKDLGAVKKVFQLALLCSKRQPTD--RPTMHEVSRVL 866 (933)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~L 866 (933)
.++.... ..+..+.+++.+|+..+|++ ||+++|++++-
T Consensus 301 --~~p~~~~------~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hp 340 (437)
T 4aw2_A 301 --QFPTQVT------DVSENAKDLIRRLICSREHRLGQNGIEDFKKHP 340 (437)
T ss_dssp --CCCSSCC------CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSG
T ss_pred --cCCcccc------cCCHHHHHHHHHHhcccccccCCCCHHHHhCCC
Confidence 0111101 12356788999999888888 99999998753
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=361.42 Aligned_cols=256 Identities=25% Similarity=0.357 Sum_probs=202.6
Q ss_pred hccCcceeeecccceeEEEEEEcC-Cc----eEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKN-CK----PVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLL 671 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 671 (933)
++|+..+.||+|+||+||+|++.. ++ +||+|.+.... ....+++.+|++++++++||||+++++++..+. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 578899999999999999999653 33 46888886543 345678999999999999999999999998754 789
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccc
Q 002349 672 FYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLC 751 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 751 (933)
|+||+++|+|.+++.. ....+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+|+...
T Consensus 94 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 94 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCTTCBHHHHHHH--STTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 9999999999999963 456799999999999999999999976 99999999999999999999999999998764
Q ss_pred cCCCc-eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCcccc
Q 002349 752 VSKSY-TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEIS 829 (933)
Q Consensus 752 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (933)
..... ......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.............. . ...+
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~------~~~~ 241 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-R------LPQP 241 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-C------CCCC
T ss_pred CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCC-C------CCCC
Confidence 33322 2233467889999999999999999999999999999999 999998654433222111111 0 0001
Q ss_pred ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCC
Q 002349 830 ATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVP 871 (933)
Q Consensus 830 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 871 (933)
...+..+.+++.+||+.||++|||++++++.|+.+..
T Consensus 242 -----~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 242 -----PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp -----TTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred -----ccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1123578899999999999999999999999987654
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=356.11 Aligned_cols=263 Identities=25% Similarity=0.397 Sum_probs=205.1
Q ss_pred hccCcceeeecccceeEEEEEEc-----CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecC--CccE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-----NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSS--SGNL 670 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~ 670 (933)
++|+..+.||+|+||+||+|++. +++.||||++........+.+.+|++++++++||||+++++++... ...+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 68899999999999999999852 5789999999877666678899999999999999999999998653 5589
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccc
Q 002349 671 LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSL 750 (933)
Q Consensus 671 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~ 750 (933)
+||||+++|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 90 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp EEEECCTTCBHHHHHHH--CGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred EEEEeCCCCCHHHHHHh--cccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 99999999999999963 344699999999999999999999966 9999999999999999999999999999876
Q ss_pred ccCCCc--eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcc---------cc
Q 002349 751 CVSKSY--TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTAN---------NA 819 (933)
Q Consensus 751 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~---------~~ 819 (933)
...... ......++..|+|||.+.+..++.++||||||+++|||++|..|+................ ..
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (295)
T 3ugc_A 165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244 (295)
T ss_dssp -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHH
Confidence 433221 1223457788999999999999999999999999999999999986432111000000000 00
Q ss_pred cccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCC
Q 002349 820 VMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLV 870 (933)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 870 (933)
......... ....+..+.+++.+||+.||++|||++|+++.|+.+.
T Consensus 245 ~~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~ 290 (295)
T 3ugc_A 245 LKNNGRLPR-----PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290 (295)
T ss_dssp HHTTCCCCC-----CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhccCcCCC-----CcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 000001111 1123467899999999999999999999999998764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=369.03 Aligned_cols=269 Identities=23% Similarity=0.329 Sum_probs=215.0
Q ss_pred cCHHHHHHHhhccCcceeeecccceeEEEEEEc------CCceEEEEEecccC-chhHHHHHHHHHHHhcC-CCCceeee
Q 002349 588 HVYEDIMRMTENLSEKYIIGYGASSTVYKCVLK------NCKPVAIKRLYSHY-PQCLKEFETELETVGSI-KHRNLVSL 659 (933)
Q Consensus 588 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~ 659 (933)
+....+....++|+..+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+++++++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 344555566789999999999999999999843 35789999997654 33456799999999999 79999999
Q ss_pred eeEEecCCc-cEEEEEecCCCCHHHHhcCCCC------------------------------------------------
Q 002349 660 QGYSLSSSG-NLLFYDFMENGSLWDILHGPTK------------------------------------------------ 690 (933)
Q Consensus 660 ~~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------ 690 (933)
++++...+. .++||||+++|+|.++++....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999987654 8999999999999999974321
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCC
Q 002349 691 ---------------KKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS 755 (933)
Q Consensus 691 ---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 755 (933)
...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 12289999999999999999999976 999999999999999999999999999986643322
Q ss_pred -ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCcccccccc
Q 002349 756 -YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISATCK 833 (933)
Q Consensus 756 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (933)
.......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+................ ...+.
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~------~~~~~--- 319 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR------MRAPD--- 319 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCC------CCCCT---
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCC------CCCCC---
Confidence 23344578999999999999999999999999999999998 99999865443333222111111 11111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCC
Q 002349 834 DLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLV 870 (933)
Q Consensus 834 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 870 (933)
..+..+.+++.+|++.||++|||++|++++|+.+.
T Consensus 320 --~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 320 --YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp --TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 12357889999999999999999999999998754
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=361.16 Aligned_cols=263 Identities=23% Similarity=0.394 Sum_probs=213.8
Q ss_pred HhhccCcceeeecccceeEEEEEEcC------CceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCc
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLKN------CKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSG 668 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 668 (933)
..++|+..+.||+|+||.||+|.+.+ ++.||||+++... ....+.+.+|++++++++||||+++++++...+.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 45789999999999999999999753 4789999997654 3446779999999999999999999999999999
Q ss_pred cEEEEEecCCCCHHHHhcCCCC---------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCC
Q 002349 669 NLLFYDFMENGSLWDILHGPTK---------------------KKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVK 727 (933)
Q Consensus 669 ~~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik 727 (933)
.++||||+++|+|.+++..... ...+++.+++.++.|++.||+|||++ +|+|||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlk 201 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLA 201 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCC
Confidence 9999999999999999964211 25799999999999999999999976 99999999
Q ss_pred CCceEeCCCCCeEEeecccccccccCCC-ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCc
Q 002349 728 SSNILLDKDFEAHLTDFGIAKSLCVSKS-YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNEC 805 (933)
Q Consensus 728 p~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~ 805 (933)
|+||+++.++.+||+|||+++....... .......||+.|+|||.+.+..++.++||||||+++|||++ |+.||.+..
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 9999999999999999999986643322 22334568899999999999999999999999999999999 999998654
Q ss_pred chhHHHHhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCCCC
Q 002349 806 NLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAP 873 (933)
Q Consensus 806 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 873 (933)
......... .... +..+. ..+..+.+++.+||+.||++|||++++++.|+.+....
T Consensus 282 ~~~~~~~~~--~~~~-----~~~~~-----~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 282 HEEVIYYVR--DGNI-----LACPE-----NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp HHHHHHHHH--TTCC-----CCCCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred hHHHHHHHh--CCCc-----CCCCC-----CCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 433322211 1111 11111 12357889999999999999999999999999887644
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=365.71 Aligned_cols=250 Identities=19% Similarity=0.256 Sum_probs=201.9
Q ss_pred cCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecCC
Q 002349 600 LSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMEN 678 (933)
Q Consensus 600 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 678 (933)
+...+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 170 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG 170 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 344678999999999999975 5889999999876656678899999999999999999999999999999999999999
Q ss_pred CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEe--CCCCCeEEeecccccccccCCCc
Q 002349 679 GSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILL--DKDFEAHLTDFGIAKSLCVSKSY 756 (933)
Q Consensus 679 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll--~~~~~~kl~DfGla~~~~~~~~~ 756 (933)
++|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||+++......
T Consensus 171 ~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~-- 243 (373)
T 2x4f_A 171 GELFDRIID--ESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-- 243 (373)
T ss_dssp CEEHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--
T ss_pred CcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--
Confidence 999998852 345689999999999999999999966 99999999999999 567899999999998764322
Q ss_pred eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHH
Q 002349 757 TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLG 836 (933)
Q Consensus 757 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (933)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.................... ... .
T Consensus 244 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~---~~~------~ 314 (373)
T 2x4f_A 244 KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDE---EFQ------D 314 (373)
T ss_dssp BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSG---GGT------T
T ss_pred ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChh---hhc------c
Confidence 2233469999999999999999999999999999999999999998766554443322221111110 011 1
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 837 AVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 837 ~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.+..+.+++.+|++.||++|||++|++++
T Consensus 315 ~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 315 ISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 23578899999999999999999999973
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=348.70 Aligned_cols=252 Identities=27% Similarity=0.462 Sum_probs=203.0
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccCch-------hHHHHHHHHHHHhcCCCCceeeeeeEEecCCcc
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQ-------CLKEFETELETVGSIKHRNLVSLQGYSLSSSGN 669 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 669 (933)
++|+..+.||+|+||+||+|.+. +++.||+|++...... ..+.+.+|++++++++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 57888999999999999999975 5789999998654321 1267899999999999999999999986554
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--eeeccCCCCceEeCCCCC-----eEEe
Q 002349 670 LLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPR--IIHRDVKSSNILLDKDFE-----AHLT 742 (933)
Q Consensus 670 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dikp~NIll~~~~~-----~kl~ 742 (933)
++||||+++|+|.+.+. .....+++..+..++.|++.||+|||++ + |+||||||+||+++.++. +||+
T Consensus 97 ~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLL--DKAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp EEEEECCTTCBHHHHHH--CTTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred eEEEEecCCCCHHHHHh--cccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 79999999999999886 3456799999999999999999999966 7 999999999999988776 9999
Q ss_pred ecccccccccCCCceeeeecccccccCccccc--cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccccc
Q 002349 743 DFGIAKSLCVSKSYTSTYIMGTIGYIDPEYAR--TSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAV 820 (933)
Q Consensus 743 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 820 (933)
|||+++.... ......||+.|+|||++. ...+++++||||+||++|+|++|+.||...................
T Consensus 172 Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 247 (287)
T 4f0f_A 172 DFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL 247 (287)
T ss_dssp CCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC
T ss_pred CCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC
Confidence 9999975422 234467999999999984 4567899999999999999999999998544333221111111111
Q ss_pred ccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccC
Q 002349 821 METVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869 (933)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 869 (933)
. +.... ..+..+.+++.+||+.||++|||++|+++.|+.+
T Consensus 248 ~----~~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 248 R----PTIPE-----DCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp C----CCCCT-----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred C----CCCCc-----ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 1 11111 1245788999999999999999999999998763
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=363.03 Aligned_cols=250 Identities=22% Similarity=0.297 Sum_probs=206.7
Q ss_pred HHhhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcC-CCCceeeeeeEEecCCcc
Q 002349 595 RMTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSI-KHRNLVSLQGYSLSSSGN 669 (933)
Q Consensus 595 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 669 (933)
...++|...+.||+|+||.||+|+++ +++.||+|+++... ....+.+..|.++++.+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34578999999999999999999986 47889999997542 23456678899999877 999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccc
Q 002349 670 LLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKS 749 (933)
Q Consensus 670 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 749 (933)
++||||+++|+|.+++. ..+.+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 94 ~lv~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 99999999999999995 346799999999999999999999966 999999999999999999999999999986
Q ss_pred cccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccc
Q 002349 750 LCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEIS 829 (933)
Q Consensus 750 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (933)
.... .......+||+.|+|||++.+..++.++||||+||++|||++|+.||.+............... .++
T Consensus 168 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~--------~~p 238 (345)
T 1xjd_A 168 NMLG-DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP--------FYP 238 (345)
T ss_dssp CCCT-TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--------CCC
T ss_pred cccC-CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCC--------CCC
Confidence 4322 2223456899999999999999999999999999999999999999987654443332222111 111
Q ss_pred ccccCHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 002349 830 ATCKDLGAVKKVFQLALLCSKRQPTDRPTMH-EVSR 864 (933)
Q Consensus 830 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-evl~ 864 (933)
.. .+..+.+++.+|++.||++||++. ++.+
T Consensus 239 ~~-----~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 239 RW-----LEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp TT-----SCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred cc-----cCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 11 235688899999999999999997 7764
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=380.32 Aligned_cols=258 Identities=25% Similarity=0.385 Sum_probs=213.5
Q ss_pred hhccCcceeeecccceeEEEEEEcC-CceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEe
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
.++|+..+.||+|+||.||+|.++. ++.||||+++... ...++|.+|++++++++|||||++++++...+..++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 4578889999999999999999875 7889999997654 3467899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS 755 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 755 (933)
+++|+|.++++. .....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 298 ~~~g~L~~~l~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 298 MTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp CTTCBHHHHHHH-SCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred cCCCCHHHHHHh-cCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence 999999999964 2345689999999999999999999966 999999999999999999999999999987643322
Q ss_pred ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCccccccccC
Q 002349 756 YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKD 834 (933)
Q Consensus 756 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (933)
.......+++.|+|||++.+..++.++|||||||++|||++ |+.||.+........... .. .....+
T Consensus 374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~--~~-----~~~~~~----- 441 (495)
T 1opk_A 374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE--KD-----YRMERP----- 441 (495)
T ss_dssp ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH--TT-----CCCCCC-----
T ss_pred eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH--cC-----CCCCCC-----
Confidence 22233456789999999999999999999999999999999 999997654333222111 11 111111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCC
Q 002349 835 LGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVP 871 (933)
Q Consensus 835 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 871 (933)
..++..+.+++.+||+.||++|||+++|++.|+.+..
T Consensus 442 ~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 442 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred CCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 1234678899999999999999999999999998754
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=371.21 Aligned_cols=261 Identities=25% Similarity=0.349 Sum_probs=210.9
Q ss_pred hhccCcceeeecccceeEEEEEEc------CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCcc
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK------NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGN 669 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 669 (933)
.++|+..+.||+|+||+||+|.+. .++.||||++.... .....++.+|+.++++++||||+++++++......
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 367889999999999999999954 35689999997543 44556789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCC----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCC---CeEEe
Q 002349 670 LLFYDFMENGSLWDILHGPT----KKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDF---EAHLT 742 (933)
Q Consensus 670 ~lv~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~---~~kl~ 742 (933)
++||||+++|+|.+++.... ....+++.+++.++.|++.||+|||++ +|+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999996321 224689999999999999999999966 999999999999999554 59999
Q ss_pred ecccccccccCCC-ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhccccc
Q 002349 743 DFGIAKSLCVSKS-YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAV 820 (933)
Q Consensus 743 DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 820 (933)
|||+|+....... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||.................
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~-- 304 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR-- 304 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC--
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--
Confidence 9999986532221 22334568999999999999999999999999999999998 9999986654433322211110
Q ss_pred ccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCCC
Q 002349 821 METVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPA 872 (933)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 872 (933)
..... ..+..+.+++.+||+.||++|||+++|++.|+.+...
T Consensus 305 -----~~~~~-----~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 305 -----MDPPK-----NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp -----CCCCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -----CCCCc-----cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 11111 1235788999999999999999999999999876543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=353.72 Aligned_cols=250 Identities=21% Similarity=0.280 Sum_probs=198.2
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccCc--------------------------hhHHHHHHHHHHHh
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYP--------------------------QCLKEFETELETVG 649 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~ 649 (933)
.++|+..+.||+|+||.||+|.+. +++.||||++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 368999999999999999999975 578899999865421 11356889999999
Q ss_pred cCCCCceeeeeeEEec--CCccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCC
Q 002349 650 SIKHRNLVSLQGYSLS--SSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVK 727 (933)
Q Consensus 650 ~l~h~niv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik 727 (933)
+++||||+++++++.. .+..++||||+++++|.+++ ....+++..+..++.|++.||+|||++ +|+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCC
Confidence 9999999999999986 56789999999999998875 345799999999999999999999976 99999999
Q ss_pred CCceEeCCCCCeEEeecccccccccCCCceeeeecccccccCccccccCC---CCcchhhHHHHHHHHHHHhCCCCCCCC
Q 002349 728 SSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSR---LTEKSDVYSFGIVLLELLTGRKAVDNE 804 (933)
Q Consensus 728 p~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGv~l~elltg~~p~~~~ 804 (933)
|+||+++.++.+||+|||+++...... .......||+.|+|||.+.+.. ++.++|||||||++|+|++|+.||.+.
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSD-ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSS-CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHHEEECCCCCEEEecCCCcccccccc-ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 999999999999999999998764332 2234457999999999998765 478899999999999999999999865
Q ss_pred cchhHHHHhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 805 CNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 805 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
................ +.. ...+..+.+++.+||+.||++|||++|++++
T Consensus 244 ~~~~~~~~~~~~~~~~-----~~~------~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 244 RIMCLHSKIKSQALEF-----PDQ------PDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp SHHHHHHHHHHCCCCC-----CSS------SCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred cHHHHHHHHhcccCCC-----CCc------cccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 4333222111111100 000 0123578899999999999999999999763
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=363.25 Aligned_cols=247 Identities=21% Similarity=0.305 Sum_probs=202.8
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
++|...+.||+|+||+||+|.+. +++.||||++.... ......+.+|+++++.++||||+++++++..++..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 58999999999999999999974 57899999986532 233467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
||+ +|+|.+++. ..+.+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 89 E~~-~g~l~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 89 EYA-GGELFDYIV---EKKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp CCC-CEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred ECC-CCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 999 689999884 346799999999999999999999976 9999999999999999999999999999876433
Q ss_pred CCceeeeecccccccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccc
Q 002349 754 KSYTSTYIMGTIGYIDPEYARTSRL-TEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATC 832 (933)
Q Consensus 754 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (933)
. .....+||+.|+|||++.+..+ ++++||||+||++|+|++|+.||.+........ ..... ...++.
T Consensus 162 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~-------~i~~~-~~~~p~-- 229 (336)
T 3h4j_B 162 N--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK-------KVNSC-VYVMPD-- 229 (336)
T ss_dssp B--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC-------CCCSS-CCCCCT--
T ss_pred c--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH-------HHHcC-CCCCcc--
Confidence 2 2234579999999999988776 789999999999999999999998643211100 00000 011111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 833 KDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 833 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
..+..+.+++.+|++.||.+|||++|++++-
T Consensus 230 ---~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 260 (336)
T 3h4j_B 230 ---FLSPGAQSLIRRMIVADPMQRITIQEIRRDP 260 (336)
T ss_dssp ---TSCHHHHHHHHTTSCSSGGGSCCHHHHTTCH
T ss_pred ---cCCHHHHHHHHHHcCCChhHCcCHHHHHhCh
Confidence 1235688999999999999999999998743
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=350.49 Aligned_cols=260 Identities=28% Similarity=0.394 Sum_probs=211.5
Q ss_pred hhccCcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEec
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFM 676 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 676 (933)
.++|+..+.||+|+||.||+|.+.+++.||||++.... ...+.+.+|++++++++||||+++++++. .+..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence 46888999999999999999999888899999997643 24578999999999999999999999986 45689999999
Q ss_pred CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCc
Q 002349 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY 756 (933)
Q Consensus 677 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 756 (933)
++++|.+++.. .....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++........
T Consensus 90 ~~~~L~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T 1qpc_A 90 ENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (279)
T ss_dssp TTCBHHHHTTS-HHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCCHHHHHhc-CCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence 99999999952 1122689999999999999999999966 9999999999999999999999999999876443322
Q ss_pred eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCccccccccCH
Q 002349 757 TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDL 835 (933)
Q Consensus 757 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (933)
......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.+............. .......
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-------~~~~~~~----- 233 (279)
T 1qpc_A 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-------YRMVRPD----- 233 (279)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-------CCCCCCT-----
T ss_pred cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcc-------cCCCCcc-----
Confidence 2333457789999999998889999999999999999999 99999865443322221111 0111111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCCCCC
Q 002349 836 GAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAPE 874 (933)
Q Consensus 836 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 874 (933)
..+..+.+++.+|++.||++|||++++++.|+.+.....
T Consensus 234 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred cccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence 124678899999999999999999999999988755443
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=361.00 Aligned_cols=253 Identities=20% Similarity=0.286 Sum_probs=201.3
Q ss_pred HhhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCC------
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSS------ 667 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 667 (933)
..++|+..+.||+|+||.||+|+++ +++.||||++.... ....+.+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 4578999999999999999999987 68899999997543 345678999999999999999999999986543
Q ss_pred ---------------------------------------------------ccEEEEEecCCCCHHHHhcCCCCCCCCCH
Q 002349 668 ---------------------------------------------------GNLLFYDFMENGSLWDILHGPTKKKKLDW 696 (933)
Q Consensus 668 ---------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~ 696 (933)
..++||||+++++|.+++.........++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 27899999999999999976444456778
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCC-----------ceeeeecccc
Q 002349 697 DTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS-----------YTSTYIMGTI 765 (933)
Q Consensus 697 ~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~-----------~~~~~~~gt~ 765 (933)
..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....... .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 88999999999999999966 999999999999999999999999999987644321 1123357999
Q ss_pred cccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHHHHHHHHHH
Q 002349 766 GYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLA 845 (933)
Q Consensus 766 ~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 845 (933)
.|+|||++.+..++.++||||+||++|||++|..|+....... ....... . +.. .......+.+++
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~~----~~~~~~~----~-~~~-----~~~~~~~~~~li 306 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRII----TDVRNLK----F-PLL-----FTQKYPQEHMMV 306 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHHH----HHHHTTC----C-CHH-----HHHHCHHHHHHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHHH----HHhhccC----C-Ccc-----cccCChhHHHHH
Confidence 9999999999999999999999999999999987764211111 0111110 0 000 112335678899
Q ss_pred HHccCCCCCCCCCHHHHHHH
Q 002349 846 LLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 846 ~~cl~~dP~~RPt~~evl~~ 865 (933)
.+|++.||++|||++|++++
T Consensus 307 ~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 307 QDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHCSSGGGSCCHHHHHHS
T ss_pred HHHccCCCCcCCCHHHHhhc
Confidence 99999999999999999974
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=359.68 Aligned_cols=246 Identities=17% Similarity=0.195 Sum_probs=207.3
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
++|+..+.||+|+||.||+|+++ +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 58899999999999999999976 58899999986532 234567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
||+++|+|.+++. ..+.+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC
Confidence 9999999999995 345799999999999999999999966 9999999999999999999999999999875322
Q ss_pred CCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccccc
Q 002349 754 KSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCK 833 (933)
Q Consensus 754 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (933)
....+||+.|+|||++.+..++.++||||+||++|||++|+.||.+................ ++.
T Consensus 195 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~--------~p~--- 259 (350)
T 1rdq_E 195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR--------FPS--- 259 (350)
T ss_dssp ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--------CCT---
T ss_pred ----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCC--------CCC---
Confidence 23457999999999999999999999999999999999999999876544433322221111 111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHH
Q 002349 834 DLGAVKKVFQLALLCSKRQPTDRPT-----MHEVSRVL 866 (933)
Q Consensus 834 ~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~L 866 (933)
..+..+.+++.+|++.||++||+ ++|++++-
T Consensus 260 --~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~ 295 (350)
T 1rdq_E 260 --HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK 295 (350)
T ss_dssp --TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred --CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCc
Confidence 12356889999999999999998 88887643
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=360.34 Aligned_cols=252 Identities=24% Similarity=0.316 Sum_probs=192.3
Q ss_pred HhhccCcceeeecccceeEEEEEEcC-CceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEE
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYD 674 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 674 (933)
..++|+..+.||+|+||.||+|.+.. ++.||||++.... ..+.+.+|++++++++||||+++++++..++..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 35679999999999999999999874 7889999997643 34668899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCC---CCCeEEeecccccccc
Q 002349 675 FMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDK---DFEAHLTDFGIAKSLC 751 (933)
Q Consensus 675 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~---~~~~kl~DfGla~~~~ 751 (933)
|+++|+|.+++. ..+.+++.++..++.|++.||+|||++ +|+||||||+||+++. ++.+||+|||+++...
T Consensus 129 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 129 LVTGGELFDRIV---EKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCCSCBHHHHHT---TCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred eCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 999999999994 456799999999999999999999976 9999999999999975 8899999999998653
Q ss_pred cCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccc
Q 002349 752 VSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISAT 831 (933)
Q Consensus 752 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (933)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+............... .. ...+..
T Consensus 203 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~-~~-~~~~~~--- 275 (349)
T 2w4o_A 203 HQ--VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCE-YY-FISPWW--- 275 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTC-CC-CCTTTT---
T ss_pred cc--cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCC-Cc-cCCchh---
Confidence 22 223345799999999999999999999999999999999999999976554432222111111 10 000100
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 832 CKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 832 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
...+..+.+++.+|++.||++|||+.|++++
T Consensus 276 ---~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 276 ---DEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp ---TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---hhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0123578899999999999999999999985
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=360.80 Aligned_cols=262 Identities=23% Similarity=0.369 Sum_probs=196.6
Q ss_pred hhccCcceeeecccceeEEEEEEcCCc----eEEEEEeccc--CchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCcc-
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKNCK----PVAIKRLYSH--YPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGN- 669 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~----~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~- 669 (933)
.++|+..+.||+|+||.||+|.+.... .||||++... .....+++.+|++++++++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 468999999999999999999976532 7999999764 344567899999999999999999999999877655
Q ss_pred -----EEEEEecCCCCHHHHhcCC---CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEE
Q 002349 670 -----LLFYDFMENGSLWDILHGP---TKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHL 741 (933)
Q Consensus 670 -----~lv~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl 741 (933)
++||||+++|+|.+++... .....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEE
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEE
Confidence 9999999999999998531 1223689999999999999999999976 9999999999999999999999
Q ss_pred eecccccccccCCCc-eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccc
Q 002349 742 TDFGIAKSLCVSKSY-TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNA 819 (933)
Q Consensus 742 ~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 819 (933)
+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||.+...............
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~- 257 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR- 257 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC-
T ss_pred eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCC-
Confidence 999999876433222 1223457889999999999999999999999999999999 9999986554443322211110
Q ss_pred cccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCCCC
Q 002349 820 VMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAP 873 (933)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 873 (933)
.... ...+..+.+++.+|++.||++|||+.++++.|+.+...+
T Consensus 258 ------~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 258 ------LKQP-----PECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp ------CCCC-----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred ------CCCC-----CccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 0001 112357889999999999999999999999998876543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=365.12 Aligned_cols=261 Identities=24% Similarity=0.358 Sum_probs=212.6
Q ss_pred hhccCcceeeecccceeEEEEEEcC--------CceEEEEEecccC-chhHHHHHHHHHHHhcC-CCCceeeeeeEEecC
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKN--------CKPVAIKRLYSHY-PQCLKEFETELETVGSI-KHRNLVSLQGYSLSS 666 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 666 (933)
.++|...+.||+|+||+||+|.+.. ++.||||++.... ....+++.+|+++++++ +||||+++++++..+
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 4688999999999999999999632 3579999997654 34457789999999999 999999999999999
Q ss_pred CccEEEEEecCCCCHHHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEe
Q 002349 667 SGNLLFYDFMENGSLWDILHGPT-------------KKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILL 733 (933)
Q Consensus 667 ~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll 733 (933)
+..++||||+++|+|.+++.... ....+++..++.++.|++.||+|||++ +|+||||||+||++
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEE
Confidence 99999999999999999996422 124699999999999999999999966 99999999999999
Q ss_pred CCCCCeEEeecccccccccCCC-ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHH
Q 002349 734 DKDFEAHLTDFGIAKSLCVSKS-YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLI 811 (933)
Q Consensus 734 ~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~ 811 (933)
+.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|+|++ |+.||.+........
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~ 304 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 304 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999987643322 22233467889999999999999999999999999999999 999998654333222
Q ss_pred HhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCCC
Q 002349 812 LSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPA 872 (933)
Q Consensus 812 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 872 (933)
.... .. ....+. ..+..+.+++.+||+.||++|||++||++.|+.+...
T Consensus 305 ~~~~--~~-----~~~~~~-----~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 353 (382)
T 3tt0_A 305 LLKE--GH-----RMDKPS-----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 353 (382)
T ss_dssp HHHT--TC-----CCCCCS-----SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHc--CC-----CCCCCc-----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 1111 11 111111 1235788999999999999999999999999887543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=347.84 Aligned_cols=251 Identities=21% Similarity=0.273 Sum_probs=208.8
Q ss_pred HhhccCcceeeecccceeEEEEEEcC-CceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEE
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYD 674 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 674 (933)
..++|+..+.||+|+||.||+|.+.. ++.||+|++........+.+.+|++++++++||||+++++++...+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 35689999999999999999999765 67899999977665667889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEe---CCCCCeEEeecccccccc
Q 002349 675 FMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILL---DKDFEAHLTDFGIAKSLC 751 (933)
Q Consensus 675 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll---~~~~~~kl~DfGla~~~~ 751 (933)
|+++++|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||++....
T Consensus 87 ~~~~~~L~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 87 LCTGGELFERVV---HKRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ccCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 999999999884 346699999999999999999999976 99999999999999 788999999999998764
Q ss_pred cCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccc
Q 002349 752 VSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISAT 831 (933)
Q Consensus 752 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (933)
... ......||+.|+|||.+.+. ++.++||||+|+++|+|++|+.||........................
T Consensus 161 ~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~------ 231 (277)
T 3f3z_A 161 PGK--MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDW------ 231 (277)
T ss_dssp TTS--CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH------
T ss_pred Ccc--chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhh------
Confidence 322 23345799999999998765 899999999999999999999999876554433332221111111000
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002349 832 CKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSR 864 (933)
Q Consensus 832 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 864 (933)
...+..+.+++.+|++.||++|||+.++++
T Consensus 232 ---~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 232 ---LNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp ---TTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ---hcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 012357889999999999999999999986
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=372.00 Aligned_cols=350 Identities=21% Similarity=0.236 Sum_probs=201.6
Q ss_pred cEEEEEcCCCCcCcccCCCCCCCCCccEEEccCCcccccCCCCccCCCCCceecccccccCCCCCcccccccchhhhhhc
Q 002349 69 TVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILK 148 (933)
Q Consensus 69 ~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~ 148 (933)
+++.|+|++|.+++. | .++.+++|++|+|++|++++ +| ++.+++|++|+|++|.+++. | ++++++|++|+|+
T Consensus 43 ~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~ 114 (457)
T 3bz5_A 43 TLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNCD 114 (457)
T ss_dssp TCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEECC
T ss_pred CCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEECC
Confidence 344555555555542 2 45555555555555555554 23 55555555555555555542 2 5555555555555
Q ss_pred ccCccCCCCcccccCCCCceeeeecCCCCCCcccccccCCCCcEEeccCccccCccCcCCcCCCCCcEEccccccccCcC
Q 002349 149 NNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEI 228 (933)
Q Consensus 149 ~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 228 (933)
+|++++ +| ++.+++|++|++++|++++. .++.+++|++|++++|...+.+ .++.+++|++|++++|++++ +
T Consensus 115 ~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l 185 (457)
T 3bz5_A 115 TNKLTK-LD--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE-L 185 (457)
T ss_dssp SSCCSC-CC--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-C
T ss_pred CCcCCe-ec--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce-e
Confidence 555554 22 55555555555555555542 2455555555555555443333 24555555555555555553 2
Q ss_pred CCCccccccceEeccccccccccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCc
Q 002349 229 PFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTK 308 (933)
Q Consensus 229 p~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 308 (933)
| .....+|+.|++++|++++. .++.+++|+.|++++|++++ +| ++.+++|+.|++++|++++.. +..+++
T Consensus 186 ~-l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~---~~~l~~ 255 (457)
T 3bz5_A 186 D-VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELD---VSTLSK 255 (457)
T ss_dssp C-CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCC---CTTCTT
T ss_pred c-cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcC---HHHCCC
Confidence 2 11223445555555555443 24444555555555555544 22 444455555555555554432 223344
Q ss_pred ceEeeeccccccccCCccccccccccccccccccCCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccceecCCc
Q 002349 309 LHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSL 388 (933)
Q Consensus 309 L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~ 388 (933)
|+.|++++| +|+.|++++|++.+.+| +..+++|+.|++++|+..+.+|. ..++|+.|++++
T Consensus 256 L~~L~l~~n--------------~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~ 316 (457)
T 3bz5_A 256 LTTLHCIQT--------------DLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDC---QAAGITELDLSQ 316 (457)
T ss_dssp CCEEECTTC--------------CCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEEC---TTCCCSCCCCTT
T ss_pred CCEEeccCC--------------CCCEEECCCCccCCccc--ccccccCCEEECCCCcccceecc---CCCcceEechhh
Confidence 444444333 45566777777666655 45677778888887776665553 334555555554
Q ss_pred ccccCCCccccccccccceeeccCCccCCCCCCCCCCccccccccccCcccccccccccccccccceEEccCCccccccc
Q 002349 389 NNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIP 468 (933)
Q Consensus 389 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 468 (933)
| ++|+.|+|++|+|++. .+..+++|+.|++++|+|++ ++.|..|++++|+++|.
T Consensus 317 ~-------------~~L~~L~L~~N~l~~l---~l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~-- 370 (457)
T 3bz5_A 317 N-------------PKLVYLYLNNTELTEL---DVSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE-- 370 (457)
T ss_dssp C-------------TTCCEEECTTCCCSCC---CCTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE--
T ss_pred c-------------ccCCEEECCCCccccc---ccccCCcCcEEECCCCCCCC--------ccccccccccCCcEEec--
Confidence 4 5788888888888874 37888888888888888885 24667778888888876
Q ss_pred hhhccccccceeeecCCCCcCcccc
Q 002349 469 EELSQLQNMFSLRLDYNNLSGDVMS 493 (933)
Q Consensus 469 ~~~~~l~~L~~L~l~~N~l~~~~~~ 493 (933)
..+..|..+++++|+++|.+|.
T Consensus 371 ---~~~~~l~~l~l~~N~l~g~ip~ 392 (457)
T 3bz5_A 371 ---GQTITMPKETLTNNSLTIAVSP 392 (457)
T ss_dssp ---EEEEECCCBCCBTTBEEEECCT
T ss_pred ---ceeeecCccccccCcEEEEcCh
Confidence 3566778888888888887764
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=361.03 Aligned_cols=264 Identities=22% Similarity=0.334 Sum_probs=210.6
Q ss_pred HhhccCcceeeecccceeEEEEEEc------CCceEEEEEecccC-chhHHHHHHHHHHHhcC-CCCceeeeeeEEecCC
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLK------NCKPVAIKRLYSHY-PQCLKEFETELETVGSI-KHRNLVSLQGYSLSSS 667 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 667 (933)
..++|...+.||+|+||.||+|.+. .++.||||++.... ....+.+.+|+++++++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 4578999999999999999999962 35679999997543 34567899999999999 8999999999999999
Q ss_pred ccEEEEEecCCCCHHHHhcCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCC
Q 002349 668 GNLLFYDFMENGSLWDILHGPTK--------------------KKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVK 727 (933)
Q Consensus 668 ~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik 727 (933)
..++||||+++|+|.+++..... ...+++..+..++.|++.||+|||++ +|+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCC
Confidence 99999999999999999964321 13489999999999999999999976 99999999
Q ss_pred CCceEeCCCCCeEEeecccccccccCCCc-eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCc
Q 002349 728 SSNILLDKDFEAHLTDFGIAKSLCVSKSY-TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNEC 805 (933)
Q Consensus 728 p~NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~ 805 (933)
|+||+++.++.+||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|+|+| |+.||.+..
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 99999999999999999999876443322 2334567889999999999999999999999999999998 999998654
Q ss_pred chhHHHHhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCCCC
Q 002349 806 NLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAP 873 (933)
Q Consensus 806 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 873 (933)
............ ..+..+. ..+..+.+++.+||+.||++|||+.+++++|+.+....
T Consensus 280 ~~~~~~~~~~~~------~~~~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 280 VDANFYKLIQNG------FKMDQPF-----YATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp CSHHHHHHHHTT------CCCCCCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred cHHHHHHHHhcC------CCCCCCC-----CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 433322211111 1111111 12467889999999999999999999999998876543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=363.92 Aligned_cols=249 Identities=24% Similarity=0.289 Sum_probs=203.0
Q ss_pred hccCcceeeecccceeEEEEEEcC-CceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
++|+..+.||+|+||.||+|.+.. ++.||+|++.... ....+.+.+|++++++++|||||++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 679999999999999999999764 7889999986532 334567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
||+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+|+.....
T Consensus 95 e~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQ---QNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp CCCTTEEHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 9999999999995 456799999999999999999999966 9999999999999999999999999999876432
Q ss_pred CCceeeeecccccccCcccccc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccc
Q 002349 754 KSYTSTYIMGTIGYIDPEYART---SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISA 830 (933)
Q Consensus 754 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (933)
......+||+.|+|||++.+ ..++.++||||+||++|||++|+.||.................. ....+.
T Consensus 169 --~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~-----~~~~p~ 241 (384)
T 4fr4_A 169 --TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT-----VVTYPS 241 (384)
T ss_dssp --CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC-----CCCCCT
T ss_pred --CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc-----ccCCCC
Confidence 23345689999999999864 45899999999999999999999999743322111111110000 001111
Q ss_pred cccCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHH
Q 002349 831 TCKDLGAVKKVFQLALLCSKRQPTDRPT-MHEVSR 864 (933)
Q Consensus 831 ~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~ 864 (933)
..+..+.+++.+||+.||++||+ ++++.+
T Consensus 242 -----~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 242 -----AWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp -----TSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred -----cCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 12357889999999999999998 777765
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=360.46 Aligned_cols=257 Identities=16% Similarity=0.190 Sum_probs=205.9
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcC-CCCceeeeeeEEecCCccEEEEEe
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSI-KHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
++|+..+.||+|+||.||+|... +++.||||++..... .+.+.+|+++++++ +||||+++++++..++..++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 57899999999999999999964 678999999865432 34688999999999 999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCC-----eEEeeccccccc
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFE-----AHLTDFGIAKSL 750 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~-----~kl~DfGla~~~ 750 (933)
+ +++|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++. +||+|||+++.+
T Consensus 87 ~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 87 L-GPSLEDLFDL--CDRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp C-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred C-CCCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 9 9999999963 256799999999999999999999966 9999999999999998887 999999999876
Q ss_pred ccCCCc------eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHH-hhhcccccccc
Q 002349 751 CVSKSY------TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLIL-SKTANNAVMET 823 (933)
Q Consensus 751 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~-~~~~~~~~~~~ 823 (933)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+......... .........
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~-- 238 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA-- 238 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH--
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc--
Confidence 433221 12356799999999999999999999999999999999999999986432211111 111000000
Q ss_pred cCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccC
Q 002349 824 VDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869 (933)
Q Consensus 824 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 869 (933)
... ..... ..+ .+.+++..|++.||.+||++++|.+.|+.+
T Consensus 239 ~~~--~~~~~--~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 239 TPI--EVLCE--NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp SCH--HHHTT--TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred CCH--HHHhc--cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 000 00000 123 788999999999999999999999988654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=357.28 Aligned_cols=250 Identities=23% Similarity=0.263 Sum_probs=198.0
Q ss_pred hhccCcceeeecccceeEEEEEE----cCCceEEEEEecccC----chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCc
Q 002349 597 TENLSEKYIIGYGASSTVYKCVL----KNCKPVAIKRLYSHY----PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSG 668 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 668 (933)
.++|+..+.||+|+||.||+|+. .+++.||+|+++... ......+.+|++++++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 36899999999999999999997 468899999997642 2334567889999999999999999999999999
Q ss_pred cEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccc
Q 002349 669 NLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAK 748 (933)
Q Consensus 669 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 748 (933)
.++||||+++++|.+++. ..+.+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLE---REGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 999999999999999995 345789999999999999999999976 99999999999999999999999999997
Q ss_pred ccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccc
Q 002349 749 SLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEI 828 (933)
Q Consensus 749 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 828 (933)
...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+................ .++
T Consensus 170 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~----~p~-- 242 (327)
T 3a62_A 170 ESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLN----LPP-- 242 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC----CCT--
T ss_pred ccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC----CCC--
Confidence 643221 2233457999999999999999999999999999999999999999876544433222211111 111
Q ss_pred cccccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHH
Q 002349 829 SATCKDLGAVKKVFQLALLCSKRQPTDRP-----TMHEVSRVL 866 (933)
Q Consensus 829 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L 866 (933)
..+..+.+++.+|++.||++|| ++.|++++-
T Consensus 243 -------~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp 278 (327)
T 3a62_A 243 -------YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHP 278 (327)
T ss_dssp -------TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSG
T ss_pred -------CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCC
Confidence 1235788999999999999999 788888753
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=360.87 Aligned_cols=257 Identities=23% Similarity=0.328 Sum_probs=204.3
Q ss_pred hccCcceeeecccceeEEEEEEcC-Cce----EEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKN-CKP----VAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLL 671 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 671 (933)
++|+..+.||+|+||+||+|.+.. ++. ||+|.+.... ....+.+.+|+.++++++||||+++++++. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 478889999999999999999754 333 7888875443 334456788999999999999999999986 456889
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccc
Q 002349 672 FYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLC 751 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 751 (933)
||||+++|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 92 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEECCTTCBSHHHHHS--SGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEeCCCCCHHHHHHH--ccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccC
Confidence 9999999999999963 346789999999999999999999976 99999999999999999999999999998764
Q ss_pred cCCC-ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCcccc
Q 002349 752 VSKS-YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEIS 829 (933)
Q Consensus 752 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (933)
.... .......||..|+|||++.+..++.++|||||||++|+|++ |+.||.+............... ...+
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-------~~~~ 239 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER-------LAQP 239 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCB-------CCCC
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC-------CCCC
Confidence 4332 22344568889999999999999999999999999999999 9999986544333222211110 0001
Q ss_pred ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCCC
Q 002349 830 ATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPA 872 (933)
Q Consensus 830 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 872 (933)
.. .+..+.+++.+||+.||++|||++++++.|+.+...
T Consensus 240 ~~-----~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 240 QI-----CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp TT-----BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred Cc-----CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11 123567899999999999999999999999887653
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=356.59 Aligned_cols=259 Identities=25% Similarity=0.410 Sum_probs=211.4
Q ss_pred hhccCcceeeecccceeEEEEEEc------CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCcc
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK------NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGN 669 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 669 (933)
.++|...+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|++++++++||||+++++++...+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 468889999999999999999862 34789999997643 34567789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCCC---------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCC
Q 002349 670 LLFYDFMENGSLWDILHGPTK---------------------KKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKS 728 (933)
Q Consensus 670 ~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp 728 (933)
++||||+++++|.+++..... ...+++.+++.++.|++.||+|||++ +|+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccch
Confidence 999999999999999964221 23489999999999999999999976 999999999
Q ss_pred CceEeCCCCCeEEeecccccccccCCCce-eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcc
Q 002349 729 SNILLDKDFEAHLTDFGIAKSLCVSKSYT-STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECN 806 (933)
Q Consensus 729 ~NIll~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~ 806 (933)
+||+++.++.+||+|||+++......... .....+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||.+...
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999998764333222 233457889999999999999999999999999999999 9999986544
Q ss_pred hhHHHHhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCC
Q 002349 807 LHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLV 870 (933)
Q Consensus 807 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 870 (933)
........... .+.... ..+..+.+++.+|++.||++|||++++++.|+.+.
T Consensus 259 ~~~~~~~~~~~-------~~~~~~-----~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 259 ERLFNLLKTGH-------RMERPD-----NCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp GGHHHHHHTTC-------CCCCCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHhhcCC-------cCCCCc-----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 33322211111 011111 12467889999999999999999999999998653
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=351.43 Aligned_cols=261 Identities=20% Similarity=0.247 Sum_probs=202.3
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYD 674 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 674 (933)
++|+..+.||+|+||+||+|.+. +++.||||++.... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57889999999999999999976 47889999997543 3345778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCC
Q 002349 675 FMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSK 754 (933)
Q Consensus 675 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 754 (933)
|+++ ++.+.+. ...+.+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~~-~l~~~~~--~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFD--SCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSE-EHHHHHH--HTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCC-CHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 9986 5555553 2356799999999999999999999976 99999999999999999999999999998764322
Q ss_pred CceeeeecccccccCccccccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhh-hcccccccccCccccc--
Q 002349 755 SYTSTYIMGTIGYIDPEYARTSR-LTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSK-TANNAVMETVDPEISA-- 830 (933)
Q Consensus 755 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~-- 830 (933)
.......||+.|+|||++.+.. ++.++||||+||++|+|++|+.||............. ...........+....
T Consensus 156 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (292)
T 3o0g_A 156 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp -SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred -ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccc
Confidence 2233457899999999998765 7999999999999999999988865433333222111 1111100000000000
Q ss_pred --------------cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 831 --------------TCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 831 --------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
..........+.+++.+|++.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00001124678899999999999999999999975
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=359.17 Aligned_cols=250 Identities=20% Similarity=0.244 Sum_probs=206.6
Q ss_pred HhhccCcceeeecccceeEEEEEEcC-CceEEEEEecccC---chhHHHHHHHHHHHhcC-CCCceeeeeeEEecCCccE
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHY---PQCLKEFETELETVGSI-KHRNLVSLQGYSLSSSGNL 670 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 670 (933)
..++|+..+.||+|+||+||+|+++. ++.||+|++.... ....+.+.+|..+++.+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 34789999999999999999999875 6889999997542 23456788999999988 8999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccc
Q 002349 671 LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSL 750 (933)
Q Consensus 671 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~ 750 (933)
+||||+++|+|.+++. ..+.+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 98 lv~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQ---QVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 9999999999999995 345799999999999999999999966 9999999999999999999999999999864
Q ss_pred ccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccc
Q 002349 751 CVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISA 830 (933)
Q Consensus 751 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (933)
.. ........+||+.|+|||++.+..++.++||||+||++|||++|+.||.+................ ++.
T Consensus 172 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~--------~p~ 242 (353)
T 2i0e_A 172 IW-DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA--------YPK 242 (353)
T ss_dssp CC-TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--------CCT
T ss_pred cc-CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCC--------CCC
Confidence 22 222334568999999999999999999999999999999999999999876544333222221111 111
Q ss_pred cccCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 002349 831 TCKDLGAVKKVFQLALLCSKRQPTDRPT-----MHEVSRV 865 (933)
Q Consensus 831 ~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 865 (933)
..+..+.+++.+|++.||++||+ ++++.++
T Consensus 243 -----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 243 -----SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp -----TSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred -----CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 12357888999999999999995 5777754
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=354.37 Aligned_cols=253 Identities=22% Similarity=0.310 Sum_probs=209.9
Q ss_pred HhhccCcceeeecccceeEEEEEEc-CCceEEEEEecccCc------hhHHHHHHHHHHHhcCCCCceeeeeeEEecCCc
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYP------QCLKEFETELETVGSIKHRNLVSLQGYSLSSSG 668 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 668 (933)
..++|+..+.||+|+||.||+|.+. +++.||+|++..... ...+.+.+|++++++++||||+++++++...+.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 3468999999999999999999976 478999999965432 135779999999999999999999999999999
Q ss_pred cEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCC----CeEEeec
Q 002349 669 NLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDF----EAHLTDF 744 (933)
Q Consensus 669 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~----~~kl~Df 744 (933)
.++||||+++++|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++ .+||+||
T Consensus 90 ~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEEECCCCSCBHHHHHH---TCSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccC
Confidence 999999999999999995 356789999999999999999999966 999999999999999887 7999999
Q ss_pred ccccccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccccccccc
Q 002349 745 GIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETV 824 (933)
Q Consensus 745 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 824 (933)
|+++...... ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||.+................ .
T Consensus 164 g~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~----~ 237 (321)
T 2a2a_A 164 GLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYD----F 237 (321)
T ss_dssp TTCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC----C
T ss_pred ccceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccc----c
Confidence 9998764322 223457999999999999999999999999999999999999999876554443322221111 1
Q ss_pred CccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 825 DPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 825 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
++.... ..+..+.+++.+|++.||++|||++|++++
T Consensus 238 ~~~~~~-----~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 238 DEEFFS-----HTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp CHHHHT-----TCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred Chhhhc-----ccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111111 113568899999999999999999999985
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=354.86 Aligned_cols=264 Identities=22% Similarity=0.295 Sum_probs=193.9
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYD 674 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 674 (933)
.++|+..+.||+|+||.||+|.++ +++.||+|++.... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467899999999999999999975 47899999996543 3345778899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCC---CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccc
Q 002349 675 FMENGSLWDILHGP---TKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLC 751 (933)
Q Consensus 675 ~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 751 (933)
|++ |+|.+++... .....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 5999888521 1234689999999999999999999966 99999999999999999999999999998764
Q ss_pred cCCCceeeeecccccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcc---
Q 002349 752 VSKSYTSTYIMGTIGYIDPEYARTS-RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPE--- 827 (933)
Q Consensus 752 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 827 (933)
.... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||.+..............+...+...+.
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence 3222 22345789999999999764 689999999999999999999999987665544433221111111100000
Q ss_pred -------ccc-----------cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 828 -------ISA-----------TCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 828 -------~~~-----------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
+.. .......+..+.+++.+|++.||++|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 000 00000123578899999999999999999999874
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=361.01 Aligned_cols=255 Identities=20% Similarity=0.234 Sum_probs=204.5
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC-----chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY-----PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNL 670 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 670 (933)
.++|+..+.||+|+||+||+|.++ +++.||||++.... ....+.+.+|++++++++||||+++++++.+++..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 468999999999999999999976 57899999985421 224577999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCC---eEEeeccc
Q 002349 671 LFYDFMENGSLWDILHGP-TKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFE---AHLTDFGI 746 (933)
Q Consensus 671 lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~---~kl~DfGl 746 (933)
+||||+++++|.+.+... .....+++..+..++.|++.||+|||++ +|+||||||+||+++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999998877421 1234589999999999999999999966 9999999999999987654 99999999
Q ss_pred ccccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCc
Q 002349 747 AKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDP 826 (933)
Q Consensus 747 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 826 (933)
++...... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+... ....... ..... ..+
T Consensus 180 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~i~--~~~~~--~~~ 253 (351)
T 3c0i_A 180 AIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGII--KGKYK--MNP 253 (351)
T ss_dssp CEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-HHHHHHH--HTCCC--CCH
T ss_pred eeEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-HHHHHHH--cCCCC--CCc
Confidence 98764332 223445799999999999999999999999999999999999999986432 1111111 11100 011
Q ss_pred cccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 827 EISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 827 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.... ..+..+.+++.+||+.||++|||+.|++++
T Consensus 254 ~~~~-----~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 254 RQWS-----HISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp HHHT-----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccc-----cCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000 123578899999999999999999999863
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=350.16 Aligned_cols=260 Identities=30% Similarity=0.469 Sum_probs=199.2
Q ss_pred hhccCcceeeecccceeEEEEEEcCCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYD 674 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 674 (933)
.++|+..+.||+|+||+||+|.+.+ .||||+++... ....+.+.+|++++++++||||+++++++ .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 3579999999999999999998654 59999987543 34457799999999999999999999965 4566899999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC-
Q 002349 675 FMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS- 753 (933)
Q Consensus 675 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~- 753 (933)
|+++++|.++++ .....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 100 ~~~~~~L~~~l~--~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 100 WCEGSSLYHHLH--ASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174 (289)
T ss_dssp CCCEEEHHHHHT--TC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred ecCCCcHHHHHh--hccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccccccc
Confidence 999999999996 3456799999999999999999999976 9999999999999999999999999999765321
Q ss_pred CCceeeeecccccccCccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccc
Q 002349 754 KSYTSTYIMGTIGYIDPEYAR---TSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISA 830 (933)
Q Consensus 754 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (933)
.........||+.|+|||.+. +..++.++||||+|+++|+|++|+.||.+.............. .... ....
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~----~~~~ 249 (289)
T 3og7_A 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRG-SLSP----DLSK 249 (289)
T ss_dssp ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHT-SCCC----CTTS
T ss_pred ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhccc-ccCc----chhh
Confidence 122233457999999999986 5678899999999999999999999998765544433322211 1111 1111
Q ss_pred cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCC
Q 002349 831 TCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVP 871 (933)
Q Consensus 831 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 871 (933)
. ....+..+.+++.+|++.||++|||++++++.|+.+..
T Consensus 250 ~--~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 250 V--RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp S--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred c--cccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 1 11234678999999999999999999999999988753
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=369.61 Aligned_cols=247 Identities=20% Similarity=0.301 Sum_probs=206.8
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
++|...+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+++++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 57889999999999999999986 68999999996542 233567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
||+++|+|.+++. ..+.+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 96 E~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 96 EYVSGGELFDYIC---KNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp ECCSSEEHHHHTT---SSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 9999999999994 456799999999999999999999965 9999999999999999999999999999876432
Q ss_pred CCceeeeecccccccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccc
Q 002349 754 KSYTSTYIMGTIGYIDPEYARTSRL-TEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATC 832 (933)
Q Consensus 754 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (933)
. .....+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.+................ .+.
T Consensus 170 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~--------~p~-- 237 (476)
T 2y94_A 170 E--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFY--------TPQ-- 237 (476)
T ss_dssp C--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCC--------CCT--
T ss_pred c--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcC--------CCc--
Confidence 2 2334579999999999998766 68999999999999999999999876544333222111110 011
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 833 KDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 833 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
..+..+.+++.+|++.||++|||++|++++
T Consensus 238 ---~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 238 ---YLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp ---TCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ---cCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 113468889999999999999999999973
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=361.89 Aligned_cols=251 Identities=22% Similarity=0.301 Sum_probs=201.6
Q ss_pred hhccCcceeeecccceeEEEEEEcC-CceEEEEEecccC---chhHHHHHHHHHHHhcC-CCCceeeeeeEEecCCccEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHY---PQCLKEFETELETVGSI-KHRNLVSLQGYSLSSSGNLL 671 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 671 (933)
.++|+..++||+|+||+||+|+++. ++.||+|+++... ....+.+.+|..+++++ +|||||++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 4689999999999999999999774 6789999997542 23345578899999887 89999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccc
Q 002349 672 FYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLC 751 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 751 (933)
||||+++|+|.+++. ..+.+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+...
T Consensus 131 V~E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 999999999999995 346799999999999999999999966 99999999999999999999999999998632
Q ss_pred cCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcch-------hHHHHhhhccccccccc
Q 002349 752 VSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNL-------HHLILSKTANNAVMETV 824 (933)
Q Consensus 752 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~-------~~~~~~~~~~~~~~~~~ 824 (933)
. ........+||+.|+|||++.+..++.++||||+||++|||++|+.||...... ............
T Consensus 205 ~-~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----- 278 (396)
T 4dc2_A 205 R-PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----- 278 (396)
T ss_dssp C-TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC-----
T ss_pred c-CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc-----
Confidence 2 222344568999999999999999999999999999999999999999642211 111111111110
Q ss_pred CccccccccCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHH
Q 002349 825 DPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTM------HEVSRV 865 (933)
Q Consensus 825 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~------~evl~~ 865 (933)
..++. ..+..+.+++.+||+.||++||++ +|++++
T Consensus 279 -~~~p~-----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 279 -IRIPR-----SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp -CCCCT-----TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred -cCCCC-----cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 11111 123567889999999999999985 566653
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=350.94 Aligned_cols=258 Identities=26% Similarity=0.386 Sum_probs=214.9
Q ss_pred HhhccCcceeeecccceeEEEEEEcC-CceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEE
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYD 674 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 674 (933)
..++|+..+.||+|+||.||+|.+.. ++.||+|++.... ...+.+.+|++++++++||||+++++++..++..++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 35688999999999999999999875 7889999997543 346788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCC
Q 002349 675 FMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSK 754 (933)
Q Consensus 675 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 754 (933)
|+++++|.+++.. .....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~~~~~~L~~~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 90 FMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CCTTEEHHHHHHH-CCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred cCCCCcHHHHHHh-cccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 9999999999964 2345699999999999999999999976 99999999999999999999999999998775444
Q ss_pred CceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCcccccccc
Q 002349 755 SYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISATCK 833 (933)
Q Consensus 755 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (933)
........+|+.|+|||.+.+..++.++||||+|+++|+|++ |..||............... .....+.
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~-------~~~~~~~--- 235 (288)
T 3kfa_A 166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-------YRMERPE--- 235 (288)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-------CCCCCCT---
T ss_pred cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcc-------CCCCCCC---
Confidence 444445567889999999999999999999999999999999 99999765433322211111 0111111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCC
Q 002349 834 DLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLV 870 (933)
Q Consensus 834 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 870 (933)
..+..+.+++.+|++.||++|||++++++.|+.+.
T Consensus 236 --~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 236 --GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp --TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 12367889999999999999999999999987654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=352.47 Aligned_cols=260 Identities=16% Similarity=0.181 Sum_probs=208.3
Q ss_pred hccCcceeeecccceeEEEEEE-cCCceEEEEEecccCchhHHHHHHHHHHHhcC-CCCceeeeeeEEecCCccEEEEEe
Q 002349 598 ENLSEKYIIGYGASSTVYKCVL-KNCKPVAIKRLYSHYPQCLKEFETELETVGSI-KHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
++|+..+.||+|+||.||+|.+ .+++.||||++.... ..+.+.+|+++++++ +|+|++++++++......++||||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 87 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 87 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence 5799999999999999999996 468899999986543 235678899999999 799999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCC-----eEEeeccccccc
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFE-----AHLTDFGIAKSL 750 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~-----~kl~DfGla~~~ 750 (933)
+ +++|.+++.. ...++++..+..++.|++.||+|||++ +|+||||||+||+++.++. +||+|||+++..
T Consensus 88 ~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 88 L-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp C-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred c-CCCHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 9 9999999963 345699999999999999999999965 9999999999999987776 999999999876
Q ss_pred ccCCCc------eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHH-hhhcccccccc
Q 002349 751 CVSKSY------TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLIL-SKTANNAVMET 823 (933)
Q Consensus 751 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~-~~~~~~~~~~~ 823 (933)
...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.+......... ...........
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 241 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc
Confidence 443221 23445799999999999999999999999999999999999999986432211111 11100000000
Q ss_pred cCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCC
Q 002349 824 VDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVP 871 (933)
Q Consensus 824 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 871 (933)
.+.... ..+..+.+++.+|++.||++||++++|++.|+.+..
T Consensus 242 -~~~~~~-----~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~ 283 (298)
T 1csn_A 242 -LRELCA-----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 283 (298)
T ss_dssp -HHHHTT-----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred -HHHHHh-----hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence 000000 124678899999999999999999999999987654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=358.61 Aligned_cols=261 Identities=21% Similarity=0.230 Sum_probs=205.5
Q ss_pred HHHHhhccCcceeeecccceeEEEEEEc-CCceEEEEEeccc-----CchhHHHHHHHHHHHhcCCCCceeeeeeEEecC
Q 002349 593 IMRMTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSH-----YPQCLKEFETELETVGSIKHRNLVSLQGYSLSS 666 (933)
Q Consensus 593 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 666 (933)
+....++|+..+.||+|+||+||+|.+. +++.||+|++... .....+.+.+|++++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 4567789999999999999999999975 4778999998643 234567899999999999999999999999999
Q ss_pred CccEEEEEecCCCCHHHHhcCCC-------------------------------------CCCCCCHHHHHHHHHHHHHH
Q 002349 667 SGNLLFYDFMENGSLWDILHGPT-------------------------------------KKKKLDWDTRLKIALGAAQG 709 (933)
Q Consensus 667 ~~~~lv~e~~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~i~~~ 709 (933)
+..++||||+++|+|.+++.... ....+++..+..++.|++.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 99999999999999999984100 01234677888999999999
Q ss_pred HHHhhcCCCCCeeeccCCCCceEeCCCC--CeEEeecccccccccCC---CceeeeecccccccCcccccc--CCCCcch
Q 002349 710 LAYLHHDCSPRIIHRDVKSSNILLDKDF--EAHLTDFGIAKSLCVSK---SYTSTYIMGTIGYIDPEYART--SRLTEKS 782 (933)
Q Consensus 710 l~~LH~~~~~~ivH~Dikp~NIll~~~~--~~kl~DfGla~~~~~~~---~~~~~~~~gt~~y~aPE~~~~--~~~~~~~ 782 (933)
|+|||++ +|+||||||+||+++.++ .+||+|||+++.+.... ........||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 9999966 999999999999998776 89999999998653322 122345679999999999875 6789999
Q ss_pred hhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 002349 783 DVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862 (933)
Q Consensus 783 DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev 862 (933)
|||||||++|||++|+.||.+................... +... ..+..+.+++.+|++.||++|||+.|+
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~------~~~~~~~~li~~~l~~~p~~Rps~~~~ 328 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFEN---PNYN------VLSPLARDLLSNLLNRNVDERFDAMRA 328 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTS---GGGG------GSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCC---cccc------cCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence 9999999999999999999876555444332222111111 1110 123578899999999999999999999
Q ss_pred HHH
Q 002349 863 SRV 865 (933)
Q Consensus 863 l~~ 865 (933)
+++
T Consensus 329 l~h 331 (345)
T 3hko_A 329 LQH 331 (345)
T ss_dssp HHS
T ss_pred hcC
Confidence 974
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=344.64 Aligned_cols=251 Identities=22% Similarity=0.339 Sum_probs=206.0
Q ss_pred hccCcceeeecccceeEEEEEEcCCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecC--CccEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSS--SGNLLFY 673 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 673 (933)
++|+..+.||+|+||.||+|+++ ++.||||++.... ....+.+.+|++++++++||||+++++++... ...++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 57889999999999999999986 6889999997653 34456799999999999999999999999887 7789999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--eeeccCCCCceEeCCCCCeEEeecccccccc
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPR--IIHRDVKSSNILLDKDFEAHLTDFGIAKSLC 751 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 751 (933)
||+++|+|.++++. .....+++..+..++.|++.||+|||++ + |+||||||+||+++.++.++++|||++....
T Consensus 89 e~~~~~~L~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 89 HWMPYGSLYNVLHE-GTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp ECCTTCBHHHHHHS-CSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred cccCCCcHHHHHhh-cccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 99999999999974 2233689999999999999999999965 6 9999999999999999999999998875432
Q ss_pred cCCCceeeeecccccccCccccccCCCCc---chhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccc
Q 002349 752 VSKSYTSTYIMGTIGYIDPEYARTSRLTE---KSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEI 828 (933)
Q Consensus 752 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 828 (933)
. ....||+.|+|||.+.+..++. ++||||||+++|||++|+.||.+.............. ..+..
T Consensus 165 ~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~------~~~~~ 232 (271)
T 3kmu_A 165 S------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEG------LRPTI 232 (271)
T ss_dssp C------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSC------CCCCC
T ss_pred c------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcC------CCCCC
Confidence 1 2246899999999998765544 8999999999999999999998655444332221111 11111
Q ss_pred cccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCC
Q 002349 829 SATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLV 870 (933)
Q Consensus 829 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 870 (933)
+. ..+..+.+++.+||+.||++|||++++++.|+.+.
T Consensus 233 ~~-----~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 233 PP-----GISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp CT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CC-----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 11 12357889999999999999999999999998764
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=351.91 Aligned_cols=263 Identities=22% Similarity=0.253 Sum_probs=201.7
Q ss_pred HhhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEE
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLL 671 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 671 (933)
..++|+..+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+.++++++||||+++++++..++..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 4578999999999999999999976 57889999997543 2334778999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccc
Q 002349 672 FYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLC 751 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 751 (933)
||||+++++|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 112 v~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 112 DMRLINGVDLAAMLR---RQGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEECCCCEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEEecCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 999999999999995 345799999999999999999999976 99999999999999999999999999998764
Q ss_pred cCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccc
Q 002349 752 VSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISAT 831 (933)
Q Consensus 752 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (933)
...........|++.|+|||.+.+..++.++||||||+++|+|++|+.||......... ..............+
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~----- 259 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMG-AHINQAIPRPSTVRP----- 259 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHH-HHHHSCCCCGGGTST-----
T ss_pred ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHH-HHhccCCCCccccCC-----
Confidence 43333334567999999999999999999999999999999999999999865432111 111111100111111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHccCCCCCC
Q 002349 832 CKDLGAVKKVFQLALLCSKRQPTDRP-TMHEVSRVLGSLVPAPE 874 (933)
Q Consensus 832 ~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~~~~~~ 874 (933)
..+..+.+++.+||+.||++|| +++++++.|+.......
T Consensus 260 ----~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 260 ----GIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp ----TCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred ----CCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 1234688899999999999999 99999999998766554
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=356.23 Aligned_cols=250 Identities=22% Similarity=0.306 Sum_probs=202.4
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcC-CCCceeeeeeEEecCCccEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSI-KHRNLVSLQGYSLSSSGNLLF 672 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 672 (933)
++|+..+.||+|+||.||+|+++ +++.||+|++.... ....+.+.+|..+++++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 57899999999999999999986 47889999997542 33456688999999988 899999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccccc
Q 002349 673 YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV 752 (933)
Q Consensus 673 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 752 (933)
|||+++|+|.+++. ..+.+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 89 ~e~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp ECCCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 99999999999995 345799999999999999999999966 999999999999999999999999999986422
Q ss_pred CCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcch-------hHHHHhhhcccccccccC
Q 002349 753 SKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNL-------HHLILSKTANNAVMETVD 825 (933)
Q Consensus 753 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~ 825 (933)
. .......+||+.|+|||++.+..++.++||||+||++|||++|+.||...... ............
T Consensus 163 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~------ 235 (345)
T 3a8x_A 163 P-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ------ 235 (345)
T ss_dssp T-TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC------
T ss_pred C-CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC------
Confidence 2 22334568999999999999999999999999999999999999999642111 111111111110
Q ss_pred ccccccccCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHH
Q 002349 826 PEISATCKDLGAVKKVFQLALLCSKRQPTDRPTM------HEVSRV 865 (933)
Q Consensus 826 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~------~evl~~ 865 (933)
..++. ..+..+.+++.+|++.||++||++ +|++++
T Consensus 236 ~~~p~-----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 236 IRIPR-----SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp CCCCT-----TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred CCCCC-----CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 11111 123568889999999999999995 666653
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=346.76 Aligned_cols=252 Identities=23% Similarity=0.324 Sum_probs=208.1
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
.++|+..+.||+|+||.||+|.++ +++.||+|++.... ....+.+.+|++++++++||||+++++++..++..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 468999999999999999999976 47899999986543 334567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCC---eEEeeccccccc
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFE---AHLTDFGIAKSL 750 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~---~kl~DfGla~~~ 750 (933)
||+++++|.+.+. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++. +||+|||++...
T Consensus 85 e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 9999999999884 346799999999999999999999976 9999999999999986655 999999999776
Q ss_pred ccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccc
Q 002349 751 CVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISA 830 (933)
Q Consensus 751 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (933)
.... ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||.+.................... ...
T Consensus 159 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~- 232 (284)
T 3kk8_A 159 NDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP---EWD- 232 (284)
T ss_dssp CSSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT---TTT-
T ss_pred ccCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCch---hhc-
Confidence 4322 2234579999999999999999999999999999999999999998765544433322222111111 000
Q ss_pred cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 831 TCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 831 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
..+..+.+++.+|++.||++|||++|++++
T Consensus 233 -----~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 233 -----TVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp -----TSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -----ccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 123568899999999999999999999874
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=382.88 Aligned_cols=264 Identities=28% Similarity=0.392 Sum_probs=216.2
Q ss_pred hhccCcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEec
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFM 676 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 676 (933)
.++|+..+.||+|+||.||+|.++++..||||+++... ...++|.+|++++++++||||+++++++.+ +..++||||+
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 46788899999999999999999988889999997654 235789999999999999999999999876 6789999999
Q ss_pred CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCc
Q 002349 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY 756 (933)
Q Consensus 677 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 756 (933)
++|+|.++++. .....+++.+++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 344 ~~gsL~~~l~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 419 (535)
T 2h8h_A 344 SKGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 419 (535)
T ss_dssp TTEEHHHHHSH-HHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHH
T ss_pred cCCcHHHHHhh-cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCcee
Confidence 99999999952 1234689999999999999999999966 9999999999999999999999999999876432222
Q ss_pred eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCccccccccCH
Q 002349 757 TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDL 835 (933)
Q Consensus 757 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (933)
......++..|+|||++.+..++.++|||||||++|||++ |+.||.+....+...... ... ......
T Consensus 420 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~--~~~-----~~~~~~----- 487 (535)
T 2h8h_A 420 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE--RGY-----RMPCPP----- 487 (535)
T ss_dssp TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHH--TTC-----CCCCCT-----
T ss_pred cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH--cCC-----CCCCCC-----
Confidence 2233457789999999999999999999999999999999 999998654433322211 110 111111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCCCCCCCCC
Q 002349 836 GAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAPEPQKQ 878 (933)
Q Consensus 836 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~ 878 (933)
.++..+.+++.+||+.||++|||+++|++.|+.+.....++..
T Consensus 488 ~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~~ 530 (535)
T 2h8h_A 488 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ 530 (535)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSCSSC
T ss_pred CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCcccC
Confidence 2346788999999999999999999999999998876665544
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=368.32 Aligned_cols=263 Identities=18% Similarity=0.202 Sum_probs=211.1
Q ss_pred HHHHHHHhhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEec
Q 002349 590 YEDIMRMTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLS 665 (933)
Q Consensus 590 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 665 (933)
+++.....++|+..+.||+|+||+||+|+.+ +++.||+|++.... ....+.+.+|..++.+++||||+++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 3444455689999999999999999999986 58899999996532 2233457899999999999999999999999
Q ss_pred CCccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecc
Q 002349 666 SSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFG 745 (933)
Q Consensus 666 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfG 745 (933)
.+..|+||||+++|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSK--FGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHH--HSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEcCCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeech
Confidence 9999999999999999999952 234799999999999999999999966 99999999999999999999999999
Q ss_pred cccccccCCCceeeeecccccccCccccc-------cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccc
Q 002349 746 IAKSLCVSKSYTSTYIMGTIGYIDPEYAR-------TSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANN 818 (933)
Q Consensus 746 la~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 818 (933)
+++.............+||+.|+|||++. +..++.++|||||||++|||++|+.||.+...............
T Consensus 208 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~ 287 (412)
T 2vd5_A 208 SCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKE 287 (412)
T ss_dssp TCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH
T ss_pred hheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhccc
Confidence 99876544433344568999999999987 35689999999999999999999999987655444332221111
Q ss_pred ccccccCccccccccCHHHHHHHHHHHHHccCCCCCCC---CCHHHHHHHH
Q 002349 819 AVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDR---PTMHEVSRVL 866 (933)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Pt~~evl~~L 866 (933)
... .+.... ..+..+.+++.+|+. +|++| |+++|++++-
T Consensus 288 ~~~---~p~~~~-----~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hp 329 (412)
T 2vd5_A 288 HLS---LPLVDE-----GVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHP 329 (412)
T ss_dssp HCC---CC---------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSG
T ss_pred CcC---CCcccc-----CCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCC
Confidence 000 011101 123578889999999 99998 6999998753
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=361.65 Aligned_cols=266 Identities=25% Similarity=0.376 Sum_probs=209.5
Q ss_pred hccCcceeeecccceeEEEEEE-----cCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEe--cCCccE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVL-----KNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSL--SSSGNL 670 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~ 670 (933)
++|+..+.||+|+||.||+|.+ ..++.||||++........+.+.+|++++++++||||+++++++. .....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5889999999999999999984 357889999998776666778999999999999999999999887 445688
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccc
Q 002349 671 LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSL 750 (933)
Q Consensus 671 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~ 750 (933)
+||||+++++|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 103 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEeecCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceec
Confidence 99999999999999952 235699999999999999999999966 9999999999999999999999999999876
Q ss_pred ccCCCce--eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcc--------ccc
Q 002349 751 CVSKSYT--STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTAN--------NAV 820 (933)
Q Consensus 751 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~--------~~~ 820 (933)
....... .....||+.|+|||++.+..++.++||||+|+++|+|++|+.||................ ...
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence 4333221 223468888999999999999999999999999999999999987432211100000000 000
Q ss_pred ccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCCCC
Q 002349 821 METVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAP 873 (933)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 873 (933)
........ ....+..+.+++.+|++.||++|||++|++++|+.+....
T Consensus 258 ~~~~~~~~-----~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 258 EEGQRLPA-----PPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HTTCCCCC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred hcccCCCC-----CCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 00000111 1123467899999999999999999999999999876544
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=361.80 Aligned_cols=254 Identities=21% Similarity=0.262 Sum_probs=194.1
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEe
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
.++|...+.||+|+||+||+|+.. +++.||||++.... ...+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 358999999999999999999987 57899999997543 2346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCC--eEEeecccccccccC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFE--AHLTDFGIAKSLCVS 753 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~--~kl~DfGla~~~~~~ 753 (933)
+++|+|.+++. ..+.+++..+..++.|++.||+|||++ +|+||||||+||+++.++. +||+|||+++....
T Consensus 98 ~~~~~L~~~l~---~~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~- 170 (361)
T 3uc3_A 98 ASGGELYERIC---NAGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL- 170 (361)
T ss_dssp CCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccc-
Confidence 99999999984 345799999999999999999999966 9999999999999987765 99999999975322
Q ss_pred CCceeeeecccccccCccccccCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccc
Q 002349 754 KSYTSTYIMGTIGYIDPEYARTSRLTEK-SDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATC 832 (933)
Q Consensus 754 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (933)
........||+.|+|||++.+..++.+ +||||+||++|+|++|+.||.+.................... .+.
T Consensus 171 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~----~~~-- 243 (361)
T 3uc3_A 171 -HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYS----IPD-- 243 (361)
T ss_dssp -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCC----CCT--
T ss_pred -cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCC----CCC--
Confidence 222334579999999999988877655 899999999999999999998543322211110000000000 000
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 833 KDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 833 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
....+..+.+++.+||+.||++|||++|++++-
T Consensus 244 -~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp 276 (361)
T 3uc3_A 244 -DIRISPECCHLISRIFVADPATRISIPEIKTHS 276 (361)
T ss_dssp -TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSH
T ss_pred -cCCCCHHHHHHHHHHccCChhHCcCHHHHHhCc
Confidence 001235788999999999999999999999753
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=346.15 Aligned_cols=248 Identities=25% Similarity=0.360 Sum_probs=204.3
Q ss_pred hhccCcceeeecccceeEEEEEEcC-CceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLF 672 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 672 (933)
.++|+..+.||+|+||.||+|.+.. ++.||+|++.... ......+.+|++++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 4689999999999999999999765 6789999986532 22356789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccccc
Q 002349 673 YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV 752 (933)
Q Consensus 673 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 752 (933)
|||+++++|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~l~~~l~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 88 LEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp ECCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 99999999999984 346799999999999999999999965 999999999999999999999999999865432
Q ss_pred CCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccc
Q 002349 753 SKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATC 832 (933)
Q Consensus 753 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (933)
. ......|++.|+|||.+.+..++.++||||+|+++|+|++|+.||.................. .+..
T Consensus 162 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~- 229 (279)
T 3fdn_A 162 S---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT--------FPDF- 229 (279)
T ss_dssp ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC--------CCTT-
T ss_pred c---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCC--------CCCc-
Confidence 2 223457999999999999999999999999999999999999999866544433322221111 1111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 833 KDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 833 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
.+..+.+++.+|++.||++|||++|++++-
T Consensus 230 ----~~~~~~~li~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 230 ----VTEGARDLISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp ----SCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred ----CCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 235678899999999999999999999753
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=371.49 Aligned_cols=259 Identities=20% Similarity=0.228 Sum_probs=200.4
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCceeeeeeEEecCC------
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSH--YPQCLKEFETELETVGSIKHRNLVSLQGYSLSSS------ 667 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 667 (933)
.++|+..+.||+|+||+||+|.+. .++.||||++... .....+++.+|+++++.++|||||++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 468999999999999999999976 4788999999754 3344677889999999999999999999997654
Q ss_pred ccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccc
Q 002349 668 GNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIA 747 (933)
Q Consensus 668 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla 747 (933)
..++||||+++ ++.+.+. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|
T Consensus 141 ~~~lv~E~~~~-~l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSE-EHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCC-CHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEee
Confidence 46999999976 5767663 2489999999999999999999966 9999999999999999999999999999
Q ss_pred cccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccccccc-----
Q 002349 748 KSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVME----- 822 (933)
Q Consensus 748 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----- 822 (933)
+..... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.....++.......+....
T Consensus 212 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~ 289 (464)
T 3ttj_A 212 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 289 (464)
T ss_dssp -----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred eecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 875432 2234568999999999999999999999999999999999999999987666555433221111000
Q ss_pred ----------------------ccCccccccc--cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 823 ----------------------TVDPEISATC--KDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 823 ----------------------~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
..+....... ........+.+++.+||+.||++|||++|++++-
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp 357 (464)
T 3ttj_A 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 357 (464)
T ss_dssp SCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred cchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcCh
Confidence 0000000000 0011246789999999999999999999999854
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=346.28 Aligned_cols=255 Identities=23% Similarity=0.321 Sum_probs=204.5
Q ss_pred hhccCcceeeecccceeEEEEEEcC----CceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKN----CKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLL 671 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 671 (933)
.++|...+.||+|+||.||+|.+.. +..||+|++.... ....+.+.+|++++++++||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 4688999999999999999999653 2359999997653 3456789999999999999999999999865 45789
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccc
Q 002349 672 FYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLC 751 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 751 (933)
||||+++++|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 90 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 90 IMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EEecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 9999999999999962 345689999999999999999999966 99999999999999999999999999998765
Q ss_pred cCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCccccc
Q 002349 752 VSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISA 830 (933)
Q Consensus 752 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (933)
...........+++.|+|||.+.+..++.++||||||+++|+|++ |+.||................. .....
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~-------~~~~~ 237 (281)
T 3cc6_A 165 DEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDR-------LPKPD 237 (281)
T ss_dssp --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCC-------CCCCT
T ss_pred cccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCC-------CCCCC
Confidence 443333444567889999999999999999999999999999998 9999975444332222111110 00111
Q ss_pred cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccC
Q 002349 831 TCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869 (933)
Q Consensus 831 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 869 (933)
..+..+.+++.+|++.||++|||++|+++.|+.+
T Consensus 238 -----~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 238 -----LCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp -----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 1235788999999999999999999999998765
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=370.00 Aligned_cols=251 Identities=25% Similarity=0.385 Sum_probs=206.1
Q ss_pred hhccCcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCC-ccEEEEEe
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSS-GNLLFYDF 675 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~ 675 (933)
.++|+..+.||+|+||.||+|.++ ++.||||+++... ..+.|.+|++++++++||||+++++++...+ ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 467888999999999999999986 5799999997653 4578999999999999999999999987665 68999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS 755 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 755 (933)
+++|+|.++++. .....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 269 ~~~g~L~~~l~~-~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 342 (450)
T 1k9a_A 269 MAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 342 (450)
T ss_dssp CTTCBHHHHHHH-HCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence 999999999963 1233479999999999999999999976 9999999999999999999999999999854221
Q ss_pred ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCccccccccC
Q 002349 756 YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKD 834 (933)
Q Consensus 756 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (933)
.....+++.|+|||++.+..++.++|||||||++|||++ |+.||.+........... .+ .....+.
T Consensus 343 --~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~--~~-----~~~~~p~---- 409 (450)
T 1k9a_A 343 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE--KG-----YKMDAPD---- 409 (450)
T ss_dssp ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHH--TT-----CCCCCCT----
T ss_pred --ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH--cC-----CCCCCCC----
Confidence 122367889999999999999999999999999999998 999998654333222111 11 1111111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCC
Q 002349 835 LGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLV 870 (933)
Q Consensus 835 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 870 (933)
.++..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 410 -~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 410 -GCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp -TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 23467899999999999999999999999998764
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=370.11 Aligned_cols=347 Identities=27% Similarity=0.418 Sum_probs=190.8
Q ss_pred CCCccEEEccCCcccccCCCCccCCCCCceecccccccCCCCCcccccccchhhhhhcccCccCCCCcccccCCCCceee
Q 002349 91 LKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFG 170 (933)
Q Consensus 91 l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ 170 (933)
+++|+.|++++|.+. .+| .+..+++|++|||++|.+++..| +.++++|++|+|++|.+++..+ ++++++|++|+
T Consensus 45 l~~l~~L~l~~~~i~-~l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~ 118 (466)
T 1o6v_A 45 LDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLT 118 (466)
T ss_dssp HHTCCEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred hccccEEecCCCCCc-cCc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEE
Confidence 445566666666665 344 25566666666666666654332 5666666666666666664333 66666666666
Q ss_pred eecCCCCCCcccccccCCCCcEEeccCccccCccCcCCcCCCCCcEEccccccccCcCCCCccccccceEeccccccccc
Q 002349 171 LRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGK 250 (933)
Q Consensus 171 L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~ 250 (933)
|++|++++..+ +..+++|++|++++|.+++ ++ .++.+++|++|+++ |.+.+..
T Consensus 119 L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~-~~~~~~~---------------------- 171 (466)
T 1o6v_A 119 LFNNQITDIDP--LKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLSFG-NQVTDLK---------------------- 171 (466)
T ss_dssp CCSSCCCCCGG--GTTCTTCSEEEEEEEEECC-CG-GGTTCTTCSEEEEE-ESCCCCG----------------------
T ss_pred CCCCCCCCChH--HcCCCCCCEEECCCCccCC-Ch-hhccCCcccEeecC-CcccCch----------------------
Confidence 66666654322 5566666666666666653 22 35666666666654 3332111
Q ss_pred cCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcceEeeeccccccccCCcccccc
Q 002349 251 IPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKL 330 (933)
Q Consensus 251 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l 330 (933)
.++.+++|++|++++|.+++. ..+..+++|++|++++|.+++..| ++.+++|+.|++++|++++. ..+..+
T Consensus 172 ---~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l 242 (466)
T 1o6v_A 172 ---PLANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASL 242 (466)
T ss_dssp ---GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGC
T ss_pred ---hhccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcC
Confidence 133444444444444444432 124444555555555555544333 44445555555555555432 234455
Q ss_pred ccccccccccccCCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCCccccccccccceeec
Q 002349 331 TDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDM 410 (933)
Q Consensus 331 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 410 (933)
++|+.|++++|++.+..+ +..+++|+.|++++|++++..+ +..+++|++|++++|++++..+ +..+++|+.|+|
T Consensus 243 ~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L 316 (466)
T 1o6v_A 243 TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTL 316 (466)
T ss_dssp TTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEEC
T ss_pred CCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEEC
Confidence 555555555555554333 5555555666666665554322 5555666666666666654433 555666666666
Q ss_pred cCCccCCCCCCCCCCccccccccccCcccccccccccccccccceEEccCCccccccchhhccccccceeeecCCCCcCc
Q 002349 411 SNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGD 490 (933)
Q Consensus 411 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 490 (933)
++|++++..| +..+++|+.|++++|++++. ..+.++++|+.|++++|++++..| +..+++|+.|++++|++++.
T Consensus 317 ~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~~ 390 (466)
T 1o6v_A 317 YFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNA 390 (466)
T ss_dssp CSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEECC
T ss_pred cCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccCC
Confidence 6666665443 55666666666666666654 356666666666666666666555 56666666666666666664
Q ss_pred c
Q 002349 491 V 491 (933)
Q Consensus 491 ~ 491 (933)
+
T Consensus 391 p 391 (466)
T 1o6v_A 391 P 391 (466)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=353.27 Aligned_cols=260 Identities=23% Similarity=0.339 Sum_probs=211.6
Q ss_pred hhccCcceeeecccceeEEEEEE------cCCceEEEEEecccCc-hhHHHHHHHHHHHhcC-CCCceeeeeeEEecCCc
Q 002349 597 TENLSEKYIIGYGASSTVYKCVL------KNCKPVAIKRLYSHYP-QCLKEFETELETVGSI-KHRNLVSLQGYSLSSSG 668 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 668 (933)
.++|+..+.||+|+||.||+|.+ ..++.||||++..... ...+.+.+|+++++++ +||||+++++++..++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 36889999999999999999985 2357899999976543 3457789999999999 99999999999999999
Q ss_pred cEEEEEecCCCCHHHHhcCCCC---------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEe
Q 002349 669 NLLFYDFMENGSLWDILHGPTK---------------KKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILL 733 (933)
Q Consensus 669 ~~lv~e~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll 733 (933)
.++||||+++|+|.+++..... ...+++..++.++.|++.||+|||++ +|+||||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEE
Confidence 9999999999999999964221 22589999999999999999999976 99999999999999
Q ss_pred CCCCCeEEeecccccccccCCCce-eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHH
Q 002349 734 DKDFEAHLTDFGIAKSLCVSKSYT-STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLI 811 (933)
Q Consensus 734 ~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~ 811 (933)
+.++.+||+|||+++......... .....||+.|+|||.+.+..++.++||||||+++|+|++ |+.||.+........
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 258 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHH
Confidence 999999999999998765433322 233457889999999999999999999999999999999 999998654433322
Q ss_pred HhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCC
Q 002349 812 LSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLV 870 (933)
Q Consensus 812 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 870 (933)
....... ...... ..+..+.+++.+|++.||++|||++|+++.|+.+.
T Consensus 259 ~~~~~~~------~~~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 259 KMIKEGF------RMLSPE-----HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp HHHHHTC------CCCCCT-----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhccCC------CCCCcc-----cCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 2111110 111111 12457889999999999999999999999998754
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=360.39 Aligned_cols=265 Identities=15% Similarity=0.222 Sum_probs=201.3
Q ss_pred hccCcceeeecccceeEEEEEEc----CCceEEEEEecccCch-----------hHHHHHHHHHHHhcCCCCceeeeeeE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK----NCKPVAIKRLYSHYPQ-----------CLKEFETELETVGSIKHRNLVSLQGY 662 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~~~~~ 662 (933)
++|...+.||+|+||.||+|.+. .+..||+|++...... ....+.+|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 57999999999999999999986 4678999998765322 12346688999999999999999999
Q ss_pred Eec----CCccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCC-
Q 002349 663 SLS----SSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDF- 737 (933)
Q Consensus 663 ~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~- 737 (933)
+.. ....++||||+ +++|.+++. ..+.+++.+++.++.|++.||+|||++ +|+||||||+||+++.++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISG---QNGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCB---GGGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSST
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCC
Confidence 987 67889999999 999999995 334899999999999999999999966 999999999999999887
Q ss_pred -CeEEeecccccccccCCCc------eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHH
Q 002349 738 -EAHLTDFGIAKSLCVSKSY------TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHL 810 (933)
Q Consensus 738 -~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~ 810 (933)
.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.......
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence 9999999999876432211 113457999999999999999999999999999999999999999643222211
Q ss_pred HHhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCC
Q 002349 811 ILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVP 871 (933)
Q Consensus 811 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 871 (933)
..... .......+.......+....+..+.+++.+||+.||++|||+++|++.|+....
T Consensus 270 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 270 VQTAK--TNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHH--HHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHHH--HhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 11110 111111111111111111234679999999999999999999999999998654
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=365.50 Aligned_cols=263 Identities=20% Similarity=0.305 Sum_probs=196.6
Q ss_pred HHhhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCC-CCceeeeeeEEecCC--c
Q 002349 595 RMTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIK-HRNLVSLQGYSLSSS--G 668 (933)
Q Consensus 595 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~--~ 668 (933)
...++|+..+.||+|+||.||+|.+. +++.||||++.... ....+++.+|+.+++++. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 45679999999999999999999975 57899999986542 344567889999999997 999999999997544 6
Q ss_pred cEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccc
Q 002349 669 NLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAK 748 (933)
Q Consensus 669 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 748 (933)
.++||||++ ++|.+++. ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+
T Consensus 86 ~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIR----ANILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEEECCS-EEHHHHHH----HTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecccC-cCHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 799999997 58999985 24789999999999999999999966 99999999999999999999999999998
Q ss_pred ccccC--------------------CCceeeeecccccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcch
Q 002349 749 SLCVS--------------------KSYTSTYIMGTIGYIDPEYART-SRLTEKSDVYSFGIVLLELLTGRKAVDNECNL 807 (933)
Q Consensus 749 ~~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~ 807 (933)
.+... ........+||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 237 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 65321 1112234579999999999987 67899999999999999999999999877665
Q ss_pred hHHHHhhhcccccccc----c-------------------Cccccccc-----------cCHHHHHHHHHHHHHccCCCC
Q 002349 808 HHLILSKTANNAVMET----V-------------------DPEISATC-----------KDLGAVKKVFQLALLCSKRQP 853 (933)
Q Consensus 808 ~~~~~~~~~~~~~~~~----~-------------------~~~~~~~~-----------~~~~~~~~l~~li~~cl~~dP 853 (933)
.++.......+..... . ........ .....+..+.+++.+||+.||
T Consensus 238 ~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP 317 (388)
T 3oz6_A 238 NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP 317 (388)
T ss_dssp HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence 5544332111100000 0 00000000 000123578899999999999
Q ss_pred CCCCCHHHHHHH
Q 002349 854 TDRPTMHEVSRV 865 (933)
Q Consensus 854 ~~RPt~~evl~~ 865 (933)
++|||++|++++
T Consensus 318 ~~R~t~~e~l~H 329 (388)
T 3oz6_A 318 NKRISANDALKH 329 (388)
T ss_dssp GGSCCHHHHTTS
T ss_pred ccCCCHHHHhCC
Confidence 999999999986
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=352.71 Aligned_cols=246 Identities=21% Similarity=0.254 Sum_probs=195.7
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcC-CCCceeeeeeEEecCCccEEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSI-KHRNLVSLQGYSLSSSGNLLF 672 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 672 (933)
.++|+..++||+|+||+||+|++. +++.||||++.... .....++..|+..+.++ +||||+++++++.+++..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 368999999999999999999987 68899999986543 23334455566665555 899999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccccc
Q 002349 673 YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV 752 (933)
Q Consensus 673 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 752 (933)
|||+ +++|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 136 ~e~~-~~~L~~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 136 TELC-GPSLQQHCEA--WGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EECC-CCBHHHHHHH--HCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred Eecc-CCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 9999 6799998853 345799999999999999999999976 999999999999999999999999999987533
Q ss_pred CCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccc
Q 002349 753 SKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATC 832 (933)
Q Consensus 753 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (933)
. .......||+.|+|||++.+ .++.++|||||||++|||++|..|+......... .... ..+.+..
T Consensus 210 ~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~-----~~~~----~~~~~~~-- 275 (311)
T 3p1a_A 210 A--GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQL-----RQGY----LPPEFTA-- 275 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHH-----TTTC----CCHHHHT--
T ss_pred C--CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH-----hccC----CCccccc--
Confidence 2 22334569999999999886 6899999999999999999998777643322211 1111 1111111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 833 KDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 833 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
..+..+.+++.+|++.||++|||++|++++
T Consensus 276 ---~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 276 ---GLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp ---TSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ---CCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 123678899999999999999999999875
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=369.92 Aligned_cols=346 Identities=27% Similarity=0.374 Sum_probs=286.0
Q ss_pred cCCCCCceecccccccCCCCCcccccccchhhhhhcccCccCCCCcccccCCCCceeeeecCCCCCCcccccccCCCCcE
Q 002349 113 GDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWY 192 (933)
Q Consensus 113 ~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 192 (933)
..+++|+.|++++|.+. .+| .+..+++|++|+|++|.+++..| ++++++|++|+|++|++.+..+ +.++++|++
T Consensus 43 ~~l~~l~~L~l~~~~i~-~l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~ 116 (466)
T 1o6v_A 43 TDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTG 116 (466)
T ss_dssp HHHHTCCEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCE
T ss_pred hHhccccEEecCCCCCc-cCc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCE
Confidence 34677888888888876 455 37778888888888888875443 7788888888888888875544 777788888
Q ss_pred EeccCccccCccCcCCcCCCCCcEEccccccccCcCCCCccccccceEeccccccccccCccccccccccEEeccCCcCc
Q 002349 193 FDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLS 272 (933)
Q Consensus 193 L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 272 (933)
|++++|.+++..+ +.++++|++|++++|++++ ++ .++.+++|+.|+++ |.+.
T Consensus 117 L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~------------------------~~-~~~~l~~L~~L~l~-~~~~ 168 (466)
T 1o6v_A 117 LTLFNNQITDIDP--LKNLTNLNRLELSSNTISD------------------------IS-ALSGLTSLQQLSFG-NQVT 168 (466)
T ss_dssp EECCSSCCCCCGG--GTTCTTCSEEEEEEEEECC------------------------CG-GGTTCTTCSEEEEE-ESCC
T ss_pred EECCCCCCCCChH--HcCCCCCCEEECCCCccCC------------------------Ch-hhccCCcccEeecC-Cccc
Confidence 8888887775432 7777777777777776652 12 36778899999996 5565
Q ss_pred CCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcceEeeeccccccccCCccccccccccccccccccCCCCCCCCcc
Q 002349 273 GPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLS 352 (933)
Q Consensus 273 ~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~ 352 (933)
+..+ +.++++|+.|++++|.+++. ..+..+++|++|++++|.+++..| ++.+++|+.|++++|++.+. ..+.
T Consensus 169 ~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~ 240 (466)
T 1o6v_A 169 DLKP--LANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLA 240 (466)
T ss_dssp CCGG--GTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGG
T ss_pred Cchh--hccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhh
Confidence 4433 89999999999999999864 358899999999999999997655 78899999999999999854 4688
Q ss_pred cCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCCccccccccccceeeccCCccCCCCCCCCCCccccccc
Q 002349 353 SCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKL 432 (933)
Q Consensus 353 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 432 (933)
.+++|+.|++++|++++..+ +..+++|++|++++|.+++..+ +..+++|+.|+|++|++++..+ +..+++|+.|
T Consensus 241 ~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L 314 (466)
T 1o6v_A 241 SLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYL 314 (466)
T ss_dssp GCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEE
T ss_pred cCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEE
Confidence 99999999999999997654 8899999999999999997655 8899999999999999997654 8899999999
Q ss_pred cccCcccccccccccccccccceEEccCCccccccchhhccccccceeeecCCCCcCcccchhhccccc-eeecCCCCCC
Q 002349 433 NLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDVMSLINCLSLS-VLFIGNPGLC 511 (933)
Q Consensus 433 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~-~~~~~N~~~C 511 (933)
+|++|++++..| +..+++|+.|++++|++++. ..+..+++|+.|++++|++++.+| +..+..+. +.+.+|+|..
T Consensus 315 ~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 315 TLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQAWTN 389 (466)
T ss_dssp ECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG-GTTCTTCCEEECCCEEEEC
T ss_pred ECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch-hhcCCCCCEEeccCCcccC
Confidence 999999998876 88999999999999999976 478999999999999999999887 67777776 6677887765
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=356.14 Aligned_cols=262 Identities=20% Similarity=0.262 Sum_probs=199.6
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccCch-hHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEe
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQ-CLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
++|...+.||+|+||+||+|.+. +++.||||++...... ....+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57889999999999999999976 5789999999654321 222456799999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS 755 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 755 (933)
++ |+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..... .
T Consensus 82 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~-~ 154 (324)
T 3mtl_A 82 LD-KDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP-T 154 (324)
T ss_dssp CS-EEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCC-c
Confidence 97 589988863 345699999999999999999999966 9999999999999999999999999999865322 2
Q ss_pred ceeeeecccccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccc---
Q 002349 756 YTSTYIMGTIGYIDPEYART-SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISAT--- 831 (933)
Q Consensus 756 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 831 (933)
.......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+..............+.......+.....
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (324)
T 3mtl_A 155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 234 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhh
Confidence 22334578999999999876 56899999999999999999999999876655544433222111111111110000
Q ss_pred ---------c-----cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 832 ---------C-----KDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 832 ---------~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
. ........+.+++.+|++.||++|||++|++++-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 283 (324)
T 3mtl_A 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHP 283 (324)
T ss_dssp HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcCh
Confidence 0 0001235788999999999999999999999743
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=362.49 Aligned_cols=265 Identities=20% Similarity=0.262 Sum_probs=206.0
Q ss_pred hhccCcceeeecc--cceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEE
Q 002349 597 TENLSEKYIIGYG--ASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLL 671 (933)
Q Consensus 597 ~~~~~~~~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 671 (933)
.++|+..+.||+| +||+||+|+++ +++.||||++.... ....+.+.+|++++++++|||||++++++..++..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3589999999999 99999999987 58899999997543 3445678899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccc
Q 002349 672 FYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLC 751 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 751 (933)
||||+++|+|.+++.. .....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.+....
T Consensus 104 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 104 VTSFMAYGSAKDLICT-HFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEECCTTCBHHHHHHH-TCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEccCCCCHHHHHhh-hcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 9999999999999964 2235699999999999999999999966 99999999999999999999999999986542
Q ss_pred cCCC------ceeeeecccccccCcccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccccc-cc
Q 002349 752 VSKS------YTSTYIMGTIGYIDPEYART--SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAV-ME 822 (933)
Q Consensus 752 ~~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~-~~ 822 (933)
.... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+................. .+
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 259 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence 2111 11222478999999999987 579999999999999999999999998655444332211110000 00
Q ss_pred c------------------------cC--------ccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 823 T------------------------VD--------PEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 823 ~------------------------~~--------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
. .. ............+..+.+++.+||+.||++|||++|++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 0 00 0000000011123568899999999999999999999975
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=365.75 Aligned_cols=354 Identities=27% Similarity=0.336 Sum_probs=268.1
Q ss_pred CCCCCCCCCccEEEccCCcccccCCCCccCCCCCceecccccccCCCCCcccccccch-------------hhhhhcccC
Q 002349 85 SPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQL-------------EFLILKNNQ 151 (933)
Q Consensus 85 ~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L-------------~~L~L~~n~ 151 (933)
.|.-...++|++|++++|++ |.+|++|+++++|++|+|++|.+.|.+|.+++++++| ++|++++|.
T Consensus 4 ~p~~~~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~ 82 (454)
T 1jl5_A 4 NPRNVSNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLG 82 (454)
T ss_dssp -------------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSC
T ss_pred cccccccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCc
Confidence 34444568999999999999 7999999999999999999999999999999999886 888999999
Q ss_pred ccCCCCcccccCCCCceeeeecCCCCCCcccccccCCCCcEEeccCccccCccCcCCcCCCCCcEEccccccccCcCCCC
Q 002349 152 LIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFN 231 (933)
Q Consensus 152 l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~ 231 (933)
+++ +|.. .++|++|++++|++++ +|.. +++|++|++++|++++ +|.. .++|++|++++|++++ +|..
T Consensus 83 l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp~~ 149 (454)
T 1jl5_A 83 LSS-LPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LPEL 149 (454)
T ss_dssp CSC-CCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CCCC
T ss_pred ccc-CCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cccc
Confidence 886 4542 3789999999999997 6643 4889999999999985 3332 2689999999999996 7754
Q ss_pred ccccccceEeccccccccccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcceE
Q 002349 232 IGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHY 311 (933)
Q Consensus 232 ~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 311 (933)
....+|++|++++|++++ +|..+ .+|++|++++|++++ +| .++++++|++|++++|++++ +|... ++|++
T Consensus 150 ~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~ 219 (454)
T 1jl5_A 150 QNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP---LSLES 219 (454)
T ss_dssp TTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC---TTCCE
T ss_pred CCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc---CcccE
Confidence 445589999999999996 55543 589999999999997 45 68999999999999999996 45433 58999
Q ss_pred eeeccccccccCCccccccccccccccccccCCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccceecCCcccc
Q 002349 312 LELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNI 391 (933)
Q Consensus 312 L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 391 (933)
|++++|+++ .+| .++.+++|+.|++++|++++ +|.. +++|+.|++++|++++ +|.. +++|++|++++|++
T Consensus 220 L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l 289 (454)
T 1jl5_A 220 IVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIF 289 (454)
T ss_dssp EECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCC
T ss_pred EECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCcc
Confidence 999999999 667 48999999999999999985 4543 4789999999999996 4543 37899999999999
Q ss_pred cCCCccccccccccceeeccCCccCCCCCCCCCCc-cccccccccCcccccccccccccccccceEEccCCccccccchh
Q 002349 392 RGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDL-EHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEE 470 (933)
Q Consensus 392 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 470 (933)
++. |.. .++|+.|++++|++++ ++ .+ ++|+.|++++|++++ +|.. +++|++|++++|++++ +|.
T Consensus 290 ~~l-~~~---~~~L~~L~l~~N~l~~-i~----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~-lp~- 354 (454)
T 1jl5_A 290 SGL-SEL---PPNLYYLNASSNEIRS-LC----DLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAE-VPE- 354 (454)
T ss_dssp SEE-SCC---CTTCCEEECCSSCCSE-EC----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC-
T ss_pred Ccc-cCc---CCcCCEEECcCCcCCc-cc----CCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCcccc-ccc-
Confidence 863 211 2689999999999985 22 23 589999999999996 5654 5889999999999995 665
Q ss_pred hccccccceeeecCCCCcC
Q 002349 471 LSQLQNMFSLRLDYNNLSG 489 (933)
Q Consensus 471 ~~~l~~L~~L~l~~N~l~~ 489 (933)
.+++|++|++++|++++
T Consensus 355 --~l~~L~~L~L~~N~l~~ 371 (454)
T 1jl5_A 355 --LPQNLKQLHVEYNPLRE 371 (454)
T ss_dssp --CCTTCCEEECCSSCCSS
T ss_pred --hhhhccEEECCCCCCCc
Confidence 57899999999999999
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=350.86 Aligned_cols=262 Identities=24% Similarity=0.298 Sum_probs=203.0
Q ss_pred hhccCcceeeecccceeEEEEEEcC-CceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
.++|+..+.||+|+||+||+|.+.. ++.||||++.... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 3679999999999999999999864 8899999986543 233566889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
||+++++|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 e~~~~~~l~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 82 EYCDHTVLHELDR---YQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp ECCSEEHHHHHHH---TSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EeCCCchHHHHHh---hhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 9999999999884 356799999999999999999999976 9999999999999999999999999999876432
Q ss_pred CCceeeeecccccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccc-----------
Q 002349 754 KSYTSTYIMGTIGYIDPEYART-SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVM----------- 821 (933)
Q Consensus 754 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~----------- 821 (933)
.. ......||+.|+|||++.+ ..++.++||||+|+++|+|++|+.||.+..................
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 156 SD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred cc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence 22 2334578999999999976 5689999999999999999999999987665544433221111100
Q ss_pred --cccCccccccccC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 822 --ETVDPEISATCKD-----LGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 822 --~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
............. ...+..+.+++.+|++.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000000000000 1124568899999999999999999999975
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=354.32 Aligned_cols=260 Identities=22% Similarity=0.373 Sum_probs=210.6
Q ss_pred hhccCcceeeecccceeEEEEEEc--------CCceEEEEEecccC-chhHHHHHHHHHHHhcC-CCCceeeeeeEEecC
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK--------NCKPVAIKRLYSHY-PQCLKEFETELETVGSI-KHRNLVSLQGYSLSS 666 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 666 (933)
.++|...+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+++++++ +||||+++++++...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 468999999999999999999974 45789999997653 34567789999999999 899999999999999
Q ss_pred CccEEEEEecCCCCHHHHhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEe
Q 002349 667 SGNLLFYDFMENGSLWDILHGPTK-------------KKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILL 733 (933)
Q Consensus 667 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll 733 (933)
+..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||++ +|+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEE
Confidence 999999999999999999964321 23589999999999999999999966 99999999999999
Q ss_pred CCCCCeEEeecccccccccCCCce-eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHH
Q 002349 734 DKDFEAHLTDFGIAKSLCVSKSYT-STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLI 811 (933)
Q Consensus 734 ~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~ 811 (933)
+.++.+||+|||+++......... .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||.+........
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 270 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHH
Confidence 999999999999998764332222 233457889999999999889999999999999999999 999997654333221
Q ss_pred HhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCC
Q 002349 812 LSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVP 871 (933)
Q Consensus 812 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 871 (933)
.... .. ...... ..+..+.+++.+||+.||++|||++|+++.|+.+..
T Consensus 271 ~~~~--~~-----~~~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 271 LLKE--GH-----RMDKPA-----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp HHHH--TC-----CCCCCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhc--CC-----CCCCCc-----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1111 10 011111 123578899999999999999999999999987754
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=355.10 Aligned_cols=267 Identities=25% Similarity=0.252 Sum_probs=203.3
Q ss_pred HHHhhccCcceeeecccceeEEEEEEc-CCceEEEEEecccCc-----hhHHHHHHHHHHHhcCCCCceeeeeeEEecCC
Q 002349 594 MRMTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYP-----QCLKEFETELETVGSIKHRNLVSLQGYSLSSS 667 (933)
Q Consensus 594 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 667 (933)
....++|+..+.||+|+||.||+|.+. +++.||||++..... ...+.+.+|++++++++||||+++++++...+
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 344678999999999999999999976 478999999965321 12346789999999999999999999999999
Q ss_pred ccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccc
Q 002349 668 GNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIA 747 (933)
Q Consensus 668 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla 747 (933)
..++||||+++ +|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLA 159 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred ceEEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccc
Confidence 99999999986 89888853 445789999999999999999999976 9999999999999999999999999999
Q ss_pred cccccCCCceeeeecccccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCc
Q 002349 748 KSLCVSKSYTSTYIMGTIGYIDPEYARTS-RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDP 826 (933)
Q Consensus 748 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 826 (933)
+...... .......||+.|+|||++.+. .++.++||||+||++|||++|..||.+..............+.......+
T Consensus 160 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 238 (346)
T 1ua2_A 160 KSFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 238 (346)
T ss_dssp STTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSS
T ss_pred eeccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhh
Confidence 8764322 223345789999999998764 58999999999999999999999998776655544332221111111111
Q ss_pred ccccc---------c-cC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 002349 827 EISAT---------C-KD-----LGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLG 867 (933)
Q Consensus 827 ~~~~~---------~-~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 867 (933)
..... . .. ...+..+.+++.+|++.||++|||++|++++-.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~ 294 (346)
T 1ua2_A 239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294 (346)
T ss_dssp STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred hhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChh
Confidence 00000 0 00 112367899999999999999999999998654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=344.71 Aligned_cols=250 Identities=26% Similarity=0.368 Sum_probs=185.1
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLF 672 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 672 (933)
.++|...+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 368999999999999999999974 68899999996532 22347789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccccc
Q 002349 673 YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV 752 (933)
Q Consensus 673 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 752 (933)
|||+++++|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 90 LEMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 999999999999963 346799999999999999999999976 999999999999999999999999999987643
Q ss_pred CCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccc
Q 002349 753 SKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATC 832 (933)
Q Consensus 753 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (933)
... ......||+.|+|||.+.+..++.++||||+|+++|+|++|+.||............... +...+.
T Consensus 165 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------~~~~~~-- 233 (278)
T 3cok_A 165 PHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA--------DYEMPS-- 233 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSS--------CCCCCT--
T ss_pred CCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhc--------ccCCcc--
Confidence 222 223457899999999999988999999999999999999999999865432222111100 001111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 833 KDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 833 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
..+..+.+++.+|++.||++|||+++++++
T Consensus 234 ---~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 234 ---FLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp ---TSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ---ccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 123578899999999999999999999874
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=371.76 Aligned_cols=250 Identities=21% Similarity=0.236 Sum_probs=198.8
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEeccc---CchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSH---YPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLF 672 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 672 (933)
.++|+..+.||+|+||.||+|... +++.||||++... .......+.+|++++++++||||+++++++...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 468999999999999999999976 5789999999753 233446678899999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeeeccCCCCceEeCCCCCeEEeecccccccc
Q 002349 673 YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHH-DCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLC 751 (933)
Q Consensus 673 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 751 (933)
|||+++|+|.+++. ....+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||+|+...
T Consensus 227 ~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 99999999999995 34679999999999999999999996 4 99999999999999999999999999998643
Q ss_pred cCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccc
Q 002349 752 VSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISAT 831 (933)
Q Consensus 752 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (933)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.................. .
T Consensus 301 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p--------~- 370 (446)
T 4ejn_A 301 KD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP--------R- 370 (446)
T ss_dssp C------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--------T-
T ss_pred CC-CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC--------c-
Confidence 22 2233456899999999999999999999999999999999999999987654443333222211111 1
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHH
Q 002349 832 CKDLGAVKKVFQLALLCSKRQPTDRP-----TMHEVSRVL 866 (933)
Q Consensus 832 ~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L 866 (933)
..+..+.+++.+||+.||++|| +++|++++-
T Consensus 371 ----~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp 406 (446)
T 4ejn_A 371 ----TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHR 406 (446)
T ss_dssp ----TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred ----cCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCc
Confidence 1135688999999999999999 999998743
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=357.41 Aligned_cols=265 Identities=23% Similarity=0.360 Sum_probs=213.9
Q ss_pred HHHHHhhccCcceeeecccceeEEEEEEc------CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEe
Q 002349 592 DIMRMTENLSEKYIIGYGASSTVYKCVLK------NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSL 664 (933)
Q Consensus 592 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 664 (933)
++....++|...+.||+|+||.||+|.+. .++.||+|++.... ......+.+|++++++++||||+++++++.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 33445678999999999999999999865 26789999997653 334567899999999999999999999999
Q ss_pred cCCccEEEEEecCCCCHHHHhcCC-------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCC
Q 002349 665 SSSGNLLFYDFMENGSLWDILHGP-------TKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDF 737 (933)
Q Consensus 665 ~~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~ 737 (933)
..+..++||||+++|+|.++++.. .....+++..++.++.|++.||+|||++ +|+||||||+||+++.++
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTC
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCC
Confidence 999999999999999999998531 1124679999999999999999999976 999999999999999999
Q ss_pred CeEEeecccccccccCCCce-eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhh
Q 002349 738 EAHLTDFGIAKSLCVSKSYT-STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKT 815 (933)
Q Consensus 738 ~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~ 815 (933)
.+||+|||+++......... .....||+.|+|||++.+..++.++||||+|+++|+|++ |+.||.+...........
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~- 254 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM- 254 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH-
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH-
Confidence 99999999998654332211 223457889999999999999999999999999999999 889997654333222211
Q ss_pred cccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCC
Q 002349 816 ANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVP 871 (933)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 871 (933)
..... ... ...+..+.+++.+|++.||++|||+.|+++.|+....
T Consensus 255 -~~~~~-----~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 255 -EGGLL-----DKP-----DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp -TTCCC-----CCC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred -cCCcC-----CCC-----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 11111 011 1124578899999999999999999999999988754
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=355.29 Aligned_cols=258 Identities=27% Similarity=0.436 Sum_probs=203.3
Q ss_pred hccCcceeeecccceeEEEEEEcC-----CceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKN-----CKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLL 671 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 671 (933)
++|...+.||+|+||.||+|.+.. +..||||++.... ......+.+|++++++++||||+++++++...+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 456677899999999999999653 2359999997653 3345678999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccc
Q 002349 672 FYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLC 751 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 751 (933)
||||+++|+|.+++.. ....+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 124 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 124 ITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp EEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 9999999999999963 346799999999999999999999976 99999999999999999999999999998764
Q ss_pred cCCCc--eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCccc
Q 002349 752 VSKSY--TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEI 828 (933)
Q Consensus 752 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 828 (933)
..... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||............. ... ....
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~--~~~-----~~~~ 271 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN--DGF-----RLPT 271 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH--TTC-----CCCC
T ss_pred cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH--CCC-----cCCC
Confidence 32221 1223356789999999999999999999999999999999 999997654433222111 110 0011
Q ss_pred cccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCCC
Q 002349 829 SATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPA 872 (933)
Q Consensus 829 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 872 (933)
. ...+..+.+++.+||+.||++||+++++++.|+.+...
T Consensus 272 ~-----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 272 P-----MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp C-----TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred c-----ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 1 12245788999999999999999999999999876543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=350.50 Aligned_cols=263 Identities=22% Similarity=0.221 Sum_probs=202.6
Q ss_pred HhhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC-----chhHHHHHHHHHHHhcCC---CCceeeeeeEEecC
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY-----PQCLKEFETELETVGSIK---HRNLVSLQGYSLSS 666 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~ 666 (933)
..++|+..+.||+|+||+||+|++. +++.||||++.... ......+.+|++++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4578999999999999999999964 57899999986432 122356677888777764 99999999999776
Q ss_pred C-----ccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEE
Q 002349 667 S-----GNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHL 741 (933)
Q Consensus 667 ~-----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl 741 (933)
. ..++||||+. ++|.+++.. .....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDK-APPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHT-CCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhh-ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEE
Confidence 5 4789999997 599999964 2234599999999999999999999976 9999999999999999999999
Q ss_pred eecccccccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccc
Q 002349 742 TDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVM 821 (933)
Q Consensus 742 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 821 (933)
+|||+++..... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+..............+...
T Consensus 162 ~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (308)
T 3g33_A 162 ADFGLARIYSYQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 239 (308)
T ss_dssp CSCSCTTTSTTC--CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred eeCccccccCCC--cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 999999865322 223445799999999999999999999999999999999999999987665554433322111111
Q ss_pred cccCcc--------cccc-ccC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 822 ETVDPE--------ISAT-CKD-----LGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 822 ~~~~~~--------~~~~-~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
....+. +... ... ......+.+++.+|++.||++|||++|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 100000 0000 000 0123678899999999999999999999875
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=343.89 Aligned_cols=251 Identities=25% Similarity=0.345 Sum_probs=205.3
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccCc------hhHHHHHHHHHHHhcCCCCceeeeeeEEecCCcc
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYP------QCLKEFETELETVGSIKHRNLVSLQGYSLSSSGN 669 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 669 (933)
.++|+..+.||+|+||.||+|.+. +++.||+|++..... ...+.+.+|++++++++||||+++++++......
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 467999999999999999999987 588999999865431 1367899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCC----CeEEeecc
Q 002349 670 LLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDF----EAHLTDFG 745 (933)
Q Consensus 670 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~----~~kl~DfG 745 (933)
++||||+++++|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++ .+||+|||
T Consensus 84 ~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 84 VLILELVSGGELFDFLA---EKESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 99999999999999994 345799999999999999999999966 999999999999998877 89999999
Q ss_pred cccccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccC
Q 002349 746 IAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVD 825 (933)
Q Consensus 746 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (933)
++....... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||................... +
T Consensus 158 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~ 231 (283)
T 3bhy_A 158 IAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDF----D 231 (283)
T ss_dssp TCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCC----C
T ss_pred cceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCC----c
Confidence 998764322 2234569999999999999999999999999999999999999998765544333222111111 1
Q ss_pred ccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002349 826 PEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSR 864 (933)
Q Consensus 826 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 864 (933)
+.... ..+..+.+++.+|++.||++|||++|+++
T Consensus 232 ~~~~~-----~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 232 EEYFS-----NTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp HHHHT-----TCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred chhcc-----cCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 11111 12356889999999999999999999997
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=363.95 Aligned_cols=265 Identities=18% Similarity=0.238 Sum_probs=204.0
Q ss_pred hhccCcceeeecccceeEEEEEEcC------CceEEEEEecccCchhH-----------HHHHHHHHHHhcCCCCceeee
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKN------CKPVAIKRLYSHYPQCL-----------KEFETELETVGSIKHRNLVSL 659 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~~ 659 (933)
.++|+..+.||+|+||.||+|.+.. ++.||||++........ ..+.+|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4589999999999999999999865 37899999876542211 123456677788899999999
Q ss_pred eeEEecC----CccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeC-
Q 002349 660 QGYSLSS----SGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLD- 734 (933)
Q Consensus 660 ~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~- 734 (933)
++++... ...++||||+ +++|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEES
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEec
Confidence 9998764 4479999999 9999999963 346799999999999999999999966 999999999999999
Q ss_pred -CCCCeEEeecccccccccCCCce------eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcch
Q 002349 735 -KDFEAHLTDFGIAKSLCVSKSYT------STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNL 807 (933)
Q Consensus 735 -~~~~~kl~DfGla~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~ 807 (933)
.++.+||+|||+++.+....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+....
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 88999999999998764322211 13345999999999999999999999999999999999999999854333
Q ss_pred hHHHHhhhcc--cccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCC
Q 002349 808 HHLILSKTAN--NAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVP 871 (933)
Q Consensus 808 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 871 (933)
.......... ....+..++.+. ....+..+.+++..|++.||++||++++|++.|+.+..
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~ 329 (364)
T 3op5_A 268 PKYVRDSKIRYRENIASLMDKCFP----AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLK 329 (364)
T ss_dssp HHHHHHHHHHHHHCHHHHHHHHSC----TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhhhhHHHHHHHhcc----cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence 3222111110 111111111110 11224678999999999999999999999999877644
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=341.92 Aligned_cols=254 Identities=22% Similarity=0.325 Sum_probs=207.1
Q ss_pred HhhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
..++|+..+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 4578999999999999999999976 57899999986543 344577899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
||+++++|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+......
T Consensus 85 e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 85 EYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp ECCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred EecCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 9999999999994 456799999999999999999999976 9999999999999999999999999999865332
Q ss_pred CC-ceeeeecccccccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccc
Q 002349 754 KS-YTSTYIMGTIGYIDPEYARTSRL-TEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISAT 831 (933)
Q Consensus 754 ~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (933)
.. .......||+.|+|||.+.+..+ +.++||||+|+++|+|++|+.||.................... +..
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~--- 231 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL----NPW--- 231 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTS----TTG---
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccccc----Cch---
Confidence 21 12334578999999999988765 7899999999999999999999986543322211111111100 000
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 832 CKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 832 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
...+..+.+++.+|++.||++|||++|++++
T Consensus 232 ---~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 232 ---KKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp ---GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---hhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 0123568889999999999999999999875
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=353.78 Aligned_cols=257 Identities=26% Similarity=0.367 Sum_probs=201.6
Q ss_pred hccCcceeeecccceeEEEEEEcC-Cc----eEEEEEeccc-CchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKN-CK----PVAIKRLYSH-YPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLL 671 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 671 (933)
++|+..+.||+|+||.||+|.+.. ++ +||+|.+... .....+.+.+|++++++++||||+++++++..+. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 578999999999999999999653 33 3577877543 3445678999999999999999999999998764 789
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccc
Q 002349 672 FYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLC 751 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 751 (933)
|+||+++|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 94 v~~~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EECCCSSCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred EEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 9999999999999963 356799999999999999999999976 99999999999999999999999999998764
Q ss_pred cCCC-ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCcccc
Q 002349 752 VSKS-YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEIS 829 (933)
Q Consensus 752 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (933)
.... .......||+.|+|||.+.+..++.++|||||||++|||++ |+.||.+.............. . ...+
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~-~------~~~~ 241 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-R------LPQP 241 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-C------CCCC
T ss_pred CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-C------CCCC
Confidence 3222 22233457889999999999999999999999999999999 999998654433322211111 0 0011
Q ss_pred ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCCC
Q 002349 830 ATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPA 872 (933)
Q Consensus 830 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 872 (933)
. ..+..+.+++.+||+.||++|||++|+++.|+.+...
T Consensus 242 ~-----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 242 P-----ICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp T-----TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred c-----cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 1 1235788999999999999999999999999887643
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=344.82 Aligned_cols=256 Identities=22% Similarity=0.329 Sum_probs=208.7
Q ss_pred hccCcce-eeecccceeEEEEEEc---CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEE
Q 002349 598 ENLSEKY-IIGYGASSTVYKCVLK---NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLF 672 (933)
Q Consensus 598 ~~~~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 672 (933)
++|...+ .||+|+||.||+|.+. .++.||||++.... ....+.+.+|++++++++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4566665 8999999999999864 56789999997653 34567799999999999999999999999 45568999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccccc
Q 002349 673 YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV 752 (933)
Q Consensus 673 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 752 (933)
|||+++++|.+++. .....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 88 ~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 88 MEMAGGGPLHKFLV--GKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EECCTTEEHHHHHT--TCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCCHHHHHH--hCCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 99999999999995 3456799999999999999999999976 999999999999999999999999999987643
Q ss_pred CCCce--eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCcccc
Q 002349 753 SKSYT--STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEIS 829 (933)
Q Consensus 753 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (933)
..... .....||+.|+|||++.+..++.++||||||+++|||++ |+.||.............. .. .+..+
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~--~~-----~~~~~ 235 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ--GK-----RMECP 235 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT--TC-----CCCCC
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhc--CC-----cCCCC
Confidence 33222 223356889999999998889999999999999999998 9999986554333222111 11 11111
Q ss_pred ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCC
Q 002349 830 ATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVP 871 (933)
Q Consensus 830 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 871 (933)
. ..+..+.+++.+||+.||++||++.++++.|+.+..
T Consensus 236 ~-----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 272 (287)
T 1u59_A 236 P-----ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 272 (287)
T ss_dssp T-----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C-----CcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1 224678899999999999999999999999987654
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=354.11 Aligned_cols=262 Identities=26% Similarity=0.410 Sum_probs=204.3
Q ss_pred hccCcceeeecccceeEEEEEE-----cCCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecC--Ccc
Q 002349 598 ENLSEKYIIGYGASSTVYKCVL-----KNCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSS--SGN 669 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 669 (933)
++|+..+.||+|+||.||+|++ ..++.||||++.... ....+.+.+|++++++++||||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4688889999999999999984 357899999997543 34457899999999999999999999999876 667
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccc
Q 002349 670 LLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKS 749 (933)
Q Consensus 670 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 749 (933)
++||||+++++|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPK--NKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccccc
Confidence 999999999999999952 345699999999999999999999976 999999999999999999999999999987
Q ss_pred cccCCCc--eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcc--------cc
Q 002349 750 LCVSKSY--TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTAN--------NA 819 (933)
Q Consensus 750 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~--------~~ 819 (933)
....... ......||..|+|||.+.+..++.++||||+|+++|+|++|+.|+................ ..
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence 6543322 2234568888999999999999999999999999999999999875321110000000000 00
Q ss_pred cccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccC
Q 002349 820 VMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869 (933)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 869 (933)
.........+ ...+..+.+++.+||+.||++|||++++++.|+.+
T Consensus 256 ~~~~~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 256 LKEGKRLPCP-----PNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHTTCCCCCC-----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhccCCCCCC-----CCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 0000011111 12246789999999999999999999999998764
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=354.03 Aligned_cols=265 Identities=25% Similarity=0.332 Sum_probs=206.5
Q ss_pred hhccCcceeeecccceeEEEEEE-cCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEe----cCCccEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVL-KNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSL----SSSGNLL 671 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~----~~~~~~l 671 (933)
.++|+..+.||+|+||.||+|.. .+++.||||++........+.+.+|++++++++||||+++++++. .....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 35899999999999999999997 468899999997766666788999999999999999999999986 3446789
Q ss_pred EEEecCCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccc
Q 002349 672 FYDFMENGSLWDILHGP-TKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSL 750 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~ 750 (933)
||||+++|+|.+++... .....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 99999999999988531 1346799999999999999999999976 9999999999999999999999999998764
Q ss_pred ccCCCc--------eeeeecccccccCccccccCC---CCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccc
Q 002349 751 CVSKSY--------TSTYIMGTIGYIDPEYARTSR---LTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNA 819 (933)
Q Consensus 751 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 819 (933)
...... ......||+.|+|||++.+.. +++++||||||+++|+|++|+.||.................
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~- 263 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQ- 263 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC-
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhcc-
Confidence 321100 012235799999999987654 68999999999999999999999963111000000000000
Q ss_pred cccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCCCCC
Q 002349 820 VMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAPE 874 (933)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 874 (933)
.. .+. ....+..+.+++.+||+.||++|||++++++.|+.+.+...
T Consensus 264 ~~---~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 309 (317)
T 2buj_A 264 LS---IPQ------SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP 309 (317)
T ss_dssp -----CCC------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred CC---CCc------cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence 00 000 01123578899999999999999999999999998865443
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=358.44 Aligned_cols=245 Identities=23% Similarity=0.244 Sum_probs=194.4
Q ss_pred hhccCcceeeecccceeEEEEEEcC-CceEEEEEecccC---chhHHHHHHHHHH-HhcCCCCceeeeeeEEecCCccEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHY---PQCLKEFETELET-VGSIKHRNLVSLQGYSLSSSGNLL 671 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~l 671 (933)
.++|+..+.||+|+||.||+|+++. ++.||+|++.... ....+.+.+|..+ ++.++||||+++++++.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 3689999999999999999999874 7789999996543 2234456677776 577899999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccc
Q 002349 672 FYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLC 751 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 751 (933)
||||+++|+|.+++. ..+.+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQ---RERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 999999999999995 346789999999999999999999966 99999999999999999999999999998642
Q ss_pred cCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccc
Q 002349 752 VSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISAT 831 (933)
Q Consensus 752 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (933)
.. .......+||+.|+|||++.+..++.++||||+||++|||++|+.||.+................ +++.
T Consensus 191 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~----~~~~---- 261 (373)
T 2r5t_A 191 EH-NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQ----LKPN---- 261 (373)
T ss_dssp CC-CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCC----CCSS----
T ss_pred cC-CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccC----CCCC----
Confidence 22 22334568999999999999999999999999999999999999999876544433322221111 1111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 002349 832 CKDLGAVKKVFQLALLCSKRQPTDRPTMHE 861 (933)
Q Consensus 832 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 861 (933)
.+..+.+++.+|++.||++||++.+
T Consensus 262 -----~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 262 -----ITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp -----SCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred -----CCHHHHHHHHHHcccCHHhCCCCCC
Confidence 1356788999999999999999853
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=347.89 Aligned_cols=252 Identities=21% Similarity=0.288 Sum_probs=205.4
Q ss_pred HhhccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEE
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYD 674 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 674 (933)
..++|...+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++...+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3568999999999999999999976 588999999986654455678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEe---CCCCCeEEeecccccccc
Q 002349 675 FMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILL---DKDFEAHLTDFGIAKSLC 751 (933)
Q Consensus 675 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll---~~~~~~kl~DfGla~~~~ 751 (933)
|+++++|.+++. ..+.+++..+..++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||+++...
T Consensus 87 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 87 LVSGGELFDRIL---ERGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCCSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred cCCCccHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 999999999984 345789999999999999999999976 99999999999999 788999999999997643
Q ss_pred cCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccc
Q 002349 752 VSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISAT 831 (933)
Q Consensus 752 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (933)
.. ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||........................+
T Consensus 161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~----- 232 (304)
T 2jam_A 161 NG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWD----- 232 (304)
T ss_dssp CB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTT-----
T ss_pred CC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccc-----
Confidence 22 1223468999999999999999999999999999999999999998655443332222111111111101
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 832 CKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 832 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
..+..+.+++.+|++.||++|||++|++++
T Consensus 233 ----~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 233 ----DISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp ----TSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ----cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 123578899999999999999999999974
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=355.19 Aligned_cols=260 Identities=25% Similarity=0.373 Sum_probs=211.2
Q ss_pred CHHHHHHHhhccCcceeeecccceeEEEEEEc-CCceEEEEEecccCc--------hhHHHHHHHHHHHhcC-CCCceee
Q 002349 589 VYEDIMRMTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYP--------QCLKEFETELETVGSI-KHRNLVS 658 (933)
Q Consensus 589 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~ 658 (933)
.++......++|+..+.||+|+||.||+|.+. +|+.||||++..... ...+.+.+|+.+++++ +||||++
T Consensus 85 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 164 (365)
T 2y7j_A 85 DWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT 164 (365)
T ss_dssp HHHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred cchhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 34555666788999999999999999999986 689999999865431 1245678999999999 7999999
Q ss_pred eeeEEecCCccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCC
Q 002349 659 LQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFE 738 (933)
Q Consensus 659 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~ 738 (933)
+++++......++||||+++++|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 165 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ 238 (365)
T 2y7j_A 165 LIDSYESSSFMFLVFDLMRKGELFDYLT---EKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQ 238 (365)
T ss_dssp EEEEEEBSSEEEEEECCCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCC
T ss_pred EEEEEeeCCEEEEEEEeCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCC
Confidence 9999999999999999999999999995 345799999999999999999999976 9999999999999999999
Q ss_pred eEEeecccccccccCCCceeeeecccccccCcccccc------CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHH
Q 002349 739 AHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYART------SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLIL 812 (933)
Q Consensus 739 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~ 812 (933)
+||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........
T Consensus 239 ikl~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 316 (365)
T 2y7j_A 239 IRLSDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRM 316 (365)
T ss_dssp EEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred EEEEecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 9999999998764322 2334679999999998864 3588999999999999999999999986554443332
Q ss_pred hhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 813 SKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 813 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.......... +... ..+..+.+++.+|++.||++|||++|++++
T Consensus 317 i~~~~~~~~~---~~~~------~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 317 IMEGQYQFSS---PEWD------DRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHHTCCCCCH---HHHS------SSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhCCCCCCC---cccc------cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 2211111100 0000 113568899999999999999999999975
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=344.48 Aligned_cols=253 Identities=21% Similarity=0.265 Sum_probs=200.9
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYD 674 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 674 (933)
.++|...+.||+|+||+||+|..+ +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 368999999999999999999975 47899999987643 3356789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEe---CCCCCeEEeeccccccc
Q 002349 675 FMENGSLWDILHGP-TKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILL---DKDFEAHLTDFGIAKSL 750 (933)
Q Consensus 675 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll---~~~~~~kl~DfGla~~~ 750 (933)
|+++|+|.+.+... .....+++..+..++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||+++..
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999988421 1236799999999999999999999966 99999999999999 45688999999999865
Q ss_pred ccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccc
Q 002349 751 CVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISA 830 (933)
Q Consensus 751 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (933)
... .......||+.|+|||++. ..++.++||||+|+++|||++|+.||.+.................... ..
T Consensus 178 ~~~--~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~----~~- 249 (285)
T 3is5_A 178 KSD--EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVE----CR- 249 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC------C-
T ss_pred CCc--ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccc----cC-
Confidence 332 2234457999999999886 468999999999999999999999998654433322222111111100 00
Q ss_pred cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 831 TCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 831 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
..+..+.+++.+|++.||++|||++|++++
T Consensus 250 -----~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 250 -----PLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp -----CCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred -----cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 013568899999999999999999999864
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=357.40 Aligned_cols=252 Identities=24% Similarity=0.324 Sum_probs=198.5
Q ss_pred hccCcceeeecccceeEEEEEEcCCceEEEEEecccC--chhHHHHHHHHHHHhcCCC--CceeeeeeEEecCCccEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHY--PQCLKEFETELETVGSIKH--RNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~ 673 (933)
++|+..+.||+|+||.||+|...+++.||||++.... ....+.+.+|++++++++| |||+++++++..+...++||
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 88 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 88 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence 5789999999999999999999889999999986543 3345778999999999976 99999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
| +.+++|.+++. ....+++.++..++.|++.||+|||++ +|+||||||+|||++ ++.+||+|||+++.....
T Consensus 89 e-~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 89 E-CGNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp C-CCSEEHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred e-CCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 9 45789999995 356799999999999999999999976 999999999999997 578999999999876433
Q ss_pred CCc-eeeeecccccccCcccccc-----------CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccc
Q 002349 754 KSY-TSTYIMGTIGYIDPEYART-----------SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVM 821 (933)
Q Consensus 754 ~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 821 (933)
... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..................
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-- 238 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH-- 238 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS--
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCc--
Confidence 222 2334679999999999865 67899999999999999999999999864433222221111110
Q ss_pred cccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 002349 822 ETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLG 867 (933)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 867 (933)
....+.. .+..+.+++.+||+.||++|||++|++++..
T Consensus 239 ---~~~~~~~-----~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~ 276 (343)
T 3dbq_A 239 ---EIEFPDI-----PEKDLQDVLKCCLKRDPKQRISIPELLAHPY 276 (343)
T ss_dssp ---CCCCCCC-----SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred ---ccCCccc-----CCHHHHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence 1111111 1246889999999999999999999997543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=344.52 Aligned_cols=257 Identities=23% Similarity=0.368 Sum_probs=203.2
Q ss_pred hccCcceeeecccceeEEEEEEcC----CceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEe-cCCccEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKN----CKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSL-SSSGNLL 671 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~l 671 (933)
.+|+..+.||+|+||.||+|.+.+ ...||+|.+.... ....+.+.+|++++++++||||+++++++. .++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 467888999999999999999653 2358999987643 345577899999999999999999999864 4567899
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccc
Q 002349 672 FYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLC 751 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 751 (933)
||||+++|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 105 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp EEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred EEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECccccccccc
Confidence 9999999999999963 456789999999999999999999966 99999999999999999999999999998664
Q ss_pred cCCC---ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCcc
Q 002349 752 VSKS---YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPE 827 (933)
Q Consensus 752 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 827 (933)
.... .......||+.|+|||.+.+..++.++||||+|+++|+|++ |..||................. ..
T Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~-------~~ 252 (298)
T 3f66_A 180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR-------LL 252 (298)
T ss_dssp CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCC-------CC
T ss_pred ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCC-------CC
Confidence 3221 12333567889999999999999999999999999999999 5555654433332222111111 00
Q ss_pred ccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCC
Q 002349 828 ISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVP 871 (933)
Q Consensus 828 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 871 (933)
.+. ..+..+.+++.+|++.||++|||++|+++.|+.+..
T Consensus 253 ~~~-----~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 253 QPE-----YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp CCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCc-----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 011 123578899999999999999999999999987654
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=347.92 Aligned_cols=260 Identities=20% Similarity=0.287 Sum_probs=208.8
Q ss_pred HHHHHhhccCcc-eeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcC-CCCceeeeeeEEecC
Q 002349 592 DIMRMTENLSEK-YIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSI-KHRNLVSLQGYSLSS 666 (933)
Q Consensus 592 ~~~~~~~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 666 (933)
......++|... +.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++++ +||||+++++++...
T Consensus 22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~ 101 (327)
T 3lm5_A 22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT 101 (327)
T ss_dssp CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence 344556678877 88999999999999976 47899999987543 33467889999999999 569999999999999
Q ss_pred CccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCC---CCCeEEee
Q 002349 667 SGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDK---DFEAHLTD 743 (933)
Q Consensus 667 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~---~~~~kl~D 743 (933)
+..++||||+++|+|.+++.. .....+++..+..++.|++.||+|||++ +|+||||||+||+++. ++.+||+|
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~D 177 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLP-ELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVD 177 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSS-CC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECC
T ss_pred CeEEEEEEecCCCcHHHHHHH-hcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEee
Confidence 999999999999999999853 2346799999999999999999999976 9999999999999998 78999999
Q ss_pred cccccccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccc
Q 002349 744 FGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMET 823 (933)
Q Consensus 744 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 823 (933)
||+++..... .......||+.|+|||++.+..++.++||||+|+++|+|++|+.||......................
T Consensus 178 fg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 255 (327)
T 3lm5_A 178 FGMSRKIGHA--CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEE 255 (327)
T ss_dssp GGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred CccccccCCc--cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCch
Confidence 9999876432 22334579999999999999999999999999999999999999998765554443332222111111
Q ss_pred cCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 824 VDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 824 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
... ..+..+.+++.+|++.||++|||+++++++-
T Consensus 256 ~~~---------~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~ 289 (327)
T 3lm5_A 256 TFS---------SVSQLATDFIQSLLVKNPEKRPTAEICLSHS 289 (327)
T ss_dssp TTT---------TSCHHHHHHHHHHSCSSGGGSCCHHHHTTCG
T ss_pred hhc---------ccCHHHHHHHHHHcCCChhhCcCHHHHhCCH
Confidence 111 1235688999999999999999999998754
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=357.02 Aligned_cols=256 Identities=23% Similarity=0.365 Sum_probs=196.0
Q ss_pred ccCcceeeecccceeEEEEEEcC--C--ceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEec-CCccEEE
Q 002349 599 NLSEKYIIGYGASSTVYKCVLKN--C--KPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLS-SSGNLLF 672 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv 672 (933)
.|...+.||+|+||+||+|.+.+ + ..||||.+.... ....+++.+|+.++++++||||+++++++.. ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 46677899999999999999642 2 358999986543 4456789999999999999999999998754 4578999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccccc
Q 002349 673 YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV 752 (933)
Q Consensus 673 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 752 (933)
|||+++|+|.++++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 170 ~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccccc
Confidence 999999999999963 445689999999999999999999966 999999999999999999999999999986533
Q ss_pred CCCc---eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCccc
Q 002349 753 SKSY---TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEI 828 (933)
Q Consensus 753 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 828 (933)
.... ......+|+.|+|||.+.+..++.++|||||||++|||++ |..||.+............... ...
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~-------~~~ 317 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR-------LLQ 317 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCC-------CCC
T ss_pred cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCC-------CCC
Confidence 2211 1233467889999999999999999999999999999999 6777765443332222111110 001
Q ss_pred cccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCC
Q 002349 829 SATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVP 871 (933)
Q Consensus 829 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 871 (933)
+. ..+..+.+++.+||+.||++|||++|+++.|+.+..
T Consensus 318 p~-----~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~ 355 (373)
T 3c1x_A 318 PE-----YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 355 (373)
T ss_dssp CT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CC-----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11 124578899999999999999999999999987654
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=353.93 Aligned_cols=264 Identities=20% Similarity=0.253 Sum_probs=198.6
Q ss_pred HHhhccCcceeeecccceeEEEEEEc-CCceEEEEEecccCc--hhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEE
Q 002349 595 RMTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYP--QCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLL 671 (933)
Q Consensus 595 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 671 (933)
...++|+..+.||+|+||+||+|++. +++.||||++..... ...+.+.+|++++++++||||+++++++..++..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 34578999999999999999999965 578999999975432 234567899999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEe-----CCCCCeEEeeccc
Q 002349 672 FYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILL-----DKDFEAHLTDFGI 746 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll-----~~~~~~kl~DfGl 746 (933)
||||+++ +|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||++ +..+.+||+|||+
T Consensus 111 v~e~~~~-~L~~~~~---~~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 111 IFEYAEN-DLKKYMD---KNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEECCSE-EHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEecCCC-CHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 9999985 9999985 345699999999999999999999976 99999999999999 4555699999999
Q ss_pred ccccccCCCceeeeecccccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccC
Q 002349 747 AKSLCVSKSYTSTYIMGTIGYIDPEYARTS-RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVD 825 (933)
Q Consensus 747 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (933)
++...... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||.+......................
T Consensus 184 a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 262 (329)
T 3gbz_A 184 ARAFGIPI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTW 262 (329)
T ss_dssp HHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred ccccCCcc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhh
Confidence 98764322 223345789999999999875 5899999999999999999999999877665554433221111111000
Q ss_pred ccc----------cccc-cCH------HHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 826 PEI----------SATC-KDL------GAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 826 ~~~----------~~~~-~~~------~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
+.. +... ... .....+.+++.+|++.||++|||++|++++-
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 320 (329)
T 3gbz_A 263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHP 320 (329)
T ss_dssp TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCc
Confidence 000 0000 000 1236788999999999999999999999743
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=361.81 Aligned_cols=333 Identities=19% Similarity=0.205 Sum_probs=287.1
Q ss_pred CcEEEEEcCCCCcCcccCCCCCCCCCccEEEccCCcccccCCCCccCCCCCceecccccccCCCCCcccccccchhhhhh
Q 002349 68 FTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLIL 147 (933)
Q Consensus 68 ~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 147 (933)
..+..|+|++|.+++. + ++.+++|++|+|++|++++ +| ++++++|++|+|++|++++ +| ++.+++|++|+|
T Consensus 64 ~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~-~~--~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l 134 (457)
T 3bz5_A 64 TGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNC 134 (457)
T ss_dssp TTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSC-CC--CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEEC
T ss_pred CCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCce-ee--cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEEC
Confidence 3678899999999984 3 8999999999999999997 44 9999999999999999996 55 899999999999
Q ss_pred cccCccCCCCcccccCCCCceeeeecCCCCCCcccccccCCCCcEEeccCccccCccCcCCcCCCCCcEEccccccccCc
Q 002349 148 KNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGE 227 (933)
Q Consensus 148 ~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~ 227 (933)
++|++++. + ++++++|++|++++|+..+.+ .+..+++|++|++++|++++ +| ++.+++|+.|++++|++++.
T Consensus 135 ~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~ 206 (457)
T 3bz5_A 135 ARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL 206 (457)
T ss_dssp TTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC
T ss_pred CCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCcCCee
Confidence 99999974 3 899999999999999776666 58899999999999999997 55 89999999999999999975
Q ss_pred CCCCccccccceEeccccccccccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCC
Q 002349 228 IPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMT 307 (933)
Q Consensus 228 ~p~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 307 (933)
+ .....+|++|++++|++++ +| ++.+++|+.|++++|++++.. ++.+++|+.|++++|
T Consensus 207 -~-l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~---~~~l~~L~~L~l~~n-------------- 264 (457)
T 3bz5_A 207 -D-LNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELD---VSTLSKLTTLHCIQT-------------- 264 (457)
T ss_dssp -C-CTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCC---CTTCTTCCEEECTTC--------------
T ss_pred -c-cccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcC---HHHCCCCCEEeccCC--------------
Confidence 2 3344589999999999998 55 889999999999999999864 456788999998776
Q ss_pred cceEeeeccccccccCCccccccccccccccccccCCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccceecCC
Q 002349 308 KLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLS 387 (933)
Q Consensus 308 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~ 387 (933)
+|+.|++++|.+.+.+| ++.+++|+.|++++|...+.+|. ...+|+.|++++| ++|++|+++
T Consensus 265 ~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~-------------~~L~~L~L~ 326 (457)
T 3bz5_A 265 DLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDC---QAAGITELDLSQN-------------PKLVYLYLN 326 (457)
T ss_dssp CCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEEC---TTCCCSCCCCTTC-------------TTCCEEECT
T ss_pred CCCEEECCCCccCCccc--ccccccCCEEECCCCcccceecc---CCCcceEechhhc-------------ccCCEEECC
Confidence 46678899999888777 57889999999999998877774 4466777776665 689999999
Q ss_pred cccccCCCccccccccccceeeccCCccCCCCCCCCCCccccccccccCcccccccccccccccccceEEccCCcccccc
Q 002349 388 LNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVI 467 (933)
Q Consensus 388 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 467 (933)
+|++++. .+..+++|+.|++++|+|++ ++.|..|++++|.++|. +++..|+.+++++|+++|.+
T Consensus 327 ~N~l~~l---~l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~i 390 (457)
T 3bz5_A 327 NTELTEL---DVSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAV 390 (457)
T ss_dssp TCCCSCC---CCTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEEC
T ss_pred CCccccc---ccccCCcCcEEECCCCCCCC--------ccccccccccCCcEEec-----ceeeecCccccccCcEEEEc
Confidence 9999984 38899999999999999985 35788899999999986 46778999999999999999
Q ss_pred chhhcc
Q 002349 468 PEELSQ 473 (933)
Q Consensus 468 p~~~~~ 473 (933)
|..+..
T Consensus 391 p~~~~~ 396 (457)
T 3bz5_A 391 SPDLLD 396 (457)
T ss_dssp CTTCBC
T ss_pred ChhHhc
Confidence 976543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=354.31 Aligned_cols=249 Identities=28% Similarity=0.352 Sum_probs=204.0
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLF 672 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 672 (933)
.+.|+..+.||+|+||+||+|... +++.||||++.... ....+++.+|++++++++||||+++++++..++..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 356889999999999999999964 68899999996543 23346789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccccc
Q 002349 673 YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV 752 (933)
Q Consensus 673 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 752 (933)
|||++ |++.+.+. .....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 133 ~e~~~-g~l~~~l~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EECCS-EEHHHHHH--HHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCC-CCHHHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 99997 58888875 2346799999999999999999999976 999999999999999999999999999986532
Q ss_pred CCCceeeeecccccccCccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccc
Q 002349 753 SKSYTSTYIMGTIGYIDPEYAR---TSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEIS 829 (933)
Q Consensus 753 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (933)
. ....||+.|+|||++. +..++.++|||||||++|||++|+.||.+.............. . +...
T Consensus 207 ~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~--~-----~~~~ 274 (348)
T 1u5q_A 207 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE--S-----PALQ 274 (348)
T ss_dssp B-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--C-----CCCC
T ss_pred C-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC--C-----CCCC
Confidence 2 2357999999999984 5678999999999999999999999998665444332221111 0 1111
Q ss_pred ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 002349 830 ATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLG 867 (933)
Q Consensus 830 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 867 (933)
....+..+.+++.+||+.||++|||+++++++..
T Consensus 275 ----~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~ 308 (348)
T 1u5q_A 275 ----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 308 (348)
T ss_dssp ----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred ----CCCCCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 0112356889999999999999999999987543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=371.46 Aligned_cols=252 Identities=23% Similarity=0.280 Sum_probs=206.0
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLF 672 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 672 (933)
.++|+..+.||+|+||.||+|+++ +++.||+|++.... ......+.+|++++++++|||||++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 357888999999999999999986 58899999996532 23456688999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccccc
Q 002349 673 YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV 752 (933)
Q Consensus 673 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 752 (933)
|||++||+|.+++.. .....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 263 mEy~~gg~L~~~l~~-~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYH-MGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHS-SSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 999999999999964 2234599999999999999999999976 999999999999999999999999999987643
Q ss_pred CCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchh--HHHHhhhcccccccccCccccc
Q 002349 753 SKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLH--HLILSKTANNAVMETVDPEISA 830 (933)
Q Consensus 753 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 830 (933)
.. .....+||+.|+|||++.+..++.++||||+||++|||++|+.||....... ......... ....++.
T Consensus 339 ~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~------~~~~~p~ 410 (576)
T 2acx_A 339 GQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE------VPEEYSE 410 (576)
T ss_dssp TC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH------CCCCCCT
T ss_pred Cc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc------ccccCCc
Confidence 32 2334589999999999999999999999999999999999999998643211 111111110 0111111
Q ss_pred cccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002349 831 TCKDLGAVKKVFQLALLCSKRQPTDRP-----TMHEVSRV 865 (933)
Q Consensus 831 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 865 (933)
..+..+.+++.+|++.||++|| +++|++++
T Consensus 411 -----~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 411 -----RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp -----TSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred -----cCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 1235788899999999999999 78998864
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=353.15 Aligned_cols=247 Identities=21% Similarity=0.284 Sum_probs=179.7
Q ss_pred ceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCC-CCceeeeeeEEecCCccEEEEEecCCCC
Q 002349 603 KYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIK-HRNLVSLQGYSLSSSGNLLFYDFMENGS 680 (933)
Q Consensus 603 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gs 680 (933)
.+.||+|+||+||+|.++ +++.||||++... ....+.+|+++++++. ||||+++++++.++...++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 378999999999999986 4789999998653 3467789999999997 9999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCC---CeEEeecccccccccCCCce
Q 002349 681 LWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDF---EAHLTDFGIAKSLCVSKSYT 757 (933)
Q Consensus 681 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~---~~kl~DfGla~~~~~~~~~~ 757 (933)
|.+++. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.++ .+||+|||+++..... ...
T Consensus 93 L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~-~~~ 165 (325)
T 3kn6_A 93 LFERIK---KKKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD-NQP 165 (325)
T ss_dssp HHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCC-CCc
Confidence 999995 356799999999999999999999966 999999999999998765 8999999999865432 222
Q ss_pred eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchh-----HHHHhhhcccccccccCccccccc
Q 002349 758 STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLH-----HLILSKTANNAVMETVDPEISATC 832 (933)
Q Consensus 758 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~ 832 (933)
.....||+.|+|||++.+..++.++||||+||++|+|++|+.||....... .........+... ......
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~--~~~~~~--- 240 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS--FEGEAW--- 240 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC--CCSHHH---
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC--CCcccc---
Confidence 344578999999999999999999999999999999999999997543210 0111111111110 000000
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 833 KDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 833 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
...+..+.+++.+|++.||++|||++|++++-
T Consensus 241 --~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~ 272 (325)
T 3kn6_A 241 --KNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNE 272 (325)
T ss_dssp --HTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCG
T ss_pred --cCCCHHHHHHHHHHCCCChhHCCCHHHHhcCh
Confidence 01246788999999999999999999998653
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=353.02 Aligned_cols=270 Identities=24% Similarity=0.365 Sum_probs=204.9
Q ss_pred HHHHHHhhccCcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcC--CCCceeeeeeEEecC--
Q 002349 591 EDIMRMTENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSI--KHRNLVSLQGYSLSS-- 666 (933)
Q Consensus 591 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~-- 666 (933)
..-....++|+..+.||+|+||.||+|.+. ++.||||++.... ...+.+|.+++... +||||+++++++...
T Consensus 30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred ccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 334455689999999999999999999986 7899999986432 34445556665554 899999999999877
Q ss_pred --CccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC-----CCCeeeccCCCCceEeCCCCCe
Q 002349 667 --SGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDC-----SPRIIHRDVKSSNILLDKDFEA 739 (933)
Q Consensus 667 --~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~ivH~Dikp~NIll~~~~~~ 739 (933)
...++||||+++|+|.++++ ...+++..+..++.|++.||+|||+++ ..+|+||||||+||+++.++.+
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 181 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLK----STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTC 181 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred CCCceEEEEeccCCCcHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCE
Confidence 67899999999999999995 246899999999999999999999431 1289999999999999999999
Q ss_pred EEeecccccccccCCCce---eeeecccccccCccccccCCCCcc------hhhHHHHHHHHHHHhC----------CCC
Q 002349 740 HLTDFGIAKSLCVSKSYT---STYIMGTIGYIDPEYARTSRLTEK------SDVYSFGIVLLELLTG----------RKA 800 (933)
Q Consensus 740 kl~DfGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------~DvwSlGv~l~elltg----------~~p 800 (933)
||+|||+++......... .....||+.|+|||++.+...+.+ +|||||||++|||++| +.|
T Consensus 182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p 261 (337)
T 3mdy_A 182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261 (337)
T ss_dssp EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence 999999997664322221 124579999999999988766654 9999999999999999 666
Q ss_pred CCCCcchh---HHHHhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCCC
Q 002349 801 VDNECNLH---HLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPA 872 (933)
Q Consensus 801 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 872 (933)
|....... ....... ......+..+.......++..+.+++.+||+.||++|||++||+++|+.+...
T Consensus 262 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 262 YHDLVPSDPSYEDMREIV----CIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp TTTTSCSSCCHHHHHHHH----TTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HhhhcCCCCchhhhHHHH----hhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence 65321111 1111111 11112222222222335678899999999999999999999999999876543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=350.91 Aligned_cols=268 Identities=23% Similarity=0.323 Sum_probs=214.2
Q ss_pred CHHHHHHHhhccCcceeeecccceeEEEEEEc------CCceEEEEEecccC-chhHHHHHHHHHHHhcC-CCCceeeee
Q 002349 589 VYEDIMRMTENLSEKYIIGYGASSTVYKCVLK------NCKPVAIKRLYSHY-PQCLKEFETELETVGSI-KHRNLVSLQ 660 (933)
Q Consensus 589 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~ 660 (933)
....+....++|...+.||+|+||+||+|.+. +++.||||++.... ....+.+.+|+++++++ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 34445555689999999999999999999852 35789999997654 33456789999999999 799999999
Q ss_pred eEEecCC-ccEEEEEecCCCCHHHHhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccC
Q 002349 661 GYSLSSS-GNLLFYDFMENGSLWDILHGPTK-------------KKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDV 726 (933)
Q Consensus 661 ~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Di 726 (933)
+++...+ ..++||||+++|+|.+++..... ...+++..+..++.|++.||+|||++ +|+||||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~di 174 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL 174 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccC
Confidence 9987755 48999999999999999964221 12389999999999999999999966 9999999
Q ss_pred CCCceEeCCCCCeEEeecccccccccCCC-ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCC
Q 002349 727 KSSNILLDKDFEAHLTDFGIAKSLCVSKS-YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNE 804 (933)
Q Consensus 727 kp~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~ 804 (933)
||+||+++.++.+||+|||+++....... .......||+.|+|||++.+..++.++||||+|+++|+|++ |+.||.+.
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999999999999999999987643332 22334568899999999999999999999999999999998 99999765
Q ss_pred cchhHHHHhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCC
Q 002349 805 CNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLV 870 (933)
Q Consensus 805 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 870 (933)
............... ...+. ..+..+.+++.+||+.||++|||++|++++|+.+.
T Consensus 255 ~~~~~~~~~~~~~~~------~~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 255 KIDEEFCRRLKEGTR------MRAPD-----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp CCSHHHHHHHHHTCC------CCCCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred chhHHHHHHhccCcc------CCCCC-----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 433332222111110 11111 12357889999999999999999999999998764
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=343.51 Aligned_cols=248 Identities=22% Similarity=0.347 Sum_probs=207.5
Q ss_pred hccCcceeeecccceeEEEEEEcC-CceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
++|...+.||+|+||.||+|.+.. ++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 578899999999999999999874 6789999986542 334567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
||+++++|.+++. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 95 e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 95 ELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp ECCTTCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred ecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 9999999999984 346799999999999999999999976 9999999999999999999999999999876422
Q ss_pred CCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccccc
Q 002349 754 KSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCK 833 (933)
Q Consensus 754 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (933)
. .......||+.|+|||.+.+..++.++||||+|+++|+|++|+.||.................. ++.
T Consensus 169 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~--- 236 (294)
T 2rku_A 169 G-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS--------IPK--- 236 (294)
T ss_dssp T-CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC--------CCT---
T ss_pred c-cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCC--------Ccc---
Confidence 2 2233457999999999999999999999999999999999999999876544433322211111 111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 834 DLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 834 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
..+..+.+++.+|++.||++|||++|++++
T Consensus 237 --~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 237 --HINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp --TSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred --ccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 113568889999999999999999999974
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=348.46 Aligned_cols=264 Identities=19% Similarity=0.286 Sum_probs=200.7
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLF 672 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 672 (933)
.++|+..+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++...+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 357999999999999999999974 68899999997532 34556789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccc
Q 002349 673 YDFMENGSLWDILHGP-TKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLC 751 (933)
Q Consensus 673 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 751 (933)
|||+++++|.+++... .....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 9999999999998521 1345689999999999999999999976 99999999999999999999999999998654
Q ss_pred cCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccc
Q 002349 752 VSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISAT 831 (933)
Q Consensus 752 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (933)
... .......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.+................... ..
T Consensus 188 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-----~~-- 259 (310)
T 2wqm_A 188 SKT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPP-----LP-- 259 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCC-----CC--
T ss_pred CCC-ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCC-----Cc--
Confidence 322 2223457899999999999999999999999999999999999999754322111111111111111 10
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCCCC
Q 002349 832 CKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAP 873 (933)
Q Consensus 832 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 873 (933)
....+..+.+++.+||+.||++|||+++|++.|+.+.+..
T Consensus 260 --~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~ 299 (310)
T 2wqm_A 260 --SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299 (310)
T ss_dssp --TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence 0112357889999999999999999999999998876544
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=359.94 Aligned_cols=251 Identities=24% Similarity=0.325 Sum_probs=198.8
Q ss_pred hccCcceeeecccceeEEEEEEcCCceEEEEEecccC--chhHHHHHHHHHHHhcCC--CCceeeeeeEEecCCccEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHY--PQCLKEFETELETVGSIK--HRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~ 673 (933)
++|+..+.||+|+||+||+|....++.||||++.... ....+.+.+|++++++++ ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 4699999999999999999998888999999986543 345677899999999996 599999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
| +.+++|.+++. ....+++.++..++.|++.||+|||++ +|+||||||+|||++ ++.+||+|||+++.+...
T Consensus 136 E-~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 136 E-CGNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp E-CCSEEHHHHHH---HCSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred e-cCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9 56889999995 345789999999999999999999965 999999999999996 589999999999876433
Q ss_pred CCc-eeeeecccccccCcccccc-----------CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccc
Q 002349 754 KSY-TSTYIMGTIGYIDPEYART-----------SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVM 821 (933)
Q Consensus 754 ~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 821 (933)
... .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||................. .
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~-~- 285 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN-H- 285 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTT-S-
T ss_pred CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCcc-c-
Confidence 221 2334579999999999865 3689999999999999999999999986543322221111111 0
Q ss_pred cccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 822 ETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
....+.. .+..+.+++.+||+.||++|||++|++++-
T Consensus 286 ---~~~~~~~-----~~~~~~~li~~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 286 ---EIEFPDI-----PEKDLQDVLKCCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp ---CCCCCCC-----SCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ---cCCCCcc-----chHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence 0111111 135688999999999999999999999754
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=345.53 Aligned_cols=258 Identities=24% Similarity=0.360 Sum_probs=205.4
Q ss_pred ccCcceeeecccceeEEEEEEcC-C---ceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCcc-EEE
Q 002349 599 NLSEKYIIGYGASSTVYKCVLKN-C---KPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGN-LLF 672 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~lv 672 (933)
.|...+.||+|+||+||+|.+.+ + ..||+|++.... ....+.+.+|++++++++||||+++++++...+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 45566899999999999998643 2 369999997644 34567889999999999999999999999876665 999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccccc
Q 002349 673 YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV 752 (933)
Q Consensus 673 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 752 (933)
|||+.+|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 102 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 999999999999963 456789999999999999999999976 999999999999999999999999999986533
Q ss_pred CCC---ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccc
Q 002349 753 SKS---YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEIS 829 (933)
Q Consensus 753 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (933)
... .......+|+.|+|||.+.+..++.++||||+|+++|+|++|..|+................... ..+
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~------~~~ 250 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL------PQP 250 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC------CCC
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC------CCC
Confidence 221 12233568899999999999999999999999999999999666654333333322221111110 011
Q ss_pred ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCCC
Q 002349 830 ATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPA 872 (933)
Q Consensus 830 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 872 (933)
. ..+..+.+++.+|++.||.+|||++++++.|+.+...
T Consensus 251 ~-----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 288 (298)
T 3pls_A 251 E-----YCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA 288 (298)
T ss_dssp T-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred c-----cchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 1 1235788999999999999999999999999876543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=357.62 Aligned_cols=250 Identities=22% Similarity=0.267 Sum_probs=191.1
Q ss_pred hccCcc-eeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhc-CCCCceeeeeeEEec----CCccE
Q 002349 598 ENLSEK-YIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGS-IKHRNLVSLQGYSLS----SSGNL 670 (933)
Q Consensus 598 ~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~----~~~~~ 670 (933)
++|... +.||+|+||+||+|.++ +++.||||++... ..+.+|++++.+ .+||||+++++++.. ....+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 466665 68999999999999976 4788999998632 456788888744 589999999998865 55689
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCC---CCCeEEeecccc
Q 002349 671 LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDK---DFEAHLTDFGIA 747 (933)
Q Consensus 671 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~---~~~~kl~DfGla 747 (933)
+||||+++|+|.+++.. .....+++.++..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||++
T Consensus 136 lv~E~~~gg~L~~~l~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEECCCSEEHHHHHHC-C---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeCCCCcHHHHHHH-hCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccc
Confidence 99999999999999964 2234699999999999999999999966 9999999999999997 789999999999
Q ss_pred cccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchh----HHHHhhhcccccccc
Q 002349 748 KSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLH----HLILSKTANNAVMET 823 (933)
Q Consensus 748 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~----~~~~~~~~~~~~~~~ 823 (933)
+..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+..... ..............
T Consensus 212 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~- 288 (400)
T 1nxk_A 212 KETTSH--NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN- 288 (400)
T ss_dssp EECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCT-
T ss_pred cccCCC--CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCC-
Confidence 865322 22345678999999999999999999999999999999999999997543221 11111111111100
Q ss_pred cCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 002349 824 VDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLG 867 (933)
Q Consensus 824 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 867 (933)
+.. ...+..+.+++.+||+.||++|||++|++++-.
T Consensus 289 --~~~------~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 324 (400)
T 1nxk_A 289 --PEW------SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 324 (400)
T ss_dssp --TTT------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred --ccc------ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 000 112357889999999999999999999998643
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=340.55 Aligned_cols=245 Identities=22% Similarity=0.318 Sum_probs=205.1
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
++|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 67999999999999999999976 46789999986532 223567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
||+++++|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 94 EFAPRGELYKELQ---KHGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EeCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 9999999999995 345789999999999999999999965 9999999999999999999999999999765322
Q ss_pred CCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccccc
Q 002349 754 KSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCK 833 (933)
Q Consensus 754 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (933)
......|++.|+|||++.+..++.++||||+|+++|+|++|+.||................. .++.
T Consensus 168 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--------~~~~--- 233 (284)
T 2vgo_A 168 ---RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL--------KFPP--- 233 (284)
T ss_dssp ---CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC--------CCCT---
T ss_pred ---ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcccc--------CCCC---
Confidence 22345799999999999999999999999999999999999999986554433322211111 1111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002349 834 DLGAVKKVFQLALLCSKRQPTDRPTMHEVSR 864 (933)
Q Consensus 834 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 864 (933)
..+..+.+++.+|++.||++|||++++++
T Consensus 234 --~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 234 --FLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp --TSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --cCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 12356889999999999999999999986
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=370.11 Aligned_cols=346 Identities=21% Similarity=0.172 Sum_probs=201.6
Q ss_pred ceecccccccCCCCCcccccccchhhhhhcccCccCCCCcccccCCCCceeeeecCCCCCCcccccccCCCCcEEeccCc
Q 002349 119 KSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNN 198 (933)
Q Consensus 119 ~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n 198 (933)
+.++.+++.++ .+|..+. ++|++|+|++|++++..|..|.++++|++|+|++|.+++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 14 RAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90 (477)
T ss_dssp TEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence 45666666665 5565443 35666666666666655566666666666666666666555555666666666666666
Q ss_pred cccCccCcCCcCCCCCcEEccccccccCcCCCCccccccceEeccccccccccCccccccccccEEeccCCcCcCCCCCC
Q 002349 199 SLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPI 278 (933)
Q Consensus 199 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~ 278 (933)
++++..+..|.++++|++|+|++|+++ +..+..|..+++|+.|+|++|.+++..+..
T Consensus 91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~-----------------------~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 147 (477)
T 2id5_A 91 RLKLIPLGVFTGLSNLTKLDISENKIV-----------------------ILLDYMFQDLYNLKSLEVGDNDLVYISHRA 147 (477)
T ss_dssp CCCSCCTTSSTTCTTCCEEECTTSCCC-----------------------EECTTTTTTCTTCCEEEECCTTCCEECTTS
T ss_pred cCCccCcccccCCCCCCEEECCCCccc-----------------------cCChhHccccccCCEEECCCCccceeChhh
Confidence 655444444555555555555555443 233445566667777777777777666666
Q ss_pred CCCCCCccEEEeeCCccCCCCCCccccCCcceEeeeccccccccCCccccccccccccccccccCCCCCCCCcccCCCCC
Q 002349 279 LGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLN 358 (933)
Q Consensus 279 ~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~ 358 (933)
|.++++|++|+|++|++++..+..+.++++|+.|+|++|.+++..+..|..+++|+.|++++|.+.+.+|.......+|+
T Consensus 148 ~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~ 227 (477)
T 2id5_A 148 FSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLT 227 (477)
T ss_dssp STTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCS
T ss_pred ccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCcccc
Confidence 77777777777777777655555566666666666666666665555566666666666666555544444444444555
Q ss_pred ceeccCcccCCCCCcccccccccceecCCcccccCCCccccccccccceeeccCCccCCCCCCCCCCccccccccccCcc
Q 002349 359 SLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQ 438 (933)
Q Consensus 359 ~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 438 (933)
.|++++|+++ ...+..+..+++|+.|+|++|.+++..+..|..+++|+.|+|++|+
T Consensus 228 ~L~l~~n~l~------------------------~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~ 283 (477)
T 2id5_A 228 SLSITHCNLT------------------------AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQ 283 (477)
T ss_dssp EEEEESSCCC------------------------SCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSC
T ss_pred EEECcCCccc------------------------ccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCc
Confidence 5555555544 3333444555555555555555555555555556666666666666
Q ss_pred cccccccccccccccceEEccCCccccccchhhccccccceeeecCCCCcCcccchhhccccc-eeecCCCCCCCcc
Q 002349 439 LTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDVMSLINCLSLS-VLFIGNPGLCGYW 514 (933)
Q Consensus 439 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~-~~~~~N~~~C~~~ 514 (933)
+++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+|......-..... ..+.++...|.++
T Consensus 284 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p 360 (477)
T 2id5_A 284 LAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATP 360 (477)
T ss_dssp CSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEES
T ss_pred cceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccchHhHHhhhhccccCccCceeCCc
Confidence 665556666666666666666666665555555666666666666666665543221111111 3345566666554
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=350.93 Aligned_cols=260 Identities=23% Similarity=0.339 Sum_probs=204.8
Q ss_pred cCcceeeecccceeEEEEEEc-----CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecC--CccEE
Q 002349 600 LSEKYIIGYGASSTVYKCVLK-----NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSS--SGNLL 671 (933)
Q Consensus 600 ~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l 671 (933)
|+..+.||+|+||+||+|.++ +++.||||++.... ....+.+.+|++++++++||||+++++++... ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 488899999999999998753 57889999997654 34567799999999999999999999999874 56789
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccc
Q 002349 672 FYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLC 751 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 751 (933)
||||+++|+|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 113 v~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 9999999999999952 3589999999999999999999976 99999999999999999999999999998765
Q ss_pred cCCCc--eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHh--------hhcccccc
Q 002349 752 VSKSY--TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILS--------KTANNAVM 821 (933)
Q Consensus 752 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~--------~~~~~~~~ 821 (933)
..... ......||..|+|||++.+..++.++||||+|+++|+|++|+.||............ ........
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence 43322 123456888999999999999999999999999999999999999743211000000 00000000
Q ss_pred cccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCC
Q 002349 822 ETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVP 871 (933)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 871 (933)
....... ....+..+.+++.+||+.||++|||++|+++.|+.+..
T Consensus 266 ~~~~~~~-----~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 310 (318)
T 3lxp_A 266 RGERLPR-----PDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310 (318)
T ss_dssp TTCCCCC-----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccCCCC-----CccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 0001111 11234678999999999999999999999999987643
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=352.76 Aligned_cols=251 Identities=22% Similarity=0.298 Sum_probs=200.3
Q ss_pred HhhccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcC-CCCceeeeeeEEecCCccEEEE
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSI-KHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 673 (933)
..++|+..+.||+|+||+||+|.++ +++.||||++..... ...+|++++.++ +||||+++++++.+++..++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4678999999999999999999976 478899999976532 235688888887 7999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCC----CCeEEeecccccc
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKD----FEAHLTDFGIAKS 749 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~----~~~kl~DfGla~~ 749 (933)
||+++|+|.+++. ..+.+++..+..++.|++.||+|||++ +|+||||||+||++.++ +.+||+|||+++.
T Consensus 96 E~~~gg~L~~~i~---~~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 96 ELMKGGELLDKIL---RQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCCSCBHHHHHH---TCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred eCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 9999999999995 456799999999999999999999976 99999999999998543 3599999999987
Q ss_pred cccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCc--chhHHHHhhhcccccccccCcc
Q 002349 750 LCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNEC--NLHHLILSKTANNAVMETVDPE 827 (933)
Q Consensus 750 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 827 (933)
...... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||.... ...... .....+... ....
T Consensus 170 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~-~~i~~~~~~--~~~~ 245 (342)
T 2qr7_A 170 LRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL-ARIGSGKFS--LSGG 245 (342)
T ss_dssp CBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHH-HHHHHCCCC--CCST
T ss_pred CcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHH-HHHccCCcc--cCcc
Confidence 643322 2334578999999999988889999999999999999999999997532 112211 111111110 0000
Q ss_pred ccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 828 ISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 828 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.. ...+..+.+++.+|++.||++|||++|++++
T Consensus 246 ~~-----~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 246 YW-----NSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp TT-----TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred cc-----ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00 0123578899999999999999999999874
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=362.12 Aligned_cols=268 Identities=19% Similarity=0.245 Sum_probs=209.6
Q ss_pred hccCcceeeecccceeEEEEEEcC-CceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCC--ccEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSS--GNLLFY 673 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~ 673 (933)
++|...+.||+|+||+||+|++.. ++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 578999999999999999999875 7899999997543 334577889999999999999999999998765 679999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEe----CCCCCeEEeecccccc
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILL----DKDFEAHLTDFGIAKS 749 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll----~~~~~~kl~DfGla~~ 749 (933)
||+++|+|.+++........+++..+..++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||+++.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 9999999999996533344599999999999999999999966 99999999999999 7788899999999987
Q ss_pred cccCCCceeeeecccccccCcccccc--------CCCCcchhhHHHHHHHHHHHhCCCCCCCCcc---hhHHHHhhhccc
Q 002349 750 LCVSKSYTSTYIMGTIGYIDPEYART--------SRLTEKSDVYSFGIVLLELLTGRKAVDNECN---LHHLILSKTANN 818 (933)
Q Consensus 750 ~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwSlGv~l~elltg~~p~~~~~~---~~~~~~~~~~~~ 818 (933)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .......... +
T Consensus 166 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~-~ 242 (396)
T 4eut_A 166 LEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT-G 242 (396)
T ss_dssp CCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH-S
T ss_pred ccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc-C
Confidence 64332 2234579999999998865 4678899999999999999999999963221 1111111111 1
Q ss_pred ccccc-------------cCcccccc-ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCC
Q 002349 819 AVMET-------------VDPEISAT-CKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVP 871 (933)
Q Consensus 819 ~~~~~-------------~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 871 (933)
..... ....++.. .-.......+.+++.+|++.||++||+++|+++.++.+..
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 10000 00001100 1124566788899999999999999999999998877654
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=350.89 Aligned_cols=249 Identities=22% Similarity=0.344 Sum_probs=208.2
Q ss_pred hhccCcceeeecccceeEEEEEEcC-CceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLF 672 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 672 (933)
.++|...+.||+|+||.||+|.+.. ++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 3689999999999999999999765 6789999986542 34567789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccccc
Q 002349 673 YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV 752 (933)
Q Consensus 673 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 752 (933)
|||+++++|.+++. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 120 ~e~~~~~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 99999999999984 346799999999999999999999976 999999999999999999999999999987642
Q ss_pred CCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccc
Q 002349 753 SKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATC 832 (933)
Q Consensus 753 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (933)
.. .......||+.|+|||++.+..++.++||||||+++|+|++|+.||................... +.
T Consensus 194 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------~~-- 262 (335)
T 2owb_A 194 DG-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI--------PK-- 262 (335)
T ss_dssp TT-CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC--------CT--
T ss_pred Cc-ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCC--------Cc--
Confidence 22 22344579999999999999999999999999999999999999998765444333222211111 11
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 833 KDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 833 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.....+.+++.+||+.||++|||++|++++
T Consensus 263 ---~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 263 ---HINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp ---TSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ---cCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 113467889999999999999999999973
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=355.95 Aligned_cols=265 Identities=22% Similarity=0.275 Sum_probs=208.2
Q ss_pred HHHHHHhhccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCC-----CCceeeeeeEEe
Q 002349 591 EDIMRMTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIK-----HRNLVSLQGYSL 664 (933)
Q Consensus 591 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~~~~~~~ 664 (933)
++-....++|...+.||+|+||+||+|++. +++.||||++... ....+.+..|+++++.++ ||||+++++++.
T Consensus 28 ~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~ 106 (360)
T 3llt_A 28 KKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM 106 (360)
T ss_dssp CTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE
T ss_pred ecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceee
Confidence 333445678999999999999999999975 5788999998643 334566788999999996 999999999999
Q ss_pred cCCccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCC---------
Q 002349 665 SSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDK--------- 735 (933)
Q Consensus 665 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~--------- 735 (933)
..+..++||||+ +++|.+++.. .....+++..+..++.|++.||+|||++ +|+||||||+|||++.
T Consensus 107 ~~~~~~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~ 181 (360)
T 3llt_A 107 YYDHMCLIFEPL-GPSLYEIITR-NNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLIT 181 (360)
T ss_dssp ETTEEEEEECCC-CCBHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEE
T ss_pred ECCeeEEEEcCC-CCCHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccc
Confidence 999999999999 8999999964 2234699999999999999999999966 9999999999999975
Q ss_pred ----------------CCCeEEeecccccccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCC
Q 002349 736 ----------------DFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRK 799 (933)
Q Consensus 736 ----------------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~ 799 (933)
++.+||+|||+|+..... .....||+.|+|||++.+..++.++||||+||++|+|++|+.
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 257 (360)
T 3llt_A 182 VRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSL 257 (360)
T ss_dssp EECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred hhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCC
Confidence 789999999999864322 234579999999999999999999999999999999999999
Q ss_pred CCCCCcchhHHHHhhhccccccccc------------------CccccccccCHH---------------HHHHHHHHHH
Q 002349 800 AVDNECNLHHLILSKTANNAVMETV------------------DPEISATCKDLG---------------AVKKVFQLAL 846 (933)
Q Consensus 800 p~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~---------------~~~~l~~li~ 846 (933)
||....................... ....+....... ....+.+++.
T Consensus 258 pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 337 (360)
T 3llt_A 258 LFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLY 337 (360)
T ss_dssp SCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHH
T ss_pred CCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHH
Confidence 9987655544433222111111000 000000000000 0156779999
Q ss_pred HccCCCCCCCCCHHHHHHH
Q 002349 847 LCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 847 ~cl~~dP~~RPt~~evl~~ 865 (933)
+||+.||++|||++|++++
T Consensus 338 ~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 338 SILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp HHCCSSGGGSCCHHHHTTS
T ss_pred HHhcCChhhCCCHHHHhcC
Confidence 9999999999999999864
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=353.24 Aligned_cols=244 Identities=23% Similarity=0.287 Sum_probs=203.6
Q ss_pred HhhccCcceeeecccceeEEEEEEc-CCceEEEEEecccCc--------hhHHHHHHHHHHHhcCCCCceeeeeeEEecC
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYP--------QCLKEFETELETVGSIKHRNLVSLQGYSLSS 666 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 666 (933)
..++|+..+.||+|+||.||+|++. +++.||||++..... ...+.+.+|++++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 4678999999999999999999965 578899999976431 1334577899999999999999999999999
Q ss_pred CccEEEEEecCCC-CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecc
Q 002349 667 SGNLLFYDFMENG-SLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFG 745 (933)
Q Consensus 667 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfG 745 (933)
+..++||||+.+| +|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFID---RHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHH---TCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999776 9999995 455799999999999999999999976 99999999999999999999999999
Q ss_pred cccccccCCCceeeeecccccccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccccccccc
Q 002349 746 IAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRL-TEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETV 824 (933)
Q Consensus 746 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 824 (933)
+++...... ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||....... . ...
T Consensus 176 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--------~----~~~ 241 (335)
T 3dls_A 176 SAAYLERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV--------E----AAI 241 (335)
T ss_dssp TCEECCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT--------T----TCC
T ss_pred cceECCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH--------h----hcc
Confidence 998764332 2334679999999999988877 889999999999999999999997522110 0 000
Q ss_pred CccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 825 DPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 825 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
.+ +. ..+..+.+++.+|++.||++|||+++++++-
T Consensus 242 ~~--~~-----~~~~~l~~li~~~L~~dP~~Rps~~ell~hp 276 (335)
T 3dls_A 242 HP--PY-----LVSKELMSLVSGLLQPVPERRTTLEKLVTDP 276 (335)
T ss_dssp CC--SS-----CCCHHHHHHHHHHTCSSGGGSCCHHHHHHCT
T ss_pred CC--Cc-----ccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 00 00 1235788999999999999999999999864
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=367.94 Aligned_cols=252 Identities=25% Similarity=0.345 Sum_probs=206.1
Q ss_pred HhhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEE
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLF 672 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 672 (933)
..++|+..+.||+|+||+||+|.++ +++.||||++.... ......+.+|++++++++||||+++++++......++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3568999999999999999999976 57899999986432 33467889999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeC---CCCCeEEeecccccc
Q 002349 673 YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLD---KDFEAHLTDFGIAKS 749 (933)
Q Consensus 673 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~---~~~~~kl~DfGla~~ 749 (933)
|||+++|+|.+.+. ....+++..+..++.|++.||+|||++ +|+||||||+||+++ .++.+||+|||+++.
T Consensus 100 ~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 100 GELYTGGELFDEII---KRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp ECCCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 99999999999884 346799999999999999999999966 999999999999995 456799999999987
Q ss_pred cccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccc
Q 002349 750 LCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEIS 829 (933)
Q Consensus 750 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (933)
.... .......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+................... +...
T Consensus 174 ~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~---~~~~ 247 (486)
T 3mwu_A 174 FQQN--TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL---PQWR 247 (486)
T ss_dssp BCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCS---GGGG
T ss_pred CCCC--CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC---cccC
Confidence 5432 22344579999999999876 4899999999999999999999999876554443332222111111 1111
Q ss_pred ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 830 ATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 830 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
..+..+.+++.+||+.||++|||+.|++++
T Consensus 248 ------~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 248 ------TISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp ------GSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred ------CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 123568899999999999999999999985
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=343.20 Aligned_cols=253 Identities=23% Similarity=0.332 Sum_probs=201.0
Q ss_pred ccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecC
Q 002349 599 NLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFME 677 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 677 (933)
+|.....||+|+||.||+|.+. +++.||||++........+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 4555668999999999999975 578899999987666667889999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCC-CCCeEEeecccccccccCCCc
Q 002349 678 NGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDK-DFEAHLTDFGIAKSLCVSKSY 756 (933)
Q Consensus 678 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~-~~~~kl~DfGla~~~~~~~~~ 756 (933)
+++|.+++........+++..+..++.|++.||+|||++ +|+||||||+||+++. ++.+||+|||+++...... .
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-~ 178 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-P 178 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCC-C
Confidence 999999996433344678999999999999999999976 9999999999999987 8999999999998754322 2
Q ss_pred eeeeecccccccCccccccCC--CCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccC
Q 002349 757 TSTYIMGTIGYIDPEYARTSR--LTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKD 834 (933)
Q Consensus 757 ~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (933)
......|++.|+|||++.+.. ++.++||||||+++|+|++|+.||................ ...+.++.
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-----~~~~~~~~---- 249 (295)
T 2clq_A 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMF-----KVHPEIPE---- 249 (295)
T ss_dssp --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHH-----CCCCCCCT----
T ss_pred cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccc-----cccccccc----
Confidence 223457999999999987653 7899999999999999999999997543322211111000 11111111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 835 LGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 835 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
..+..+.+++.+||+.||++|||+++++++
T Consensus 250 -~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 250 -SMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp -TSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred -cCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 123578899999999999999999999874
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=352.55 Aligned_cols=265 Identities=21% Similarity=0.285 Sum_probs=207.3
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecC-------
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSS------- 666 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------- 666 (933)
.++|+..+.||+|+||+||+|++. +++.||||++.... ......+.+|++++++++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 368999999999999999999985 68899999986543 23356788999999999999999999998763
Q ss_pred -CccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecc
Q 002349 667 -SGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFG 745 (933)
Q Consensus 667 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfG 745 (933)
+..++||||+++ +|.+.+. .....+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLS--NVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHH--CTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHh--hccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccch
Confidence 457999999975 7777775 3345799999999999999999999966 99999999999999999999999999
Q ss_pred cccccccCC---CceeeeecccccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccc
Q 002349 746 IAKSLCVSK---SYTSTYIMGTIGYIDPEYART-SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVM 821 (933)
Q Consensus 746 la~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 821 (933)
+++.+.... ........||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+..................
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 998764221 122334578999999999876 4589999999999999999999999987766555444333222222
Q ss_pred cccCccccc------------cccCH-------HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 002349 822 ETVDPEISA------------TCKDL-------GAVKKVFQLALLCSKRQPTDRPTMHEVSRVLG 867 (933)
Q Consensus 822 ~~~~~~~~~------------~~~~~-------~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 867 (933)
....+.... ..... .....+.+++.+|++.||++|||++|++++-.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 314 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 314 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCC
Confidence 211111110 00000 01345889999999999999999999998643
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=367.51 Aligned_cols=252 Identities=23% Similarity=0.317 Sum_probs=202.9
Q ss_pred HhhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEE
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLF 672 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 672 (933)
..++|+..+.||+|+||+||+|+++ +++.||+|++.... ......+.+|++++++++|||||++++++.+....++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3568999999999999999999986 57889999997543 33467789999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCC---CCeEEeecccccc
Q 002349 673 YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKD---FEAHLTDFGIAKS 749 (933)
Q Consensus 673 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~---~~~kl~DfGla~~ 749 (933)
|||+++|+|.+.+. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.. +.+||+|||+++.
T Consensus 115 ~e~~~~g~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 115 MECYKGGELFDEII---HRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp EECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 99999999999884 346799999999999999999999966 99999999999999764 5599999999987
Q ss_pred cccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccc
Q 002349 750 LCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEIS 829 (933)
Q Consensus 750 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (933)
.... .......||+.|+|||++. ..++.++||||+||++|+|++|+.||.+................... +...
T Consensus 189 ~~~~--~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~---~~~~ 262 (494)
T 3lij_A 189 FENQ--KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDS---PEWK 262 (494)
T ss_dssp CBTT--BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCS---GGGT
T ss_pred CCCC--ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc---hhcc
Confidence 6432 2234457999999999886 46999999999999999999999999876654443333222211111 1111
Q ss_pred ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 830 ATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 830 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
..+..+.+++.+||+.||++|||+.|++++
T Consensus 263 ------~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 263 ------NVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp ------TSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ------cCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 123568899999999999999999999863
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=346.08 Aligned_cols=255 Identities=23% Similarity=0.363 Sum_probs=205.2
Q ss_pred hhccCcce-eeecccceeEEEEEEc---CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccE
Q 002349 597 TENLSEKY-IIGYGASSTVYKCVLK---NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNL 670 (933)
Q Consensus 597 ~~~~~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 670 (933)
.++|...+ .||+|+||.||+|.+. .++.||||++.... ....+++.+|++++++++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 35777777 9999999999999653 36789999997643 33467899999999999999999999999 566789
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccc
Q 002349 671 LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSL 750 (933)
Q Consensus 671 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~ 750 (933)
+||||+++++|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 94 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEEECCTTEEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCCHHHHHH---hCcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 9999999999999995 345699999999999999999999976 9999999999999999999999999999876
Q ss_pred ccCCCce--eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCcc
Q 002349 751 CVSKSYT--STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPE 827 (933)
Q Consensus 751 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 827 (933)
....... .....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||.+............ .. .+.
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~--~~-----~~~ 240 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK--GE-----RMG 240 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT--TC-----CCC
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc--CC-----CCC
Confidence 4433322 222356789999999998889999999999999999999 9999986554332222111 11 111
Q ss_pred ccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCC
Q 002349 828 ISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLV 870 (933)
Q Consensus 828 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 870 (933)
.+. ..+..+.+++.+||+.||++||+++++++.|+.+.
T Consensus 241 ~~~-----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 241 CPA-----GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp CCT-----TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCC-----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111 12467889999999999999999999999998764
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=348.46 Aligned_cols=256 Identities=20% Similarity=0.292 Sum_probs=198.0
Q ss_pred hccCcc-eeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcC-CCCceeeeeeEEecCCccEEEEE
Q 002349 598 ENLSEK-YIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSI-KHRNLVSLQGYSLSSSGNLLFYD 674 (933)
Q Consensus 598 ~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 674 (933)
+.|.+. +.||+|+||+||+|.+. +++.||||++........+.+.+|++++.++ +||||+++++++.+++..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 467663 68999999999999965 5889999999776656678899999999985 79999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCC---eEEeecccccccc
Q 002349 675 FMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFE---AHLTDFGIAKSLC 751 (933)
Q Consensus 675 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~---~kl~DfGla~~~~ 751 (933)
|+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++. +||+|||+++...
T Consensus 92 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 92 KMRGGSILSHIH---KRRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp CCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred cCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 999999999995 345789999999999999999999976 9999999999999998766 9999999997653
Q ss_pred cCCC------ceeeeecccccccCcccccc-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchh------------
Q 002349 752 VSKS------YTSTYIMGTIGYIDPEYART-----SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLH------------ 808 (933)
Q Consensus 752 ~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~------------ 808 (933)
.... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.....
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 2211 11223469999999999875 458899999999999999999999997543211
Q ss_pred -HHHHhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 809 -HLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 809 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
............ ..+.... ...+..+.+++.+|++.||++|||++|++++-
T Consensus 246 ~~~~~~~i~~~~~--~~~~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 297 (316)
T 2ac3_A 246 QNMLFESIQEGKY--EFPDKDW-----AHISCAAKDLISKLLVRDAKQRLSAAQVLQHP 297 (316)
T ss_dssp HHHHHHHHHHCCC--CCCHHHH-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHST
T ss_pred HHHHHHHHhccCc--ccCchhc-----ccCCHHHHHHHHHHhhCChhhCCCHHHHhcCh
Confidence 000011111100 0000000 01235788999999999999999999999853
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=369.12 Aligned_cols=251 Identities=22% Similarity=0.334 Sum_probs=208.4
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLF 672 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 672 (933)
.++|+..+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|++++++++||||+++++++...+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 468999999999999999999976 68899999986542 34567899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEe---CCCCCeEEeecccccc
Q 002349 673 YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILL---DKDFEAHLTDFGIAKS 749 (933)
Q Consensus 673 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll---~~~~~~kl~DfGla~~ 749 (933)
|||+.+|+|.+.+. ....+++..+..++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||+++.
T Consensus 105 ~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 105 GEVYTGGELFDEII---SRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp ECCCCSCBHHHHHH---TCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 99999999999985 456799999999999999999999976 99999999999999 5678999999999987
Q ss_pred cccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccc
Q 002349 750 LCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEIS 829 (933)
Q Consensus 750 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (933)
+.... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+................... +...
T Consensus 179 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~---~~~~ 252 (484)
T 3nyv_A 179 FEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFEL---PQWK 252 (484)
T ss_dssp BCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS---GGGG
T ss_pred ccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCC---cccc
Confidence 64332 2234579999999999876 6899999999999999999999999876655444333222111111 1111
Q ss_pred ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 830 ATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 830 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
..+..+.+++.+|++.||++|||++|++++
T Consensus 253 ------~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 253 ------KVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp ------GSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ------cCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 123578899999999999999999999974
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=352.40 Aligned_cols=262 Identities=24% Similarity=0.332 Sum_probs=203.7
Q ss_pred hhccCcceeeecccceeEEEEEEcC-CceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
.++|+..+.||+|+||.||+|++.. ++.||||++.... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 3689999999999999999999865 7899999986543 233556889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
||+++++|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 104 e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 104 EFVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp ECCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 9999999998874 345699999999999999999999976 9999999999999999999999999999865432
Q ss_pred CCceeeeecccccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccccc------------
Q 002349 754 KSYTSTYIMGTIGYIDPEYARTS-RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAV------------ 820 (933)
Q Consensus 754 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~------------ 820 (933)
. .......||+.|+|||++.+. .++.++||||+||++|+|++|+.||................+..
T Consensus 178 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (331)
T 4aaa_A 178 G-EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP 256 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred c-cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence 2 223345789999999999875 78999999999999999999999998766554443222111110
Q ss_pred --ccccCcccccccc----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 821 --METVDPEISATCK----DLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 821 --~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.....+....... ....+..+.+++.+||+.||++|||++|++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000011100000 01224678999999999999999999999864
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=338.73 Aligned_cols=247 Identities=19% Similarity=0.304 Sum_probs=197.4
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
++|...+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 57899999999999999999986 68899999986542 234567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
||+++++|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 91 e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 91 EYVSGGELFDYIC---KHGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp ECCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred eccCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 9999999999995 345689999999999999999999976 9999999999999999999999999999875432
Q ss_pred CCceeeeecccccccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccc
Q 002349 754 KSYTSTYIMGTIGYIDPEYARTSRL-TEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATC 832 (933)
Q Consensus 754 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (933)
. ......|++.|+|||.+.+..+ +.++||||+|+++|+|++|+.||.................. .+.
T Consensus 165 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~-- 232 (276)
T 2h6d_A 165 E--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFY--------IPE-- 232 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC--------CCT--
T ss_pred c--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc--------Cch--
Confidence 2 2234568999999999988765 68999999999999999999999865433322221111100 111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 833 KDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 833 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
..+..+.+++.+|++.||++|||++|++++
T Consensus 233 ---~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 233 ---YLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ---hcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 123568899999999999999999999984
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=341.15 Aligned_cols=247 Identities=23% Similarity=0.315 Sum_probs=200.4
Q ss_pred ccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEec----CCccEE
Q 002349 599 NLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLS----SSGNLL 671 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~l 671 (933)
.|...+.||+|+||.||+|.+. ++..||+|++.... ....+.+.+|++++++++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 4677789999999999999976 46789999986542 3456778999999999999999999998865 345789
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--eeeccCCCCceEeC-CCCCeEEeeccccc
Q 002349 672 FYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPR--IIHRDVKSSNILLD-KDFEAHLTDFGIAK 748 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dikp~NIll~-~~~~~kl~DfGla~ 748 (933)
||||+++++|.+++. ....+++..+..++.|++.||+|||++ + |+||||||+||+++ .++.+||+|||++.
T Consensus 107 v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 107 VTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEecCCCCHHHHHH---HccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 999999999999995 346789999999999999999999965 6 99999999999998 78999999999997
Q ss_pred ccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccc
Q 002349 749 SLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEI 828 (933)
Q Consensus 749 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 828 (933)
.... .......||+.|+|||++.+ .++.++||||+|+++|+|++|+.||................. ... ..
T Consensus 181 ~~~~---~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~----~~ 251 (290)
T 1t4h_A 181 LKRA---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV-KPA----SF 251 (290)
T ss_dssp GCCT---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC-CCG----GG
T ss_pred cccc---cccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccC-Ccc----cc
Confidence 5432 22344579999999998875 589999999999999999999999987555544433222111 111 11
Q ss_pred cccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 829 SATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 829 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
... .+..+.+++.+||+.||++|||++|++++
T Consensus 252 ~~~-----~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 252 DKV-----AIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp GGC-----CCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCC-----CCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 111 12468899999999999999999999874
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=344.13 Aligned_cols=252 Identities=26% Similarity=0.399 Sum_probs=205.3
Q ss_pred HhhccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEec---------
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLS--------- 665 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------- 665 (933)
..++|+..+.||+|+||.||+|.+. +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4578999999999999999999986 68999999997543 356789999999999999999998854
Q ss_pred -------CCccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCC
Q 002349 666 -------SSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFE 738 (933)
Q Consensus 666 -------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~ 738 (933)
....++||||+++++|.++++. .....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEK-RRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHH-GGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCC
Confidence 3447899999999999999953 1235789999999999999999999966 9999999999999999999
Q ss_pred eEEeecccccccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccc
Q 002349 739 AHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANN 818 (933)
Q Consensus 739 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 818 (933)
+||+|||++....... ......||+.|+|||.+.+..++.++||||||+++|+|++|..|+........ .....
T Consensus 161 ~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~----~~~~~ 234 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFT----DLRDG 234 (284)
T ss_dssp EEECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHH----HHHTT
T ss_pred EEECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHHHH----Hhhcc
Confidence 9999999998764332 22345699999999999999999999999999999999999998853211111 11111
Q ss_pred ccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCCCCC
Q 002349 819 AVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAPE 874 (933)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 874 (933)
.. ... .+..+.+++.+|++.||++|||+.|+++.|+.+...++
T Consensus 235 ~~--------~~~-----~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 235 II--------SDI-----FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp CC--------CTT-----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred cc--------ccc-----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 11 111 13467889999999999999999999999988766544
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=354.08 Aligned_cols=259 Identities=25% Similarity=0.351 Sum_probs=209.6
Q ss_pred hhccCcceeeecccceeEEEEEEcC------CceEEEEEecccC-chhHHHHHHHHHHHhcC-CCCceeeeeeEEecCCc
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKN------CKPVAIKRLYSHY-PQCLKEFETELETVGSI-KHRNLVSLQGYSLSSSG 668 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 668 (933)
.++|+..+.||+|+||.||+|.+.. .+.||+|++.... ....+.+.+|+++++++ +||||+++++++...+.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 4689999999999999999999753 2479999997654 34457789999999999 89999999999999999
Q ss_pred cEEEEEecCCCCHHHHhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCC
Q 002349 669 NLLFYDFMENGSLWDILHGPT-----------KKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDF 737 (933)
Q Consensus 669 ~~lv~e~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~ 737 (933)
.++||||+++|+|.+++.... ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCC
Confidence 999999999999999985311 134689999999999999999999976 999999999999999999
Q ss_pred CeEEeecccccccccCCCc-eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhh
Q 002349 738 EAHLTDFGIAKSLCVSKSY-TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKT 815 (933)
Q Consensus 738 ~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~ 815 (933)
.+||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||++ |..||.+............
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~ 281 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK 281 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHH
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHh
Confidence 9999999999866433322 2233467889999999999999999999999999999998 9999986543333222111
Q ss_pred cccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccC
Q 002349 816 ANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869 (933)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 869 (933)
... ....+. ..+..+.+++.+||+.||++|||++|+++.|+.+
T Consensus 282 ~~~------~~~~~~-----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 282 DGY------QMAQPA-----FAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp HTC------CCCCCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCC------CCCCCC-----CCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 110 011111 1235788999999999999999999999998764
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=346.57 Aligned_cols=263 Identities=18% Similarity=0.228 Sum_probs=200.7
Q ss_pred HHhhccCcceeeecccceeEEEEEE-cCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEE-ecCCccEEE
Q 002349 595 RMTENLSEKYIIGYGASSTVYKCVL-KNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYS-LSSSGNLLF 672 (933)
Q Consensus 595 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~lv 672 (933)
...++|+..+.||+|+||.||+|.+ .+++.||||++..... ...+.+|++++++++|++++..++++ ...+..++|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 3457899999999999999999997 4678999998755432 24578899999999988777666655 566778999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEe---CCCCCeEEeecccccc
Q 002349 673 YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILL---DKDFEAHLTDFGIAKS 749 (933)
Q Consensus 673 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll---~~~~~~kl~DfGla~~ 749 (933)
|||+ +++|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||+++.
T Consensus 84 ~e~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 84 MELL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp EECC-CCBHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred EEcc-CCCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 9999 9999999962 345799999999999999999999976 99999999999999 7889999999999987
Q ss_pred cccCCC------ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHH-hhhccccccc
Q 002349 750 LCVSKS------YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLIL-SKTANNAVME 822 (933)
Q Consensus 750 ~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~-~~~~~~~~~~ 822 (933)
...... .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||.+......... ..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence 644322 122345799999999999999999999999999999999999999975322111000 0000000000
Q ss_pred ccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCC
Q 002349 823 TVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVP 871 (933)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 871 (933)
.. +.... ..+..+.+++.+|++.||++|||++++++.|+.+..
T Consensus 238 ~~-~~~~~-----~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 238 PI-EVLCK-----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp CH-HHHTT-----TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred hh-hhhhc-----cCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence 00 00000 123678999999999999999999999999987654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=376.13 Aligned_cols=248 Identities=22% Similarity=0.344 Sum_probs=200.5
Q ss_pred eeecccceeEEEEEEc---CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecCCCC
Q 002349 605 IIGYGASSTVYKCVLK---NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGS 680 (933)
Q Consensus 605 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 680 (933)
.||+|+||.||+|.++ ++..||||+++... ....+++.+|++++++++|||||++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999875 45679999997653 3456889999999999999999999999976 56899999999999
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCce--e
Q 002349 681 LWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYT--S 758 (933)
Q Consensus 681 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~--~ 758 (933)
|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......... .
T Consensus 422 L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 496 (613)
T 2ozo_A 422 LHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 496 (613)
T ss_dssp HHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred HHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeec
Confidence 9999963 456799999999999999999999966 99999999999999999999999999998764332221 2
Q ss_pred eeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHH
Q 002349 759 TYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGA 837 (933)
Q Consensus 759 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 837 (933)
....+++.|+|||++.+..++.++|||||||++|||++ |+.||.+............ +. ....+. .+
T Consensus 497 ~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~--~~-----~~~~p~-----~~ 564 (613)
T 2ozo_A 497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ--GK-----RMECPP-----EC 564 (613)
T ss_dssp -----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHT--TC-----CCCCCT-----TC
T ss_pred cCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc--CC-----CCCCCC-----cC
Confidence 22346789999999999999999999999999999998 9999987655443322211 11 111111 23
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHHHccCC
Q 002349 838 VKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLV 870 (933)
Q Consensus 838 ~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 870 (933)
+..+.+++.+||+.||++||++++|++.|+.+.
T Consensus 565 ~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 565 PPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp CHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 467899999999999999999999999998754
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=345.51 Aligned_cols=260 Identities=25% Similarity=0.376 Sum_probs=198.9
Q ss_pred HhhccCcceeeecccceeEEEEEEcC----CceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCc-
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLKN----CKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSG- 668 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~- 668 (933)
..++|...+.||+|+||.||+|.+.. ++.||+|++.... ....+.+.+|++++++++||||+++++++.....
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 45688899999999999999998653 4579999987543 3345678999999999999999999999987653
Q ss_pred ----cEEEEEecCCCCHHHHhcCC---CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEE
Q 002349 669 ----NLLFYDFMENGSLWDILHGP---TKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHL 741 (933)
Q Consensus 669 ----~~lv~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl 741 (933)
.++||||+++|+|.+++... .....+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEE
Confidence 49999999999999998421 2345799999999999999999999965 9999999999999999999999
Q ss_pred eecccccccccCCCc-eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccc
Q 002349 742 TDFGIAKSLCVSKSY-TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNA 819 (933)
Q Consensus 742 ~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 819 (933)
+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||................
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-- 266 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH-- 266 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC--
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC--
Confidence 999999876433221 2233467889999999999999999999999999999999 889997655443332221111
Q ss_pred cccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCC
Q 002349 820 VMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLV 870 (933)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 870 (933)
.+.... ..+..+.+++.+|++.||++|||++++++.|+.+.
T Consensus 267 -----~~~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 267 -----RLKQPE-----DCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp -----CCCCBT-----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCCCCc-----cccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111111 12357889999999999999999999999998764
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=354.03 Aligned_cols=255 Identities=24% Similarity=0.297 Sum_probs=199.3
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCC------
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSS------ 667 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 667 (933)
.++|+..+.||+|+||.||+|.+. +++.||||++.... ....+++.+|++++++++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 467999999999999999999975 58899999996543 334567899999999999999999999997663
Q ss_pred ccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccc
Q 002349 668 GNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIA 747 (933)
Q Consensus 668 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla 747 (933)
..++||||+ +++|.+++.. ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 459999999 7899999852 5689999999999999999999966 9999999999999999999999999999
Q ss_pred cccccCCCceeeeecccccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccccccccc--
Q 002349 748 KSLCVSKSYTSTYIMGTIGYIDPEYART-SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETV-- 824 (933)
Q Consensus 748 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 824 (933)
+..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+......+.......+......
T Consensus 176 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~ 251 (367)
T 1cm8_A 176 RQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 251 (367)
T ss_dssp EECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred cccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 875322 234578999999999887 6799999999999999999999999987766555433322111111000
Q ss_pred ------------------CccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 825 ------------------DPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 825 ------------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
...+..... ..+..+.+++.+|++.||++|||++|++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 252 RLQSDEAKNYMKGLPELEKKDFASILT--NASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTCT--TCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhhhHHHHHHHHhCCCCCCCCHHHHCC--CCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 000111000 124578899999999999999999999985
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=357.83 Aligned_cols=254 Identities=24% Similarity=0.289 Sum_probs=204.5
Q ss_pred hhccCcceeeecccceeEEEEEE----cCCceEEEEEecccC----chhHHHHHHHHHHHhcC-CCCceeeeeeEEecCC
Q 002349 597 TENLSEKYIIGYGASSTVYKCVL----KNCKPVAIKRLYSHY----PQCLKEFETELETVGSI-KHRNLVSLQGYSLSSS 667 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 667 (933)
.++|+..+.||+|+||.||+|+. .+++.||||+++... ....+.+.+|+++++++ +||||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36899999999999999999997 367899999986532 23345677899999999 6999999999999999
Q ss_pred ccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccc
Q 002349 668 GNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIA 747 (933)
Q Consensus 668 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla 747 (933)
..++||||+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLS---QRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 9999999999999999995 345799999999999999999999966 9999999999999999999999999999
Q ss_pred cccccCCCceeeeecccccccCccccccC--CCCcchhhHHHHHHHHHHHhCCCCCCCCcch---hHHHHhhhccccccc
Q 002349 748 KSLCVSKSYTSTYIMGTIGYIDPEYARTS--RLTEKSDVYSFGIVLLELLTGRKAVDNECNL---HHLILSKTANNAVME 822 (933)
Q Consensus 748 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGv~l~elltg~~p~~~~~~~---~~~~~~~~~~~~~~~ 822 (933)
+.+............||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..........
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~----- 281 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS----- 281 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC-----
T ss_pred eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhcc-----
Confidence 87644433334456799999999999863 4789999999999999999999999743221 1111111100
Q ss_pred ccCccccccccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHcc
Q 002349 823 TVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRP-----TMHEVSRVLGS 868 (933)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L~~ 868 (933)
.+..+. ..+..+.+++.+||+.||++|| +++|++++..-
T Consensus 282 --~~~~~~-----~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f 325 (355)
T 1vzo_A 282 --EPPYPQ-----EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325 (355)
T ss_dssp --CCCCCT-----TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred --CCCCCc-----ccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcch
Confidence 011111 1235678899999999999999 99999986543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=350.22 Aligned_cols=265 Identities=23% Similarity=0.332 Sum_probs=211.2
Q ss_pred HHHHHHhhccCcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhc--CCCCceeeeeeEEecCC-
Q 002349 591 EDIMRMTENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGS--IKHRNLVSLQGYSLSSS- 667 (933)
Q Consensus 591 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~- 667 (933)
..-....++|...+.||+|+||.||+|.+. ++.||||++... ..+.+.+|+++++. ++||||+++++++....
T Consensus 35 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~ 110 (342)
T 1b6c_B 35 LVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNG 110 (342)
T ss_dssp HHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred eecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence 334456689999999999999999999985 789999998643 34667888888887 78999999999998876
Q ss_pred ---ccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhh--------cCCCCCeeeccCCCCceEeCCC
Q 002349 668 ---GNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLH--------HDCSPRIIHRDVKSSNILLDKD 736 (933)
Q Consensus 668 ---~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~ivH~Dikp~NIll~~~ 736 (933)
..++||||+++|+|.+++. ...+++..++.++.|++.||+||| +. +|+||||||+||+++.+
T Consensus 111 ~~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~ 183 (342)
T 1b6c_B 111 TWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKN 183 (342)
T ss_dssp SCCCEEEEECCCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTT
T ss_pred ccceeEEEEeecCCCcHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCC
Confidence 7899999999999999995 246899999999999999999999 55 99999999999999999
Q ss_pred CCeEEeecccccccccCCCc---eeeeecccccccCccccccCC------CCcchhhHHHHHHHHHHHhC----------
Q 002349 737 FEAHLTDFGIAKSLCVSKSY---TSTYIMGTIGYIDPEYARTSR------LTEKSDVYSFGIVLLELLTG---------- 797 (933)
Q Consensus 737 ~~~kl~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlGv~l~elltg---------- 797 (933)
+.+||+|||+++........ ......||+.|+|||++.+.. ++.++|||||||++|||++|
T Consensus 184 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~ 263 (342)
T 1b6c_B 184 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 263 (342)
T ss_dssp SCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccc
Confidence 99999999999876443322 123457999999999998762 34789999999999999999
Q ss_pred CCCCCCCcc----hhHHHHhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCC
Q 002349 798 RKAVDNECN----LHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVP 871 (933)
Q Consensus 798 ~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 871 (933)
+.||..... ...+.. .... ....+.++........+..+.+++.+||+.||++|||+++|+++|+.+..
T Consensus 264 ~~p~~~~~~~~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~ 336 (342)
T 1b6c_B 264 QLPYYDLVPSDPSVEEMRK-VVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336 (342)
T ss_dssp CCTTTTTSCSSCCHHHHHH-HHTT----SCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCccccCcCcccHHHHHH-HHHH----HHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 778864321 112111 1111 11223333322344667889999999999999999999999999987653
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=359.47 Aligned_cols=255 Identities=25% Similarity=0.338 Sum_probs=194.0
Q ss_pred HHhhccCcceeeecccceeEEEEEEcC-CceEEEEEecccC--------chhHHHHHHHHHHHhcCCCCceeeeeeEEec
Q 002349 595 RMTENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHY--------PQCLKEFETELETVGSIKHRNLVSLQGYSLS 665 (933)
Q Consensus 595 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 665 (933)
...++|...+.||+|+||+||+|.+.. ++.||||++.... ......+.+|++++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 456799999999999999999999764 7899999986532 1122347899999999999999999999864
Q ss_pred CCccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCC---CCeEEe
Q 002349 666 SSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKD---FEAHLT 742 (933)
Q Consensus 666 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~---~~~kl~ 742 (933)
+..++||||+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.+ +.+||+
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred -CceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEe
Confidence 45799999999999999984 456799999999999999999999966 99999999999999754 459999
Q ss_pred ecccccccccCCCceeeeecccccccCcccccc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccc
Q 002349 743 DFGIAKSLCVSKSYTSTYIMGTIGYIDPEYART---SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNA 819 (933)
Q Consensus 743 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 819 (933)
|||+|+.... ........||+.|+|||++.+ ..++.++||||+||++|+|++|+.||............... ..
T Consensus 285 DFG~a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~-~~ 361 (419)
T 3i6u_A 285 DFGHSKILGE--TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS-GK 361 (419)
T ss_dssp CSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHT-TC
T ss_pred ecccceecCC--CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhc-CC
Confidence 9999987643 222345679999999999863 56889999999999999999999999754332222111111 00
Q ss_pred cccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 820 VMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
. . ..+.... ..+..+.+++.+|++.||++|||++|++++-
T Consensus 362 ~-~-~~~~~~~-----~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp 401 (419)
T 3i6u_A 362 Y-N-FIPEVWA-----EVSEKALDLVKKLLVVDPKARFTTEEALRHP 401 (419)
T ss_dssp C-C-CCHHHHT-----TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred C-C-CCchhhc-----ccCHHHHHHHHHHccCChhHCcCHHHHhCCc
Confidence 0 0 0011100 1235788999999999999999999999853
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=352.60 Aligned_cols=259 Identities=20% Similarity=0.251 Sum_probs=196.6
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCC------
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSS------ 667 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 667 (933)
.++|+..+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 368999999999999999999976 57889999997542 334567889999999999999999999997665
Q ss_pred ccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccc
Q 002349 668 GNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIA 747 (933)
Q Consensus 668 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla 747 (933)
..++||||+++ +|.+.+. ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeecc
Confidence 67999999975 7888884 3489999999999999999999976 9999999999999999999999999999
Q ss_pred cccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccccccc----c
Q 002349 748 KSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVME----T 823 (933)
Q Consensus 748 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----~ 823 (933)
+..... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+......+.......+.... .
T Consensus 175 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 252 (371)
T 2xrw_A 175 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 252 (371)
T ss_dssp -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTT
T ss_pred cccccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 865322 2233457999999999999999999999999999999999999999877655544332221111000 0
Q ss_pred c----------------------Ccccccccc---CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 824 V----------------------DPEISATCK---DLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 824 ~----------------------~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
+ .+....... .......+.+++.+|++.||++|||++|++++-
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 320 (371)
T 2xrw_A 253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 320 (371)
T ss_dssp SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence 0 000000000 012356789999999999999999999999743
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=353.73 Aligned_cols=270 Identities=25% Similarity=0.366 Sum_probs=196.9
Q ss_pred hhccCcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHH--HHHHhcCCCCceeeeeeEEec-----CCcc
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETE--LETVGSIKHRNLVSLQGYSLS-----SSGN 669 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E--~~~l~~l~h~niv~~~~~~~~-----~~~~ 669 (933)
.++|+..+.||+|+||.||+|.. +++.||||++.... ...+..| +..+..++||||+++++++.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 36889999999999999999987 56899999986543 2334444 444556899999999985532 2356
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC------CCCeeeccCCCCceEeCCCCCeEEee
Q 002349 670 LLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDC------SPRIIHRDVKSSNILLDKDFEAHLTD 743 (933)
Q Consensus 670 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------~~~ivH~Dikp~NIll~~~~~~kl~D 743 (933)
++||||+++|+|.+++.. ...++..+..++.|++.||+|||+.+ ..+|+||||||+|||++.++.+||+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp EEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred EEEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence 899999999999999952 34589999999999999999999431 11999999999999999999999999
Q ss_pred cccccccccCCC-------ceeeeecccccccCcccccc-------CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhH
Q 002349 744 FGIAKSLCVSKS-------YTSTYIMGTIGYIDPEYART-------SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHH 809 (933)
Q Consensus 744 fGla~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~ 809 (933)
||+++.+..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........
T Consensus 164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~ 243 (336)
T 3g2f_A 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243 (336)
T ss_dssp CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence 999987643221 11223469999999999987 3567799999999999999999877643221110
Q ss_pred HH---Hhhhccc---------ccccccCccccccc-cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCCCCC
Q 002349 810 LI---LSKTANN---------AVMETVDPEISATC-KDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAPE 874 (933)
Q Consensus 810 ~~---~~~~~~~---------~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~ 874 (933)
.. ....... .......+.++... .....+..+.+++.+||+.||++|||++|+++.|+.+.....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~ 321 (336)
T 3g2f_A 244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWE 321 (336)
T ss_dssp CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCC
T ss_pred HHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHH
Confidence 00 0000000 00011111222111 123456789999999999999999999999999988765443
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=338.21 Aligned_cols=252 Identities=18% Similarity=0.252 Sum_probs=200.4
Q ss_pred HhhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC----chhHHHHHHHHHHHhcCCCCceeeeeeEEe--cCCc
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY----PQCLKEFETELETVGSIKHRNLVSLQGYSL--SSSG 668 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~ 668 (933)
..++|...+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|++++++++||||+++++++. +...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 3478999999999999999999975 57899999996542 334677999999999999999999999984 4557
Q ss_pred cEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccc
Q 002349 669 NLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAK 748 (933)
Q Consensus 669 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 748 (933)
.++||||++++ +.+++.. .....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.
T Consensus 83 ~~lv~e~~~~~-l~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDS-VPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEEECCSEE-HHHHHHH-STTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEehhccCC-HHHHHHh-CcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccc
Confidence 89999999876 7777653 2356799999999999999999999976 99999999999999999999999999998
Q ss_pred ccccC-CCceeeeecccccccCccccccCC--CCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccC
Q 002349 749 SLCVS-KSYTSTYIMGTIGYIDPEYARTSR--LTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVD 825 (933)
Q Consensus 749 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (933)
..... .........||+.|+|||++.+.. ++.++||||+|+++|||++|+.||.+...............
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~------- 230 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY------- 230 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC-------
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCC-------
Confidence 76422 222234457999999999998654 37899999999999999999999986544333222211111
Q ss_pred ccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 826 PEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 826 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.++. ..+..+.+++.+|++.||++|||++|++++
T Consensus 231 -~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 -AIPG-----DCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp -CCCS-----SSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -CCCC-----ccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111 123578899999999999999999999974
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=344.46 Aligned_cols=259 Identities=18% Similarity=0.210 Sum_probs=204.1
Q ss_pred hhccCcceeeecccceeEEEEEE-cCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEE-ecCCccEEEEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVL-KNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYS-LSSSGNLLFYD 674 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~lv~e 674 (933)
.++|+..+.||+|+||.||+|++ .+++.||||++..... .+.+.+|++++++++|++++..+.++ ...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46899999999999999999997 4688999999865432 35688999999999988866666655 56677799999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEe---CCCCCeEEeecccccccc
Q 002349 675 FMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILL---DKDFEAHLTDFGIAKSLC 751 (933)
Q Consensus 675 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll---~~~~~~kl~DfGla~~~~ 751 (933)
|+ +++|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||+++...
T Consensus 86 ~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 8999999962 345799999999999999999999976 99999999999999 488999999999998764
Q ss_pred cCCCc------eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcch---hHHHHhhhccccccc
Q 002349 752 VSKSY------TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNL---HHLILSKTANNAVME 822 (933)
Q Consensus 752 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~---~~~~~~~~~~~~~~~ 822 (933)
..... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.+.... ........ .....
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~ 237 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE--KKMST 237 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH--HHHHS
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcc--cccCC
Confidence 43221 123457999999999999999999999999999999999999999753221 11111000 00000
Q ss_pred ccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCC
Q 002349 823 TVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVP 871 (933)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 871 (933)
. .+.... ..+..+.+++.+||+.||++|||++++++.|+.+..
T Consensus 238 ~-~~~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 280 (296)
T 3uzp_A 238 P-IEVLCK-----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp C-HHHHTT-----TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred c-hHHHHh-----hCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHH
Confidence 0 000000 123578899999999999999999999999987654
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=345.51 Aligned_cols=253 Identities=21% Similarity=0.286 Sum_probs=201.4
Q ss_pred hhccCcceeeecccceeEEEEEEcC-CceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEe
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
.++|+..+.||+|+||.||+|.+.. ++.||+|++........+.+.+|++++++++||||+++++++..++..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 4689999999999999999999874 789999999776666678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS 755 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 755 (933)
+++++|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++...... .
T Consensus 98 ~~~~~l~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~ 171 (302)
T 2j7t_A 98 CPGGAVDAIMLE--LDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-L 171 (302)
T ss_dssp CTTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-H
T ss_pred CCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccc-c
Confidence 999999998852 345699999999999999999999976 9999999999999999999999999998643211 1
Q ss_pred ceeeeecccccccCcccc-----ccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccc
Q 002349 756 YTSTYIMGTIGYIDPEYA-----RTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISA 830 (933)
Q Consensus 756 ~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (933)
.......||+.|+|||++ .+..++.++||||||+++|+|++|+.||................ ......
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~----- 244 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD--PPTLLT----- 244 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC--CCCCSS-----
T ss_pred cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccC--CcccCC-----
Confidence 122335799999999988 36678999999999999999999999998655443322211111 000000
Q ss_pred cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 831 TCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 831 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
....+..+.+++.+|++.||++|||+++++++
T Consensus 245 ---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 245 ---PSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp ---GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred ---ccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 11123578899999999999999999999874
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=354.78 Aligned_cols=260 Identities=22% Similarity=0.323 Sum_probs=204.0
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEe
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
++|+..+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|++++++++||||+++++++..++..++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 57899999999999999999977 57889999997653 34467789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS 755 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 755 (933)
+++++|.+++. ....+++..+..++.|++.||+|||+. .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 113 ~~~~~L~~~l~---~~~~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 185 (360)
T 3eqc_A 113 MDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 185 (360)
T ss_dssp CTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred CCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence 99999999995 345789999999999999999999952 28999999999999999999999999999765322
Q ss_pred ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccC----------
Q 002349 756 YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVD---------- 825 (933)
Q Consensus 756 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------- 825 (933)
......||+.|+|||++.+..++.++||||+||++|+|++|+.||........................
T Consensus 186 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (360)
T 3eqc_A 186 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264 (360)
T ss_dssp -C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred -cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence 223457999999999999999999999999999999999999999864432221111000000000000
Q ss_pred ---------------------ccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 826 ---------------------PEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 826 ---------------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
............+..+.+++.+|++.||++|||++|++++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ---------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0000000011124578899999999999999999999864
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=338.81 Aligned_cols=249 Identities=26% Similarity=0.393 Sum_probs=208.1
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEe
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
+.|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++......++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 56889999999999999999975 57899999996543 34567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS 755 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 755 (933)
+++++|.+++. ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 102 ~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~- 173 (303)
T 3a7i_A 102 LGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ- 173 (303)
T ss_dssp CTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-
T ss_pred CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccc-
Confidence 99999999984 35799999999999999999999976 99999999999999999999999999998764322
Q ss_pred ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCH
Q 002349 756 YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDL 835 (933)
Q Consensus 756 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (933)
.......||+.|+|||++.+..++.++||||||+++|+|++|+.||............... ..+.+...
T Consensus 174 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------~~~~~~~~---- 242 (303)
T 3a7i_A 174 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN-------NPPTLEGN---- 242 (303)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-------CCCCCCSS----
T ss_pred cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcC-------CCCCCccc----
Confidence 2233457999999999999999999999999999999999999999865443332221111 11111111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 836 GAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 836 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
.+..+.+++.+|++.||++|||+++++++.
T Consensus 243 -~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 243 -YSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp -CCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred -cCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 235688999999999999999999998754
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=365.70 Aligned_cols=252 Identities=25% Similarity=0.335 Sum_probs=204.1
Q ss_pred HhhccCcceeeecccceeEEEEEEcC-CceEEEEEecccCc-------------hhHHHHHHHHHHHhcCCCCceeeeee
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHYP-------------QCLKEFETELETVGSIKHRNLVSLQG 661 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~~~~ 661 (933)
..++|...+.||+|+||+||+|.++. ++.||+|++..... ...+.+.+|++++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 35789999999999999999999764 68899999865421 23567899999999999999999999
Q ss_pred EEecCCccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCC---C
Q 002349 662 YSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDF---E 738 (933)
Q Consensus 662 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~---~ 738 (933)
++.++...++||||+++|+|.+.+. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQII---NRHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCcc
Confidence 9999999999999999999999984 346799999999999999999999966 999999999999998776 6
Q ss_pred eEEeecccccccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccc
Q 002349 739 AHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANN 818 (933)
Q Consensus 739 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 818 (933)
+||+|||+++..... .......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+...............
T Consensus 188 ~kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~ 264 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKD--YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKY 264 (504)
T ss_dssp EEECCCTTCEECCTT--SCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred EEEEECCCCEEcCCC--CccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC
Confidence 999999999876432 23344579999999999874 699999999999999999999999987655444333222211
Q ss_pred ccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 819 AVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
..... ... ..+..+.+++.+|++.||.+|||++|++++
T Consensus 265 ~~~~~---~~~------~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 265 YFDFN---DWK------NISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp CCCHH---HHT------TSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCcc---ccC------CCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 11100 000 123578899999999999999999999964
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=342.87 Aligned_cols=257 Identities=22% Similarity=0.279 Sum_probs=205.1
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEe--cCCccEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSL--SSSGNLL 671 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~l 671 (933)
.++|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++. .....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999976 57899999997543 344567899999999999999999999874 3567899
Q ss_pred EEEecCCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC-----eeeccCCCCceEeCCCCCeEEeecc
Q 002349 672 FYDFMENGSLWDILHGPT-KKKKLDWDTRLKIALGAAQGLAYLHHDCSPR-----IIHRDVKSSNILLDKDFEAHLTDFG 745 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-----ivH~Dikp~NIll~~~~~~kl~DfG 745 (933)
||||+++++|.+++.... ....+++..++.++.|++.||+|||+. + |+||||||+||+++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 999999999999985321 234599999999999999999999976 6 9999999999999999999999999
Q ss_pred cccccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccC
Q 002349 746 IAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVD 825 (933)
Q Consensus 746 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (933)
+++....... ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||............. ....
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~--~~~~----- 233 (279)
T 2w5a_A 162 LARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR--EGKF----- 233 (279)
T ss_dssp HHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HTCC-----
T ss_pred hheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHh--hccc-----
Confidence 9987543221 1223468999999999999999999999999999999999999998654332221111 1111
Q ss_pred ccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccC
Q 002349 826 PEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869 (933)
Q Consensus 826 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 869 (933)
+.++. ..+..+.+++.+||+.||++|||++|+++++...
T Consensus 234 ~~~~~-----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~ 272 (279)
T 2w5a_A 234 RRIPY-----RYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272 (279)
T ss_dssp CCCCT-----TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred ccCCc-----ccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence 11111 1235788999999999999999999999876543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=352.65 Aligned_cols=270 Identities=19% Similarity=0.232 Sum_probs=203.7
Q ss_pred cCHHHHHHHhhccCcceeeecccceeEEEEEEcCCceEEEEEecccCc-----------hhHHHHHHHHHHHhcCCCCce
Q 002349 588 HVYEDIMRMTENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYP-----------QCLKEFETELETVGSIKHRNL 656 (933)
Q Consensus 588 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~h~ni 656 (933)
...+++....++|...+.||+|+||.||+|...+++.||||++..... ...+.+.+|++++++++||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 346778888999999999999999999999988899999999865321 123778999999999999999
Q ss_pred eeeeeEEec-----CCccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCce
Q 002349 657 VSLQGYSLS-----SSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNI 731 (933)
Q Consensus 657 v~~~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NI 731 (933)
+++++++.. ....++||||++ |+|.+.+. .....+++..+..++.|++.||+|||++ +|+||||||+||
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NI 165 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIH--DQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNI 165 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHH--CTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHE
Confidence 999999854 335799999998 58888886 3455799999999999999999999976 999999999999
Q ss_pred EeCCCCCeEEeecccccccccCCCceeeeecccccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHH
Q 002349 732 LLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYART-SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHL 810 (933)
Q Consensus 732 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~ 810 (933)
+++.++.+||+|||+++..... .......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.......
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 243 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL 243 (362)
T ss_dssp EECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred EEcCCCCEEEEecCcccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9999999999999999754322 22344578999999999877 67899999999999999999999999876544443
Q ss_pred HHhhhcccccc-------------cccCccccccc------cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 811 ILSKTANNAVM-------------ETVDPEISATC------KDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 811 ~~~~~~~~~~~-------------~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.......+... +.......... ........+.+++.+|++.||++|||++|++++
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 244 NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 32211110000 00000000000 000123568899999999999999999999975
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=360.93 Aligned_cols=261 Identities=19% Similarity=0.243 Sum_probs=186.7
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecC-----Cc
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSS-----SG 668 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~ 668 (933)
.++|+..+.||+|+||+||+|+++ +++.||||++.... ....+++.+|++++++++|||||++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 368999999999999999999976 57899999996543 33457789999999999999999999998543 56
Q ss_pred cEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccc
Q 002349 669 NLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAK 748 (933)
Q Consensus 669 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 748 (933)
.|+||||+ +++|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+
T Consensus 132 ~~lv~e~~-~~~L~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFR---TPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCC-SEEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEecc-ccchhhhcc---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccch
Confidence 89999998 468999985 456799999999999999999999966 99999999999999999999999999998
Q ss_pred ccccCCC--------------------------ceeeeecccccccCcccc-ccCCCCcchhhHHHHHHHHHHHh-----
Q 002349 749 SLCVSKS--------------------------YTSTYIMGTIGYIDPEYA-RTSRLTEKSDVYSFGIVLLELLT----- 796 (933)
Q Consensus 749 ~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGv~l~ellt----- 796 (933)
....... ......+||+.|+|||++ .+..++.++||||+||++|||++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~ 284 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence 7642211 122345789999999976 56679999999999999999999
Q ss_pred ------CCCCCCCCcc--------------------hhHHHHhhhccccc--------------------ccccCccccc
Q 002349 797 ------GRKAVDNECN--------------------LHHLILSKTANNAV--------------------METVDPEISA 830 (933)
Q Consensus 797 ------g~~p~~~~~~--------------------~~~~~~~~~~~~~~--------------------~~~~~~~~~~ 830 (933)
|+.+|.+... ..++.......+.. .......+..
T Consensus 285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (458)
T 3rp9_A 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE 364 (458)
T ss_dssp CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence 6666654321 01111000000000 0000000000
Q ss_pred cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 831 TCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 831 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
..+ .....+.+++.+||..||++|||++|++++-
T Consensus 365 ~~~--~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp 398 (458)
T 3rp9_A 365 RFP--ASSADAIHLLKRMLVFNPNKRITINECLAHP 398 (458)
T ss_dssp GST--TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred HCC--CCCHHHHHHHHHHhccCccccCCHHHHhcCH
Confidence 011 1246788999999999999999999999853
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=354.86 Aligned_cols=198 Identities=25% Similarity=0.338 Sum_probs=166.7
Q ss_pred hhccCcceeeecccceeEEEEEEcC-CceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecC-----Cc
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSS-----SG 668 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~ 668 (933)
.++|...+.||+|+||.||+|.+.. ++.||||++.... ....+++.+|++++++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 4689999999999999999999764 7889999997643 33457789999999999999999999999766 56
Q ss_pred cEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccc
Q 002349 669 NLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAK 748 (933)
Q Consensus 669 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 748 (933)
.|+||||++ ++|.+++. ....+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+|+
T Consensus 105 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFK---TPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 899999996 59999995 456799999999999999999999966 99999999999999999999999999998
Q ss_pred ccccCCCc---------------------eeeeecccccccCcccc-ccCCCCcchhhHHHHHHHHHHHhCCCCC
Q 002349 749 SLCVSKSY---------------------TSTYIMGTIGYIDPEYA-RTSRLTEKSDVYSFGIVLLELLTGRKAV 801 (933)
Q Consensus 749 ~~~~~~~~---------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~DvwSlGv~l~elltg~~p~ 801 (933)
........ .....+||+.|+|||++ .+..++.++||||+||++|||++|..||
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 76432211 12456899999999986 5567999999999999999999855444
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=364.88 Aligned_cols=251 Identities=20% Similarity=0.265 Sum_probs=204.5
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
++|...+.||+|+||.||+|+++ +++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 67888899999999999999986 58999999996542 233567889999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccccc
Q 002349 674 DFMENGSLWDILHGPT-KKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV 752 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 752 (933)
||++||+|.+++.... ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.+..
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 9999999999986422 245799999999999999999999966 999999999999999999999999999987643
Q ss_pred CCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcc---hhHHHHhhhcccccccccCcccc
Q 002349 753 SKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECN---LHHLILSKTANNAVMETVDPEIS 829 (933)
Q Consensus 753 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 829 (933)
... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......... ... ..++
T Consensus 342 ~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~-~~~------~~~p 413 (543)
T 3c4z_A 342 GQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVL-EQA------VTYP 413 (543)
T ss_dssp TCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHH-HCC------CCCC
T ss_pred CCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHh-hcc------cCCC
Confidence 322 23345899999999999999999999999999999999999999986432 111111111 110 0111
Q ss_pred ccccCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 002349 830 ATCKDLGAVKKVFQLALLCSKRQPTDRPTM-----HEVSR 864 (933)
Q Consensus 830 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~ 864 (933)
. ..+..+.+++.+|++.||++||++ +++.+
T Consensus 414 ~-----~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 414 D-----KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp T-----TSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred c-----ccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 1 123578889999999999999975 66664
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=348.31 Aligned_cols=263 Identities=25% Similarity=0.401 Sum_probs=207.5
Q ss_pred hhccCcceeeecccceeEEEEEE-----cCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCC--cc
Q 002349 597 TENLSEKYIIGYGASSTVYKCVL-----KNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSS--GN 669 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~ 669 (933)
.++|+..+.||+|+||.||+|.+ .+++.||||++........+.+.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35788899999999999999984 357899999998776667788999999999999999999999987654 68
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccc
Q 002349 670 LLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKS 749 (933)
Q Consensus 670 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 749 (933)
++||||+++++|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHH--STTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 999999999999999963 345699999999999999999999966 999999999999999999999999999987
Q ss_pred cccCCCce--eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcc---------c
Q 002349 750 LCVSKSYT--STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTAN---------N 818 (933)
Q Consensus 750 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~---------~ 818 (933)
........ .....++..|+|||.+.+..++.++||||||+++|||++|..||................ .
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence 65433221 123457788999999999889999999999999999999999986421100000000000 0
Q ss_pred ccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccC
Q 002349 819 AVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869 (933)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 869 (933)
.......... ....+..+.+++.+||+.||++|||+.|+++.|+.+
T Consensus 275 ~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 275 LLKNNGRLPR-----PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HHHTTCCCCC-----CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HhhcCCCCCC-----CCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0000000111 112346789999999999999999999999998765
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=363.01 Aligned_cols=320 Identities=19% Similarity=0.176 Sum_probs=259.6
Q ss_pred cEEEccCCcccccCCCCccCCCCCceecccccccCCCCCcccccccchhhhhhcccCccCCCCcccccCCCCceeeeecC
Q 002349 95 QSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGN 174 (933)
Q Consensus 95 ~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N 174 (933)
+.++.++++++ .+|..+. ++|++|||++|.+++..|..|.++++|++|+|++|.+++..|..|+++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 14 RAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90 (477)
T ss_dssp TEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence 47899999998 7887664 68999999999999888899999999999999999999988999999999999999999
Q ss_pred CCCCCcccccccCCCCcEEeccCccccCccCcCCcCCCCCcEEccccccccCcCCCCccccccceEeccccccccccCcc
Q 002349 175 NLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSV 254 (933)
Q Consensus 175 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~ 254 (933)
++++..+..|.++++|++|+|++|.+++..|..+.++++|++|+|++|++++ ..+..
T Consensus 91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~-----------------------~~~~~ 147 (477)
T 2id5_A 91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVY-----------------------ISHRA 147 (477)
T ss_dssp CCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCE-----------------------ECTTS
T ss_pred cCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccce-----------------------eChhh
Confidence 9997776778999999999999999999889999999999999998888763 33456
Q ss_pred ccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcceEeeeccccccccCCcccccccccc
Q 002349 255 IGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLF 334 (933)
Q Consensus 255 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~ 334 (933)
|..+++|+.|+|++|.+++..+..|.++++|+.|+|++|.+.+..+..|..+++|+.|++++|.+.+.+|.......+|+
T Consensus 148 ~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~ 227 (477)
T 2id5_A 148 FSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLT 227 (477)
T ss_dssp STTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCS
T ss_pred ccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCcccc
Confidence 77889999999999999988778899999999999999999988888999999999999999998888888887888999
Q ss_pred ccccccccCCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCCccccccccccceeeccCCc
Q 002349 335 DLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNK 414 (933)
Q Consensus 335 ~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 414 (933)
.|++++|++++..+..+..+++|+.|+|++|++++..+..|..+++|++|+|++|++++..|..|..+++|+.|+|++|+
T Consensus 228 ~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 307 (477)
T 2id5_A 228 SLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQ 307 (477)
T ss_dssp EEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSC
T ss_pred EEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCc
Confidence 99999999996554567778888888888887776666566666666666666665555545555555555555555555
Q ss_pred cCCCCCCCCCCccccccccccCcccc
Q 002349 415 ISGSIPSPLGDLEHLLKLNLSRNQLT 440 (933)
Q Consensus 415 l~~~~p~~~~~l~~L~~L~Ls~N~l~ 440 (933)
|++..+..|..+++|+.|+|++|.++
T Consensus 308 l~~~~~~~~~~l~~L~~L~l~~N~l~ 333 (477)
T 2id5_A 308 LTTLEESVFHSVGNLETLILDSNPLA 333 (477)
T ss_dssp CSCCCGGGBSCGGGCCEEECCSSCEE
T ss_pred CceeCHhHcCCCcccCEEEccCCCcc
Confidence 44433333444444444444444443
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=354.63 Aligned_cols=260 Identities=17% Similarity=0.201 Sum_probs=203.4
Q ss_pred hccCcceeeecccceeEEEEEEcC---------CceEEEEEecccCchhHHHHHHHHHHHhcCCCCceee----------
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKN---------CKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVS---------- 658 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------- 658 (933)
++|...+.||+|+||.||+|.+.. ++.||||++... +.+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 589999999999999999999764 788999998654 46789999999999999987
Q ss_pred -----eeeEEec-CCccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceE
Q 002349 659 -----LQGYSLS-SSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNIL 732 (933)
Q Consensus 659 -----~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIl 732 (933)
+++++.. +...++||||+ +++|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+||+
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl 191 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIF 191 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEE
Confidence 5677765 67789999999 99999999631 236799999999999999999999976 9999999999999
Q ss_pred eCCCC--CeEEeecccccccccCCCc------eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 002349 733 LDKDF--EAHLTDFGIAKSLCVSKSY------TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNE 804 (933)
Q Consensus 733 l~~~~--~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~ 804 (933)
++.++ .+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99998 8999999999876432211 113347999999999999999999999999999999999999999865
Q ss_pred c-chhHHHHhhhc-ccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCC
Q 002349 805 C-NLHHLILSKTA-NNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVP 871 (933)
Q Consensus 805 ~-~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 871 (933)
. ........... ............. ....+..+.+++.+|++.||++|||++++++.|+.+..
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 336 (352)
T 2jii_A 272 LPNTEDIMKQKQKFVDKPGPFVGPCGH----WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQ 336 (352)
T ss_dssp TTCHHHHHHHHHHHHHSCCCEECTTSC----EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHhccCChhhhhhhccc----cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHH
Confidence 4 22222111110 0000000000000 00123678999999999999999999999999987654
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=351.16 Aligned_cols=255 Identities=22% Similarity=0.296 Sum_probs=188.8
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCC-CCceeeeeeEEe--------cCC
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIK-HRNLVSLQGYSL--------SSS 667 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~--------~~~ 667 (933)
.+|+..+.||+|+||.||+|++. +++.||||++........+.+.+|+.+++++. ||||+++++++. ...
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 47899999999999999999975 57899999997766666778999999999996 999999999984 334
Q ss_pred ccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--eeeccCCCCceEeCCCCCeEEeecc
Q 002349 668 GNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPR--IIHRDVKSSNILLDKDFEAHLTDFG 745 (933)
Q Consensus 668 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dikp~NIll~~~~~~kl~DfG 745 (933)
..++||||++ |+|.+++........+++..++.++.|++.||+|||++ + |+||||||+||+++.++.+||+|||
T Consensus 108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 108 EFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred eEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecCc
Confidence 4789999996 69999885433456799999999999999999999965 7 9999999999999999999999999
Q ss_pred cccccccCCCce-----------eeeecccccccCcccc---ccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHH
Q 002349 746 IAKSLCVSKSYT-----------STYIMGTIGYIDPEYA---RTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLI 811 (933)
Q Consensus 746 la~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~ 811 (933)
+++......... .....||+.|+|||++ .+..++.++|||||||++|+|++|+.||..........
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~ 263 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVN 263 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhc
Confidence 998764322211 1134689999999998 56678999999999999999999999997543321111
Q ss_pred HhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCC
Q 002349 812 LSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVP 871 (933)
Q Consensus 812 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 871 (933)
.... ..... ..+..+.+++.+||+.||++|||++|+++.|+.+..
T Consensus 264 ------~~~~----~~~~~-----~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 264 ------GKYS----IPPHD-----TQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp --------CC----CCTTC-----CSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------Cccc----CCccc-----ccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0000 00000 112347789999999999999999999999987754
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=346.67 Aligned_cols=258 Identities=24% Similarity=0.372 Sum_probs=205.2
Q ss_pred hccCcceeeecccceeEEEEEEc-CCce--EEEEEecccC-chhHHHHHHHHHHHhcC-CCCceeeeeeEEecCCccEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKP--VAIKRLYSHY-PQCLKEFETELETVGSI-KHRNLVSLQGYSLSSSGNLLF 672 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~--vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 672 (933)
++|+..+.||+|+||.||+|++. +++. ||+|++.... ....+.+.+|+++++++ +||||+++++++...+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57899999999999999999965 4554 4999886532 33456789999999999 899999999999999999999
Q ss_pred EEecCCCCHHHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCe
Q 002349 673 YDFMENGSLWDILHGPT-------------KKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEA 739 (933)
Q Consensus 673 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~ 739 (933)
|||+++|+|.+++.... ....+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence 99999999999996421 234799999999999999999999966 99999999999999999999
Q ss_pred EEeecccccccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhccc
Q 002349 740 HLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANN 818 (933)
Q Consensus 740 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 818 (933)
||+|||+++..... .......+++.|+|||++.+..++.++||||+|+++|||++ |+.||.+........... ..
T Consensus 182 kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~--~~ 257 (327)
T 1fvr_A 182 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP--QG 257 (327)
T ss_dssp EECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG--GT
T ss_pred EEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh--cC
Confidence 99999999753221 12233457889999999999889999999999999999998 999998654433222111 11
Q ss_pred ccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCCC
Q 002349 819 AVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPA 872 (933)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 872 (933)
....... ..+..+.+++.+|++.||++|||++|+++.|+.+...
T Consensus 258 -----~~~~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 258 -----YRLEKPL-----NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp -----CCCCCCT-----TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -----CCCCCCC-----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 1111111 1235788999999999999999999999999876543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=340.61 Aligned_cols=251 Identities=25% Similarity=0.381 Sum_probs=198.2
Q ss_pred hhccCcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecC-CccEEEEEe
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSS-SGNLLFYDF 675 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~ 675 (933)
.++|+..+.||+|+||.||+|.++ ++.||||++.... ..+.+.+|++++++++||||+++++++... +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 368999999999999999999875 6899999987543 457789999999999999999999997654 478999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS 755 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 755 (933)
+++++|.+++.. .....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 97 ~~~~~L~~~l~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 170 (278)
T 1byg_A 97 MAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 170 (278)
T ss_dssp CTTEEHHHHHHH-HHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCCHHHHHHh-cccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence 999999999952 1122388999999999999999999966 9999999999999999999999999999764322
Q ss_pred ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCccccccccC
Q 002349 756 YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKD 834 (933)
Q Consensus 756 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (933)
.....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||............. .. ..+....
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~--~~-----~~~~~~~---- 237 (278)
T 1byg_A 171 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE--KG-----YKMDAPD---- 237 (278)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT--TT-----CCCCCCT----
T ss_pred --ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh--cC-----CCCCCcc----
Confidence 223357889999999999999999999999999999998 999997654332222111 11 1111111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCC
Q 002349 835 LGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLV 870 (933)
Q Consensus 835 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 870 (933)
..+..+.+++.+|++.||++|||+.|+++.|+.+.
T Consensus 238 -~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 238 -GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp -TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -cCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 12467889999999999999999999999987653
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=342.19 Aligned_cols=252 Identities=25% Similarity=0.361 Sum_probs=203.1
Q ss_pred HhhccCcceeeecccceeEEEEEEcC-CceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEE
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYD 674 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 674 (933)
..++|+..+.||+|+||.||+|.+.. ++.||+|++.... ..+.+.+|++++++++||||+++++++...+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 45689999999999999999999764 7899999997643 35778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCC
Q 002349 675 FMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSK 754 (933)
Q Consensus 675 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 754 (933)
|+++++|.+++. .....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 105 ~~~~~~L~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 105 YCGAGSVSDIIR--LRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp CCTTEEHHHHHH--HHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred cCCCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 999999999985 2346799999999999999999999966 99999999999999999999999999998764322
Q ss_pred CceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccC
Q 002349 755 SYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKD 834 (933)
Q Consensus 755 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (933)
.......|++.|+|||.+.+..++.++||||||+++|+|++|+.||................. +.... .
T Consensus 180 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------~~~~~---~ 248 (314)
T 3com_A 180 -AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPP-------PTFRK---P 248 (314)
T ss_dssp -SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-------CCCSS---G
T ss_pred -cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC-------cccCC---c
Confidence 223345799999999999999999999999999999999999999986554433322111110 01100 0
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 835 LGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 835 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
...+..+.+++.+|++.||.+|||+.+++++
T Consensus 249 ~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 249 ELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp GGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1123578899999999999999999999863
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=342.76 Aligned_cols=257 Identities=25% Similarity=0.370 Sum_probs=199.1
Q ss_pred hccCcceeeecccceeEEEEEEcC--Cc--eEEEEEeccc---CchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKN--CK--PVAIKRLYSH---YPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNL 670 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~--~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 670 (933)
++|+..+.||+|+||+||+|.+.. ++ .||||+++.. .....+.+.+|++++++++||||+++++++..+. .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 578999999999999999998642 33 6899988754 2345678899999999999999999999998765 88
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccc
Q 002349 671 LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSL 750 (933)
Q Consensus 671 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~ 750 (933)
+||||+++++|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 97 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeEecccCCCHHHHHHh--ccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccccc
Confidence 99999999999999952 345689999999999999999999976 9999999999999999999999999999876
Q ss_pred ccCCCce--eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCcc
Q 002349 751 CVSKSYT--STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPE 827 (933)
Q Consensus 751 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 827 (933)
....... .....+|..|+|||++.+..++.++||||||+++|+|++ |+.||.................. ..
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~------~~ 245 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER------LP 245 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCC------CC
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCC------CC
Confidence 4333221 233467889999999999889999999999999999999 99999865443332222111110 00
Q ss_pred ccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCC
Q 002349 828 ISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVP 871 (933)
Q Consensus 828 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 871 (933)
.. ...+..+.+++.+|++.||++|||++++++.|+.+.+
T Consensus 246 ~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 246 RP-----EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp CC-----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred CC-----cCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 01 1224678899999999999999999999999987654
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=344.11 Aligned_cols=261 Identities=25% Similarity=0.351 Sum_probs=206.2
Q ss_pred hhccCcceeeecccceeEEEEEEc------CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCcc
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK------NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGN 669 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 669 (933)
.++|...+.||+|+||.||+|.+. +++.||||++.... .....++.+|+.++++++||||+++++++......
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 468999999999999999999843 46789999997543 34566789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCC----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCC---CCCeEEe
Q 002349 670 LLFYDFMENGSLWDILHGPT----KKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDK---DFEAHLT 742 (933)
Q Consensus 670 ~lv~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~---~~~~kl~ 742 (933)
++||||+++++|.+++.... ....+++..++.++.|++.||+|||++ +|+||||||+||+++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEEC
Confidence 99999999999999996422 124589999999999999999999966 9999999999999984 4569999
Q ss_pred ecccccccccCCC-ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhccccc
Q 002349 743 DFGIAKSLCVSKS-YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAV 820 (933)
Q Consensus 743 DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 820 (933)
|||+++....... .......||+.|+|||++.+..++.++||||||+++|+|++ |+.||.............. ...
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~--~~~ 263 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS--GGR 263 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT--TCC
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhc--CCC
Confidence 9999976533222 12233568899999999999999999999999999999998 9999976544332221111 110
Q ss_pred ccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCCC
Q 002349 821 METVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPA 872 (933)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 872 (933)
+.... ..+..+.+++.+||+.||++||+++++++.|+.+...
T Consensus 264 -----~~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 264 -----MDPPK-----NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp -----CCCCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -----CCCCC-----CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 11111 1235788999999999999999999999999876543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=354.63 Aligned_cols=258 Identities=24% Similarity=0.278 Sum_probs=198.2
Q ss_pred hccCcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCc------cEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSG------NLL 671 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------~~l 671 (933)
.+|+..+.||+|+||+||+|++..+..||+|++..... ...+|+++++.++||||+++++++..... .++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 47999999999999999999998877899998865432 22479999999999999999999865433 789
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeC-CCCCeEEeeccccccc
Q 002349 672 FYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLD-KDFEAHLTDFGIAKSL 750 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~-~~~~~kl~DfGla~~~ 750 (933)
||||++++.+....+.......+++..+..++.|++.||+|||++ +|+||||||+||+++ .++.+||+|||+|+..
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 999998754443332112356799999999999999999999966 999999999999999 7899999999999876
Q ss_pred ccCCCceeeeecccccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccc----------
Q 002349 751 CVSKSYTSTYIMGTIGYIDPEYARTS-RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNA---------- 819 (933)
Q Consensus 751 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~---------- 819 (933)
.... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||.+..............+.
T Consensus 193 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 270 (394)
T 4e7w_A 193 IAGE--PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN 270 (394)
T ss_dssp CTTC--CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred cCCC--CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence 3322 22345789999999998765 5899999999999999999999999877655554432221110
Q ss_pred --cccccCcccc-----ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 820 --VMETVDPEIS-----ATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 820 --~~~~~~~~~~-----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
..+...+... ... ....+..+.+++.+||+.||++|||+.|++++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 271 PNYMEHKFPQIRPHPFSKVF-RPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp GGGSSSCCCCCCCCCHHHHS-CTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hhhhhhccccccCCcHHHhc-cccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0000000000 000 01124678999999999999999999999975
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=348.93 Aligned_cols=261 Identities=21% Similarity=0.299 Sum_probs=206.9
Q ss_pred hhccCcceeeecccceeEEEEEEcCCceEEEEEecccCch-----------------hHHHHHHHHHHHhcCCCCceeee
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQ-----------------CLKEFETELETVGSIKHRNLVSL 659 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~E~~~l~~l~h~niv~~ 659 (933)
.++|...+.||+|+||.||+|.+ +++.||||++...... ..+.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 36899999999999999999999 8899999998653211 11789999999999999999999
Q ss_pred eeEEecCCccEEEEEecCCCCHHHH------hcCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeeeccCCCCceE
Q 002349 660 QGYSLSSSGNLLFYDFMENGSLWDI------LHGPTKKKKLDWDTRLKIALGAAQGLAYLHH-DCSPRIIHRDVKSSNIL 732 (933)
Q Consensus 660 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dikp~NIl 732 (933)
++++.+.+..++||||+++++|.++ +.. .....+++..+..++.|++.||+|||+ + +|+||||||+||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEE
Confidence 9999999999999999999999998 532 225789999999999999999999996 5 9999999999999
Q ss_pred eCCCCCeEEeecccccccccCCCceeeeecccccccCccccccC-CCCc-chhhHHHHHHHHHHHhCCCCCCCCcchhHH
Q 002349 733 LDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTS-RLTE-KSDVYSFGIVLLELLTGRKAVDNECNLHHL 810 (933)
Q Consensus 733 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DvwSlGv~l~elltg~~p~~~~~~~~~~ 810 (933)
++.++.+||+|||.+...... ......|++.|+|||++.+. .++. ++||||+|+++|||++|+.||.........
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 261 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred EcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 999999999999999875332 33446799999999999887 6666 999999999999999999999876553332
Q ss_pred HHhhhcc-cccccccCccccc------cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 811 ILSKTAN-NAVMETVDPEISA------TCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 811 ~~~~~~~-~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
....... ............. .......+..+.+++.+||+.||++|||++|++++
T Consensus 262 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 2221111 1111000000000 00001234678999999999999999999999874
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=338.32 Aligned_cols=253 Identities=28% Similarity=0.382 Sum_probs=206.3
Q ss_pred HhhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---------chhHHHHHHHHHHHhcCC-CCceeeeeeEEe
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---------PQCLKEFETELETVGSIK-HRNLVSLQGYSL 664 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~ 664 (933)
..++|+..+.||+|+||.||+|.++ +++.||||++.... ....+.+.+|+++++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3468999999999999999999986 57899999986542 123456789999999995 999999999999
Q ss_pred cCCccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeec
Q 002349 665 SSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDF 744 (933)
Q Consensus 665 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 744 (933)
.....++||||+++++|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred cCCeEEEEEeccCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecc
Confidence 9999999999999999999995 346799999999999999999999976 9999999999999999999999999
Q ss_pred ccccccccCCCceeeeecccccccCccccc------cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccc
Q 002349 745 GIAKSLCVSKSYTSTYIMGTIGYIDPEYAR------TSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANN 818 (933)
Q Consensus 745 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 818 (933)
|++....... ......|++.|+|||++. ...++.++||||||+++|+|++|+.||.................
T Consensus 169 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 246 (298)
T 1phk_A 169 GFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY 246 (298)
T ss_dssp TTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred cchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCc
Confidence 9998764322 233457999999999885 45688999999999999999999999986654433322221111
Q ss_pred ccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 819 AVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
... .+.. ...+..+.+++.+|++.||++|||++|++++
T Consensus 247 ~~~---~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 247 QFG---SPEW------DDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp CCC---TTTG------GGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ccC---cccc------cccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 111 0110 1124578899999999999999999999874
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=360.51 Aligned_cols=242 Identities=16% Similarity=0.180 Sum_probs=188.4
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEeccc---CchhHHHHHHHH---HHHhcCCCCceeeee-------eE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSH---YPQCLKEFETEL---ETVGSIKHRNLVSLQ-------GY 662 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~h~niv~~~-------~~ 662 (933)
.++|...+.||+|+||.||+|.+. +++.||||++... .....+.+.+|+ +.+++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 367888999999999999999964 5899999999743 334567899999 555566899999998 66
Q ss_pred EecCCc-----------------cEEEEEecCCCCHHHHhcCCC----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 002349 663 SLSSSG-----------------NLLFYDFMENGSLWDILHGPT----KKKKLDWDTRLKIALGAAQGLAYLHHDCSPRI 721 (933)
Q Consensus 663 ~~~~~~-----------------~~lv~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 721 (933)
+..++. .++||||+ +|+|.+++.... ....+++..+..++.|++.||+|||++ +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 655432 78999999 679999995311 112344588889999999999999976 99
Q ss_pred eeccCCCCceEeCCCCCeEEeecccccccccCCCceeeeecccccccCccccccC-----------CCCcchhhHHHHHH
Q 002349 722 IHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTS-----------RLTEKSDVYSFGIV 790 (933)
Q Consensus 722 vH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DvwSlGv~ 790 (933)
+||||||+|||++.++.+||+|||+|+.... ......| +.|+|||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999986322 3344567 999999999887 89999999999999
Q ss_pred HHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002349 791 LLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSR 864 (933)
Q Consensus 791 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 864 (933)
+|||++|+.||.+........ ....... ..+..+.+++.+||+.||++|||+.|+++
T Consensus 303 l~elltg~~Pf~~~~~~~~~~-----------~~~~~~~------~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGGSE-----------WIFRSCK------NIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHSSCCC------CCSG-----------GGGSSCC------CCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHCCCCCcccccccchh-----------hhhhhcc------CCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999999997543221110 0000000 12357889999999999999999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=374.40 Aligned_cols=247 Identities=23% Similarity=0.374 Sum_probs=199.0
Q ss_pred eeeecccceeEEEEEEc---CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecCC
Q 002349 604 YIIGYGASSTVYKCVLK---NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMEN 678 (933)
Q Consensus 604 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 678 (933)
+.||+|+||+||+|.+. .++.||||+++... ....+++.+|++++++++|||||++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999754 35789999997643 3346789999999999999999999999964 458899999999
Q ss_pred CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCc--
Q 002349 679 GSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY-- 756 (933)
Q Consensus 679 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~-- 756 (933)
|+|.++++ ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+......
T Consensus 454 g~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 99999995 456799999999999999999999976 9999999999999999999999999999876433321
Q ss_pred eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCccccccccCH
Q 002349 757 TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDL 835 (933)
Q Consensus 757 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (933)
......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+............. . ....+.
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~--~-----~~~~p~----- 595 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG--E-----RMGCPA----- 595 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT--C-----CCCCCT-----
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--C-----CCCCCC-----
Confidence 2233457889999999999999999999999999999998 99999876544332222111 1 111111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccC
Q 002349 836 GAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869 (933)
Q Consensus 836 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 869 (933)
.++..+.+++..||+.||++||++++|++.|+.+
T Consensus 596 ~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 596 GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 2346789999999999999999999999998754
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=349.45 Aligned_cols=251 Identities=16% Similarity=0.164 Sum_probs=202.8
Q ss_pred hhccCcceeeecccceeEEEEE------EcCCceEEEEEecccCchhHHHHHHHHHHHhcCC---CCceeeeeeEEecCC
Q 002349 597 TENLSEKYIIGYGASSTVYKCV------LKNCKPVAIKRLYSHYPQCLKEFETELETVGSIK---HRNLVSLQGYSLSSS 667 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~ 667 (933)
.++|...+.||+|+||+||+|. ...++.||||++.... ..++.+|++++++++ |+||+++++++...+
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 3678999999999999999994 3457899999997643 456778888888886 999999999999999
Q ss_pred ccEEEEEecCCCCHHHHhcCC--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCC----------
Q 002349 668 GNLLFYDFMENGSLWDILHGP--TKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDK---------- 735 (933)
Q Consensus 668 ~~~lv~e~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~---------- 735 (933)
..++||||+++|+|.++++.. .....+++..+..++.|++.||+|||++ +|+||||||+|||++.
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC-----
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcccccc
Confidence 999999999999999999521 1356799999999999999999999965 9999999999999998
Q ss_pred -CCCeEEeeccccccccc-CCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHh
Q 002349 736 -DFEAHLTDFGIAKSLCV-SKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILS 813 (933)
Q Consensus 736 -~~~~kl~DfGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~ 813 (933)
++.+||+|||+|+.+.. .........+||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----- 292 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE----- 292 (365)
T ss_dssp -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-----
T ss_pred ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-----
Confidence 89999999999976532 22333455689999999999999999999999999999999999999996432100
Q ss_pred hhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCC-CCHHHHHHHHccCC
Q 002349 814 KTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDR-PTMHEVSRVLGSLV 870 (933)
Q Consensus 814 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Pt~~evl~~L~~~~ 870 (933)
... ...+... ...+.+.+++..|++.+|.+| |+++++.+.|+...
T Consensus 293 -----~~~---~~~~~~~----~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l 338 (365)
T 3e7e_A 293 -----CKP---EGLFRRL----PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338 (365)
T ss_dssp -----EEE---CSCCTTC----SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred -----eee---chhcccc----CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence 000 0111111 123567788999999999998 67888888777654
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=336.66 Aligned_cols=247 Identities=19% Similarity=0.264 Sum_probs=200.8
Q ss_pred HhhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcC-CCCceeeeeeEEecCCccEE
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSI-KHRNLVSLQGYSLSSSGNLL 671 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 671 (933)
..++|+..+.||+|+||+||+|.+. +++.||+|++.... .....++.+|+..+.++ +||||+++++++.+++..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 4578999999999999999999986 68899999987642 34456788999999999 99999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCC--------------
Q 002349 672 FYDFMENGSLWDILHGPT-KKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKD-------------- 736 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~-------------- 736 (933)
||||+++++|.+++.... ....+++..+..++.|++.||+|||++ +|+||||||+||+++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 999999999999995311 125689999999999999999999976 99999999999999844
Q ss_pred -----CCeEEeecccccccccCCCceeeeecccccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHH
Q 002349 737 -----FEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTS-RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHL 810 (933)
Q Consensus 737 -----~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~ 810 (933)
..+||+|||.++...... ...||+.|+|||.+.+. .+++++|||||||++|+|++|..++.........
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~ 240 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEI 240 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHHHH
T ss_pred ccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHHHH
Confidence 479999999998764322 23589999999999876 5678999999999999999999877654322221
Q ss_pred HHhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 811 ILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 811 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
. ... .+.++.. .+..+.+++.+|++.||++|||++|++++
T Consensus 241 ~-----~~~-----~~~~~~~-----~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 241 R-----QGR-----LPRIPQV-----LSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp H-----TTC-----CCCCSSC-----CCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred H-----cCC-----CCCCCcc-----cCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 1 111 1111111 23578899999999999999999999875
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=351.31 Aligned_cols=258 Identities=25% Similarity=0.285 Sum_probs=188.1
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecC------C
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSS------S 667 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~ 667 (933)
.++|+..+.||+|+||.||+|.+. +++.||||++.... ....+++.+|++++++++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 468999999999999999999965 57899999996542 33456788999999999999999999998754 5
Q ss_pred ccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccc
Q 002349 668 GNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIA 747 (933)
Q Consensus 668 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla 747 (933)
..++||||+ +++|.+++. ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecccc
Confidence 579999999 689998884 35799999999999999999999966 9999999999999999999999999999
Q ss_pred cccccCCCceeeeecccccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCc
Q 002349 748 KSLCVSKSYTSTYIMGTIGYIDPEYART-SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDP 826 (933)
Q Consensus 748 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 826 (933)
+..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+......+.......+........
T Consensus 180 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~ 255 (367)
T 2fst_X 180 RHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 255 (367)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred cccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 865321 234579999999999887 678999999999999999999999998776655443332211111000000
Q ss_pred ccc------------c-cccCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 827 EIS------------A-TCKDL-----GAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 827 ~~~------------~-~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
.+. . ..... .....+.+++.+|++.||++|||++|++++-
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp 313 (367)
T 2fst_X 256 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 313 (367)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcCh
Confidence 000 0 00000 1135688999999999999999999999753
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=359.57 Aligned_cols=259 Identities=19% Similarity=0.256 Sum_probs=204.0
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCCC-CceeeeeeEEecCCccEEEEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIKH-RNLVSLQGYSLSSSGNLLFYD 674 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e 674 (933)
.++|+..++||+|+||.||+|.+. +++.||||++..... ..++.+|+++++.++| ++|..+..++...+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 368999999999999999999974 588999998765432 2457889999999976 566666777777888899999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEe---CCCCCeEEeecccccccc
Q 002349 675 FMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILL---DKDFEAHLTDFGIAKSLC 751 (933)
Q Consensus 675 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll---~~~~~~kl~DfGla~~~~ 751 (933)
|+ +++|.+++.. ....+++..++.++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||+++.+.
T Consensus 84 ~~-g~sL~~ll~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 9999999962 346799999999999999999999976 99999999999999 688999999999998765
Q ss_pred cCCCc------eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHH-hhhccccccccc
Q 002349 752 VSKSY------TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLIL-SKTANNAVMETV 824 (933)
Q Consensus 752 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~-~~~~~~~~~~~~ 824 (933)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+......... ............
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence 43321 12256799999999999999999999999999999999999999986433211111 111111110000
Q ss_pred CccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccC
Q 002349 825 DPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869 (933)
Q Consensus 825 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 869 (933)
..+.. ..+.++.+++..||+.||++||++++|++.|+.+
T Consensus 238 -~~l~~-----~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 238 -EALCR-----GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp -HHHHT-----TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred -HHHhc-----CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 00101 1246789999999999999999999999988665
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=374.68 Aligned_cols=250 Identities=20% Similarity=0.241 Sum_probs=207.9
Q ss_pred HhhccCcceeeecccceeEEEEEEcC-CceEEEEEecccC---chhHHHHHHHHHHHhcC-CCCceeeeeeEEecCCccE
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHY---PQCLKEFETELETVGSI-KHRNLVSLQGYSLSSSGNL 670 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 670 (933)
..++|+..+.||+|+||.||+|+++. ++.||||+++... ....+.+..|..++..+ +||+|+++++++.+.+..|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 45789999999999999999999764 7789999997532 33456788899999988 7999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccc
Q 002349 671 LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSL 750 (933)
Q Consensus 671 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~ 750 (933)
+||||+++|+|.++++ ..+.+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+..
T Consensus 419 lV~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQ---QVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 9999999999999995 346799999999999999999999966 9999999999999999999999999999864
Q ss_pred ccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccc
Q 002349 751 CVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISA 830 (933)
Q Consensus 751 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (933)
... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+................+. .
T Consensus 493 ~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p--------~ 563 (674)
T 3pfq_A 493 IWD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP--------K 563 (674)
T ss_dssp CCT-TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCC--------T
T ss_pred ccC-CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCC--------c
Confidence 322 2234456899999999999999999999999999999999999999987655444433322211111 1
Q ss_pred cccCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 002349 831 TCKDLGAVKKVFQLALLCSKRQPTDRPTM-----HEVSRV 865 (933)
Q Consensus 831 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~~ 865 (933)
..+.++.+++.+||+.||++||++ +||.++
T Consensus 564 -----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 564 -----SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp -----TSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred -----cCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 123578899999999999999997 777653
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=341.81 Aligned_cols=261 Identities=29% Similarity=0.413 Sum_probs=189.3
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYD 674 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 674 (933)
.++|+..+.||+|+||.||+|.+. +++.||||++.... ....+++.+|++++++++||||+++++++...+..++|||
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 93 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK 93 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence 468999999999999999999965 57899999986543 3345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcC-----CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccc
Q 002349 675 FMENGSLWDILHG-----PTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKS 749 (933)
Q Consensus 675 ~~~~gsL~~~l~~-----~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 749 (933)
|+++++|.+++.. ......+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 170 (303)
T 2vwi_A 94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAF 170 (303)
T ss_dssp CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence 9999999999852 11345699999999999999999999976 999999999999999999999999999976
Q ss_pred cccCCC----ceeeeecccccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccc-
Q 002349 750 LCVSKS----YTSTYIMGTIGYIDPEYART-SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMET- 823 (933)
Q Consensus 750 ~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~- 823 (933)
...... .......||+.|+|||++.+ ..++.++||||+|+++|+|++|+.||......................
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 250 (303)
T 2vwi_A 171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETG 250 (303)
T ss_dssp CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-
T ss_pred eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccc
Confidence 543211 11234579999999999876 568999999999999999999999998655444332221111110000
Q ss_pred -cCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 824 -VDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 824 -~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.++.... ..+..+.+++.+||+.||++|||+++++++
T Consensus 251 ~~~~~~~~-----~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 251 VQDKEMLK-----KYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp ----CCCC-----CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cccchhhh-----hhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0011111 123578899999999999999999999875
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=341.25 Aligned_cols=253 Identities=26% Similarity=0.351 Sum_probs=197.8
Q ss_pred HhhccCcceeeecccceeEEEEEEcC-CceEEEEEecccC--------chhHHHHHHHHHHHhcCCCCceeeeeeEEecC
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHY--------PQCLKEFETELETVGSIKHRNLVSLQGYSLSS 666 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 666 (933)
..++|...+.||+|+||.||+|.+.. ++.||||++.... ......+.+|++++++++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 45789999999999999999999764 7899999986532 12234588999999999999999999998765
Q ss_pred CccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCC---eEEee
Q 002349 667 SGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFE---AHLTD 743 (933)
Q Consensus 667 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~---~kl~D 743 (933)
. .++||||+++++|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEcc
Confidence 5 899999999999999994 456799999999999999999999976 9999999999999987654 99999
Q ss_pred cccccccccCCCceeeeecccccccCccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccccc
Q 002349 744 FGIAKSLCVSKSYTSTYIMGTIGYIDPEYAR---TSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAV 820 (933)
Q Consensus 744 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 820 (933)
||+++..... .......||+.|+|||++. +..++.++|||||||++|+|++|+.||............... ...
T Consensus 161 fg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~ 237 (322)
T 2ycf_A 161 FGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS-GKY 237 (322)
T ss_dssp CTTCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHH-TCC
T ss_pred Cccceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHh-Ccc
Confidence 9999875322 2223456999999999874 467899999999999999999999999754332221111110 000
Q ss_pred ccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 821 METVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
...+.... ..+..+.+++.+|++.||++|||+++++++
T Consensus 238 --~~~~~~~~-----~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 238 --NFIPEVWA-----EVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp --CCCHHHHT-----TSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred --ccCchhhh-----hcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 00111111 123578899999999999999999999863
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=351.42 Aligned_cols=374 Identities=17% Similarity=0.170 Sum_probs=228.2
Q ss_pred cCCCCCCCCCCCC-CccceEecCCCCcEEEEEcCCCCcCcccCCCCCCCCCccEEEccCCcccccCCC-CccCCCCCcee
Q 002349 44 LYDWTDSPSSDYC-VWRGITCDNVTFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPD-EIGDCSSLKSL 121 (933)
Q Consensus 44 l~~w~~~~~~~~c-~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~-~l~~l~~L~~L 121 (933)
+++|... .+|| .|.+..|.-...++ ............-..++++++|++++|.++. +|. .|.++++|++|
T Consensus 3 ~~~~~~~--~~C~~~~~~~~c~~~~~~i-----~~~~~~~~~~~~~~~l~~l~~l~l~~~~l~~-l~~~~~~~l~~L~~L 74 (390)
T 3o6n_A 3 VKPRQPE--YKCIDSNLQYDCVFYDVHI-----DMQTQDVYFGFEDITLNNQKIVTFKNSTMRK-LPAALLDSFRQVELL 74 (390)
T ss_dssp ----CCE--ECBCC------EEEESCEE-----CSSCCCCEESCSSGGGCCCSEEEEESCEESE-ECTHHHHHCCCCSEE
T ss_pred cCCCCCc--cceehhhhhhccceeeeee-----ecccccccccccccccCCceEEEecCCchhh-CChhHhcccccCcEE
Confidence 5778643 4555 46666553222121 2212222222233456788889998888884 554 46888888888
Q ss_pred cccccccCCCCCcccccccchhhhhhcccCccCCCCcccccCCCCceeeeecCCCCCCcccccccCCCCcEEeccCcccc
Q 002349 122 DLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLT 201 (933)
Q Consensus 122 ~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~ 201 (933)
+|++|.+++..|..|..+++|++|+|++|.+++..|..|+++++|++|+|++|+++...+..|.++++|++|++++|.++
T Consensus 75 ~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~ 154 (390)
T 3o6n_A 75 NLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE 154 (390)
T ss_dssp ECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred ECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccC
Confidence 88888888666677888888888888888888777777888888888888888887444444567777777777777777
Q ss_pred CccCcCCcCCCCCcEEccccccccCcCCCCccccccceEeccccccccccCccccccccccEEeccCCcCcCCCCCCCCC
Q 002349 202 GSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGN 281 (933)
Q Consensus 202 ~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 281 (933)
+..|..+.++++|++|++++|++++. .++.+++|+.|++++|.+++
T Consensus 155 ~~~~~~~~~l~~L~~L~l~~n~l~~~--------------------------~~~~l~~L~~L~l~~n~l~~-------- 200 (390)
T 3o6n_A 155 RIEDDTFQATTSLQNLQLSSNRLTHV--------------------------DLSLIPSLFHANVSYNLLST-------- 200 (390)
T ss_dssp BCCTTTTSSCTTCCEEECCSSCCSBC--------------------------CGGGCTTCSEEECCSSCCSE--------
T ss_pred ccChhhccCCCCCCEEECCCCcCCcc--------------------------ccccccccceeecccccccc--------
Confidence 66666667777777777666665521 02233445555555554432
Q ss_pred CCCccEEEeeCCccCCCCCCccccCCcceEeeeccccccccCCccccccccccccccccccCCCCCCCCcccCCCCCcee
Q 002349 282 LSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLN 361 (933)
Q Consensus 282 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 361 (933)
+...++|+.|++++|.++.. |.. .. ++|+.|+
T Consensus 201 ---------------------~~~~~~L~~L~l~~n~l~~~-~~~--~~------------------------~~L~~L~ 232 (390)
T 3o6n_A 201 ---------------------LAIPIAVEELDASHNSINVV-RGP--VN------------------------VELTILK 232 (390)
T ss_dssp ---------------------EECCSSCSEEECCSSCCCEE-ECC--CC------------------------SSCCEEE
T ss_pred ---------------------cCCCCcceEEECCCCeeeec-ccc--cc------------------------ccccEEE
Confidence 11123455555555555422 111 11 2344444
Q ss_pred ccCcccCCCCCcccccccccceecCCcccccCCCccccccccccceeeccCCccCCCCCCCCCCccccccccccCccccc
Q 002349 362 VHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTG 441 (933)
Q Consensus 362 l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 441 (933)
+++|++++. ..+..+++|++|++++|.+++..|..+..+++|+.|+|++|++++ +|..+..+++|+.|+|++|+++
T Consensus 233 l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~- 308 (390)
T 3o6n_A 233 LQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL- 308 (390)
T ss_dssp CCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-
T ss_pred CCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-
Confidence 444444432 345555566666666666665556666666666666666666663 4555667777888888888877
Q ss_pred ccccccccccccceEEccCCccccccchhhccccccceeeecCCCCcCcccchhhccccc-eeecCCCCCCCccc
Q 002349 442 FIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDVMSLINCLSLS-VLFIGNPGLCGYWL 515 (933)
Q Consensus 442 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~-~~~~~N~~~C~~~l 515 (933)
.+|..+..+++|++|+|++|++++. | +..+++|+.|++++|+|+|..... -+..+. ..+.+++..|.++.
T Consensus 309 ~~~~~~~~l~~L~~L~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~~~~~~-~~~~~~~~~~~~~~~~c~~~~ 379 (390)
T 3o6n_A 309 HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSLRA-LFRNVARPAVDDADQHCKIDY 379 (390)
T ss_dssp CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHHHH-HTTTCCTTTBCCCCSCCCTTC
T ss_pred ecCccccccCcCCEEECCCCcccee-C--chhhccCCEEEcCCCCccchhHHH-HHHHHHhhcccccCceecccc
Confidence 4566677888888888888888754 3 667788888888888888754321 112222 45677888888654
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=348.09 Aligned_cols=270 Identities=20% Similarity=0.216 Sum_probs=194.7
Q ss_pred HHHHHHhhccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCc-
Q 002349 591 EDIMRMTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSG- 668 (933)
Q Consensus 591 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~- 668 (933)
+......++|+..+.||+|+||.||+|.+. +++.||||++.... .....+.+|++.++.++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 556777899999999999999999999986 57899999986543 234456778888999999999999999865433
Q ss_pred ------cEEEEEecCCCCHHHHhc-CCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCC-CCCeE
Q 002349 669 ------NLLFYDFMENGSLWDILH-GPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDK-DFEAH 740 (933)
Q Consensus 669 ------~~lv~e~~~~gsL~~~l~-~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~-~~~~k 740 (933)
.++||||++++ |.+.+. .......+++..+..++.|++.||.|||.+ +.+|+||||||+||+++. ++.+|
T Consensus 95 ~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp CTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTTEEE
T ss_pred cccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCCcEE
Confidence 78999999874 444332 113456789999999999999999999933 349999999999999997 89999
Q ss_pred EeecccccccccCCCceeeeecccccccCccccccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccc
Q 002349 741 LTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSR-LTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNA 819 (933)
Q Consensus 741 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 819 (933)
|+|||+++...... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+................
T Consensus 173 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 250 (360)
T 3e3p_A 173 LCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGC 250 (360)
T ss_dssp ECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred EeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCC
Confidence 99999998764322 223457899999999987654 899999999999999999999999876655444332211111
Q ss_pred ccc----ccCcc-------------cccc--ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 820 VME----TVDPE-------------ISAT--CKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 820 ~~~----~~~~~-------------~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
... ...+. .... ......+..+.+++.+||+.||++|||++|++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 251 PSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp CCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000 00000 0000 0011135689999999999999999999999975
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=355.83 Aligned_cols=260 Identities=20% Similarity=0.233 Sum_probs=203.5
Q ss_pred hhccCcceeeecccceeEEEEEEcC-CceEEEEEecccCchhHHHHHHHHHHHhcC------CCCceeeeeeEEecCCcc
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHYPQCLKEFETELETVGSI------KHRNLVSLQGYSLSSSGN 669 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~~~~~~~ 669 (933)
..+|+..+.||+|+||+||+|.+.. ++.||||++... ....+.+.+|+++++.+ +|+||+++++++......
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 3579999999999999999999764 789999999754 23346677888888877 577999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCC--eEEeecccc
Q 002349 670 LLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFE--AHLTDFGIA 747 (933)
Q Consensus 670 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~--~kl~DfGla 747 (933)
++||||+. ++|.+++.. .....+++..+..++.|++.||+|||++ +|+||||||+|||++.++. +||+|||+|
T Consensus 175 ~lv~e~~~-~~L~~~l~~-~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKK-NKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEECCCC-CBHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEeccC-CCHHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 99999996 689998864 2334599999999999999999999976 9999999999999999987 999999999
Q ss_pred cccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccccccccc---
Q 002349 748 KSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETV--- 824 (933)
Q Consensus 748 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--- 824 (933)
+..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+..............+.....+
T Consensus 250 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~ 325 (429)
T 3kvw_A 250 CYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDA 325 (429)
T ss_dssp EETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred eecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHh
Confidence 764322 2335799999999999999999999999999999999999999987665544432221110000000
Q ss_pred --------C----c-----------------------ccc--ccccCH------HHHHHHHHHHHHccCCCCCCCCCHHH
Q 002349 825 --------D----P-----------------------EIS--ATCKDL------GAVKKVFQLALLCSKRQPTDRPTMHE 861 (933)
Q Consensus 825 --------~----~-----------------------~~~--~~~~~~------~~~~~l~~li~~cl~~dP~~RPt~~e 861 (933)
+ + ... ...... .....+.+++.+||+.||++|||++|
T Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e 405 (429)
T 3kvw_A 326 SKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQ 405 (429)
T ss_dssp BTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred hhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHH
Confidence 0 0 000 000000 01356889999999999999999999
Q ss_pred HHHHH
Q 002349 862 VSRVL 866 (933)
Q Consensus 862 vl~~L 866 (933)
++++-
T Consensus 406 ~L~Hp 410 (429)
T 3kvw_A 406 ALRHP 410 (429)
T ss_dssp HHTST
T ss_pred HhCCh
Confidence 99854
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=337.08 Aligned_cols=254 Identities=22% Similarity=0.287 Sum_probs=188.2
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccCc--hhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYP--QCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
.++|+..+.||+|+||+||+|.+. +++.||||++..... ...+.+.++...++.++||||+++++++..++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 468999999999999999999975 678999999976532 22334455666688889999999999999999999999
Q ss_pred EecCCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccccc
Q 002349 674 DFMENGSLWDILHGP-TKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV 752 (933)
Q Consensus 674 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 752 (933)
||+++ +|.+++... .....+++..+..++.|++.||+|||++ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 99974 887776421 2356799999999999999999999952 2899999999999999999999999999987543
Q ss_pred CCCceeeeecccccccCcccc----ccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccc
Q 002349 753 SKSYTSTYIMGTIGYIDPEYA----RTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEI 828 (933)
Q Consensus 753 ~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 828 (933)
. .......||+.|+|||++ .+..++.++||||+|+++|+|++|+.||.................. +..
T Consensus 163 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------~~~ 234 (290)
T 3fme_A 163 D--VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS------PQL 234 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCC------CCC
T ss_pred c--ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCC------CCc
Confidence 2 222334799999999996 5567899999999999999999999999853332222221111111 111
Q ss_pred cccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 829 SATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 829 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
. ....+..+.+++.+|++.||++|||++|++++
T Consensus 235 ~----~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 235 P----ADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp C----TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred c----cccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 1 01123578899999999999999999999873
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=350.26 Aligned_cols=266 Identities=22% Similarity=0.280 Sum_probs=185.0
Q ss_pred hhccCc-ceeeecccceeEEEEEEc---CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEe--cCCccE
Q 002349 597 TENLSE-KYIIGYGASSTVYKCVLK---NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSL--SSSGNL 670 (933)
Q Consensus 597 ~~~~~~-~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~ 670 (933)
.+.|.. +++||+|+||+||+|+++ .++.||||++.... ....+.+|++++++++||||+++++++. .....+
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 345665 458999999999999976 46889999997543 2357889999999999999999999995 467789
Q ss_pred EEEEecCCCCHHHHhcCC------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEe----CCCCCeE
Q 002349 671 LFYDFMENGSLWDILHGP------TKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILL----DKDFEAH 740 (933)
Q Consensus 671 lv~e~~~~gsL~~~l~~~------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll----~~~~~~k 740 (933)
+||||+++ +|.+++... .....+++..+..++.|++.||+|||++ +|+||||||+|||+ +.++.+|
T Consensus 97 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 97 LLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEE
Confidence 99999974 788777411 1233599999999999999999999966 99999999999999 6779999
Q ss_pred EeecccccccccCCC--ceeeeecccccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcch---------h
Q 002349 741 LTDFGIAKSLCVSKS--YTSTYIMGTIGYIDPEYARTS-RLTEKSDVYSFGIVLLELLTGRKAVDNECNL---------H 808 (933)
Q Consensus 741 l~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~p~~~~~~~---------~ 808 (933)
|+|||+|+....... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.... .
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 252 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence 999999987643211 223446799999999999874 5899999999999999999999999754321 1
Q ss_pred HHHHhhhcccccccccCcccccc-----------------cc--------CHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 002349 809 HLILSKTANNAVMETVDPEISAT-----------------CK--------DLGAVKKVFQLALLCSKRQPTDRPTMHEVS 863 (933)
Q Consensus 809 ~~~~~~~~~~~~~~~~~~~~~~~-----------------~~--------~~~~~~~l~~li~~cl~~dP~~RPt~~evl 863 (933)
.+.......+.......+.+... .. .......+.+++.+||+.||++|||++|++
T Consensus 253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L 332 (405)
T 3rgf_A 253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 332 (405)
T ss_dssp HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 11111110000000000000000 00 000134678999999999999999999999
Q ss_pred HHHcc
Q 002349 864 RVLGS 868 (933)
Q Consensus 864 ~~L~~ 868 (933)
++-.-
T Consensus 333 ~hp~f 337 (405)
T 3rgf_A 333 QDPYF 337 (405)
T ss_dssp TSGGG
T ss_pred cChhh
Confidence 86543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=346.39 Aligned_cols=260 Identities=22% Similarity=0.271 Sum_probs=204.1
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecC-----Ccc
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSS-----SGN 669 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~ 669 (933)
.++|+..+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|++++++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 458999999999999999999976 57889999997543 33457789999999999999999999999765 357
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccc
Q 002349 670 LLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKS 749 (933)
Q Consensus 670 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 749 (933)
++||||++ |+|.+++. ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 106 ~iv~e~~~-~~L~~~l~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLK----TQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCS-EEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccC-cCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 99999997 59999985 34699999999999999999999966 999999999999999999999999999987
Q ss_pred cccCCCce--eeeecccccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccc---
Q 002349 750 LCVSKSYT--STYIMGTIGYIDPEYART-SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMET--- 823 (933)
Q Consensus 750 ~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 823 (933)
........ .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+..............+.....
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 257 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 257 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 64332221 234579999999998754 558999999999999999999999998766555443322111110000
Q ss_pred -------------cC----ccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 824 -------------VD----PEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 824 -------------~~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
.. ....... ......+.+++.+|++.||++|||++|++++-
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 315 (364)
T 3qyz_A 258 CIINLKARNYLLSLPHKNKVPWNRLF--PNADSKALDLLDKMLTFNPHKRIEVEQALAHP 315 (364)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHC--TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred HhhhhhHHHHHHhcCCccCCCHHHhC--CCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 00 0000000 01235788999999999999999999999753
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=341.11 Aligned_cols=260 Identities=22% Similarity=0.317 Sum_probs=196.9
Q ss_pred hccCcceeeecccceeEEEEEEcC-CceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEe------------
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSL------------ 664 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~------------ 664 (933)
++|...+.||+|+||.||+|.+.. ++.||+|++........+.+.+|++++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 578999999999999999999875 7899999998776667788999999999999999999999874
Q ss_pred --cCCccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeC-CCCCeEE
Q 002349 665 --SSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLD-KDFEAHL 741 (933)
Q Consensus 665 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~-~~~~~kl 741 (933)
.....++||||++ |+|.+++. .+++++..+..++.|++.||+|||++ +|+||||||+||+++ .++.+||
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEE
T ss_pred ccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEE
Confidence 3456799999997 59999984 35689999999999999999999976 999999999999997 5679999
Q ss_pred eecccccccccCCC--ceeeeecccccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccc
Q 002349 742 TDFGIAKSLCVSKS--YTSTYIMGTIGYIDPEYART-SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANN 818 (933)
Q Consensus 742 ~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~ 818 (933)
+|||+++....... .......+|..|+|||.+.+ ..++.++||||||+++|||++|+.||.+...............
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 242 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSC
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 99999987532211 11233467899999998865 6789999999999999999999999987665444332211111
Q ss_pred ccccc--------cC----ccccccccC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 819 AVMET--------VD----PEISATCKD-----LGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 819 ~~~~~--------~~----~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
..... .. ......... ...+..+.+++.+|++.||++|||++|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp CCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 00000 00 000000000 0124678999999999999999999999874
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=350.28 Aligned_cols=262 Identities=21% Similarity=0.251 Sum_probs=198.5
Q ss_pred HHHhhccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecC------
Q 002349 594 MRMTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSS------ 666 (933)
Q Consensus 594 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------ 666 (933)
....++|+..+.||+|+||+||+|.+. +++.||||++..... ...+|+++++.++|||||++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 345678999999999999999999974 588999999865432 234799999999999999999998443
Q ss_pred --------------------------------CccEEEEEecCCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHh
Q 002349 667 --------------------------------SGNLLFYDFMENGSLWDILHGP-TKKKKLDWDTRLKIALGAAQGLAYL 713 (933)
Q Consensus 667 --------------------------------~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~L 713 (933)
...++||||+++ +|.+.+... .....+++..+..++.|+++||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 337899999984 777766421 2356799999999999999999999
Q ss_pred hcCCCCCeeeccCCCCceEeC-CCCCeEEeecccccccccCCCceeeeecccccccCccccccC-CCCcchhhHHHHHHH
Q 002349 714 HHDCSPRIIHRDVKSSNILLD-KDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTS-RLTEKSDVYSFGIVL 791 (933)
Q Consensus 714 H~~~~~~ivH~Dikp~NIll~-~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l 791 (933)
|++ +|+||||||+||+++ .++.+||+|||+|+...... ......||+.|+|||++.+. .++.++||||+||++
T Consensus 158 H~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 158 HSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 955 999999999999998 68899999999998764322 23345789999999998875 489999999999999
Q ss_pred HHHHhCCCCCCCCcchhHHHHhhhccccc------------ccccCccccccc----cCHHHHHHHHHHHHHccCCCCCC
Q 002349 792 LELLTGRKAVDNECNLHHLILSKTANNAV------------METVDPEISATC----KDLGAVKKVFQLALLCSKRQPTD 855 (933)
Q Consensus 792 ~elltg~~p~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~ 855 (933)
|||++|+.||.+......+.......+.. .+...+...... .....+..+.+++.+||+.||++
T Consensus 233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 99999999999776665554332211110 000000000000 00112457889999999999999
Q ss_pred CCCHHHHHHH
Q 002349 856 RPTMHEVSRV 865 (933)
Q Consensus 856 RPt~~evl~~ 865 (933)
|||+.|++++
T Consensus 313 R~t~~e~l~h 322 (383)
T 3eb0_A 313 RINPYEAMAH 322 (383)
T ss_dssp SCCHHHHHTS
T ss_pred CCCHHHHhcC
Confidence 9999999863
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=342.23 Aligned_cols=254 Identities=17% Similarity=0.224 Sum_probs=199.3
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCC-CCceeeeeeEEec--CCccEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIK-HRNLVSLQGYSLS--SSGNLLFY 673 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~--~~~~~lv~ 673 (933)
++|+..+.||+|+||+||+|.+. +++.||||++... ..+.+.+|++++++++ ||||+++++++.. ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 68999999999999999999964 5789999998743 3567899999999997 9999999999987 56789999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCC-CeEEeeccccccccc
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDF-EAHLTDFGIAKSLCV 752 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~-~~kl~DfGla~~~~~ 752 (933)
||+++++|.+++. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++ .+||+|||+++....
T Consensus 113 e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp ECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred eccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 9999999999984 388999999999999999999966 999999999999999776 899999999987643
Q ss_pred CCCceeeeecccccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcc-c--ccc-------
Q 002349 753 SKSYTSTYIMGTIGYIDPEYART-SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTAN-N--AVM------- 821 (933)
Q Consensus 753 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~-~--~~~------- 821 (933)
... .....|+..|+|||++.+ ..++.++||||+||++|+|++|+.||................ + ...
T Consensus 184 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 261 (330)
T 3nsz_A 184 GQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 261 (330)
T ss_dssp TCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred CCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence 322 234578999999999887 678999999999999999999999996433322211110000 0 000
Q ss_pred cccCcc---------------ccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 822 ETVDPE---------------ISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 822 ~~~~~~---------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
...++. ..........+..+.+++.+|++.||++|||++|++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000000 00000001124678999999999999999999999975
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=340.96 Aligned_cols=258 Identities=19% Similarity=0.267 Sum_probs=204.4
Q ss_pred hccCcceeeecccceeEEEEEE-c-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCC------ceeeeeeEEecCCcc
Q 002349 598 ENLSEKYIIGYGASSTVYKCVL-K-NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHR------NLVSLQGYSLSSSGN 669 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~~~~~~~~~~~~ 669 (933)
++|+..+.||+|+||+||+|.+ + +++.||||++... ....+.+.+|+++++.++|+ +++++++++...+..
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 5899999999999999999997 3 5788999998654 33456788999999988665 499999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCC--------------
Q 002349 670 LLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDK-------------- 735 (933)
Q Consensus 670 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~-------------- 735 (933)
++||||+ +++|.+++.. ....++++..+..++.|++.||+|||++ +|+||||||+||+++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKE-NGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEECC-CCBHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEEcCC-CCCHHHHHHh-cCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccccc
Confidence 9999999 8899999863 2234689999999999999999999976 9999999999999987
Q ss_pred -----CCCeEEeecccccccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHH
Q 002349 736 -----DFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHL 810 (933)
Q Consensus 736 -----~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~ 810 (933)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||+||++|||++|+.||.........
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 243 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL 243 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH
T ss_pred cccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 678999999999864322 23457999999999999999999999999999999999999999866554433
Q ss_pred HHhhhcccccccc-------------------------------cCccccccccCHHHHHHHHHHHHHccCCCCCCCCCH
Q 002349 811 ILSKTANNAVMET-------------------------------VDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTM 859 (933)
Q Consensus 811 ~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 859 (933)
............. ..+...........+..+.+++.+|++.||++|||+
T Consensus 244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 323 (339)
T 1z57_A 244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL 323 (339)
T ss_dssp HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence 2221111111000 000000011122456789999999999999999999
Q ss_pred HHHHHH
Q 002349 860 HEVSRV 865 (933)
Q Consensus 860 ~evl~~ 865 (933)
+|++++
T Consensus 324 ~ell~h 329 (339)
T 1z57_A 324 REALKH 329 (339)
T ss_dssp HHHTTS
T ss_pred HHHhcC
Confidence 999864
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=371.16 Aligned_cols=256 Identities=24% Similarity=0.343 Sum_probs=205.7
Q ss_pred HhhccCcceeeecccceeEEEEEEcC----CceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccE
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLKN----CKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNL 670 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 670 (933)
..++|+..+.||+|+||.||+|.+.. +..||+|++.... ....+.+.+|+.++++++||||+++++++. ++..+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 35788899999999999999999753 4579999987643 344577999999999999999999999985 45689
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccc
Q 002349 671 LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSL 750 (933)
Q Consensus 671 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~ 750 (933)
+||||+++|+|.++++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 467 lv~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp EEEECCTTCBHHHHHHH--TTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred EEEEcCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 99999999999999963 345689999999999999999999976 9999999999999999999999999999876
Q ss_pred ccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCcccc
Q 002349 751 CVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEIS 829 (933)
Q Consensus 751 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (933)
............+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.............. ....+
T Consensus 542 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~-------~~~~~ 614 (656)
T 2j0j_A 542 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-------RLPMP 614 (656)
T ss_dssp CC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTC-------CCCCC
T ss_pred CCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-------CCCCC
Confidence 5444333444567889999999999999999999999999999997 999998655443332221111 01111
Q ss_pred ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccC
Q 002349 830 ATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869 (933)
Q Consensus 830 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 869 (933)
. ..+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 615 ~-----~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 615 P-----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp T-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred c-----cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1 1245788999999999999999999999998765
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=332.15 Aligned_cols=254 Identities=24% Similarity=0.329 Sum_probs=205.7
Q ss_pred HHHhhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccE
Q 002349 594 MRMTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNL 670 (933)
Q Consensus 594 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 670 (933)
....++|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++...+..+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 345679999999999999999999986 57899999986543 345678999999999999999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCC---CCeEEeecccc
Q 002349 671 LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKD---FEAHLTDFGIA 747 (933)
Q Consensus 671 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~---~~~kl~DfGla 747 (933)
+||||+++++|.+.+. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.+ +.+||+|||++
T Consensus 98 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 98 IVGELYTGGELFDEII---KRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EEECCCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEEccCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 9999999999999884 345789999999999999999999966 99999999999999754 47999999999
Q ss_pred cccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcc
Q 002349 748 KSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPE 827 (933)
Q Consensus 748 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 827 (933)
....... ......||+.|+|||.+.+. ++.++||||+|+++|+|++|+.||.+.................. .+.
T Consensus 172 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~ 245 (287)
T 2wei_A 172 TCFQQNT--KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFD---LPQ 245 (287)
T ss_dssp GTBCCCS--SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC---SGG
T ss_pred eeecCCC--ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC---chh
Confidence 8654322 22334689999999998764 89999999999999999999999987554433222211111100 000
Q ss_pred ccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 828 ISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 828 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
. ...+..+.+++.+|++.||++|||++|++++
T Consensus 246 ~------~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 246 W------RTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp G------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred h------hhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 0 0123578899999999999999999999973
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=342.88 Aligned_cols=255 Identities=22% Similarity=0.273 Sum_probs=200.4
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCcc----
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGN---- 669 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~---- 669 (933)
.++|...+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+.++++++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 458889999999999999999976 57899999997643 33457788999999999999999999999877655
Q ss_pred --EEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccc
Q 002349 670 --LLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIA 747 (933)
Q Consensus 670 --~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla 747 (933)
++||||++ ++|.+.+. ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999997 58988873 3489999999999999999999976 9999999999999999999999999999
Q ss_pred cccccCCCceeeeecccccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccccccccc--
Q 002349 748 KSLCVSKSYTSTYIMGTIGYIDPEYART-SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETV-- 824 (933)
Q Consensus 748 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 824 (933)
+.... ......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+..............+......
T Consensus 192 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 267 (371)
T 4exu_A 192 RHADA----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 267 (371)
T ss_dssp ------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred ccccc----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHH
Confidence 86532 2234578999999999987 6789999999999999999999999987665544433222111110000
Q ss_pred ------------------CccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 825 ------------------DPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 825 ------------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
........ ...+..+.+++.+|++.||++|||++|++++-
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 325 (371)
T 4exu_A 268 KLNDKAAKSYIQSLPQTPRKDFTQLF--PRASPQAADLLEKMLELDVDKRLTAAQALTHP 325 (371)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCHHHHS--TTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred HhhhhhhhhhhhccCCCcchhHHHhc--cccChHHHHHHHHHCCCChhhcCCHHHHhcCc
Confidence 00000000 01246788999999999999999999999753
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=344.92 Aligned_cols=258 Identities=24% Similarity=0.361 Sum_probs=201.5
Q ss_pred hhccCcceeeecccceeEEEEEEcCCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYD 674 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 674 (933)
.++|+..+.||+|+||.||+|.+++ .||+|++.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 109 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence 4688999999999999999999865 59999986542 3334567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCC
Q 002349 675 FMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSK 754 (933)
Q Consensus 675 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 754 (933)
|+++++|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++ ++.+||+|||+++......
T Consensus 110 ~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 110 LCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ 183 (319)
T ss_dssp CCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred cccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence 9999999999963 345789999999999999999999976 999999999999998 6799999999987643211
Q ss_pred ----CceeeeecccccccCcccccc---------CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccc
Q 002349 755 ----SYTSTYIMGTIGYIDPEYART---------SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVM 821 (933)
Q Consensus 755 ----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 821 (933)
........|++.|+|||++.+ ..++.++||||||+++|||++|+.||.............. ..
T Consensus 184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~--~~-- 259 (319)
T 2y4i_B 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGT--GM-- 259 (319)
T ss_dssp ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHT--TC--
T ss_pred ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcc--CC--
Confidence 112233468999999999874 3578999999999999999999999986544333222111 11
Q ss_pred cccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCCCC
Q 002349 822 ETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAP 873 (933)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 873 (933)
.+.... ...+..+.+++.+||+.||++|||++++++.|+.+....
T Consensus 260 ---~~~~~~----~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 260 ---KPNLSQ----IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp ---CCCCCC----SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred ---CCCCCc----CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 111110 011246788999999999999999999999999987654
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=344.98 Aligned_cols=261 Identities=20% Similarity=0.226 Sum_probs=204.0
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCC-CC-----ceeeeeeEEecCCcc
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIK-HR-----NLVSLQGYSLSSSGN 669 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~~~~~~~~~~~~ 669 (933)
.++|+..+.||+|+||+||+|.+. +++.||||++... .....++.+|+++++.++ |+ +|+++++++...+..
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 131 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence 568999999999999999999976 4788999999753 234566788999988884 44 499999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeC--CCCCeEEeecccc
Q 002349 670 LLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLD--KDFEAHLTDFGIA 747 (933)
Q Consensus 670 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~--~~~~~kl~DfGla 747 (933)
++||||++ ++|.+++.. .....+++..+..++.|++.||.|||.+ ..+|+||||||+|||++ .++.+||+|||+|
T Consensus 132 ~lv~e~~~-~~L~~~l~~-~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 132 CLVFEMLS-YNLYDLLRN-TNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EEEEECCC-CBHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEecCC-CCHHHHHhh-cCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 99999996 599999864 2235699999999999999999999954 45999999999999995 4788999999999
Q ss_pred cccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccccccc-----
Q 002349 748 KSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVME----- 822 (933)
Q Consensus 748 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----- 822 (933)
+..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+..............+....
T Consensus 209 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 284 (382)
T 2vx3_A 209 CQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQ 284 (382)
T ss_dssp EETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred eecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 876322 23457999999999999999999999999999999999999999876655444322211110000
Q ss_pred ---------ccC------------------cc-------------------ccccccCHHHHHHHHHHHHHccCCCCCCC
Q 002349 823 ---------TVD------------------PE-------------------ISATCKDLGAVKKVFQLALLCSKRQPTDR 856 (933)
Q Consensus 823 ---------~~~------------------~~-------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~R 856 (933)
.+. +. .........+...+.+++.+||+.||++|
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R 364 (382)
T 2vx3_A 285 APKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTR 364 (382)
T ss_dssp CTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTS
T ss_pred hHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhC
Confidence 000 00 00000112334578999999999999999
Q ss_pred CCHHHHHHH
Q 002349 857 PTMHEVSRV 865 (933)
Q Consensus 857 Pt~~evl~~ 865 (933)
||++|++++
T Consensus 365 pta~e~L~h 373 (382)
T 2vx3_A 365 IQPYYALQH 373 (382)
T ss_dssp CCHHHHTTS
T ss_pred CCHHHHhcC
Confidence 999999875
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=339.63 Aligned_cols=261 Identities=21% Similarity=0.245 Sum_probs=202.5
Q ss_pred HhhccCcceeeecccceeEEEEEEc--CCceEEEEEecccCc--hhHHHHHHHHHHHhcC---CCCceeeeeeEEe----
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLK--NCKPVAIKRLYSHYP--QCLKEFETELETVGSI---KHRNLVSLQGYSL---- 664 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~---- 664 (933)
+.++|+..+.||+|+||.||+|.+. +++.||+|++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4578999999999999999999983 578899999865331 2233566777777666 8999999999987
Q ss_pred -cCCccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEee
Q 002349 665 -SSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTD 743 (933)
Q Consensus 665 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 743 (933)
.....++||||++ |+|.+++.. .....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHh-cccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEec
Confidence 5567899999998 599999864 2234589999999999999999999976 999999999999999999999999
Q ss_pred cccccccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccc----
Q 002349 744 FGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNA---- 819 (933)
Q Consensus 744 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~---- 819 (933)
||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+................
T Consensus 164 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (326)
T 1blx_A 164 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 241 (326)
T ss_dssp CCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred CcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcc
Confidence 99998654222 233457899999999999999999999999999999999999999876655443322211000
Q ss_pred -ccccc-----------CccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 820 -VMETV-----------DPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 820 -~~~~~-----------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
+.... ........ ...+..+.+++.+||+.||++|||++|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 242 DWPRDVALPRQAFHSKSAQPIEKFV--TDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTC--CSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cCccccccchhhhcccCcchhhhcc--ccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000 00000000 1124678899999999999999999999964
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=340.47 Aligned_cols=254 Identities=24% Similarity=0.342 Sum_probs=198.8
Q ss_pred HHhhccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcC-CCCceeeeeeEEec------C
Q 002349 595 RMTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSI-KHRNLVSLQGYSLS------S 666 (933)
Q Consensus 595 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~------~ 666 (933)
...++|+..+.||+|+||.||+|.+. +++.||||++.... ...+.+.+|+++++++ +||||+++++++.. .
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 99 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 99 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCC
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcccc
Confidence 34678999999999999999999975 57899999986543 3457789999999999 89999999999976 4
Q ss_pred CccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccc
Q 002349 667 SGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGI 746 (933)
Q Consensus 667 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl 746 (933)
...++||||+++++|.+++... ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 175 (326)
T 2x7f_A 100 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGV 175 (326)
T ss_dssp CEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcC
Confidence 5789999999999999999632 235789999999999999999999976 999999999999999999999999999
Q ss_pred ccccccCCCceeeeecccccccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccc
Q 002349 747 AKSLCVSKSYTSTYIMGTIGYIDPEYAR-----TSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVM 821 (933)
Q Consensus 747 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 821 (933)
+....... .......||+.|+|||++. +..++.++|||||||++|+|++|+.||.+............. ..
T Consensus 176 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~- 251 (326)
T 2x7f_A 176 SAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN--PA- 251 (326)
T ss_dssp TC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS--CC-
T ss_pred ceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC--cc-
Confidence 98653221 1223457999999999987 567899999999999999999999999865544333221111 10
Q ss_pred cccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 822 ETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
+... ....+..+.+++.+||+.||++|||+++++++
T Consensus 252 ----~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 252 ----PRLK----SKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp ----CCCS----CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ----ccCC----ccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1110 01123578899999999999999999999874
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=355.17 Aligned_cols=258 Identities=26% Similarity=0.299 Sum_probs=195.7
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecC----C--ccE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSS----S--GNL 670 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----~--~~~ 670 (933)
.+|+..+.||+|+||+||+|++. +++.||||++.... +...+|++++++++|||||++++++... + ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46888999999999999999986 48899999986542 2235799999999999999999988542 1 256
Q ss_pred EEEEecCCCCHHHHhcC-CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCC-CCeEEeeccccc
Q 002349 671 LFYDFMENGSLWDILHG-PTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKD-FEAHLTDFGIAK 748 (933)
Q Consensus 671 lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~-~~~kl~DfGla~ 748 (933)
+||||+++ ++.+.+.. ......+++..+..++.|+++||+|||++ +|+||||||+|||++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 89999986 66665531 12356799999999999999999999965 99999999999999965 568999999998
Q ss_pred ccccCCCceeeeecccccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccc--------
Q 002349 749 SLCVSKSYTSTYIMGTIGYIDPEYARTS-RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNA-------- 819 (933)
Q Consensus 749 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~-------- 819 (933)
...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.....++.......+.
T Consensus 206 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~ 283 (420)
T 1j1b_A 206 QLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 283 (420)
T ss_dssp ECCTTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred hcccCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 764322 22345789999999998765 7899999999999999999999999877655544332221110
Q ss_pred ----cccccCccccccc----cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 820 ----VMETVDPEISATC----KDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 820 ----~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
..+...+.+.... .....+..+.+++.+||+.||++|||+.|++++
T Consensus 284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 0000001100000 001124678899999999999999999999874
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=339.50 Aligned_cols=260 Identities=22% Similarity=0.273 Sum_probs=201.9
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecC-----Ccc
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSS-----SGN 669 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~ 669 (933)
.++|+..+.||+|+||.||+|.+. +++.||||++.... ......+.+|++++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 468999999999999999999976 57899999996543 33456788999999999999999999988654 668
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccc
Q 002349 670 LLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKS 749 (933)
Q Consensus 670 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 749 (933)
++||||++ ++|.+++. ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 90 ~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIS----TQMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEECCCS-EEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeccC-ccHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 99999997 58999985 24689999999999999999999966 999999999999999999999999999987
Q ss_pred cccCCCc---------eeeeecccccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccc
Q 002349 750 LCVSKSY---------TSTYIMGTIGYIDPEYART-SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNA 819 (933)
Q Consensus 750 ~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 819 (933)
....... ......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+..............+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence 6432211 1123478999999998765 67899999999999999999999999876544433322111110
Q ss_pred ccc-----------------ccC----ccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 820 VME-----------------TVD----PEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 820 ~~~-----------------~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
... ... ....... ...+..+.+++.+|++.||++|||++|++++-
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 307 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMF--PRVNPKGIDLLQRMLVFDPAKRITAKEALEHP 307 (353)
T ss_dssp CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHS--TTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred CchhccccccccchhhHHhhcccCCCCcchhhhc--ccCCHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence 000 000 0000000 01246788999999999999999999999843
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=366.67 Aligned_cols=335 Identities=18% Similarity=0.197 Sum_probs=228.4
Q ss_pred CCCCccEEEccCCcccccCCCCccCCCCCceecccccccCCCCCcccccccchhhhhhcccCccCCCCcccccCCCCcee
Q 002349 90 DLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVF 169 (933)
Q Consensus 90 ~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L 169 (933)
.+++++.|++++|.+....+..|+++++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..|..|+++++|++|
T Consensus 49 ~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 128 (597)
T 3oja_B 49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 128 (597)
T ss_dssp GGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEE
Confidence 46788889999988885444557888889999999888887777788888888888888888888777778888888888
Q ss_pred eeecCCCCCCcccccccCCCCcEEeccCccccCccCcCCcCCCCCcEEccccccccCcCCCCccccccceEecccccccc
Q 002349 170 GLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTG 249 (933)
Q Consensus 170 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~ 249 (933)
+|++|.+++..+..|.++++|++|+|++|.+++..|..++++++|++|+|++|++++.
T Consensus 129 ~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---------------------- 186 (597)
T 3oja_B 129 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---------------------- 186 (597)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC----------------------
T ss_pred EeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc----------------------
Confidence 8888888755555567777777777777777777777777777777777777766521
Q ss_pred ccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcceEeeeccccccccCCccccc
Q 002349 250 KIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGK 329 (933)
Q Consensus 250 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~ 329 (933)
.++.+++|+.|++++|.+++ +...++|+.|++++|.++...+ .+
T Consensus 187 ----~~~~l~~L~~L~l~~n~l~~-----------------------------l~~~~~L~~L~ls~n~l~~~~~-~~-- 230 (597)
T 3oja_B 187 ----DLSLIPSLFHANVSYNLLST-----------------------------LAIPIAVEELDASHNSINVVRG-PV-- 230 (597)
T ss_dssp ----CGGGCTTCSEEECCSSCCSE-----------------------------EECCTTCSEEECCSSCCCEEEC-SC--
T ss_pred ----ChhhhhhhhhhhcccCcccc-----------------------------ccCCchhheeeccCCccccccc-cc--
Confidence 02233445555555554442 1122345555555555542211 11
Q ss_pred cccccccccccccCCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCCccccccccccceee
Q 002349 330 LTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLD 409 (933)
Q Consensus 330 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 409 (933)
. ++|+.|++++|++++ +..+..+++|++|+|++|.+++..|..|..+++|+.|+
T Consensus 231 ~------------------------~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 284 (597)
T 3oja_B 231 N------------------------VELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLY 284 (597)
T ss_dssp C------------------------SCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEE
T ss_pred C------------------------CCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEE
Confidence 1 234444455554443 24455566666666666666666666666667777777
Q ss_pred ccCCccCCCCCCCCCCccccccccccCcccccccccccccccccceEEccCCccccccchhhccccccceeeecCCCCcC
Q 002349 410 MSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSG 489 (933)
Q Consensus 410 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 489 (933)
|++|.+++ +|..+..+++|+.|+|++|.++ .+|..+..+++|+.|+|++|++++.. +..+++|+.|+|++|+|+|
T Consensus 285 Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~L~~L~l~~N~~~~ 359 (597)
T 3oja_B 285 ISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK---LSTHHTLKNLTLSHNDWDC 359 (597)
T ss_dssp CTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC---CCTTCCCSEEECCSSCEEH
T ss_pred CCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcC---hhhcCCCCEEEeeCCCCCC
Confidence 77777764 4666677788888888888888 56777888888888888888888653 6677888899999999988
Q ss_pred cccchhhccccc-eeecCCCCCCCcc
Q 002349 490 DVMSLINCLSLS-VLFIGNPGLCGYW 514 (933)
Q Consensus 490 ~~~~~~~~~~~~-~~~~~N~~~C~~~ 514 (933)
..... -+..+. ..+.+++..|+.+
T Consensus 360 ~~~~~-~~~~~~~~~~~~~~~~C~~~ 384 (597)
T 3oja_B 360 NSLRA-LFRNVARPAVDDADQHCKID 384 (597)
T ss_dssp HHHHH-HTTTCCTTTBCCCCCCCCTT
T ss_pred hhHHH-HHHHHhhhccccccccCCcc
Confidence 64321 122222 4577888899864
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=349.73 Aligned_cols=252 Identities=11% Similarity=-0.009 Sum_probs=179.8
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccCc---hhHHHHHHHH---HHHhcCCCCceeeee-------eEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYP---QCLKEFETEL---ETVGSIKHRNLVSLQ-------GYS 663 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~---~~l~~l~h~niv~~~-------~~~ 663 (933)
.+|...+.||+|+||+||+|.+. +++.||||++..... ...+.+.+|+ +.++. +||||++++ +++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence 46888999999999999999976 688999999977542 3445677785 45555 799988755 444
Q ss_pred ecC-----------------CccEEEEEecCCCCHHHHhcCCCCCCCCCHHHH------HHHHHHHHHHHHHhhcCCCCC
Q 002349 664 LSS-----------------SGNLLFYDFMENGSLWDILHGPTKKKKLDWDTR------LKIALGAAQGLAYLHHDCSPR 720 (933)
Q Consensus 664 ~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~i~~~l~~LH~~~~~~ 720 (933)
... ...++||||++ |+|.+++.. ....+++..+ ..++.|++.||+|||++ +
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~--~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFST--LDFVYVFRGDEGILALHILTAQLIRLAANLQSK---G 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHH--HHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHH--hccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---C
Confidence 332 23799999998 899999963 1234455556 78889999999999966 9
Q ss_pred eeeccCCCCceEeCCCCCeEEeecccccccccCCCceeeeecccccccCcccccc--CCCCcchhhHHHHHHHHHHHhCC
Q 002349 721 IIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYART--SRLTEKSDVYSFGIVLLELLTGR 798 (933)
Q Consensus 721 ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGv~l~elltg~ 798 (933)
|+||||||+|||++.++.+||+|||+|+.... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999986532 1224467799999999987 67999999999999999999999
Q ss_pred CCCCCCcchhHHHHhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002349 799 KAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSR 864 (933)
Q Consensus 799 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 864 (933)
.||.+............... .........+. ....+..+.+++.+||+.||++|||++++++
T Consensus 291 ~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 291 LPFGLVTPGIKGSWKRPSLR-VPGTDSLAFGS---CTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CSTTBCCTTCTTCCCBCCTT-SCCCCSCCCTT---SSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCcCcccccchhhhhhh-hccccccchhh---ccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 99986532211000000000 00000001110 0122467889999999999999999999975
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=332.59 Aligned_cols=253 Identities=24% Similarity=0.384 Sum_probs=194.3
Q ss_pred HhhccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEec---------
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLS--------- 665 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------- 665 (933)
..++|+..+.||+|+||.||+|++. +++.||||++... ....+.+.+|++++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 4678999999999999999999975 6889999998643 3445778999999999999999999998864
Q ss_pred ----CCccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEE
Q 002349 666 ----SSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHL 741 (933)
Q Consensus 666 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl 741 (933)
....++||||+++|+|.++++. ....+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHH--SCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhc--cccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEE
Confidence 3457899999999999999963 345688999999999999999999976 9999999999999999999999
Q ss_pred eecccccccccCC-------------CceeeeecccccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcch
Q 002349 742 TDFGIAKSLCVSK-------------SYTSTYIMGTIGYIDPEYARTS-RLTEKSDVYSFGIVLLELLTGRKAVDNECNL 807 (933)
Q Consensus 742 ~DfGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~p~~~~~~~ 807 (933)
+|||+++...... ........||+.|+|||++.+. .++.++||||+||++|+|++ ||......
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~ 234 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER 234 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH
Confidence 9999998653221 1122345689999999999865 68999999999999999998 55432222
Q ss_pred hHHHHhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 808 HHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 808 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.......... ....++.... ..+..+.+++.+|++.||++|||+++++++
T Consensus 235 ~~~~~~~~~~---~~~~~~~~~~-----~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 235 VNILKKLRSV---SIEFPPDFDD-----NKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHHHHST---TCCCCTTCCT-----TTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHhcccc---ccccCccccc-----cchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 2211111110 0111111111 224568899999999999999999999985
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=339.32 Aligned_cols=254 Identities=22% Similarity=0.279 Sum_probs=198.8
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCc------
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSG------ 668 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------ 668 (933)
++|...+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+.++++++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 57889999999999999999976 58899999996643 2345678999999999999999999999987654
Q ss_pred cEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccc
Q 002349 669 NLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAK 748 (933)
Q Consensus 669 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 748 (933)
.++||||++ ++|.+++. ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 104 ~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred EEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccccc
Confidence 499999997 58888773 3489999999999999999999976 99999999999999999999999999998
Q ss_pred ccccCCCceeeeecccccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccc------
Q 002349 749 SLCVSKSYTSTYIMGTIGYIDPEYART-SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVM------ 821 (933)
Q Consensus 749 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~------ 821 (933)
..... .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+..............+...
T Consensus 175 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 250 (353)
T 3coi_A 175 HADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 250 (353)
T ss_dssp C------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred CCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 65321 234578999999999887 6789999999999999999999999987655443332211111000
Q ss_pred --------------cccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 822 --------------ETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 822 --------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
....+.+.... ...+..+.+++.+|++.||++|||++|++++-
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp 307 (353)
T 3coi_A 251 LNDKAAKSYIQSLPQTPRKDFTQLF--PRASPQAADLLEKMLELDVDKRLTAAQALTHP 307 (353)
T ss_dssp CSCHHHHHHHHTSCBCSSCCTTTTC--TTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred HhhHHHHHHHHhCcCCCCccHHHhc--CCcCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence 00000111000 12246789999999999999999999999753
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=335.31 Aligned_cols=252 Identities=24% Similarity=0.321 Sum_probs=197.6
Q ss_pred hhccCcceeeecccceeEEEEEEcCCceEEEEEecccC--chhHHHHHHHHHHHhcCC--CCceeeeeeEEecCCccEEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHY--PQCLKEFETELETVGSIK--HRNLVSLQGYSLSSSGNLLF 672 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv 672 (933)
.++|+..+.||+|+||.||+|.+.+++.||||++.... ....+.+.+|++++++++ ||||+++++++..++..++|
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 106 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 106 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEE
T ss_pred cceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEE
Confidence 46799999999999999999999889999999986543 345677899999999997 59999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccccc
Q 002349 673 YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV 752 (933)
Q Consensus 673 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 752 (933)
|| +.+++|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||++++ +.+||+|||+++....
T Consensus 107 ~e-~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~ 178 (313)
T 3cek_A 107 ME-CGNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQP 178 (313)
T ss_dssp EC-CCSEEHHHHHH---HCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC---
T ss_pred Ee-cCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccccC
Confidence 99 56789999995 346789999999999999999999976 9999999999999965 8999999999987643
Q ss_pred CCCc-eeeeecccccccCcccccc-----------CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccccc
Q 002349 753 SKSY-TSTYIMGTIGYIDPEYART-----------SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAV 820 (933)
Q Consensus 753 ~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 820 (933)
.... ......||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||..................
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~- 257 (313)
T 3cek_A 179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH- 257 (313)
T ss_dssp -----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS-
T ss_pred ccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhccc-
Confidence 3221 2234579999999999875 46889999999999999999999999765433222211111110
Q ss_pred ccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 821 METVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
....+.. .+..+.+++.+||+.||++||+++|++++-
T Consensus 258 ----~~~~~~~-----~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 258 ----EIEFPDI-----PEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp ----CCCCCCC-----SCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ----ccCCccc-----chHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 1111111 135788999999999999999999999753
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=347.03 Aligned_cols=259 Identities=23% Similarity=0.214 Sum_probs=198.7
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCC--------CCceeeeeeEEe----
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIK--------HRNLVSLQGYSL---- 664 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~~~~~~~---- 664 (933)
++|+..+.||+|+||+||+|++. +++.||||++... ....+.+.+|++++++++ |+||+++++++.
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 68999999999999999999965 4788999999753 334567889999999985 788999999987
Q ss_pred cCCccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCC-------
Q 002349 665 SSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDF------- 737 (933)
Q Consensus 665 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~------- 737 (933)
.....++||||+ ++++.+.+.. .....+++..+..++.|++.||+|||+++ +|+||||||+|||++.++
T Consensus 116 ~~~~~~lv~e~~-~~~l~~~~~~-~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 116 NGTHICMVFEVL-GHHLLKWIIK-SNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp TEEEEEEEECCC-CCBHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHH
T ss_pred CCceEEEEEecc-CccHHHHHHh-cccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhh
Confidence 556789999999 5566666542 23357999999999999999999999532 899999999999999775
Q ss_pred ------------------------------------------CeEEeecccccccccCCCceeeeecccccccCcccccc
Q 002349 738 ------------------------------------------EAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYART 775 (933)
Q Consensus 738 ------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 775 (933)
.+||+|||+++..... .....||+.|+|||++.+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~ 267 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIG 267 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHT
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcC
Confidence 7999999999875422 233479999999999999
Q ss_pred CCCCcchhhHHHHHHHHHHHhCCCCCCCCcch------hHHHHhhhccccccc-----------ccC-----ccc-----
Q 002349 776 SRLTEKSDVYSFGIVLLELLTGRKAVDNECNL------HHLILSKTANNAVME-----------TVD-----PEI----- 828 (933)
Q Consensus 776 ~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~------~~~~~~~~~~~~~~~-----------~~~-----~~~----- 828 (933)
..++.++|||||||++|||++|+.||...... ..........+.... ... ..+
T Consensus 268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (397)
T 1wak_A 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP 347 (397)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence 99999999999999999999999999743321 111111000000000 000 000
Q ss_pred --------cccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 829 --------SATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 829 --------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
............+.+++.+||+.||++|||++|++++
T Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0001123456789999999999999999999999874
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=337.24 Aligned_cols=258 Identities=21% Similarity=0.263 Sum_probs=202.6
Q ss_pred hccCcceeeecccceeEEEEEEcC-C-ceEEEEEecccCchhHHHHHHHHHHHhcCCCCc------eeeeeeEEecCCcc
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKN-C-KPVAIKRLYSHYPQCLKEFETELETVGSIKHRN------LVSLQGYSLSSSGN 669 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~-~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~~~ 669 (933)
++|+..+.||+|+||+||+|.... + +.||+|++... ....+.+.+|++++++++|++ ++.+++++...+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 689999999999999999999753 3 68999998653 334567888999999997665 99999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEe----------------
Q 002349 670 LLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILL---------------- 733 (933)
Q Consensus 670 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll---------------- 733 (933)
++||||+ ++++.+.+.. .....+++.++..++.|++.||+|||++ +|+||||||+||++
T Consensus 98 ~lv~e~~-~~~l~~~l~~-~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKE-NNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEEECC-CCBHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred EEEEecc-CCChHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccccccc
Confidence 9999999 5677776643 2335799999999999999999999965 99999999999999
Q ss_pred ---CCCCCeEEeecccccccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHH
Q 002349 734 ---DKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHL 810 (933)
Q Consensus 734 ---~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~ 810 (933)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++||||+||++|||++|+.||.........
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 248 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL 248 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 56789999999999864322 23457999999999999999999999999999999999999999876554443
Q ss_pred HHhhhcccccccc-------------------------------cCccccccccCHHHHHHHHHHHHHccCCCCCCCCCH
Q 002349 811 ILSKTANNAVMET-------------------------------VDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTM 859 (933)
Q Consensus 811 ~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 859 (933)
.......+..... ..+.......+......+.+++.+||+.||++|||+
T Consensus 249 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 328 (355)
T 2eu9_A 249 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITL 328 (355)
T ss_dssp HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCH
Confidence 3222211111100 000000111223445689999999999999999999
Q ss_pred HHHHHH
Q 002349 860 HEVSRV 865 (933)
Q Consensus 860 ~evl~~ 865 (933)
+|++++
T Consensus 329 ~e~l~h 334 (355)
T 2eu9_A 329 AEALLH 334 (355)
T ss_dssp HHHTTS
T ss_pred HHHhcC
Confidence 999864
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=336.30 Aligned_cols=254 Identities=21% Similarity=0.248 Sum_probs=172.6
Q ss_pred hhccCcc-eeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEec----CCccE
Q 002349 597 TENLSEK-YIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLS----SSGNL 670 (933)
Q Consensus 597 ~~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~ 670 (933)
.++|... ++||+|+||+||+|.++ +++.||||++.... ....+....++.++||||+++++++.. ....+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 4678884 46999999999999987 58899999986531 222223334566799999999999876 44578
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCC---CCCeEEeecccc
Q 002349 671 LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDK---DFEAHLTDFGIA 747 (933)
Q Consensus 671 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~---~~~~kl~DfGla 747 (933)
+||||+++|+|.+++.. .....+++.++..++.|++.||+|||++ +|+||||||+||+++. ++.+||+|||++
T Consensus 103 lv~e~~~gg~L~~~l~~-~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQE-RGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEECCTTEEHHHHHHT-C-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEeccCCCCHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 99999999999999964 2235799999999999999999999976 9999999999999986 455999999999
Q ss_pred cccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcc
Q 002349 748 KSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPE 827 (933)
Q Consensus 748 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 827 (933)
+..... ......||+.|+|||++.+..++.++||||+|+++|+|++|+.||.......................+..
T Consensus 179 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (336)
T 3fhr_A 179 KETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP 255 (336)
T ss_dssp EEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTT
T ss_pred eecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCch
Confidence 865322 22345789999999999888899999999999999999999999975433221100000000000000000
Q ss_pred ccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 828 ISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 828 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
. ....+..+.+++.+|++.||++|||++|++++-
T Consensus 256 ~-----~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 289 (336)
T 3fhr_A 256 E-----WSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP 289 (336)
T ss_dssp T-----STTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred h-----hccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 0 012246788999999999999999999999843
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=346.50 Aligned_cols=252 Identities=24% Similarity=0.328 Sum_probs=188.3
Q ss_pred ccCcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcC-CCCceeeeeeEEecCCccEEEEEecC
Q 002349 599 NLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSI-KHRNLVSLQGYSLSSSGNLLFYDFME 677 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~ 677 (933)
.|...+.||+|+||+||.+...+++.||||++... ..+.+.+|+++++++ +|||||++++++.+++..++||||++
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 44556789999999998777777899999998653 245678899999876 89999999999999999999999996
Q ss_pred CCCHHHHhcCCCCCC----CCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCC-------------CCeE
Q 002349 678 NGSLWDILHGPTKKK----KLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKD-------------FEAH 740 (933)
Q Consensus 678 ~gsL~~~l~~~~~~~----~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~-------------~~~k 740 (933)
|+|.+++....... ..++..++.++.|++.||+|||++ +|+||||||+||+++.+ +.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 69999996422111 113335678999999999999966 99999999999999754 4899
Q ss_pred EeecccccccccCCCc---eeeeecccccccCcccccc-------CCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhH
Q 002349 741 LTDFGIAKSLCVSKSY---TSTYIMGTIGYIDPEYART-------SRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHH 809 (933)
Q Consensus 741 l~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~ 809 (933)
|+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.+......
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~ 248 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES 248 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH
Confidence 9999999876443221 1234579999999999876 568999999999999999999 9999976543322
Q ss_pred HHHhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 810 LILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 810 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
..... .... . .. ....+...+..+.+++.+|++.||++|||+.+++++
T Consensus 249 ~i~~~--~~~~-~----~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 249 NIIRG--IFSL-D----EM-KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp HHHHT--CCCC-C----CC-TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHhcC--CCCc-c----cc-cccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 11111 0000 0 00 111233556789999999999999999999999864
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=343.56 Aligned_cols=249 Identities=21% Similarity=0.289 Sum_probs=188.5
Q ss_pred hccCcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcC-CCCceeeeeeEEecCCccEEEEEec
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSI-KHRNLVSLQGYSLSSSGNLLFYDFM 676 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 676 (933)
.+|+..++||+|+||+||.....+++.||||++..... ..+.+|+++++++ +|||||++++++.+....++||||+
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 46888899999999997665566789999999965432 2356899999999 7999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCC-----CCCeEEeecccccccc
Q 002349 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDK-----DFEAHLTDFGIAKSLC 751 (933)
Q Consensus 677 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~-----~~~~kl~DfGla~~~~ 751 (933)
+ |+|.+++.. ......+..+..++.|++.||+|||++ +|+||||||+||+++. ...+||+|||+|+...
T Consensus 101 ~-g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 101 A-ATLQEYVEQ--KDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp S-EEHHHHHHS--SSCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred C-CCHHHHHHh--cCCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 6 599999963 233455556789999999999999966 9999999999999953 3468899999998764
Q ss_pred cCCC--ceeeeecccccccCccccc---cCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccC
Q 002349 752 VSKS--YTSTYIMGTIGYIDPEYAR---TSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVD 825 (933)
Q Consensus 752 ~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (933)
.... .......||+.|+|||++. +..++.++||||+||++|||++ |..||............ .. .......
T Consensus 175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~--~~-~~~~~~~ 251 (432)
T 3p23_A 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL--GA-CSLDCLH 251 (432)
T ss_dssp -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHT--TC-CCCTTSC
T ss_pred CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHh--cc-CCccccC
Confidence 3321 2234467999999999997 4567889999999999999999 89999654332222111 11 0111111
Q ss_pred ccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 826 PEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 826 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
........+.+++.+|++.||++|||++|++++
T Consensus 252 -------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 252 -------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp -------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 112344567899999999999999999999864
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=329.66 Aligned_cols=252 Identities=21% Similarity=0.297 Sum_probs=182.4
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccCc-h-hHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYP-Q-CLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
.++|+..+.||+|+||.||+|.+. +++.||||++..... . ..+.+.++..+++.++||||+++++++..++..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 367889999999999999999986 588999999976532 2 2334455566788889999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
||+ ++.+..+.. .....+++..+..++.|++.||+|||+. .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 104 e~~-~~~~~~l~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 104 ELM-GTCAEKLKK--RMQGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp CCC-SEEHHHHHH--HHTSCCCHHHHHHHHHHHHHHHHHHHHH--HCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecc-CCcHHHHHH--HhccCCCHHHHHHHHHHHHHHHHHHHhh--CCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 999 556665553 2246789999999999999999999951 28999999999999999999999999999765332
Q ss_pred CCceeeeecccccccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccc
Q 002349 754 KSYTSTYIMGTIGYIDPEYAR-----TSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEI 828 (933)
Q Consensus 754 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 828 (933)
. ......||+.|+|||++. +..++.++||||||+++|+|++|+.||................. .+..
T Consensus 179 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~------~~~~ 250 (318)
T 2dyl_A 179 K--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE------PPLL 250 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSC------CCCC
T ss_pred c--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccC------CCCC
Confidence 2 223457999999999984 45688999999999999999999999986433332222211111 1111
Q ss_pred cccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002349 829 SATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSR 864 (933)
Q Consensus 829 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 864 (933)
+.. ...+..+.+++.+||+.||.+|||++++++
T Consensus 251 ~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 251 PGH---MGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CSS---SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred Ccc---CCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 110 012357889999999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=337.10 Aligned_cols=260 Identities=17% Similarity=0.198 Sum_probs=197.6
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCC-----------CCceeeeeeEEec
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIK-----------HRNLVSLQGYSLS 665 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~~ 665 (933)
++|...+.||+|+||+||+|.+. +++.||||++... ....+.+.+|++++++++ ||||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 57899999999999999999974 5789999999753 234567889999999886 8999999999876
Q ss_pred CC----ccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeC------C
Q 002349 666 SS----GNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLD------K 735 (933)
Q Consensus 666 ~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~------~ 735 (933)
.+ ..++||||+ +++|.+++.. .....+++..+..++.|++.||+|||++ .+|+||||||+||+++ .
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~i~~qi~~aL~~lH~~--~~ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKK-YEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTT
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHH-hhccCCcHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChHHeEEeccCCCcC
Confidence 54 678999999 8899999864 2345699999999999999999999953 2899999999999994 4
Q ss_pred CCCeEEeecccccccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcch------hH
Q 002349 736 DFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNL------HH 809 (933)
Q Consensus 736 ~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~------~~ 809 (933)
.+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..
T Consensus 174 ~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 249 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 249 (373)
T ss_dssp EEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred cceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence 458999999999875432 23347899999999999999999999999999999999999999754311 11
Q ss_pred HHHhhhccccccc--------------------ccCc-c-------c-cccccCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 002349 810 LILSKTANNAVME--------------------TVDP-E-------I-SATCKDLGAVKKVFQLALLCSKRQPTDRPTMH 860 (933)
Q Consensus 810 ~~~~~~~~~~~~~--------------------~~~~-~-------~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 860 (933)
........+.... .+.. . . .........+..+.+++.+||+.||++|||++
T Consensus 250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 329 (373)
T 1q8y_A 250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 329 (373)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHH
Confidence 1111000000000 0000 0 0 00011235567899999999999999999999
Q ss_pred HHHHHH
Q 002349 861 EVSRVL 866 (933)
Q Consensus 861 evl~~L 866 (933)
|++++-
T Consensus 330 ell~hp 335 (373)
T 1q8y_A 330 GLVNHP 335 (373)
T ss_dssp HHHTCG
T ss_pred HHhhCh
Confidence 999853
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=331.92 Aligned_cols=255 Identities=27% Similarity=0.359 Sum_probs=178.4
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC-chhHHHHHHHHH-HHhcCCCCceeeeeeEEecCCccEEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY-PQCLKEFETELE-TVGSIKHRNLVSLQGYSLSSSGNLLFYD 674 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e 674 (933)
++|...+.||+|+||.||+|.++ +++.||||++.... .....++.+|+. +++.++||||+++++++...+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 57888999999999999999986 58899999997653 233445566665 7778899999999999999999999999
Q ss_pred ecCCCCHHHHhcCC--CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccccc
Q 002349 675 FMENGSLWDILHGP--TKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV 752 (933)
Q Consensus 675 ~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 752 (933)
|+++ +|.+++... .....+++..+..++.|++.||.|||++ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 178 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence 9985 787776410 1256789999999999999999999952 2899999999999999999999999999987533
Q ss_pred CCCceeeeecccccccCcccc----ccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccc
Q 002349 753 SKSYTSTYIMGTIGYIDPEYA----RTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEI 828 (933)
Q Consensus 753 ~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 828 (933)
.. ......||+.|+|||++ .+..++.++||||||+++|+|++|+.||............ ......+.+
T Consensus 179 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~------~~~~~~~~~ 250 (327)
T 3aln_A 179 SI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQ------VVKGDPPQL 250 (327)
T ss_dssp -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CC------CCCSCCCCC
T ss_pred cc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHH------HhcCCCCCC
Confidence 22 22334699999999998 4567899999999999999999999999754322111110 111111111
Q ss_pred cccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002349 829 SATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSR 864 (933)
Q Consensus 829 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 864 (933)
.... ....+..+.+++.+||+.||++|||++++++
T Consensus 251 ~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 251 SNSE-EREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCS-SCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCcc-cccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 1100 0112467889999999999999999999976
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=357.03 Aligned_cols=261 Identities=22% Similarity=0.263 Sum_probs=199.4
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEeccc-CchhHHHHHHHHHHHhcCCCCceeeeeeEEec------CCc
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSH-YPQCLKEFETELETVGSIKHRNLVSLQGYSLS------SSG 668 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~~ 668 (933)
.++|+..+.||+|+||.||+|.+. +++.||||++... .....+.+.+|++++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 368999999999999999999975 5889999998764 34456778999999999999999999998765 667
Q ss_pred cEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCC---eEEeecc
Q 002349 669 NLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFE---AHLTDFG 745 (933)
Q Consensus 669 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~---~kl~DfG 745 (933)
.++||||+++|+|.+++........+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 899999999999999997544455799999999999999999999966 9999999999999997765 8999999
Q ss_pred cccccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccc----ccc
Q 002349 746 IAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANN----AVM 821 (933)
Q Consensus 746 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~----~~~ 821 (933)
+++...... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||........+........ ...
T Consensus 170 ~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~ 247 (676)
T 3qa8_A 170 YAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY 247 (676)
T ss_dssp CCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSC
T ss_pred ccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhh
Confidence 998764332 23445799999999999999999999999999999999999999976533332211100000 000
Q ss_pred ccc------Ccccccc-ccCHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 002349 822 ETV------DPEISAT-CKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862 (933)
Q Consensus 822 ~~~------~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~ev 862 (933)
+.. ....+.. .-....+..+.+++.+|+..||++|||++|+
T Consensus 248 ~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp CCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred hhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 000 0000000 0112346789999999999999999999773
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=332.31 Aligned_cols=248 Identities=21% Similarity=0.269 Sum_probs=192.5
Q ss_pred HHHHHhhccCcceeeecccceeEEEEEEc-CCceEEEEEecccCch------hHHHHHHHHHHHhcC----CCCceeeee
Q 002349 592 DIMRMTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQ------CLKEFETELETVGSI----KHRNLVSLQ 660 (933)
Q Consensus 592 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~h~niv~~~ 660 (933)
+.....++|+..+.||+|+||.||+|.+. +++.||||++...... ....+.+|+++++++ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 34455678999999999999999999865 5789999999654321 223456799999988 899999999
Q ss_pred eEEecCCccEEEEEe-cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeC-CCCC
Q 002349 661 GYSLSSSGNLLFYDF-MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLD-KDFE 738 (933)
Q Consensus 661 ~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~-~~~~ 738 (933)
+++...+..++|||| +.+++|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+||+++ .++.
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 178 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYIT---EKGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGC 178 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTE
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCe
Confidence 999999999999999 78999999995 345799999999999999999999976 999999999999999 8899
Q ss_pred eEEeecccccccccCCCceeeeecccccccCccccccCCCC-cchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcc
Q 002349 739 AHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLT-EKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTAN 817 (933)
Q Consensus 739 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~ 817 (933)
+||+|||+++...... .....|+..|+|||++.+..+. .++||||+|+++|+|++|+.||...... .. ..
T Consensus 179 ~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~---~~ 249 (312)
T 2iwi_A 179 AKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI---LE---AE 249 (312)
T ss_dssp EEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH---HH---TC
T ss_pred EEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHH---hh---hc
Confidence 9999999998764322 2345699999999999877664 5899999999999999999999753211 00 00
Q ss_pred cccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 002349 818 NAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLG 867 (933)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 867 (933)
. .+.. ..+..+.+++.+|++.||++|||++|++++-.
T Consensus 250 ~--------~~~~-----~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~ 286 (312)
T 2iwi_A 250 L--------HFPA-----HVSPDCCALIRRCLAPKPSSRPSLEEILLDPW 286 (312)
T ss_dssp C--------CCCT-----TSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTT
T ss_pred c--------CCcc-----cCCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 0 0111 12356889999999999999999999998543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=330.01 Aligned_cols=242 Identities=23% Similarity=0.339 Sum_probs=199.1
Q ss_pred HhhccCcceeeecccceeEEEEEEc-CCceEEEEEecccCch------hHHHHHHHHHHHhcCC--CCceeeeeeEEecC
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQ------CLKEFETELETVGSIK--HRNLVSLQGYSLSS 666 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~ 666 (933)
..++|+..+.||+|+||.||+|.+. +++.||||++...... ..+.+.+|+.++++++ ||||+++++++..+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 4568999999999999999999965 5789999999654321 2345678999999996 59999999999999
Q ss_pred CccEEEEEecCC-CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeC-CCCCeEEeec
Q 002349 667 SGNLLFYDFMEN-GSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLD-KDFEAHLTDF 744 (933)
Q Consensus 667 ~~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~-~~~~~kl~Df 744 (933)
+..++||||+.+ ++|.+++. ....+++..+..++.|++.||+|||+. +|+||||||+||+++ .++.+||+||
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCC
T ss_pred CcEEEEEEcCCCCccHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 999999999976 89999985 356799999999999999999999966 999999999999999 7899999999
Q ss_pred ccccccccCCCceeeeecccccccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccc
Q 002349 745 GIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRL-TEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMET 823 (933)
Q Consensus 745 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 823 (933)
|+++..... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||..... ... ... .
T Consensus 195 g~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---~~~-----~~~--~ 261 (320)
T 3a99_A 195 GSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---IIR-----GQV--F 261 (320)
T ss_dssp TTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---HHH-----CCC--C
T ss_pred ccccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh---hhc-----ccc--c
Confidence 999876432 2234569999999999987766 6889999999999999999999975321 100 000 0
Q ss_pred cCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 824 VDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 824 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
... ..+..+.+++.+||+.||++|||++|++++
T Consensus 262 ~~~---------~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 262 FRQ---------RVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp CSS---------CCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ccc---------cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111 123578899999999999999999999874
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=318.61 Aligned_cols=233 Identities=12% Similarity=0.073 Sum_probs=184.3
Q ss_pred hccCcceeeecccceeEEEEEEcC-CceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
++|+..+.||+|+||.||+|.+.. ++.||||++.... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 579999999999999999999865 7899999997653 234477899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
||+++++|.+++.. + ....++.+++.|++.||+|||++ +|+||||||+||+++.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp ECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc--------
Confidence 99999999999942 2 35667899999999999999976 99999999999999999999998544
Q ss_pred CCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccccc
Q 002349 754 KSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCK 833 (933)
Q Consensus 754 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (933)
|++ .++.++|||||||++|||++|+.||.+........... ....... +.....
T Consensus 175 -------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~---~~~~~~~-~~~~~~-- 228 (286)
T 3uqc_A 175 -------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE---RDTAGQP-IEPADI-- 228 (286)
T ss_dssp -------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC---BCTTSCB-CCHHHH--
T ss_pred -------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH---HHhccCC-CChhhc--
Confidence 333 36889999999999999999999998654322110000 0000000 000000
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCCCC
Q 002349 834 DLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAP 873 (933)
Q Consensus 834 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~ 873 (933)
....+..+.+++.+||+.||++| |++|+++.|+.+....
T Consensus 229 ~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 229 DRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp CTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred ccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 01224678899999999999999 9999999998875543
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=321.88 Aligned_cols=257 Identities=32% Similarity=0.570 Sum_probs=164.6
Q ss_pred cccEEeccCCcCcC--CCCCCCCCCCCccEEEeeC-CccCCCCCCccccCCcceEeeeccccccccCCcccccccccccc
Q 002349 260 ALAVLDLSCNMLSG--PIPPILGNLSYTEKLYLHS-NKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDL 336 (933)
Q Consensus 260 ~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L 336 (933)
+++.|+|++|.+++ .+|..|+++++|++|+|++ |.+.+.+|..|.++++|++|+|++|++++.+|..|..+++|++|
T Consensus 51 ~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L 130 (313)
T 1ogq_A 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred eEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEE
Confidence 45555555555555 4555555555556666653 55555555556666666666666666665556666666666666
Q ss_pred ccccccCCCCCCCCcccCCCCCceeccCcccCCCCCccccccc-ccceecCCcccccCCCccccccccccceeeccCCcc
Q 002349 337 NVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLE-SMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKI 415 (933)
Q Consensus 337 ~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 415 (933)
++++|++.+.+|..+..+++|++|++++|++++.+|..+..++ +|++|++++|++++.+|..+..++ |+.|+|++|.+
T Consensus 131 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l 209 (313)
T 1ogq_A 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNML 209 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEE
T ss_pred eCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcc
Confidence 6666666655666666666666666666666656666666665 666666666666666666666665 66666666666
Q ss_pred CCCCCCCCCCccccccccccCcccccccccccccccccceEEccCCccccccchhhccccccceeeecCCCCcCcccchh
Q 002349 416 SGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDVMSLI 495 (933)
Q Consensus 416 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~ 495 (933)
++.+|..|..+++|+.|+|++|++++.+|. +..+++|++|+|++|++++.+|..+..+++|+.|+|++|+++|.+|...
T Consensus 210 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~ 288 (313)
T 1ogq_A 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG 288 (313)
T ss_dssp EECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCST
T ss_pred cCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCc
Confidence 666666666666666666666666655554 6666677777777777776677777777777777777777776666655
Q ss_pred hccccc-eeecCCCCCCCcccCCcc
Q 002349 496 NCLSLS-VLFIGNPGLCGYWLHSAC 519 (933)
Q Consensus 496 ~~~~~~-~~~~~N~~~C~~~l~~~~ 519 (933)
++..+. ..+.+||++||.++. .|
T Consensus 289 ~l~~L~~l~l~~N~~lc~~p~~-~C 312 (313)
T 1ogq_A 289 NLQRFDVSAYANNKCLCGSPLP-AC 312 (313)
T ss_dssp TGGGSCGGGTCSSSEEESTTSS-CC
T ss_pred cccccChHHhcCCCCccCCCCC-CC
Confidence 555555 557778888887764 45
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=318.64 Aligned_cols=218 Identities=28% Similarity=0.383 Sum_probs=143.7
Q ss_pred cccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcceEeeeccccccccCCccccccccccc
Q 002349 256 GLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFD 335 (933)
Q Consensus 256 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~ 335 (933)
..+++|+.|++++|.....++ .+..+++|++|++++|.+.+..+ +..+++|+.|++++|.+++..+ +..+++|+.
T Consensus 129 ~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~ 203 (347)
T 4fmz_A 129 ANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHY 203 (347)
T ss_dssp TTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCE
T ss_pred ccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCccccccc--ccCCCccce
Confidence 344444444444443322222 24455555555555555553322 5555566666666666553322 555666666
Q ss_pred cccccccCCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCCccccccccccceeeccCCcc
Q 002349 336 LNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKI 415 (933)
Q Consensus 336 L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 415 (933)
|++++|.+.+..+ +..+++|+.|++++|++++..+ +..+++|++|++++|.+++. ..+..+++|+.|++++|++
T Consensus 204 L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l 277 (347)
T 4fmz_A 204 FTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQI 277 (347)
T ss_dssp EECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCC
T ss_pred eecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCcc
Confidence 6666666654333 5666677777777777764333 66777777777777777753 4577778888888888888
Q ss_pred CCCCCCCCCCccccccccccCcccccccccccccccccceEEccCCccccccchhhccccccceeeecCCCCc
Q 002349 416 SGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLS 488 (933)
Q Consensus 416 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 488 (933)
++. ..+..+++|+.|++++|++++..|..|.++++|++|+|++|++++..| +..+++|++|++++|+++
T Consensus 278 ~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 278 SDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp CCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred CCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 754 457788888888888888888888888889999999999999987766 888899999999999875
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-35 Score=321.88 Aligned_cols=279 Identities=20% Similarity=0.280 Sum_probs=155.7
Q ss_pred CChHHHHHHHHHHHhC-CCCCCCcCCCC--CCCCCCCCCccceEecC--------CCCcEEEEEcCCCCcCcccCCCCCC
Q 002349 22 VDSEDGATLLKIKKSF-RDVDNVLYDWT--DSPSSDYCVWRGITCDN--------VTFTVIALNLSGLNLDGEISPAVGD 90 (933)
Q Consensus 22 ~~~~d~~all~~k~~~-~~~~~~l~~w~--~~~~~~~c~w~gv~C~~--------~~~~v~~l~l~~~~l~~~~~~~l~~ 90 (933)
...+|+.||++||+++ .|+.+.+.+|. .....++|.|.|++|+. ...+|+.|+|++++++ .+|+.+++
T Consensus 24 ~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l~~ 102 (328)
T 4fcg_A 24 ALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFR 102 (328)
T ss_dssp CCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCGGG
T ss_pred cCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhhhh
Confidence 3467899999999998 57777888993 11257899999999953 2245556666666655 55555555
Q ss_pred CCCccEEEccCCcccccCCCCccCCCCCceecccccccCCCCCcccccccchhhhhhcccCccCCCCcccccCCCCceee
Q 002349 91 LKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFG 170 (933)
Q Consensus 91 l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ 170 (933)
+++|++|+|++|.++ .+|..|+++++|++|+|++|.++ .+|..++++++|++|+|++|++.+.+|..++..
T Consensus 103 l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~------- 173 (328)
T 4fcg_A 103 LSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST------- 173 (328)
T ss_dssp GTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEE-------
T ss_pred CCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhc-------
Confidence 666666666666555 55555555566666666655555 555555555555555555555555555444320
Q ss_pred eecCCCCCCcccccccCCCCcEEeccCccccCccCcCCcCCCCCcEEccccccccCcCCCCccccccceEeccccccccc
Q 002349 171 LRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGK 250 (933)
Q Consensus 171 L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~ 250 (933)
..+..|.++++|++|+|++|.++ .+|..++++++|++|+|++|++++
T Consensus 174 --------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~------------------------ 220 (328)
T 4fcg_A 174 --------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA------------------------ 220 (328)
T ss_dssp --------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC------------------------
T ss_pred --------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc------------------------
Confidence 00111223455555555555554 445455555555555555554441
Q ss_pred cCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcceEeeeccccccccCCcccccc
Q 002349 251 IPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKL 330 (933)
Q Consensus 251 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l 330 (933)
+|..++.+++|++|+|++|.+.+.+|..|+++++|++|+|++|++.+.+|..+.++++|++|+|++|.+.+.+|..++.+
T Consensus 221 l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L 300 (328)
T 4fcg_A 221 LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQL 300 (328)
T ss_dssp CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGS
T ss_pred CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhc
Confidence 22234444555555555555555555555555555555555555555555555555555555555555555555555555
Q ss_pred ccccccccccccC
Q 002349 331 TDLFDLNVANNHL 343 (933)
Q Consensus 331 ~~L~~L~L~~N~l 343 (933)
++|+.+++..+.+
T Consensus 301 ~~L~~l~l~~~~~ 313 (328)
T 4fcg_A 301 PANCIILVPPHLQ 313 (328)
T ss_dssp CTTCEEECCGGGS
T ss_pred cCceEEeCCHHHH
Confidence 5555554444433
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-35 Score=352.45 Aligned_cols=237 Identities=22% Similarity=0.285 Sum_probs=191.9
Q ss_pred hccCcceeeecccceeEEEEEEc--CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCc-----c
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK--NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSG-----N 669 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-----~ 669 (933)
++|++.+.||+|+||+||+|.+. +++.||||++.... ....+.+.+|++++++++|||||++++++...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 68999999999999999999986 57899999986543 3455678999999999999999999999987665 6
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccc
Q 002349 670 LLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKS 749 (933)
Q Consensus 670 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 749 (933)
|+||||+++++|.+++. ..+++.++..++.|++.||+|||++ +|+||||||+||+++.+ .+||+|||+++.
T Consensus 160 ~lv~E~~~g~~L~~~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKG-----QKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEECCCCEECC---------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchh
Confidence 99999999999998773 2699999999999999999999976 99999999999999986 999999999987
Q ss_pred cccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccc
Q 002349 750 LCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEIS 829 (933)
Q Consensus 750 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (933)
.... ....||+.|+|||++.+.. +.++|||||||++|+|++|..||.+... ....
T Consensus 231 ~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~---------------~~~~---- 285 (681)
T 2pzi_A 231 INSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYV---------------DGLP---- 285 (681)
T ss_dssp TTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEEC---------------SSCC----
T ss_pred cccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccc---------------cccc----
Confidence 6432 3457999999999987764 8999999999999999999988864210 0000
Q ss_pred ccccCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHHHcc
Q 002349 830 ATCKDLGAVKKVFQLALLCSKRQPTDRPT-MHEVSRVLGS 868 (933)
Q Consensus 830 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~~L~~ 868 (933)
...........+.+++.+|++.||++||+ ++++...+..
T Consensus 286 ~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 286 EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 00111123467889999999999999995 5555555543
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-34 Score=317.38 Aligned_cols=307 Identities=24% Similarity=0.387 Sum_probs=172.0
Q ss_pred CCCCCCccEEEccCCcccccCCCCccCCCCCceecccccccCCCCCcccccccchhhhhhcccCccCCCCcccccCCCCc
Q 002349 88 VGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLK 167 (933)
Q Consensus 88 l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~ 167 (933)
+..+++|++|++++|.+. .+| .+..+++|++|+|++|.+++ +|. +..+++|++|+|++|.+++ +| .++.+++|+
T Consensus 40 ~~~l~~L~~L~l~~~~i~-~~~-~~~~~~~L~~L~l~~n~i~~-~~~-~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~L~ 113 (347)
T 4fmz_A 40 QEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQITD-ISP-LSNLVKLTNLYIGTNKITD-IS-ALQNLTNLR 113 (347)
T ss_dssp HHHHTTCSEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCS
T ss_pred chhcccccEEEEeCCccc-cch-hhhhcCCccEEEccCCcccc-chh-hhcCCcCCEEEccCCcccC-ch-HHcCCCcCC
Confidence 346677888888888777 344 37778888888888887774 333 7777777777777777764 33 567777777
Q ss_pred eeeeecCCCCCCcccccccCCCCcEEeccCccccCccCcCCcCCCCCcEEccccccccCcCCCCccccccceEecccccc
Q 002349 168 VFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQL 247 (933)
Q Consensus 168 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~l 247 (933)
+|+|++|++.+..+ +..+++|++|++++|.....++ .+..+++|++|++++|++++..
T Consensus 114 ~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~------------------- 171 (347)
T 4fmz_A 114 ELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVT------------------- 171 (347)
T ss_dssp EEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCG-------------------
T ss_pred EEECcCCcccCchh--hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCch-------------------
Confidence 77777777764322 6666666666666665443333 2556666666666655554211
Q ss_pred ccccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcceEeeeccccccccCCccc
Q 002349 248 TGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPAL 327 (933)
Q Consensus 248 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l 327 (933)
+ +..+++|+.|++++|.+++..+ +..+++|+.|++++|.+++..+ +..+++|++|++++|++++..+ +
T Consensus 172 ----~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~ 239 (347)
T 4fmz_A 172 ----P--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--L 239 (347)
T ss_dssp ----G--GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--G
T ss_pred ----h--hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--h
Confidence 1 3445555556666555553322 4555555555555555553322 4455555555555555543222 4
Q ss_pred cccccccccccccccCCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCCccccccccccce
Q 002349 328 GKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDT 407 (933)
Q Consensus 328 ~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 407 (933)
..+++|+.|++++|+++ +. ..+..+++|++|++++|.+++. ..+..+++|+.
T Consensus 240 ~~l~~L~~L~l~~n~l~------------------------~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~ 291 (347)
T 4fmz_A 240 ANLSQLTWLEIGTNQIS------------------------DI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNS 291 (347)
T ss_dssp TTCTTCCEEECCSSCCC------------------------CC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSE
T ss_pred hcCCCCCEEECCCCccC------------------------CC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCE
Confidence 44444444444444444 21 2344444455555555544432 23445555555
Q ss_pred eeccCCccCCCCCCCCCCccccccccccCcccccccccccccccccceEEccCCccc
Q 002349 408 LDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLT 464 (933)
Q Consensus 408 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 464 (933)
|+|++|.+++..|..+..+++|+.|++++|++++..| +..+++|++|++++|+|+
T Consensus 292 L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 292 LFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp EECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred EECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 5555555555555555555555555555555554444 555666666666666554
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=324.60 Aligned_cols=312 Identities=22% Similarity=0.228 Sum_probs=206.7
Q ss_pred ccchhhhhhcccCccCCCCcccccCCCCceeeeecCCCCCCcccccccCCCCcEEeccCccccCccCcCCcCCCCCcEEc
Q 002349 139 LKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLD 218 (933)
Q Consensus 139 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ 218 (933)
+++|++|++++|.++...+..+..+++|++|+|++|++.+..+..|..+++|++|+|++|.+++..|..++++++|+
T Consensus 44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~--- 120 (390)
T 3o6n_A 44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLT--- 120 (390)
T ss_dssp GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC---
T ss_pred cCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCC---
Confidence 34555555555555533223344555555555555555443334444444444444444444444444444444444
Q ss_pred cccccccCcCCCCccccccceEeccccccccccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCC
Q 002349 219 LSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGH 298 (933)
Q Consensus 219 L~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 298 (933)
+|+|++|.++...+..|.++++|++|+|++|.+++.
T Consensus 121 --------------------------------------------~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~ 156 (390)
T 3o6n_A 121 --------------------------------------------VLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERI 156 (390)
T ss_dssp --------------------------------------------EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBC
T ss_pred --------------------------------------------EEECCCCccCcCCHHHhcCCCCCcEEECCCCccCcc
Confidence 444444444433333344445555555555555444
Q ss_pred CCCccccCCcceEeeeccccccccCCccccccccccccccccccCCCCCCCCcccCCCCCceeccCcccCCCCCcccccc
Q 002349 299 IPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRL 378 (933)
Q Consensus 299 ~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l 378 (933)
.+..+..+++|++|++++|++++. .+..+++|+.|++++|.+.+ +...++|+.|++++|++... |.. ..
T Consensus 157 ~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~-----~~~~~~L~~L~l~~n~l~~~-~~~--~~ 225 (390)
T 3o6n_A 157 EDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINVV-RGP--VN 225 (390)
T ss_dssp CTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCSE-----EECCSSCSEEECCSSCCCEE-ECC--CC
T ss_pred ChhhccCCCCCCEEECCCCcCCcc---ccccccccceeecccccccc-----cCCCCcceEEECCCCeeeec-ccc--cc
Confidence 444455555555555555555532 23445556666666665542 23335788888888888744 322 24
Q ss_pred cccceecCCcccccCCCccccccccccceeeccCCccCCCCCCCCCCccccccccccCcccccccccccccccccceEEc
Q 002349 379 ESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDL 458 (933)
Q Consensus 379 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 458 (933)
++|+.|++++|.+++. ..+..+++|++|+|++|.+++..|..|..+++|+.|+|++|++++ +|..+..+++|++|+|
T Consensus 226 ~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L 302 (390)
T 3o6n_A 226 VELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDL 302 (390)
T ss_dssp SSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEEC
T ss_pred ccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEEC
Confidence 7899999999999964 578999999999999999999889999999999999999999995 5777889999999999
Q ss_pred cCCccccccchhhccccccceeeecCCCCcCcccchhhccccc-eeecCCCCCCCcc
Q 002349 459 SHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDVMSLINCLSLS-VLFIGNPGLCGYW 514 (933)
Q Consensus 459 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~-~~~~~N~~~C~~~ 514 (933)
++|+++ .+|..+..+++|+.|++++|+++... ...+..+. +.+.+|||.|+|.
T Consensus 303 ~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~~--~~~~~~L~~L~l~~N~~~~~~~ 356 (390)
T 3o6n_A 303 SHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK--LSTHHTLKNLTLSHNDWDCNSL 356 (390)
T ss_dssp CSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC--CCTTCCCSEEECCSSCEEHHHH
T ss_pred CCCcce-ecCccccccCcCCEEECCCCccceeC--chhhccCCEEEcCCCCccchhH
Confidence 999999 56778899999999999999998874 34555666 7789999999863
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-35 Score=330.96 Aligned_cols=240 Identities=17% Similarity=0.189 Sum_probs=179.3
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCC-Ccee---------------
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKH-RNLV--------------- 657 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-~niv--------------- 657 (933)
.+|...++||+|+||+||+|.+. +++.||||++.... ....+.+.+|+.+++.++| +|..
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 45778889999999999999965 58899999987433 2336789999999999987 2211
Q ss_pred ee------eeEEec-----CCccEEEEEecCCCCHHHHhcC----CCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCee
Q 002349 658 SL------QGYSLS-----SSGNLLFYDFMENGSLWDILHG----PTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRII 722 (933)
Q Consensus 658 ~~------~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iv 722 (933)
.+ ..++.. ....+++|+++ +++|.++++. ......+++..+..++.|+++||+|||++ +|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 11 111111 12346666665 6799998841 12345688899999999999999999966 999
Q ss_pred eccCCCCceEeCCCCCeEEeecccccccccCCCceeeeecccccccCcccc----------ccCCCCcchhhHHHHHHHH
Q 002349 723 HRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYA----------RTSRLTEKSDVYSFGIVLL 792 (933)
Q Consensus 723 H~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DvwSlGv~l~ 792 (933)
||||||+|||++.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||||||++|
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 9999999999999999999999999865322 344567 999999999 5556889999999999999
Q ss_pred HHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 002349 793 ELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVS 863 (933)
Q Consensus 793 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 863 (933)
||++|+.||.......... .. +... . ..+..+.+++.+||+.||++||++.+++
T Consensus 309 elltg~~Pf~~~~~~~~~~----------~~----~~~~-~--~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGGSE----------WI----FRSC-K--NIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHSSCCCCTTGGGSCSG----------GG----GSSC-C--CCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHCCCCCCCcchhhhHH----------HH----Hhhc-c--cCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 9999999997643221110 00 0000 0 1236788999999999999999987775
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=325.14 Aligned_cols=244 Identities=16% Similarity=0.130 Sum_probs=185.1
Q ss_pred hhccCcceeeecccceeEEEEEEcCCceEEEEEecccC--------chhHHHHHHHHHHHhcCC---------CCceeee
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHY--------PQCLKEFETELETVGSIK---------HRNLVSL 659 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~~ 659 (933)
.++|+..+.||+|+||+||+|++ +++.||||++.... ....+.+.+|++++++++ |||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46789999999999999999998 56999999997542 223477899999998886 6666655
Q ss_pred eeE-----------------Eec-------------CCccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHH
Q 002349 660 QGY-----------------SLS-------------SSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQG 709 (933)
Q Consensus 660 ~~~-----------------~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~ 709 (933)
.++ +.+ .+..++||||+++|++.+.+. ...+++..+..++.|++.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~----~~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR----TKLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT----TTCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH----hcCCCHHHHHHHHHHHHHH
Confidence 554 332 678899999999997777663 2568999999999999999
Q ss_pred HHHhh-cCCCCCeeeccCCCCceEeCCCC--------------------CeEEeecccccccccCCCceeeeeccccccc
Q 002349 710 LAYLH-HDCSPRIIHRDVKSSNILLDKDF--------------------EAHLTDFGIAKSLCVSKSYTSTYIMGTIGYI 768 (933)
Q Consensus 710 l~~LH-~~~~~~ivH~Dikp~NIll~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~ 768 (933)
|+||| ++ +|+||||||+|||++.++ .+||+|||+|+.... ....||+.|+
T Consensus 174 L~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------~~~~gt~~y~ 244 (336)
T 2vuw_A 174 LAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------GIVVFCDVSM 244 (336)
T ss_dssp HHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET------TEEECCCCTT
T ss_pred HHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC------CcEEEeeccc
Confidence 99999 77 999999999999999887 899999999987642 1347999999
Q ss_pred CccccccCCCCcchhhHHHHHH-HHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHHHHHHHHHHHH
Q 002349 769 DPEYARTSRLTEKSDVYSFGIV-LLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALL 847 (933)
Q Consensus 769 aPE~~~~~~~~~~~DvwSlGv~-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 847 (933)
|||++.+.. +.++||||+|++ .+++++|..||.+......................+. .....+..+.+++.+
T Consensus 245 aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~s~~~~dli~~ 318 (336)
T 2vuw_A 245 DEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTP-----AMKQIKRKIQEFHRT 318 (336)
T ss_dssp CSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSH-----HHHHHHHHHHHHHHH
T ss_pred ChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchh-----hhhhcCHHHHHHHHH
Confidence 999998776 899999998777 7788999999864211111111111010111100000 012356789999999
Q ss_pred ccCCCCCCCCCHHHHH-HH
Q 002349 848 CSKRQPTDRPTMHEVS-RV 865 (933)
Q Consensus 848 cl~~dP~~RPt~~evl-~~ 865 (933)
||+.| |++|++ ++
T Consensus 319 ~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 319 MLNFS-----SATDLLCQH 332 (336)
T ss_dssp GGGSS-----SHHHHHHHC
T ss_pred HhccC-----CHHHHHhcC
Confidence 99977 999998 54
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=311.29 Aligned_cols=232 Identities=21% Similarity=0.262 Sum_probs=178.0
Q ss_pred hccCcc-eeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHH-hcCCCCceeeeeeEEec----CCccE
Q 002349 598 ENLSEK-YIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETV-GSIKHRNLVSLQGYSLS----SSGNL 670 (933)
Q Consensus 598 ~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~----~~~~~ 670 (933)
++|... +.||+|+||.||+|.+. +++.||+|++.. ...+.+|++++ +..+||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 466666 78999999999999975 578999999864 24677888888 55699999999999876 66789
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCC---CCCeEEeecccc
Q 002349 671 LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDK---DFEAHLTDFGIA 747 (933)
Q Consensus 671 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~---~~~~kl~DfGla 747 (933)
+||||+++|+|.+++.. .....+++..+..++.|++.||+|||++ +|+||||||+||+++. ++.+||+|||++
T Consensus 92 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEECCCCSCBHHHHHHH-CTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 99999999999999964 2234799999999999999999999966 9999999999999998 788999999998
Q ss_pred cccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcc
Q 002349 748 KSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPE 827 (933)
Q Consensus 748 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 827 (933)
.... +..++.++||||+||++|||++|+.||........... . ....... ...
T Consensus 168 ~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~--~-~~~~~~~-~~~ 220 (299)
T 3m2w_A 168 KETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG--M-KTRIRMG-QYE 220 (299)
T ss_dssp EECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC--S-CCSSCTT-CCS
T ss_pred cccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH--H-HHHHhhc-ccc
Confidence 6532 23467899999999999999999999975432221100 0 0000000 000
Q ss_pred ccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 002349 828 ISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866 (933)
Q Consensus 828 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 866 (933)
.+... ....+..+.+++.+|++.||++|||++|++++-
T Consensus 221 ~~~~~-~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp 258 (299)
T 3m2w_A 221 FPNPE-WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 258 (299)
T ss_dssp SCHHH-HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred CCchh-cccCCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence 00000 011246788999999999999999999999743
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=341.12 Aligned_cols=333 Identities=20% Similarity=0.196 Sum_probs=236.3
Q ss_pred CcCCCCCCCCCCCCC----ccceEecCC----C------------CcEEEEEcCCCCcCcccCCCCCCCCCccEEEccCC
Q 002349 43 VLYDWTDSPSSDYCV----WRGITCDNV----T------------FTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGN 102 (933)
Q Consensus 43 ~l~~w~~~~~~~~c~----w~gv~C~~~----~------------~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n 102 (933)
.+++|.. +.+||. |.++.|+.. . ..+..++++++.++...+..+.++++|++|+|++|
T Consensus 8 ~l~~~~~--~~~C~~~~~~~~c~~~~~~i~~~~~~~~~~~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n 85 (597)
T 3oja_B 8 NVKPRQP--EYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDL 85 (597)
T ss_dssp ---CCCS--EECCCCC--CCSEEECSCEECSSCCCCEESCSSGGGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTS
T ss_pred cccCCCC--CCcCcccCcCceeEecCceecccccccccCcccccCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCC
Confidence 4678864 345663 766655421 0 23567888888888655556889999999999999
Q ss_pred cccccCCCCccCCCCCceecccccccCCCCCcccccccchhhhhhcccCccCCCCcccccCCCCceeeeecCCCCCCccc
Q 002349 103 RLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSP 182 (933)
Q Consensus 103 ~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~ 182 (933)
.+++..|..|+++++|++|+|++|.+++..|..|+++++|++|+|++|.+++..+..|+++++|++|+|++|.+++..|.
T Consensus 86 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 165 (597)
T 3oja_B 86 QIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDD 165 (597)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTT
T ss_pred CCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChh
Confidence 99988888999999999999999999998888899999999999999999976666689999999999999999998888
Q ss_pred ccccCCCCcEEeccCccccCccCcCCcCCCCCcEEccccccccCcCCCCccccccceEeccccccccccCcccccccccc
Q 002349 183 DMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALA 262 (933)
Q Consensus 183 ~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~ 262 (933)
.|..+++|++|+|++|.+++. .++.+++|+.|++++|.+++. ....+|+
T Consensus 166 ~~~~l~~L~~L~L~~N~l~~~---~~~~l~~L~~L~l~~n~l~~l----------------------------~~~~~L~ 214 (597)
T 3oja_B 166 TFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLSTL----------------------------AIPIAVE 214 (597)
T ss_dssp TTTTCTTCCEEECTTSCCSBC---CGGGCTTCSEEECCSSCCSEE----------------------------ECCTTCS
T ss_pred hhhcCCcCcEEECcCCCCCCc---ChhhhhhhhhhhcccCccccc----------------------------cCCchhh
Confidence 999999999999999999964 256788899999998887631 1223466
Q ss_pred EEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcceEeeeccccccccCCcccccccccccccccccc
Q 002349 263 VLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNH 342 (933)
Q Consensus 263 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~ 342 (933)
.|++++|.++...+..+ ++|+.|+|++|.+++ +..+..+++|+.|+|++|.+++..|..|+.+++|+.|+|++|+
T Consensus 215 ~L~ls~n~l~~~~~~~~---~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 289 (597)
T 3oja_B 215 ELDASHNSINVVRGPVN---VELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNR 289 (597)
T ss_dssp EEECCSSCCCEEECSCC---SCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSC
T ss_pred eeeccCCcccccccccC---CCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCC
Confidence 66666666653322221 456666666666664 2455666666666666666665555555555555555555555
Q ss_pred CCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCCccccccccccceeeccCCccCCCCCCC
Q 002349 343 LEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSP 422 (933)
Q Consensus 343 l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~ 422 (933)
+++ +|..+ ..+++|++|+|++|.++ .+|..+..+++|+.|+|++|.|++. |
T Consensus 290 l~~-l~~~~------------------------~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~-~-- 340 (597)
T 3oja_B 290 LVA-LNLYG------------------------QPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K-- 340 (597)
T ss_dssp CCE-EECSS------------------------SCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--
T ss_pred CCC-CCccc------------------------ccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCc-C--
Confidence 543 23333 33445555555555554 3444555566666666666666543 2
Q ss_pred CCCccccccccccCcccccc
Q 002349 423 LGDLEHLLKLNLSRNQLTGF 442 (933)
Q Consensus 423 ~~~l~~L~~L~Ls~N~l~~~ 442 (933)
+..+++|+.|+|++|.+++.
T Consensus 341 ~~~~~~L~~L~l~~N~~~~~ 360 (597)
T 3oja_B 341 LSTHHTLKNLTLSHNDWDCN 360 (597)
T ss_dssp CCTTCCCSEEECCSSCEEHH
T ss_pred hhhcCCCCEEEeeCCCCCCh
Confidence 55567777888888887754
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-33 Score=306.58 Aligned_cols=293 Identities=20% Similarity=0.292 Sum_probs=150.5
Q ss_pred chhhhhhcccCccCCCCcccccCCCCceeeeecCCCCCCcccccccCCCCcEEeccCccccCccCcCCcCCCCCcEEccc
Q 002349 141 QLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLS 220 (933)
Q Consensus 141 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~ 220 (933)
+|+.+++++|.++ .+|..+. ++|+.|+|++|++.+..+..|.++++|++|++++|.+++..|..++++++|++|+|+
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 110 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence 3444444444444 3443332 455555666655554444555556666666666666665556666666666666666
Q ss_pred cccccCcCCCCccccccceEeccccccccccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccC--CC
Q 002349 221 YNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLT--GH 298 (933)
Q Consensus 221 ~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~ 298 (933)
+|+++ .+|..+ . ++|++|++++|.+++..+..|.++++|+.|++++|.++ +.
T Consensus 111 ~n~l~-~l~~~~-----------------------~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 164 (332)
T 2ft3_A 111 KNHLV-EIPPNL-----------------------P--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGF 164 (332)
T ss_dssp SSCCC-SCCSSC-----------------------C--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGS
T ss_pred CCcCC-ccCccc-----------------------c--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCC
Confidence 66655 222211 1 34455555555555444444555555555555555553 23
Q ss_pred CCCccccCCcceEeeeccccccccCCccccccccccccccccccCCCCCCCCcccCCCCCceeccCcccCCCCCcccccc
Q 002349 299 IPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRL 378 (933)
Q Consensus 299 ~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l 378 (933)
.+..+..+ +|++|++++|++++ +|..+. ++|++|++++|++.+..+..+..+++|+.|++++|++++..+..|..+
T Consensus 165 ~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l 240 (332)
T 2ft3_A 165 EPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFL 240 (332)
T ss_dssp CTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGC
T ss_pred CcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCC
Confidence 44445554 55566666665553 333332 455555555555555555555555555555555555555444455555
Q ss_pred cccceecCCcccccCCCccccccccccceeeccCCccCCCCCCCCCCccccccccccCcccccccccccccccccceEEc
Q 002349 379 ESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDL 458 (933)
Q Consensus 379 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 458 (933)
++|++|+|++|+++ .+|..+..+++|+.|+|++|+|++..+..|..... -....+|+.|++
T Consensus 241 ~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~------------------~~~~~~l~~L~l 301 (332)
T 2ft3_A 241 PTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGF------------------GVKRAYYNGISL 301 (332)
T ss_dssp TTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSC------------------CSSSCCBSEEEC
T ss_pred CCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHcccccc------------------ccccccccceEe
Confidence 55555555555555 44444555555555555555555443333332100 000244556666
Q ss_pred cCCccc--cccchhhccccccceeeecCC
Q 002349 459 SHNHLT--GVIPEELSQLQNMFSLRLDYN 485 (933)
Q Consensus 459 s~N~l~--~~~p~~~~~l~~L~~L~l~~N 485 (933)
++|.++ +..|..+..+++|+.+++++|
T Consensus 302 ~~N~~~~~~~~~~~~~~l~~L~~l~l~~n 330 (332)
T 2ft3_A 302 FNNPVPYWEVQPATFRCVTDRLAIQFGNY 330 (332)
T ss_dssp CSSSSCGGGSCGGGGTTBCCSTTEEC---
T ss_pred ecCcccccccCcccccccchhhhhhcccc
Confidence 666555 455555666666666666655
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=303.41 Aligned_cols=291 Identities=19% Similarity=0.251 Sum_probs=206.6
Q ss_pred EEcCCCCcCcccCCCCCCCCCccEEEccCCcccccCCCCccCCCCCceecccccccCCCCCcccccccchhhhhhcccCc
Q 002349 73 LNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQL 152 (933)
Q Consensus 73 l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l 152 (933)
+++++++++ .+|..+. +.|++|+|++|++++..+..|+++++|++|+|++|.+++..|..|+++++|++|+|++|++
T Consensus 36 l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l 112 (330)
T 1xku_A 36 VQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 112 (330)
T ss_dssp EECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCC
T ss_pred EEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcC
Confidence 334445555 4555543 6899999999999987777899999999999999999988899999999999999999999
Q ss_pred cCCCCcccccCCCCceeeeecCCCCCCcccccccCCCCcEEeccCccccC--ccCcCCcCCCCCcEEccccccccCcCCC
Q 002349 153 IGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTG--SIPQNIGNCTSFQVLDLSYNQLSGEIPF 230 (933)
Q Consensus 153 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~--~~p~~l~~l~~L~~L~L~~N~l~~~~p~ 230 (933)
+ .+|..+. ++|++|++++|++++..+..+.++++|++|++++|.++. ..+..+.++++|++|++++|+++. +|.
T Consensus 113 ~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~-l~~ 188 (330)
T 1xku_A 113 K-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQ 188 (330)
T ss_dssp S-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CCS
T ss_pred C-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc-CCc
Confidence 8 5676665 799999999999998878889999999999999999963 678889999999999999999883 444
Q ss_pred CccccccceEeccccccccccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcce
Q 002349 231 NIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLH 310 (933)
Q Consensus 231 ~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~ 310 (933)
.+. .+|++|++++|++++..|..+..+++|+.|+|++|.+++..+..|..+++|++|+|++|+++ .+|..+..+++|+
T Consensus 189 ~~~-~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~ 266 (330)
T 1xku_A 189 GLP-PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQ 266 (330)
T ss_dssp SCC-TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCC
T ss_pred ccc-ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcC
Confidence 332 45666666666666655666666666666666666666555555555666666666666655 4555555555555
Q ss_pred EeeeccccccccCCccccccccccccccccccCCCCCCCCcccCCCCCceeccCcccCC--CCCcccccccccceecCCc
Q 002349 311 YLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNG--TIPPAFQRLESMTYLNLSL 388 (933)
Q Consensus 311 ~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~--~~~~~~~~l~~L~~L~L~~ 388 (933)
+|++++|+|++..+..|.... .......|+.|++++|.+.. ..|..|..+.+|+.++|++
T Consensus 267 ~L~l~~N~i~~~~~~~f~~~~------------------~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~ 328 (330)
T 1xku_A 267 VVYLHNNNISAIGSNDFCPPG------------------YNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGN 328 (330)
T ss_dssp EEECCSSCCCCCCTTSSSCSS------------------CCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC--
T ss_pred EEECCCCcCCccChhhcCCcc------------------cccccccccceEeecCcccccccCccccccccceeEEEecc
Confidence 555555555544333332210 00112456666777776642 4556677777777777777
Q ss_pred cc
Q 002349 389 NN 390 (933)
Q Consensus 389 N~ 390 (933)
|+
T Consensus 329 N~ 330 (330)
T 1xku_A 329 YK 330 (330)
T ss_dssp --
T ss_pred cC
Confidence 64
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-32 Score=298.67 Aligned_cols=287 Identities=22% Similarity=0.273 Sum_probs=164.9
Q ss_pred CCceeeeecCCCCCCcccccccCCCCcEEeccCccccCccCcCCcCCCCCcEEccccccccCcCCCCccccccceEeccc
Q 002349 165 NLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQG 244 (933)
Q Consensus 165 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~ 244 (933)
+|+.+++++|.++ .+|..+. ++|++|++++|.+++..|..+.++++|++|+|++|+++
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~------------------- 91 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS------------------- 91 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-------------------
T ss_pred cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccC-------------------
Confidence 4555666655554 3343332 34555555555555444444455555444444444433
Q ss_pred cccccccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcceEeeeccccccccCC
Q 002349 245 NQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIP 324 (933)
Q Consensus 245 n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 324 (933)
+..|..|+.+++|++|+|++|.++ .+|..+. ++|++|++++|++++..+..|.++++|+.|++++|.++.
T Consensus 92 ----~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~--- 161 (332)
T 2ft3_A 92 ----KIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLEN--- 161 (332)
T ss_dssp ----EECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBG---
T ss_pred ----ccCHhHhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCcccc---
Confidence 334455566666666666666666 3333332 556666666666665444455666666666666666542
Q ss_pred ccccccccccccccccccCCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCCccccccccc
Q 002349 325 PALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGN 404 (933)
Q Consensus 325 ~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 404 (933)
.+..+..+..+ +|+.|++++|++++ +|..+. ++|++|++++|.+++..+..+..+++
T Consensus 162 -------------------~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~ 218 (332)
T 2ft3_A 162 -------------------SGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSK 218 (332)
T ss_dssp -------------------GGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTT
T ss_pred -------------------CCCCcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCC
Confidence 01333344444 45555555555543 232222 45666666666666555566666666
Q ss_pred cceeeccCCccCCCCCCCCCCccccccccccCcccccccccccccccccceEEccCCccccccchhhcc------ccccc
Q 002349 405 LDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQ------LQNMF 478 (933)
Q Consensus 405 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~------l~~L~ 478 (933)
|+.|+|++|++++..+..|..+++|+.|+|++|+++ .+|..+.++++|+.|+|++|++++..+..+.. .++|+
T Consensus 219 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~ 297 (332)
T 2ft3_A 219 LYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYN 297 (332)
T ss_dssp CSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBS
T ss_pred CCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHcccccccccccccc
Confidence 777777777776666666777777777777777777 56667777778888888888887766666654 36789
Q ss_pred eeeecCCCCc--Ccccc-hhhccccc-eeecCC
Q 002349 479 SLRLDYNNLS--GDVMS-LINCLSLS-VLFIGN 507 (933)
Q Consensus 479 ~L~l~~N~l~--~~~~~-~~~~~~~~-~~~~~N 507 (933)
.|++++|++. +..+. ...+..+. +.+.+|
T Consensus 298 ~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n 330 (332)
T 2ft3_A 298 GISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330 (332)
T ss_dssp EEECCSSSSCGGGSCGGGGTTBCCSTTEEC---
T ss_pred ceEeecCcccccccCcccccccchhhhhhcccc
Confidence 9999999998 33332 23344444 444444
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-32 Score=298.83 Aligned_cols=268 Identities=21% Similarity=0.264 Sum_probs=145.7
Q ss_pred CCceeeeecCCCCCCcccccccCCCCcEEeccCccccCccCcCCcCCCCCcEEccccccccCcCCCCccccccceEeccc
Q 002349 165 NLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQG 244 (933)
Q Consensus 165 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~ 244 (933)
+|+.|+|++|++++..+..|.++++|++|+|++|.+++..|..++++++|++|+|++|+++ .+|..+. .+|++|++++
T Consensus 53 ~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~-~~L~~L~l~~ 130 (330)
T 1xku_A 53 DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP-KTLQELRVHE 130 (330)
T ss_dssp TCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC-TTCCEEECCS
T ss_pred CCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhc-ccccEEECCC
Confidence 4444455555444444444455555555555555555444555555555555555555555 3333222 3455555555
Q ss_pred cccccccCccccccccccEEeccCCcCcC--CCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcceEeeecccccccc
Q 002349 245 NQLTGKIPSVIGLMQALAVLDLSCNMLSG--PIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGH 322 (933)
Q Consensus 245 n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~ 322 (933)
|++++..+..+..+++|++|++++|.++. ..+..|.++++|++|++++|.++. +|..+. ++|++|++++|++++.
T Consensus 131 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~ 207 (330)
T 1xku_A 131 NEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGLP--PSLTELHLDGNKITKV 207 (330)
T ss_dssp SCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CCSSCC--TTCSEEECTTSCCCEE
T ss_pred CcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc-CCcccc--ccCCEEECCCCcCCcc
Confidence 55555555566667777777777776643 455566666666666666666663 343332 4555666666655555
Q ss_pred CCccccccccccccccccccCCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCCccccccc
Q 002349 323 IPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRI 402 (933)
Q Consensus 323 ~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 402 (933)
.+..+..+++|+.|++++|++++..+..+..+++|+.|++++|+++ .+|..+..+
T Consensus 208 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-------------------------~lp~~l~~l 262 (330)
T 1xku_A 208 DAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-------------------------KVPGGLADH 262 (330)
T ss_dssp CTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-------------------------SCCTTTTTC
T ss_pred CHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-------------------------cCChhhccC
Confidence 5555555555555555555555444444444444555555544444 334444444
Q ss_pred cccceeeccCCccCCCCCCCCCC------ccccccccccCccccc--ccccccccccccceEEccCCc
Q 002349 403 GNLDTLDMSNNKISGSIPSPLGD------LEHLLKLNLSRNQLTG--FIPGEFGNLRSVMEIDLSHNH 462 (933)
Q Consensus 403 ~~L~~L~Ls~N~l~~~~p~~~~~------l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~ 462 (933)
++|++|+|++|+|++..+..|.. .+.|+.|++++|.+.. ..|..|..+.+|+.++|++|+
T Consensus 263 ~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 263 KYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp SSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred CCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 44555555555554444444432 3566777777777653 556778888888888888874
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-36 Score=352.29 Aligned_cols=379 Identities=21% Similarity=0.135 Sum_probs=221.4
Q ss_pred CCccEEEccCCcccccCCC-CccCCCCCceecccccccCC----CCCcccccccchhhhhhcccCccCCCCcccc-cCC-
Q 002349 92 KDLQSIDLRGNRLSGQIPD-EIGDCSSLKSLDLSFNELYG----DIPFSISKLKQLEFLILKNNQLIGPIPSTLS-QLP- 164 (933)
Q Consensus 92 ~~L~~L~Ls~n~l~~~~p~-~l~~l~~L~~L~Ls~n~l~~----~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~-~l~- 164 (933)
++|++|||++|+++..... .+..+++|++|+|++|.+++ .++..+..+++|++|+|++|.+++..+..+. .++
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 4577888888877643322 26677778888888777763 2345556666777777777766543333222 233
Q ss_pred ---CCceeeeecCCCCC----CcccccccCCCCcEEeccCccccCccCcCCc-----CCCCCcEEccccccccCcCCCCc
Q 002349 165 ---NLKVFGLRGNNLVG----TLSPDMCQLSGLWYFDVRNNSLTGSIPQNIG-----NCTSFQVLDLSYNQLSGEIPFNI 232 (933)
Q Consensus 165 ---~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~-----~l~~L~~L~L~~N~l~~~~p~~~ 232 (933)
+|++|+|++|+++. .++..+..+++|++|++++|.+++..+..+. ..++|++|+|++|++++....
T Consensus 83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~-- 160 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCE-- 160 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHH--
T ss_pred CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHH--
Confidence 46666666666653 3355555555666666666655533222221 133455555555544421110
Q ss_pred cccccceEeccccccccccCccccccccccEEeccCCcCcCCCCCCCC-----CCCCccEEEeeCCccCCC----CCCcc
Q 002349 233 GFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILG-----NLSYTEKLYLHSNKLTGH----IPPEL 303 (933)
Q Consensus 233 ~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~~----~p~~l 303 (933)
.++..+..+++|++|++++|.+++..+..+. ..++|++|+|++|.+++. ++..+
T Consensus 161 -----------------~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l 223 (461)
T 1z7x_W 161 -----------------PLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIV 223 (461)
T ss_dssp -----------------HHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHH
T ss_pred -----------------HHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHH
Confidence 2244455566777777777776544333332 245677777777777653 35556
Q ss_pred ccCCcceEeeeccccccccC-----CccccccccccccccccccCCCC----CCCCcccCCCCCceeccCcccCCCCCcc
Q 002349 304 GNMTKLHYLELNDNQLTGHI-----PPALGKLTDLFDLNVANNHLEGP----IPDNLSSCTNLNSLNVHGNKLNGTIPPA 374 (933)
Q Consensus 304 ~~l~~L~~L~L~~N~l~~~~-----~~~l~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~l~~N~l~~~~~~~ 374 (933)
..+++|++|++++|.+++.. +..+..+++|+.|++++|+++.. ++..+..+++|++|++++|++.+..+..
T Consensus 224 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~ 303 (461)
T 1z7x_W 224 ASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARL 303 (461)
T ss_dssp HHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHH
T ss_pred HhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHH
Confidence 66777777777777776432 22223466777777777776642 3445556677777777777765433333
Q ss_pred cccc-----cccceecCCcccccCC----CccccccccccceeeccCCccCCCCCCCCCC-----ccccccccccCcccc
Q 002349 375 FQRL-----ESMTYLNLSLNNIRGP----IPVELSRIGNLDTLDMSNNKISGSIPSPLGD-----LEHLLKLNLSRNQLT 440 (933)
Q Consensus 375 ~~~l-----~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~ 440 (933)
+... ++|++|++++|.+++. ++..+..+++|++|+|++|.+++..+..+.. .++|+.|+|++|+++
T Consensus 304 l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~ 383 (461)
T 1z7x_W 304 LCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVS 383 (461)
T ss_dssp HHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCC
T ss_pred HHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCC
Confidence 3322 5777777777777654 3444556677777777777776543333332 457777777777777
Q ss_pred c----ccccccccccccceEEccCCccccccchhhc-----cccccceeeecCCCCcC
Q 002349 441 G----FIPGEFGNLRSVMEIDLSHNHLTGVIPEELS-----QLQNMFSLRLDYNNLSG 489 (933)
Q Consensus 441 ~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~l~~N~l~~ 489 (933)
+ .+|..+..+++|++|+|++|++++.....+. ...+|+.|++.+|.+..
T Consensus 384 ~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~~ 441 (461)
T 1z7x_W 384 DSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE 441 (461)
T ss_dssp HHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCH
T ss_pred hhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccCH
Confidence 5 5666777777777777777777654332222 12346666666665544
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=7.6e-36 Score=345.69 Aligned_cols=385 Identities=21% Similarity=0.187 Sum_probs=253.4
Q ss_pred cEEEEEcCCCCcCcccCCC-CCCCCCccEEEccCCcccc----cCCCCccCCCCCceecccccccCCCCCcccc-ccc--
Q 002349 69 TVIALNLSGLNLDGEISPA-VGDLKDLQSIDLRGNRLSG----QIPDEIGDCSSLKSLDLSFNELYGDIPFSIS-KLK-- 140 (933)
Q Consensus 69 ~v~~l~l~~~~l~~~~~~~-l~~l~~L~~L~Ls~n~l~~----~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~-~l~-- 140 (933)
+++.|||++++++...... +..+++|++|+|++|++++ .++..+..+++|++|||++|.+++..+..+. .++
T Consensus 4 ~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~ 83 (461)
T 1z7x_W 4 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 83 (461)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred cceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhC
Confidence 6789999999998654443 7789999999999999985 4677888999999999999999865555543 455
Q ss_pred --chhhhhhcccCccC----CCCcccccCCCCceeeeecCCCCCCccccccc-----CCCCcEEeccCccccCc----cC
Q 002349 141 --QLEFLILKNNQLIG----PIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQ-----LSGLWYFDVRNNSLTGS----IP 205 (933)
Q Consensus 141 --~L~~L~L~~n~l~~----~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~-----l~~L~~L~L~~n~l~~~----~p 205 (933)
+|++|+|++|+++. .+|..+..+++|++|+|++|.+++..+..+.. .++|++|++++|.+++. ++
T Consensus 84 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~ 163 (461)
T 1z7x_W 84 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA 163 (461)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHH
Confidence 69999999999984 56888999999999999999997655544432 56899999999999874 36
Q ss_pred cCCcCCCCCcEEccccccccCcCCCCcc------ccccceEeccccccccc----cCccccccccccEEeccCCcCcCCC
Q 002349 206 QNIGNCTSFQVLDLSYNQLSGEIPFNIG------FLQIATLSLQGNQLTGK----IPSVIGLMQALAVLDLSCNMLSGPI 275 (933)
Q Consensus 206 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~------~~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~ 275 (933)
..+..+++|++|++++|+++...+..+. ..+|++|+|++|++++. ++..+..+++|++|++++|.+++..
T Consensus 164 ~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~ 243 (461)
T 1z7x_W 164 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 243 (461)
T ss_dssp HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHH
T ss_pred HHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHH
Confidence 6677789999999999998754333221 22567777777776653 4555566666777777766665421
Q ss_pred -----CCCCCCCCCccEEEeeCCccCCC----CCCccccCCcceEeeeccccccccCCccccccccccccccccccCCCC
Q 002349 276 -----PPILGNLSYTEKLYLHSNKLTGH----IPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGP 346 (933)
Q Consensus 276 -----~~~~~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~ 346 (933)
+..+..+++|++|+|++|.+++. ++..+..+++|++|++++|.+++..+..+...
T Consensus 244 ~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~---------------- 307 (461)
T 1z7x_W 244 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCET---------------- 307 (461)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHH----------------
T ss_pred HHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHH----------------
Confidence 12222455666666666666532 34445555566666666665553322222211
Q ss_pred CCCCcccCCCCCceeccCcccCCC----CCcccccccccceecCCcccccCCCcccccc-----ccccceeeccCCccCC
Q 002349 347 IPDNLSSCTNLNSLNVHGNKLNGT----IPPAFQRLESMTYLNLSLNNIRGPIPVELSR-----IGNLDTLDMSNNKISG 417 (933)
Q Consensus 347 ~p~~l~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-----l~~L~~L~Ls~N~l~~ 417 (933)
.....++|++|++++|.+++. ++..+..+++|++|++++|.+++..+..+.. .++|++|+|++|.+++
T Consensus 308 ---l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~ 384 (461)
T 1z7x_W 308 ---LLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSD 384 (461)
T ss_dssp ---HTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCH
T ss_pred ---hccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCCh
Confidence 000113555555555555533 2344555566666666666666444443332 4567777777777764
Q ss_pred ----CCCCCCCCccccccccccCcccccccccccc-----cccccceEEccCCccccccchhhc
Q 002349 418 ----SIPSPLGDLEHLLKLNLSRNQLTGFIPGEFG-----NLRSVMEIDLSHNHLTGVIPEELS 472 (933)
Q Consensus 418 ----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~Ls~N~l~~~~p~~~~ 472 (933)
.+|..+..+++|++|+|++|++++.....+. ...+|+.|++.+|.+....+..+.
T Consensus 385 ~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~~~~~~~l~ 448 (461)
T 1z7x_W 385 SSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQ 448 (461)
T ss_dssp HHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHHHHHH
T ss_pred hhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccCHHHHHHHH
Confidence 5566666677777777777777644222221 133577777777776655554443
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=290.88 Aligned_cols=285 Identities=21% Similarity=0.237 Sum_probs=198.0
Q ss_pred CCCCCCccceEecCCCCcEEEEEcCCCCcCcccCCCCCCCCCccEEEccCCcccccCCCCccCCCCCceecccccccCCC
Q 002349 52 SSDYCVWRGITCDNVTFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGD 131 (933)
Q Consensus 52 ~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~ 131 (933)
..++|.|.|+ |+ +++++++ .+|..+. ++|++|+|++|++++..+..|+++++|++|+|++|.+++.
T Consensus 26 ~~~~C~~~~~-c~----------~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~ 91 (353)
T 2z80_A 26 ASLSCDRNGI-CK----------GSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTI 91 (353)
T ss_dssp -CCEECTTSE-EE----------CCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEE
T ss_pred cCCCCCCCeE-ee----------CCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCcc
Confidence 3577999987 74 4566777 5666555 4899999999999976666899999999999999999987
Q ss_pred CCcccccccchhhhhhcccCccCCCCcccccCCCCceeeeecCCCCCCcc-cccccCCCCcEEeccCc-cccCccCcCCc
Q 002349 132 IPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLS-PDMCQLSGLWYFDVRNN-SLTGSIPQNIG 209 (933)
Q Consensus 132 ~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~n-~l~~~~p~~l~ 209 (933)
.|..|+++++|++|+|++|++++..+..++++++|++|+|++|++++..+ ..+..+++|++|++++| .+++..+..+.
T Consensus 92 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~ 171 (353)
T 2z80_A 92 EEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFA 171 (353)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTT
T ss_pred CHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHcc
Confidence 78889999999999999999986555558889999999999998885443 46788888888888888 46665667788
Q ss_pred CCCCCcEEccccccccCcCCCCccc-cccceEeccccccccccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEE
Q 002349 210 NCTSFQVLDLSYNQLSGEIPFNIGF-LQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKL 288 (933)
Q Consensus 210 ~l~~L~~L~L~~N~l~~~~p~~~~~-~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 288 (933)
++++|++|++++|++++..|..+.. .+|++|++++|+++...+..+..+++|+.|++++|.+++..+..+..
T Consensus 172 ~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~------- 244 (353)
T 2z80_A 172 GLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELST------- 244 (353)
T ss_dssp TCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC-----------
T ss_pred CCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCcccccccccccc-------
Confidence 8888888888888877655554433 24555555555554333333334555555555555555443332221
Q ss_pred EeeCCccCCCCCCccccCCcceEeeeccccccc----cCCccccccccccccccccccCCCCCCCCcccCCCCCceeccC
Q 002349 289 YLHSNKLTGHIPPELGNMTKLHYLELNDNQLTG----HIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHG 364 (933)
Q Consensus 289 ~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~----~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~ 364 (933)
......++.++|+++.+++ .+|..+..+++|+.|++++|+++...+..|..+++|++|++++
T Consensus 245 --------------~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 310 (353)
T 2z80_A 245 --------------GETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHT 310 (353)
T ss_dssp ----------------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred --------------ccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeC
Confidence 1123344555555555543 3566677778888888888888743333357888888888888
Q ss_pred cccCCCC
Q 002349 365 NKLNGTI 371 (933)
Q Consensus 365 N~l~~~~ 371 (933)
|++.+..
T Consensus 311 N~~~~~~ 317 (353)
T 2z80_A 311 NPWDCSC 317 (353)
T ss_dssp SCBCCCH
T ss_pred CCccCcC
Confidence 8887543
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=284.24 Aligned_cols=289 Identities=20% Similarity=0.234 Sum_probs=201.2
Q ss_pred CCCCCCccceEecCCCCcEEEEEcCCCCcCcccCCCCCCCCCccEEEccCCcccccCCCCccCCCCCceecccccccCC-
Q 002349 52 SSDYCVWRGITCDNVTFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYG- 130 (933)
Q Consensus 52 ~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~- 130 (933)
..+.|.|.+|.|++. +++ .+|..+. ++|++|+|++|+++...+..|+++++|++|+|++|.++.
T Consensus 3 ~~C~C~~~~l~c~~~------------~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~ 67 (306)
T 2z66_A 3 SRCSCSGTEIRCNSK------------GLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFK 67 (306)
T ss_dssp TTCEEETTEEECCSS------------CCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEE
T ss_pred CCCeeCCCEEEcCCC------------Ccc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcc
Confidence 346688999888643 333 4454443 689999999999984433458999999999999999873
Q ss_pred -CCCcccccccchhhhhhcccCccCCCCcccccCCCCceeeeecCCCCCCcc-cccccCCCCcEEeccCccccCccCcCC
Q 002349 131 -DIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLS-PDMCQLSGLWYFDVRNNSLTGSIPQNI 208 (933)
Q Consensus 131 -~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~p~~l 208 (933)
.+|..+..+++|++|+|++|.++ .+|..+..+++|++|+|++|++++..+ ..+..+++|++|++++|.+++..+..+
T Consensus 68 ~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 146 (306)
T 2z66_A 68 GCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIF 146 (306)
T ss_dssp EEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTT
T ss_pred cCcccccccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhc
Confidence 33677778889999999999988 467778888999999999998886655 567888888888888888888778888
Q ss_pred cCCCCCcEEccccccccCcCCCCccccccceEeccccccccccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEE
Q 002349 209 GNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKL 288 (933)
Q Consensus 209 ~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 288 (933)
..+++|++|++++|++++. ..|..+..+++|++|+|++|.+++..|..|..+++|++|
T Consensus 147 ~~l~~L~~L~l~~n~l~~~----------------------~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 204 (306)
T 2z66_A 147 NGLSSLEVLKMAGNSFQEN----------------------FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 204 (306)
T ss_dssp TTCTTCCEEECTTCEEGGG----------------------EECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred ccCcCCCEEECCCCccccc----------------------cchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEE
Confidence 8888888888888877641 234445556666666666666666556666666666666
Q ss_pred EeeCCccCCCCCCccccCCcceEeeeccccccccCCccccccc-cccccccccccCCCCCC--CCcccCCCCCceeccCc
Q 002349 289 YLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLT-DLFDLNVANNHLEGPIP--DNLSSCTNLNSLNVHGN 365 (933)
Q Consensus 289 ~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~-~L~~L~L~~N~l~~~~p--~~l~~l~~L~~L~l~~N 365 (933)
+|++|++++..+..+..+++|++|+|++|++++..|..+..++ +|+.|++++|++.+... .....+...+.+.+..+
T Consensus 205 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~ 284 (306)
T 2z66_A 205 NMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVE 284 (306)
T ss_dssp ECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGG
T ss_pred ECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhcccc
Confidence 6666666655555566666666666666666666666666663 66666666666654221 01122334445555666
Q ss_pred ccCCCCCcccccc
Q 002349 366 KLNGTIPPAFQRL 378 (933)
Q Consensus 366 ~l~~~~~~~~~~l 378 (933)
.+....|..+.+.
T Consensus 285 ~~~C~~p~~~~g~ 297 (306)
T 2z66_A 285 RMECATPSDKQGM 297 (306)
T ss_dssp GCBEEESGGGTTC
T ss_pred ccccCCchhhCCc
Confidence 6665566655543
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-30 Score=289.31 Aligned_cols=277 Identities=18% Similarity=0.205 Sum_probs=199.3
Q ss_pred EEccccccccCcCCCCccccccceEeccccccccccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCcc
Q 002349 216 VLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKL 295 (933)
Q Consensus 216 ~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l 295 (933)
..++++|.++ .+|..+. .++++|+|++|++++..+..|..+++|++|+|++|.+++..+..|+++++|++|+|++|++
T Consensus 35 ~c~~~~~~l~-~iP~~~~-~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l 112 (353)
T 2z80_A 35 ICKGSSGSLN-SIPSGLT-EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYL 112 (353)
T ss_dssp EEECCSTTCS-SCCTTCC-TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred EeeCCCCCcc-ccccccc-ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcC
Confidence 3444444444 2333222 2455555555555555555677777888888888888777777777888888888888888
Q ss_pred CCCCCCccccCCcceEeeeccccccccCC-ccccccccccccccccc-cCCCCCCCCcccCCCCCceeccCcccCCCCCc
Q 002349 296 TGHIPPELGNMTKLHYLELNDNQLTGHIP-PALGKLTDLFDLNVANN-HLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPP 373 (933)
Q Consensus 296 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~~-~~l~~l~~L~~L~L~~N-~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~ 373 (933)
++..+..+.++++|++|++++|++++..+ ..+..+++|++|++++| .+.+..+..+.++++|+.|++++|++++..|.
T Consensus 113 ~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 192 (353)
T 2z80_A 113 SNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPK 192 (353)
T ss_dssp SSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTT
T ss_pred CcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHH
Confidence 75555557778888888888888874433 36777888888888887 46655667778888888888888888877778
Q ss_pred ccccccccceecCCcccccCCCccccccccccceeeccCCccCCCCCCCCC---CccccccccccCccccc----ccccc
Q 002349 374 AFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLG---DLEHLLKLNLSRNQLTG----FIPGE 446 (933)
Q Consensus 374 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~~L~Ls~N~l~~----~~p~~ 446 (933)
.|..+++|++|++++|.++......+..+++|+.|+|++|.+++..+..+. ....++.++|++|.+++ .+|..
T Consensus 193 ~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~ 272 (353)
T 2z80_A 193 SLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKL 272 (353)
T ss_dssp TTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHH
T ss_pred HHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchhhhHHH
Confidence 888888888888888888644444455678888888888888866555443 24556667777777664 47888
Q ss_pred cccccccceEEccCCccccccchhhccccccceeeecCCCCcCcccch
Q 002349 447 FGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDVMSL 494 (933)
Q Consensus 447 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~ 494 (933)
+.++++|++|+|++|+++...+..+..+++|++|+|++|+++|..+.+
T Consensus 273 l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~~l 320 (353)
T 2z80_A 273 LNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 320 (353)
T ss_dssp HHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHHHH
T ss_pred HhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCCCc
Confidence 999999999999999999544444689999999999999999988754
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-32 Score=316.26 Aligned_cols=219 Identities=26% Similarity=0.229 Sum_probs=174.1
Q ss_pred ccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcceEeeeccccccccCCcccccccccccc
Q 002349 257 LMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDL 336 (933)
Q Consensus 257 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L 336 (933)
.+++|+.|+|++|.+++..|..|+++++|++|+|++|.+++..| +..+++|++|+|++|.|++.. ..++|+.|
T Consensus 32 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~-----~~~~L~~L 104 (487)
T 3oja_A 32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIETL 104 (487)
T ss_dssp TGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEE-----ECTTCCEE
T ss_pred cCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCC-----CCCCcCEE
Confidence 44578888888888887777788888888888888888876555 778888888888888887543 23788888
Q ss_pred ccccccCCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCCccccc-cccccceeeccCCcc
Q 002349 337 NVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELS-RIGNLDTLDMSNNKI 415 (933)
Q Consensus 337 ~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l 415 (933)
++++|.+.+..+. .+++|+.|++++|++++..|..|+.+++|++|+|++|.+++.+|..+. .+++|+.|+|++|.|
T Consensus 105 ~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l 181 (487)
T 3oja_A 105 HAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI 181 (487)
T ss_dssp ECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCC
T ss_pred ECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcc
Confidence 8888888866554 346788888888888887788888888888888888888887777775 688888888888888
Q ss_pred CCCCCCCCCCccccccccccCcccccccccccccccccceEEccCCccccccchhhccccccceeeecCCCCcC
Q 002349 416 SGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSG 489 (933)
Q Consensus 416 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 489 (933)
++..+ +..+++|+.|+|++|+|++..| .|..+++|+.|+|++|+|++ +|..+..+++|+.|++++|++.|
T Consensus 182 ~~~~~--~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c 251 (487)
T 3oja_A 182 YDVKG--QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHC 251 (487)
T ss_dssp CEEEC--CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCH
T ss_pred ccccc--cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcC
Confidence 86532 3358888889999998886544 48888889999999998885 67778888888888888888884
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-33 Score=336.43 Aligned_cols=430 Identities=12% Similarity=0.070 Sum_probs=310.2
Q ss_pred CCCCccceEecCCCCcEEEEEcCCCCcCcccCCCCCCCCCccEEEccCCcc---cccCCCCcc------------CCCCC
Q 002349 54 DYCVWRGITCDNVTFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRL---SGQIPDEIG------------DCSSL 118 (933)
Q Consensus 54 ~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l---~~~~p~~l~------------~l~~L 118 (933)
-|++|.++.+... + .+.+.+ .....++..+..+++|++|+|+++.. .+.+|..++ .+++|
T Consensus 40 vck~W~~~~~~~~--~--~l~~~~-~~~~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L 114 (592)
T 3ogk_B 40 VCRRWFKIDSETR--E--HVTMAL-CYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQL 114 (592)
T ss_dssp SCHHHHHHHHHHC--C--EEEESC-GGGSCHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTC
T ss_pred HhHHHHHhhhccc--c--EEEEee-ccccChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCC
Confidence 3458999865321 2 222222 23333444566788899999987532 245555544 78999
Q ss_pred ceecccccccCCCCCcccccc--cchhhhhhcccC-ccC-CCCcccccCCCCceeeeecCCCCCC----cccccccCCCC
Q 002349 119 KSLDLSFNELYGDIPFSISKL--KQLEFLILKNNQ-LIG-PIPSTLSQLPNLKVFGLRGNNLVGT----LSPDMCQLSGL 190 (933)
Q Consensus 119 ~~L~Ls~n~l~~~~p~~~~~l--~~L~~L~L~~n~-l~~-~~p~~l~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L 190 (933)
++|+|++|.+++..+..+..+ .+|++|+|++|. ++. .++....++++|++|+|++|.+++. ++..+..+++|
T Consensus 115 ~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L 194 (592)
T 3ogk_B 115 KSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSL 194 (592)
T ss_dssp CEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCC
T ss_pred CeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCc
Confidence 999999999887777777664 459999999887 221 1233345789999999999998766 44455678999
Q ss_pred cEEeccCcccc----CccCcCCcCCCCCcEEccccccccCcCCCCc-cccccceEeccccccc---cccCcccccccccc
Q 002349 191 WYFDVRNNSLT----GSIPQNIGNCTSFQVLDLSYNQLSGEIPFNI-GFLQIATLSLQGNQLT---GKIPSVIGLMQALA 262 (933)
Q Consensus 191 ~~L~L~~n~l~----~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~-~~~~L~~L~L~~n~l~---~~~p~~~~~l~~L~ 262 (933)
++|++++|.++ +.++..+.++++|+.|++++|.+.+ +|..+ ...+|++|+++++... +..+..+..+++|+
T Consensus 195 ~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~ 273 (592)
T 3ogk_B 195 EVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLC 273 (592)
T ss_dssp CEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCC
T ss_pred cEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhcccccc
Confidence 99999999987 3445556788999999999998875 34333 3457889988864333 33455677888999
Q ss_pred EEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCC-CccccCCcceEeeeccccccccCCcccccccccccccccc-
Q 002349 263 VLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIP-PELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVAN- 340 (933)
Q Consensus 263 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~- 340 (933)
.|+++++.. +.+|..+..+++|++|+|++|.+++... ..+..+++|+.|+++++...+.++..+..+++|++|++++
T Consensus 274 ~L~l~~~~~-~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g 352 (592)
T 3ogk_B 274 RLGLSYMGP-NEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERG 352 (592)
T ss_dssp EEEETTCCT-TTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECC
T ss_pred ccCccccch-hHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEEeecC
Confidence 999988644 3677788889999999999999765433 3367889999999994433333444456788999999993
Q ss_pred ----------ccCCCC-CCCCcccCCCCCceeccCcccCCCCCccccc-ccccceecCC----cccccCC-----Ccccc
Q 002349 341 ----------NHLEGP-IPDNLSSCTNLNSLNVHGNKLNGTIPPAFQR-LESMTYLNLS----LNNIRGP-----IPVEL 399 (933)
Q Consensus 341 ----------N~l~~~-~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~-l~~L~~L~L~----~N~l~~~-----~~~~~ 399 (933)
|.+++. ++..+..+++|++|+++.|++++..+..+.. +++|+.|+++ .|.+++. ++..+
T Consensus 353 ~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~ 432 (592)
T 3ogk_B 353 ADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLL 432 (592)
T ss_dssp CCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHH
T ss_pred ccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHH
Confidence 555532 1222345889999999999998766666665 8899999996 6778764 33446
Q ss_pred ccccccceeeccCCc--cCCCCCCCCC-CccccccccccCccccc-ccccccccccccceEEccCCccccc-cchhhccc
Q 002349 400 SRIGNLDTLDMSNNK--ISGSIPSPLG-DLEHLLKLNLSRNQLTG-FIPGEFGNLRSVMEIDLSHNHLTGV-IPEELSQL 474 (933)
Q Consensus 400 ~~l~~L~~L~Ls~N~--l~~~~p~~~~-~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l 474 (933)
..+++|+.|+|++|. +++..+..+. .+++|++|+|++|++++ .++..+.++++|++|+|++|++++. ++.....+
T Consensus 433 ~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l 512 (592)
T 3ogk_B 433 IGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKL 512 (592)
T ss_dssp HHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHC
T ss_pred HhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhc
Confidence 778999999997543 6554444443 37889999999999986 3455668899999999999998765 34455679
Q ss_pred cccceeeecCCCCcCc
Q 002349 475 QNMFSLRLDYNNLSGD 490 (933)
Q Consensus 475 ~~L~~L~l~~N~l~~~ 490 (933)
++|++|+|++|+++..
T Consensus 513 ~~L~~L~ls~n~it~~ 528 (592)
T 3ogk_B 513 PSLRYLWVQGYRASMT 528 (592)
T ss_dssp SSCCEEEEESCBCCTT
T ss_pred CccCeeECcCCcCCHH
Confidence 9999999999998765
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-29 Score=275.34 Aligned_cols=250 Identities=23% Similarity=0.279 Sum_probs=206.4
Q ss_pred eEeccccccccccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCC--CCCccccCCcceEeeecc
Q 002349 239 TLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGH--IPPELGNMTKLHYLELND 316 (933)
Q Consensus 239 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~p~~l~~l~~L~~L~L~~ 316 (933)
.++++++.++ .+|..+ .++|++|+|++|.++...+..|.++++|++|+|++|.++.. .+..+..+++|++|+|++
T Consensus 11 ~l~c~~~~l~-~ip~~~--~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~ 87 (306)
T 2z66_A 11 EIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF 87 (306)
T ss_dssp EEECCSSCCS-SCCSCC--CTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCS
T ss_pred EEEcCCCCcc-cCCCCC--CCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCC
Confidence 3445555554 233332 25788888888888866666678888888888888888732 356677788899999999
Q ss_pred ccccccCCccccccccccccccccccCCCCCC-CCcccCCCCCceeccCcccCCCCCcccccccccceecCCcccccC-C
Q 002349 317 NQLTGHIPPALGKLTDLFDLNVANNHLEGPIP-DNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRG-P 394 (933)
Q Consensus 317 N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~ 394 (933)
|.++ .+|..+..+++|++|++++|++.+..+ ..+..+++|++|++++|++.+..+..|..+++|++|++++|.+++ .
T Consensus 88 n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 166 (306)
T 2z66_A 88 NGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENF 166 (306)
T ss_dssp CSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGE
T ss_pred Cccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCcccccc
Confidence 9888 466678888899999999998886554 578888999999999999988888888899999999999999986 5
Q ss_pred CccccccccccceeeccCCccCCCCCCCCCCccccccccccCcccccccccccccccccceEEccCCccccccchhhccc
Q 002349 395 IPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQL 474 (933)
Q Consensus 395 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 474 (933)
.|..+..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++..+..|.++++|+.|+|++|++++..|..+..+
T Consensus 167 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~ 246 (306)
T 2z66_A 167 LPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHF 246 (306)
T ss_dssp ECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCC
T ss_pred chhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhh
Confidence 78888899999999999999998888899999999999999999998888889999999999999999999999889888
Q ss_pred c-ccceeeecCCCCcCccc
Q 002349 475 Q-NMFSLRLDYNNLSGDVM 492 (933)
Q Consensus 475 ~-~L~~L~l~~N~l~~~~~ 492 (933)
+ +|++|+|++|+++|...
T Consensus 247 ~~~L~~L~L~~N~~~~~c~ 265 (306)
T 2z66_A 247 PSSLAFLNLTQNDFACTCE 265 (306)
T ss_dssp CTTCCEEECTTCCEECSGG
T ss_pred hccCCEEEccCCCeecccC
Confidence 5 89999999999988643
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.4e-29 Score=284.23 Aligned_cols=249 Identities=28% Similarity=0.349 Sum_probs=187.1
Q ss_pred cceEeccccccccccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcceEeeecc
Q 002349 237 IATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELND 316 (933)
Q Consensus 237 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~ 316 (933)
...++..++.++ .+|..+. ++++.|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++
T Consensus 45 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~ 121 (440)
T 3zyj_A 45 FSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFD 121 (440)
T ss_dssp SCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCS
T ss_pred CCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCC
Confidence 456777777777 3555443 5778888888888877777888888888888888888877677788888888888888
Q ss_pred ccccccCCccccccccccccccccccCCCCCCCCcccCCCCCceeccCc-ccCCCCCcccccccccceecCCcccccCCC
Q 002349 317 NQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGN-KLNGTIPPAFQRLESMTYLNLSLNNIRGPI 395 (933)
Q Consensus 317 N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 395 (933)
|++++..+..|..+++|++|+|++|++....+..|..+++|+.|++++| .+....+..|.++++|++|+|++|+++. +
T Consensus 122 n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~ 200 (440)
T 3zyj_A 122 NRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-I 200 (440)
T ss_dssp SCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS-C
T ss_pred CcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc-c
Confidence 8888666667788888888888888887666667778888888888874 4444444567778888888888888773 3
Q ss_pred ccccccccccceeeccCCccCCCCCCCCCCccccccccccCcccccccccccccccccceEEccCCccccccchhhcccc
Q 002349 396 PVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQ 475 (933)
Q Consensus 396 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 475 (933)
| .+..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|.++++|+.|+|++|+|++..+..+..++
T Consensus 201 ~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 279 (440)
T 3zyj_A 201 P-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLH 279 (440)
T ss_dssp C-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCT
T ss_pred c-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhcccc
Confidence 3 467777788888888888777777777788888888888888877777777788888888888888777777777777
Q ss_pred ccceeeecCCCCcCc
Q 002349 476 NMFSLRLDYNNLSGD 490 (933)
Q Consensus 476 ~L~~L~l~~N~l~~~ 490 (933)
+|+.|+|++|+|.|+
T Consensus 280 ~L~~L~L~~Np~~Cd 294 (440)
T 3zyj_A 280 HLERIHLHHNPWNCN 294 (440)
T ss_dssp TCCEEECCSSCEECS
T ss_pred CCCEEEcCCCCccCC
Confidence 777777766655543
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.3e-29 Score=285.30 Aligned_cols=248 Identities=22% Similarity=0.259 Sum_probs=123.4
Q ss_pred cEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcceEeeeccccccccCCccccccccccccccccc
Q 002349 262 AVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANN 341 (933)
Q Consensus 262 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N 341 (933)
..++.+++.++ .+|..+. ++++.|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|
T Consensus 46 ~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n 122 (440)
T 3zyj_A 46 SKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDN 122 (440)
T ss_dssp CEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSS
T ss_pred CEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCC
Confidence 34455555554 2333322 34455555555555444455555555555555555555444445555555555555555
Q ss_pred cCCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccceecCCcc-cccCCCccccccccccceeeccCCccCCCCC
Q 002349 342 HLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLN-NIRGPIPVELSRIGNLDTLDMSNNKISGSIP 420 (933)
Q Consensus 342 ~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p 420 (933)
++++..+..|..+++|++|++++|+++...+..|..+++|++|+|++| .+....+..|..+++|+.|+|++|+++ .+|
T Consensus 123 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~ 201 (440)
T 3zyj_A 123 RLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP 201 (440)
T ss_dssp CCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC
T ss_pred cCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc
Confidence 555444444555555555555555555444445555555555555552 233222334455555555555555554 233
Q ss_pred CCCCCccccccccccCcccccccccccccccccceEEccCCccccccchhhccccccceeeecCCCCcCcccch-hhccc
Q 002349 421 SPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDVMSL-INCLS 499 (933)
Q Consensus 421 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~~~ 499 (933)
.+..+++|+.|+|++|+|++..|..|.++++|+.|+|++|++++..+..|..+++|+.|+|++|++++.++.. ..+..
T Consensus 202 -~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 280 (440)
T 3zyj_A 202 -NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHH 280 (440)
T ss_dssp -CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTT
T ss_pred -ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccC
Confidence 2445555555555555555555555555555555555555555555555555555555555555555444332 22333
Q ss_pred cc-eeecCCCCCCCcc
Q 002349 500 LS-VLFIGNPGLCGYW 514 (933)
Q Consensus 500 ~~-~~~~~N~~~C~~~ 514 (933)
+. +.+.+|||.|+|.
T Consensus 281 L~~L~L~~Np~~CdC~ 296 (440)
T 3zyj_A 281 LERIHLHHNPWNCNCD 296 (440)
T ss_dssp CCEEECCSSCEECSST
T ss_pred CCEEEcCCCCccCCCC
Confidence 33 4445555555553
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=5.3e-29 Score=286.97 Aligned_cols=231 Identities=27% Similarity=0.314 Sum_probs=151.4
Q ss_pred ccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcceEeeeccccccccCCcccccccccccccc
Q 002349 259 QALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNV 338 (933)
Q Consensus 259 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L 338 (933)
++|+.|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|
T Consensus 75 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 154 (452)
T 3zyi_A 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWL 154 (452)
T ss_dssp TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEEC
T ss_pred CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEEC
Confidence 35555666666665555555666666666666666666555555666666666666666666555555556666666666
Q ss_pred ccccCCCCCCCCcccCCCCCceeccCc-ccCCCCCcccccccccceecCCcccccCCCccccccccccceeeccCCccCC
Q 002349 339 ANNHLEGPIPDNLSSCTNLNSLNVHGN-KLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISG 417 (933)
Q Consensus 339 ~~N~l~~~~p~~l~~l~~L~~L~l~~N-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 417 (933)
++|++....+..|..+++|+.|++++| .+....+..|.++++|++|+|++|++++. | .+..+++|+.|+|++|+|++
T Consensus 155 ~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~ 232 (452)
T 3zyi_A 155 RNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-P-NLTPLVGLEELEMSGNHFPE 232 (452)
T ss_dssp CSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-C-CCTTCTTCCEEECTTSCCSE
T ss_pred CCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-c-cccccccccEEECcCCcCcc
Confidence 666665555555666666666666663 33333334566666777777777776643 2 46667777777777777777
Q ss_pred CCCCCCCCccccccccccCcccccccccccccccccceEEccCCccccccchhhccccccceeeecCCCCcCcc
Q 002349 418 SIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDV 491 (933)
Q Consensus 418 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 491 (933)
..|..|.++++|+.|+|++|++++..|..|.++++|+.|+|++|+|++..+..+..+++|+.|+|++|+|.|+.
T Consensus 233 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC 306 (452)
T 3zyi_A 233 IRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDC 306 (452)
T ss_dssp ECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECST
T ss_pred cCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCC
Confidence 77777777777777777777777777777777777777777777777766677777777777777777776654
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-28 Score=284.34 Aligned_cols=251 Identities=22% Similarity=0.236 Sum_probs=225.9
Q ss_pred cccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcceEeeeccccccccCCccccccccccccccc
Q 002349 260 ALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVA 339 (933)
Q Consensus 260 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~ 339 (933)
....++.+++.++ .+|..+. ++++.|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|+
T Consensus 55 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~ 131 (452)
T 3zyi_A 55 QFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELF 131 (452)
T ss_dssp SSCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECC
Confidence 4567888888888 4555443 689999999999999889999999999999999999999988999999999999999
Q ss_pred cccCCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccceecCCc-ccccCCCccccccccccceeeccCCccCCC
Q 002349 340 NNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSL-NNIRGPIPVELSRIGNLDTLDMSNNKISGS 418 (933)
Q Consensus 340 ~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 418 (933)
+|++++..+..|..+++|++|+|++|+++...+..|.++++|++|++++ |.+....+..|..+++|+.|+|++|++++.
T Consensus 132 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~ 211 (452)
T 3zyi_A 132 DNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM 211 (452)
T ss_dssp SSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC
T ss_pred CCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc
Confidence 9999988888899999999999999999987788999999999999999 456555556799999999999999999954
Q ss_pred CCCCCCCccccccccccCcccccccccccccccccceEEccCCccccccchhhccccccceeeecCCCCcCcccch-hhc
Q 002349 419 IPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDVMSL-INC 497 (933)
Q Consensus 419 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~ 497 (933)
| .+..+++|+.|+|++|++++..|..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|++++.++.. ..+
T Consensus 212 -~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 289 (452)
T 3zyi_A 212 -P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPL 289 (452)
T ss_dssp -C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTC
T ss_pred -c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccc
Confidence 4 5889999999999999999999999999999999999999999999999999999999999999999887654 445
Q ss_pred cccc-eeecCCCCCCCccc
Q 002349 498 LSLS-VLFIGNPGLCGYWL 515 (933)
Q Consensus 498 ~~~~-~~~~~N~~~C~~~l 515 (933)
..+. +.+.+|||.|+|.+
T Consensus 290 ~~L~~L~L~~Np~~CdC~~ 308 (452)
T 3zyi_A 290 RYLVELHLHHNPWNCDCDI 308 (452)
T ss_dssp TTCCEEECCSSCEECSTTT
T ss_pred cCCCEEEccCCCcCCCCCc
Confidence 6666 77899999999965
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-28 Score=270.34 Aligned_cols=227 Identities=18% Similarity=0.259 Sum_probs=174.2
Q ss_pred ccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcceEeeeccccccccCCcccccccccccccc
Q 002349 259 QALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNV 338 (933)
Q Consensus 259 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L 338 (933)
.+++.|+|++|.++ .+|..++++++|++|+|++|.++ .+|..+.++++|++|+|++|+++ .+|..++.+++|++|++
T Consensus 81 ~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L 157 (328)
T 4fcg_A 81 PGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSI 157 (328)
T ss_dssp TTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEE
T ss_pred cceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEEC
Confidence 44555555555555 44445555555555555555555 45555555555555555555555 44555555555555566
Q ss_pred ccccCCCCCCCCcc---------cCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCCccccccccccceee
Q 002349 339 ANNHLEGPIPDNLS---------SCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLD 409 (933)
Q Consensus 339 ~~N~l~~~~p~~l~---------~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 409 (933)
++|++.+.+|..+. ++++|++|++++|+++ .+|..|..+++|++|+|++|++++ +|..+..+++|++|+
T Consensus 158 ~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~ 235 (328)
T 4fcg_A 158 RACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELD 235 (328)
T ss_dssp EEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEE
T ss_pred CCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEE
Confidence 55555555555544 5899999999999998 788889999999999999999995 566789999999999
Q ss_pred ccCCccCCCCCCCCCCccccccccccCcccccccccccccccccceEEccCCccccccchhhccccccceeeecCCCCcC
Q 002349 410 MSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSG 489 (933)
Q Consensus 410 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 489 (933)
|++|.+.+.+|..|..+++|+.|+|++|++.+.+|..+.++++|++|+|++|++.+.+|..+..+++|+.+++..|.+..
T Consensus 236 Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~~ 315 (328)
T 4fcg_A 236 LRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQ 315 (328)
T ss_dssp CTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSCC
T ss_pred CcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999998876654
Q ss_pred c
Q 002349 490 D 490 (933)
Q Consensus 490 ~ 490 (933)
.
T Consensus 316 l 316 (328)
T 4fcg_A 316 L 316 (328)
T ss_dssp -
T ss_pred H
Confidence 3
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=9e-30 Score=278.10 Aligned_cols=247 Identities=23% Similarity=0.288 Sum_probs=145.5
Q ss_pred CCCCCccEEEccCCcccccCCCCccCCCCCceeccccccc-CCCCCcccc-------cccchhhhhhcccCccCCCCccc
Q 002349 89 GDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNEL-YGDIPFSIS-------KLKQLEFLILKNNQLIGPIPSTL 160 (933)
Q Consensus 89 ~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l-~~~~p~~~~-------~l~~L~~L~L~~n~l~~~~p~~l 160 (933)
+..++|++|++++|.+ .+|..+... |++|+|++|.+ .+.+|..+. ++++|++|+|++|++++.+|..+
T Consensus 40 ~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 115 (312)
T 1wwl_A 40 GGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPL 115 (312)
T ss_dssp EEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCS
T ss_pred ccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHH
Confidence 3455677777777777 567666554 77777777777 445666555 67777777777777777777765
Q ss_pred --ccCCCCceeeeecCCCCCCcccccccC-----CCCcEEeccCccccCccCcCCcCCCCCcEEccccccccCcCC--CC
Q 002349 161 --SQLPNLKVFGLRGNNLVGTLSPDMCQL-----SGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIP--FN 231 (933)
Q Consensus 161 --~~l~~L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p--~~ 231 (933)
+.+++|++|+|++|++++. |..+..+ ++|++|+|++|++++..|..++++++|++|+|++|++.+.++ ..
T Consensus 116 ~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 194 (312)
T 1wwl_A 116 LEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISA 194 (312)
T ss_dssp SSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHH
T ss_pred HHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHH
Confidence 7777777777777777766 6666666 777777777777777666777777777777777777654321 11
Q ss_pred ---ccccccceEecccccccc---ccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCcccc
Q 002349 232 ---IGFLQIATLSLQGNQLTG---KIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGN 305 (933)
Q Consensus 232 ---~~~~~L~~L~L~~n~l~~---~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~ 305 (933)
....+|++|+|++|++++ .....+..+++|++|+|++|++++..|. ..+..
T Consensus 195 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-----------------------~~~~~ 251 (312)
T 1wwl_A 195 LCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGA-----------------------PSCDW 251 (312)
T ss_dssp SCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCC-----------------------SCCCC
T ss_pred HHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccch-----------------------hhhhh
Confidence 112244444444444441 1112223344555555555555443321 23333
Q ss_pred CCcceEeeeccccccccCCccccccccccccccccccCCCCCCCCcccCCCCCceeccCcccC
Q 002349 306 MTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLN 368 (933)
Q Consensus 306 l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~ 368 (933)
+++|++|+|++|+|+ .+|..+. ++|+.|++++|++++. |. +..+++|++|++++|+++
T Consensus 252 l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~ 309 (312)
T 1wwl_A 252 PSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFL 309 (312)
T ss_dssp CTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTT
T ss_pred cCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCC
Confidence 444555555555554 3344333 4555555555555433 33 555555555555555554
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.9e-29 Score=293.17 Aligned_cols=287 Identities=28% Similarity=0.334 Sum_probs=151.7
Q ss_pred CCcCCCCCCCCCCCCCccceE--------ecCCCCcEEEEEcCCCCcCcccCCCCCCCCCccEEEccCCcccccCCCCcc
Q 002349 42 NVLYDWTDSPSSDYCVWRGIT--------CDNVTFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIG 113 (933)
Q Consensus 42 ~~l~~w~~~~~~~~c~w~gv~--------C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~ 113 (933)
...++|.. ..+||.|+|.. |.. ..++.|++++++++ .+|..+. ++|++|+|++|+|+ .+|.
T Consensus 10 ~~w~~W~~--~~~~~~~~~r~~~~~~~~~c~~--~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~--- 78 (622)
T 3g06_A 10 AVWSAWRR--AAPAEESRGRAAVVQKMRACLN--NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA--- 78 (622)
T ss_dssp CHHHHHHH--TCCGGGHHHHHHHHHHHHHHHH--HCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---
T ss_pred HHHHHHHh--cCCcchhccccccCcccccccC--CCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---
Confidence 44567864 35789997643 322 23567777777777 6666555 67777777777777 4555
Q ss_pred CCCCCceecccccccCCCCCcccccccchhhhhhcccCccCCCCcccccCCCCceeeeecCCCCCCcccccccCCCCcEE
Q 002349 114 DCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYF 193 (933)
Q Consensus 114 ~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 193 (933)
.+++|++|+|++|.|+ .+|. .+++|++|+|++|++++ +|. .+++|+.|+|++|++++ +|.. +++|++|
T Consensus 79 ~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L 146 (622)
T 3g06_A 79 LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQEL 146 (622)
T ss_dssp CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEE
T ss_pred cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEE
Confidence 4567777777777776 4554 45666666666666664 333 34556666666665553 2221 2444444
Q ss_pred eccCccccCccCcCCcCCCCCcEEccccccccCcCCCCccccccceEeccccccccccCccccccccccEEeccCCcCcC
Q 002349 194 DVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSG 273 (933)
Q Consensus 194 ~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 273 (933)
+|++|.+++ +|. .+++|+.|++++|+ +++ +| ..+++|+.|+|++|.+++
T Consensus 147 ~Ls~N~l~~-l~~---~~~~L~~L~L~~N~-----------------------l~~-l~---~~~~~L~~L~Ls~N~l~~ 195 (622)
T 3g06_A 147 SVSDNQLAS-LPA---LPSELCKLWAYNNQ-----------------------LTS-LP---MLPSGLQELSVSDNQLAS 195 (622)
T ss_dssp ECCSSCCSC-CCC---CCTTCCEEECCSSC-----------------------CSC-CC---CCCTTCCEEECCSSCCSC
T ss_pred ECcCCcCCC-cCC---ccCCCCEEECCCCC-----------------------CCC-Cc---ccCCCCcEEECCCCCCCC
Confidence 444444442 222 12233444444443 332 22 234556666666666653
Q ss_pred CCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcceEeeeccccccccCCccccccccccccccccccCCCCCCCCccc
Q 002349 274 PIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSS 353 (933)
Q Consensus 274 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~ 353 (933)
+|.. +++|+.|++++|.++. +|.. +++|+.|+|++|+|++ +| ..+++|+.|++++|+|+ .+|. .
T Consensus 196 -l~~~---~~~L~~L~L~~N~l~~-l~~~---~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~ 259 (622)
T 3g06_A 196 -LPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---L 259 (622)
T ss_dssp -CCCC---CTTCCEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---C
T ss_pred -CCCc---cchhhEEECcCCcccc-cCCC---CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---c
Confidence 2222 2456666666666652 3322 2455666666665553 33 23345555555555554 2332 3
Q ss_pred CCCCCceeccCcccCCCCCcccccccccceecCCcccccCCCcccc
Q 002349 354 CTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVEL 399 (933)
Q Consensus 354 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 399 (933)
+++|+.|+|++|+|+ .+|..|.++++|+.|+|++|.+++..|..+
T Consensus 260 ~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l 304 (622)
T 3g06_A 260 PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL 304 (622)
T ss_dssp CTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHH
T ss_pred cccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHH
Confidence 344555555555554 334444444555555555554444444433
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-28 Score=263.32 Aligned_cols=210 Identities=25% Similarity=0.336 Sum_probs=123.1
Q ss_pred CCccEEEeeCCccCCCCCCccccCCcceEeeeccccccccCCcccccccccccccccccc-CCCCCCCCcccCCCCCcee
Q 002349 283 SYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNH-LEGPIPDNLSSCTNLNSLN 361 (933)
Q Consensus 283 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~-l~~~~p~~l~~l~~L~~L~ 361 (933)
++|++|+|++|.+++..+..|..+++|++|+|++|.+++..|..|..+++|++|++++|+ +....|..+..+++|++|+
T Consensus 32 ~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~ 111 (285)
T 1ozn_A 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (285)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEE
Confidence 345555555555554444445555555555555555554445555555555555555554 4444455555555555566
Q ss_pred ccCcccCCCCCcccccccccceecCCcccccCCCccccccccccceeeccCCccCCCCCCCCCCccccccccccCccccc
Q 002349 362 VHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTG 441 (933)
Q Consensus 362 l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 441 (933)
+++|++++..+..|..+++|++|++++|++++..+..+..+++|+.|+|++|++++..+..|..+++|+.|+|++|++++
T Consensus 112 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 191 (285)
T 1ozn_A 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191 (285)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred CCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccc
Confidence 66655555555555556666666666666655555555566666666666666665444556666666666666666666
Q ss_pred ccccccccccccceEEccCCccccccchhhccccccceeeecCCCCcCccc
Q 002349 442 FIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDVM 492 (933)
Q Consensus 442 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~ 492 (933)
..|..|.++++|+.|+|++|++++..+..+..+++|+.|++++|++.|..+
T Consensus 192 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~ 242 (285)
T 1ozn_A 192 VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242 (285)
T ss_dssp ECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred cCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCC
Confidence 666666666666666666666666555556666666666666666666544
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-29 Score=276.96 Aligned_cols=251 Identities=21% Similarity=0.204 Sum_probs=146.8
Q ss_pred CcCCCCCcEEccccccccCcCCCCccccccceEecccccc-ccccCcccc-------ccccccEEeccCCcCcCCCCCCC
Q 002349 208 IGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQL-TGKIPSVIG-------LMQALAVLDLSCNMLSGPIPPIL 279 (933)
Q Consensus 208 l~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~l-~~~~p~~~~-------~l~~L~~L~Ls~N~l~~~~~~~~ 279 (933)
++..++|+.|++++|.+ .+|..+... ++.|+|++|++ .+.+|..+. .+++|++|+|++|.+++.+|..+
T Consensus 39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~-L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 115 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVDTE--ADLGQFTDI-IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPL 115 (312)
T ss_dssp EEEEEECTTHHHHCCTT--CCCHHHHHH-HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCS
T ss_pred EccCCCceeEeeccccc--ccHHHHHHH-HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHH
Confidence 45556677777777777 455444332 66666666666 334555444 56677777777777776666655
Q ss_pred --CCCCCccEEEeeCCccCCCCCCccccC-----CcceEeeeccccccccCCccccccccccccccccccCCCCCCCCcc
Q 002349 280 --GNLSYTEKLYLHSNKLTGHIPPELGNM-----TKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLS 352 (933)
Q Consensus 280 --~~l~~L~~L~L~~N~l~~~~p~~l~~l-----~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~ 352 (933)
+.+++|++|+|++|++++. |..+..+ ++|++|+|++|++++..|..|+.+++|++|++++|++.+.++
T Consensus 116 ~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~---- 190 (312)
T 1wwl_A 116 LEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG---- 190 (312)
T ss_dssp SSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHH----
T ss_pred HHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchH----
Confidence 6667777777777777655 5555555 566666666666665555555555555555555555433210
Q ss_pred cCCCCCceeccCcccCCCCCccc--ccccccceecCCcccccCC---CccccccccccceeeccCCccCCCCC-CCCCCc
Q 002349 353 SCTNLNSLNVHGNKLNGTIPPAF--QRLESMTYLNLSLNNIRGP---IPVELSRIGNLDTLDMSNNKISGSIP-SPLGDL 426 (933)
Q Consensus 353 ~l~~L~~L~l~~N~l~~~~~~~~--~~l~~L~~L~L~~N~l~~~---~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l 426 (933)
.+..+ ..+++|++|+|++|++++. ....+..+++|+.|+|++|++++.+| ..+..+
T Consensus 191 ------------------~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l 252 (312)
T 1wwl_A 191 ------------------LISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWP 252 (312)
T ss_dssp ------------------HHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCC
T ss_pred ------------------HHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhc
Confidence 11112 4445555555555555421 11223345566666666666665553 344456
Q ss_pred cccccccccCcccccccccccccccccceEEccCCccccccchhhccccccceeeecCCCCcC
Q 002349 427 EHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSG 489 (933)
Q Consensus 427 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 489 (933)
++|++|+|++|+|+ .+|..+. ++|++|||++|+|++. |. +..+++|++|+|++|++++
T Consensus 253 ~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 253 SQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp TTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred CCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 66666666666666 4555554 6667777777777655 44 6666777777777776664
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.8e-28 Score=262.85 Aligned_cols=252 Identities=22% Similarity=0.222 Sum_probs=198.3
Q ss_pred eEeccccccccccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcceEeeecccc
Q 002349 239 TLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQ 318 (933)
Q Consensus 239 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~ 318 (933)
+++++++.++. +|..+ .++|++|+|++|.+++..+..|.++++|++|+|++|.+++..|..|..+++|++|++++|.
T Consensus 15 ~~~c~~~~l~~-ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 91 (285)
T 1ozn_A 15 TTSCPQQGLQA-VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91 (285)
T ss_dssp EEECCSSCCSS-CCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCT
T ss_pred EEEcCcCCccc-CCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCC
Confidence 34444444442 33322 3577778888888777666777788888888888888877767778888888888888886
Q ss_pred -ccccCCccccccccccccccccccCCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCCcc
Q 002349 319 -LTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPV 397 (933)
Q Consensus 319 -l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 397 (933)
++...|..+..+++|++|++++|++.+..|..+..+++|++|++++|++++..+..|..+++|++|+|++|++++..+.
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 171 (285)
T 1ozn_A 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPER 171 (285)
T ss_dssp TCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTT
T ss_pred CccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHH
Confidence 7766677788888888888888888877777888888888888888888877777788888899999999988877667
Q ss_pred ccccccccceeeccCCccCCCCCCCCCCccccccccccCcccccccccccccccccceEEccCCccccccchhhcccccc
Q 002349 398 ELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNM 477 (933)
Q Consensus 398 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 477 (933)
.+..+++|+.|+|++|.+++..|..|..+++|+.|+|++|++++..+..|.++++|+.|+|++|++.+..+.. .....+
T Consensus 172 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~-~~~~~l 250 (285)
T 1ozn_A 172 AFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWAWL 250 (285)
T ss_dssp TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH-HHHHHH
T ss_pred HhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcH-HHHHHH
Confidence 7888899999999999999888899999999999999999999887788999999999999999998655432 233556
Q ss_pred ceeeecCCCCcCcccch
Q 002349 478 FSLRLDYNNLSGDVMSL 494 (933)
Q Consensus 478 ~~L~l~~N~l~~~~~~~ 494 (933)
+.+..+.|.+.|..|..
T Consensus 251 ~~~~~~~~~~~c~~p~~ 267 (285)
T 1ozn_A 251 QKFRGSSSEVPCSLPQR 267 (285)
T ss_dssp HHCCSEECCCBEEESGG
T ss_pred HhcccccCccccCCchH
Confidence 66778888888876653
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-31 Score=317.93 Aligned_cols=414 Identities=11% Similarity=0.077 Sum_probs=309.2
Q ss_pred cEEEEEcCCCCc---CcccCCCCC------------CCCCccEEEccCCcccccCCCCccCC--CCCceecccccc-cCC
Q 002349 69 TVIALNLSGLNL---DGEISPAVG------------DLKDLQSIDLRGNRLSGQIPDEIGDC--SSLKSLDLSFNE-LYG 130 (933)
Q Consensus 69 ~v~~l~l~~~~l---~~~~~~~l~------------~l~~L~~L~Ls~n~l~~~~p~~l~~l--~~L~~L~Ls~n~-l~~ 130 (933)
++..|+|+++.. .|.+|..++ .+++|++|+|++|.+++..+..++.+ .+|++|+|++|. ++.
T Consensus 74 ~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~ 153 (592)
T 3ogk_B 74 NLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTT 153 (592)
T ss_dssp TCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEH
T ss_pred CCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCH
Confidence 477888877532 234444444 78999999999999987777777764 459999999987 221
Q ss_pred -CCCcccccccchhhhhhcccCccCC----CCcccccCCCCceeeeecCCCCC----CcccccccCCCCcEEeccCcccc
Q 002349 131 -DIPFSISKLKQLEFLILKNNQLIGP----IPSTLSQLPNLKVFGLRGNNLVG----TLSPDMCQLSGLWYFDVRNNSLT 201 (933)
Q Consensus 131 -~~p~~~~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~n~l~ 201 (933)
.++..+.++++|++|+|++|.+++. ++..+..+++|++|+|++|.+++ .++..+.++++|++|++++|.+.
T Consensus 154 ~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~ 233 (592)
T 3ogk_B 154 DGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEIL 233 (592)
T ss_dssp HHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGG
T ss_pred HHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHH
Confidence 1222335789999999999999876 44456789999999999999973 34445678899999999999998
Q ss_pred CccCcCCcCCCCCcEEcccccccc---CcCCCCcc-ccccceEeccccccccccCccccccccccEEeccCCcCcCCCC-
Q 002349 202 GSIPQNIGNCTSFQVLDLSYNQLS---GEIPFNIG-FLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIP- 276 (933)
Q Consensus 202 ~~~p~~l~~l~~L~~L~L~~N~l~---~~~p~~~~-~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~- 276 (933)
+ +|..+.++++|++|+++.+... +..+..+. ..+|+.|+++++. .+.+|..+..+++|++|+|++|.+++...
T Consensus 234 ~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~-~~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~ 311 (592)
T 3ogk_B 234 E-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMG-PNEMPILFPFAAQIRKLDLLYALLETEDHC 311 (592)
T ss_dssp G-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCC-TTTGGGGGGGGGGCCEEEETTCCCCHHHHH
T ss_pred H-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccc-hhHHHHHHhhcCCCcEEecCCCcCCHHHHH
Confidence 6 7788999999999999864432 12222222 3478999998864 34678888899999999999999765433
Q ss_pred CCCCCCCCccEEEeeCCccC-CCCCCccccCCcceEeeec-----------cccccccCCc-cccccccccccccccccC
Q 002349 277 PILGNLSYTEKLYLHSNKLT-GHIPPELGNMTKLHYLELN-----------DNQLTGHIPP-ALGKLTDLFDLNVANNHL 343 (933)
Q Consensus 277 ~~~~~l~~L~~L~L~~N~l~-~~~p~~l~~l~~L~~L~L~-----------~N~l~~~~~~-~l~~l~~L~~L~L~~N~l 343 (933)
..+..+++|++|+++ +.+. +.++..+..+++|++|+++ .|.+++.... ....+++|++|+++.|.+
T Consensus 312 ~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l 390 (592)
T 3ogk_B 312 TLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDI 390 (592)
T ss_dssp HHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCC
T ss_pred HHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCc
Confidence 346789999999999 4444 3344445678999999999 3677644222 245589999999999999
Q ss_pred CCCCCCCccc-CCCCCceecc----CcccCCC-----CCcccccccccceecCCcc--cccCCCcccccc-ccccceeec
Q 002349 344 EGPIPDNLSS-CTNLNSLNVH----GNKLNGT-----IPPAFQRLESMTYLNLSLN--NIRGPIPVELSR-IGNLDTLDM 410 (933)
Q Consensus 344 ~~~~p~~l~~-l~~L~~L~l~----~N~l~~~-----~~~~~~~l~~L~~L~L~~N--~l~~~~~~~~~~-l~~L~~L~L 410 (933)
++..+..+.. +++|+.|+++ .|++++. ++..+.++++|++|++++| .+++..+..+.. +++|++|+|
T Consensus 391 ~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L 470 (592)
T 3ogk_B 391 TNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLL 470 (592)
T ss_dssp CHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEE
T ss_pred cHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeec
Confidence 8766666665 8999999996 7788864 3344777999999999854 366555555543 889999999
Q ss_pred cCCccCCC-CCCCCCCccccccccccCcccccc-cccccccccccceEEccCCccccccchhh-ccccccceeeecCC
Q 002349 411 SNNKISGS-IPSPLGDLEHLLKLNLSRNQLTGF-IPGEFGNLRSVMEIDLSHNHLTGVIPEEL-SQLQNMFSLRLDYN 485 (933)
Q Consensus 411 s~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~l~~N 485 (933)
++|.+++. ++..+..+++|++|+|++|.+++. ++..+..+++|++|+|++|++++.-...+ ..++.+....+..+
T Consensus 471 ~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~~~ 548 (592)
T 3ogk_B 471 GYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSR 548 (592)
T ss_dssp CSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTTCTTGGGGCCTTEEEEEECCC
T ss_pred cCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHHHHHHHHHhCCCcEEEEecCc
Confidence 99999863 445567889999999999998855 44455789999999999999987644333 35666655555443
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7e-29 Score=291.35 Aligned_cols=184 Identities=16% Similarity=0.088 Sum_probs=130.2
Q ss_pred eecccceeEEEEE-EcCCceEEEEEecccC----------chhHHHHHHHHHHHhcC-CCCceeeeeeEEecCCccEEEE
Q 002349 606 IGYGASSTVYKCV-LKNCKPVAIKRLYSHY----------PQCLKEFETELETVGSI-KHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 606 lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 673 (933)
.+.|+.|.+..++ .-.|+.+|||.+.... ....++|.+|+++|+++ .|+||+++++++.+++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 5667777666655 3347889999996542 12346799999999999 7999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
||++|++|.+++. ..++++.. +|+.||+.||+|+|++ |||||||||+|||++++|.+||+|||+|+.....
T Consensus 322 Eyv~G~~L~d~i~---~~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 322 EKLPGRLLSDMLA---AGEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp ECCCSEEHHHHHH---TTCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred ecCCCCcHHHHHH---hCCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 9999999999995 45667654 5889999999999976 9999999999999999999999999999876433
Q ss_pred CCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCC
Q 002349 754 KSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKA 800 (933)
Q Consensus 754 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p 800 (933)
. ......+||++|||||++.+. +..++|+||+|++++++.++..+
T Consensus 393 ~-~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 C-SWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp --CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred C-ccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 2 233456899999999999764 67789999999998887665443
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=9.6e-27 Score=274.86 Aligned_cols=268 Identities=27% Similarity=0.356 Sum_probs=160.5
Q ss_pred chhhhhhcccCccCCCCcccccCCCCceeeeecCCCCCCcccccccCCCCcEEeccCccccCccCcCCcCCCCCcEEccc
Q 002349 141 QLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLS 220 (933)
Q Consensus 141 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~ 220 (933)
+++.|++++|.++ .+|..+. ++|+.|+|++|+++ .+|. .+++|++|+|++|+++ .+|. .+++|++|+|+
T Consensus 41 ~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls 109 (622)
T 3g06_A 41 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIF 109 (622)
T ss_dssp CCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEEC
T ss_pred CCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECc
Confidence 4677777777777 5666554 67777777777776 3333 4566666666666666 3444 45666666666
Q ss_pred cccccCcCCCCccccccceEeccccccccccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCC
Q 002349 221 YNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIP 300 (933)
Q Consensus 221 ~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 300 (933)
+|++++ +|. .+++|+.|++++|++++ +|.. +++|++|+|++|++++ +|
T Consensus 110 ~N~l~~-l~~--------------------------~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~-l~ 157 (622)
T 3g06_A 110 SNPLTH-LPA--------------------------LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LP 157 (622)
T ss_dssp SCCCCC-CCC--------------------------CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CC
T ss_pred CCcCCC-CCC--------------------------CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCC-cC
Confidence 666653 221 23445555555555553 2222 2555555555555553 23
Q ss_pred CccccCCcceEeeeccccccccCCccccccccccccccccccCCCCCCCCcccCCCCCceeccCcccCCCCCcccccccc
Q 002349 301 PELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLES 380 (933)
Q Consensus 301 ~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~ 380 (933)
. .+++|+.|++++|+|++ +| ..+++|+.|++++|++++ +|.. +++|+.|++++|+++. +|.. +++
T Consensus 158 ~---~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~~-l~~~---~~~ 222 (622)
T 3g06_A 158 A---LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---PSG 222 (622)
T ss_dssp C---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSS-CCCC---CTT
T ss_pred C---ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCcccc-cCCC---CCC
Confidence 2 23455566666666653 33 234556666666666653 3322 3566666666666663 3322 356
Q ss_pred cceecCCcccccCCCccccccccccceeeccCCccCCCCCCCCCCccccccccccCcccccccccccccccccceEEccC
Q 002349 381 MTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSH 460 (933)
Q Consensus 381 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 460 (933)
|++|+|++|++++ +| ..+++|+.|+|++|+|+ .+|. .+++|+.|+|++|+|+ .+|..|.++++|+.|+|++
T Consensus 223 L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~ 293 (622)
T 3g06_A 223 LKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEG 293 (622)
T ss_dssp CCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCS
T ss_pred CCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecC
Confidence 7777777777764 33 34466777777777777 3444 4566777777777777 5577777777777777777
Q ss_pred Cccccccchhhcccc
Q 002349 461 NHLTGVIPEELSQLQ 475 (933)
Q Consensus 461 N~l~~~~p~~~~~l~ 475 (933)
|++++.+|..+..++
T Consensus 294 N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 294 NPLSERTLQALREIT 308 (622)
T ss_dssp CCCCHHHHHHHHHHH
T ss_pred CCCCCcCHHHHHhcc
Confidence 777777777666655
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.5e-29 Score=272.55 Aligned_cols=248 Identities=21% Similarity=0.245 Sum_probs=136.7
Q ss_pred cCCCCceeeeecCCCCCCcccccccCCCCcEEeccCccccCccCcCCcCCCCCcEEccccccccCcCCCCccccccceEe
Q 002349 162 QLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLS 241 (933)
Q Consensus 162 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~ 241 (933)
.+++|++|+|++|++++..|..|..+++|++|+|++|.+++..+ +..+++|++|+|++|++++..
T Consensus 32 ~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~------------- 96 (317)
T 3o53_A 32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL------------- 96 (317)
T ss_dssp TGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEE-------------
T ss_pred cCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcccccc-------------
Confidence 34445555555555554444445555555555555555554333 555566666666655554211
Q ss_pred ccccccccccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcceEeeeccccccc
Q 002349 242 LQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTG 321 (933)
Q Consensus 242 L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ 321 (933)
..++|++|++++|.+++..+.. +++|++|++++|++++..+..+..+++|++|+|++|++++
T Consensus 97 ---------------~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 158 (317)
T 3o53_A 97 ---------------VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDT 158 (317)
T ss_dssp ---------------ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCE
T ss_pred ---------------CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCc
Confidence 1134555555555554433322 3455666666666665555556666666666666666665
Q ss_pred cCCcccc-ccccccccccccccCCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCCccccc
Q 002349 322 HIPPALG-KLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELS 400 (933)
Q Consensus 322 ~~~~~l~-~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 400 (933)
..+..+. .+++|++|++++|++++. + ....+++|++|+|++|++++. |..+.
T Consensus 159 ~~~~~~~~~l~~L~~L~L~~N~l~~~-~-------------------------~~~~l~~L~~L~Ls~N~l~~l-~~~~~ 211 (317)
T 3o53_A 159 VNFAELAASSDTLEHLNLQYNFIYDV-K-------------------------GQVVFAKLKTLDLSSNKLAFM-GPEFQ 211 (317)
T ss_dssp EEGGGGGGGTTTCCEEECTTSCCCEE-E-------------------------CCCCCTTCCEEECCSSCCCEE-CGGGG
T ss_pred ccHHHHhhccCcCCEEECCCCcCccc-c-------------------------cccccccCCEEECCCCcCCcc-hhhhc
Confidence 5444442 445555555555555422 1 111244555555555555532 33355
Q ss_pred cccccceeeccCCccCCCCCCCCCCccccccccccCcccc-cccccccccccccceEEcc-CCccccccchh
Q 002349 401 RIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLT-GFIPGEFGNLRSVMEIDLS-HNHLTGVIPEE 470 (933)
Q Consensus 401 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls-~N~l~~~~p~~ 470 (933)
.+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|.++ +.+|..+..+++|+.|+++ .+.++|..|..
T Consensus 212 ~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~~ 282 (317)
T 3o53_A 212 SAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEE 282 (317)
T ss_dssp GGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSCC
T ss_pred ccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchhc
Confidence 6666666666666666 45666677777777777777777 6667777777777777777 33566655543
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.7e-29 Score=273.08 Aligned_cols=257 Identities=21% Similarity=0.201 Sum_probs=133.1
Q ss_pred ccEEEccCCcccccCCCCccCCCCCceecccccccCCCCCcccccccchhhhhhcccCccCCCCcccccCCCCceeeeec
Q 002349 94 LQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRG 173 (933)
Q Consensus 94 L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~ 173 (933)
++.++++.+.+...++..+..+++|++|+|++|.+++..|..|..+++|++|+|++|++++..| ++.+++|++|+|++
T Consensus 12 l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~ 89 (317)
T 3o53_A 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNN 89 (317)
T ss_dssp EEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCS
T ss_pred eeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcC
Confidence 3445555555543333334445566666666666655555555555555555555555554332 55555555555555
Q ss_pred CCCCCCcccccccCCCCcEEeccCccccCccCcCCcCCCCCcEEccccccccCcCCCCccccccceEeccccccccccCc
Q 002349 174 NNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPS 253 (933)
Q Consensus 174 N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~ 253 (933)
|+++ +.. ..++|++|++++|++++..+.. ..+|++|++++|++++..+.
T Consensus 90 n~l~------------------------~l~-----~~~~L~~L~l~~n~l~~~~~~~--~~~L~~L~l~~N~l~~~~~~ 138 (317)
T 3o53_A 90 NYVQ------------------------ELL-----VGPSIETLHAANNNISRVSCSR--GQGKKNIYLANNKITMLRDL 138 (317)
T ss_dssp SEEE------------------------EEE-----ECTTCCEEECCSSCCSEEEECC--CSSCEEEECCSSCCCSGGGB
T ss_pred Cccc------------------------ccc-----CCCCcCEEECCCCccCCcCccc--cCCCCEEECCCCCCCCccch
Confidence 5544 211 2245555555555554322221 12344444444444444444
Q ss_pred cccccccccEEeccCCcCcCCCCCCCC-CCCCccEEEeeCCccCCCCCCccccCCcceEeeeccccccccCCcccccccc
Q 002349 254 VIGLMQALAVLDLSCNMLSGPIPPILG-NLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTD 332 (933)
Q Consensus 254 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~ 332 (933)
.++.+++|++|+|++|.+++..+..+. .+++|++|+|++|.+++. + ....+++|++|+|++|++++. |..+..+++
T Consensus 139 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~ 215 (317)
T 3o53_A 139 DEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAFM-GPEFQSAAG 215 (317)
T ss_dssp CTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCEE-CGGGGGGTT
T ss_pred hhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCCcc-hhhhcccCc
Confidence 555566666666666666655444442 456666666666666533 2 122355666666666666532 333555555
Q ss_pred ccccccccccCCCCCCCCcccCCCCCceeccCcccC-CCCCcccccccccceecCC
Q 002349 333 LFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLN-GTIPPAFQRLESMTYLNLS 387 (933)
Q Consensus 333 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~L~ 387 (933)
|+.|++++|+++ .+|..+..+++|+.|++++|++. +.++..+..+++|+.|+++
T Consensus 216 L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~ 270 (317)
T 3o53_A 216 VTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (317)
T ss_dssp CSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHH
T ss_pred ccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECC
Confidence 666666666555 34445555555555555555555 4444455555555555554
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.7e-27 Score=274.16 Aligned_cols=234 Identities=20% Similarity=0.212 Sum_probs=188.4
Q ss_pred ccceEeccccccccccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcceEeeec
Q 002349 236 QIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELN 315 (933)
Q Consensus 236 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~ 315 (933)
+|++|+|++|++++..|..|+.+++|++|+|++|.+++..| |+.+++|++|+|++|.|++.. ..++|++|+++
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~-----~~~~L~~L~L~ 107 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELL-----VGPSIETLHAA 107 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEE-----ECTTCCEEECC
T ss_pred CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCC-----CCCCcCEEECc
Confidence 34455555555555556677778888888888888876655 778888888888888887432 23788888888
Q ss_pred cccccccCCccccccccccccccccccCCCCCCCCcccCCCCCceeccCcccCCCCCcccc-cccccceecCCcccccCC
Q 002349 316 DNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQ-RLESMTYLNLSLNNIRGP 394 (933)
Q Consensus 316 ~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~ 394 (933)
+|.+++..+. .+++|+.|++++|.+++..|..+..+++|+.|+|++|++++.+|..|. .+++|++|+|++|.+++.
T Consensus 108 ~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~ 184 (487)
T 3oja_A 108 NNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV 184 (487)
T ss_dssp SSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE
T ss_pred CCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc
Confidence 8888876554 356788888888888888788888889999999999999887887776 789999999999999866
Q ss_pred CccccccccccceeeccCCccCCCCCCCCCCccccccccccCcccccccccccccccccceEEccCCccc-cccchhhcc
Q 002349 395 IPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLT-GVIPEELSQ 473 (933)
Q Consensus 395 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~ 473 (933)
.+ +..+++|+.|+|++|.|++. |..+..+++|+.|+|++|.|++ +|..+..+++|+.|++++|.+. +.+|..+..
T Consensus 185 ~~--~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~ 260 (487)
T 3oja_A 185 KG--QVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSK 260 (487)
T ss_dssp EC--CCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTT
T ss_pred cc--cccCCCCCEEECCCCCCCCC-CHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHHh
Confidence 32 34588999999999999964 4458899999999999999995 6888999999999999999998 778888888
Q ss_pred ccccceeeec
Q 002349 474 LQNMFSLRLD 483 (933)
Q Consensus 474 l~~L~~L~l~ 483 (933)
++.|+.++++
T Consensus 261 l~~L~~l~~~ 270 (487)
T 3oja_A 261 NQRVQTVAKQ 270 (487)
T ss_dssp CHHHHHHHHH
T ss_pred CCCCcEEecc
Confidence 9888887775
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.93 E-value=7.3e-26 Score=241.67 Aligned_cols=169 Identities=25% Similarity=0.247 Sum_probs=109.1
Q ss_pred CCCCCccceEecCCCCcEEEEEcCCCCcCcccCCCCCCCCCccEEEccCCcccccCCCCccCCCCCceecccccccCCCC
Q 002349 53 SDYCVWRGITCDNVTFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDI 132 (933)
Q Consensus 53 ~~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~ 132 (933)
.++|.|.|+.|+-. ..+..+++++++++ .+|..+. ++|++|+|++|++++..+..|+++++|++|+|++|.++...
T Consensus 2 ~~~C~~~~~~C~c~-~~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~ 77 (270)
T 2o6q_A 2 EALCKKDGGVCSCN-NNKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLP 77 (270)
T ss_dssp CCCBGGGTCSBEEE-TTTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCC
T ss_pred CccCCCCCCCCEeC-CCCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeC
Confidence 47899999888532 23446788888888 4665554 57888888888888655567888888888888888877444
Q ss_pred CcccccccchhhhhhcccCccCCCCcccccCCCCceeeeecCCCCCCcccccccCCCCcEEeccCccccCccCcCCcCCC
Q 002349 133 PFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCT 212 (933)
Q Consensus 133 p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~ 212 (933)
+..|.++++|++|+|++|.+++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|.+++..+..+..++
T Consensus 78 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~ 157 (270)
T 2o6q_A 78 AGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLT 157 (270)
T ss_dssp TTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred hhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCc
Confidence 44456677777777777777655555566666666666666666655544555555555555555555543333344444
Q ss_pred CCcEEcccccccc
Q 002349 213 SFQVLDLSYNQLS 225 (933)
Q Consensus 213 ~L~~L~L~~N~l~ 225 (933)
+|++|+|++|+++
T Consensus 158 ~L~~L~L~~n~l~ 170 (270)
T 2o6q_A 158 SLKELRLYNNQLK 170 (270)
T ss_dssp TCCEEECCSSCCS
T ss_pred ccceeEecCCcCc
Confidence 4444444444443
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.9e-26 Score=242.40 Aligned_cols=212 Identities=23% Similarity=0.233 Sum_probs=121.2
Q ss_pred ccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcceEeeeccccccccCCcccccccccccccc
Q 002349 259 QALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNV 338 (933)
Q Consensus 259 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L 338 (933)
++|++|+|++|.+++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|++
T Consensus 28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 107 (276)
T 2z62_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence 34566666666665555555555555666666555555444445555555555555555555554455555555555555
Q ss_pred ccccCCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCCccccccccccceeeccCCccCCC
Q 002349 339 ANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGS 418 (933)
Q Consensus 339 ~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 418 (933)
++|++.+..+..+..+++|++|++++|++++. .+|..+..+++|+.|+|++|++++.
T Consensus 108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-----------------------~l~~~~~~l~~L~~L~Ls~N~l~~~ 164 (276)
T 2z62_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSF-----------------------KLPEYFSNLTNLEHLDLSSNKIQSI 164 (276)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCC-----------------------CCCGGGGGCTTCCEEECCSSCCCEE
T ss_pred CCCCccccCchhcccCCCCCEEECcCCcccee-----------------------cCchhhccCCCCCEEECCCCCCCcC
Confidence 55555544444444555555555555554432 1244444455555555555555544
Q ss_pred CCCCCCCccccc----cccccCcccccccccccccccccceEEccCCccccccchhhccccccceeeecCCCCcCcccch
Q 002349 419 IPSPLGDLEHLL----KLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDVMSL 494 (933)
Q Consensus 419 ~p~~~~~l~~L~----~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~ 494 (933)
.+..|..+++|+ .|++++|++++..+..+.. .+|+.|+|++|++++..+..+..+++|+.|+|++|+|+|..+.+
T Consensus 165 ~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~l 243 (276)
T 2z62_A 165 YCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 243 (276)
T ss_dssp CGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTTT
T ss_pred CHHHhhhhhhccccceeeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCCch
Confidence 444444444444 5667777777555554443 36777777777777666666777778888888877777766543
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=8.7e-30 Score=304.79 Aligned_cols=425 Identities=15% Similarity=0.146 Sum_probs=278.4
Q ss_pred CCCccceEecCCCCcEEEEEcCCCCcCcccCCCCCCCCCccEEEccCCcccc---cCCCC------------ccCCCCCc
Q 002349 55 YCVWRGITCDNVTFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSG---QIPDE------------IGDCSSLK 119 (933)
Q Consensus 55 ~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~---~~p~~------------l~~l~~L~ 119 (933)
|++|+++... ....++++++.-. .....+..+++|++|+|+++.... ..|.. ...+++|+
T Consensus 34 ck~W~~~~~~----~~~~l~~~~~~~~-~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~ 108 (594)
T 2p1m_B 34 CKSWYEIERW----CRRKVFIGNCYAV-SPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLE 108 (594)
T ss_dssp CHHHHHHHHH----HCCEEEESSTTSS-CHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCC
T ss_pred HHHHHHhhhh----hceEEeecccccc-CHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCC
Confidence 4578887221 1224444443211 111235567778888888765221 22221 24577888
Q ss_pred eecccccccCCCCCcccc-cccchhhhhhccc-CccCC-CCcccccCCCCceeeeecCCCCCCcccccc----cCCCCcE
Q 002349 120 SLDLSFNELYGDIPFSIS-KLKQLEFLILKNN-QLIGP-IPSTLSQLPNLKVFGLRGNNLVGTLSPDMC----QLSGLWY 192 (933)
Q Consensus 120 ~L~Ls~n~l~~~~p~~~~-~l~~L~~L~L~~n-~l~~~-~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~----~l~~L~~ 192 (933)
+|+|++|.+++..+..+. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+. .+++|++
T Consensus 109 ~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~ 188 (594)
T 2p1m_B 109 EIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVS 188 (594)
T ss_dssp EEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCE
T ss_pred eEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcE
Confidence 888888888776666665 6788888888888 44432 344455788888888888887765544443 5568888
Q ss_pred EeccCcc--ccC-ccCcCCcCCCCCcEEccccc-cccCcCCCCcc-ccccceEec-------cccccccccCcccccccc
Q 002349 193 FDVRNNS--LTG-SIPQNIGNCTSFQVLDLSYN-QLSGEIPFNIG-FLQIATLSL-------QGNQLTGKIPSVIGLMQA 260 (933)
Q Consensus 193 L~L~~n~--l~~-~~p~~l~~l~~L~~L~L~~N-~l~~~~p~~~~-~~~L~~L~L-------~~n~l~~~~p~~~~~l~~ 260 (933)
|++++|. ++. .++..+.++++|++|++++| .+++ +|..+. ..+|++|++ ..|.+.+ ++..+..+++
T Consensus 189 L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~-l~~~l~~~~~ 266 (594)
T 2p1m_B 189 LNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSG-LSVALSGCKE 266 (594)
T ss_dssp EECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHH-HHHHHHTCTT
T ss_pred EEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHH-HHHHHhcCCC
Confidence 8888886 221 11222345688888888887 3333 333332 346777874 4444554 3446788888
Q ss_pred ccEE-eccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCC-CccccCCcceEeeecccccccc-CCccccccccccccc
Q 002349 261 LAVL-DLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIP-PELGNMTKLHYLELNDNQLTGH-IPPALGKLTDLFDLN 337 (933)
Q Consensus 261 L~~L-~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~-~~~~l~~l~~L~~L~ 337 (933)
|+.| .+..... +.++..+..+++|++|+|++|.+++... ..+..+++|+.|++++| ++.. ++.....+++|+.|+
T Consensus 267 L~~Ls~~~~~~~-~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~ 344 (594)
T 2p1m_B 267 LRCLSGFWDAVP-AYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELR 344 (594)
T ss_dssp CCEEECCBTCCG-GGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEE
T ss_pred cccccCCcccch-hhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEE
Confidence 8888 4443332 2344455577899999999998764322 23567889999999988 4432 222233578899998
Q ss_pred ccc---------ccCCCCCCCCcc-cCCCCCceeccCcccCCCCCcccc-cccccceecCC--c----ccccCCC-----
Q 002349 338 VAN---------NHLEGPIPDNLS-SCTNLNSLNVHGNKLNGTIPPAFQ-RLESMTYLNLS--L----NNIRGPI----- 395 (933)
Q Consensus 338 L~~---------N~l~~~~p~~l~-~l~~L~~L~l~~N~l~~~~~~~~~-~l~~L~~L~L~--~----N~l~~~~----- 395 (933)
+.+ +.+++.....+. .+++|+.|.++.|++++.....+. .+++|+.|+++ + |.++...
T Consensus 345 L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~ 424 (594)
T 2p1m_B 345 VFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGF 424 (594)
T ss_dssp EECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHH
T ss_pred EecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHH
Confidence 843 344432222222 478999999988988865555554 58899999998 4 5565321
Q ss_pred ccccccccccceeeccCCccCCCCCCCCCC-ccccccccccCccccccccccc-ccccccceEEccCCccccccch-hhc
Q 002349 396 PVELSRIGNLDTLDMSNNKISGSIPSPLGD-LEHLLKLNLSRNQLTGFIPGEF-GNLRSVMEIDLSHNHLTGVIPE-ELS 472 (933)
Q Consensus 396 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~-~~~ 472 (933)
+..+..+++|+.|+|++ .+++..+..+.. +++|+.|+|++|.+++..+..+ .++++|++|+|++|++++.... ...
T Consensus 425 ~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~ 503 (594)
T 2p1m_B 425 GAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANAS 503 (594)
T ss_dssp HHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGG
T ss_pred HHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHH
Confidence 22356788999999987 666554445554 7889999999999987666555 6789999999999999765554 445
Q ss_pred cccccceeeecCCCCcC
Q 002349 473 QLQNMFSLRLDYNNLSG 489 (933)
Q Consensus 473 ~l~~L~~L~l~~N~l~~ 489 (933)
.+++|+.|++++|+++.
T Consensus 504 ~l~~L~~L~l~~~~~~~ 520 (594)
T 2p1m_B 504 KLETMRSLWMSSCSVSF 520 (594)
T ss_dssp GGGGSSEEEEESSCCBH
T ss_pred hCCCCCEEeeeCCCCCH
Confidence 68999999999999843
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3e-25 Score=237.82 Aligned_cols=230 Identities=27% Similarity=0.286 Sum_probs=186.7
Q ss_pred EEccccccccCcCCCCccccccceEeccccccccccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCcc
Q 002349 216 VLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKL 295 (933)
Q Consensus 216 ~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l 295 (933)
..+..+..++ .+|..+. .++++|+|++|++++..+..|..+++|++|+|++|.+++..+..|.++++|++|+|++|.+
T Consensus 11 ~~~c~~~~l~-~ip~~l~-~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 88 (276)
T 2z62_A 11 TYQCMELNFY-KIPDNLP-FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88 (276)
T ss_dssp EEECTTSCCS-SCCSSSC-TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred eEEecCCCcc-ccCCCCC-CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCcc
Confidence 3455555555 4565543 4799999999999988888999999999999999999988888999999999999999999
Q ss_pred CCCCCCccccCCcceEeeeccccccccCCccccccccccccccccccCCCC-CCCCcccCCCCCceeccCcccCCCCCcc
Q 002349 296 TGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGP-IPDNLSSCTNLNSLNVHGNKLNGTIPPA 374 (933)
Q Consensus 296 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~-~p~~l~~l~~L~~L~l~~N~l~~~~~~~ 374 (933)
++..+..|.++++|++|++++|.+++..+..+..+++|++|++++|++.+. +|..+..+++|++|++++|++++..+..
T Consensus 89 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 168 (276)
T 2z62_A 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD 168 (276)
T ss_dssp CEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGG
T ss_pred CccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHH
Confidence 988889999999999999999999988777899999999999999999864 5888888999999999999888766666
Q ss_pred cccccccceecCCcccccCCCccccccccccceeeccCCccCCCCCCCCCCccccccccccCcccccccccccccccccc
Q 002349 375 FQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVM 454 (933)
Q Consensus 375 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 454 (933)
|..+++|+.+.+ .|++++|.+++..+..+.. .+|+.|+|++|++++..+..|.++++|+
T Consensus 169 ~~~l~~L~~l~l--------------------~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 227 (276)
T 2z62_A 169 LRVLHQMPLLNL--------------------SLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQ 227 (276)
T ss_dssp GHHHHTCTTCCE--------------------EEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCC
T ss_pred hhhhhhccccce--------------------eeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHhccccccc
Confidence 666665552221 5666667666444444433 4688888888888877666778888888
Q ss_pred eEEccCCccccccc
Q 002349 455 EIDLSHNHLTGVIP 468 (933)
Q Consensus 455 ~L~Ls~N~l~~~~p 468 (933)
.|+|++|++++..|
T Consensus 228 ~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 228 KIWLHTNPWDCSCP 241 (276)
T ss_dssp EEECCSSCBCCCTT
T ss_pred EEEccCCcccccCC
Confidence 88888888886543
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-24 Score=232.64 Aligned_cols=205 Identities=27% Similarity=0.338 Sum_probs=129.1
Q ss_pred cccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcceEeeeccccccccCCccccccccccccccc
Q 002349 260 ALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVA 339 (933)
Q Consensus 260 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~ 339 (933)
+.+.++++++.++. +|..+. +++++|+|++|++++..+..|.++++|++|+|++|+++...+
T Consensus 17 ~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~--------------- 78 (270)
T 2o6q_A 17 NKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPA--------------- 78 (270)
T ss_dssp TTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCT---------------
T ss_pred CCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeCh---------------
Confidence 45667777777763 443332 455666666666655444455555555555555555553333
Q ss_pred cccCCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCCccccccccccceeeccCCccCCCC
Q 002349 340 NNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSI 419 (933)
Q Consensus 340 ~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 419 (933)
..|..+++|++|++++|++++..+..|..+++|++|++++|++++..+..|..+++|++|+|++|.|++..
T Consensus 79 ---------~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~ 149 (270)
T 2o6q_A 79 ---------GIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLP 149 (270)
T ss_dssp ---------TTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred ---------hhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccC
Confidence 33444555555555555555444445555556666666666666555555666667777777777776555
Q ss_pred CCCCCCccccccccccCcccccccccccccccccceEEccCCccccccchhhccccccceeeecCCCCcCcc
Q 002349 420 PSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDV 491 (933)
Q Consensus 420 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 491 (933)
+..|..+++|+.|+|++|++++..+..|.++++|++|+|++|++++..+..+..+++|+.|+|++|+|.|..
T Consensus 150 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 221 (270)
T 2o6q_A 150 KGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTC 221 (270)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSS
T ss_pred HhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCC
Confidence 556777777777777777777766667777888888888888887766666777788888777777665543
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.92 E-value=4e-25 Score=238.06 Aligned_cols=204 Identities=25% Similarity=0.285 Sum_probs=156.4
Q ss_pred CCCCCCccEEEeeCCccCCCCCCccccCCcceEeeeccccccccCCccccccccccccccccccCCCCCCCCcccCCCCC
Q 002349 279 LGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLN 358 (933)
Q Consensus 279 ~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~ 358 (933)
+.++++++++++++|.++ .+|..+. ++++.|+|++|++++..+..|..+++|+.|++++|.+++..+. ..+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~ 80 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLG 80 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCC
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCC
Confidence 567788899999999888 4565554 6888999999999888788888888888888888888754332 6778888
Q ss_pred ceeccCcccCCCCCcccccccccceecCCcccccCCCccccccccccceeeccCCccCCCCCCCCCCccccccccccCcc
Q 002349 359 SLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQ 438 (933)
Q Consensus 359 ~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 438 (933)
.|++++|+++ .+|..+..+++|++|+|++|++++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+
T Consensus 81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 159 (290)
T 1p9a_G 81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN 159 (290)
T ss_dssp EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCc
Confidence 8888888887 566777778888888888888887766777777888888888888876666667777778888888888
Q ss_pred cccccccccccccccceEEccCCccccccchhhccccccceeeecCCCCcC
Q 002349 439 LTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSG 489 (933)
Q Consensus 439 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 489 (933)
|++..+..|.++++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|.|
T Consensus 160 l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C 209 (290)
T 1p9a_G 160 LTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (290)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred CCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccC
Confidence 77666666777777777888777777 566666666677766666655544
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.3e-28 Score=292.51 Aligned_cols=414 Identities=13% Similarity=0.078 Sum_probs=293.9
Q ss_pred cEEEEEcCCCCcCccc---CC------------CCCCCCCccEEEccCCcccccCCCCcc-CCCCCceeccccc-ccCCC
Q 002349 69 TVIALNLSGLNLDGEI---SP------------AVGDLKDLQSIDLRGNRLSGQIPDEIG-DCSSLKSLDLSFN-ELYGD 131 (933)
Q Consensus 69 ~v~~l~l~~~~l~~~~---~~------------~l~~l~~L~~L~Ls~n~l~~~~p~~l~-~l~~L~~L~Ls~n-~l~~~ 131 (933)
++..|+|+++.....+ |. ....+++|++|+|++|.+++..+..+. .+++|++|+|++| .++..
T Consensus 67 ~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~ 146 (594)
T 2p1m_B 67 KVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTD 146 (594)
T ss_dssp TCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHH
T ss_pred CceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHH
Confidence 5678888886532211 11 124678999999999999887777776 7999999999999 55532
Q ss_pred -CCcccccccchhhhhhcccCccCCCCcccc----cCCCCceeeeecCC--CCCC-cccccccCCCCcEEeccCc-cccC
Q 002349 132 -IPFSISKLKQLEFLILKNNQLIGPIPSTLS----QLPNLKVFGLRGNN--LVGT-LSPDMCQLSGLWYFDVRNN-SLTG 202 (933)
Q Consensus 132 -~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~----~l~~L~~L~L~~N~--l~~~-~~~~~~~l~~L~~L~L~~n-~l~~ 202 (933)
++..+.++++|++|+|++|.+++..+..+. .+++|+.|+|++|. +... ++..+..+++|++|++++| .+.+
T Consensus 147 ~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~ 226 (594)
T 2p1m_B 147 GLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEK 226 (594)
T ss_dssp HHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHH
T ss_pred HHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHH
Confidence 444456899999999999998876555444 67799999999997 2211 1122345799999999999 4554
Q ss_pred ccCcCCcCCCCCcEEccccc-------cccCcCCCCccccccceE-eccccccccccCccccccccccEEeccCCcCcCC
Q 002349 203 SIPQNIGNCTSFQVLDLSYN-------QLSGEIPFNIGFLQIATL-SLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGP 274 (933)
Q Consensus 203 ~~p~~l~~l~~L~~L~L~~N-------~l~~~~p~~~~~~~L~~L-~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 274 (933)
+|..+.++++|++|+++.+ .+.+..+......+|+.| .+.+... +.++..+..+++|+.|+|++|.+++.
T Consensus 227 -l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~~~~L~~Ls~~~~~~~-~~l~~~~~~~~~L~~L~L~~~~l~~~ 304 (594)
T 2p1m_B 227 -LATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVP-AYLPAVYSVCSRLTTLNLSYATVQSY 304 (594)
T ss_dssp -HHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHHTCTTCCEEECCBTCCG-GGGGGGHHHHTTCCEEECTTCCCCHH
T ss_pred -HHHHHhcCCcceEcccccccCccchhhHHHHHHHHhcCCCcccccCCcccch-hhHHHHHHhhCCCCEEEccCCCCCHH
Confidence 7888889999999996554 333322212233467777 3443322 34566666889999999999997654
Q ss_pred CC-CCCCCCCCccEEEeeCCccCCC-CCCccccCCcceEeeec---------cccccccCCcccc-cccccccccccccc
Q 002349 275 IP-PILGNLSYTEKLYLHSNKLTGH-IPPELGNMTKLHYLELN---------DNQLTGHIPPALG-KLTDLFDLNVANNH 342 (933)
Q Consensus 275 ~~-~~~~~l~~L~~L~L~~N~l~~~-~p~~l~~l~~L~~L~L~---------~N~l~~~~~~~l~-~l~~L~~L~L~~N~ 342 (933)
.. ..+..+++|++|++++| ++.. ++.....+++|+.|+++ .+.+++.....+. .+++|+.|.++.|.
T Consensus 305 ~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~ 383 (594)
T 2p1m_B 305 DLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQ 383 (594)
T ss_dssp HHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESC
T ss_pred HHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCC
Confidence 32 23568899999999988 4422 22223458999999994 3556543333333 47899999999999
Q ss_pred CCCCCCCCcc-cCCCCCceecc--C----cccCCCCC-----cccccccccceecCCcccccCCCcccccc-ccccceee
Q 002349 343 LEGPIPDNLS-SCTNLNSLNVH--G----NKLNGTIP-----PAFQRLESMTYLNLSLNNIRGPIPVELSR-IGNLDTLD 409 (933)
Q Consensus 343 l~~~~p~~l~-~l~~L~~L~l~--~----N~l~~~~~-----~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-l~~L~~L~ 409 (933)
+++..+..+. .+++|+.|+++ + |.+++... ..+..+++|+.|+|++ .+++..+..+.. +++|+.|+
T Consensus 384 l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~ 462 (594)
T 2p1m_B 384 MTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLS 462 (594)
T ss_dssp CCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEE
T ss_pred cCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEee
Confidence 8765544554 58999999999 4 56663222 2266789999999987 666555555655 88999999
Q ss_pred ccCCccCCCCCCCC-CCccccccccccCccccccccc-ccccccccceEEccCCccccccchhh-ccccccceeeecCCC
Q 002349 410 MSNNKISGSIPSPL-GDLEHLLKLNLSRNQLTGFIPG-EFGNLRSVMEIDLSHNHLTGVIPEEL-SQLQNMFSLRLDYNN 486 (933)
Q Consensus 410 Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~l~~N~ 486 (933)
|++|.+++..+..+ ..+++|+.|+|++|.+++.... ....+++|+.|++++|+++......+ ..+++|+...+..+.
T Consensus 463 L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~~ 542 (594)
T 2p1m_B 463 VAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERG 542 (594)
T ss_dssp EESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEECSSS
T ss_pred ccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEecCCC
Confidence 99999976555444 5689999999999999765544 44568999999999999965444444 456777665555543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-25 Score=261.57 Aligned_cols=185 Identities=17% Similarity=0.186 Sum_probs=146.0
Q ss_pred CcceeeecccceeEEEEEEcCCceEEEEEecccCc--------hhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEE
Q 002349 601 SEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYP--------QCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLF 672 (933)
Q Consensus 601 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 672 (933)
...++||+|+||.||+|.. .++.+|+|+...... ...+++.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4456899999999999954 457889988654321 1234589999999999999999777777778888999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccccc
Q 002349 673 YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV 752 (933)
Q Consensus 673 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 752 (933)
|||+++++|.++++. +..++.|+++||+|||++ +|+||||||+|||++. .+||+|||+|+....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999952 568999999999999966 9999999999999999 999999999998744
Q ss_pred CCCce------eeeecccccccCcccccc--CCCCcchhhHHHHHHHHHHHhCCCCCC
Q 002349 753 SKSYT------STYIMGTIGYIDPEYART--SRLTEKSDVYSFGIVLLELLTGRKAVD 802 (933)
Q Consensus 753 ~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DvwSlGv~l~elltg~~p~~ 802 (933)
..... .....||+.|||||++.. ..|+..+|+|+..+-..+.+.++.+|.
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 32211 235679999999999987 568888999999999998888777653
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.9e-24 Score=232.69 Aligned_cols=204 Identities=25% Similarity=0.232 Sum_probs=139.5
Q ss_pred ccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcceEeeeccccccccCCcccccccccc
Q 002349 255 IGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLF 334 (933)
Q Consensus 255 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~ 334 (933)
++.+++++.+++++|.++. +|..+. ++++.|+|++|++++..+..|..+++|++|+|++|.|++..+. ..+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~~-ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~ 80 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLG 80 (290)
T ss_dssp EECSTTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCC
T ss_pred ccccCCccEEECCCCCCCc-CCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCC
Confidence 4556667777777777763 343332 5667777777777766666777777777777777777754332 5667777
Q ss_pred ccccccccCCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCCccccccccccceeeccCCc
Q 002349 335 DLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNK 414 (933)
Q Consensus 335 ~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 414 (933)
.|++++|++. .+|..+..+++|++|++++|++++..+..|.++++|++|+|++|++++..+..|..+++|+.|+|++|+
T Consensus 81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 159 (290)
T 1p9a_G 81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN 159 (290)
T ss_dssp EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCc
Confidence 7777777776 556666777777777777777776666667777777777777777776666666677777777777777
Q ss_pred cCCCCCCCCCCccccccccccCcccccccccccccccccceEEccCCcccc
Q 002349 415 ISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTG 465 (933)
Q Consensus 415 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 465 (933)
|++..+..|..+++|+.|+|++|+|+ .+|..+..+.+|+.|+|++|++..
T Consensus 160 l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C 209 (290)
T 1p9a_G 160 LTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (290)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred CCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccC
Confidence 77555555666777777777777777 556666666677777777777654
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=9.3e-25 Score=233.29 Aligned_cols=182 Identities=29% Similarity=0.337 Sum_probs=97.0
Q ss_pred cccCCcceEeeeccccccccCCccccccccccccccccccCCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccc
Q 002349 303 LGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMT 382 (933)
Q Consensus 303 l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 382 (933)
+..+++|++|++++|.+++. ..+..+++|++|++++|++++..+..+..+++|++|++++|++++..+..|..+++|+
T Consensus 59 l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 136 (272)
T 3rfs_A 59 IQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLT 136 (272)
T ss_dssp GGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC
T ss_pred cccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCC
Confidence 33344444444444444421 2344444444444444444444444444555555555555555544444455555555
Q ss_pred eecCCcccccCCCccccccccccceeeccCCccCCCCCCCCCCccccccccccCcccccccccccccccccceEEccCCc
Q 002349 383 YLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNH 462 (933)
Q Consensus 383 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 462 (933)
+|++++|++++..+..+..+++|+.|+|++|++++..+..|..+++|+.|+|++|++++..|..|.++++|+.|+|++|+
T Consensus 137 ~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 216 (272)
T 3rfs_A 137 YLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNP 216 (272)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCC
Confidence 55555555554444445555556666666666655555555566666666666666665555556666666666666666
Q ss_pred cccccchhhccccccceeeecCCCCcCcccc
Q 002349 463 LTGVIPEELSQLQNMFSLRLDYNNLSGDVMS 493 (933)
Q Consensus 463 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~ 493 (933)
+.+. +++|+.|++.+|.++|.+|.
T Consensus 217 ~~~~-------~~~l~~l~~~~n~~~g~ip~ 240 (272)
T 3rfs_A 217 WDCT-------CPGIRYLSEWINKHSGVVRN 240 (272)
T ss_dssp BCCC-------TTTTHHHHHHHHHTGGGBBC
T ss_pred cccc-------CcHHHHHHHHHHhCCCcccC
Confidence 6543 23456666666666665553
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-24 Score=232.38 Aligned_cols=166 Identities=24% Similarity=0.293 Sum_probs=79.8
Q ss_pred cccCCcceEeeeccccccccCCccccccccccccccccccCCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccc
Q 002349 303 LGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMT 382 (933)
Q Consensus 303 l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 382 (933)
+..+++|++|++++|.+++..+..|..+++|++|++++|++++..+..+..+++|++|++++|++++..+..|..+++|+
T Consensus 81 l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 160 (272)
T 3rfs_A 81 LKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLT 160 (272)
T ss_dssp GTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred hcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCC
Confidence 33344444444444444433333344444444444444444433333444444444444444444444444444444555
Q ss_pred eecCCcccccCCCccccccccccceeeccCCccCCCCCCCCCCccccccccccCcccccccccccccccccceEEccCCc
Q 002349 383 YLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNH 462 (933)
Q Consensus 383 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 462 (933)
+|++++|++++..+..+..+++|+.|+|++|++++..+..+..+++|+.|+|++|.+.+. +++|+.|+++.|+
T Consensus 161 ~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~ 233 (272)
T 3rfs_A 161 ELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINK 233 (272)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHH
T ss_pred EEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHh
Confidence 555555555444444444555555555555555544444455555555555555555432 2345555555566
Q ss_pred cccccchhhcccc
Q 002349 463 LTGVIPEELSQLQ 475 (933)
Q Consensus 463 l~~~~p~~~~~l~ 475 (933)
++|.+|..++.++
T Consensus 234 ~~g~ip~~~~~~~ 246 (272)
T 3rfs_A 234 HSGVVRNSAGSVA 246 (272)
T ss_dssp TGGGBBCTTSCBC
T ss_pred CCCcccCcccccC
Confidence 6666665555444
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=6e-24 Score=231.73 Aligned_cols=205 Identities=22% Similarity=0.217 Sum_probs=105.1
Q ss_pred CCCCceecccccccCCCCCccc--ccccchhhhhhcccCccCCCC----cccccCCCCceeeeecCCCCCCcccccccCC
Q 002349 115 CSSLKSLDLSFNELYGDIPFSI--SKLKQLEFLILKNNQLIGPIP----STLSQLPNLKVFGLRGNNLVGTLSPDMCQLS 188 (933)
Q Consensus 115 l~~L~~L~Ls~n~l~~~~p~~~--~~l~~L~~L~L~~n~l~~~~p----~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 188 (933)
+++|++|+|++|.+++.+|..+ ..+++|++|+|++|.+++..+ ..+..+++|++|+|++|++.+..+..|..++
T Consensus 90 ~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~ 169 (310)
T 4glp_A 90 YSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFP 169 (310)
T ss_dssp HSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCT
T ss_pred cCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCC
Confidence 3446666666666655555555 555566666666666555433 2233455555555555555555445555555
Q ss_pred CCcEEeccCccccCc--c--CcCCcCCCCCcEEccccccccCcCCCCccccccceEeccccccccccCccccccccccEE
Q 002349 189 GLWYFDVRNNSLTGS--I--PQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVL 264 (933)
Q Consensus 189 ~L~~L~L~~n~l~~~--~--p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 264 (933)
+|++|+|++|++.+. + +..++.+++|++|+|++|+++. ++ +.....++.+++|++|
T Consensus 170 ~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~-------------------~~~~~l~~~l~~L~~L 229 (310)
T 4glp_A 170 ALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PT-------------------GVCAALAAAGVQPHSL 229 (310)
T ss_dssp TCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HH-------------------HHHHHHHHHTCCCSSE
T ss_pred CCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hH-------------------HHHHHHHhcCCCCCEE
Confidence 555555555554421 1 1122444555555555554431 00 0001124556777777
Q ss_pred eccCCcCcCCCCCCCCCC---CCccEEEeeCCccCCCCCCccccCCcceEeeeccccccccCCccccccccccccccccc
Q 002349 265 DLSCNMLSGPIPPILGNL---SYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANN 341 (933)
Q Consensus 265 ~Ls~N~l~~~~~~~~~~l---~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N 341 (933)
+|++|++++..|..+..+ ++|++|+|++|+|+ .+|..+. ++|++|+|++|+|++. |. +..+++|+.|++++|
T Consensus 230 ~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N 304 (310)
T 4glp_A 230 DLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGN 304 (310)
T ss_dssp ECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSST
T ss_pred ECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCC
Confidence 777777776666655554 46666666666665 3444442 4555555555555532 21 334444444444444
Q ss_pred cCC
Q 002349 342 HLE 344 (933)
Q Consensus 342 ~l~ 344 (933)
+++
T Consensus 305 ~l~ 307 (310)
T 4glp_A 305 PFL 307 (310)
T ss_dssp TTS
T ss_pred CCC
Confidence 443
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.90 E-value=6e-26 Score=250.87 Aligned_cols=268 Identities=20% Similarity=0.222 Sum_probs=186.5
Q ss_pred CCCCccceEecCCCCcEEEEEcCCCCcCcccCCCCCCC--CCccEEEccCCcccccCCCCccCCCCCceecccccccCCC
Q 002349 54 DYCVWRGITCDNVTFTVIALNLSGLNLDGEISPAVGDL--KDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGD 131 (933)
Q Consensus 54 ~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l--~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~ 131 (933)
-|.+|+++.|+.. .+..++++++.+. +..+..+ +.++.|++++|.+.+..+. +.++++|++|+|++|.+++.
T Consensus 35 vc~~W~~~~~~~~--~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~ 108 (336)
T 2ast_B 35 VCKRWYRLASDES--LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVS 108 (336)
T ss_dssp SCHHHHHHHTCST--TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHH
T ss_pred HHHHHHHHhcCch--hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHH
Confidence 4558999988643 4567888888877 3345556 7889999999999876554 66789999999999988765
Q ss_pred -CCcccccccchhhhhhcccCccCCCCcccccCCCCceeeeecC-CCCCC-cccccccCCCCcEEeccCc-cccCc-cCc
Q 002349 132 -IPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGN-NLVGT-LSPDMCQLSGLWYFDVRNN-SLTGS-IPQ 206 (933)
Q Consensus 132 -~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N-~l~~~-~~~~~~~l~~L~~L~L~~n-~l~~~-~p~ 206 (933)
+|..+..+++|++|+|++|.+++..|..++.+++|++|+|++| .+++. ++..+..+++|++|++++| .+++. ++.
T Consensus 109 ~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~ 188 (336)
T 2ast_B 109 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQV 188 (336)
T ss_dssp HHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHH
T ss_pred HHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHH
Confidence 7777888888888888888888777888888888888888888 56642 5556777888888888888 77753 566
Q ss_pred CCcCCC-CCcEEccccccccCcCCCCccccccceEeccccccc-cccCccccccccccEEeccCCc-CcCCCCCCCCCCC
Q 002349 207 NIGNCT-SFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLT-GKIPSVIGLMQALAVLDLSCNM-LSGPIPPILGNLS 283 (933)
Q Consensus 207 ~l~~l~-~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~l~-~~~p~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~ 283 (933)
.+..++ +|++|++++|.+. ++ +.++..+..+++|+.|++++|. +++..+..+..++
T Consensus 189 ~~~~l~~~L~~L~l~~~~~~---------------------~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~ 247 (336)
T 2ast_B 189 AVAHVSETITQLNLSGYRKN---------------------LQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLN 247 (336)
T ss_dssp HHHHSCTTCCEEECCSCGGG---------------------SCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCT
T ss_pred HHHhcccCCCEEEeCCCccc---------------------CCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCC
Confidence 667777 7777777777421 11 2344555667777777777777 6656666777777
Q ss_pred CccEEEeeCCc-cCCCCCCccccCCcceEeeeccccccccCCccccccc-cccccccccccCCCCCCCCcc
Q 002349 284 YTEKLYLHSNK-LTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLT-DLFDLNVANNHLEGPIPDNLS 352 (933)
Q Consensus 284 ~L~~L~L~~N~-l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~-~L~~L~L~~N~l~~~~p~~l~ 352 (933)
+|++|+|++|. +.......+.++++|+.|++++| ++ ...+..+. .+..|++++|++++..|..++
T Consensus 248 ~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~---~~~~~~l~~~l~~L~l~~n~l~~~~~~~~~ 314 (336)
T 2ast_B 248 YLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VP---DGTLQLLKEALPHLQINCSHFTTIARPTIG 314 (336)
T ss_dssp TCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SC---TTCHHHHHHHSTTSEESCCCSCCTTCSSCS
T ss_pred CCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cC---HHHHHHHHhhCcceEEecccCccccCCccc
Confidence 77777777774 22111124666777777777766 32 12333332 355666666666666555544
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.6e-23 Score=219.15 Aligned_cols=203 Identities=17% Similarity=0.187 Sum_probs=152.0
Q ss_pred ccCCCCCCCCCccEEEccCCcccccCCCCccCCCCCceecccccc-cCCCCCcccccccchhhhhhcc-cCccCCCCccc
Q 002349 83 EISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNE-LYGDIPFSISKLKQLEFLILKN-NQLIGPIPSTL 160 (933)
Q Consensus 83 ~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~-l~~~~p~~~~~l~~L~~L~L~~-n~l~~~~p~~l 160 (933)
.+|. +. ++|++|+|++|++++..+..|+++++|++|+|++|+ +++..+..|.++++|++|+|++ |++++..+..|
T Consensus 25 ~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f 101 (239)
T 2xwt_C 25 RIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDAL 101 (239)
T ss_dssp SCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSE
T ss_pred ccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHh
Confidence 4555 43 389999999999997766789999999999999997 8766666899999999999998 99997777889
Q ss_pred ccCCCCceeeeecCCCCCCcccccccCCCCc---EEeccCc-cccCccCcCCcCCCCCc-EEccccccccCcCCCCcccc
Q 002349 161 SQLPNLKVFGLRGNNLVGTLSPDMCQLSGLW---YFDVRNN-SLTGSIPQNIGNCTSFQ-VLDLSYNQLSGEIPFNIGFL 235 (933)
Q Consensus 161 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~---~L~L~~n-~l~~~~p~~l~~l~~L~-~L~L~~N~l~~~~p~~~~~~ 235 (933)
.++++|++|+|++|++++ +|. +..+++|+ +|++++| .+++..+..|.++++|+ +|++++|+++ .+|..
T Consensus 102 ~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~---- 174 (239)
T 2xwt_C 102 KELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGY---- 174 (239)
T ss_dssp ECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTT----
T ss_pred CCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHh----
Confidence 999999999999999986 555 88888888 9999999 89877777789999999 9999999887 33322
Q ss_pred ccceEeccccccccccCccccccccccEEeccCCc-CcCCCCCCCCCC-CCccEEEeeCCccCCCCCCccccCCcceEee
Q 002349 236 QIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNM-LSGPIPPILGNL-SYTEKLYLHSNKLTGHIPPELGNMTKLHYLE 313 (933)
Q Consensus 236 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 313 (933)
.+.. ++|+.|+|++|+ +++..+..|.++ ++|+.|+|++|++++. |.. .+++|+.|+
T Consensus 175 ------------------~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l-~~~--~~~~L~~L~ 232 (239)
T 2xwt_C 175 ------------------AFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTAL-PSK--GLEHLKELI 232 (239)
T ss_dssp ------------------TTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCC-CCT--TCTTCSEEE
T ss_pred ------------------hcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccC-Chh--HhccCceee
Confidence 1122 455555555553 554445555555 5666666666666532 222 345566666
Q ss_pred eccc
Q 002349 314 LNDN 317 (933)
Q Consensus 314 L~~N 317 (933)
++++
T Consensus 233 l~~~ 236 (239)
T 2xwt_C 233 ARNT 236 (239)
T ss_dssp CTTC
T ss_pred ccCc
Confidence 5544
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=3.4e-25 Score=247.16 Aligned_cols=255 Identities=19% Similarity=0.189 Sum_probs=196.5
Q ss_pred EEEcCCCCcCcccCCCCCCCCCccEEEccCCcccccCC----CCccCCC-CCceecccccccCCCCCcccccc-----cc
Q 002349 72 ALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIP----DEIGDCS-SLKSLDLSFNELYGDIPFSISKL-----KQ 141 (933)
Q Consensus 72 ~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p----~~l~~l~-~L~~L~Ls~n~l~~~~p~~~~~l-----~~ 141 (933)
..+|+.++++|.+|..+...++|++|+|++|.+++..+ +.|.+++ +|++|+|++|.+++..+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 35788899999988888888889999999999987655 6788888 89999999999998888888776 89
Q ss_pred hhhhhhcccCccCCCCccccc----C-CCCceeeeecCCCCCCccccccc-----CCCCcEEeccCccccCcc----CcC
Q 002349 142 LEFLILKNNQLIGPIPSTLSQ----L-PNLKVFGLRGNNLVGTLSPDMCQ-----LSGLWYFDVRNNSLTGSI----PQN 207 (933)
Q Consensus 142 L~~L~L~~n~l~~~~p~~l~~----l-~~L~~L~L~~N~l~~~~~~~~~~-----l~~L~~L~L~~n~l~~~~----p~~ 207 (933)
|++|+|++|.+++..+..++. + ++|++|+|++|++++..+..++. .++|++|+|++|.+++.. +..
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 999999999999877765544 4 89999999999998776665543 368999999999998533 344
Q ss_pred CcCCC-CCcEEccccccccCcCCCCcc-----c-cccceEeccccccccc----cCccccc-cccccEEeccCCcCcCCC
Q 002349 208 IGNCT-SFQVLDLSYNQLSGEIPFNIG-----F-LQIATLSLQGNQLTGK----IPSVIGL-MQALAVLDLSCNMLSGPI 275 (933)
Q Consensus 208 l~~l~-~L~~L~L~~N~l~~~~p~~~~-----~-~~L~~L~L~~n~l~~~----~p~~~~~-l~~L~~L~Ls~N~l~~~~ 275 (933)
+..++ +|++|+|++|++++..+..+. . .+|++|+|++|++++. ++..+.. .++|++|+|++|.+++..
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~ 241 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPS 241 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCC
T ss_pred HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHH
Confidence 45555 899999999999866654332 1 3788899999988863 4445554 358888999988888654
Q ss_pred C----CCCCCCCCccEEEeeCCccCCCC-------CCccccCCcceEeeeccccccccCCcc
Q 002349 276 P----PILGNLSYTEKLYLHSNKLTGHI-------PPELGNMTKLHYLELNDNQLTGHIPPA 326 (933)
Q Consensus 276 ~----~~~~~l~~L~~L~L~~N~l~~~~-------p~~l~~l~~L~~L~L~~N~l~~~~~~~ 326 (933)
+ ..+..+++|+.|+|++|.+.+.. +..+..+++|+.||+++|++.+..+..
T Consensus 242 ~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~~~ 303 (362)
T 3goz_A 242 LENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIP 303 (362)
T ss_dssp HHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGCHH
T ss_pred HHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcchHH
Confidence 4 34567788888888888855332 345677788888888888887654433
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=3.3e-25 Score=247.32 Aligned_cols=251 Identities=20% Similarity=0.214 Sum_probs=194.3
Q ss_pred EEEccCCcccccCCCCccCCCCCceecccccccCCCCC----ccccccc-chhhhhhcccCccCCCCcccccC-----CC
Q 002349 96 SIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIP----FSISKLK-QLEFLILKNNQLIGPIPSTLSQL-----PN 165 (933)
Q Consensus 96 ~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p----~~~~~l~-~L~~L~L~~n~l~~~~p~~l~~l-----~~ 165 (933)
+++|++|+++|.+|..+...++|++|||++|.+++..+ ..|.+++ +|++|+|++|.+++..+..++.+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 47899999999999888888889999999999997766 6778888 89999999999998888888775 99
Q ss_pred CceeeeecCCCCCCcccccccC-----CCCcEEeccCccccCccCcCCc----C-CCCCcEEccccccccCcCCCCc---
Q 002349 166 LKVFGLRGNNLVGTLSPDMCQL-----SGLWYFDVRNNSLTGSIPQNIG----N-CTSFQVLDLSYNQLSGEIPFNI--- 232 (933)
Q Consensus 166 L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~L~~n~l~~~~p~~l~----~-l~~L~~L~L~~N~l~~~~p~~~--- 232 (933)
|++|+|++|++++..+..++.. ++|++|+|++|.+++..+..+. . .++|++|+|++|++++..+..+
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 9999999999998777755544 8999999999999876665443 3 3699999999999985433322
Q ss_pred -c-c-cccceEeccccccccccCcccccc-----ccccEEeccCCcCcCC----CCCCCCC-CCCccEEEeeCCccCCCC
Q 002349 233 -G-F-LQIATLSLQGNQLTGKIPSVIGLM-----QALAVLDLSCNMLSGP----IPPILGN-LSYTEKLYLHSNKLTGHI 299 (933)
Q Consensus 233 -~-~-~~L~~L~L~~n~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~----~~~~~~~-l~~L~~L~L~~N~l~~~~ 299 (933)
. . .+|++|+|++|++++..+..+... ++|++|+|++|.+++. ++..+.. .++|++|+|++|.+++..
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~ 241 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPS 241 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCC
T ss_pred HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHH
Confidence 1 2 278899999999887776555443 5889999999988863 3334444 358888888888888654
Q ss_pred C----CccccCCcceEeeecccccccc-------CCccccccccccccccccccCCCC
Q 002349 300 P----PELGNMTKLHYLELNDNQLTGH-------IPPALGKLTDLFDLNVANNHLEGP 346 (933)
Q Consensus 300 p----~~l~~l~~L~~L~L~~N~l~~~-------~~~~l~~l~~L~~L~L~~N~l~~~ 346 (933)
+ ..+..+++|+.|+|++|.+.+. ++..+..+++|+.|++++|++...
T Consensus 242 ~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~ 299 (362)
T 3goz_A 242 LENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPS 299 (362)
T ss_dssp HHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGG
T ss_pred HHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCc
Confidence 4 3346678888888888885433 233566777788888888877644
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=2e-23 Score=227.54 Aligned_cols=203 Identities=19% Similarity=0.184 Sum_probs=113.3
Q ss_pred cccccEEeccCCcCcCCCCCCC--CCCCCccEEEeeCCccCCCCC----CccccCCcceEeeeccccccccCCccccccc
Q 002349 258 MQALAVLDLSCNMLSGPIPPIL--GNLSYTEKLYLHSNKLTGHIP----PELGNMTKLHYLELNDNQLTGHIPPALGKLT 331 (933)
Q Consensus 258 l~~L~~L~Ls~N~l~~~~~~~~--~~l~~L~~L~L~~N~l~~~~p----~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~ 331 (933)
+++|++|++++|.+++..|..+ ..+++|++|+|++|.+++..+ ..+..+++|++|+|++|++++..+..+..++
T Consensus 90 ~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~ 169 (310)
T 4glp_A 90 YSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFP 169 (310)
T ss_dssp HSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCT
T ss_pred cCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCC
Confidence 3457777777777766666666 666666666666666665433 2233455555555555555555555555555
Q ss_pred cccccccccccCCCC--CCCCcccCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCCcc----cccccccc
Q 002349 332 DLFDLNVANNHLEGP--IPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPV----ELSRIGNL 405 (933)
Q Consensus 332 ~L~~L~L~~N~l~~~--~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~----~~~~l~~L 405 (933)
+|++|++++|++.+. ++ .+..+..+++|++|+|++|+++. ++. .+..+++|
T Consensus 170 ~L~~L~Ls~N~l~~~~~~~----------------------~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l~~L 226 (310)
T 4glp_A 170 ALTSLDLSDNPGLGERGLM----------------------AALCPHKFPAIQNLALRNTGMET-PTGVCAALAAAGVQP 226 (310)
T ss_dssp TCCEEECCSCTTCHHHHHH----------------------TTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHHTCCC
T ss_pred CCCEEECCCCCCccchhhh----------------------HHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhcCCCC
Confidence 555555555554321 10 01112344444555555554431 111 13455566
Q ss_pred ceeeccCCccCCCCCCCCCCc---cccccccccCcccccccccccccccccceEEccCCccccccchhhccccccceeee
Q 002349 406 DTLDMSNNKISGSIPSPLGDL---EHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRL 482 (933)
Q Consensus 406 ~~L~Ls~N~l~~~~p~~~~~l---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 482 (933)
++|||++|+|++..|..+..+ ++|++|+|++|+|+ .+|..+. ++|++|||++|+|++. |. +..+++|+.|+|
T Consensus 227 ~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L 301 (310)
T 4glp_A 227 HSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTL 301 (310)
T ss_dssp SSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEEC
T ss_pred CEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEEC
Confidence 666666666665555555554 46666666666666 4455543 5677777777777653 22 456677777777
Q ss_pred cCCCCc
Q 002349 483 DYNNLS 488 (933)
Q Consensus 483 ~~N~l~ 488 (933)
++|+|+
T Consensus 302 ~~N~l~ 307 (310)
T 4glp_A 302 DGNPFL 307 (310)
T ss_dssp SSTTTS
T ss_pred cCCCCC
Confidence 777665
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.89 E-value=9.2e-23 Score=215.04 Aligned_cols=182 Identities=21% Similarity=0.274 Sum_probs=122.6
Q ss_pred cceEeeeccccccccCCccccccccccccccccccCCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccceecCC
Q 002349 308 KLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLS 387 (933)
Q Consensus 308 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~ 387 (933)
..+.++++++.++ .+|..+. ++++.|++++|++.+..+..|.++++|++|++++|++++..+..|..+++|++|+|+
T Consensus 15 ~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 91 (251)
T 3m19_A 15 GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA 91 (251)
T ss_dssp GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence 3445555555555 3444333 355666666666665555556666666666666666666666666666666666666
Q ss_pred cccccCCCccccccccccceeeccCCccCCCCCCCCCCccccccccccCcccccccccccccccccceEEccCCcccccc
Q 002349 388 LNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVI 467 (933)
Q Consensus 388 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 467 (933)
+|++++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..+..|.++++|++|+|++|++++..
T Consensus 92 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 171 (251)
T 3m19_A 92 NNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVP 171 (251)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccC
Confidence 66666666666667777777777777777666666677777777777777777666667777777777777777777777
Q ss_pred chhhccccccceeeecCCCCcCccc
Q 002349 468 PEELSQLQNMFSLRLDYNNLSGDVM 492 (933)
Q Consensus 468 p~~~~~l~~L~~L~l~~N~l~~~~~ 492 (933)
+..+..+++|+.|+|++|+|+|...
T Consensus 172 ~~~~~~l~~L~~L~l~~N~~~c~~~ 196 (251)
T 3m19_A 172 HGAFDRLGKLQTITLFGNQFDCSRC 196 (251)
T ss_dssp TTTTTTCTTCCEEECCSCCBCTTST
T ss_pred HHHHhCCCCCCEEEeeCCceeCCcc
Confidence 7777777778888888888777643
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.6e-23 Score=217.64 Aligned_cols=196 Identities=18% Similarity=0.211 Sum_probs=112.8
Q ss_pred CccEEEeeCCccCCCCCCccccCCcceEeeecccc-ccccCCcccccccccccccccc-ccCCCCCCCCcccCCCCCcee
Q 002349 284 YTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQ-LTGHIPPALGKLTDLFDLNVAN-NHLEGPIPDNLSSCTNLNSLN 361 (933)
Q Consensus 284 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~-l~~~~~~~l~~l~~L~~L~L~~-N~l~~~~p~~l~~l~~L~~L~ 361 (933)
+|++|+|++|++++..+..|.++++|++|++++|+ +++..+..|..+++|++|++++ |++++..+..|.++++|++|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 45555555555554444445555555555555554 4444444455555555555555 555544444555555555555
Q ss_pred ccCcccCCCCCcccccccccc---eecCCcc-cccCCCccccccccccc-eeeccCCccCCCCCCCCCCccccccccccC
Q 002349 362 VHGNKLNGTIPPAFQRLESMT---YLNLSLN-NIRGPIPVELSRIGNLD-TLDMSNNKISGSIPSPLGDLEHLLKLNLSR 436 (933)
Q Consensus 362 l~~N~l~~~~~~~~~~l~~L~---~L~L~~N-~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 436 (933)
+++|++++ +|. |..+++|+ +|++++| .+++..+..|..+++|+ .|++++|+++...+..|.. ++|+.|+|++
T Consensus 112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~ 188 (239)
T 2xwt_C 112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLNK 188 (239)
T ss_dssp EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECTT
T ss_pred CCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcCC
Confidence 55555554 333 55555555 6666666 66655555566666666 6667666666332333333 6777777777
Q ss_pred cc-cccccccccccc-cccceEEccCCccccccchhhccccccceeeecCC
Q 002349 437 NQ-LTGFIPGEFGNL-RSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYN 485 (933)
Q Consensus 437 N~-l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N 485 (933)
|+ +++..+..|.++ ++|+.|+|++|++++..+. .+++|+.|+++++
T Consensus 189 n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 189 NKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNT 236 (239)
T ss_dssp CTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC
T ss_pred CCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCc
Confidence 74 776666677777 7777777777777744333 4566666666654
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=5.5e-23 Score=228.04 Aligned_cols=245 Identities=18% Similarity=0.149 Sum_probs=166.5
Q ss_pred CCCCccceEecCCCCcEEEEEcCCCCcCcccCCCCCCCCCccEEEccCCcccccCCCCccCCCCCceecccccccCCCCC
Q 002349 54 DYCVWRGITCDNVTFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIP 133 (933)
Q Consensus 54 ~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p 133 (933)
+.|.|+.|.|++ ++|+ .+|..+ .+++++|+|++|+|+...+.+|.++++|++|+|++|++.+.+|
T Consensus 7 C~C~~~~v~C~~------------~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~ 71 (350)
T 4ay9_X 7 CHCSNRVFLCQE------------SKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIE 71 (350)
T ss_dssp SEEETTEEEEES------------TTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEEC
T ss_pred cEeeCCEEEecC------------CCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccC
Confidence 446777777753 4555 567665 3689999999999995444579999999999999999977776
Q ss_pred c-ccccccchhh-hhhcccCccCCCCcccccCCCCceeeeecCCCCCCcccccccCCCCcEEeccC-ccccCccCcCCcC
Q 002349 134 F-SISKLKQLEF-LILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRN-NSLTGSIPQNIGN 210 (933)
Q Consensus 134 ~-~~~~l~~L~~-L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-n~l~~~~p~~l~~ 210 (933)
. .|.++++|++ +.++.|+++...|..|..+++|++|++++|++.+..+..+....++..|++.+ |++....+..|..
T Consensus 72 ~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~ 151 (350)
T 4ay9_X 72 ADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVG 151 (350)
T ss_dssp TTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTT
T ss_pred hhHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhh
Confidence 5 5788988775 66778999988888899999999999999999877777777888888898865 5666555556666
Q ss_pred CC-CCcEEccccccccCcCCCCccccccceEeccc-cccccccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEE
Q 002349 211 CT-SFQVLDLSYNQLSGEIPFNIGFLQIATLSLQG-NQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKL 288 (933)
Q Consensus 211 l~-~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 288 (933)
+. .++.|+|++|+|+...+..+...++++|++.+ |.++...+..|..+++|++|||++|+|+...+..|. +|+.|
T Consensus 152 ~~~~l~~L~L~~N~i~~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~---~L~~L 228 (350)
T 4ay9_X 152 LSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLE---NLKKL 228 (350)
T ss_dssp SBSSCEEEECCSSCCCEECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCT---TCCEE
T ss_pred cchhhhhhccccccccCCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhc---cchHh
Confidence 54 57888888888874444444445566666653 444433334556666666666666666644333333 33333
Q ss_pred EeeCCccCCCCCCccccCCcceEeeeccc
Q 002349 289 YLHSNKLTGHIPPELGNMTKLHYLELNDN 317 (933)
Q Consensus 289 ~L~~N~l~~~~p~~l~~l~~L~~L~L~~N 317 (933)
.+.++.--..+| .+.++++|+.+++.++
T Consensus 229 ~~l~~~~l~~lP-~l~~l~~L~~l~l~~~ 256 (350)
T 4ay9_X 229 RARSTYNLKKLP-TLEKLVALMEASLTYP 256 (350)
T ss_dssp ECTTCTTCCCCC-CTTTCCSCCEEECSCH
T ss_pred hhccCCCcCcCC-CchhCcChhhCcCCCC
Confidence 332222111333 2455555555555543
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.88 E-value=2e-22 Score=212.43 Aligned_cols=181 Identities=25% Similarity=0.322 Sum_probs=114.1
Q ss_pred ccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcceEeeeccccccccCCcccccccccccccc
Q 002349 259 QALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNV 338 (933)
Q Consensus 259 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L 338 (933)
.+.+.++++++.++ .+|..+. ++++.|+|++|.+++..+..|.++++|++|+|++|++++.
T Consensus 14 ~~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~---------------- 74 (251)
T 3m19_A 14 EGKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTL---------------- 74 (251)
T ss_dssp GGGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCC----------------
T ss_pred CCCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCcc----------------
Confidence 34566777777666 3333332 3555555555555555555555555555555555555544
Q ss_pred ccccCCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCCccccccccccceeeccCCccCCC
Q 002349 339 ANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGS 418 (933)
Q Consensus 339 ~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 418 (933)
.+..|..+++|++|++++|++++..+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|+|++.
T Consensus 75 --------~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 146 (251)
T 3m19_A 75 --------SAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSI 146 (251)
T ss_dssp --------CTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred --------CHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCcc
Confidence 444445555555555555555555555555666666666666666655555566667777777777777766
Q ss_pred CCCCCCCccccccccccCcccccccccccccccccceEEccCCccccc
Q 002349 419 IPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGV 466 (933)
Q Consensus 419 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 466 (933)
.+..|..+++|+.|+|++|+|++..+..|.++++|+.|+|++|++++.
T Consensus 147 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 147 PAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 666777777788888888888777777788888888888888888765
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.2e-22 Score=207.55 Aligned_cols=187 Identities=23% Similarity=0.201 Sum_probs=149.6
Q ss_pred CCCCCCccceEecCCCCcEEEEEcCCCCcCcccCCCCCCCCCccEEEccCCcccccCCCCccCCCCCceecccccccCCC
Q 002349 52 SSDYCVWRGITCDNVTFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGD 131 (933)
Q Consensus 52 ~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~ 131 (933)
..+.|.|.+|.|+.. +++ .+|..+ .++|++|+|++|++++..+..|+++++|++|+|++|++++.
T Consensus 3 ~~C~C~~~~v~c~~~------------~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 67 (208)
T 2o6s_A 3 SRCSCSGTTVECYSQ------------GRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSL 67 (208)
T ss_dssp TTCEEETTEEECCSS------------CCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCC
T ss_pred CCCEECCCEEEecCC------------Ccc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCcc
Confidence 456789999999653 233 344433 35899999999999976667789999999999999999976
Q ss_pred CCcccccccchhhhhhcccCccCCCCcccccCCCCceeeeecCCCCCCcccccccCCCCcEEeccCccccCccCcCCcCC
Q 002349 132 IPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNC 211 (933)
Q Consensus 132 ~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l 211 (933)
.+..|..+++|++|+|++|++++..+..++.+++|++|+|++|++++..+..|..+++|++|++++|++++..+..+..+
T Consensus 68 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l 147 (208)
T 2o6s_A 68 PNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRL 147 (208)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTC
T ss_pred ChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccC
Confidence 66678999999999999999997777778999999999999999997777778899999999999999997777778999
Q ss_pred CCCcEEccccccccCcCCCCccccccceEeccccccccccCccccccc
Q 002349 212 TSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQ 259 (933)
Q Consensus 212 ~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~ 259 (933)
++|++|++++|.+.+..| .++.|+++.|+++|.+|..++.++
T Consensus 148 ~~L~~L~l~~N~~~~~~~------~l~~L~~~~n~~~g~ip~~~~~l~ 189 (208)
T 2o6s_A 148 TSLQYIWLHDNPWDCTCP------GIRYLSEWINKHSGVVRNSAGSVA 189 (208)
T ss_dssp TTCCEEECCSCCBCCCTT------TTHHHHHHHHHCTTTBBCTTSSBC
T ss_pred CCccEEEecCCCeecCCC------CHHHHHHHHHhCCceeeccCcccc
Confidence 999999999998775433 455556666666666665555443
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.88 E-value=3.1e-25 Score=249.98 Aligned_cols=242 Identities=21% Similarity=0.235 Sum_probs=168.8
Q ss_pred cCccccccccccEEeccCCcCcCC----CCCCCCCCCCccEEEeeCCc---cCCCCCCcc-------ccCCcceEeeecc
Q 002349 251 IPSVIGLMQALAVLDLSCNMLSGP----IPPILGNLSYTEKLYLHSNK---LTGHIPPEL-------GNMTKLHYLELND 316 (933)
Q Consensus 251 ~p~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~---l~~~~p~~l-------~~l~~L~~L~L~~ 316 (933)
++..+..+++|+.|+|++|.+++. ++..|..+++|++|+|++|. +++.+|..+ ..+++|++|+|++
T Consensus 24 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~ 103 (386)
T 2ca6_A 24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD 103 (386)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred HHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCC
Confidence 344455556666666666666543 22335556666666666643 333334333 4566677777777
Q ss_pred ccccc----cCCccccccccccccccccccCCCCCCCC----cccC---------CCCCceeccCcccC-CCCC---ccc
Q 002349 317 NQLTG----HIPPALGKLTDLFDLNVANNHLEGPIPDN----LSSC---------TNLNSLNVHGNKLN-GTIP---PAF 375 (933)
Q Consensus 317 N~l~~----~~~~~l~~l~~L~~L~L~~N~l~~~~p~~----l~~l---------~~L~~L~l~~N~l~-~~~~---~~~ 375 (933)
|.+++ .+|..+..+++|+.|+|++|.++...+.. +..+ ++|++|++++|+++ +.++ ..+
T Consensus 104 n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l 183 (386)
T 2ca6_A 104 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 183 (386)
T ss_dssp CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHH
T ss_pred CcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHH
Confidence 77665 35556666667777777777664322222 2223 78888888888886 3344 456
Q ss_pred ccccccceecCCcccccC-----CCccccccccccceeeccCCccC----CCCCCCCCCccccccccccCcccccc----
Q 002349 376 QRLESMTYLNLSLNNIRG-----PIPVELSRIGNLDTLDMSNNKIS----GSIPSPLGDLEHLLKLNLSRNQLTGF---- 442 (933)
Q Consensus 376 ~~l~~L~~L~L~~N~l~~-----~~~~~~~~l~~L~~L~Ls~N~l~----~~~p~~~~~l~~L~~L~Ls~N~l~~~---- 442 (933)
..+++|++|+|++|+++. ..+..+..+++|+.|+|++|.++ +.+|..+..+++|+.|+|++|++++.
T Consensus 184 ~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~ 263 (386)
T 2ca6_A 184 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAA 263 (386)
T ss_dssp HHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHH
T ss_pred HhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHH
Confidence 678888899999988872 34447788889999999999985 56777888889999999999999866
Q ss_pred ccccc--ccccccceEEccCCcccc----ccchhh-ccccccceeeecCCCCcCccc
Q 002349 443 IPGEF--GNLRSVMEIDLSHNHLTG----VIPEEL-SQLQNMFSLRLDYNNLSGDVM 492 (933)
Q Consensus 443 ~p~~~--~~l~~L~~L~Ls~N~l~~----~~p~~~-~~l~~L~~L~l~~N~l~~~~~ 492 (933)
+|..+ +++++|+.|+|++|++++ .+|..+ .++++|+.|+|++|++++..+
T Consensus 264 l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 264 VVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp HHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred HHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence 56666 348999999999999998 488777 668999999999999987654
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.87 E-value=2.4e-25 Score=250.90 Aligned_cols=264 Identities=17% Similarity=0.185 Sum_probs=129.5
Q ss_pred cCCCCccCCCCCceecccccccCCCCCc----ccccccchhhhhhccc---CccCCCCccc-------ccCCCCceeeee
Q 002349 107 QIPDEIGDCSSLKSLDLSFNELYGDIPF----SISKLKQLEFLILKNN---QLIGPIPSTL-------SQLPNLKVFGLR 172 (933)
Q Consensus 107 ~~p~~l~~l~~L~~L~Ls~n~l~~~~p~----~~~~l~~L~~L~L~~n---~l~~~~p~~l-------~~l~~L~~L~L~ 172 (933)
.++..+..+++|++|+|++|.+++..+. .+..+++|++|+|++| ++++.+|..+ ..+++|++|+|+
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls 102 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 102 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence 4566677777777777777777654333 3456666777777664 3344444444 455666666666
Q ss_pred cCCCCC----CcccccccCCCCcEEeccCccccCccCcCCcC----C---------CCCcEEccccccccCcCCCCcccc
Q 002349 173 GNNLVG----TLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGN----C---------TSFQVLDLSYNQLSGEIPFNIGFL 235 (933)
Q Consensus 173 ~N~l~~----~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~----l---------~~L~~L~L~~N~l~~~~p~~~~~~ 235 (933)
+|.+++ .++..+..+++|++|+|++|.+++..+..+.. + ++|++|+|++|+++.
T Consensus 103 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~--------- 173 (386)
T 2ca6_A 103 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLEN--------- 173 (386)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTG---------
T ss_pred CCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCc---------
Confidence 666654 24445555555555555555554322222211 1 333333333333320
Q ss_pred ccceEeccccccccccC---ccccccccccEEeccCCcCcC-----CCCCCCCCCCCccEEEeeCCccCCCCCCccccCC
Q 002349 236 QIATLSLQGNQLTGKIP---SVIGLMQALAVLDLSCNMLSG-----PIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMT 307 (933)
Q Consensus 236 ~L~~L~L~~n~l~~~~p---~~~~~l~~L~~L~Ls~N~l~~-----~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 307 (933)
+.++ ..+..+++|+.|+|++|.++. ..+..+..+++|+.|+|++|.++...
T Consensus 174 -------------~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g-------- 232 (386)
T 2ca6_A 174 -------------GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLG-------- 232 (386)
T ss_dssp -------------GGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHH--------
T ss_pred -------------HHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHH--------
Confidence 1112 233444455555555555541 12224444444444444444443000
Q ss_pred cceEeeeccccccccCCccccccccccccccccccCCCC----CCCCc--ccCCCCCceeccCcccCC----CCCccc-c
Q 002349 308 KLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGP----IPDNL--SSCTNLNSLNVHGNKLNG----TIPPAF-Q 376 (933)
Q Consensus 308 ~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~----~p~~l--~~l~~L~~L~l~~N~l~~----~~~~~~-~ 376 (933)
.+.+|..+..+++|+.|+|++|++++. ++..+ +.+++|+.|+|++|++++ .+|..+ .
T Consensus 233 ------------~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~ 300 (386)
T 2ca6_A 233 ------------SSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDE 300 (386)
T ss_dssp ------------HHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHH
T ss_pred ------------HHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHh
Confidence 023334444444444444444444432 22333 225566666666666664 245444 4
Q ss_pred cccccceecCCcccccCCCc--ccc-ccccccceeeccC
Q 002349 377 RLESMTYLNLSLNNIRGPIP--VEL-SRIGNLDTLDMSN 412 (933)
Q Consensus 377 ~l~~L~~L~L~~N~l~~~~~--~~~-~~l~~L~~L~Ls~ 412 (933)
++++|++|++++|.+++..+ ..+ ..++.++.+++..
T Consensus 301 ~l~~L~~L~l~~N~l~~~~~~~~~l~~~l~~~~~~~l~~ 339 (386)
T 2ca6_A 301 KMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDE 339 (386)
T ss_dssp HCTTCCEEECTTSBSCTTSHHHHHHHHHHHHHTCCEECC
T ss_pred cCCCceEEEccCCcCCcchhHHHHHHHHhhhcCcchhhh
Confidence 46667777777777665543 222 2244444455544
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.87 E-value=4.1e-23 Score=240.77 Aligned_cols=155 Identities=27% Similarity=0.329 Sum_probs=109.8
Q ss_pred cCCCCCCCCCCCC-----Cccce-EecCCCCcEEEEEcCCCCcCcccCCCCCCCCCccEEEccCCcccccCCCCccCCCC
Q 002349 44 LYDWTDSPSSDYC-----VWRGI-TCDNVTFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSS 117 (933)
Q Consensus 44 l~~w~~~~~~~~c-----~w~gv-~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~ 117 (933)
+.+|.. ..++| .|.|+ .|.. .+++.|+|++|++++ +|..+. ++|++|+|++|+|+ .+| +.+++
T Consensus 33 l~~W~~--~~~~~~~~~~~~~~l~~C~~--~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~ 101 (571)
T 3cvr_A 33 WDKWEK--QALPGENRNEAVSLLKECLI--NQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPAS 101 (571)
T ss_dssp HHHHHT--TCCTTCCHHHHHHHHHHHHH--TTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTT
T ss_pred HHHHhc--cCCccccccchhhhcccccc--CCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCC
Confidence 556754 34567 79999 7863 367788899988886 776663 78888888888888 677 45788
Q ss_pred CceecccccccCCCCCcccccccchhhhhhcccCccCCCCcccccCCCCceeeeecCCCCCCcccccccCCCCcEEeccC
Q 002349 118 LKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRN 197 (933)
Q Consensus 118 L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 197 (933)
|++|+|++|.|++ +|. +.+ +|++|+|++|++++ +|. .+++|+.|+|++|+|++ +|. .+++|++|+|++
T Consensus 102 L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~ 169 (571)
T 3cvr_A 102 LEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRN 169 (571)
T ss_dssp CCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCS
T ss_pred CCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCC
Confidence 8888888888886 666 655 78888888888776 555 56777777777777765 443 456666666666
Q ss_pred ccccCccCcCCcCCCCCcEEcccccccc
Q 002349 198 NSLTGSIPQNIGNCTSFQVLDLSYNQLS 225 (933)
Q Consensus 198 n~l~~~~p~~l~~l~~L~~L~L~~N~l~ 225 (933)
|.|++ +|. +. ++|+.|+|++|+|+
T Consensus 170 N~L~~-lp~-l~--~~L~~L~Ls~N~L~ 193 (571)
T 3cvr_A 170 NQLTF-LPE-LP--ESLEALDVSTNLLE 193 (571)
T ss_dssp SCCSC-CCC-CC--TTCCEEECCSSCCS
T ss_pred CCCCC-cch-hh--CCCCEEECcCCCCC
Confidence 66664 554 44 56666666666655
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.87 E-value=1.9e-22 Score=219.34 Aligned_cols=197 Identities=25% Similarity=0.402 Sum_probs=109.7
Q ss_pred ccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcceEeeeccccccccCCcccccccccc
Q 002349 255 IGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLF 334 (933)
Q Consensus 255 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~ 334 (933)
+..+++|+.|++++|.++. ++ .+..+++|++|+|++|.+++..+ +..+++|++|+|++|++++. ..+..+++|+
T Consensus 37 ~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~ 110 (308)
T 1h6u_A 37 QADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIK 110 (308)
T ss_dssp HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCC
T ss_pred HHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCC
Confidence 3456677777777777764 23 46666777777777777764433 66666666666666666642 2455555555
Q ss_pred ccccccccCCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCCccccccccccceeeccCCc
Q 002349 335 DLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNK 414 (933)
Q Consensus 335 ~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 414 (933)
.|++++|++++. + .+..+++|++|++++|+++ +..+ +..+++|+.|+|++|+
T Consensus 111 ~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~------------------------~~~~--l~~l~~L~~L~l~~n~ 162 (308)
T 1h6u_A 111 TLDLTSTQITDV-T-PLAGLSNLQVLYLDLNQIT------------------------NISP--LAGLTNLQYLSIGNAQ 162 (308)
T ss_dssp EEECTTSCCCCC-G-GGTTCTTCCEEECCSSCCC------------------------CCGG--GGGCTTCCEEECCSSC
T ss_pred EEECCCCCCCCc-h-hhcCCCCCCEEECCCCccC------------------------cCcc--ccCCCCccEEEccCCc
Confidence 555555555532 2 1444555555555555544 3322 4444555555555555
Q ss_pred cCCCCCCCCCCccccccccccCcccccccccccccccccceEEccCCccccccchhhccccccceeeecCCCCcCcc
Q 002349 415 ISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDV 491 (933)
Q Consensus 415 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 491 (933)
+++..+ +..+++|+.|+|++|++++..+ +..+++|+.|+|++|++++..| +..+++|+.|++++|++++.+
T Consensus 163 l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~~~ 233 (308)
T 1h6u_A 163 VSDLTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQP 233 (308)
T ss_dssp CCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEECCC
T ss_pred CCCChh--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeecCC
Confidence 543222 5555555555555555554332 5555666666666666654432 555666666666666665533
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.87 E-value=4.5e-24 Score=235.74 Aligned_cols=199 Identities=21% Similarity=0.259 Sum_probs=105.5
Q ss_pred CCceeeeecCCCCCCcccccccC--CCCcEEeccCccccCccCcCCcCCCCCcEEccccccccCcCCCCccccccceEec
Q 002349 165 NLKVFGLRGNNLVGTLSPDMCQL--SGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSL 242 (933)
Q Consensus 165 ~L~~L~L~~N~l~~~~~~~~~~l--~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L 242 (933)
.++.|++++|.+. +..+..+ ++++.|++++|.+.+..+. +.++++|++|+|++|++++.
T Consensus 48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~--------------- 108 (336)
T 2ast_B 48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVS--------------- 108 (336)
T ss_dssp TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHH---------------
T ss_pred hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHH---------------
Confidence 3667777777665 4445555 6667777777766655443 44566666666666555421
Q ss_pred cccccccccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCC-ccCCC-CCCccccCCcceEeeeccc-cc
Q 002349 243 QGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSN-KLTGH-IPPELGNMTKLHYLELNDN-QL 319 (933)
Q Consensus 243 ~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~-~p~~l~~l~~L~~L~L~~N-~l 319 (933)
.++..+..+++|++|+|++|.+++..+..++.+++|++|+|++| .+++. ++..+.++++|++|++++| .+
T Consensus 109 -------~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l 181 (336)
T 2ast_B 109 -------TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDF 181 (336)
T ss_dssp -------HHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTC
T ss_pred -------HHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCc
Confidence 14444555666666666666666555555556666666666666 45431 3444555666666666666 55
Q ss_pred ccc-CCccccccc-ccccccccccc--CC-CCCCCCcccCCCCCceeccCcc-cCCCCCcccccccccceecCCcc
Q 002349 320 TGH-IPPALGKLT-DLFDLNVANNH--LE-GPIPDNLSSCTNLNSLNVHGNK-LNGTIPPAFQRLESMTYLNLSLN 389 (933)
Q Consensus 320 ~~~-~~~~l~~l~-~L~~L~L~~N~--l~-~~~p~~l~~l~~L~~L~l~~N~-l~~~~~~~~~~l~~L~~L~L~~N 389 (933)
++. ++..+..++ +|++|++++|. ++ +.++..+..+++|+.|++++|. +++..+..+..+++|++|++++|
T Consensus 182 ~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~ 257 (336)
T 2ast_B 182 TEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRC 257 (336)
T ss_dssp CHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTC
T ss_pred ChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCC
Confidence 532 334444455 55555555552 22 1222333344444444444444 33333334444444444444444
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=3.6e-22 Score=221.49 Aligned_cols=246 Identities=20% Similarity=0.158 Sum_probs=122.8
Q ss_pred ceEeccccccccccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCC-CccccCCcceE-eeec
Q 002349 238 ATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIP-PELGNMTKLHY-LELN 315 (933)
Q Consensus 238 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~-L~L~ 315 (933)
++++.++++++ .+|..+ .+++++|+|++|+|+.+.+.+|.++++|++|+|++|++.+.+| ..|.++++|.. +.++
T Consensus 12 ~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 44566666666 344433 2456666666666665555566666666666666666654443 34556655443 4455
Q ss_pred cccccccCCccccccccccccccccccCCCCCCCCcccCCCCCceeccC-cccCCCCCcccccccccceecCCcccccCC
Q 002349 316 DNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHG-NKLNGTIPPAFQRLESMTYLNLSLNNIRGP 394 (933)
Q Consensus 316 ~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 394 (933)
+|+++...|..|..+++|++|++++|++....+..+....++..|++.+ |++....+..|..+.
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~--------------- 153 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLS--------------- 153 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSB---------------
T ss_pred CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcc---------------
Confidence 5666655555666666666666666666544444444445555555543 344433333444332
Q ss_pred CccccccccccceeeccCCccCCCCCCCCCCccccccccccC-cccccccccccccccccceEEccCCccccccchhhcc
Q 002349 395 IPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSR-NQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQ 473 (933)
Q Consensus 395 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 473 (933)
..++.|+|++|+|+ .+|.......+|+.|++++ |.++.+.+..|.++++|++|||++|+|+...+..+.+
T Consensus 154 --------~~l~~L~L~~N~i~-~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~ 224 (350)
T 4ay9_X 154 --------FESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLEN 224 (350)
T ss_dssp --------SSCEEEECCSSCCC-EECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTT
T ss_pred --------hhhhhhcccccccc-CCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhcc
Confidence 13444555555554 2333333334455555542 3444333344555555555555555555443334444
Q ss_pred ccccceeeecCCCCcCcccchhhccccceeecCCCCCCCc
Q 002349 474 LQNMFSLRLDYNNLSGDVMSLINCLSLSVLFIGNPGLCGY 513 (933)
Q Consensus 474 l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~N~~~C~~ 513 (933)
+++|+.+++ ++++.. |.+..+..+......|+|.|.|
T Consensus 225 L~~L~~l~~--~~l~~l-P~l~~l~~L~~l~l~~~~~c~~ 261 (350)
T 4ay9_X 225 LKKLRARST--YNLKKL-PTLEKLVALMEASLTYPSHCCA 261 (350)
T ss_dssp CCEEECTTC--TTCCCC-CCTTTCCSCCEEECSCHHHHHH
T ss_pred chHhhhccC--CCcCcC-CCchhCcChhhCcCCCCccccc
Confidence 444333332 222222 2333444444334456666644
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=1.7e-22 Score=215.96 Aligned_cols=150 Identities=14% Similarity=0.194 Sum_probs=120.6
Q ss_pred HHHHhhccCcceeeecccceeEEEEEEcCCceEEEEEecccCc------------------hhHHHHHHHHHHHhcCCCC
Q 002349 593 IMRMTENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYP------------------QCLKEFETELETVGSIKHR 654 (933)
Q Consensus 593 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~ 654 (933)
+......|+..+.||+|+||.||+|.+.+++.||+|+++.... .....+.+|++++++++
T Consensus 85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-- 162 (282)
T 1zar_A 85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-- 162 (282)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence 3334456667799999999999999997789999999964321 13456899999999999
Q ss_pred ceeeeeeEEecCCccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeC
Q 002349 655 NLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLD 734 (933)
Q Consensus 655 niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~ 734 (933)
| +++.+++.. +..++||||+++++|.+ +.. .....++.|++.||+|||++ +|+||||||+|||++
T Consensus 163 ~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~ 227 (282)
T 1zar_A 163 G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS 227 (282)
T ss_dssp T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE
T ss_pred C-CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE
Confidence 5 666665543 56799999999999988 521 23457999999999999966 999999999999999
Q ss_pred CCCCeEEeecccccccccCCCceeeeecccccccCccccc
Q 002349 735 KDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYAR 774 (933)
Q Consensus 735 ~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~ 774 (933)
++.+||+|||+|+. +..|+|||++.
T Consensus 228 -~~~vkl~DFG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 228 -EEGIWIIDFPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp -TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred -CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence 99999999999963 34578899774
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.86 E-value=5.2e-22 Score=215.86 Aligned_cols=211 Identities=25% Similarity=0.358 Sum_probs=156.9
Q ss_pred CCcEEccccccccCcCCCCccccccceEeccccccccccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeC
Q 002349 213 SFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHS 292 (933)
Q Consensus 213 ~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 292 (933)
.+..+.+..+.++..++ .....+|++|++++|+++. ++ .+..+++|++|+|++|.+++..+ +..+++|++|+|++
T Consensus 20 ~~~~~~l~~~~~~~~~~-~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~ 94 (308)
T 1h6u_A 20 NAIKIAAGKSNVTDTVT-QADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSG 94 (308)
T ss_dssp HHHHHHTTCSSTTSEEC-HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCS
T ss_pred HHHHHHhCCCCcCceec-HHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccC
Confidence 34445566666654322 2234589999999999985 44 58899999999999999997655 99999999999999
Q ss_pred CccCCCCCCccccCCcceEeeeccccccccCCccccccccccccccccccCCCCCCCCcccCCCCCceeccCcccCCCCC
Q 002349 293 NKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIP 372 (933)
Q Consensus 293 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~ 372 (933)
|++++. ..+..+++|++|++++|++++. + .+..+++|+.|++++|++++..+ +..+++|+.|++++|++++..+
T Consensus 95 n~l~~~--~~~~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~ 168 (308)
T 1h6u_A 95 NPLKNV--SAIAGLQSIKTLDLTSTQITDV-T-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP 168 (308)
T ss_dssp CCCSCC--GGGTTCTTCCEEECTTSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG
T ss_pred CcCCCc--hhhcCCCCCCEEECCCCCCCCc-h-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh
Confidence 999964 3799999999999999999964 3 38999999999999999986544 7788888888888888875333
Q ss_pred cccccccccceecCCcccccCCCccccccccccceeeccCCccCCCCCCCCCCccccccccccCcccc
Q 002349 373 PAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLT 440 (933)
Q Consensus 373 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 440 (933)
+..+++|+.|++++|++++..+ +..+++|+.|+|++|++++.. .+..+++|+.|+|++|+++
T Consensus 169 --l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~ 230 (308)
T 1h6u_A 169 --LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTIT 230 (308)
T ss_dssp --GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEE
T ss_pred --hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeee
Confidence 6777777777777777764433 555666666666666665332 2455555555555555554
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.86 E-value=8.9e-22 Score=229.52 Aligned_cols=189 Identities=30% Similarity=0.399 Sum_probs=152.0
Q ss_pred cccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcceEeeeccccccccCCccccccccccccccc
Q 002349 260 ALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVA 339 (933)
Q Consensus 260 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~ 339 (933)
+|+.|+|++|.|++ +|..+. ++|++|+|++|+|+ .+| ..+++|++|+|++|+|++ +|. +.+ +|+.|+++
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence 78888888888886 555443 67888888888888 566 456888899999998886 666 655 88889999
Q ss_pred cccCCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCCccccccccccceeeccCCccCCCC
Q 002349 340 NNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSI 419 (933)
Q Consensus 340 ~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 419 (933)
+|++++ +|. .+++|+.|++++|+|++ +|. .+++|++|+|++|+|++ +|. |. ++|+.|+|++|+|+ .+
T Consensus 129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~l 195 (571)
T 3cvr_A 129 NNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SL 195 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SC
T ss_pred CCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-ch
Confidence 998886 555 67889999999999986 554 56889999999999986 555 65 88999999999998 66
Q ss_pred CCCCCCcccc-------ccccccCcccccccccccccccccceEEccCCccccccchhhccccc
Q 002349 420 PSPLGDLEHL-------LKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQN 476 (933)
Q Consensus 420 p~~~~~l~~L-------~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 476 (933)
|. |.. +| +.|+|++|+|+ .+|..+.++++|+.|+|++|+|++.+|..+..+..
T Consensus 196 p~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 255 (571)
T 3cvr_A 196 PA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA 255 (571)
T ss_dssp CC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred hh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence 66 655 77 99999999999 57888888999999999999999999998888765
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.8e-20 Score=191.46 Aligned_cols=161 Identities=22% Similarity=0.243 Sum_probs=80.8
Q ss_pred CccEEEeeCCccCCCCCCccccCCcceEeeeccccccccCCccccccccccccccccccCCCCCCCCcccCCCCCceecc
Q 002349 284 YTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVH 363 (933)
Q Consensus 284 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~ 363 (933)
+|++|+|++|++++..+..|..+++|++|++++|++++..+..|..+++|++|++++|++++..+..|..+++|++|+++
T Consensus 29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 108 (208)
T 2o6s_A 29 QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALN 108 (208)
T ss_dssp TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcC
Confidence 44555555555544444444445555555555555554433344445555555555555544444444555555555555
Q ss_pred CcccCCCCCcccccccccceecCCcccccCCCccccccccccceeeccCCccCCCCCCCCCCccccccccccCccccccc
Q 002349 364 GNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFI 443 (933)
Q Consensus 364 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 443 (933)
+|++++..+..|..+++|++|++++|++++..+..+..+++|+.|+|++|.+.+ .+++|++|+++.|+++|.+
T Consensus 109 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~i 181 (208)
T 2o6s_A 109 TNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVV 181 (208)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTB
T ss_pred CCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCcee
Confidence 555554444445555555555555555554444445555555555555554442 2334555555555555555
Q ss_pred cccccccc
Q 002349 444 PGEFGNLR 451 (933)
Q Consensus 444 p~~~~~l~ 451 (933)
|..+++++
T Consensus 182 p~~~~~l~ 189 (208)
T 2o6s_A 182 RNSAGSVA 189 (208)
T ss_dssp BCTTSSBC
T ss_pred eccCcccc
Confidence 55554443
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.82 E-value=3.9e-20 Score=191.78 Aligned_cols=162 Identities=22% Similarity=0.178 Sum_probs=142.1
Q ss_pred CCCCCCccceEecCCCCcEEEEEcCCCCcCcccCCCCCCCCCccEEEccCCcccccCCCCccCCCCCceecccccccCCC
Q 002349 52 SSDYCVWRGITCDNVTFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGD 131 (933)
Q Consensus 52 ~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~ 131 (933)
+.+.|+|.+|.|++. +++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|.|++.
T Consensus 15 ~~~~Cs~~~v~c~~~------------~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i 79 (229)
T 3e6j_A 15 SQCSCSGTTVDCRSK------------RHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGAL 79 (229)
T ss_dssp TTCEEETTEEECTTS------------CCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred CCCEEeCCEeEccCC------------CcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCc
Confidence 468899999999643 233 5555444 8899999999999998899999999999999999999866
Q ss_pred CCcccccccchhhhhhcccCccCCCCcccccCCCCceeeeecCCCCCCcccccccCCCCcEEeccCccccCccCcCCcCC
Q 002349 132 IPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNC 211 (933)
Q Consensus 132 ~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l 211 (933)
.+..|..+++|++|+|++|++++..+..|..+++|++|+|++|+++ .+|..+..+++|++|+|++|++++..+..+..+
T Consensus 80 ~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 158 (229)
T 3e6j_A 80 PVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRL 158 (229)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTC
T ss_pred ChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCC
Confidence 6667899999999999999999877778899999999999999998 778899999999999999999997777789999
Q ss_pred CCCcEEccccccccCcCC
Q 002349 212 TSFQVLDLSYNQLSGEIP 229 (933)
Q Consensus 212 ~~L~~L~L~~N~l~~~~p 229 (933)
++|+.|+|++|.+.+..+
T Consensus 159 ~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 159 SSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp TTCCEEECTTSCBCTTBG
T ss_pred CCCCEEEeeCCCccCCcc
Confidence 999999999999886543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=2.1e-22 Score=236.18 Aligned_cols=267 Identities=21% Similarity=0.155 Sum_probs=158.9
Q ss_pred CccceEecCCCCcEEEEEcCCCCcCcccCCCCCCCCCccEEEccCCc-------ccccCCCC---ccCCCCCceeccccc
Q 002349 57 VWRGITCDNVTFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNR-------LSGQIPDE---IGDCSSLKSLDLSFN 126 (933)
Q Consensus 57 ~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~-------l~~~~p~~---l~~l~~L~~L~Ls~n 126 (933)
.|+++.|+....+|..+++..-.+.- ..+.. =-.+.+.+.. ..+..+.. +..+++|+.|+|++|
T Consensus 286 ~W~~~~~~~~~~~vw~~~~~~~~~~~----~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~L~~L~Ls~n 359 (567)
T 1dce_A 286 EWRTPDGRNRPSHVWLCDLPAASLND----QLPQH--TFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVE 359 (567)
T ss_dssp CCBCTTSSCCSEEEEEEECCGGGTST----TSSEE--EEEEEETTTTEEEEEEEETTCSEEEEECCSTTTTSSSCCCCHH
T ss_pred eeccCCcccccceeEEeecCcccccc----ccccc--eEEEeeccCCCCccccccCCCchhhhcccccCccceeccCChh
Confidence 58888887777788888876543321 00000 0011111100 11111112 256888888999999
Q ss_pred ccCCCCCcccccccchhhhhhcccCccCCCCcccccCCCCceeeeecCCCCCCcccccccCCCCcEEe-ccCccccCccC
Q 002349 127 ELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFD-VRNNSLTGSIP 205 (933)
Q Consensus 127 ~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~-L~~n~l~~~~p 205 (933)
+++ .+|.+++++++|++|++++|.....+|.. +..+.+.+.+|..++.+++|+.|+ ++.|.+.
T Consensus 360 ~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~l-----------l~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~---- 423 (567)
T 1dce_A 360 KST-VLQSELESCKELQELEPENKWCLLTIILL-----------MRALDPLLYEKETLQYFSTLKAVDPMRAAYLD---- 423 (567)
T ss_dssp HHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHH-----------HHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH----
T ss_pred hHH-hhHHHHHHHHHHHHhccccchhhhhHHHH-----------HHhcccccCCHHHHHHHHhcccCcchhhcccc----
Confidence 887 78888889999999988776521111100 111122334444555555555555 4444332
Q ss_pred cCCcCCCCCcEEccccccccCcCCCCccccccceEeccccccccccCccccccccccEEeccCCcCcCCCCCCCCCCCCc
Q 002349 206 QNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYT 285 (933)
Q Consensus 206 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 285 (933)
+|+.+.+++|.++...+ ..|+.|+|++|++++ +|. ++.+++|+.|+|++|.|+ .+|..|+++++|
T Consensus 424 -------~L~~l~l~~n~i~~l~~-----~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L 488 (567)
T 1dce_A 424 -------DLRSKFLLENSVLKMEY-----ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCL 488 (567)
T ss_dssp -------HHHHHHHHHHHHHHHHH-----TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTC
T ss_pred -------hhhhhhhhcccccccCc-----cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCC
Confidence 34445555555553211 135556666666664 444 677777777777777777 566677777777
Q ss_pred cEEEeeCCccCCCCCCccccCCcceEeeeccccccccC-CccccccccccccccccccCCCCCCCC---cccCCCCCcee
Q 002349 286 EKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHI-PPALGKLTDLFDLNVANNHLEGPIPDN---LSSCTNLNSLN 361 (933)
Q Consensus 286 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~-~~~l~~l~~L~~L~L~~N~l~~~~p~~---l~~l~~L~~L~ 361 (933)
+.|+|++|+|++ +| .+.++++|+.|+|++|+|++.. |..++.+++|+.|+|++|++++..|.. +..+++|+.|+
T Consensus 489 ~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~ 566 (567)
T 1dce_A 489 EVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 566 (567)
T ss_dssp CEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEE
T ss_pred CEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccC
Confidence 777777777775 45 6777777777777777777665 777777777777777777777554432 22367777775
Q ss_pred c
Q 002349 362 V 362 (933)
Q Consensus 362 l 362 (933)
+
T Consensus 567 l 567 (567)
T 1dce_A 567 T 567 (567)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.82 E-value=1.9e-21 Score=235.32 Aligned_cols=269 Identities=20% Similarity=0.199 Sum_probs=134.3
Q ss_pred CChHHHHHHHHHHHhCCCC-CCCcCCCCCCCCCCCCCccceEecCCCCcEEEEEcCCCCcCcccCCCCCCCCCccE----
Q 002349 22 VDSEDGATLLKIKKSFRDV-DNVLYDWTDSPSSDYCVWRGITCDNVTFTVIALNLSGLNLDGEISPAVGDLKDLQS---- 96 (933)
Q Consensus 22 ~~~~d~~all~~k~~~~~~-~~~l~~w~~~~~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~---- 96 (933)
....++++|+++......+ ...-.+|... .+..+.|.+++++. .+++.|+|.++++... +..+.....|..
T Consensus 129 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~--~~~~~l~L~~n~~~~~-~~~~l~~l~Ls~~~i~ 204 (727)
T 4b8c_D 129 LVDCTKQALMEMADTLTDSKTAKKQQPTGD-STPSGTATNSAVST--PLTPKIELFANGKDEA-NQALLQHKKLSQYSID 204 (727)
T ss_dssp ---CCCHHHHHHHHHHHHHHTTC---------------------------------------------------------
T ss_pred ccccchhhhhhhhhhcccccCcccCCCcCC-CCccccCCCceecC--CccceEEeeCCCCCcc-hhhHhhcCccCccccc
Confidence 3455778999998776322 2233456433 45677899998864 5799999999998863 433332222222
Q ss_pred -EEccCCcccccCCCCccCCCCCceecccccccCCCCCcccccccchhhhhhcccCccCCCCcccccCCCCceeeeecCC
Q 002349 97 -IDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNN 175 (933)
Q Consensus 97 -L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~ 175 (933)
++++.|.+. ..|..+..+++|+.|+|++|.+. .+|..+.++++|++|+|++|.|+ .+|..|++|++|++|+|++|+
T Consensus 205 ~~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~ 281 (727)
T 4b8c_D 205 EDDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNR 281 (727)
T ss_dssp ------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSC
T ss_pred Ccccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCc
Confidence 233334444 45778999999999999999998 88888889999999999999999 889999999999999999999
Q ss_pred CCCCcccccccCCCCcEEeccCccccCccCcCCcCCCCCcEEccccccccCcCCCCccccc--cceEeccccccccccCc
Q 002349 176 LVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQ--IATLSLQGNQLTGKIPS 253 (933)
Q Consensus 176 l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~--L~~L~L~~n~l~~~~p~ 253 (933)
|+ .+|..|+++++|++|+|++|.|+ .+|..|+++++|++|+|++|+|++.+|..+.... ...|+|++|.+++.+|.
T Consensus 282 l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~ 359 (727)
T 4b8c_D 282 LT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH 359 (727)
T ss_dssp CS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_pred CC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc
Confidence 99 77999999999999999999998 7888899999999999999999988877665432 23456777777766654
Q ss_pred cccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcceEeeeccccccc
Q 002349 254 VIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTG 321 (933)
Q Consensus 254 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ 321 (933)
. |+.|+++.|... -..+ +.+.+..+..+..+.++....+++|-+.+
T Consensus 360 ~------l~~l~l~~n~~~---~~~~-------------~~l~~~~~~~~~~l~~~~~~~ls~Nil~~ 405 (727)
T 4b8c_D 360 E------RRFIEINTDGEP---QREY-------------DSLQQSTEHLATDLAKRTFTVLSYNTLCQ 405 (727)
T ss_dssp C---------------------------------------------------------------CCCG
T ss_pred c------cceeEeeccccc---cccc-------------CCccccccchhhcccccceeeeecccccc
Confidence 3 445555555110 0111 13333334445556666777777777653
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.81 E-value=6.7e-20 Score=188.66 Aligned_cols=160 Identities=21% Similarity=0.264 Sum_probs=139.0
Q ss_pred CCCCCCccceEecCCCCcEEEEEcCCCCcCcccCCCCCCCCCccEEEccCCcccccCCCCccCCCCCceecccccccCCC
Q 002349 52 SSDYCVWRGITCDNVTFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGD 131 (933)
Q Consensus 52 ~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~ 131 (933)
..+.|.|+.|.|+ +++++ .+|..+. +.|++|+|++|+|++..+..|.++++|++|+|++|.+++.
T Consensus 7 ~~C~C~~~~v~c~------------~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~ 71 (220)
T 2v9t_B 7 AACTCSNNIVDCR------------GKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISEL 71 (220)
T ss_dssp TTSEEETTEEECT------------TSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEE
T ss_pred CCCEECCCEEEcC------------CCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCc
Confidence 3445666666654 45555 4666554 6899999999999977777899999999999999999988
Q ss_pred CCcccccccchhhhhhcccCccCCCCcccccCCCCceeeeecCCCCCCcccccccCCCCcEEeccCccccCccCcCCcCC
Q 002349 132 IPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNC 211 (933)
Q Consensus 132 ~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l 211 (933)
.|..|.++++|++|+|++|+++...+..|..+++|+.|+|++|++++..|..|..+++|++|+|++|++++..+..+..+
T Consensus 72 ~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 151 (220)
T 2v9t_B 72 APDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPL 151 (220)
T ss_dssp CTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTC
T ss_pred CHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCC
Confidence 89999999999999999999997666678999999999999999999889999999999999999999998888889999
Q ss_pred CCCcEEccccccccC
Q 002349 212 TSFQVLDLSYNQLSG 226 (933)
Q Consensus 212 ~~L~~L~L~~N~l~~ 226 (933)
++|+.|+|++|++..
T Consensus 152 ~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 152 RAIQTMHLAQNPFIC 166 (220)
T ss_dssp TTCCEEECCSSCEEC
T ss_pred CCCCEEEeCCCCcCC
Confidence 999999999999864
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.80 E-value=3.9e-20 Score=205.94 Aligned_cols=158 Identities=30% Similarity=0.320 Sum_probs=92.7
Q ss_pred ccccccccccCCCCCCCCcc-cCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCCccccccccccceeecc
Q 002349 333 LFDLNVANNHLEGPIPDNLS-SCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMS 411 (933)
Q Consensus 333 L~~L~L~~N~l~~~~p~~l~-~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls 411 (933)
++.|+|++|+|++..+..+. .+++|+.|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|+
T Consensus 41 l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 120 (361)
T 2xot_A 41 TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLY 120 (361)
T ss_dssp CSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECC
Confidence 44444444444444444444 55555555555555555445555555666666666666655555556666666666666
Q ss_pred CCccCCCCCCCCCCccccccccccCccccccccccc---ccccccceEEccCCccccccchhhcccccc--ceeeecCCC
Q 002349 412 NNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEF---GNLRSVMEIDLSHNHLTGVIPEELSQLQNM--FSLRLDYNN 486 (933)
Q Consensus 412 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~---~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L--~~L~l~~N~ 486 (933)
+|+|++..|..|.++++|+.|+|++|+|++..+..| .++++|+.|||++|+|++..+..+..++.+ +.|+|++|+
T Consensus 121 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~ 200 (361)
T 2xot_A 121 NNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNP 200 (361)
T ss_dssp SSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSC
T ss_pred CCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCC
Confidence 666665566666666667777777776665444444 457777777777777776655666666653 555555555
Q ss_pred CcCc
Q 002349 487 LSGD 490 (933)
Q Consensus 487 l~~~ 490 (933)
|.|.
T Consensus 201 ~~C~ 204 (361)
T 2xot_A 201 LECD 204 (361)
T ss_dssp EECC
T ss_pred ccCC
Confidence 5443
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=1e-19 Score=187.25 Aligned_cols=155 Identities=17% Similarity=0.200 Sum_probs=137.4
Q ss_pred EEEcCCCCcCcccCCCCCCCCCccEEEccCCcccccCC-CCccCCCCCceecccccccCCCCCcccccccchhhhhhccc
Q 002349 72 ALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIP-DEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNN 150 (933)
Q Consensus 72 ~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p-~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n 150 (933)
.+++++++++ .+|..+. ..+++|+|++|+|++..| ..|.++++|++|+|++|.|++..|..|.++++|++|+|++|
T Consensus 15 ~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 4566677777 4676654 356899999999997755 45899999999999999999877788999999999999999
Q ss_pred CccCCCCcccccCCCCceeeeecCCCCCCcccccccCCCCcEEeccCccccCccCcCCcCCCCCcEEccccccccCcCC
Q 002349 151 QLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIP 229 (933)
Q Consensus 151 ~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p 229 (933)
++++..|..|+.+++|++|+|++|++++..|..|..+++|++|+|++|++++..|..|..+++|+.|+|++|.+++..+
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 9998888889999999999999999999889999999999999999999999889999999999999999999986443
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.80 E-value=5.4e-20 Score=204.77 Aligned_cols=179 Identities=22% Similarity=0.252 Sum_probs=152.9
Q ss_pred cccccccccCCCCCCCCcccCCCCCceeccCcccCCCCCcccc-cccccceecCCcccccCCCccccccccccceeeccC
Q 002349 334 FDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQ-RLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSN 412 (933)
Q Consensus 334 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 412 (933)
+.+++++|+++ .+|..+. ..++.|+|++|+|++..+..|. .+++|++|+|++|+|++..+..|..+++|++|+|++
T Consensus 21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 45677777776 4555443 4589999999999988888888 999999999999999988888999999999999999
Q ss_pred CccCCCCCCCCCCccccccccccCcccccccccccccccccceEEccCCccccccchhh---ccccccceeeecCCCCcC
Q 002349 413 NKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEEL---SQLQNMFSLRLDYNNLSG 489 (933)
Q Consensus 413 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~---~~l~~L~~L~l~~N~l~~ 489 (933)
|+|++..+..|..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..+ ..+++|+.|+|++|+|++
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 177 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK 177 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence 99998888889999999999999999999999999999999999999999997666666 679999999999999998
Q ss_pred cccc-hhhcccc--c-eeecCCCCCCCccc
Q 002349 490 DVMS-LINCLSL--S-VLFIGNPGLCGYWL 515 (933)
Q Consensus 490 ~~~~-~~~~~~~--~-~~~~~N~~~C~~~l 515 (933)
.++. +..+..+ . +.+.+|||.|+|.+
T Consensus 178 l~~~~~~~l~~~~l~~l~l~~N~~~C~C~l 207 (361)
T 2xot_A 178 LPLTDLQKLPAWVKNGLYLHNNPLECDCKL 207 (361)
T ss_dssp CCHHHHHHSCHHHHTTEECCSSCEECCHHH
T ss_pred cCHHHhhhccHhhcceEEecCCCccCCcCc
Confidence 7654 2333332 2 67899999999965
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=1e-19 Score=187.20 Aligned_cols=136 Identities=21% Similarity=0.270 Sum_probs=90.3
Q ss_pred CCceeccCcccCCCCC-cccccccccceecCCcccccCCCccccccccccceeeccCCccCCCCCCCCCCcccccccccc
Q 002349 357 LNSLNVHGNKLNGTIP-PAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLS 435 (933)
Q Consensus 357 L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 435 (933)
++.|++++|+|++..+ ..|..+++|++|+|++|++++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|+
T Consensus 34 ~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 113 (220)
T 2v70_A 34 TAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLR 113 (220)
T ss_dssp CSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECT
T ss_pred CCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECC
Confidence 4555555555554433 345666666666666666665555566666666666666666666666666667777777777
Q ss_pred CcccccccccccccccccceEEccCCccccccchhhccccccceeeecCCCCcCccc
Q 002349 436 RNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDVM 492 (933)
Q Consensus 436 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~ 492 (933)
+|+|++..|..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|+|..+
T Consensus 114 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 114 SNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp TSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 777776667777777777777777777777667777777777777777777766543
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.3e-19 Score=186.53 Aligned_cols=153 Identities=23% Similarity=0.315 Sum_probs=104.8
Q ss_pred ccccccccCCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCCccccccccccceeeccCCc
Q 002349 335 DLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNK 414 (933)
Q Consensus 335 ~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 414 (933)
.+++++|.++ .+|..+. ++|+.|++++|+|++..+..|..+++|++|+|++|++++..|..|..+++|++|+|++|+
T Consensus 15 ~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~ 91 (220)
T 2v9t_B 15 IVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91 (220)
T ss_dssp EEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSC
T ss_pred EEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCc
Confidence 3444444444 2333332 456666666666665555566666677777777777766666677777777777777777
Q ss_pred cCCCCCCCCCCccccccccccCcccccccccccccccccceEEccCCccccccchhhccccccceeeecCCCCcCc
Q 002349 415 ISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGD 490 (933)
Q Consensus 415 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 490 (933)
|+...+..|..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..+..+++|+.|+|++|+|.|.
T Consensus 92 l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 167 (220)
T 2v9t_B 92 ITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICD 167 (220)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred CCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCC
Confidence 7755555667777777777777777777777777788888888888888877777777777787777776666543
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.79 E-value=1.3e-19 Score=213.79 Aligned_cols=80 Identities=15% Similarity=0.147 Sum_probs=35.9
Q ss_pred cchhhhhhcccCccCCCCcccccCCCCceeeeecCCCCCCcccccccCCCCcEEeccCccccCccCcCCcCCCCCcEEcc
Q 002349 140 KQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDL 219 (933)
Q Consensus 140 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 219 (933)
.++..+.|+.+.+.+.++ +..|++|+.|+|++|.+... +.+..+++|+.|+|++|.+++..| +..+++|+.|+|
T Consensus 21 ~~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~L 94 (605)
T 1m9s_A 21 AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFL 94 (605)
T ss_dssp HHHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCC--TTGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEEC
T ss_pred HHHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCCC--hHHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEEC
Confidence 344444454444443221 34445555555555554422 134444444444444444443322 444444444444
Q ss_pred cccccc
Q 002349 220 SYNQLS 225 (933)
Q Consensus 220 ~~N~l~ 225 (933)
++|+++
T Consensus 95 s~N~l~ 100 (605)
T 1m9s_A 95 DENKIK 100 (605)
T ss_dssp CSSCCC
T ss_pred cCCCCC
Confidence 444443
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.79 E-value=1.9e-19 Score=212.42 Aligned_cols=173 Identities=24% Similarity=0.389 Sum_probs=88.0
Q ss_pred ccccchhhhhhcccCccCCCCcccccCCCCceeeeecCCCCCCcccccccCCCCcEEeccCccccCccCcCCcCCCCCcE
Q 002349 137 SKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQV 216 (933)
Q Consensus 137 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~ 216 (933)
..|++|+.|+|++|.+.. +| .++.+++|+.|+|++|++.+..+ +..+++|++|+|++|.+++ +| .+..+++|+.
T Consensus 40 ~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~ 113 (605)
T 1m9s_A 40 NELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKS 113 (605)
T ss_dssp HHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCE
T ss_pred hcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCE
Confidence 344444444444444442 22 34445555555555555543322 4455555555555555543 22 4555555555
Q ss_pred EccccccccCcCCCCccccccceEeccccccccccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccC
Q 002349 217 LDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLT 296 (933)
Q Consensus 217 L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 296 (933)
|+|++|++++ ++......+|+.|+|++|++++. ..++.+++|+.|+|++|.|++..| +..+++|+.|+|++|+|+
T Consensus 114 L~Ls~N~l~~-l~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~ 188 (605)
T 1m9s_A 114 LSLEHNGISD-INGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS 188 (605)
T ss_dssp EECTTSCCCC-CGGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred EEecCCCCCC-CccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCC
Confidence 5555555542 12111122333333333333332 345566666666666666665544 666666666666666666
Q ss_pred CCCCCccccCCcceEeeecccccccc
Q 002349 297 GHIPPELGNMTKLHYLELNDNQLTGH 322 (933)
Q Consensus 297 ~~~p~~l~~l~~L~~L~L~~N~l~~~ 322 (933)
+. ..+..+++|+.|+|++|.+.+.
T Consensus 189 ~l--~~l~~l~~L~~L~L~~N~l~~~ 212 (605)
T 1m9s_A 189 DL--RALAGLKNLDVLELFSQECLNK 212 (605)
T ss_dssp BC--GGGTTCTTCSEEECCSEEEECC
T ss_pred CC--hHHccCCCCCEEEccCCcCcCC
Confidence 43 3466666666666666666643
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.79 E-value=7.1e-20 Score=197.15 Aligned_cols=186 Identities=25% Similarity=0.382 Sum_probs=95.9
Q ss_pred EeccccccccccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcceEeeeccccc
Q 002349 240 LSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQL 319 (933)
Q Consensus 240 L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l 319 (933)
+.+..+.+++..+ +..+++|+.|++++|.++.. + .+..+++|++|+|++|++++..+ +..+++|++|++++|++
T Consensus 29 ~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l 102 (291)
T 1h6t_A 29 DNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKV 102 (291)
T ss_dssp HHTTCSCTTSEEC--HHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred HHhcCCCcccccc--hhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcC
Confidence 3444444443221 23455555555555555533 1 24455555555555555553322 44455555555555544
Q ss_pred cccCCccccccccccccccccccCCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCCcccc
Q 002349 320 TGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVEL 399 (933)
Q Consensus 320 ~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 399 (933)
++. + .+..+++|++|++++|++++. ..+..+++|++|++++|++++. ..+
T Consensus 103 ~~~-------------------------~-~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l 152 (291)
T 1h6t_A 103 KDL-------------------------S-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVL 152 (291)
T ss_dssp CCG-------------------------G-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGG
T ss_pred CCC-------------------------h-hhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhh
Confidence 421 1 244445555555555555432 2345555555555555555543 345
Q ss_pred ccccccceeeccCCccCCCCCCCCCCccccccccccCcccccccccccccccccceEEccCCcccc
Q 002349 400 SRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTG 465 (933)
Q Consensus 400 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 465 (933)
..+++|+.|+|++|++++..+ +..+++|+.|+|++|++++. | .+.++++|+.|++++|+++.
T Consensus 153 ~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 153 SRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp GGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEEC
T ss_pred ccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCcccC
Confidence 555666666666666654333 55566666666666666643 2 25666666666666666654
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.78 E-value=7e-19 Score=182.29 Aligned_cols=156 Identities=20% Similarity=0.268 Sum_probs=115.1
Q ss_pred ccccccccccCCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCCccccccccccceeeccC
Q 002349 333 LFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSN 412 (933)
Q Consensus 333 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 412 (933)
.+.++.+++++. .+|..+. ++|+.|+|++|++++..|..|..+++|++|+|++|+++...+..|..+++|+.|+|++
T Consensus 21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 97 (229)
T 3e6j_A 21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT 97 (229)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence 344555555554 3443332 5677777777777766667777777777777777777665556667777788888888
Q ss_pred CccCCCCCCCCCCccccccccccCcccccccccccccccccceEEccCCccccccchhhccccccceeeecCCCCcCccc
Q 002349 413 NKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDVM 492 (933)
Q Consensus 413 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~ 492 (933)
|+|++..+..|..+++|+.|+|++|+|+ .+|..+.++++|+.|+|++|+|++..+..+..+++|+.|+|++|+|.|..+
T Consensus 98 N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 98 NQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred CcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 8887666667778888888888888888 667778888888888888888887777778888888888888888887765
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.78 E-value=2.3e-19 Score=193.14 Aligned_cols=191 Identities=24% Similarity=0.318 Sum_probs=131.2
Q ss_pred CCCCcEEccccccccCcCCCCccccccceEeccccccccccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEe
Q 002349 211 CTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYL 290 (933)
Q Consensus 211 l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 290 (933)
+.++..+.+..+.+++..+. -...++++|++++|.++.. + .+..+++|++|+|++|++++..+ +.++++|++|+|
T Consensus 23 l~~~~~~~l~~~~~~~~~~~-~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l 97 (291)
T 1h6t_A 23 FAETIKDNLKKKSVTDAVTQ-NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFL 97 (291)
T ss_dssp HHHHHHHHTTCSCTTSEECH-HHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred HHHHHHHHhcCCCcccccch-hhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEEC
Confidence 34455566777777643322 2345799999999999865 3 48889999999999999997665 999999999999
Q ss_pred eCCccCCCCCCccccCCcceEeeeccccccccCCccccccccccccccccccCCCCCCCCcccCCCCCceeccCcccCCC
Q 002349 291 HSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGT 370 (933)
Q Consensus 291 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~ 370 (933)
++|++++ + ..+..+++|++|++++|++++. ..+..+++|+.|++++|++++. ..+..+++|+.|++++|++++.
T Consensus 98 ~~n~l~~-~-~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~ 171 (291)
T 1h6t_A 98 DENKVKD-L-SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDI 171 (291)
T ss_dssp CSSCCCC-G-GGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCC
T ss_pred CCCcCCC-C-hhhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccc
Confidence 9999996 3 3489999999999999999853 4566777777777777777643 3455566666666666666543
Q ss_pred CCcccccccccceecCCcccccCCCccccccccccceeeccCCccC
Q 002349 371 IPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKIS 416 (933)
Q Consensus 371 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 416 (933)
.+ +..+++|++|++++|.+++. + .+..+++|+.|++++|+++
T Consensus 172 ~~--l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~ 213 (291)
T 1h6t_A 172 VP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECL 213 (291)
T ss_dssp GG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEE
T ss_pred hh--hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCccc
Confidence 32 55555555555555555432 1 2444444444444444444
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=3.8e-21 Score=225.55 Aligned_cols=217 Identities=22% Similarity=0.212 Sum_probs=178.7
Q ss_pred ccccchhhhhhcccCccCCCCcccccCCCCceeeeecCCCCCCcccccccCCCCcEEeccCccccCccCcCCcCCCCCcE
Q 002349 137 SKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQV 216 (933)
Q Consensus 137 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~ 216 (933)
..+++|+.|+|++|+++ .+|..+++|++|+.|++++|.....++. .+..+.+.+.+|..++++++|+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~-----------ll~~~~~~~~~~~~l~~l~~L~~ 413 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIIL-----------LMRALDPLLYEKETLQYFSTLKA 413 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHH-----------HHHHHCTGGGHHHHHHHHHHHHH
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHH-----------HHHhcccccCCHHHHHHHHhccc
Confidence 56889999999999998 7899999999999999977653211221 11233455678889999999999
Q ss_pred Ec-cccccccCcCCCCccccccceEeccccccccccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCcc
Q 002349 217 LD-LSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKL 295 (933)
Q Consensus 217 L~-L~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l 295 (933)
|+ ++.|.+. +|..+.+.+|.++...+ ..|+.|+|++|.|++ +|. |+++++|+.|+|++|+|
T Consensus 414 L~~l~~n~~~----------~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l 475 (567)
T 1dce_A 414 VDPMRAAYLD----------DLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRL 475 (567)
T ss_dssp HCGGGHHHHH----------HHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCC
T ss_pred Ccchhhcccc----------hhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCcccc
Confidence 99 7888764 56677888888875433 248999999999996 565 99999999999999999
Q ss_pred CCCCCCccccCCcceEeeeccccccccCCccccccccccccccccccCCCCC-CCCcccCCCCCceeccCcccCCCCCc-
Q 002349 296 TGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPI-PDNLSSCTNLNSLNVHGNKLNGTIPP- 373 (933)
Q Consensus 296 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~-p~~l~~l~~L~~L~l~~N~l~~~~~~- 373 (933)
+ .+|..++++++|+.|+|++|+|++ +| .++.+++|+.|+|++|+|++.. |..+..+++|+.|+|++|++++.+|.
T Consensus 476 ~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~ 552 (567)
T 1dce_A 476 R-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQ 552 (567)
T ss_dssp C-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCT
T ss_pred c-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHH
Confidence 9 789999999999999999999996 56 8999999999999999999876 99999999999999999999976553
Q ss_pred --ccccccccceecC
Q 002349 374 --AFQRLESMTYLNL 386 (933)
Q Consensus 374 --~~~~l~~L~~L~L 386 (933)
.+..+++|+.|++
T Consensus 553 ~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 553 ERLAEMLPSVSSILT 567 (567)
T ss_dssp THHHHHCTTCSEEEC
T ss_pred HHHHHHCcccCccCC
Confidence 2445889998864
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.76 E-value=2e-18 Score=182.83 Aligned_cols=171 Identities=20% Similarity=0.278 Sum_probs=118.0
Q ss_pred cccchhhhhhcccCccCCCCcccccCCCCceeeeecCCCCCCcccccccCCCCcEEeccCccccCccCcCCcCCCCCcEE
Q 002349 138 KLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVL 217 (933)
Q Consensus 138 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L 217 (933)
.+.++..+++++|.+++. + .+..+++|+.|++++|+++. ++ .+..+++|++|+|++|++++..+ +.++++|++|
T Consensus 17 ~l~~l~~l~l~~~~i~~~-~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L 90 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTDL-V-SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHHTCSCTTSE-E-CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred HHHHHHHHHhcCCCcccc-c-chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence 466677777777777643 2 46677777777777777763 33 56677777777777777775443 7777777777
Q ss_pred ccccccccCcCCCCccccccceEeccccccccccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCC
Q 002349 218 DLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTG 297 (933)
Q Consensus 218 ~L~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 297 (933)
+|++|++++ +|.... .+|++|+|++|++++. ..+..+++|+.|+|++|++++. + .++.+++|+.|+|++|++++
T Consensus 91 ~L~~N~l~~-l~~~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~ 164 (263)
T 1xeu_A 91 SVNRNRLKN-LNGIPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITN 164 (263)
T ss_dssp ECCSSCCSC-CTTCCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCB
T ss_pred ECCCCccCC-cCcccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcc
Confidence 777777764 333222 5666677777766653 3467778888888888888765 2 57777888888888888875
Q ss_pred CCCCccccCCcceEeeecccccccc
Q 002349 298 HIPPELGNMTKLHYLELNDNQLTGH 322 (933)
Q Consensus 298 ~~p~~l~~l~~L~~L~L~~N~l~~~ 322 (933)
. ..+..+++|+.|++++|.+++.
T Consensus 165 ~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 165 T--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp C--TTSTTCCCCCEEEEEEEEEECC
T ss_pred h--HHhccCCCCCEEeCCCCcccCC
Confidence 5 5677777888888888877754
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=1.6e-18 Score=182.91 Aligned_cols=136 Identities=19% Similarity=0.215 Sum_probs=106.6
Q ss_pred cCcceeeecccceeEEEEEE-cCCce--EEEEEecccCch------------------------hHHHHHHHHHHHhcCC
Q 002349 600 LSEKYIIGYGASSTVYKCVL-KNCKP--VAIKRLYSHYPQ------------------------CLKEFETELETVGSIK 652 (933)
Q Consensus 600 ~~~~~~lG~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 652 (933)
|+..+.||+|+||.||+|.+ .+|+. ||||+++..... ....+.+|++++++++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999998 67888 999987543211 1135789999999998
Q ss_pred CCce--eeeeeEEecCCccEEEEEecCC-C----CHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhh-cCCCCCeeec
Q 002349 653 HRNL--VSLQGYSLSSSGNLLFYDFMEN-G----SLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLH-HDCSPRIIHR 724 (933)
Q Consensus 653 h~ni--v~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~ivH~ 724 (933)
|+++ ..++++ ...++||||+.+ | +|.+.... .++..+..++.|++.||.||| +. +|+||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~---givHr 195 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEA---ELVHA 195 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTS---CEECS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHC---CEEeC
Confidence 8764 333332 367899999942 3 67766521 234567889999999999999 76 99999
Q ss_pred cCCCCceEeCCCCCeEEeeccccccc
Q 002349 725 DVKSSNILLDKDFEAHLTDFGIAKSL 750 (933)
Q Consensus 725 Dikp~NIll~~~~~~kl~DfGla~~~ 750 (933)
||||+|||++. .++|+|||+|...
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999998 9999999999754
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.74 E-value=1.4e-18 Score=184.01 Aligned_cols=170 Identities=21% Similarity=0.319 Sum_probs=91.7
Q ss_pred cccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcceEeeeccccccccCCccccccccccccc
Q 002349 258 MQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLN 337 (933)
Q Consensus 258 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~ 337 (933)
+.++..++++.|.+++.. .+..+++|+.|++++|.++. ++ .+..+++|++|+|++|++++..+ +..+++|+.|+
T Consensus 18 l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~ 91 (263)
T 1xeu_A 18 LANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELS 91 (263)
T ss_dssp HHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEE
T ss_pred HHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEE
Confidence 344455555555554322 34455555555555555552 23 45555555555555555554332 55555555555
Q ss_pred cccccCCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCCccccccccccceeeccCCccCC
Q 002349 338 VANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISG 417 (933)
Q Consensus 338 L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 417 (933)
+++|++++ +|. +.. ++|+.|++++|++++. ..+..+++|++|++++|++++. + .+..+++|+.|+|++|++++
T Consensus 92 L~~N~l~~-l~~-~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~ 164 (263)
T 1xeu_A 92 VNRNRLKN-LNG-IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITN 164 (263)
T ss_dssp CCSSCCSC-CTT-CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCB
T ss_pred CCCCccCC-cCc-ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcc
Confidence 55555553 222 112 5666666666666542 2455666666666666666643 2 45556666666666666654
Q ss_pred CCCCCCCCccccccccccCcccccc
Q 002349 418 SIPSPLGDLEHLLKLNLSRNQLTGF 442 (933)
Q Consensus 418 ~~p~~~~~l~~L~~L~Ls~N~l~~~ 442 (933)
. ..+..+++|+.|++++|.+++.
T Consensus 165 ~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 165 T--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp C--TTSTTCCCCCEEEEEEEEEECC
T ss_pred h--HHhccCCCCCEEeCCCCcccCC
Confidence 3 4555666666666666666543
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.74 E-value=5.2e-19 Score=214.05 Aligned_cols=142 Identities=21% Similarity=0.275 Sum_probs=62.4
Q ss_pred CCccccCCcceEeeeccccccccCCccccccccccccccccccCCCCCCCCcccCCCCCceeccCcccCCCCCccccccc
Q 002349 300 PPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLE 379 (933)
Q Consensus 300 p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~ 379 (933)
+..+..+++|+.|+|++|.+. .+|..+..+++|+.|+|++|.|+ .+|..|..+++|+.|+|++|+|+ .+|..|+.++
T Consensus 217 ~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~ 293 (727)
T 4b8c_D 217 KDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCF 293 (727)
T ss_dssp -----CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGT
T ss_pred hhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCC
Confidence 444444444445555544444 33434444444444444444444 34444444444444444444444 3344444444
Q ss_pred ccceecCCcccccCCCccccccccccceeeccCCccCCCCCCCCCCccc-cccccccCccccccccc
Q 002349 380 SMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEH-LLKLNLSRNQLTGFIPG 445 (933)
Q Consensus 380 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~p~ 445 (933)
+|++|+|++|.|+ .+|..|..+++|+.|+|++|.|++.+|..+..+.. +..|+|++|.+++.+|.
T Consensus 294 ~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~ 359 (727)
T 4b8c_D 294 QLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH 359 (727)
T ss_dssp TCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_pred CCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc
Confidence 4444444444444 33444444444444444444444444444333211 12244555555544443
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.72 E-value=6.5e-18 Score=170.67 Aligned_cols=105 Identities=23% Similarity=0.349 Sum_probs=46.4
Q ss_pred CCCCceecccccccCCCCCcccccccchhhhhhcccCccCCCCcccccCCCCceeeeecCCCCCCcccccccCCCCcEEe
Q 002349 115 CSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFD 194 (933)
Q Consensus 115 l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 194 (933)
+++|++|+|++|.++ .+| .+..+++|++|++++|.++. +..++.+++|++|++++|++++..+..++.+++|++|+
T Consensus 43 l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~ 118 (197)
T 4ezg_A 43 MNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLD 118 (197)
T ss_dssp HHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEE
T ss_pred cCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEE
Confidence 333444444444333 223 23334444444444443321 12344444444444444444444444444444455555
Q ss_pred ccCccccCccCcCCcCCCCCcEEcccccc
Q 002349 195 VRNNSLTGSIPQNIGNCTSFQVLDLSYNQ 223 (933)
Q Consensus 195 L~~n~l~~~~p~~l~~l~~L~~L~L~~N~ 223 (933)
+++|.+++..|..++.+++|++|++++|+
T Consensus 119 Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~ 147 (197)
T 4ezg_A 119 ISHSAHDDSILTKINTLPKVNSIDLSYNG 147 (197)
T ss_dssp CCSSBCBGGGHHHHTTCSSCCEEECCSCT
T ss_pred ecCCccCcHhHHHHhhCCCCCEEEccCCC
Confidence 55555544444445555555555555554
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.72 E-value=9.7e-18 Score=168.52 Aligned_cols=112 Identities=22% Similarity=0.353 Sum_probs=60.2
Q ss_pred ccceecCCcccccCCCcc-ccccccccceeeccCCccCCCCCCCCCCccccccccccCcccccccccccccccccceEEc
Q 002349 380 SMTYLNLSLNNIRGPIPV-ELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDL 458 (933)
Q Consensus 380 ~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 458 (933)
+|++|++++|++++..+. .|..+++|++|+|++|+|++..|..|..+++|++|+|++|+|++..|..|.++++|++|+|
T Consensus 30 ~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 109 (192)
T 1w8a_A 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL 109 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEEC
Confidence 444555555555433332 2455555555555555555555555555555555555555555555555555555555555
Q ss_pred cCCccccccchhhccccccceeeecCCCCcCcc
Q 002349 459 SHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDV 491 (933)
Q Consensus 459 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 491 (933)
++|+|++.+|..+..+++|++|+|++|+|+|..
T Consensus 110 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 142 (192)
T 1w8a_A 110 YDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp CSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred CCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcC
Confidence 555555555555555555555555555555543
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.72 E-value=1.2e-17 Score=167.80 Aligned_cols=180 Identities=20% Similarity=0.249 Sum_probs=120.8
Q ss_pred cccccccccCCCCCCCCcccCCCCCceeccCcccCCCCCc-ccccccccceecCCcccccCCCccccccccccceeeccC
Q 002349 334 FDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPP-AFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSN 412 (933)
Q Consensus 334 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~ 412 (933)
+.+++++|+++ .+|..+.. +|++|++++|++++..+. .|..+++|++|+|++|++++..|..|..+++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 44555555554 34443332 677777777777755553 477788888888888888877778888888888888888
Q ss_pred CccCCCCCCCCCCccccccccccCcccccccccccccccccceEEccCCccccccchhhccccccceeeecCCCCcCccc
Q 002349 413 NKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDVM 492 (933)
Q Consensus 413 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~ 492 (933)
|+|++..+..|.++++|++|+|++|+|++..|..|..+++|++|+|++|++++..+... -...++...+.++...|..|
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~-~~~~l~~~~~~~~~~~C~~P 166 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW-FAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHH-HHHHHHHHCCSGGGCBBCSS
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchH-HHHHHHHcCCCCCCCCCCCC
Confidence 88887777788888888888888888888888888888999999999999887665211 11223444555666665444
Q ss_pred chhhccccc-eeecCCCCCCCcccCCcc
Q 002349 493 SLINCLSLS-VLFIGNPGLCGYWLHSAC 519 (933)
Q Consensus 493 ~~~~~~~~~-~~~~~N~~~C~~~l~~~~ 519 (933)
.- +.... ..+..+...|...-...|
T Consensus 167 ~~--l~~~~l~~l~~~~~~C~~~~~~~c 192 (192)
T 1w8a_A 167 SK--VRDVQIKDLPHSEFKCSSENSEGC 192 (192)
T ss_dssp TT--TTTSBGGGSCTTTCCCCCC---CC
T ss_pred hH--HcCCChhhCcHhhcCcCCCCCCCC
Confidence 31 12222 234556666765544433
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.71 E-value=7.9e-18 Score=170.07 Aligned_cols=108 Identities=21% Similarity=0.373 Sum_probs=43.1
Q ss_pred ccCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCCccccccccccceeeccCCc-cCCCCCCCCCCccccc
Q 002349 352 SSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNK-ISGSIPSPLGDLEHLL 430 (933)
Q Consensus 352 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~ 430 (933)
..+++|++|++++|++++..+..|..+++|++|++++|++++..+..+..+++|+.|+|++|. ++ .+| .+..+++|+
T Consensus 85 ~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~ 162 (197)
T 4ezg_A 85 SGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELK 162 (197)
T ss_dssp TTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCC
T ss_pred hcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCC
Confidence 333444444444444443333334444444444444444443334444444444444444444 22 222 233344444
Q ss_pred cccccCcccccccccccccccccceEEccCCcc
Q 002349 431 KLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHL 463 (933)
Q Consensus 431 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 463 (933)
.|++++|++++. + .+.++++|+.|++++|++
T Consensus 163 ~L~l~~n~i~~~-~-~l~~l~~L~~L~l~~N~i 193 (197)
T 4ezg_A 163 SLNIQFDGVHDY-R-GIEDFPKLNQLYAFSQTI 193 (197)
T ss_dssp EEECTTBCCCCC-T-TGGGCSSCCEEEECBC--
T ss_pred EEECCCCCCcCh-H-HhccCCCCCEEEeeCccc
Confidence 444444444321 1 333444444444444443
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.69 E-value=4.3e-18 Score=186.94 Aligned_cols=219 Identities=13% Similarity=0.065 Sum_probs=148.8
Q ss_pred ccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcceEeeeccccc----cccCCcccccccc
Q 002349 257 LMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQL----TGHIPPALGKLTD 332 (933)
Q Consensus 257 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l----~~~~~~~l~~l~~ 332 (933)
.+++|+.|+|.+ .++.+.+.+|.++++|+.|++.+|.+....+.+|..+.++..+.+..+.. .......|.++..
T Consensus 99 g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~ 177 (329)
T 3sb4_A 99 GKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEP 177 (329)
T ss_dssp ECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCC
T ss_pred ccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccc
Confidence 388888888888 77777778888888888888888888777777888877777777665322 2222334444455
Q ss_pred cc-ccccccccCCCCCCCC----cccCCCCCceeccCcccCCCCCccc-ccccccceecCCcccccCCCccccccccccc
Q 002349 333 LF-DLNVANNHLEGPIPDN----LSSCTNLNSLNVHGNKLNGTIPPAF-QRLESMTYLNLSLNNIRGPIPVELSRIGNLD 406 (933)
Q Consensus 333 L~-~L~L~~N~l~~~~p~~----l~~l~~L~~L~l~~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 406 (933)
|+ .+.+.... .++.. -....+++.+.+.++-.. .....+ ..+++|+.|+|++|+++......|.++++|+
T Consensus 178 L~~~i~~~~~~---~l~~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~ 253 (329)
T 3sb4_A 178 LETTIQVGAMG---KLEDEIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLL 253 (329)
T ss_dssp CEEEEEECTTC---CHHHHHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCC
T ss_pred cceeEEecCCC---cHHHHHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCC
Confidence 44 23222211 11110 012344455555544211 111111 2367888888888888877777788888888
Q ss_pred eeeccCCccCCCCCCCCCCccccc-cccccCcccccccccccccccccceEEccCCccccccchhhccccccceeee
Q 002349 407 TLDMSNNKISGSIPSPLGDLEHLL-KLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRL 482 (933)
Q Consensus 407 ~L~Ls~N~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 482 (933)
.|+|.+| ++.+.+..|.++.+|+ .|++.+ +++.+.+.+|.++++|+.|++++|+++...+..|.++++|+.++.
T Consensus 254 ~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 254 KIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp EEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred EEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 8888887 7767777888888888 888888 777677788888888888888888888777788888888887753
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.68 E-value=1.3e-17 Score=183.08 Aligned_cols=290 Identities=14% Similarity=0.133 Sum_probs=155.2
Q ss_pred cccCCCCCC--CCCccEEEccCCcccccCCCCccC-CCCCceecccccccC--CCCCcccccccchhhhhhcccCccCCC
Q 002349 82 GEISPAVGD--LKDLQSIDLRGNRLSGQIPDEIGD-CSSLKSLDLSFNELY--GDIPFSISKLKQLEFLILKNNQLIGPI 156 (933)
Q Consensus 82 ~~~~~~l~~--l~~L~~L~Ls~n~l~~~~p~~l~~-l~~L~~L~Ls~n~l~--~~~p~~~~~l~~L~~L~L~~n~l~~~~ 156 (933)
|.++..+.. +.+|+.|.++++ +.+.--..+.. +++|++|||++|++. ...+..+ +.++.+.+..|.+.
T Consensus 13 g~l~~~l~~~~~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~---~~~~~~~~~~~~I~--- 85 (329)
T 3sb4_A 13 GTLISMMTEEEANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTY---PNGKFYIYMANFVP--- 85 (329)
T ss_dssp TCGGGGSCHHHHHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSS---GGGCCEEECTTEEC---
T ss_pred CcHHhhccchhhCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCccccc---cccccccccccccC---
Confidence 344444443 667788888764 22111112333 778888888888887 2222122 22333444444322
Q ss_pred Cccccc--------CCCCceeeeecCCCCCCcccccccCCCCcEEeccCccccCccCcCCcCCCCCcEEccccccc----
Q 002349 157 PSTLSQ--------LPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQL---- 224 (933)
Q Consensus 157 p~~l~~--------l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l---- 224 (933)
+..|.+ +++|+.|+|.+ +++...+..|.++++|+.+++++|.+....+.+|.++.++..+.++.+..
T Consensus 86 ~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~ 164 (329)
T 3sb4_A 86 AYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFK 164 (329)
T ss_dssp TTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTS
T ss_pred HHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcc
Confidence 234555 88888888887 77766666788888888888888888766677787777777777665322
Q ss_pred cCcCCCCc-cccccc-eEeccccccccccCccc----cccccccEEeccCCcCcCCCCCCC-CCCCCccEEEeeCCccCC
Q 002349 225 SGEIPFNI-GFLQIA-TLSLQGNQLTGKIPSVI----GLMQALAVLDLSCNMLSGPIPPIL-GNLSYTEKLYLHSNKLTG 297 (933)
Q Consensus 225 ~~~~p~~~-~~~~L~-~L~L~~n~l~~~~p~~~----~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~~ 297 (933)
.......+ ....++ .+.+.... .++..+ -...+++.+.+.++-.. .....+ ..+++|+.|+|++|+++.
T Consensus 165 ~~i~~~~f~~~~~L~~~i~~~~~~---~l~~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~ 240 (329)
T 3sb4_A 165 NRWEHFAFIEGEPLETTIQVGAMG---KLEDEIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATT 240 (329)
T ss_dssp TTTTTSCEEESCCCEEEEEECTTC---CHHHHHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCE
T ss_pred ccccccccccccccceeEEecCCC---cHHHHHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcce
Confidence 10001111 111222 12221110 011110 11233444444433111 000011 124556666666666654
Q ss_pred CCCCccccCCcceEeeeccccccccCCcccccccccc-ccccccccCCCCCCCCcccCCCCCceeccCcccCCCCCcccc
Q 002349 298 HIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLF-DLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQ 376 (933)
Q Consensus 298 ~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~-~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~ 376 (933)
+.+.+|.++++|+.|+|.+| ++.+.+.+|.++++|+ .+++.+ .++.+.+..|.+|++|+.+++++|+++.+.+.+|.
T Consensus 241 I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~ 318 (329)
T 3sb4_A 241 IPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFG 318 (329)
T ss_dssp ECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTC
T ss_pred ecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhc
Confidence 44555666666666666665 5545555666666666 666665 55545556666666666666666666655566676
Q ss_pred cccccceec
Q 002349 377 RLESMTYLN 385 (933)
Q Consensus 377 ~l~~L~~L~ 385 (933)
++++|+.++
T Consensus 319 ~~~~L~~ly 327 (329)
T 3sb4_A 319 NGVPSKLIY 327 (329)
T ss_dssp TTCCCCEEE
T ss_pred CCcchhhhc
Confidence 666666664
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.66 E-value=1.1e-16 Score=157.03 Aligned_cols=133 Identities=22% Similarity=0.209 Sum_probs=110.4
Q ss_pred CCCccEEEccCCccc-ccCCCCccCCCCCceecccccccCCCCCcccccccchhhhhhcccCccCCCCcccccCCCCcee
Q 002349 91 LKDLQSIDLRGNRLS-GQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVF 169 (933)
Q Consensus 91 l~~L~~L~Ls~n~l~-~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L 169 (933)
.++|++|+|++|+++ +.+|..+..+++|++|+|++|.+++. ..+..+++|++|+|++|++++.+|..+..+++|++|
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 100 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence 477888888888887 77888888888888888888888855 678888888888888888887778778888899999
Q ss_pred eeecCCCCCCc-ccccccCCCCcEEeccCccccCccC---cCCcCCCCCcEEcccccccc
Q 002349 170 GLRGNNLVGTL-SPDMCQLSGLWYFDVRNNSLTGSIP---QNIGNCTSFQVLDLSYNQLS 225 (933)
Q Consensus 170 ~L~~N~l~~~~-~~~~~~l~~L~~L~L~~n~l~~~~p---~~l~~l~~L~~L~L~~N~l~ 225 (933)
+|++|++++.. +..+..+++|++|++++|.+++..+ ..+..+++|++|++++|.+.
T Consensus 101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 99999888643 2678888899999999998886544 47888899999999988876
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.65 E-value=2.4e-16 Score=156.15 Aligned_cols=136 Identities=21% Similarity=0.248 Sum_probs=91.6
Q ss_pred CCCCCCccceEecCCCCcEEEEEcCCCCcCcccCCCCCCCCCccEEEccCCcccccCCCCccCCCCCceecccccccCCC
Q 002349 52 SSDYCVWRGITCDNVTFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGD 131 (933)
Q Consensus 52 ~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~ 131 (933)
..+.|.|+++.|++. +++ .+|..+ .++|++|+|++|++++..+..|+++++|++|+|++|.+++.
T Consensus 3 ~~C~C~~~~l~~~~~------------~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 67 (177)
T 2o6r_A 3 SRCSCSGTEIRCNSK------------GLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSL 67 (177)
T ss_dssp TTCEEETTEEECCSS------------CCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCC
T ss_pred CCCEeCCCEEEecCC------------CCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEe
Confidence 345678888888643 333 344333 26788899999988866666778888888888888888865
Q ss_pred CCcccccccchhhhhhcccCccCCCCcccccCCCCceeeeecCCCCCCcccccccCCCCcEEeccCccccC
Q 002349 132 IPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTG 202 (933)
Q Consensus 132 ~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 202 (933)
.+..|..+++|++|+|++|++++..+..++.+++|++|+|++|++++..+..+..+++|++|++++|.+.+
T Consensus 68 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 138 (177)
T 2o6r_A 68 PDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 138 (177)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred ChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeec
Confidence 55556777777777777777776555556667777777777766664444344555555555555555553
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.64 E-value=3.9e-16 Score=156.69 Aligned_cols=129 Identities=28% Similarity=0.383 Sum_probs=101.4
Q ss_pred CceeccCcccCCCCCcccccccccceecCCcccccCCCccccccccccceeeccCCccCCCCCCCCCCccccccccccCc
Q 002349 358 NSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRN 437 (933)
Q Consensus 358 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 437 (933)
+.+++++|+++ .+|..+. ++|++|+|++|+++ .+|..|..+++|+.|+|++|.|++..+..|.++++|+.|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 45677777776 3444332 46778888888887 56677888888888888888888777778888888888888888
Q ss_pred ccccccccccccccccceEEccCCccccccchhhccccccceeeecCCCCcCc
Q 002349 438 QLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGD 490 (933)
Q Consensus 438 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 490 (933)
+|++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|+|.|.
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~ 141 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCD 141 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecC
Confidence 88888888888888999999999998877777788888888888877766654
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.63 E-value=1.3e-16 Score=153.17 Aligned_cols=128 Identities=21% Similarity=0.225 Sum_probs=93.3
Q ss_pred CCCccEEEccCCccc-ccCCCCccCCCCCceecccccccCCCCCcccccccchhhhhhcccCccCCCCcccccCCCCcee
Q 002349 91 LKDLQSIDLRGNRLS-GQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVF 169 (933)
Q Consensus 91 l~~L~~L~Ls~n~l~-~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L 169 (933)
.++|++|++++|.++ +.+|..++.+++|++|+|++|.+++. ..++.+++|++|+|++|.+++.+|..++.+++|++|
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence 356777777777776 66777777777777777777777754 567777777777777777776677777777777777
Q ss_pred eeecCCCCCC-cccccccCCCCcEEeccCccccCccC---cCCcCCCCCcEEccc
Q 002349 170 GLRGNNLVGT-LSPDMCQLSGLWYFDVRNNSLTGSIP---QNIGNCTSFQVLDLS 220 (933)
Q Consensus 170 ~L~~N~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~p---~~l~~l~~L~~L~L~ 220 (933)
++++|++++. .+..+..+++|++|++++|.+++..+ ..+..+++|++|+++
T Consensus 94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 7777777753 34667777788888888887776544 467778888888775
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.63 E-value=2.3e-16 Score=154.81 Aligned_cols=133 Identities=21% Similarity=0.250 Sum_probs=71.1
Q ss_pred CCCceeccCcccC-CCCCcccccccccceecCCcccccCCCccccccccccceeeccCCccCCCCCCCCCCccccccccc
Q 002349 356 NLNSLNVHGNKLN-GTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNL 434 (933)
Q Consensus 356 ~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 434 (933)
+|+.|++++|+++ +.+|..+..+++|++|++++|.+++. ..+..+++|++|+|++|++++.+|..+..+++|+.|+|
T Consensus 25 ~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 102 (168)
T 2ell_A 25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNL 102 (168)
T ss_dssp SCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEEC
T ss_pred cCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEec
Confidence 3444444444444 33444444444444444444444433 44445555555555555555444444444555555555
Q ss_pred cCccccccc-ccccccccccceEEccCCccccccc---hhhccccccceeeecCCCCcCc
Q 002349 435 SRNQLTGFI-PGEFGNLRSVMEIDLSHNHLTGVIP---EELSQLQNMFSLRLDYNNLSGD 490 (933)
Q Consensus 435 s~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~l~~N~l~~~ 490 (933)
++|++++.. +..+.++++|+.|++++|++++..+ ..+..+++|++|++++|.+...
T Consensus 103 s~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~ 162 (168)
T 2ell_A 103 SGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEA 162 (168)
T ss_dssp BSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBC
T ss_pred cCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhc
Confidence 555555432 2556666666666666666665444 3566666666666666666544
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.62 E-value=1.4e-16 Score=173.89 Aligned_cols=137 Identities=13% Similarity=0.088 Sum_probs=100.6
Q ss_pred cCcceeeecccceeEEEEEEcCCceEEEEEecccCch--------------hHH--------HHHHHHHHHhcCCCCcee
Q 002349 600 LSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQ--------------CLK--------EFETELETVGSIKHRNLV 657 (933)
Q Consensus 600 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------~~~--------~~~~E~~~l~~l~h~niv 657 (933)
|++...||+|+||.||+|...+|+.||||+++..... ... ...+|...|.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 8889999999999999999999999999987532100 001 124567777777544432
Q ss_pred eeeeEEecCCccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCC
Q 002349 658 SLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDF 737 (933)
Q Consensus 658 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~ 737 (933)
...-+.. ...++||||++|++|.++.. .+....++.|++.+|.|||++ |||||||||.|||+++++
T Consensus 177 vp~p~~~--~~~~LVME~i~G~~L~~l~~---------~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dg 242 (397)
T 4gyi_A 177 VPEPIAQ--SRHTIVMSLVDALPMRQVSS---------VPDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEK 242 (397)
T ss_dssp CCCEEEE--ETTEEEEECCSCEEGGGCCC---------CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEE
T ss_pred CCeeeec--cCceEEEEecCCccHhhhcc---------cHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCC
Confidence 2111111 23579999999988876542 123457889999999999976 999999999999998776
Q ss_pred ----------CeEEeeccccccc
Q 002349 738 ----------EAHLTDFGIAKSL 750 (933)
Q Consensus 738 ----------~~kl~DfGla~~~ 750 (933)
.+.|+||+-+...
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEET
T ss_pred CcccccccccceEEEEeCCcccC
Confidence 3899999987643
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.1e-15 Score=153.57 Aligned_cols=125 Identities=27% Similarity=0.368 Sum_probs=76.6
Q ss_pred EEcCCCCcCcccCCCCCCCCCccEEEccCCcccccCCCCccCCCCCceecccccccCCCCCcccccccchhhhhhcccCc
Q 002349 73 LNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQL 152 (933)
Q Consensus 73 l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l 152 (933)
+++++++++ .+|..+. ++|++|+|++|+|+ .+|..|.++++|++|+|++|.|++..|..|.++++|++|+|++|++
T Consensus 15 l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l 90 (193)
T 2wfh_A 15 VRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL 90 (193)
T ss_dssp EECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCcc
Confidence 445555665 4555443 46777777777776 5667777777777777777777765556666666666666666666
Q ss_pred cCCCCcccccCCCCceeeeecCCCCCCcccccccCCCCcEEeccCcccc
Q 002349 153 IGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLT 201 (933)
Q Consensus 153 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~ 201 (933)
++..|..|..+++|++|+|++|++++..+..|..+++|++|+|++|.+.
T Consensus 91 ~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 91 RCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp CBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred CEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 6655555666666666666666665433334444444444444444443
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.1e-15 Score=151.45 Aligned_cols=135 Identities=21% Similarity=0.294 Sum_probs=95.5
Q ss_pred CCceeccCcccCCCCCcccccccccceecCCcccccCCCccccccccccceeeccCCccCCCCCCCCCCccccccccccC
Q 002349 357 LNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSR 436 (933)
Q Consensus 357 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 436 (933)
.+.+++++|+++. +|..+ .++|++|++++|++++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++
T Consensus 9 ~~~l~~~~~~l~~-~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLTS-VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCSS-CCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCcc-CCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 3456666666653 33222 24667777777777766556667777777777777777766666677777888888888
Q ss_pred cccccccccccccccccceEEccCCccccccchhhccccccceeeecCCCCcCcccch
Q 002349 437 NQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDVMSL 494 (933)
Q Consensus 437 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~ 494 (933)
|+|++..+..|.++++|++|+|++|++++..+..+..+++|+.|+|++|+++|..+.+
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~l 143 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 143 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHHHH
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCccH
Confidence 8888776777778888888888888888666666777888888888888888876643
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.60 E-value=3.8e-16 Score=149.88 Aligned_cols=126 Identities=19% Similarity=0.312 Sum_probs=64.8
Q ss_pred CCCceeccCcccC-CCCCcccccccccceecCCcccccCCCccccccccccceeeccCCccCCCCCCCCCCccccccccc
Q 002349 356 NLNSLNVHGNKLN-GTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNL 434 (933)
Q Consensus 356 ~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 434 (933)
+|+.|++++|+++ +.+|..+..+++|++|++++|.+++. ..+..+++|++|+|++|.+++.+|..+..+++|++|++
T Consensus 18 ~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l 95 (149)
T 2je0_A 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL 95 (149)
T ss_dssp GCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEEC
T ss_pred cCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEEC
Confidence 3344444444443 33333344444444444444444433 33444445555555555554444444444555555555
Q ss_pred cCcccccc-cccccccccccceEEccCCccccccc---hhhccccccceeeec
Q 002349 435 SRNQLTGF-IPGEFGNLRSVMEIDLSHNHLTGVIP---EELSQLQNMFSLRLD 483 (933)
Q Consensus 435 s~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~l~ 483 (933)
++|++++. .+..+.++++|++|++++|++++..+ ..+..+++|+.|+++
T Consensus 96 s~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 96 SGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp TTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 55555542 23556666666666666666665544 456666677766664
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.57 E-value=1.3e-14 Score=162.58 Aligned_cols=210 Identities=14% Similarity=0.157 Sum_probs=108.2
Q ss_pred ccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcceEeeeccccccccCCccccc
Q 002349 250 KIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGK 329 (933)
Q Consensus 250 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~ 329 (933)
..+..|..+++|+.++|+.|.++.+....|. ..+|+.+.|..+ ++.+...+|.++++|+.+++..| ++.+...+|.+
T Consensus 171 I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~ 247 (401)
T 4fdw_A 171 LKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE 247 (401)
T ss_dssp ECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT
T ss_pred ehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc
Confidence 3344455555566666655555544444444 355555555532 44344445555555555555543 33333344444
Q ss_pred cccccccccccccCCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCCccccccccccceee
Q 002349 330 LTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLD 409 (933)
Q Consensus 330 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 409 (933)
.+|+.+.+ .+.+.......|.+|++|+.+++.+|.+.. +.+.......|.++++|+.++
T Consensus 248 -~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~-------------------~~~~~I~~~aF~~c~~L~~l~ 306 (401)
T 4fdw_A 248 -SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFND-------------------DPEAMIHPYCLEGCPKLARFE 306 (401)
T ss_dssp -CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCC-------------------CTTCEECTTTTTTCTTCCEEC
T ss_pred -CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccC-------------------CcccEECHHHhhCCccCCeEE
Confidence 44555555 233333334444455555555554444320 000023344555556666666
Q ss_pred ccCCccCCCCCCCCCCccccccccccCcccccccccccccccccceEEccCCccccccchhhcccc-ccceeeecCCC
Q 002349 410 MSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQ-NMFSLRLDYNN 486 (933)
Q Consensus 410 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~l~~N~ 486 (933)
|. +.++......|.++++|+.|+|..| ++.+.+.+|.++ +|+.+++++|.+....+..|..++ ++..|.+..|.
T Consensus 307 l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~ 381 (401)
T 4fdw_A 307 IP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAES 381 (401)
T ss_dssp CC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGG
T ss_pred eC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHH
Confidence 65 3355455556666666666666443 555556666666 666666666666655556666653 45666665543
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.56 E-value=2.1e-14 Score=161.00 Aligned_cols=221 Identities=13% Similarity=0.122 Sum_probs=154.9
Q ss_pred cccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcceEeeeccccccccCCccccccccccccccc
Q 002349 260 ALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVA 339 (933)
Q Consensus 260 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~ 339 (933)
+|+.+++..| ++.+...+|.+ .+|+.+.|.. .++.+.+.+|.++++|+.+++++|+++.+....|. ..+|+.+.+.
T Consensus 136 ~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp 211 (401)
T 4fdw_A 136 QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLP 211 (401)
T ss_dssp CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECC
T ss_pred CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEeC
Confidence 4555555444 44344455555 3466666653 44444455666666666666666666644444444 4666666666
Q ss_pred cccCCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCCccccccccccceeeccCCccC---
Q 002349 340 NNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKIS--- 416 (933)
Q Consensus 340 ~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~--- 416 (933)
++ +.......|.++++|+.+++..| ++.+...+|.+ .+|+.+.+ .|.++......|.++++|+.+++.+|.+.
T Consensus 212 ~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~ 287 (401)
T 4fdw_A 212 VT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDP 287 (401)
T ss_dssp TT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCT
T ss_pred Cc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCc
Confidence 33 55455566777777777777764 44455566666 67777777 45566566677888888888888887664
Q ss_pred --CCCCCCCCCccccccccccCcccccccccccccccccceEEccCCccccccchhhccccccceeeecCCCCcCcc
Q 002349 417 --GSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDV 491 (933)
Q Consensus 417 --~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 491 (933)
...+..|.++++|+.++|. |.++.+...+|.++.+|+.++|.+| ++...+.+|.++ +|+.+++++|.+....
T Consensus 288 ~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~ 361 (401)
T 4fdw_A 288 EAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVF 361 (401)
T ss_dssp TCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCC
T ss_pred ccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccc
Confidence 4667889999999999999 5588788899999999999999665 887778999999 9999999999876543
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.55 E-value=2.8e-17 Score=166.17 Aligned_cols=150 Identities=22% Similarity=0.288 Sum_probs=112.5
Q ss_pred cEEEEEcCCCCcCcccCC------CCCCCCCccEEEccCCcccccCCCCccCCCCCceecccccccCCCCCcccccccch
Q 002349 69 TVIALNLSGLNLDGEISP------AVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQL 142 (933)
Q Consensus 69 ~v~~l~l~~~~l~~~~~~------~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L 142 (933)
.|+.++++++.++|.+|+ .+..+++|++|+|++|++++ +| .++++++|++|+|++|.++ .+|..+..+++|
T Consensus 19 ~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L 95 (198)
T 1ds9_A 19 SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTL 95 (198)
T ss_dssp CCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHC
T ss_pred cccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcC
Confidence 445556666667776665 77788888888888888885 66 7888888888888888887 677777777888
Q ss_pred hhhhhcccCccCCCCcccccCCCCceeeeecCCCCCCcc-cccccCCCCcEEeccCccccCccCcC----------CcCC
Q 002349 143 EFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLS-PDMCQLSGLWYFDVRNNSLTGSIPQN----------IGNC 211 (933)
Q Consensus 143 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~p~~----------l~~l 211 (933)
++|+|++|++++ +| .++.+++|++|+|++|++++..+ ..+..+++|++|++++|.+++.+|.. +..+
T Consensus 96 ~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l 173 (198)
T 1ds9_A 96 EELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRL 173 (198)
T ss_dssp SEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHC
T ss_pred CEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhC
Confidence 888888888875 44 57788888888888888875332 46777888888888888887665553 6777
Q ss_pred CCCcEEcccccccc
Q 002349 212 TSFQVLDLSYNQLS 225 (933)
Q Consensus 212 ~~L~~L~L~~N~l~ 225 (933)
++|+.|| +|.++
T Consensus 174 ~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 174 PNLKKLD--GMPVD 185 (198)
T ss_dssp SSCSEEC--CGGGT
T ss_pred CCcEEEC--CcccC
Confidence 7777776 55554
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.54 E-value=1e-16 Score=162.00 Aligned_cols=152 Identities=22% Similarity=0.287 Sum_probs=91.6
Q ss_pred cccccccccccccCCCCCCC------CcccCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCCcccccccc
Q 002349 330 LTDLFDLNVANNHLEGPIPD------NLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIG 403 (933)
Q Consensus 330 l~~L~~L~L~~N~l~~~~p~------~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 403 (933)
...++.++++.+.+.+..|. .+..+++|++|++++|++++ +| .+..+++|++|++++|.++ .+|..+..++
T Consensus 17 ~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~ 93 (198)
T 1ds9_A 17 RKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVAD 93 (198)
T ss_dssp TTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHH
T ss_pred cccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCC
Confidence 34455555555555544444 55566666666666666664 34 5666666666666666666 4455555556
Q ss_pred ccceeeccCCccCCCCCCCCCCccccccccccCcccccccc-cccccccccceEEccCCccccccchh----------hc
Q 002349 404 NLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIP-GEFGNLRSVMEIDLSHNHLTGVIPEE----------LS 472 (933)
Q Consensus 404 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~----------~~ 472 (933)
+|+.|+|++|++++ +| .+..+++|+.|+|++|++++..+ ..+.++++|++|++++|++++.+|.. +.
T Consensus 94 ~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~ 171 (198)
T 1ds9_A 94 TLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVK 171 (198)
T ss_dssp HCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHH
T ss_pred cCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHH
Confidence 66666666666664 33 45666666677777776664332 45667777777777777776665542 66
Q ss_pred cccccceeeecCCCCc
Q 002349 473 QLQNMFSLRLDYNNLS 488 (933)
Q Consensus 473 ~l~~L~~L~l~~N~l~ 488 (933)
.+++|+.|| +|.++
T Consensus 172 ~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 172 RLPNLKKLD--GMPVD 185 (198)
T ss_dssp HCSSCSEEC--CGGGT
T ss_pred hCCCcEEEC--CcccC
Confidence 677777665 55554
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.52 E-value=5e-15 Score=146.40 Aligned_cols=134 Identities=25% Similarity=0.334 Sum_probs=107.3
Q ss_pred CCCCCCCCccEEEccCCcccccCCCCccCCC-CCceecccccccCCCCCcccccccchhhhhhcccCccCCCCcccccCC
Q 002349 86 PAVGDLKDLQSIDLRGNRLSGQIPDEIGDCS-SLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLP 164 (933)
Q Consensus 86 ~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~-~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~ 164 (933)
+.+.++.+|++|+|++|+++ .+|. +..+. +|++|+|++|.+++. ..|+.+++|++|+|++|++++..+..++.++
T Consensus 13 ~~~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 88 (176)
T 1a9n_A 13 AQYTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALP 88 (176)
T ss_dssp CEEECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCT
T ss_pred HhcCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCC
Confidence 34567788999999999988 4554 55554 899999999998854 5788889999999999999865445558899
Q ss_pred CCceeeeecCCCCCCccc--ccccCCCCcEEeccCccccCccCcC----CcCCCCCcEEcccccccc
Q 002349 165 NLKVFGLRGNNLVGTLSP--DMCQLSGLWYFDVRNNSLTGSIPQN----IGNCTSFQVLDLSYNQLS 225 (933)
Q Consensus 165 ~L~~L~L~~N~l~~~~~~--~~~~l~~L~~L~L~~n~l~~~~p~~----l~~l~~L~~L~L~~N~l~ 225 (933)
+|++|+|++|+++ .+|. .+..+++|++|++++|.++ .+|.. +..+++|++||++.|.+.
T Consensus 89 ~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 89 DLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp TCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 9999999999986 4555 7888899999999999988 45664 788899999999888765
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.52 E-value=7.9e-14 Score=156.91 Aligned_cols=329 Identities=12% Similarity=0.083 Sum_probs=151.0
Q ss_pred CCCCCCCCccEEEccCCcccccCCCCccCCCCCceecccccccCCCCCcccccccchhhhhhcccCccCCCCcccccCCC
Q 002349 86 PAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPN 165 (933)
Q Consensus 86 ~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~ 165 (933)
.+|.++++|+.+.|..+ ++..-..+|.+|++|+.++|..+ +.......|.++.+|+.+.+..+ +.......|.++..
T Consensus 65 ~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~~ 141 (394)
T 4fs7_A 65 AAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCDF 141 (394)
T ss_dssp TTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCCC
T ss_pred HHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeecccc
Confidence 35677777777777643 55333456777777777777644 33233344666666666555443 22223334444433
Q ss_pred CceeeeecCCCCCCcccccccCCCCcEEeccCccccCccCcCCcCCCCCcEEccccccccCcCCCCccccccceEecccc
Q 002349 166 LKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGN 245 (933)
Q Consensus 166 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n 245 (933)
++......... .....|.++++|+.+.+.++..+ .....|.++++|+.+++..| +
T Consensus 142 ~~~~~~~~~~~--i~~~aF~~c~~L~~i~l~~~~~~-I~~~~F~~c~~L~~i~l~~~-~--------------------- 196 (394)
T 4fs7_A 142 KEITIPEGVTV--IGDEAFATCESLEYVSLPDSMET-LHNGLFSGCGKLKSIKLPRN-L--------------------- 196 (394)
T ss_dssp SEEECCTTCCE--ECTTTTTTCTTCCEEECCTTCCE-ECTTTTTTCTTCCBCCCCTT-C---------------------
T ss_pred cccccCccccc--cchhhhcccCCCcEEecCCccce-eccccccCCCCceEEEcCCC-c---------------------
Confidence 33222221111 11233444444555444433211 22233444444444443322 1
Q ss_pred ccccccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcceEeeeccccccccCCc
Q 002349 246 QLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPP 325 (933)
Q Consensus 246 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~ 325 (933)
+......|.....|+.+.+..+... +...+....+|+.+.+..+ ++.....
T Consensus 197 --~~I~~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~-------------------------~~~i~~~ 247 (394)
T 4fs7_A 197 --KIIRDYCFAECILLENMEFPNSLYY--LGDFALSKTGVKNIIIPDS-------------------------FTELGKS 247 (394)
T ss_dssp --CEECTTTTTTCTTCCBCCCCTTCCE--ECTTTTTTCCCCEEEECTT-------------------------CCEECSS
T ss_pred --eEeCchhhccccccceeecCCCceE--eehhhcccCCCceEEECCC-------------------------ceecccc
Confidence 1111223334444444444433221 1112222234444444321 1212223
Q ss_pred cccccccccccccccccCCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCCcccccccccc
Q 002349 326 ALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNL 405 (933)
Q Consensus 326 ~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 405 (933)
.|..+..|+.+.+..+... .....|..+..++.+....+.+. ...|..+.+|+.+.+..+ ++.....+|.++.+|
T Consensus 248 ~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L 322 (394)
T 4fs7_A 248 VFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSL 322 (394)
T ss_dssp TTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTC
T ss_pred cccccccceeEEcCCCcce-eeccccccccccceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCC
Confidence 3344444444444333222 23334444444544444443321 234445555555555433 333334455555666
Q ss_pred ceeeccCCccCCCCCCCCCCccccccccccCcccccccccccccccccceEEccCCccccccchhhcccccccee
Q 002349 406 DTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSL 480 (933)
Q Consensus 406 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 480 (933)
+.++|.++ ++......|.++.+|+.+++..| ++.+-..+|.++.+|+.+++..| ++ .+...|.+.++|+.+
T Consensus 323 ~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~I 393 (394)
T 4fs7_A 323 VSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKWI 393 (394)
T ss_dssp CEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred CEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcEE
Confidence 66666433 44344556666666666666655 55555666777777777766544 22 233455556655543
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.51 E-value=3.6e-13 Score=151.53 Aligned_cols=322 Identities=11% Similarity=0.059 Sum_probs=201.1
Q ss_pred cEEEEEcCCCCcCcccCCCCCCCCCccEEEccCCcccccCCCCccCCCCCceecccccccCCCCCcccccccchhhhhhc
Q 002349 69 TVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILK 148 (933)
Q Consensus 69 ~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~ 148 (933)
.++.+.|.. +++..-..+|.++++|+.++|.++ ++..-..+|.++.+|+.+.+..+ +......+|.+...+......
T Consensus 72 ~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~~~~~~~~~ 148 (394)
T 4fs7_A 72 KVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCDFKEITIPE 148 (394)
T ss_dssp TEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCCCSEEECCT
T ss_pred CceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeecccccccccCc
Confidence 567778764 466434457999999999999865 55334567999999999988765 332445567666554444433
Q ss_pred ccCccCCCCcccccCCCCceeeeecCCCCCCcccccccCCCCcEEeccCccccCccCcCCcCCCCCcEEccccccccCcC
Q 002349 149 NNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEI 228 (933)
Q Consensus 149 ~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 228 (933)
.... .....|.++++|+.+.+.++. .......|.++.+|+.+++..| ++......+.++..|+.+.+..+...
T Consensus 149 ~~~~--i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~--- 221 (394)
T 4fs7_A 149 GVTV--IGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYY--- 221 (394)
T ss_dssp TCCE--ECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE---
T ss_pred cccc--cchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceE---
Confidence 3332 234679999999999997654 3344567889999999999877 55455667889999998887655432
Q ss_pred CCCccccccceEeccccccccccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCc
Q 002349 229 PFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTK 308 (933)
Q Consensus 229 p~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 308 (933)
+........+|+.+.+..+ ++.+....|.+...|+.+.+..+... .....|..+..
T Consensus 222 ----------------------i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~ 277 (394)
T 4fs7_A 222 ----------------------LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSG 277 (394)
T ss_dssp ----------------------ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTT
T ss_pred ----------------------eehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccc
Confidence 1111223356777777643 33355567788888888888776544 55567777777
Q ss_pred ceEeeeccccccccCCccccccccccccccccccCCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccceecCCc
Q 002349 309 LHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSL 388 (933)
Q Consensus 309 L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~ 388 (933)
++.+....+.+. ...|..+.+|+.+.+.++ +......+|.++.+|+.+++.++ +
T Consensus 278 l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v--------------------- 331 (394)
T 4fs7_A 278 LKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-V--------------------- 331 (394)
T ss_dssp CCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-C---------------------
T ss_pred cceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-c---------------------
Confidence 777777655432 234555555665555433 33233344555555555555422 3
Q ss_pred ccccCCCccccccccccceeeccCCccCCCCCCCCCCccccccccccCcccccccccccccccccceE
Q 002349 389 NNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEI 456 (933)
Q Consensus 389 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 456 (933)
+.....+|.++.+|+.++|..| ++......|.++.+|+.+++..+ ++ .+..+|.++++|+.+
T Consensus 332 ---~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~I 393 (394)
T 4fs7_A 332 ---EEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKWI 393 (394)
T ss_dssp ---CEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred ---cEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcEE
Confidence 3233344555555555555544 44344556666666776666544 33 234567777776654
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.50 E-value=3.8e-14 Score=139.04 Aligned_cols=111 Identities=22% Similarity=0.333 Sum_probs=84.5
Q ss_pred cceecCCcccccCCCccccccccccceeeccCCccCCCCCCCCCCccccccccccCcccccccccccccccccceEEccC
Q 002349 381 MTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSH 460 (933)
Q Consensus 381 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 460 (933)
.+.+++++|.++ .+|..+. ++|+.|+|++|+|++..|..|..+++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 355666666666 3444442 5777888888888877777788888888888888888877777788888888888888
Q ss_pred CccccccchhhccccccceeeecCCCCcCcccch
Q 002349 461 NHLTGVIPEELSQLQNMFSLRLDYNNLSGDVMSL 494 (933)
Q Consensus 461 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~ 494 (933)
|+|++..+..|..+++|+.|+|++|+|+|..+.+
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~~l 121 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCACSDI 121 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTTBGGG
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCCchhH
Confidence 8888777777888888888888888888876543
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.50 E-value=8.8e-15 Score=144.65 Aligned_cols=133 Identities=20% Similarity=0.215 Sum_probs=80.2
Q ss_pred cccCCCCCceeccCcccCCCCCcccccc-cccceecCCcccccCCCccccccccccceeeccCCccCCCCCCCCCCcccc
Q 002349 351 LSSCTNLNSLNVHGNKLNGTIPPAFQRL-ESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHL 429 (933)
Q Consensus 351 l~~l~~L~~L~l~~N~l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 429 (933)
+..+.+|+.|++++|+++. ++. +..+ ++|++|++++|.+++. ..+..+++|++|+|++|.|++..+..|..+++|
T Consensus 15 ~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp EECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred cCCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 3344455555555555552 232 2222 2566666666666543 455666666666666666664433444666677
Q ss_pred ccccccCccccccccc--ccccccccceEEccCCccccccch----hhccccccceeeecCCCCcC
Q 002349 430 LKLNLSRNQLTGFIPG--EFGNLRSVMEIDLSHNHLTGVIPE----ELSQLQNMFSLRLDYNNLSG 489 (933)
Q Consensus 430 ~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~l~~N~l~~ 489 (933)
++|+|++|+|+ .+|. .+.++++|+.|++++|+++. +|. .+..+++|+.|++++|....
T Consensus 91 ~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~~~ 154 (176)
T 1a9n_A 91 TELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKLKE 154 (176)
T ss_dssp CEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred CEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCHHH
Confidence 77777777775 3444 67777777777777777763 444 37777777777777776653
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.47 E-value=8.5e-14 Score=136.98 Aligned_cols=109 Identities=23% Similarity=0.363 Sum_probs=80.0
Q ss_pred ceecCCcccccCCCccccccccccceeeccCCccCCCCCCCCCCccccccccccCcccccccccccccccccceEEccCC
Q 002349 382 TYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHN 461 (933)
Q Consensus 382 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 461 (933)
+.+++++|+++ .+|..+. ++|+.|+|++|+|++..|..|..+++|++|+|++|+|+++.+..|.++++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 45566666665 4444443 56777777777777777777777888888888888888766666778888888888888
Q ss_pred ccccccchhhccccccceeeecCCCCcCcccc
Q 002349 462 HLTGVIPEELSQLQNMFSLRLDYNNLSGDVMS 493 (933)
Q Consensus 462 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~ 493 (933)
+|++..+..|..+++|+.|+|++|+|.+.+..
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~~ 123 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCECRD 123 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCTTBGG
T ss_pred ccceeCHHHhccccCCCEEEeCCCCccccccc
Confidence 88876666688888888888888888877654
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.41 E-value=3.4e-13 Score=132.23 Aligned_cols=108 Identities=27% Similarity=0.367 Sum_probs=87.5
Q ss_pred CCceeccCcccCCCCCcccccccccceecCCcccccCCCccccccccccceeeccCCccCCCCCCCCCCccccccccccC
Q 002349 357 LNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSR 436 (933)
Q Consensus 357 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 436 (933)
.+.+++++|+++. +|..+. ++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..|..+++|++|+|++
T Consensus 11 ~~~l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 4667777777774 454442 6788888888888877788888888888888888888877777788889999999999
Q ss_pred cccccccccccccccccceEEccCCcccccc
Q 002349 437 NQLTGFIPGEFGNLRSVMEIDLSHNHLTGVI 467 (933)
Q Consensus 437 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 467 (933)
|+|++..+..|.++++|+.|+|++|++++..
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence 9999877778999999999999999988654
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.39 E-value=4.7e-13 Score=131.64 Aligned_cols=103 Identities=22% Similarity=0.217 Sum_probs=67.7
Q ss_pred EEEcCCCCcCcccCCCCCCCCCccEEEccCCcccccCCCCccCCCCCceecccccccCCCCCcccccccchhhhhhcccC
Q 002349 72 ALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQ 151 (933)
Q Consensus 72 ~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~ 151 (933)
.+++++++++ .+|..+. ++|++|+|++|+|++..|..|+++++|++|+|++|+|++..+..|.++++|++|+|++|+
T Consensus 16 ~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~ 92 (174)
T 2r9u_A 16 LVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNH 92 (174)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCc
Confidence 5677777775 5665554 677777777777776667777777777777777777775444445666666666666666
Q ss_pred ccCCCCcccccCCCCceeeeecCCCC
Q 002349 152 LIGPIPSTLSQLPNLKVFGLRGNNLV 177 (933)
Q Consensus 152 l~~~~p~~l~~l~~L~~L~L~~N~l~ 177 (933)
|++..+..|..+++|++|+|++|.+.
T Consensus 93 l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 93 LKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred cceeCHHHhccccCCCEEEeCCCCcc
Confidence 66544444666666666666666654
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.31 E-value=1.7e-12 Score=143.39 Aligned_cols=110 Identities=20% Similarity=0.158 Sum_probs=93.1
Q ss_pred CCCccceEecCCCCcEEEEEcCCCCcCcccCCCCCCCCCccEEEccC-CcccccCCCCccCCCCCceecccccccCCCCC
Q 002349 55 YCVWRGITCDNVTFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRG-NRLSGQIPDEIGDCSSLKSLDLSFNELYGDIP 133 (933)
Q Consensus 55 ~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~-n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p 133 (933)
.|.|.+|.|++. |+|+ .+|. |..+++|++|+|++ |+|++..|..|++|++|++|+|++|+|++..|
T Consensus 7 ~C~~~~v~~~~~-----------n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 73 (347)
T 2ifg_A 7 PHGSSGLRCTRD-----------GALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAP 73 (347)
T ss_dssp CSSSSCEECCSS-----------CCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECT
T ss_pred cccCCEEEcCCC-----------CCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCH
Confidence 488888888532 1566 4777 99999999999996 99998777889999999999999999999888
Q ss_pred cccccccchhhhhhcccCccCCCCcccccCCCCceeeeecCCCCC
Q 002349 134 FSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVG 178 (933)
Q Consensus 134 ~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~ 178 (933)
..|.+|++|++|+|++|+|++..+..+..++ |+.|+|++|.+..
T Consensus 74 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 74 DAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp TGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred HHhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCccC
Confidence 8999999999999999999976666666665 9999999998874
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.24 E-value=6.2e-12 Score=138.84 Aligned_cols=102 Identities=23% Similarity=0.256 Sum_probs=45.0
Q ss_pred eeccCc-ccCCCCCcccccccccceecCCc-ccccCCCccccccccccceeeccCCccCCCCCCCCCCccccccccccCc
Q 002349 360 LNVHGN-KLNGTIPPAFQRLESMTYLNLSL-NNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRN 437 (933)
Q Consensus 360 L~l~~N-~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 437 (933)
++.+++ +|+. +|. +..+++|++|+|++ |.|++..+..|..+++|+.|+|++|+|++..|..|.++++|+.|+|++|
T Consensus 13 v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 90 (347)
T 2ifg_A 13 LRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (347)
T ss_dssp EECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred EEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence 344444 4442 333 44444444444443 4444444444444444444444444444444444444444444444444
Q ss_pred ccccccccccccccccceEEccCCccc
Q 002349 438 QLTGFIPGEFGNLRSVMEIDLSHNHLT 464 (933)
Q Consensus 438 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 464 (933)
+|++..+..|..++ |+.|+|++|+|.
T Consensus 91 ~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 91 ALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp CCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred ccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 44433333333333 444444444444
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=1.7e-11 Score=129.55 Aligned_cols=148 Identities=16% Similarity=0.090 Sum_probs=115.9
Q ss_pred HHHHHhhccCcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCC-CCceeeeeeEEecCCccE
Q 002349 592 DIMRMTENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIK-HRNLVSLQGYSLSSSGNL 670 (933)
Q Consensus 592 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 670 (933)
.+....+.|.....+|.|+.+.||++... ++.+++|+...........+.+|+++++.+. +..+.++++++...+..+
T Consensus 8 ~l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~ 86 (263)
T 3tm0_A 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence 34556678888888999999999999855 5789999987532223346889999999884 677888999998888899
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcC----------------------------------
Q 002349 671 LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHD---------------------------------- 716 (933)
Q Consensus 671 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---------------------------------- 716 (933)
+||||++|.++.+... +......++.++++++..||+.
T Consensus 87 lv~e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T 3tm0_A 87 LLMSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred EEEEecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence 9999999999987641 1122347888999999999971
Q ss_pred ----------------------CCCCeeeccCCCCceEeCCCCCeEEeeccccc
Q 002349 717 ----------------------CSPRIIHRDVKSSNILLDKDFEAHLTDFGIAK 748 (933)
Q Consensus 717 ----------------------~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 748 (933)
....++|+|++|.||+++++..+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01458999999999999876556799999774
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.23 E-value=6.1e-11 Score=133.22 Aligned_cols=330 Identities=12% Similarity=0.106 Sum_probs=175.0
Q ss_pred CCCccCCC-CCceecccccccCCCCCcccccccchhhhhhcccC---ccCCCCcccccCCCCceeeeecCCCCCCccccc
Q 002349 109 PDEIGDCS-SLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQ---LIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDM 184 (933)
Q Consensus 109 p~~l~~l~-~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~---l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~ 184 (933)
..+|.++. .|+.+.+..+ ++..-..+|.++++|+.+.+..|. ++..-...|.++.+|+.+.+..+ ++......|
T Consensus 56 ~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF 133 (394)
T 4gt6_A 56 DRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAF 133 (394)
T ss_dssp TTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTT
T ss_pred HhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhh
Confidence 34677774 5888888644 553445667777888887777664 44333456667777776666443 332333455
Q ss_pred ccCCCCcEEeccCccccCccCcCCcCCCCCcEEccccccccCcCCCCccccccceEeccccccccccCccccccccccEE
Q 002349 185 CQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVL 264 (933)
Q Consensus 185 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 264 (933)
..+.+|+.+.+..+- .......+..+.+|+.+.+..+ ++ ..-...|. ..+|+.+
T Consensus 134 ~~c~~L~~i~lp~~~-~~I~~~~F~~c~~L~~i~~~~~-~~-----------------------~I~~~aF~-~~~l~~i 187 (394)
T 4gt6_A 134 HHCEELDTVTIPEGV-TSVADGMFSYCYSLHTVTLPDS-VT-----------------------AIEERAFT-GTALTQI 187 (394)
T ss_dssp TTCTTCCEEECCTTC-CEECTTTTTTCTTCCEEECCTT-CC-----------------------EECTTTTT-TCCCSEE
T ss_pred hhhccccccccccee-eeecccceecccccccccccce-ee-----------------------Eecccccc-ccceeEE
Confidence 666666666665432 2233344555566665555432 11 11112222 2345556
Q ss_pred eccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccc-cCCcceEeeeccccccccCCccccccccccccccccccC
Q 002349 265 DLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELG-NMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHL 343 (933)
Q Consensus 265 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~-~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l 343 (933)
.+..+... ....+|.+..+++......+.... +...+. .......... .+.....+..+.+. +.+
T Consensus 188 ~ip~~~~~-i~~~af~~c~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~ip-~~v 253 (394)
T 4gt6_A 188 HIPAKVTR-IGTNAFSECFALSTITSDSESYPA-IDNVLYEKSANGDYALI-----------RYPSQREDPAFKIP-NGV 253 (394)
T ss_dssp EECTTCCE-ECTTTTTTCTTCCEEEECCSSSCB-SSSCEEEECTTSCEEEE-----------ECCTTCCCSEEECC-TTE
T ss_pred EECCcccc-cccchhhhccccceeccccccccc-ccceeeccccccccccc-----------ccccccccceEEcC-Ccc
Confidence 65544322 444556666666666655444331 111111 0000000000 00111122222222 122
Q ss_pred CCCCCCCcccCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCCccccccccccceeeccCCccCCCCCCCC
Q 002349 344 EGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPL 423 (933)
Q Consensus 344 ~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 423 (933)
.......|.++.+|+.+.+.++..+ +...+|.++++|+.+.+. +.++......|.++.+|+.++|..+ ++......|
T Consensus 254 ~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF 330 (394)
T 4gt6_A 254 ARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAF 330 (394)
T ss_dssp EEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTT
T ss_pred eEcccceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHh
Confidence 2233456777777777777655443 445667777777777775 3455455566777777888777654 554556778
Q ss_pred CCccccccccccCcccccccccccccccccceEEccCCccccccchhhccccccceeeecCCCC
Q 002349 424 GDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNL 487 (933)
Q Consensus 424 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l 487 (933)
.++.+|+.+.|..+ ++.+-..+|.++.+|+.+++.+|.... ..+....+|+.+.+..|.+
T Consensus 331 ~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~ 390 (394)
T 4gt6_A 331 AGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSI 390 (394)
T ss_dssp TTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC----------
T ss_pred hCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCE
Confidence 88888888888644 665666788888888888888775431 3556666777776665543
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.22 E-value=5.5e-14 Score=155.97 Aligned_cols=38 Identities=21% Similarity=0.166 Sum_probs=19.6
Q ss_pred CCccEEEeeCCccCCCCCCccccC-----CcceEeeecccccc
Q 002349 283 SYTEKLYLHSNKLTGHIPPELGNM-----TKLHYLELNDNQLT 320 (933)
Q Consensus 283 ~~L~~L~L~~N~l~~~~p~~l~~l-----~~L~~L~L~~N~l~ 320 (933)
+.|+.|+|++|.++......+... ++|+.|+|++|.++
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~ 114 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLD 114 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCC
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCC
Confidence 455666666666653322222222 45666666666554
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.20 E-value=1.2e-13 Score=153.24 Aligned_cols=164 Identities=16% Similarity=0.183 Sum_probs=92.4
Q ss_pred CCccEEEccCCcccccCCCCccC-----CCCCceecccccccCCCCCccc-ccccchhhhhhcccCccCCCCccc-----
Q 002349 92 KDLQSIDLRGNRLSGQIPDEIGD-----CSSLKSLDLSFNELYGDIPFSI-SKLKQLEFLILKNNQLIGPIPSTL----- 160 (933)
Q Consensus 92 ~~L~~L~Ls~n~l~~~~p~~l~~-----l~~L~~L~Ls~n~l~~~~p~~~-~~l~~L~~L~L~~n~l~~~~p~~l----- 160 (933)
+.|++|+|++|.|+......|.. .++|++|||++|.++......+ ..+++|++|+|++|.++......+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 45677777777776432222222 2577777777777754333333 345667777777777654333333
Q ss_pred ccCCCCceeeeecCCCCCC----cccccccCCCCcEEeccCccccCc----cCcCCcCCCCCcEEccccccccCcCCCCc
Q 002349 161 SQLPNLKVFGLRGNNLVGT----LSPDMCQLSGLWYFDVRNNSLTGS----IPQNIGNCTSFQVLDLSYNQLSGEIPFNI 232 (933)
Q Consensus 161 ~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~p~~~ 232 (933)
...++|+.|+|++|.++.. ++..+..+++|++|+|++|.|+.. ++..+...++|++|+|++|.++.....
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~-- 229 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAAL-- 229 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHH--
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHH--
Confidence 2346677777777776532 233335566677777777766532 234455556666666666665421110
Q ss_pred cccccceEeccccccccccCccccccccccEEeccCCcCcCC
Q 002349 233 GFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGP 274 (933)
Q Consensus 233 ~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 274 (933)
.+...+...++|++|+|++|.|++.
T Consensus 230 -----------------~l~~~L~~~~~L~~L~Ls~N~i~~~ 254 (372)
T 3un9_A 230 -----------------ALARAAREHPSLELLHLYFNELSSE 254 (372)
T ss_dssp -----------------HHHHHHHHCSSCCEEECTTSSCCHH
T ss_pred -----------------HHHHHHHhCCCCCEEeccCCCCCHH
Confidence 1233344556677777777776644
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.20 E-value=1.9e-10 Score=129.22 Aligned_cols=329 Identities=9% Similarity=0.097 Sum_probs=179.4
Q ss_pred CCCCCCC-CccEEEccCCcccccCCCCccCCCCCceecccccc---cCCCCCcccccccchhhhhhcccCccCCCCcccc
Q 002349 86 PAVGDLK-DLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNE---LYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLS 161 (933)
Q Consensus 86 ~~l~~l~-~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~---l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~ 161 (933)
.+|.+.. .|+.+.+..+ ++..-..+|.+|++|+.+.++.|. ++.....+|.++.+|+.+.+..+ ++......|.
T Consensus 57 ~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~ 134 (394)
T 4gt6_A 57 RVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFH 134 (394)
T ss_dssp TTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTT
T ss_pred hhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhh
Confidence 4677774 5999999764 664456789999999999998874 55344567889999999998765 4445556789
Q ss_pred cCCCCceeeeecCCCCCCcccccccCCCCcEEeccCccccCccCcCCcCCCCCcEEccccccccCcCCCCccccccceEe
Q 002349 162 QLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLS 241 (933)
Q Consensus 162 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~ 241 (933)
.+.+|+.+.+..+ +.......|..+.+|+.+.+..+ ++..-..+|. ..+|+.+.+..+-..
T Consensus 135 ~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~-~~~l~~i~ip~~~~~---------------- 195 (394)
T 4gt6_A 135 HCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFT-GTALTQIHIPAKVTR---------------- 195 (394)
T ss_dssp TCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTT-TCCCSEEEECTTCCE----------------
T ss_pred hhcccccccccce-eeeecccceecccccccccccce-eeEecccccc-ccceeEEEECCcccc----------------
Confidence 9999999999754 44355567889999999999765 4423334444 456887776544321
Q ss_pred ccccccccccCccccccccccEEeccCCcCcCCCCCCC-CCCCCccEEEeeCCccCCCCCCccccCCcceEeeecccccc
Q 002349 242 LQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPIL-GNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLT 320 (933)
Q Consensus 242 L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 320 (933)
.....|....++.......+..... ...+ ........... .+.....+..+.+. +.++
T Consensus 196 --------i~~~af~~c~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~ip-~~v~ 254 (394)
T 4gt6_A 196 --------IGTNAFSECFALSTITSDSESYPAI-DNVLYEKSANGDYALI-----------RYPSQREDPAFKIP-NGVA 254 (394)
T ss_dssp --------ECTTTTTTCTTCCEEEECCSSSCBS-SSCEEEECTTSCEEEE-----------ECCTTCCCSEEECC-TTEE
T ss_pred --------cccchhhhccccceecccccccccc-cceeeccccccccccc-----------ccccccccceEEcC-Ccce
Confidence 1112233334444444433332211 1111 00000000000 00111122222221 1222
Q ss_pred ccCCccccccccccccccccccCCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCCccccc
Q 002349 321 GHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELS 400 (933)
Q Consensus 321 ~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 400 (933)
.....+|..+..|+.+.+.++... .....|.++++|+.+.+. +.++.+...+|.++.+|+.+.|..+ ++.....+|.
T Consensus 255 ~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~ 331 (394)
T 4gt6_A 255 RIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFA 331 (394)
T ss_dssp EECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTT
T ss_pred EcccceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhh
Confidence 233344455555555555433322 333455555666666554 3344344455666666666666543 4434445666
Q ss_pred cccccceeeccCCccCCCCCCCCCCccccccccccCcccccccccccccccccceEEccCCcc
Q 002349 401 RIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHL 463 (933)
Q Consensus 401 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 463 (933)
++.+|+.+.|..+ ++......|.++.+|+.+++.+|.... ..|....+|+.+.+..|.+
T Consensus 332 ~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~ 390 (394)
T 4gt6_A 332 GCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSI 390 (394)
T ss_dssp TCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC----------
T ss_pred CCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCE
Confidence 6667777776543 554455667777777777777765441 3566667777777766654
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.05 E-value=1e-10 Score=123.37 Aligned_cols=137 Identities=13% Similarity=0.077 Sum_probs=100.9
Q ss_pred ccCcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCc--eeeeeeEEecCCccEEEEEec
Q 002349 599 NLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRN--LVSLQGYSLSSSGNLLFYDFM 676 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~ 676 (933)
.+....+.+.|..+.||++...+|+.+++|..... ....+.+|+++++.+++.+ +.+++++...++..++||||+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 44443333456669999998777788999987654 2345788999999886544 456888888877889999999
Q ss_pred CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC---------------------------------------
Q 002349 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDC--------------------------------------- 717 (933)
Q Consensus 677 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--------------------------------------- 717 (933)
+|.++. .. . .+ ...++.++++.+..||+..
T Consensus 98 ~G~~l~--~~---~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (264)
T 1nd4_A 98 PGQDLL--SS---H---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 166 (264)
T ss_dssp SSEETT--TS---C---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred CCcccC--cC---c---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence 998874 21 1 11 2367788888888888631
Q ss_pred ----------------CCCeeeccCCCCceEeCCCCCeEEeecccccc
Q 002349 718 ----------------SPRIIHRDVKSSNILLDKDFEAHLTDFGIAKS 749 (933)
Q Consensus 718 ----------------~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 749 (933)
...++|+|++|.||++++++.+.|+|||.+..
T Consensus 167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11299999999999998776677999998753
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.93 E-value=1.6e-08 Score=112.86 Aligned_cols=83 Identities=4% Similarity=-0.034 Sum_probs=46.4
Q ss_pred ccccccchhhhhhcccCccCCCCcccccCCCCceeeeecCCCCCCcccccccCCCCcEEeccCccccCccCcCCcCCCCC
Q 002349 135 SISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSF 214 (933)
Q Consensus 135 ~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L 214 (933)
++....+|+.+.+.. .++......|.++++|+.+.|..+ ++......|.+. +|+.+.+..+ ++.....+|.. .+|
T Consensus 41 ~~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~-~~L 115 (379)
T 4h09_A 41 WYKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG-TDL 115 (379)
T ss_dssp TGGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-CCC
T ss_pred ccccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceecc-CCc
Confidence 355566777777754 345444556888888888888643 553444456554 5666665443 33222233333 356
Q ss_pred cEEccccc
Q 002349 215 QVLDLSYN 222 (933)
Q Consensus 215 ~~L~L~~N 222 (933)
+.+.+..+
T Consensus 116 ~~i~lp~~ 123 (379)
T 4h09_A 116 DDFEFPGA 123 (379)
T ss_dssp SEEECCTT
T ss_pred ccccCCCc
Confidence 66665443
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.90 E-value=5.2e-12 Score=131.45 Aligned_cols=161 Identities=20% Similarity=0.197 Sum_probs=88.6
Q ss_pred CCCCccceEecCCCCcEEEEEcCC---CCcCcccCC-CCCCCCCccEEEccCCcccccCCC-CccCCCCCce--eccccc
Q 002349 54 DYCVWRGITCDNVTFTVIALNLSG---LNLDGEISP-AVGDLKDLQSIDLRGNRLSGQIPD-EIGDCSSLKS--LDLSFN 126 (933)
Q Consensus 54 ~~c~w~gv~C~~~~~~v~~l~l~~---~~l~~~~~~-~l~~l~~L~~L~Ls~n~l~~~~p~-~l~~l~~L~~--L~Ls~n 126 (933)
..|.|.|+.|+....+|+.+...+ ..+.|.+.+ .+..++. .|+..+|.-++.++- .|...+.|+. ++++.|
T Consensus 76 ~l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N 153 (267)
T 3rw6_A 76 ALKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLN 153 (267)
T ss_dssp HHHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTT
T ss_pred HHHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCC
Confidence 358899999987655665554433 233333332 1111111 222233333332221 2455555555 566666
Q ss_pred ccC---CCCCcccccccchhhhhhcccCccC--CCCcccccCCCCceeeeecCCCCCCcccccccCC--CCcEEeccCcc
Q 002349 127 ELY---GDIPFSISKLKQLEFLILKNNQLIG--PIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLS--GLWYFDVRNNS 199 (933)
Q Consensus 127 ~l~---~~~p~~~~~l~~L~~L~L~~n~l~~--~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~--~L~~L~L~~n~ 199 (933)
... +.++....++++|+.|+|++|+|++ .+|..++.+++|+.|+|++|+|++. ..+..+. +|++|+|++|.
T Consensus 154 ~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Np 231 (267)
T 3rw6_A 154 RRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNS 231 (267)
T ss_dssp SHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTST
T ss_pred HHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCc
Confidence 432 2222222456677777777777776 4456666777777777777777654 2333333 67777777777
Q ss_pred ccCccCc-------CCcCCCCCcEEc
Q 002349 200 LTGSIPQ-------NIGNCTSFQVLD 218 (933)
Q Consensus 200 l~~~~p~-------~l~~l~~L~~L~ 218 (933)
+.+.+|+ .+..+++|+.||
T Consensus 232 l~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 232 LCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp TGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred CccccCcchhHHHHHHHHCcccCeEC
Confidence 7665552 245666676665
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.90 E-value=2.2e-08 Score=111.75 Aligned_cols=103 Identities=6% Similarity=-0.065 Sum_probs=65.2
Q ss_pred CCccCCCCCceecccccccCCCCCcccccccchhhhhhcccCccCCCCcccccCCCCceeeeecCCCCCCcccccccCCC
Q 002349 110 DEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSG 189 (933)
Q Consensus 110 ~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 189 (933)
+++....+|+.+.+.. .++.....+|.++.+|+.+.|..+ ++..-...|.++ +|+.+.+..+ +.......|.. .+
T Consensus 40 ~~~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~-~~ 114 (379)
T 4h09_A 40 PWYKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG-TD 114 (379)
T ss_dssp TTGGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-CC
T ss_pred cccccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceecc-CC
Confidence 3677778899988874 355344567999999999999765 554555677776 6877777543 44333334544 57
Q ss_pred CcEEeccCccccCccCcCCcCCCCCcEEcc
Q 002349 190 LWYFDVRNNSLTGSIPQNIGNCTSFQVLDL 219 (933)
Q Consensus 190 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 219 (933)
|+.+.+..+-.. .....|.+. +|+.+.+
T Consensus 115 L~~i~lp~~~~~-i~~~~F~~~-~l~~~~~ 142 (379)
T 4h09_A 115 LDDFEFPGATTE-IGNYIFYNS-SVKRIVI 142 (379)
T ss_dssp CSEEECCTTCCE-ECTTTTTTC-CCCEEEE
T ss_pred cccccCCCcccc-ccccccccc-eeeeeec
Confidence 999988765322 223334443 4555444
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.89 E-value=3.7e-09 Score=117.01 Aligned_cols=142 Identities=13% Similarity=0.172 Sum_probs=107.1
Q ss_pred cceeeecccceeEEEEEEcCCceEEEEEec--ccC-chhHHHHHHHHHHHhcCC--CCceeeeeeEEecC---CccEEEE
Q 002349 602 EKYIIGYGASSTVYKCVLKNCKPVAIKRLY--SHY-PQCLKEFETELETVGSIK--HRNLVSLQGYSLSS---SGNLLFY 673 (933)
Q Consensus 602 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~---~~~~lv~ 673 (933)
..+.++.|.++.||++...+ ..+++|+.. ... ......+.+|+++++.+. +..+.++++++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 45679999999999998765 578888775 322 122456788999999987 45578888888766 4479999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC------------------------------------
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDC------------------------------------ 717 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------------ 717 (933)
||++|..+.+.. ...++..++..++.+++++|..||+..
T Consensus 121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999997775422 234678889999999999999999620
Q ss_pred -------------------CCCeeeccCCCCceEeCCCCC--eEEeecccccc
Q 002349 718 -------------------SPRIIHRDVKSSNILLDKDFE--AHLTDFGIAKS 749 (933)
Q Consensus 718 -------------------~~~ivH~Dikp~NIll~~~~~--~kl~DfGla~~ 749 (933)
...++|+|+++.||+++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999997753 68999998864
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.85 E-value=3.2e-10 Score=124.50 Aligned_cols=63 Identities=19% Similarity=0.313 Sum_probs=34.4
Q ss_pred ccccccccccCccccccccccc---ccccccceEEccCCccccc----cchhhccccccceeeecCCCCc
Q 002349 426 LEHLLKLNLSRNQLTGFIPGEF---GNLRSVMEIDLSHNHLTGV----IPEELSQLQNMFSLRLDYNNLS 488 (933)
Q Consensus 426 l~~L~~L~Ls~N~l~~~~p~~~---~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~ 488 (933)
+++|+.|+|++|.++...+..+ ..+++|++|+|+.|.|++. ++..+..+++|+.|+|++|.++
T Consensus 251 ~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~ 320 (362)
T 2ra8_A 251 FPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320 (362)
T ss_dssp CTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred CCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCC
Confidence 4556666666665553332222 2356666666666666553 2333345566666666666654
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.84 E-value=1.7e-09 Score=116.76 Aligned_cols=184 Identities=18% Similarity=0.165 Sum_probs=122.2
Q ss_pred ceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCC-CCc--eeeeeeEEecCC---ccEEEEEec
Q 002349 603 KYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIK-HRN--LVSLQGYSLSSS---GNLLFYDFM 676 (933)
Q Consensus 603 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~~~~~~~~~~---~~~lv~e~~ 676 (933)
.+.++.|.+..||++. +.+++|+.... .....+.+|+++++.+. +.. +.+++.+..... ..|+|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3568999999999863 56899986433 34567899999998873 332 334444433333 348899999
Q ss_pred CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcC----------------------------------------
Q 002349 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHD---------------------------------------- 716 (933)
Q Consensus 677 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---------------------------------------- 716 (933)
+|.++.+... ..++.+++..++.++++.+..||+.
T Consensus 99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9988765431 2467788888888999888888851
Q ss_pred ---------------CCCCeeeccCCCCceEeCC--CCCeEEeecccccccccCCCceeeeecccccc---cCcccccc-
Q 002349 717 ---------------CSPRIIHRDVKSSNILLDK--DFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGY---IDPEYART- 775 (933)
Q Consensus 717 ---------------~~~~ivH~Dikp~NIll~~--~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y---~aPE~~~~- 775 (933)
....++|+|++|.||++++ ...+.++||+.+..-....... ....+ ..|+....
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~-----~~~~~~~~~~~~~~~~~ 248 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFI-----SLMEDDEEYGMEFVSKI 248 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHH-----TTCCTTTSCCHHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHH-----HHHhhccccCHHHHHHH
Confidence 0135899999999999998 4567899999886532110000 00011 12221110
Q ss_pred ----CC---------CCcchhhHHHHHHHHHHHhCCCCCC
Q 002349 776 ----SR---------LTEKSDVYSFGIVLLELLTGRKAVD 802 (933)
Q Consensus 776 ----~~---------~~~~~DvwSlGv~l~elltg~~p~~ 802 (933)
+. .....+.|++|.++|.+.+|..+|-
T Consensus 249 l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 249 LNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 00 1123689999999999999987763
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.82 E-value=4.3e-10 Score=123.49 Aligned_cols=111 Identities=14% Similarity=0.185 Sum_probs=53.2
Q ss_pred CCccEEEccCCcccc-c-------CCCCccCCCCCceecccccccCCCCCcccccccchhhhhhcccCccCCCCcccccC
Q 002349 92 KDLQSIDLRGNRLSG-Q-------IPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQL 163 (933)
Q Consensus 92 ~~L~~L~Ls~n~l~~-~-------~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l 163 (933)
..++.|.+....+.| . +..++.++++|+.|.+..+.... ..++... .+.+...+..+
T Consensus 107 ~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~--------------~~is~~~-~~~L~~ll~~~ 171 (362)
T 2ra8_A 107 PSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEE--------------QEISWIE-QVDLSPVLDAM 171 (362)
T ss_dssp GGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTT--------------CCGGGCB-CCBCHHHHHTC
T ss_pred hhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhh--------------ccccccc-ccCHHHHHhcC
Confidence 345667776544442 1 23345567778888776543210 0000000 01233344555
Q ss_pred CCCceeeeecCCCCCCcccccccCCCCcEEeccCccccCccCcCCc--CCCCCcEEccc
Q 002349 164 PNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIG--NCTSFQVLDLS 220 (933)
Q Consensus 164 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~--~l~~L~~L~L~ 220 (933)
++|+.|+|++|.-. .++. + .+++|++|+|..|.+.......+. .+++|+.|+|+
T Consensus 172 P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~ 227 (362)
T 2ra8_A 172 PLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLY 227 (362)
T ss_dssp TTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEE
T ss_pred CCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEe
Confidence 66666666665211 1222 2 256666666666665433222332 56666666664
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.48 E-value=3.2e-09 Score=105.23 Aligned_cols=95 Identities=12% Similarity=0.149 Sum_probs=52.8
Q ss_pred ccCCCCCCCCCccEEEccCC-cccc----cCCCCccCCCCCceecccccccCCCC----CcccccccchhhhhhcccCcc
Q 002349 83 EISPAVGDLKDLQSIDLRGN-RLSG----QIPDEIGDCSSLKSLDLSFNELYGDI----PFSISKLKQLEFLILKNNQLI 153 (933)
Q Consensus 83 ~~~~~l~~l~~L~~L~Ls~n-~l~~----~~p~~l~~l~~L~~L~Ls~n~l~~~~----p~~~~~l~~L~~L~L~~n~l~ 153 (933)
.+...+...+.|++|+|++| .|.. .+.+.+...++|++|+|++|.|.... ...+...++|++|+|++|.+.
T Consensus 27 ~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~ 106 (185)
T 1io0_A 27 TLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 106 (185)
T ss_dssp HHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred HHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCC
Confidence 44455667788888888888 7763 23445666778888888888876322 222233344555555555544
Q ss_pred CC----CCcccccCCCCceeee--ecCCCC
Q 002349 154 GP----IPSTLSQLPNLKVFGL--RGNNLV 177 (933)
Q Consensus 154 ~~----~p~~l~~l~~L~~L~L--~~N~l~ 177 (933)
+. +...+...++|++|+| ++|.+.
T Consensus 107 ~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~ 136 (185)
T 1io0_A 107 GSGILALVEALQSNTSLIELRIDNQSQPLG 136 (185)
T ss_dssp HHHHHHHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred HHHHHHHHHHHHhCCCceEEEecCCCCCCC
Confidence 32 2233334444444444 444443
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.45 E-value=1.6e-08 Score=105.19 Aligned_cols=80 Identities=25% Similarity=0.333 Sum_probs=53.0
Q ss_pred ccccccceeeccCCccCC--CCCCCCCCccccccccccCccccccccccccccc--ccceEEccCCccccccc-------
Q 002349 400 SRIGNLDTLDMSNNKISG--SIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLR--SVMEIDLSHNHLTGVIP------- 468 (933)
Q Consensus 400 ~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~p------- 468 (933)
.++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|++|+|++|.+++.+|
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~ 244 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS 244 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence 456677777777777775 3345556677777777777777754 2344444 78888888888876555
Q ss_pred hhhccccccceee
Q 002349 469 EELSQLQNMFSLR 481 (933)
Q Consensus 469 ~~~~~l~~L~~L~ 481 (933)
..+..+++|+.||
T Consensus 245 ~il~~~P~L~~LD 257 (267)
T 3rw6_A 245 AIRERFPKLLRLD 257 (267)
T ss_dssp HHHHHCTTCCEES
T ss_pred HHHHHCcccCeEC
Confidence 2356777777664
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=2.5e-06 Score=91.64 Aligned_cols=136 Identities=19% Similarity=0.138 Sum_probs=96.6
Q ss_pred ceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCCCC---ceeeeeeEEe-cCCccEEEEEecCC
Q 002349 603 KYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHR---NLVSLQGYSL-SSSGNLLFYDFMEN 678 (933)
Q Consensus 603 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~-~~~~~~lv~e~~~~ 678 (933)
...++.|....||+. ++.+++|+-.. ......+.+|+++++.+.+. .+.+++.+.. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 356889999999988 56788988532 23456789999999999653 3556666664 44567899999999
Q ss_pred CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcC------------------------------------------
Q 002349 679 GSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHD------------------------------------------ 716 (933)
Q Consensus 679 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~------------------------------------------ 716 (933)
..+.+... ..++..+...++.++++.|..||+.
T Consensus 98 ~~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 88876321 1234555556666666666666532
Q ss_pred ---------------CCCCeeeccCCCCceEeCC---CCCe-EEeecccccc
Q 002349 717 ---------------CSPRIIHRDVKSSNILLDK---DFEA-HLTDFGIAKS 749 (933)
Q Consensus 717 ---------------~~~~ivH~Dikp~NIll~~---~~~~-kl~DfGla~~ 749 (933)
....++|+|+++.||+++. ++.+ .|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1235799999999999997 4554 8999998754
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.29 E-value=2.8e-08 Score=98.34 Aligned_cols=119 Identities=12% Similarity=0.160 Sum_probs=72.6
Q ss_pred cCCCCccCCCCCceeccccc-ccCCC----CCcccccccchhhhhhcccCccCC----CCcccccCCCCceeeeecCCCC
Q 002349 107 QIPDEIGDCSSLKSLDLSFN-ELYGD----IPFSISKLKQLEFLILKNNQLIGP----IPSTLSQLPNLKVFGLRGNNLV 177 (933)
Q Consensus 107 ~~p~~l~~l~~L~~L~Ls~n-~l~~~----~p~~~~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~L~~N~l~ 177 (933)
.+...+...++|++|+|++| .+... +...+...++|++|+|++|.+... +...+...++|++|+|++|.|.
T Consensus 27 ~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~ 106 (185)
T 1io0_A 27 TLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 106 (185)
T ss_dssp HHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred HHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCC
Confidence 34456777889999999998 87632 233344556777777777777542 2334445567777777777776
Q ss_pred CC----cccccccCCCCcEEec--cCccccCc----cCcCCcCCCCCcEEcccccccc
Q 002349 178 GT----LSPDMCQLSGLWYFDV--RNNSLTGS----IPQNIGNCTSFQVLDLSYNQLS 225 (933)
Q Consensus 178 ~~----~~~~~~~l~~L~~L~L--~~n~l~~~----~p~~l~~l~~L~~L~L~~N~l~ 225 (933)
.. +...+...++|++|+| ++|.++.. +...+...++|++|+|++|.+.
T Consensus 107 ~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 107 GSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 42 2344455566667776 66666532 2233444456666666666553
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.16 E-value=5.9e-06 Score=87.08 Aligned_cols=135 Identities=17% Similarity=0.162 Sum_probs=96.1
Q ss_pred eeecccce-eEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCC-CCceeeeeeEEecCCccEEEEEecCCCCH
Q 002349 605 IIGYGASS-TVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIK-HRNLVSLQGYSLSSSGNLLFYDFMENGSL 681 (933)
Q Consensus 605 ~lG~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL 681 (933)
.+..|..| .||+.... ++..+++|+-... ....+.+|+..++.+. +--+.++++++.+.+..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 45667666 68988765 4567899986433 3456888999998874 33366788888888899999999999887
Q ss_pred HHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC--------------------------------------------
Q 002349 682 WDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDC-------------------------------------------- 717 (933)
Q Consensus 682 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-------------------------------------------- 717 (933)
.+.... .......+..+++..+..||...
T Consensus 108 ~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 108 FQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 765421 11233445566666666666310
Q ss_pred -----------CCCeeeccCCCCceEeCCCCCeEEeecccccc
Q 002349 718 -----------SPRIIHRDVKSSNILLDKDFEAHLTDFGIAKS 749 (933)
Q Consensus 718 -----------~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 749 (933)
...++|+|+.+.||++++++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12378999999999999877777999998753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.08 E-value=6e-06 Score=90.96 Aligned_cols=81 Identities=9% Similarity=0.023 Sum_probs=56.0
Q ss_pred ceee-ecccceeEEEEEEc-------CCceEEEEEecccC---chhHHHHHHHHHHHhcCC-C--CceeeeeeEEecC--
Q 002349 603 KYII-GYGASSTVYKCVLK-------NCKPVAIKRLYSHY---PQCLKEFETELETVGSIK-H--RNLVSLQGYSLSS-- 666 (933)
Q Consensus 603 ~~~l-G~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~-- 666 (933)
.+.| +.|....+|+.... +++.+++|+..... ......+.+|+++++.+. + -.+.++++++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88999999998764 25678888765432 101245778888888874 2 3466778777655
Q ss_pred -CccEEEEEecCCCCHHH
Q 002349 667 -SGNLLFYDFMENGSLWD 683 (933)
Q Consensus 667 -~~~~lv~e~~~~gsL~~ 683 (933)
+..++||||++|..+.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 35689999999876543
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.80 E-value=2.9e-05 Score=84.85 Aligned_cols=140 Identities=19% Similarity=0.200 Sum_probs=79.6
Q ss_pred eeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCC-----CCceeeee-e--EEecCCccEEEEEe
Q 002349 604 YIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIK-----HRNLVSLQ-G--YSLSSSGNLLFYDF 675 (933)
Q Consensus 604 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~~~-~--~~~~~~~~~lv~e~ 675 (933)
..|+.|..+.||++...++ .+++|+.... ..++..|+++++.+. .|.++... | +....+..+++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677899999987665 5899988652 233445555555542 34333311 1 12235667899999
Q ss_pred cCCCCHH--------------HHhcCC--CC--C-------CCCCHHHH-------------------------------
Q 002349 676 MENGSLW--------------DILHGP--TK--K-------KKLDWDTR------------------------------- 699 (933)
Q Consensus 676 ~~~gsL~--------------~~l~~~--~~--~-------~~l~~~~~------------------------------- 699 (933)
++|..+. ..+|.. .. . ..-.|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 111210 00 0 01122211
Q ss_pred HHHHHHHHHHHHHhhc----------CCCCCeeeccCCCCceEeCCCCCeEEeeccccc
Q 002349 700 LKIALGAAQGLAYLHH----------DCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAK 748 (933)
Q Consensus 700 ~~i~~~i~~~l~~LH~----------~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 748 (933)
..+...+..++++|++ .....++|+|+++.||+++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 1111223445666653 014589999999999999888899999999774
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.76 E-value=6.3e-05 Score=84.05 Aligned_cols=75 Identities=9% Similarity=-0.025 Sum_probs=49.8
Q ss_pred ceeeecccceeEEEEEEc-CCceEEEEEecccCc-------hhHHHHHHHHHHHhcCCC--C-ceeeeeeEEecCCccEE
Q 002349 603 KYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYP-------QCLKEFETELETVGSIKH--R-NLVSLQGYSLSSSGNLL 671 (933)
Q Consensus 603 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~-niv~~~~~~~~~~~~~l 671 (933)
.+.||.|.++.||++... +++.++||....... ....++..|+++++.+.. + .+.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457999999999999754 467899997653211 123456788888887732 3 34455544 3456789
Q ss_pred EEEecCCC
Q 002349 672 FYDFMENG 679 (933)
Q Consensus 672 v~e~~~~g 679 (933)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.71 E-value=6.1e-06 Score=79.39 Aligned_cols=84 Identities=15% Similarity=0.075 Sum_probs=49.0
Q ss_pred CCccEEEccCCcccccCCCCccCCCCCceecccccc-cCCCCCcccccc----cchhhhhhcccC-ccCCCCcccccCCC
Q 002349 92 KDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNE-LYGDIPFSISKL----KQLEFLILKNNQ-LIGPIPSTLSQLPN 165 (933)
Q Consensus 92 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~-l~~~~p~~~~~l----~~L~~L~L~~n~-l~~~~p~~l~~l~~ 165 (933)
..|++|||+++.|+..--..+.++++|++|+|++|. ++...-..++.+ ++|++|+|++|. +++.--..+.++++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 467788888877765433456777888888888774 553322233332 246666666653 54433334555566
Q ss_pred CceeeeecCC
Q 002349 166 LKVFGLRGNN 175 (933)
Q Consensus 166 L~~L~L~~N~ 175 (933)
|++|+|+++.
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 6666665553
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.70 E-value=4e-06 Score=80.62 Aligned_cols=85 Identities=12% Similarity=0.035 Sum_probs=41.6
Q ss_pred CCCceecccccccCCCCCcccccccchhhhhhcccCccCCCCcccccCCCCceeeeecCCCCCCcccccccC----CCCc
Q 002349 116 SSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQL----SGLW 191 (933)
Q Consensus 116 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l----~~L~ 191 (933)
.+|++||||++.++...-..+.++++|++|+|++|. ++++.--..++.+ ++|+
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~-----------------------~ItD~gL~~L~~~~~~~~~L~ 117 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCH-----------------------YIEDGCLERLSQLENLQKSML 117 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCT-----------------------TCCHHHHHHHHTCHHHHHHCC
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCC-----------------------ccCHHHHHHHHhcccccCCCC
Confidence 457777777776654333334444555555555543 1332222223332 2455
Q ss_pred EEeccCcc-ccCccCcCCcCCCCCcEEcccccc
Q 002349 192 YFDVRNNS-LTGSIPQNIGNCTSFQVLDLSYNQ 223 (933)
Q Consensus 192 ~L~L~~n~-l~~~~p~~l~~l~~L~~L~L~~N~ 223 (933)
+|+|++|. ++..--..+.++++|+.|+|+++.
T Consensus 118 ~L~Ls~C~~ITD~Gl~~L~~~~~L~~L~L~~c~ 150 (176)
T 3e4g_A 118 EMEIISCGNVTDKGIIALHHFRNLKYLFLSDLP 150 (176)
T ss_dssp EEEEESCTTCCHHHHHHGGGCTTCCEEEEESCT
T ss_pred EEEcCCCCcCCHHHHHHHhcCCCCCEEECCCCC
Confidence 55555542 443333345556666666666553
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.63 E-value=0.0001 Score=78.23 Aligned_cols=79 Identities=14% Similarity=0.205 Sum_probs=58.4
Q ss_pred ccCcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCCCC---ceeeeeeEEecCCccEEEEEe
Q 002349 599 NLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHR---NLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~~~~~~~lv~e~ 675 (933)
+......+|.|..+.||+....+|+.|+||+-..........|.+|++.|+.+.-. -+.+++++ +..++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEe
Confidence 45556789999999999999999999999987655444455688999998887421 24445544 235789999
Q ss_pred cCCCCH
Q 002349 676 MENGSL 681 (933)
Q Consensus 676 ~~~gsL 681 (933)
++++..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987643
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.62 E-value=7.7e-05 Score=83.96 Aligned_cols=78 Identities=14% Similarity=0.188 Sum_probs=49.2
Q ss_pred CCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCceeeeecc--cccccCccccccC---CCCcchhhHHHHHHHH
Q 002349 718 SPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMG--TIGYIDPEYARTS---RLTEKSDVYSFGIVLL 792 (933)
Q Consensus 718 ~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~~~~~DvwSlGv~l~ 792 (933)
...++|+|++|.||+++.++ ++++||+.+..-... ..-....+ ...|.+|+..... ......++......+|
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~--~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG--FDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH--HHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH--HHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 45899999999999999876 999999988653211 11011111 1346666655421 1123456668888888
Q ss_pred HHHhCC
Q 002349 793 ELLTGR 798 (933)
Q Consensus 793 elltg~ 798 (933)
+.++++
T Consensus 308 ~~y~~~ 313 (420)
T 2pyw_A 308 NLFNKR 313 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 887653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00025 Score=75.74 Aligned_cols=140 Identities=15% Similarity=0.135 Sum_probs=92.7
Q ss_pred CcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCC---CCceeeeeeEEecCCccEEEEEecC
Q 002349 601 SEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIK---HRNLVSLQGYSLSSSGNLLFYDFME 677 (933)
Q Consensus 601 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~ 677 (933)
...+.|+.|.+..+|+.... ++.++||+.... ....+.+|++.|+.+. ...+.+++++....+..++||||++
T Consensus 39 ~~~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp CEEEEECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeeEEeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 34467999999999998864 567889987543 3567889999888883 3568888888887888999999999
Q ss_pred CCCHHH-----------HhcCCCC-C------------------CCCCHHHHH---HHH----------------HHHHH
Q 002349 678 NGSLWD-----------ILHGPTK-K------------------KKLDWDTRL---KIA----------------LGAAQ 708 (933)
Q Consensus 678 ~gsL~~-----------~l~~~~~-~------------------~~l~~~~~~---~i~----------------~~i~~ 708 (933)
+..+.. .+|.... . -.-+|.+.. ++. ..++.
T Consensus 115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~ 194 (312)
T 3jr1_A 115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ 194 (312)
T ss_dssp CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence 876421 2232111 0 012454322 111 11111
Q ss_pred H-HHHhhc-CCCCCeeeccCCCCceEeCCCCCeEEeecc
Q 002349 709 G-LAYLHH-DCSPRIIHRDVKSSNILLDKDFEAHLTDFG 745 (933)
Q Consensus 709 ~-l~~LH~-~~~~~ivH~Dikp~NIll~~~~~~kl~DfG 745 (933)
. ...|.. ...+.++|+|+.+.||+++.++ +.|.|++
T Consensus 195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1 223421 1246799999999999999887 8899974
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.22 E-value=1.4e-05 Score=78.37 Aligned_cols=70 Identities=17% Similarity=0.221 Sum_probs=37.8
Q ss_pred cCCCCCCCCCccEEEccCC-cccc----cCCCCccCCCCCceecccccccCCCCC----cccccccchhhhhhcccCcc
Q 002349 84 ISPAVGDLKDLQSIDLRGN-RLSG----QIPDEIGDCSSLKSLDLSFNELYGDIP----FSISKLKQLEFLILKNNQLI 153 (933)
Q Consensus 84 ~~~~l~~l~~L~~L~Ls~n-~l~~----~~p~~l~~l~~L~~L~Ls~n~l~~~~p----~~~~~l~~L~~L~L~~n~l~ 153 (933)
+...+.+-+.|++|+|++| +|.. .+-+.+..-+.|+.|+|++|.|....- ..+..-+.|++|+|++|.|.
T Consensus 33 l~~ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig 111 (197)
T 1pgv_A 33 INRLREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 111 (197)
T ss_dssp HHHHHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred HHHHHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCC
Confidence 3344455667777888774 6642 233445556677777777777753222 22223344555555555544
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.18 E-value=0.0025 Score=68.53 Aligned_cols=158 Identities=15% Similarity=0.127 Sum_probs=87.6
Q ss_pred cCHHHHHHHhhccCcc-----eeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCc--eeeee
Q 002349 588 HVYEDIMRMTENLSEK-----YIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRN--LVSLQ 660 (933)
Q Consensus 588 ~~~~~~~~~~~~~~~~-----~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~ 660 (933)
.+.+++....++|... +.|+.|....+|+....++ .+++|...... ....+..|+++++.+.... +.+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 3456666666667652 3567788899999987665 68899886531 1234566777777663222 23333
Q ss_pred eE------EecCCccEEEEEecCCCCHHH--------------HhcCC----CCC--CCC---CHHHHHH----------
Q 002349 661 GY------SLSSSGNLLFYDFMENGSLWD--------------ILHGP----TKK--KKL---DWDTRLK---------- 701 (933)
Q Consensus 661 ~~------~~~~~~~~lv~e~~~~gsL~~--------------~l~~~----~~~--~~l---~~~~~~~---------- 701 (933)
.. ....+..+++|+|++|..+.. .+|.. ... ... .|.....
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 21 112345689999999865321 11210 000 001 1222110
Q ss_pred --HHHHHHHHHHHhhcC----CCCCeeeccCCCCceEeCCCCCeEEeeccccc
Q 002349 702 --IALGAAQGLAYLHHD----CSPRIIHRDVKSSNILLDKDFEAHLTDFGIAK 748 (933)
Q Consensus 702 --i~~~i~~~l~~LH~~----~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 748 (933)
+...+...++++++. ...+++|+|+++.||+++++..+.++||+.+.
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 001133444555421 13479999999999999987666899999775
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.15 E-value=0.0051 Score=66.32 Aligned_cols=158 Identities=11% Similarity=0.087 Sum_probs=90.0
Q ss_pred cCHHHHHHHhhccCc-----ceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCCCC--ceeeee
Q 002349 588 HVYEDIMRMTENLSE-----KYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHR--NLVSLQ 660 (933)
Q Consensus 588 ~~~~~~~~~~~~~~~-----~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~ 660 (933)
.+.+.+..+.+.|.. ...++ |....||++...+|+.+++|...... .....+..|..+++.+... .+++++
T Consensus 11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~ 88 (328)
T 1zyl_A 11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPV 88 (328)
T ss_dssp CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCC
T ss_pred CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeeccee
Confidence 344556666555532 24577 88889999887777789999986432 1245667788888777422 234444
Q ss_pred eE-----EecCCccEEEEEecCCCCHH-----HH---------hcC----CC--CCCCCCHHHH----------------
Q 002349 661 GY-----SLSSSGNLLFYDFMENGSLW-----DI---------LHG----PT--KKKKLDWDTR---------------- 699 (933)
Q Consensus 661 ~~-----~~~~~~~~lv~e~~~~gsL~-----~~---------l~~----~~--~~~~l~~~~~---------------- 699 (933)
.. ....+..+++|||++|..+. .. +|. .. .....++...
T Consensus 89 ~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 168 (328)
T 1zyl_A 89 AFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPS 168 (328)
T ss_dssp CBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCT
T ss_pred ecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCH
Confidence 43 11234557899999875432 00 111 00 0112222211
Q ss_pred ------HHHHHHHHHHHHHhhc-CCCCCeeeccCCCCceEeCCCCCeEEeecccccc
Q 002349 700 ------LKIALGAAQGLAYLHH-DCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKS 749 (933)
Q Consensus 700 ------~~i~~~i~~~l~~LH~-~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 749 (933)
...+..++..++..-. .....++|+|+++.||+++ + .+.++||+.+..
T Consensus 169 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 169 GLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp TTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1111222222222211 1134689999999999999 4 899999997753
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.12 E-value=0.0013 Score=70.05 Aligned_cols=74 Identities=4% Similarity=0.035 Sum_probs=46.0
Q ss_pred cCcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCce-eeeeeEEecCCccEEEEEec-C
Q 002349 600 LSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNL-VSLQGYSLSSSGNLLFYDFM-E 677 (933)
Q Consensus 600 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~-~ 677 (933)
+...+.|+.|....+|++ +.+++|+....... .....+|+.+++.+....+ .+++++ ..+.-++++||+ +
T Consensus 20 ~~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~ 91 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAG 91 (301)
T ss_dssp CCSCEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTT
T ss_pred ccceeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCC
Confidence 333678999999999998 56888887653221 1123567777777643223 345443 344457899999 6
Q ss_pred CCCH
Q 002349 678 NGSL 681 (933)
Q Consensus 678 ~gsL 681 (933)
|.++
T Consensus 92 g~~l 95 (301)
T 3dxq_A 92 AQTM 95 (301)
T ss_dssp CEEC
T ss_pred CccC
Confidence 5444
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.00 E-value=0.00061 Score=62.37 Aligned_cols=53 Identities=28% Similarity=0.369 Sum_probs=31.9
Q ss_pred cccccCcccc-cccccccccccccceEEccCCccccccchhhccccccceeeecCC
Q 002349 431 KLNLSRNQLT-GFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYN 485 (933)
Q Consensus 431 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N 485 (933)
.++.+++.|+ ..+|..+. .+|+.|+|++|+|+...+..|..+++|+.|+|++|
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 65 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGAN 65 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSS
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCC
Confidence 4555555554 23343321 35677777777777666666777777776655543
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.87 E-value=0.0038 Score=67.53 Aligned_cols=141 Identities=13% Similarity=0.092 Sum_probs=71.5
Q ss_pred eeeeccccee-EEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCCC--CceeeeeeEEecCCccEEEEEecCCCC
Q 002349 604 YIIGYGASST-VYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKH--RNLVSLQGYSLSSSGNLLFYDFMENGS 680 (933)
Q Consensus 604 ~~lG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~gs 680 (933)
+.|+.|+... +|+....+++.+++|....... ..+..|+++++.+.. -.+.+++.+.... -+++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcc
Confidence 3466665554 6677654466777776543221 233456666666532 2345566653322 378999997766
Q ss_pred HHHHhc---------------------CCCC--CCCCCHHHHH-------H-------------HHHHHHHHHHHhh---
Q 002349 681 LWDILH---------------------GPTK--KKKLDWDTRL-------K-------------IALGAAQGLAYLH--- 714 (933)
Q Consensus 681 L~~~l~---------------------~~~~--~~~l~~~~~~-------~-------------i~~~i~~~l~~LH--- 714 (933)
+.+.+. .... ...++..... . ....+...++.+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 654332 1100 0112221110 0 0001111222221
Q ss_pred cCCCCCeeeccCCCCceEeCCC----CCeEEeecccccc
Q 002349 715 HDCSPRIIHRDVKSSNILLDKD----FEAHLTDFGIAKS 749 (933)
Q Consensus 715 ~~~~~~ivH~Dikp~NIll~~~----~~~kl~DfGla~~ 749 (933)
......++|||+.+.||+++.+ +.+.|+||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1114579999999999999875 6789999998864
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.76 E-value=7.6e-05 Score=73.15 Aligned_cols=114 Identities=17% Similarity=0.208 Sum_probs=62.5
Q ss_pred CCccCCCCCceeccccc-ccCCC----CCcccccccchhhhhhcccCccCC----CCcccccCCCCceeeeecCCCCCCc
Q 002349 110 DEIGDCSSLKSLDLSFN-ELYGD----IPFSISKLKQLEFLILKNNQLIGP----IPSTLSQLPNLKVFGLRGNNLVGTL 180 (933)
Q Consensus 110 ~~l~~l~~L~~L~Ls~n-~l~~~----~p~~~~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~ 180 (933)
..+.+-+.|++|+|++| .|... +-..+..-+.|++|+|++|++... +...+...+.|++|+|++|.|....
T Consensus 35 ~ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~G 114 (197)
T 1pgv_A 35 RLREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPEL 114 (197)
T ss_dssp HHHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHH
T ss_pred HHHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHH
Confidence 34455678889999885 66522 223344456677777777777642 2333445566777777777776322
Q ss_pred ----ccccccCCCCcEEeccCc---cccC----ccCcCCcCCCCCcEEcccccc
Q 002349 181 ----SPDMCQLSGLWYFDVRNN---SLTG----SIPQNIGNCTSFQVLDLSYNQ 223 (933)
Q Consensus 181 ----~~~~~~l~~L~~L~L~~n---~l~~----~~p~~l~~l~~L~~L~L~~N~ 223 (933)
-+.+..-+.|++|+|++| .+.. .+.+.+..-+.|+.|+++.|.
T Consensus 115 a~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~ 168 (197)
T 1pgv_A 115 LARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 168 (197)
T ss_dssp HHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCC
Confidence 223333455666666544 2221 122334444555555555444
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.68 E-value=0.0028 Score=71.06 Aligned_cols=73 Identities=16% Similarity=0.189 Sum_probs=49.5
Q ss_pred ceeeecccceeEEEEEEcC--------CceEEEEEecccCchhHHHHHHHHHHHhcCCCCce-eeeeeEEecCCccEEEE
Q 002349 603 KYIIGYGASSTVYKCVLKN--------CKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNL-VSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 603 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~ 673 (933)
.+.|+.|....||++...+ ++.+++|+..... ....+.+|+.+++.+...++ .++++.+.+ .+||
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 3568889999999998753 4678999874421 11455679998888853333 566665532 3899
Q ss_pred EecCCCCH
Q 002349 674 DFMENGSL 681 (933)
Q Consensus 674 e~~~~gsL 681 (933)
||++|.++
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99986443
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.58 E-value=0.013 Score=66.06 Aligned_cols=73 Identities=15% Similarity=0.101 Sum_probs=47.6
Q ss_pred eeeecccceeEEEEEEcC-CceEEEEEecccCchhHHHHHHHHHHHhcCCCCce-eeeeeEEecCCccEEEEEecCCCCH
Q 002349 604 YIIGYGASSTVYKCVLKN-CKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNL-VSLQGYSLSSSGNLLFYDFMENGSL 681 (933)
Q Consensus 604 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~gsL 681 (933)
+.|+.|-...+|++...+ ++.+++|+....... .-+..+|+.+++.+...++ .++++++. + ..||||++|.++
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 468889999999998765 477888887443221 1112578888888865444 46676663 2 359999987544
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.54 E-value=0.0063 Score=66.69 Aligned_cols=141 Identities=18% Similarity=0.194 Sum_probs=82.8
Q ss_pred eeeecccceeEEEEEEcC--------CceEEEEEecccCchhHHHHHHHHHHHhcCC-CCceeeeeeEEecCCccEEEEE
Q 002349 604 YIIGYGASSTVYKCVLKN--------CKPVAIKRLYSHYPQCLKEFETELETVGSIK-HRNLVSLQGYSLSSSGNLLFYD 674 (933)
Q Consensus 604 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 674 (933)
+.+..|-...+|++...+ ++.+++|+.... ......+.+|+++++.+. +.-..++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 467778888999998642 467888886332 223456678999988874 2223566666543 28999
Q ss_pred ecCCCCHHH-----------------HhcCCC--CCCCCC--HHHHHHHHHHHHH-------------------HHHHhh
Q 002349 675 FMENGSLWD-----------------ILHGPT--KKKKLD--WDTRLKIALGAAQ-------------------GLAYLH 714 (933)
Q Consensus 675 ~~~~gsL~~-----------------~l~~~~--~~~~l~--~~~~~~i~~~i~~-------------------~l~~LH 714 (933)
|++|..+.. .+|... ...... +.++.++..++.. .++.|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 999865431 112211 111222 3455555544322 122322
Q ss_pred ----cC-CCCCeeeccCCCCceEeCCC----CCeEEeecccccc
Q 002349 715 ----HD-CSPRIIHRDVKSSNILLDKD----FEAHLTDFGIAKS 749 (933)
Q Consensus 715 ----~~-~~~~ivH~Dikp~NIll~~~----~~~kl~DfGla~~ 749 (933)
.. ....++|+|+.+.||+++.+ +.+.++||..|..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 11 13468899999999999876 7899999998854
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.50 E-value=0.0026 Score=58.14 Aligned_cols=57 Identities=23% Similarity=0.344 Sum_probs=42.4
Q ss_pred eeeccCCccC-CCCCCCCCCccccccccccCcccccccccccccccccceEEccCCcccc
Q 002349 407 TLDMSNNKIS-GSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTG 465 (933)
Q Consensus 407 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 465 (933)
.++.+++.++ ..+|..+. ++|+.|+|++|+|+.+.+..|..+++|+.|+|++|.+.-
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~C 69 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRC 69 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBC
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeec
Confidence 6677777775 24554432 357888888888887777788888889999999998763
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.36 E-value=0.024 Score=55.63 Aligned_cols=103 Identities=17% Similarity=0.133 Sum_probs=68.1
Q ss_pred CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCcee
Q 002349 679 GSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTS 758 (933)
Q Consensus 679 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 758 (933)
-||.++|. ..+.++++++++.++.|.+.+|.-.-.. . .-..+=+.|..|++..+|.|...+ +.+.
T Consensus 33 vSL~eIL~--~~~~PlsEEqaWALc~Qc~~~L~~~~~~-~-~~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILR--LYNQPINEEQAWAVCYQCCGSLRAAARR-R-QPRHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHH--HHTSCCCHHHHHHHHHHHHHHHHHHHHT-T-CCCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHH--HcCCCcCHHHHHHHHHHHHHHHHhhhhc-c-cCCceecCCcceEEecCCceeccc-cccc----------
Confidence 37899986 4578999999999999999998876211 0 111333457899999999998764 2110
Q ss_pred eeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCC
Q 002349 759 TYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKA 800 (933)
Q Consensus 759 ~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p 800 (933)
.....+.|||... ...+.+.=|||+|+++|..+--..|
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0122466888764 3467889999999999998864443
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.23 E-value=0.013 Score=63.43 Aligned_cols=31 Identities=16% Similarity=0.288 Sum_probs=27.6
Q ss_pred CCeeeccCCCCceEeCCCCCeEEeecccccc
Q 002349 719 PRIIHRDVKSSNILLDKDFEAHLTDFGIAKS 749 (933)
Q Consensus 719 ~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 749 (933)
..++|+|+.+.||+++.++.+.++||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4699999999999999888899999987754
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.22 E-value=0.0063 Score=66.87 Aligned_cols=73 Identities=15% Similarity=0.102 Sum_probs=43.8
Q ss_pred eeeecccceeEEEEEEcC---------CceEEEEEecccCchhHHHHHHHHHHHhcCCCCc-eeeeeeEEecCCccEEEE
Q 002349 604 YIIGYGASSTVYKCVLKN---------CKPVAIKRLYSHYPQCLKEFETELETVGSIKHRN-LVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 604 ~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~ 673 (933)
..++.|....+|++...+ ++.+++|+...... ...+...|+++++.+...+ +.++++.. . -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 467888888999998654 25788887654322 1122467888888774333 34566544 2 37899
Q ss_pred EecCCCCH
Q 002349 674 DFMENGSL 681 (933)
Q Consensus 674 e~~~~gsL 681 (933)
||++|..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987543
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.06 E-value=0.16 Score=56.38 Aligned_cols=141 Identities=14% Similarity=0.139 Sum_probs=83.2
Q ss_pred ceeeecccceeEEEEEEcC--------CceEEEEEecccCchhHHHHHHHHHHHhcCCCCc-eeeeeeEEecCCccEEEE
Q 002349 603 KYIIGYGASSTVYKCVLKN--------CKPVAIKRLYSHYPQCLKEFETELETVGSIKHRN-LVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 603 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~ 673 (933)
.+.+..|-...+|+....+ ++.+++|+..... ...-+..+|.++++.+...+ ..++++.+. -+.||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 3467778888999998763 5778888864432 22223367888888774222 345555432 37899
Q ss_pred EecCCCCHHH-----------------HhcCC--------C--CCCCCCHHHHHHHHHHH-------------------H
Q 002349 674 DFMENGSLWD-----------------ILHGP--------T--KKKKLDWDTRLKIALGA-------------------A 707 (933)
Q Consensus 674 e~~~~gsL~~-----------------~l~~~--------~--~~~~l~~~~~~~i~~~i-------------------~ 707 (933)
||++|..+.. .+|.. . ...+.-+.++.++..++ .
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 9999865421 01110 0 11111244444443322 1
Q ss_pred HHHHHhhc---------------------CCCCCeeeccCCCCceEeCCCCCeEEeecccccc
Q 002349 708 QGLAYLHH---------------------DCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKS 749 (933)
Q Consensus 708 ~~l~~LH~---------------------~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 749 (933)
..+.+|.+ .....++|+|+.+.||+ +.++.+.++||..|..
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 22233321 11345889999999999 7788999999998864
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=85.23 E-value=2.1 Score=42.01 Aligned_cols=123 Identities=10% Similarity=0.106 Sum_probs=83.8
Q ss_pred HHHHHhcCCCCceeeeeeEEecCCccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeee
Q 002349 644 ELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIH 723 (933)
Q Consensus 644 E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH 723 (933)
|+..|.. .||+.+.. .+-.+.+.+.+.|+.-+. ...+- .-...+...+++++.+++...++++ .=+|
T Consensus 36 el~LL~~-~~~~Fl~~-~I~e~eD~v~~~y~~~~~--~~~f~----~ik~~~~~eKlr~l~ni~~l~~~~~-----~r~t 102 (215)
T 4ann_A 36 LMYLLEQ-HSPYFIDA-ELTELRDSFQIHYDINDN--HTPFD----NIKSFTKNEKLRYLLNIKNLEEVNR-----TRYT 102 (215)
T ss_dssp GGGGGGS-CCTTBCCE-EEEECSSEEEEEECCCTT--SEEGG----GGGGSCHHHHHHHHHHGGGGGGGGG-----SSEE
T ss_pred HHHHHhc-cCCcccce-EEEEcccEEEEEEEcCcc--cCCHH----HHHhcCHHHHHHHHHHHHHHHHHhc-----CceE
Confidence 4444543 68888865 455556655555554432 22221 1235789999999999999887777 3488
Q ss_pred ccCCCCceEeCCCCCeEEeecccccccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 002349 724 RDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVD 802 (933)
Q Consensus 724 ~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~ 802 (933)
--+.|+|++++.++.+++.-.|+-..+ +|. ..++..=.-.+=+++..+++++..|+
T Consensus 103 f~L~P~NL~f~~~~~p~i~~RGik~~l------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 103 FVLAPDELFFTRDGLPIAKTRGLQNVV------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp CCCSGGGEEECTTSCEEESCCEETTTB------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEEecceEEEcCCCCEEEEEccCccCC------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 899999999999999999887764332 121 12333334567788899999998885
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=83.66 E-value=2.1 Score=46.97 Aligned_cols=30 Identities=30% Similarity=0.423 Sum_probs=25.1
Q ss_pred CeeeccCCCCceEe------CCCCCeEEeecccccc
Q 002349 720 RIIHRDVKSSNILL------DKDFEAHLTDFGIAKS 749 (933)
Q Consensus 720 ~ivH~Dikp~NIll------~~~~~~kl~DfGla~~ 749 (933)
.++|+|+.+.||++ +++..++++||-.|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 35799999999999 4567799999998864
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 933 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-61 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-59 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-59 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-56 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-56 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-56 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-55 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-55 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-54 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-54 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-53 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-53 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 8e-53 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-52 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-52 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-52 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-52 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-51 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-51 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-51 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 9e-51 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-50 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-50 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-49 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-49 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 8e-49 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-48 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-47 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-47 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 8e-46 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-45 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-45 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-45 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-44 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-44 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-44 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 8e-42 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-41 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-39 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-39 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-39 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-38 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-38 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-37 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-36 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-36 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-35 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-35 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-35 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-35 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-35 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-34 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-34 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-34 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 9e-33 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-32 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-32 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-31 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-30 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-23 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-04 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-29 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-22 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-06 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-26 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-26 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-26 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-26 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-25 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 8e-25 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 8e-21 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-18 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-16 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-09 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-24 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-23 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-16 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-15 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 9e-11 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-19 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-11 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-11 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 6e-11 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 8e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-04 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 7e-11 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-10 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-09 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-09 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 7e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.001 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.002 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.002 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 8e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-09 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 3e-08 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 8e-07 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 6e-06 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 4e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 6e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-08 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-07 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-06 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-07 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-06 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-06 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 6e-06 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 9e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.001 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-07 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 1e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 3e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.001 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.003 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 6e-07 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 1e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.002 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.004 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 7e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 2e-05 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 8e-05 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 2e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 7e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 9e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 7e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 9e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 3e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.001 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (529), Expect = 2e-61
Identities = 78/268 (29%), Positives = 127/268 (47%), Gaps = 17/268 (6%)
Query: 606 IGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLS 665
IG G+ TVYK V + + + PQ L+ F+ E+ + +H N++ GYS +
Sbjct: 16 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 74
Query: 666 SSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRD 725
+ + + E SL+ LH + K + + IA AQG+ YLH IIHRD
Sbjct: 75 APQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRD 129
Query: 726 VKSSNILLDKDFEAHLTDFGIAKSLC-VSKSYTSTYIMGTIGYIDPEYART---SRLTEK 781
+KS+NI L +D + DFG+A S S+ + G+I ++ PE R + + +
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 782 SDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKV 841
SDVY+FGIVL EL+TG+ N N +I + ++ + C K +
Sbjct: 190 SDVYAFGIVLYELMTGQLPYSNINNRDQII--FMVGRGYLSPDLSKVRSNC-----PKAM 242
Query: 842 FQLALLCSKRQPTDRPTMHEVSRVLGSL 869
+L C K++ +RP ++ + L
Sbjct: 243 KRLMAECLKKKRDERPLFPQILASIELL 270
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 2e-59
Identities = 73/284 (25%), Positives = 119/284 (41%), Gaps = 17/284 (5%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLV 657
E+L + +G G V+ VAIK L + F E + + ++H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75
Query: 658 SLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDC 717
L +S + ++M GSL D L G T K + +A A G+AY+
Sbjct: 76 QLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVER-- 131
Query: 718 SPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSR 777
+HRD++++NIL+ ++ + DFG+A+ + ++ I + PE A R
Sbjct: 132 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 190
Query: 778 LTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGA 837
T KSDV+SFGI+L EL T + ++ + V C +
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL------DQVERGYRMPCPPECPE--- 241
Query: 838 VKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAPEPQKQPTS 881
+ L C +++P +RPT + L + EPQ QP
Sbjct: 242 --SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGE 283
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 4e-59
Identities = 71/269 (26%), Positives = 113/269 (42%), Gaps = 17/269 (6%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLV 657
E L +G G V+ VA+K L F E + ++H+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 658 SLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDC 717
L + + ++MENGSL D L P KL + L +A A+G+A++
Sbjct: 72 RLYAVV-TQEPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 718 SPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSR 777
IHRD++++NIL+ + DFG+A+ + ++ I + PE
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 778 LTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGA 837
T KSDV+SFGI+L E++T + +I + C +
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI------QNLERGYRMVRPDNCPE--- 237
Query: 838 VKKVFQLALLCSKRQPTDRPTMHEVSRVL 866
+++QL LC K +P DRPT + VL
Sbjct: 238 --ELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (495), Expect = 2e-56
Identities = 67/291 (23%), Positives = 120/291 (41%), Gaps = 33/291 (11%)
Query: 606 IGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLS 665
IG G V++ + + VA+K S + E E+ ++H N++
Sbjct: 11 IGKGRFGEVWRGKWRG-EEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADNK 68
Query: 666 SSGNL----LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDC---- 717
+G L D+ E+GSL+D L+ + + + +K+AL A GLA+LH +
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 718 -SPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTS---TYIMGTIGYIDPEYA 773
P I HRD+KS NIL+ K+ + D G+A + + +GT Y+ PE
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184
Query: 774 RTS------RLTEKSDVYSFGIVLLELLTGRK----AVDNECNLHHLILSKTANNAVMET 823
S +++D+Y+ G+V E+ D + + L+ S + + +
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 244
Query: 824 V-----DPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869
V P I + A++ + ++ C R T + + L L
Sbjct: 245 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 2e-56
Identities = 66/273 (24%), Positives = 115/273 (42%), Gaps = 17/273 (6%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLV 657
L+ IG G V+ N VAIK + ++F E E + + H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLV 63
Query: 658 SLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDC 717
L G L + L ++FME+G L D L T++ +T L + L +G+ +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCEGM---AYLE 118
Query: 718 SPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSR 777
+IHRD+ + N L+ ++ ++DFG+ + + + +ST + + PE SR
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 178
Query: 778 LTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGA 837
+ KSDV+SFG+++ E+ + K + ++ +
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV------EDISTGFRLYKPRLAST--- 229
Query: 838 VKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLV 870
V+Q+ C K +P DRP + R L +
Sbjct: 230 --HVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 4e-56
Identities = 64/263 (24%), Positives = 108/263 (41%), Gaps = 23/263 (8%)
Query: 605 IIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSL 664
IG G V + VA+K + + + F E + ++H NLV L G +
Sbjct: 14 TIGKGEFGDVMLGDYRG-NKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIV 70
Query: 665 SSSGNL-LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIH 723
G L + ++M GSL D L + L D LK +L + + YL +H
Sbjct: 71 EEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 126
Query: 724 RDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSD 783
RD+ + N+L+ +D A ++DFG+ K S T + + PE R + + KSD
Sbjct: 127 RDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPEALREKKFSTKSD 182
Query: 784 VYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQ 843
V+SFGI+L E+ + + L ++ V + + C V++
Sbjct: 183 VWSFGILLWEIYSFGRVPYPRIPLKDVV------PRVEKGYKMDAPDGCPP-----AVYE 231
Query: 844 LALLCSKRQPTDRPTMHEVSRVL 866
+ C RP+ ++ L
Sbjct: 232 VMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 191 bits (486), Expect = 2e-55
Identities = 71/303 (23%), Positives = 126/303 (41%), Gaps = 34/303 (11%)
Query: 590 YEDIMRMTENLSEKY---------IIGYGASSTVYKCVLK----NCKPVAIKRLYSHY-P 635
+ED +++ +IG G V LK VAIK L S Y
Sbjct: 9 FEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE 68
Query: 636 QCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLD 695
+ ++F +E +G H N++ L+G S+ ++ +FMENGSL L +
Sbjct: 69 KQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR--QNDGQFT 126
Query: 696 WDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS 755
+ + G A G+ YL +HRD+ + NIL++ + ++DFG+++ L S
Sbjct: 127 VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 756 Y----TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLI 811
++ I + PE + + T SDV+S+GIV+ E+++ + + +I
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVI 243
Query: 812 LSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVP 871
NA+ + C + QL L C ++ RP ++ L ++
Sbjct: 244 ------NAIEQDYRLPPPMDC-----PSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292
Query: 872 APE 874
P
Sbjct: 293 NPN 295
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 4e-55
Identities = 71/285 (24%), Positives = 131/285 (45%), Gaps = 24/285 (8%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLKN-----CKPVAIKRLYSHY-PQCLKEFETELETVGSI 651
++ + +IG G VYK +LK PVAIK L + Y + +F E +G
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 652 KHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLA 711
H N++ L+G ++ ++MENG+L L K + + + G A G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGM- 123
Query: 712 YLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLC--VSKSYTSTYIMGTIGYID 769
+ + +HRD+ + NIL++ + ++DFG+++ L +YT++ I +
Sbjct: 124 --KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 770 PEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEIS 829
PE + T SDV+SFGIV+ E++T + E + H ++ A+ +
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM------KAINDGFRLPTP 235
Query: 830 ATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAPE 874
C ++QL + C +++ RP ++ +L L+ AP+
Sbjct: 236 MDC-----PSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 275
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 3e-54
Identities = 49/265 (18%), Positives = 104/265 (39%), Gaps = 17/265 (6%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLV 657
++L+ +G G V + VAIK + EF E + + ++ H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLV 62
Query: 658 SLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDC 717
L G + ++M NG L + L + + L++ + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLR--EMRHRFQTQQLLEMCKDVCEAMEYLES-- 118
Query: 718 SPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSR 777
+ +HRD+ + N L++ ++DFG+++ + + +S + + PE S+
Sbjct: 119 -KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 778 LTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGA 837
+ KSD+++FG+++ E+ + K + + + +
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA------EHIAQGLRLYRPHLASE--- 228
Query: 838 VKKVFQLALLCSKRQPTDRPTMHEV 862
KV+ + C + +RPT +
Sbjct: 229 --KVYTIMYSCWHEKADERPTFKIL 251
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 187 bits (476), Expect = 5e-54
Identities = 65/273 (23%), Positives = 119/273 (43%), Gaps = 17/273 (6%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLKNC-KPVAIKRLYSHYPQCLKEFETELETVGSIKHRNL 656
+++ K+ +G G VY+ V K VA+K L ++EF E + IKH NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 75
Query: 657 VSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHD 716
V L G + +FM G+L D L ++++ L +A + + YL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLE-- 132
Query: 717 CSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTS 776
IHRD+ + N L+ ++ + DFG+++ + I + PE +
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 191
Query: 777 RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLG 836
+ + KSDV++FG++L E+ T + +L + + + E C
Sbjct: 192 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY------ELLEKDYRMERPEGC---- 241
Query: 837 AVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869
+KV++L C + P+DRP+ E+ + ++
Sbjct: 242 -PEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 3e-53
Identities = 57/277 (20%), Positives = 111/277 (40%), Gaps = 24/277 (8%)
Query: 597 TENLS-EKYIIGYGASSTVYKCVLKNCK---PVAIKRLY-SHYPQCLKEFETELETVGSI 651
+NL +G G +V + V + K VAIK L +E E + + +
Sbjct: 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL 66
Query: 652 KHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLA 711
+ +V L G + +L + G L L G K++++ ++ + G+
Sbjct: 67 DNPYIVRLIGV-CQAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMK 123
Query: 712 YLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY--TSTYIMGTIGYID 769
YL +HRD+ + N+LL A ++DFG++K+L SY + + +
Sbjct: 124 YLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 180
Query: 770 PEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEIS 829
PE + + +SDV+S+G+ + E L+ + + ++ + + E
Sbjct: 181 PECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM------AFIEQGKRMECP 234
Query: 830 ATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866
C +++ L C + DRP V + +
Sbjct: 235 PECPP-----ELYALMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 7e-53
Identities = 54/204 (26%), Positives = 96/204 (47%), Gaps = 10/204 (4%)
Query: 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHR 654
++ + +G G V+K K + +A K ++ P + EL+ +
Sbjct: 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 64
Query: 655 NLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLH 714
+V G S + + M+ GSL +L K ++ K+++ +GL YL
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 715 HDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYAR 774
+I+HRDVK SNIL++ E L DFG++ L S + + +GT Y+ PE +
Sbjct: 122 EKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYMSPERLQ 176
Query: 775 TSRLTEKSDVYSFGIVLLELLTGR 798
+ + +SD++S G+ L+E+ GR
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGR 200
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 8e-53
Identities = 60/273 (21%), Positives = 105/273 (38%), Gaps = 21/273 (7%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLY--SHYPQCLKEFETELETVGSIKHR 654
E+ Y IG G+ K K + K + K L S + +E+ + +KH
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 655 NLVSLQGYSLSSSGNLLF--YDFMENGSLWDILHGPTKKKK-LDWDTRLKIALGAAQGLA 711
N+V + + L+ ++ E G L ++ TK+++ LD + L++ L
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 712 YLH--HDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYID 769
H D ++HRD+K +N+ LD L DFG+A+ L S+ ++ T Y+
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVG-TPYYMS 182
Query: 770 PEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEIS 829
PE EKSD++S G +L EL + K + S
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--LAGKIREGKFRR-IPYRYS 239
Query: 830 ATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
+ + + RP++ E+
Sbjct: 240 DELNE---------IITRMLNLKDYHRPSVEEI 263
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 3e-52
Identities = 58/266 (21%), Positives = 104/266 (39%), Gaps = 26/266 (9%)
Query: 605 IIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQG 661
IG G+ TVYK + VA L + F+ E E + ++H N+V
Sbjct: 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75
Query: 662 YSLSSSGN----LLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDC 717
S+ +L + M +G+L L + K + +GL +LH
Sbjct: 76 SWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT 132
Query: 718 SPRIIHRDVKSSNILL-DKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTS 776
P IIHRD+K NI + + D G+A + ++ + ++GT ++ PE
Sbjct: 133 -PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT---LKRASFAKAVIGTPEFMAPEMYE-E 187
Query: 777 RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLG 836
+ E DVY+FG+ +LE+ T N I + + + D K+
Sbjct: 188 KYDESVDVYAFGMCMLEMATSEYPYSECQN-AAQIYRRVTSGVKPASFDKVAIPEVKE-- 244
Query: 837 AVKKVFQLALLCSKRQPTDRPTMHEV 862
+ C ++ +R ++ ++
Sbjct: 245 -------IIEGCIRQNKDERYSIKDL 263
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 3e-52
Identities = 58/275 (21%), Positives = 109/275 (39%), Gaps = 26/275 (9%)
Query: 599 NLSEKYIIGYGASSTVYKCVLKN---CKPVAIKRLYSHY--PQCLKEFETELETVGSIKH 653
L +K +G G TV K + K VA+K L + P E E + + +
Sbjct: 9 TLEDK-ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN 67
Query: 654 RNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYL 713
+V + G + +L + E G L L + + + +++ + G+ YL
Sbjct: 68 PYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYL 123
Query: 714 HHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY--TSTYIMGTIGYIDPE 771
+HRD+ + N+LL A ++DFG++K+L ++Y T+ + + PE
Sbjct: 124 EE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 772 YARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISAT 831
+ + KSDV+SFG+++ E + + + + + A
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT------AMLEKGERMGCPAG 234
Query: 832 CKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866
C ++++ L LC +RP V L
Sbjct: 235 C-----PREMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 182 bits (463), Expect = 3e-52
Identities = 63/298 (21%), Positives = 112/298 (37%), Gaps = 43/298 (14%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLKNC------KPVAIKRLYSHY-PQCLKEFETELETVGS 650
N+ IG GA V++ VA+K L +F+ E +
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 651 IKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTK-------------------- 690
+ N+V L G L +++M G L + L +
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 691 -KKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKS 749
L +L IA A G+AYL + +HRD+ + N L+ ++ + DFG++++
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 750 LCVSKSYT-STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLH 808
+ + Y I ++ PE +R T +SDV+++G+VL E+ +
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 249
Query: 809 HLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866
+I V + C +++ L LC + P DRP+ + R+L
Sbjct: 250 EVI------YYVRDGNILACPENC-----PLELYNLMRLCWSKLPADRPSFCSIHRIL 296
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 5e-52
Identities = 64/283 (22%), Positives = 112/283 (39%), Gaps = 27/283 (9%)
Query: 590 YEDIMRMTENLSEKY----IIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETE 644
YE + R N + + +G GA VYK K A K + + + L+++ E
Sbjct: 1 YEHVTR-DLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVE 59
Query: 645 LETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIAL 704
++ + S H N+V L + + +F G++ ++ ++ L +
Sbjct: 60 IDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCK 117
Query: 705 GAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGT 764
L YLH +IIHRD+K+ NIL D + L DFG++ + ++I GT
Sbjct: 118 QTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GT 173
Query: 765 IGYIDPEYARTSRL-----TEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNA 819
++ PE K+DV+S GI L+E+ N ++L +
Sbjct: 174 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL-NPMRVLLKIAKSEP 232
Query: 820 VMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
S+ KD +KK C ++ R T ++
Sbjct: 233 PTLAQPSRWSSNFKDF--LKK-------CLEKNVDARWTTSQL 266
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 2e-51
Identities = 74/296 (25%), Positives = 123/296 (41%), Gaps = 31/296 (10%)
Query: 598 ENLSEKYI----IGYGASSTVYKCV-LKNCKPVAIKRLYSHYPQCLKEFETELETVGSIK 652
+ +KY IG GAS TVY + + + VAI+++ + E+ + K
Sbjct: 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK 75
Query: 653 HRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAY 712
+ N+V+ L + +++ GSL D++ + +D + Q L +
Sbjct: 76 NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEF 131
Query: 713 LHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEY 772
LH S ++IHRD+KS NILL D LTDFG + +S ST + GT ++ PE
Sbjct: 132 LH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEV 187
Query: 773 ARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATC 832
K D++S GI+ +E++ G NE N + N ++SA
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE-NPLRALYLIATNGTPELQNPEKLSAIF 246
Query: 833 KDLGAVKKVFQLALLCSKRQPTDRPTMHEV--------SRVLGSLVPAPEPQKQPT 880
+D + + C R + E+ ++ L SL P K+ T
Sbjct: 247 RDF--LNR-------CLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEAT 293
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 2e-51
Identities = 58/319 (18%), Positives = 109/319 (34%), Gaps = 51/319 (15%)
Query: 588 HVYEDIMRMTENL-----SEKY----IIGYGASSTVYKCVLKN------CKPVAIKRLYS 632
+ Y D +L E ++G GA V VA+K L
Sbjct: 18 YFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKE 77
Query: 633 HY-PQCLKEFETELETVGSI-KHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTK 690
+ +EL+ + + H N+V+L G S L +++ G L + L +
Sbjct: 78 KADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKRE 137
Query: 691 K--------------------KKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSN 730
K L ++ L A A+G+ +L +HRD+ + N
Sbjct: 138 KFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARN 194
Query: 731 ILLDKDFEAHLTDFGIAKSLCVSKSYTS-TYIMGTIGYIDPEYARTSRLTEKSDVYSFGI 789
+L+ + DFG+A+ + +Y + ++ PE T KSDV+S+GI
Sbjct: 195 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGI 254
Query: 790 VLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCS 849
+L E+ + + + + ++++ + C
Sbjct: 255 LLWEIFSLGVNPYPGIPVDANFY-----KLIQNGFKMDQPFYA-----TEEIYIIMQSCW 304
Query: 850 KRQPTDRPTMHEVSRVLGS 868
RP+ ++ LG
Sbjct: 305 AFDSRKRPSFPNLTSFLGC 323
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 4e-51
Identities = 65/264 (24%), Positives = 106/264 (40%), Gaps = 30/264 (11%)
Query: 605 IIGYGASSTVYKCVLKNC-KPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQ 660
+G G VY K +A+K L+ + E+E ++H N++ L
Sbjct: 13 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 72
Query: 661 GYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPR 720
GY ++ L ++ G+++ L K K D A L+Y H S R
Sbjct: 73 GYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCH---SKR 126
Query: 721 IIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTE 780
+IHRD+K N+LL E + DFG + S+ T + GT+ Y+ PE E
Sbjct: 127 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT---LCGTLDYLPPEMIEGRMHDE 183
Query: 781 KSDVYSFGIVLLELLTGRK--AVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAV 838
K D++S G++ E L G+ + + I V T ++ +DL +
Sbjct: 184 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR------VEFTFPDFVTEGARDL--I 235
Query: 839 KKVFQLALLCSKRQPTDRPTMHEV 862
+ K P+ RP + EV
Sbjct: 236 SR-------LLKHNPSQRPMLREV 252
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 179 bits (454), Expect = 9e-51
Identities = 67/276 (24%), Positives = 111/276 (40%), Gaps = 33/276 (11%)
Query: 598 ENLSEKY----IIGYGASSTVYKCV-LKNCKPVAIKRLYSHY---PQCLKEFETELETVG 649
++ + + IG+G+ VY ++N + VAIK++ + ++ E+ +
Sbjct: 11 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 650 SIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQG 709
++H N + +G L L ++ + + KK L + GA QG
Sbjct: 71 KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQG 127
Query: 710 LAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYID 769
LAYLH S +IHRDVK+ NILL + L DFG A + + +GT ++
Sbjct: 128 LAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA-----PANSFVGTPYWMA 179
Query: 770 PEYARTS---RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDP 826
PE + K DV+S GI +EL + + N + L A N
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYHIAQNESPALQSG 237
Query: 827 EISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
S ++ C ++ P DRPT +
Sbjct: 238 HWSEYFRN---------FVDSCLQKIPQDRPTSEVL 264
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 1e-50
Identities = 58/262 (22%), Positives = 100/262 (38%), Gaps = 20/262 (7%)
Query: 605 IIGYGASSTVYKCVLK-NCKPVAIKRL-YSHYPQCLKEFETELETVGSIKHRNLVSLQGY 662
+G GA V V + + VA+K + C + + E+ + H N+V G+
Sbjct: 12 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71
Query: 663 SLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRII 722
+ LF ++ G L+D + + + G+ YLH I
Sbjct: 72 RREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 125
Query: 723 HRDVKSSNILLDKDFEAHLTDFGIAKSLCV-SKSYTSTYIMGTIGYIDPEYARTSRL-TE 780
HRD+K N+LLD+ ++DFG+A ++ + GT+ Y+ PE + E
Sbjct: 126 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 185
Query: 781 KSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKK 840
DV+S GIVL +L G D + + +I + L + K
Sbjct: 186 PVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN-PWKKIDSAPLAL--LHK 242
Query: 841 VFQLALLCSKRQPTDRPTMHEV 862
P+ R T+ ++
Sbjct: 243 -------ILVENPSARITIPDI 257
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 2e-50
Identities = 65/291 (22%), Positives = 121/291 (41%), Gaps = 27/291 (9%)
Query: 588 HVYEDIMRMTENLSEKYIIGYGASSTVYKCVLKNCK----PVAIKRL-YSHYPQCLKEFE 642
HV + + +E +IG G VY L + A+K L + +F
Sbjct: 19 HVVIGPSSLIVHFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFL 76
Query: 643 TELETVGSIKHRNLVSLQGYSLSSSGNLLF-YDFMENGSLWDILHGPTKKKKLDWDTRLK 701
TE + H N++SL G L S G+ L +M++G L + + +
Sbjct: 77 TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIG 134
Query: 702 IALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYT---S 758
L A+G+ S + +HRD+ + N +LD+ F + DFG+A+ + + +
Sbjct: 135 FGLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 191
Query: 759 TYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANN 818
T + ++ E +T + T KSDV+SFG++L EL+T + N +
Sbjct: 192 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT------V 245
Query: 819 AVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869
+++ C D ++++ L C + RP+ E+ + ++
Sbjct: 246 YLLQGRRLLQPEYCPD-----PLYEVMLKCWHPKAEMRPSFSELVSRISAI 291
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 1e-49
Identities = 66/308 (21%), Positives = 125/308 (40%), Gaps = 39/308 (12%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLKN---CKPVAIKRLYSHY-PQCLKEFETELETVGSI-K 652
++ + +IG G V K +K AIKR+ + ++F ELE + +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 653 HRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHG-------------PTKKKKLDWDTR 699
H N+++L G L ++ +G+L D L + L
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 700 LKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTST 759
L A A+G+ YL + IHRD+ + NIL+ +++ A + DFG+++ V T
Sbjct: 130 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 186
Query: 760 YIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNA 819
+ ++ E S T SDV+S+G++L E+++ L
Sbjct: 187 --RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY------EK 238
Query: 820 VMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAPEPQKQP 879
+ + E C D +V+ L C + +P +RP+ ++ L ++ +++
Sbjct: 239 LPQGYRLEKPLNCDD-----EVYDLMRQCWREKPYERPSFAQILVSLNRML-----EERK 288
Query: 880 TSIPSALL 887
T + + L
Sbjct: 289 TYVNTTLY 296
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 4e-49
Identities = 66/316 (20%), Positives = 113/316 (35%), Gaps = 46/316 (14%)
Query: 588 HVYEDIMRMT---------ENLSEKYIIGYGASSTVYKCVLK------NCKPVAIKRLY- 631
+VY D ++ LS +G GA V + VA+K L
Sbjct: 4 YVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP 63
Query: 632 SHYPQCLKEFETELETVGSIK-HRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHG--- 687
S + + +EL+ + + H N+V+L G L+ ++ G L + L
Sbjct: 64 SAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRD 123
Query: 688 ------------PTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDK 735
+ LD + L + A+G+A+L S IHRD+ + NILL
Sbjct: 124 SFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTH 180
Query: 736 DFEAHLTDFGIAKSLCVSKSYT-STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLEL 794
+ DFG+A+ + +Y + ++ PE T +SDV+S+GI L EL
Sbjct: 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 240
Query: 795 LTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPT 854
+ + + K A D + C P
Sbjct: 241 FSLGSSPYPGMPVDSKFY-KMIKEGFRMLSPEHAPAEMYD---------IMKTCWDADPL 290
Query: 855 DRPTMHEVSRVLGSLV 870
RPT ++ +++ +
Sbjct: 291 KRPTFKQIVQLIEKQI 306
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 8e-49
Identities = 60/270 (22%), Positives = 106/270 (39%), Gaps = 25/270 (9%)
Query: 606 IGYGASSTVYKCVLK----NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVS 658
+G G+ V + VA+K L P+ + +F E+ + S+ HRNL+
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 659 LQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCS 718
L G + + + GSL D + T + A+ A+G+ YL S
Sbjct: 76 LYGVV-LTPPMKMVTELAPLGSLLD--RLRKHQGHFLLGTLSRYAVQVAEGMGYLE---S 129
Query: 719 PRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY--TSTYIMGTIGYIDPEYARTS 776
R IHRD+ + N+LL + DFG+ ++L + + + + PE +T
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 777 RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLG 836
+ SD + FG+ L E+ T + N ++ + E C
Sbjct: 190 TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL-----HKIDKEGERLPRPEDC---- 240
Query: 837 AVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866
+ ++ + + C +P DRPT + L
Sbjct: 241 -PQDIYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 2e-48
Identities = 71/316 (22%), Positives = 121/316 (38%), Gaps = 25/316 (7%)
Query: 593 IMRMTENLSEKYIIGYGASSTVYKCVLKN-----CKPVAIKRLY-SHYPQCLKEFETELE 646
I++ TE + ++G GA TVYK + PVAIK L + P+ KE E
Sbjct: 5 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 647 TVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGA 706
+ S+ + ++ L G L+S+ L M G L D + K + L +
Sbjct: 64 VMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLD--YVREHKDNIGSQYLLNWCVQI 120
Query: 707 AQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV-SKSYTSTYIMGTI 765
A+G+ YL R++HRD+ + N+L+ +TDFG+AK L K Y + I
Sbjct: 121 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 766 GYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVD 825
++ E T +SDV+S+G+ + EL+T + + + + +
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS------SILEKGER 231
Query: 826 PEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAPEPQKQPTSIPSA 885
C V+ + + C RP E+ + P+
Sbjct: 232 LPQPPIC-----TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERM 286
Query: 886 LLSSAKVPCYKDEYAN 901
L S + +
Sbjct: 287 HLPSPTDSNFYRALMD 302
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 170 bits (432), Expect = 2e-47
Identities = 56/272 (20%), Positives = 110/272 (40%), Gaps = 23/272 (8%)
Query: 598 ENLSEKY----IIGYGASSTVYKCV-LKNCKPVAIKRLYSHYPQCLKEFETELETVGSIK 652
+++ + Y +G GA V++ A K + + + + E++T+ ++
Sbjct: 22 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR 81
Query: 653 HRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAY 712
H LV+L + ++ Y+FM G L++ + + K+ D ++ +GL +
Sbjct: 82 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA--DEHNKMSEDEAVEYMRQVCKGLCH 139
Query: 713 LHHDCSPRIIHRDVKSSNILLDKDFEAH--LTDFGIAKSLCVSKSYTSTYIMGTIGYIDP 770
+H +H D+K NI+ L DFG+ L + GT + P
Sbjct: 140 MH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL--DPKQSVKVTTGTAEFAAP 194
Query: 771 EYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISA 830
E A + +D++S G++ LL+G E + L K+ + + ++ IS
Sbjct: 195 EVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE 254
Query: 831 TCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
KD ++K P R T+H+
Sbjct: 255 DGKDF--IRK-------LLLADPNTRMTIHQA 277
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 4e-47
Identities = 62/271 (22%), Positives = 111/271 (40%), Gaps = 22/271 (8%)
Query: 605 IIGYGASSTVYKCVLKNCK----PVAIKRLYSHYPQCLKE-FETELETVGSIKHRNLVSL 659
IG G V++ + + + VAIK + ++E F E T+ H ++V L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 660 QGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSP 719
G ++ + + + G L L +K LD + + A + LAYL S
Sbjct: 74 IGV-ITENPVWIIMELCTLGELRSFLQ--VRKYSLDLASLILYAYQLSTALAYLE---SK 127
Query: 720 RIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLT 779
R +HRD+ + N+L+ + L DFG+++ + S Y ++ I ++ PE R T
Sbjct: 128 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 187
Query: 780 EKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVK 839
SDV+ FG+ + E+L + ++ + N + + P T
Sbjct: 188 SASDVWMFGVCMWEILMHGVKPFQGVKNND-VIGRIENGERLP-MPPNCPPTLYS----- 240
Query: 840 KVFQLALLCSKRQPTDRPTMHEVSRVLGSLV 870
L C P+ RP E+ L +++
Sbjct: 241 ----LMTKCWAYDPSRRPRFTELKAQLSTIL 267
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 166 bits (421), Expect = 8e-46
Identities = 56/271 (20%), Positives = 108/271 (39%), Gaps = 23/271 (8%)
Query: 599 NLSEKY----IIGYGASSTVYKCV-LKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKH 653
++ + Y +G GA V++CV + K + + YP + E+ + + H
Sbjct: 26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH 85
Query: 654 RNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYL 713
L++L +L +F+ G L+D + + K+ + A +GL ++
Sbjct: 86 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHM 143
Query: 714 HHDCSPRIIHRDVKSSNILLDKDFEAH--LTDFGIAKSLCVSKSYTSTYIMGTIGYIDPE 771
H I+H D+K NI+ + + + DFG+A L + T + PE
Sbjct: 144 H---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL--NPDEIVKVTTATAEFAAPE 198
Query: 772 YARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISAT 831
+ +D+++ G++ LL+G E +L L K + E +S
Sbjct: 199 IVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPE 258
Query: 832 CKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
KD +K +++P R T+H+
Sbjct: 259 AKDF--IKN-------LLQKEPRKRLTVHDA 280
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 3e-45
Identities = 68/298 (22%), Positives = 117/298 (39%), Gaps = 36/298 (12%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLK------NCKPVAIKRLYSHYPQC-LKEFETELETVGS 650
+ L +G GA V + C+ VA+K L + +EL+ +
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 651 IKHR-NLVSLQGYSLSSSGNLLF-YDFMENGSLWDILHG-------------PTKKKKLD 695
I H N+V+L G G L+ +F + G+L L K L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 696 WDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS 755
+ + + A+G+ +L S + IHRD+ + NILL + + DFG+A+ +
Sbjct: 133 LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 756 YT-STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSK 814
Y + ++ PE T +SDV+SFG++L E+ + + + +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249
Query: 815 TANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPA 872
M D +++Q L C +P+ RPT E+ LG+L+ A
Sbjct: 250 LKEGTRMRAPD----------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 5e-45
Identities = 63/284 (22%), Positives = 113/284 (39%), Gaps = 29/284 (10%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLKNC------KPVAIKRLY-SHYPQCLKEFETELETVGS 650
E ++ +G G+ VY+ V K VAIK + + + EF E +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 651 IKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKK-------KKLDWDTRLKIA 703
++V L G L+ + M G L L +++A
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 704 LGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY-TSTYIM 762
A G+AYL + + +HRD+ + N ++ +DF + DFG+ + + + Y +
Sbjct: 140 GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 763 GTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVME 822
+ ++ PE + T SDV+SFG+VL E+ T + + ++ VME
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL------RFVME 250
Query: 823 TVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866
+ C D +F+L +C + P RP+ E+ +
Sbjct: 251 GGLLDKPDNCPD-----MLFELMRMCWQYNPKMRPSFLEIISSI 289
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 8e-45
Identities = 63/275 (22%), Positives = 101/275 (36%), Gaps = 28/275 (10%)
Query: 595 RMTENLSEKYIIGYGASSTVYKCV-LKNCKPVAIKRLYSHY---PQCLKEFETELETVGS 650
+ E+ I+G G+ STV L + AIK L + + E + +
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 651 IKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGL 710
+ H V L + +NG L + K D A+ +
Sbjct: 65 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYT---AEIV 118
Query: 711 AYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV-SKSYTSTYIMGTIGYID 769
+ L + IIHRD+K NILL++D +TDFG AK L SK + +GT Y+
Sbjct: 119 SALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 178
Query: 770 PEYARTSRLTEKSDVYSFGIVLLELLTGRK--AVDNECNLHHLILSKTANNAVMETVDPE 827
PE + SD+++ G ++ +L+ G NE + I+ +
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY------DFPEK 232
Query: 828 ISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
+DL V+K T R E+
Sbjct: 233 FFPKARDL--VEK-------LLVLDATKRLGCEEM 258
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 160 bits (406), Expect = 1e-44
Identities = 68/283 (24%), Positives = 122/283 (43%), Gaps = 30/283 (10%)
Query: 599 NLSEKY----IIGYGASSTVYKCV-LKNCKPVAIKRLYSHY---PQCLKEFETELETVGS 650
+LS++Y I+G+G S V+ L+ + VA+K L + P F E + +
Sbjct: 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63
Query: 651 IKHRNLVSLQGYSLSSSGNL----LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGA 706
+ H +V++ + + + ++++ +L DI+H + + +++ A
Sbjct: 64 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADA 120
Query: 707 AQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY--TSTYIMGT 764
Q L + IIHRDVK +NI++ + DFGIA+++ S + + ++GT
Sbjct: 121 CQALNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 177
Query: 765 IGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETV 824
Y+ PE AR + +SDVYS G VL E+LTG + + +
Sbjct: 178 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR 237
Query: 825 DPEISATCKDLGAVKKVFQLALLCSKRQPTDRP-TMHEVSRVL 866
+SA + V K + P +R T E+ L
Sbjct: 238 HEGLSADLDAV--VLK-------ALAKNPENRYQTAAEMRADL 271
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 1e-44
Identities = 64/297 (21%), Positives = 118/297 (39%), Gaps = 38/297 (12%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLK--------NCKPVAIKRLYSHY-PQCLKEFETELETV 648
+ L +G GA V VA+K L S + L + +E+E +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 649 GSI-KHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILH-------------GPTKKKKL 694
I KH+N+++L G + ++ G+L + L +++L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 695 DWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSK 754
+ A A+G+ YL S + IHRD+ + N+L+ +D + DFG+A+ +
Sbjct: 133 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 755 SYTSTY-IMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILS 813
Y T + ++ PE T +SDV+SFG++L E+ T + + L
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF-- 247
Query: 814 KTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLV 870
+ E + + C +++ + C P+ RPT ++ L +V
Sbjct: 248 ----KLLKEGHRMDKPSNC-----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 3e-44
Identities = 54/272 (19%), Positives = 104/272 (38%), Gaps = 24/272 (8%)
Query: 598 ENLSEKYI----IGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIK 652
+ L EKY+ +G G V++CV + K K + + E+ + +
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIAR 59
Query: 653 HRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAY 712
HRN++ L S ++ ++F+ +++ ++ T +L+ + + L +
Sbjct: 60 HRNILHLHESFESMEELVMIFEFISGLDIFERIN--TSAFELNEREIVSYVHQVCEALQF 117
Query: 713 LHHDCSPRIIHRDVKSSNILLDKDFEAH--LTDFGIAKSLCVSKSYTSTYIMGTIGYIDP 770
LH S I H D++ NI+ + + +FG A+ L ++ Y P
Sbjct: 118 LH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEYYAP 172
Query: 771 EYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISA 830
E + ++ +D++S G ++ LL+G E N + A E EIS
Sbjct: 173 EVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI 232
Query: 831 TCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
D V + ++ R T E
Sbjct: 233 EAMDF--VDR-------LLVKERKSRMTASEA 255
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 152 bits (385), Expect = 8e-42
Identities = 73/282 (25%), Positives = 114/282 (40%), Gaps = 34/282 (12%)
Query: 598 ENLSEKYIIGYGASSTVYKCV-LKNCKPVAIKRL---------YSHYPQCLKEFETELET 647
EN K I+G G SS V +C+ CK A+K + + + E++
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 648 VGSIK-HRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGA 706
+ + H N++ L+ +++ L +D M+ G L+D L +K L KI
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRAL 119
Query: 707 AQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIG 766
+ + LH I+HRD+K NILLD D LTDFG + L + GT
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTPS 174
Query: 767 YIDPEYARTSRL------TEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAV 820
Y+ PE S ++ D++S G+++ LL G + + L + + N
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 234
Query: 821 METVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
+ S T KDL V + QP R T E
Sbjct: 235 GSPEWDDYSDTVKDL--VSR-------FLVVQPQKRYTAEEA 267
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 152 bits (385), Expect = 2e-41
Identities = 57/274 (20%), Positives = 100/274 (36%), Gaps = 20/274 (7%)
Query: 595 RMTENLSEKY----IIGYGASSTVYKCV-LKNCKPVAIKRL-YSHYPQCLKEFETELETV 648
+ E++ + Y ++G GA S V + K VAIK + E E+ +
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 649 GSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQ 708
IKH N+V+L S L + G L+D + +K ++
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV---EKGFYTERDASRLIFQVLD 118
Query: 709 GLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYI 768
+ YLH + LD+D + ++DFG++K ++ GT GY+
Sbjct: 119 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST--ACGTPGYV 176
Query: 769 DPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEI 828
PE ++ D +S G++ LL G +E + A +I
Sbjct: 177 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI 236
Query: 829 SATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
S + KD ++ ++ P R T +
Sbjct: 237 SDSAKDF--IRH-------LMEKDPEKRFTCEQA 261
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 148 bits (373), Expect = 4e-40
Identities = 49/285 (17%), Positives = 92/285 (32%), Gaps = 26/285 (9%)
Query: 596 MTENLSEKY----IIGYGASSTVYKCV-LKNCKPVAIKRLYSHYPQCLKEFETELETVGS 650
M + +Y IG G+ +Y + + VAIK + E +
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLE--CVKTKHPQLHIESKIYKM 58
Query: 651 IKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGL 710
++ + + + + + SL D+ + +K T L +A +
Sbjct: 59 MQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFN--FCSRKFSLKTVLLLADQMISRI 116
Query: 711 AYLHHDCSPRIIHRDVKSSNIL---LDKDFEAHLTDFGIAKSLCVSKSYT------STYI 761
Y+H S IHRDVK N L K ++ DFG+AK ++++ + +
Sbjct: 117 EYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL 173
Query: 762 MGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVM 821
GT Y + + D+ S G VL+ G + + M
Sbjct: 174 TGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 233
Query: 822 ETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVL 866
T + + C + D+P + ++
Sbjct: 234 STPIEVLCKGYP-----SEFATYLNFCRSLRFDDKPDYSYLRQLF 273
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 3e-39
Identities = 59/280 (21%), Positives = 109/280 (38%), Gaps = 32/280 (11%)
Query: 598 ENLSEKY----IIGYGASSTVYKCVLKNC-KPVAIKRL------YSHYPQCLKEFETELE 646
EN+ + Y +G G + V KC K+ A K + S ++ E E+
Sbjct: 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 647 TVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGA 706
+ I+H N+++L + + +L + + G L+D L +K+ L + +
Sbjct: 66 ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA---EKESLTEEEATEFLKQI 122
Query: 707 AQGLAYLHHDCSPRIIHRDVKSSNILLDKD----FEAHLTDFGIAKSLCVSKSYTSTYIM 762
G+ ++ S +I H D+K NI+L + DFG+A + I
Sbjct: 123 LNGV---YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIF 177
Query: 763 GTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVME 822
GT ++ PE L ++D++S G++ LL+G + L N +
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 237
Query: 823 TVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
SA KD +++ + P R T+ +
Sbjct: 238 EYFSNTSALAKDF--IRR-------LLVKDPKKRMTIQDS 268
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 146 bits (369), Expect = 3e-39
Identities = 61/264 (23%), Positives = 105/264 (39%), Gaps = 26/264 (9%)
Query: 605 IIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQ 660
+G G+ V+ + N + A+K L + ++ E + + H ++ +
Sbjct: 11 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70
Query: 661 GYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPR 720
G + + D++E G L+ +L AA+ L + S
Sbjct: 71 GTFQDAQQIFMIMDYIEGGELFSLLRKS------QRFPNPVAKFYAAEVCLALEYLHSKD 124
Query: 721 IIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTE 780
II+RD+K NILLDK+ +TDFG AK + + + GT YI PE T +
Sbjct: 125 IIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYTLCGTPDYIAPEVVSTKPYNK 180
Query: 781 KSDVYSFGIVLLELLTGRK--AVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAV 838
D +SFGI++ E+L G N + IL+ P + KDL +
Sbjct: 181 SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE------LRFPPFFNEDVKDL--L 232
Query: 839 KKVFQLALLCSKRQPTDRPTMHEV 862
++ + S+R + +V
Sbjct: 233 SRL--ITRDLSQRLGNLQNGTEDV 254
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 3e-39
Identities = 63/271 (23%), Positives = 101/271 (37%), Gaps = 29/271 (10%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRL---YSHYPQCLKEFETELETVG-SIK 652
E+ ++G G+ V+ K + AIK L ++ E + + +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 653 HRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAY 712
H L + + +++ G L + K D A GL +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQF 118
Query: 713 LHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEY 772
L S I++RD+K NILLDKD + DFG+ K + + T+T+ GT YI PE
Sbjct: 119 L---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF-CGTPDYIAPEI 174
Query: 773 ARTSRLTEKSDVYSFGIVLLELLTGRK--AVDNECNLHHLILSKTANNAVMETVDPEISA 830
+ D +SFG++L E+L G+ +E L H I +
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN------PFYPRWLEK 228
Query: 831 TCKDLGAVKKVFQLALLCSKRQPTDRPTMHE 861
KDL + K R+P R +
Sbjct: 229 EAKDL--LVK-------LFVREPEKRLGVRG 250
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 142 bits (359), Expect = 2e-38
Identities = 54/283 (19%), Positives = 98/283 (34%), Gaps = 28/283 (9%)
Query: 602 EKY----IIGYGASSTVYKCVLKNCKPVAIK--RLYSHYPQCLKEFETELETVGSIKHRN 655
EKY IG G VYK + A+K RL E+ + +KH N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 656 LVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHH 715
+V L + +L ++ ++ + + L+ T L G+AY H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCH- 117
Query: 716 DCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYART 775
R++HRD+K N+L++++ E + DFG+A++ + + I+ +
Sbjct: 118 --DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 776 SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDL 835
+ + D++S G + E++ G L+ P ++ K
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 836 ----------------GAVKKVFQLALLCSKRQPTDRPTMHEV 862
G + L K P R T +
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 144 bits (363), Expect = 4e-38
Identities = 54/270 (20%), Positives = 90/270 (33%), Gaps = 27/270 (10%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLKNC-KPVAIKRL------YSHYPQCLKEFETELETVGS 650
+ S IIG G VY C + K A+K L L V +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 651 IKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGL 710
+V + + D M G L L + A GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120
Query: 711 AYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDP 770
++H + +++RD+K +NILLD+ ++D G+A K + +GT GY+ P
Sbjct: 121 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMAP 174
Query: 771 EYARTSR-LTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEIS 829
E + +D +S G +L +LL G + + +E + S
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE-LPDSFS 233
Query: 830 ATCKDLGAVKKVFQLALLCSKRQPTDRPTM 859
+ L ++ +R R
Sbjct: 234 PELRSL--LEG-------LLQRDVNRRLGC 254
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 7e-37
Identities = 57/281 (20%), Positives = 99/281 (35%), Gaps = 29/281 (10%)
Query: 606 IGYGASSTVYKCVLK--NCKPVAIKRL-----YSHYPQCLKEFETELETVGSIKHRNLVS 658
IG GA V+K + VA+KR+ P L + + +H N+V
Sbjct: 15 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 74
Query: 659 LQGYSLSSSGNLLFYDFMENGSLW---DILHGPTKKKKLDWDTRLKIALGAAQGLAYLHH 715
L S + + + + + +T + +GL +LH
Sbjct: 75 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH- 133
Query: 716 DCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYART 775
S R++HRD+K NIL+ + L DFG+A+ + TS ++ T+ Y PE
Sbjct: 134 --SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS--VVVTLWYRAPEVLLQ 189
Query: 776 SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHL------ILSKTANNAVMETVDPEIS 829
S D++S G + E+ + ++ L I + + P +
Sbjct: 190 SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA 249
Query: 830 ATCKDLGAVKKVF--------QLALLCSKRQPTDRPTMHEV 862
K ++K L L C P R + +
Sbjct: 250 FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 1e-36
Identities = 69/289 (23%), Positives = 109/289 (37%), Gaps = 47/289 (16%)
Query: 605 IIGYGASSTVYKCVLKNC-KPVAIKRL-----YSHYPQCLKEFETELETVGSIKHRNLVS 658
+G G +TVYK KN + VAIK++ + E++ + + H N++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 659 LQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCS 718
L S L +DFME I L L QGL YLH
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW- 120
Query: 719 PRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRL 778
I+HRD+K +N+LLD++ L DFG+AKS S + T+ + T Y PE +R+
Sbjct: 121 --ILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYTHQVVTRWYRAPELLFGARM 177
Query: 779 -TEKSDVYSFGIVLLELLTGR------------------------KAVDNECNLHHLILS 813
D+++ G +L ELL + + C+L +
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 814 KTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
K+ + + DL ++ +F P R T +
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDL--IQGLFL-------FNPCARITATQA 277
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 136 bits (343), Expect = 4e-36
Identities = 42/286 (14%), Positives = 85/286 (29%), Gaps = 28/286 (9%)
Query: 600 LSEKY----IIGYGASSTVYKCV-LKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHR 654
+ Y IG G+ +++ L N + VAIK + E T +
Sbjct: 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFE--PRRSDAPQLRDEYRTYKLLAGC 60
Query: 655 NLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLH 714
+ Y + + + SL D+L +K T A + +H
Sbjct: 61 TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLD--LCGRKFSVKTVAMAAKQMLARVQSIH 118
Query: 715 HDCSPRIIHRDVKSSNILLDKDFEAH-----LTDFGIAKSLCVSKS------YTSTYIMG 763
+++RD+K N L+ + + + DFG+ K + + G
Sbjct: 119 ---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 764 TIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMET 823
T Y+ + + D+ + G V + L G + + T
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235
Query: 824 VDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869
E+ A ++ ++ P + + +
Sbjct: 236 PLRELCAGFP-----EEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 1e-35
Identities = 75/282 (26%), Positives = 108/282 (38%), Gaps = 32/282 (11%)
Query: 605 IIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYS 663
+IG G+ VY+ L + + VAIK++ + EL+ + + H N+V L+ +
Sbjct: 27 VIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 664 LSSSGN------LLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDC 717
SS L D++ H K+ L + LAY+H
Sbjct: 83 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH--- 139
Query: 718 SPRIIHRDVKSSNILLDKDFEAH-LTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTS 776
S I HRD+K N+LLD D L DFG AK L V +YI +
Sbjct: 140 SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSYICSRYYRAPELIFGAT 198
Query: 777 RLTEKSDVYSFGIVLLELLTGRK--AVDNECNLHHLILS----------KTANNAVMETV 824
T DV+S G VL ELL G+ D+ + I+ + N E
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 258
Query: 825 DPEISATCKDLGAVKKVFQLAL-LCSK---RQPTDRPTMHEV 862
P+I A + A+ LCS+ PT R T E
Sbjct: 259 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 2e-35
Identities = 54/261 (20%), Positives = 96/261 (36%), Gaps = 28/261 (10%)
Query: 605 IIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQ 660
++G G V K + A+K L + TE + + +H L +L+
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 661 GYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPR 720
+ ++ G L+ L +++ + A+ ++ L + S
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLS---RERVFTEERARFYG---AEIVSALEYLHSRD 125
Query: 721 IIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTE 780
+++RD+K N++LDKD +TDFG+ K S T GT Y+ PE +
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGI-SDGATMKTFCGTPEYLAPEVLEDNDYGR 184
Query: 781 KSDVYSFGIVLLELLTGRK--AVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAV 838
D + G+V+ E++ GR + L LIL + +S K L +
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR------FPRTLSPEAKSL--L 236
Query: 839 KKVFQLALLCSKRQPTDRPTM 859
K+ P R
Sbjct: 237 AG-------LLKKDPKQRLGG 250
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 4e-35
Identities = 56/270 (20%), Positives = 98/270 (36%), Gaps = 31/270 (11%)
Query: 605 IIGYGASSTVYKCV-LKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYS 663
++G G + V + + + A+K L P+ +E E + + ++V +
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKML-QDCPKARREVELHWR---ASQCPHIVRIVDVY 74
Query: 664 LSSSGN----LLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSP 719
+ L+ + ++ G L+ + + +I + + YLH S
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLH---SI 130
Query: 720 RIIHRDVKSSNILLDKDFE---AHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTS 776
I HRDVK N+L LTDFG AK S T+ T Y+ PE
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP--CYTPYYVAPEVLGPE 188
Query: 777 RLTEKSDVYSFGIVLLELLTGRKAVDNECNL----HHLILSKTANNAVMETVDPEISATC 832
+ + D++S G+++ LL G + L + E+S
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEV 248
Query: 833 KDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
K L ++ K +PT R T+ E
Sbjct: 249 KML--IRN-------LLKTEPTQRMTITEF 269
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 4e-35
Identities = 53/293 (18%), Positives = 95/293 (32%), Gaps = 42/293 (14%)
Query: 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIK--RLYSHYPQCLKEFETELETVGSIKHR 654
EN + IG G VYK K + VA+K RL + E+ + + H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 655 NLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLH 714
N+V L + + L ++F+ + + QGLA+
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFC- 118
Query: 715 HDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYAR 774
S R++HRD+K N+L++ + L DFG+A++ V + ++
Sbjct: 119 --HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 775 TSRLTEKSDVYSFGIVLLELLTGRK--AVDNECNLHHLILSKTAN--------------- 817
+ D++S G + E++T R D+E + I
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 818 --------NAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
V P + + L + + P R +
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSL--LSQ-------MLHYDPNKRISAKAA 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 5e-35
Identities = 59/291 (20%), Positives = 107/291 (36%), Gaps = 30/291 (10%)
Query: 599 NLSEKY----IIGYGASSTVYKCV-LKNCKPVAIKRL-YSHYPQCLKEFETELETVGSIK 652
++ +Y IG GA V N VAIK++ + + E++ + +
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 64
Query: 653 HRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAY 712
H N++ + + + + ++ + L+ K + L D +GL Y
Sbjct: 65 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKY 124
Query: 713 LHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY--TSTYIMGTIGYIDP 770
+H S ++HRD+K SN+LL+ + + DFG+A+ + T + T Y P
Sbjct: 125 IH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181
Query: 771 EYARTSRL-TEKSDVYSFGIVLLELLTGRKAVDNECNLHHL------------------I 811
E S+ T+ D++S G +L E+L+ R + L L I
Sbjct: 182 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241
Query: 812 LSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
K N + ++ A K L P R + +
Sbjct: 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 1e-34
Identities = 56/278 (20%), Positives = 104/278 (37%), Gaps = 42/278 (15%)
Query: 600 LSEKY----IIGYGASSTVYKCV-LKNCKPVAIKRLYSHY------PQCLKEFETELETV 648
L +Y ++G G +VY + + + PVAIK + E+ +
Sbjct: 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 649 GSIK--HRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGA 706
+ ++ L + +L + E T++ L +
Sbjct: 62 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQV 119
Query: 707 AQGLAYLHHDCSPRIIHRDVKSSNILLDKD-FEAHLTDFGIAKSLCVSKSYTSTYIMGTI 765
+ + + + ++HRD+K NIL+D + E L DFG L K T GT
Sbjct: 120 LEAVRHC---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTR 173
Query: 766 GYIDPEYARTSRL-TEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETV 824
Y PE+ R R + V+S GI+L +++ G +++ + +
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV----------FF 223
Query: 825 DPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
+S+ C+ L ++ C +P+DRPT E+
Sbjct: 224 RQRVSSECQHL--IRW-------CLALRPSDRPTFEEI 252
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (326), Expect = 7e-34
Identities = 54/294 (18%), Positives = 101/294 (34%), Gaps = 48/294 (16%)
Query: 602 EKY----IIGYGASSTVYKCVLK-NCKPVAIKRLY--SHYPQCLKEFETELETVGSIKHR 654
+KY IG G TV+K + + VA+KR+ E+ + +KH+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 655 NLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLH 714
N+V L S L ++F + LD + Q L L
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS---CNGDLDPEIVKSFL---FQLLKGLG 115
Query: 715 HDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYAR 774
S ++HRD+K N+L++++ E L +FG+A++ + S ++
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 775 TSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLI----------------------- 811
+ D++S G + EL + + ++ +
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235
Query: 812 ---LSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
+ V P+++AT +DL ++ K P R + E
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDL--LQN-------LLKCNPVQRISAEEA 280
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 131 bits (329), Expect = 9e-34
Identities = 43/262 (16%), Positives = 97/262 (37%), Gaps = 22/262 (8%)
Query: 605 IIGYGASSTVYKCV-LKNCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQ 660
+G G+ V ++ A+K L + ++ E + ++ LV L+
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 661 GYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPR 720
+S + +++ G ++ L + + A YLH S
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLH---SLD 161
Query: 721 IIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTE 780
+I+RD+K N+L+D+ +TDFG AK + + + GT + PE + +
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWTLCGTPEALAPEIILSKGYNK 217
Query: 781 KSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGAVKK 840
D ++ G+++ E+ G + + + ++ ++L
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNL----- 272
Query: 841 VFQLALLCSKRQPTDRPTMHEV 862
L + +KR + ++++
Sbjct: 273 ---LQVDLTKRFGNLKNGVNDI 291
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 9e-33
Identities = 55/291 (18%), Positives = 102/291 (35%), Gaps = 40/291 (13%)
Query: 606 IGYGASSTVYKCV-LKNCKPVAIKRLY--SHYPQCLKEFETELETVGSIKHRNLVSLQG- 661
IG G V+K K + VA+K++ + E++ + +KH N+V+L
Sbjct: 18 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77
Query: 662 -------YSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLH 714
Y+ L +DF E+ + + K ++ L L+
Sbjct: 78 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVM---QMLLNGLY 131
Query: 715 HDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTY---IMGTIGYIDPE 771
+ +I+HRD+K++N+L+ +D L DFG+A++ ++K+ + T+ Y PE
Sbjct: 132 YIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191
Query: 772 YARTSRL-TEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEIS- 829
R D++ G ++ E+ T + H L L ++ V P +
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDN 251
Query: 830 ------------------ATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEV 862
K L P R +
Sbjct: 252 YELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 6e-32
Identities = 63/301 (20%), Positives = 114/301 (37%), Gaps = 22/301 (7%)
Query: 590 YEDIMRMTENLSEKY----IIGYGASSTVYKCV-LKNCKPVAIKRLYSHY--PQCLKEFE 642
+++ + + Y +G GA V V + VAIK+LY + K
Sbjct: 6 RQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY 65
Query: 643 TELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHG-PTKKKKLDWDTRLK 701
EL + ++H N++ L F DF G K +KL D
Sbjct: 66 RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQF 125
Query: 702 IALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYI 761
+ +GL Y+H + IIHRD+K N+ +++D E + DFG+A+ S + Y+
Sbjct: 126 LVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEMTGYV 179
Query: 762 MGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRK--AVDNECNLHHLILSKTANNA 819
+ R T+ D++S G ++ E++TG+ + + I+
Sbjct: 180 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK------ 233
Query: 820 VMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAPEPQKQP 879
V T E + A + L L K + ++ L + + +++
Sbjct: 234 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV 293
Query: 880 T 880
T
Sbjct: 294 T 294
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 6e-32
Identities = 63/268 (23%), Positives = 107/268 (39%), Gaps = 30/268 (11%)
Query: 605 IIGYGASSTVYKCVLKNCKP----VAIKRL----YSHYPQCLKEFETELETVGSIKHR-N 655
++G GA V+ + A+K L + + TE + + I+
Sbjct: 31 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 90
Query: 656 LVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHH 715
LV+L + + L D++ G L+ L + + + + + + L H
Sbjct: 91 LVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQ------IYVGEIVLALEH 144
Query: 716 DCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYART 775
II+RD+K NILLD + LTDFG++K ++ + GTI Y+ P+ R
Sbjct: 145 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG 204
Query: 776 SR--LTEKSDVYSFGIVLLELLTGRK--AVDNECNLHHLILSKTANNAVMETVDPEISAT 831
+ D +S G+++ ELLTG VD E N I + + E+SA
Sbjct: 205 GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS--EPPYPQEMSAL 262
Query: 832 CKDLGAVKKVFQLALLCSKRQPTDRPTM 859
KDL +++ + P R
Sbjct: 263 AKDL--IQR-------LLMKDPKKRLGC 281
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 123 bits (310), Expect = 6e-31
Identities = 77/392 (19%), Positives = 143/392 (36%), Gaps = 32/392 (8%)
Query: 70 VIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELY 129
+ L N+ +S DL + ++ + D + ++L ++ S N+L
Sbjct: 24 KMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLT 79
Query: 130 GDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSG 189
P L +L +++ NNQ+ P + L
Sbjct: 80 DITPL--KNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL--- 134
Query: 190 LWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTG 249
++ +N+++ + + L +
Sbjct: 135 -NRLELSSNTISDISALSGLTSLQQLSFGNQVTD-----LKPLANLTTLERLDISSNKVS 188
Query: 250 KIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKL 309
I + L L + N +S P L+ ++L L+ N+L L ++T L
Sbjct: 189 DISVLAKLTNL-ESLIATNNQISDITPLG--ILTNLDELSLNGNQLKD--IGTLASLTNL 243
Query: 310 HYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNG 369
L+L +NQ++ P L LT L +L + N + P L+ T L +L ++ N
Sbjct: 244 TDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNEN--QL 297
Query: 370 TIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHL 429
L+++TYL L NNI P +S + L L +NNK+S S L +L ++
Sbjct: 298 EDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNI 353
Query: 430 LKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHN 461
L+ NQ++ P NL + ++ L+
Sbjct: 354 NWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 120 bits (302), Expect = 5e-30
Identities = 81/396 (20%), Positives = 135/396 (34%), Gaps = 32/396 (8%)
Query: 90 DLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKN 149
L + L ++ + D + +L + I + L L + N
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSN 75
Query: 150 NQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIG 209
NQL P L L L + N +
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQ--------ITDI 125
Query: 210 NCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCN 269
+ S I + +L + + L LD+S N
Sbjct: 126 DPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSN 185
Query: 270 MLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGK 329
+L L+ E L +N+++ P +T L L LN NQL L
Sbjct: 186 K--VSDISVLAKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKD--IGTLAS 239
Query: 330 LTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLN 389
LT+L DL++ANN + P LS T L L + N+++ P L ++T L L+ N
Sbjct: 240 LTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNEN 295
Query: 390 NIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGN 449
+ P+ + NL L + N IS P + L L +L + N+++ N
Sbjct: 296 QLEDISPIS--NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLAN 349
Query: 450 LRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYN 485
L ++ + HN ++ + P L+ L + L L+
Sbjct: 350 LTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 99.7 bits (247), Expect = 7e-23
Identities = 75/420 (17%), Positives = 147/420 (35%), Gaps = 80/420 (19%)
Query: 122 DLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLS 181
D N+++ D + L + +L + + + + L + +
Sbjct: 9 DTPINQIFTD-----TALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGI----- 56
Query: 182 PDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPF-NIGFLQIATL 240
S+ G + + ++ S NQL+ P N+ L +
Sbjct: 57 ----------------KSIDG-----VEYLNNLTQINFSNNQLTDITPLKNLTKLVDILM 95
Query: 241 SLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIP-------------PILGNLSYTEK 287
+ + ++ L + ++ + LS
Sbjct: 96 NNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTS 155
Query: 288 LYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPI 347
L S L N+T L L+++ N+++ KLT+L L NN +
Sbjct: 156 LQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL--AKLTNLESLIATNNQISDIT 213
Query: 348 PDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDT 407
P + TNL+ L+++GN+L L ++T L+L+ N I P LS + L
Sbjct: 214 PLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTE 267
Query: 408 LDMSNNKISGSIP--------------------SPLGDLEHLLKLNLSRNQLTGFIPGEF 447
L + N+IS P SP+ +L++L L L N ++ P
Sbjct: 268 LKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--V 325
Query: 448 GNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDVMSLINCLSLSVLFIGN 507
+L + + ++N ++ L+ L N+ L +N +S + L N ++ L + +
Sbjct: 326 SSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISD-LTPLANLTRITQLGLND 382
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 73.9 bits (180), Expect = 2e-14
Identities = 42/204 (20%), Positives = 73/204 (35%), Gaps = 14/204 (6%)
Query: 45 YDWTDSPSSDYCVWRGITCDNVTFTVIALNLSGLNLDG---EISPAVGDLKDLQSIDLRG 101
+ + + ++T I NL L+L+G + + L +L +DL
Sbjct: 191 SVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLAN 250
Query: 102 NRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLS 161
N++S P + + L L L N++ P + N+ S +S
Sbjct: 251 NQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLE----LNENQLEDISPIS 304
Query: 162 QLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSY 221
L NL L NN+ + L+ L NN ++ ++ N T+ L +
Sbjct: 305 NLKNLTYLTLYFNNISD--ISPVSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGH 360
Query: 222 NQLSGEIPFNIGFLQIATLSLQGN 245
NQ+S P +I L L
Sbjct: 361 NQISDLTPLA-NLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 1e-04
Identities = 43/265 (16%), Positives = 86/265 (32%), Gaps = 40/265 (15%)
Query: 281 NLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVAN 340
L+ K L +T + ++ ++ L+ + + + L +L +N +N
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSN 75
Query: 341 NHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPV--- 397
N L P L + T L + ++ N++ P A + L + P+
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133
Query: 398 ---------ELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNL-SRNQLTGFIPGEF 447
+S I L L G+ + L L +L L +
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193
Query: 448 GNLRSVMEIDLSHNHLTGVIP--------------------EELSQLQNMFSLRLDYNNL 487
L ++ + ++N ++ + P L+ L N+ L L N +
Sbjct: 194 AKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQI 253
Query: 488 SGDVMSLINCLSLSVLFIGNPGLCG 512
S + L L+ L +G +
Sbjct: 254 SN-LAPLSGLTKLTELKLGANQISN 277
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 116 bits (291), Expect = 4e-29
Identities = 82/307 (26%), Positives = 123/307 (40%), Gaps = 31/307 (10%)
Query: 23 DSEDGATLLKIKKSFRDVDNVLYDWTDSPSSDYCVWRGITCDNVTFT--VIALNLSGLNL 80
+ +D LL+IKK + L W + W G+ CD T T V L+LSGLNL
Sbjct: 4 NPQDKQALLQIKKDLGN-PTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNL 62
Query: 81 DG--EISPAVGDLKDLQSIDLRGN-RLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSIS 137
I ++ +L L + + G L G IP I + L L ++ + G IP +S
Sbjct: 63 PKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLS 122
Query: 138 KLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWY-FDVR 196
++K L L N L G +P ++S LPNL GN + G + S L+ +
Sbjct: 123 QIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTIS 182
Query: 197 NNSLTGSIPQNIGNCTSFQVLDLSYNQ-----------------------LSGEIPFNIG 233
N LTG IP N V L+ ++
Sbjct: 183 RNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGL 242
Query: 234 FLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSN 293
+ L L+ N++ G +P + ++ L L++S N L G IP GNL + +N
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANN 301
Query: 294 KLTGHIP 300
K P
Sbjct: 302 KCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 97.5 bits (241), Expect = 1e-22
Identities = 77/263 (29%), Positives = 122/263 (46%), Gaps = 6/263 (2%)
Query: 261 LAVLDLSCNMLSG--PIPPILGNLSYTEKLYLHSN-KLTGHIPPELGNMTKLHYLELNDN 317
+ LDLS L PIP L NL Y LY+ L G IPP + +T+LHYL +
Sbjct: 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHT 111
Query: 318 QLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQR 377
++G IP L ++ L L+ + N L G +P ++SS NL + GN+++G IP ++
Sbjct: 112 NVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS 171
Query: 378 LESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRN 437
+ N NL +D+S N + G G ++ +
Sbjct: 172 FSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNT-QKIHLAK 230
Query: 438 QLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDVMSLINC 497
F G+ G +++ +DL +N + G +P+ L+QL+ + SL + +NNL G++ N
Sbjct: 231 NSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNL 290
Query: 498 LSLSVL-FIGNPGLCGYWLHSAC 519
V + N LCG L AC
Sbjct: 291 QRFDVSAYANNKCLCGSPL-PAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 47.4 bits (111), Expect = 4e-06
Identities = 36/141 (25%), Positives = 70/141 (49%), Gaps = 3/141 (2%)
Query: 349 DNLSSCTNLNSLNVHGNKLNG--TIPPAFQRLESMTYLNLSLN-NIRGPIPVELSRIGNL 405
D + +N+L++ G L IP + L + +L + N+ GPIP ++++ L
Sbjct: 44 DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103
Query: 406 DTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTG 465
L +++ +SG+IP L ++ L+ L+ S N L+G +P +L +++ I N ++G
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163
Query: 466 VIPEELSQLQNMFSLRLDYNN 486
IP+ +F+ N
Sbjct: 164 AIPDSYGSFSKLFTSMTISRN 184
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 1e-26
Identities = 65/305 (21%), Positives = 116/305 (38%), Gaps = 30/305 (9%)
Query: 590 YEDIMRMTENLSEKY----IIGYGASSTVYKCV-LKNCKPVAIKRLYSHY--PQCLKEFE 642
+++ + + E+Y +G GA +V K VA+K+L + K
Sbjct: 6 RQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 65
Query: 643 TELETVGSIKHRNLVSLQGY-----SLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWD 697
EL + +KH N++ L SL ++ + L +I K +KL D
Sbjct: 66 RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI----VKCQKLTDD 121
Query: 698 TRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYT 757
+ +GL Y+H S IIHRD+K SN+ +++D E + DFG+A +
Sbjct: 122 HVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEM 175
Query: 758 STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRK--AVDNECNLHHLILSKT 815
+ Y+ + D++S G ++ ELLTGR + + LIL
Sbjct: 176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR-- 233
Query: 816 ANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAPEP 875
++ T E+ A + L + + ++ L + +
Sbjct: 234 ----LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDS 289
Query: 876 QKQPT 880
K+ T
Sbjct: 290 DKRIT 294
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (274), Expect = 2e-26
Identities = 62/303 (20%), Positives = 114/303 (37%), Gaps = 19/303 (6%)
Query: 592 DIMRMTENLSEKY----IIGYGASSTVYKCV-LKNCKPVAIKRLYSHY--PQCLKEFETE 644
++ T + ++Y IG GA V + VAIK+L + K E
Sbjct: 7 EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRE 66
Query: 645 LETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIAL 704
L + + H+N++SL F D L D + +LD + +
Sbjct: 67 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLY 126
Query: 705 GAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGT 764
G+ +LH IIHRD+K SNI++ D + DFG+A++ S+ T + T
Sbjct: 127 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVT 181
Query: 765 IGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAV--DNECNLHHLILSK--TANNAV 820
Y PE E D++S G ++ E++ + + + + ++ + T
Sbjct: 182 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241
Query: 821 METVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVP---APEPQK 877
M+ + P + ++ + L P D + L+ +P K
Sbjct: 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 301
Query: 878 QPT 880
+ +
Sbjct: 302 RIS 304
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 108 bits (270), Expect = 3e-26
Identities = 36/200 (18%), Positives = 80/200 (40%), Gaps = 20/200 (10%)
Query: 605 IIGYGASSTVYKCV-LKNCKPVAIKRLYSHYPQCLKEFETELETVGSIK-HRNLVSLQGY 662
+G G S V++ + + N + V +K L P K+ + E++ + +++ N+++L
Sbjct: 42 KLGRGKYSEVFEAINITNNEKVVVKILK---PVKKKKIKREIKILENLRGGPNIITLADI 98
Query: 663 SLSSSGNLLF--YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPR 720
++ + N + + L + L Y H
Sbjct: 99 VKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG--- 149
Query: 721 IIHRDVKSSNILLD-KDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRL- 778
I+HRDVK N+++D + + L D+G+A+ + + + PE ++
Sbjct: 150 IMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVRVASRYFKGPELLVDYQMY 207
Query: 779 TEKSDVYSFGIVLLELLTGR 798
D++S G +L ++ +
Sbjct: 208 DYSLDMWSLGCMLASMIFRK 227
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 107 bits (266), Expect = 6e-26
Identities = 55/316 (17%), Positives = 115/316 (36%), Gaps = 26/316 (8%)
Query: 51 PSSDYCVWRGITCDNVTFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPD 110
P C R + C ++ + +L D +DL+ N+++
Sbjct: 5 PFRCQCHLRVVQCSDLGLEKVPKDLP---------------PDTALLDLQNNKITEIKDG 49
Query: 111 EIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFG 170
+ + +L +L L N++ P + + L +LE L L NQL +P + +
Sbjct: 50 DFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE-LPEKMPKTLQELRVH 108
Query: 171 LRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPF 230
V + + +G + ++ ++ IP
Sbjct: 109 ENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ 167
Query: 231 NIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYL 290
+ + L L GN++T + + + LA L LS N +S L N + +L+L
Sbjct: 168 GL-PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHL 226
Query: 291 HSNKLTGHIPPELGNMTKLHYLELNDNQLTG------HIPPALGKLTDLFDLNVANNHLE 344
++NKL +P L + + + L++N ++ P K +++ +N ++
Sbjct: 227 NNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
Query: 345 -GPIPDNLSSCTNLNS 359
I + C + +
Sbjct: 286 YWEIQPSTFRCVYVRA 301
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 104 bits (259), Expect = 5e-25
Identities = 60/282 (21%), Positives = 108/282 (38%), Gaps = 13/282 (4%)
Query: 213 SFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLS 272
+V+ S L ++P ++ A L LQ N++T ++ L L L N +S
Sbjct: 11 HLRVVQCSDLGLE-KVPKDL-PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 68
Query: 273 GPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTD 332
P L E+LYL N+L + +L E ++ + L
Sbjct: 69 KISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGL-NQMI 127
Query: 333 LFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIR 392
+ +L G L+ + + + TIP S+T L+L N I
Sbjct: 128 VVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT 184
Query: 393 GPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRS 452
L + NL L +S N IS L + HL +L+L+ N+L +PG + +
Sbjct: 185 KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKY 243
Query: 453 VMEIDLSHNHLTGV------IPEELSQLQNMFSLRLDYNNLS 488
+ + L +N+++ + P ++ + + L N +
Sbjct: 244 IQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 103 bits (257), Expect = 8e-25
Identities = 62/310 (20%), Positives = 118/310 (38%), Gaps = 18/310 (5%)
Query: 182 PDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFL-QIATL 240
P CQ + L +P+++ +LDL N+++ + L + TL
Sbjct: 5 PFRCQCHLR-VVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTL 60
Query: 241 SLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIP 300
L N+++ P + L L LS N L + L K+ +
Sbjct: 61 ILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVF 120
Query: 301 PELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSL 360
L M + L N + +G A + L + +A+ ++ IP L +L L
Sbjct: 121 NGLNQMIVV-ELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTEL 176
Query: 361 NVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIP 420
++ GNK+ + + L ++ L LS N+I L+ +L L ++NNK+ +P
Sbjct: 177 HLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVP 235
Query: 421 SPLGDLEHLLKLNLSRNQLTGFIPGEF------GNLRSVMEIDLSHNHLT--GVIPEELS 472
L D +++ + L N ++ +F S + L N + + P
Sbjct: 236 GGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFR 295
Query: 473 QLQNMFSLRL 482
+ +++L
Sbjct: 296 CVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 92.0 bits (227), Expect = 8e-21
Identities = 51/235 (21%), Positives = 94/235 (40%), Gaps = 10/235 (4%)
Query: 275 IPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLF 334
+P L T L L +NK+T + N+ LH L L +N+++ P A L L
Sbjct: 25 VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82
Query: 335 DLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIR-- 392
L ++ N L+ + L N++ F L M + L N ++
Sbjct: 83 RLYLSKNQLKELPEKMPKTLQELRVHE---NEITKVRKSVFNGLNQMIVVELGTNPLKSS 139
Query: 393 GPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRS 452
G + L + +++ I+ P G L +L+L N++T L +
Sbjct: 140 GIENGAFQGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLKGLNN 196
Query: 453 VMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDVMSLINCLSLSVLFIGN 507
+ ++ LS N ++ V L+ ++ L L+ N L L + + V+++ N
Sbjct: 197 LAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHN 251
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 85.1 bits (209), Expect = 2e-18
Identities = 43/227 (18%), Positives = 83/227 (36%), Gaps = 8/227 (3%)
Query: 273 GPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTD 332
GP+ P + L +P +L L+L +N++T L +
Sbjct: 1 GPVCPFRCQCHLRV-VQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKN 56
Query: 333 LFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIR 392
L L + NN + P + L L + N+L + L+ + + +R
Sbjct: 57 LHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVR 116
Query: 393 GPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRS 452
+ L+++ ++ L + K SG ++ L + ++ +T G +L
Sbjct: 117 KSVFNGLNQMIVVE-LGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLT- 174
Query: 453 VMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDVMSLINCLS 499
E+ L N +T V L L N+ L L +N++S +
Sbjct: 175 --ELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTP 219
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 79.3 bits (194), Expect = 1e-16
Identities = 44/216 (20%), Positives = 86/216 (39%), Gaps = 8/216 (3%)
Query: 309 LHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLN 368
L ++ +D L +P L D L++ NN + + + NL++L + NK++
Sbjct: 12 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 68
Query: 369 GTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEH 428
P AF L + L LS N ++ + L + K+ S+ + L
Sbjct: 69 KISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLN-QMI 127
Query: 429 LLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLS 488
+++L + + +G G F ++ + I ++ ++T + L L LD N ++
Sbjct: 128 VVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLT---ELHLDGNKIT 184
Query: 489 G-DVMSLINCLSLSVLFIGNPGLCGYWLHSACRDSH 523
D SL +L+ L + + S H
Sbjct: 185 KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPH 220
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 57.7 bits (138), Expect = 2e-09
Identities = 36/157 (22%), Positives = 52/157 (33%), Gaps = 7/157 (4%)
Query: 352 SSCT-NLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDM 410
C +L + L +P L+L N I + + NL TL +
Sbjct: 6 FRCQCHLRVVQCSDLGLE-KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLIL 62
Query: 411 SNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEE 470
NNKIS P L L +L LS+NQL L+ + N +T V
Sbjct: 63 INNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRV---HENEITKVRKSV 119
Query: 471 LSQLQNMFSLRLDYNNLSGDVMSLINCLSLSVLFIGN 507
+ L M + L N L + + L
Sbjct: 120 FNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIR 156
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 102 bits (254), Expect = 6e-24
Identities = 43/209 (20%), Positives = 77/209 (36%), Gaps = 19/209 (9%)
Query: 606 IGYGASSTVYKCV-LKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSL 664
+G+G STV+ + N VA+K + + E E++ + + +
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79
Query: 665 S-------------SSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLA 711
+ +G + F G L + + + +I+ GL
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139
Query: 712 YLHHDCSPRIIHRDVKSSNILLDK-DFEAHLTDFGIAK-SLCVSKSYTSTYIMGTIGYID 769
Y+H C IIH D+K N+L++ D +L IA T + T Y
Sbjct: 140 YMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197
Query: 770 PEYARTSRLTEKSDVYSFGIVLLELLTGR 798
PE + +D++S ++ EL+TG
Sbjct: 198 PEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.9 bits (247), Expect = 1e-23
Identities = 54/283 (19%), Positives = 92/283 (32%), Gaps = 9/283 (3%)
Query: 185 CQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQG 244
C L ++P I + Q + L N++S + + T+
Sbjct: 8 CYNEPKVTTSCPQQGLQ-AVPVGIPAAS--QRIFLHGNRISHVPAASFRACRNLTILWLH 64
Query: 245 NQLTGKIPSVIGLMQALAVLDLSCNM--LSGPIPPILGNLSYTEKLYLHSNKLTGHIPPE 302
+ + +I + AL + L P L L+L L P
Sbjct: 65 SNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGL 124
Query: 303 LGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNV 362
+ L YL L DN L L +L L + N + +L+ L +
Sbjct: 125 FRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLL 184
Query: 363 HGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSP 422
H N++ P AF+ L + L L NN+ L+ + L L +++N +
Sbjct: 185 HQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA- 243
Query: 423 LGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTG 465
L K S +++ +P L+ N L G
Sbjct: 244 RPLWAWLQKFRGSSSEVPCSLPQRLAGRDL---KRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.3 bits (191), Expect = 2e-16
Identities = 61/286 (21%), Positives = 92/286 (32%), Gaps = 11/286 (3%)
Query: 62 TCDNVTFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSL 121
C N + L + + Q I L GNR+S C +L L
Sbjct: 7 VCYNEPKVTT--SCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTIL 61
Query: 122 DLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPI-PSTLSQLPNLKVFGLRGNNLVGTL 180
L N L + + L LE L L +N + + P+T L L L L
Sbjct: 62 WLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELG 121
Query: 181 SPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATL 240
L+ L Y +++N+L + + L L N++S L
Sbjct: 122 PGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDR 181
Query: 241 -SLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHI 299
L N++ P + L L L N LS L L + L L+ N
Sbjct: 182 LLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC 241
Query: 300 PPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEG 345
L + +++ +P L DL L N L+G
Sbjct: 242 RA-RPLWAWLQKFRGSSSEVPCSLPQRLAGR-DLKRLAA--NDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.8 bits (182), Expect = 3e-15
Identities = 52/217 (23%), Positives = 95/217 (43%), Gaps = 3/217 (1%)
Query: 275 IPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLF 334
+P + + +++++LH N+++ L L L+ N L A L L
Sbjct: 26 VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 335 DLNVANNHLEGPI-PDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRG 393
L++++N + P L++L++ L P F+ L ++ YL L N ++
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143
Query: 394 PIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSV 453
+GNL L + N+IS L L +L L +N++ P F +L +
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203
Query: 454 MEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGD 490
M + L N+L+ + E L+ L+ + LRL+ N D
Sbjct: 204 MTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD 240
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.4 bits (147), Expect = 9e-11
Identities = 41/221 (18%), Positives = 70/221 (31%), Gaps = 4/221 (1%)
Query: 312 LELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTI 371
L +P + + L+ N + + +C NL L +H N L
Sbjct: 16 TSCPQQGLQ-AVPVGIPAASQRIFLH--GNRISHVPAASFRACRNLTILWLHSNVLARID 72
Query: 372 PPAFQRLESMTYLNLSLNNIRGPI-PVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLL 430
AF L + L+LS N + P +G L TL + + P L L
Sbjct: 73 AAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQ 132
Query: 431 KLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGD 490
L L N L F +L ++ + L N ++ V L ++ L L N ++
Sbjct: 133 YLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192
Query: 491 VMSLINCLSLSVLFIGNPGLCGYWLHSACRDSHPTERVTIS 531
L + A + + ++
Sbjct: 193 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLN 233
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 84.8 bits (209), Expect = 2e-19
Identities = 29/199 (14%), Positives = 64/199 (32%), Gaps = 24/199 (12%)
Query: 605 IIGYGASSTVYKCVLKNCKPVAIKRL----------YSHYPQCLKEFETELETVGSIKHR 654
++G G S V+ C + +K F + R
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 655 NLVSLQGYSLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLH 714
L LQG Y + N ++ L + ++ + ++ + +A +
Sbjct: 67 ALQKLQGL-----AVPKVYAWEGN-AVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120
Query: 715 HDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYAR 774
H I+H D+ N+L+ + + DF + + + + + I ++R
Sbjct: 121 HRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEV--GEEGWREILERDVRNIITYFSR 174
Query: 775 TSRLTEKSDVYSFGIVLLE 793
+ D+ S +L+
Sbjct: 175 --TYRTEKDINSAIDRILQ 191
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.6 bits (153), Expect = 1e-11
Identities = 47/198 (23%), Positives = 72/198 (36%), Gaps = 7/198 (3%)
Query: 264 LDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHI 323
++ L+ +PP L T L+L N L L T+L L L+ +LT
Sbjct: 15 VNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQ 71
Query: 324 PPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTY 383
+ DL+ + L L+V N+L A + L +
Sbjct: 72 VDGTLPVLGTLDLSHNQLQSLPLLGQT---LPALTVLDVSFNRLTSLPLGALRGLGELQE 128
Query: 384 LNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFI 443
L L N ++ P L+ L+ L ++NN ++ L LE+L L L N L I
Sbjct: 129 LYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TI 187
Query: 444 PGEFGNLRSVMEIDLSHN 461
P F + L N
Sbjct: 188 PKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.2 bits (152), Expect = 2e-11
Identities = 40/207 (19%), Positives = 72/207 (34%), Gaps = 8/207 (3%)
Query: 208 IGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLS 267
+ S ++ L+ +P ++ L L N L + + L L+L
Sbjct: 6 VSKVASHLEVNCDKRNLT-ALPPDLP-KDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 268 -CNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPA 326
+ + L L + + +P + L L+++ N+LT A
Sbjct: 64 RAELTKLQVDGTLPVLGTLDLSHNQLQ----SLPLLGQTLPALTVLDVSFNRLTSLPLGA 119
Query: 327 LGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNL 386
L L +L +L + N L+ P L+ L L++ N L LE++ L L
Sbjct: 120 LRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLL 179
Query: 387 SLNNIRGPIPVELSRIGNLDTLDMSNN 413
N++ IP L + N
Sbjct: 180 QENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.7 bits (148), Expect = 6e-11
Identities = 49/211 (23%), Positives = 83/211 (39%), Gaps = 7/211 (3%)
Query: 280 GNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVA 339
++ ++ LT +PP+L T L L++N L L T L LN+
Sbjct: 7 SKVASHLEVNCDKRNLT-ALPPDLPKDTT--ILHLSENLLYTFSLATLMPYTRLTQLNL- 62
Query: 340 NNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVEL 399
+ E + L +L++ N+ ++P Q L ++T L++S N + L
Sbjct: 63 -DRAELTKLQVDGTLPVLGTLDLSHNQ-LQSLPLLGQTLPALTVLDVSFNRLTSLPLGAL 120
Query: 400 SRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLS 459
+G L L + N++ P L L KL+L+ N LT G L ++ + L
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ 180
Query: 460 HNHLTGVIPEELSQLQNMFSLRLDYNNLSGD 490
N L IP+ + L N +
Sbjct: 181 ENSLY-TIPKGFFGSHLLPFAFLHGNPWLCN 210
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.1 bits (144), Expect = 2e-10
Identities = 43/201 (21%), Positives = 69/201 (34%), Gaps = 7/201 (3%)
Query: 239 TLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGH 298
++ LT +P + + +L LS N+L L + +L L +LT
Sbjct: 14 EVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL 70
Query: 299 IPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLN 358
+ + +P L L L+V+ N L L L
Sbjct: 71 QVD---GTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQ 127
Query: 359 SLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGS 418
L + GN+L P + L+L+ NN+ L+ + NLDTL + N + +
Sbjct: 128 ELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-T 186
Query: 419 IPSPLGDLEHLLKLNLSRNQL 439
IP L L N
Sbjct: 187 IPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.0 bits (136), Expect = 2e-09
Identities = 44/179 (24%), Positives = 62/179 (34%), Gaps = 3/179 (1%)
Query: 190 LWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTG 249
+ N L + T L+L + G L + +
Sbjct: 33 TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE--LTKLQVDGTLPVLGTLDLSHNQLQ 90
Query: 250 KIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKL 309
+P + + AL VLD+S N L+ L L ++LYL N+L P L KL
Sbjct: 91 SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKL 150
Query: 310 HYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLN 368
L L +N LT L L +L L + N L IP L +HGN
Sbjct: 151 EKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.4 bits (124), Expect = 8e-08
Identities = 51/314 (16%), Positives = 84/314 (26%), Gaps = 58/314 (18%)
Query: 62 TCDNVTFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSL 121
V + + +N NL + P + KD + L N L + + L L
Sbjct: 5 EVSKVA-SHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQL 60
Query: 122 DLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLS 181
+L EL
Sbjct: 61 NLDRAELTKL-------------------------------------------------- 70
Query: 182 PDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLS 241
L L D+ +N L + S + G ++ L
Sbjct: 71 QVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELY 130
Query: 242 LQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPP 301
L+GN+L P ++ L L L+ N L+ +L L + L L N L IP
Sbjct: 131 LKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPK 189
Query: 302 ELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLN 361
L + L+ N + N N ++ D + +N+ S+
Sbjct: 190 GFFGSHLLPFAFLHGNPW--LCNCEILYFRRWLQDNAENVYVWKQGVDVKAMTSNVASVQ 247
Query: 362 VHG-NKLNGTIPPA 374
+K P
Sbjct: 248 CDNSDKFPVYKYPG 261
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.1 bits (105), Expect = 2e-05
Identities = 31/201 (15%), Positives = 61/201 (30%), Gaps = 11/201 (5%)
Query: 398 ELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEID 457
E+S++ + ++ ++ ++P L + L+LS N L F + +++
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 458 LSH-NHLTGVIPEELSQLQNMFSLRLDYNNLSGDVMSLINCLSLSVLFIGNPGLCGYWLH 516
L + L L + +L +L L V F L L
Sbjct: 62 LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121
Query: 517 SACRDSHPTERVTISKAAILGIALGALVILLMILVAACRPHNPTHFPDGSLDKPVNYSTP 576
+ K G+ + + +N T P G L+ N T
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLS----LANNNLTELPAGLLNGLENLDT- 176
Query: 577 KLVILHMNMALHVYEDIMRMT 597
++L N + +
Sbjct: 177 --LLLQENSLYTIPKGFFGSH 195
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.0 bits (97), Expect = 2e-04
Identities = 14/64 (21%), Positives = 27/64 (42%), Gaps = 3/64 (4%)
Query: 375 FQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNL 434
++ S +N N+ +P +L + + L +S N + + L L +LNL
Sbjct: 6 VSKVASHLEVNCDKRNLTA-LPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 435 SRNQ 438
R +
Sbjct: 63 DRAE 66
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.0 bits (149), Expect = 7e-11
Identities = 47/269 (17%), Positives = 88/269 (32%), Gaps = 19/269 (7%)
Query: 73 LNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLS-GQIPDEIGDCSSLKSLDLSFNELYGD 131
L+L+G NL ++ G L I R R Q E ++ +DLS + +
Sbjct: 5 LDLTGKNLHPDV---TGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVS 61
Query: 132 -IPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGL 190
+ +S+ +L+ L L+ +L PI +TL++ NL L G + + S
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 121
Query: 191 WYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIA----------TL 240
++ + +++ + ++ LSG
Sbjct: 122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 181
Query: 241 SLQGNQLTGKIPSVIGLMQALAVLDLS-CNMLSGPIPPILGNLSYTEKLYLHSNKLTGHI 299
L + L L LS C + LG + + L + G +
Sbjct: 182 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTL 241
Query: 300 PPELGNMTKLHYLELNDNQLTGHIPPALG 328
+ L++N + T P +G
Sbjct: 242 QLLKEALPH---LQINCSHFTTIARPTIG 267
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.6 bits (127), Expect = 3e-08
Identities = 38/278 (13%), Positives = 82/278 (29%), Gaps = 18/278 (6%)
Query: 119 KSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNL-V 177
++LDL+ L+ D+ + + + + P+ S ++ L + + V
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFS-PFRVQHMDLSNSVIEV 60
Query: 178 GTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQI 237
TL + Q S L + L+ I + ++ L+LS E
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120
Query: 238 ATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTG 297
+ L + + + ++ + + G Y + + +
Sbjct: 121 SRLD------ELNLSWCFDFTEKHVQVAVAHVSETITQLNLSG--------YRKNLQKSD 166
Query: 298 HIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVAN-NHLEGPIPDNLSSCTN 356
+H + L +L L L+++ + L
Sbjct: 167 LSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPT 226
Query: 357 LNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGP 394
L +L V G +GT+ + L + I P
Sbjct: 227 LKTLQVFGIVPDGTLQLLKEALPHLQINCSHFTTIARP 264
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.8 bits (99), Expect = 1e-04
Identities = 19/94 (20%), Positives = 40/94 (42%), Gaps = 3/94 (3%)
Query: 407 TLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGV 466
TLD++ + + L ++ R+ + + F R V +DLS++ +
Sbjct: 4 TLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVS 61
Query: 467 -IPEELSQLQNMFSLRLDYNNLSGDVMSLINCLS 499
+ LSQ + +L L+ LS +++ + S
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNS 95
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 59.8 bits (143), Expect = 6e-10
Identities = 54/323 (16%), Positives = 93/323 (28%), Gaps = 37/323 (11%)
Query: 185 CQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQG 244
C ++ N L+ S+P+ + S L S N L+ E+P L+ +
Sbjct: 35 CLDRQAHELELNNLGLS-SLPELPPHLES---LVASCNSLT-ELPELPQSLKSLLVD--- 86
Query: 245 NQLTGKIPSVIGLMQALAVLDLSCN----------MLSGPIPPILGNLSYTEKLYLHSNK 294
+ ++ L L L +S N I + N S +
Sbjct: 87 ---NNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLE 143
Query: 295 LTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSC 354
+L + +L L + L ++ + L +
Sbjct: 144 FIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNL 203
Query: 355 TNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDM---- 410
L ++ N L N + P + + +
Sbjct: 204 PFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELP 263
Query: 411 ----SNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGV 466
N S I S L +LN+S N+L +P L + S NHL
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLE---RLIASFNHLAE- 318
Query: 467 IPEELSQLQNMFSLRLDYNNLSG 489
+PE L+ L ++YN L
Sbjct: 319 VPELPQNLK---QLHVEYNPLRE 338
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 58.3 bits (139), Expect = 1e-09
Identities = 24/103 (23%), Positives = 45/103 (43%), Gaps = 12/103 (11%)
Query: 381 MTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLT 440
+ LN I +L+ L++SNNK+ +P+ LE +L S N L
Sbjct: 262 LPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHLA 317
Query: 441 GFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLD 483
+P NL+ ++ + +N L P+ +++ LR++
Sbjct: 318 E-VPELPQNLK---QLHVEYNPLRE-FPDIPESVED---LRMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 56.0 bits (133), Expect = 8e-09
Identities = 51/344 (14%), Positives = 94/344 (27%), Gaps = 37/344 (10%)
Query: 115 CSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGN 174
L+L+ L +P LE L+ N L ++LP L
Sbjct: 37 DRQAHELELNNLGL-SSLP---ELPPHLESLVASCNSL--------TELPEL-------- 76
Query: 175 NLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGF 234
+L + + L L N ++ + S+ ++ ++
Sbjct: 77 --PQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKK 134
Query: 235 LQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNK 294
L SL+ + +Q L L + LS + ++
Sbjct: 135 LPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNIL 194
Query: 295 LTGHIPP-----ELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPD 349
L D + + +
Sbjct: 195 EELPELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSEN 254
Query: 350 NLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLD 409
S + L + N + I S+ LN+S N + +P L+ L
Sbjct: 255 IFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPAL---PPRLERLI 310
Query: 410 MSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGF--IPGEFGNLR 451
S N ++ +P +L+ L++ N L F IP +LR
Sbjct: 311 ASFNHLA-EVPELPQNLKQ---LHVEYNPLREFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 54.1 bits (128), Expect = 4e-08
Identities = 28/109 (25%), Positives = 41/109 (37%), Gaps = 11/109 (10%)
Query: 184 MCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQ 243
LS L N+ + I S + L++S N+L E+P L+ L
Sbjct: 256 FSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE--RLIAS 312
Query: 244 GNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHS 292
N L V L Q L L + N L P I ++ E L ++S
Sbjct: 313 FNHLA----EVPELPQNLKQLHVEYNPLRE-FPDIPESV---EDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 52.9 bits (125), Expect = 8e-08
Identities = 24/124 (19%), Positives = 44/124 (35%), Gaps = 9/124 (7%)
Query: 45 YDWTDSPSSDYCVWRGITCDNVTFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRL 104
D + P S + + + EI L+ +++ N+L
Sbjct: 237 TDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKL 296
Query: 105 SGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLP 164
++P L+ L SFN L ++P LKQL ++ N L P +
Sbjct: 297 I-ELPALPP---RLERLIASFNHL-AEVPELPQNLKQLH---VEYNPLRE-FPDIPESVE 347
Query: 165 NLKV 168
+L++
Sbjct: 348 DLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 52.1 bits (123), Expect = 2e-07
Identities = 56/326 (17%), Positives = 92/326 (28%), Gaps = 26/326 (7%)
Query: 92 KDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQ 151
+ ++L LS +P+ L+SL S N L ++P LK L
Sbjct: 38 RQAHELELNNLGLS-SLPELPP---HLESLVASCNSL-TELPELPQSLKSLLVDNNNLKA 92
Query: 152 LIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSG-LWYFDVRNNSLTGSIPQNIGN 210
L P + + + + L SL N
Sbjct: 93 LSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQL 152
Query: 211 CTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVL------ 264
++ +L + ++ L LSL+ I + +Q L L
Sbjct: 153 EELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYAD 212
Query: 265 -----DLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQL 319
L S + N S +++L N
Sbjct: 213 NNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNAS 272
Query: 320 TGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLE 379
+ I L +LNV+NN L +P L L N L +P Q L+
Sbjct: 273 SNEIRSLCDLPPSLEELNVSNNKLIE-LPALPP---RLERLIASFNHLA-EVPELPQNLK 327
Query: 380 SMTYLNLSLNNIRGPIPVELSRIGNL 405
L++ N +R P + +L
Sbjct: 328 ---QLHVEYNPLRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 50.6 bits (119), Expect = 4e-07
Identities = 23/102 (22%), Positives = 40/102 (39%), Gaps = 14/102 (13%)
Query: 289 YLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIP 348
+ N + I L L +++N+L +P +L L + NHL +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL---IASFNHLAE-VP 320
Query: 349 DNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNN 390
+ NL L+V N L P + +E +L +N+
Sbjct: 321 ELPQ---NLKQLHVEYNPLR-EFPDIPESVE-----DLRMNS 353
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 56.6 bits (135), Expect = 2e-09
Identities = 35/216 (16%), Positives = 70/216 (32%), Gaps = 22/216 (10%)
Query: 281 NLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVAN 340
L+ K+ + +T + ++ + L +T + L +L L + +
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKD 72
Query: 341 NHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLS------------- 387
N + P + L+ + K I
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 388 -LNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGE 446
L I G + +S S +PL +L L L N+++ P
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190
Query: 447 FGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRL 482
+L +++E+ L +N ++ V P L+ N+F + L
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 56.6 bits (135), Expect = 2e-09
Identities = 40/211 (18%), Positives = 71/211 (33%), Gaps = 22/211 (10%)
Query: 264 LDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHI 323
+ + ++ + +L L +T + + L LEL DNQ+T
Sbjct: 24 IAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKDNQITDLA 79
Query: 324 PPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRL----- 378
P +L+ I S T + + Q L
Sbjct: 80 PLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLN 139
Query: 379 ---------ESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHL 429
LS+ N + L+ + L TL +NKIS SPL L +L
Sbjct: 140 QITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD--ISPLASLPNL 197
Query: 430 LKLNLSRNQLTGFIPGEFGNLRSVMEIDLSH 460
++++L NQ++ P N ++ + L++
Sbjct: 198 IEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 53.5 bits (127), Expect = 2e-08
Identities = 41/229 (17%), Positives = 79/229 (34%), Gaps = 17/229 (7%)
Query: 134 FSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYF 193
F L + + + + T + L + G + T + L+ L
Sbjct: 13 FPDPALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGV--TTIEGVQYLNNLIGL 68
Query: 194 DVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPS 253
++++N +T + N T L+LS N L +
Sbjct: 69 ELKDNQIT--DLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLA 126
Query: 254 VIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLE 313
+ +Q L + I I T YL L N++KL L+
Sbjct: 127 GLSNLQVL-------YLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLK 179
Query: 314 LNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNV 362
+DN+++ P L L +L ++++ NN + P L++ +NL + +
Sbjct: 180 ADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 48.9 bits (115), Expect = 7e-07
Identities = 29/212 (13%), Positives = 64/212 (30%), Gaps = 21/212 (9%)
Query: 70 VIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELY 129
I + N+ ++ A DL + ++ G ++ + + ++L L+L N++
Sbjct: 21 AIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQIT 76
Query: 130 GDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSG 189
P L + + I S + ++ L
Sbjct: 77 DLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYL 136
Query: 190 LWYFDVRNNSLTG--------------SIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFL 235
+ L G S + N + L N++S P
Sbjct: 137 DLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISPLA-SLP 195
Query: 236 QIATLSLQGNQLTGKIPSVIGLMQALAVLDLS 267
+ + L+ NQ++ P + L ++ L+
Sbjct: 196 NLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 0.001
Identities = 14/55 (25%), Positives = 23/55 (41%), Gaps = 3/55 (5%)
Query: 190 LWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPF-NIGFLQIATLSLQ 243
L +N ++ P + + + + L NQ+S P N L I TL+ Q
Sbjct: 175 LTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTNQ 227
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.9 bits (89), Expect = 0.002
Identities = 11/56 (19%), Positives = 22/56 (39%), Gaps = 4/56 (7%)
Query: 94 LQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKN 149
L ++ N++S P + +L + L N++ P + L + L N
Sbjct: 175 LTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPL--ANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.5 bits (88), Expect = 0.002
Identities = 13/67 (19%), Positives = 27/67 (40%), Gaps = 5/67 (7%)
Query: 157 PSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQV 216
+ L+ L L N + + L L ++NN ++ P + N ++ +
Sbjct: 166 LTPLANLSKLTTLKADDNKISD--ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFI 221
Query: 217 LDLSYNQ 223
+ L+ NQ
Sbjct: 222 VTLT-NQ 227
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 53.2 bits (127), Expect = 4e-09
Identities = 24/121 (19%), Positives = 40/121 (33%), Gaps = 7/121 (5%)
Query: 311 YLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGT 370
L L LT + L +L + L++++N L P L++ L L N
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDN--ALE 56
Query: 371 IPPAFQRLESMTYLNLSLNNIRG-PIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHL 429
L + L L N ++ L L L++ N + L +
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
Query: 430 L 430
L
Sbjct: 116 L 116
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 53.2 bits (127), Expect = 4e-09
Identities = 27/120 (22%), Positives = 51/120 (42%), Gaps = 7/120 (5%)
Query: 360 LNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSI 419
L++ L T+ ++L +T+L+LS N +R P L+ + L+ L S+N +
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALE--N 57
Query: 420 PSPLGDLEHLLKLNLSRNQLTGF-IPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMF 478
+ +L L +L L N+L + ++ ++L N L +L M
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEML 116
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 52.4 bits (125), Expect = 8e-09
Identities = 25/121 (20%), Positives = 48/121 (39%), Gaps = 6/121 (4%)
Query: 215 QVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGP 274
+VL L++ L+ + L + L L N+L P++ L + L + +
Sbjct: 1 RVLHLAHKDLT-VLCHLEQLLLVTHLDLSHNRLRALPPALAALRC---LEVLQASDNALE 56
Query: 275 IPPILGNLSYTEKLYLHSNKLTGHIPPE-LGNMTKLHYLELNDNQLTGHIPPALGKLTDL 333
+ NL ++L L +N+L + L + +L L L N L +L ++
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
Query: 334 F 334
Sbjct: 116 L 116
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 51.6 bits (123), Expect = 2e-08
Identities = 28/120 (23%), Positives = 47/120 (39%), Gaps = 7/120 (5%)
Query: 336 LNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPI 395
L++A+ L + +L + L++ N+L +PPA L + L S N +
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALENVD 59
Query: 396 PVELSRIGNLDTLDMSNNKI-SGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVM 454
V L + NN++ + PL L+ LNL N L G L ++
Sbjct: 60 GVANLPRLQ--ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEML 116
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 51.6 bits (123), Expect = 2e-08
Identities = 25/110 (22%), Positives = 47/110 (42%), Gaps = 6/110 (5%)
Query: 119 KSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVG 178
+ L L+ +L + + +L + L L +N+L P+ L+ L L+V + ++
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVL--QASDNAL 55
Query: 179 TLSPDMCQLSGLWYFDVRNNSLTG-SIPQNIGNCTSFQVLDLSYNQLSGE 227
+ L L + NN L + Q + +C +L+L N L E
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 50.1 bits (119), Expect = 5e-08
Identities = 28/122 (22%), Positives = 49/122 (40%), Gaps = 6/122 (4%)
Query: 288 LYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPI 347
L+L LT + L + + +L+L+ N+L PPAL L L L ++N LE
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQASDNALENVD 59
Query: 348 PDNLSSCTNLNSLNVHGNKLNGTIPP-AFQRLESMTYLNLSLNNIRGPIPVELSRIGNLD 406
+ L L + N+L + + LNL N++ ++ L
Sbjct: 60 GVA--NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117
Query: 407 TL 408
++
Sbjct: 118 SV 119
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.8 bits (113), Expect = 3e-07
Identities = 26/109 (23%), Positives = 46/109 (42%), Gaps = 6/109 (5%)
Query: 383 YLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGF 442
L+L+ ++ + L ++ + LD+S+N++ P+ L L L L S N L
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENV 58
Query: 443 IPGEFGNLRSVMEIDLSHNHLTGV-IPEELSQLQNMFSLRLDYNNLSGD 490
NL + E+ L +N L + L + L L N+L +
Sbjct: 59 DG--VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 46.2 bits (109), Expect = 1e-06
Identities = 21/105 (20%), Positives = 35/105 (33%), Gaps = 5/105 (4%)
Query: 194 DVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPS 253
+ + LT + ++ LDLS+N+L P + L+ + + +
Sbjct: 4 HLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVDG 60
Query: 254 VIGLMQALAVLDLSCNML-SGPIPPILGNLSYTEKLYLHSNKLTG 297
V L + L L N L L + L L N L
Sbjct: 61 VANLPRLQ-ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.5 bits (107), Expect = 2e-06
Identities = 26/107 (24%), Positives = 47/107 (43%), Gaps = 6/107 (5%)
Query: 73 LNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDI 132
L+L+ +L + + L + +DL NRL P + L+ L ++ +
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQ--ASDNALEN 57
Query: 133 PFSISKLKQLEFLILKNNQLIG-PIPSTLSQLPNLKVFGLRGNNLVG 178
++ L +L+ L+L NN+L L P L + L+GN+L
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.9 bits (135), Expect = 6e-09
Identities = 17/91 (18%), Positives = 34/91 (37%), Gaps = 5/91 (5%)
Query: 404 NLDTLDMSNNKISGS-IPSPLGDLEHLLKLNLSRNQLTG----FIPGEFGNLRSVMEIDL 458
++ +LD+ ++S + L L+ + L LT I ++ E++L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 459 SHNHLTGVIPEELSQLQNMFSLRLDYNNLSG 489
N L V + Q S ++ +L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.4 bits (113), Expect = 3e-06
Identities = 13/93 (13%), Positives = 30/93 (32%), Gaps = 10/93 (10%)
Query: 356 NLNSLNVHGNKLNGT-IPPAFQRLESMTYLNLSLNNIRG----PIPVELSRIGNLDTLDM 410
++ SL++ +L+ L+ + L + I L L L++
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 411 SNNKISGSIPSPLGDL-----EHLLKLNLSRNQ 438
+N++ + + KL+L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.0 bits (112), Expect = 3e-06
Identities = 20/89 (22%), Positives = 33/89 (37%), Gaps = 13/89 (14%)
Query: 94 LQSIDLRGNRLSGQ----IPDEIGDCSSLKSLDLSFNELYGDIPFSISK-----LKQLEF 144
L+ + L +S + + SL+ LDLS N L + + LE
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430
Query: 145 LILKNNQLIGPIPSTLSQL----PNLKVF 169
L+L + + L L P+L+V
Sbjct: 431 LVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.9 bits (109), Expect = 8e-06
Identities = 14/81 (17%), Positives = 31/81 (38%), Gaps = 9/81 (11%)
Query: 404 NLDTLDMSNNKISG----SIPSPLGDLEHLLKLNLSRNQLTGFIPGEFG-----NLRSVM 454
L L +++ +S S+ + L L +L+LS N L + +
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 455 EIDLSHNHLTGVIPEELSQLQ 475
++ L + + + + L L+
Sbjct: 430 QLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.9 bits (109), Expect = 9e-06
Identities = 16/85 (18%), Positives = 30/85 (35%), Gaps = 5/85 (5%)
Query: 73 LNLSGLNL-DGEISPAVGDLKDLQSIDLRGNRLSGQ----IPDEIGDCSSLKSLDLSFNE 127
L++ L D + + L+ Q + L L+ I + +L L+L NE
Sbjct: 7 LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66
Query: 128 LYGDIPFSISKLKQLEFLILKNNQL 152
L + + Q ++ L
Sbjct: 67 LGDVGVHCVLQGLQTPSCKIQKLSL 91
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.5 bits (108), Expect = 1e-05
Identities = 17/106 (16%), Positives = 35/106 (33%), Gaps = 5/106 (4%)
Query: 93 DLQSIDLRGNRLS-GQIPDEIGDCSSLKSLDLSFNEL----YGDIPFSISKLKQLEFLIL 147
D+QS+D++ LS + + + + + L L DI ++ L L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 148 KNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYF 193
++N+L + Q ++ +L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTL 108
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.5 bits (108), Expect = 1e-05
Identities = 13/89 (14%), Positives = 29/89 (32%), Gaps = 15/89 (16%)
Query: 73 LNLSGLNLDGE----ISPAVGDLKDLQSIDLRGNRLSGQIPDEIGD-----CSSLKSLDL 123
L L+ ++ ++ + L+ +DL N L ++ + L+ L L
Sbjct: 374 LWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVL 433
Query: 124 SFNELYGDIPFSISKLKQLEFLILKNNQL 152
++ +L+ L L
Sbjct: 434 YDIYWSEEME------DRLQALEKDKPSL 456
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.1 bits (107), Expect = 1e-05
Identities = 14/89 (15%), Positives = 29/89 (32%), Gaps = 9/89 (10%)
Query: 348 PDNLSSCTNLNSLNVHGNKLNGT----IPPAFQRLESMTYLNLSLNNIRGPIPVELSRI- 402
+ L L + ++ + + S+ L+LS N + ++L
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 403 ----GNLDTLDMSNNKISGSIPSPLGDLE 427
L+ L + + S + L LE
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 2e-05
Identities = 17/149 (11%), Positives = 35/149 (23%), Gaps = 5/149 (3%)
Query: 380 SMTYLNLSLNNIRGPIPVEL-SRIGNLDTLDMSNNKISG----SIPSPLGDLEHLLKLNL 434
+ L++ + EL + + + + ++ I S L L +LNL
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 435 SRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDVMSL 494
N+L + L +LR +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDN 122
Query: 495 INCLSLSVLFIGNPGLCGYWLHSACRDSH 523
+ + L L +
Sbjct: 123 LLGDAGLQLLCEGLLDPQCRLEKLQLEYC 151
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.0 bits (104), Expect = 4e-05
Identities = 20/94 (21%), Positives = 34/94 (36%), Gaps = 10/94 (10%)
Query: 235 LQIATLSLQGNQLTGK-IPSVIGLMQALAVLDLSCNMLSG----PIPPILGNLSYTEKLY 289
L I +L +Q +L+ ++ L+Q V+ L L+ I L +L
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 290 LHSNKLTGHIPPELG-----NMTKLHYLELNDNQ 318
L SN+L + K+ L L +
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (102), Expect = 6e-05
Identities = 16/84 (19%), Positives = 28/84 (33%), Gaps = 9/84 (10%)
Query: 305 NMTKLHYLELNDNQLTG----HIPPALGKLTDLFDLNVANNHLEGPIPDNLSS-----CT 355
+ L L L D ++ + L L +L+++NN L L
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 356 NLNSLNVHGNKLNGTIPPAFQRLE 379
L L ++ + + Q LE
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (102), Expect = 6e-05
Identities = 20/90 (22%), Positives = 29/90 (32%), Gaps = 6/90 (6%)
Query: 215 QVLDLSYNQLSGEIPFNI--GFLQIATLSLQGNQLTGK----IPSVIGLMQALAVLDLSC 268
Q LD+ +LS + Q + L LT I S + + ALA L+L
Sbjct: 5 QSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRS 64
Query: 269 NMLSGPIPPILGNLSYTEKLYLHSNKLTGH 298
N L + T + L
Sbjct: 65 NELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 1e-04
Identities = 17/82 (20%), Positives = 25/82 (30%), Gaps = 9/82 (10%)
Query: 258 MQALAVLDLSCNMLSG----PIPPILGNLSYTEKLYLHSNKLTGHIPPELG-----NMTK 308
L VL L+ +S + L +L L +N L +L
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427
Query: 309 LHYLELNDNQLTGHIPPALGKL 330
L L L D + + L L
Sbjct: 428 LEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.3 bits (97), Expect = 3e-04
Identities = 15/80 (18%), Positives = 28/80 (35%), Gaps = 9/80 (11%)
Query: 428 HLLKLNLSRNQLTG----FIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQ-----LQNMF 478
L L L+ ++ + S+ E+DLS+N L +L + +
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 479 SLRLDYNNLSGDVMSLINCL 498
L L S ++ + L
Sbjct: 430 QLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 3e-04
Identities = 12/90 (13%), Positives = 27/90 (30%), Gaps = 5/90 (5%)
Query: 309 LHYLELNDNQLT-GHIPPALGKLTDLFDLNVANNHLEG----PIPDNLSSCTNLNSLNVH 363
+ L++ +L+ L L + + + L I L L LN+
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 364 GNKLNGTIPPAFQRLESMTYLNLSLNNIRG 393
N+L + + +++
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 5e-04
Identities = 12/82 (14%), Positives = 27/82 (32%), Gaps = 10/82 (12%)
Query: 188 SGLWYFDVRNNSLTG----SIPQNIGNCTSFQVLDLSYNQLSGEIPFNIG------FLQI 237
S L + + ++ S+ + S + LDLS N L + +
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 238 ATLSLQGNQLTGKIPSVIGLMQ 259
L L + ++ + ++
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 5e-04
Identities = 15/104 (14%), Positives = 29/104 (27%), Gaps = 22/104 (21%)
Query: 142 LEFLILKNNQLI-GPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSL 200
++ L ++ +L L L +V L L +
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGL--------------------TEAR 43
Query: 201 TGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIG-FLQIATLSLQ 243
I + + L+L N+L + LQ + +Q
Sbjct: 44 CKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQ 87
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (89), Expect = 0.002
Identities = 15/102 (14%), Positives = 28/102 (27%), Gaps = 10/102 (9%)
Query: 191 WYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFL-----QIATLSLQGN 245
+ + + + +VL L+ +S ++ + L L N
Sbjct: 348 SNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNN 407
Query: 246 QLTGKIPSVI--GLMQ---ALAVLDLSCNMLSGPIPPILGNL 282
L + + Q L L L S + L L
Sbjct: 408 CLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 52.5 bits (124), Expect = 3e-08
Identities = 42/178 (23%), Positives = 70/178 (39%), Gaps = 8/178 (4%)
Query: 288 LYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPAL-GKLTDLFDLNVANNHLEGP 346
+ L IP ++ L LNDN+L L G+L L L + N L G
Sbjct: 13 VDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGI 69
Query: 347 IPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLD 406
P+ +++ L + NK+ F L + LNL N I +P + +L
Sbjct: 70 EPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLT 129
Query: 407 TLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLT 464
+L++++N + + E L K +L+ P + +R V DL H+
Sbjct: 130 SLNLASNPFNCNCH-LAWFAEWLRKKSLNGGAARCGAPSK---VRDVQIKDLPHSEFK 183
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 48.3 bits (113), Expect = 8e-07
Identities = 36/189 (19%), Positives = 65/189 (34%), Gaps = 10/189 (5%)
Query: 182 PDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNI--GFLQIAT 239
P MC G D L IP++I L L+ N+L + +
Sbjct: 3 PAMCHCEGT-TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVK 58
Query: 240 LSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHI 299
L L+ NQLTG P+ + L L N + + L + L L+ N+++ +
Sbjct: 59 LELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVM 118
Query: 300 PPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNS 359
P ++ L L L N + A L ++ P + ++
Sbjct: 119 PGSFEHLNSLTSLNLASNPFNCNCHLA-WFAEWLRKKSLNGGAARCGAPSKVR---DVQI 174
Query: 360 LNVHGNKLN 368
++ ++
Sbjct: 175 KDLPHSEFK 183
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 45.6 bits (106), Expect = 6e-06
Identities = 37/186 (19%), Positives = 65/186 (34%), Gaps = 14/186 (7%)
Query: 49 DSPSSDYCVWRGITCDNVTFTVI---------ALNLSGLNLDGEI-SPAVGDLKDLQSID 98
D P+ +C + C I L L+ L G L L ++
Sbjct: 1 DCPAMCHCEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLE 60
Query: 99 LRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPS 158
L+ N+L+G P+ S ++ L L N++ L QL+ L L +NQ+ +P
Sbjct: 61 LKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPG 120
Query: 159 TLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLD 218
+ L +L L N L + + P + + Q+ D
Sbjct: 121 SFEHLNSLTSLNLASNPFNC-NCHLAWFAEWLRKKSLNGGAARCGAPSKVRDV---QIKD 176
Query: 219 LSYNQL 224
L +++
Sbjct: 177 LPHSEF 182
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 43.3 bits (100), Expect = 4e-05
Identities = 40/167 (23%), Positives = 72/167 (43%), Gaps = 7/167 (4%)
Query: 275 IPPILGNLSYTEKLYLHSNKLTGHIPPEL-GNMTKLHYLELNDNQLTGHIPPALGKLTDL 333
IP + +T +L L+ N+L L G + L LEL NQLTG P A + +
Sbjct: 23 IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI 80
Query: 334 FDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRG 393
+L + N ++ L +LN++ N+++ +P +F+ L S+T LNL+ N
Sbjct: 81 QELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140
Query: 394 PIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLT 440
+ L ++ PS + D++ +L ++
Sbjct: 141 NCHLA-WFAEWLRKKSLNGGAARCGAPSKVRDVQI---KDLPHSEFK 183
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 39.8 bits (91), Expect = 6e-04
Identities = 31/158 (19%), Positives = 55/158 (34%), Gaps = 4/158 (2%)
Query: 347 IPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESM-TYLNLSLNNIRGPIPVELSRIGNL 405
IP ++ + L ++ N+L L L N + G P ++
Sbjct: 23 IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI 80
Query: 406 DTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTG 465
L + NKI L L LNL NQ++ +PG F +L S+ ++L+ N
Sbjct: 81 QELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140
Query: 466 VIPEELSQLQNMFSLRLDYNNLSGDVMSLINCLSLSVL 503
+ + L+ S + + + L
Sbjct: 141 NCHLA-WFAEWLRKKSLNGGAARCGAPSKVRDVQIKDL 177
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 54.5 bits (129), Expect = 3e-08
Identities = 41/327 (12%), Positives = 87/327 (26%), Gaps = 35/327 (10%)
Query: 73 LNLSGLNLDG--EISPAVGDLKDLQSIDLRGNRLSGQ----IPDEIGDCSSLKSLDLSFN 126
L L + + + + + ++ I L GN + + + + I L+ + S
Sbjct: 10 LKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDI 69
Query: 127 ELYGDIPFSISKLKQLEFLILKNNQLI---GPIPSTLSQLPNLKVFGLRGNNLVGTLSPD 183
L+ L +LK +L + + L + + L
Sbjct: 70 FTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLH 129
Query: 184 MCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSL- 242
L + ++ + N + + N+L + L
Sbjct: 130 NNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLH 189
Query: 243 -------------QGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLY 289
+ L + L + ++ S + L + +L
Sbjct: 190 TVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELG 249
Query: 290 LHSNKLTGHIPPELGNM------TKLHYLELNDNQLTGHIPPAL-----GKLTDLFDLNV 338
L+ L+ + + L L L N++ L K+ DL L +
Sbjct: 250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 309
Query: 339 ANNHLEGPIPDNLSSCTNLNSLNVHGN 365
N D + + S G
Sbjct: 310 NGNRFSE-EDDVVDEIREVFSTRGRGE 335
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 51.4 bits (121), Expect = 3e-07
Identities = 36/311 (11%), Positives = 82/311 (26%), Gaps = 33/311 (10%)
Query: 203 SIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFL-----QIATLSLQGNQLTGKIPSVIGL 257
S+ + S + + LS N + E + + +
Sbjct: 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEA 81
Query: 258 MQALAVLDLSCNMLSGPIPP---ILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLEL 314
++ L L C L +L + H+ + ++
Sbjct: 82 LRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKI 141
Query: 315 NDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPA 374
+ L + N LE + + L + I P
Sbjct: 142 ARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE 201
Query: 375 FQRLESMTYL-------------NLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPS 421
+ L N + + + L NL L +++ +S +
Sbjct: 202 GIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAA 261
Query: 422 PLGD------LEHLLKLNLSRNQLTG-----FIPGEFGNLRSVMEIDLSHNHLTGVIPEE 470
+ D L L L N++ + ++ ++L+ N + +
Sbjct: 262 AVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE-EDDV 320
Query: 471 LSQLQNMFSLR 481
+ +++ +FS R
Sbjct: 321 VDEIREVFSTR 331
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 49.1 bits (115), Expect = 1e-06
Identities = 37/311 (11%), Positives = 94/311 (30%), Gaps = 36/311 (11%)
Query: 93 DLQSIDLRGNRLSGQ----IPDEIGDCSSLKSLDLSFNELYGD----IPFSISKLKQLEF 144
++ L+ + ++ + + + + S+K + LS N + + + +I+ K LE
Sbjct: 4 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63
Query: 145 LILKNNQ---LIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLT 201
+ + IP L L + + + + + + + ++
Sbjct: 64 AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 123
Query: 202 GSIPQNIGNCTSFQVLDLSYNQLSGEIPFNI-GFLQIATLSLQGNQLT----GKIPSVIG 256
+ + ++ + + ++ N+L +
Sbjct: 124 EHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ 183
Query: 257 LMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYL---------HSNKLTGHIPPELGNMT 307
+ L + + N + L L ++ + + L +
Sbjct: 184 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWP 243
Query: 308 KLHYLELNDNQLTGHIPPALG------KLTDLFDLNVANNHLEGPIPDNLSS-----CTN 356
L L LND L+ A+ + L L + N +E L + +
Sbjct: 244 NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPD 303
Query: 357 LNSLNVHGNKL 367
L L ++GN+
Sbjct: 304 LLFLELNGNRF 314
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.4 bits (121), Expect = 1e-07
Identities = 24/227 (10%), Positives = 61/227 (26%), Gaps = 7/227 (3%)
Query: 239 TLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGH 298
Q +++T +IPS L + L L EK+ + N +
Sbjct: 12 VFLCQESKVT-EIPS--DLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEV 68
Query: 299 IPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLN 358
I ++ + + + + ++ ++ +L
Sbjct: 69 IEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQ 128
Query: 359 SLNVHGNKLNGTIPPAFQRLESMTY----LNLSLNNIRGPIPVELSRIGNLDTLDMSNNK 414
+ + +++ L L+ N I+ + + NN
Sbjct: 129 KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNN 188
Query: 415 ISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHN 461
+ + L++SR ++ NL+ + +
Sbjct: 189 LEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.4 bits (113), Expect = 1e-06
Identities = 34/238 (14%), Positives = 69/238 (28%), Gaps = 11/238 (4%)
Query: 93 DLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQL 152
+ + ++++ +IP ++ + L +L + S LE + + N +
Sbjct: 9 SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 65
Query: 153 IGPIPSTLSQLPNLKVFGLRG--NNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGN 210
+ I + + NNL+ L L Y + N + + +
Sbjct: 66 LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 125
Query: 211 CTSFQVLDLSYNQLSGEIPFNIGFLQIAT---LSLQGNQLTGKIPSVIGLMQALAVLDLS 267
+LD+ N I N L L N + Q +
Sbjct: 126 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSD 185
Query: 268 CNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPP 325
N L + S L + ++ L N+ KL + + +P
Sbjct: 186 NNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.2 bits (110), Expect = 3e-06
Identities = 29/243 (11%), Positives = 59/243 (24%), Gaps = 12/243 (4%)
Query: 184 MCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIAT-LSL 242
+C S F + + +T IP ++ + L +L + +
Sbjct: 5 ICHCSNR-VFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEI 60
Query: 243 QGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPE 302
N + I + + + + YL + P+
Sbjct: 61 SQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPD 120
Query: 303 LGNMTKLHYLELNDNQLTGHIPPALGKLTDLFD----LNVANNHLEGPIPDNLSSCTNLN 358
+ + L + L+ L L + N ++ +
Sbjct: 121 VHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDE 180
Query: 359 SLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGS 418
N L F L++S I L + L N K
Sbjct: 181 LNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---K 237
Query: 419 IPS 421
+P+
Sbjct: 238 LPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.4 bits (108), Expect = 6e-06
Identities = 38/251 (15%), Positives = 70/251 (27%), Gaps = 23/251 (9%)
Query: 56 CVWRGITCDNVTFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDC 115
C R C T I +L ++ + +L
Sbjct: 8 CSNRVFLCQESKVTEIPSDLP---------------RNAIELRFVLTKLRVIQKGAFSGF 52
Query: 116 SSLKSLDLSFNELYGDI----PFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGL 171
L+ +++S N++ I ++ KL ++ N I P +
Sbjct: 53 GDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISN 112
Query: 172 RGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFN 231
G + + L N T +G +L L+ N +
Sbjct: 113 TGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCA 172
Query: 232 IGFLQIATLSLQGNQLTGKIP-SVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYL 290
Q+ L+L N ++P V +LD+S + L NL
Sbjct: 173 FNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232
Query: 291 HSNKLTGHIPP 301
++ K +P
Sbjct: 233 YNLK---KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.6 bits (98), Expect = 9e-05
Identities = 30/238 (12%), Positives = 65/238 (27%), Gaps = 7/238 (2%)
Query: 205 PQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVL 264
I +C++ +V ++++ EIP ++ L +L L +
Sbjct: 2 HHRICHCSN-RVFLCQESKVT-EIPSDL-PRNAIELRFVLTKLRVIQKGAFSGFGDLEKI 58
Query: 265 DLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIP 324
++S N + I + + + L +
Sbjct: 59 EISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHL 118
Query: 325 PALGKLTDLFDLNVANNHLEGPIPDNLSSCTN----LNSLNVHGNKLNGTIPPAFQRLES 380
P + K+ L + + +S L ++ N + AF +
Sbjct: 119 PDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQL 178
Query: 381 MTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQ 438
NN+ LD+S +I L +L+ L + +
Sbjct: 179 DELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.6 bits (98), Expect = 1e-04
Identities = 31/267 (11%), Positives = 75/267 (28%), Gaps = 30/267 (11%)
Query: 109 PDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKV 168
I CS+ + +++ +IP + + L +L S +L+
Sbjct: 2 HHRICHCSN-RVFLCQESKV-TEIPSDLPR--NAIELRFVLTKLRVIQKGAFSGFGDLEK 57
Query: 169 FGLRGNNLVGTLSPDMCQLSGLWYFDVRN--NSLTGSIPQNIGNCTSFQVLDLSYNQLSG 226
+ N+++ + D+ + N+L P+ N + Q L +S +
Sbjct: 58 IEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKH 117
Query: 227 EIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTE 286
+ L + N+ + +G +
Sbjct: 118 LPDVHKIHSLQKVLLDIQDN---------------------INIHTIERNSFVGLSFESV 156
Query: 287 KLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGP 346
L+L+ N + ++N L + L+++ +
Sbjct: 157 ILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSL 216
Query: 347 IPDNLSSCTNLNSLNVHGNKLNGTIPP 373
L + L + + + K +P
Sbjct: 217 PSYGLENLKKLRARSTYNLK---KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (90), Expect = 0.001
Identities = 28/229 (12%), Positives = 53/229 (23%), Gaps = 33/229 (14%)
Query: 288 LYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPI 347
+K+T IP +L L +L A DL + ++ N + I
Sbjct: 13 FLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 69
Query: 348 PDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELS------- 400
++ S N L ++N ++
Sbjct: 70 EADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQK 129
Query: 401 ---------------------RIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQL 439
L ++ N I + N L
Sbjct: 130 VLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNL 189
Query: 440 TGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLS 488
F + +D+S + + L L+ + + NL
Sbjct: 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (90), Expect = 0.001
Identities = 14/64 (21%), Positives = 27/64 (42%), Gaps = 3/64 (4%)
Query: 404 NLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHL 463
+ +K++ IPS L + ++L +L G F + +I++S N +
Sbjct: 9 SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 65
Query: 464 TGVI 467
VI
Sbjct: 66 LEVI 69
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.0 bits (116), Expect = 2e-07
Identities = 23/136 (16%), Positives = 51/136 (37%), Gaps = 5/136 (3%)
Query: 347 IPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLD 406
+ +S + + + L P LN +++ + + I L
Sbjct: 12 LKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRR-SSMAATLRIIEENIPELL 68
Query: 407 TLDMSNNKISG--SIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLT 464
+L++SNN++ + S + +L LNLS N+L + + E+ L N L+
Sbjct: 69 SLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS 128
Query: 465 GVIPEELSQLQNMFSL 480
++ + + +
Sbjct: 129 DTFRDQSTYISAIRER 144
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.1 bits (111), Expect = 1e-06
Identities = 23/120 (19%), Positives = 46/120 (38%), Gaps = 5/120 (4%)
Query: 371 IPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLL 430
+ + + L L +R +L L+ ++ + ++ ++ LL
Sbjct: 12 LKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELL 68
Query: 431 KLNLSRNQLTGF--IPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLS 488
LNLS N+L + ++ ++LS N L + + + L LD N+LS
Sbjct: 69 SLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS 128
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.3 bits (101), Expect = 3e-05
Identities = 27/154 (17%), Positives = 48/154 (31%), Gaps = 13/154 (8%)
Query: 265 DLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIP 324
+L + + I+ + L L P+L L + +
Sbjct: 3 ELKPEQVEQ-LKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRRSSMAAT-LR 58
Query: 325 PALGKLTDLFDLNVANNHLEG--PIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMT 382
+ +L LN++NN L + + NL LN+ GN+L + +
Sbjct: 59 IIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLE 118
Query: 383 YLNLSLNNIRGPIPVE-------LSRIGNLDTLD 409
L L N++ + R L LD
Sbjct: 119 ELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.6 bits (89), Expect = 0.001
Identities = 29/179 (16%), Positives = 57/179 (31%), Gaps = 30/179 (16%)
Query: 147 LKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQ 206
LK Q + + +S+ + L L PD+ + + R++ ++
Sbjct: 4 LKPEQ-VEQLKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRRSSMAA-TLRI 59
Query: 207 NIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDL 266
N L+LS N+L S++ L +L+L
Sbjct: 60 IEENIPELLSLNLSNNRLYRLDDM---------------------SSIVQKAPNLKILNL 98
Query: 267 SCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYL-----ELNDNQLT 320
S N L E+L+L N L+ + ++ + L+ ++L
Sbjct: 99 SGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLDGHELP 157
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.5 bits (86), Expect = 0.003
Identities = 23/99 (23%), Positives = 38/99 (38%), Gaps = 9/99 (9%)
Query: 79 NLDGEISPAVGDLKDLQSIDLRGNRLSGQ--IPDEIGDCSSLKSLDLSFNELYGDIPFSI 136
++ + ++ +L S++L NRL + + +LK L+LS NEL +
Sbjct: 52 SMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDK 111
Query: 137 SKLKQLEFLILKNNQLIGPIPST-------LSQLPNLKV 168
K +LE L L N L + P L
Sbjct: 112 IKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLR 150
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.0 bits (113), Expect = 6e-07
Identities = 29/140 (20%), Positives = 51/140 (36%), Gaps = 7/140 (5%)
Query: 85 SPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEF 144
+ + + +DLRG ++ I + ++D S NE+ F L++L+
Sbjct: 11 AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGF--PLLRRLKT 67
Query: 145 LILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMC----QLSGLWYFDVRNNSL 200
L++ NN++ LP+L L N+LV D L+ L +
Sbjct: 68 LLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNK 127
Query: 201 TGSIPQNIGNCTSFQVLDLS 220
I +VLD
Sbjct: 128 KHYRLYVIYKVPQVRVLDFQ 147
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (95), Expect = 1e-04
Identities = 29/140 (20%), Positives = 54/140 (38%), Gaps = 5/140 (3%)
Query: 351 LSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDM 410
++ L++ G K+ I L+ ++ S N IR + L TL +
Sbjct: 14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGF--PLLRRLKTLLV 70
Query: 411 SNNKISGSIPSPLGDLEHLLKLNLSRNQLTGF-IPGEFGNLRSVMEIDLSHNHLTGVIPE 469
+NN+I L L +L L+ N L +L+S+ + + N +T
Sbjct: 71 NNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHY 130
Query: 470 ELSQLQNMFSLR-LDYNNLS 488
L + + +R LD+ +
Sbjct: 131 RLYVIYKVPQVRVLDFQKVK 150
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (87), Expect = 0.002
Identities = 27/136 (19%), Positives = 49/136 (36%), Gaps = 8/136 (5%)
Query: 373 PAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKL 432
+ L+L I I + + D +D S+N+I L L L
Sbjct: 12 AQYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTL 68
Query: 433 NLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEE----LSQLQNMFSLRLDYNNLS 488
++ N++ G L + E+ L++N L + + L L + LR N
Sbjct: 69 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 128
Query: 489 GDVMSLINCL-SLSVL 503
+ +I + + VL
Sbjct: 129 HYRLYVIYKVPQVRVL 144
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.8 bits (84), Expect = 0.004
Identities = 24/169 (14%), Positives = 48/169 (28%), Gaps = 33/169 (19%)
Query: 200 LTGSIPQNIG---NCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIG 256
LT + + N + LDL ++ I ++
Sbjct: 3 LTAELIEQAAQYTNAVRDRELDLRGYKIP------------------------VIENLGA 38
Query: 257 LMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELND 316
+ +D S N + L + L +++N++ + L L L +
Sbjct: 39 TLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTN 96
Query: 317 NQLTG----HIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLN 361
N L +L LT L L + + + + L+
Sbjct: 97 NSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 45.8 bits (107), Expect = 7e-06
Identities = 41/222 (18%), Positives = 79/222 (35%), Gaps = 20/222 (9%)
Query: 265 DLSCNMLSGPIPPI----LGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLT 320
L ++ P P + T K L +T + + + + N++ +
Sbjct: 2 PLGSETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK 59
Query: 321 GHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLES 380
+ L ++ L + N L P L+ + + +
Sbjct: 60 S--VQGIQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDEN------KVKDLSSLKDL 111
Query: 381 MTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLT 440
+LSL + L + L++L + NNKI+ L L L+L NQ++
Sbjct: 112 KKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLS--RLTKLDTLSLEDNQIS 169
Query: 441 GFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRL 482
+P L + + LS NH++ + L+ L+N+ L L
Sbjct: 170 DIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLEL 207
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 45.4 bits (106), Expect = 1e-05
Identities = 36/207 (17%), Positives = 72/207 (34%), Gaps = 15/207 (7%)
Query: 134 FSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYF 193
FS + LK + + T ++L ++ +++ + L +
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDI--KSVQGIQYLPNVTKL 73
Query: 194 DVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPS 253
+ N LT + + N + L L N++ + I
Sbjct: 74 FLNGNKLTD--IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLK-----SLSLEHNGISD 126
Query: 254 VIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLE 313
+ GL+ + L +L L+ + L L N+++ +P L +TKL L
Sbjct: 127 INGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLY 184
Query: 314 LNDNQLTGHIPPALGKLTDLFDLNVAN 340
L+ N ++ AL L +L L + +
Sbjct: 185 LSKNHISD--LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 44.2 bits (103), Expect = 2e-05
Identities = 16/81 (19%), Positives = 34/81 (41%), Gaps = 10/81 (12%)
Query: 418 SIPSPLGD------LEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEEL 471
++P+P+ +K NL + +T + L S+ +I +++ + V +
Sbjct: 9 TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--I 64
Query: 472 SQLQNMFSLRLDYNNLSGDVM 492
L N+ L L+ N L+
Sbjct: 65 QYLPNVTKLFLNGNKLTDIKP 85
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 44.2 bits (103), Expect = 2e-05
Identities = 30/202 (14%), Positives = 62/202 (30%), Gaps = 16/202 (7%)
Query: 258 MQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDN 317
+L ++ + L+ +++ +++ + + + + L LN N
Sbjct: 23 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS--VQGIQYLPNVTKLFLNGN 78
Query: 318 QLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQR 377
+LT P L L +L L + N ++ SL +G + Q
Sbjct: 79 KLTDIKP--LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQL 136
Query: 378 LESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRN 437
N + + I PL L L L LS+N
Sbjct: 137 ESLYLGNNKITDITVLSRL-------TKLDTLSLEDNQISDIV-PLAGLTKLQNLYLSKN 188
Query: 438 QLTGFIPGEFGNLRSVMEIDLS 459
++ L+++ ++L
Sbjct: 189 HISDLRA--LAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 1e-04
Identities = 37/203 (18%), Positives = 75/203 (36%), Gaps = 15/203 (7%)
Query: 305 NMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHG 364
+ L +T + +L + + N+ ++ + N+ L ++G
Sbjct: 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNG 77
Query: 365 NKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLG 424
NKL P A + +L+ + + +S S + L
Sbjct: 78 NKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLK------SLSLEHNGISDINGLV 131
Query: 425 DLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDY 484
L L L L N++T L + + L N ++ ++P L+ L + +L L
Sbjct: 132 HLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSK 187
Query: 485 NNLSGDVMSLINCLSLSVLFIGN 507
N++S D+ +L +L VL + +
Sbjct: 188 NHIS-DLRALAGLKNLDVLELFS 209
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.6 bits (101), Expect = 2e-05
Identities = 23/142 (16%), Positives = 44/142 (30%), Gaps = 5/142 (3%)
Query: 115 CSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPS-TLSQLPNLKVFGLRG 173
L + + D + + L L ++N Q + + L L L+ +
Sbjct: 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 174 NNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQL--SGEIPFN 231
+ L L ++ N+L S+ S Q L LS N L S + +
Sbjct: 66 SGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRWL 124
Query: 232 IGFLQIATLSLQGNQLTGKIPS 253
+ + + +L
Sbjct: 125 QRWEEEGLGGVPEQKLQCHGQG 146
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.7 bits (96), Expect = 8e-05
Identities = 26/149 (17%), Positives = 50/149 (33%), Gaps = 4/149 (2%)
Query: 259 QALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPEL-GNMTKLHYLELNDN 317
+ L + + L +LY+ + + H+ + +L L + +
Sbjct: 8 HGSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 318 QLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPA-FQ 376
L P A L LN++ N LE + +L L + GN L+ + Q
Sbjct: 67 GLRFVAPDAFHFTPRLSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPLHCSCALRWLQ 125
Query: 377 RLESMTYLNLSLNNIRGPIPVELSRIGNL 405
R E + ++ L+ + N
Sbjct: 126 RWEEEGLGGVPEQKLQCHGQGPLAHMPNA 154
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.5 bits (93), Expect = 2e-04
Identities = 20/115 (17%), Positives = 37/115 (32%), Gaps = 3/115 (2%)
Query: 404 NLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQ-LTGFIPGEFGNLRSVMEIDLSHNH 462
L + + L E+L +L + Q L + L + + + +
Sbjct: 9 GSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG 67
Query: 463 LTGVIPEELSQLQNMFSLRLDYNNLSG-DVMSLINCLSLSVLFIGNPGLCGYWLH 516
L V P+ + L L +N L ++ ++ GNP C L
Sbjct: 68 LRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALR 122
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.0 bits (89), Expect = 7e-04
Identities = 24/151 (15%), Positives = 45/151 (29%), Gaps = 2/151 (1%)
Query: 301 PELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVA-NNHLEGPIPDNLSSCTNLNS 359
P+ L + L +L +L + HL+ +L L +
Sbjct: 2 PDACCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60
Query: 360 LNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSI 419
L + + L P AF ++ LNLS N + + + + + N
Sbjct: 61 LTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCA 120
Query: 420 PSPLGDLEHLLKLNLSRNQLTGFIPGEFGNL 450
L E + +L G ++
Sbjct: 121 LRWLQRWEEEGLGGVPEQKLQCHGQGPLAHM 151
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.6 bits (88), Expect = 9e-04
Identities = 27/146 (18%), Positives = 47/146 (32%), Gaps = 4/146 (2%)
Query: 283 SYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPP-ALGKLTDLFDLNVANN 341
+ L + L L L + + Q H+ L L +L +L + +
Sbjct: 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 342 HLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVE-LS 400
L PD L+ LN+ N ++ + S+ L LS N + + L
Sbjct: 67 GLRFVAPDAFHFTPRLSRLNLSFNA-LESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQ 125
Query: 401 RIGNLDTLDMSNNKISGSIPSPLGDL 426
R + K+ PL +
Sbjct: 126 RWEEEGLGGVPEQKLQCHGQGPLAHM 151
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 7e-05
Identities = 25/173 (14%), Positives = 54/173 (31%), Gaps = 22/173 (12%)
Query: 70 VIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELY 129
+ L N+ +S DL + ++ + D + ++L ++ S N+L
Sbjct: 20 KMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLT 75
Query: 130 GDIPFSISKL----------------KQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRG 173
P + I + L
Sbjct: 76 DITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLEL 135
Query: 174 NNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSG 226
++ + + L+ L + +N +T P + N T+ + LD+S N++S
Sbjct: 136 SSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSNKVSD 186
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 9e-05
Identities = 36/200 (18%), Positives = 73/200 (36%), Gaps = 15/200 (7%)
Query: 134 FSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYF 193
F+ + L + +L + + + + L + + + L+ L
Sbjct: 12 FTDTALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQI 67
Query: 194 DVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPS 253
+ NN LT + N T + ++ NQ++ P +I
Sbjct: 68 NFSNNQLTD--ITPLKNLTKLVDILMNNNQIADITPLANLTNLT-----GLTLFNNQITD 120
Query: 254 VIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLE 313
+ L + L + + L L+ ++L SN++T P L N+T L L+
Sbjct: 121 IDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLD 178
Query: 314 LNDNQLTGHIPPALGKLTDL 333
++ N+++ L KLT+L
Sbjct: 179 ISSNKVSD--ISVLAKLTNL 196
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 3e-04
Identities = 42/200 (21%), Positives = 78/200 (39%), Gaps = 16/200 (8%)
Query: 281 NLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVAN 340
L+ K L +T + ++ ++ L+ + + + L +L +N +N
Sbjct: 16 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSN 71
Query: 341 NHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELS 400
N L P + +N + + + N +
Sbjct: 72 NQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT--- 128
Query: 401 RIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSH 460
NL+ L++S+N IS S L L L +LN S NQ+T P NL ++ +D+S
Sbjct: 129 ---NLNRLELSSNTIS--DISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISS 181
Query: 461 NHLTGVIPEELSQLQNMFSL 480
N ++ + L++L N+ SL
Sbjct: 182 NKVSDI--SVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.9 bits (89), Expect = 0.001
Identities = 30/222 (13%), Positives = 62/222 (27%), Gaps = 39/222 (17%)
Query: 91 LKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNN 150
L + L ++ + D + +L I + +E+
Sbjct: 17 LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRL--------GIKSIDGVEY------ 60
Query: 151 QLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGN 210
L NL N L + + +
Sbjct: 61 ------------LNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNL 108
Query: 211 CTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNM 270
+ + + N+ L++++ ++ + S+ L S N
Sbjct: 109 TGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNF-------SSNQ 161
Query: 271 LSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYL 312
++ P L NL+ E+L + SNK++ L +T L L
Sbjct: 162 VTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESL 199
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 933 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.97 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.95 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.9 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.9 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.85 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.83 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.76 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.76 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.75 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.75 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.74 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.74 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.73 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.69 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.68 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.68 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.5 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.48 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.48 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.47 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.46 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.43 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.42 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.39 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.37 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.3 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.29 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.24 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.49 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.48 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.37 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.78 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.48 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.39 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.36 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.73 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.72 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.39 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.13 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.52 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=420.63 Aligned_cols=255 Identities=27% Similarity=0.376 Sum_probs=201.4
Q ss_pred hccCcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecC
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFME 677 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 677 (933)
++|+..+.||+|+||+||+|++.+++.||||++.... ...++|.+|++++++++|||||+++|++..++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 4678889999999999999999988899999997643 345789999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCce
Q 002349 678 NGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYT 757 (933)
Q Consensus 678 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 757 (933)
+|+|.++++ .....+++..+..++.|+|.||+|||++ +|+||||||+|||+++++.+||+|||+|+.........
T Consensus 84 ~g~L~~~l~--~~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 84 HGCLSDYLR--TQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp TCBHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCcHHHHhh--ccccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 999999986 3456789999999999999999999976 99999999999999999999999999998775444444
Q ss_pred eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHH
Q 002349 758 STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGA 837 (933)
Q Consensus 758 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 837 (933)
.....||+.|+|||++.+..++.++|||||||++|||+|+..|+................. .+..+. .+
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~------~~~~p~-----~~ 227 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF------RLYKPR-----LA 227 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTC------CCCCCT-----TS
T ss_pred ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcC------CCCCcc-----cc
Confidence 4456799999999999999999999999999999999996555443333333322211111 111111 12
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHHHccC
Q 002349 838 VKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869 (933)
Q Consensus 838 ~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 869 (933)
+.++.+++.+||+.||++|||++||+++|+++
T Consensus 228 ~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 228 STHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 35788999999999999999999999999865
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=419.55 Aligned_cols=253 Identities=23% Similarity=0.325 Sum_probs=206.4
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYD 674 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 674 (933)
.++|+..+.||+|+||+||+|+++ +++.||||++.... .+..+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 367999999999999999999986 58899999996543 3345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCC
Q 002349 675 FMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSK 754 (933)
Q Consensus 675 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 754 (933)
|+++|+|.+++. ....+++.++..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+......
T Consensus 84 y~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 84 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ccCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 999999999994 456899999999999999999999966 99999999999999999999999999998764332
Q ss_pred C-ceeeeecccccccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccc
Q 002349 755 S-YTSTYIMGTIGYIDPEYARTSRL-TEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATC 832 (933)
Q Consensus 755 ~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (933)
. ......+||+.|||||++.+..+ +.++||||+||++|||++|+.||...................... .+
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~-~~------ 230 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP-WK------ 230 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTT-GG------
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCc-cc------
Confidence 2 22345689999999999988876 578999999999999999999997654433332222211111110 00
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 833 KDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 833 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
..+..+.+++.+||+.||++|||++|++++
T Consensus 231 ---~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 231 ---KIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp ---GSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 113567789999999999999999999774
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-49 Score=419.99 Aligned_cols=259 Identities=31% Similarity=0.460 Sum_probs=206.5
Q ss_pred hhccCcceeeecccceeEEEEEEcCCceEEEEEeccc--CchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSH--YPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYD 674 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 674 (933)
.++|+..+.||+|+||+||+|++++ .||||+++.. .....+.|.+|++++++++|||||++++++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 3578889999999999999998654 5999998654 34556789999999999999999999998754 56899999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCC
Q 002349 675 FMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSK 754 (933)
Q Consensus 675 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 754 (933)
|+++|+|.++++. ....+++..+..++.|+++||+|||++ +||||||||+|||++.++.+||+|||+|+......
T Consensus 84 y~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 84 WCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCCEEEHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred cCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 9999999999963 446799999999999999999999965 99999999999999999999999999998764332
Q ss_pred C-ceeeeecccccccCccccccC---CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccc
Q 002349 755 S-YTSTYIMGTIGYIDPEYARTS---RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISA 830 (933)
Q Consensus 755 ~-~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (933)
. .......||+.|||||++.+. .++.++|||||||++|||+||+.||.+................ .+....
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~-----~p~~~~ 233 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYL-----SPDLSK 233 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSC-----CCCGGG
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCC-----CCcchh
Confidence 2 233456899999999998653 5899999999999999999999999876555443322221111 111111
Q ss_pred cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCC
Q 002349 831 TCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLV 870 (933)
Q Consensus 831 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 870 (933)
. ....+..+.+++.+||+.||++|||++||++.|+.+.
T Consensus 234 ~--~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 234 V--RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp S--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred c--cccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1 1123467899999999999999999999999998764
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-49 Score=414.77 Aligned_cols=246 Identities=25% Similarity=0.369 Sum_probs=209.2
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
++|+..+.||+|+||+||+|+++ +++.||+|++.... ....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999986 57899999986432 334577899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
||+++|+|.+++. ....+++.++..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~---~~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 9999999999995 456799999999999999999999966 9999999999999999999999999999875432
Q ss_pred CCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccccc
Q 002349 754 KSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCK 833 (933)
Q Consensus 754 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (933)
......||+.|||||++.+..++.++||||+||++|||++|+.||.+................ ++..
T Consensus 160 ---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~--------~p~~-- 226 (263)
T d2j4za1 160 ---RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT--------FPDF-- 226 (263)
T ss_dssp ---CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCC--------CCTT--
T ss_pred ---cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC--------CCcc--
Confidence 234567999999999999999999999999999999999999999876554443332221111 1111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 834 DLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 834 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.+.++.+++.+||+.||++|||++|++++
T Consensus 227 ---~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 227 ---VTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp ---SCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ---CCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 23568889999999999999999999873
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-49 Score=423.97 Aligned_cols=259 Identities=25% Similarity=0.384 Sum_probs=217.6
Q ss_pred hhccCcceeeecccceeEEEEEEcC-CceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEe
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKN-CKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
.++|+..+.||+|+||+||+|+++. ++.||||+++... ...++|.+|++++++++|||||++++++.+++..++||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 4578889999999999999999864 7889999987643 3467899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS 755 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 755 (933)
+++|+|.+++.. .....+++..+..++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+|+.......
T Consensus 95 ~~~g~l~~~l~~-~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 95 MTYGNLLDYLRE-CNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp CTTCBHHHHHHH-SCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred ccCcchHHHhhh-ccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence 999999999864 2346789999999999999999999976 999999999999999999999999999998765555
Q ss_pred ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCH
Q 002349 756 YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDL 835 (933)
Q Consensus 756 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (933)
.......|++.|+|||++.+..++.++|||||||++|||++|+.||................ ..+..+.
T Consensus 171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~------~~~~~~~----- 239 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD------YRMERPE----- 239 (287)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT------CCCCCCT-----
T ss_pred eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC------CCCCCCc-----
Confidence 54555678999999999999999999999999999999999888776555544433221111 1111111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCC
Q 002349 836 GAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVP 871 (933)
Q Consensus 836 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 871 (933)
..+..+.+++.+||+.||++|||++||++.|+.+..
T Consensus 240 ~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 240 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 124678899999999999999999999999987654
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-49 Score=419.12 Aligned_cols=250 Identities=24% Similarity=0.336 Sum_probs=211.3
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEec
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFM 676 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 676 (933)
++|+..+.||+|+||+||+|+++ +++.||||++........+.+.+|++++++++|||||++++++.+++..|+||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 47999999999999999999975 58899999997665555678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCc
Q 002349 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY 756 (933)
Q Consensus 677 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 756 (933)
++|+|.+++. ...+++.++..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+.... .
T Consensus 100 ~gg~L~~~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~ 171 (293)
T d1yhwa1 100 AGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-S 171 (293)
T ss_dssp TTCBHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-C
T ss_pred CCCcHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccc-c
Confidence 9999999884 34699999999999999999999966 99999999999999999999999999998764332 2
Q ss_pred eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHH
Q 002349 757 TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLG 836 (933)
Q Consensus 757 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (933)
.....+||+.|||||++.+..++.++||||+||++|+|++|+.||.+.................. ..+. .
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~-----~~~~-----~ 241 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL-----QNPE-----K 241 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC-----SSGG-----G
T ss_pred cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC-----CCcc-----c
Confidence 33456799999999999999999999999999999999999999987665544433222111000 0111 1
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 837 AVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 837 ~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.+..+.+++.+||+.||++|||++|++++
T Consensus 242 ~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 23568889999999999999999999874
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.3e-49 Score=423.54 Aligned_cols=257 Identities=26% Similarity=0.385 Sum_probs=200.4
Q ss_pred hccCcceeeecccceeEEEEEEcC-C---ceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKN-C---KPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLF 672 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 672 (933)
++|+..++||+|+||+||+|.++. + ..||||++.... ....++|.+|++++++++|||||+++|++..++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 345566899999999999999763 2 258899886643 44567899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccccc
Q 002349 673 YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV 752 (933)
Q Consensus 673 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 752 (933)
||||++|+|.+++. ...+.+++.++..++.|+|+||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 106 ~Ey~~~g~L~~~~~--~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLR--QNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHH--TTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeec--cccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccC
Confidence 99999999999886 3456799999999999999999999965 999999999999999999999999999987643
Q ss_pred CCCce----eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCcc
Q 002349 753 SKSYT----STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPE 827 (933)
Q Consensus 753 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 827 (933)
..... .....||+.|||||.+.++.++.++|||||||++|||+| |+.||.+............ +. .+.
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~--~~-----~~~ 253 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ--DY-----RLP 253 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT--TC-----CCC
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHc--CC-----CCC
Confidence 32211 222468999999999999999999999999999999998 8999986654433222111 11 111
Q ss_pred ccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCC
Q 002349 828 ISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVP 871 (933)
Q Consensus 828 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 871 (933)
.+ ...+..+.+++.+||+.||++|||++||++.|+.+..
T Consensus 254 ~~-----~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 254 PP-----MDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp CC-----TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CC-----ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 11 1234678999999999999999999999999987653
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-49 Score=417.83 Aligned_cols=256 Identities=27% Similarity=0.377 Sum_probs=210.6
Q ss_pred hhccCcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEec
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFM 676 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 676 (933)
.++|+..+.||+|+||+||+|.+++++.||||+++... ...+.|.+|++++++++|||||+++|++.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 35788899999999999999999988899999997644 345789999999999999999999998754 5679999999
Q ss_pred CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCc
Q 002349 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY 756 (933)
Q Consensus 677 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 756 (933)
++|+|.++++. ....++++..+..++.||++||+|||++ +|+||||||+|||+++++.+||+|||+|+........
T Consensus 90 ~~g~L~~~~~~-~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 90 ENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp TTCBHHHHTTS-HHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCcHHHHHhh-cCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCccc
Confidence 99999998853 2233699999999999999999999966 9999999999999999999999999999987544444
Q ss_pred eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHH
Q 002349 757 TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLG 836 (933)
Q Consensus 757 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (933)
......||+.|||||++.+..++.++|||||||++|||+||+.|+................ ..+..+. .
T Consensus 166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~------~~~~~p~-----~ 234 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG------YRMVRPD-----N 234 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT------CCCCCCT-----T
T ss_pred cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc------CCCCCcc-----c
Confidence 4445679999999999999999999999999999999999766665444433332221111 1111111 1
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHHccC
Q 002349 837 AVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869 (933)
Q Consensus 837 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 869 (933)
.+..+.+++.+||+.||++|||++||++.|+.+
T Consensus 235 ~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 235 CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 245788999999999999999999999988764
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-48 Score=405.81 Aligned_cols=254 Identities=20% Similarity=0.317 Sum_probs=215.3
Q ss_pred hccCcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecC
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFME 677 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 677 (933)
++|+..+.||+|+||+||+|++++++.||||+++... ...++|.+|++++++++|||||+++|++.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 5788899999999999999999988899999997643 345789999999999999999999999999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCce
Q 002349 678 NGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYT 757 (933)
Q Consensus 678 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 757 (933)
+|+|.+++. .....+++..+.+++.|+++||+|||++ +|+||||||+||++++++.+||+|||+|+.........
T Consensus 83 ~g~l~~~~~--~~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 83 NGCLLNYLR--EMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp TEEHHHHHH--SGGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred CCcHHHhhh--ccccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence 999999975 3456789999999999999999999966 99999999999999999999999999998765544444
Q ss_pred eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCccccccccCHH
Q 002349 758 STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLG 836 (933)
Q Consensus 758 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (933)
.....||+.|+|||++.+..++.++|||||||++|||+| |+.||.+....+..... ..+ ..+..+. .
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i--~~~-----~~~~~p~-----~ 225 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI--AQG-----LRLYRPH-----L 225 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH--HTT-----CCCCCCT-----T
T ss_pred ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHH--HhC-----CCCCCcc-----c
Confidence 445679999999999999999999999999999999998 89999876544332221 111 1111111 1
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHHccC
Q 002349 837 AVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869 (933)
Q Consensus 837 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 869 (933)
.+..+.+++.+||+.||++|||+++++++|.++
T Consensus 226 ~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 226 ASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred ccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 235788999999999999999999999998653
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-49 Score=418.33 Aligned_cols=252 Identities=21% Similarity=0.278 Sum_probs=209.9
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEec
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFM 676 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 676 (933)
+.|+..+.||+|+||+||+|+++ +++.||||++........+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46888999999999999999976 57889999998776667788999999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCc
Q 002349 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY 756 (933)
Q Consensus 677 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 756 (933)
++|+|.+++. ...+++++.++..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+...... .
T Consensus 92 ~~g~L~~~~~--~~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~ 165 (288)
T d2jfla1 92 AGGAVDAVML--ELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-Q 165 (288)
T ss_dssp TTEEHHHHHH--HHTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-H
T ss_pred CCCcHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc-c
Confidence 9999999875 2345799999999999999999999976 99999999999999999999999999997653221 1
Q ss_pred eeeeecccccccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccc
Q 002349 757 TSTYIMGTIGYIDPEYAR-----TSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISAT 831 (933)
Q Consensus 757 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (933)
......||+.|||||++. +..|+.++||||+||++|||++|+.||.+....+........... .+..
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~-------~~~~- 237 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPP-------TLAQ- 237 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCC-------CCSS-
T ss_pred cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC-------CCCc-
Confidence 223467999999999984 456899999999999999999999999876655544332221111 1110
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 832 CKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 832 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
....+..+.+++.+||+.||++|||++|++++
T Consensus 238 --~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 238 --PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp --GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred --cccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11224578899999999999999999999874
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-48 Score=412.07 Aligned_cols=264 Identities=26% Similarity=0.371 Sum_probs=210.1
Q ss_pred hccCcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecC
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFME 677 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 677 (933)
++|+..+.||+|+||+||+|++++++.||||++.... ...+.|.+|+.++++++|||||+++|++.+ +..++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 6899999999999999999999988899999996543 345789999999999999999999999854 56899999999
Q ss_pred CCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCce
Q 002349 678 NGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYT 757 (933)
Q Consensus 678 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 757 (933)
+|+|.+++.. .....+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+.......
T Consensus 95 ~g~l~~~~~~-~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 170 (285)
T d1fmka3 95 KGSLLDFLKG-ETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 170 (285)
T ss_dssp TCBHHHHHSH-HHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCchhhhhhh-cccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence 9999998853 2234699999999999999999999976 99999999999999999999999999998765444444
Q ss_pred eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccCHHH
Q 002349 758 STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDLGA 837 (933)
Q Consensus 758 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 837 (933)
.....||+.|+|||++.++.++.++|||||||++|||++|..|+................. .+..+. ..
T Consensus 171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~------~~~~~~-----~~ 239 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY------RMPCPP-----EC 239 (285)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC------CCCCCT-----TS
T ss_pred eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC------CCCCCc-----cc
Confidence 4556799999999999999999999999999999999997777655444443332221111 111111 12
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCCCCCCCCC
Q 002349 838 VKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPAPEPQKQ 878 (933)
Q Consensus 838 ~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~ 878 (933)
++++.+++.+||+.||++|||+++|++.|+.......|+.+
T Consensus 240 ~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~ 280 (285)
T d1fmka3 240 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ 280 (285)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCC
T ss_pred CHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCC
Confidence 45788999999999999999999999999987765554443
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-48 Score=411.25 Aligned_cols=256 Identities=21% Similarity=0.275 Sum_probs=196.8
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEec--CCccEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLS--SSGNLL 671 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l 671 (933)
.++|+..+.||+|+||+||+|+++ +++.||||++.... ....+.+.+|++++++++|||||++++++.+ .+..|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 368999999999999999999976 57899999997643 3345678999999999999999999999865 455789
Q ss_pred EEEecCCCCHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHhhcCC--CCCeeeccCCCCceEeCCCCCeEEeeccccc
Q 002349 672 FYDFMENGSLWDILHGP-TKKKKLDWDTRLKIALGAAQGLAYLHHDC--SPRIIHRDVKSSNILLDKDFEAHLTDFGIAK 748 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 748 (933)
||||+++|+|.+++... .....+++..++.++.|++.||+|||+.. ..+|+||||||+|||++.++.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 99999999999998532 13467999999999999999999999741 1249999999999999999999999999998
Q ss_pred ccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccc
Q 002349 749 SLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEI 828 (933)
Q Consensus 749 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 828 (933)
.+.... .......||+.|||||++.+..+++++|||||||++|||+||+.||.+....+...... .... +.+
T Consensus 163 ~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~--~~~~-----~~~ 234 (269)
T d2java1 163 ILNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR--EGKF-----RRI 234 (269)
T ss_dssp HC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH--HTCC-----CCC
T ss_pred ecccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHH--cCCC-----CCC
Confidence 764332 22345689999999999999999999999999999999999999998655443322211 1111 111
Q ss_pred cccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 829 SATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 829 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
+. ..+.++.+++.+||+.||++|||++|++++
T Consensus 235 ~~-----~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 235 PY-----RYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp CT-----TSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred Cc-----ccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 11 123578899999999999999999999864
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-48 Score=411.44 Aligned_cols=248 Identities=23% Similarity=0.267 Sum_probs=205.9
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
++|+..+.||+|+||+||+|+++ +++.||||++.... ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999985 58899999986532 334567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
||+++|+|.+++. ..+.+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~---~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhh---ccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccC
Confidence 9999999999984 456899999999999999999999966 9999999999999999999999999999876433
Q ss_pred CC-ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccc
Q 002349 754 KS-YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATC 832 (933)
Q Consensus 754 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (933)
.. ......+||+.|||||++.+..++.++||||+||++|||++|+.||.+................ ++..
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~--------~p~~- 232 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD--------FPEK- 232 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCC--------CCTT-
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCC--------CCcc-
Confidence 22 2334567999999999999999999999999999999999999999876554443322221111 1111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 002349 833 KDLGAVKKVFQLALLCSKRQPTDRPTMHEVSR 864 (933)
Q Consensus 833 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 864 (933)
.+..+.+++.+||+.||++|||++|+.+
T Consensus 233 ----~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 233 ----FFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp ----CCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred ----CCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 1356788999999999999999999743
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.1e-47 Score=416.96 Aligned_cols=253 Identities=21% Similarity=0.300 Sum_probs=213.9
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEe
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
.++|++.+.||+|+||+||+|+++ +|+.||||++........+.+.+|++++++++|||||++++++.+++..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 468999999999999999999975 5889999999877666677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCC--CCCeEEeecccccccccC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDK--DFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~--~~~~kl~DfGla~~~~~~ 753 (933)
|++|+|.+++. ...+++++.++..++.||+.||+|||++ +||||||||+|||++. ++.+||+|||+|+.+...
T Consensus 105 ~~gg~L~~~l~--~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVA--DEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHT--CTTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHH--hhcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 99999999985 2456799999999999999999999966 9999999999999964 578999999999876433
Q ss_pred CCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccccc
Q 002349 754 KSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCK 833 (933)
Q Consensus 754 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (933)
.......||+.|||||++.+..++.++||||+||++|||++|+.||.+....+.+...............+
T Consensus 180 --~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~------- 250 (350)
T d1koaa2 180 --QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFS------- 250 (350)
T ss_dssp --SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGG-------
T ss_pred --cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccc-------
Confidence 33445689999999999999999999999999999999999999998766554443333222221111111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 834 DLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 834 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
..+..+.+++.+||+.||++|||++|++++
T Consensus 251 --~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 251 --GISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp --GCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred --CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 113567889999999999999999999986
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=408.48 Aligned_cols=254 Identities=22% Similarity=0.340 Sum_probs=207.7
Q ss_pred hccCccee-eecccceeEEEEEEcC---CceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEE
Q 002349 598 ENLSEKYI-IGYGASSTVYKCVLKN---CKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLF 672 (933)
Q Consensus 598 ~~~~~~~~-lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 672 (933)
++|...+. ||+|+||+||+|.++. +..||||+++... ....++|.+|++++++++|||||+++|++.. +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 45666664 9999999999998653 4579999997654 3456789999999999999999999999865 468999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccccc
Q 002349 673 YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV 752 (933)
Q Consensus 673 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 752 (933)
|||+++|+|.+++. ..+..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+|+.+..
T Consensus 87 mE~~~~g~L~~~l~--~~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLV--GKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHT--TCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCcHHHHhh--ccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcccc
Confidence 99999999999985 3456799999999999999999999965 999999999999999999999999999987754
Q ss_pred CCCce--eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCcccc
Q 002349 753 SKSYT--STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEIS 829 (933)
Q Consensus 753 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (933)
..... .....||+.|||||++.+..++.++|||||||++|||+| |+.||.+....+...... .+. .+..+
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~--~~~-----~~~~p 234 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE--QGK-----RMECP 234 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH--TTC-----CCCCC
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH--cCC-----CCCCC
Confidence 33322 233568999999999999999999999999999999998 899998665443322221 111 11121
Q ss_pred ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccC
Q 002349 830 ATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869 (933)
Q Consensus 830 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 869 (933)
. ..+.++.+++.+||+.||++|||+.+|.+.|+..
T Consensus 235 ~-----~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 235 P-----ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp T-----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred C-----cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1 1246788999999999999999999999988753
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.6e-48 Score=413.89 Aligned_cols=252 Identities=23% Similarity=0.267 Sum_probs=194.8
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYD 674 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 674 (933)
.+.|+..+.||+|+||+||+|+++ +++.||||++.... ....+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467999999999999999999976 57899999997543 2334668899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeC---CCCCeEEeecccccccc
Q 002349 675 FMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLD---KDFEAHLTDFGIAKSLC 751 (933)
Q Consensus 675 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~---~~~~~kl~DfGla~~~~ 751 (933)
|++||+|.+++. ..+.+++.++..++.|++.||+|||++ +|+||||||+||++. +++.+||+|||+|+...
T Consensus 88 ~~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 88 LVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCSCBHHHHHH---TCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred ccCCCcHHHhhh---cccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 999999999995 456799999999999999999999966 999999999999995 57899999999998653
Q ss_pred cCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccc
Q 002349 752 VSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISAT 831 (933)
Q Consensus 752 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (933)
.. ......+||+.|||||++.+..+++++||||+||++|||++|+.||.+......................+
T Consensus 162 ~~--~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~----- 234 (307)
T d1a06a_ 162 PG--SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWD----- 234 (307)
T ss_dssp -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTT-----
T ss_pred CC--CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCcccc-----
Confidence 32 22344679999999999999999999999999999999999999998766554443332222211111111
Q ss_pred ccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 832 CKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 832 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
..+..+.+++.+||+.||++|||++|++++
T Consensus 235 ----~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 235 ----DISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp ----TSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ----CCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 123568899999999999999999999985
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=404.41 Aligned_cols=247 Identities=23% Similarity=0.329 Sum_probs=199.1
Q ss_pred CcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEec----CCccEEEE
Q 002349 601 SEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLS----SSGNLLFY 673 (933)
Q Consensus 601 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~ 673 (933)
+..+.||+|+||+||+|.++ +++.||+|++.... ....+.+.+|++++++++|||||++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 45568999999999999976 47889999986542 3445679999999999999999999999864 34578999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeC-CCCCeEEeeccccccccc
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLD-KDFEAHLTDFGIAKSLCV 752 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~-~~~~~kl~DfGla~~~~~ 752 (933)
||+++|+|.+++. ....+++..+..++.|++.||+|||++ ..+|+||||||+|||++ +++.+||+|||+|+....
T Consensus 92 E~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHh---ccccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 9999999999995 456799999999999999999999976 23399999999999997 578999999999986432
Q ss_pred CCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccc
Q 002349 753 SKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATC 832 (933)
Q Consensus 753 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (933)
......+||+.|||||++.+ .++.++||||+||++|||++|+.||.+............. .... +.+...
T Consensus 168 ---~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~-~~~~----~~~~~~- 237 (270)
T d1t4ha_ 168 ---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKP----ASFDKV- 237 (270)
T ss_dssp ---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TCCC----GGGGGC-
T ss_pred ---CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc-CCCC----cccCcc-
Confidence 23345689999999999876 5999999999999999999999999865554443322211 1111 111111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 833 KDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 833 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.+.++.+++.+||+.||++|||++|++++
T Consensus 238 ----~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 238 ----AIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp ----CCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ----CCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 12467889999999999999999999874
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-48 Score=421.04 Aligned_cols=257 Identities=23% Similarity=0.354 Sum_probs=206.1
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYD 674 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 674 (933)
.++|+..+.||+|+||+||+|++. +++.||+|+++... ....+.+.+|++++++++|||||+++++|.++++.++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 468999999999999999999976 57899999997543 4445778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCC
Q 002349 675 FMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSK 754 (933)
Q Consensus 675 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 754 (933)
|+++|+|.++++ +.+.+++..+..++.|++.||+|||+. .+|+||||||+|||++.++.+||+|||+|+.+...
T Consensus 85 y~~gg~L~~~l~---~~~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~- 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 158 (322)
T ss_dssp CCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred cCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-
Confidence 999999999995 346799999999999999999999952 28999999999999999999999999999876432
Q ss_pred CceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhc-cccccc-----------
Q 002349 755 SYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTA-NNAVME----------- 822 (933)
Q Consensus 755 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~-~~~~~~----------- 822 (933)
.....+||+.|||||++.+..|++++||||+||++|||++|+.||.+............. .+....
T Consensus 159 --~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 159 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp --TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred --ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence 223468999999999999999999999999999999999999999765433221110000 000000
Q ss_pred -----------------------ccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 823 -----------------------TVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 823 -----------------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
..++..+. ...+.++.+++.+||+.||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPS----GVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSCCCCCCB----TTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccchhHHHHHhhhhccCCccCcc----ccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 00000000 0113568899999999999999999999874
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=409.71 Aligned_cols=259 Identities=27% Similarity=0.443 Sum_probs=204.7
Q ss_pred hccCcceeeecccceeEEEEEEcCC-----ceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKNC-----KPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLL 671 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 671 (933)
+.|+..++||+|+||+||+|.++.. ..||||++.... .....+|.+|++++++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4678889999999999999997642 369999997644 3345679999999999999999999999999999999
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccc
Q 002349 672 FYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLC 751 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 751 (933)
||||+.++++.+.+. .....+++.++..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+.
T Consensus 87 v~e~~~~~~l~~~~~--~~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLR--EKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHH--HTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEecccCcchhhhh--cccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhccc
Confidence 999999999999875 3456799999999999999999999966 99999999999999999999999999998764
Q ss_pred cCCC--ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccc
Q 002349 752 VSKS--YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEIS 829 (933)
Q Consensus 752 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (933)
.... .......||+.|||||++.++.++.++|||||||++|||++|+.|+.............. .+ ..+..+
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~-~~-----~~~~~~ 235 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-DG-----FRLPTP 235 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TT-----CCCCCC
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHh-cc-----CCCCCc
Confidence 3322 223345689999999999999999999999999999999997777655444443332211 11 111111
Q ss_pred ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCCC
Q 002349 830 ATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVPA 872 (933)
Q Consensus 830 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 872 (933)
. ..+..+.+++.+||+.||++||||+||++.|+.+...
T Consensus 236 ~-----~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 236 M-----DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp T-----TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred h-----hhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 1 2346789999999999999999999999999876543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.9e-47 Score=415.74 Aligned_cols=252 Identities=21% Similarity=0.306 Sum_probs=214.1
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEec
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFM 676 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 676 (933)
++|+..+.||+|+||+||+|++. +++.||||++........+.+.+|++++++++|||||++++++.+++..|+|||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 57999999999999999999975 58999999998766556678899999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeC--CCCCeEEeecccccccccCC
Q 002349 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLD--KDFEAHLTDFGIAKSLCVSK 754 (933)
Q Consensus 677 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~--~~~~~kl~DfGla~~~~~~~ 754 (933)
++|+|.+.+. ....++++.++..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+|+.+...
T Consensus 109 ~gg~L~~~~~--~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~- 182 (352)
T d1koba_ 109 SGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD- 182 (352)
T ss_dssp CCCBHHHHTT--CTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred CCChHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCC-
Confidence 9999999874 3455799999999999999999999966 999999999999998 5789999999999886433
Q ss_pred CceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccccC
Q 002349 755 SYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKD 834 (933)
Q Consensus 755 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (933)
.......||+.|||||++.+..++.++||||+||++|||+||+.||.+......................+
T Consensus 183 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~-------- 253 (352)
T d1koba_ 183 -EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFS-------- 253 (352)
T ss_dssp -SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTT--------
T ss_pred -CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccc--------
Confidence 23445689999999999999999999999999999999999999998776655544333322222221111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 835 LGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 835 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
..+..+.+++.+||+.||++|||++|++++
T Consensus 254 -~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 254 -SVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp -TSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 123567899999999999999999999875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-47 Score=404.73 Aligned_cols=246 Identities=24% Similarity=0.373 Sum_probs=199.5
Q ss_pred eeeecccceeEEEEEEcC---CceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEecCC
Q 002349 604 YIIGYGASSTVYKCVLKN---CKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFMEN 678 (933)
Q Consensus 604 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 678 (933)
+.||+|+||+||+|.+++ ++.||||+++... +...++|.+|++++++++|||||+++|++.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 479999999999998753 4679999996542 3446789999999999999999999999865 457899999999
Q ss_pred CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCce-
Q 002349 679 GSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSYT- 757 (933)
Q Consensus 679 gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~~- 757 (933)
|+|.++++ ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+.......
T Consensus 92 g~L~~~l~---~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHh---hccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 99999995 456799999999999999999999966 99999999999999999999999999998764433322
Q ss_pred -eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCccccccccCH
Q 002349 758 -STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDL 835 (933)
Q Consensus 758 -~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (933)
.....||+.|||||.+.+..++.++|||||||++|||+| |+.||.+....+...... .+. .+..+.
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~--~~~-----~~~~p~----- 233 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE--KGE-----RMGCPA----- 233 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH--TTC-----CCCCCT-----
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHH--cCC-----CCCCCc-----
Confidence 234578999999999999999999999999999999998 899998655433222211 111 111111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcc
Q 002349 836 GAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGS 868 (933)
Q Consensus 836 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 868 (933)
..+.++.+++.+||+.||++|||+++|.+.|+.
T Consensus 234 ~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 234 GCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred ccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 224678899999999999999999999988764
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-47 Score=413.97 Aligned_cols=256 Identities=23% Similarity=0.349 Sum_probs=207.6
Q ss_pred hccCcceeeecccceeEEEEEEcCC------ceEEEEEecccC-chhHHHHHHHHHHHhcC-CCCceeeeeeEEecCCcc
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKNC------KPVAIKRLYSHY-PQCLKEFETELETVGSI-KHRNLVSLQGYSLSSSGN 669 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~~------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 669 (933)
++|+..++||+|+||+||+|++... ..||||++.... ......+.+|+.+++++ +|||||++++++.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 6788999999999999999997542 369999986543 44567789999999998 899999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCC
Q 002349 670 LLFYDFMENGSLWDILHGPTK--------------------KKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSS 729 (933)
Q Consensus 670 ~lv~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~ 729 (933)
++|||||++|+|.++++.... ...+++..++.++.|+++||+|||++ +||||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchh
Confidence 999999999999999964321 23589999999999999999999966 9999999999
Q ss_pred ceEeCCCCCeEEeecccccccccCCCc-eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcch
Q 002349 730 NILLDKDFEAHLTDFGIAKSLCVSKSY-TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNL 807 (933)
Q Consensus 730 NIll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~ 807 (933)
||+++.++.+||+|||+|+........ ......||+.|||||++.+..++.++|||||||++|||+| |+.||.+....
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999999876443332 2334678999999999999999999999999999999998 89999865544
Q ss_pred hHHHHhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 002349 808 HHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLG 867 (933)
Q Consensus 808 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 867 (933)
.......... ..+..+. ..+..+.+++.+||+.||++|||++||+++|.
T Consensus 274 ~~~~~~~~~~------~~~~~p~-----~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 ANFYKLIQNG------FKMDQPF-----YATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HHHHHHHHTT------CCCCCCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHhcC------CCCCCCC-----cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 4333221111 1111111 12467889999999999999999999999985
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.2e-47 Score=409.75 Aligned_cols=246 Identities=26% Similarity=0.319 Sum_probs=204.8
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
+.|+..+.||+|+||+||+|++. +++.||||++.... ....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 46899999999999999999975 57889999997543 234467899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
|||++|++..++. ...++++.++..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp ECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 9999999987763 456799999999999999999999966 999999999999999999999999999986532
Q ss_pred CCceeeeecccccccCcccccc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccc
Q 002349 754 KSYTSTYIMGTIGYIDPEYART---SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISA 830 (933)
Q Consensus 754 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (933)
.....||+.|||||++.+ ..|+.++|||||||++|||++|+.||.+............... . .+.
T Consensus 168 ----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~--~-----~~~- 235 (309)
T d1u5ra_ 168 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES--P-----ALQ- 235 (309)
T ss_dssp ----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC--C-----CCS-
T ss_pred ----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC--C-----CCC-
Confidence 234579999999999864 4589999999999999999999999987655544332222111 1 111
Q ss_pred cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 831 TCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 831 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
....+..+.+++.+||+.||++|||++|++++
T Consensus 236 ---~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 236 ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp ---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ---CCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 01123578899999999999999999999873
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=404.54 Aligned_cols=252 Identities=21% Similarity=0.301 Sum_probs=210.4
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC------chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCcc
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY------PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGN 669 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 669 (933)
.++|+..+.||+|+||+||+|+++ +|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 367999999999999999999985 58899999986432 22457899999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCC----CeEEeecc
Q 002349 670 LLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDF----EAHLTDFG 745 (933)
Q Consensus 670 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~----~~kl~DfG 745 (933)
++|||||++|+|.+++. ..+.+++..+..++.|++.||+|||++ +|+||||||+||+++.++ .+|++|||
T Consensus 89 ~iv~E~~~gg~L~~~i~---~~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhc---cccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchh
Confidence 99999999999999995 346799999999999999999999966 999999999999998776 49999999
Q ss_pred cccccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccC
Q 002349 746 IAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVD 825 (933)
Q Consensus 746 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (933)
+|+...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+.................
T Consensus 163 ~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 240 (293)
T d1jksa_ 163 LAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 240 (293)
T ss_dssp TCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred hhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhc
Confidence 998764332 234457999999999999999999999999999999999999999876655544333222211111111
Q ss_pred ccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 826 PEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 826 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
+ ..+..+.+++.+||+.||++|||++|++++
T Consensus 241 ~---------~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 241 S---------NTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp T---------TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred C---------CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1 123567889999999999999999999885
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-46 Score=397.67 Aligned_cols=256 Identities=24% Similarity=0.348 Sum_probs=199.2
Q ss_pred hhccCcceeeecccceeEEEEEEcC----CceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKN----CKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLL 671 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 671 (933)
.++|+..+.||+|+||+||+|++.. +..||||+++... ....+.|.+|++++++++|||||++++++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 3688999999999999999999753 3468999886544 334567999999999999999999999986 467899
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccc
Q 002349 672 FYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLC 751 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 751 (933)
||||+++|+|.+++. .....+++..++.++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+|+...
T Consensus 85 v~E~~~~g~l~~~~~--~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQ--VRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEECCTTEEHHHHHH--HTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEeccCCcHHhhhh--ccCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheecc
Confidence 999999999999875 3456799999999999999999999966 99999999999999999999999999998775
Q ss_pred cCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCccccc
Q 002349 752 VSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISA 830 (933)
Q Consensus 752 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 830 (933)
...........||+.|+|||++.+..++.++|||||||++|||+| |..||.+....+....... +.. +..+.
T Consensus 160 ~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~--~~~-----~~~~~ 232 (273)
T d1mp8a_ 160 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN--GER-----LPMPP 232 (273)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT--TCC-----CCCCT
T ss_pred CCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHc--CCC-----CCCCC
Confidence 544445556678999999999999999999999999999999998 8889986655443322221 111 11111
Q ss_pred cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCC
Q 002349 831 TCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLV 870 (933)
Q Consensus 831 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 870 (933)
..+..+.+++.+||+.||++|||++||++.|+.+.
T Consensus 233 -----~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 233 -----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp -----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 12457889999999999999999999999987653
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-46 Score=402.49 Aligned_cols=248 Identities=21% Similarity=0.257 Sum_probs=209.4
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
++|+..+.||+|+||+||+|+++ +++.||||++.... ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 67999999999999999999975 58999999996532 334577899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
||+++|+|.+++. ..+.+++..+..++.|++.||+|||++ +|+||||||+|||++.+|.+||+|||+|+.....
T Consensus 85 ey~~gg~L~~~~~---~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eccCCCchhhhhh---cccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 9999999999995 456799999999999999999999966 9999999999999999999999999999875432
Q ss_pred CCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccccc
Q 002349 754 KSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCK 833 (933)
Q Consensus 754 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (933)
.......+||+.|||||++.+..|+.++||||+||++|||++|+.||.+................. +..
T Consensus 159 -~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~--------p~~-- 227 (337)
T d1o6la_ 159 -GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF--------PRT-- 227 (337)
T ss_dssp -TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--------CTT--
T ss_pred -CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCC--------Ccc--
Confidence 223445689999999999999999999999999999999999999998766544333322221111 111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 002349 834 DLGAVKKVFQLALLCSKRQPTDRPT-----MHEVSRV 865 (933)
Q Consensus 834 ~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 865 (933)
.+.++.+++.+||+.||++||+ ++|++++
T Consensus 228 ---~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 228 ---LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ---SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ---CCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 1346788999999999999994 8888864
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.5e-45 Score=398.39 Aligned_cols=245 Identities=24% Similarity=0.312 Sum_probs=208.0
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
++|+..+.||+|+||+||+|+++ +|+.||||+++... ....+.+.+|+.++++++|||||++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 57999999999999999999975 58899999996532 334677899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
||++||+|..++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCcccccccc---ccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 9999999999984 566789999999999999999999955 9999999999999999999999999999876432
Q ss_pred CCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccccc
Q 002349 754 KSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCK 833 (933)
Q Consensus 754 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (933)
....+||+.|||||++.+..++.++||||+||++|||++|+.||.+................. ++.
T Consensus 158 ----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~----p~~------ 223 (316)
T d1fota_ 158 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF----PPF------ 223 (316)
T ss_dssp ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCC----CTT------
T ss_pred ----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCC----CCC------
Confidence 234689999999999999999999999999999999999999998765544433322221111 111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002349 834 DLGAVKKVFQLALLCSKRQPTDRP-----TMHEVSRV 865 (933)
Q Consensus 834 ~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 865 (933)
.+..+.+++.+|++.||.+|+ |+++++++
T Consensus 224 ---~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 224 ---FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp ---SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ---CCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 134678899999999999996 89999874
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1e-45 Score=394.12 Aligned_cols=258 Identities=24% Similarity=0.388 Sum_probs=204.3
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCc----
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSG---- 668 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---- 668 (933)
.++|+..+.||+|+||+||+|++. +++.||||+++... ....+.+.+|++++++++|||||++++++...+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 367999999999999999999975 58899999997543 3345679999999999999999999999876543
Q ss_pred cEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccc
Q 002349 669 NLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAK 748 (933)
Q Consensus 669 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 748 (933)
.|+||||++|++|.+++. ..+++++.++..++.|++.||+|||++ +|+||||||+||+++.++.++++|||.++
T Consensus 86 ~~lvmE~~~g~~L~~~~~---~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhc---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhh
Confidence 789999999999999884 456799999999999999999999976 99999999999999999999999999987
Q ss_pred ccccCCC--ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCc
Q 002349 749 SLCVSKS--YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDP 826 (933)
Q Consensus 749 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 826 (933)
....... ......+||+.|||||++.+..+++++||||+||++|||+||+.||.+......................+
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE 239 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSS
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhcc
Confidence 6533222 23345679999999999999999999999999999999999999998766554433322222111111111
Q ss_pred cccccccCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHccC
Q 002349 827 EISATCKDLGAVKKVFQLALLCSKRQPTDRP-TMHEVSRVLGSL 869 (933)
Q Consensus 827 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~ 869 (933)
..+..+.+++.+|++.||++|| |++++.+.|..+
T Consensus 240 ---------~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 240 ---------GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp ---------SCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ---------CCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 1235788999999999999999 899998877653
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-45 Score=397.98 Aligned_cols=260 Identities=23% Similarity=0.381 Sum_probs=210.9
Q ss_pred HhhccCcceeeecccceeEEEEEEcC------CceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCc
Q 002349 596 MTENLSEKYIIGYGASSTVYKCVLKN------CKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSG 668 (933)
Q Consensus 596 ~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 668 (933)
..++|+..+.||+|+||+||+|++++ ++.||||++.... .+..++|.+|++++++++||||+++++++...+.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 45789999999999999999999753 4689999997654 3346779999999999999999999999999999
Q ss_pred cEEEEEecCCCCHHHHhcCC---------------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCC
Q 002349 669 NLLFYDFMENGSLWDILHGP---------------------TKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVK 727 (933)
Q Consensus 669 ~~lv~e~~~~gsL~~~l~~~---------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik 727 (933)
.++||||+++|+|.++++.. .....+++..++.++.|++.||+|||++ +|||||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEc
Confidence 99999999999999998531 1223589999999999999999999965 99999999
Q ss_pred CCceEeCCCCCeEEeecccccccccCCC-ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCC-CCCCCCc
Q 002349 728 SSNILLDKDFEAHLTDFGIAKSLCVSKS-YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGR-KAVDNEC 805 (933)
Q Consensus 728 p~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~-~p~~~~~ 805 (933)
|+|||++.++.+||+|||+|+....... .......||+.|+|||.+.+..++.++|||||||++|||++|. .||.+..
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 9999999999999999999986643322 2234567899999999999999999999999999999999996 5676554
Q ss_pred chhHHHHhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCC
Q 002349 806 NLHHLILSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLV 870 (933)
Q Consensus 806 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 870 (933)
..+..... ..+.. +..+. ..+.++.+++.+||+.||++||||.||++.|+.+.
T Consensus 248 ~~e~~~~v--~~~~~-----~~~p~-----~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 248 HEEVIYYV--RDGNI-----LACPE-----NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HHHHHHHH--HTTCC-----CCCCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHHHHHH--HcCCC-----CCCCc-----cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 44332221 11111 11111 12357889999999999999999999999998764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2e-45 Score=389.61 Aligned_cols=251 Identities=28% Similarity=0.389 Sum_probs=207.5
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccCc---------hhHHHHHHHHHHHhcCC-CCceeeeeeEEecC
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYP---------QCLKEFETELETVGSIK-HRNLVSLQGYSLSS 666 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 666 (933)
++|+..+.||+|+||+||+|++. +++.||||++..... ...+.+.+|+.++++++ |||||++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 68999999999999999999975 688999999865431 12345889999999997 99999999999999
Q ss_pred CccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccc
Q 002349 667 SGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGI 746 (933)
Q Consensus 667 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGl 746 (933)
+..|+||||+++|+|.++++ ..+++++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchh
Confidence 99999999999999999995 456899999999999999999999976 999999999999999999999999999
Q ss_pred ccccccCCCceeeeecccccccCcccccc------CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccccc
Q 002349 747 AKSLCVSKSYTSTYIMGTIGYIDPEYART------SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAV 820 (933)
Q Consensus 747 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 820 (933)
|+...... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.+.................
T Consensus 157 a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~ 234 (277)
T d1phka_ 157 SCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 234 (277)
T ss_dssp CEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred eeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 98764322 3344679999999998863 357889999999999999999999998776544433322221111
Q ss_pred ccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 821 METVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.. +... ..++++.+++.+||+.||++|||++|++++
T Consensus 235 ~~---~~~~------~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 235 GS---PEWD------DYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp CT---TTGG------GSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CC---cccc------cCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 11 1111 123578899999999999999999999864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-45 Score=397.46 Aligned_cols=252 Identities=18% Similarity=0.219 Sum_probs=210.0
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEe
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
.++|+..+.||+|+||+||+|.++ +++.||||+++... .....+.+|++++++++|||||++++++.+++..|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 468999999999999999999986 57889999997654 3345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCC--CCeEEeecccccccccC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKD--FEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~--~~~kl~DfGla~~~~~~ 753 (933)
|+||+|.+++.. ....+++.++..++.|++.||+|||++ +|+||||||+|||++.+ ..+||+|||+++....
T Consensus 83 ~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~- 156 (321)
T d1tkia_ 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP- 156 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT-
T ss_pred CCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhcccc-
Confidence 999999999952 345799999999999999999999966 99999999999999854 5899999999987633
Q ss_pred CCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccccc
Q 002349 754 KSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCK 833 (933)
Q Consensus 754 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (933)
........||+.|+|||...+..++.++||||+||++|+|++|+.||.+......................+.
T Consensus 157 -~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~------ 229 (321)
T d1tkia_ 157 -GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKE------ 229 (321)
T ss_dssp -TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTT------
T ss_pred -CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccC------
Confidence 2334456799999999999999999999999999999999999999987765544433322222211111111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 834 DLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 834 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.+.++.+++.+|+..||++|||++|++++
T Consensus 230 ---~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 230 ---ISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp ---SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 13567889999999999999999999974
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-46 Score=392.66 Aligned_cols=254 Identities=24% Similarity=0.363 Sum_probs=198.8
Q ss_pred hccCcceeeecccceeEEEEEEcC----CceEEEEEeccc---CchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKN----CKPVAIKRLYSH---YPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNL 670 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 670 (933)
++|+..+.||+|+||.||+|++.. ...||||++... ..+..++|.+|++++++++|||||+++|++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 578889999999999999998643 236899998654 23456789999999999999999999999975 4678
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccc
Q 002349 671 LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSL 750 (933)
Q Consensus 671 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~ 750 (933)
+||||+++|++.+.+. .....+++..++.++.|+|.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 87 lv~e~~~~~~l~~~~~--~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLR--KHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHH--HHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhh--cccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhc
Confidence 9999999999999885 3456799999999999999999999966 9999999999999999999999999999987
Q ss_pred ccCCCce--eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCcc
Q 002349 751 CVSKSYT--STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPE 827 (933)
Q Consensus 751 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 827 (933)
....... .....|+..|+|||++.+..++.++|||||||++|||+| |+.||.+....+........ . ..+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~-~-----~~~~ 235 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE-G-----ERLP 235 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS-C-----CCCC
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhC-C-----CCCC
Confidence 4433322 334568899999999999999999999999999999998 89999866554433322211 1 1111
Q ss_pred ccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHcc
Q 002349 828 ISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGS 868 (933)
Q Consensus 828 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 868 (933)
.+. ..+..+.+++.+||+.||++|||++||.+.|.+
T Consensus 236 ~~~-----~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 236 RPE-----DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp CCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred Ccc-----cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 111 123578899999999999999999999998865
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-46 Score=389.26 Aligned_cols=249 Identities=25% Similarity=0.388 Sum_probs=196.6
Q ss_pred hccCcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEec-CCccEEEEEec
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLS-SSGNLLFYDFM 676 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~ 676 (933)
++|+..+.||+|+||.||+|+++ ++.||||+++.. ...+.|.+|++++++++|||||+++|++.+ .+..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 56888899999999999999986 578999999654 345789999999999999999999999865 45689999999
Q ss_pred CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCc
Q 002349 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY 756 (933)
Q Consensus 677 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 756 (933)
++|+|.++++. .....+++..+++++.||+.||+|||+. +|+||||||+||+++.++.+|++|||+++....
T Consensus 84 ~~g~L~~~l~~-~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~---- 155 (262)
T d1byga_ 84 AKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS---- 155 (262)
T ss_dssp TTEEHHHHHHH-HHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCHHHHHHh-cCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCC----
Confidence 99999999953 1223589999999999999999999965 999999999999999999999999999986532
Q ss_pred eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCccccccccCH
Q 002349 757 TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEISATCKDL 835 (933)
Q Consensus 757 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (933)
......+|+.|+|||++.+..+++++|||||||++|||+| |+.||......+ ..... ..+ ..+.++..
T Consensus 156 ~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~-~~~~i-~~~-----~~~~~~~~---- 224 (262)
T d1byga_ 156 TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-VVPRV-EKG-----YKMDAPDG---- 224 (262)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG-HHHHH-TTT-----CCCCCCTT----
T ss_pred CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH-HHHHH-HcC-----CCCCCCcc----
Confidence 2233468999999999999999999999999999999998 677776543332 22211 111 11222221
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccC
Q 002349 836 GAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869 (933)
Q Consensus 836 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 869 (933)
.+.++.+++.+||+.||++|||+++++++|+.+
T Consensus 225 -~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 225 -CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp -CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 235788999999999999999999999999765
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-45 Score=398.07 Aligned_cols=255 Identities=25% Similarity=0.360 Sum_probs=203.2
Q ss_pred hccCcceeeecccceeEEEEEEcC-Cc----eEEEEEeccc-CchhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKN-CK----PVAIKRLYSH-YPQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLL 671 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 671 (933)
++|+..++||+|+||+||+|.+.. ++ +||+|+++.. ..+..++|.+|++++++++|||||+++|++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 368999999999999999999753 33 5899988654 345577899999999999999999999999865 5678
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccc
Q 002349 672 FYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLC 751 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~ 751 (933)
++||+.+|+|.+.+. .....+++..+..++.|||.||+|||++ +|+||||||+|||++.++.+||+|||+|+...
T Consensus 88 v~e~~~~~~l~~~~~--~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVR--EHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHH--HTSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCccccccc--ccccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceecc
Confidence 899999999999886 3466899999999999999999999965 99999999999999999999999999998765
Q ss_pred cCCCc-eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHHhhhcccccccccCcccc
Q 002349 752 VSKSY-TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLILSKTANNAVMETVDPEIS 829 (933)
Q Consensus 752 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (933)
..... ......||+.|||||++.++.++.++|||||||++|||+| |+.||.+....+....... +. .+..+
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~--~~-----~~~~p 235 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK--GE-----RLPQP 235 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHH--TC-----CCCCC
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc--CC-----CCCCC
Confidence 43332 2334568999999999999999999999999999999998 7888876543332221111 11 11111
Q ss_pred ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCC
Q 002349 830 ATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLV 870 (933)
Q Consensus 830 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 870 (933)
. ..+..+.+++.+||+.||++|||++||+++|..+.
T Consensus 236 ~-----~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 236 P-----ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp T-----TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred c-----ccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 1 12457889999999999999999999999887653
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.3e-45 Score=398.95 Aligned_cols=245 Identities=17% Similarity=0.194 Sum_probs=207.9
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFY 673 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 673 (933)
++|+..+.||+|+||+||+|+++ +|+.||||++.... ....+.+.+|++++++++|||||++++++......++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999976 58999999986432 334567899999999999999999999999999999999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccC
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVS 753 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~ 753 (933)
||+.+|+|.+++. ..+.+++..+..++.|++.||+|||++ +||||||||+|||++.++.+||+|||+|+.+...
T Consensus 121 e~~~~g~l~~~l~---~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHh---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 9999999999984 446799999999999999999999966 9999999999999999999999999999876422
Q ss_pred CCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccccc
Q 002349 754 KSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCK 833 (933)
Q Consensus 754 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (933)
.....||+.|||||++.+..++.++||||+||++|||+||+.||.+.................. .
T Consensus 195 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p--------~--- 259 (350)
T d1rdqe_ 195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP--------S--- 259 (350)
T ss_dssp ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--------T---
T ss_pred ----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCC--------c---
Confidence 2345799999999999999999999999999999999999999987655444333222211111 1
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002349 834 DLGAVKKVFQLALLCSKRQPTDRP-----TMHEVSRV 865 (933)
Q Consensus 834 ~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 865 (933)
..+..+.+++.+||+.||++|+ |+++++++
T Consensus 260 --~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 260 --HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp --TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred --cCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 1235688999999999999994 89999874
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=390.04 Aligned_cols=253 Identities=23% Similarity=0.369 Sum_probs=203.1
Q ss_pred ceeeecccceeEEEEEEcCC----ceEEEEEeccc-CchhHHHHHHHHHHHhcCCCCceeeeeeEEec-CCccEEEEEec
Q 002349 603 KYIIGYGASSTVYKCVLKNC----KPVAIKRLYSH-YPQCLKEFETELETVGSIKHRNLVSLQGYSLS-SSGNLLFYDFM 676 (933)
Q Consensus 603 ~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~ 676 (933)
.++||+|+||+||+|.+.++ ..||||+++.. .....++|.+|++++++++|||||+++|++.. +...++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46899999999999997542 35899999753 34556789999999999999999999999865 45789999999
Q ss_pred CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCc
Q 002349 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY 756 (933)
Q Consensus 677 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 756 (933)
++|+|.++++ .....+++..+++++.|+++||.|+|+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~--~~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIR--NETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHH--CTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhc--cccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 9999999987 3455788999999999999999999965 9999999999999999999999999999876433222
Q ss_pred ---eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccccccc
Q 002349 757 ---TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATCK 833 (933)
Q Consensus 757 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (933)
......||+.|+|||.+.+..++.++||||||+++|||+||+.||.......+......... .+..+.
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~------~~~~p~--- 257 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR------RLLQPE--- 257 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTC------CCCCCT---
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC------CCCCcc---
Confidence 22335789999999999999999999999999999999999888875544333322221111 111111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCC
Q 002349 834 DLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVP 871 (933)
Q Consensus 834 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 871 (933)
..+..+.+++.+||+.||++||++.||+++|+.+..
T Consensus 258 --~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 258 --YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp --TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --cCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 123578899999999999999999999999987754
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=390.28 Aligned_cols=256 Identities=26% Similarity=0.248 Sum_probs=200.1
Q ss_pred ceeeecccceeEEEEEEc-CCceEEEEEecccCc-----hhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEec
Q 002349 603 KYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYP-----QCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDFM 676 (933)
Q Consensus 603 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 676 (933)
.++||+|+||+||+|+++ +++.||||++..... ...+.+.+|++++++++|||||++++++..++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 468999999999999975 588999999865432 12356889999999999999999999999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCCc
Q 002349 677 ENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKSY 756 (933)
Q Consensus 677 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~~ 756 (933)
+++++..+. .....+++.++..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+.......
T Consensus 83 ~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~- 155 (299)
T d1ua2a_ 83 ETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR- 155 (299)
T ss_dssp SEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-
T ss_pred cchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc-
Confidence 998777766 3566799999999999999999999966 999999999999999999999999999987643322
Q ss_pred eeeeecccccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCc---------
Q 002349 757 TSTYIMGTIGYIDPEYARTS-RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDP--------- 826 (933)
Q Consensus 757 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 826 (933)
.....+||+.|+|||++.+. .++.++||||+||++|||++|+.||.+....+.........+.......+
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhh
Confidence 23345799999999988654 67999999999999999999999998777666554332211111000000
Q ss_pred ccccc-ccC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 827 EISAT-CKD-----LGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 827 ~~~~~-~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
..... ... ......+.+++.+|++.||++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 00000 000 0123578899999999999999999999975
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-45 Score=394.83 Aligned_cols=247 Identities=23% Similarity=0.309 Sum_probs=205.6
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHHHHHHHHHh-cCCCCceeeeeeEEecCCccEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEFETELETVG-SIKHRNLVSLQGYSLSSSGNLLF 672 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~lv 672 (933)
++|...+.||+|+||+||+|+++ +++.||||+++... ....+.+.+|..++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999986 58899999996532 233456667777665 68999999999999999999999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccccc
Q 002349 673 YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCV 752 (933)
Q Consensus 673 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~ 752 (933)
|||+++|+|.++++ ....+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+....
T Consensus 82 mEy~~~g~L~~~i~---~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccc
Confidence 99999999999995 456789999999999999999999966 999999999999999999999999999986543
Q ss_pred CCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccccccc
Q 002349 753 SKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEISATC 832 (933)
Q Consensus 753 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (933)
.. .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+......+........ .++..
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~--------~~p~~- 225 (320)
T d1xjda_ 156 GD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP--------FYPRW- 225 (320)
T ss_dssp TT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--------CCCTT-
T ss_pred cc-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--------CCCcc-
Confidence 22 233446899999999999999999999999999999999999999987665544433322211 11111
Q ss_pred cCHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 002349 833 KDLGAVKKVFQLALLCSKRQPTDRPTMH-EVSR 864 (933)
Q Consensus 833 ~~~~~~~~l~~li~~cl~~dP~~RPt~~-evl~ 864 (933)
.+.++.+++.+||+.||++|||+. |+++
T Consensus 226 ----~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 226 ----LEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ----SCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ----CCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 135688999999999999999995 7764
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-45 Score=394.68 Aligned_cols=260 Identities=24% Similarity=0.347 Sum_probs=198.5
Q ss_pred hhccCcceeeecccceeEEEEEEcC------CceEEEEEecccC-chhHHHHHHHHHHHhcC-CCCceeeeeeEEecC-C
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKN------CKPVAIKRLYSHY-PQCLKEFETELETVGSI-KHRNLVSLQGYSLSS-S 667 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-~ 667 (933)
.++|+..+.||+|+||+||+|.+.. ++.||||+++... ....+.+.+|.+++.++ +|+|||.+++++... .
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 4789999999999999999999643 3679999997543 34456778888888877 689999999998765 4
Q ss_pred ccEEEEEecCCCCHHHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeC
Q 002349 668 GNLLFYDFMENGSLWDILHGPT-------------KKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLD 734 (933)
Q Consensus 668 ~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~ 734 (933)
..++|||||++|+|.++++... ....+++.+++.++.|+++||+|||++ +|+||||||+|||++
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeEC
Confidence 6799999999999999986321 134589999999999999999999966 999999999999999
Q ss_pred CCCCeEEeecccccccccCCCc-eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCC-CCCCCCcchhHHHH
Q 002349 735 KDFEAHLTDFGIAKSLCVSKSY-TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGR-KAVDNECNLHHLIL 812 (933)
Q Consensus 735 ~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~-~p~~~~~~~~~~~~ 812 (933)
.++.+||+|||+|+........ ......||+.|||||++.+..++.++|||||||++|||+||. .||.+.........
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~ 248 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 9999999999999876433322 234467999999999999999999999999999999999975 57765444333322
Q ss_pred hhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCC
Q 002349 813 SKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLV 870 (933)
Q Consensus 813 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 870 (933)
... .+. .+..+.. .+.++.+++.+||+.||++|||++||+++|+.+.
T Consensus 249 ~~~-~~~-----~~~~~~~-----~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 249 RLK-EGT-----RMRAPDY-----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp HHH-HTC-----CCCCCTT-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHh-cCC-----CCCCCcc-----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 211 111 1111111 2357889999999999999999999999998653
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-45 Score=393.57 Aligned_cols=257 Identities=24% Similarity=0.371 Sum_probs=204.9
Q ss_pred hccCcceeeecccceeEEEEEEcC-Cc--eEEEEEeccc-CchhHHHHHHHHHHHhcC-CCCceeeeeeEEecCCccEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKN-CK--PVAIKRLYSH-YPQCLKEFETELETVGSI-KHRNLVSLQGYSLSSSGNLLF 672 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 672 (933)
++|+..+.||+|+||+||+|.+++ +. .||||++... .....++|.+|+++++++ +|||||+++|++.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 678889999999999999999764 33 5788888644 344566799999999999 799999999999999999999
Q ss_pred EEecCCCCHHHHhcCC-------------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCe
Q 002349 673 YDFMENGSLWDILHGP-------------TKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEA 739 (933)
Q Consensus 673 ~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~ 739 (933)
|||+++|+|.++++.. .....+++..+..++.|+|.||.|+|++ +|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 9999999999999642 2346799999999999999999999966 99999999999999999999
Q ss_pred EEeecccccccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCC-CCCCCcchhHHHHhhhccc
Q 002349 740 HLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRK-AVDNECNLHHLILSKTANN 818 (933)
Q Consensus 740 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~-p~~~~~~~~~~~~~~~~~~ 818 (933)
||+|||+|+...... ......||..|+|||.+.+..++.++|||||||++|||++|.. ||.+. .......... .+
T Consensus 167 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~-~~~~~~~~i~-~~ 242 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-TCAELYEKLP-QG 242 (309)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-CHHHHHHHGG-GT
T ss_pred EEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC-CHHHHHHHHH-hc
Confidence 999999998653222 2234568999999999999999999999999999999999765 56544 3333322211 11
Q ss_pred ccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCC
Q 002349 819 AVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVP 871 (933)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 871 (933)
..+..+. ..+.++.+++.+||+.||++||||+||++.|+.+..
T Consensus 243 -----~~~~~~~-----~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 243 -----YRLEKPL-----NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp -----CCCCCCT-----TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----CCCCCCc-----cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1111211 124578899999999999999999999999987653
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-45 Score=392.56 Aligned_cols=268 Identities=23% Similarity=0.307 Sum_probs=202.7
Q ss_pred hhccCcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecCC----ccEEE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSSS----GNLLF 672 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv 672 (933)
.++|...+.||+|+||.||+|++ +|+.||||++..... ....++.|+..+.+++|||||++++++...+ ..++|
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 35677889999999999999997 468999999965422 1222345566667789999999999997654 47899
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcC-----CCCCeeeccCCCCceEeCCCCCeEEeecccc
Q 002349 673 YDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHD-----CSPRIIHRDVKSSNILLDKDFEAHLTDFGIA 747 (933)
Q Consensus 673 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~Dikp~NIll~~~~~~kl~DfGla 747 (933)
|||+++|+|.++++. .++++..+..++.|+|.||+|+|+. ..++|+||||||+|||++.++.+||+|||++
T Consensus 80 ~Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 999999999999963 4689999999999999999999952 1359999999999999999999999999999
Q ss_pred cccccCCCc---eeeeecccccccCccccccCC------CCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHH-------
Q 002349 748 KSLCVSKSY---TSTYIMGTIGYIDPEYARTSR------LTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLI------- 811 (933)
Q Consensus 748 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~------- 811 (933)
+........ ......||+.|||||++.+.. ++.++|||||||++|||+||..||..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 877443322 233467999999999987642 5778999999999999999998875322111000
Q ss_pred --HhhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCC
Q 002349 812 --LSKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLV 870 (933)
Q Consensus 812 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 870 (933)
..........+..+|.++......+....+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 00000011112233444443334456778999999999999999999999999997654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.2e-44 Score=398.88 Aligned_cols=249 Identities=22% Similarity=0.255 Sum_probs=199.9
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC---chhHHHH---HHHHHHHhcCCCCceeeeeeEEecCCccE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY---PQCLKEF---ETELETVGSIKHRNLVSLQGYSLSSSGNL 670 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~---~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 670 (933)
++|++.+.||+|+||+||+|++. +|+.||||++.... ......+ .+|+++++.++|||||++++++.+++..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57999999999999999999976 58999999985432 1112223 34577888889999999999999999999
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccc
Q 002349 671 LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSL 750 (933)
Q Consensus 671 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~ 750 (933)
+||||+++|+|.+++. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+
T Consensus 84 ivmE~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHH---hcccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 9999999999999994 456789999999999999999999966 9999999999999999999999999999876
Q ss_pred ccCCCceeeeecccccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCcccc
Q 002349 751 CVSKSYTSTYIMGTIGYIDPEYART-SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEIS 829 (933)
Q Consensus 751 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 829 (933)
.... .....||+.|||||++.+ ..+++++||||+||++|||+||+.||.+................ ....+
T Consensus 158 ~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~-----~~~~~ 229 (364)
T d1omwa3 158 SKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM-----AVELP 229 (364)
T ss_dssp SSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSC-----CCCCC
T ss_pred CCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC-----CCCCC
Confidence 4332 234579999999999864 56899999999999999999999999864433222111111110 11111
Q ss_pred ccccCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 002349 830 ATCKDLGAVKKVFQLALLCSKRQPTDRPT-----MHEVSRV 865 (933)
Q Consensus 830 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~ 865 (933)
. ..+..+.+++.+||+.||++||| ++|++++
T Consensus 230 ~-----~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 230 D-----SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp S-----SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred C-----CCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 1 12356889999999999999999 7888764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=394.46 Aligned_cols=253 Identities=22% Similarity=0.258 Sum_probs=197.8
Q ss_pred hhccCcce-eeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcC-CCCceeeeeeEEec----CCcc
Q 002349 597 TENLSEKY-IIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSI-KHRNLVSLQGYSLS----SSGN 669 (933)
Q Consensus 597 ~~~~~~~~-~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~----~~~~ 669 (933)
.++|.+.. +||+|+||+||+|++. +++.||||+++. ...+.+|++++.++ +|||||+++++|.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 46788764 6999999999999975 588999999864 25678899987655 89999999999865 4567
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCC---CCCeEEeeccc
Q 002349 670 LLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDK---DFEAHLTDFGI 746 (933)
Q Consensus 670 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~---~~~~kl~DfGl 746 (933)
|+|||||+||+|.+++.. .....+++.++..++.|++.||+|||++ +|+||||||+|||++. .+.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~-~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHS-CSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCcHHHHHHh-cCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccce
Confidence 999999999999999963 2235799999999999999999999966 9999999999999985 56799999999
Q ss_pred ccccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCc
Q 002349 747 AKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDP 826 (933)
Q Consensus 747 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 826 (933)
|+...... ......||+.|||||++.+..|+.++||||+||++|+|+||+.||.+.............. .... .
T Consensus 161 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i--~~~~--~ 234 (335)
T d2ozaa1 161 AKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI--RMGQ--Y 234 (335)
T ss_dssp CEECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CC--CSCS--S
T ss_pred eeeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHH--hcCC--C
Confidence 98764332 2345679999999999999999999999999999999999999997654332221110000 0000 0
Q ss_pred cccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 827 EISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 827 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.++.. .....+.++.+++.+|++.||++|||+.|++++
T Consensus 235 ~~~~~-~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 235 EFPNP-EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp SCCTT-HHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCc-ccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 00000 001234678899999999999999999999984
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-44 Score=386.39 Aligned_cols=262 Identities=22% Similarity=0.263 Sum_probs=204.2
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYD 674 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 674 (933)
++|+..+.||+|+||+||+|++. +++.||||+++... ....+.+.+|++++++++|||||++++++.++...++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 68999999999999999999975 58899999996543 2346788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCC
Q 002349 675 FMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSK 754 (933)
Q Consensus 675 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 754 (933)
|+.++.+..... .....+++..+..++.|++.||+|||++ +||||||||+|||++.++.+||+|||.|+......
T Consensus 82 ~~~~~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCchhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCc
Confidence 997654443333 3456799999999999999999999966 99999999999999999999999999998764322
Q ss_pred CceeeeecccccccCccccccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCccc-----
Q 002349 755 SYTSTYIMGTIGYIDPEYARTSR-LTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDPEI----- 828 (933)
Q Consensus 755 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 828 (933)
.......||+.|+|||.+.... ++.++||||+||++|+|++|+.||.+......+.......+...+...+..
T Consensus 157 -~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (298)
T d1gz8a_ 157 -RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235 (298)
T ss_dssp -BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred -ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccc
Confidence 2334457999999999887765 578999999999999999999999876655544332221111111111100
Q ss_pred -----ccc-ccC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 829 -----SAT-CKD-----LGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 829 -----~~~-~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
... ..+ ......+.+++.+|++.||++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 000 000 0123578899999999999999999999985
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=390.04 Aligned_cols=259 Identities=22% Similarity=0.316 Sum_probs=209.3
Q ss_pred hccCcceeeecccceeEEEEEEc------CCceEEEEEecccC-chhHHHHHHHHHHHhcC-CCCceeeeeeEEecCCcc
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK------NCKPVAIKRLYSHY-PQCLKEFETELETVGSI-KHRNLVSLQGYSLSSSGN 669 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 669 (933)
++|+..+.||+|+||.||+|++. .++.||||+++... .....+|.+|+.+++++ +|||||++++++.+++..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 58888999999999999999863 35689999997654 34556789999999999 699999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCCC---------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeC
Q 002349 670 LLFYDFMENGSLWDILHGPT---------------KKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLD 734 (933)
Q Consensus 670 ~lv~e~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~ 734 (933)
++||||+++|+|.++++... ....+++..+..++.||++||+|||++ +||||||||+||+++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccccccc
Confidence 99999999999999986421 233689999999999999999999976 999999999999999
Q ss_pred CCCCeEEeecccccccccCCC-ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCC-CCCCCCcchhHHHH
Q 002349 735 KDFEAHLTDFGIAKSLCVSKS-YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGR-KAVDNECNLHHLIL 812 (933)
Q Consensus 735 ~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~-~p~~~~~~~~~~~~ 812 (933)
.++.+|++|||+++....... .......||+.|+|||++.+..++.++|||||||++|||+|++ +||...........
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~ 259 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHH
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999987654333 2334568999999999999999999999999999999999954 44544333332221
Q ss_pred hhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCC
Q 002349 813 SKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLV 870 (933)
Q Consensus 813 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 870 (933)
. ...+ ..+..+. ..+..+.+++.+||+.||++||||+||+++|+++.
T Consensus 260 ~-i~~~-----~~~~~~~-----~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 260 M-IKEG-----FRMLSPE-----HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp H-HHHT-----CCCCCCT-----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H-HhcC-----CCCCCcc-----cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 1 1111 1111111 12357889999999999999999999999997643
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-44 Score=386.10 Aligned_cols=260 Identities=23% Similarity=0.364 Sum_probs=211.3
Q ss_pred hhccCcceeeecccceeEEEEEEcC------CceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCcc
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLKN------CKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGN 669 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 669 (933)
.++|+..+.||+|+||+||+|.++. ++.||||+++... ......|.+|++++++++|||||++++++..++..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 4688899999999999999998742 4689999997543 34455789999999999999999999999999999
Q ss_pred EEEEEecCCCCHHHHhcCC-------CCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEe
Q 002349 670 LLFYDFMENGSLWDILHGP-------TKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLT 742 (933)
Q Consensus 670 ~lv~e~~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~ 742 (933)
++||||+++|+|.++++.. .....+++..+..++.|+|+||.|||++ +|+||||||+|||++.++.+||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEe
Confidence 9999999999999988521 2234579999999999999999999966 99999999999999999999999
Q ss_pred ecccccccccCCCce-eeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCC-CCCCCCcchhHHHHhhhccccc
Q 002349 743 DFGIAKSLCVSKSYT-STYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGR-KAVDNECNLHHLILSKTANNAV 820 (933)
Q Consensus 743 DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~-~p~~~~~~~~~~~~~~~~~~~~ 820 (933)
|||+|+......... .....||+.|+|||.+.+..++.++||||||+++|||+||. .||.+....+...... .+..
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~--~~~~ 253 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM--EGGL 253 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH--TTCC
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH--hCCC
Confidence 999998764333222 23346899999999999999999999999999999999985 6666544333332211 1111
Q ss_pred ccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCCC
Q 002349 821 METVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLVP 871 (933)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 871 (933)
+..+. ..+..+.+++.+||+.||++|||+++|+++|++...
T Consensus 254 -----~~~p~-----~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 254 -----LDKPD-----NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp -----CCCCT-----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred -----CCCcc-----cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 11111 123578999999999999999999999999987643
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-44 Score=383.96 Aligned_cols=258 Identities=24% Similarity=0.367 Sum_probs=205.5
Q ss_pred hccCcceeeecccceeEEEEEEcC--------CceEEEEEecccCc-hhHHHHHHHHHHHhcC-CCCceeeeeeEEecCC
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKN--------CKPVAIKRLYSHYP-QCLKEFETELETVGSI-KHRNLVSLQGYSLSSS 667 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 667 (933)
++|...+.||+|+||.||+|+... +..||||+++.... ....++.+|+..+.++ +|||||++++++.+++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 578889999999999999998643 24699999976543 4457788999999888 8999999999999999
Q ss_pred ccEEEEEecCCCCHHHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeC
Q 002349 668 GNLLFYDFMENGSLWDILHGPT-------------KKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLD 734 (933)
Q Consensus 668 ~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~ 734 (933)
..++||||+++|+|.+++.... ....+++.+++.++.|++.||+|||++ +||||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeec
Confidence 9999999999999999996432 124689999999999999999999976 999999999999999
Q ss_pred CCCCeEEeecccccccccCCCc-eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCcchhHHHH
Q 002349 735 KDFEAHLTDFGIAKSLCVSKSY-TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLT-GRKAVDNECNLHHLIL 812 (933)
Q Consensus 735 ~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~ellt-g~~p~~~~~~~~~~~~ 812 (933)
.++.+||+|||+++........ ......||+.|+|||.+.++.|++++|||||||++|||++ |..||.+........
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~- 248 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK- 248 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH-
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHH-
Confidence 9999999999999876543322 2344578999999999999999999999999999999998 677887544333222
Q ss_pred hhhcccccccccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCC
Q 002349 813 SKTANNAVMETVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLV 870 (933)
Q Consensus 813 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 870 (933)
....+. .+..+.. .+..+.+++.+||+.||++|||++||++.|+.+.
T Consensus 249 -~i~~~~-----~~~~p~~-----~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 249 -LLKEGH-----RMDKPSN-----CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp -HHHTTC-----CCCCCSS-----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHHcCC-----CCCCCcc-----chHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 111111 1111111 2357899999999999999999999999997653
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7e-44 Score=382.05 Aligned_cols=261 Identities=20% Similarity=0.249 Sum_probs=204.9
Q ss_pred hccCcceeeecccceeEEEEEEcCCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEEe
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 675 (933)
++|+..++||+|+||+||+|++++++.||||++.... ....+.+.+|+.++++++|||||++++++..++..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 6899999999999999999999999999999996643 33457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCCC
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSKS 755 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~~ 755 (933)
+.++.+..+. ...+.+++..+..++.|++.||+|||++ +||||||||+|||++.++.+|++|||.|.......
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~- 154 (286)
T d1ob3a_ 82 LDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV- 154 (286)
T ss_dssp CSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc-
Confidence 9887777776 4567899999999999999999999976 99999999999999999999999999998764322
Q ss_pred ceeeeecccccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCc--------
Q 002349 756 YTSTYIMGTIGYIDPEYARTS-RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDP-------- 826 (933)
Q Consensus 756 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 826 (933)
.......|++.|+|||.+.+. .++.++||||+||++|||++|+.||.+..............+.......+
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T d1ob3a_ 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhc
Confidence 233445789999999998764 56899999999999999999999998765544433321111110000000
Q ss_pred --ccc------ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 827 --EIS------ATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 827 --~~~------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
... ...........+.+++.+|++.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 000001123578899999999999999999999864
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-43 Score=381.17 Aligned_cols=260 Identities=20% Similarity=0.236 Sum_probs=200.8
Q ss_pred hhccCcceeeecccceeEEEEEEc-C-CceEEEEEecccC--chhHHHHHHHHHHHhcC---CCCceeeeeeEEec----
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-N-CKPVAIKRLYSHY--PQCLKEFETELETVGSI---KHRNLVSLQGYSLS---- 665 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~---- 665 (933)
.++|++.+.||+|+||+||+|++. + ++.||||+++... ......+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999974 3 5679999986532 22234456777776665 79999999999853
Q ss_pred -CCccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeec
Q 002349 666 -SSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDF 744 (933)
Q Consensus 666 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 744 (933)
....+++|||++++++..... .....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecch
Confidence 346789999999887765543 3556789999999999999999999976 9999999999999999999999999
Q ss_pred ccccccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccc-
Q 002349 745 GIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMET- 823 (933)
Q Consensus 745 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~- 823 (933)
|+++..... .......||+.|||||++.+..|+.++||||+||++|||++|+.||.+......+.......+.....
T Consensus 161 g~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (305)
T d1blxa_ 161 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238 (305)
T ss_dssp CSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred hhhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhc
Confidence 999865322 23345689999999999999999999999999999999999999998776655544332211110000
Q ss_pred ---------------cCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 824 ---------------VDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 824 ---------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
......... ......+.+++.+||+.||++|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 239 WPRDVALPRQAFHSKSAQPIEKFV--TDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTC--CSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccccccchhhhhccccccchhhcc--ccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000000 0123567889999999999999999999875
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=376.83 Aligned_cols=240 Identities=23% Similarity=0.335 Sum_probs=196.9
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccCc------hhHHHHHHHHHHHhcCC--CCceeeeeeEEecCCc
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYP------QCLKEFETELETVGSIK--HRNLVSLQGYSLSSSG 668 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~ 668 (933)
++|++.+.||+|+||+||+|++. +++.||||++..... ....++.+|+.++++++ |||||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57999999999999999999975 588999999865321 12244678999999996 8999999999999999
Q ss_pred cEEEEEecCC-CCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCC-CCeEEeeccc
Q 002349 669 NLLFYDFMEN-GSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKD-FEAHLTDFGI 746 (933)
Q Consensus 669 ~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~-~~~kl~DfGl 746 (933)
.++||||+.+ +++.+++. ....+++.++..++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~---~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeccCcchHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcccc
Confidence 9999999976 68888874 456799999999999999999999966 99999999999999854 7999999999
Q ss_pred ccccccCCCceeeeecccccccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccC
Q 002349 747 AKSLCVSKSYTSTYIMGTIGYIDPEYARTSRL-TEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVD 825 (933)
Q Consensus 747 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 825 (933)
|+..... ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||..... .. .... ..+
T Consensus 158 a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---i~---~~~~----~~~ 224 (273)
T d1xwsa_ 158 GALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---II---RGQV----FFR 224 (273)
T ss_dssp CEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---HH---HCCC----CCS
T ss_pred ceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH---Hh---hccc----CCC
Confidence 9865322 2344679999999999988765 5779999999999999999999975321 11 0110 111
Q ss_pred ccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 826 PEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 826 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
+. .+.++.+++.+||+.||++|||++|++++
T Consensus 225 ~~---------~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 225 QR---------VSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp SC---------CCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CC---------CCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 11 13568889999999999999999999874
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=1.2e-42 Score=378.20 Aligned_cols=293 Identities=32% Similarity=0.505 Sum_probs=217.2
Q ss_pred CChHHHHHHHHHHHhCCCCCCCcCCCCCCCCCCCC--CccceEecCCC--CcEEEEEcCCCCcCc--ccCCCCCCCCCcc
Q 002349 22 VDSEDGATLLKIKKSFRDVDNVLYDWTDSPSSDYC--VWRGITCDNVT--FTVIALNLSGLNLDG--EISPAVGDLKDLQ 95 (933)
Q Consensus 22 ~~~~d~~all~~k~~~~~~~~~l~~w~~~~~~~~c--~w~gv~C~~~~--~~v~~l~l~~~~l~~--~~~~~l~~l~~L~ 95 (933)
|.++|++||++||+++.||. .+++|.. ++||| .|.||+|++.+ +||+.|||++++++| .+|+.+++|++|+
T Consensus 3 c~~~e~~aLl~~k~~~~~~~-~l~sW~~--~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~ 79 (313)
T d1ogqa_ 3 CNPQDKQALLQIKKDLGNPT-TLSSWLP--TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN 79 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCCG-GGTTCCT--TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCS
T ss_pred CCHHHHHHHHHHHHHCCCCC-cCCCCCC--CCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCcccc
Confidence 78999999999999999874 7999974 57999 49999998744 489999999999988 4677888888888
Q ss_pred EEEccC-CcccccCCCCccCCCCCceecccccccCCCCCcccccccchhhhhhcccCccCCCCcccccCCCCceeeeecC
Q 002349 96 SIDLRG-NRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGN 174 (933)
Q Consensus 96 ~L~Ls~-n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N 174 (933)
+|+|++ |+++|.+|++|++|++|++|||++|++.+..|..+..+.+|+++++++|.+.+.+|..++++++|+.+++++|
T Consensus 80 ~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n 159 (313)
T d1ogqa_ 80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159 (313)
T ss_dssp EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred ccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeecccc
Confidence 888876 7788888888888888888888888877777777777777777777777777777766766666666666666
Q ss_pred CCCCCcccccccCCCCcEEeccCccccCccCcCCcCCCCCcEEccccccccCcCCCCccccccceEeccccccccccCcc
Q 002349 175 NLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSV 254 (933)
Q Consensus 175 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~ 254 (933)
.+.+.+|..+..+.++ ++.+++++|++++..|..+.......+++.++...+.+|..
T Consensus 160 ~l~~~ip~~~~~l~~l-----------------------~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~ 216 (313)
T d1ogqa_ 160 RISGAIPDSYGSFSKL-----------------------FTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVL 216 (313)
T ss_dssp CCEEECCGGGGCCCTT-----------------------CCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGG
T ss_pred cccccccccccccccc-----------------------ccccccccccccccccccccccccccccccccccccccccc
Confidence 6665555555444443 14444444444444444444444445555666666666777
Q ss_pred ccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcceEeeeccccccccCCcccccccccc
Q 002349 255 IGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLF 334 (933)
Q Consensus 255 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~ 334 (933)
++.+++|+.+++++|.+.+.++ .++.+++|+.|+|++|+++|.+|..|+++++|++|+|++|+|+|.+|. ++++++|+
T Consensus 217 ~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~ 294 (313)
T d1ogqa_ 217 FGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFD 294 (313)
T ss_dssp CCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSC
T ss_pred cccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCC
Confidence 7777888888888888876544 577778888888888888878888888888888888888888877774 56777777
Q ss_pred cccccccc
Q 002349 335 DLNVANNH 342 (933)
Q Consensus 335 ~L~L~~N~ 342 (933)
.+++++|+
T Consensus 295 ~l~l~~N~ 302 (313)
T d1ogqa_ 295 VSAYANNK 302 (313)
T ss_dssp GGGTCSSS
T ss_pred HHHhCCCc
Confidence 77777776
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-42 Score=373.41 Aligned_cols=265 Identities=20% Similarity=0.262 Sum_probs=203.6
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEec--------
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLS-------- 665 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-------- 665 (933)
.++|++.+.||+|+||+||+|++. +++.||||++.... ....+++.+|++++++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 368999999999999999999975 68999999985442 3345778999999999999999999998865
Q ss_pred CCccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecc
Q 002349 666 SSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFG 745 (933)
Q Consensus 666 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfG 745 (933)
....++||||++++.+.... .....++...+..++.|++.||+|||++ +|+||||||+|||++.++.+|++|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecc
Confidence 34578999999887766655 3566789999999999999999999966 99999999999999999999999999
Q ss_pred cccccccCCCc---eeeeecccccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccc
Q 002349 746 IAKSLCVSKSY---TSTYIMGTIGYIDPEYARTS-RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVM 821 (933)
Q Consensus 746 la~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 821 (933)
+++.+...... .....+||+.|+|||++.+. .+++++||||+||++|||++|+.||.+..................
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 242 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 99876432221 12235799999999998765 689999999999999999999999987766555544333222221
Q ss_pred cccCcccc------------ccccC-------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHc
Q 002349 822 ETVDPEIS------------ATCKD-------LGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLG 867 (933)
Q Consensus 822 ~~~~~~~~------------~~~~~-------~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 867 (933)
........ ..... ......+.+++.+||+.||++|||++|++++-.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpf 307 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 307 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChh
Confidence 11111100 00000 111245678999999999999999999998643
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-42 Score=376.52 Aligned_cols=258 Identities=27% Similarity=0.280 Sum_probs=196.0
Q ss_pred ccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCceeeeeeEEecC------CccEE
Q 002349 599 NLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNLVSLQGYSLSS------SGNLL 671 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~l 671 (933)
+|+..++||+|+||+||+|++. +++.||||++..... .+.+|++++++++|||||++++++... .+.++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 6888899999999999999986 588999999976432 234799999999999999999998543 34689
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCC-CeEEeeccccccc
Q 002349 672 FYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDF-EAHLTDFGIAKSL 750 (933)
Q Consensus 672 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~-~~kl~DfGla~~~ 750 (933)
||||++++.+..+.+.......+++.++..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+|+..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 999998765444433223456799999999999999999999955 999999999999999775 8999999999876
Q ss_pred ccCCCceeeeecccccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccc----------
Q 002349 751 CVSKSYTSTYIMGTIGYIDPEYART-SRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNA---------- 819 (933)
Q Consensus 751 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~---------- 819 (933)
.... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||................+.
T Consensus 174 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 251 (350)
T d1q5ka_ 174 VRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251 (350)
T ss_dssp CTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred cCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence 4332 2334579999999998765 47899999999999999999999999876655444322111000
Q ss_pred --cccccCccccc----cccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 820 --VMETVDPEISA----TCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 820 --~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
......+.... ..........+.+++.+|++.||++|||++|++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000000000 00011224568899999999999999999999974
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-41 Score=372.62 Aligned_cols=260 Identities=20% Similarity=0.264 Sum_probs=199.4
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC-chhHHHHHHHHHHHhcCCCCceeeeeeEEecCC----ccE
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY-PQCLKEFETELETVGSIKHRNLVSLQGYSLSSS----GNL 670 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~ 670 (933)
+++|++.+.||+|+||+||+|++. +++.||||++.... ....+.+.+|++++++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 457999999999999999999975 68999999997543 344567899999999999999999999987653 345
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccccc
Q 002349 671 LFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSL 750 (933)
Q Consensus 671 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~ 750 (933)
++++|+.+|+|.+++. ..++++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+..
T Consensus 87 ~l~~~~~~g~L~~~l~----~~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLK----TQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 6667778999999995 34699999999999999999999976 9999999999999999999999999999876
Q ss_pred ccCCCc--eeeeecccccccCccccc-cCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccc----
Q 002349 751 CVSKSY--TSTYIMGTIGYIDPEYAR-TSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMET---- 823 (933)
Q Consensus 751 ~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---- 823 (933)
...... .....+||+.|+|||++. +..++.++||||+||++|+|++|+.||.+....................
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence 433222 234467999999999984 4567899999999999999999999998765444333221111110000
Q ss_pred ------------cC----ccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 824 ------------VD----PEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 824 ------------~~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.. .......+ ....++.+++.+|++.||++|||++|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFP--NADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCT--TSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhcccccCCccCCCCHHHhCC--CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 00000000 112468899999999999999999999985
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-41 Score=373.57 Aligned_cols=260 Identities=24% Similarity=0.294 Sum_probs=199.3
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCC------
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSS------ 667 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 667 (933)
.++|++.+.||+|+||+||+|.++ +++.||||+++... ....+.+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 358999999999999999999976 58899999997543 334567899999999999999999999997654
Q ss_pred ccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccc
Q 002349 668 GNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIA 747 (933)
Q Consensus 668 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla 747 (933)
+.++||||+ +++|..+.+ ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+|++|||+|
T Consensus 97 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccce
Confidence 469999999 567888774 35799999999999999999999966 9999999999999999999999999999
Q ss_pred cccccCCCceeeeecccccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccccccc----
Q 002349 748 KSLCVSKSYTSTYIMGTIGYIDPEYARTS-RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVME---- 822 (933)
Q Consensus 748 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---- 822 (933)
+..... .....||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+......+............
T Consensus 169 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (346)
T d1cm8a_ 169 RQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244 (346)
T ss_dssp EECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred eccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHh
Confidence 875432 2345799999999998764 5789999999999999999999999876655544332221111100
Q ss_pred ----------------ccCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HccCC
Q 002349 823 ----------------TVDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV--LGSLV 870 (933)
Q Consensus 823 ----------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~~ 870 (933)
........... .....+.+++.+||..||++|||++|++++ ++.+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 245 RLQSDEAKNYMKGLPELEKKDFASILT--NASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTCT--TCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhcchhhhhhhccCCcccccchHHhcc--CCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 00000010000 123567889999999999999999999985 44443
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-42 Score=371.01 Aligned_cols=253 Identities=23% Similarity=0.284 Sum_probs=203.3
Q ss_pred hccCcceeeecccceeEEEEEEc----CCceEEEEEecccC----chhHHHHHHHHHHHhcCCC-CceeeeeeEEecCCc
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK----NCKPVAIKRLYSHY----PQCLKEFETELETVGSIKH-RNLVSLQGYSLSSSG 668 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~ 668 (933)
++|+..+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999863 37889999986532 2345668899999999966 899999999999999
Q ss_pred cEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccc
Q 002349 669 NLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAK 748 (933)
Q Consensus 669 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 748 (933)
.++||||+.+|+|.+++. ..+.+++..+..++.|++.||+|+|+. +|+||||||+||+++.++.+||+|||+|+
T Consensus 104 ~~~v~e~~~~~~L~~~i~---~~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLS---QRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHH---hcccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchh
Confidence 999999999999999995 455678999999999999999999965 99999999999999999999999999998
Q ss_pred ccccCCCceeeeecccccccCccccccC--CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCc
Q 002349 749 SLCVSKSYTSTYIMGTIGYIDPEYARTS--RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDP 826 (933)
Q Consensus 749 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 826 (933)
.+............|++.|+|||.+.+. .++.++||||+||++|||++|+.||.+................. .+
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~----~~ 253 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS----EP 253 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC----CC
T ss_pred hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC----CC
Confidence 7754444444556899999999999765 46889999999999999999999997654332221111111000 01
Q ss_pred cccccccCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 002349 827 EISATCKDLGAVKKVFQLALLCSKRQPTDRP-----TMHEVSRV 865 (933)
Q Consensus 827 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 865 (933)
.++. ..+.++.+++.+||+.||++|| |++|++++
T Consensus 254 ~~~~-----~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 254 PYPQ-----EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp CCCT-----TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred CCcc-----cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 1111 1246788999999999999999 58888864
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-41 Score=360.97 Aligned_cols=261 Identities=20% Similarity=0.222 Sum_probs=205.8
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecCCccEEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSSSGNLLFYD 674 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 674 (933)
++|+..+.||+|+||+||+|++. +++.||||+++... ....+++.+|+.++++++|||||++++++......++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999975 57889999986543 3446788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeecccccccccCC
Q 002349 675 FMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKSLCVSK 754 (933)
Q Consensus 675 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~~~~~~ 754 (933)
++.++++..+++ ..+.+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+|++|||.|+......
T Consensus 82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999999988884 456789999999999999999999976 99999999999999999999999999998764332
Q ss_pred CceeeeecccccccCccccccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhh-hcccccccccC-------
Q 002349 755 SYTSTYIMGTIGYIDPEYARTSR-LTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSK-TANNAVMETVD------- 825 (933)
Q Consensus 755 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~------- 825 (933)
. ......+++.|+|||.+.+.. ++.++||||+||++|||++|+.||....+..+..... .......+...
T Consensus 156 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 156 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp S-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred c-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcc
Confidence 2 233346788999999987664 6899999999999999999999976544443332211 11110000000
Q ss_pred --------c-cccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 826 --------P-EISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 826 --------~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
+ ..............+.+++.+|++.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 000000001123567889999999999999999999874
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4e-41 Score=360.83 Aligned_cols=259 Identities=17% Similarity=0.184 Sum_probs=204.0
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCCC-CceeeeeeEEecCCccEEEEEe
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIKH-RNLVSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~ 675 (933)
++|++.+.||+|+||+||+|++. +++.||||++.... ....+.+|++.++.++| +|++.+++++..+...++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 57999999999999999999976 57899999885543 23456788899999965 8999999999999999999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCC-----CCCeEEeeccccccc
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDK-----DFEAHLTDFGIAKSL 750 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~-----~~~~kl~DfGla~~~ 750 (933)
+ +++|.++++ .....+++.++..++.|++.||+|||++ +|+||||||+||+++. ++.+||+|||+|+.+
T Consensus 83 ~-~~~l~~~~~--~~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 83 L-GPSLEDLLD--LCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp C-CCBHHHHHH--HTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred c-CCCHHHHHH--hhccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 9 689999986 3455799999999999999999999955 9999999999999974 578999999999876
Q ss_pred ccCCC------ceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHh-hhcccccccc
Q 002349 751 CVSKS------YTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILS-KTANNAVMET 823 (933)
Q Consensus 751 ~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~-~~~~~~~~~~ 823 (933)
..... ......+||+.|||||++.+..+++++|||||||++|||+||+.||.+.......... ........ .
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~-~ 235 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS-T 235 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH-S
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC-C
Confidence 43221 1233467999999999999999999999999999999999999999754332221111 11000000 0
Q ss_pred cCccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccCC
Q 002349 824 VDPEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSLV 870 (933)
Q Consensus 824 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 870 (933)
..+.+.. ..++++.+++..|++.+|++||+++.+.+.|+.+.
T Consensus 236 ~~~~l~~-----~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~ 277 (293)
T d1csna_ 236 PLRELCA-----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277 (293)
T ss_dssp CHHHHTT-----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred ChHHhcC-----CCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 0011111 12357889999999999999999999988877653
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-41 Score=364.54 Aligned_cols=259 Identities=19% Similarity=0.210 Sum_probs=196.9
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCCCCce-eeeeeEEecCCccEEEEEe
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNL-VSLQGYSLSSSGNLLFYDF 675 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~ 675 (933)
++|+..+.||+|+||+||+|++. +++.||||++..... ..++.+|++++++++|+|+ +.+.+++.+++..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 57999999999999999999975 578999998865432 3457889999999987665 5555666778888999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeC---CCCCeEEeeccccccccc
Q 002349 676 MENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLD---KDFEAHLTDFGIAKSLCV 752 (933)
Q Consensus 676 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~---~~~~~kl~DfGla~~~~~ 752 (933)
+. +++.+.+. .....+++..+..++.|++.||+|||++ +|+||||||+|||++ .+..+|++|||+|+.+..
T Consensus 85 ~~-~~l~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 LG-PSLEDLFN--FCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CC-CBHHHHHH--HTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred cC-Cchhhhhh--hccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 94 56666654 3456799999999999999999999966 999999999999986 456799999999997754
Q ss_pred CCCc------eeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCc
Q 002349 753 SKSY------TSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDP 826 (933)
Q Consensus 753 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 826 (933)
.... ......||+.|||||.+.+..+++++|||||||++|||+||+.||........................+
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence 3221 2334679999999999999999999999999999999999999997543332221111100000000000
Q ss_pred cccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHccC
Q 002349 827 EISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRVLGSL 869 (933)
Q Consensus 827 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 869 (933)
.... ..+.++.+++..|++.+|++||+++++.+.|+.+
T Consensus 239 ~~~~-----~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 239 VLCK-----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp HHTT-----TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred Hhcc-----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 1111 1246788999999999999999999998888764
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.4e-40 Score=361.87 Aligned_cols=254 Identities=15% Similarity=0.193 Sum_probs=196.8
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCC-CCceeeeeeEEecC--CccEEEE
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIK-HRNLVSLQGYSLSS--SGNLLFY 673 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~ 673 (933)
++|++.++||+|+||+||+|++. +++.||||+++.. ..+++.+|++++++++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 58999999999999999999975 5889999998654 3467899999999995 99999999998744 5688999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCC-CeEEeeccccccccc
Q 002349 674 DFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDF-EAHLTDFGIAKSLCV 752 (933)
Q Consensus 674 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~-~~kl~DfGla~~~~~ 752 (933)
||+++++|.+.. +.+++.++..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+|+....
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999987764 3589999999999999999999966 999999999999998765 589999999987643
Q ss_pred CCCceeeeecccccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHH-Hhhhcc-------------
Q 002349 753 SKSYTSTYIMGTIGYIDPEYARTS-RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLI-LSKTAN------------- 817 (933)
Q Consensus 753 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~-~~~~~~------------- 817 (933)
.. ......||+.|+|||.+.+. .++.++||||+||++|||++|+.||.......... ......
T Consensus 183 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 183 GQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp TC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred CC--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence 32 23445799999999998765 57999999999999999999999997554332211 100000
Q ss_pred c----ccccccC-------ccccccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 818 N----AVMETVD-------PEISATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 818 ~----~~~~~~~-------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
. ....... ..............++.+++.+|+..||++|||++|++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0000000 0000000011123568899999999999999999999874
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-40 Score=366.54 Aligned_cols=257 Identities=20% Similarity=0.235 Sum_probs=192.2
Q ss_pred hccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecC------Cc
Q 002349 598 ENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSS------SG 668 (933)
Q Consensus 598 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~ 668 (933)
++|++.++||+|+||+||+|++. +++.||||++.... ....+++.+|+.++++++|||||+++++|... .+
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57999999999999999999986 58999999997543 34456789999999999999999999999643 57
Q ss_pred cEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccc
Q 002349 669 NLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAK 748 (933)
Q Consensus 669 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 748 (933)
.|+||||+.++. .+.++ ..+++..+..++.|++.||+|||++ ||+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l-~~~~~-----~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANL-CQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEH-HHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHH-HHhhh-----cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhh
Confidence 799999997654 44442 3589999999999999999999966 99999999999999999999999999988
Q ss_pred ccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhccccc--------
Q 002349 749 SLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAV-------- 820 (933)
Q Consensus 749 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~-------- 820 (933)
.... ........||+.|+|||++.+..+++++||||+||++|+|++|+.||.+.................
T Consensus 168 ~~~~--~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (355)
T d2b1pa1 168 TAGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_dssp ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred cccc--ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence 6532 233445679999999999999999999999999999999999999998665444432221100000
Q ss_pred -------------------ccccCccccccc--cCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 821 -------------------METVDPEISATC--KDLGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 821 -------------------~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
............ ........+.+++.+|+..||++|||++|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000000000 012345678899999999999999999999975
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-40 Score=362.56 Aligned_cols=258 Identities=23% Similarity=0.270 Sum_probs=198.7
Q ss_pred hhccCcceeeecccceeEEEEEEc-CCceEEEEEecccC--chhHHHHHHHHHHHhcCCCCceeeeeeEEecC-----Cc
Q 002349 597 TENLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHY--PQCLKEFETELETVGSIKHRNLVSLQGYSLSS-----SG 668 (933)
Q Consensus 597 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~ 668 (933)
.++|++.+.||+|+||+||+|++. +++.||||++.... ....+++.+|++++++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 568999999999999999999975 58999999997543 33456788999999999999999999998643 34
Q ss_pred cEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEeeccccc
Q 002349 669 NLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAK 748 (933)
Q Consensus 669 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 748 (933)
.+++|+|+.+|+|.++++ .+++++.++..++.|++.||+|||++ +|+||||||+|||++.++.+|++|||.|.
T Consensus 97 ~~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhcc----cccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhc
Confidence 577788888999999994 34699999999999999999999966 99999999999999999999999999997
Q ss_pred ccccCCCceeeeecccccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCcchhHHHHhhhcccccccccCc-
Q 002349 749 SLCVSKSYTSTYIMGTIGYIDPEYARTS-RLTEKSDVYSFGIVLLELLTGRKAVDNECNLHHLILSKTANNAVMETVDP- 826 (933)
Q Consensus 749 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwSlGv~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~- 826 (933)
.... ......||+.|+|||...+. .++.++||||+||++|+|++|+.||.+.......................
T Consensus 170 ~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (348)
T d2gfsa1 170 HTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 245 (348)
T ss_dssp CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred ccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 6532 22345789999999987765 46899999999999999999999998766554443322211111100000
Q ss_pred -----------cccc-cccC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 002349 827 -----------EISA-TCKD-----LGAVKKVFQLALLCSKRQPTDRPTMHEVSRV 865 (933)
Q Consensus 827 -----------~~~~-~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 865 (933)
.... .... ......+.+++.+|++.||++|||++|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 0000 0000 0123567899999999999999999999984
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.2e-35 Score=324.40 Aligned_cols=260 Identities=18% Similarity=0.165 Sum_probs=189.4
Q ss_pred ccCcceeeecccceeEEEEEEc-CCceEEEEEecccCchhHHHHHHHHHHHhcCC-----------CCceeeeeeEEecC
Q 002349 599 NLSEKYIIGYGASSTVYKCVLK-NCKPVAIKRLYSHYPQCLKEFETELETVGSIK-----------HRNLVSLQGYSLSS 666 (933)
Q Consensus 599 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~~~ 666 (933)
+|++.++||+|+||+||+|++. +++.||||+++... ...+.+.+|++++++++ |+||+++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 5899999999999999999975 68999999997543 23467788999988875 57899999988643
Q ss_pred --CccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCC------
Q 002349 667 --SGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFE------ 738 (933)
Q Consensus 667 --~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~------ 738 (933)
...+++|+++..+..............+++..+..++.|++.|++|||+. .+|+||||||+|||++.++.
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCcccccce
Confidence 45567777765544333222224566789999999999999999999962 38999999999999986653
Q ss_pred eEEeecccccccccCCCceeeeecccccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCcch------hHHHH
Q 002349 739 AHLTDFGIAKSLCVSKSYTSTYIMGTIGYIDPEYARTSRLTEKSDVYSFGIVLLELLTGRKAVDNECNL------HHLIL 812 (933)
Q Consensus 739 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwSlGv~l~elltg~~p~~~~~~~------~~~~~ 812 (933)
++++|||.|+.... .....+||+.|+|||++.+..++.++||||+||++++|++|+.||...... .....
T Consensus 171 ~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~ 246 (362)
T d1q8ya_ 171 IKIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246 (362)
T ss_dssp EEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred eeEeeccccccccc----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence 89999999976532 224457999999999999999999999999999999999999999743211 01100
Q ss_pred hhhcccc--------------------cccccCcc--------cc-ccccCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 002349 813 SKTANNA--------------------VMETVDPE--------IS-ATCKDLGAVKKVFQLALLCSKRQPTDRPTMHEVS 863 (933)
Q Consensus 813 ~~~~~~~--------------------~~~~~~~~--------~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 863 (933)
.....+. ........ .. ...........+.+++.+|+..||++|||++|++
T Consensus 247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L 326 (362)
T d1q8ya_ 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 326 (362)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 0000000 00000000 00 0011234567899999999999999999999999
Q ss_pred HH
Q 002349 864 RV 865 (933)
Q Consensus 864 ~~ 865 (933)
++
T Consensus 327 ~H 328 (362)
T d1q8ya_ 327 NH 328 (362)
T ss_dssp TC
T ss_pred cC
Confidence 85
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.97 E-value=4.2e-32 Score=294.43 Aligned_cols=256 Identities=32% Similarity=0.573 Sum_probs=159.0
Q ss_pred ccEEeccCCcCcC--CCCCCCCCCCCccEEEeeC-CccCCCCCCccccCCcceEeeeccccccccCCccccccccccccc
Q 002349 261 LAVLDLSCNMLSG--PIPPILGNLSYTEKLYLHS-NKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLN 337 (933)
Q Consensus 261 L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~ 337 (933)
++.|+|++|.+++ .+|+.++++++|++|+|++ |+++|.+|.+++++++|++|+|++|++.+..+..+..+..|+.++
T Consensus 52 v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~ 131 (313)
T d1ogqa_ 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLD 131 (313)
T ss_dssp EEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEE
T ss_pred EEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccc
Confidence 4555555555554 2455555555666666654 555555566666666666666666666655555556666666666
Q ss_pred cccccCCCCCCCCcccCCCCCceeccCcccCCCCCccccccccc-ceecCCcccccCCCccccccccccceeeccCCccC
Q 002349 338 VANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESM-TYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKIS 416 (933)
Q Consensus 338 L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L-~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 416 (933)
+++|.+.+.+|..+.++++|+.+++++|++.+.+|..+..+.++ +.++++.|++++..|..+..+..+ .+++++|.+.
T Consensus 132 l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~ 210 (313)
T d1ogqa_ 132 FSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLE 210 (313)
T ss_dssp CCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEE
T ss_pred cccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-cccccccccc
Confidence 66666655666666666666666666666666666666555554 556666666666666655555433 4666666666
Q ss_pred CCCCCCCCCccccccccccCcccccccccccccccccceEEccCCccccccchhhccccccceeeecCCCCcCcccchhh
Q 002349 417 GSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNLSGDVMSLIN 496 (933)
Q Consensus 417 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~ 496 (933)
+.+|..+..+++|+.|++++|.+++.+| .++.+++|+.|+|++|+++|.+|..++++++|++|+|++|+|+|.+|...+
T Consensus 211 ~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~ 289 (313)
T d1ogqa_ 211 GDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGN 289 (313)
T ss_dssp ECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTT
T ss_pred cccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCccc
Confidence 6666666666666666666666665443 466666666666666666666666666666666666666666666666555
Q ss_pred ccccc-eeecCCCCCCCcccCCcc
Q 002349 497 CLSLS-VLFIGNPGLCGYWLHSAC 519 (933)
Q Consensus 497 ~~~~~-~~~~~N~~~C~~~l~~~~ 519 (933)
+..+. ..+.+|+.+||.|+ ++|
T Consensus 290 L~~L~~l~l~~N~~l~g~pl-p~c 312 (313)
T d1ogqa_ 290 LQRFDVSAYANNKCLCGSPL-PAC 312 (313)
T ss_dssp GGGSCGGGTCSSSEEESTTS-SCC
T ss_pred CCCCCHHHhCCCccccCCCC-CCC
Confidence 55555 55677777888776 456
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=1.7e-29 Score=282.07 Aligned_cols=342 Identities=25% Similarity=0.358 Sum_probs=204.2
Q ss_pred CCCCccEEEccCCcccccCCCCccCCCCCceecccccccCCCCCcccccccchhhhhhcccCccCCCCcccccCCCCcee
Q 002349 90 DLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVF 169 (933)
Q Consensus 90 ~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L 169 (933)
++.+|++|++++|+|+. + +.++.|++|++|||++|+|++ +| .|+++++|++|+|++|.+++.. .++.+++|+.|
T Consensus 42 ~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~-l~-~l~~L~~L~~L~L~~n~i~~i~--~l~~l~~L~~L 115 (384)
T d2omza2 42 DLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTD-IT-PLKNLTKLVDILMNNNQIADIT--PLANLTNLTGL 115 (384)
T ss_dssp HHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCCCG--GGTTCTTCCEE
T ss_pred HhCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCC-Cc-cccCCccccccccccccccccc--ccccccccccc
Confidence 34456666666666652 2 245556666666666666653 22 2555555555555555555322 25555555555
Q ss_pred eeecCCCCCCcccccccCCCCcEEeccCccccCccCcCCcCCCCCcEEccccccccCcCCCCccccccceEecccccccc
Q 002349 170 GLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTG 249 (933)
Q Consensus 170 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~ 249 (933)
++++|.+++..+ ......+..+....|.+....+.............. ..
T Consensus 116 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~-----------------------~~----- 165 (384)
T d2omza2 116 TLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGN-----------------------QV----- 165 (384)
T ss_dssp ECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEE-----------------------SC-----
T ss_pred cccccccccccc--cccccccccccccccccccccccccccccccccccc-----------------------cc-----
Confidence 555555543221 222333344444444333221111111111111110 00
Q ss_pred ccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcceEeeeccccccccCCccccc
Q 002349 250 KIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGK 329 (933)
Q Consensus 250 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~ 329 (933)
.....+...+.........|... ....+..+++++.+++++|.+++..| +..+++|+.|++++|++++. +.+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~ 239 (384)
T d2omza2 166 TDLKPLANLTTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLAS 239 (384)
T ss_dssp CCCGGGTTCTTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGG
T ss_pred chhhhhccccccccccccccccc--cccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhc
Confidence 11122233333444444444432 23445566677777777777765433 44556777777777777642 35667
Q ss_pred cccccccccccccCCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCCccccccccccceee
Q 002349 330 LTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLD 409 (933)
Q Consensus 330 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 409 (933)
+++|+.|++++|++++.. .+..+++|+.|++++|++++.. .+..++.++.+.++.|.+++. ..+..+++++.|+
T Consensus 240 l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ 313 (384)
T d2omza2 240 LTNLTDLDLANNQISNLA--PLSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLT 313 (384)
T ss_dssp CTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEE
T ss_pred ccccchhccccCccCCCC--cccccccCCEeeccCcccCCCC--ccccccccccccccccccccc--cccchhcccCeEE
Confidence 777777777777776543 3667778888888888877543 366777788888888888753 3467778888888
Q ss_pred ccCCccCCCCCCCCCCccccccccccCcccccccccccccccccceEEccCCccccccchhhccccccceeeecCC
Q 002349 410 MSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYN 485 (933)
Q Consensus 410 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N 485 (933)
+++|++++.. .+..+++|++|++++|+|++ ++ .|.++++|++|+|++|+|++..| +.++++|+.|+|++|
T Consensus 314 ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 314 LYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp CCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred CCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 8888888643 37788888888888888885 33 58888888888888888887665 788888888888887
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=1.8e-28 Score=273.69 Aligned_cols=339 Identities=27% Similarity=0.387 Sum_probs=247.1
Q ss_pred cEEEEEcCCCCcCcccCCCCCCCCCccEEEccCCcccccCCCCccCCCCCceecccccccCCCCCcccccccchhhhhhc
Q 002349 69 TVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILK 148 (933)
Q Consensus 69 ~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~ 148 (933)
.++.|++++++++. + +.+..+++|++|+|++|+|++ +| .|+++++|++|+|++|.+.+.. .++.+++|+.|+++
T Consensus 45 ~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~-l~-~l~~L~~L~~L~L~~n~i~~i~--~l~~l~~L~~L~~~ 118 (384)
T d2omza2 45 QVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTD-IT-PLKNLTKLVDILMNNNQIADIT--PLANLTNLTGLTLF 118 (384)
T ss_dssp TCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECC
T ss_pred CCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCC-Cc-cccCCccccccccccccccccc--cccccccccccccc
Confidence 57899999999884 3 468899999999999999995 44 3999999999999999998543 38999999999999
Q ss_pred ccCccCCCCcccccCCCCceeeeecCCCCCCcccccccCCCCcEEeccCccccCccCcCCcCCCCCcEEccccccccCcC
Q 002349 149 NNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEI 228 (933)
Q Consensus 149 ~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 228 (933)
+|.+++..+ ......+..+....|.+....+..................+. .+...+.........|...
T Consensus 119 ~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~--- 188 (384)
T d2omza2 119 NNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLK-----PLANLTTLERLDISSNKVS--- 188 (384)
T ss_dssp SSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCG-----GGTTCTTCCEEECCSSCCC---
T ss_pred ccccccccc--ccccccccccccccccccccccccccccccccccccccchhh-----hhccccccccccccccccc---
Confidence 999986533 456678888889888887554444333333333333322222 2333444444444444332
Q ss_pred CCCccccccceEeccccccccccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCc
Q 002349 229 PFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTK 308 (933)
Q Consensus 229 p~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 308 (933)
....+..+++++.+++++|.+++..| +...++|++|++++|+++.. ..+..+++
T Consensus 189 ----------------------~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~ 242 (384)
T d2omza2 189 ----------------------DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTN 242 (384)
T ss_dssp ----------------------CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTT
T ss_pred ----------------------cccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccc
Confidence 22334556667777777777765543 34556777777777777642 35667777
Q ss_pred ceEeeeccccccccCCccccccccccccccccccCCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccceecCCc
Q 002349 309 LHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSL 388 (933)
Q Consensus 309 L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~ 388 (933)
|+.|++++|.+++.. .+..+++|+.|++++|++.+.. .+..++.++.+++++|++++ ...+..+++++.|++++
T Consensus 243 L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~ 316 (384)
T d2omza2 243 LTDLDLANNQISNLA--PLSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYF 316 (384)
T ss_dssp CSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCS
T ss_pred cchhccccCccCCCC--cccccccCCEeeccCcccCCCC--cccccccccccccccccccc--ccccchhcccCeEECCC
Confidence 888888888777543 3667778888888888877443 36677888888888888875 23577788888899998
Q ss_pred ccccCCCccccccccccceeeccCCccCCCCCCCCCCccccccccccCcccccccccccccccccceEEccCC
Q 002349 389 NNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHN 461 (933)
Q Consensus 389 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 461 (933)
|++++.. .+..+++|++|+|++|+|++ ++ .+.++++|++|++++|+|++..| +.++++|++|+|++|
T Consensus 317 n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 317 NNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp SCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred CCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 8888653 37788899999999999884 33 68889999999999999997765 888999999999988
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.95 E-value=8.2e-27 Score=251.38 Aligned_cols=249 Identities=22% Similarity=0.323 Sum_probs=180.5
Q ss_pred CCCCCCCccceEecCCCCcEEEEEcCCCCcCcccCCCCCCCCCccEEEccCCcccccCCCCccCCCCCceecccccccCC
Q 002349 51 PSSDYCVWRGITCDNVTFTVIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYG 130 (933)
Q Consensus 51 ~~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~ 130 (933)
|..+-|.|++|.|++ ++++ .+|+.+. +++++|+|++|+|+...+.+|.++++|++|++++|.+..
T Consensus 5 p~~c~c~~~~~~C~~------------~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~ 69 (305)
T d1xkua_ 5 PFRCQCHLRVVQCSD------------LGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69 (305)
T ss_dssp CTTCEEETTEEECTT------------SCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCC
T ss_pred CCCCEecCCEEEecC------------CCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccc
Confidence 455668888888864 3455 6676664 689999999999995444579999999999999999998
Q ss_pred CCCcccccccchhhhhhcccCccCCCCcccccCCCCceeeeecCCCCCCcccccccCCCCcEEeccCcccc--CccCcCC
Q 002349 131 DIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLT--GSIPQNI 208 (933)
Q Consensus 131 ~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~--~~~p~~l 208 (933)
..|..|.++++|++|++++|+++. +|..+ ...|+.|++++|.+.+..+..+.....+..++...|... ...+..+
T Consensus 70 i~~~~f~~l~~L~~L~l~~n~l~~-l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~ 146 (305)
T d1xkua_ 70 ISPGAFAPLVKLERLYLSKNQLKE-LPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAF 146 (305)
T ss_dssp BCTTTTTTCTTCCEEECCSSCCSB-CCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGG
T ss_pred cchhhhhCCCccCEecccCCccCc-Cccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCcccc
Confidence 778899999999999999999984 55543 468899999999999777777888888999999888544 3455678
Q ss_pred cCCCCCcEEccccccccCcCCCCccccccceEeccccccccccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEE
Q 002349 209 GNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKL 288 (933)
Q Consensus 209 ~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 288 (933)
..+++|+++++++|+++ .+|..+ ..++++|++++|..++..+..+..++.+++|++++|.+++..+..|.++++|++|
T Consensus 147 ~~l~~L~~l~l~~n~l~-~l~~~~-~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L 224 (305)
T d1xkua_ 147 QGMKKLSYIRIADTNIT-TIPQGL-PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLREL 224 (305)
T ss_dssp GGCTTCCEEECCSSCCC-SCCSSC-CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEE
T ss_pred ccccccCccccccCCcc-ccCccc-CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceee
Confidence 88899999999999887 344332 2356666666666665555556556666666666666655555555555555555
Q ss_pred EeeCCccCCCCCCccccCCcceEeeecccccc
Q 002349 289 YLHSNKLTGHIPPELGNMTKLHYLELNDNQLT 320 (933)
Q Consensus 289 ~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 320 (933)
+|++|+|+ .+|.+|..+++|++|+|++|+|+
T Consensus 225 ~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~ 255 (305)
T d1xkua_ 225 HLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS 255 (305)
T ss_dssp ECCSSCCS-SCCTTTTTCSSCCEEECCSSCCC
T ss_pred eccccccc-ccccccccccCCCEEECCCCccC
Confidence 55555555 33445555555555555555555
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.93 E-value=2.4e-25 Score=239.80 Aligned_cols=223 Identities=22% Similarity=0.275 Sum_probs=105.9
Q ss_pred CCceeeeecCCCCCCcccccccCCCCcEEeccCccccCccCcCCcCCCCCcEEccccccccCcCCCCccccccceEeccc
Q 002349 165 NLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIPFNIGFLQIATLSLQG 244 (933)
Q Consensus 165 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~ 244 (933)
++++|+|++|+|+...+..|.++++|++|++++|.+....|..|.++++|++|++++|+++ .+|... ...+..|.+.+
T Consensus 32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~-~l~~~~-~~~l~~L~~~~ 109 (305)
T d1xkua_ 32 DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM-PKTLQELRVHE 109 (305)
T ss_dssp TCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSC-CTTCCEEECCS
T ss_pred CCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccC-cCccch-hhhhhhhhccc
Confidence 4444444444444333334444455555555555555444455555555555555555554 222221 12344444444
Q ss_pred cccccccCccccccccccEEeccCCcCc--CCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcceEeeecccccccc
Q 002349 245 NQLTGKIPSVIGLMQALAVLDLSCNMLS--GPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGH 322 (933)
Q Consensus 245 n~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~ 322 (933)
|.+.+..+..+.....+..++...|... ...+..|..+++|+.+++++|.++. +|..+ +++|+.|+++
T Consensus 110 n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~-l~~~~--~~~L~~L~l~------- 179 (305)
T d1xkua_ 110 NEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGL--PPSLTELHLD------- 179 (305)
T ss_dssp SCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CCSSC--CTTCSEEECT-------
T ss_pred cchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccc-cCccc--CCccCEEECC-------
Confidence 4444444444444455555555555332 1223344444445555555444442 22221 2344444444
Q ss_pred CCccccccccccccccccccCCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCCccccccc
Q 002349 323 IPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRI 402 (933)
Q Consensus 323 ~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 402 (933)
+|.+.+..+..+.+++.+++|++++|.+.+..+..|.++++|++|+|++|+|+ .+|..+..+
T Consensus 180 -----------------~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l 241 (305)
T d1xkua_ 180 -----------------GNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADH 241 (305)
T ss_dssp -----------------TSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTC
T ss_pred -----------------CCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccc
Confidence 44444444444444445555555555555444555555555555555555555 334455555
Q ss_pred cccceeeccCCccCC
Q 002349 403 GNLDTLDMSNNKISG 417 (933)
Q Consensus 403 ~~L~~L~Ls~N~l~~ 417 (933)
++|++|+|++|+|+.
T Consensus 242 ~~L~~L~Ls~N~i~~ 256 (305)
T d1xkua_ 242 KYIQVVYLHNNNISA 256 (305)
T ss_dssp SSCCEEECCSSCCCC
T ss_pred cCCCEEECCCCccCc
Confidence 555555555555553
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=2.3e-25 Score=237.10 Aligned_cols=205 Identities=23% Similarity=0.266 Sum_probs=89.7
Q ss_pred cccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcceEeee-ccccccccCCcccccccccccccc
Q 002349 260 ALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLEL-NDNQLTGHIPPALGKLTDLFDLNV 338 (933)
Q Consensus 260 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L-~~N~l~~~~~~~l~~l~~L~~L~L 338 (933)
++++|+|++|+|+...+..|.++++|++|++++|++....+..+..++.+..++. ..|.++...+..|.++++|++|++
T Consensus 33 ~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l 112 (284)
T d1ozna_ 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL 112 (284)
T ss_dssp TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEec
Confidence 3444444444444333344444444444444444444444444444444444433 233333333444444444444444
Q ss_pred ccccCCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCCccccccccccceeeccCCccCCC
Q 002349 339 ANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGS 418 (933)
Q Consensus 339 ~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 418 (933)
++|.+....+..+....+|+.+++++|+++++.+..|..+++|+.|++++|++++..+..|.++++|+.+++++|++++.
T Consensus 113 ~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i 192 (284)
T d1ozna_ 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192 (284)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEE
T ss_pred CCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhcccccc
Confidence 44444433333444444444444444444433334444444444444444444443344444444444444444444444
Q ss_pred CCCCCCCccccccccccCcccccccccccccccccceEEccCCccc
Q 002349 419 IPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLT 464 (933)
Q Consensus 419 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 464 (933)
.|..|..+++|++|++++|++++..|..|.++++|++|+|++|++.
T Consensus 193 ~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~ 238 (284)
T d1ozna_ 193 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238 (284)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEE
T ss_pred ChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCC
Confidence 4444444444444444444444444444444444444444444444
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1.6e-25 Score=238.40 Aligned_cols=249 Identities=24% Similarity=0.266 Sum_probs=195.8
Q ss_pred cceEeccccccccccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEee-CCccCCCCCCccccCCcceEeeec
Q 002349 237 IATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLH-SNKLTGHIPPELGNMTKLHYLELN 315 (933)
Q Consensus 237 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~-~N~l~~~~p~~l~~l~~L~~L~L~ 315 (933)
+++|+|++|+|+...+..|..+++|++|++++|++.+..+..+.++..++.+... .|.++...+..|.++++|++|+++
T Consensus 34 ~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~ 113 (284)
T d1ozna_ 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLD 113 (284)
T ss_dssp CSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECT
T ss_pred CCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEecC
Confidence 4555555555555555677888888888888888888888888888888888764 567777778888888889999999
Q ss_pred cccccccCCccccccccccccccccccCCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCC
Q 002349 316 DNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPI 395 (933)
Q Consensus 316 ~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 395 (933)
+|.+....+..+....+|+.+++++|++++..+..|..+++|+.|++++|++++..+..|.++++|+++++++|++++..
T Consensus 114 ~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~ 193 (284)
T d1ozna_ 114 RCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVH 193 (284)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred CcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccC
Confidence 98888777777888888899999999988777778888888999999999998888888888999999999999998888
Q ss_pred ccccccccccceeeccCCccCCCCCCCCCCccccccccccCcccccccccccccccccceEEccCCccccccchhhcccc
Q 002349 396 PVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQ 475 (933)
Q Consensus 396 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 475 (933)
|..|..+++|++||+++|++.+..+..|..+++|++|+|++|.+.+.-+. -.-...++.+....++++...|..+++.
T Consensus 194 ~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~-~~l~~~l~~~~~~~~~~~C~~p~~l~g~- 271 (284)
T d1ozna_ 194 PHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRLAGR- 271 (284)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG-HHHHHHHHHCCSEECCCBEEESGGGTTC-
T ss_pred hhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccc-hHHHHHHHhCcCCCCceEeCCchHHcCC-
Confidence 88899999999999999999888888888899999999999988864331 1122346677777788887777776542
Q ss_pred ccceeeecCCCCcC
Q 002349 476 NMFSLRLDYNNLSG 489 (933)
Q Consensus 476 ~L~~L~l~~N~l~~ 489 (933)
...+++.|.|+|
T Consensus 272 --~l~~l~~~~l~g 283 (284)
T d1ozna_ 272 --DLKRLAANDLQG 283 (284)
T ss_dssp --BGGGSCGGGSCC
T ss_pred --ccccCCHHHCCC
Confidence 334455555543
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=2.2e-24 Score=226.93 Aligned_cols=201 Identities=24% Similarity=0.288 Sum_probs=162.9
Q ss_pred CCCCCccEEEeeCCccCCCCCCccccCCcceEeeeccccccccCCccccccccccccccccccCCCCCCCCcccCCCCCc
Q 002349 280 GNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNS 359 (933)
Q Consensus 280 ~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 359 (933)
.+...+.+++.+++.++ .+|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|+|+. ++ .++.+++|++
T Consensus 7 ~~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~ 81 (266)
T d1p9ag_ 7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGT 81 (266)
T ss_dssp ECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCE
T ss_pred cccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cc-cccccccccc
Confidence 34566777899999998 5677664 578999999999997777788999999999999999874 33 3567888999
Q ss_pred eeccCcccCCCCCcccccccccceecCCcccccCCCccccccccccceeeccCCccCCCCCCCCCCccccccccccCccc
Q 002349 360 LNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQL 439 (933)
Q Consensus 360 L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 439 (933)
|++++|++++ .+..+..+++|++|++++|.+....+..+..+.+++.|++++|.++...+..+..+++|+.|++++|+|
T Consensus 82 L~Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l 160 (266)
T d1p9ag_ 82 LDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL 160 (266)
T ss_dssp EECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred cccccccccc-cccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccc
Confidence 9999998884 566788888888888888888877777888888888888888888877777778888888888888888
Q ss_pred ccccccccccccccceEEccCCccccccchhhccccccceeeecCCCC
Q 002349 440 TGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNNL 487 (933)
Q Consensus 440 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l 487 (933)
++..+..|..+++|++|||++|+|+ .+|..+..+++|+.|+|++|+|
T Consensus 161 ~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~ 207 (266)
T d1p9ag_ 161 TELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207 (266)
T ss_dssp SCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCB
T ss_pred cccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCC
Confidence 8887788888888888888888888 6777777777777777665433
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=8.8e-24 Score=222.23 Aligned_cols=202 Identities=26% Similarity=0.229 Sum_probs=132.4
Q ss_pred ccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcceEeeeccccccccCCcccccccccccc
Q 002349 257 LMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDL 336 (933)
Q Consensus 257 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L 336 (933)
...++.++|.+++.|+ .+|+.+. +++++|+|++|+|++..+..|.++++|++|+|++|+|+.. + .++.+++|+.|
T Consensus 8 ~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L 82 (266)
T d1p9ag_ 8 KVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGTL 82 (266)
T ss_dssp CSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCEE
T ss_pred ccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-c-ccccccccccc
Confidence 3445555667766666 3454442 4566777777777655555666777777777777777632 2 34566677777
Q ss_pred ccccccCCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCCccccccccccceeeccCCccC
Q 002349 337 NVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKIS 416 (933)
Q Consensus 337 ~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 416 (933)
+|++|++. ..+..+..+++|+.|++++|++.+..+..+..+.++++|++++|.++...+..+..+++|+.|++++|+|+
T Consensus 83 ~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~ 161 (266)
T d1p9ag_ 83 DLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT 161 (266)
T ss_dssp ECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS
T ss_pred cccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccccccccc
Confidence 77777766 34556666677777777777776666666666677777777777776666666666677777777777777
Q ss_pred CCCCCCCCCccccccccccCcccccccccccccccccceEEccCCcccc
Q 002349 417 GSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTG 465 (933)
Q Consensus 417 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 465 (933)
+..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|.+..
T Consensus 162 ~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~C 209 (266)
T d1p9ag_ 162 ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (266)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred ccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCC
Confidence 666666667777777777777776 566666666777777777776653
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=1.4e-22 Score=201.40 Aligned_cols=164 Identities=14% Similarity=0.234 Sum_probs=121.5
Q ss_pred CcceeeecccceeEEEEEEcCCceEEEEEecccCc------------------hhHHHHHHHHHHHhcCCCCceeeeeeE
Q 002349 601 SEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYP------------------QCLKEFETELETVGSIKHRNLVSLQGY 662 (933)
Q Consensus 601 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~~~~~ 662 (933)
.++++||+|+||+||+|...+|+.||||+++.... .....+.+|+..+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 45789999999999999998899999998753211 012335678999999999999988766
Q ss_pred EecCCccEEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeeeccCCCCceEeCCCCCeEEe
Q 002349 663 SLSSSGNLLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDFEAHLT 742 (933)
Q Consensus 663 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~ 742 (933)
. ..+++|||++++.+.+ ++......++.|++.|++|||++ +|+||||||+|||++++ .++++
T Consensus 83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEEC
T ss_pred c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEE
Confidence 3 3479999998765433 33445678999999999999976 99999999999999965 58999
Q ss_pred ecccccccccCCCceeeeecccccccC------ccccccCCCCcchhhHHHHHHHH
Q 002349 743 DFGIAKSLCVSKSYTSTYIMGTIGYID------PEYARTSRLTEKSDVYSFGIVLL 792 (933)
Q Consensus 743 DfGla~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~~DvwSlGv~l~ 792 (933)
|||.|+........ .|.. .|.+ .+.|..++|+||..--+.
T Consensus 145 DFG~a~~~~~~~~~---------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 145 DFPQSVEVGEEGWR---------EILERDVRNIITYF-SRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CCTTCEETTSTTHH---------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHHH
T ss_pred ECCCcccCCCCCcH---------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHHh
Confidence 99999765322211 1111 1111 356788999999865443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.85 E-value=5.6e-20 Score=201.31 Aligned_cols=59 Identities=27% Similarity=0.392 Sum_probs=36.4
Q ss_pred ccccceeeccCCccCCCCCCCCCCccccccccccCcccccccccccccccccceEEccCCccccccch
Q 002349 402 IGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPE 469 (933)
Q Consensus 402 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 469 (933)
+++|++|+|++|+|+ .+|.. +++|+.|+|++|+|+ .+|.. +++|++|+|++|+|+ .+|.
T Consensus 283 ~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~ 341 (353)
T d1jl5a_ 283 PPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPD 341 (353)
T ss_dssp CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCC
T ss_pred CCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCc
Confidence 456777777777776 45543 356666777777776 34432 346677777777776 3444
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.83 E-value=1.6e-19 Score=197.53 Aligned_cols=311 Identities=27% Similarity=0.331 Sum_probs=173.0
Q ss_pred EEEEEcCCCCcCcccCCCCCCCCCccEEEccCCcccccCCCCccCCCCCceecccccccCCCCCcccccccchhhhhhcc
Q 002349 70 VIALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKN 149 (933)
Q Consensus 70 v~~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~ 149 (933)
+.+|||++++|+ .+|+. +++|++|+|++|+|+ .+|+.+ .+|+.|++++|+++ .++. + .+.|++|+|++
T Consensus 40 l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~-l--p~~L~~L~L~~ 107 (353)
T d1jl5a_ 40 AHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSD-L--PPLLEYLGVSN 107 (353)
T ss_dssp CSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCS-C--CTTCCEEECCS
T ss_pred CCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhh-h--ccccccccccc
Confidence 457889998887 46653 467888899999888 678654 46788888888887 3442 1 13588888888
Q ss_pred cCccCCCCcccccCCCCceeeeecCCCCCCcccccccCCCCcEEeccCccccCccCcCCcCCCCCcEEccccccccCcCC
Q 002349 150 NQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLDLSYNQLSGEIP 229 (933)
Q Consensus 150 n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p 229 (933)
|.++ .+|. ++.+++|++|++++|.+.... .....+..+++.++... .+..+..++.++.|++++|.+... +
T Consensus 108 n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~----~~~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~~~-~ 178 (353)
T d1jl5a_ 108 NQLE-KLPE-LQNSSFLKIIDVDNNSLKKLP----DLPPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKKL-P 178 (353)
T ss_dssp SCCS-SCCC-CTTCTTCCEEECCSSCCSCCC----CCCTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCSSC-C
T ss_pred cccc-cccc-hhhhccceeeccccccccccc----cccccccchhhcccccc--ccccccccccceeccccccccccc-c
Confidence 8887 4553 677888888888888876332 22455666776666554 234567777788888887776522 1
Q ss_pred CCccccccceEeccccccccccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcc
Q 002349 230 FNIGFLQIATLSLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKL 309 (933)
Q Consensus 230 ~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L 309 (933)
... .....+...++. +. .+ ..+..++.|+.+++++|.... ++. ...++
T Consensus 179 ~~~--~~~~~l~~~~~~------------------------~~-~~-~~~~~l~~L~~l~l~~n~~~~-~~~---~~~~l 226 (353)
T d1jl5a_ 179 DLP--LSLESIVAGNNI------------------------LE-EL-PELQNLPFLTTIYADNNLLKT-LPD---LPPSL 226 (353)
T ss_dssp CCC--TTCCEEECCSSC------------------------CS-SC-CCCTTCTTCCEEECCSSCCSS-CCS---CCTTC
T ss_pred ccc--cccccccccccc------------------------cc-cc-ccccccccccccccccccccc-ccc---ccccc
Confidence 111 112223333332 22 11 123344444555554444431 221 12334
Q ss_pred eEeeeccccccccCCccccccccccccccccccCCCCCCCCcccC-CCCCceeccCcccCCCCCcccccccccceecCCc
Q 002349 310 HYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSC-TNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSL 388 (933)
Q Consensus 310 ~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l-~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~ 388 (933)
..+.+.+|.+.. .+.. ...+..+++..+.+.+ +..+ ......++..|.+.+ ....+++|++|+|++
T Consensus 227 ~~~~~~~~~~~~-~~~~---~~~l~~~~~~~~~~~~-----l~~l~~~~~~~~~~~~~~~~----~~~~~~~L~~L~Ls~ 293 (353)
T d1jl5a_ 227 EALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSG-----LSELPPNLYYLNASSNEIRS----LCDLPPSLEELNVSN 293 (353)
T ss_dssp CEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSE-----ESCCCTTCCEEECCSSCCSE----ECCCCTTCCEEECCS
T ss_pred cccccccccccc-cccc---cccccccccccccccc-----cccccchhcccccccCcccc----ccccCCCCCEEECCC
Confidence 444444444442 1111 1223333333333221 1111 122334444444432 223346677777777
Q ss_pred ccccCCCccccccccccceeeccCCccCCCCCCCCCCccccccccccCcccccccccccccccccceEEc
Q 002349 389 NNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDL 458 (933)
Q Consensus 389 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 458 (933)
|+|+ .+|.. +++|+.|+|++|+|+ .+|.. +++|++|+|++|+|+ .+|... .+|+.|.+
T Consensus 294 N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~~~---~~L~~L~~ 351 (353)
T d1jl5a_ 294 NKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPDIP---ESVEDLRM 351 (353)
T ss_dssp SCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCCCC---TTCCEEEC
T ss_pred CccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCccc---cccCeeEC
Confidence 7776 34433 456777777777777 45543 346777888888877 455432 24555544
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.76 E-value=4e-19 Score=181.55 Aligned_cols=187 Identities=26% Similarity=0.455 Sum_probs=105.7
Q ss_pred CCCCccEEEeeCCccCCCCCCccccCCcceEeeeccccccccCCccccccccccccccccccCCCCCCCCcccCCCCCce
Q 002349 281 NLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSL 360 (933)
Q Consensus 281 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 360 (933)
.+.+|+.|++.+|.|+. + +.+..+++|++|++++|++++..| +..+++|+.+++++|.++. + ..+.++++|+.+
T Consensus 39 ~l~~L~~L~l~~~~i~~-l-~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~-i-~~l~~l~~L~~l 112 (227)
T d1h6ua2 39 DLDGITTLSAFGTGVTT-I-EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-V-SAIAGLQSIKTL 112 (227)
T ss_dssp HHHTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-C-GGGTTCTTCCEE
T ss_pred HcCCcCEEECCCCCCCc-c-hhHhcCCCCcEeecCCceeecccc--ccccccccccccccccccc-c-cccccccccccc
Confidence 33444444444444442 1 224444444444444444443221 4444455555555554442 1 134455555566
Q ss_pred eccCcccCCCCCcccccccccceecCCcccccCCCccccccccccceeeccCCccCCCCCCCCCCccccccccccCcccc
Q 002349 361 NVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLT 440 (933)
Q Consensus 361 ~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 440 (933)
++++|...+. ..+...+.+..+.++.+.+... ..+...++|+.|++++|.+.+. ..+.++++|+.|+|++|+++
T Consensus 113 ~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l~ 186 (227)
T d1h6ua2 113 DLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKIS 186 (227)
T ss_dssp ECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCC
T ss_pred cccccccccc--chhccccchhhhhchhhhhchh--hhhccccccccccccccccccc--hhhcccccceecccCCCccC
Confidence 6655555432 2344555666666666666533 2355566777777777776532 23667777777777777777
Q ss_pred cccccccccccccceEEccCCccccccchhhccccccceeeec
Q 002349 441 GFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLD 483 (933)
Q Consensus 441 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 483 (933)
+. + .+.++++|++|+|++|++++..| +.++++|+.|+++
T Consensus 187 ~l-~-~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~ls 225 (227)
T d1h6ua2 187 DI-S-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225 (227)
T ss_dssp CC-G-GGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEE
T ss_pred CC-h-hhcCCCCCCEEECcCCcCCCCcc--cccCCCCCEEEee
Confidence 53 2 37777888888888888875433 7777888888776
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=1.9e-18 Score=178.39 Aligned_cols=215 Identities=14% Similarity=0.103 Sum_probs=148.2
Q ss_pred cCCCCcCcccCCCCCCCCCccEEEccCCcccccCCCCccCCCCCceecccccccCCCCC-cccccccchhhhhhcc-cCc
Q 002349 75 LSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIP-FSISKLKQLEFLILKN-NQL 152 (933)
Q Consensus 75 l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p-~~~~~l~~L~~L~L~~-n~l 152 (933)
.++.+++ .+|+.+. +++++|+|++|+|+...+..|.++++|++|+|++|.+...+| ..|.+++++++|++.. |.+
T Consensus 15 c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l 91 (242)
T d1xwdc1 15 CQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNL 91 (242)
T ss_dssp EESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTC
T ss_pred EeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccc
Confidence 3445666 6666553 578999999999985445578999999999999999876554 4578888888888764 677
Q ss_pred cCCCCcccccCCCCceeeeecCCCCCCccc-ccccCCCCcEEeccCccccCccCcCCcCCC-CCcEEccccccccCcCCC
Q 002349 153 IGPIPSTLSQLPNLKVFGLRGNNLVGTLSP-DMCQLSGLWYFDVRNNSLTGSIPQNIGNCT-SFQVLDLSYNQLSGEIPF 230 (933)
Q Consensus 153 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~-~L~~L~L~~N~l~~~~p~ 230 (933)
....+..|.++++|++|++++|++....+. .+..+..+..+...++.+....+..+..++ .++.|++++|+++
T Consensus 92 ~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~----- 166 (242)
T d1xwdc1 92 LYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ----- 166 (242)
T ss_dssp CEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-----
T ss_pred cccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccc-----
Confidence 777777788889999999988888643322 233455555556666666644444454443 4555555555554
Q ss_pred CccccccceEeccccccccccCccccccccc-cEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcc
Q 002349 231 NIGFLQIATLSLQGNQLTGKIPSVIGLMQAL-AVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKL 309 (933)
Q Consensus 231 ~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L-~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L 309 (933)
...+..+. ..++ +.+++++|+++...+..|.++++|++|+|++|+|+...+..|.++++|
T Consensus 167 ------------------~i~~~~~~-~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L 227 (242)
T d1xwdc1 167 ------------------EIHNCAFN-GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKL 227 (242)
T ss_dssp ------------------EECTTTTT-TCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEE
T ss_pred ------------------cccccccc-chhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCccc
Confidence 32222222 3333 344567777876666678888888888888888886656678888888
Q ss_pred eEeeecc
Q 002349 310 HYLELND 316 (933)
Q Consensus 310 ~~L~L~~ 316 (933)
+.|++.+
T Consensus 228 ~~l~~~~ 234 (242)
T d1xwdc1 228 RARSTYN 234 (242)
T ss_dssp ESSSEES
T ss_pred ccCcCCC
Confidence 8887754
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=1.4e-18 Score=177.36 Aligned_cols=202 Identities=23% Similarity=0.359 Sum_probs=150.1
Q ss_pred eccccccccccCccccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcceEeeecccccc
Q 002349 241 SLQGNQLTGKIPSVIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLT 320 (933)
Q Consensus 241 ~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 320 (933)
+++.+++++.. .+..+.+|+.|++.+|.++.. +.+..+++|++|++++|++++..| +..+++|+++++++|.++
T Consensus 25 ~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~ 98 (227)
T d1h6ua2 25 AAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK 98 (227)
T ss_dssp HTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS
T ss_pred HhCCCCcCCcC--CHHHcCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeecccc--cccccccccccccccccc
Confidence 34444444332 345667778888888877743 347778888888888888875433 777888888888888877
Q ss_pred ccCCccccccccccccccccccCCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCCccccc
Q 002349 321 GHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELS 400 (933)
Q Consensus 321 ~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 400 (933)
.. ..+..+++|+.++++++...+. ..+...+.++.+.++++.+... ..+...++|++|++++|.+.+.. .+.
T Consensus 99 ~i--~~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~--~l~ 170 (227)
T d1h6ua2 99 NV--SAIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLT--PLA 170 (227)
T ss_dssp CC--GGGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCCG--GGT
T ss_pred cc--cccccccccccccccccccccc--chhccccchhhhhchhhhhchh--hhhccccccccccccccccccch--hhc
Confidence 32 3567788888888888877643 2356677888888888887643 34677888999999999887543 378
Q ss_pred cccccceeeccCCccCCCCCCCCCCccccccccccCcccccccccccccccccceEEccC
Q 002349 401 RIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSH 460 (933)
Q Consensus 401 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 460 (933)
++++|+.|+|++|++++. + .+.++++|++|+|++|+|+++.| +.++++|+.|++++
T Consensus 171 ~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 171 NLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226 (227)
T ss_dssp TCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEE
T ss_pred ccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCCcc--cccCCCCCEEEeeC
Confidence 889999999999999853 3 48889999999999999996543 88999999999974
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=2.3e-18 Score=177.70 Aligned_cols=200 Identities=15% Similarity=0.112 Sum_probs=105.9
Q ss_pred CccEEEeeCCccCCCCCCccccCCcceEeeeccccccccC-Ccccccccccccccccc-ccCCCCCCCCcccCCCCCcee
Q 002349 284 YTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHI-PPALGKLTDLFDLNVAN-NHLEGPIPDNLSSCTNLNSLN 361 (933)
Q Consensus 284 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~-~~~l~~l~~L~~L~L~~-N~l~~~~p~~l~~l~~L~~L~ 361 (933)
++++|+|++|+|+...+..|.++++|++|++++|.+...+ +..|..+++++++.+.. |++....+..|.++++|++++
T Consensus 30 ~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~ 109 (242)
T d1xwdc1 30 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL 109 (242)
T ss_dssp CCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEE
T ss_pred CCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccc
Confidence 3444555555544333334444555555555555444322 22344445555544432 344444444455555555555
Q ss_pred ccCcccCCCCCc-ccccccccceecCCcccccCCCcccccccc-ccceeeccCCccCCCCCCCCCCcccc-ccccccCcc
Q 002349 362 VHGNKLNGTIPP-AFQRLESMTYLNLSLNNIRGPIPVELSRIG-NLDTLDMSNNKISGSIPSPLGDLEHL-LKLNLSRNQ 438 (933)
Q Consensus 362 l~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L-~~L~Ls~N~ 438 (933)
+++|++....+. .+..+..+..+..+++.+....+..|..++ .++.|++++|+++...+..+. ..++ +.+++++|+
T Consensus 110 l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~-~~~l~~~~~l~~n~ 188 (242)
T d1xwdc1 110 ISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFN-GTQLDELNLSDNNN 188 (242)
T ss_dssp EESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTTT-TCCEEEEECTTCTT
T ss_pred cchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccccccccccc-chhhhccccccccc
Confidence 555555432221 223344444445555555544444454443 566677777777643333333 3333 344566677
Q ss_pred cccccccccccccccceEEccCCccccccchhhccccccceeeecC
Q 002349 439 LTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDY 484 (933)
Q Consensus 439 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 484 (933)
|+...+..|.++++|++|+|++|+|+...+..|.++++|+.+++.+
T Consensus 189 l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~ 234 (242)
T d1xwdc1 189 LEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN 234 (242)
T ss_dssp CCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEES
T ss_pred cccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCCC
Confidence 7755555677777777777777777765566677777777766643
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=5e-22 Score=226.14 Aligned_cols=376 Identities=20% Similarity=0.154 Sum_probs=202.0
Q ss_pred CccEEEccCCccccc-CCCCccCCCCCceecccccccCC----CCCcccccccchhhhhhcccCccCC----CCcccc-c
Q 002349 93 DLQSIDLRGNRLSGQ-IPDEIGDCSSLKSLDLSFNELYG----DIPFSISKLKQLEFLILKNNQLIGP----IPSTLS-Q 162 (933)
Q Consensus 93 ~L~~L~Ls~n~l~~~-~p~~l~~l~~L~~L~Ls~n~l~~----~~p~~~~~l~~L~~L~L~~n~l~~~----~p~~l~-~ 162 (933)
+|++||+++|++++. +.+-+..+++|+.|+|++|.++. .++..+..+++|++|||++|.++.. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 577888888888752 22335667788888888887762 2333455666677777777766421 111121 1
Q ss_pred CCCCceeeeecCCCCCC----cccccccCCCCcEEeccCccccCccCcCCc-----CCCCCcEEccccccccCcCCCCcc
Q 002349 163 LPNLKVFGLRGNNLVGT----LSPDMCQLSGLWYFDVRNNSLTGSIPQNIG-----NCTSFQVLDLSYNQLSGEIPFNIG 233 (933)
Q Consensus 163 l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~-----~l~~L~~L~L~~N~l~~~~p~~~~ 233 (933)
..+|++|+|++|++++. ++..+..+++|++|++++|.++......+. .......
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~----------------- 145 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEK----------------- 145 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCE-----------------
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhccccccccccc-----------------
Confidence 23566666666666532 223344555555666555555421111110 0001111
Q ss_pred ccccceEecccccccc----ccCccccccccccEEeccCCcCcCCC----CCCC-CCCCCccEEEeeCCccCCC----CC
Q 002349 234 FLQIATLSLQGNQLTG----KIPSVIGLMQALAVLDLSCNMLSGPI----PPIL-GNLSYTEKLYLHSNKLTGH----IP 300 (933)
Q Consensus 234 ~~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~----~~~~-~~l~~L~~L~L~~N~l~~~----~p 300 (933)
.......+.. .....+.....++.++++++...... ...+ ........+++..+.+... ..
T Consensus 146 ------~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~ 219 (460)
T d1z7xw1 146 ------LQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLC 219 (460)
T ss_dssp ------EECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHH
T ss_pred ------ccccccccchhhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhccc
Confidence 1111111110 01111233445556666655443110 0000 1112344555555544321 11
Q ss_pred CccccCCcceEeeeccccccc-----cCCccccccccccccccccccCCCC----CCCCcccCCCCCceeccCcccCCCC
Q 002349 301 PELGNMTKLHYLELNDNQLTG-----HIPPALGKLTDLFDLNVANNHLEGP----IPDNLSSCTNLNSLNVHGNKLNGTI 371 (933)
Q Consensus 301 ~~l~~l~~L~~L~L~~N~l~~-----~~~~~l~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~l~~N~l~~~~ 371 (933)
..+...+.++.+++++|.+.. ...........++.+++++|.+... ....+...+.++.+++++|.++...
T Consensus 220 ~~l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~ 299 (460)
T d1z7xw1 220 GIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEG 299 (460)
T ss_dssp HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHH
T ss_pred ccccccccccccchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 123345667777777776542 1222333455677777777766532 1123345667777778777765322
Q ss_pred Cccc-----ccccccceecCCcccccCCCcccc----ccccccceeeccCCccCCC----CCCCCC-CccccccccccCc
Q 002349 372 PPAF-----QRLESMTYLNLSLNNIRGPIPVEL----SRIGNLDTLDMSNNKISGS----IPSPLG-DLEHLLKLNLSRN 437 (933)
Q Consensus 372 ~~~~-----~~l~~L~~L~L~~N~l~~~~~~~~----~~l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~Ls~N 437 (933)
...+ .....|+.+++++|.++......+ ...++|++|+|++|+|++. ++..+. ..+.|++|+|++|
T Consensus 300 ~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n 379 (460)
T d1z7xw1 300 ARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADC 379 (460)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred cchhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCC
Confidence 2211 123568888888888775433333 3456788888888888642 222232 3566888999999
Q ss_pred ccccc----cccccccccccceEEccCCccccccchhhc-----cccccceeeecCCCCcCcc
Q 002349 438 QLTGF----IPGEFGNLRSVMEIDLSHNHLTGVIPEELS-----QLQNMFSLRLDYNNLSGDV 491 (933)
Q Consensus 438 ~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~l~~N~l~~~~ 491 (933)
.|+.. +...+..+++|++|||++|+|+......+. +..+|+.|++++|.+....
T Consensus 380 ~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~~ 442 (460)
T d1z7xw1 380 DVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEM 442 (460)
T ss_dssp CCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHH
T ss_pred CCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHHH
Confidence 88743 445566778899999999988864444332 2346888999988887543
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.74 E-value=1.2e-18 Score=172.67 Aligned_cols=90 Identities=29% Similarity=0.462 Sum_probs=38.7
Q ss_pred cccccccceecCCcccccCCCccccccccccceeeccCCccCCCCCCCCCCccccccccccCcccccccccccccccccc
Q 002349 375 FQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVM 454 (933)
Q Consensus 375 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 454 (933)
|.++++|+.|+|++|.+....+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|+++.|..|.++++|+
T Consensus 50 f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~ 129 (192)
T d1w8aa_ 50 FGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLT 129 (192)
T ss_dssp GGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCC
T ss_pred cCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccc
Confidence 33344444444444444433334444444444444444444433344444444444444444444444444444444444
Q ss_pred eEEccCCccc
Q 002349 455 EIDLSHNHLT 464 (933)
Q Consensus 455 ~L~Ls~N~l~ 464 (933)
+|+|++|.+.
T Consensus 130 ~l~L~~N~~~ 139 (192)
T d1w8aa_ 130 SLNLASNPFN 139 (192)
T ss_dssp EEECTTCCBC
T ss_pred cccccccccc
Confidence 4444444444
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.74 E-value=4.1e-22 Score=226.89 Aligned_cols=384 Identities=20% Similarity=0.181 Sum_probs=221.1
Q ss_pred cEEEEEcCCCCcCcc-cCCCCCCCCCccEEEccCCcccc----cCCCCccCCCCCceecccccccCCC----CCcccc-c
Q 002349 69 TVIALNLSGLNLDGE-ISPAVGDLKDLQSIDLRGNRLSG----QIPDEIGDCSSLKSLDLSFNELYGD----IPFSIS-K 138 (933)
Q Consensus 69 ~v~~l~l~~~~l~~~-~~~~l~~l~~L~~L~Ls~n~l~~----~~p~~l~~l~~L~~L~Ls~n~l~~~----~p~~~~-~ 138 (933)
.+.+||++++++++. +...+..++++++|+|++|+|+. .++..+..+++|++|||++|.|+.. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 688999999999873 23445678899999999999873 4556678999999999999998632 122222 2
Q ss_pred ccchhhhhhcccCccCC----CCcccccCCCCceeeeecCCCCCCcccccc-----cCCCCcEEeccCccccCc----cC
Q 002349 139 LKQLEFLILKNNQLIGP----IPSTLSQLPNLKVFGLRGNNLVGTLSPDMC-----QLSGLWYFDVRNNSLTGS----IP 205 (933)
Q Consensus 139 l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~-----~l~~L~~L~L~~n~l~~~----~p 205 (933)
..+|++|+|++|++++. ++..+..+++|++|+|++|.++......+. ..............+... .-
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA 162 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhcccc
Confidence 35799999999999754 456678899999999999998743222221 122334444444333211 11
Q ss_pred cCCcCCCCCcEEccccccccCcCC----CCc--cccccceEeccccccccc----cCccccccccccEEeccCCcCcC--
Q 002349 206 QNIGNCTSFQVLDLSYNQLSGEIP----FNI--GFLQIATLSLQGNQLTGK----IPSVIGLMQALAVLDLSCNMLSG-- 273 (933)
Q Consensus 206 ~~l~~l~~L~~L~L~~N~l~~~~p----~~~--~~~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~-- 273 (933)
..+.....++.++++++......- ..+ .......+.+..+.+... ....+...+.++.++++.|.+..
T Consensus 163 ~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~ 242 (460)
T d1z7xw1 163 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 242 (460)
T ss_dssp HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhccccccc
Confidence 223445677778877776532100 000 111344555555554321 11223345566666666665432
Q ss_pred ---CCCCCCCCCCCccEEEeeCCccCCCC----CCccccCCcceEeeeccccccccCCccccccccccccccccccCCCC
Q 002349 274 ---PIPPILGNLSYTEKLYLHSNKLTGHI----PPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGP 346 (933)
Q Consensus 274 ---~~~~~~~~l~~L~~L~L~~N~l~~~~----p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~ 346 (933)
.....+.....++.|++++|.+.... ...+...+.++.+++++|.++......+..
T Consensus 243 ~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~----------------- 305 (460)
T d1z7xw1 243 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCE----------------- 305 (460)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHH-----------------
T ss_pred cchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhc-----------------
Confidence 11222333445566666666554211 112333455555555555554221111100
Q ss_pred CCCCcccCCCCCceeccCcccCCCCCc----ccccccccceecCCcccccCCC----ccccc-cccccceeeccCCccCC
Q 002349 347 IPDNLSSCTNLNSLNVHGNKLNGTIPP----AFQRLESMTYLNLSLNNIRGPI----PVELS-RIGNLDTLDMSNNKISG 417 (933)
Q Consensus 347 ~p~~l~~l~~L~~L~l~~N~l~~~~~~----~~~~l~~L~~L~L~~N~l~~~~----~~~~~-~l~~L~~L~Ls~N~l~~ 417 (933)
........|+.+++++|.++..... .+...++|++|+|++|++++.. +..+. ..+.|++|+|++|.|+.
T Consensus 306 --~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~ 383 (460)
T d1z7xw1 306 --TLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSD 383 (460)
T ss_dssp --HHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCH
T ss_pred --cccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCCh
Confidence 0001223566666666665533222 2334456777777777775422 22222 34568888888888764
Q ss_pred C----CCCCCCCccccccccccCccccccccccc----c-cccccceEEccCCccccccchhh
Q 002349 418 S----IPSPLGDLEHLLKLNLSRNQLTGFIPGEF----G-NLRSVMEIDLSHNHLTGVIPEEL 471 (933)
Q Consensus 418 ~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~----~-~l~~L~~L~Ls~N~l~~~~p~~~ 471 (933)
. ++..+..+++|++|+|++|+|+......| . +...|+.|++++|++.......+
T Consensus 384 ~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~~~~~l 446 (460)
T d1z7xw1 384 SSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRL 446 (460)
T ss_dssp HHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHHHHH
T ss_pred HHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHHHHHHH
Confidence 2 33345556788888888888875433332 2 33469999999999886555544
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.73 E-value=2.9e-18 Score=169.95 Aligned_cols=177 Identities=19% Similarity=0.223 Sum_probs=145.8
Q ss_pred ceEeeeccccccccCCccccccccccccccccccCCC-CCCCCcccCCCCCceeccCcccCCCCCcccccccccceecCC
Q 002349 309 LHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEG-PIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLS 387 (933)
Q Consensus 309 L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~ 387 (933)
.+.++.++++++ .+|..+. +++++|+|++|+|++ ..+..|.++++|+.|++++|++....+..|..+++|++|+|+
T Consensus 10 ~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls 86 (192)
T d1w8aa_ 10 GTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence 457899999999 6776653 689999999999976 446678899999999999999998888999999999999999
Q ss_pred cccccCCCccccccccccceeeccCCccCCCCCCCCCCccccccccccCcccccccccccccccccceEEccCCcccccc
Q 002349 388 LNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVI 467 (933)
Q Consensus 388 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 467 (933)
+|+|+...+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|.+....+..+ -...++.+.+..|.++...
T Consensus 87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~-~~~~l~~~~l~~~~~~c~~ 165 (192)
T d1w8aa_ 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW-FAEWLRKKSLNGGAARCGA 165 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHH-HHHHHHHHCCSGGGCBBCS
T ss_pred cccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHH-HhhhhhhhcccCCCeEeCC
Confidence 999998888889999999999999999998888899999999999999999985543222 2345677788888888777
Q ss_pred chhhccccccceeeecCCCCcCccc
Q 002349 468 PEELSQLQNMFSLRLDYNNLSGDVM 492 (933)
Q Consensus 468 p~~~~~l~~L~~L~l~~N~l~~~~~ 492 (933)
|..+ ..++.++|+.|.|.|..+
T Consensus 166 p~~l---~~~~l~~L~~n~l~C~~~ 187 (192)
T d1w8aa_ 166 PSKV---RDVQIKDLPHSEFKCSSE 187 (192)
T ss_dssp STTT---TTSBGGGSCTTTCCCCCC
T ss_pred Chhh---cCCEeeecCHhhCcCCCC
Confidence 7654 445567788888877654
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=1.3e-17 Score=167.57 Aligned_cols=80 Identities=20% Similarity=0.366 Sum_probs=36.1
Q ss_pred ccchhhhhhcccCccCCCCcccccCCCCceeeeecCCCCCCcccccccCCCCcEEeccCccccCccCcCCcCCCCCcEEc
Q 002349 139 LKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSGLWYFDVRNNSLTGSIPQNIGNCTSFQVLD 218 (933)
Q Consensus 139 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ 218 (933)
+.+|++|++++|.+++. + .+..+++|++|+|++|++++.. .++.+++|++|++++|++++ +| .+.++++|+.|+
T Consensus 45 L~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~ 118 (210)
T d1h6ta2 45 LNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLS 118 (210)
T ss_dssp HHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEE
T ss_pred hcCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccccc-cc-cccccccccccc
Confidence 34444444444444432 1 2444455555555555444321 23444455555555554442 22 244455555555
Q ss_pred cccccc
Q 002349 219 LSYNQL 224 (933)
Q Consensus 219 L~~N~l 224 (933)
+++|.+
T Consensus 119 l~~~~~ 124 (210)
T d1h6ta2 119 LEHNGI 124 (210)
T ss_dssp CTTSCC
T ss_pred cccccc
Confidence 555444
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.69 E-value=4.1e-17 Score=163.90 Aligned_cols=166 Identities=27% Similarity=0.392 Sum_probs=92.3
Q ss_pred ccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcceEeeeccccccccCCcccccccccccc
Q 002349 257 LMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDL 336 (933)
Q Consensus 257 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L 336 (933)
.+.+|+.|++++|.++... .+..+++|++|+|++|+|++.. .++.+++|++|++++|++++ ++ .+..+++|+.|
T Consensus 44 ~L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L 117 (210)
T d1h6ta2 44 ELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSL 117 (210)
T ss_dssp HHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEE
T ss_pred HhcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccccc-cc-ccccccccccc
Confidence 3556666666666665432 2555666666666666666432 24555666666666666553 22 24444455555
Q ss_pred ccccccCCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCCccccccccccceeeccCCccC
Q 002349 337 NVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKIS 416 (933)
Q Consensus 337 ~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 416 (933)
++++|.+ .. ...+..+++|+.+++++|.+++. ..+..+++|+.+++++|+++
T Consensus 118 ~l~~~~~------------------------~~--~~~l~~l~~l~~l~~~~n~l~~~--~~~~~l~~L~~l~l~~n~l~ 169 (210)
T d1h6ta2 118 SLEHNGI------------------------SD--INGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQIS 169 (210)
T ss_dssp ECTTSCC------------------------CC--CGGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCC
T ss_pred ccccccc------------------------cc--ccccccccccccccccccccccc--cccccccccccccccccccc
Confidence 5544444 31 12344455555555555555422 23445566666666666665
Q ss_pred CCCCCCCCCccccccccccCcccccccccccccccccceEEccC
Q 002349 417 GSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSH 460 (933)
Q Consensus 417 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 460 (933)
+. + .+.++++|+.|+|++|+|+. +| .|.++++|+.|+|++
T Consensus 170 ~i-~-~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 170 DI-V-PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp CC-G-GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred cc-c-cccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence 42 2 26666677777777777764 33 467777777777753
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.68 E-value=1.4e-17 Score=165.84 Aligned_cols=177 Identities=28% Similarity=0.425 Sum_probs=80.8
Q ss_pred EEeccCCcCcCCCCCCCCCCCCccEEEeeCCccCCCCCCccccCCcceEeeeccccccccCCcccccccccccccccccc
Q 002349 263 VLDLSCNMLSGPIPPILGNLSYTEKLYLHSNKLTGHIPPELGNMTKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNH 342 (933)
Q Consensus 263 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~ 342 (933)
.+.++.+.+++.+. ...+.++++|++++|.++.. +.+..+++|++|++++|++++..+ ++++++|+.|++++|.
T Consensus 22 ~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~ 95 (199)
T d2omxa2 22 KTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQ 95 (199)
T ss_dssp HHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred HHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCcccccccccccc
Confidence 34445554443321 22344555555555555421 234455555555555555553221 4455555555555554
Q ss_pred CCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCCccccccccccceeeccCCccCCCCCCC
Q 002349 343 LEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSP 422 (933)
Q Consensus 343 l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~ 422 (933)
+.. ++ .+.++++|+.|++++|.+... ..+..+++ |+.|++++|++.. + +.
T Consensus 96 ~~~-~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~------------------------L~~L~l~~n~l~~-~-~~ 145 (199)
T d2omxa2 96 IAD-IT-PLANLTNLTGLTLFNNQITDI--DPLKNLTN------------------------LNRLELSSNTISD-I-SA 145 (199)
T ss_dssp CCC-CG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTT------------------------CSEEECCSSCCCC-C-GG
T ss_pred ccc-cc-ccccccccccccccccccccc--cccchhhh------------------------hHHhhhhhhhhcc-c-cc
Confidence 442 11 244444455555544444421 12333444 4444444444431 1 12
Q ss_pred CCCccccccccccCcccccccccccccccccceEEccCCccccccchhhccccccce
Q 002349 423 LGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFS 479 (933)
Q Consensus 423 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 479 (933)
+..+++|+.|++++|++++.. .++++++|++|++++|++++. + .++.+++|+.
T Consensus 146 l~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i~~i-~-~l~~L~~L~~ 198 (199)
T d2omxa2 146 LSGLTSLQQLNFSSNQVTDLK--PLANLTTLERLDISSNKVSDI-S-VLAKLTNLES 198 (199)
T ss_dssp GTTCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCSE
T ss_pred ccccccccccccccccccCCc--cccCCCCCCEEECCCCCCCCC-c-cccCCCCCCc
Confidence 444444555555555554322 245555555555555555532 2 3455555544
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.68 E-value=5e-17 Score=161.82 Aligned_cols=178 Identities=24% Similarity=0.359 Sum_probs=137.8
Q ss_pred CcceEeeeccccccccCCccccccccccccccccccCCCCCCCCcccCCCCCceeccCcccCCCCCcccccccccceecC
Q 002349 307 TKLHYLELNDNQLTGHIPPALGKLTDLFDLNVANNHLEGPIPDNLSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNL 386 (933)
Q Consensus 307 ~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L 386 (933)
.++..+.++.+.+++.+. ...+.++++|++++|.+.. + +.+..+++|++|++++|++++..+ ++++++|++|++
T Consensus 18 ~~~i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l 91 (199)
T d2omxa2 18 AEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILM 91 (199)
T ss_dssp HHHHHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred HHHHHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccCccc--ccCCcccccccc
Confidence 344445566666665432 3456777788888887763 2 347788889999999998886433 888999999999
Q ss_pred CcccccCCCccccccccccceeeccCCccCCCCCCCCCCccccccccccCcccccccccccccccccceEEccCCccccc
Q 002349 387 SLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGV 466 (933)
Q Consensus 387 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 466 (933)
++|.+... + .+..+++|+.|++++|.+... ..+..+++|+.|++++|++.. ++ .+..+++|+.|++++|++++.
T Consensus 92 ~~n~~~~~-~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~~-~l~~~~~L~~L~l~~n~l~~l 165 (199)
T d2omxa2 92 NNNQIADI-T-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLNFSSNQVTDL 165 (199)
T ss_dssp CSSCCCCC-G-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCCC
T ss_pred cccccccc-c-ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhcc-cc-cccccccccccccccccccCC
Confidence 99988743 3 478899999999999998753 358889999999999999984 33 588999999999999999975
Q ss_pred cchhhccccccceeeecCCCCcCcccchhhccc
Q 002349 467 IPEELSQLQNMFSLRLDYNNLSGDVMSLINCLS 499 (933)
Q Consensus 467 ~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~ 499 (933)
. .+.++++|+.|++++|+++.. +.+..+..
T Consensus 166 ~--~l~~l~~L~~L~ls~N~i~~i-~~l~~L~~ 195 (199)
T d2omxa2 166 K--PLANLTTLERLDISSNKVSDI-SVLAKLTN 195 (199)
T ss_dssp G--GGTTCTTCCEEECCSSCCCCC-GGGGGCTT
T ss_pred c--cccCCCCCCEEECCCCCCCCC-ccccCCCC
Confidence 4 389999999999999999874 33444443
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.50 E-value=4.8e-15 Score=141.31 Aligned_cols=129 Identities=23% Similarity=0.303 Sum_probs=102.3
Q ss_pred CCCCCCCCccEEEccCCcccccCCCCccCCCCCceecccccccCCCCCcccccccchhhhhhcccCccCCCCcccccCCC
Q 002349 86 PAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPN 165 (933)
Q Consensus 86 ~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~ 165 (933)
+.+.+...+++|||++|+|+ .+|..+..+++|++||||+|.|+ .++ .|..+++|++|+|++|+++...+..+..+++
T Consensus 12 ~~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~ 88 (162)
T d1a9na_ 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPD 88 (162)
T ss_dssp CEEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred HhccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccc
Confidence 34667788999999999998 56776788899999999999988 454 5888899999999999998655555678899
Q ss_pred CceeeeecCCCCCCcc-cccccCCCCcEEeccCccccCccCc----CCcCCCCCcEEc
Q 002349 166 LKVFGLRGNNLVGTLS-PDMCQLSGLWYFDVRNNSLTGSIPQ----NIGNCTSFQVLD 218 (933)
Q Consensus 166 L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~p~----~l~~l~~L~~L~ 218 (933)
|++|+|++|++..... ..+..+++|++|++++|.++. .|. .+..+++|++||
T Consensus 89 L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~-~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 89 LTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp CCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEET
T ss_pred cccceeccccccccccccccccccccchhhcCCCcccc-ccchHHHHHHHCCCcCeeC
Confidence 9999999999875422 467788889999999988873 332 467788888887
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.48 E-value=7e-16 Score=162.54 Aligned_cols=223 Identities=20% Similarity=0.219 Sum_probs=100.2
Q ss_pred EEEcCCCCcCcccCCCCCCCCCccEEEccCCcccccCCCCccCCCCCceecccccccCCC-CCcccccccchhhhhhccc
Q 002349 72 ALNLSGLNLDGEISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGD-IPFSISKLKQLEFLILKNN 150 (933)
Q Consensus 72 ~l~l~~~~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~-~p~~~~~l~~L~~L~L~~n 150 (933)
.+||+++.+.+.....+.. ..+..+.++...+...+ .......+|++|||++|.+++. ++..+.++++|++|+|++|
T Consensus 4 ~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~-~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~ 81 (284)
T d2astb2 4 TLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPL-AEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGL 81 (284)
T ss_dssp EEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCC-CSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTC
T ss_pred EEECCCCCCCchHHHHHHh-ccceEeeccccccccch-hhhccCCCCCEEECCCCccCHHHHHHHHHhCCCccccccccc
Confidence 4566665554322211111 12334555544444222 2233445666666666665432 2223455555666666655
Q ss_pred CccCCCCcccccCCCCceeeeecC-CCCCCc-ccccccCCCCcEEeccCc-cccCc-cCcCCcC-CCCCcEEcccccccc
Q 002349 151 QLIGPIPSTLSQLPNLKVFGLRGN-NLVGTL-SPDMCQLSGLWYFDVRNN-SLTGS-IPQNIGN-CTSFQVLDLSYNQLS 225 (933)
Q Consensus 151 ~l~~~~p~~l~~l~~L~~L~L~~N-~l~~~~-~~~~~~l~~L~~L~L~~n-~l~~~-~p~~l~~-l~~L~~L~L~~N~l~ 225 (933)
.+++..+..++.+++|++|+|+++ .++... ..-+.++++|++|++++| .++.. +...+.. .++|+.|+++++.
T Consensus 82 ~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~-- 159 (284)
T d2astb2 82 RLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYR-- 159 (284)
T ss_dssp BCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCG--
T ss_pred CCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhcccc--
Confidence 555544555555555555555553 232111 111223444555555443 22210 1111111 1234444333221
Q ss_pred CcCCCCccccccceEecccccccc-ccCccccccccccEEeccCC-cCcCCCCCCCCCCCCccEEEeeC-CccCCCCCCc
Q 002349 226 GEIPFNIGFLQIATLSLQGNQLTG-KIPSVIGLMQALAVLDLSCN-MLSGPIPPILGNLSYTEKLYLHS-NKLTGHIPPE 302 (933)
Q Consensus 226 ~~~p~~~~~~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~ 302 (933)
+.++. .+...+..+++|++|++++| .+++.....+.++++|++|+|++ +.+++.....
T Consensus 160 -------------------~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~ 220 (284)
T d2astb2 160 -------------------KNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLE 220 (284)
T ss_dssp -------------------GGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGG
T ss_pred -------------------cccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHH
Confidence 11221 12222344566666666654 35555555555666666666665 3454444444
Q ss_pred cccCCcceEeeeccc
Q 002349 303 LGNMTKLHYLELNDN 317 (933)
Q Consensus 303 l~~l~~L~~L~L~~N 317 (933)
++++++|+.|+++++
T Consensus 221 L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 221 LGEIPTLKTLQVFGI 235 (284)
T ss_dssp GGGCTTCCEEECTTS
T ss_pred HhcCCCCCEEeeeCC
Confidence 555566666666554
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.48 E-value=2.3e-14 Score=129.79 Aligned_cols=102 Identities=25% Similarity=0.344 Sum_probs=69.3
Q ss_pred cEEEccCCcccccCCCCccCCCCCceecccccccCCCCCcccccccchhhhhhcccCccCCCCcccccCCCCceeeeecC
Q 002349 95 QSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQLPNLKVFGLRGN 174 (933)
Q Consensus 95 ~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N 174 (933)
|+|+|++|+++ .+| .++++++|++|||++|+|+ .+|..|+.+++|++|++++|++++ +| .++.+++|++|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 46777777777 444 4777777777777777776 566667777777777777777774 33 4677777777777777
Q ss_pred CCCCCc-ccccccCCCCcEEeccCcccc
Q 002349 175 NLVGTL-SPDMCQLSGLWYFDVRNNSLT 201 (933)
Q Consensus 175 ~l~~~~-~~~~~~l~~L~~L~L~~n~l~ 201 (933)
++++.. ...+..+++|++|++++|.++
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 776432 234566666666666666665
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.47 E-value=1.3e-14 Score=138.24 Aligned_cols=126 Identities=21% Similarity=0.190 Sum_probs=67.1
Q ss_pred cCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCCccccccccccceeeccCCccCCCCCCCCCCccccccc
Q 002349 353 SCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKL 432 (933)
Q Consensus 353 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 432 (933)
++.+|++|+|++|+|+. ++..+..+++|++|+|++|+|+.. ..+..+++|++|++++|+++...+..+..+++|+.|
T Consensus 16 n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L 92 (162)
T d1a9na_ 16 NAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTEL 92 (162)
T ss_dssp CTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEE
T ss_pred CcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCccccccccccccc
Confidence 34444455555555542 233444455555555555555422 234555555566666665554333334455666666
Q ss_pred cccCcccccccc-cccccccccceEEccCCcccccc---chhhccccccceee
Q 002349 433 NLSRNQLTGFIP-GEFGNLRSVMEIDLSHNHLTGVI---PEELSQLQNMFSLR 481 (933)
Q Consensus 433 ~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~---p~~~~~l~~L~~L~ 481 (933)
++++|+|+.... ..+..+++|++|++++|+++... +..+..+++|+.||
T Consensus 93 ~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 93 ILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp ECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred eeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 666666653321 34666677777777777665332 23456677777665
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.46 E-value=5.5e-14 Score=127.19 Aligned_cols=101 Identities=24% Similarity=0.353 Sum_probs=53.3
Q ss_pred ceeccCcccCCCCCcccccccccceecCCcccccCCCccccccccccceeeccCCccCCCCCCCCCCccccccccccCcc
Q 002349 359 SLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLLKLNLSRNQ 438 (933)
Q Consensus 359 ~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 438 (933)
.|++++|+++ .++ .+..+++|++|++++|+|+ .+|..+..+++|+.|++++|+|++ +| .+..+++|++|++++|+
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCc
Confidence 4555555555 222 2455555555555555555 334445555555555555555553 22 35555556666666665
Q ss_pred cccccc-cccccccccceEEccCCccc
Q 002349 439 LTGFIP-GEFGNLRSVMEIDLSHNHLT 464 (933)
Q Consensus 439 l~~~~p-~~~~~l~~L~~L~Ls~N~l~ 464 (933)
|+.... ..+..+++|+.|++++|+++
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 553321 34555666666666666655
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.43 E-value=2e-15 Score=158.95 Aligned_cols=64 Identities=23% Similarity=0.230 Sum_probs=32.3
Q ss_pred cccccccccEEeccCCcCcCCCCCCCCCCCCccEEEeeCC-ccCCC-CCCccccCCcceEeeeccc
Q 002349 254 VIGLMQALAVLDLSCNMLSGPIPPILGNLSYTEKLYLHSN-KLTGH-IPPELGNMTKLHYLELNDN 317 (933)
Q Consensus 254 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~-~p~~l~~l~~L~~L~L~~N 317 (933)
.+..+++|++|+|++|.+++..+..++.+++|++|+|+++ .++.. +..-+.++++|++|+++++
T Consensus 66 l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c 131 (284)
T d2astb2 66 ILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWC 131 (284)
T ss_dssp HHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCC
T ss_pred HHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccc
Confidence 3445556666666666655544455555556666666553 33311 1111234455555555553
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.42 E-value=8.5e-16 Score=167.14 Aligned_cols=139 Identities=18% Similarity=0.211 Sum_probs=93.9
Q ss_pred CCCCCceeccCcccCCCC----CcccccccccceecCCcccccCC-----CccccccccccceeeccCCccCCC----CC
Q 002349 354 CTNLNSLNVHGNKLNGTI----PPAFQRLESMTYLNLSLNNIRGP-----IPVELSRIGNLDTLDMSNNKISGS----IP 420 (933)
Q Consensus 354 l~~L~~L~l~~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~-----~~~~~~~l~~L~~L~Ls~N~l~~~----~p 420 (933)
.+.|+.+++++|++.... ...+...+.|+.|+|++|++... +...+...++|+.|+|++|.++.. +.
T Consensus 157 ~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~ 236 (344)
T d2ca6a1 157 APPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALA 236 (344)
T ss_dssp CCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHH
T ss_pred Ccccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccccccc
Confidence 456777777777765321 22345567788888888887632 233456677888888888887532 33
Q ss_pred CCCCCccccccccccCccccccccccc----cc--ccccceEEccCCcccccc----chhhc-cccccceeeecCCCCcC
Q 002349 421 SPLGDLEHLLKLNLSRNQLTGFIPGEF----GN--LRSVMEIDLSHNHLTGVI----PEELS-QLQNMFSLRLDYNNLSG 489 (933)
Q Consensus 421 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~----~~--l~~L~~L~Ls~N~l~~~~----p~~~~-~l~~L~~L~l~~N~l~~ 489 (933)
..+..+++|++|+|++|.|++.-...+ .. .+.|++||+++|+|+..- ...+. +.++|+.|+|++|++..
T Consensus 237 ~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 237 IALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp HHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred ccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 456677888899999998875433322 22 357899999999987532 33333 56789999999999976
Q ss_pred ccc
Q 002349 490 DVM 492 (933)
Q Consensus 490 ~~~ 492 (933)
...
T Consensus 317 ~~~ 319 (344)
T d2ca6a1 317 EDD 319 (344)
T ss_dssp TSH
T ss_pred cch
Confidence 543
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.39 E-value=2.1e-15 Score=164.00 Aligned_cols=94 Identities=20% Similarity=0.124 Sum_probs=47.9
Q ss_pred cCCCCccCCCCCceecccccccCCCCC----cccccccchhhhhhcccCccCC----------CCcccccCCCCceeeee
Q 002349 107 QIPDEIGDCSSLKSLDLSFNELYGDIP----FSISKLKQLEFLILKNNQLIGP----------IPSTLSQLPNLKVFGLR 172 (933)
Q Consensus 107 ~~p~~l~~l~~L~~L~Ls~n~l~~~~p----~~~~~l~~L~~L~L~~n~l~~~----------~p~~l~~l~~L~~L~L~ 172 (933)
.+...+.....|+.|+|++|.++.... ..+...++|+.|+++++..... +...+..+++|+.|+|+
T Consensus 22 ~l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~ 101 (344)
T d2ca6a1 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 101 (344)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccc
Confidence 344556677888888888887753222 2234456666666665543311 11123344555555555
Q ss_pred cCCCCCCc----ccccccCCCCcEEeccCccc
Q 002349 173 GNNLVGTL----SPDMCQLSGLWYFDVRNNSL 200 (933)
Q Consensus 173 ~N~l~~~~----~~~~~~l~~L~~L~L~~n~l 200 (933)
+|.+.... ...+...++|++|++++|.+
T Consensus 102 ~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l 133 (344)
T d2ca6a1 102 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGL 133 (344)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCC
T ss_pred ccccccccccchhhhhcccccchheecccccc
Confidence 55554321 11222344455555554444
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.37 E-value=5.8e-13 Score=125.71 Aligned_cols=107 Identities=21% Similarity=0.285 Sum_probs=48.8
Q ss_pred eeccCCccCCCCCCCCCCccccccccccCc-ccccccccccccccccceEEccCCccccccchhhccccccceeeecCCC
Q 002349 408 LDMSNNKISGSIPSPLGDLEHLLKLNLSRN-QLTGFIPGEFGNLRSVMEIDLSHNHLTGVIPEELSQLQNMFSLRLDYNN 486 (933)
Q Consensus 408 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~ 486 (933)
++.+++.+. ..|..+..+++|++|++++| .|+.+.+.+|.++++|+.|+|++|+|++..|..|..+++|++|+|++|+
T Consensus 13 l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~ 91 (156)
T d2ifga3 13 LRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA 91 (156)
T ss_dssp EECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSC
T ss_pred EEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCC
Confidence 444444443 33444444444444444433 2444444444444444444444444444444444444444444444444
Q ss_pred CcCcccchhhccccc-eeecCCCCCCCccc
Q 002349 487 LSGDVMSLINCLSLS-VLFIGNPGLCGYWL 515 (933)
Q Consensus 487 l~~~~~~~~~~~~~~-~~~~~N~~~C~~~l 515 (933)
|+..++.......+. +.+.+|||.|+|.+
T Consensus 92 l~~l~~~~~~~~~l~~L~L~~Np~~C~C~~ 121 (156)
T d2ifga3 92 LESLSWKTVQGLSLQELVLSGNPLHCSCAL 121 (156)
T ss_dssp CSCCCSTTTCSCCCCEEECCSSCCCCCGGG
T ss_pred CcccChhhhccccccccccCCCcccCCchH
Confidence 444444333322333 44555666666543
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.30 E-value=2.6e-14 Score=141.15 Aligned_cols=110 Identities=25% Similarity=0.301 Sum_probs=50.1
Q ss_pred cccCCCCCceeccCcccCCCCCcccccccccceecCCcccccCCCccccccccccceeeccCCccCCCCCCCCCCccccc
Q 002349 351 LSSCTNLNSLNVHGNKLNGTIPPAFQRLESMTYLNLSLNNIRGPIPVELSRIGNLDTLDMSNNKISGSIPSPLGDLEHLL 430 (933)
Q Consensus 351 l~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 430 (933)
+..+++|++|+|++|+|+. ++ .+..+++|++|+|++|.++ .++..+..+++|+.|++++|+|+.. ..+..+++|+
T Consensus 44 l~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~~L~ 118 (198)
T d1m9la_ 44 LSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKLVNLR 118 (198)
T ss_dssp HHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHHHHHSS
T ss_pred HhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-ccccccccccccccccccccccccc--cccccccccc
Confidence 4444444444444444442 22 2444444555555555444 2233333334455555555554421 1244445555
Q ss_pred cccccCcccccccc-cccccccccceEEccCCcccc
Q 002349 431 KLNLSRNQLTGFIP-GEFGNLRSVMEIDLSHNHLTG 465 (933)
Q Consensus 431 ~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~ 465 (933)
.|+|++|+|+.... ..+.++++|+.|+|++|+++.
T Consensus 119 ~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~ 154 (198)
T d1m9la_ 119 VLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp EEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHH
T ss_pred ccccccchhccccccccccCCCccceeecCCCcccc
Confidence 55555555543221 244555555555555555543
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.29 E-value=1.7e-14 Score=142.45 Aligned_cols=130 Identities=22% Similarity=0.281 Sum_probs=100.6
Q ss_pred cCCCCCCCCCccEEEccCCcccccCCCCccCCCCCceecccccccCCCCCcccccccchhhhhhcccCccCCCCcccccC
Q 002349 84 ISPAVGDLKDLQSIDLRGNRLSGQIPDEIGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGPIPSTLSQL 163 (933)
Q Consensus 84 ~~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l 163 (933)
++.++..+++|++|+|++|+|+ .++ .|.++++|++|+|++|.|+ .+|..+..+++|++|++++|+++. + +.+..+
T Consensus 40 l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~l 114 (198)
T d1m9la_ 40 MDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEKL 114 (198)
T ss_dssp CHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHHH
T ss_pred hhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-c-cccccc
Confidence 4456788899999999999998 455 5888999999999999987 677666667789999999999885 3 357888
Q ss_pred CCCceeeeecCCCCCCcc-cccccCCCCcEEeccCccccCccCcC----------CcCCCCCcEEc
Q 002349 164 PNLKVFGLRGNNLVGTLS-PDMCQLSGLWYFDVRNNSLTGSIPQN----------IGNCTSFQVLD 218 (933)
Q Consensus 164 ~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~n~l~~~~p~~----------l~~l~~L~~L~ 218 (933)
++|+.|+|++|+++.... ..+..+++|++|+|++|.+....+.. +..+++|+.||
T Consensus 115 ~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 115 VNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp HHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred ccccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence 889999999998875422 46788888888888888876544332 45677777776
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.24 E-value=6.6e-12 Score=118.32 Aligned_cols=106 Identities=20% Similarity=0.175 Sum_probs=65.9
Q ss_pred ecCCcccccCCCccccccccccceeeccCC-ccCCCCCCCCCCccccccccccCcccccccccccccccccceEEccCCc
Q 002349 384 LNLSLNNIRGPIPVELSRIGNLDTLDMSNN-KISGSIPSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNH 462 (933)
Q Consensus 384 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 462 (933)
++.+++.+. ..|..+..+++|++|++++| .|+...+..|.++++|+.|+|++|+|+.+.|.+|.++++|++|+|++|+
T Consensus 13 l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~ 91 (156)
T d2ifga3 13 LRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA 91 (156)
T ss_dssp EECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSC
T ss_pred EEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCC
Confidence 444444444 33444555556666666544 3655555566777777777777777776667777777777777777777
Q ss_pred cccccchhhccccccceeeecCCCCcCcc
Q 002349 463 LTGVIPEELSQLQNMFSLRLDYNNLSGDV 491 (933)
Q Consensus 463 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 491 (933)
|+...+..+.. .+|+.|+|++|+|.|..
T Consensus 92 l~~l~~~~~~~-~~l~~L~L~~Np~~C~C 119 (156)
T d2ifga3 92 LESLSWKTVQG-LSLQELVLSGNPLHCSC 119 (156)
T ss_dssp CSCCCSTTTCS-CCCCEEECCSSCCCCCG
T ss_pred CcccChhhhcc-ccccccccCCCcccCCc
Confidence 77444444443 35777777777776543
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.49 E-value=7.8e-09 Score=97.52 Aligned_cols=106 Identities=22% Similarity=0.168 Sum_probs=57.8
Q ss_pred ccCCCCCceecccccccCCCCCcccccccchhhhhhcccCccCC--CCcccccCCCCceeeeecCCCCCCcccccccCCC
Q 002349 112 IGDCSSLKSLDLSFNELYGDIPFSISKLKQLEFLILKNNQLIGP--IPSTLSQLPNLKVFGLRGNNLVGTLSPDMCQLSG 189 (933)
Q Consensus 112 l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~--~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 189 (933)
+..+..+..|+++.+... .++..+..+++|++|+|++|+++.. ++..+..+++|+.|+|++|+++...+-.+....+
T Consensus 38 l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~ 116 (162)
T d1koha1 38 LVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLK 116 (162)
T ss_dssp TTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCC
T ss_pred hhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccc
Confidence 344444445555444433 3333344566666666666666642 2234556666777777777766433323334445
Q ss_pred CcEEeccCccccCccCc-------CCcCCCCCcEEc
Q 002349 190 LWYFDVRNNSLTGSIPQ-------NIGNCTSFQVLD 218 (933)
Q Consensus 190 L~~L~L~~n~l~~~~p~-------~l~~l~~L~~L~ 218 (933)
|+.|++++|.+...... .+..+++|+.||
T Consensus 117 L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 117 LEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp CSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred cceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence 66667777766644332 245677777776
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.48 E-value=7.3e-09 Score=97.70 Aligned_cols=82 Identities=23% Similarity=0.179 Sum_probs=43.8
Q ss_pred ccccccceeeccCCccCCCC--CCCCCCccccccccccCcccccccccccccccccceEEccCCccccccc-------hh
Q 002349 400 SRIGNLDTLDMSNNKISGSI--PSPLGDLEHLLKLNLSRNQLTGFIPGEFGNLRSVMEIDLSHNHLTGVIP-------EE 470 (933)
Q Consensus 400 ~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-------~~ 470 (933)
..+++|++|+|++|+|+... +..+..+++|+.|+|++|+|+...+-.+.+..+|+.|++++|++++... ..
T Consensus 62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i 141 (162)
T d1koha1 62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAI 141 (162)
T ss_dssp HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHH
T ss_pred HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHH
Confidence 44555555555555555321 2334445566666666666664433333344456666666666664433 22
Q ss_pred hccccccceee
Q 002349 471 LSQLQNMFSLR 481 (933)
Q Consensus 471 ~~~l~~L~~L~ 481 (933)
+..+|+|+.||
T Consensus 142 ~~~~P~L~~LD 152 (162)
T d1koha1 142 RERFPKLLRLD 152 (162)
T ss_dssp HTTSTTCCEET
T ss_pred HHHCCCCCEEC
Confidence 45567777654
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.37 E-value=4.4e-07 Score=92.77 Aligned_cols=149 Identities=15% Similarity=0.077 Sum_probs=102.7
Q ss_pred HHHHHHhhccCcceeeecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCC-CCceeeeeeEEecCCcc
Q 002349 591 EDIMRMTENLSEKYIIGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIK-HRNLVSLQGYSLSSSGN 669 (933)
Q Consensus 591 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 669 (933)
.++....+.|+..+..+.++.+.||+... +++.+++|+...........+.+|+..++.+. +--+.+++++...++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 46677777887766655555578999864 44668888886654444556788888887764 33356778888888889
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhcCC--------------------------------
Q 002349 670 LLFYDFMENGSLWDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHHDC-------------------------------- 717 (933)
Q Consensus 670 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-------------------------------- 717 (933)
++||++++|.++.+.... ......++.++++.+..||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~~--------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEEECCSSEEHHHHTTT--------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred EEEEEecccccccccccc--------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence 999999999888665421 0112234455555555555310
Q ss_pred ------------------------CCCeeeccCCCCceEeCCCCCeEEeeccccc
Q 002349 718 ------------------------SPRIIHRDVKSSNILLDKDFEAHLTDFGIAK 748 (933)
Q Consensus 718 ------------------------~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 748 (933)
...++|+|+.|.||++++++.+-|+||+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1237899999999999987666799999875
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.78 E-value=3.7e-05 Score=77.49 Aligned_cols=130 Identities=15% Similarity=0.117 Sum_probs=85.4
Q ss_pred eeecccc-eeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCCC--CceeeeeeEEecCCccEEEEEecCCCCH
Q 002349 605 IIGYGAS-STVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKH--RNLVSLQGYSLSSSGNLLFYDFMENGSL 681 (933)
Q Consensus 605 ~lG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~gsL 681 (933)
.+..|.. +.||+...+++..+++|.-.... ...+.+|++.++.+.. -.+.+++++..+++..++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4555554 67899998888888999765443 2346677777776632 3356778888888888999999988655
Q ss_pred HHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHhhc----------------------------------------------
Q 002349 682 WDILHGPTKKKKLDWDTRLKIALGAAQGLAYLHH---------------------------------------------- 715 (933)
Q Consensus 682 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---------------------------------------------- 715 (933)
.+.- ... ...+.+++..+.-||+
T Consensus 94 ~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 3211 111 1112223333333331
Q ss_pred -----C----CCCCeeeccCCCCceEeCCCCCeEEeeccccc
Q 002349 716 -----D----CSPRIIHRDVKSSNILLDKDFEAHLTDFGIAK 748 (933)
Q Consensus 716 -----~----~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~ 748 (933)
. ....++|+|+.|.||+++++..+-|+||+.+.
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1 01347999999999999987667899999774
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.48 E-value=8.3e-06 Score=76.50 Aligned_cols=40 Identities=15% Similarity=0.330 Sum_probs=23.6
Q ss_pred CCCCccEEEccCC-ccccc----CCCCccCCCCCceecccccccC
Q 002349 90 DLKDLQSIDLRGN-RLSGQ----IPDEIGDCSSLKSLDLSFNELY 129 (933)
Q Consensus 90 ~l~~L~~L~Ls~n-~l~~~----~p~~l~~l~~L~~L~Ls~n~l~ 129 (933)
+.+.|++|+|+++ .++.. +-..+...+.|++|+|++|.+.
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~ 57 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAIS 57 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCB
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccc
Confidence 4566777777763 45421 2234555666777777777665
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.39 E-value=0.00021 Score=76.76 Aligned_cols=75 Identities=12% Similarity=0.083 Sum_probs=48.7
Q ss_pred eeeecccceeEEEEEEcC-CceEEEEEeccc-------CchhHHHHHHHHHHHhcCC-C--CceeeeeeEEecCCccEEE
Q 002349 604 YIIGYGASSTVYKCVLKN-CKPVAIKRLYSH-------YPQCLKEFETELETVGSIK-H--RNLVSLQGYSLSSSGNLLF 672 (933)
Q Consensus 604 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~~~~~lv 672 (933)
+.||.|....||++...+ ++.|+||.-... .+....+...|+++++.+. + ..+.+++.+ +++..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 468999999999998654 678999965321 1122344567888887662 2 345555554 45567899
Q ss_pred EEecCCCC
Q 002349 673 YDFMENGS 680 (933)
Q Consensus 673 ~e~~~~gs 680 (933)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997654
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.36 E-value=6.7e-06 Score=77.19 Aligned_cols=110 Identities=16% Similarity=0.206 Sum_probs=57.6
Q ss_pred cCCCCCceeccccc-ccCCC----CCcccccccchhhhhhcccCccCC----CCcccccCCCCceeeeecCCCCCCc---
Q 002349 113 GDCSSLKSLDLSFN-ELYGD----IPFSISKLKQLEFLILKNNQLIGP----IPSTLSQLPNLKVFGLRGNNLVGTL--- 180 (933)
Q Consensus 113 ~~l~~L~~L~Ls~n-~l~~~----~p~~~~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~--- 180 (933)
.+.++|++|+|+++ .++.. +-..+...+.|++|+|++|.+... +...+...+.|++|+|++|.++...
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence 34578888888864 45421 122344456677777777766532 2223445566677777766665321
Q ss_pred -ccccccCCCCcEEeccCccccCc-------cCcCCcCCCCCcEEccccc
Q 002349 181 -SPDMCQLSGLWYFDVRNNSLTGS-------IPQNIGNCTSFQVLDLSYN 222 (933)
Q Consensus 181 -~~~~~~l~~L~~L~L~~n~l~~~-------~p~~l~~l~~L~~L~L~~N 222 (933)
-..+...++|++|++++|.+... +...+...++|+.|+++.+
T Consensus 92 l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~ 141 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFA 141 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCC
T ss_pred HHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCC
Confidence 12334445566666665543311 2233334455555555443
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.73 E-value=5.2e-05 Score=70.80 Aligned_cols=42 Identities=10% Similarity=0.144 Sum_probs=26.7
Q ss_pred CCCCCCccEEEccC-Ccccc----cCCCCccCCCCCceecccccccC
Q 002349 88 VGDLKDLQSIDLRG-NRLSG----QIPDEIGDCSSLKSLDLSFNELY 129 (933)
Q Consensus 88 l~~l~~L~~L~Ls~-n~l~~----~~p~~l~~l~~L~~L~Ls~n~l~ 129 (933)
..+.+.|++|+|++ +.++. .+-..+...++|++|+|++|.++
T Consensus 13 ~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~ 59 (166)
T d1io0a_ 13 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSN 59 (166)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCC
T ss_pred HhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCccc
Confidence 34557777888876 45542 12334556777777777777765
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.72 E-value=0.0021 Score=66.68 Aligned_cols=135 Identities=11% Similarity=0.114 Sum_probs=77.6
Q ss_pred eeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCce--eeeee-----EEecCCccEEEEEecCCCCHH--
Q 002349 612 STVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRNL--VSLQG-----YSLSSSGNLLFYDFMENGSLW-- 682 (933)
Q Consensus 612 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~~~~-----~~~~~~~~~lv~e~~~~gsL~-- 682 (933)
-.||++...+|+.|++|+.+... ...+++..|.+.+..+....+ +..+. .+...+..+.++++++|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 47999999999999999986542 235667888888887743222 11111 223345578899999863321
Q ss_pred ---HH---------hc----CC--CCCCCCCHH----------------------HHHHHHHHHHHHHHHh-hcCCCCCe
Q 002349 683 ---DI---------LH----GP--TKKKKLDWD----------------------TRLKIALGAAQGLAYL-HHDCSPRI 721 (933)
Q Consensus 683 ---~~---------l~----~~--~~~~~l~~~----------------------~~~~i~~~i~~~l~~L-H~~~~~~i 721 (933)
.. +| .. ..+...++. .....+..+...+.-. .+....++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 00 01 00 011112211 1122223333333222 12224579
Q ss_pred eeccCCCCceEeCCCCCeEEeecccccc
Q 002349 722 IHRDVKSSNILLDKDFEAHLTDFGIAKS 749 (933)
Q Consensus 722 vH~Dikp~NIll~~~~~~kl~DfGla~~ 749 (933)
+|+|+.+.|||++++ ..++||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999754 46899998753
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.39 E-value=7.5e-05 Score=69.68 Aligned_cols=112 Identities=13% Similarity=0.177 Sum_probs=61.8
Q ss_pred ccCCCCCceecccc-cccCCC----CCcccccccchhhhhhcccCccCCC----CcccccCCCCceeeeecCCCCCC---
Q 002349 112 IGDCSSLKSLDLSF-NELYGD----IPFSISKLKQLEFLILKNNQLIGPI----PSTLSQLPNLKVFGLRGNNLVGT--- 179 (933)
Q Consensus 112 l~~l~~L~~L~Ls~-n~l~~~----~p~~~~~l~~L~~L~L~~n~l~~~~----p~~l~~l~~L~~L~L~~N~l~~~--- 179 (933)
..+.++|++|+|++ +.++.. +-..+...++|++|+|++|.++... -..+...+.|+.|++++|.+...
T Consensus 13 ~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~ 92 (166)
T d1io0a_ 13 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL 92 (166)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH
T ss_pred HhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHH
Confidence 45568888888887 456422 2223345667777777777765422 22344566777777777766532
Q ss_pred -cccccccCCCCcEEec--cCccccC----ccCcCCcCCCCCcEEcccccc
Q 002349 180 -LSPDMCQLSGLWYFDV--RNNSLTG----SIPQNIGNCTSFQVLDLSYNQ 223 (933)
Q Consensus 180 -~~~~~~~l~~L~~L~L--~~n~l~~----~~p~~l~~l~~L~~L~L~~N~ 223 (933)
+...+...++|+.++| ++|.+.. .+.+.+...+.|+.|+++.+.
T Consensus 93 ~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~ 143 (166)
T d1io0a_ 93 ALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ 143 (166)
T ss_dssp HHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred HHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCC
Confidence 1233445556655333 3455542 233334455566666655443
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.13 E-value=0.024 Score=58.01 Aligned_cols=158 Identities=15% Similarity=0.120 Sum_probs=84.5
Q ss_pred CHHHHHHHhhccCccee-----eecccceeEEEEEEcCCceEEEEEecccCchhHHHHHHHHHHHhcCCCCc-----eee
Q 002349 589 VYEDIMRMTENLSEKYI-----IGYGASSTVYKCVLKNCKPVAIKRLYSHYPQCLKEFETELETVGSIKHRN-----LVS 658 (933)
Q Consensus 589 ~~~~~~~~~~~~~~~~~-----lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-----iv~ 658 (933)
+.+++.....+|..++. |..|---+.|+....+| .+++|+..... ..+++..|++++..+...+ .+.
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccce
Confidence 45778888888877554 34566678899988776 48999886532 2345566677777664222 221
Q ss_pred eee---EEecCCccEEEEEecCCCCHHH--------------Hhc----CCC--CCCCCCH------------------H
Q 002349 659 LQG---YSLSSSGNLLFYDFMENGSLWD--------------ILH----GPT--KKKKLDW------------------D 697 (933)
Q Consensus 659 ~~~---~~~~~~~~~lv~e~~~~gsL~~--------------~l~----~~~--~~~~l~~------------------~ 697 (933)
..+ +.......+.++.+..+..... .++ ... ....... .
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence 111 1122344566677766533211 000 000 0000000 0
Q ss_pred HHHHHHHHHHHHHHHhhc-CCCCCeeeccCCCCceEeCCCCCeEEeecccccc
Q 002349 698 TRLKIALGAAQGLAYLHH-DCSPRIIHRDVKSSNILLDKDFEAHLTDFGIAKS 749 (933)
Q Consensus 698 ~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dikp~NIll~~~~~~kl~DfGla~~ 749 (933)
.....+......+...+. ....++||+|+.++||+++++...-|.||+.+..
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 111222222222333222 2256899999999999999887778999998753
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.52 E-value=0.013 Score=62.40 Aligned_cols=72 Identities=17% Similarity=0.228 Sum_probs=48.2
Q ss_pred eeeecccceeEEEEEEcCC--------ceEEEEEecccCchhHHHHHHHHHHHhcCCCCce-eeeeeEEecCCccEEEEE
Q 002349 604 YIIGYGASSTVYKCVLKNC--------KPVAIKRLYSHYPQCLKEFETELETVGSIKHRNL-VSLQGYSLSSSGNLLFYD 674 (933)
Q Consensus 604 ~~lG~G~~g~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e 674 (933)
+.|+.|-.-.+|++...++ +.|++++.- .. .......+|..+++.+.-.++ .++++++.+ .+|||
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 4688888999999987643 346665554 32 233456789999888853343 477777642 67999
Q ss_pred ecCCCCH
Q 002349 675 FMENGSL 681 (933)
Q Consensus 675 ~~~~gsL 681 (933)
|++|..+
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987543
|